PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kazi, S; Castaneda, JM; Savolainen, A; Xu, YD; Liu, N; Qiao, HY; Ramirez-Solis, R; Nozawa, K; Yu, ZF; Matzuk, MM; Prunskaite-Hyyrylainen, R				Kazi, Samina; Castaneda, Julio M.; Savolainen, Audrey; Xu, Yiding; Liu, Ning; Qiao, Huanyu; Ramirez-Solis, Ramiro; Nozawa, Kaori; Yu, Zhifeng; Matzuk, Martin M.; Prunskaite-Hyyrylainen, Renata			MRNIP interacts with sex body chromatin to support meiotic progression, spermatogenesis, and male fertility in mice	FASEB JOURNAL			English	Article						diplotene; liquid-liquid phase separation; male infertility; pachytene; subnuclear; XY body	DOUBLE-STRAND BREAKS; CELL NUCLEAR ANTIGEN; XY BODY; CROSSING-OVER; CHROMOSOME INACTIVATION; MOUSE SPERMATOCYTES; WILD-TYPE; PROTEIN; EXPRESSION; MEIOSIS	Meiosis has a principal role in sexual reproduction to generate haploid gametes in both sexes. During meiosis, the cell nucleus hosts a dynamic environment where some genes are transcriptionally activated, and some are inactivated at the same time. This becomes possible through subnuclear compartmentalization. The sex body, sequestering X and Y chromosomes during male meiosis and creating an environment for the meiotic sex chromosome inactivation (MSCI) is one of the best known and studied subnuclear compartments. Herein, we show that MRNIP forms droplet-like accumulations that fuse together to create a distinct subnuclear compartment that partially overlaps with the sex body chromatin during diplotene. We demonstrate that Mrnip(-/-) spermatocytes have impaired DNA double-strand break (DSB) repair, they display reduced sex body formation and defective MSCI. We show that Mrnip(-/-) undergoes critical meiocyte loss at the diplotene stage. Furthermore, we determine that DNA DSBs (induced by SPO11) and synapsis initiation (facilitated by SYCP1) precede Mrnip expression in testes. Altogether, our findings indicate that in addition to an emerging role in DNA DSB repair, MRNIP has an essential function in spermatogenesis during meiosis I by forming drop-like accumulations interacting with the sex body.	[Kazi, Samina; Savolainen, Audrey; Prunskaite-Hyyrylainen, Renata] Univ Oulu, Fac Biochem & Mol Med, Aapistie 7A, FI-90220 Oulu, Finland; [Castaneda, Julio M.] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka, Japan; [Xu, Yiding; Liu, Ning; Qiao, Huanyu] Univ Illinois, Dept Comparat Biosci, Urbana, IL USA; [Ramirez-Solis, Ramiro] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Nozawa, Kaori; Yu, Zhifeng; Matzuk, Martin M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX USA; [Yu, Zhifeng; Matzuk, Martin M.] Baylor Coll Med, Ctr Drug Discovery, Houston, TX USA	University of Oulu; Osaka University; University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; University of Texas Health San Antonio; Baylor College of Medicine; Baylor College of Medicine	Prunskaite-Hyyrylainen, R (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Aapistie 7A, FI-90220 Oulu, Finland.	renata.prunskaite@oulu.fi		Kazi, Samina/0000-0003-4476-1007	Academy of Finland (AKA) [285151, 336449]; Bill and Melinda Gates Foundation (GF) [INV-001902]; HHS | National Institutes of Health (NIH) [R00 HD082375, R01 GM135549]; HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01HD088412, P01HD087157]; HHS | NIH | National Cancer Institute (NCI) [NCI-CA125123]; MEXT | Japan Society for the Promotion of Science (JSPS) [JP18K14715, JP20K15804]; Oulun Yliopisto (University of Oulu); Sigrid Juseliuksen Saatio (Sigrid Juselius Stiftelse)	Academy of Finland (AKA)(Academy of FinlandFinnish Funding Agency for Technology & Innovation (TEKES)); Bill and Melinda Gates Foundation (GF); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); HHS | NIH | National Cancer Institute (NCI); MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Oulun Yliopisto (University of Oulu); Sigrid Juseliuksen Saatio (Sigrid Juselius Stiftelse)	Academy of Finland (AKA), Grant/Award Number: 285151 and 336449; Bill and Melinda Gates Foundation (GF), Grant/Award Number: INV-001902; HHS | National Institutes of Health (NIH), Grant/Award Number: R00 HD082375 and R01 GM135549; HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R01HD088412 and P01HD087157; HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: NCI--CA125123; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP18K14715 and JP20K15804; Oulun Yliopisto (University of Oulu); Sigrid Juseliuksen Saatio (Sigrid Juselius Stiftelse)	Abe H, 2020, CURR BIOL, V30, P408, DOI 10.1016/j.cub.2019.11.064; Alavattam KG, 2022, CELL MOL LIFE SCI, V79, DOI 10.1007/s00018-021-04075-3; Andersen SL, 2010, BIOESSAYS, V32, P1058, DOI 10.1002/bies.201000087; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bennett LG, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba5974; Bradley J, 2004, NAT GENET, V36, P872, DOI 10.1038/ng1390; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; CHAPMAN DL, 1994, INT J DEV BIOL, V38, P491; Cobb J, 1999, CHROMOSOMA, V108, P412, DOI 10.1007/s004120050393; Daniel K, 2011, NAT CELL BIOL, V13, P599, DOI 10.1038/ncb2213; Dantzer F, 2006, P NATL ACAD SCI USA, V103, P14854, DOI 10.1073/pnas.0604252103; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Eaker S, 2002, DEV BIOL, V249, P85, DOI 10.1006/dbio.2002.0708; EVANS EP, 1964, CYTOGENETICS, V3, P289, DOI 10.1159/000129818; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Goodenough U, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016154; HALL PA, 1990, J PATHOL, V162, P285, DOI 10.1002/path.1711620403; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hermann BP, 2018, CELL REP, V25, P1650, DOI 10.1016/j.celrep.2018.10.026; Ichijima Y, 2011, GENE DEV, V25, P959, DOI 10.1101/gad.2030811; Inselman A, 2003, CYTOGENET GENOME RES, V103, P277, DOI 10.1159/000076813; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; James RD, 2002, CHROMOSOME RES, V10, P549, DOI 10.1023/A:1020910601858; Jarvis S, 2005, HUM REPROD, V20, P108, DOI 10.1093/humrep/deh565; Jiang HW, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007300; Keegan KS, 1996, GENE DEV, V10, P2423, DOI 10.1101/gad.10.19.2423; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KIERSZENBAUM AL, 1974, J CELL BIOL, V60, P39, DOI 10.1083/jcb.60.1.39; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kulkarni DS, 2020, NATURE, V586, P623, DOI 10.1038/s41586-020-2645-6; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; Letunic I, 2021, NUCLEIC ACIDS RES, V49, pD458, DOI 10.1093/nar/gkaa937; Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922; Li WX, 2006, CELL RES, V16, P402, DOI 10.1038/sj.cr.7310052; Lin M, 2021, BIOCHEM BIOPH RES CO, V550, P127, DOI 10.1016/j.bbrc.2021.02.143; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahadevaiah SK, 2008, J CELL BIOL, V182, P263, DOI 10.1083/jcb.200710195; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Makino Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42578-z; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; MCKEE BD, 1993, CHROMOSOMA, V102, P71, DOI 10.1007/BF00356023; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Moens PB, 1997, CHROMOSOMA, V106, P207, DOI 10.1007/s004120050241; Oura S, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008954; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Peterson SE, 2011, METHODS MOL BIOL, V767, P191, DOI 10.1007/978-1-61779-201-4_14; Piovesan D, 2021, NUCLEIC ACIDS RES, V49, pD361, DOI 10.1093/nar/gkaa1058; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Plug AW, 1998, J CELL SCI, V111, P413; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Prunskaite-Hyyrylainen R, 2016, HUM MOL GENET, V25, P1059, DOI 10.1093/hmg/ddv621; Prunskaite-Hyyrylainen R, 2014, FASEB J, V28, P1568, DOI 10.1096/fj.13-233247; Qiao HY, 2018, MOL CELL, V72, P211, DOI 10.1016/j.molcel.2018.08.031; Qiao HY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002790; Reynolds A, 2013, NAT GENET, V45, P269, DOI 10.1038/ng.2541; RICHLER C, 1994, MOL BIOL CELL, V5, P1341, DOI 10.1091/mbc.5.12.1341; Rohozinski J, 2004, P NATL ACAD SCI USA, V101, P11695, DOI 10.1073/pnas.0401130101; Royo H, 2013, GENE DEV, V27, P1484, DOI 10.1101/gad.219477.113; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Song N, 2011, ACTA HISTOCHEM CYTOC, V44, P183, DOI 10.1267/ahc.11027; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Staples CJ, 2016, CELL REP, V16, P2565, DOI 10.1016/j.celrep.2016.07.087; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2015, ANNU REV GENET, V49, P395, DOI 10.1146/annurev-genet-112414-055145; Turner JMA, 2000, CHROMOSOMA, V109, P426, DOI 10.1007/s004120000097; Vernet N, 2016, HUM MOL GENET, V25, P5300, DOI 10.1093/hmg/ddw344; Vranis NM, 2010, GENES-BASEL, V1, P505, DOI 10.3390/genes1030505; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wang YL, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-30303-w; Wojtasz L, 2012, GENE DEV, V26, P958, DOI 10.1101/gad.187559.112; Xu XL, 2003, DEVELOPMENT, V130, P2001, DOI 10.1242/dev.00410; Xu YD, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.674203; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	80	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22479	10.1096/fj.202101168RR	http://dx.doi.org/10.1096/fj.202101168RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3M2JG	35920200	Green Published			2022-12-26	WOS:000835283400001
J	Mangu, SVVSR; Patel, K; Sukhdeo, SV; Savitha, MR; Sharan, K				Mangu, S. V. V. S. Ravi; Patel, Kalpana; Sukhdeo, Shinde Vijay; Savitha, M. R.; Sharan, Kunal			Maternal high-cholesterol diet negatively programs offspring bone development and downregulates hedgehog signaling in osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTNATAL-GROWTH; MASS ACHIEVEMENT; EARLY-PREGNANCY; BLOOD-PRESSURE; LIPID PROFILE; WESTERN DIET; HYPERCHOLESTEROLEMIA; OSTEOPOROSIS; CHILDREN; NUTRITION	Cholesterol is one of the essential intrauterine factors required for fetal growth and development. Maternal high cholesterol levels are known to be detrimental for offspring health. However, its long-term effect on offspring skeletal development remains to be elucidated. We performed our studies in two strains of mice (C57BL6/J and Swiss Albino) and human subjects (65 mother-female newborn dyads) to understand the regulation of offspring skeletal growth by maternal high cholesterol. We found that mice offspring from high-cholesterol-fed dams had low birth weight, smaller body length, and delayed skeletal ossification at the E18.5 embryonic stage. Moreover, we observed that the offspring did not recover from the reduced skeletal mass and exhibited a low bone mass phenotype throughout their life. We attributed this effect to reduced osteoblast cell activity with a concomitant increase in the osteoclast cell population. Our investigation of the molecular mechanism revealed that offspring from high-cholesterol-fed dams had a decrease in the expression of ligands and proteins involved in hedgehog signaling. Further, our cross-sectional study of human subjects showed a significant inverse correlation between maternal blood cholesterol levels and cord blood bone formation markers. Moreover, the bone formation markers were significantly lower in the female newborns of hypercholesterolemic mothers compared with mothers with normal cholesterolemic levels. Together, our results suggest that maternal high cholesterol levels deleteriously program offspring bone mass and bone quality and downregulate the hedgehog signaling pathway in their osteoblasts.	[Mangu, S. V. V. S. Ravi; Patel, Kalpana; Sharan, Kunal] CSIR Cent Food Technol Res Inst, Dept Mol Nutr, Mysuru, India; [Mangu, S. V. V. S. Ravi; Patel, Kalpana; Sharan, Kunal] Acad Sci & Innovat Res AcSIR, Ghaziabad, India; [Sukhdeo, Shinde Vijay] CSIR Cent Food Technol Res Inst, Dept Meat & Marine Sci, Mysuru, India; [Savitha, M. R.] Mysore Med Coll & Res Inst, Dept Paediat, Mysuru, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI)	Sharan, K (corresponding author), CSIR Cent Food Technol Res Inst, Dept Mol Nutr, Mysuru, India.; Sharan, K (corresponding author), Acad Sci & Innovat Res AcSIR, Ghaziabad, India.	sharan.kunal@gmail.com		Sharan, Kunal/0000-0003-2139-2544	Science and Engineering Research Board (SERB), Government of India; Council of Scientific & Industrial Research (CSIR), India	Science and Engineering Research Board (SERB), Government of India; Council of Scientific & Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	Funding from the Science and Engineering Research Board (SERB), Government of India (K. S.) and research fellowship grants from the Council of Scientific & Industrial Research (CSIR), India (S. V. V. S. R. M. and K. P.) are also acknowledged.	Albertsson-Wikland K, 1998, HORM RES, V49, P7, DOI 10.1159/000053080; AlbertssonWikland K, 1997, ACTA PAEDIATR, V86, P193; Amano K, 2014, J BIOL CHEM, V289, P24898, DOI 10.1074/jbc.M114.570507; Asgari MM, 2015, DERMATOL SURG, V41, P481, DOI 10.1097/DSS.0000000000000292; Bachagol D, 2018, J NUTR BIOCHEM, V52, P18, DOI 10.1016/j.jnutbio.2017.09.023; Barengolts EI, 1998, CALCIFIED TISSUE INT, V62, P209, DOI 10.1007/s002239900419; Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730; Barker DJP, 1998, MOTHERS BABIES HLTH; Bowers M, 2012, DEV BIOL, V370, P110, DOI 10.1016/j.ydbio.2012.07.017; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Boyd J D, 1967, J Obstet Gynaecol Br Commonw, V74, P161; Campbell DM, 1996, BRIT J OBSTET GYNAEC, V103, P273, DOI 10.1111/j.1471-0528.1996.tb09718.x; Che L, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3601-1; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Cordain L, 2000, AM J CLIN NUTR, V71, P682, DOI 10.1093/ajcn/71.3.682; de Assis SMA, 2003, PEDIATR NEPHROL, V18, P328, DOI 10.1007/s00467-003-1082-8; Eastell R, 2008, P NUTR SOC, V67, P157, DOI 10.1017/S002966510800699X; EATON SB, 1985, NEW ENGL J MED, V312, P283, DOI 10.1056/NEJM198501313120505; EATON SB, 1988, AM J MED, V84, P739, DOI 10.1016/0002-9343(88)90113-1; Edison RJ, 2007, PEDIATRICS, V120, P723, DOI 10.1542/peds.2006-1939; Ehlen Harald W. A., 2006, Birth Defects Research, V78, P267, DOI 10.1002/bdrc.20076; Ellur G, 2021, CELL MOL LIFE SCI, V78, P1729, DOI 10.1007/s00018-020-03608-6; Gavva C, 2020, INT J BIOL MACROMOL, V145, P558, DOI 10.1016/j.ijbiomac.2019.12.189; Godfrey K, 1996, BRIT MED J, V312, P410, DOI 10.1136/bmj.312.7028.410; Gordon SM, 2015, J PROTEOME RES, V14, P2686, DOI 10.1021/acs.jproteome.5b00213; Grimes SB., 2018, EFFECT PREGNANCY LIP; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hu J, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-47; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jaquiery AL, 2011, PEDIATR RES, V70, P261, DOI 10.1203/PDR.0b013e3182242deb; Jayalekshmi VS, 2021, MOL CELL BIOCHEM, V476, P401, DOI 10.1007/s11010-020-03916-2; Jeong TD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/398397; Kaabia Z, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34329-3; Kopp W, 2019, DIABET METAB SYND OB, V12, P2221, DOI 10.2147/DMSO.S216791; Kuo TR, 2017, BIOMARK RES, V5, DOI 10.1186/s40364-017-0097-4; LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217; Lanham SA, 2010, OSTEOPOROSIS INT, V21, P1703, DOI 10.1007/s00198-009-1118-4; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Luo J, 2020, NAT REV MOL CELL BIO, V21, P225, DOI 10.1038/s41580-019-0190-7; Magura L, 2008, CANCER CAUSE CONTROL, V19, P1259, DOI 10.1007/s10552-008-9197-7; Mandal CC, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00165; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; McNamara D. J., 2005, ENCY HUMAN NUTR, V2nd; MOORE FD, 1973, NEW ENGL J MED, V289, P40, DOI 10.1056/NEJM197307052890109; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Napoli C, 1999, LANCET, V354, P1234, DOI 10.1016/S0140-6736(99)02131-5; Ohba S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186665; Ohba S, 2016, J DEV BIOL, V4, DOI 10.3390/jdb4020020; Oliver MH, 2005, PEDIATR RES, V57, P591, DOI 10.1203/01.PDR.0000155942.18096.9C; Oppi S, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00046; Orozco P, 2004, EUR J EPIDEMIOL, V19, P1105, DOI 10.1007/s10654-004-1706-8; Oxlund H, 2004, BONE, V34, P609, DOI 10.1016/j.bone.2003.12.014; Pahwa H, 2020, MOL CELL BIOCHEM, V469, P109, DOI 10.1007/s11010-020-03732-8; Palinski W, 2009, J CARDIOVASC TRANSL, V2, P277, DOI 10.1007/s12265-009-9108-7; PASYK KA, 1989, PLAST RECONSTR SURG, V83, P939, DOI 10.1097/00006534-198906000-00001; Patel K, 2022, PHYTOMEDICINE, V99, DOI 10.1016/j.phymed.2022.154024; Pelton K, 2012, AM J PATHOL, V181, P928, DOI 10.1016/j.ajpath.2012.05.034; Prieto-Potin I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4261; Reichert JC, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt316; Rigueur D, 2014, METHODS MOL BIOL, V1130, P113, DOI 10.1007/978-1-62703-989-5_9; ROBINSON J, 1995, REPROD FERT DEVELOP, V7, P333, DOI 10.1071/RD9950333; Sasai N, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01103; Sharan K, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12423; Sharan K, 2011, J BONE MINER RES, V26, P2096, DOI 10.1002/jbmr.434; Sivas F, 2009, RHEUMATOL INT, V29, P885, DOI 10.1007/s00296-008-0784-4; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Sridhar SB, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.02.030; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stagi S, 2013, CLIN CASES MINER BON, V10, P172, DOI 10.11138/ccmbm/2013.10.3.172; Swarnkar G, 2011, EUR J PHARMACOL, V658, P65, DOI 10.1016/j.ejphar.2011.02.032; Tickle C, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00014; van Wyk L, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00274; vandenElzen HJ, 1996, BRIT J OBSTET GYNAEC, V103, P117; VANENGELEN MAJ, 1995, J ANIM SCI, V73, P1948; Vrijkotte TGM, 2012, J CLIN ENDOCR METAB, V97, P3917, DOI 10.1210/jc.2012-1295; Wechsler A, 2003, SCIENCE, V302, P2087, DOI 10.1126/science.1090776; Wierbowski BM, 2020, DEV CELL, V55, P450, DOI 10.1016/j.devcel.2020.09.017; Woollett LA, 2005, AM J CLIN NUTR, V82, P1155, DOI 10.1093/ajcn/82.6.1155; Woollett LA, 2001, CURR OPIN LIPIDOL, V12, P305, DOI 10.1097/00041433-200106000-00010; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Wu GY, 1998, J NUTR, V128, P2395, DOI 10.1093/jn/128.12.2395; Yamaguchi T, 2002, ENDOCR J, V49, P211, DOI 10.1507/endocrj.49.211; Yang J, 2015, INT J ORAL SCI, V7, P73, DOI 10.1038/ijos.2015.14; You L, 2011, ACTA PHARMACOL SIN, V32, P1498, DOI 10.1038/aps.2011.135; Zheng J, 2018, EXP BIOL MED, V243, P836, DOI 10.1177/1535370218779024	85	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102324	10.1016/j.jbc.2022.1023240	http://dx.doi.org/10.1016/j.jbc.2022.1023240			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9EO	35931113				2022-12-26	WOS:000863182500013
J	Schihada, H; Klompstra, TM; Humphrys, LJ; Cervenka, I; Dadvar, S; Kolb, P; Ruas, JL; Schulte, G				Schihada, Hannes; Klompstra, Thomas M.; Humphrys, Laura J.; Cervenka, Igor; Dadvar, Shamim; Kolb, Peter; Ruas, Jorge L.; Schulte, Gunnar			Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify receptor-transducer coupling and mediate intracellular pathway bias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; MIGRATION; AGONIST; ACID	Within the intestine, the human G protein-coupled receptor (GPCR) GPR35 is involved in oncogenic signaling, bacterial infections, and inflammatory bowel disease. GPR35 is known to be expressed as two distinct isoforms that differ only in the length of their extracellular N-termini by 31 amino acids, but detailed insights into their functional differences are lacking. Through gene expression analysis in immune and gastrointestinal cells, we show that these isoforms emerge from distinct promoter usage and alternative splicing. Additionally, we employed optical assays in living cells to thoroughly profile both GPR35 isoforms for constitutive and ligand-induced activation and signaling of 10 different heterotrimeric G proteins, ligand-induced arrestin recruitment, and receptor internalization. Our results reveal that the extended N-terminus of the long isoform limits G protein activation yet elevates receptor-beta-arrestin interaction. To better understand the structural basis for this bias, we examined structural models of GPR35 and conducted experiments with mutants of both isoforms. We found that a proposed disulfide bridge between the N-terminus and extracellular loop 3, present in both isoforms, is crucial for constitutive G(13) activation, while an additional cysteine contributed by the extended N-terminus of the long GPR35 isoform limits the extent of agonist-induced receptor-beta-arrestin2 interaction. The pharmacological profiles and mechanistic insights of our study provide clues for the future design of isoform-specific GPR35 ligands that selectively modulate GPR35-transducer interactions and allow for mechanism-based therapies against, for example, inflammatory bowel disease or bacterial infections of the gastrointestinal system.	[Schihada, Hannes; Klompstra, Thomas M.; Cervenka, Igor; Dadvar, Shamim; Ruas, Jorge L.; Schulte, Gunnar] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Schihada, Hannes; Kolb, Peter] Philipps Univ Marburg, Dept Pharmaceut Chem, Marburg, Germany; [Humphrys, Laura J.] Univ Regensburg, Inst Pharm, Regensburg, Germany	Karolinska Institutet; Philipps University Marburg; University of Regensburg	Schihada, H; Schulte, G (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.; Schihada, H (corresponding author), Philipps Univ Marburg, Dept Pharmaceut Chem, Marburg, Germany.	hannes.schihada@ki.se; gunnar.schulte@ki.se	; Kolb, Peter/A-3782-2008	Dadvar, Shamim/0000-0002-2000-1161; Klompstra, Thomas Maarten/0000-0002-1632-0733; Humphrys, Laura/0000-0003-4019-5538; Kolb, Peter/0000-0003-4089-614X	Karolinska Institutet [2020-02125]; ERASMUS+ students exchange program	Karolinska Institutet(Karolinska Institutet); ERASMUS+ students exchange program	Funding and additional information-The work was supported by grants from Karolinska Institutet (2020-02125 to I. C.) . The research activity of T. K. at Karolinska Institutet was supported by the ERASMUS+ students exchange program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agudelo LZ, 2018, CELL METAB, V27, P378, DOI 10.1016/j.cmet.2018.01.004; Ali Haytham, 2019, Tumour Biol, V41, p1010428319858885, DOI 10.1177/1010428319858885; Amir NASBM, 2018, J IMMUNOL, V201, P714, DOI 10.4049/jimmunol.1700884; Boleij A, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02014-3; Burczyk MS, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.121971; Cong ZT, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2106606118; De Giovanni M, 2022, CELL, V185, P815, DOI 10.1016/j.cell.2022.01.010; Divorty N, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101655; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Garrido-Martin D, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006360; Ippolito M, 2022, MOL PHARMACOL, V101, P87, DOI 10.1124/molpharm.121.000332; Jenkins L, 2012, J PHARMACOL EXP THER, V343, P683, DOI 10.1124/jpet.112.198945; Jenkins L, 2011, BRIT J PHARMACOL, V162, P733, DOI 10.1111/j.1476-5381.2010.01082.x; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kaya B, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.717392; Kaya B, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107979; Klarenbeek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122513; Kooistra AJ, 2021, NUCLEIC ACIDS RES, V49, pD335, DOI 10.1093/nar/gkaa1080; Lin LC, 2021, ACS PHARMACOL TRANSL, V4, P1835, DOI 10.1021/acsptsci.1c00224; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; MacKenzie AE, 2014, MOL PHARMACOL, V85, P91, DOI 10.1124/mol.113.089482; Madeira F, 2022, NUCLEIC ACIDS RES, V50, pW276, DOI 10.1093/nar/gkac240; Markovic D, 2009, CELL MOL LIFE SCI, V66, P3337, DOI 10.1007/s00018-009-0093-4; Marti-Solano M, 2020, NATURE, V587, P650, DOI 10.1038/s41586-020-2888-2; Martin AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138463; Matysik-Wozniak A, 2019, EXP EYE RES, V179, P188, DOI 10.1016/j.exer.2018.11.011; McCallum JE, 2015, J VASC RES, V52, P383, DOI 10.1159/000444754; Min KD, 2010, BIOCHEM BIOPH RES CO, V393, P55, DOI 10.1016/j.bbrc.2010.01.076; Minneman K P, 2001, Mol Interv, V1, P108; Moller J, 2020, NAT CHEM BIOL, V16, P946, DOI 10.1038/s41589-020-0566-1; Namkung Y, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat1631; Ohshiro H, 2008, BIOCHEM BIOPH RES CO, V365, P344, DOI 10.1016/j.bbrc.2007.10.197; Okumura S, 2004, CANCER SCI, V95, P131, DOI 10.1111/j.1349-7006.2004.tb03193.x; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Quon T, 2020, ACS PHARMACOL TRANSL, V3, P801, DOI 10.1021/acsptsci.0c00079; Ronkainen VP, 2014, CARDIOVASC RES, V101, P69, DOI 10.1093/cvr/cvt226; Schihada Hannes, 2021, Sci Signal, V14, peabf1653, DOI 10.1126/scisignal.abf1653; Schneditz G, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau9048; Stoddart LA, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01451-w; Taniguchi Y, 2006, FEBS LETT, V580, P5003, DOI 10.1016/j.febslet.2006.08.015; Tsukahara T, 2017, PHARMACOL RES, V123, P27, DOI 10.1016/j.phrs.2017.06.009; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wesslowski J, 2020, J BIOL CHEM, V295, P8759, DOI 10.1074/jbc.RA120.012892; Xu L, 2021, CELL RES, V31, P1311, DOI 10.1038/s41422-021-00525-6; Zhao PW, 2010, MOL PHARMACOL, V78, P560, DOI 10.1124/mol.110.066746	45	1	1	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102328	10.1016/j.jbc.2022.102328	http://dx.doi.org/10.1016/j.jbc.2022.102328			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A7IQ	35933013	gold, Green Published			2022-12-26	WOS:000863057500001
J	Riedel, M; Amann, N; Recker, F; Hennigs, A; Heublein, S; Meyer, B; Karge, A; Eisenkolb, G; Lammert, J; Graf, A; Klein, E; Weiss, M; Riedel, F				Riedel, Maximilian; Amann, Niklas; Recker, Florian; Hennigs, Andre; Heublein, Sabine; Meyer, Bastian; Karge, Anne; Eisenkolb, Gabriel; Lammert, Jacqueline; Graf, Anna; Klein, Evelyn; Weiss, Martin; Riedel, Fabian			The COVID-19 pandemic and its impact on medical teaching in obstetrics and gynecology-A nationwide expert survey among teaching coordinators at German university hospitals	PLOS ONE			English	Article							ENTRUSTABLE PROFESSIONAL ACTIVITIES; EDUCATION; WORKPLACE; KNOWLEDGE	PurposeThe COVID-19 pandemic has imposed severe challenges on medical education at German university hospitals. In this first German nationwide expert survey, we addressed the responsible university teaching coordinators in obstetrics and gynecology departments and investigated their experiences during the pandemic as well as their opinions on future developments, especially with regard to the broader implementation of e-learning in the standard curriculum. MethodsThe questionnaire included 42 items and was disseminated among teaching coordinators at all 41 departments of obstetrics and gynecology at German university hospitals via an email that included a weblink to the online survey provider. Responses were collected between 19 April and 7 June 2021. ResultsIn total, 30 responses were collected from 41 departments across Germany and their respective teaching coordinators in obstetrics and gynecology. The general opinion of the medical teaching provided during the pandemic was positive, whereas the teaching quality in practical skills was considered inferior and not equivalent to the standard face-to-face curriculum. Lectures and seminars had to be substituted by remote-learning alternatives, while clinical clerkships were reduced in length and provided less patient contact. Students in their final year experienced only a few differences in the clinical and teaching routine. Teaching coordinators in obstetrics and gynecology stated that they intend to incorporate more e-learning into the curriculum in the future. ConclusionThe medical educators' views presented here may help to complement the already-thoroughly investigated experiences of students under the restrictions of the COVID-19 pandemic. Medical educators in obstetrics and gynecology at German university hospitals have successfully established online and hybrid teaching alternatives to their standard face-to-face courses. Building on recent experiences, digitalization could help to improve future medical education.	[Riedel, Maximilian; Meyer, Bastian; Karge, Anne; Eisenkolb, Gabriel; Lammert, Jacqueline; Graf, Anna; Klein, Evelyn] Tech Univ Munich TU, Dept Gynecol & Obstet, Klinikum rechts Isar, Munich, Germany; [Amann, Niklas] Friedrich Alexander Univ Erlangen Nuremberg FAU, Dept Gynecol & Obstet, Erlangen, Germany; [Recker, Florian] Bonn Univ Hosp, Dept Gynecol & Obstet, Bonn, Germany; [Hennigs, Andre; Heublein, Sabine; Riedel, Fabian] Heidelberg Univ Hosp, Dept Gynecol & Obstet, Heidelberg, Germany; [Weiss, Martin] Univ Tubingen, Dept Womens Hlth, Tubingen, Germany; [Weiss, Martin] Univ Tubingen, NMI Nat & Med Sci Inst, Reutlingen, Germany	Technical University of Munich; University of Erlangen Nuremberg; University of Bonn; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Riedel, M (corresponding author), Tech Univ Munich TU, Dept Gynecol & Obstet, Klinikum rechts Isar, Munich, Germany.	maximilian.riedel@mri.tum.de	Recker, Florian/ABP-4557-2022	Recker, Florian/0000-0001-9135-4338; Meyer, Bastian/0000-0001-7634-9362; Hennigs, Andre/0000-0002-7998-3796				Abbasi S, 2020, PAK J MED SCI, V36, pS57, DOI 10.12669/pjms.36.COVID19-S4.2766; Al-Balas M, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02257-4; Alsoufi A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242905; AMBOSS, 2020, AMBOSS MED KNOWL DIS; [Anonymous], 2021, HOCHSCHULREKTORENKON; [Anonymous], 2020, MEDIZINSTUDIUM 2020; [Anonymous], 2021, JUNGES FORUM DGGG; [Anonymous], 2020, DIGITALE LEHRE VORAU; [Anonymous], 2021, RKI BEFRAGUNG KRANKE; Beason-Abmayr B, 2021, ADV PHYSIOL EDUC, V45, P384, DOI 10.1152/advan.00248.2020; Bundesministerium fur Bildung und Forschung, 2017, MAST MED 2020; Camargo CP, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e2286; Compton S, 2020, MED EDUC, V54, P943, DOI 10.1111/medu.14268; de Leeuw Robert, 2019, JMIR Med Educ, V5, pe13128, DOI 10.2196/13128; Devitt P, 1998, AUST NZ J SURG, V68, P284, DOI 10.1111/j.1445-2197.1998.tb02084.x; Dornan T, 2006, MED TEACH, V28, P3, DOI 10.1080/01421590500410971; Ellaway R, 2008, MED TEACH, V30, P455, DOI [10.1080/01421590802108349, 10.1080/01421590802108331]; Enyama D, 2021, BMC MED EDUC, V21, DOI 10.1186/s12909-021-02953-9; Fischer Gerhard, 2015, WHAT CAN RESIDENTIAL; Fischer M.R., 2021, DIGITAL TEACHING PAN, DOI [10.3205/ZMA001507, DOI 10.3205/ZMA001507]; Fransen F, 2018, INT J MED EDUC, V9, P11, DOI 10.5116/ijme.5a47.8ab0; Fritze O, 2017, GMS J MED EDU, V34, DOI 10.3205/zma001086; Goh P.S., 2020, MEDEDPUBLISH, V9, P19, DOI 10.15694/mep.2020.000049.1; Irby DM, 2010, ACAD MED, V85, P220, DOI 10.1097/ACM.0b013e3181c88449; Karani R, 2014, ACAD MED, V89, P490, DOI 10.1097/ACM.0000000000000141; Kaul V, 2021, CHEST, V159, P1949, DOI 10.1016/j.chest.2020.12.026; Kay D, 2019, ADV PHYSIOL EDUC, V43, P408, DOI 10.1152/advan.00033.2019; Kuhn S, 2018, BUNDESGESUNDHEITSBLA, V61, P201, DOI 10.1007/s00103-017-2673-z; Loda T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241660; Lomis K, 2017, ACAD MED, V92, P765, DOI 10.1097/ACM.0000000000001543; Lou YP, 2006, ETR&D-EDUC TECH RES, V54, P141, DOI 10.1007/s11423-006-8252-x; Maertens H, 2016, BRIT J SURG, V103, P1428, DOI 10.1002/bjs.10236; Mahan JD, 2014, CURR PROB PEDIATR AD, V44, P137, DOI 10.1016/j.cppeds.2014.01.002; Middeke A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203851; Mihalynuk T, 2006, MED EDUC, V40, P1065, DOI 10.1111/j.1365-2929.2006.02614.x; Naciri A, 2021, J EDUC EVAL HEALTH P, V18, DOI 10.3352/jeehp.2021.18.27; Nepal Samata, 2020, J Nepal Health Res Counc, V18, P551, DOI 10.33314/jnhrc.v18i3.2851; Nikendei C, 2012, Z EVIDENZ FORTBILD Q, V106, P75, DOI 10.1016/j.zefq.2012.01.002; Nikendei C, 2009, MED TEACH, V31, P591, DOI 10.1080/01421590902833010; Nordquist J, 2019, MED TEACH, V41, P366, DOI 10.1080/0142159X.2019.1566601; O'Neill E, 2011, J HOSP INFECT, V79, P368, DOI 10.1016/j.jhin.2011.08.008; Olmes GL, 2021, ARCH GYNECOL OBSTET, V304, P957, DOI 10.1007/s00404-021-06131-6; Rahm AK, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249425; Ren RN, 2021, AEM EDUC TRAIN, V5, DOI 10.1002/aet2.10594; Riedel F, 2019, BMC MED EDUC, V19, DOI 10.1186/s12909-019-1457-6; Riedel F, 2016, ARCH GYNECOL OBSTET, V294, P1235, DOI 10.1007/s00404-016-4168-9; Riedel M, 2022, ARCH GYNECOL OBSTET, V305, P1041, DOI 10.1007/s00404-021-06356-5; Riedel M, 2022, ARCH GYNECOL OBSTET, V305, P129, DOI 10.1007/s00404-021-06232-2; Ruiz JG, 2006, ACAD MED, V81, P207, DOI 10.1097/00001888-200603000-00002; Sandars J, 2020, INT J MED EDUC, V11, P169, DOI 10.5116/ijme.5f20.55f2; Schultz-Pernice Florian, 2020, EVIDENZORIENTIERTES; Shah AV, 2014, J AM OSTEOPATH ASSOC, V114, P654, DOI 10.7556/jaoa.2014.130; Skochelak SE, 2017, ACAD MED, V92, P16, DOI 10.1097/ACM.0000000000001160; Speidel R., 2021, GMS J MED EDU, V38, DOI [10.3205/zma001497, DOI 10.3205/ZMA001497]; Tang Brandon, 2018, JMIR Med Educ, V4, pe11, DOI 10.2196/mededu.9091; Tarpada SP, 2016, J ORTHOP, V13, P425, DOI 10.1016/j.jor.2016.09.004; Ten Cate O, 2017, GMS J MED EDU, V34, DOI 10.3205/zma001146; ten Cate O, 2015, MED TEACH, V37, P983, DOI 10.3109/0142159X.2015.1060308; Torda A, 2020, INTERN MED J, V50, P1150, DOI 10.1111/imj.14882; Vaona A, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011736.pub2; Zavlin Dmitry, 2017, Ger Med Sci, V15, pDoc15, DOI 10.3205/000256	61	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2022	17	8							e0269562	10.1371/journal.pone.0269562	http://dx.doi.org/10.1371/journal.pone.0269562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5A3IT	35930549	gold, Green Published			2022-12-26	WOS:000862784200004
J	Richardson, S; Martinez, J; Hirsch, JS; Cerise, J; Lesser, M; Roswell, RO; Davidson, KW				Richardson, Safiya; Martinez, Johanna; Hirsch, Jamie S.; Cerise, Jane; Lesser, Martin; Roswell, Robert O.; Davidson, Karina W.		Northwell Hlth COVID-19 Res Consor	Association of race/ethnicity with mortality in patients hospitalized with COVID-19	PLOS ONE			English	Article							HEALTH; DISPARITIES; POPULATION; INEQUITIES; RACISM; RACE	Objective To evaluate racial and ethnic differences in mortality among patients hospitalized with coronavirus disease 2019 (COVID-19) after adjusting for baseline characteristics and comorbidities. Methods This retrospective cohort study at 13 acute care facilities in the New York City metropolitan area included sequentially hospitalized patients between March 1, 2020, and April 27, 2020. Last day of follow up was July 31, 2020. Patient demographic information, including race/ ethnicity and comorbidities, were collected. The primary outcome was in-hospital mortality. Results A total of 10 869 patients were included in the study (median age, 65 years [interquartile range (IQR) 54-77; range, 18-107 years]; 40.5% female). In adjusted time-to-event analysis, increased age, male sex, insurance type (Medicare and Self-Pay), unknown smoking status, and a higher score on the Charlson Comorbidity Index were significantly associated with higher in-hospital mortality. Adjusted risk of hospital mortality for Black, Asian, Hispanic, multiracial/other, and unknown race/ethnicity patients were similar to risk for White patients. Conclusions In a large diverse cohort of patients hospitalized with COVID-19, patients from racial/ethnic minorities experienced similar mortality risk as White patients.	[Richardson, Safiya; Hirsch, Jamie S.; Lesser, Martin; Davidson, Karina W.] Northwell Hlth, Feinstein Inst Med Res, Inst Hlth Innovat & Outcomes Res, Manhasset, NY 11030 USA; [Richardson, Safiya; Martinez, Johanna; Hirsch, Jamie S.; Cerise, Jane; Lesser, Martin; Roswell, Robert O.; Davidson, Karina W.] Northwell Hlth, Donald & Barbara Zucker Sch Med, Hofstra Northwell, Hempstead, NY 11030 USA; [Hirsch, Jamie S.] Northwell Hlth, Dept Informat Serv, New Hyde Pk, NY USA; [Cerise, Jane; Lesser, Martin] Northwell Hlth, Biostat Unit, Feinstein Inst Med Res, Manhasset, NY USA; [Davidson, Karina W.] Northwell Hlth, Inst Hlth Syst Sci, Feinstein Inst Med Res, New Hyde Pk, NY USA	Northwell Health; Northwell Health; Northwell Health; Northwell Health; Northwell Health	Richardson, S (corresponding author), Northwell Hlth, Feinstein Inst Med Res, Inst Hlth Innovat & Outcomes Res, Manhasset, NY 11030 USA.; Richardson, S (corresponding author), Northwell Hlth, Donald & Barbara Zucker Sch Med, Hofstra Northwell, Hempstead, NY 11030 USA.	srichard12@northwell.edu	Davidson, Karina/GWC-0996-2022	Davidson, Karina/0000-0002-9162-477X	National Institute on Aging [R24AG064191]; National Library of Medicine [R01LM012836]; National Heart, Lung, and Blood Institute [K23HL145114]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants R24AG064191 from the National Institute on Aging (https://www.nia.nih.gov/); R01LM012836 from the National Library of Medicine (https://www.nlm.nih.gov/); and K23HL145114 from the National Heart, Lung, and Blood Institute (https://www.nhlbi.nih.gov/).None of the funding sources had any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. The views expressed in this paper are those of the authors and do not represent the views of the National Institutes of Health, the United States Department of Health and Human Services, or any other government entity. Karina W. Davidson is a member of the United States Preventive Services Task Force (USPSTF). This article does not represent the views and policies of the USPSTF.	Azar KMJ, 2020, HEALTH AFFAIR, V39, P1253, DOI 10.1377/hlthaff.2020.00598; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Bassett MT, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003402; Bibbins-Domingo K, 2020, ANN INTERN MED, V173, P233, DOI 10.7326/M20-2247; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chowkwanyun M, 2020, NEW ENGL J MED, V383, P201, DOI 10.1056/NEJMp2012910; Cogburn CD, 2019, MILBANK Q, V97, P736, DOI 10.1111/1468-0009.12411; Eaglehouse YL, 2019, JAMA SURG, V154, DOI 10.1001/jamasurg.2018.5113; Feagin J, 2014, SOC SCI MED, V103, P7, DOI 10.1016/j.socscimed.2013.09.006; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P545, DOI 10.15585/mmwr.mm6918e1; Gu T, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25197; Health N.D.o, 2020, AG ADJ RAT PER 1000; Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006; Kabarriti R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19795; Kaufman JS, 2015, AM J EPIDEMIOL, V181, P464, DOI 10.1093/aje/kwu319; Khazanchi R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19933; Kim TS, 2021, OBESITY, V29, P279, DOI 10.1002/oby.23076; Lai PH, 2020, JAMA CARDIOL, V5, P1154, DOI 10.1001/jamacardio.2020.2488; Majure DT, 2021, AM J CARDIOL, V138, P100, DOI 10.1016/j.amjcard.2020.09.060; Munoz-Price LS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.21892; Nair V, 2020, AM J TRANSPLANT, V20, P1819, DOI 10.1111/ajt.15967; Nelson A, 2002, J NATL MED ASSOC, V94, P666; Ogedegbe G, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.26881; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Raifman MA, 2020, AM J PREV MED, V59, P137, DOI 10.1016/j.amepre.2020.04.003; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rogers RG, 2017, BIODEMOGR SOC BIOL, V63, P189, DOI 10.1080/19485565.2017.1281100; Shah KSV, 2014, EUR J PREV CARDIOL, V21, P619, DOI 10.1177/2047487312451815; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Williams DR, 2019, ANNU REV PUBL HEALTH, V40, P105, DOI 10.1146/annurev-publhealth-040218-043750; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Yehia BR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18039	33	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0267505	10.1371/journal.pone.0267505	http://dx.doi.org/10.1371/journal.pone.0267505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925973	Green Published, gold			2022-12-26	WOS:000848077100005
J	Wang, B; Jiang, W; Zheng, XD; Han, Y; Liu, RJ				Wang, Bo; Jiang, Wei; Zheng, Xiaodong; Han, Yu; Liu, Runjie			Research on a Weighted Gene Co-expression Network Analysis method for mining pathogenic genes in thyroid cancer	PLOS ONE			English	Article							PROSTATE-CANCER; COMPLEX DISEASES; NONCODING RNAS; MICRORNA; METASTASIS; PROLIFERATION; CARCINOMA; GROWTH; CELLS; TUMOR	Thyroid cancer (TC) is one of the most common thyroid malignancies occurring worldwide, and accounts for about 1% of all the malignant tumors. It is one of the fastest growing tumor and can occur at any age, but it is more common in women. It is important to find the pathogenesis and treatment targets of TC. In this pursuit, the present study was envisaged to investigate the effective carcinogenic biological macromolecules, so as to provide a better understanding of the occurrence and development of TC. The clinical and gene expression data were collected from The Cancer Genome Atlas (TCGA). We clustered mRNA and long non-coding RNA (lncRNA) into different modules by Weighted Gene Co-expression Network Analysis (WGCNA), and calculated the correlation coefficient between the genes and clinical phenotypes. Using WGCNA, we identified the module with the highest correlation coefficient. Subsequently, by using the differential genes expression analysis to screen the differential micro-RNA (miRNA), the univariate Cox proportional hazard regression was employed to screen the hub genes related to overall survival (OS), with P < 0.05 as the statistical significance threshold. Finally, we designed a hub competitive endogenous RNA (ceRNA) network of disease-associated lncRNAs, miRNAs, and mRNAs. From the results of enrichment analysis, the association of these genes could be related to the occurrence and development of TC, and these hub RNAs can be valuable prognostic markers and therapeutic targets in TC.	[Wang, Bo; Jiang, Wei; Zheng, Xiaodong; Han, Yu; Liu, Runjie] Qiqihar Univ, Coll Comp & Control Engn, Qiqihar, Peoples R China	Qiqihar University	Wang, B (corresponding author), Qiqihar Univ, Coll Comp & Control Engn, Qiqihar, Peoples R China.	bowangdr@qqhru.edu.cn			Young Innovative Talents Project of Basic Scientific Research Business Expenses for Provincial Universities of Heilongjiang Province [135509210]	Young Innovative Talents Project of Basic Scientific Research Business Expenses for Provincial Universities of Heilongjiang Province	This work was supported by the grants of the Young Innovative Talents Project of Basic Scientific Research Business Expenses for Provincial Universities of Heilongjiang Province, No. 135509210.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Chen X, 2019, BRIEF BIOINFORM, V20, P515, DOI 10.1093/bib/bbx130; Chen X, 2017, BRIEF BIOINFORM, V18, P558, DOI 10.1093/bib/bbw060; Chen X, 2018, BIOINFORMATICS, V34, P4256, DOI 10.1093/bioinformatics/bty503; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chevli KK, 2014, J UROLOGY, V191, P1743, DOI 10.1016/j.juro.2013.12.005; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.1; Eder M, 2005, NEW ENGL J MED, V352, P2446, DOI 10.1056/NEJMcibr051201; Fagin JA, 2016, NEW ENGL J MED, V375, P1054, DOI 10.1056/NEJMra1501993; Gomez A, 2019, ATHEROSCLEROSIS, V291, P44, DOI 10.1016/j.atherosclerosis.2019.10.013; Gou LS, 2019, CANCER BIOL THER, V20, P1355, DOI 10.1080/15384047.2019.1617567; Hsieh TH, 2015, ONCOTARGET, V6, P494, DOI 10.18632/oncotarget.2674; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; La Vecchia C, 2017, NAT REV ENDOCRINOL, V13, P318, DOI 10.1038/nrendo.2017.53; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Li WY, 2021, FREE RADICAL BIO MED, V177, P31, DOI 10.1016/j.freeradbiomed.2021.10.009; Li YY, 2018, INT J MOL MED, V41, P3006, DOI 10.3892/ijmm.2018.3494; Lin SJ, 2019, CANCER MANAG RES, V11, P8557, DOI 10.2147/CMAR.S217886; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu HS, 2020, KNOWL-BASED SYST, V191, DOI 10.1016/j.knosys.2019.105261; Liu W, 2022, INTERDISCIP SCI, V14, P168, DOI 10.1007/s12539-021-00478-9; Luo JH, 2021, HEREDITAS, V158, DOI 10.1186/s41065-021-00198-6; Malaguarnera R, 2020, CANCERS, V12, DOI 10.3390/cancers12113109; Matson DR, 2017, EXP MOL PATHOL, V103, P288, DOI 10.1016/j.yexmp.2017.11.009; Mo BY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00702; Musumeci M, 2011, ONCOGENE, V30, P4231, DOI 10.1038/onc.2011.140; Nozhat Z, 2016, MOL DIAGN THER, V20, P13, DOI 10.1007/s40291-015-0175-y; Obara Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05456-0; Peng WZ, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0197-7; Peng XJ, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00941; Ru P, 2012, MOL CANCER THER, V11, P1166, DOI 10.1158/1535-7163.MCT-12-0100; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sauerbrei W, 2018, JNCI-J NATL CANCER I, V110, P803, DOI 10.1093/jnci/djy088; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Sui GQ, 2020, J CELL PHYSIOL, V235, P6615, DOI 10.1002/jcp.29557; Sui J, 2016, INT J ONCOL, V49, P2023, DOI 10.3892/ijo.2016.3716; Tanno B, 2005, CELL DEATH DIFFER, V12, P213, DOI 10.1038/sj.cdd.4401546; Tavares C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051448; Wang CC, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbab286; Wang P, 2019, J CELL BIOCHEM, V120, P18927, DOI 10.1002/jcb.29213; Wang Y, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0837-6; Wen D, 2018, CANCER MED-US, V7, P285, DOI 10.1002/cam4.1272; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yang H, 2013, HEPATOLOGY, V58, P205, DOI 10.1002/hep.26315; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang HD, 2015, TUMOR BIOL, V36, P1355, DOI 10.1007/s13277-015-3199-3; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141042; Zhang L, 2021, INTERDISCIP SCI, V13, P535, DOI 10.1007/s12539-021-00458-z; Zhang L, 2021, GENOMICS, V113, P874, DOI 10.1016/j.ygeno.2021.02.002; Zhang YP, 2016, ONCOTARGET, V7, P64148, DOI 10.18632/oncotarget.11637; Zheng Y, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-1016-6	56	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2022	17	8							e0272403	10.1371/journal.pone.0272403	http://dx.doi.org/10.1371/journal.pone.0272403			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6Q1QK	35913967	gold, Green Published			2022-12-26	WOS:000891393600001
J	Hussain, R; Akram, T; Hassali, MA; Muneswarao, J; Rehman, AU; Hashmi, F; Babar, ZUD				Hussain, Rabia; Akram, Tayyaba; Hassali, Mohamed Azmi; Muneswarao, Jaya; Rehman, Anees Ur; Hashmi, Furqan; Babar, Zaheer-Ud-Din			Barriers and facilitators to pharmacovigilance activities in Pakistan: A healthcare professionals-based survey	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; PHARMACISTS; KNOWLEDGE; PERCEPTIONS; HOSPITALS; ATTITUDE	The timely reporting of adverse drug reactions (ADRs) could improve pharmacovigilance (PV) in a healthcare system. However, in almost all healthcare systems barriers exist that lead to the underreporting of ADRs. The objective of this study was to identify the barriers and facilitators regarding PV activities from the point of view of healthcare professionals (HCPs) in Lahore, Pakistan. A cross-sectional questionnaire-based survey was conducted between September 2018 to January 2019. The data was collected through convenience sampling of physicians, pharmacists, and nurses at tertiary care public hospitals in Lahore. A total of 384 questionnaires were distributed, and 346 HCPs responded to the survey. Over 62% percent of physicians and 54.8% of nurses agreed that they did not know how to report an ADR in their workplace. About 43.2% of pharmacists and 40.1% of nurses disagreed that they were not aware of the need for ADR reporting. Furthermore, 41.6% of nurses identified a lack of financial reimbursement and 51.8% highlighted a lack of support from a colleague as a reason that could lead to the underreporting of ADR. The majority of participants, including 69.6% physicians, 48.6% pharmacists, and 55.3% nurses identified the lack of knowledge about the existence of a national PV centre. Extra time for ADR reporting, incentives, continuous medical education, reminders, and availability of an online ADR reporting system was classed as the facilitators and were agreed upon by the majority of HCPs.	[Hussain, Rabia; Hassali, Mohamed Azmi] Univ Sains Malaysia, Sch Pharmaceut Sci, Dept Social & Adm Pharm, George Town, Malaysia; [Akram, Tayyaba] COMSATS Inst Informat Technol, Dept Math, Lahore, Pakistan; [Muneswarao, Jaya] Hosp Pulau Penang, Jalan Residensi, George Town, Pulau Pinang, Malaysia; [Rehman, Anees Ur] Bahauddin Zakariya Univ, Fac Pharm, Dept Pharm Practice, Multan, Pakistan; [Hashmi, Furqan] Univ Punjab, Univ Coll Pharm, Lahore, Pakistan; [Babar, Zaheer-Ud-Din] Univ Huddersfield, Dept Pharm, Huddersfield, W Yorkshire, England	Universiti Sains Malaysia; COMSATS University Islamabad (CUI); Bahauddin Zakariya University; University of Punjab; University of Huddersfield	Hussain, R (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Dept Social & Adm Pharm, George Town, Malaysia.	rabia.hussain2010@gmail.com		Hussain, Rabia/0000-0001-8183-0855				Adegbuyi TA, 2021, HOSP PHARM, V56, P751, DOI 10.1177/0018578720957968; Aldryhim AY, 2019, EXPERT OPIN DRUG SAF, V18, P745, DOI 10.1080/14740338.2019.1632287; [Anonymous], 2022, YELLOW CARD MED HEAL; [Anonymous], 2008, UNION COMMISSION STA; Babar ZJFPdf, 2022, ASSESSMENT CURRENT S; Bracchi RCG, 2005, BRIT J CLIN PHARMACO, V60, P221, DOI 10.1111/j.1365-2125.2005.02419.x; Cochran W.G., 1977, SAMPLING TECHNIQUE, V3rd ed.; Crea KA, 2011, DRUG INFORM GUIDE PH; Davies EC, 2010, BRIT J CLIN PHARMACO, V70, P749, DOI 10.1111/j.1365-2125.2010.03751.x; European Commission, 2008, STRENGTHENING PHARMA; Fornasier G, 2018, INT J CLIN PHARM-NET, V40, P744, DOI 10.1007/s11096-018-0657-1; Ganesan S, 2017, BIOL MED IMPACT ED I, V8, P203; Gonzalez-Gonzalez C, 2013, DRUG SAFETY, V36, P317, DOI 10.1007/s40264-013-0058-2; Gordhon Y, 2020, EVALUATING KNOWLEDGE, V12; Gupta R, 2018, INT J RES MED SCI, V6, P623, DOI DOI 10.18203/2320-6012.IJRMS20180310; Hadi MA, 2017, INTEGR PHARM RES PRA, V6, P91, DOI 10.2147/IPRP.S105881; Haines HM, 2020, EUR J CLIN PHARMACOL, V76, P991, DOI 10.1007/s00228-020-02862-8; Hashmi A., 2021, PAKISTAN MAKES MOST; Hossain N, 2016, JCPSP-J COLL PHYSICI, V26, P696, DOI 2408; Hussain R, 2020, MED SAFETY GLOBALIZE, P1, DOI DOI 10.1007/978-981-15-2724-1_1; Hussain R, 2021, J PHARM POLICY PRACT, V14, DOI 10.1186/s40545-020-00287-3; Hussain R, 2021, J PUBLIC HEALTH-HEID, V29, P159, DOI 10.1007/s10389-019-01116-x; Hussain R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093039; Hussain R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072209; Hussain R, 2019, J PHARM POLICY PRACT, V12, DOI 10.1186/s40545-019-0178-x; Hussain R, 2018, J PHARM POLICY PRACT, V11, DOI 10.1186/s40545-018-0143-0; Ibrahim DM, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.14731; KARCH FE, 1975, JAMA-J AM MED ASSOC, V234, P1236, DOI 10.1001/jama.234.12.1236; Khalil H, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-019-4651-7; Kiwanuka M, 2019, NO TANZANIA CROSS SE, V3, P151; Kunwor P, 2020, IMPACT ED INTERVENTI, V20, P1; Kwint HF, 2011, DRUG AGING, V28, P305, DOI 10.2165/11586850-000000000-00000; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Lynn RM, 2010, ARCH DIS CHILD, V95, P262, DOI 10.1136/adc.2009.158766; Mateen A., 2020, TRAGEDY PAKISTAN BUI; Mirbaha F, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0302-5; Mouton JP, 2015, BRIT J CLIN PHARMACO, V80, P818, DOI 10.1111/bcp.12567; MPA S, 2020, WHO CAN REPORT SUSPE; Nisa ZU, 2018, SAUDI PHARM J, V26, P453, DOI 10.1016/j.jsps.2018.02.014; NPC-DRAP, 2021, MED VIGILANCE REPORT; Opadeyi AO, 2019, THER ADV DRUG SAF, V10, DOI 10.1177/2042098618816279; Ortega A, 2008, ANN PHARMACOTHER, V42, P1491, DOI 10.1345/aph.1L130; PDCUP, 2021, DRUG SAFETY ALERTS; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Saeed F., 2019, PITB IMPLEMENT HOSP; Salehi T, 2021, NURSESKNOWLEDGE ATTI, V2021; Santosh KC, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-16; Sweis D, 2000, DRUG SAFETY, V23, P165, DOI 10.2165/00002018-200023020-00006; Syed A, 2018, PHARMACY, V6, DOI 10.3390/pharmacy6020029; Terblanche Antionette, 2017, Hosp Pract (1995), V45, P238, DOI 10.1080/21548331.2017.1381013; Toklu HZ, 2008, PHARM WORLD SCI, V30, P556, DOI 10.1007/s11096-008-9209-4; Vallano A, 2005, BRIT J CLIN PHARMACO, V60, P653, DOI 10.1111/j.1365-2125.2005.02504.x; Vessal G, 2009, PHARM WORLD SCI, V31, P183, DOI 10.1007/s11096-008-9276-6; Wajiha Iffat, 2014, African Journal of Pharmacy and Pharmacology, V8, P379; WHO, 2017, 3 WHOGLOBAL PATIENT; WHO, 2021, WHO PROGRAMME INT DR; WHO-EMRO, 2017, HLTH SERVICE DELIVER; Yu YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155517; Zimmermann A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241377	59	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2022	17	7							e0271587	10.1371/journal.pone.0271587	http://dx.doi.org/10.1371/journal.pone.0271587			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Q0KX	35905133	Green Published, gold			2022-12-26	WOS:000855776900040
J	Omidi, P; Cayless, A; Langenbucher, A				Omidi, Pooria; Cayless, Alan; Langenbucher, Achim			Intensity simulation of photic effects after cataract surgery for off-axis light sources	PLOS ONE			English	Article							NEGATIVE DYSPHOTOPSIA	Photopsia is a photic phenomenon that can be associated with intraocular lenses after cataract surgery. To calculate the relative light intensity of photic effects observed after cataract surgery at the foveal region as the most sensitive region of the retina, photopsia was simulated using the ZEMAX optical design software. The simulations are based on the Liou-Brennan eye model with a pupil diameter of 4.5 mm and incorporating implanted IOLs. The hydrophilic IOLs implanted in the eye model have a power of 21 diopter (D) with an optic diameter of 6 mm and 7 mm. Four different intensity detectors are located in specific regions of the eye in this simulation. The ray-tracing analysis was carried out for variations of incident ray angle of 0 degrees to 90 degrees (temporally) in steps of 1 degrees. Depending on the range of incident ray angle, the light intensity was detected at detectors located on the fovea, nasal side of the retina, or the edge surface of the IOLs. Some portion of the input light was detected at specific incident angles in the foveal region. By altering the IOLs edge design to a fully reflective or anti-reflective surface, the range over which the light intensity is detected on the fovea can be shifted. Additionally, with the absorbing edge design, no intensity was detected at the foveal region for incident ray angles larger than 5 degrees. Therefore an absorbing edge design can make photic effects less disturbing for patients.	[Omidi, Pooria; Langenbucher, Achim] Saarland Univ, Dept Expt Ophthalmol, Homburg, Saar, Germany; [Cayless, Alan] Open Univ, Sch Phys Sci, Milton Keynes, Bucks, England	Universitatsklinikum des Saarlandes; Open University - UK	Omidi, P (corresponding author), Saarland Univ, Dept Expt Ophthalmol, Homburg, Saar, Germany.	Pooria.omidi@uks.eu		Omidi, Pooria/0000-0003-3928-1738	Rolf M. Schwiete Stiftung [11/2018]	Rolf M. Schwiete Stiftung	This work is original and has not been published or is currently under consideration for publication elsewhere. J.S. was supported in part by the Rolf M. Schwiete Stiftung under project nr. 11/2018. (https://schwiete-stiftung.com/).	Cecchini P, 2020, INT OPHTHALMOL, V40, P369, DOI 10.1007/s10792-019-01193-7; Cooke DL, 2010, J CATARACT REFR SURG, V36, P1620, DOI 10.1016/j.jcrs.2010.06.022; Davison JA, 2000, J CATARACT REFR SURG, V26, P1346, DOI 10.1016/S0886-3350(00)00611-8; Erie JC, 2019, J CATARACT REFR SURG, V45, P1013, DOI 10.1016/j.jcrs.2019.01.019; Holladay J T, 1985, J Am Intraocul Implant Soc, V11, P21; Holladay JT, 2012, J CATARACT REFR SURG, V38, P1251, DOI 10.1016/j.jcrs.2012.01.032; HOLLADAY JT, 1986, SURV OPHTHALMOL, V30, P385, DOI 10.1016/0039-6257(86)90092-5; Holladay JT, 1999, J CATARACT REFR SURG, V25, P748, DOI 10.1016/S0886-3350(99)00038-3; Liou HL, 1997, J OPT SOC AM A, V14, P1684, DOI 10.1364/JOSAA.14.001684; MASKET S, 1993, J CATARACT REFR SURG, V19, P690, DOI 10.1016/S0886-3350(13)80336-7; Masket S, 2019, EXPERT REV OPHTHALMO, V14, P1, DOI 10.1080/17469899.2018.1560263; Narvaez J, 2005, J CATARACT REFR SURG, V31, P846, DOI 10.1016/j.jcrs.2004.08.059; Omidi P, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0262457; Osher RH, 2008, J CATARACT REFR SURG, V34, P1699, DOI 10.1016/j.jcrs.2008.06.026; Radford SW, 2007, J CATARACT REFR SURG, V33, P88, DOI 10.1016/j.jcrs.2006.09.014; Schwiegerling J, 2006, CURR OPIN OPHTHALMOL, V17, P27, DOI 10.1097/01.icu.0000193065.09499.7e; Tester R, 2000, J CATARACT REFR SURG, V26, P810, DOI 10.1016/S0886-3350(00)00427-2; Vamosi P, 2010, J CATARACT REFR SURG, V36, P418, DOI 10.1016/j.jcrs.2009.10.035	18	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8							e0272705	10.1371/journal.pone.0272705	http://dx.doi.org/10.1371/journal.pone.0272705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P8ZE	35930598	Green Published, Green Accepted, gold			2022-12-26	WOS:000837822100003
J	Baughman, HER; Narang, D; Chen, W; Suarez, ACV; Lee, J; Bachochin, MJ; Gunther, TR; Wolynes, PG; Komives, EA				Baughman, Hannah E. R.; Narang, Dominic; Chen, Wei; Suarez, Amalia C. Villagran; Lee, Joan; Bachochin, Maxwell J.; Gunther, Tristan R.; Wolynes, Peter G.; Komives, Elizabeth A.			An intrinsically disordered transcription activation domain increases the DNA binding affinity and reduces the specificity of NF kappa B p50/RelA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P50/P65 HETERODIMER; CRYSTAL-STRUCTURE; GENE-EXPRESSION; P65 SUBUNIT; ALPHA; SITES; REVEALS; COMPLEX; DISSOCIATION; FLEXIBILITY	Many transcription factors contain intrinsically disordered transcription activation domains (TADs), which mediate interactions with coactivators to activate transcription. Historically, DNA-binding domains and TADs have been considered as modular units, but recent studies have shown that TADs can influence DNA binding. Whether these results can be generalized to more TADs is not clear. Here, we bio-physically characterized the NFKB p50/RelA heterodimer including the RelA TAD and investigated the TAD's influence on NFKB-DNA interactions. In solution, we show the RelA TAD is disordered but compact, with helical tendency in two regions that interact with coactivators. We determined that the presence of the TAD increased the stoichiometry of NFKB- DNA complexes containing promoter DNA sequences with tandem KB recognition motifs by promoting the binding of NFKB dimers in excess of the number of KB sites. In addition, we measured the binding affinity of p50/RelA for DNA containing tandem KB sites and single KB sites. While the presence of the TAD enhanced the binding affinity of p50/RelA for all KB sequences tested, it also increased the affinity for nonspe-cific DNA sequences by over 10-fold, leading to an overall decrease in specificity for KB DNA sequences. In contrast, previous studies have generally reported that TADs decrease DNA-binding affinity and increase sequence specificity. Our results reveal a novel function of the RelA TAD in promoting binding to nonconsensus DNA, which sheds light on previous observations of extensive nonconsensus DNA binding by NFKB in vivo in response to strong inflammatory signals.	[Baughman, Hannah E. R.; Narang, Dominic; Chen, Wei; Suarez, Amalia C. Villagran; Lee, Joan; Bachochin, Maxwell J.; Gunther, Tristan R.; Komives, Elizabeth A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Wolynes, Peter G.] Rice Univ, Dept Chem, Houston, TX USA; [Wolynes, Peter G.] Rice Univ, Ctr Theoret Biol Phys, Houston, TX USA	University of California System; University of California San Diego; Rice University; Rice University	Komives, EA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	ekomives@ucsd.edu		Baughman, Hannah/0000-0003-0615-2403	National Institutes of Health [PO1 GM071862]; Mathers Foundation [MF-2012-01149]; American Cancer Society - CEO?s Against Cancer Tri-State Chapter Postdoctoral Fellowship; American Cancer Society; IRACDA postdoctoral fellowship [K12 GM068524]; D. R. Bullard-Welch Chair at Rice University [C-0016]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; American Cancer Society - CEO?s Against Cancer Tri-State Chapter Postdoctoral Fellowship(American Cancer Society); American Cancer Society(American Cancer Society); IRACDA postdoctoral fellowship; D. R. Bullard-Welch Chair at Rice University	This work was supported by the National Institutes of Health [PO1 GM071862 to E. A. K.] and by The Mathers Foundation [grant number MF-2012-01149] . H. E. B. R. was supported by an American Cancer Society - CEO?s Against Cancer Tri-State Chapter Postdoctoral Fellowship, PF-22-073-01-DMC, DOI# https://doi.org/10.53354/pc.gr.153567 from the American Cancer Society and by an IRACDA postdoctoral fellowship (K12 GM068524) . Additional support was provided to P. G. W. from the D. R. Bullard-Welch Chair at Rice University (Grant No. C-0016) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almaden JV, 2014, CELL REP, V9, P2098, DOI 10.1016/j.celrep.2014.11.024; Alverdi V, 2014, P NATL ACAD SCI USA, V111, P225, DOI 10.1073/pnas.1318115111; Antonaki A, 2011, J BIOL CHEM, V286, P38768, DOI 10.1074/jbc.M111.234161; Bergqvist S, 2009, P NATL ACAD SCI USA, V106, P19328, DOI 10.1073/pnas.0908797106; Berkowitz B, 2002, J BIOL CHEM, V277, P24694, DOI 10.1074/jbc.M200006200; Bernado P, 2012, MOL BIOSYST, V8, P151, DOI 10.1039/c1mb05275f; Bigman LS, 2022, J MOL BIOL, V434, DOI 10.1016/j.jmb.2022.167660; Bista M, 2012, P NATL ACAD SCI USA, V109, P15752, DOI 10.1073/pnas.1214176109; Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Bourgeois B, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109446; Brignall R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00609; Brodsky S, 2020, MOL CELL, V79, P459, DOI 10.1016/j.molcel.2020.05.032; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Callegari A, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007891; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen W, 2021, NUCLEIC ACIDS RES, V49, P11211, DOI 10.1093/nar/gkab874; Chen-Park FE, 2002, J BIOL CHEM, V277, P24701, DOI 10.1074/jbc.M200007200; Davtyan A, 2012, J PHYS CHEM B, V116, P8494, DOI 10.1021/jp212541y; Dembinski HE, 2017, P NATL ACAD SCI USA, V114, P1916, DOI 10.1073/pnas.1610192114; Diermeier S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0536-6; Dragan AI, 2008, J MOL BIOL, V384, P335, DOI 10.1016/j.jmb.2008.09.015; Emenecker RJ, 2021, BIOPHYS J, V120, P4312, DOI 10.1016/j.bpj.2021.08.039; Erijman A, 2020, MOL CELL, V79, P1066, DOI 10.1016/j.molcel.2020.08.013; Escalante CR, 2002, STRUCTURE, V10, P383, DOI 10.1016/S0969-2126(02)00723-2; Garcia DA, 2021, NUCLEIC ACIDS RES, V49, P6605, DOI 10.1093/nar/gkab072; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; He F, 2019, P NATL ACAD SCI USA, V116, P8859, DOI 10.1073/pnas.1903077116; Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jarmoskaite I, 2020, ELIFE, V9, DOI 10.7554/eLife.57264; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Katan-Khaykovich Y, 2001, EUR J BIOCHEM, V268, P3108, DOI 10.1046/j.1432-1327.2001.02211.x; Kolovos P, 2016, GENOME RES, V26, P1478, DOI 10.1101/gr.210005.116; Krishnamurthy S, 2009, CURR BIOL, V19, pR153, DOI 10.1016/j.cub.2008.11.052; Krois AS, 2018, P NATL ACAD SCI USA, V115, pE11302, DOI 10.1073/pnas.1814051115; Lambert SA, 2018, CELL, V175, P598, DOI 10.1016/j.cell.2018.09.045; LEBOWITZ JH, 1989, GENE DEV, V3, P1625, DOI 10.1101/gad.3.10.1625; Lecoq L, 2017, NUCLEIC ACIDS RES, V45, P5564, DOI 10.1093/nar/gkx146; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Liu Y, 2008, J BIOL CHEM, V283, P20874, DOI 10.1074/jbc.M800375200; Lobanov MY, 2008, MOL BIOL+, V42, P623, DOI 10.1134/S0026893308040195; Lumpkin RJ, 2019, MOL CELL PROTEOMICS, V18, P2516, DOI 10.1074/mcp.TIR119.001731; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Masson GR, 2019, NAT METHODS, V16, P595, DOI 10.1038/s41592-019-0459-y; Mukherjee SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001647; Mulero MC, 2019, NUCLEIC ACIDS RES, V47, P9967, DOI 10.1093/nar/gkz739; Musacchio A, 2022, EMBO J, V41, DOI 10.15252/embj.2021109952; Narang D, 2018, J MOL BIOL, V430, P1510, DOI 10.1016/j.jmb.2018.03.020; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Peacock RB, 2021, BIOCHEMISTRY-US, V60, P3441, DOI 10.1021/acs.biochem.1c00277; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Phillips R, 2009, P NATL ACAD SCI USA, V106, P21465, DOI 10.1073/pnas.0907732106; Potoyan DA, 2016, P NATL ACAD SCI USA, V113, P110, DOI 10.1073/pnas.1520483112; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Ramsey KM, 2019, BIOCHEMISTRY-US, V58, P2555, DOI 10.1021/acs.biochem.9b00008; Ravarani CNJ, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20188190; Rosenblum G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23148-2; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; Staller MV, 2018, CELL SYST, V6, P444, DOI 10.1016/j.cels.2018.01.015; Stormberg T, 2021, BBA-GEN SUBJECTS, V1865, DOI 10.1016/j.bbagen.2021.129934; Stroud JC, 2009, J MOL BIOL, V393, P98, DOI 10.1016/j.jmb.2009.08.023; Sue SC, 2008, J MOL BIOL, V380, P917, DOI 10.1016/j.jmb.2008.05.048; Trojanowski J, 2022, MOL CELL, V82, P1878, DOI 10.1016/j.molcel.2022.04.017; Tsai MY, 2016, PROTEIN SCI, V25, P255, DOI 10.1002/pro.2751; Tunyasuvunakool K, 2021, NATURE, V596, P590, DOI 10.1038/s41586-021-03828-1; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; WANG Y, 1994, NUCLEIC ACIDS RES, V22, P3113, DOI 10.1093/nar/22.15.3113; Weinkam P, 2012, P NATL ACAD SCI USA, V109, P4875, DOI 10.1073/pnas.1116274109; Wiebe MS, 2003, J BIOL CHEM, V278, P17901, DOI 10.1074/jbc.M212211200; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012; Zhao B, 2014, CELL REP, V8, P1595, DOI 10.1016/j.celrep.2014.07.037	81	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102349	10.1016/j.jbc.2022.102349	http://dx.doi.org/10.1016/j.jbc.2022.102349			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A7IQ	35934050	Green Published, gold			2022-12-26	WOS:000863057500005
J	Hill, JD; De Forcrand, C; Cuthel, AM; Adeyemi, OJ; Shallcross, AJ; Grudzen, CR				Hill, Jacob D.; De Forcrand, Claire; Cuthel, Allison M.; Adeyemi, Oluwaseun John; Shallcross, Amanda J.; Grudzen, Corita R.			Emergency provider perspectives on facilitators and barriers to home and community services for older adults with serious life limiting illness: A qualitative study	PLOS ONE			English	Article							PALLIATIVE CARE; INTENSITY; PATIENT	BackgroundOlder adults account for a large proportion of emergency department visits, but those with serious life-limiting illness may benefit most from referral to home and community services instead of hospitalization. We aim to document emergency provider perspectives on facilitators and barriers to accessing home and community services for older adults with serious life-limiting illness. MethodsWe conducted interviewer-administered semi-structured interviews with emergency providers from health systems across the United States to obtain provider perspectives on facilitators and barriers to accessing home and community services. We completed qualitative thematic analysis using an iterative process to develop themes and subthemes to summarize provider responses. ResultsWe interviewed 8 emergency nurses and 10 emergency physicians across 11 health systems. Emergency providers were familiar with local home and community services. Facilitators to accessing these services include care management and social workers. Barriers include services that are not accessible full-time to receive referrals, insurance/payment, and the busy nature of the emergency department. The most helpful reported services were hospice, physical therapy, occupational therapy, and visiting nursing services. Home-based palliative care and full-time emergency department-based care management and social work were the services most desired by providers. Providers expressed support for improving access to home and community services in the hopes of decreasing unnecessary emergency visits and inpatient admissions, and to provide patients with greater options for supportive care. ConclusionObtaining the perspective of emergency providers highlights important considerations to accessing HCS for older-adults with serious life-limiting illness from the emergency department. This study provides foundational information for futures studies and initiatives for improving access to home and community services directly from the emergency department.	[Hill, Jacob D.; Cuthel, Allison M.; Adeyemi, Oluwaseun John; Grudzen, Corita R.] New York Univ, Ronald O Perelman Dept Emergency Med, Grossman Sch Med, New York, NY 10016 USA; [De Forcrand, Claire] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Shallcross, Amanda J.] New York Univ, Dept Populat Hlth, Grossman Sch Med, New York, NY USA	New York University; University of Wisconsin System; University of Wisconsin Madison; New York University	Hill, JD (corresponding author), New York Univ, Ronald O Perelman Dept Emergency Med, Grossman Sch Med, New York, NY 10016 USA.	Jacob.hill@nyulangone.org			National Institutes of Health (NIH) Health Care Systems Research Collaboratory by the NIH Common Fund from the Office of Strategic Coordination within the Office of the NIH Director [U24AT009676]; National Institute on Aging [UG3/UH3 AT009844]; NIH- National Center for Complementary and Integrative Health (NCCIH) [UH3 AT009844]	National Institutes of Health (NIH) Health Care Systems Research Collaboratory by the NIH Common Fund from the Office of Strategic Coordination within the Office of the NIH Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH- National Center for Complementary and Integrative Health (NCCIH)	This work is supported within the National Institutes of Health (NIH) Health Care Systems Research Collaboratory by the NIH Common Fund through cooperative agreement [U24AT009676] from the Office of Strategic Coordination within the Office of the NIH Director and cooperative agreement [UG3/UH3 AT009844] from the National Institute on Aging. Support was also provided by the NIH- National Center for Complementary and Integrative Health (NCCIH) through cooperative agreement [UH3 AT009844]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Author CRG has received the UG3/UH3 funding that supports this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], HOME DEDOOSE; Armstrong MJ, 2020, AM J HOSP PALLIAT ME, V37, P728, DOI 10.1177/1049909119897241; Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Beckstrand RL, 2017, J EMERG NURS, V43, P214, DOI 10.1016/j.jen.2017.03.012; Charmaz K., 2006, CONSTRUCTING GROUNDE; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Flory J, 2004, HEALTH AFFAIR, V23, P194, DOI 10.1377/hlthaff.23.3.194; Frey B., 2018, SAGE ENCY ED RES MEA, DOI 10.4135/9781506326139; Friedman AB, 2022, J AM GERIATR SOC, V70, P501, DOI 10.1111/jgs.17503; Grudzen CR, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030099; Grudzen CR, 2012, J PAIN SYMPTOM MANAG, V43, P1, DOI 10.1016/j.jpainsymman.2011.03.022; Gualano MR, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18158172; Haines KL, 2018, AM J HOSP PALLIAT ME, V35, P1081, DOI 10.1177/1049909117753377; Harasym P, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-037466; Hill JD, 2021, AM J HOSP PALLIAT ME, V38, P12, DOI 10.1177/1049909120920230; Kiger ME, 2020, MED TEACH, V42, P846, DOI 10.1080/0142159X.2020.1755030; LoPresti MA, 2016, AM J HOSP PALLIAT ME, V33, P291, DOI 10.1177/1049909114565658; Marsack J, 2018, LGBT HEALTH, V5, P273, DOI 10.1089/lgbt.2016.0182; McKenna P, 2019, CLIN EXP EMERG MED, V6, P189, DOI 10.15441/ceem.18.022; Mullins PM, 2013, ACAD EMERG MED, V20, P479, DOI 10.1111/acem.12134; Niska Richard, 2010, Natl Health Stat Report, P1; Person J, 2013, INT EMERG NURS, V21, P222, DOI 10.1016/j.ienj.2012.10.001; Rainsford S, 2017, PALLIATIVE MED, V31, P895, DOI 10.1177/0269216316685234; Samuels-Kalow ME, 2020, WEST J EMERG MED, V21, P964, DOI 10.5811/westjem.2020.3.45932; Stone SC, 2011, J PALLIAT MED, V14, P1333, DOI 10.1089/jpm.2011.0106; STRUTZEL E, 1968, NURS RES, V17, P364; Teno JM, 2018, JAMA-J AM MED ASSOC, V320, P264, DOI 10.1001/jama.2018.8981; Thomas EV, 2019, BODY IMAGE, V30, P81, DOI 10.1016/j.bodyim.2019.05.007; Vasunilashorn Sarinnapha, 2012, J Aging Res, V2012, P120952, DOI 10.1155/2012/120952; Vincent GK., 2010, NEXT 4 DECADES OLDER; Wennberg JE, 2009, HEALTH AFFAIR, V28, P103, DOI 10.1377/hlthaff.28.1.103; Wilson JG, 2020, J PAIN SYMPTOM MANAG, V59, P372, DOI 10.1016/j.jpainsymman.2019.09.020	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2022	17	8							e0270961	10.1371/journal.pone.0270961	http://dx.doi.org/10.1371/journal.pone.0270961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5A3IT	35930579	gold, Green Published			2022-12-26	WOS:000862784200015
J	Vargas, A; Restrepo, S; Diaz, D				Vargas, Andres; Restrepo, Sebastian; Diaz, David			The portfolio effect in a small-scale fishery reduces catch and fishing income variability in a highly dynamic ecosystem	PLOS ONE			English	Article							DIVERSIFICATION; COMMUNITY; DIVERSITY; SALINITY; POVERTY	It is an increasingly accepted idea that biological diversity stabilizes ecosystem processes and the services they provide to society. By reducing biomass fluctuation, biodiversity could mitigate the impact of changing environmental conditions on rural incomes as long as people exploits a diverse set of natural assets. This effect is analogous to the risk-spreading function of financial portfolios. This paper presents evidence of the portfolio effect for an open-access artisanal fishery in an estuarine ecosystem, located in a Colombian Biosphere Reserve. Using catch statistics from 2002 to 2018, we evaluate the contribution of catch diversity to the stabilization of fishing income. We find that changes in catch composition are related to seasonal and interannual variations in salinity conditions. The portfolio effect arises from asynchronous fluctuations of fish species due to fluctuating environmental conditions. Catch diversification, instead of specialization, help achieve resilient fisheries.	[Vargas, Andres; Diaz, David] Univ Norte, Dept Econ, Barranquilla, Atlantico, Colombia; [Restrepo, Sebastian] Pontificia Univ Javeriana, Dept Desarrollo Rural & Reg, Bogota, Colombia	Universidad del Norte; Pontificia Universidad Javeriana	Vargas, A (corresponding author), Univ Norte, Dept Econ, Barranquilla, Atlantico, Colombia.	andresmv@uninorte.edu.co		Restrepo Calle, Sebastian/0000-0001-9583-5155; Vargas, Andres/0000-0002-8642-6154	Universidad del Norte [2017-30]	Universidad del Norte	Andres Vargas and David Diaz received funding from Universidad del Norte, www.uninorte.edu.co. Grant number 2017-30. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SC, 2017, P NATL ACAD SCI USA, V114, P10797, DOI 10.1073/pnas.1702506114; Anderson SC, 2013, METHODS ECOL EVOL, V4, P971, DOI 10.1111/2041-210X.12093; Balvanera P., 2016, ROUTLEDGE HDB ECOSYS, P45, DOI [10.4324/9781315775302-5, DOI 10.4324/9781315775302-5]; Barbier EB, 2010, ENVIRON DEV ECON, V15, P635, DOI 10.1017/S1355770X1000032X; Barletta M, 2005, J FISH BIOL, V66, P45, DOI 10.1111/j.0022-1112.2005.00582.x; Blanco JA, 2006, ESTUAR COAST SHELF S, V66, P157, DOI 10.1016/j.ecss.2005.08.001; Cline TJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14042; Coomes OT, 2010, FISHERIES MANAG ECOL, V17, P513, DOI 10.1111/j.1365-2400.2010.00750.x; Dalton MG, 2001, J ENVIRON ECON MANAG, V42, P336, DOI 10.1006/jeem.2000.1158; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Finkbeiner EM, 2015, GLOBAL ENVIRON CHANG, V32, P139, DOI 10.1016/j.gloenvcha.2015.03.009; Gross K, 2014, AM NAT, V183, P1, DOI 10.1086/673915; Kasperski S, 2013, P NATL ACAD SCI USA, V110, P2076, DOI 10.1073/pnas.1212278110; Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746; Loreau M, 2021, BIOL REV, V96, P2333, DOI 10.1111/brv.12756; Loreau M, 2013, ECOL LETT, V16, P106, DOI 10.1111/ele.12073; Maldonado J., 2022, MAR FISH SCI, V35, P181, DOI DOI 10.47193/mafis.3522022010504; Michler JD, 2017, WORLD DEV, V89, P214, DOI 10.1016/j.worlddev.2016.08.011; Noack F, 2019, J ASSOC ENVIRON RESO, V6, P823, DOI 10.1086/703487; Pellowe KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182200; Perrings C, 2018, HBK ECON, P61, DOI 10.1016/bs.hesenv.2018.03.002; Quaas M, 2019, ECOL ECON, V165, DOI 10.1016/j.ecolecon.2019.106388; Rivillas-Ospina G, 2020, WATER-SUI, V12, DOI 10.3390/w12051513; Robinson JPW, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz0587; Rodriguez-Rodriguez JA., 2018, WETLAND BOOK 2 DISTR, V2, P757, DOI [10.1007/978-94-007-6173-5, DOI 10.1007/978-94-007-6173-5]; ROSENMAN RE, 1986, J ENVIRON ECON MANAG, V13, P348, DOI 10.1016/0095-0696(86)90005-7; Rueda Mario, 2011, FAO Fisheries and Aquaculture Technical Paper, V544, P117; Sanchirico JN, 2008, ECOL ECON, V64, P586, DOI 10.1016/j.ecolecon.2007.04.006; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Sethi SA, 2014, MAR POLICY, V48, P134, DOI 10.1016/j.marpol.2014.03.027; Torres B, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10051432; Torres-Guevara LE, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8060549; Vilardy SP, 2011, HYDROLOG SCI J, V56, P1423, DOI 10.1080/02626667.2011.631497; Whitfield AK, 2012, ESTUAR COAST SHELF S, V97, P78, DOI 10.1016/j.ecss.2011.11.026	34	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2022	17	8							e0271172	10.1371/journal.pone.0271172	http://dx.doi.org/10.1371/journal.pone.0271172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5A3IT	35930546	gold, Green Published			2022-12-26	WOS:000862784200007
J	Amirova, A; Lucas, R; Cowie, MR; Haddad, M				Amirova, Aliya; Lucas, Rebecca; Cowie, Martin R.; Haddad, Mark			Perceived barriers and enablers influencing physical activity in heart failure: A qualitative one-to-one interview study	PLOS ONE			English	Article							BEHAVIOR-CHANGE; METAANALYSIS; ACCEPTANCE; ADHERENCE	In heart failure (HF), increased physical activity is associated with improved quality of life, reduced hospitalisation, and increased longevity and is an important aim of treatment. However, physical activity levels in individuals living with HF are typically extremely low. This qualitative study with one-to-one interviews systematically explores perceived clinical, environmental, and psychosocial barriers and enablers in older adults (>= 70 years old) living with HF. Semi-structured interviews (N = 16) based on the Theoretical Domains Framework elicited 39 belief statements describing the barriers and enablers to physical activity. Theoretical domains containing these beliefs and corresponding constructs that were both pervasive and common were deemed most relevant. These were: concerns about physical activity (Beliefs about Consequences), self-efficacy (Beliefs about Capabilities), social support (Social Influences), major health event (Environmental Context and Resources), goal behavioural (Goal), action planning (Behavioural Regulation). This work extends the limited research on the modifiable barriers and enablers for physical activity participation by individuals living with HF. The research findings provide insights for cardiologists, HF-specialist nurses, and physiotherapists to help co-design and deliver a physical activity intervention more likely to be effective for individuals living with HF.	[Amirova, Aliya] Kings Coll London, Guys Hosp, Inst Psychiat Psychol & Neurosci, Hlth Psychol Sect, London, England; [Lucas, Rebecca] St Raphaels Hosp Hosp & Hlth Care, Sutton, Surrey, England; [Cowie, Martin R.] Royal Brompton Hosp, London, England; [Cowie, Martin R.] Kings Coll London, Fac Life Sci & Med, Sch Cardiovasc Med & Sci, London, England; [Haddad, Mark] City Univ London, Sch Hlth Sci, Hlth Serv Res & Management, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Royal Brompton Hospital; University of London; King's College London; City University London	Amirova, A (corresponding author), Kings Coll London, Guys Hosp, Inst Psychiat Psychol & Neurosci, Hlth Psychol Sect, London, England.	aliya.1.amirova@kcl.ac.uk	Amirova, Aliya/GPF-5416-2022; Cowie, Martin R/AAQ-2818-2020	Cowie, Martin R/0000-0001-7457-2552; Amirova, Aliya/0000-0001-6476-7604	City University of London PhD studentship; City University of London	City University of London PhD studentship; City University of London	AA received City University of London PhD studentship. funder: City University of London The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychological Association, 2007, APA DICT PSYCHOL; Amirova A, 2022, HEALTH PSYCHOL REV, DOI 10.1080/17437199.2022.2090411; Amirova A, 2021, OPEN HEART, V8, DOI 10.1136/openhrt-2021-001687; Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9; Bandura A., 1997, SELF EFFICACY EXERCI; Belardinelli R, 2012, J AM COLL CARDIOL, V60, P1521, DOI 10.1016/j.jacc.2012.06.036; Bragazzi NL, 2021, EUR J PREV CARDIOL, V28, P1682, DOI 10.1093/eurjpc/zwaa147; British Heart Foundation, 2018, NAT AUD CARD REH NAC; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Checa C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243974; Comrie B., 1976, GRAMMAR CAUSATIVE CO, P259; Conraads VM, 2012, EUR J HEART FAIL, V14, P451, DOI 10.1093/eurjhf/hfs048; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Criteria Committee of the American Heart Association Affiliate NYC, 1994, NOMENCLATURE CRITERI, V9th; Dalal HM., 2018, BR J GEN PRACT, V68; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Epiphaniou E, 2010, J OBES, V2010, DOI 10.1155/2010/859413; Francis JJ, 2009, BRIT J HEALTH PSYCH, V14, P625, DOI 10.1348/135910708X397025; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Greaves CJ., 2016, PILOT FEASIBILITY ST, V2, P37, DOI [10.1186/s40814-016-0075-x, DOI 10.1186/S40814-016-0075-X]; Groenewegen A, 2020, EUR J HEART FAIL, V22, P1342, DOI 10.1002/ejhf.1858; Hayes SC, 1999, PSYCHOL REC, V49, P33, DOI 10.1007/BF03395305; Hofmann W, 2008, J PERS SOC PSYCHOL, V95, P962, DOI 10.1037/a0012705; Hollands GJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1218; Ivanova E, 2015, MED SCI SPORT EXER, V47, P1251, DOI 10.1249/MSS.0000000000000536; Jones NR, 2019, EUR J HEART FAIL, V21, P1306, DOI 10.1002/ejhf.1594; Kanfer FH, 1991, SELF MANAGEMENT METH; Kok G, 2016, HEALTH PSYCHOL REV, V10, P297, DOI 10.1080/17437199.2015.1077155; Krippendorff K., 2007, DEP PAPERS ASC, P43; Kwasnicka D, 2016, HEALTH PSYCHOL REV, V10, P277, DOI 10.1080/17437199.2016.1151372; Lally P, 2013, HEALTH PSYCHOL REV, V7, pS137, DOI 10.1080/17437199.2011.603640; Lewinter C, 2015, EUR J PREV CARDIOL, V22, P1504, DOI 10.1177/2047487314559853; McDonald S, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0186-4; NICE, 2018, NICE OV CHRON HEART; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; O'Cathain A, 2019, PILOT FEASIBILITY ST, V5, DOI 10.1186/s40814-019-0425-6; O'Donnell J, 2020, OPEN HEART, V7, DOI 10.1136/openhrt-2019-001099; Ogden J, 2008, HEALTH-LONDON, V12, P419, DOI 10.1177/1363459308094417; Pihl E, 2011, SCAND J CARING SCI, V25, P3, DOI 10.1111/j.1471-6712.2010.00780.x; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Roese NJ., 1995, WHAT MIGHT HAVE BEEN, P1; Ryan RM, 2000, CONTEMP EDUC PSYCHOL, V25, P54, DOI 10.1006/ceps.1999.1020; Sagar VA, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2014-000163; Schwarzer R, 2016, ACTUAL PSICOL, V30, P119, DOI 10.15517/ap.v30i121.23458; Skinner B.F., 1971, ENCY ED, V7, P29, DOI [10.4135/9781452229409.n13, DOI 10.4135/9781452229409.N13]; Skivington K, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2061; Taylor N, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-74; Taylor RS, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009994; Taylor R, 2019, JACC-HEART FAIL, V7, P691, DOI 10.1016/j.jchf.2019.04.023; Taylor RS, 2019, EUR J PREV CARDIOL, V26, P1252, DOI 10.1177/2047487319833507; Tierney S, 2012, HEART FAIL REV, V17, P107, DOI 10.1007/s10741-011-9252-4; Tierney S, 2011, INT J NURS STUD, V48, P1234, DOI 10.1016/j.ijnurstu.2011.03.003; Tierney S, 2011, HEALTH PSYCHOL, V30, P401, DOI 10.1037/a0022848; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Vlaeyen JWS, 2016, PAIN, V157, P1588, DOI 10.1097/j.pain.0000000000000574; Wilson K, 2015, PSYCHOL BULL, V141, P474, DOI 10.1037/a0038295; Zhang CQ, 2019, HEALTH PSYCHOL, V38, P623, DOI 10.1037/hea0000728	59	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271743	10.1371/journal.pone.0271743	http://dx.doi.org/10.1371/journal.pone.0271743			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925964	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000848077100047
J	Kang, JH; Kim, HJ; Song, SI				Kang, Jeong-Hyun; Kim, Hyun Jun; Song, Seung Il			Obstructive sleep apnea and anatomical structures of the nasomaxillary complex in adolescents	PLOS ONE			English	Article							RAPID MAXILLARY EXPANSION; RISK-FACTORS; RESPIRATORY EVENTS; AIRWAY; CHILDREN; SKELETAL; OSA; DIMENSIONS; MANAGEMENT; MORPHOLOGY	The aim of the present study was to reveal the associations between skeletal and soft tissue features of the nasomaxillary complex and development and severity of obstructive sleep apnea (OSA) in adolescents. A total of 100 adolescents (mean age, 14.9 +/- 1.4 years; age range, 13-17 years) were enrolled. All participants underwent full-night polysomnography and had an assessment of size and position of the tongue, tonsillar size, body mass index (BMI), and circumference of the waist, neck, and hip. The skeletal features of the nasomaxillary complex, including the zygomatic arch width, nasal cavity width, nasal base width, intercanine width, intermolar width, maxillary dental arch length, palatal vault angle, palatal depth, and SNA were measured on the three-dimensional images constructed with computed tomography data. Participants with an apnea and hypopnea index (AHI) of lower than 5 (AHI <= 5) were classified as control and participants while those with an AHI of greater than 5 were classified as OSA group. Each variable with a significant outcome in the independent T-test and age and sex factors were integrated into the multivariate linear regression and the dependent variable was AHI. There were significant differences in the BMI and hip circumference between two groups. The width of nasal base, palatal vault angle and SNA also showed significant differences between groups. The results from multivariate linear regression demonstrated that the BMI, width of the nasal base, and SNA showed significant contributions to the severity of OSA in adolescents. The features of the nasomaxillary complex seemed to have significant influences on development and severity of OSA.	[Kang, Jeong-Hyun] Ajou Univ, Inst Oral Hlth Sci, Clin Oral Med & Orofacial Pain, Sch Med, Suwon, Gyeonggi Do, South Korea; [Kim, Hyun Jun] Ajou Univ, Sch Med, Dept Otolaryngol, Suwon, Gyeonggi Do, South Korea; [Song, Seung Il] Ajou Univ, Inst Oral Hlth Sci, Dept Oral & Maxillofacial Surg, Sch Med, Suwon, Gyeonggi Do, South Korea	Ajou University; Ajou University; Ajou University	Song, SI (corresponding author), Ajou Univ, Inst Oral Hlth Sci, Dept Oral & Maxillofacial Surg, Sch Med, Suwon, Gyeonggi Do, South Korea.	seungilsong@hanmail.net		Kang, Jeong Hyun/0000-0001-7124-8693; Kim, Hyun Jun/0000-0002-3134-0142; SONG, SEUNG IL/0000-0001-9504-6471	National Research Foundation of Korea [2021R1H1A2093767]	National Research Foundation of Korea(National Research Foundation of Korea)	Funder Name: National Research Foundation of Korea Grant Number: 2021R1H1A2093767 Grant Recipient: Hyun Jun Kim The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts BE, 2015, J CRANIO MAXILL SURG, V43, P2106, DOI 10.1016/j.jcms.2015.10.013; Accardo JA, 2010, SLEEP, V33, P1333, DOI 10.1093/sleep/33.10.1333; Ahn SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135796; Akay MC, 2014, J ORAL MAXIL SURG, V72, P1559, DOI 10.1016/j.joms.2014.03.010; [Anonymous], 1986, World Health Organ Tech Rep Ser, V731, P1; [Anonymous], 2014, AM ACAD SLEEP MED IN; Avci S, 2019, SLEEP BREATH, V23, P103, DOI 10.1007/s11325-018-1667-x; Bach N, 2013, J ORAL REHABIL, V40, P818, DOI 10.1111/joor.12102; Baker-Smith CM, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.121.022427; Bayat M, 2017, CRANIO, V35, P321, DOI 10.1080/08869634.2016.1239850; Bell RB, 2001, CLEFT PALATE-CRAN J, V38, P147, DOI 10.1597/1545-1569(2001)038<0147:SAFTTO>2.0.CO;2; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bicakci AA, 2005, ANGLE ORTHOD, V75, P1; BRODSKY L, 1989, PEDIATR CLIN N AM, V36, P1551; BRODSKY L, 1987, INT J PEDIATR OTORHI, V13, P149, DOI 10.1016/0165-5876(87)90091-7; Chi L, 2011, EUR RESPIR J, V38, P348, DOI 10.1183/09031936.00119210; Dempsey JA, 2002, CHEST, V122, P840, DOI 10.1378/chest.122.3.840; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Ersu R, 2004, CHEST, V126, P19, DOI 10.1378/chest.126.1.19; Fastuca R, 2017, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-017-0404-3; Fastuca R, 2015, ANGLE ORTHOD, V85, P955, DOI 10.2319/072014-504.1; FUJIOKA M, 1979, AM J ROENTGENOL, V133, P401, DOI 10.2214/ajr.133.3.401; Haim A, 2021, PEDIATR PULM, V56, P3983, DOI 10.1002/ppul.25652; Hsu PP, 2005, CLIN OTOLARYNGOL, V30, P234, DOI 10.1111/j.1365-2273.2005.00983.x; Ingram DG, 2015, INT J PEDIATR OTORHI, V79, P666, DOI 10.1016/j.ijporl.2015.02.011; Isaiah A, 2017, OTOLARYNG HEAD NECK, V157, P128, DOI 10.1177/0194599817700370; Joffe A, 2000, MED CLIN N AM, V84, P769, DOI 10.1016/S0025-7125(05)70260-1; Kaditis A, 2012, SLEEP MED, V13, P217, DOI 10.1016/j.sleep.2011.09.009; Kang KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078666; Katyal V, 2013, AM J ORTHOD DENTOFAC, V144, P860, DOI 10.1016/j.ajodo.2013.08.015; Kim ST, 2017, SLEEP BREATH, V21, P885, DOI 10.1007/s11325-017-1506-5; Kumar HVM, 2014, J CLIN SLEEP MED, V10, P985, DOI 10.5664/jcsm.4032; Lee JH, 2022, SLEEP MED CLIN, V17, P111, DOI 10.1016/j.jsmc.2021.10.009; Lowe AA, 1996, AM J ORTHOD DENTOFAC, V110, P653, DOI 10.1016/S0889-5406(96)80043-6; Marcus CL, 2012, PEDIATRICS, V130, pE714, DOI 10.1542/peds.2012-1672; Marshall NS, 2008, SLEEP, V31, P1079; Nada RM, 2013, EUR J ORAL SCI, V121, P450, DOI 10.1111/eos.12068; Paluch Z, 2013, ACTA ODONTOL SCAND, V71, P1599, DOI 10.3109/00016357.2013.780291; Peker Y, 2006, EUR RESPIR J, V28, P596, DOI 10.1183/09031936.06.00107805; Peltomaki T, 2007, EUR J ORTHODONT, V29, P426, DOI 10.1093/ejo/cjm055; Pirelli P, 2021, SLEEP MED, V86, P81, DOI 10.1016/j.sleep.2021.08.011; Proffit WR., 2007, CONT ORTHODONTICS, P690; Rodrigues MM, 2017, INT J ORAL MAX SURG, V46, P1284, DOI 10.1016/j.ijom.2017.05.009; SAMSOON GLT, 1987, ANAESTHESIA, V42, P487, DOI 10.1111/j.1365-2044.1987.tb04039.x; Sanchez-Armengol Angeles, 2001, Chest, V119, P1393, DOI 10.1378/chest.119.5.1393; Sateia MJ, 2014, CHEST, V146, P1387, DOI 10.1378/chest.14-0970; Schwab RJ, 2015, AM J RESP CRIT CARE, V191, P1295, DOI 10.1164/rccm.201501-0169OC; Schwab RJ, 2003, AM J RESP CRIT CARE, V168, P522, DOI 10.1164/rccm.200208-866OC; Sedky K, 2014, SLEEP MED REV, V18, P349, DOI 10.1016/j.smrv.2013.12.003; Tapia IE, 2008, SLEEP, V31, P1737, DOI 10.1093/sleep/31.12.1737; Trosman I, 2013, PEDIATR ANN, V42, P195, DOI 10.3928/00904481-20130924-09; Tsai MH, 2004, INT J COLORECTAL DIS, V19, P268, DOI 10.1007/s00384-003-0558-0; Nguyen T, 2015, ANGLE ORTHOD, V85, P591, DOI 10.2319/041614-282.1; Villa M.P., 2016, ERJ OPEN RES, P00049, DOI [10.1183/23120541.00049-2015, DOI 10.1183/23120541.00049-2015]; Villa MP, 2015, SLEEP MED, V16, P709, DOI 10.1016/j.sleep.2014.11.019; Vinha PP, 2016, J ORAL MAXIL SURG, V74, P369, DOI 10.1016/j.joms.2015.06.157; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young T, 2008, SLEEP, V31, P1071	58	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272262	10.1371/journal.pone.0272262	http://dx.doi.org/10.1371/journal.pone.0272262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925992	gold, Green Published			2022-12-26	WOS:000848077100079
J	Kotov, JA; Xu, Y; Carey, ND; Cyster, JG				Kotov, Jessica A.; Xu, Ying; Carey, Nicholas D.; Cyster, Jason G.			LT beta R overexpression promotes plasma cell accumulation	PLOS ONE			English	Article							KAPPA-B PATHWAY; HOMEOSTASIS; RECEPTOR; INHIBITION; EXPRESSION; MCL-1; PAX5	Multiple myeloma (MM), a malignancy of plasma cells (PCs), has diverse genetic underpinnings and in rare cases these include amplification of the lymphotoxin b receptor (Ltbr) locus. LT beta R has well defined roles in supporting lymphoid tissue development and function through actions in stromal and myeloid cells, but whether it is functional in PCs is unknown. Here we showed that LtbrmRNA was upregulated in mouse PCs compared to follicular B cells, but deficiency in the receptor did not cause a reduction in PC responses to a T-dependent or T-independent immunogen. However, LT beta R overexpression (OE) enhanced PC formation in vitro after LPS or anti-CD40 stimulation. In vivo, LT beta R OE led to increased antigen-specific splenic and bone marrow (BM) plasma cells responses. LT beta R OE PCs had increased expression of Nfkb2 and of the NF-kB target genes Bcl2 and Mcl1, factors involved in the formation of long-lived BM PCs. Our findings suggest a pathway by which Ltbrgene amplifications may contribute to MM development through increased NF-kB activity and induction of an anti-apoptotic transcriptional program.	[Kotov, Jessica A.; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Kotov, Jessica A.; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Carey, Nicholas D.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.; Cyster, JG (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu		Kotov, Jessica Amy/0000-0002-1205-5178	Howard Hughes Medical Institute; Life Sciences Research Foundation Postdoctoral Fellowship; National Institutes of Health [R01 AI040098, R01 AI045073, T32 AI007334]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Life Sciences Research Foundation Postdoctoral Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Howard Hughes Medical Institute funding to J.G.C. and J.A. K. National Institutes of Health Grants (R01 AI040098, R01 AI045073 to J.G.C.; T32 AI007334 to J.A.K.) and the Life Sciences Research Foundation Postdoctoral Fellowship to J.A.K.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Browning JL, 2008, IMMUNOL REV, V223, P202, DOI 10.1111/j.1600-065X.2008.00633.x; Caers J, 2018, HAEMATOLOGICA, V103, P1772, DOI 10.3324/haematol.2018.189159; Carrington EM, 2010, P NATL ACAD SCI USA, V107, P10967, DOI 10.1073/pnas.1005256107; de Mel S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/232546; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Ehlers S, 2003, J IMMUNOL, V170, P5210, DOI 10.4049/jimmunol.170.10.5210; Engelhardt M, 2020, HAEMATOLOGICA, V105, P1183, DOI 10.3324/haematol.2019.242958; Gnoni Antonio, 2020, Oncotarget, V11, P480, DOI 10.18632/oncotarget.27439; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Heo SK, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247368; Hopner SS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21317-x; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kitada S, 2004, JNCI-J NATL CANCER I, V96, P642, DOI 10.1093/jnci/djh153; Legut M, 2022, NATURE, V603, P728, DOI 10.1038/s41586-022-04494-7; Liu HD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-98; Maminska A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0848; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Pawlyn C, 2019, BLOOD, V133, P660, DOI 10.1182/blood-2018-09-825331; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Riffelmacher T, 2021, MUCOSAL IMMUNOL, V14, P679, DOI 10.1038/s41385-021-00378-7; Roberts AW, 2021, BLOOD, V138, P1120, DOI 10.1182/blood.2020006785; Saltarella I, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010167; Solimando AG, 2021, HAEMATOLOGICA, V106, P1943, DOI 10.3324/haematol.2019.239913; Sun SC, 2017, NAT REV IMMUNOL, V17, P545, DOI 10.1038/nri.2017.52; Touzeau C, 2016, LEUKEMIA, V30, P761, DOI 10.1038/leu.2015.184; Viatour P, 2003, LEUKEMIA, V17, P1349, DOI 10.1038/sj.leu.2402982; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Wege AK, 2014, INNATE IMMUN-LONDON, V20, P461, DOI 10.1177/1753425913497242; Xiang H, 2006, MOL CELL BIOL, V26, P8599, DOI 10.1128/MCB.01062-06	34	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0270907	10.1371/journal.pone.0270907	http://dx.doi.org/10.1371/journal.pone.0270907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925983	Green Published, gold			2022-12-26	WOS:000848077100028
J	Alghannam, AF; Almasud, AA; Alghnam, SA; Alharbi, DS; Aljubairi, MS; Altalhi, AS; Jan, AM; Alothman, SA				Alghannam, Abdullah F.; Almasud, Alaa A.; Alghnam, Suliman A.; Alharbi, Dalal S.; Aljubairi, Mohanad S.; Altalhi, Arwa S.; Jan, Azad M.; Alothman, Shaima A.			Prevalence of sarcopenia among Saudis and its association with lifestyle behaviors: Protocol for cross-sectional study	PLOS ONE			English	Article							PHYSICAL PERFORMANCE BATTERY; GLYCEMIC LOAD VALUES; SLEEP QUALITY INDEX; MUSCLE MASS; OLDER-ADULTS; RISK-FACTORS; STRENGTH; SUPPLEMENTATION; ADOLESCENTS; RELIABILITY	BackgroundSarcopenia is an age-related muscular disease manifesting as a loss of muscle function and mass-leads to detrimental consequences at both individual and community levels. Modifiable lifestyle factors (such as physical behaviors and nutritional habits) may be involved in sarcopenia etiology. European Working Group on Sarcopenia in Older Population (EWGOSP2) established a cut-off point for sarcopenia diagnosis based on the European population and they recommend the use of a regional normative population. However, no sufficient data on sarcopenia prevalence is presently available in Saudi Arabia. Therefore, this project aims to define appropriate reference values from healthy Saudi young adults (Phase I) and to investigate the prevalence of sarcopenia in Saudi Arabia (Phase II) and examine selected modifiable lifestyle correlates of sarcopenia (Phase I, II). MethodsThe project will involve two phases. Phase I will include 1532 healthy Saudi young adults aged between 20-40 years. While, Phase II will include 1532 Saudi older adults aged >= 50 years. The study will measure vital signs, anthropometrics, muscle mass using bioelectrical impedance analysis and dual-energy X-ray absorptiometry, muscle strength using handgrip strength and maximal isometric strength, physical function using short physical performance battery, and 6-minute walk test to measure aerobic endurance. To explore the associations between lifestyle behaviors with sarcopenia indices, physical activity, sedentary behaviour and sleep will be evaluated subjectively using Global Physical Activity Questionnaire and Pittsburgh Sleep Quality Index and objectively via ActivPAL accelerometers. A three-day dietary food record will also be used to evaluate dietary intake. Additionally, EuroQOL five-dimension questionnaire will be utilized to assess health-related quality of life. DiscussionThe study will have significant implications in recognizing the prevalence of sarcopenia in Saudi population, which will guide our future interventional studies aimed at early prevention and treatment of this disease.	[Alghannam, Abdullah F.; Almasud, Alaa A.; Alharbi, Dalal S.; Aljubairi, Mohanad S.; Altalhi, Arwa S.; Jan, Azad M.; Alothman, Shaima A.] Princess Nourah Bint Abdulrahman Univ, Lifestyle & Hlth Res Ctr, Hlth Sci Res Ctr, Riyadh, Saudi Arabia; [Alghnam, Suliman A.] King Abdul Aziz Med City, King Abdullah Int Med Res Ctr, Natl Guard Hlth Affairs, Riyadh, Saudi Arabia	Princess Nourah bint Abdulrahman University; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdullah International Medical Research Center (KAIMRC); Ministry of National Guard - Health Affairs; National Guard Health Affairs - Saudi Arabia	Alghannam, AF (corresponding author), Princess Nourah Bint Abdulrahman Univ, Lifestyle & Hlth Res Ctr, Hlth Sci Res Ctr, Riyadh, Saudi Arabia.	AFAlghannam@pnu.edu.sa	Alghannam, Abdullah/AAI-2235-2019	Alghannam, Abdullah/0000-0002-6118-7337	Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia [PNURSP2022R309]; Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia	Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia(Princess Nourah bint Abdulrahman University); Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia(Princess Nourah bint Abdulrahman University)	This research project is funded by Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2022R309), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	da Camara SMA, 2013, GERIATR GERONTOL INT, V13, P421, DOI 10.1111/j.1447-0594.2012.00920.x; Akune T, 2014, GERIATR GERONTOL INT, V14, P695, DOI 10.1111/ggi.12155; Alkahtani SA, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1483-7; Alzaben AS, 2015, CAN J DIET PRACT RES, V76, P56, DOI 10.3148/cjdpr-2014-040; [Anonymous], 2018, M6284ICDC102018; Antunes AC, 2017, NUTR DIET, V74, P46, DOI 10.1111/1747-0080.12287; Armstrong T, 2006, J PUBLIC HEALTH-HEID, V14, P66, DOI 10.1007/s10389-006-0024-x; Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Beaudart C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169548; Bekairy Abdulkareem M, 2018, Int J Health Sci (Qassim), V12, P16; Buckinx F, 2018, J CACHEXIA SARCOPENI, V9, P269, DOI 10.1002/jcsm.12268; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chang KV, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.09.013; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2019, LANCET, V393, P2636, DOI 10.1016/S0140-6736(19)31138-9; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Cruz-Jentoft AJ, 2017, AGING CLIN EXP RES, V29, P43, DOI 10.1007/s40520-016-0709-0; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; De Buyser SL, 2016, AGE AGEING, V45, P603, DOI 10.1093/ageing/afw071; de Courten M., 2002, AUSTRALASIAN EPIDEMI, V9, P6, DOI DOI 10.3316/INFORMIT.432366132879428; Dent E, 2018, J NUTR HEALTH AGING, V22, P1148, DOI 10.1007/s12603-018-1139-9; Dodds RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113637; Doyle C, 2019, J SPORT MED PHYS FIT, V59, P1221, DOI 10.23736/S0022-4707.18.09186-7; Duque G, 2021, J NUTR HEALTH AGING, V25, P716, DOI 10.1007/s12603-021-1640-4; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Francis P, 2017, CLIN PHYSIOL FUNCT I, V37, P448, DOI 10.1111/cpf.12332; Freiberger E, 2012, AGE AGEING, V41, P712, DOI 10.1093/ageing/afs099; Freire AN, 2012, J AGING HEALTH, V24, P863, DOI 10.1177/0898264312438551; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; General Authority for Statistics SA, 2017, POPULATION ESTIMATES; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Janssen I, 2000, J APPL PHYSIOL, V89, P81; JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362; Kim H, 2013, GERIATR GERONTOL INT, V13, P458, DOI 10.1111/j.1447-0594.2012.00923.x; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Lauretani F, 2019, AGING CLIN EXP RES, V31, P1435, DOI 10.1007/s40520-018-1082-y; Luhrmann PM, 1999, EUR J NUTR, V38, P235, DOI 10.1007/s003940050066; Lyden K, 2017, MED SCI SPORT EXER, V49, P1022, DOI 10.1249/MSS.0000000000001177; Mager DR, 2015, JPEN-PARENTER ENTER, V39, P73, DOI 10.1177/0148607113501201; Malmstrom TK, 2016, J CACHEXIA SARCOPENI, V7, P28, DOI 10.1002/jcsm.12048; Maltais ML, 2016, J STRENGTH COND RES, V30, P1680, DOI 10.1519/JSC.0000000000001255; Mayhew AJ, 2019, AGE AGEING, V48, P48, DOI 10.1093/ageing/afy106; McLean RR, 2014, J GERONTOL A-BIOL, V69, P576, DOI 10.1093/gerona/glu012; Morley JE, 2011, J AM MED DIR ASSOC, V12, P403, DOI 10.1016/j.jamda.2011.04.014; Nascimento CM, 2019, FREE RADICAL BIO MED, V132, P42, DOI 10.1016/j.freeradbiomed.2018.08.035; Pourhoseingholi Mohamad Amin, 2013, Gastroenterol Hepatol Bed Bench, V6, P14; Prevention CfDCa, 2018, HLTH REL QUAL LIF HR; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Rondanelli M, 2016, AM J CLIN NUTR, V103, P830, DOI 10.3945/ajcn.115.113357; Rosenberg IH, 2011, CLIN GERIATR MED, V27, P337, DOI 10.1016/j.cger.2011.03.003; Sayer AA, 2008, J NUTR HEALTH AGING, V12, P427, DOI 10.1007/BF02982703; Schaap LA, 2018, J GERONTOL A-BIOL, V73, P1199, DOI 10.1093/gerona/glx245; Shafiee G, 2017, J DIABETES METAB DIS, V16, DOI 10.1186/s40200-017-0299-1; Silva AM, 2010, AM J HUM BIOL, V22, P76, DOI 10.1002/ajhb.20956; Sousa AS, 2016, EUR J CLIN NUTR, V70, P1046, DOI 10.1038/ejcn.2016.73; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Suleiman KH, 2010, WESTERN J NURS RES, V32, P250, DOI 10.1177/0193945909348230; THORSTENSSON A, 1976, J APPL PHYSIOL, V40, P12, DOI 10.1152/jappl.1976.40.1.12; UN (United Nations Department of Economic and Social Affairs Population Division), 2019, STESASERA427 UN POP; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	62	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271672	http://dx.doi.org/10.1371/journal.pone.0271672			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917305	gold, Green Published			2022-12-26	WOS:000837840000024
J	Cartereau, A; Pineau, X; Lebreton, J; Mathe-Allainmat, M; Taillebois, E; Thany, SH				Cartereau, Alison; Pineau, Xavier; Lebreton, Jacques; Mathe-Allainmat, Monique; Taillebois, Emiliane; Thany, Steeve H.			Impairments in learning and memory performances associated with nicotinic receptor expression in the honeybee Apis mellifera after exposure to a sublethal dose of sulfoxaflor	PLOS ONE			English	Article							PROBOSCIS EXTENSION RESPONSE; NEONICOTINOID INSECTICIDES; SUBCHRONIC EXPOSURE; BEE; PESTICIDES; GENES; THIAMETHOXAM; RETRIEVAL; SUBUNITS; BRAIN	Sulfoxaflor is a new insecticide which acts on the nicotinic acetylcholine receptor (nAChRs) in a similar way to neonicotinoids. However, sufloxaflor (SFX) is thought to act in a different manner and is thus proposed as an alternative in crop protection. The goal of this study is to evaluate the toxicity of SFX and its sublethal effect on the honeybee Apis mellifera after acute exposure. In toxicological assay studies, the LD50 value and sublethal dose (corresponding to the NOEL: no observed effect level) were 96 and 15 ng/bee, respectively. Using the proboscis extension response paradigm, we found that an SFX dose of 15 ng/bee significantly impairs learning and memory retrieval when applied 12 h before conditioning or 24 h after olfactory conditioning. SFX had no effect on honeybee olfactory performance when exposure happened after the conditioning. Relative quantitative PCR experiments performed on the six nicotinic acetylcholine receptor subunits demonstrated that they are differently expressed in the honeybee brain after SFX exposure, whether before or after conditioning. We found that intoxicated bees with learning defects showed a strong expression of the Amel beta 1 subunit. They displayed overexpression of Amel alpha 9 and Amel beta 2, and down-regulation of Amel alpha 1, Amel alpha 3 and Amel alpha 7 subunits. These results demonstrated for the first time that a sublethal dose of SFX could affect honeybee learning and memory performance and modulate the expression of specific nAChR subunits in the brain.	[Cartereau, Alison; Pineau, Xavier; Taillebois, Emiliane; Thany, Steeve H.] Univ Orleans, Lab Biol Ligneux & Grandes Cultures LBLGC, USC INRAE 1328, Orleans, France; [Lebreton, Jacques; Mathe-Allainmat, Monique] Univ Nantes, CEISAM UMR CNRS 6230, UFR Sci & Tech, Nantes, France	INRAE; Universite de Orleans; Nantes Universite	Thany, SH (corresponding author), Univ Orleans, Lab Biol Ligneux & Grandes Cultures LBLGC, USC INRAE 1328, Orleans, France.	steeve.thany@univ-orleans.fr		THANY, Steeve/0000-0002-4333-177X	French Agency for Food, Environmental and Occupational Health and Safety (ANSES), EVALSUB project [2020/01/214]	French Agency for Food, Environmental and Occupational Health and Safety (ANSES), EVALSUB project	This work was funded by a grant from the French Agency for Food, Environmental and Occupational Health and Safety (ANSES), EVALSUB project N degrees 2020/01/214. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arndt KE, 2015, ORG PROCESS RES DEV, V19, P454, DOI 10.1021/acs.oprd.5b00007; Babcock JM, 2011, PEST MANAG SCI, V67, P328, DOI 10.1002/ps.2069; Bacci L., 2018, Journal of Entomological and Acarological Research, V50, P51, DOI 10.4081/jear.2018.7836; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benzidane Y, 2017, NEUROTOXICOLOGY, V62, P239, DOI 10.1016/j.neuro.2017.08.001; Boff S, 2021, ECOTOX ENVIRON SAFE, V211, DOI 10.1016/j.ecoenv.2020.111869; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cabirol A, 2019, INSECTS, V10, DOI 10.3390/insects10100344; Cabirol A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196749; Cartereau A, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00418; Casida JE, 2009, CHEM RES TOXICOL, V22, P609, DOI 10.1021/tx8004949; Christen V, 2016, ENVIRON SCI TECHNOL, V50, P4071, DOI 10.1021/acs.est.6b00678; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dupuis J, 2012, NEUROSCI BIOBEHAV R, V36, P1553, DOI 10.1016/j.neubiorev.2012.04.003; Dupuis JP, 2011, J NEUROPHYSIOL, V106, P1604, DOI 10.1152/jn.00126.2011; Emami Mohammad Saeed, 2016, Archives of Phytopathology and Plant Protection, V49, P11, DOI 10.1080/03235408.2016.1147122; European Commission, 2013, OFFICIAL J EUROPEAN, V56, P12, DOI [10.2903/j.efsa.2013.3067, DOI 10.2903/J.EFSA.2013.3067]; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3814; Fairbrother A, 2014, ENVIRON TOXICOL CHEM, V33, P719, DOI 10.1002/etc.2527; Gauthier M., 2012, HONEYBEE NEUROBIOLOG, P155, DOI DOI 10.1007/978-94-007-2099-213; Gauthier M, 2006, NEUROBIOL LEARN MEM, V86, P164, DOI 10.1016/j.nlm.2006.02.003; Gauthier M, 2010, ADV EXP MED BIOL, V683, P97; Giurfa M, 2012, LEARN MEMORY, V19, P54, DOI 10.1101/lm.024711.111; Grunewald B, 2019, INSECTS, V10, DOI 10.3390/insects10120420; HENDERSON CF, 1955, J ECON ENTOMOL, V48, P157, DOI 10.1093/jee/48.2.157; Houchat JN, 2019, NEUROTOXICOLOGY, V74, P132, DOI 10.1016/j.neuro.2019.06.003; Iqbal J, 2019, NEOTROP ENTOMOL, V48, P373, DOI 10.1007/s13744-018-0651-2; Iqbal J, 2019, SAUDI J BIOL SCI, V26, P563, DOI 10.1016/j.sjbs.2018.08.002; Iturbe-Requena SL, 2020, CHEMOSPHERE, V242, DOI 10.1016/j.chemosphere.2019.125293; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Jones AK, 2006, GENOME RES, V16, P1422, DOI 10.1101/gr.4549206; Kablau A, 2020, PESTIC BIOCHEM PHYS, V170, DOI 10.1016/j.pestbp.2020.104703; Kadala A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39193-3; Lansdell SJ, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-73; Li ZG, 2017, PESTIC BIOCHEM PHYS, V140, P1, DOI 10.1016/j.pestbp.2017.06.010; Louis T, 2012, EUR J NEUROSCI, V36, P3438, DOI 10.1111/j.1460-9568.2012.08261.x; Lozano VC, 1996, BEHAV BRAIN RES, V81, P215, DOI 10.1016/S0166-4328(96)89081-4; Lozano VC, 2001, J COMP PHYSIOL A, V187, P249, DOI 10.1007/s003590100196; Markussen MDK, 2010, PEST MANAG SCI, V66, P1257, DOI 10.1002/ps.2007; Matsumoto Y, 2012, J NEUROSCI METH, V211, P159, DOI 10.1016/j.jneumeth.2012.08.018; Menail AH, 2020, ENTOMOL GEN, V40, P207, DOI 10.1127/entomologia/2020/0796; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Moon K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200369; Mustard JA, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.217174; OECD (Organization for Economic Co-operation and Development), 1998, FISH SHORT TERM TOX; Perry T, 2021, INSECT BIOCHEM MOLEC, V131, DOI 10.1016/j.ibmb.2021.103547; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phelps JD, 2020, ECOTOXICOLOGY, V29, P359, DOI 10.1007/s10646-020-02182-8; Rinkevich FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139841; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Salgado VL, 2021, PEST MANAG SCI, V77, P3663, DOI 10.1002/ps.6396; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Shi TF, 2017, J ECON ENTOMOL, V110, P2283, DOI 10.1093/jee/tox262; Siviter H, 2019, PEERJ, V7, DOI 10.7717/peerj.7208; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Taillebois E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096669; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; Tamburini G, 2021, SCI TOTAL ENVIRON, V778, DOI 10.1016/j.scitotenv.2021.146084; Tesovnik T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187079; Thany SH, 2005, GENE, V344, P125, DOI 10.1016/j.gene.2004.09.010; Thany SH, 2003, INSECT MOL BIOL, V12, P255, DOI 10.1046/j.1365-2583.2003.00409.x; Thorbek P, 2017, ENVIRON TOXICOL CHEM, V36, P831, DOI 10.1002/etc.3581; Tison L, 2019, ECOTOX ENVIRON SAFE, V180, P139, DOI 10.1016/j.ecoenv.2019.05.007; Tison L, 2017, J EXP BIOL, V220, P3695, DOI 10.1242/jeb.154518; Tong LD, 2019, CHEMOSPHERE, V237, DOI 10.1016/j.chemosphere.2019.124408; Tosi S, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0433; Wang X, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev080; Watson GB, 2021, PESTIC BIOCHEM PHYS, V178, DOI 10.1016/j.pestbp.2021.104924; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Xu XY, 2020, J MOL GRAPH MODEL, V98, DOI 10.1016/j.jmgm.2020.107586; Yu XL, 2011, ARCH INSECT BIOCHEM, V77, P163, DOI 10.1002/arch.20432; Zhu YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176837; Zhu YM, 2011, J AGR FOOD CHEM, V59, P2950, DOI 10.1021/jf102765x	77	0	0	14	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8							e0272514	10.1371/journal.pone.0272514	http://dx.doi.org/10.1371/journal.pone.0272514			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921304	Green Published, gold			2022-12-26	WOS:000839311900057
J	Low, YL; Wong, SY; Lee, EKH; Muhammed, MH				Low, Yoke Lee; Wong, Shin Yee; Lee, Eric Kim Hor; Muhammed, Mohd Hareeff			Prevalence of respiratory viruses among paediatric patients in acute respiratory illnesses in Malaysia	PLOS ONE			English	Article							SEASONAL INFLUENZA; INFECTIONS; CHILDREN; EPIDEMIOLOGY	ObjectivesAcute respiratory infections (ARIs) are one of the leading causes of childhood morbidity and mortality worldwide. However, there is limited surveillance data on the epidemiological burden of respiratory pathogens in tropical countries like Malaysia. This study aims to estimate the prevalence of respiratory pathogens causing ARIs among children aged MethodsNasopharyngeal swab specimens received at 12 laboratories located in different states of Malaysia from 2015-2019 were studied. Detection of 18 respiratory pathogens were performed using multiplex PCR. ResultsData from a total of 23,306 paediatric patients who presented with ARI over a five-year period was studied. Of these, 18538 (79.5%) were tested positive. The most prevalent respiratory pathogens detected in this study were enterovirus/ rhinovirus (6837/ 23000; 29.7%), influenza virus (5176/ 23000; 22.5%) and respiratory syncytial virus (RSV) (3652/ 23000; 15.9%). Throughout the study period, RSV demonstrated the most pronounce seasonality; peak infection occurred during July to September. Whereas the influenza virus was detected year-round in Malaysia. No seasonal variation was noted in other respiratory pathogens. The risk of RSV hospitalisation was found to be significantly higher in children aged less than two years old, whereas hospitalisation rates for the influenza virus peaked at children aged between 3-6 years old. ConclusionThis study provides insight into the epidemiology and the seasonality of the causative pathogens of ARI among the paediatric population in Malaysia. Knowledge of seasonal respiratory pathogens epidemiological dynamics will facilitate the identification of a target window for vaccination.	[Low, Yoke Lee; Muhammed, Mohd Hareeff] Pantai Premier Pathol Sdn Bhd, Kuala Lumpur, Malaysia; [Wong, Shin Yee; Lee, Eric Kim Hor] Pantai Hosp Kuala Lumpur, Kuala Lumpur, Malaysia		Low, YL (corresponding author), Pantai Premier Pathol Sdn Bhd, Kuala Lumpur, Malaysia.	yokelee.low@premierpathology.com.my		Low, YokeLee/0000-0002-2833-9466				Abubakar I., 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Anders KL, 2015, PEDIATR INFECT DIS J, V34, P361, DOI 10.1097/INF.0000000000000643; Assane Dieng, 2018, Microbiol Insights, V11, p1178636118758651, DOI 10.1177/1178636118758651; Bellau-Pujol S, 2005, J VIROL METHODS, V126, P53, DOI 10.1016/j.jviromet.2005.01.020; Bicer S, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-22; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Broor S, 2020, INFLUENZA OTHER RESP, V14, P622, DOI 10.1111/irv.12672; Chauhan JC, 2017, PEDIATR CRIT CARE ME, V18, pE333, DOI 10.1097/PCC.0000000000001232; Dagne H, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-1997-2; Das S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02478; Dong W, 2016, ARCH VIROL, V161, P1907, DOI 10.1007/s00705-016-2866-z; Fan J, 1998, CLIN INFECT DIS, V26, P1397, DOI 10.1086/516357; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Gulen F, 2014, TURK PEDIATR ARSIVI, V49, P42, DOI 10.5152/tpa.2014.1121; Homaira N, 2019, J INFECT DIS, V220, P550, DOI 10.1093/infdis/jiy671; Hong KW, 2015, JPN J INFECT DIS, V68, P20, DOI 10.7883/yoken.JJID.2013.466; Khor CS, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-32; Lee MW, 2021, SINGAP MED J, V62, P642, DOI 10.11622/smedj.2020075; Lim FJ, 2016, RESPIROLOGY, V21, P648, DOI 10.1111/resp.12741; Loeffelholz Michael, 2010, Int J Microbiol, V2010, P126049, DOI 10.1155/2010/126049; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Mancinelli L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-015-1333-x; Ministry of Health, MAL HLTH FACT 2019; Monto AS, 2002, AM J MED, V112, p4S; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Piedimonte G, 2014, PEDIATR REV, V35, P519, DOI 10.1542/pir.35-12-519; Saat Z, 2010, SE ASIAN J TROP MED, V41, P1368; Sloots TP, 2008, J CLIN VIROL, V42, P233, DOI 10.1016/j.jcv.2008.03.002; Soto JA, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01507; Sullivan Sheena G, 2019, Ther Adv Vaccines Immunother, V7, p2515135519826481, DOI 10.1177/2515135519826481; Thongpan I., 2020, SCI REP-UK, V10, P1; van der Zalm MM, 2009, J PEDIATR-US, V154, P396, DOI 10.1016/j.jpeds.2008.08.036; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Wang X, 2020, LANCET GLOB HEALTH, V8, pE497, DOI 10.1016/S2214-109X(19)30545-5; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Xu B, 2021, LANCET PLANET HEALTH, V5, pE154, DOI 10.1016/S2542-5196(20)30297-7; Yew SM, 2019, J THORAC DIS, V11, P4626, DOI 10.21037/jtd.2019.10.69; Young BE, 2020, HUM VACC IMMUNOTHER, V16, P1659, DOI 10.1080/21645515.2019.1703455; Yuan HK, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009050	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0265288	http://dx.doi.org/10.1371/journal.pone.0265288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921317	gold, Green Published			2022-12-26	WOS:000839311900008
J	Zhang, Q; Li, D; Zhao, HH; Zhang, X				Zhang, Qi; Li, Dan; Zhao, Haihua; Zhang, Xu			Decitabine attenuates ischemic stroke by reducing astrocytes proliferation in rats	PLOS ONE			English	Article							EPIGENETIC REGULATION; DNA METHYLATION; SCAR FORMATION; PROTECTION; P27(KIP1); CELL; NEURODEGENERATION	DNA methylation regulates epigenetic gene expression in ischemic stroke. Decitabine attenuates ischemic stroke by inhibiting DNA methylation. However, the underlying mechanism of this effect is not known. A model of ischemic stroke in Sprague-Dawley rats was induced through middle cerebral artery occlusion followed by reperfusion step. The rats were randomly treated with decitabine or vehicle by a one-time intraperitoneal injection. Sham rats received similar treatments. Four days after treatment, the rats were perfused with saline or 4% paraformaldehyde after which the brain was excised. DNA methylation level and brain infarct volume were determined by dot blot and histochemistry, respectively. The cellular co-localization and quantitative analysis of DNA methylation were assessed by immunohistochemistry and expression levels of cdkn1b (p27) mRNA and protein were measured by qRT-PCR and immunohistochemistry, respectively. The proliferation of astrocytes and number of neurons were determined by immunohistochemistry. Rats treated with decitabine showed hypomethylation and reduced infarct volume in the cortex. DNA methylation was decreased in astrocytes. Decitabine upregulated p27 mRNA and protein expression levels and attenuated the proliferation of astrocytes in vivo and vitro. Decitabine promotes p27 gene expression possibly by inhibiting its DNA methylation, thereby decreases the proliferation of astrocytes, neuronal death and infarct volume after ischemic stroke.	[Zhang, Qi; Li, Dan; Zhao, Haihua; Zhang, Xu] China Med Univ, Coll Basic Med Sci, Dept Human Anat, Shenyang, Peoples R China	China Medical University	Zhang, X (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Human Anat, Shenyang, Peoples R China.	xzhang76@cmu.edu.cn						Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Chan SL, 2018, STROKE, V49, P1969, DOI 10.1161/STROKEAHA.118.022056; Cheng X, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1597-y; Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011; Choi IA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072019; Choudhury GR, 2016, NEUROBIOL DIS, V85, P234, DOI 10.1016/j.nbd.2015.05.003; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; Demyanenko SV, 2020, MOL NEUROBIOL, V57, P226, DOI 10.1007/s12035-019-01772-w; Dock H, 2015, TRANSL STROKE RES, V6, P296, DOI 10.1007/s12975-015-0397-7; Endres M, 2000, J NEUROSCI, V20, P3175, DOI 10.1523/JNEUROSCI.20-09-03175.2000; Feliciello I, 2013, EPIGENETICS-US, V8, P534, DOI 10.4161/epi.24507; Hauck L, 2008, NAT MED, V14, P315, DOI 10.1038/nm1729; Hira K, 2018, STROKE, V49, P2483, DOI 10.1161/STROKEAHA.118.021272; Hu ZP, 2017, MOL NEUROBIOL, V54, P1887, DOI 10.1007/s12035-016-9788-3; Hwang JY, 2017, NAT REV NEUROSCI, V18, P347, DOI 10.1038/nrn.2017.46; Koguchi K, 2002, GLIA, V37, P93, DOI 10.1002/glia.10017; Kostuk EW, 2019, GLIA, V67, P1542, DOI 10.1002/glia.23627; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Liang CC, 2017, STEM CELL TRANSL MED, V6, P1227, DOI 10.1002/sctm.16-0212; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liddelow SA, 2016, NATURE, V532, P182, DOI 10.1038/nature17318; Liu F, 2014, NEPHROL DIAL TRANSPL, V29, P1879, DOI 10.1093/ndt/gfu202; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loris ZB, 2018, TRANSL STROKE RES, V9, P146, DOI 10.1007/s12975-017-0565-z; Neal M, 2018, BBA-MOL BASIS DIS, V1864, P432, DOI 10.1016/j.bbadis.2017.11.004; Sandvig I, 2018, EUR J NEUROSCI, V47, P1414, DOI 10.1111/ejn.13959; Secondo A, 2019, STROKE, V50, P1240, DOI 10.1161/STROKEAHA.118.024115; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Vartak-Sharma N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-195; Weng YL, 2013, NEUROTHERAPEUTICS, V10, P556, DOI 10.1007/s13311-013-0223-4; Yang QL, 2016, MOL NEUROBIOL, V53, P436, DOI 10.1007/s12035-014-9027-8; Yong-Quan G, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418771815; Zhang RR, 2018, CELL DEATH DIFFER, V25, P1503, DOI 10.1038/s41418-018-0058-y; Zhang X, 2019, BRAIN RES BULL, V146, P136, DOI 10.1016/j.brainresbull.2018.11.003; Zhao HP, 2016, AGING DIS, V7, P295, DOI 10.14336/AD.2015.1009	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272482	http://dx.doi.org/10.1371/journal.pone.0272482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917376	Green Published, gold			2022-12-26	WOS:000837840000019
J	Partipilo, M; Yang, G; Mascotti, ML; Wijma, HJ; Slotboom, DJ; Fraaije, MW				Partipilo, Michele; Yang, Guang; Mascotti, Maria Laura; Wijma, Hein J.; Slotboom, Dirk Jan; Fraaije, Marco W.			A conserved sequence motif in the Escherichia coli soluble FAD-containing pyridine nucleotide transhydrogenase is important for reaction efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COFACTOR REGENERATION; PHYSIOLOGICAL ROLES; GENE; UDHA; DEHYDROGENASE; METABOLISM; FLAVINS; CLONING; OXYGEN; PNTAB	Soluble pyridine nucleotide transhydrogenases (STHs) are flavoenzymes involved in the redox homeostasis of the essential cofactors NAD(H) and NADP(H). They catalyze the reversible transfer of reducing equivalents between the two nicotinamide cofactors. The soluble transhydrogenase from Escherichia coli (SthA) has found wide use in both in vivo and in vitro applications to steer reducing equivalents toward NADPH-requiring reactions. However, mechanistic insight into SthA function is still lacking. In this work, we present a biochemical characterization of SthA, focusing for the first time on the reactivity of the flavoenzyme with molecular oxygen. We report on oxidase activity of SthA that takes place both during transhydrogenation and in the absence of an oxidized nicotinamide cofactor as an electron acceptor. We find that this reaction produces the reactive oxygen species hydrogen peroxide and superoxide anion. Furthermore, we explore the evolutionary significance of the well-conserved CXXXXT motif that distinguishes STHs from the related family of flavoprotein disulfide reductases in which a CXXXXC motif is conserved. Our mutational analysis revealed the cysteine and threonine combination in SthAleads to better coupling efficiency of transhydrogenation and reduced reactive oxygen species release compared to enzyme variants with mutated motifs. These results expand our mechanistic understanding of SthA by high-lighting reactivity with molecular oxygen and the importance of the evolutionarily conserved sequence motif.	[Partipilo, Michele; Slotboom, Dirk Jan] Univ Groningen, Groningen Inst Biomol Sci & Biotechnol, Membrane Enzymol Grp, Groningen, Netherlands; [Yang, Guang; Mascotti, Maria Laura; Wijma, Hein J.; Fraaije, Marco W.] Univ Groningen, Groningen Inst Biomol Sci & Biotechnol, Mol Enzymol Grp, Groningen, Netherlands; [Mascotti, Maria Laura] Univ Nacl San Luis, Fac Quim Bioquim & Farm, IMIBIO SL CONICET, San Luis, Argentina	University of Groningen; University of Groningen; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Luis	Slotboom, DJ (corresponding author), Univ Groningen, Groningen Inst Biomol Sci & Biotechnol, Membrane Enzymol Grp, Groningen, Netherlands.; Fraaije, MW (corresponding author), Univ Groningen, Groningen Inst Biomol Sci & Biotechnol, Mol Enzymol Grp, Groningen, Netherlands.	d.j.slotboom@rug.nl; m.w.fraaije@rug.nl	; Wijma, Hein Jakob/A-8761-2014; Mascotti, Maria Laura/H-9501-2017	Partipilo, Michele/0000-0003-4150-2341; Wijma, Hein Jakob/0000-0003-0891-6972; Mascotti, Maria Laura/0000-0002-5817-4631	NWO Gravitation program (Building a Synthetic Cell) [024.003.019]; Chinese Scholarship Council (CSC); oLIFE fellowship, European Union's Horizon 2020 research and innovation programme [847675CO-FUND]	NWO Gravitation program (Building a Synthetic Cell); Chinese Scholarship Council (CSC)(China Scholarship Council); oLIFE fellowship, European Union's Horizon 2020 research and innovation programme	M. P. and D. J. S. were supported by the NWO Gravitation program (Building a Synthetic Cell) grant 024.003.019. G. Y. was supported by a Chinese Scholarship Council (CSC) scholarship. M. L. M. was supported by an oLIFE fellowship, European Union's Horizon 2020 research and innovation programme, Grant/Award Number: 847675CO-FUND.	Aliverti A, 1999, METH MOL B, V131, P9; ANDERSON BM, 1963, BIOCHEMISTRY-US, V2, P1017, DOI 10.1021/bi00905a019; Argyrou A, 2004, PROG NUCLEIC ACID RE, V78, P89, DOI 10.1016/S0079-6603(04)78003-4; Blank LM, 2010, ANTIOXID REDOX SIGN, V13, P349, DOI 10.1089/ars.2009.2931; Boonstra B, 1999, J BACTERIOL, V181, P1030, DOI 10.1128/JB.181.3.1030-1034.1999; Boonstra B, 2000, FEMS MICROBIOL LETT, V191, P87, DOI 10.1016/S0378-1097(00)00375-X; Boonstra B, 2000, APPL ENVIRON MICROB, V66, P5161, DOI 10.1128/AEM.66.12.5161-5166.2000; Bowie JU, 2020, TRENDS BIOTECHNOL, V38, P766, DOI 10.1016/j.tibtech.2019.12.024; BUTLER J, 1975, BIOCHIM BIOPHYS ACTA, V408, P215, DOI 10.1016/0005-2728(75)90124-3; Cao ZY, 2022, CURR MICROBIOL, V79, DOI 10.1007/s00284-021-02727-y; Cao ZY, 2011, FEMS MICROBIOL LETT, V320, P9, DOI 10.1111/j.1574-6968.2011.02287.x; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Catucci G, 2019, FREE RADICAL BIO MED, V145, P250, DOI 10.1016/j.freeradbiomed.2019.09.038; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; CHUNG AE, 1970, J BACTERIOL, V102, P438, DOI 10.1128/JB.102.2.438-447.1970; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Federowicz S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004264; Gran-Scheuch A., 2021, ACS SUSTAIN CHEM ENG, DOI [10.1021/acssuschemeng.1c02012, DOI 10.1021/ACSSUSCHEMENG.1C02012]; GUNSALUS RP, 1994, RES MICROBIOL, V145, P437, DOI 10.1016/0923-2508(94)90092-2; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; HOEK JB, 1988, BIOCHEM J, V254, P1; Huvet M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-721; Jackson JB, 2003, FEBS LETT, V545, P18, DOI 10.1016/S0014-5793(03)00388-0; Jan J, 2013, BIOTECHNOL PROGR, V29, P1124, DOI 10.1002/btpr.1765; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; KAPLAN NO, 1952, J BIOL CHEM, V195, P107; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kitatsuji C., 2016, SCI REP-UK, V6, P1; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; Lemoine F, 2018, NATURE, V556, P452, DOI 10.1038/s41586-018-0043-0; Liu JH, 2018, J IND MICROBIOL BIOT, V45, P313, DOI 10.1007/s10295-018-2031-7; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Mouri T, 2009, BIOTECHNOL PROGR, V25, P1372, DOI 10.1002/btpr.231; Partipilo M, 2021, JACS AU, V1, P2280, DOI 10.1021/jacsau.1c00406; REYNAFARJE B, 1985, ANAL BIOCHEM, V145, P406, DOI 10.1016/0003-2697(85)90381-1; Robinson R, 2011, BIOCHEMISTRY-US, V50, P8489, DOI 10.1021/bi200933h; Rogozin IB, 2002, NUCLEIC ACIDS RES, V30, P2212, DOI 10.1093/nar/30.10.2212; RydstroM J., 1976, ENZYME, V13, P51; Sanchez AM, 2006, BIOTECHNOL PROGR, V22, P420, DOI 10.1021/bp050375u; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Shi T, 2018, SYN SYST BIOTECHNO, V3, P186, DOI 10.1016/j.synbio.2018.05.002; STORZ G, 1992, J NUTR, V122, P627, DOI 10.1093/jn/122.suppl_3.627; Valentino H, 2019, METHOD ENZYMOL, V620, P51, DOI 10.1016/bs.mie.2019.03.006; van Berkel WJH, 1999, METH MOL B, V131, P61; van Rijsewijk BRBH, 2016, MICROBIOL-SGM, V162, P1672, DOI 10.1099/mic.0.000346; VANDENBROEK HW, 1971, EUR J BIOCHEM, V24, P46; WANG R, 1991, BIOCHEMISTRY-US, V30, P7895, DOI 10.1021/bi00246a004; Wang ZK, 2012, BIOCHEM ENG J, V67, P126, DOI 10.1016/j.bej.2012.06.006; Xu W, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1415-x; Zhao HJ, 2008, ANN MICROBIOL, V58, P275, DOI 10.1007/BF03175329	53	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102304	10.1016/j.jbc.2022.102304	http://dx.doi.org/10.1016/j.jbc.2022.102304			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9EO	35933012	Green Published, gold			2022-12-26	WOS:000863182500011
J	Zhu, Q; Wang, DH; Liang, F; Tong, X; Liang, ZY; Wang, XY; Chen, YS; Mo, DL				Zhu, Qi; Wang, Dinghui; Liang, Feng; Tong, Xian; Liang, Ziyun; Wang, Xiaoyu; Chen, Yaosheng; Mo, Delin			Protein arginine methyltransferase PRMT1 promotes adipogenesis by modulating transcription factors C/EBP beta and PPAR gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE REGULATOR; HISTONE H4; METHYLATION; WNT; ACTIVATION; STABILITY; EXPANSION; AXIN	Protein arginine methyltransferase 1 (PRMT1) methylates a variety of histone and nonhistone protein substrates to regulate multiple cellular functions such as transcription, DNA damage response, and signal transduction. It has been reported as an emerging regulator of various metabolic pathways including glucose metabolism in the liver, atrophy in the skeletal muscle, and lipid catabolism in the adipose tissue. However, the underlying mechanisms governing how PRMT1 regulates adipogenesis remain elusive. Here, we delineate the roles of PRMT1 in mitotic clonal expansion and adipocyte differentiation. Gain and loss of functions demonstrate that PRMT1 is essential for adipogenesis of 3T3-L1 and C3H10T1/2 cells. Mechanistically, we show PRMT1 promotes the expression of transcription factor peroxisome proliferator-activated receptor-gamma (PPAR gamma) by catalyzing histone modification H4R3me2a and impedes the activation of Wnt/beta-catenin signaling by increasing the level of Axin to accelerate adipogenic differentiation. In addition, we demonstrate mitotic clonal expansion is suppressed by PRMT1 deficiency. PRMT1 interacts with transcription factor CCATT enhancer-binding protein beta (C/ EBP beta), and the absence of PRMT1 leads to the depressed phosphorylation of C/EBP beta. Interestingly, we discover PRMT1 acts as a positive regulator of C/EBP beta protein stability through decreasing the level of E3 ubiquitin ligase Smurf2, which promotes the ubiquitination and degradation of C/EBP beta, thus facilitating adipogenesis. Collectively, these discoveries highlight a critical role of PRMT1 in adipogenesis and provide potential therapeutic targets for the treatment of obesity.	[Zhu, Qi; Wang, Dinghui; Liang, Feng; Tong, Xian; Liang, Ziyun; Wang, Xiaoyu; Chen, Yaosheng; Mo, Delin] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Mo, DL (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.	modelin@mail.sysu.edu.cn			National Natural Science Foundation of China [32072697]; Science and Technology Project of Zhanjiang [2019A01004]; Key-Area Research and Development Program of Guangxi Province [AB19245030]; China Agriculture Research System [CASR-35]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Zhanjiang; Key-Area Research and Development Program of Guangxi Province; China Agriculture Research System	We are grateful to School of Life Sciences of Sun Yat-sen University, Guangdong Provincial State Key Laboratory of Bio-control, China Agriculture Research. This research was supported by the National Natural Science Foundation of China (32072697), the Science and Technology Project of Zhanjiang (2019A01004), the Key-Area Research and Development Program of Guangxi Province (AB19245030), and China Agriculture Research System (CASR-35).	Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bissinger EM, 2011, BIOORGAN MED CHEM, V19, P3717, DOI 10.1016/j.bmc.2011.02.032; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Cha B, 2011, ONCOGENE, V30, P2379, DOI 10.1038/onc.2010.610; Cha B, 2015, MOL CELLS, V38, P723, DOI 10.14348/molcells.2015.0113; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen L, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101275; Choi D, 2012, HEPATOLOGY, V56, P1546, DOI 10.1002/hep.25809; Choi S, 2021, DIABETES, V70, P1664, DOI 10.2337/db20-1050; Choi S, 2019, AUTOPHAGY, V15, P1069, DOI 10.1080/15548627.2019.1569931; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Ghaben AL, 2019, NAT REV MOL CELL BIO, V20, P242, DOI 10.1038/s41580-018-0093-z; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Hwang JW, 2019, INT J MOL MED, V43, P2462, DOI 10.3892/ijmm.2019.4147; Jackson-Weaver O, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107739; Jeffery E, 2015, NAT CELL BIOL, V17, P376, DOI 10.1038/ncb3122; Jia ZH, 2020, ADV SCI, V7, DOI 10.1002/advs.202002602; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kim S, 2010, J BIOL CHEM, V285, P36420, DOI 10.1074/jbc.M110.137471; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; Krstic J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092622; LeBlanc SE, 2012, MOL ENDOCRINOL, V26, P583, DOI 10.1210/me.2011-1162; Leem YE, 2019, BIOCHEM BIOPH RES CO, V517, P484, DOI 10.1016/j.bbrc.2019.07.096; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Li ZW, 2020, CELL DEATH DIFFER, V27, P3226, DOI 10.1038/s41418-020-00615-9; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Morigny P, 2021, NAT REV ENDOCRINOL, V17, P276, DOI 10.1038/s41574-021-00471-8; Pyun JH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07606-y; Qiao XN, 2019, ENDOCRINOLOGY, V160, P2773, DOI 10.1210/en.2019-00504; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sanchez-Bailon MP, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26413-6; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tikhanovich I, 2017, J BIOL CHEM, V292, P6882, DOI 10.1074/jbc.M117.778761; Vishvanath L, 2019, J CLIN INVEST, V129, P4022, DOI 10.1172/JCI129191; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Zhang L, 2015, ELIFE, V4, DOI 10.7554/eLife.07938; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhu Q, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03799-1	45	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102309	10.1016/j.jbc.2022.102309	http://dx.doi.org/10.1016/j.jbc.2022.102309			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6F7ME	35921899	Green Published, gold			2022-12-26	WOS:000884241800002
J	Park, Y; Yum, HR; Shin, SY; Park, SH				Park, Yooyeon; Yum, Hae Ri; Shin, Sun Young; Park, Shin Hae			Ocular biometric changes following unilateral cataract surgery in children	PLOS ONE			English	Article							INTRAOCULAR-LENS IMPLANTATION; EYE GROWTH; PEDIATRIC PSEUDOPHAKIA; REFRACTIVE CHANGES; LENGTH GROWTH; MYOPIC SHIFT; LENSECTOMY; AGE	PurposeTo analyze ocular biometric changes following unilateral cataract surgery in children. MethodsA total of 57 children aged under 13 years who underwent unilateral cataract surgery were analyzed. Groups were classified according to their age at surgery: group I (age <3), II (3 <= age <6), III (6 <= age <9), and IV (age >= 9). The myopic shift, axial growth, and corneal curvature changes were compared between the pseudophakic eyes and the fellow phakic eyes. ResultsDuring 7.81 +/- 4.39 years, the overall myopic shift (D) and the rate of myopic shift (D/year) were significantly higher at -3.25 +/- 3.21 D and -0.45 +/- 0.44 D/year in the pseudophakic eyes than -1.78 +/- 2.10 D and -0.22 +/- 0.29 D/year in the fellow phakic eyes (P = 0.01, 0.004). Group I (-1.14 +/- 0.66 vs -0.02 +/- 0.45 D/year) and group II (-0.63 +/- 0.37 vs -0.31 +/- 0.29 D/year) showed significantly higher rate of myopic shift in the pseudophakic eyes than in the phakic eyes. The rate of myopic shift in the pseudophakic eyes decreased in the older age groups (P = 0.001). There was no significant between-eye difference in the changes in axial length and keratometric values postoperatively. ConclusionFollowing unilateral cataract surgery, a significant postoperative myopic shift was noticed in the pseudophakic eyes compared to the fellow phakic eyes in groups under 6 years old. Postoperative myopic shift and the resultant anisometropia should be considered when selecting the optimal power of IOL in young children requiring unilateral cataract surgery.	[Park, Yooyeon] Dankook Univ, Coll Med, Dept Ophthalmol, Cheonan, South Korea; [Yum, Hae Ri] Catholic Univ Korea, Eunpyeong St Marys Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Shin, Sun Young; Park, Shin Hae] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea	Dankook University; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Park, SH (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea.	vaccine@catholic.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, & Future Planning [NRF-2016R1C1B1016590]; Department of Ophthalmology, College of Medicine, Catholic University of Korea , , Man-Soo Kim Research Fund	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, & Future Planning(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Department of Ophthalmology, College of Medicine, Catholic University of Korea , , Man-Soo Kim Research Fund	This study was supported to SHP, the corresponding author, by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, & Future Planning (NRF-2016R1C1B1016590) and by the Department of Ophthalmology, College of Medicine, Catholic University of Korea, Man-Soo Kim Research Fund, 2022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadieh H, 2001, CURR OPIN OPHTHALMOL, V12, P30, DOI 10.1097/00055735-200102000-00006; Al Shamrani M, 2012, SAUDI J OPHTHALMOL, V26, P271, DOI 10.1016/j.sjopt.2012.05.005; Ashworth JL, 2007, BRIT J OPHTHALMOL, V91, P596, DOI 10.1136/bjo.2006.108571; Astle WF, 2007, CLIN EXP OPHTHALMOL, V35, P244, DOI 10.1111/j.1442-9071.2006.01446.x; Choi JA, 2014, INVEST OPHTH VIS SCI, V55, P2041, DOI [10.1167/iovs.13-12853, 10.1167/IOVS.13-12853]; Enyedi LB, 1998, AM J OPHTHALMOL, V126, P772, DOI 10.1016/S0002-9394(98)00247-5; GORDON RA, 1985, ARCH OPHTHALMOL-CHIC, V103, P785; Hussin HM, 2009, J CATARACT REFR SURG, V35, P1223, DOI 10.1016/j.jcrs.2009.03.015; Inatomi M, 2004, J AAPOS, V8, P50, DOI 10.1016/j.jaapos.2003.08.008; KORA Y, 1993, OPHTHALMIC SURG LAS, V24, P467; Kraus CL, 2016, EYE, V30, P1199, DOI 10.1038/eye.2016.152; Kugelberg M, 2004, J CATARACT REFR SURG, V30, P1345, DOI 10.1016/j.jcrs.2003.10.023; Kugelberg U, 1996, J CATARACT REFR SURG, V22, P337, DOI 10.1016/S0886-3350(96)80246-X; Lambert SR, 2012, INVEST OPHTH VIS SCI, V53, P7539, DOI 10.1167/iovs.12-10285; Lambert SR, 1998, ARCH OPHTHALMOL-CHIC, V116, P781, DOI 10.1001/archopht.116.6.781; LAMBERT SR, 1995, INVEST OPHTH VIS SCI, V36, P300; Lambert SR, 1999, J AAPOS, V3, P344, DOI 10.1016/S1091-8531(99)70043-1; Leiba H, 2006, J AAPOS, V10, P460, DOI 10.1016/j.jaapos.2006.06.006; Lim DH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207690; McClatchey SK, 1997, J PEDIAT OPHTH STRAB, V34, P88; McClatchey SK, 2000, OPHTHALMOLOGY, V107, P118, DOI 10.1016/S0161-6420(99)00033-0; McClatchey SK., 2005, PEDIAT CATARACT SURG, P30; Munro RJ, 2015, INVEST OPHTH VIS SCI, V56, P3121, DOI 10.1167/iovs.14-15980; Plager DA, 2002, J CATARACT REFR SURG, V28, P810, DOI 10.1016/S0886-3350(01)01156-7; Sminia ML, 2010, BRIT J OPHTHALMOL, V94, P547, DOI 10.1136/bjo.2009.160192; STONE RA, 1995, VISION RES, V35, P1195, DOI 10.1016/0042-6989(94)00232-B; Twelker JD, 2009, OPTOMETRY VISION SCI, V86, P918, DOI 10.1097/OPX.0b013e3181b2f903; Vasavada AR, 2004, AM J OPHTHALMOL, V138, P915, DOI 10.1016/j.ajo.2004.06.068; Wallace DK, 2018, OPHTHALMOLOGY, V125, P1961, DOI 10.1016/j.ophtha.2018.05.001; Weakley D, 2017, AM J OPHTHALMOL, V180, P1, DOI 10.1016/j.ajo.2017.05.008; Weakley DR, 2017, OPHTHALMOLOGY, V124, P822, DOI 10.1016/j.ophtha.2016.12.040; Wildsoet CF, 1997, OPHTHAL PHYSL OPT, V17, P279, DOI 10.1111/j.1475-1313.1997.tb00059.x; Yam JCS, 2012, J PEDIAT OPHTH STRAB, V49, P308, DOI 10.3928/01913913-20120501-04; Yang Meng-Ling, 2008, Chang Gung Med J, V31, P52; 심재옥, 2005, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V46, P768; 김연덕, 2007, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V48, P251	36	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2022	17	8							e0272369	10.1371/journal.pone.0272369	http://dx.doi.org/10.1371/journal.pone.0272369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5A3IT	35930578	Green Published, gold			2022-12-26	WOS:000862784200013
J	Rahimzadeh, CY; Barzinjy, AA; Mohammed, AS; Hamad, SM				Rahimzadeh, Chiya Yousef; Barzinjy, Azeez Abdullah; Mohammed, Ahmed Salih; Hamad, Samir Mustafa			Green synthesis of SiO2 nanoparticles from Rhus coriaria L. extract: Comparison with chemically synthesized SiO2 nanoparticles	PLOS ONE			English	Article							SILICA NANOPARTICLES; OXIDE NANOPARTICLES; ZNO NANOPARTICLES; MONODISPERSE SIO2; NITRO-COMPOUNDS; CEMENT; BIOSYNTHESIS; REDUCTION; PARTICLES; MECHANISM	The usage of the green synthesis method to produce nanoparticles (NPs) has received great acceptance among the scientific community in recent years. This, perhaps, is owing to its eco-friendliness and the utilization of non-toxic materials during the synthesizing process. The green synthesis approach also supplies a reducing and a capping agent, which increases the stability of the NPs through the available phytochemicals in the plant extractions. The present study describes a green synthesis method to produce nano-silica (SiO2) NPs utilizing Rhus coriaria L. extract and sodium metasilicate (Na2SiO3.5H(2)O) under reflux conditions. Sodium hydroxide (NaOH) is added to the mixture to control the pH of the solution. Then, the obtained NPs have been compared with the chemically synthesized SiO2 NPs. The structure, thermal, and morphological properties of the SiO2 NPs, both green synthesized and chemically synthesized, were characterized using Fourier-transform infrared spectroscopy (FTIR), Ultraviolet-Visible Spectroscopy (UV-Vis), X-ray diffraction (XRD), and Field Emission Scanning Electron Microscopy (FESEM). Also, the elemental compassion distribution was studied by energy-dispersive X-ray spectroscopy (EDX). In addition, the zeta potential, dynamic light scatter (DLS), thermogravimetric analysis (TGA), and differential scanning calorimetry (DSC) was used to study the stability, thermal properties, and surface area of the SiO2 NPs. The overall results revealed that the green synthesis of SiO2 NPs outperforms chemically synthesized SiO2 NPs. This is expected since the green synthesis method provides higher stability, enhanced thermal properties, and a high surface area through the available phytochemicals in the Rhus coriaria L. extract.	[Rahimzadeh, Chiya Yousef; Hamad, Samir Mustafa] Soran Univ, Sci Res Ctr, Soran, Kurdistan Regio, Iraq; [Rahimzadeh, Chiya Yousef] Soran Univ, Fac Engn, Civil Engn Dept, Soran, Kurdistan Regio, Iraq; [Barzinjy, Azeez Abdullah] Salahaddin Univ Erbil, Coll Educ, Dept Phys, Erbil, Kurdistan Regio, Iraq; [Barzinjy, Azeez Abdullah] Tishk Int Univ, Fac Educ, Dept Phys Educ, Erbil, Kurdistan Regio, Iraq; [Mohammed, Ahmed Salih] Univ Sulaimani, Coll Engn, Civil Engn Dept, Kurdistan, Iraq; [Hamad, Samir Mustafa] Cihan Univ Erbil, Comp Dept, Erbil, Iraq	Soran University; Soran University; Salahaddin University; Tishk International University; University of Sulimanyah; Cihan University-Erbil	Rahimzadeh, CY (corresponding author), Soran Univ, Sci Res Ctr, Soran, Kurdistan Regio, Iraq.; Rahimzadeh, CY (corresponding author), Soran Univ, Fac Engn, Civil Engn Dept, Soran, Kurdistan Regio, Iraq.; Barzinjy, AA (corresponding author), Salahaddin Univ Erbil, Coll Educ, Dept Phys, Erbil, Kurdistan Regio, Iraq.; Barzinjy, AA (corresponding author), Tishk Int Univ, Fac Educ, Dept Phys Educ, Erbil, Kurdistan Regio, Iraq.	chiya.yousef@soran.edu.iq; azeez.azeez@su.edu.krd	Mohammed, Ahmed Salih/AAE-8528-2022; Barzinjy, Azeez Abdullah/W-6517-2019	Mohammed, Ahmed Salih/0000-0003-4306-3274; Barzinjy, Azeez Abdullah/0000-0003-4009-9845				Abd El Aleem S, 2014, CONSTR BUILD MATER, V59, P151, DOI 10.1016/j.conbuildmat.2014.02.039; Abd Elmohsen Sohila A., 2019, Novel Research in Microbiology Journal, V3, P546, DOI 10.21608/nrmj.2019.66747; Ahmed A.A., MAT SCI ENG C-MATER; Assefi M, 2015, ADV POWDER TECHNOL, V26, P1583, DOI 10.1016/j.apt.2015.09.004; Azeez HH, 2020, JORDAN J PHYS, V13, P123, DOI 10.47011/13.2.4; Azeez HH, 2020, DESALIN WATER TREAT, V190, P179, DOI 10.5004/dwt.2020.25648; Bahmani SH, 2014, CONSTR BUILD MATER, V64, P350, DOI 10.1016/j.conbuildmat.2014.04.086; Bajpai N, 2014, LUMINESCENCE, V29, P669, DOI 10.1002/bio.2604; Barzinjy A., 2019, EAJSE, V4, P74, DOI DOI 10.23918/EAJSE.V4I3SIP74; Barzinjy AA, 2020, J MATER SCI-MATER EL, V31, P11303, DOI 10.1007/s10854-020-03679-y; Barzinjy AA, 2019, JORDAN J PHYS, V12, P45; Barzinjy AA, 2020, CURR ORG SYNTH, V17, P558, DOI 10.2174/1570179417666200628140547; Barzinjy AA, 2020, MICRO NANO LETT, V15, P415, DOI 10.1049/mnl.2019.0501; Barzinjy AA, 2020, SN APPL SCI, V2, DOI 10.1007/s42452-020-2813-1; Chandra H, 2020, BIOCATAL AGR BIOTECH, V24, DOI 10.1016/j.bcab.2020.101518; Dubey RS, 2015, MATER TODAY-PROC, V2, P3575, DOI 10.1016/j.matpr.2015.07.098; Dyshlyuk L, 2020, INT BIODETER BIODEGR, V146, DOI 10.1016/j.ibiod.2019.104821; Ek S, 2001, THERMOCHIM ACTA, V379, P201, DOI 10.1016/S0040-6031(01)00618-9; El Far B, 2020, INT J HEAT MASS TRAN, V156, DOI 10.1016/j.ijheatmasstransfer.2020.119789; Gour A, 2019, ARTIF CELL NANOMED B, V47, P844, DOI 10.1080/21691401.2019.1577878; Holzwarth U, 2011, NAT NANOTECHNOL, V6, P534, DOI 10.1038/nnano.2011.145; Hyeon T, 2003, CHEM COMMUN, P927, DOI 10.1039/b207789b; Iravani S, 2014, RES PHARM SCI, V9, P385; Iravani S, 2011, GREEN CHEM, V13, P2638, DOI 10.1039/c1gc15386b; Jadoun S, 2021, ENVIRON CHEM LETT, V19, P355, DOI 10.1007/s10311-020-01074-x; Jiang XF, 2019, CERAM INT, V45, P7673, DOI 10.1016/j.ceramint.2019.01.067; Junior J.A.A., 2014, NEW J GLASS CERAMICS, V4, P29, DOI DOI 10.4236/njgc.2014.42004; Kim JM, 2009, CERAM INT, V35, P1015, DOI 10.1016/j.ceramint.2008.04.011; Kong DY, 2018, CEMENT CONCRETE COMP, V87, P98, DOI 10.1016/j.cemconcomp.2017.12.007; Kumar H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228458; Land G, 2018, CEMENT CONCRETE COMP, V87, P73, DOI 10.1016/j.cemconcomp.2017.12.006; Li XY, 2018, APPL SURF SCI, V436, P283, DOI 10.1016/j.apsusc.2017.11.241; Li Z, 2021, ENERGIES, V14, DOI 10.3390/en14030703; Marousek J, 2022, POLYMERS-BASEL, V14, DOI 10.3390/polym14020266; Mohd NK, 2017, AIP CONF PROC, V1885, DOI 10.1063/1.5002317; Mubeen I, 2021, INORG NANO-MET CHEM, DOI 10.1080/24701556.2021.1978491; Nadaroglu H., 2017, INT J INNOVATIVE RES, V1, P6; Nasrollahzadeh M, 2018, MATER RES BULL, V102, P24, DOI 10.1016/j.materresbull.2018.01.032; Niksefat N, 2014, DESALINATION, V343, P140, DOI 10.1016/j.desal.2014.03.031; Park SK, 2000, J IND ENG CHEM, V6, P365; Parveen K, 2016, AIP CONF PROC, V1724, DOI 10.1063/1.4945168; Pitkethy M.J., 2003, MATER TODAY, V6, P36; Rai S, 2018, MATER TODAY-PROC, V5, P9196, DOI 10.1016/j.matpr.2017.10.044; Rajput N., 2015, INT J ADV ENG TECHNO, V7, P1806, DOI DOI 10.4236/ANP.2016.51004; Rezaeian Masoud, 2021, Nanomedicine (Lond), V16, P1581, DOI 10.2217/nnm-2021-0040; Sachan D., 2021, ENV NANOTECHNOL MONI, V16, P100467, DOI [10.1016/j.enmm.2021.100467, DOI 10.1016/J.ENMM.2021.100467]; Sajadi SM, 2018, CHEMISTRYSELECT, V3, P12274, DOI 10.1002/slct.201802707; Shah M, 2015, MATERIALS, V8, P7278, DOI 10.3390/ma8115377; Sharma P, 2021, APPL NANOSCI, DOI 10.1007/s13204-021-01898-1; Shnawa BH, 2022, EMERGENT MATER, V5, P683, DOI 10.1007/s42247-021-00264-9; Silviana Silviana, 2018, MATEC Web of Conferences, V156, DOI 10.1051/matecconf/201815605021; Singh J, 2018, J NANOBIOTECHNOL, V16, DOI 10.1186/s12951-018-0408-4; Stark WJ, 2015, CHEM SOC REV, V44, P5793, DOI 10.1039/c4cs00362d; Talabani RF, 2021, NANOMATERIALS-BASEL, V11, DOI 10.3390/nano11092421; Tso CP, 2010, WATER SCI TECHNOL, V61, P127, DOI 10.2166/wst.2010.787; Verma J., 2018, BIOMED J SCI TECH RE, V10, P7890, DOI DOI 10.26717/BJSTR.2018.10.001972; Vijayalakshmi U, 2015, J INDIAN CHEM SOC, V92, P675; Wang BX, 2006, INT J THERMOPHYS, V27, P139, DOI 10.1007/s10765-006-0022-9; Xu RL, 2008, PARTICUOLOGY, V6, P112, DOI 10.1016/j.partic.2007.12.002; Yadav VK, 2019, MATER TODAY-PROC, V18, P4351; Yanagishita T, 2004, LANGMUIR, V20, P554, DOI 10.1021/la030314a; Yu L.Y., 2014, T TECH PUBL	62	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2022	17	8							e0268184	10.1371/journal.pone.0268184	http://dx.doi.org/10.1371/journal.pone.0268184			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5A3IT	35930607	Green Published, gold			2022-12-26	WOS:000862784200009
J	Hyrina, A; Burdette, D; Song, ZJ; Ramirez, R; Okesli-Armlovich, A; Vijayakumar, A; Bates, J; Trevaskis, JL; Fletcher, SP; Lee, WA; Holdorf, MM				Hyrina, Anastasia; Burdette, Dara; Song, Zhijuan; Ramirez, Ricardo; Okesli-Armlovich, Ayse; Vijayakumar, Archana; Bates, Jamie; Trevaskis, James L.; Fletcher, Simon P.; Lee, William A.; Holdorf, Meghan M.			Targeting lipid biosynthesis pathways for hepatitis B virus cure	PLOS ONE			English	Article							REDUCTASE INHIBITORS STATINS; ACETYL-COA CARBOXYLASE; SURFACE-ANTIGEN; GENE-EXPRESSION; PHOSPHATIDYLETHANOLAMINE; METABOLISM; MOUSE; CELLS; HBV	Chronic hepatitis B virus (HBV) infection is characterized by the presence of high circulating levels of non-infectious lipoprotein-like HBV surface antigen (HBsAg) particles thought to contribute to chronic immune dysfunction in patients. Lipid and metabolomic analysis of humanized livers from immunodeficient chimeric mice (uPA/SCID) revealed that HBV infection dysregulates several lipid metabolic pathways. Small molecule inhibitors of lipid biosynthetic pathway enzymes acetyl-CoA carboxylase (ACC), fatty acid synthase, and subtilisin kexin isozyme-1/site-1 protease in HBV-infected HepG2-NTCP cells demonstrated potent and selective reduction of extracellular HBsAg. However, a liver-targeted ACC inhibitor did not show antiviral activity in HBV-infected liver chimeric mice, despite evidence of on-target engagement. Our study suggests that while HBsAg production may be dependent on hepatic de novo lipogenesis in vitro, this may be overcome by extrahepatic sources (such as lipolysis or diet) in vivo. Thus, a combination of agents targeting more than one lipid metabolic pathway may be necessary to reduce HBsAg levels in patients with chronic HBV infection.	[Hyrina, Anastasia; Burdette, Dara; Song, Zhijuan; Ramirez, Ricardo; Okesli-Armlovich, Ayse; Vijayakumar, Archana; Bates, Jamie; Trevaskis, James L.; Fletcher, Simon P.; Lee, William A.; Holdorf, Meghan M.] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA	Gilead Sciences	Hyrina, A (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	anastasia.hyrina@gilead.com		Hyrina, Anastasia/0000-0003-0412-6404	Gilead Sciences	Gilead Sciences(Gilead Sciences)	All the work in this manuscript was supported by Gilead Sciences.	Alves-Bezerra M, 2018, COMPR PHYSIOL, V8, P1, DOI 10.1002/cphy.c170012; Bates J, 2020, J HEPATOL, V73, P896, DOI 10.1016/j.jhep.2020.04.037; Brownsey RW, 1997, BIOCHEM SOC T, V25, P1232, DOI 10.1042/bst0251232; Burton AR, 2018, J CLIN INVEST, V128, P4588, DOI [10.1172/jci121960, 10.1172/JCI121960]; Chayama K, 2011, J GASTROEN HEPATOL, V26, P13, DOI 10.1111/j.1440-1746.2010.06470.x; Decorsiere A, 2016, NATURE, V531, P386, DOI 10.1038/nature17170; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; GAVILANES F, 1982, J BIOL CHEM, V257, P7770; Goedeke L, 2018, HEPATOLOGY, V68, P2197, DOI 10.1002/hep.30097; Hajjou M, 2005, J MED VIROL, V77, P57, DOI 10.1002/jmv.20427; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Horl G, 2011, J BIOL CHEM, V286, P17338, DOI 10.1074/jbc.M111.234534; Huang QX, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49367-8; Hyrina A, 2019, CELL REP, V29, P2970, DOI 10.1016/j.celrep.2019.10.113; Hyrina A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174483; Igel M, 2002, J CLIN PHARMACOL, V42, P835, DOI 10.1177/009127002401102731; Ishida Y, 2018, HEPATOLOGY, V68, P473, DOI 10.1002/hep.29891; de Oya NJ, 2019, EMERG MICROBES INFEC, V8, P624, DOI 10.1080/22221751.2019.1604084; Kim GA, 2014, GUT, V63, P1325, DOI 10.1136/gutjnl-2013-305517; Kim KH, 2007, GASTROENTEROLOGY, V132, P1955, DOI 10.1053/j.gastro.2007.03.039; Kotyla P, 2010, THER ADV MUSCULOSKEL, V2, P257, DOI 10.1177/1759720X10384307; Lamontagne RJ, 2018, METABOLISM, V83, P50, DOI 10.1016/j.metabol.2018.01.007; Lawitz EJ, 2018, CLIN GASTROENTEROL H, V16, P1983, DOI 10.1016/j.cgh.2018.04.042; Le Bert N, 2020, J HEPATOL, V72, P34, DOI 10.1016/j.jhep.2019.07.015; Li HD, 2015, SCI REP-UK, V5, DOI 10.1038/srep08421; Lin YL, 2003, VIROLOGY, V314, P253, DOI 10.1016/S0042-6822(03)00403-3; Liou JW, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23073897; Loomba R, 2018, GASTROENTEROLOGY, V155, P1463, DOI 10.1053/j.gastro.2018.07.027; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; Menne S, 2015, J HEPATOL, V62, P1237, DOI 10.1016/j.jhep.2014.12.026; Michler T, 2020, GASTROENTEROLOGY, V158, P1762, DOI 10.1053/j.gastro.2020.01.032; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Nassal M, 2015, GUT, V64, P1972, DOI 10.1136/gutjnl-2015-309809; Niu CR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169648; Okesli-Armlovich A, 2020, HEPATOLOGY, V72, p326A; Olmstead AD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002468; Qu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104988; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salimzadeh L, 2018, J CLIN INVEST, V128, P4573, DOI [10.1172/JCI121957, 10.1172/jci121957]; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; SATOH O, 1990, J LIPID RES, V31, P1293; Schmidt NM, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22967-7; Schoeman JC, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0318-8; Seto WK, 2018, LANCET, V392, P2313, DOI 10.1016/S0140-6736(18)31865-8; SIMON K, 1988, J CELL BIOL, V107, P2163, DOI 10.1083/jcb.107.6.2163; Tateno C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142145; Tsuge M, 2005, HEPATOLOGY, V42, P1046, DOI 10.1002/hep.20892; Tu T, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040075; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Yang F, 2008, J HEPATOL, V48, P12, DOI 10.1016/j.jhep.2007.06.021; Yasumoto J, 2017, J GEN VIROL, V98, P1762, DOI 10.1099/jgv.0.000813; Zhang JX, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.636897; Zoulim F, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021501	56	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0270273	10.1371/journal.pone.0270271	http://dx.doi.org/10.1371/journal.pone.0270271			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925919	gold, Green Published			2022-12-26	WOS:000848077100019
J	Okada, S; Chen, C; Watanabe, HK; Isobe, N; Takai, K				Okada, Satoshi; Chen, Chong; Watanabe, Hiromi Kayama; Isobe, Noriyuki; Takai, Ken			Unusual bromine enrichment in the gastric mill and setae of the hadal amphipod Hirondellea gigas	PLOS ONE			English	Article							CALCIUM-CARBONATE; SEAWATER; ZINC	The hadal amphipod Hirondellea gigas is an emblematic animal of the Pacific trenches, and has a number of special adaptations to thrive in this 'extreme' environment, which includes the deepest part of the Earth's ocean. One such adaptation that has been suggested is the presence of an 'aluminum gel shield' on the surface of its body in order to prevent the dissolution of calcitic exoskeleton below the carbonate compensation depth. However, this has not been investigated under experimental conditions that sufficiently prevent aluminum artefacts, and the possibility of other elements with similar characteristic X-ray energy as aluminum (such as bromine) has not been considered. Here, we show with new electron microscopy data gathered under optimized conditions to minimize aluminum artefacts that H. gigas actually does not have an aluminum shield-instead many parts of its body are enriched in bromine, particularly gastric ossicles and setae. Results from elemental analyses pointed to the use of calcite partially substituted with magnesium by H. gigas in its exoskeleton, in order to suppress dissolution. Our results exemplify the necessity of careful sample preparation and analysis of the signals in energy-dispersive X-ray spectroscopic analysis, and the importance of analyses at different electron energies.	[Okada, Satoshi; Chen, Chong; Watanabe, Hiromi Kayama; Takai, Ken] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Extra Cutting Edge Sci & Technol Avant Garde, Yokosuka, Kanagawa, Japan; [Isobe, Noriyuki] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Res Inst Marine Resources Utilizat MRU, Biogeochem Res Ctr, Yokosuka, Kanagawa, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Okada, S (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Extra Cutting Edge Sci & Technol Avant Garde, Yokosuka, Kanagawa, Japan.	okadasa@jamstec.go.jp	Isobe, Noriyuki/N-6106-2017	Isobe, Noriyuki/0000-0001-8571-3373; Okada, Satoshi/0000-0001-5417-5955	Japan Society for the Promotion of Science (JSPS) [JP19K15379]; JSPS [18K06401]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	S.O., [Grant-in-Aid for Young Scientists Grant Number JP19K15379], Japan Society for the Promotion of Science (JSPS), https://www.jsps.go.jp/; C.C. and H.K.W., [Grant-in-Aid for Scientific Research Grant Number 18K06401], JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI N, 1995, FISHERIES SCI, V61, P43, DOI 10.2331/fishsci.61.43; BEARDEN JA, 1967, REV MOD PHYS, V39, P78, DOI 10.1103/RevModPhys.39.78; Becker A, 2005, DALTON T, P1814, DOI 10.1039/b412062k; Becker C, 2018, ARTHROPOD STRUCT DEV, V47, P498, DOI 10.1016/j.asd.2018.07.002; Bentov S., 2016, EXTRACELLULAR COMPOS; Bentov S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22118; Bentov S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1839; Bourget E., 1987, BARNACLE BIOL; Brandao SN, 2019, PROG OCEANOGR, V178, DOI 10.1016/j.pocean.2019.102144; Broomell CC, 2008, ACTA BIOMATER, V4, P2045, DOI 10.1016/j.actbio.2008.06.017; Broomell CC, 2006, J EXP BIOL, V209, P3219, DOI 10.1242/jeb.02373; BURKHOLDER PR, 1966, APPL MICROBIOL, V14, P649, DOI 10.1128/AEM.14.4.649-653.1966; Cauchie HM, 2002, HYDROBIOLOGIA, V470, P63, DOI 10.1023/A:1015615819301; Cooksey Chris, 2013, Science Progress, V96, P171, DOI 10.3184/003685013X13680345111425; Cotruvo JA, 2019, ACS CENTRAL SCI, V5, P1496, DOI 10.1021/acscentsci.9b00642; Du K, 2007, ULTRAMICROSCOPY, V107, P281, DOI 10.1016/j.ultramic.2006.08.003; Gorgoll RM, 2016, J AM CHEM SOC, V138, P9675, DOI 10.1021/jacs.6b05414; Harano K, 2014, J POLYM SCI POL PHYS, V52, P833, DOI 10.1002/polb.23493; JOY DC, 1992, ULTRAMICROSCOPY, V47, P80, DOI 10.1016/0304-3991(92)90186-N; Keyser D., 2004, Revista Espanola de Micropaleontologia, V36, P1; Kobayashi H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0206710; Kobayashi H, 2018, BIOSCI BIOTECH BIOCH, V82, P1123, DOI 10.1080/09168451.2018.1459178; Kobayashi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042727; LOVELL FM, 1966, J AM CHEM SOC, V88, P4510, DOI 10.1021/ja00971a040; LOWENSTAM HA, 1992, P NATL ACAD SCI USA, V89, P10573, DOI 10.1073/pnas.89.22.10573; LUFT JH, 1961, J BIOPHYS BIOCHEM CY, V9, P409, DOI 10.1083/jcb.9.2.409; Luquet G, 2012, ZOOKEYS, P103, DOI 10.3897/zookeys.176.2318; MEENAKSHI VR, 1969, COMP BIOCHEM PHYSIOL, V29, P611, DOI 10.1016/0010-406X(69)91612-0; Millero FJ, 2008, DEEP-SEA RES PT I, V55, P50, DOI 10.1016/j.dsr.2007.10.001; MORSE JW, 1979, SCIENCE, V205, P904, DOI 10.1126/science.205.4409.904; MUCCI A, 1984, GEOCHIM COSMOCHIM AC, V48, P815, DOI 10.1016/0016-7037(84)90103-0; Neues F, 2011, J STRUCT BIOL, V175, P10, DOI 10.1016/j.jsb.2011.03.019; Newbury DE, 2007, SCANNING, V29, P137, DOI 10.1002/sca.20009; Obata H, 2017, J OCEANOGR, V73, P333, DOI 10.1007/s10872-016-0407-8; Postek MT, 2015, PROC SPIE, V9636, DOI 10.1117/12.2195344; Schofield RMS, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91795-y; Schofield RMS, 2009, J STRUCT BIOL, V166, P272, DOI 10.1016/j.jsb.2009.01.007; Solter S, 2002, TETRAHEDRON LETT, V43, P3385, DOI 10.1016/S0040-4039(02)00470-7; Sugawara A, 2006, ANGEW CHEM INT EDIT, V45, P2876, DOI 10.1002/anie.200503800; Suri A, 2020, J ELECTRON SPECTROSC, V241, DOI 10.1016/j.elspec.2019.02.002; Tynyakov J, 2015, J EXP BIOL, V218, P3487, DOI 10.1242/jeb.123539	41	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272032	10.1371/journal.pone.0272032	http://dx.doi.org/10.1371/journal.pone.0272032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925928	Green Published, gold			2022-12-26	WOS:000848077100065
J	Rowley, OC; Courtney, R; Northfield, T; Seymour, J				Rowley, Olivia C.; Courtney, Robert; Northfield, Tobin; Seymour, Jamie			Environmental drivers of the occurrence and abundance of the Irukandji jellyfish (Carukia barnesi)	PLOS ONE			English	Article							BLOOMS	Understanding the links between species and their environment is critical for species management. This is particularly true for organisms of medical and/or economic significance. The 'Irukandji' jellyfish (Carukia barnesi) is well known for its small size, cryptic nature, and highly venomous sting. Being the namesake of the Irukandji syndrome, contact with this marine stinger often leads to hospitalization and can be fatal. Consequently, the annual occurrence of this organism is believed to cost the Australian government an estimated $AUD3 billion annually in medical costs and losses for tourism. Despite its economic importance the logistical difficulties related to surveying C. barnesi in situ has led to a paucity of knowledge regarding its ecology and significantly impeded management strategies to date. In this study, we use six years of direct C. barnesicapture data to explore patterns pertaining to the annual occurrence and abundance of this species in the nearshore waters of the Cairns coast. We provide novel insights into trends in medusae aggregations and size distribution and primarily focus on the potential role of environmental drivers for annual C. barnesi occurrence patterns. Using a two-part hurdle model, eight environmental parameters were investigated over four time periods for associations with records of medusa presence and abundance. Final models showed a small amount of variation in medusa presence and abundance patterns could be accounted for by long-term trends pertaining to rainfall and wind direction. However, the assessed environmental parameters could not explain high annual variation or site location effects. Ultimately best-fit models had very low statistical inference power explaining between 16 and 20% of the variance in the data, leaving approximately 80% of all variation in medusa presence and abundance unexplained.	[Rowley, Olivia C.; Courtney, Robert; Seymour, Jamie] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Qld, Australia; [Northfield, Tobin] Washington State Univ, Tree Fruit Res & Extens Ctr, Washington, DC USA; [Rowley, Olivia C.] James Cook Univ, Australian Inst Trop Hlth & Med, Div Trop Hlth & Med, Cairns, Qld, Australia	James Cook University; Washington State University; James Cook University	Rowley, OC (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Qld, Australia.	olivia.rowley@my.jcu.edu.au		Rowley, Olivia/0000-0002-0809-342X	Queensland Lions Foundation - OR the ER Walker Bequest Bursary	Queensland Lions Foundation - OR the ER Walker Bequest Bursary	Funding was provided by the Queensland Lions Foundation - OR the ER Walker Bequest Bursary - OR The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes J. H., 1964, Medical Journal of Australia, V1, P897; Barton K., 2022, MULTIMODEL INFERENCE; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boco SR, 2019, SCI TOTAL ENVIRON, V685, P471, DOI 10.1016/j.scitotenv.2019.05.451; Bordehore C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230768; Bordehore C, 2016, OCEAN COAST MANAGE, V131, P45, DOI 10.1016/j.ocecoaman.2016.08.008; Bordehore C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137272; Bordehore Cesar, 2011, Marine Biodiversity Records, V4; Canepa A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181611; Carrette TJ, 2013, DIVING HYPERB MED, V43, P9; Carrette TJ, 2012, DIVING HYPERB MED, V42, P214; Chiaverano LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077039; Coates MM, 2003, INTEGR COMP BIOL, V43, P542, DOI 10.1093/icb/43.4.542; Courtney R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159380; Courtney R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151197; Courtney R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124256; Decker MB, 2007, MAR ECOL PROG SER, V329, P99, DOI 10.3354/meps329099; Ehrlen J, 2015, ECOL LETT, V18, P303, DOI 10.1111/ele.12410; Flecker H., 1952, Medical Journal of Australia, V39, P89; Gershwin LA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1168; Gordon M, 2004, HYDROBIOLOGIA, V530, P339, DOI 10.1007/s10750-004-2655-7; Gordon MR, 2009, HYDROBIOLOGIA, V616, P87, DOI 10.1007/s10750-008-9594-7; Gordon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031277; Graham WM, 2003, BIOL INVASIONS, V5, P53, DOI 10.1023/A:1024046707234; Grange S., 2014, TECHNICAL NOTE AVERA, DOI [10.13140/RG.2.1.3349.2006, DOI 10.13140/RG.2.1.3349.2006]; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P181, DOI 10.1007/BF00026460; Heim-Ballew H, 2019, HYDROBIOLOGIA, V827, P247, DOI 10.1007/s10750-018-3771-0; Ishii Haruto, 2001, Bulletin of Plankton Society of Japan, V48, P55; Ives AR, 2019, SYST BIOL, V68, P234, DOI 10.1093/sysbio/syy060; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Keesing JK, 2016, HYDROBIOLOGIA, V768, P19, DOI 10.1007/s10750-015-2525-5; Kingsford MJ, 2012, HYDROBIOLOGIA, V690, P257, DOI 10.1007/s10750-012-1041-0; Kingsford Michael J., 2014, P267; Kinsey B., 1986, MORE BARNES BOX JELL, V1st ed; Lazaridis E., 2014, LUNAR LUNAR PHASE DI; Nilsson DE, 2005, NATURE, V435, P201, DOI 10.1038/nature03484; Purcell JE, 2005, LIMNOL OCEANOGR, V50, P376, DOI 10.4319/lo.2005.50.1.0376; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2012, ANNU REV MAR SCI, V4, P209, DOI 10.1146/annurev-marine-120709-142751; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Seymour JE, 2020, PLANKTON BENTHOS RES, V15, P73, DOI 10.3800/pbr.15.73; Seymour JE, 2004, MED J AUSTRALIA, V181, P707, DOI 10.5694/j.1326-5377.2004.tb06529.x; SOUTHCOTT R. V., 1967, AUST J ZOOL, V15, P651, DOI 10.1071/ZO9670651; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Venables W., 2013, MODERN APPL STAT S, V53, P86; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zuur AF, 2007, STAT BIOL HEALTH, P1	48	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272359	10.1371/journal.pone.0272359	http://dx.doi.org/10.1371/journal.pone.0272359			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925949	gold, Green Accepted, Green Published			2022-12-26	WOS:000848077100084
J	Sharma, S; Bressler, RD; Bhopal, A; Norheim, OF				Sharma, Siddhanth; Bressler, R. Daniel; Bhopal, Anand; Norheim, Ole F.			The global temperature-related mortality impact of earlier decarbonization for the Australian health sector and economy: A modelling study	PLOS ONE			English	Article							SOCIAL COST; CARBON	BackgroundSustained elevated concentration of GHGs is predicted to increase global mortality. With the Australian health sector responsible for 7% of the nation's GHG emissions, the benefits and costs of various decarbonisation trajectories are currently being investigated. To assist with this effort, we model the impact earlier decarbonisation has on temperature-related mortality. DesignWe used DICE-EMR, an Integrated Assessment Model with an endogenous mortality response, to simulate Australian GHG trajectories and estimate the temperature-related mortality impact of early decarbonisation. We modelled a linear decline of the Australian health sector's and economy's GHG annual emissions to net-zero targets of 2040 and 2050. Main outcome measureDeaths averted and monetary-equivalent welfare gain. ResultsDecarbonisation of the Australian health sector by 2050 and 2040 is projected to avert an estimated 69,000 and 77,000 global temperature-related deaths respectively in a Baseline global emissions scenario. Australian economy decarbonisation by 2050 and 2040 is projected to avert an estimated 988,000 and 1,101,000 global deaths respectively. Assuming a low discount rate and high global emissions trajectory, we estimate a monetary equivalent welfare gain of $151 billion if the Australian health sector decarbonises by 2040, only accounting for the benefits in reducing temperature-related mortality. ConclusionsEarlier decarbonisation has a significant impact on temperature-related mortality. Many uncertainties exist and health impacts other than temperature-related mortality are not captured by this analysis. Nevertheless, such models can help communicate the health risk of climate change and improve climate policy decision making.	[Sharma, Siddhanth; Bhopal, Anand; Norheim, Ole F.] Univ Bergen, Bergen Ctr Eth & Prior Setting, Bergen, Norway; [Bressler, R. Daniel] Columbia Univ, Sch Int & Publ Affairs, New York, NY USA	University of Bergen; Columbia University	Sharma, S (corresponding author), Univ Bergen, Bergen Ctr Eth & Prior Setting, Bergen, Norway.	siddhanth.sharma@health.wa.gov.au		Sharma, Siddhanth/0000-0002-4802-6977; Bhopal, Anand/0000-0002-2766-8102				Abbafati C, 2020, LANCET, V396, P1135, DOI 10.1016/S0140-6736(20)31404-5; Bhopal A, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-067199; Bressler RD, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24487-w; Broome John, 2012, CLIMATE MATTERS ETHI; Carleton T., 2021, U CHICAGO BECKER FRI, DOI [DOI 10.2139/SSRN.3764255, 10.2139/ssrn.3764255]; Carleton T. A., 2020, WORKING PAPER, DOI [10.3386/w27599, DOI 10.2139/SSRN.3224365]; Department of Industry Science Energy and Resources., 2021, NAT GREENH ACC FACT; Devlin N, 2020, AUST HEALTH REV, V44, P337, DOI 10.1071/AH20057; Gasparrini A, 2017, LANCET PLANET HEALTH, V1, pE360, DOI 10.1016/S2542-5196(17)30156-0; Gollier C, 2014, ANNU REV RESOUR ECON, V6, P273, DOI 10.1146/annurev-resource-100913-012516; Goulder LH, 2002, NATURE, V419, P673, DOI 10.1038/419673a; Hales S., 2014, QUANTITATIVE RISK AS; Hamilton I, 2021, LANCET PLANET HEALTH, V5, pE74, DOI 10.1016/S2542-5196(20)30249-7; Lenzen M, 2020, LANCET PLANET HEALTH, V4, pE271, DOI 10.1016/S2542-5196(20)30121-2; Malik A, 2018, LANCET PLANET HEALTH, V2, pE27, DOI 10.1016/S2542-5196(17)30180-8; Millner A, 2013, J ENVIRON ECON MANAG, V65, P310, DOI 10.1016/j.jeem.2012.09.006; Nordhaus WD, 2017, P NATL ACAD SCI USA, V114, P1518, DOI 10.1073/pnas.1609244114; Norheim OF, 2019, GLOBAL HLTH PRIORITY, P361; Robinson LA, 2019, J BENEFIT-COST ANAL, V10, P15, DOI 10.1017/bca.2018.26; Salas RN, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3785; Scovronick N, 2019, EPIDEMIOLOGY, V30, P642, DOI 10.1097/EDE.0000000000001057; Scovronick N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09499-x; Talley NJ, 2021, MED J AUSTRALIA, V214, P75, DOI 10.5694/mja2.50895; Torjesen I, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3856; United Nations Department of Economic and Social Affairs Population Division, 2020, INT MIGR STOCK 2020; Weeramanthri T., 2020, CLIMATE HLTH WA INQU; Weingart SN, 2000, BRIT MED J, V320, P774, DOI 10.1136/bmj.320.7237.774; Zhang Y, 2020, MED J AUSTRALIA, DOI 10.5694/mja2.50869	28	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271550	http://dx.doi.org/10.1371/journal.pone.0271550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921296	gold, Green Published			2022-12-26	WOS:000839311900066
J	Toledo, E; Dim, S; Edri, A; Greenshpan, Y; Ottolenghi, A; Eisner, N; Tzadka, S; Pandey, A; Ben Nun, H; Le Saux, G; Porgador, A; Schvartzman, M				Toledo, Esti; Dim, Sharon; Edri, Avishay; Greenshpan, Yariv; Ottolenghi, Aner; Eisner, Nadav; Tzadka, Sivan; Pandey, Ashish; Ben Nun, Haggai; Le Saux, Guillaume; Porgador, Angel; Schvartzman, Mark			Nanocomposite coatings for the prevention of surface contamination by coronavirus	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; COPPER; NANOPARTICLES; SILVER; OXIDE; INACTIVATION; COMPOSITES	The current Covid-19 pandemic has a profound impact on all aspects of our lives. Aside from contagion by aerosols, the presence of the SARS-CoV-2 is ubiquitous on surfaces that millions of people handle daily. Therefore, controlling this pandemic involves the reduction of potential infections via contaminated surfaces. We developed antiviral surfaces by preparing suspensions of copper and cupric oxide nanoparticles in two different polymer matrices, poly(methyl methacrylate) and polyepoxide. For total copper contents as low as 5%, the composite material showed remarkable antiviral properties against the HCoV-OC43 human coronavirus and against a model lentivirus and proved well-resistant to accelerated aging conditions. Importantly, we showed that the Cu/CuO mixture showed optimal performances. This product can be implemented to produce a simple and inexpensive coating with long-term antiviral properties and will open the way to developing surface coatings against a broad spectrum of pathogens including SARS-CoV-2.	[Toledo, Esti; Tzadka, Sivan; Pandey, Ashish; Ben Nun, Haggai; Le Saux, Guillaume; Schvartzman, Mark] Ben Gurion Univ Negev, Dept Mat Engn, Beer Sheva, Israel; [Toledo, Esti; Tzadka, Sivan; Pandey, Ashish; Ben Nun, Haggai; Le Saux, Guillaume; Schvartzman, Mark] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, Beer Sheva, Israel; [Dim, Sharon; Edri, Avishay; Greenshpan, Yariv; Ottolenghi, Aner; Eisner, Nadav; Porgador, Angel] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Schvartzman, M (corresponding author), Ben Gurion Univ Negev, Dept Mat Engn, Beer Sheva, Israel.; Schvartzman, M (corresponding author), Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, Beer Sheva, Israel.; Porgador, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel.	angel@bgu.ac.il; marksc@bgu.ac.il		Pandey, Ashish/0000-0002-9931-5912; Toledo, Esti/0000-0003-3103-816X	Israel Innovation Authority; Israel Science Foundations: F.I.R.S.T. [2058/18]; Israel Ministry of Science and Technology; Ariane de Rothschild Women's Doctoral scholar ships program for outstanding female Ph.D. students, and Israel Scholarship Education Foundation (ISEF)	Israel Innovation Authority; Israel Science Foundations: F.I.R.S.T.; Israel Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); Ariane de Rothschild Women's Doctoral scholar ships program for outstanding female Ph.D. students, and Israel Scholarship Education Foundation (ISEF)	This work was funded by the Israel Innovation Authority, and Israel Science Foundations: F.I.R.S.T. Individual Grant # 2058/18. ET is supported by Israel Ministry of Science and Technology, Ariane de Rothschild Women's Doctoral scholar ships program for outstanding female Ph.D. students, and Israel Scholarship Education Foundation (ISEF).	Alayande AB, 2021, MEMBRANES-BASEL, V11, DOI 10.3390/membranes11070458; [Anonymous], USE COPPER HELP PREV; Applerot G, 2012, SMALL, V8, P3326, DOI 10.1002/smll.201200772; Bae YH, 2018, COMPOS SCI TECHNOL, V155, P144, DOI 10.1016/j.compscitech.2017.11.021; Bleichert P, 2014, BIOMETALS, V27, P1179, DOI 10.1007/s10534-014-9781-0; Borkow G, 2005, CURR MED CHEM, V12, P2163, DOI 10.2174/0929867054637617; Cioffi N, 2005, CHEM MATER, V17, P5255, DOI 10.1021/cm0505244; Delgado K, 2011, LETT APPL MICROBIOL, V53, P50, DOI 10.1111/j.1472-765X.2011.03069.x; Grace M, 2009, J ENG FIBER FABR, V4, P24; Harvey AP, 2021, ENVIRON SCI TECH LET, V8, P168, DOI 10.1021/acs.estlett.0c00875; Ishida N, 2020, APPL BIOCHEM BIOTECH, V190, P645, DOI 10.1007/s12010-019-03108-9; Ishida T., 2018, WORLD SCINEWS, V99, P148; Jin FL, 2015, J IND ENG CHEM, V29, P1, DOI 10.1016/j.jiec.2015.03.026; Kanigicherla VKP, 1998, MICROSYST TECHNOL, V4, P77, DOI 10.1007/s005420050100; Kevadiya BD, 2021, NAT MATER, V20, P593, DOI 10.1038/s41563-020-00906-z; Kumari P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16581-1; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Lieberman D, 2009, J CLIN MICROBIOL, V47, P3439, DOI 10.1128/JCM.00886-09; Lu HZ, 2020, J MED VIROL, V92, P546, DOI 10.1002/jmv.25738; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Palza H, 2015, J BIOACT COMPAT POL, V30, P366, DOI 10.1177/0883911515578870; Rakowska PD, 2021, COMMUN MATER, V2, DOI 10.1038/s43246-021-00153-y; Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006; Tyberg CS, 2000, POLYMER, V41, P5053, DOI 10.1016/S0032-3861(99)00574-1; Valian NK, 2022, J MED VIROL, V94, P1450, DOI 10.1002/jmv.27460; Vincent M, 2018, J APPL MICROBIOL, V124, P1032, DOI 10.1111/jam.13681; Vitiello A, 2022, J INTERN MED, V292, P81, DOI 10.1111/joim.13478; Warnes SL, 2015, APPL ENVIRON MICROB, V81, P1085, DOI 10.1128/AEM.03280-14; Warnes SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075017; Wu CK, 2006, CHEM MATER, V18, P6054, DOI 10.1021/cm061596d; Xie CJ, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09296-y; Xu RB, 2020, IEEE PHOTONICS J, V12, DOI [10.1109/JPHOT.2020.2979564, 10.1038/s41368-020-0080-z]; Yoon KY, 2007, SCI TOTAL ENVIRON, V373, P572, DOI 10.1016/j.scitotenv.2006.11.007; Zamora-Ledezma C, 2020, MOLECULES, V25, DOI 10.3390/molecules25204620; Zhdanov VP, 2021, J BIOL PHYS, V47, P95, DOI 10.1007/s10867-021-09570-z; Zuniga JM, 2020, EXPERT REV MED DEVIC, V17, P477, DOI 10.1080/17434440.2020.1756771	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272307	http://dx.doi.org/10.1371/journal.pone.0272307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917302	gold, Green Published			2022-12-26	WOS:000837840000003
J	Yi, Y; Park, YH				Yi, YuMi; Park, Yeon-Hwan			Structural equation model of the relationship between functional ability, mental health, and quality of life in older adults living alone	PLOS ONE			English	Article							BODY-MASS INDEX; COMMUNITY; ARRANGEMENTS; LONELINESS; MOBILITY; PARTICIPATION; DEFINITIONS; PREFERENCES; DISABILITY; PEOPLE	AimsLiving alone, a reality in an increasing number of older adults recently, is a risk factor for low quality of life. This study identified the predictors of quality of life in older adults living alone based on mental health and the International Classification of Functioning, Disability, and Health. MethodsThis secondary data analysis used information from the 2018 Assessing the Requirements of Customized Health Care and Daily Living Support Services survey (N = 1,022), collected from adults aged >= 65 living alone in Siheung City, South Korea, from August to October 2018. The exogenous variables were body functions (hand grip strength, timed "up and go" test score, and body mass index), daily living activities (Korean Instrumental Activities of the Daily Living Scale), social activity participation (social activity engagement, neighbor contacts, and family contacts), and participation in economic activity (frequency). The endogenous variables were mental health (Geriatric Depression Scale Short Form-Korean Version and UCLA Loneliness Scale) and quality of life (EuroQoL-5 Dimension-3 Level and EuroQoL-Visual Analog Scale). ResultsAfter modifying the hypothetical model, which had failed to satisfy the recommended fitness level, the (modified) model had good fitness indices Q (CMIN / df) 2.90, GFI 1, AGFI 1, RMSEA 0.04, CFI 0.90 and PCFI 0.53. Of the nine pathways of the modified model, five were statistically significant. Quality of life was affected by body functions, daily living activities, social activity participation, and mental health. These variables explained 68.2% of the factors affecting quality of life. ConclusionsBy highlighting the role of mental health, this model provides a useful framework for improving the quality of life of older adults who live alone and function at various levels in the community. Focusing on advancing mental health through body functions, daily living activities, and social activity participation can improve quality of life.	[Yi, YuMi] Dong Eui Univ, Coll Nat Sci, Dept Nursing, Busan, South Korea; [Park, Yeon-Hwan] Seoul Natl Univ, Res Inst Nursing Sci, Coll Nursing, Seoul, South Korea; [Park, Yeon-Hwan] Seoul Natl Univ, Coll Nursing, Seoul, South Korea	Dong-Eui University; Seoul National University (SNU); Seoul National University (SNU)	Park, YH (corresponding author), Seoul Natl Univ, Res Inst Nursing Sci, Coll Nursing, Seoul, South Korea.; Park, YH (corresponding author), Seoul Natl Univ, Coll Nursing, Seoul, South Korea.	hanipyh@snu.ac.kr		Park, Yeon-Hwan/0000-0002-5236-6683	Ministry of Health & Welfare, Republic of Korea [HI18C1284]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	We would like to thank the older adults who participated in this study. We also gratefully acknowledge the help of the Siheung City Public Health Center, Director Park Munghee, and Mrs. Park Kyungwon for their cooperation with the progress of this study.	Bae BR, 2017, STRUCTURAL EQUATION; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bilotta C, 2012, HEALTH SOC CARE COMM, V20, P32, DOI 10.1111/j.1365-2524.2011.01011.x; Birman MV, 2016, J HAND SURG-AM, V41, P133, DOI 10.1016/j.jhsa.2015.11.008; Bowling A., 2005, AGEING WELL QUALITY; Bowling Ann, 2009, Curr Gerontol Geriatr Res, V2009, P298950, DOI 10.1155/2009/298950; Bucholz EM, 2012, ARCH INTERN MED, V172, P1084, DOI 10.1001/archinternmed.2012.2649; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cho Sung Hui, 2016, [Korean Journal of Gerontological Social Welfare, 노인복지연구], V71, P35; Covinsky KE, 2013, JAMA INTERN MED, V173, P321, DOI 10.1001/jamainternmed.2013.1617; Dale B, 2012, INT J QUAL STUD HEAL, V7, DOI 10.3402/qhw.v7i0.18456; Davison KK, 2002, J AM GERIATR SOC, V50, P1802, DOI 10.1046/j.1532-5415.2002.50508.x; Depp CA, 2006, AM J GERIAT PSYCHIAT, V14, P6, DOI 10.1097/01.JGP.0000192501.03069.bc; Di Gessa G, 2014, J EPIDEMIOL COMMUN H, V68, P261, DOI 10.1136/jech-2013-202820; Do HK, 2015, ANN GERIATR MED RES, V19, P61, DOI 10.4235/jkgs.2015.19.2.61; Ennis SK, 2014, J GEN INTERN MED, V29, P1451, DOI 10.1007/s11606-014-2904-z; Eun Lee Si, 2016, [Korean Journal of Adult Nursing, 성인간호학회지], V28, P659, DOI 10.7475/kjan.2016.28.6.659; Fujikawa M., 2013, THESIS U WISCONSIN M; Gaymu J, 2008, EUR J AGEING, V5, P5, DOI 10.1007/s10433-008-0072-x; Geirsdottir OG, 2012, J NUTR HEALTH AGING, V16, P62, DOI 10.1007/s12603-011-0076-7; Gorgon E, 2007, PHYSIOTHER RES INT, V12, P72, DOI 10.1002/pri.348; Granic A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149699; Greenfield EA, 2011, J APPL GERONTOL, V30, P524, DOI 10.1177/0733464810364985; Han Sam-Sung, 2012, [The Korean Journal of Health Service Management, 보건의료산업학회지], V6, P29; Henning-Smith C, 2016, J APPL GERONTOL, V35, P39, DOI 10.1177/0733464814530805; HYUN MOON JI, 2018, [The Journal of the Korea Contents Association, 한국콘텐츠학회 논문지], V18, P44, DOI 10.5392/JKCA.2018.18.01.044; Jin-Gu Kim., 2011, [Korean Journal of Gerontological Social Welfare, 노인복지연구], V51, P35; Kang JS, 2010, KOREAN J GERONTOLOGI, V48, P279, DOI [10.21194/kjgsw..48.201006.279, DOI 10.21194/KJGSW..48.201006.279]; Kee BS, 1996, J KOREAN NEUROPSYCHI, V35, P298; Kim gs, 2010, AMOS 18 0 ANAL STRUC; Kim Hyunju, 2013, [Korean Journal of Gerontological Social Welfare, 노인복지연구], V60, P97; Kim J-H, 2007, KOREA J POP STUD, V30, P57; Kim Jae Jun, 2017, [Journal of the Korean Society of Biological Therapies in Psychiatry, 생물치료정신의학], V23, P164, DOI 10.22802/jksbtp.2017.23.3.164; Kim MY., 2015, J DIGIT CONVERG, V13, P25, DOI [10.14400/JDC.2015.13.4.25, DOI 10.14400/JDC.2015.13.4.25]; Kim O.S., 1997, J KOREAN ACAD NURS, V27, P871, DOI [DOI 10.4040/JNAS.1997.27.4.871, 10.4040/jnas.1997.27.4.871]; 신성일, 2013, [Korea Journal of Counseling, 상담학연구], V14, P3673; Ko H, 2019, ARCH GERONTOL GERIAT, V83, P239, DOI 10.1016/j.archger.2019.05.009; Kwak Y, 2017, IRAN J PUBLIC HEALTH, V46, P1512; Kwon OK, 2016, P KOREA GERONTOLOGIC, P1; Lau DT, 2009, AM J PUBLIC HEALTH, V99, P1315, DOI 10.2105/AJPH.2008.151142; Lee Hyunji, 2012, [Journal of community welfare, 한국지역사회복지학], V42, P157; Levasseur M, 2010, SOC SCI MED, V71, P2141, DOI 10.1016/j.socscimed.2010.09.041; Liao KH, 2014, INT J OCCUP SAF ERGO, V20, P77, DOI 10.1080/10803548.2014.11077039; Lim Lena L, 2011, Curr Gerontol Geriatr Res, V2011, P673181, DOI 10.1155/2011/673181; Lin PC, 2008, J CLIN NURS, V17, P1610, DOI 10.1111/j.1365-2702.2007.02081.x; Lopes MJ, 2013, REV LAT-AM ENFERM, V21, P52, DOI 10.1590/S0104-11692013000700008; Luna-Heredia E, 2005, CLIN NUTR, V24, P250, DOI 10.1016/j.clnu.2004.10.007; Manacy P., 2008, THESIS FLORIDA STATE; McInnis-Dittrich K., 2014, SOCIAL WORK OLDER AD, V4th ed; McMunn A, 2009, AGEING SOC, V29, P765, DOI 10.1017/S0144686X08008350; Ministry of Health and Welfare Korea Institute for Health and Social Affairs, 2019, 2018 COMPR SURV CHIL; Nakahara J., 2013, INT J PSYCHOL RES, V5, P112, DOI [10.5539/ijps.v5n1p112, DOI 10.5539/IJPS.V5N1P112]; Oh BT., 2017, KOREAN J CLIN GERI, V18, P22, DOI [DOI 10.15656/KJCG.2017.18.1.22, 10.15656/kjcg.2017.18.1.22]; Pain K, 1998, J REHABIL, V64, P5; Park Jeong-Mo, 2016, [Journal of Korean Public Health Nursing, 한국보건간호학회지], V30, P337; Park S-H, 2014, J OCCUP THER AGED DE, V8, P43; Park SY., 2009, J KOREAN PUBLIC HLTH, V23, P78; Passier PECA, 2013, QUAL LIFE RES, V22, P1027, DOI 10.1007/s11136-012-0236-1; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Power JEM, 2019, PSYCHOL AGING, V34, P152, DOI 10.1037/pag0000287; Ran Park Ae, 2017, [The Journal of the Korea Contents Association, 한국콘텐츠학회 논문지], V17, P212, DOI 10.5392/JKCA.2017.17.03.212; Ratcliffe J, 2017, QUAL LIFE RES, V26, P299, DOI 10.1007/s11136-016-1391-6; Rivers CS, 2018, ARCH PHYS MED REHAB, V99, P443, DOI 10.1016/j.apmr.2017.06.012; Rose DJ, 2002, J AGING PHYS ACTIV, V10, P466, DOI 10.1123/japa.10.4.466; RUCHLIN HS, 1991, AM J PUBLIC HEALTH, V81, P498, DOI 10.2105/AJPH.81.4.498; RUSSELL D, 1980, J PERS SOC PSYCHOL, V39, P472, DOI 10.1037/0022-3514.39.3.472; Russell D, 2009, J HEALTH SOC BEHAV, V50, P460, DOI 10.1177/002214650905000406; Russell D, 2009, J GERONTOL B-PSYCHOL, V64, P95, DOI 10.1093/geronb/gbn002; Saito Emiko, 2005, Nurs Health Sci, V7, P29; Scharlach A, 2012, GERONTOLOGIST, V52, P418, DOI 10.1093/geront/gnr083; Sereny M, 2011, RES AGING, V33, P172, DOI 10.1177/0164027510392387; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; So H, 2011, J KOREAN ACAD NURS, V41, P481, DOI 10.4040/jkan.2011.41.4.481; Soo Kim Hyang, 2017, [Journal of the Korea Convergence Society, 한국융합학회논문지], V8, P207, DOI 10.15207/JKCS.2017.8.7.207; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; SUH，Soonrim, 2014, [Journal of the Korea Gerontological Society, 한국노년학], V34, P705; Suk-Jung Han，, 2014, [Journal of Korean Public Health Nursing, 한국보건간호학회지], V28, P333; Sung Soonchang, 2014, [The Korean Society of Living Environmental System, 한국생활환경학회지], V21, P223; Tomioka K, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0491-7; United Nations N. Y., 2017, POPULATION; van Roekel EH, 2014, CANCER EPIDEM BIOMAR, V23, P1394, DOI 10.1158/1055-9965.EPI-13-1144; WHOQoL Group, 1994, QUALITY LIFE ASSESSM, P41; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Won CW, 2002, J KOREAN GERIATR SOC, V6, P107, DOI DOI 10.1037/T06803-000]; World Health Organization(WHO), 2001, INT CLASS FUNCT DIS; Yoon Soonduck, 2004, [Journal of the Korea Gerontological Society, 한국노년학], V24, P57; Yoshimitsu Koji, 2017, BMC Res Notes, V10, P512, DOI 10.1186/s13104-017-2836-x; Zali M, 2017, EDUC GERONTOL, V43, P582, DOI 10.1080/03601277.2017.1376450; 이소정, 2016, [Social Welfare Policy, 사회복지정책], V43, P165; 주경희, 2011, [Korean Journal of Social Welfare Studies, 사회복지연구], V42, P5; 박경혜, 2006, [Journal of the Korea Gerontological Society, 한국노년학], V26, P275	91	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0269003	http://dx.doi.org/10.1371/journal.pone.0269003			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921330	Green Published, gold			2022-12-26	WOS:000839311900009
J	Cavalu, S; Sharaf, H; Saber, S; Youssef, ME; Abdelhamid, AM; Mourad, AAE; Ibrahim, S; Allam, S; Elgharabawy, RM; El-Ahwany, E; Amin, NA; Shata, A; Eldegla, M; Atef, M; Aboraya, M; Mohamed, M; Anz, N; Abd Elmotelb, D; Gabr, F; Elzablawy, D; Hamada, M; Yehia, A; Osama, D; Mohammed, OA				Cavalu, Simona; Sharaf, Hossam; Saber, Sameh; Youssef, Mahmoud E.; Abdelhamid, Amir Mohamed; Mourad, Ahmed A. E.; Ibrahim, Samar; Allam, Shady; Elgharabawy, Rehab Mohamed; El-Ahwany, Eman; Amin, Noha A.; Shata, Ahmed; Eldegla, Mai; Atef, Marina; Aboraya, Maii; Mohamed, Mayar; Anz, Niera; Abd Elmotelb, Dina; Gabr, Fayrouz; Elzablawy, Dalia; Hamada, Menna; Yehia, Amr; Osama, Dalia; Mohammed, Osama A.			Ambroxol, a mucolytic agent, boosts HO-1, suppresses NF-kappa B, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitis	FASEB JOURNAL			English	Article						ambroxol hydrochloride; HO-1; NF-kappa B; Nrf2; oxidative stress; ulcerative colitis	FREE-RADICAL PRODUCTION; ESCHERICHIA-COLI; HEME OXYGENASE-1; INFLAMMATORY RESPONSE; LUNG INJURY; MODEL; HYDROCHLORIDE; ACTIVATION; EXPRESSION; PROTECTION	Ulcerative colitis (UC) is a chronic inflammatory bowel disease of unknown etiology that increases the risk of developing colorectal cancer and imposes a lifelong healthcare burden on millions of patients worldwide. Current treatment strategies are associated with significant risks and have been shown to be fairly effective. Hence, discovering new therapies that have better efficacy and safety profiles than currently exploited therapeutic strategies is challenging. It has been well delineated that NF-kappa B/Nrf2 crosstalk is a chief player in the interplay between oxidative stress and inflammation. Ambroxol hydrochloride, a mucolytic agent, has shown antioxidant and anti-inflammatory activity in humans and animals and has not yet been examined for the management of UC. Therefore, our approach was to investigate whether ambroxol could be effective to combat UC using the common acetic acid rat model. Interestingly, a high dose of oral ambroxol (200 mg/kg/day) reasonably improved the microscopic and macroscopic features of the injured colon. This was linked to low disease activity and a reduction in the colonic weight/length ratio. In the context of that, ambroxol boosted Nrf2 activity and upregulated HO-1 and catalase to augment the antioxidant defense against oxidative damage. Besides, ambroxol inactivated NF-kappa B signaling and its consequent target pro-inflammatory mediators, IL-6 and TNF-alpha. In contrast, IL-10 is upregulated. Consistent with these results, myeloperoxidase activity is suppressed. Moreover, ambroxol decreased the susceptibility of the injured colon to apoptosis. To conclude, our findings highlight the potential application of ambroxol to modify the progression of UC by its anti-inflammatory, antioxidant, and antiapoptotic properties.	[Cavalu, Simona] Univ Oradea, Fac Med & Pharm, P Ta 1 Decembrie 10, Oradea 410087, Romania; [Sharaf, Hossam; Eldegla, Mai; Atef, Marina; Aboraya, Maii; Mohamed, Mayar; Anz, Niera; Abd Elmotelb, Dina; Gabr, Fayrouz; Elzablawy, Dalia; Hamada, Menna; Yehia, Amr; Osama, Dalia] Delta Univ Sci & Technol, Fac Pharm, Dept Biochem, Gamasa, Egypt; [Saber, Sameh; Youssef, Mahmoud E.; Abdelhamid, Amir Mohamed] Delta Univ Sci & Technol, Fac Pharm, Dept Pharmacol, Gamasa, Egypt; [Mourad, Ahmed A. E.] Port Said Univ, Fac Pharm, Dept Pharmacol & Toxicol, Port Said, Egypt; [Ibrahim, Samar] Ahram Canadian Univ, Fac Pharm, Dept Pharm Practice, Giza, Egypt; [Allam, Shady] Menoufia Univ, Fac Pharm, Dept Pharmacol & Toxicol, Menoufia, Egypt; [Elgharabawy, Rehab Mohamed] Tanta Univ, Fac Pharm, Pharmacol & Toxicol Dept, Tanta, Egypt; [El-Ahwany, Eman] Theodor Bilharz Res Inst, Dept Immunol, Giza, Egypt; [Amin, Noha A.] Theodor Bilharz Res Inst, Dept Haematol, Giza, Egypt; [Shata, Ahmed] Mansoura Univ, Fac Med, Dept Clin Pharmacol, Mansoura, Egypt; [Shata, Ahmed] Delta Univ Sci & Technol, Dept Clin Pharm, Fac Pharm, Gamasa, Egypt; [Mohammed, Osama A.] Ain Shams Univ, Fac Med, Dept Clin Pharmacol, Cairo, Egypt; [Mohammed, Osama A.] Bisha Univ, Fac Med, Dept Clin Pharmacol, Bisha, Saudi Arabia	University of Oradea; Delta University for Science & Technology; Delta University for Science & Technology; Egyptian Knowledge Bank (EKB); Port Said University; Egyptian Knowledge Bank (EKB); Menofia University; Egyptian Knowledge Bank (EKB); Tanta University; Egyptian Knowledge Bank (EKB); Theodor Bilharz Research Institute (TBRI); Egyptian Knowledge Bank (EKB); Theodor Bilharz Research Institute (TBRI); Egyptian Knowledge Bank (EKB); Mansoura University; Delta University for Science & Technology; Egyptian Knowledge Bank (EKB); Ain Shams University; University of Bisha	Cavalu, S (corresponding author), Univ Oradea, Fac Med & Pharm, P Ta 1 Decembrie 10, Oradea 410087, Romania.	simona.cavalu@gmail.com	CAVALU, SIMONA/AAV-5882-2021; Abdelhamid, Amir Mohamed/ABG-3588-2020	CAVALU, SIMONA/0000-0001-7810-8925; Abdelhamid, Amir Mohamed/0000-0002-8630-2872				Abdelhamid AM, 2021, LIFE SCI, V286, DOI 10.1016/j.lfs.2021.120070; Al-Horani R, 2022, NAT REV DRUG DISCOV, V21, P15, DOI 10.1038/d41573-021-00194-5; Araujo JA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00119; ARENA/OLAW, 2002, I AN CAR US COMM GUI, V2nd; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Bishr A, 2019, CAN J PHYSIOL PHARM, V97, P55, DOI 10.1139/cjpp-2018-0528; Cao DW, 2019, EUR REV MED PHARMACO, V23, P5004, DOI 10.26355/eurrev_201906_18092; Closa D, 2004, IUBMB LIFE, V56, P185, DOI 10.1080/15216540410001701642; Davinelli S, 2022, MOLECULES, V27, DOI 10.3390/molecules27020502; de la Vega MR, 2018, CANCER CELL, V34, P21, DOI 10.1016/j.ccell.2018.03.022; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dulai PS, 2014, GUT, V63, P1843, DOI 10.1136/gutjnl-2014-307126; El-Rous MA, 2021, INFLAMMOPHARMACOLOGY, V29, P1169, DOI 10.1007/s10787-021-00818-7; Fumery M, 2018, CLIN GASTROENTEROL H, V16, P343, DOI 10.1016/j.cgh.2017.06.016; Glorieux C, 2015, FREE RADICAL BIO MED, V87, P84, DOI 10.1016/j.freeradbiomed.2015.06.017; Hafez MM, 2009, APPL BIOCHEM BIOTECH, V158, P97, DOI 10.1007/s12010-008-8312-2; Haque S E, 2005, Indian J Physiol Pharmacol, V49, P57; Hartmann RM, 2012, DIGEST DIS SCI, V57, P2038, DOI 10.1007/s10620-012-2134-3; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He XQ, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.S7-002; Hiemstra S, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-10857-x; Iwamoto M, 1996, J PATHOL, V180, P152; Jairath V, 2020, LANCET GASTROENTEROL, V5, P2, DOI 10.1016/S2468-1253(19)30358-9; Jang YY, 2003, PHARMACOL TOXICOL, V92, P173, DOI 10.1034/j.1600-0773.2003.920407.x; Jensen SR, 2015, INT J MED MICROBIOL, V305, P925, DOI 10.1016/j.ijmm.2015.10.002; Ji XQ, 2014, WORLD J GASTROENTERO, V20, P13501, DOI 10.3748/wjg.v20.i37.13501; Joshi SV, 2011, INDIAN J PHARMACOL, V43, P656, DOI 10.4103/0253-7613.89821; Kanauchi Y, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-021-04154-2; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; KEYSE SM, 1987, J BIOL CHEM, V262, P14821; Khalil R, 2020, TOXICOL APPL PHARM, V407, DOI 10.1016/j.taap.2020.115246; Lee CS, 2002, PHARMACOL TOXICOL, V91, P140, DOI 10.1034/j.1600-0773.2002.910309.x; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Maines MD, 1999, J PHARMACOL EXP THER, V291, P911; Malerba M, 2008, EXPERT OPIN DRUG MET, V4, P1119, DOI 10.1517/17425255.4.8.1119 ; Marks DJB, 2006, GUT, V55, P1662, DOI 10.1136/gut.2006.104943; Mei Y, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02969; Nandi A, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9613090; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pariente B, 2011, INFLAMM BOWEL DIS, V17, P1415, DOI 10.1002/ibd.21506; Petersen AM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-171; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Saber S, 2021, BIOMED PHARMACOTHER, V142, DOI 10.1016/j.biopha.2021.112029; Saber S, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14040341; Saber S, 2021, LIFE SCI, V270, DOI 10.1016/j.lfs.2021.119123; Saber S, 2020, CANCER CHEMOTH PHARM, V85, P331, DOI 10.1007/s00280-020-04033-z; Saber S, 2019, ARCH BIOCHEM BIOPHYS, V671, P185, DOI 10.1016/j.abb.2019.07.014; Seidelin JB, 2009, SCAND J GASTROENTERO, V44, P1429, DOI 10.3109/00365520903301212; Silveira CRA, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1252-3; Albert-Garay JS, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-05284-x; Sokol H, 2006, J CLIN MICROBIOL, V44, P3172, DOI 10.1128/JCM.02600-05; Stetinova V, 2004, CLIN EXP MED, V4, P152, DOI 10.1007/s10238-004-0050-3; Stetinova V, 2009, GEN PHYSIOL BIOPHYS, V28, P309, DOI 10.4149/gpb_2009_03_309; Su X, 2004, INTENS CARE MED, V30, P133, DOI 10.1007/s00134-003-2001-y; Sunkari S, 2019, INT IMMUNOPHARMACOL, V71, P301, DOI 10.1016/j.intimp.2019.03.035; Turkseven S, 2005, AM J PHYSIOL-HEART C, V289, pH701, DOI 10.1152/ajpheart.00024.2005; Wang R, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.670159; Wang XD, 2001, GENE DEV, V15, P2922; Weiser T, 2008, CNS NEUROSCI THER, V14, P17, DOI 10.1111/j.1527-3458.2007.00032.x; Wu G, 2004, J CARD FAIL, V10, P519, DOI 10.1016/j.cardfail.2004.02.002; Yang SY, 2017, STEM CELL REP, V8, P728, DOI 10.1016/j.stemcr.2017.01.011; Youssef ME, 2022, ENVIRON SCI POLLUT R, V29, P25723, DOI 10.1007/s11356-021-17831-6; Youssef ME, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.719984; Zhao JM, 2017, ACTA CHIR BELG, V117, P232, DOI 10.1080/00015458.2017.1287395	67	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9								10.1096/fj.202200749R	http://dx.doi.org/10.1096/fj.202200749R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3R2QD	35947115				2022-12-26	WOS:000838762200001
J	Su, Y; Iacob, RE; Li, J; Engen, JR; Springer, TA				Su, Yang; Iacob, Roxana E.; Li, Jing; Engen, John R.; Springer, Timothy A.			Dynamics of integrin alpha 5 beta 1, fibronectin, and their complex reveal sites of interaction and conformational change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; ARG-GLY-ASP; LIGAND-BINDING; ALPHA 5; CELL; ALPHA(5)BETA(1); DOMAINS; RGD; RECOGNITION; KINETICS	Integrin alpha 5 beta 1 mediates cell adhesion to the extracellular matrix by binding fibronectin (Fn). Selectivity for Fn by alpha 5 beta 1 is achieved through recognition of an RGD motif in the 10th type III Fn domain (Fn10) and the synergy site in the ninth type III Fn domain (Fn9). However, details of the interaction dynamics are unknown. Here, we compared synergy-site and Fn-truncation mutations for their alpha 5 beta 1-binding affinities and stabilities. We also interrogated binding of the alpha 5 beta 1 ectodomain headpiece fragment to Fn using hydrogen-deuterium exchange (HDX) mass spectrometry to probe binding sites and sites of integrin conformational change. Our results suggest the synergistic effect of Fn9 requires both specific residues and a folded domain. We found some residues considered important for synergy are required for stability. Additionally, we show decreases in fibronectin HDX are localized to a synergy peptide containing contacting residues in two beta-strands, an intervening loop in Fn9, and the RGD-containing loop in Fn10, indicative of binding sites. We also identified binding sites in the alpha 5-subunit beta-propeller domain for the Fn9 synergy site and in the beta 1-subunit beta I domain for Fn10 based on decreases in alpha 5 beta 1 HDX. Interestingly, the dominant effect of Fn binding was an increase in alpha 5 beta 1 deuterium exchange distributed over multiple sites that undergo changes in conformation or solvent accessibility and appear to be sites where energy is stored in the higher-energy, open-integrin conformation. Together, our results highlight regions important for alpha 5 beta 1 binding to Fn and dynamics associated with this interaction.	[Su, Yang; Li, Jing; Springer, Timothy A.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Su, Yang; Li, Jing; Springer, Timothy A.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Su, Yang; Li, Jing; Springer, Timothy A.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Iacob, Roxana E.; Engen, John R.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Northeastern University	Springer, TA (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Springer, TA (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Springer, TA (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.	springer@crystal.harvard.edu			NIH [R01 -HL -131729]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information - This work was supported by NIH grant R01 -HL -131729 and a research collaboration with Wa- ters Corporation (J. R. E.) . The content is solely the responsibility of the authors and does not necessarily represent the of fi cial views of the National Institutes of Health.	Altroff H, 2003, J BIOL CHEM, V278, P491, DOI 10.1074/jbc.M209992200; Anderson JM, 2022, MOL BIOL CELL, V33, DOI 10.1091/mbc.E21-11-0536; AOTA S, 1994, J BIOL CHEM, V269, P24756; Copie V, 1998, J MOL BIOL, V277, P663; Engen JR, 2015, ANNU REV ANAL CHEM, V8, P127, DOI 10.1146/annurev-anchem-062011-143113; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Goh KL, 1997, DEVELOPMENT, V124, P4309; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Humphries JD, 2000, J BIOL CHEM, V275, P20337, DOI 10.1074/jbc.M000568200; KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Li J, 2018, J CELL BIOL, V217, P397, DOI 10.1083/jcb.201701169; Li J, 2017, EMBO J, V36, P629, DOI 10.15252/embj.201695803; LITVINOVICH SV, 1995, J MOL BIOL, V248, P611, DOI 10.1006/jmbi.1995.0246; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; Masson GR, 2019, NAT METHODS, V16, P595, DOI 10.1038/s41592-019-0459-y; Miyazaki N, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216754; Mould AP, 1997, J BIOL CHEM, V272, P17283, DOI 10.1074/jbc.272.28.17283; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6; Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038; Plaxco KW, 1997, J MOL BIOL, V270, P763, DOI 10.1006/jmbi.1997.1148; Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schaffner Florence, 2013, Cancers (Basel), V5, P27, DOI 10.3390/cancers5010027; Schumacher S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe9716; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Sen M, 2013, J CELL BIOL, V203, P629, DOI 10.1083/jcb.201308083; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Su Y, 2016, P NATL ACAD SCI USA, V113, pE3872, DOI 10.1073/pnas.1605074113; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Wang JC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13248-5; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1498, DOI 10.1016/j.jasms.2006.05.014; Xia W, 2014, P NATL ACAD SCI USA, V111, P17863, DOI 10.1073/pnas.1420645111; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	45	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102323	10.1016/j.jbc.2022.102323	http://dx.doi.org/10.1016/j.jbc.2022.102323			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4V3XX	35931112	Green Published, gold			2022-12-26	WOS:000859414300012
J	Park, SY; Yoo, JW; Song, SK; Kim, CH; Lee, SH				Park, Soon-Young; Yoo, Jung-Woo; Song, Sang-Keun; Kim, Cheol-Hee; Lee, Soon-Hwan			Numerical study on advective fog formation and its characteristic associated with cold water upwelling	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; DROPLET SPECTROMETER; RADIATION FOG; PART I; MODEL; EVENT; RESOLUTION; IMPACT; SENSITIVITY; SCHEME	Recent rapid industrial development in the Korean Peninsula has increased the impacts of meteorological disasters on marine and coastal environments. In particular, marine fog driven by summer cold water masses can inhibit transport and aviation; yet a lack of observational data hinders our understanding of this phenomena. The present study aimed to analyze the differences in cold water mass formation according to sea surface temperature (SST) resolution and its effects on the occurrence and distribution of sea fog over the Korean Peninsula from June 23-July 1, 2016, according to the Weather Research and Forecasting model. Data from the Final Operational Model Global Tropospheric Analyses were provided at 1 degrees and 0.25 degrees resolutions and NOAA real-time global SST (RTG-SST) data were provided at 0.083 degrees. While conventional analyses have used initial SST distributions throughout the entire simulation period, small-scale, rapidly developing oceanic phenomena (e.g., cold water masses) lasting for several days act as an important mediating factor between the lower atmosphere and sea. RTG-SST was successful at identifying fog presence and maintained the most extensive horizontal distribution of cold water masses. In addition, it was confirmed that the difference in SST resolution led to varying sizes and strengths of the warm pools that provided water vapor from the open sea area to the atmosphere. On examining the horizontal water vapor transport and the vertical structure of the generated sea fog using the RTG-SST, water vapors were found to be continuously introduced by the southwesterly winds from June 29 to 30, creating a fog event throughout June 30. Accordingly, high-resolution SST data must be input into numerical models whenever possible. It is expected that the findings of this study can contribute to the reduction of ship accidents via the accurate simulation of sea fog.	[Park, Soon-Young; Yoo, Jung-Woo] Pusan Natl Univ, Inst Environm Studies, Busan, South Korea; [Song, Sang-Keun] Jeju Natl Univ, Dept Earth & Marine Sci, Jeju, South Korea; [Kim, Cheol-Hee] Pusan Natl Univ, Dept Atmospher Sci, Busan, South Korea; [Lee, Soon-Hwan] Pusan Natl Univ, Dept Earth Sci Educ, Busan, South Korea	Pusan National University; Jeju National University; Pusan National University; Pusan National University	Lee, SH (corresponding author), Pusan Natl Univ, Dept Earth Sci Educ, Busan, South Korea.	withshlee@pusan.ac.kr		Kim, Cheol-Hee/0000-0002-2967-4987; Park, Soon-Young/0000-0001-6858-6392; LEE, SOON-HWAN/0000-0002-7902-830X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2020R1A6A1A03044834]; Ministry of Science, ICT and Future Planning [2020R1A2C2011081]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea); Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2020R1A6A1A03044834) and by the Ministry of Science, ICT and Future Planning (2020R1A2C2011081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banacos PC, 2005, WEATHER FORECAST, V20, P351, DOI 10.1175/WAF858.1; Boutle IA, 2016, Q J ROY METEOR SOC, V142, P360, DOI 10.1002/qj.2656; Chen F, 2001, MON WEATHER REV, V129, P569, DOI 10.1175/1520-0493(2001)129<0569:CAALSH>2.0.CO;2; Cho YK, 2000, J APPL METEOROL, V39, P2473, DOI 10.1175/1520-0450(2000)039<2473:SFATKP>2.0.CO;2; Fu G, 2006, ATMOS RES, V81, P293, DOI 10.1016/j.atmosres.2006.01.005; Gao SH, 2007, ADV ATMOS SCI, V24, P65, DOI 10.1007/s00376-007-0065-2; Gultepe I, 2007, PURE APPL GEOPHYS, V164, P1121, DOI 10.1007/s00024-007-0211-x; Gultepe I, 2007, WEATHER FORECAST, V22, P444, DOI 10.1175/WAF1011.1; Gultepe I, 2021, BOUND-LAY METEOROL, V181, P227, DOI 10.1007/s10546-021-00659-5; Gultepe I, 2014, B AM METEOROL SOC, V95, P211, DOI 10.1175/BAMS-D-11-00071.1; Gultepe I, 2009, B AM METEOROL SOC, V90, P341, DOI 10.1175/2008BAMS2354.1; Haeffelin M, 2010, B AM METEOROL SOC, V91, P767, DOI 10.1175/2009BAMS2671.1; Hu HQ, 2014, MON WEATHER REV, V142, P1803, DOI 10.1175/MWR-D-13-00004.1; Iacono MJ, 2000, J GEOPHYS RES-ATMOS, V105, P14873, DOI 10.1029/2000JD900091; Jung JH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67785-x; Kain JS, 2004, J APPL METEOROL, V43, P170, DOI 10.1175/1520-0450(2004)043<0170:TKCPAU>2.0.CO;2; Kim Ju-Yeon, 2019, [Journal of the Korean Society of Marine Environment & Safety, 해양환경안전학회지], V25, P581, DOI 10.7837/kosomes.2019.25.5.581; Morrison H, 2009, MON WEATHER REV, V137, P991, DOI 10.1175/2008MWR2556.1; Nakanishi M, 2006, BOUND-LAY METEOROL, V119, P397, DOI 10.1007/s10546-005-9030-8; National Academy of Agricultural Sciences, 2012, FRAMEWORK K 12 SCI E, P1; Niu SJ, 2010, ADV ATMOS SCI, V27, P1259, DOI 10.1007/s00376-010-8192-6; Philip A, 2016, WEATHER FORECAST, V31, P1655, DOI 10.1175/WAF-D-16-0074.1; Price JD, 2018, B AM METEOROL SOC, V99, P2061, DOI 10.1175/BAMS-D-16-0299.1; Roman-Cascon C, 2016, Q J ROY METEOR SOC, V142, P1048, DOI 10.1002/qj.2708; Skamarock W C, 2008, DESCRIPTION ADV RES, P1, DOI [DOI 10.5065/D68S4MVH, 10.5065/D68S4MVH]; Song SK, 2020, OCEAN SCI M, pA124A; Spiegel JK, 2012, ATMOS MEAS TECH, V5, P2237, DOI 10.5194/amt-5-2237-2012; Steeneveld GJ, 2015, BOUND-LAY METEOROL, V154, P265, DOI 10.1007/s10546-014-9973-8; Tang YM, 2012, J APPL METEOROL CLIM, V51, P986, DOI 10.1175/JAMC-D-11-0253.1; Thiebaux J, 2003, B AM METEOROL SOC, V84, P645, DOI 10.1175/BAMS-84-5-645; Yang D, 2010, WEATHER FORECAST, V25, P727, DOI 10.1175/2009WAF2222337.1; Yang Y, 2019, ATMOS RES, V215, P253, DOI 10.1016/j.atmosres.2018.09.004	32	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2022	17	8							e0267895	10.1371/journal.pone.0267895	http://dx.doi.org/10.1371/journal.pone.0267895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6E5OF	35939425	gold, Green Published			2022-12-26	WOS:000883428500001
J	Calvo-Paniagua, J; Diaz-Arribas, MJ; Valera-Calero, JA; Gallardo-Vidal, MI; Fernandez-de-Las-Penas, C; Lopez-de-Uralde-Villanueva, I; del Corral, T; Plaza-Manzano, G				Calvo-Paniagua, Jose; Jose Diaz-Arribas, Maria; Antonio Valera-Calero, Juan; Isabel Gallardo-Vidal, Maria; Fernandez-de-Las-Penas, Cesar; Lopez-de-Uralde-Villanueva, Ibai; del Corral, Tamara; Plaza-Manzano, Gustavo			A tele-health primary care rehabilitation program improves self-perceived exertion in COVID-19 survivors experiencing Post-COVID fatigue and dyspnea: A quasi-experimental study	PLOS ONE			English	Article							TELEREHABILITATION	Background Current evidence suggests that up to 70% of COVID-19 survivors develop post-COVID symptoms during the following months after infection. Fatigue and dyspnea seem to be the most prevalent post-COVID symptoms. Objective To analyze whether a tele-rehabilitation exercise program is able to improve self-perceived physical exertion in patients with post-COVID fatigue and dyspnea. Methods Sixty-eight COVID-19 survivors exhibiting post-COVID fatigue and dyspnea derived to four Primary Health Care centers located in Madrid were enrolled in this quasi-experimental study. A tele-rehabilitation program based on patient education, physical activity, airway clearing, and breathing exercise interventions was structured on eighteen sessions (3 sessions/week). Self-perceived physical exertion during daily living activities, dyspnea severity, health-related quality of life and distance walked and changes in oxygen saturation and heart rate during the 6-Minute walking test were assessed at baseline, after the program and at 1- and 3-months follow-up periods. Results Daily living activities, dyspnea severity and quality of life improved significantly at all followups (p<0.001). Additionally, a significant increase in oxygen saturation before and after the 6-Minute Walking test was found when compared with baseline (P<0.001). Heart rate adaptations at rest were found during the follow-up periods (P = 0.012). Lower perceived exertion before and after the 6-Minute Walking test were also observed, even if larger distance were walked (P<0.001). Conclusion Tele-rehabilitation programs could be an effective strategy to reduce post-COVID fatigue and dyspnea in COVID-19 survivors. In addition, it could also reduce the economic burden of acute COVID-19, reaching a greater number of patients and releasing Intensive Unit Care beds for prioritized patients with a severe disease.	[Calvo-Paniagua, Jose] Ctr Salud Dr Castroviejo, Gerencia Asistencial Atenc Primaria Madrid, Madrid, Spain; [Jose Diaz-Arribas, Maria; Lopez-de-Uralde-Villanueva, Ibai; del Corral, Tamara; Plaza-Manzano, Gustavo] Univ Complutense Madrid, Dept Radiol Rehabil & Physiotherapy, Madrid, Spain; [Jose Diaz-Arribas, Maria; Lopez-de-Uralde-Villanueva, Ibai; del Corral, Tamara; Plaza-Manzano, Gustavo] Inst Invest Sanitaria San Carlos IdISSC, Madrid, Spain; [Antonio Valera-Calero, Juan] Univ Camilo Jose Cela, Dept Phys Therapy, VALTRADOFI Res Grp, Madrid, Spain; [Isabel Gallardo-Vidal, Maria] Ctr Salud Valdelasfuentes, Gerencia Asistencial Atenc Primaria Madrid, Madrid, Spain; [Fernandez-de-Las-Penas, Cesar] Univ Rey Juan Carlos, Dept Phys Therapy Occupat Therapy Rehabil & Phys, Alcorcon, Spain	Complutense University of Madrid; Camilo Jose Cela University; Universidad Rey Juan Carlos	Diaz-Arribas, MJ (corresponding author), Univ Complutense Madrid, Dept Radiol Rehabil & Physiotherapy, Madrid, Spain.; Diaz-Arribas, MJ (corresponding author), Inst Invest Sanitaria San Carlos IdISSC, Madrid, Spain.	mjdiazar@med.ucm.es		Valera Calero, Juan Antonio/0000-0002-3379-8392; Lopez-de-Uralde-Villanueva, Ibai/0000-0001-7474-5257; Diaz-Arribas, Maria Jose/0000-0002-6231-107X	Foundation for Biosanitary Research and Innovation in Primary Care (FIIBAP); Regional Ministry of Health of the Community of Madrid [HAC/667/2020]	Foundation for Biosanitary Research and Innovation in Primary Care (FIIBAP); Regional Ministry of Health of the Community of Madrid	Funded by the Foundation for Biosanitary Research and Innovation in Primary Care (FIIBAP) and the Regional Ministry of Health of the Community of Madrid through non-refundable grants from the credits awarded to the Community of Madrid by the Spanish Government Fund COVID-19, included in Order HAC/667/2020. Funders had no role in the study design, data collection and analysis, decision to publish nor preparation of the manuscript.	Ammar A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240204; Bohannon RW, 2017, J EVAL CLIN PRACT, V23, P377, DOI 10.1111/jep.12629; Cortes-Telles A, 2021, RESP PHYSIOL NEUROBI, V288, DOI 10.1016/j.resp.2021.103644; Davido B, 2020, CLIN MICROBIOL INFEC, V26, P1448, DOI 10.1016/j.cmi.2020.07.028; Davies KAB, 2019, THER ADV ENDOCRINOL, V10, DOI 10.1177/2042018819888824; Demeco A, 2020, J INT MED RES, V48, DOI 10.1177/0300060520948382; Fernandez-de-las-Penas C, 2022, EUR J INTERN MED, V100, P133, DOI 10.1016/j.ejim.2022.02.013; Fernandez-De-las-Penas C, 2021, RESPIRATION, DOI 10.1159/000518854; Fernandez-de-las-Penas C, 2022, INFECTION, V50, P285, DOI 10.1007/s15010-021-01696-5; Fernandez-de-las-Penas C, 2021, EUR J INTERN MED, V92, P55, DOI 10.1016/j.ejim.2021.06.009; Fernandez-de-las-Penas C, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052621; Fiani B, 2020, CUREUS, V12, DOI 10.7759/cureus.10563; Garrigues E, 2020, J INFECTION, V81, pE4, DOI 10.1016/j.jinf.2020.08.029; Han Q, 2022, PATHOGENS, V11, DOI 10.3390/pathogens11020269; Hsu KY, 2013, SINGAP MED J, V54, P321, DOI 10.11622/smedj.2013125; Jacobs LG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243882; Kendrick K R, 2000, J Emerg Nurs, V26, P216; Lee K, 2009, GLOB INST, P1; Lima-Martinez MM, 2021, CLIN INVEST ARTERIOS, V33, P151, DOI 10.1016/j.arteri.2020.10.001; Lin L, 2020, Zhonghua Yi Xue Za Zhi, V100, pE001, DOI 10.3760/cma.j.issn.0376-2491.2020.0001; Lopez-Leon S, 2021, SCI REP-UK, V11, DOI [10.1038/s41598-021-95565-8, 10.1101/2021.01.27.21250617]; Oronsky B, 2021, CLIN REV ALLERG IMMU, DOI 10.1007/s12016-021-08848-3; Peretti Alessandro, 2017, JMIR Rehabil Assist Technol, V4, pe7, DOI 10.2196/rehab.7511; Pinto AJ, 2020, NAT REV RHEUMATOL, V16, P347, DOI 10.1038/s41584-020-0427-z; Rogante M, 2010, NEUROREHABILITATION, V27, P287, DOI 10.3233/NRE-2010-0612; Sepulveda-Loyola W, 2020, J NUTR HEALTH AGING, DOI [10.1007/s12603-020-1500-7, 10.1007/s12603-020-1469-2]; Simera I, 2010, EUR J CLIN INVEST, V40, P35, DOI 10.1111/j.1365-2362.2009.02234.x; Sykes DL, 2021, EUR RESPIR J, V58, DOI [10.1007/s00408-021-00423-z, 10.1183/13993003.congress-2021.OA4189]; Turolla A, 2020, PHYS THER, V100, P1260, DOI 10.1093/ptj/pzaa093; Vallve C, 2005, MED CLIN-BARCELONA, V125, P38, DOI 10.1016/S0025-7753(05)72208-9; Wang TNJ, 2020, AM J PHYS MED REHAB, V99, P769, DOI 10.1097/PHM.0000000000001505; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115; Zheng KI, 2021, J MED VIROL, V93, P323, DOI 10.1002/jmv.26294	33	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271802	10.1371/journal.pone.0271802	http://dx.doi.org/10.1371/journal.pone.0271802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35926004	Green Published, gold			2022-12-26	WOS:000848077100053
J	Parra, C; Grijalva, F; Nunez, B; Nunez, A; Perez, N; Benitez, D				Parra, Carla; Grijalva, Felipe; Nunez, Bryan; Nunez, Alejandra; Perez, Noel; Benitez, Diego			Automatic identification of intestinal parasites in reptiles using microscopic stool images and convolutional neural networks	PLOS ONE			English	Article								Captive environments trigger the propagation and multiplication of parasites among different reptile species, thus weakening their immune response and causing infections and diseases. Technological advances of convolutional neural networks have opened a new field for detecting and classifying diseases which have shown great potential to overcome the shortcomings of manual detection performed by experts. Therefore, we propose an approach to identify six captive reptiles parasitic agents (Ophionyssus natricis, Blastocystis sp, Oxiurdo egg, Rhytidoides similis, Strongyloides, Taenia) or the absence of such parasites from a microscope stool images dataset. Towards this end, we first use an image segmentation stage to detect the parasite within the image, which combines the Contrast Limited Adaptive Histogram Equalization (CLAHE) technique, the OTSU binarization method, and morphological operations. Then, we carry out a classification stage through MobileNet CNN under a transfer learning scheme. This method was validated on a stool image dataset containing 3616 images data samples and 26 videos from the six parasites mentioned above. The results obtained indicate that our transfer learning-based approach can learn a helpful representation from the dataset. We obtained an average accuracy of 94.26% across the seven classes (i.e., six parasitic agents and the absence of parasites), which statistically outperformed, at a 95% confidence level, a custom CNN trained from scratch.	[Parra, Carla] Nuevas Comunicac Iberia SA, NuCom, Barcelona, Spain; [Grijalva, Felipe] Univ Amer UDLA, Fac Engn & Appl Sci FICA, Telecommun Engn, Quito, Ecuador; [Grijalva, Felipe; Nunez, Bryan] Escuela Politec Nacl, Dept Elect Telecomunicac & Redes Informac DETRI, Quito, Ecuador; [Nunez, Alejandra] Univ Tecn Ambato, Carrera Med Vet & Zootecnia, Ambato, Ecuador; [Perez, Noel; Benitez, Diego] Univ San Francisco Quito USFQ, Colegio Ciencias & Ingn El Politecn, Quito, Ecuador	Universidad de Las Americas - Ecuador; Escuela Politecnica Nacional Ecuador; Universidad Tecnica de Ambato	Grijalva, F (corresponding author), Univ Amer UDLA, Fac Engn & Appl Sci FICA, Telecommun Engn, Quito, Ecuador.; Grijalva, F (corresponding author), Escuela Politec Nacl, Dept Elect Telecomunicac & Redes Informac DETRI, Quito, Ecuador.	felipe.grijalva@udla.edu.ec	; Perez, Noel/E-1894-2014	Nunez, Bryan/0000-0003-0147-9845; Perez, Noel/0000-0003-3166-745X; Grijalva, Felipe/0000-0001-6162-3429				Andrew G. Howard, 2017, Arxiv, DOI arXiv:1704.04861; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Bengio Y, 2004, J MACH LEARN RES, V5, P1089; Bhargavi K., 2014, INT J INNOV RES DEV, V3, P234; Bishop C. M, 2006, PATTERN RECOGNITION; Bock S., 2019, P 2019 INT JOINT C N, P1; Bower DS, 2019, AUSTRAL ECOL, V44, P433, DOI 10.1111/aec.12695; Cho J., 2007, RED, V346, P244; Croft H. T., 1991, SPRINGER SCI BUSINES; Espinoza K, 2016, COMPUT ELECTRON AGR, V127, P495, DOI 10.1016/j.compag.2016.07.008; Evans AN, 2006, IEEE T IMAGE PROCESS, V15, P1454, DOI 10.1109/TIP.2005.864164; Ginoris YP, 2007, ANAL CHIM ACTA, V595, P160, DOI 10.1016/j.aca.2006.12.055; Hanbury A, 2004, INT C PATT RECOG, P672, DOI 10.1109/ICPR.2004.1334259; Jacobson E, 2021, DIS PATHOLOGY REPTIL; Jorge F, 2013, PARASITOL RES, V112, P4001, DOI 10.1007/s00436-013-3588-8; Kalchbrenner N., 2014, P 52 ANN M ASS COMP, V1, P655, DOI 10.3115/v1/P14-1062; Kazeminia S, 2020, ARTIF INTELL MED, V109, DOI 10.1016/j.artmed.2020.101938; Khatun Most Monjila, 2014, Journal of Threatened Taxa, V6, P6142, DOI 10.11609/JoTT.o3093.6142-7; Kim JY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50437-0; Li QL, 2020, MED PHYS, V47, P4212, DOI 10.1002/mp.14352; Li Q, 2014, I C CONT AUTOMAT ROB, P844, DOI 10.1109/ICARCV.2014.7064414; Li YN, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201800410; Mader DR, 2013, CURRENT THERAPY REPT; Mendoza-Roldan JA, 2020, TRENDS PARASITOL, V36, P677, DOI 10.1016/j.pt.2020.04.014; Nagamori Y, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-04215-x; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PIZER SM, 1987, COMPUT VISION GRAPH, V39, P355, DOI 10.1016/S0734-189X(87)80186-X; Quinn J.A., 2016, P MACHINE LEARNING H, P271; RAGNEMALM I, 1992, PATTERN RECOGN LETT, V13, P161, DOI 10.1016/0167-8655(92)90055-5; Ramalingam B, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20185280; Razzak MI, 2018, L N COMPUT VIS BIOME, V26, P323, DOI 10.1007/978-3-319-65981-7_12; Razzak Muhammad Imran, 2015, INT J BIOMETRICS BIO, V9, P1; Roder Mateus, 2020, Artificial Intelligence and Soft Computing. 19th International Conference, ICAISC 2020. Proceedings. Lecture Notes in Artificial Intelligence Subseries of Lecture Notes in Computer Science (LNAI 12415), P242, DOI 10.1007/978-3-030-61401-0_23; Ronneberger O., 2015, P INT C MED IM COM, P234, DOI DOI 10.1007/978-3-319-24574-4_28; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Tan CQ, 2018, LECT NOTES COMPUT SC, V11141, P270, DOI 10.1007/978-3-030-01424-7_27; Targ S., 2016, ARXIV, DOI DOI 10.48550/ARXIV.1603.08029; Tran T, 2018, 2018 IEEE INTERNATIONAL CONFERENCE ON ELECTRONICS AND COMMUNICATION ENGINEERING (ICECE 2018), P13, DOI 10.1109/ICECOME.2018.8644754; Valle E., 2017, ARXIV PREPRINT ARXIV, V1, P770; Weiss Karl, 2016, Journal of Big Data, V3, DOI 10.1186/s40537-016-0043-6; Wilson DR, 2001, IEEE IJCNN, P115, DOI 10.1109/IJCNN.2001.939002; Xu J, 2020, IEEE SYMP COMP COMMU, P703	43	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271529	10.1371/journal.pone.0271529	http://dx.doi.org/10.1371/journal.pone.0271529			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925986	Green Published, Green Submitted, gold			2022-12-26	WOS:000848077100042
J	Eggert, T; Nguyen, PV; Ernst, K; Loosli, SV; Straube, A				Eggert, Thomas; Phuong Van Nguyen; Ernst, Katharina; Loosli, Sandra, V; Straube, Andreas			A new test to detect impairments of sequential visuospatial memory due to lesions of the temporal lobe	PLOS ONE			English	Article							VERBAL-LEARNING TEST; EPISODIC MEMORY; INTERFERENCE; HIPPOCAMPUS; ACQUISITION; PERFORMANCE; HANDEDNESS; EXPLICIT; GENDER; PRE	This study investigates visuospatial memory in patients with unilateral lesions of the temporal lobe and the hippocampus resulting from surgery to treat drug-resistant epilepsy. To detect impairments of visuospatial memory in these individuals, a memory test should be specific to episodic memory, the type of memory in which the hippocampus is crucially involved. However, most known visuospatial memory tests do not focus on episodic memory. We hypothesized that a new sequential visuospatial memory test, which has been previously developed and applied only in healthy subjects, might be suitable to fill this gap. The test requires the subject to reproduce a memorized sequence of target locations in ordered recall by typing on a blank graphics tablet. The length of the memorized sequence extended successively after repeated presentation of a sequence of 20 target positions. The test was done twice on day one and again after one week. Visual working memory was tested with the Corsi block-tapping task. The performance in the new test was also related to the performance of the patients in the standard test battery of the neuropsychological examination in the clinical context. Thirteen patients and 14 controls participated. Patients showed reduced learning speed in the new sequential visuospatial memory task. Right-sided lesions induced stronger impairments than left-sided lesions. After one week, retention was reduced in the patients with left-sided lesions. The performance of the patients in commonly used tests of the neuropsychological standard battery did not differ compared to healthy subjects, whereas the new test allowed discrimination between patients and controls at a high correct-decision rate of 0.89. The Corsi block-span of the patients was slightly shorter than that of the controls. The results suggest that the new test provides a specific investigation of episodic visuospatial memory. Hemispheric asymmetries were consistent with the general hypothesis of right hemispheric dominance in visuospatial processing.	[Eggert, Thomas; Phuong Van Nguyen; Ernst, Katharina; Loosli, Sandra, V; Straube, Andreas] Ludwig Maximilians Univ Munchen, Dept Neurol, Univ Hosp, Munich, Germany	University of Munich	Eggert, T (corresponding author), Ludwig Maximilians Univ Munchen, Dept Neurol, Univ Hosp, Munich, Germany.	eggert@lrz.uni-muenchen.de						Baddeley A, 2011, J COGNITIVE NEUROSCI, V23, P3855, DOI 10.1162/jocn_a_00066; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Beck IR, 2012, ARCH CLIN NEUROPSYCH, V27, P510, DOI 10.1093/arclin/acs056; BOCK O, 1993, EXP BRAIN RES, V95, P111; Boucher O, 2015, EPILEPSY BEHAV, V43, P53, DOI 10.1016/j.yebeh.2014.11.016; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Drever J, 2011, BEHAV BRAIN RES, V220, P74, DOI 10.1016/j.bbr.2011.01.027; Drever J, 2011, BEHAV RES METHODS, V43, P269, DOI 10.3758/s13428-010-0025-0; Eggert T, 2014, BEHAV BRAIN RES, V262, P21, DOI 10.1016/j.bbr.2013.12.047; Elliott G, 2014, CORTEX, V54, P16, DOI 10.1016/j.cortex.2014.02.001; Elwood RW, 1995, NEUROPSYCHOL REV, V5, P173, DOI 10.1007/BF02214761; Ezzati A, 2016, NEUROPSYCHOLOGIA, V93, P380, DOI 10.1016/j.neuropsychologia.2016.08.016; FRISK V, 1990, NEUROPSYCHOLOGIA, V28, P349, DOI 10.1016/0028-3932(90)90061-R; Gallagher C, 2007, BRIT J CLIN PSYCHOL, V46, P35, DOI 10.1348/014466506X106047; Ghilardi MF, 2009, J NEUROPHYSIOL, V101, P2218, DOI 10.1152/jn.01138.2007; Gleissner U, 1998, J NEUROL NEUROSUR PS, V65, P665, DOI 10.1136/jnnp.65.5.665; HELMSTAEDTER C, 1991, CORTEX, V27, P547, DOI 10.1016/S0010-9452(13)80004-4; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Kramer JH, 2003, J INT NEUROPSYCH SOC, V9, P97, DOI 10.1017/S1355617703910113; LAMBERTI G, 1978, ARCH PSYCHIAT NERVEN, V225, P143, DOI 10.1007/BF00343398; Lendt M, 1999, EPILEPSIA, V40, P1543, DOI 10.1111/j.1528-1157.1999.tb02038.x; LEVENSHT.VI, 1965, DOKL AKAD NAUK SSSR+, V163, P845; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Loring DW, 1988, J EPILEPSY, V1, P53, DOI DOI 10.1016/S0896-6974(88)80057-4; Moscovitch M, 2016, ANNU REV PSYCHOL, V67, P105, DOI 10.1146/annurev-psych-113011-143733; Moye J, 1997, NEUROPSYCHOL REV, V7, P157, DOI 10.1023/B:NERV.0000005907.34499.43; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osterrieth PA., 1944, ARCH PSYCHOLOGIE; Rey A., 1958, EXAMEN CLIN PSYCHOL; Sakai K, 2003, EXP BRAIN RES, V152, P229, DOI 10.1007/s00221-003-1548-8; Scott C, 2006, IEEE T IMAGE PROCESS, V15, P1831, DOI 10.1109/TIP.2006.877038; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Seggar LB, 2002, BEHAV THER, V33, P253, DOI 10.1016/S0005-7894(02)80028-4; Shin MS, 2006, NAT PROTOC, V1, P892, DOI 10.1038/nprot.2006.115; SMITH ML, 1995, NEUROPSYCHOLOGIA, V33, P275; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; TUCKER DM, 1986, NEUROPSYCHOLOGIA, V24, P277, DOI 10.1016/0028-3932(86)90061-8; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Tulving E., 1993, CURRENT DIRECTIONS P, V2, P67, DOI [10.1111/1467-8721.ep10770899, DOI 10.1111/1467-8721.EP10770899]; Visser M, 2019, CORTEX, V110, P80, DOI 10.1016/j.cortex.2018.02.017; Weidlich S, 2001, DIAGNOSTICUM CEREBRA; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002	43	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2022	17	7							e0272365	10.1371/journal.pone.0272365	http://dx.doi.org/10.1371/journal.pone.0272365			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Q0KX	35905135	gold, Green Published			2022-12-26	WOS:000855776900069
J	Paulin, KA; Cortez, D; Eichman, BF				Paulin, Katherine A.; Cortez, David; Eichman, Brandt F.			The SOS response-associated peptidase (SRAP) domain of YedK catalyzes ring opening of abasic sites and reversal of its DNA-protein cross-link	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STRAND BREAKS; ENDONUCLEASE; FORMALDEHYDE; OXAZOLIDINE; MECHANISM; CYSTEINE; BYPASS; REPAIR	Apurinic/apyrimidinic (AP, or abasic) sites in DNA are one of the most common forms of DNA damage. AP sites are reactive and form cross-links to both proteins and DNA, are prone to strand breakage, and inhibit DNA replication and transcription. The replication-associated AP site repair protein HMCES protects cells from strand breaks, inhibits mutagenic translesion synthesis, and participates in repair of interstrand DNA cross-links derived from AP sites by forming a stable thiazolidine DNA-protein cross-link (DPC) to AP sites in single-stranded DNA (ssDNA). Despite the importance of HMCES to genome maintenance and the evolutionary conservation of its catalytic SRAP (SOS Response Associated Peptidase) domain, the enzymatic mechanisms of DPC formation and resolution are unknown. Using the bacterial homolog YedK, we show that the SRAP domain catalyzes conversion of the AP site to its reactive, ring-opened aldehyde form, and we provide structural evidence for the Schiff base intermediate that forms prior to the more stable thiazolidine. We also report two new activities, whereby SRAP reacts with polyunsaturated aldehydes at DNA 3 '-ends generated by bifunctional DNA glycosylases and catalyzes direct reversal of the DPC to regenerate the AP site, the latter of which we observe in both YedK and HMCES-SRAP proteins. Taken together, this work provides insights into possible mechanisms by which HMCES DPCs are resolved in cells.	[Paulin, Katherine A.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Cortez, David; Eichman, Brandt F.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Eichman, BF (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.; Eichman, BF (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	brandt.eichman@vanderbilt.edu		Paulin, Katherine/0000-0002-9311-9136	National Institutes of Health [R35GM136401, R01ES030575, F31ES032334]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by grants from the National Institutes of Health (R35GM136401 to B. F. E., R01ES030575 to D. C., and F31ES032334 to K. A. P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amidon KM, 2020, DNA REPAIR, V94, DOI 10.1016/j.dnarep.2020.102903; Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Aravind L, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-20; BAILLY V, 1987, BIOCHEM J, V242, P565, DOI 10.1042/bj2420565; Canle M, 1996, PURE APPL CHEM, V68, P813, DOI 10.1351/pac199668040813; Cook A. H., 1949, CHEM PENICILLIN, P921; COVEY JM, 1989, CANCER RES, V49, P5016; ESTERBAUER H, 1976, TETRAHEDRON, V32, P285, DOI 10.1016/0040-4020(76)87015-9; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; Gilboa R, 2002, J BIOL CHEM, V277, P19811, DOI 10.1074/jbc.M202058200; Halabelian L, 2019, NAT STRUCT MOL BIOL, V26, P607, DOI 10.1038/s41594-019-0246-6; Haldar T, 2022, CHEM RES TOXICOL, V35, P218, DOI 10.1021/acs.chemrestox.1c00409; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Ide H, 2018, DNA REPAIR, V71, P190, DOI 10.1016/j.dnarep.2018.08.024; JUST G, 1976, CAN J CHEM, V54, P2089, DOI 10.1139/v76-299; KALLEN RG, 1971, J AM CHEM SOC, V93, P6236, DOI 10.1021/ja00752a040; Kamps JJAG, 2019, COMMUN CHEM, V2, DOI 10.1038/s42004-019-0224-2; Kojima N, 2009, J AM CHEM SOC, V131, P13208, DOI 10.1021/ja904767k; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Krokan HE, 2014, DNA REPAIR, V19, P38, DOI 10.1016/j.dnarep.2014.03.028; Kweon SM, 2017, CELL REP, V21, P482, DOI 10.1016/j.celrep.2017.09.055; Lhomme J, 1999, BIOPOLYMERS, V52, P65, DOI 10.1002/1097-0282(1999)52:2<65::AID-BIP1>3.0.CO;2-U; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; MANOHARAN M, 1988, J AM CHEM SOC, V110, P1620, DOI 10.1021/ja00213a044; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Mehta KPM, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107705; MELAMEDE RJ, 1994, BIOCHEMISTRY-US, V33, P1255, DOI 10.1021/bi00171a028; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Mohni KN, 2019, CELL, V176, P144, DOI 10.1016/j.cell.2018.10.055; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nakamura J, 2020, DNA REPAIR, V88, DOI 10.1016/j.dnarep.2020.102806; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OVEREND WG, 1950, J CHEM SOC, P2769, DOI 10.1039/jr9500002769; Pan YH, 2022, LEUKEMIA, V36, P1123, DOI 10.1038/s41375-021-01499-5; Pommier Y, 1999, DRUG RESIST UPDATE, V2, P307, DOI 10.1054/drup.1999.0102; Powers KT, 2018, DNA REPAIR, V71, P127, DOI 10.1016/j.dnarep.2018.08.016; Price NE, 2014, J AM CHEM SOC, V136, P3483, DOI 10.1021/ja410969x; Purmal AA, 1996, MUTAT RES-DNA REPAIR, V364, P193, DOI 10.1016/S0921-8777(96)00032-8; Quinones JL, 2020, DNA REPAIR, V87, DOI 10.1016/j.dnarep.2019.102773; Ratner S, 1937, J AM CHEM SOC, V59, P200, DOI 10.1021/ja01280a050; Saiz C, 2009, ORG LETT, V11, P3170, DOI 10.1021/ol901104a; SCHAAPER RM, 1983, P NATL ACAD SCI-BIOL, V80, P487, DOI 10.1073/pnas.80.2.487; Schubert MP, 1936, J BIOL CHEM, V114, P341; Semlow DR, 2022, NAT STRUCT MOL BIOL, V29, P451, DOI 10.1038/s41594-022-00764-0; Shukla V, 2020, MOL CELL, V77, P384, DOI 10.1016/j.molcel.2019.10.031; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Srivastava M, 2020, EMBO REP, V21, DOI 10.15252/embr.201949123; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Thompson PS, 2020, DNA REPAIR, V90, DOI 10.1016/j.dnarep.2020.102866; Thompson PS, 2019, NAT STRUCT MOL BIOL, V26, P613, DOI 10.1038/s41594-019-0255-5; Tsutakawa SE, 2014, DNA REPAIR, V19, P95, DOI 10.1016/j.dnarep.2014.03.022; Wang N, 2019, NUCLEIC ACIDS RES, V47, P10388, DOI 10.1093/nar/gkz744; WILDE JA, 1989, J AM CHEM SOC, V111, P1894, DOI 10.1021/ja00187a062; Wu LZ, 2022, GENE DEV, V36, P433, DOI 10.1101/gad.349438.122; Wu RA, 2019, NATURE, V567, P267, DOI 10.1038/s41586-019-1002-0; Yang ZY, 2017, NUCLEIC ACIDS RES, V45, P6275, DOI 10.1093/nar/gkx394; Zharkov DO, 1997, J BIOL CHEM, V272, P5335, DOI 10.1074/jbc.272.8.5335	59	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102307	10.1016/j.jbc.2022.102307	http://dx.doi.org/10.1016/j.jbc.2022.102307			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9EO	35934051	Green Published, gold			2022-12-26	WOS:000863182500005
J	Pietrobono, S; De Paolo, R; Mangiameli, D; Marranci, A; Battisti, I; Franchin, C; Arrigoni, G; Melisi, D; Poliseno, L; Stecca, B				Pietrobono, Silvia; De Paolo, Raffaella; Mangiameli, Domenico; Marranci, Andrea; Battisti, Ilaria; Franchin, Cinzia; Arrigoni, Giorgio; Melisi, Davide; Poliseno, Laura; Stecca, Barbara			p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANCE PROTEIN ABCG2; P-GLYCOPROTEIN ABCB1; MEK INHIBITION; ACQUIRED-RESISTANCE; SELF-RENEWAL; VEMURAFENIB; BINDING; DABRAFENIB	Despite recent advances in the development of BRAF kinase inhibitors (BRAFi) for BRAF-mutant melanomas, development of resistance remains a major clinical problem. In addition to genetic alterations associated with intrinsic resistance, several adaptive response mechanisms are known to be rapidly acti-vated to allow cell survival in response to treatment, limiting efficacy. A better understanding of the mechanisms driving resistance is urgently needed to improve the success of BRAF-targeted therapies and to make therapeutic intervention more durable. In this study, we identify the mitogen-activated pro-tein kinase (MAPK) p38 as a novel mediator of the adaptive response of melanoma cells to BRAF-targeted therapy. Our findings demonstrate that BRAFi leads to an early increase in p38 activation, which promotes phosphorylation of the tran-scription factor SOX2 at Ser251, enhancing SOX2 stability, nuclear localization, and transcriptional activity. Furthermore, functional studies show that SOX2 depletion increases sensi-tivity of melanoma cells to BRAFi, whereas overexpression of a phosphomimetic SOX2-S251E mutant is sufficient to drive resistance and desensitize melanoma cells to BRAFi in vitro and in a zebrafish xenograft model. We also found that SOX2 phosphorylation at Ser251 confers resistance to BRAFi by binding to the promoter and increasing transcriptional acti-vation of the ATP-binding cassette drug efflux transporter ABCG2. In summary, we unveil a p38/SOX2-mediated mech-anism of adaptive response to BRAFi, which provides pro -survival signals to melanoma cells against the cytotoxic effects of BRAFi prior to acquiring resistance.	[Pietrobono, Silvia; Stecca, Barbara] Inst Canc Res & Prevent CRL ISPRO, Core Res Lab, Florence, Italy; [Pietrobono, Silvia; Mangiameli, Domenico; Melisi, Davide] Univ Verona, Digest Mol Clin Oncol Res Unit, Verona, Italy; [De Paolo, Raffaella; Marranci, Andrea; Poliseno, Laura] CRL ISPRO, Oncogen Unit, Pisa, Italy; [De Paolo, Raffaella; Marranci, Andrea; Poliseno, Laura] CNR, Inst Clin Physiol, Pisa, Italy; [De Paolo, Raffaella] Univ Siena, Dept Med Biotechnol, Siena, Italy; [Battisti, Ilaria; Franchin, Cinzia; Arrigoni, Giorgio] Univ Padua, Prote Ctr, Padua, Italy; [Battisti, Ilaria; Franchin, Cinzia; Arrigoni, Giorgio] Azienda Osped Padova, Padua, Italy; [Battisti, Ilaria; Franchin, Cinzia; Arrigoni, Giorgio] Univ Padua, Dept Biomed Sci, Padua, Italy; [Melisi, Davide] Azienda Osped Univ Integrata, Expt Canc Med Unit, Verona, Italy	University of Verona; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Siena; University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Pietrobono, S; Stecca, B (corresponding author), Inst Canc Res & Prevent CRL ISPRO, Core Res Lab, Florence, Italy.; Pietrobono, S (corresponding author), Univ Verona, Digest Mol Clin Oncol Res Unit, Verona, Italy.	silvia.pietrobono@univr.it; b.stecca@ispro.toscana.it	Franchin, Cinzia/AAM-1196-2021; Poliseno, Laura/B-5711-2012	Franchin, Cinzia/0000-0001-9223-117X; Marranci, Andrea/0000-0002-8334-8795; De Paolo, Raffaella/0000-0002-9151-2866; Stecca, Barbara/0000-0003-1197-1622; Poliseno, Laura/0000-0001-6557-955X	Institute for Cancer Research and Prevention (ISPRO); Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG-23091, IG-23719]; University of Padova [BIRD189887/18]; AIRC fellowship [21168]	Institute for Cancer Research and Prevention (ISPRO); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); University of Padova; AIRC fellowship(Fondazione AIRC per la ricerca sul cancro)	This work was supported by institutional funding from the Institute for Cancer Research and Prevention (ISPRO) to B. S. and L. P., and Associazione Italiana per la Ricerca sul Cancro (AIRC) to B. S. (IG-23091) and Davide Melisi (IG-23719) . G. A. was funded by the University of Padova (Grant number: BIRD189887/18) . S. P. was supported by AIRC fellowship (project n. 21168) .	Andreucci E, 2017, J MOL MED, V95, P1341, DOI 10.1007/s00109-017-1590-9; Ascierto PA, 2013, J CLIN ONCOL, V31, P3205, DOI 10.1200/JCO.2013.49.8691; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Belluzzi E, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-015-0066-z; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Cesarini V, 2017, ONCOGENE, V36, P4508, DOI 10.1038/onc.2017.53; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Dorris ER, 2016, CANCER BIOL THER, V17, P526, DOI 10.1080/15384047.2016.1139230; Dratkiewicz E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010113; Durmus S, 2012, MOL PHARMACEUT, V9, P3236, DOI 10.1021/mp3003144; Eberl M, 2012, EMBO MOL MED, V4, P218, DOI 10.1002/emmm.201100201; Fallahi-Sichani M, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20166796; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hartman ML, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010142; Huser L, 2018, INT J CANCER, V143, P3131, DOI 10.1002/ijc.31609; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Kefford R, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.8503; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Li Y, 2021, CELL COMMUN SIGNAL, V19, DOI 10.1186/s12964-020-00627-5; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Luebker SA, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00268; Menon DR, 2018, CANCER RES, V78, P6561, DOI 10.1158/0008-5472.CAN-18-0330; Michaelis Martin, 2014, BMC Res Notes, V7, P710, DOI 10.1186/1756-0500-7-710; Mittapalli RK, 2012, J PHARMACOL EXP THER, V342, P33, DOI 10.1124/jpet.112.192195; Novak D, 2020, SEMIN CANCER BIOL, V67, P74, DOI 10.1016/j.semcancer.2019.08.007; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; Ouyang J, 2015, J BIOL CHEM, V290, P22782, DOI 10.1074/jbc.M115.658195; Pietrobono S, 2021, ONCOGENE, V40, P3799, DOI 10.1038/s41388-021-01783-9; Pietrobono S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19575-2; Pietrobono S, 2016, J INVEST DERMATOL, V136, P2059, DOI 10.1016/j.jid.2016.06.610; Potu Harish, 2021, Oncotarget, V12, P160, DOI 10.18632/oncotarget.27869; Richard G, 2016, EMBO MOL MED, V8, P1143, DOI 10.15252/emmm.201505971; Robert C, 2019, NEW ENGL J MED, V381, P626, DOI 10.1056/NEJMoa1904059; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Rossi A, 2019, EUR J PHARMACOL, V862, DOI 10.1016/j.ejphar.2019.172621; Saei A, 2019, CANCERS, V11, DOI 10.3390/cancers11081176; Santini R, 2014, ONCOGENE, V33, P4697, DOI 10.1038/onc.2014.71; Schaefer T, 2020, ONCOGENE, V39, P278, DOI 10.1038/s41388-019-0997-x; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Vitiello M, 2017, ONCOTARGET, V8, P25395, DOI 10.18632/oncotarget.15915; Wang Z, 2019, ONCOGENE, V38, P5250, DOI 10.1038/s41388-019-0790-x; Wu CP, 2013, BIOCHEM PHARMACOL, V85, P325, DOI 10.1016/j.bcp.2012.11.003; Zhang SZ, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00242-3; Zhang SZ, 2020, PROTEIN CELL, V11, P82, DOI 10.1007/s13238-019-00673-x; Zhu FY, 2017, STEM CELL REP, V9, P429, DOI 10.1016/j.stemcr.2017.07.004; Zubrilov I, 2015, CANCER LETT, V361, P86, DOI 10.1016/j.canlet.2015.02.041	48	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102353	10.1016/j.jbc.2022.102353	http://dx.doi.org/10.1016/j.jbc.2022.102353			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9IM	35944584	gold, Green Published			2022-12-26	WOS:000863192700004
J	Alahyari, S; Rajaeinejad, M; Jalaeikhoo, H; Chegini, L; Aghdam, MA; Asgari, A; Nasiri, M; Khoshdel, A; Faridfar, A				Alahyari, Sam; Rajaeinejad, Mohsen; Jalaeikhoo, Hasan; Chegini, Leila; Aghdam, Maryam Almasi; Asgari, Ali; Nasiri, Malihe; Khoshdel, Alireza; Faridfar, Ali			Immunological evaluation of patients with 2019 novel coronavirus pneumonia: CD4+and CD16+cells may predict severity and prognosis	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; FC-GAMMA RECEPTOR; CD4(+) T-CELLS; CYTOKINE STORM; COV INFECTION; COVID-19; SAP; MONOCYTES; RESPONSES; IMMUNITY	PurposeAvailable but insufficient evidence shows that changes may occur in the immune system following coronavirus disease 2019 (COVID-19). The present study aimed at evaluating immunological changes in patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pneumonia compared with the control group. MethodThe present study was performed on 95 patients with COVID-19 (32 severe and 63 moderate cases) and 22 healthy controls. Relationship between immune cells, disease severity and lung involvement was assessed. Binary logistic regression and ROC curve tests were used for statistical analysis. ResultsA significant decrease was observed in CD20(+) cell counts of the patients. To differentiate patients from healthy individuals, the cutoff point for the CD4(+) cell count was 688 /mu L, sensitivity 0.96, and specificity 0.84. An increase in CD4(+) cells reduces the odds of severe disease (odds ratio = 0.82, P = 0.047) and death (odds ratio = 0.74, P = 0.029). CD4(+) cells play a pivotal role in the severity of lung involvement (P = 0.03). In addition to CD4(+) cells, Fc gamma receptor III (Fc gamma RIII) (CD16) also played a significant prognosis (odds ratio = 0.55, P = 0.047). In severe cases, C-reactive protein, Blood urea nitrogen, and Creatine phosphokinase levels, as well as neutrophil counts, were significantly higher than those of moderate ones whereas lymphocyte count in severe cases was lower than that of moderate ones. ConclusionThe number of total T-cells and B-cells in patients with COVID-19 was lower than that of controls; however, their NK cells increased. Fc gamma RIII and CD4(+) cells are of great importance due to their association with COVID-19 prognosis.	[Alahyari, Sam] AJA Univ Med Sci, Sci & Res branch, Tehran, Iran; [Alahyari, Sam] Shahid Beheshti Univ Med Sci, Fac Med, Tehran, Iran; [Rajaeinejad, Mohsen; Jalaeikhoo, Hasan; Faridfar, Ali] AJA Univ Med Sci, AJA Canc Epidemiol Res & Treatment Ctr AJA CERTC, Tehran, Iran; [Chegini, Leila] Aja Univ Med Sci, Fac Med, Tehran, Iran; [Aghdam, Maryam Almasi] Shahid Beheshti Univ Med Sci, Dept Pathol, Tehran, Iran; [Asgari, Ali] AJA Univ Med Sci, Infect Dis Res Ctr, Tehran, Iran; [Nasiri, Malihe] Shahid Beheshti Univ Med Sci, Dept Biostat, Tehran, Iran; [Khoshdel, Alireza] Aja Univ Med Sci, Modern Epidemiol Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Rajaeinejad, M (corresponding author), AJA Univ Med Sci, AJA Canc Epidemiol Res & Treatment Ctr AJA CERTC, Tehran, Iran.	mrajaei@gmail.com		, Mohsen/0000-0003-3146-1144				ANDERSON P, 1990, P NATL ACAD SCI USA, V87, P2274, DOI 10.1073/pnas.87.6.2274; Bomhof G, 2020, BRIT J HAEMATOL, V190, pE61, DOI 10.1111/bjh.16850; Chang SH, 2021, CTS-CLIN TRANSL SCI, V14, P1625, DOI 10.1111/cts.13036; Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen J, 2010, J VIROL, V84, P1289, DOI 10.1128/JVI.01281-09; Chimen M, 2017, J IMMUNOL, V198, P2834, DOI 10.4049/jimmunol.1601281; Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1148/radiol.2020200230, 10.1007/s00330-019-06574-1]; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Johnson S, 2009, IMMUNITY, V30, P218, DOI 10.1016/j.immuni.2008.11.015; Kalia V, 2015, IMMUNITY, V42, P1116, DOI 10.1016/j.immuni.2015.05.023; Kamperschroer C, 2006, J IMMUNOL, V177, P5317, DOI 10.4049/jimmunol.177.8.5317; Kim HY, 2006, J CLIN INVEST, V116, P2484, DOI 10.1172/JCI27219; KLAASSEN RJL, 1990, J IMMUNOL, V144, P599; Laidlaw BJ, 2016, NAT REV IMMUNOL, V16, P102, DOI 10.1038/nri.2015.10; LANIER LL, 1989, SCIENCE, V246, P1611, DOI 10.1126/science.2531919; Li M, 1996, J EXP MED, V183, P1259, DOI 10.1084/jem.183.3.1259; Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8; Liu YW, 2020, J INFECTION, V81, pE6, DOI 10.1016/j.jinf.2020.04.002; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Mahallawi WH, 2018, CYTOKINE, V104, P8, DOI 10.1016/j.cyto.2018.01.025; McCausland MM, 2007, J IMMUNOL, V178, P817, DOI 10.4049/jimmunol.178.2.817; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Muratori P, 2021, CTS-CLIN TRANSL SCI, V14, P1627, DOI 10.1111/cts.13026; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Northrop JK, 2006, J IMMUNOL, V177, P1062, DOI 10.4049/jimmunol.177.2.1062; Paris AJ, 2016, AM J PHYSIOL-LUNG C, V311, pL1062, DOI 10.1152/ajplung.00327.2016; Pascolini S, 2021, CTS-CLIN TRANSL SCI, V14, P502, DOI 10.1111/cts.12908; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; RA C, 1989, NATURE, V341, P752, DOI 10.1038/341752a0; RAVETCH JV, 1989, J EXP MED, V170, P481, DOI 10.1084/jem.170.2.481; Sacks JA, 2008, J IMMUNOL, V180, P4570, DOI 10.4049/jimmunol.180.7.4570; Sanyaolu Adekunle, 2020, SN Compr Clin Med, V2, P1069, DOI 10.1007/s42399-020-00363-4; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sheikhi A, 2021, HUM VACC IMMUNOTHER, V17, P92, DOI 10.1080/21645515.2020.1787066; Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yang SC, 2021, BIOMED J, V44, P439, DOI 10.1016/j.bj.2020.09.001; Zemans RL, 2017, THORAX, V72, P1, DOI 10.1136/thoraxjnl-2016-209170; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zhao QW, 2020, INT J INFECT DIS, V96, P131, DOI 10.1016/j.ijid.2020.04.086; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhou YL, 2020, ANN PALLIAT MED, V9, P428, DOI 10.21037/apm.2020.03.26; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; Zulfiqar AA, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2010472	54	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2022	17	8							e0268712	10.1371/journal.pone.0268712	http://dx.doi.org/10.1371/journal.pone.0268712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5A3IT	35930526	Green Published, gold			2022-12-26	WOS:000862784200005
J	Vakili, J; Sizemore, L; Rebeiro, PF; Tyndall, B; Talley, P; Whaley, K; Brantley, M				Vakili, Jessica; Sizemore, Lindsey; Rebeiro, Peter F.; Tyndall, Ben; Talley, Pamela; Whaley, Kristyn; Brantley, Meredith			Assessment of Tennessee's county-level vulnerability to hepatitis C virus and HIV outbreaks using socioeconomic, healthcare, and substance use indicators	PLOS ONE			English	Article							INJECT DRUGS; INFECTION; PEOPLE; HCV	Background Human immunodeficiency virus (HIV), hepatitis C virus (HCV), and injection drug use are syndemic in the central Appalachian states. In Tennessee (TN), declines in HIV among persons who inject drugs (PWID) stalled, and HCV infection rates increased significantly from 2013-2017. To better target strategies to address the syndemic, county-level socioeconomic, opioid use, access to healthcare, and health factors were modeled to identify indicators predictive of vulnerability to an HIV/HCV outbreak among PWID in TN. Methods Newly reported chronic HCV cases among persons aged 13-39 years in 2016-2017 were used as a proxy for county-level HIV/HCV vulnerability among TN's 95 counties. Seventy-five publicly available county-level measures from 2016-2017 were collected and reduced through multiple dimension reduction techniques. Negative binomial regression identified indicators associated with HCV which were used to calculate county-level vulnerability to a local HIV/HCV outbreak. Results Thirteen county-level indicators were identified as strongly predictive of HIV/HCV vulnerability with the statistically significant indicators being percentage of the population aged 20-44 years, per capita income, teen birth rate, percentage of clients in TDMHSAS-funded opioid treatment and recovery, syphilis case rate, and percentage of homes with at least one vehicle. Based on the 13 indicators, we identified the distribution of vulnerability to an HIV/HCV outbreak among TN's counties. Eleven high vulnerability counties were identified, with the preponderance located in east and middle TN. Conclusion This analysis identified the county-level factors most associated with vulnerability to an HIV/HCV outbreak among PWID in TN. These results, alongside routine surveillance, will guide targeted prevention and linkage to care efforts for the most vulnerable communities.	[Vakili, Jessica; Sizemore, Lindsey; Tyndall, Ben; Talley, Pamela; Whaley, Kristyn; Brantley, Meredith] Tennessee Dept Hlth, Nashville, TN 37243 USA; [Rebeiro, Peter F.] Vanderbilt Univ, Dept Med, Sch Med, Nashville, TN 37212 USA; [Rebeiro, Peter F.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA	Tennessee Department Health; Vanderbilt University; Vanderbilt University	Vakili, J (corresponding author), Tennessee Dept Hlth, Nashville, TN 37243 USA.	jessica.vakili@tn.gov		Tyndall, Benjamin/0000-0001-5514-4149	Centers for Disease Control and Prevention National Center for Injury Prevention and Control [TP18-1801]; National Institutes of Health [P30AI110527, K01-AI131895, R21-AI145686]	Centers for Disease Control and Prevention National Center for Injury Prevention and Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	JV was supported by the Centers for Disease Control and Prevention National Center for Injury Prevention and Control [TP18-1801 Opioid Overdose Crisis Cooperative Agreement]. PFR was supported by the National Institutes of Health [P30AI110527, K01-AI131895, and R21-AI145686]. URLs: https://www.cdc.gov/, https://www.nih.gov/.	Akyar E, 2016, EMERG INFECT DIS, V22, P907, DOI 10.3201/eid2205.151980; [Anonymous], 2021, HEPATITIS C CHRONIC; [Anonymous], 2020, ADDRESSING SUBSTANCE; [Anonymous], 2021, VIR HEP SURV REP US; Armitage EV, 2010, ALCOHOL TREAT Q, V28, P339, DOI 10.1080/07347324.2010.488539; Brantley ML, 2019, AIDS BEHAV, V23, P304, DOI 10.1007/s10461-019-02657-8; cdc.gov, HIV SO US; census, EXPLORE CENSUS DATA; Cranston K, 2019, MMWR-MORBID MORTAL W, V68, P253, DOI 10.15585/mmwr.mm6810a6; Degenhardt L, 2017, LANCET GLOB HEALTH, V5, pE1192, DOI 10.1016/S2214-109X(17)30375-3; Evans ME, 2018, MMWR-MORBID MORTAL W, V67, P257, DOI 10.15585/mmwr.mm6708a6; Gibson DR, 2001, AIDS, V15, P1329, DOI 10.1097/00002030-200107270-00002; Goedel WC, 2020, CLIN INFECT DIS, V70, P1096, DOI 10.1093/cid/ciz321; Gonsalves GS, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab128; Grebely J, 2012, LANCET INFECT DIS, V12, P408, DOI 10.1016/S1473-3099(12)70010-5; Hagan H, 2011, J INFECT DIS, V204, P74, DOI 10.1093/infdis/jir196; Hess K, 2018, HIV SURVEILLANCE REP; hhs.gov, HEPATITIS C BASIC IN; Kathleen, 2019, HEPVU RELEASES STATE; Keeshin SW, 2016, AM J MED SCI, V352, P609, DOI 10.1016/j.amjms.2016.10.002; Kingery KL, 2018, J YOUTH DEV, V13, P259, DOI 10.5195/jyd.2018.649; Levitt A, 2020, J INFECT DIS, V222, pS213, DOI 10.1093/infdis/jiaa432; Lin CCC, 2018, HEALTH AFFAIR, V37, P1967, DOI 10.1377/hlthaff.2018.05125; Mace S, USE TELEHEALTH BEHAV; Magidson JF, 2021, J SUBST ABUSE TREAT, V122, DOI 10.1016/j.jsat.2020.108248; Mizuno Y, 2018, AIDS, V32, P2557, DOI 10.1097/QAD.0000000000001987; National Center for health statistics, 2022, CDC GOV; National Institute on Drug Abuse, 2020, TENN OP INV DEATHS R; Nhac.org, HIDTA COUNTIES STATE; Platt L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012021.pub2; Rickles M, 2018, CLIN INFECT DIS, V66, P1722, DOI 10.1093/cid/cix1079; Samhsa.gov, MAP SAMHSA BEHAV HLT; Sizemore L, 2020, PUBLIC HEALTH REP, V135, P329, DOI 10.1177/0033354920915445; Sizmore L, 2019, NAVIGATING CURATIVE; Tennessee Bureau of Investigation, US; Tennessee Department of Health, US; Tennessee Department of Health, 2019, TENN CHRON PAIN GUID; Tennessee Department of Health, 2019, COUNT LEV VULN HIV H; Tennessee Department of Mental Health and Substance Abuse Services, DAT RES PLANN; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; tn.gov, TRIMS DATA REQUEST; tn.gov/, HARM REDUCTION SYRIN; Van Handel MM, 2016, JAIDS-J ACQ IMM DEF, V73, P323, DOI 10.1097/QAI.0000000000001098; Www.tn.gov, TENNESSEES ANN OVERD	44	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0270891	10.1371/journal.pone.0270891	http://dx.doi.org/10.1371/journal.pone.0270891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925969	gold, Green Published			2022-12-26	WOS:000848077100027
J	Braswell, AEE; Leyk, S; Connor, DSS; Uhl, JHH				Braswell, Anna E. E.; Leyk, Stefan; Connor, Dylan S. S.; Uhl, Johannes H. H.			Creeping disaster along the US coastline: Understanding exposure to sea level rise and hurricanes through historical development	PLOS ONE			English	Article							CLIMATE-CHANGE; MITIGATION; DAMAGE; VULNERABILITY; ADAPTATION; ATLANTIC	Current estimates of U.S. property at risk of coastal hazards and sea level rise (SLR) are staggering-evaluated at over a trillion U.S. dollars. Despite being enormous in the aggregate, potential losses due to SLR depend on mitigation, adaptation, and exposure and are highly uneven in their distribution across coastal cities. We provide the first analysis of how changes in exposure (how and when) have unfolded over more than a century of coastal urban development in the United States. We do so by leveraging new historical settlement layers from the Historical Settlement Data Compilation for the U.S. (HISDAC-US) to examine building patterns within and between the SLR zones of the conterminous United States since the early twentieth century. Our analysis reveals that SLR zones developed faster and continue to have higher structure density than non-coastal, urban, and inland areas. These patterns are particularly prominent in locations affected by hurricanes. However, density levels in historically less-developed coastal areas are now quickly converging on early settled SLR zones, many of which have reached building saturation. These "saturation effects" suggest that adaptation polices targeting existing buildings and developed areas are likely to grow in importance relative to the protection of previously undeveloped land.	[Braswell, Anna E. E.] Univ Florida, Inst Food & Agr Sci, Sch Forest Fisheries & Geomat Sci, Gainesville, FL 32611 USA; [Braswell, Anna E. E.] Univ Florida, Florida Sea Grant, Gainesville, FL 32611 USA; [Braswell, Anna E. E.; Leyk, Stefan; Uhl, Johannes H. H.] Univ Colorado Boulder, Cooperat Inst Res Environm Sci, Earth Lab, Boulder, CO 80309 USA; [Leyk, Stefan] Univ Colorado Boulder, Dept Geog, Boulder, CO USA; [Leyk, Stefan; Uhl, Johannes H. H.] Univ Colorado Boulder, Inst Behav Sci, Boulder, CO USA; [Connor, Dylan S. S.] Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Arizona State University; Arizona State University-Tempe	Braswell, AEE (corresponding author), Univ Florida, Inst Food & Agr Sci, Sch Forest Fisheries & Geomat Sci, Gainesville, FL 32611 USA.; Braswell, AEE (corresponding author), Univ Florida, Florida Sea Grant, Gainesville, FL 32611 USA.; Braswell, AEE (corresponding author), Univ Colorado Boulder, Cooperat Inst Res Environm Sci, Earth Lab, Boulder, CO 80309 USA.	a.braswell@ufl.edu		Braswell, Anna/0000-0002-3677-0635	Earth Lab through CU Boulder's Grand Challenge Initiative; Cooperative Institute for Research in Environmental Sciences (CIRES) at CU Boulder; Innovative Seed Grant program at CU Boulder; Institute of Behavioral Science; National Science Foundation [1924670, 2121976]; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [P2CHD066613]	Earth Lab through CU Boulder's Grand Challenge Initiative; Cooperative Institute for Research in Environmental Sciences (CIRES) at CU Boulder; Innovative Seed Grant program at CU Boulder; Institute of Behavioral Science; National Science Foundation(National Science Foundation (NSF)); Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health	"Funding for this work was provided by Earth Lab through CU Boulder's Grand Challenge Initiative (AB, SL, UL; https://www.colorado.edu/ grandchallenge/), the Cooperative Institute for Research in Environmental Sciences (CIRES) at CU Boulder (AB, SL, UL), the Innovative Seed Grant program at CU Boulder (AB, SL; https://www. colorado.edu/researchinnovation/fundingawards/ innovative-seed-grantprogram), the Institute of Behavioral Science (SL, DC, UL), and National Science Foundation (awards #1924670 and #2121976 to CU Boulder; SL, DC, AB, JU; https:// www.nsf.gov/funding/pgm_summ.jsp?pims_id= 13353). Support has been provided through the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (Award Number P2CHD066613 to University of Colorado Population Center; SL, DC; https://www.nichd.nih.gov/NSF).Thefunders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH or CUPC."	Abbott C., 2003, OAH MAGAZINE HIST, V18, P11; Armstrong S, 2019, NAT HAZARD EARTH SYS, V19, P2497, DOI 10.5194/nhess-19-2497-2019; Balch JK, 2020, EARTHS FUTURE, V8, DOI 10.1029/2019EF001319; Balk D., 2012, NEW GLOBAL FRONTIER, P197; Balk D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208487; Baltagi B.H., 2008, ECONOMETRIC ANAL PAN; Boustan LP, 2020, J URBAN ECON, V118, DOI 10.1016/j.jue.2020.103257; Buchanan MK, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/abb266; Climate Central, 2019, OC DOOR NEW HOM RIS; Connor DS, 2020, P NATL ACAD SCI USA, V117, P30309, DOI 10.1073/pnas.2010222117; Crossett K.M., 2004, POPULATION TRENDS CO; Dehring CA, 2013, LAND ECON, V89, P597, DOI 10.3368/le.89.4.597; Demuth JL, 2016, WEATHER CLIM SOC, V8, P327, DOI 10.1175/WCAS-D-15-0074.1; Department of Homeland Security Office of Inspector General, 2017, OIG17110 US DEP HOM, P2017; Deyle R, 2008, J AM PLANN ASSOC, V74, P349, DOI 10.1080/01944360802229612; Dinan T, 2017, ECOL ECON, V138, P186, DOI 10.1016/j.ecolecon.2017.03.034; FEMA, 2013, P942 FEMA; FEMA, 2018, P2021 FEMA; FEMA, 2013, HURR SAND FEMA ACT R; Fishman R, 2000, HOUS POLICY DEBATE, V11, P199; FRONSTIN P, 1994, SOUTHERN ECON J, V61, P387, DOI 10.2307/1059986; Glaeser EL, 2008, SOUTH ECON J, V74, P610; Glaeser EL., 2001, NATL BUREAU EC RES, pw8357, DOI [10.3386/w8357, DOI 10.3386/W8357]; Gormsem E., 1997, GeoJournal, V42, P39, DOI 10.1023/A:1006840622450; Gunawansa A, 2014, SUSTAIN DEV, V22, P52, DOI 10.1002/sd.527; Gutmann MP, 2010, POPUL ENVIRON, V31, P3, DOI 10.1007/s11111-009-0088-y; Haasnoot M, 2021, SCIENCE, V372, P1287, DOI 10.1126/science.abi6594; Hallegatte S, 2013, NAT CLIM CHANGE, V3, P802, DOI [10.1038/nclimate1979, 10.1038/NCLIMATE1979]; Hauer ME, 2016, NAT CLIM CHANGE, V6, P691, DOI [10.1038/nclimate2961, 10.1038/NCLIMATE2961]; Highfield WE, 2014, J PLAN EDUC RES, V34, P287, DOI 10.1177/0739456X14531828; Hinkel J, 2014, P NATL ACAD SCI USA, V111, P3292, DOI 10.1073/pnas.1222469111; Huang X, 2019, NAT HAZARD EARTH SYS, V19, P2141, DOI 10.5194/nhess-19-2141-2019; Iglesias V, 2021, EARTHS FUTURE, V9, DOI 10.1029/2020EF001795; Jagger T, 2001, J APPL METEOROL, V40, P853, DOI 10.1175/1520-0450(2001)040<0853:ADPMOH>2.0.CO;2; Kulp S, 2017, CLIMATIC CHANGE, V142, P477, DOI 10.1007/s10584-017-1963-7; Landsea CW, 2013, MON WEATHER REV, V141, P3576, DOI 10.1175/MWR-D-12-00254.1; Laukkonen J, 2009, HABITAT INT, V33, P287, DOI 10.1016/j.habitatint.2008.10.003; Lazarus ED, 2018, NAT SUSTAIN, V1, P759, DOI 10.1038/s41893-018-0185-y; Leonard B, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2107273118; Leyk S., 2018, **DATA OBJECT**, DOI 10.7910/DVN/PKJ90M; Leyk S., 2018, **DATA OBJECT**, DOI 10.7910/DVN/1WB9E4; Leyk S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba2937; Leyk S, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0329-6; Leyk S, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.175; Logan JR, 2016, DEMOGRAPHY, V53, P1511, DOI 10.1007/s13524-016-0496-4; Lorie M, 2020, CLIM RISK MANAG, V29, DOI 10.1016/j.crm.2020.100233; Malmstadt J, 2009, SOUTHEAST GEOGR, V49, P108, DOI 10.1353/sgo.0.0045; Markley SN, 2022, SCI DATA, V9, DOI 10.1038/s41597-022-01184-x; McPhillips LE, 2018, EARTHS FUTURE, V6, P441, DOI 10.1002/2017EF000686; Meerow S, 2020, J AM PLANN ASSOC, V86, P39, DOI 10.1080/01944363.2019.1652108; Noaa, 2012, DET METH MAPP SEA LE, V5; NOAA, 2017, SEA LEV RIS DAT; Office of Management and Budget, 2010, FED REGISTER, V75, P1; Oppenheimer M., 2019, IPCC SPECIAL REPORT, DOI DOI 10.1126/SCIENCE.AAM6284; Pais JF, 2008, SOC FORCES, V86, P1415, DOI 10.1353/sof.0.0047; Pesaresi M., 2017, 28556 EUR EN; Robinson C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227436; Shepard CC, 2012, NAT HAZARDS, V60, P727, DOI 10.1007/s11069-011-0046-8; Solecki W, 2019, WIRES CLIM CHANGE, V10, DOI 10.1002/wcc.616; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Sutton-Grier AE, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10020523; Tomiczek T, 2014, J WATERW PORT COAST, V140, P43, DOI 10.1061/(ASCE)WW.1943-5460.0000212; U.S. Census Bureau, 2019, US; Uhl JH., 2020, **DATA OBJECT**, DOI 10.7910/DVN/YSWMDR; Uhl JH., 2020, **DATA OBJECT**, DOI 10.7910/DVN/T8H5KF; Uhl JH., 2020, **DATA OBJECT**, DOI 10.7910/DVN/SJ213V; Uhl JH, 2021, COMMUN EARTH ENVIRON, V2, DOI 10.1038/s43247-020-00082-7; Uhl JH, 2021, EARTH SYST SCI DATA, V13, P119, DOI 10.5194/essd-13-119-2021; Union of Concerned Scientists, 2018, UND RIS SEAS CHRON F; USFWS, 2019, NAT WETL INV VERS 2; USGS, 2018, PROT AR DAT US PAD U, DOI [10.5066/P955KPLE, DOI 10.5066/P955KPLE]; Zhang KQ, 2011, CLIMATIC CHANGE, V106, P537, DOI 10.1007/s10584-010-9987-2; Zillow, 2017, ZTRAX ZILL T ASS DAT	73	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0269741	http://dx.doi.org/10.1371/journal.pone.0269741			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921258	gold, Green Published, Green Submitted			2022-12-26	WOS:000839311900026
J	Nonaka, L; Masuda, M; Yano, H				Nonaka, Lisa; Masuda, Michiaki; Yano, Hirokazu			Atypical integrative element with strand-biased circularization activity assists interspecies antimicrobial resistance gene transfer from Vibrio alfacsensis	PLOS ONE			English	Article							CONJUGATIVE ELEMENTS; PLASMID; SITE; DNA; RECOMBINATION; MOBILIZATION; GENOME; FAMILY; TRANSPOSON; DIVERSITY	The exchange of antimicrobial resistance (AMR) genes between aquaculture and terrestrial microbial populations has emerged as a serious public health concern. However, the nature of the mobile genetic elements in marine bacteria is poorly documented. To gain insight into the genetic mechanisms underlying AMR gene transfer from marine bacteria, we mated a multidrug-resistant Vibrio alfacsensis strain with an Escherichia coli strain, and then determined the complete genome sequences of the donor and the transconjugant strains. Sequence analysis revealed a conjugative multidrug resistance plasmid in the donor strain, which was integrated into the chromosome of the recipient. The plasmid backbone in the transconjugant chromosome was flanked by two copies of a 7.1 kb unclassifiable integrative element harboring a beta-lactamase gene. The 7.1 kb element and the previously reported element Tn6283 share four coding sequences, two of which encode the catalytic R-H-R-Y motif of tyrosine recombinases. Polymerase chain reaction and sequencing experiments revealed that these elements generate a circular copy of one specific strand without leaving an empty site on the donor molecule, in contrast to the movement of integron gene cassettes or ICE/IMEs discovered to date. These elements are termed SEs (strand-biased circularizing integrative elements): SE-6945 (the 7.1 kb element) and SE-6283 (Tn6283). The copy number and location of SE-6945 in the chromosome affected the antibiotic resistance levels of the transconjugants. SEs were identified in the genomes of other Vibrio species. Overall, these results suggest that SEs are involved in the spread of AMR genes among marine bacteria.	[Nonaka, Lisa; Masuda, Michiaki] Dokkyo Med Univ, Dept Microbiol, Sch Med, Mibu, Tochigi, Japan; [Nonaka, Lisa] Shokei Univ, Fac Human Life Sci, Kumamoto, Japan; [Yano, Hirokazu] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Japan; [Yano, Hirokazu] Tohoku Univ, Grad Sch Life Sci, Sendai, Japan; [Yano, Hirokazu] Natl Inst Infect Dis, Antimicrobial Resistance Res Ctr, Higashimurayama, Japan	Dokkyo Medical University; University of Tsukuba; Tohoku University; National Institute of Infectious Diseases (NIID)	Nonaka, L (corresponding author), Dokkyo Med Univ, Dept Microbiol, Sch Med, Mibu, Tochigi, Japan.; Nonaka, L (corresponding author), Shokei Univ, Fac Human Life Sci, Kumamoto, Japan.; Yano, H (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Japan.; Yano, H (corresponding author), Tohoku Univ, Grad Sch Life Sci, Sendai, Japan.; Yano, H (corresponding author), Natl Inst Infect Dis, Antimicrobial Resistance Res Ctr, Higashimurayama, Japan.	nonaka20@shokei-gakuen.ac.jp; h-yano@niid.go.jp	Yano, Hirokazu/O-7933-2015	Yano, Hirokazu/0000-0001-5144-3459	JSPS KAKENHI [18K05790, 22K05790]; Mishima Kaium Memorial Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mishima Kaium Memorial Foundation	We thank the National Bioresource Project of the National Institute of Genetics, Japan, for providing the E. coli strains BW25113, JW2669, and JW0452. We thank Atsushi Ota and Fumito Maruyama at Hiroshima University for their support for the annotation on the TJ249 assembly. We thank Yuichi Otsuka at Saitama University for helpful discussions and Yuta Sugimoto at Ehime University for experimental support. We thank Kenji K Kojima at Genetic Information Research Institute for the discussion on transposon classification, and Yasukazu Daigaku at Tohoku University for the discussion on DNA protein cross link repair. We thank Editage for language editing (job number LINON_4_4).	Achard A, 2007, J BACTERIOL, V189, P4328, DOI 10.1128/JB.00213-07; Alcock BP, 2020, NUCLEIC ACIDS RES, V48, pD517, DOI 10.1093/nar/gkz935; Auchtung JM, 2005, P NATL ACAD SCI USA, V102, P12554, DOI 10.1073/pnas.0505835102; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beaber JW, 2002, CELL MOL LIFE SCI, V59, P2065, DOI 10.1007/s000180200006; Bouvier M, 2005, EMBO J, V24, P4356, DOI 10.1038/sj.emboj.7600898; Burrus V, 2003, J BACTERIOL, V185, P5045, DOI 10.1128/JB.185.17.5045-5054.2003; Cabello FC, 2016, LANCET INFECT DIS, V16, pE127, DOI 10.1016/S1473-3099(16)00100-6; Cabello FC, 2013, ENVIRON MICROBIOL, V15, P1917, DOI 10.1111/1462-2920.12134; CABEZON E, 1994, J BACTERIOL, V176, P4455, DOI 10.1128/jb.176.14.4455-4458.1994; CAPARON MG, 1989, CELL, V59, P1027, DOI 10.1016/0092-8674(89)90759-9; Carraro N, 2016, MBIO, V7, DOI 10.1128/mBio.00509-16; Carraro N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004714; Carraro N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00044; Chandler M, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0031-2014; Chandler M, 2013, NAT REV MICROBIOL, V11, P525, DOI 10.1038/nrmicro3067; Chen JR, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0714-6; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Clinical and Laboratory Standards Institute, 2012, M07 CLSI, V9; COLLIS CM, 1992, J BACTERIOL, V174, P1574, DOI 10.1128/jb.174.5.1574-1585.1992; Cornejo-Granados F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11805-w; Curcio MJ, 2003, NAT REV MOL CELL BIO, V4, P865, DOI 10.1038/nrm1241; Daccord A, 2010, MOL MICROBIOL, V78, P576, DOI 10.1111/j.1365-2958.2010.07364.x; Dahmane N, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00337-17; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Doublet B, 2005, MOL MICROBIOL, V55, P1911, DOI 10.1111/j.1365-2958.2005.04520.x; Egerton S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00873; Elliott KT, 2013, FUTURE MICROBIOL, V8, P887, DOI 10.2217/fmb.13.53; Encinas D, 2014, J BACTERIOL, V196, P1551, DOI 10.1128/JB.01464-13; Escudero JA, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0019-2014; Feldgarden M, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00483-19; Folster JP, 2014, EMERG INFECT DIS, V20, P1951, DOI 10.3201/eid2011.140889; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gomez-Gil B, 2012, INT J SYST EVOL MICR, V62, P2955, DOI 10.1099/ijs.0.033191-0; Guedon G, 2017, GENES-BASEL, V8, DOI 10.3390/genes8110337; Jain C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07641-9; Jayaram M, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0021-2014; Johnson CM, 2015, ANNU REV GENET, V49, P577, DOI 10.1146/annurev-genet-112414-055018; Karakonstantis S, 2020, J ANTIMICROB CHEMOTH, V75, P271, DOI 10.1093/jac/dkz401; Kishida K, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02359-16; Kolmogorov M, 2019, NAT BIOTECHNOL, V37, P540, DOI 10.1038/s41587-019-0072-8; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Liu M, 2013, INT J ANTIMICROB AG, V42, P575, DOI 10.1016/j.ijantimicag.2013.08.014; Llewellyn MS, 2016, ISME J, V10, P1280, DOI 10.1038/ismej.2015.189; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Naito M, 2016, DNA RES, V23, P11, DOI 10.1093/dnares/dsv032; Neela FA, 2007, J MICROBIOL, V45, P64; Nonaka L, 2015, LETT APPL MICROBIOL, V61, P1, DOI 10.1111/lam.12414; Nonaka L, 2007, MICROBES ENVIRON, V22, P355, DOI 10.1264/jsme2.22.355; Nonaka L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198613; Nonaka L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00152; Nonaka L, 2012, MICROBES ENVIRON, V27, P263, DOI 10.1264/jsme2.ME11338; Nunes-Duby SE, 1998, NUCLEIC ACIDS RES, V26, P391, DOI 10.1093/nar/26.2.391; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Pavlovic G, 2004, MICROBIOL-SGM, V150, P759, DOI 10.1099/mic.0.26883-0; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; POLARD P, 1995, GENE DEV, V9, P2846, DOI 10.1101/gad.9.22.2846; Roberts AP, 2008, PLASMID, V60, P167, DOI 10.1016/j.plasmid.2008.08.001; Rodriguez-Beltran J, 2021, NAT REV MICROBIOL, V19, P347, DOI 10.1038/s41579-020-00497-1; Rousseau P, 2008, J BACTERIOL, V190, P6111, DOI 10.1128/JB.00452-08; Rowe-Magnus DA, 2002, MOL MICROBIOL, V43, P1657, DOI 10.1046/j.1365-2958.2002.02861.x; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sekyere JO, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00897-20; Stokes HW, 1997, MOL MICROBIOL, V26, P731, DOI 10.1046/j.1365-2958.1997.6091980.x; STOKES HW, 1989, MOL MICROBIOL, V3, P1669, DOI 10.1111/j.1365-2958.1989.tb00153.x; Takemura AE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00038; Tansirichaiya S, 2019, MOBILE DNA-UK, V10, DOI 10.1186/s13100-019-0182-3; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Val ME, 2005, MOL CELL, V19, P559, DOI 10.1016/j.molcel.2005.07.002; Verma J, 2019, P NATL ACAD SCI USA, V116, P6226, DOI 10.1073/pnas.1900141116; Villa L, 2020, METHODS MOL BIOL, V2075, P309, DOI 10.1007/978-1-4939-9877-7_22; Wisniewski JA, 2016, MOL MICROBIOL, V99, P884, DOI 10.1111/mmi.13270; Yano H, 2021, COMPLETE GENOME TRAN; Yano H, 2021, ILLUMINA READS ANAL; Yano H, 2013, MICROBIOL-SGM, V159, P2303, DOI 10.1099/mic.0.068387-0; Zhang HM, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-019-0366-z	77	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8							e0271627	10.1371/journal.pone.0271627	http://dx.doi.org/10.1371/journal.pone.0271627			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917316	gold, Green Submitted, Green Published			2022-12-26	WOS:000837840000015
J	Wang, HC; Wang, N; Wang, YL; Li, H				Wang, Haochen; Wang, Ning; Wang, Yilun; Li, Hui			Association between sarcopenia and osteoarthritis: A protocol for meta-analysis	PLOS ONE			English	Article							EXTENSOR MUSCLE WEAKNESS; KNEE OSTEOARTHRITIS; OLDER-ADULTS; RISK; MASS; OBESITY; DISEASE; PREVALENCE; MORTALITY; QUALITY	BackgroundSarcopenia, a relatively new syndrome referring to the age-related decline of muscle strength and degenerative loss of skeletal muscle mass and function, often resulting in frailty, disability, and mortality. Osteoarthritis, as a prevalent joint degenerative disease, is affecting over 250 million patients worldwide, and it is the fifth leading cause of disability. Despite the high prevalence of osteoarthritis, there are still lack of efficient treatment potions in clinics, partially due to the heterogeneous and complexity of osteoarthritis pathology. Previous studies revealed the association between sarcopenia and osteoarthritis, but the conclusions remain controversial and the prevalence of sarcopenia within osteoarthritis patients still needs to be elucidated. To identify the current evidence on the prevalence of sarcopenia and its association with osteoarthritis across studies, we performed this systematic review and meta-analysis that would help us to further confirm the association between these two diseases. Methods and analysisElectronic sources including PubMed, Embase, and Web of Science will be searched systematically following appropriate strategies to identify relevant studies from inception up to 28 February 2022 with no language restriction. Two investigators will evaluate the preselected studies independently for inclusion, data extraction and quality assessment using a standardized protocol. Meta-analysis will be performed to pool the estimated effect using studies assessing an association between sarcopenia and osteoarthritis. Subgroup analyses will also be performed when data are sufficient. Heterogeneity and publication bias of included studies will be investigated. PROSPERO registration numberCRD42020155694.	[Wang, Haochen; Wang, Ning; Wang, Yilun; Li, Hui] Cent South Univ, Xiangya Hosp, Dept Orthopaed, Changsha, Hunan, Peoples R China	Central South University	Li, H (corresponding author), Cent South Univ, Xiangya Hosp, Dept Orthopaed, Changsha, Hunan, Peoples R China.	lihui1988@csu.edu.cn			National Natural Science Foundation of China [81902265]; Youth Science Foundation of Xiangya Hospital [2021Q14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Science Foundation of Xiangya Hospital	Everyone who contributed significantly to the work has been listed.	Akune T, 2014, GERIATR GERONTOL INT, V14, P695, DOI 10.1111/ggi.12155; Atkins JL, 2014, J AM GERIATR SOC, V62, P253, DOI 10.1111/jgs.12652; Bahat G, 2016, EUR GERIATR MED, V7, P220, DOI 10.1016/j.eurger.2015.12.012; Baker KR, 2004, ARTHRITIS RHEUM-US, V50, P1815, DOI 10.1002/art.20261; Barazzoni R, 2018, CLIN NUTR, V37, P1787, DOI 10.1016/j.clnu.2018.04.018; Batsis JA, 2016, INT J OBESITY, V40, P761, DOI 10.1038/ijo.2015.243; Beattie KA, 2012, ARTHRIT CARE RES, V64, P22, DOI 10.1002/acr.20628; Bischoff-Ferrari HA, 2015, OSTEOPOROSIS INT, V26, P2793, DOI 10.1007/s00198-015-3194-y; Bone AE, 2017, CHRON RESP DIS, V14, P85, DOI 10.1177/1479972316679664; Bruyere O, 2019, MATURITAS, V119, P61, DOI 10.1016/j.maturitas.2018.11.003; Chang KV, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.09.013; Chung SM, 2016, OSTEOPOROSIS INT, V27, P2447, DOI 10.1007/s00198-016-3548-0; Cruz-Jentoft AJ, 2019, LANCET, V393, P2636, DOI 10.1016/S0140-6736(19)31138-9; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; De Buyser SL, 2016, AGE AGEING, V45, P603, DOI 10.1093/ageing/afw071; Dell'isola A, 2018, ACTA ORTHOP, V89, P406, DOI 10.1080/17453674.2018.1464314; Dickinson JM, 2013, EXERC SPORT SCI REV, V41, P216, DOI 10.1097/JES.0b013e3182a4e699; dos Santos L, 2017, J CACHEXIA SARCOPENI, V8, P245, DOI 10.1002/jcsm.12160; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Glyn-Jones S, 2015, LANCET, V386, P376, DOI 10.1016/S0140-6736(14)60802-3; Go SW, 2013, KOREAN J FAM MED, V34, P281, DOI 10.4082/kjfm.2013.34.4.281; Godziuk K, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2175-7; Herzog R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-154; Ho KKW, 2021, BMC GERIATR, V21, DOI 10.1186/s12877-020-01929-6; Holmberg S, 2005, SCAND J RHEUMATOL, V34, P59, DOI 10.1080/03009740510017922; Hunter DJ, 2019, LANCET, V393, P1745, DOI 10.1016/S0140-6736(19)30417-9; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Jeon H, 2019, AGING CLIN EXP RES, V31, P1557, DOI 10.1007/s40520-018-1108-5; Karlsson MK, 2015, CLIN ORTHOP RELAT R, V473, P258, DOI 10.1007/s11999-014-3973-3; Kemmler W, 2015, CLIN INTERV AGING, V10, P1565, DOI 10.2147/CIA.S89585; Kim HT, 2016, KOREAN J INTERN MED, V31, P585, DOI 10.3904/kjim.2015.156; Lee SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166385; Lee S, 2012, ARTHRITIS RHEUM-US, V64, P3947, DOI 10.1002/art.37696; Losina E, 2011, ANN INTERN MED, V154, P217, DOI 10.7326/0003-4819-154-4-201102150-00001; Loureiro A, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2230-4; Malmstrom TK, 2016, J CACHEXIA SARCOPENI, V7, P28, DOI 10.1002/jcsm.12048; Marzetti E, 2013, INT J BIOCHEM CELL B, V45, P2288, DOI 10.1016/j.biocel.2013.06.024; Mayhew AJ, 2019, AGE AGEING, V48, P48, DOI 10.1093/ageing/afy106; Misra D, 2019, ARTHRITIS RHEUMATOL, V71, P232, DOI 10.1002/art.40692; Oiestad BE, 2015, OSTEOARTHR CARTILAGE, V23, P171, DOI 10.1016/j.joca.2014.10.008; Papalia R, 2014, Musculoskelet Surg, V98, P9, DOI 10.1007/s12306-014-0311-6; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Puthran R, 2016, MED EDUC, V50, P456, DOI 10.1111/medu.12962; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Schaap LA, 2018, J GERONTOL A-BIOL, V73, P1199, DOI 10.1093/gerona/glx245; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7647; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Steffl M, 2017, CLIN INTERV AGING, V12, P835, DOI 10.2147/CIA.S132940; Wells G.A., NEWCASTLE OTTAWA SCA	49	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272284	http://dx.doi.org/10.1371/journal.pone.0272284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921336	gold, Green Published			2022-12-26	WOS:000839311900011
J	Yan, T; Tourangeau, R				Yan, Ting; Tourangeau, Roger			Detecting underreporters of abortions and miscarriages in the national study of family growth, 2011-2015	PLOS ONE			English	Article							LATENT CLASS ANALYSIS; SENSITIVE QUESTIONS; UNITED-STATES	This paper draws on individual-level data from the National Study of Family Growth (NSFG) to identify likely underreporters of abortion and miscarriage and examine their characteristics. The NSFG asks about abortion and miscarriage twice, once in the computer-assisted personal interviewing (CAPI) part of the questionnaire and the other in the audio computer-assisted self-interviewing (ACASI) part. We used two different methods to identify likely underreporters of abortion and miscarriage: direct comparison of answers obtained from CAPI and ACASI and latent class models. The two methods produce very similar results. Although miscarriages are just as prone to underreporting as abortions, characteristics of women underreporting abortion differ somewhat from those misreporting miscarriages. Underreporters of abortions tended to be older, poorer, less likely to be Hispanic or Black, and more likely to have no religion. They also reported more traditional attitudes toward sexual behavior. By contrast, underreporters of miscarriage also tended to be older, poorer, and more likely to be Hispanic or Black, but were also more likely to have children in the household, had fewer pregnancies, and held less traditional attitudes toward marriage.	[Yan, Ting; Tourangeau, Roger] Westat Corp, Rockville, MD 20850 USA	Westat	Yan, T (corresponding author), Westat Corp, Rockville, MD 20850 USA.	tingyan@westat.com			Eunice Kennedy Shriver National Institute of Child Health & Human Development [R01HD084473]	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to Laura Lindberg and Isaac Maddow-Zimet for providing recodes of the key variables and for their comments on an earlier draft of this paper.	ANDERSON BA, 1994, DEMOGRAPHY, V31, P115, DOI 10.2307/2061911; Bardos J, 2015, OBSTET GYNECOL, V125, P1313, DOI 10.1097/AOG.0000000000000859; Biemer PP, 2002, J R STAT SOC A STAT, V165, P97, DOI 10.1111/1467-985X.00612; Bommaraju A, 2016, SEX REPROD HEALTHC, V10, P62, DOI 10.1016/j.srhc.2016.10.008; Cowan SK, 2014, SOCIOL SCI, V1, P466, DOI 10.15195/v1.a26; Desai S, 2021, MATERN CHILD HLTH J, V25, P1187, DOI 10.1007/s10995-021-03157-9; Fu HS, 1998, FAM PLANN PERSPECT, V30, P128, DOI 10.2307/2991627; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; JONES EF, 1992, DEMOGRAPHY, V29, P113, DOI 10.2307/2061366; Jones RK, 2007, STUD FAMILY PLANN, V38, P187, DOI 10.1111/j.1728-4465.2007.00130.x; Kreuter F, 2008, J R STAT SOC A STAT, V171, P723, DOI 10.1111/j.1467-985X.2007.00530.x; Lanza ST, 2015, PROC LCA PROC LTA US; Lara D, 2004, SOCIOL METHOD RES, V32, P529, DOI 10.1177/0049124103262685; Lazarsfeld P.F., 1968, LATENT STRUCTURE ANA; Lindberg L, 2018, STUD FAMILY PLANN, V49, P259, DOI 10.1111/sifp.12068; London K, 1990, ANN M POP ASS AM 199; McCutcheon AllanL., 1987, LATENT CLASS ANAL; Medeiros M, 2012, CIENC SAUDE COLETIVA, V17, P1721, DOI 10.1590/S1413-81232012000700010; Mosher WD, 1994, M POPULATION ASS AM; Sarac M, 2020, J BIOSOC SCI, V52, P213, DOI 10.1017/S0021932019000397; Sinclair MD., 1998, SURV METHODOL, V24, P157; Substance Abuse and Mental Health Services Administration (SAMHSA), 2009, NAT SURV DRUG US HLT; Tennekoon VS, 2017, DEMOGR RES, V36, P41, DOI 10.4054/DemRes.2017.36.2; Tierney KI, 2019, POPUL RES POLICY REV, V38, P417, DOI 10.1007/s11113-019-09511-8; Tourangeau R, 1997, J OFF STAT, V13, P341; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Yan T, 2021, ANNU REV STAT APPL, V8, P109, DOI 10.1146/annurev-statistics-040720-033353; Yan T, 2012, SOC SCI RES, V41, P1017, DOI 10.1016/j.ssresearch.2012.05.006	28	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271288	http://dx.doi.org/10.1371/journal.pone.0271288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921280	Green Published, gold			2022-12-26	WOS:000839311900076
J	Fruergaard, MU; Dach, I; Andersen, JL; Ozol, M; Shahsavar, A; Quistgaard, EM; Poulsen, H; Fedosova, NU; Nissen, P				Fruergaard, Marlene U.; Dach, Ingrid; Andersen, Jacob L.; Ozol, Mette; Shahsavar, Azadeh; Quistgaard, Esben M.; Poulsen, Hanne; Fedosova, Natalya U.; Nissen, Poul			The Na+,K+-ATPase in complex with beryllium fluoride mimics an ATPase phosphorylated state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ION PATHWAY; K+-ATPASE; NA+; TRANSPORT; PHOSPHOENZYME; CA2+-ATPASE; RELEASE; PUMP; NA,K-ATPASE	The Na+, K+-ATPase generates electrochemical gradients of Na+ and K+ across the plasma membrane via a functional cycle that includes various phosphoenzyme intermediates. However, the structure and function of these intermediates and how metal fluorides mimick them require further investigation. Here, we describe a 4.0 A resolution crystal structure and functional properties of the pig kidney Na+,K+-ATPase stabilized by the inhibitor beryllium fluoride (denoted E2-BeFx). E2-BeFx is expected to mimic properties of the E2P phosphoenzyme, yet with unknown characteristics of ion and ligand binding. The structure resembles the E2P form obtained by phosphorylation from inorganic phosphate (P-i) and stabilized by cardiotonic steroids, including a low-affinity Mg2+ site near ion binding site II. Our anomalous Fourier analysis of the crystals soaked in Rb+ (a K+ congener) followed by a low-resolution rigid-body refinement (6.9-7.5 A) revealed preocclusion transitions leading to activation of the dephosphorylation reaction. We show that the Mg2+ location indicates a site of initial K+ recognition and acceptance upon binding to the outward-open E2P state after Na+ release. Furthermore, using binding and activity studies, we find that the BeFx-inhibited enzyme is also able to bind ADP/ATP and Na+. These results relate the E2-BeFx complex to a transient K+- and ADP-sensitive E*P intermediate of the functional cycle of the Na+, K+-ATPase, prior to E2P.	[Fruergaard, Marlene U.; Dach, Ingrid; Andersen, Jacob L.; Ozol, Mette; Shahsavar, Azadeh; Quistgaard, Esben M.; Poulsen, Hanne; Nissen, Poul] Aarhus Univ, Dept Mol Biol & Genet, DANDRITE Nordic EMBL Partnership Mol Med, Aarhus C, Denmark; [Andersen, Jacob L.; Fedosova, Natalya U.] Aarhus Univ, Dept Biomed, Aarhus C, Denmark; [Dach, Ingrid] Otoc Korunu, Prague, Czech Republic; [Andersen, Jacob L.] Meelunie GPI, Hedensted, Denmark; [Ozol, Mette] Eurofins Labs, Galten, Denmark; [Shahsavar, Azadeh] Univ Copenhagen, Dept Pharmacol & Drug Design, Copenhagen, Denmark; [Quistgaard, Esben M.] Danish Med Agcy, Copenhagen, Denmark; [Poulsen, Hanne] Aarhus Univ Hosp, Dept Pathol, Aarhus, Denmark	Aarhus University; Aarhus University; University of Copenhagen; Aarhus University	Nissen, P (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, DANDRITE Nordic EMBL Partnership Mol Med, Aarhus C, Denmark.; Fedosova, NU (corresponding author), Aarhus Univ, Dept Biomed, Aarhus C, Denmark.	nf@biomed.au.dk; pn@mbg.au.dk		Shahsavar, Azadeh/0000-0001-5405-597X; Fedosova, Natalya U./0000-0002-1706-6108	Danish National Research Foundation through the PUMPkin center of excellence; Danish Council for Independent Research [DFF-7016-00125]; A.P. Moller Foundation for the Advancement of Medical Science; Lundbeck Foundation [R155-2015-2666, R310-2018-3713, R163-2013-16294]; DANSCATT program of the Danish Council for Independent Research [7129-00006B]	Danish National Research Foundation through the PUMPkin center of excellence; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); A.P. Moller Foundation for the Advancement of Medical Science; Lundbeck Foundation(Lundbeckfonden); DANSCATT program of the Danish Council for Independent Research	This work was supported by grants from the Danish National Research Foundation through the PUMPkin center of excellence (to P. N.), the Danish Council for Independent Research (grant no.: DFF-7016-00125; to N. U. F.), the A.P. Moller Foundation for the Advancement of Medical Science (to N. U. F.), the Lundbeck Foundation (grant nos.: R155-2015-2666 and R310-2018-3713; to P. N.; R163-2013-16294 to H. P.). Travel support for synchrotron data collection and screening (to P. N.) was provided by the DANSCATT program of the Danish Council for Independent Research (grant no.: 7129-00006B).	Abe K, 2018, NATURE, V556, P214, DOI 10.1038/s41586-018-0003-8; Abe K, 2012, P NATL ACAD SCI USA, V109, P18401, DOI 10.1073/pnas.1212294109; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Andersson M, 2014, NAT STRUCT MOL BIOL, V21, P43, DOI 10.1038/nsmb.2721; BLOSTEIN R, 1983, J BIOL CHEM, V258, P7948; Castillo JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8622; Cornelius F, 1998, BIOCHEMISTRY-US, V37, P16686, DOI 10.1021/bi981571v; Danko S, 2009, J BIOL CHEM, V284, P22722, DOI 10.1074/jbc.M109.029702; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faraj SE, 2019, BBA-BIOMEMBRANES, V1861, P355, DOI 10.1016/j.bbamem.2018.10.020; ESMANN M, 1988, METHOD ENZYMOL, V156, P105; ESMANN M, 1985, BIOCHEM BIOPH RES CO, V127, P857, DOI 10.1016/S0006-291X(85)80022-X; FORBUSH B, 1987, J BIOL CHEM, V262, P11116; Gregersen JL, 2016, ACTA CRYSTALLOGR F, V72, P282, DOI 10.1107/S2053230X1600279X; Hilbers F, 2016, METHODS MOL BIOL, V1377, P305, DOI 10.1007/978-1-4939-3179-8_27; Hiraizumi M, 2019, SCIENCE, V365, P1149, DOI 10.1126/science.aay3353; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; HOBBS AS, 1985, J BIOL CHEM, V260, P2035; Holmgren M, 2000, NATURE, V403, P898, DOI 10.1038/35002599; HOWELL PL, 1992, J APPL CRYSTALLOGR, V25, P81, DOI 10.1107/S0021889891010385; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanai R, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2123226119; Kanai R, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2020438118; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; KARLISH SJD, 1978, BIOCHIM BIOPHYS ACTA, V525, P252, DOI 10.1016/0005-2744(78)90219-X; Klodos I, 2002, KIDNEY INT, V62, P2097, DOI 10.1046/j.1523-1755.2002.00654.x; Laursen M, 2015, P NATL ACAD SCI USA, V112, P1755, DOI 10.1073/pnas.1422997112; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Laursen M, 2009, J BIOL CHEM, V284, P13513, DOI 10.1074/jbc.C900031200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; NORBY JG, 1983, J GEN PHYSIOL, V82, P725, DOI 10.1085/jgp.82.6.725; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; Ogawa H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9004; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; POST RL, 1975, J BIOL CHEM, V250, P691; POST RL, 1969, J GEN PHYSIOL, V54, pS306, DOI 10.1085/jgp.54.1.306; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stanley KS, 2016, BIOPHYS J, V111, P2430, DOI 10.1016/j.bpj.2016.09.042; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Timcenko M, 2019, NATURE, V571, P366, DOI 10.1038/s41586-019-1344-7; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; Yamasaki K, 2015, J BIOL CHEM, V290, P27868, DOI 10.1074/jbc.M115.693770; YODA S, 1986, J BIOL CHEM, V261, P1147	51	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102317	10.1016/j.jbc.2022.102317	http://dx.doi.org/10.1016/j.jbc.2022.102317			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5B1GH	35926706	Green Published, gold			2022-12-26	WOS:000863323200005
J	Gonnin, L; Richard, CA; Gutsche, I; Chevret, D; Troussier, J; Vasseur, JJ; Debart, F; Eleoue, JF; Galloux, M				Gonnin, Lorene; Richard, Charles-Adrien; Gutsche, Irina; Chevret, Didier; Troussier, Joris; Vasseur, Jean-Jacques; Debart, Francoise; Eleoue, Jean-Francois; Galloux, Marie			Importance of RNA length for in vitro encapsidation by the nucleoprotein of human respiratory syncytial virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BINDING-SITE; COMPLEX; PHOSPHOPROTEIN; TRANSCRIPTION; INFECTIONS; TAXONOMY; SEQUENCE; PROTEIN	Respiratory syncytial virus has a negative-sense single -stranded RNA genome constitutively encapsidated by the viral nucleoprotein N, forming a helical nucleocapsid which is the template for viral transcription and replication by the viral polymerase L. Recruitment of L onto the nucleocapsid depends on the viral phosphoprotein P, which is an essential L cofactor. A prerequisite for genome and antigenome encapsidation is the presence of the monomeric, RNA-free, neosynthesized N pro-tein, named N0. Stabilization of N0 depends on the binding of the N-terminal residues of P to its surface, which prevents N oligomerization. However, the mechanism involved in the transition from N0-P to nucleocapsid assembly, and thus in the specificity of viral genome encapsidation, is still unknown. Furthermore, the specific role of N oligomerization and RNA in the morphogenesis of viral factories, where viral transcription and replication occur, have not been elucidated although the interaction between P and N complexed to RNA has been shown to be responsible for this process. Here, using a chimeric protein comprising N and the first 40 N-terminal residues of P, we succeeded in purifying a recombinant N0-like protein competent for RNA encapsidation in vitro. Our results showed the importance of RNA length for stable encapsidation and revealed that the nature of the 50 end of RNA does not explain the specificity of encapsidation. Finally, we showed that RNA encapsidation is crucial for the in vitro reconstitution of pseudo-viral factories. Together, our findings provide insight into respiratory syncytial virus viral genome encapsidation specificity.	[Gonnin, Lorene; Richard, Charles-Adrien; Chevret, Didier; Eleoue, Jean-Francois; Galloux, Marie] Univ Paris Saclay, INRAE, UVSQ, VIM, Jouy En Josas, France; [Gutsche, Irina] Univ Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France; [Troussier, Joris; Debart, Francoise] Univ Montpellier, CNRS, UMR, IBMM,ENSCM, Montpellier, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Eleoue, JF; Galloux, M (corresponding author), Univ Paris Saclay, INRAE, UVSQ, VIM, Jouy En Josas, France.	jean-francois.eleouet@inrae.fr; marie.galloux@inrae.fr	Debart, Francoise/D-4320-2019	Debart, Francoise/0000-0003-3422-3926; Vasseur, Jean-Jacques/0000-0002-4379-6139; RICHARD, Charles-Adrien/0000-0001-5306-2297; ELeouet, Jean-Francois/0000-0002-7361-4885	Region Ile de France, France; Grenoble InstructERIC center (ISBG) [UAR 3518 CNRS-CEA-UGA-EMBL]; French Agence Nationale de la Recherche [ANR-10-INBS-0005-02, ANR-21-CE15-0030-02, ANR-17-EURE-0003]; University Grenoble Alpes graduate school, France [ANR-19-CE11-0017]; Auvergne-Rhpne-Alpes Region; Fondation Recherche Medicale (FRM); fonds FEDER; GIS-Infrastructures en Biologie Sante et Agronomie (IBISA)	Region Ile de France, France(Region Ile-de-France); Grenoble InstructERIC center (ISBG); French Agence Nationale de la Recherche(French National Research Agency (ANR)); University Grenoble Alpes graduate school, France; Auvergne-Rhpne-Alpes Region(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine); Fondation Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); fonds FEDER; GIS-Infrastructures en Biologie Sante et Agronomie (IBISA)	We thank Stephane Duquerroy (Institut Pas-teur, France) for the scientific discussions related to this work. Protein purification benefited from the purchase of a gel filtration system funded by the Region Ile de France, France (DIM OneHealth 2018). For electron microscopy observations, this work used the EM platform of the Grenoble Instruct-ERIC center (ISBG; UAR 3518 CNRS-CEA-UGA-EMBL) within the Grenoble Partnership for Structural Biology (PSB), supported by the French Agence Nationale de la Recherche (ANR-10-INBS-0005-02) and financed within the University Grenoble Alpes graduate school, France and the specific program ANR-17-EURE-0003. The electron microscope facility is supported by the Auvergne-Rhpne-Alpes Region, the Fondation Recherche Medicale (FRM), the fonds FEDER, and the GIS-Infrastructures en Biologie Sante et Agronomie (IBISA). This work was carried out with the financial support of the French Agence Nationale de la Recherche, France, specific programs ANR DecRisP n degrees ANR-19-CE11-0017 and ANR RSVFact n degrees ANR-21-CE15-0030-02.	Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1; Aggarwal M, 2018, J VIROL, V92, DOI 10.1128/JVI.01304-17; Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Alberti S, 2018, J MOL BIOL, V430, P4806, DOI 10.1016/j.jmb.2018.06.038; Asner S, 2013, PEDIATR INFECT DIS J, V32, P1073, DOI 10.1097/INF.0b013e31829dff4d; Bajorek M., 2021, J VIROL, V11, P1225; Bakker SE, 2013, J GEN VIROL, V94, P1734, DOI 10.1099/vir.0.053025-0; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Brocca S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239045; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; COLLINS PL, 1995, P NATL ACAD SCI USA, V92, P11563, DOI 10.1073/pnas.92.25.11563; Collins PL, 2007, FIELDS VIROLOGY, P1601; Conley MJ, 2022, EMBO J, V41, DOI 10.15252/embj.2021109728; Cowton VM, 2006, J GEN VIROL, V87, P1805, DOI 10.1099/vir.0.81786-0; Dong XF, 2022, J VIROL, V96, DOI 10.1128/JVI.01648-21; Esneau C, 2019, J BIOL CHEM, V294, P3647, DOI 10.1074/jbc.RA118.006453; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fearns R, 1999, J VIROL, V73, P5852, DOI 10.1128/JVI.73.7.5852-5864.1999; Fearns R, 2017, VIRUS RES, V234, P87, DOI 10.1016/j.virusres.2017.01.008; Galloux M, 2020, MBIO, V11, DOI 10.1128/mBio.01202-20; Galloux M, 2015, J VIROL, V89, P3484, DOI 10.1128/JVI.03666-14; Galloux M, 2012, J VIROL, V86, P8375, DOI 10.1128/JVI.00058-12; Gao YR, 2020, J BIOL CHEM, V295, P883, DOI 10.1074/jbc.RA119.011602; GARCIA J, 1993, VIROLOGY, V195, P243, DOI 10.1006/viro.1993.1366; Gilman MSA, 2019, CELL, V179, P193, DOI 10.1016/j.cell.2019.08.014; Guryanov SG, 2016, J VIROL, V90, P2849, DOI 10.1128/JVI.02865-15; Guseva S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz7095; HEFTI E, 1975, J VIROL, V15, P90, DOI 10.1128/JVI.15.1.90-96.1975; HEFTI E, 1975, BIOCHEM BIOPH RES CO, V66, P785, DOI 10.1016/0006-291X(75)90578-1; Heinrich BS, 2018, MBIO, V9, DOI 10.1128/mBio.02290-17; Ker DS, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009740; Kirchdoerfer RN, 2015, CELL REP, V12, P140, DOI 10.1016/j.celrep.2015.06.003; Leyrat C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002248; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nikolic J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00102-9; Noton SL, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007548; Noton SL, 2015, VIROLOGY, V479, P545, DOI 10.1016/j.virol.2015.01.014; O'Brien KL, 2019, LANCET, V394, P757, DOI 10.1016/S0140-6736(19)30721-4; Parey N, 2006, ORG LETT, V8, P3869, DOI 10.1021/ol0616182; Renner M, 2016, ELIFE, V5, DOI 10.7554/eLife.12627; Richard CA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006920; Rima B, 2018, ARCH VIROL, V163, P1395, DOI 10.1007/s00705-018-3720-2; Rima B, 2017, J GEN VIROL, V98, P2912, DOI 10.1099/jgv.0.000959; Rincheval V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00655-9; Risso-Ballester J, 2021, NATURE, V595, P596, DOI 10.1038/s41586-021-03703-z; Samal SK, 1996, J VIROL, V70, P5075, DOI 10.1128/JVI.70.8.5075-5082.1996; Shah JN, 2011, BLOOD, V117, P2755, DOI 10.1182/blood-2010-08-263400; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Shimobayashi SF, 2021, NATURE, V599, P503, DOI 10.1038/s41586-021-03905-5; Song XY, 2019, ELIFE, V8, DOI 10.7554/eLife.45057; Sourimant J, 2015, J VIROL, V89, P4421, DOI 10.1128/JVI.03619-14; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Thillier Y, 2012, RNA, V18, P856, DOI 10.1261/rna.030932.111; Tran TL, 2007, J GEN VIROL, V88, P196, DOI 10.1099/vir.0.82282-0; Yabukarsi F, 2014, NAT STRUCT MOL BIOL, V21, P754, DOI 10.1038/nsmb.2868; Zhang N, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02027-y; Zhou YQ, 2019, J VIROL, V93, DOI 10.1128/JVI.00948-19; Zhu TF, 2017, J VIROL, V91, DOI [10.1128/JVI.00996-17, 10.1128/jvi.00996-17]; Zinzula L, 2021, J STRUCT BIOL, V213, DOI 10.1016/j.jsb.2021.107750; Zlatev I, 2010, ORG LETT, V12, P2190, DOI 10.1021/ol1004214	60	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102337	10.1016/j.jbc.2022.102337	http://dx.doi.org/10.1016/j.jbc.2022.102337			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9IM	35931116	Green Published, Green Submitted, gold			2022-12-26	WOS:000863192700011
J	Kholmukhamedov, A; Li, L; Lindsey, CC; Hu, J; Nieminen, AL; Takemoto, K; Beeson, GC; Beneker, CM; McInnes, C; Beeson, CC; Lemasters, JJ				Kholmukhamedov, Andaleb; Li, Li; Lindsey, Christopher C.; Hu, Jiangting; Nieminen, Anna-Liisa; Takemoto, Kenji; Beeson, Gyda C.; Beneker, Chad M.; McInnes, Campbell; Beeson, Craig C.; Lemasters, John J.			A new fluorescent sensor mitoferrofluor indicates the presence of chelatable iron in polarized and depolarized mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION; LYSOSOMAL IRON; CELLS; TRANSLOCATION; AUTOPHAGY; MOBILIZATION; HEPATOCYTES; MITOPHAGY; CALCIUM; INJURY	Mitochondrial chelatable iron contributes to the severity of several injury processes, including ischemia/reperfusion, oxidative stress, and drug toxicity. However, methods to measure this species in living cells are lacking. To measure mitochondrial chelatable iron in living cells, here we synthesized a new fluorescent indicator, mitoferrofluor (MFF). We designed cationic MFF to accumulate electrophoretically in polarized mitochondria, where a reactive group then forms covalent adducts with mitochondrial proteins to retain MFF even after subsequent depolarization. We also show in cell-free medium that Fe2+ (and Cu2+), but not Fe3+, Ca2+, or other biologically relevant divalent cations, strongly quenched MFF fluorescence. Using confocal microscopy, we demonstrate in hepatocytes that red MFF fluorescence colocalized with the green fluorescence of the mitochondrial membrane potential (Delta Psi(m)) indicator, rhodamine 123 (Rh123), indicating selective accumulation into the mitochondria. Unlike Rh123, mitochondria retained MFF after Delta Psi(m) collapse. Furthermore, intracellular delivery of iron with membrane-permeant Fe3+/8-hydroxyquinoline (FeHQ) quenched MFF fluorescence by similar to 80% in hepatocytes and other cell lines, which was substantially restored by the membrane-permeant transition metal chelator pyridoxal isonicotinoyl hydrazone. We also show FeHQ quenched the fluorescence of cytosolically coloaded calcein, another Fe2+ indicator, confirming that Fe3+ in FeHQ undergoes intracellular reduction to Fe2+. Finally, MFF fluorescence did not change after addition of the calcium mobilizer thapsigargin, which shows MFF is insensitive to physiologically relevant increases of mitochondrial Ca2+. In conclusion, the new sensor reagent MFF fluorescence is an indicator of mitochondrial chelatable Fe2+ in normal hepatocytes with polarized mitochondria as well as in cells undergoing loss of Delta Psi(m).	[Kholmukhamedov, Andaleb; Li, Li; Hu, Jiangting; Nieminen, Anna-Liisa; Takemoto, Kenji; Beeson, Craig C.; Lemasters, John J.] Med Univ South Carolina, Ctr Cell Death Injury & Regenerat, Charleston, SC 29209 USA; [Kholmukhamedov, Andaleb; Li, Li; Lindsey, Christopher C.; Hu, Jiangting; Nieminen, Anna-Liisa; Takemoto, Kenji; Beeson, Gyda C.; Beeson, Craig C.; Lemasters, John J.] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29209 USA; [Nieminen, Anna-Liisa; Lemasters, John J.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29209 USA; [Beneker, Chad M.; McInnes, Campbell] Univ South Carolina, Dept Drug Discovery & Biomed Sci, Coll Pharm, Columbia, SC USA; [Lemasters, John J.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29209 USA; [Kholmukhamedov, Andaleb] Werfen, 6260 Sequence Dr, San Diego, CA 92121 USA; [Lindsey, Christopher C.] Natl Inst Child Hlth & Human Dev, 6710B Rockledge Dr, Bethesda, MD 20817 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lemasters, JJ (corresponding author), Med Univ South Carolina, Ctr Cell Death Injury & Regenerat, Charleston, SC 29209 USA.; Lemasters, JJ (corresponding author), Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29209 USA.; Lemasters, JJ (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29209 USA.; Lemasters, JJ (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29209 USA.	JJLemasters@musc.edu			 [T32DK083262]		J. H. was the recipient of a postdoctoral training award from T32DK083262. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berndt C, 2017, ANTIOXID REDOX SIGN, V27, P1235, DOI 10.1089/ars.2017.7132; Breuer William, 1995, American Journal of Physiology, V268, pC1354; Cabantchik ZI, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00045; CHACON E, 1994, BIOPHYS J, V66, P942, DOI 10.1016/S0006-3495(94)80904-X; CRICHTON RR, 1987, EUR J BIOCHEM, V164, P485, DOI 10.1111/j.1432-1033.1987.tb11155.x; De Stefani D, 2016, ANNU REV BIOCHEM, V85, P161, DOI 10.1146/annurev-biochem-060614-034216; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Elmore SP, 2004, ARCH BIOCHEM BIOPHYS, V422, P145, DOI 10.1016/j.abb.2003.12.031; Garcia-Perez C, 2008, J BIOL CHEM, V283, P32771, DOI 10.1074/jbc.M803385200; Gaschler MM, 2017, BIOCHEM BIOPH RES CO, V482, P419, DOI 10.1016/j.bbrc.2016.10.086; Hirayama T, 2019, FREE RADICAL BIO MED, V133, P38, DOI 10.1016/j.freeradbiomed.2018.07.004; Hirayama T, 2018, METALLOMICS, V10, P794, DOI 10.1039/c8mt00049b; HOEK JB, 1980, J BIOL CHEM, V255, P1458; Holmes-Hampton GP, 2014, METHOD ENZYMOL, V547, P275, DOI 10.1016/B978-0-12-801415-8.00015-1; Hu JT, 2020, TOXICOL APPL PHARM, V392, DOI 10.1016/j.taap.2020.114930; Hu JT, 2016, FREE RADICAL BIO MED, V97, P418, DOI 10.1016/j.freeradbiomed.2016.06.024; Hung HI, 2013, J BIOL CHEM, V288, P677, DOI 10.1074/jbc.M112.422667; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Kon K, 2010, TOXICOL SCI, V117, P101, DOI 10.1093/toxsci/kfq175; Lemasters JJ., 2001, LIVER BIOL PATHOBIOL, P257; Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004; Marchi S, 2017, ADV EXP MED BIOL, V997, P49, DOI 10.1007/978-981-10-4567-7_4; Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034; Orrenius S, 2015, BIOCHEM BIOPH RES CO, V460, P72, DOI 10.1016/j.bbrc.2015.01.137; Paul BT, 2017, EXPERT REV HEMATOL, V10, P65, DOI 10.1080/17474086.2016.1268047; Petrat F, 2002, BIOCHEM J, V362, P137, DOI 10.1042/0264-6021:3620137; Petrat F, 2002, BIOL CHEM, V383, P489, DOI 10.1515/BC.2002.051; Petrat F, 2001, BIOCHEM J, V356, P61, DOI 10.1042/0264-6021:3560061; Pierre JL, 2003, CURR MED CHEM, V10, P1077, DOI 10.2174/0929867033457584; PONKA P, 1979, FEBS LETT, V97, P317, DOI 10.1016/0014-5793(79)80111-8; Rauen U, 2004, J HEPATOL, V40, P607, DOI 10.1016/j.jhep.2003.12.021; Rauen U, 2007, CHEMBIOCHEM, V8, P341, DOI 10.1002/cbic.200600311; Rodriguez-Enriquez S, 2009, AUTOPHAGY, V5, P1099, DOI 10.4161/auto.5.8.9825; Saggu S, 2012, PHOTOCHEM PHOTOBIOL, V88, P461, DOI 10.1111/j.1751-1097.2012.01081.x; STARKE PE, 1985, J BIOL CHEM, V260, P99; Taniguchi M, 2018, PHOTOCHEM PHOTOBIOL, V94, P290, DOI 10.1111/php.12860; Terman A, 2013, ANTIOXID REDOX SIGN, V18, P888, DOI 10.1089/ars.2012.4885; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Uchiyama A, 2008, HEPATOLOGY, V48, P1644, DOI 10.1002/hep.22498; Ward DM, 2019, ANNU REV PHYSIOL, V81, P453, DOI 10.1146/annurev-physiol-020518-114742; YI J, 1995, ANAT RECORD, V242, P137, DOI 10.1002/ar.1092420202; Zhang X, 2013, FREE RADICAL BIO MED, V63, P243, DOI 10.1016/j.freeradbiomed.2013.05.004; Zhang Y.-Z., 1994, Molecular Biology of the Cell, V5, p113A	43	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102336	10.1016/j.jbc.2022.102336	http://dx.doi.org/10.1016/j.jbc.2022.102336			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6F7ME	35931111	gold, Green Published			2022-12-26	WOS:000884241800010
J	Shih, PK; Chen, JX; Lin, MC; Wu, SC				Shih, Pin-Keng; Chen, Jian-Xun; Lin, Mei-Chen; Wu, Shih-Chi			Risk of peripheral artery occlusive disease in patients with lower leg fracture who received fixation and non-fixation treatments: A population cohort study	PLOS ONE			English	Article							DIAGNOSIS; INJURIES; TIBIA	Background The risk of peripheral artery occlusive disease (PAOD) in patients with lower leg fracture who underwent fixation procedures is not yet completely understood. Therefore, the current study aimed to examine the risk of subsequent PAOD in patients with lower leg fracture who received fixation and non-fixation treatments. Methods We included 6538 patients with lower leg fracture who received non-fixation treatment and a matched cohort comprising 26152 patients who received fixation treatment from the National Health Insurance Database. Patients were frequency matched according to age, sex, and index year. The incidence and risk of PAOD in patients with lower leg fracture who received fixation and non-fixation treatments were evaluated via the stratification of different characteristics and comorbidities. Results Non-fixation treatment, male sex, older age (>= 50 years old), diabetes mellitus, and gout were associated with a significantly higher risk of lower extremity PAOD compare to each comparison group, respectively. Moreover, there was a significant correlation between fixation treatment and a lower risk of lower extremity PAOD in women (adjusted hazard ratio [aHR] = 0.58, 95% confidence interval [CI] = 0.38-0.90), women aged > 50 years (aHR = 0.61, 95% CI = 0.38-0.96), and patients with coronary artery disease (aHR = 0.43, 95% CI = (0.23-0.81). Further, patients with fixation treatment had a significantly lower risk of lower extremity PAOD within 2 years after trauma (aHR = 0.57, 95% CI = 0.34-0.97). The Kaplan-Meier analysis showed that the cumulative incidence of PAOD was significantly higher in the non-fixation treatment group than in the fixation treatment group at the end of the 10 year follow-up period (log-rank test: P = 0.022). Conclusion Patients with lower leg fracture who received non-fixation treatment had a significantly higher risk of PAOD than those who received fixation treatment. Moreover, the risk of PAOD was higher in women aged > 50 years, as well as in coronary artery disease patients who received non-fixation treatment than in those who received fixation treatment. Therefore, regular assessment of vessel patency are recommended for these patients. Nevertheless, further studies must be conducted to validate the results of our study.	[Shih, Pin-Keng; Chen, Jian-Xun; Lin, Mei-Chen; Wu, Shih-Chi] China Med Univ, Sch Med, Taichung, Taiwan; [Shih, Pin-Keng; Chen, Jian-Xun] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Lin, Mei-Chen] China Med Univ & Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wu, Shih-Chi] China Med Univ Hosp, Trauma & Emergency Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Wu, SC (corresponding author), China Med Univ, Sch Med, Taichung, Taiwan.; Wu, SC (corresponding author), China Med Univ Hosp, Trauma & Emergency Ctr, Taichung, Taiwan.	rw114@mail.cmuh.org.tw			Ministry of Health and Welfare, Taiwan [109-TDUB-212-114004]; MOST Clinical Trial Consortium for Stroke [MOST 108-2321-B-039-003]; China Medical University Hospital [DMR-111-048]	Ministry of Health and Welfare, Taiwan; MOST Clinical Trial Consortium for Stroke; China Medical University Hospital	This study is supported in part by Ministry of Health and Welfare, Taiwan (109-TDUB-212-114004), MOST Clinical Trial Consortium for Stroke (MOST 108-2321-B-039-003), China Medical University Hospital (DMR-111-048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday AW, 2019, CURR CARDIOL REP, V21, DOI 10.1007/s11886-019-1129-5; [Anonymous], 2015, MEDICINE, V94, pe1164; Bardin T, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0890-9; Bauersachs R, 2019, CARDIOVASC THER, V2019, DOI 10.1155/2019/8295054; Beale B, 2020, VET CLIN N AM-SMALL, V50, P183, DOI 10.1016/j.cvsm.2019.08.008; Born CT, 2018, J AM ACAD ORTHOP SUR, V26, pE167, DOI 10.5435/JAAOS-D-16-00387; Brinker MR, 1997, J TRAUMA, V42, P11, DOI 10.1097/00005373-199701000-00004; Coleman JJ, 2016, AM SURGEON, V82, P820; Collins TC, 2009, CIRCULATION, V119, P2305, DOI 10.1161/CIRCULATIONAHA.108.820993; Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849; DICKSON K, 1994, CLIN ORTHOP RELAT R, P189; Dickson K F, 1995, Contemp Orthop, V30, P489; Firnhaber JM, 2019, AM FAM PHYSICIAN, V99, P362; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Guled U, 2015, CHIN J TRAUMATOL, V18, P238, DOI 10.1016/j.cjtee.2015.09.001; Hong CT, 2018, CLIN EPIDEMIOL, V10, P1147, DOI 10.2147/CLEP.S163493; Kalyan JP, 2015, J SURG CASE REP, DOI 10.1093/jscr/rjv138; Kolls BJ, 2019, STROKE, V50, P1356, DOI 10.1161/STROKEAHA.118.023534; Lassen MR, 2002, NEW ENGL J MED, V347, P726, DOI 10.1056/NEJMoa011327; Lawall H, 2016, DTSCH ARZTEBL INT, V113, P729, DOI [10.3238/arztebl.2016.0729, 10.3238/arztebl.2016.729]; Liao KM, 2019, INT J CHRONIC OBSTR, V14, P1455, DOI 10.2147/COPD.S202029; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Narula N, 2020, ARTERIOSCL THROM VAS, V40, P1982, DOI 10.1161/ATVBAHA.119.312864; Nemati Masoud, 2013, Pak J Biol Sci, V16, P145; Nemeth B, 2018, J THROMB HAEMOST, V16, P2218, DOI 10.1111/jth.14278; Peng K, 2020, MENOPAUSE, V27, P311, DOI 10.1097/GME.0000000000001478; Singh P, 2017, WORLD J CARDIOL, V9, P583, DOI 10.4330/wjc.v9.i7.583; Swedish Council on Health Technology Assessment, 2008, 187 SWED COUNC HLTH; Thomas M, 2020, J PSYCHOSOM RES, V131, DOI 10.1016/j.jpsychores.2020.109963; Ungprasert P, 2018, J POSTGRAD MED, V64, P220, DOI 10.4103/jpgm.JPGM_685_17; Vestergaard V, 2020, ACTA ORTHOP, V91, P109, DOI 10.1080/17453674.2019.1698148; Vierhout BP, 2006, EUR J PEDIATR SURG, V16, P432, DOI 10.1055/s-2006-924737; Zhu W, 2020, BIOMED ENVIRON SCI, V33, P217, DOI 10.3967/bes2020.031	33	0	0	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272068	10.1371/journal.pone.0272068	http://dx.doi.org/10.1371/journal.pone.0272068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925984	gold, Green Published			2022-12-26	WOS:000848077100068
J	Matsukawa, T; Yin, MM; Baslan, T; Chung, YJ; Cao, DC; Bertoli, R; Zhu, YLJ; Walker, RL; Freeland, A; Knudsen, E; Lowe, SW; Meltzer, PS; Aplan, PD				Matsukawa, Toshihiro; Yin, Mianmian; Baslan, Timour; Chung, Yang Jo; Cao, Dengchao; Bertoli, Ryan; Zhu, Yuelin J.; Walker, Robert L.; Freeland, Amy; Knudsen, Erik; Lowe, Scott W.; Meltzer, Paul S.; Aplan, Peter D.			Mcm2 hypomorph leads to acute leukemia or hematopoietic stem cell failure, dependent on genetic context	FASEB JOURNAL			English	Article						B-cell precursor acute lymphoblastic leukemia; bone marrow failure; DNA stress; Mcm2; tumor suppressor gene	ACUTE LYMPHOBLASTIC-LEUKEMIA; MYELODYSPLASTIC SYNDROMES; BETHESDA PROPOSALS; SOMATIC MUTATIONS; BCOR; CLASSIFICATION; IDENTIFICATION; INSTABILITY; DEFICIENCY; NEOPLASMS	Minichromosome maintenance proteins (Mcm2-7) form a hexameric complex that unwinds DNA ahead of a replicative fork. The deficiency of Mcm proteins leads to replicative stress and consequent genomic instability. Mice with a germline insertion of a Cre cassette into the 3 ' UTR of the Mcm2 gene (designated Mcm2(Cre)) have decreased Mcm2 expression and invariably develop precursor T-cell lymphoblastic leukemia/lymphoma (pre-T LBL), due to 100-1000 kb deletions involving important tumor suppressor genes. To determine whether mice that were protected from pre-T LBL would develop non-T-cell malignancies, we used two approaches. Mice engrafted with Mcm2(Cre/Cre) Lin(-)Sca-1(+)Kit(+) hematopoietic stem/progenitor cells did not develop hematologic malignancy; however, these mice died of hematopoietic stem cell failure by 6 months of age. Placing the Mcm2(Cre) allele onto an athymic nu/nu background completely prevented pre-T LBL and extended survival of these mice three-fold (median 296.5 vs. 80.5 days). Ultimately, most Mcm2(Cre/Cre);nu/nu mice developed B-cell precursor acute lymphoblastic leukemia (BCP-ALL). We identified recurrent deletions of 100-1000 kb that involved genes known or suspected to be involved in BCP-ALL, including Pax5, Nf1, Ikzf3, and Bcor. Moreover, whole-exome sequencing identified recurrent mutations of genes known to be involved in BCP-ALL progression, such as Jak1/Jak3, Ptpn11, and Kras. These findings demonstrate that an Mcm2(Cre/Cre) hypomorph can induce hematopoietic dysfunction via hematopoietic stem cell failure as well as a "deletor" phenotype affecting known or suspected tumor suppressor genes.	[Matsukawa, Toshihiro; Yin, Mianmian; Chung, Yang Jo; Cao, Dengchao; Bertoli, Ryan; Zhu, Yuelin J.; Walker, Robert L.; Meltzer, Paul S.; Aplan, Peter D.] NCI, Genet Branch, Ctr Canc Res, NIH, 37 Room 6002,37 Convent Dr, Bethesda, MD 20892 USA; [Baslan, Timour; Lowe, Scott W.] Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY USA; [Freeland, Amy; Knudsen, Erik] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, New York, NY USA; [Lowe, Scott W.] Howard Hughes Med Inst, Chevy Chase, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Roswell Park Cancer Institute; Howard Hughes Medical Institute	Aplan, PD (corresponding author), NCI, Genet Branch, Ctr Canc Res, NIH, 37 Room 6002,37 Convent Dr, Bethesda, MD 20892 USA.	aplanp@mail.nih.gov		Matsukawa, Toshihiro/0000-0003-2371-3778; Cao, Dengchao/0000-0001-9808-991X	HHS | NIH | National Cancer Institute (NCI) [SC0130378, SC010379]; Memorial Sloan-Kettering Cancer Center (MSK); Naito Foundation; Uehara Memorial Foundation	HHS | NIH | National Cancer Institute (NCI); Memorial Sloan-Kettering Cancer Center (MSK); Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation)	HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: SC0130378 and SC010379; Memorial Sloan-Kettering Cancer Center (MSK); Naito Foundation; Uehara Memorial Foundation	Alvarez S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9548; Bagley BN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003034; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Beauchamp EM, 2021, BLOOD CANCER DISCOV, V2, P500, DOI 10.1158/2643-3230.BCD-20-0224; Bleichert F, 2017, SCIENCE, V355, DOI 10.1126/science.aah6317; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; Chervinsky DS, 2001, CANCER RES, V61, P6382; Chervinsky DS, 2001, LEUKEMIA, V15, P141, DOI 10.1038/sj.leu.2401997; Chuang CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001110; Damm F, 2013, BLOOD, V122, P3169, DOI 10.1182/blood-2012-11-469619; EATON GJ, 1976, TRANSPLANTATION, V22, P217, DOI 10.1097/00007890-197609000-00001; Gough SM, 2017, BLOOD ADV, V1, P1749, DOI 10.1182/bloodadvances.2017009837; Gough SM, 2014, CANCER DISCOV, V4, P564, DOI 10.1158/2159-8290.CD-13-0419; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; Gu ZH, 2019, NAT GENET, V51, P296, DOI 10.1038/s41588-018-0315-5; Hunger SP, 2015, NEW ENGL J MED, V373, P1541, DOI 10.1056/NEJMra1400972; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Iwasaki H, 2007, ONCOGENE, V26, P6687, DOI 10.1038/sj.onc.1210754; Jallades L, 2017, HAEMATOLOGICA, V102, P1758, DOI 10.3324/haematol.2016.160192; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; KAUSHIK A, 1995, EUR J IMMUNOL, V25, P631, DOI 10.1002/eji.1830250249; Kawabata T, 2011, MAMM GENOME, V22, P506, DOI 10.1007/s00335-011-9333-7; Kiel MJ, 2014, BLOOD, V124, P1460, DOI 10.1182/blood-2014-03-559542; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin YW, 2005, BLOOD, V106, P287, DOI 10.1182/blood-2004-12-4794; Macheret M, 2015, ANNU REV PATHOL-MECH, V10, P425, DOI 10.1146/annurev-pathol-012414-040424; Matsukawa T, 2020, STEM CELLS, V38, P1366, DOI 10.1002/stem.3263; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Montecino-Rodriguez E, 2016, IMMUNITY, V45, P527, DOI 10.1016/j.immuni.2016.07.012; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Orr SJ, 2010, ONCOGENE, V29, P3803, DOI 10.1038/onc.2010.138; Paulsson K, 2008, GENE CHROMOSOME CANC, V47, P26, DOI 10.1002/gcc.20502; Pruitt SC, 2007, STEM CELLS, V25, P3121, DOI 10.1634/stemcells.2007-0483; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Raza-Egilmez SZ, 1998, CANCER RES, V58, P4269; Rusiniak ME, 2012, ONCOGENE, V31, P4034, DOI 10.1038/onc.2011.566; SCHEIFF JM, 1978, ANAT EMBRYOL, V153, P115, DOI 10.1007/BF00343368; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; Szadvari I, 2016, PHYSIOL RES, V65, pS441, DOI 10.33549/physiolres.933526; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Wong TN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02858-0; Xiang ZF, 2008, BLOOD, V111, P4809, DOI 10.1182/blood-2007-05-090308; Yin MM, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131434; Yin MM, 2019, BLOOD, V133, P2610, DOI 10.1182/blood.2018864173; Zhang JH, 2011, BLOOD, V118, P3080, DOI 10.1182/blood-2011-03-341412	51	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22430	10.1096/fj.202200061RR	http://dx.doi.org/10.1096/fj.202200061RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3M2QF	35920299	Green Accepted			2022-12-26	WOS:000835302700001
J	Santos, MN; Paushter, DH; Zhang, TT; Wu, XC; Feng, TC; Lou, JY; Du, H; Becker, SM; Fragoza, R; Yu, HY; Hu, FH				Santos, Mariela Nunez; Paushter, Daniel H.; Zhang, Tingting; Wu, Xiaochun; Feng, Tuancheng; Lou, Jiaoying; Du, Huan; Becker, Stephanie M.; Fragoza, Robert; Yu, Haiyuan; Hu, Fenghua			Progranulin-derived granulin E and lysosome membrane protein CD68 interact to reciprocally regulate their protein homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; INFLAMMATION; PROSAPOSIN; PHENOTYPES; MUTATIONS; RECEPTORS; CHAPERONE	Progranulin (PGRN) is a glycoprotein implicated in several neurodegenerative diseases. It is highly expressed in microglia and macrophages and can be secreted or delivered to the lysosome compartment. PGRN comprises 7.5 granulin repeats and is processed into individual granulin peptides within the lysosome, but the functions of these peptides are largely unknown. Here, we identify CD68, a lysosome membrane protein mainly expressed in hematopoietic cells, as a binding partner of PGRN and PGRN-derived granulin E. Deletion analysis of CD68 showed that this interaction is mediated by the mucin- proline-rich domain of CD68. While CD68 deficiency does not affect the lysosomal localization of PGRN, it results in a specific decrease in the levels of granulin E but no other granulin peptides. On the other hand, the deficiency of PGRN, and its derivative granulin peptides, leads to a significant shift in the molecular weight of CD68, without altering CD68 localization within the cell. Our results support that granulin E and CD68 reciprocally regulate each other's protein homeostasis.	[Santos, Mariela Nunez; Paushter, Daniel H.; Zhang, Tingting; Wu, Xiaochun; Feng, Tuancheng; Lou, Jiaoying; Du, Huan; Becker, Stephanie M.; Hu, Fenghua] Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Lou, Jiaoying] Beijing Univ Chinese Med, Dongfang Hosp, Dept Gynecol, Beijing, Peoples R China; [Fragoza, Robert; Yu, Haiyuan] Cornell Univ, Weill Inst Cell & Mol Biol, Dept Computat Biol, Ithaca, NY USA	Cornell University; Beijing University of Chinese Medicine; Cornell University	Hu, FH (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	fh87@cornell.edu		Becker, Stephanie/0000-0003-0565-5930	National Institute of Neurological Disorders and Stroke/National Institute on Aging (National Institutes of Health) [R01NS088448, R01NS095954]; Blue field project	National Institute of Neurological Disorders and Stroke/National Institute on Aging (National Institutes of Health); Blue field project	This work is supported by the National Institute of Neurological Disorders and Stroke/National Institute on Aging (National Institutes of Health; grant nos.: R01NS088448 and R01NS095954) and the Blue field project to cure frontotemporal dementia to F. H. The funders are not involved in the study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almeida MR, 2016, NEUROBIOL AGING, V41, DOI 10.1016/j.neurobiolaging.2016.02.019; Arrant AE, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0872-6; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Beel S, 2017, HUM MOL GENET, V26, P2850, DOI 10.1093/hmg/ddx162; Brady OA, 2013, HUM MOL GENET, V22, P685, DOI 10.1093/hmg/dds475; Butlers VJ, 2019, J MOL BIOL, V431, P1038, DOI 10.1016/j.jmb.2019.01.027; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Chistiakov DA, 2017, LAB INVEST, V97, P4, DOI 10.1038/labinvest.2016.116; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Du H, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202000874; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Holler CJ, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0100-17.2017; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Jian JL, 2017, GENES DIS, V4, P125, DOI 10.1016/j.gendis.2017.05.001; Kao AW, 2017, NAT REV NEUROSCI, V18, P325, DOI 10.1038/nrn.2017.36; Lee CW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0196-6; Logan T, 2021, CELL, V184, P4651, DOI 10.1016/j.cell.2021.08.002; Mohan S, 2021, MOL NEURODEGENER, V16, DOI 10.1186/s13024-021-00472-1; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nicholson AM, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt102; Paushter DH, 2018, ACTA NEUROPATHOL, V136, P1, DOI 10.1007/s00401-018-1861-8; Rabinovici GD, 2010, CNS DRUGS, V24, P375, DOI 10.2165/11533100-000000000-00000; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; Song L, 2011, J LIPID RES, V52, P1542, DOI 10.1194/jlr.M015412; Terpstra V, 1998, P NATL ACAD SCI USA, V95, P1806, DOI 10.1073/pnas.95.4.1806; Tolkatchev D, 2008, PROTEIN SCI, V17, P711, DOI 10.1110/ps.073295308; Valdez C, 2020, HUM MOL GENET, V29, P716, DOI 10.1093/hmg/ddz229; Valdez C, 2017, HUM MOL GENET, V26, P4861, DOI 10.1093/hmg/ddx364; Vancha AR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-23; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Wu YW, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109581; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhang TT, 2022, MOL NEURODEGENER, V17, DOI 10.1186/s13024-021-00513-9; Zhou XL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212382; Zhou XL, 2017, J NEUROCHEM, V143, P236, DOI 10.1111/jnc.14110; Zhou XL, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0205-9; Zhou XL, 2017, ACTA NEUROPATHOL, V134, P151, DOI 10.1007/s00401-017-1719-5; Zhou XL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15277; Zhou XL, 2015, J CELL BIOL, V210, P991, DOI 10.1083/jcb.201502029	42	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102348	10.1016/j.jbc.2022.102348	http://dx.doi.org/10.1016/j.jbc.2022.102348			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9IM	35933009	gold, Green Published			2022-12-26	WOS:000863192700006
J	Yao, XL; El-Samahy, MA; Li, XD; Bao, YJ; Guo, JH; Yang, F; Wang, ZB; Li, K; Zhang, YL; Wang, F				Yao, Xiaolei; El-Samahy, Mohamed AbdFatah; Li, Xiaodan; Bao, Yongjin; Guo, Jiahe; Yang, Fan; Wang, Zhibo; Li, Kang; Zhang, Yanli; Wang, Feng			LncRNA-412.25 activates the LIF/STAT3 signaling pathway in ovarian granulosa cells of Hu sheep by sponging miR-346	FASEB JOURNAL			English	Article						apoptosis; granulosa cells; Hu sheep; lncRNA-412; 25; miR-346	LEUKEMIA INHIBITORY FACTOR; LITTER SIZE; ATRETIC FOLLICLES; STROMAL CELLS; BONE-MARROW; PROLIFERATION; APOPTOSIS; DIFFERENTIATION; EXPRESSION; PROMOTES	Although long non-coding RNAs (lncRNAs) are reported to regulate follicular development and reproductive disease pathogenesis, the underlying mechanisms have not been elucidated. In this study, lncRNA expression profiling of different-sized healthy follicles from Hu sheep with different prolificacy revealed 50 613 lncRNAs. Numerous lncRNAs were differentially expressed among different comparison groups. This study characterized one novel transcript, lncRNA-412.25 (from healthy follicles with a diameter of >5 mm), which was predominantly expressed in the high prolificacy group and localized to the cytoplasm of granulosa cells (GCs). LncRNA-412.25 knockdown promoted and inhibited Hu sheep GC apoptosis and proliferation, respectively. Interestingly, lncRNA-412.25 could directly bind to miR-346, which can target the gene of leukemia inhibitory factor (LIF). Knockdown of lncRNA-412.25 promoted GC apoptosis by downregulating LIF expression, where this effect was attenuated by miR-346. Moreover, the miR-346 inhibitor mitigated the lncRNA-412.25 knockdown-induced downregulation of phosphorylated protein of signal transducer and activator of transcription 3 (STAT3), which was validated using immunofluorescence analysis. Our results demonstrated that lncRNA-412.25 regulates GC proliferation and apoptosis in Hu sheep by binding to miR-346 and then activating the LIF/STAT3 pathway. These findings provide novel insights into the mechanisms underlying prolificacy in sheep.	[Yao, Xiaolei; El-Samahy, Mohamed AbdFatah; Li, Xiaodan; Bao, Yongjin; Guo, Jiahe; Yang, Fan; Wang, Zhibo; Li, Kang; Zhang, Yanli; Wang, Feng] Nanjing Agr Univ, Hu Sheep Acad, Nanjing 210095, Peoples R China; [Yao, Xiaolei; El-Samahy, Mohamed AbdFatah; Li, Xiaodan; Bao, Yongjin; Guo, Jiahe; Yang, Fan; Wang, Zhibo; Li, Kang; Zhang, Yanli; Wang, Feng] Nanjing Agr Univ, Jiangsu Livestock Embryo Engn Lab, Nanjing, Peoples R China; [El-Samahy, Mohamed AbdFatah] Minist Agr, ARC, Anim Prod Res Inst, Giza, Egypt	Nanjing Agricultural University; Nanjing Agricultural University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Ministry of Agriculture & Land Reclamation - Egypt	Wang, F (corresponding author), Nanjing Agr Univ, Hu Sheep Acad, Nanjing 210095, Peoples R China.	caeet@njau.edu.cn	Wang, Zhibo/GSD-3371-2022		National Natural Science Foundation of China [31872357, 32002174]; Jiangsu Planned Projects for Postdoctoral Research Funds [2021K254B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Planned Projects for Postdoctoral Research Funds	National Natural Science Foundation of China, Grant/Award Number: 31872357 and 32002174; Jiangsu Planned Projects for Postdoctoral Research Funds, Grant/Award Number: 2021K254B	Bai N, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0838-8; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen XW, 2020, OPEN LIFE SCI, V15, P423, DOI 10.1515/biol-2020-0039; Chen YF, 2021, LIFE SCI, V277, DOI 10.1016/j.lfs.2021.119076; Chen Y, 2019, MOL CELL ENDOCRINOL, V490, P15, DOI 10.1016/j.mce.2019.03.009; Chu MX, 2007, J ANIM SCI, V85, P598, DOI 10.2527/jas.2006-324; Chu MX, 2011, MOL BIOL REP, V38, P4071, DOI 10.1007/s11033-010-0526-z; Du X, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0864-x; Ernst EH, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00078; Feng X, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171350; Gao XX, 2020, BBA-GENE REGUL MECH, V1863, DOI 10.1016/j.bbagrm.2020.194606; Ghosh S, 2020, GENES-BASEL, V11, DOI 10.3390/genes11030251; HARESIGN W, 1985, LIVEST PROD SCI, V13, P3, DOI 10.1016/0301-6226(85)90075-2; Huang X, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0392-4; Ilha GF, 2015, REPRODUCTION, V150, P395, DOI 10.1530/REP-15-0026; Kawazoe T, 2020, MOL CANCER RES, V18, P1876, DOI 10.1158/1541-7786.MCR-20-0186; La YF, 2019, PEERJ, V7, DOI 10.7717/peerj.6938; Lan YY, 2020, STEM CELLS, V38, P340, DOI 10.1002/stem.3130; Lass A, 2001, FERTIL STERIL, V76, P1091, DOI 10.1016/S0015-0282(01)02878-3; Li H, 2018, J CELL PHYSIOL, V233, P4643, DOI 10.1002/jcp.26230; Li L, 2021, ARCH MED SCI, V17, P785, DOI 10.5114/aoms.2019.89254; Lin HC, 2009, MOL BIOL REP, V36, P1833, DOI 10.1007/s11033-008-9387-0; Ling YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183163; Liu AJ, 2021, REPROD DOMEST ANIM, V56, P604, DOI 10.1111/rda.13898; Liu GL, 2020, MOL THER-NUCL ACIDS, V20, P205, DOI 10.1016/j.omtn.2020.02.007; Lu CL, 2005, CHINESE SCI BULL, V50, P2665, DOI 10.1360/982005-983; Matsuda F, 2012, J REPROD DEVELOP, V58, P44, DOI 10.1262/jrd.2011-012; Matsushita K, 2014, J CELL BIOCHEM, V115, P1262, DOI 10.1002/jcb.24777; Miao XY, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01049; Miao XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep39398; Miao XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep35299; MOOR RM, 1978, J ENDOCRINOL, V77, P309, DOI 10.1677/joe.0.0770309; Murphy MJ, 2016, ENDOCRINOLOGY, V157, P4378, DOI 10.1210/en.2016-1283; Nilsson EE, 2002, MOL CELL ENDOCRINOL, V188, P65, DOI 10.1016/S0303-7207(01)00746-8; Oskowitz AZ, 2008, P NATL ACAD SCI USA, V105, P18372, DOI 10.1073/pnas.0809807105; Perks CM, 2003, HUM REPROD, V18, P2672, DOI 10.1093/humrep/deg496; Robker RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101182; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shabbir S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85245-y; Shin JE, 2011, MOL CELLS, V31, P181, DOI 10.1007/s10059-011-0020-z; Spotter A, 2005, J ANIM SCI, V83, P2264; Subramani E, 2013, FERTIL STERIL, V100, pS297, DOI 10.1016/j.fertnstert.2013.07.1052; Sun XY, 2003, PROG BIOCHEM BIOPHYS, V30, P180; Taylor DH, 2015, MOL REPROD DEV, V82, P932, DOI 10.1002/mrd.22581; Thompson LH, 2010, CELL CYCLE, V9, P4213, DOI 10.4161/cc.9.20.13543; Wang JC, 2019, BIOMED PHARMACOTHER, V120, DOI 10.1016/j.biopha.2019.109551; Wang TS, 2015, BIOL OPEN, V4, P893, DOI 10.1242/bio.011890; Yang M, 2017, CELL PHYSIOL BIOCHEM, V44, P293, DOI 10.1159/000484885; Yao XL, 2021, MOL THER-NUCL ACIDS, V24, P223, DOI 10.1016/j.omtn.2021.02.030; Yao XL, 2020, REPROD FERT DEVELOP, V32, P335, DOI 10.1071/RD18442; Yao XL, 2018, THERIOGENOLOGY, V114, P70, DOI 10.1016/j.theriogenology.2018.03.014; Yao XL, 2017, THERIOGENOLOGY, V102, P162, DOI 10.1016/j.theriogenology.2017.08.002; Yao XL, 2017, THERIOGENOLOGY, V95, P54, DOI 10.1016/j.theriogenology.2017.02.018; Yu H, 2019, PHARMAZIE, V74, P243, DOI 10.1691/ph.2019.8881; Yuan XL, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060295; Yuan ZH, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9110958; Yue GH, 1996, ANIM REPROD SCI, V44, P223, DOI 10.1016/0378-4320(96)01562-X; Zhang L, 2019, J CELL PHYSIOL, V234, P4754, DOI 10.1002/jcp.27272; Zheng J, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020157; Zhu HL, 2020, GENOMICS, V112, P3597, DOI 10.1016/j.ygeno.2020.04.011; Zhu WY, 2017, ONCOTARGET, V8, P65218, DOI 10.18632/oncotarget.18060	62	0	0	8	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22467	10.1096/fj.202200632R	http://dx.doi.org/10.1096/fj.202200632R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3N5KX	35929417				2022-12-26	WOS:000836187400001
J	Denetclaw, WF; Otto, ZK; Christie, S; Allen, E; Cruz, M; Potter, KA; Mehta, KM				Denetclaw, Wilfred F.; Otto, Zara K.; Christie, Samantha; Allen, Estrella; Cruz, Maria; Potter, Kassandra A.; Mehta, Kala M.			Dine Navajo Resilience to the COVID-19 pandemic	PLOS ONE			English	Article							PREVALENCE	Objective To date, there are no studies of COVID-19 cases and deaths in the Navajo Nation, US. The primary objective of this manuscript is to understand whether counties with a higher proportion of Navajo (Dine) population also had higher cases and deaths of COVID-19 and whether these dropped with vaccination. Method We undertook a cross-sectional analysis of county level data from March 16, 2020-May 11, 2021. Data were obtained from public repositories and the US Census for the Navajo Nation, including northeastern Arizona, southeastern Utah, and northwestern New Mexico. The primary outcome measure is the number of individuals with confirmed cases or deaths of COVID-19. A secondary outcome was COVID-19 vaccinations. Results The 11 counties in Navajo Nation have a wide variation in the percent Navajo population, the resources available (ICU beds and occupancy), and COVID-19 outcomes. Overall, there was a substantial increase in the number of cases from March 16 -July 16, 2020 (the height of the pandemic) with a doubling time of 10.12 days on Navajo Nation. The percent Navajo population was a strong predictor of COVID-19 cases and deaths per million population. COVID-19 vaccinations were inversely associated with COVID-19 cases and deaths in these counties. Conclusions The COVID-19 pandemic on the Navajo Nation is a story of resilience. Navajo Nation was one of the hardest hit areas of the United States, with peak cases and deaths due to COVID-19. With an aggressive vaccination effort, these cases and deaths were strikingly curtailed, showing the resilience of the Navajo (Dine) people.	[Denetclaw, Wilfred F.; Otto, Zara K.; Christie, Samantha; Allen, Estrella; Potter, Kassandra A.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Cruz, Maria] San Francisco State Univ, Dept Publ Hlth, San Francisco, CA 94132 USA; [Mehta, Kala M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	California State University System; San Francisco State University; California State University System; San Francisco State University; University of California System; University of California San Francisco	Mehta, KM (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	kala.mehta@ucsf.edu		Mehta, Kala/0000-0001-8281-5796	National Institute for General Medical Disciplines [U54 GM118986]; SFBUILD I grant-National Institutes of Health [GM118984, 11895, 11896]; Center for Cellular Construction - Science and Technology Center - National Science Foundation [DBI-1548297]	National Institute for General Medical Disciplines; SFBUILD I grant-National Institutes of Health; Center for Cellular Construction - Science and Technology Center - National Science Foundation	Dr. Kala M. Mehta is funded by the National Institute for General Medical Disciplines U54 GM118986 San Francisco Building Infrastructure Leading to Diversity (SFBUILD II) grant. Maria Cruz, Samantha Christie and Estrella Allen were SFBUILD scholars funded by the SFBUILD I grant-National Institutes of Health, GM118984, 11895, and 11896. Dr. W. Denetclaw is supported by the Center for Cellular Construction, which is a Science and Technology Center funded by the National Science Foundation (DBI-1548297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ES, 2019, AM J PUBLIC HEALTH, V109, P270, DOI 10.2105/AJPH.2018.304799; Brown C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-031794; Denetclaw W., 2021, CTR CELLULAR CONSTRU; Github, 2020, NEW YORK TIMES; Henderson PN, 2016, TOB CONTROL, V25, pi26, DOI 10.1136/tobaccocontrol-2016-053109; Hochman ME, 2007, KIDNEY INT, V71, P931, DOI 10.1038/sj.ki.5002100; Ingram JC, 2020, J VAC SCI TECHNOL A, V38, DOI 10.1116/1.5142283; Kahn-John M, 2021, J TRANSCULT NURS, V32, P256, DOI 10.1177/1043659620920679; Kaiser Health News, 2020, ICU BEDS ICU BED OCC; Kakol M, 2021, J RURAL HEALTH, V37, P197, DOI 10.1111/jrh.12451; Kim C, 1998, ARCH INTERN MED, V158, P2245, DOI 10.1001/archinte.158.20.2245; Kovich H, 2020, NEW ENGL J MED, V383, P105, DOI 10.1056/NEJMp2012114; Lin Y, 2020, ENVIRON SCI POLLUT R, V27, P30542, DOI 10.1007/s11356-020-09257-3; Meltzer GY, 2020, J RACIAL ETHN HEALTH, V7, P698, DOI 10.1007/s40615-020-00700-2; Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003; Navajo Division of Health and Navajo Epidemiology Center, 2013, NAV POP PROF; Navajo Epidemiology Center, 2016, NAV NAT SURV REP 199; Navajo Nation Department of Health, US; Navajo Nation Epidemiology Center, 2021, US; REID RA, 1982, HUM ORGAN, V41, P147, DOI 10.17730/humo.41.2.3255x5j875008786; Rodriguez-Lonebear D, 2020, J PUBLIC HEALTH MAN, V26, P371, DOI 10.1097/PHH.0000000000001206; Rosenthal EL, 2020, J AMBUL CARE MANAG, V43, P301, DOI 10.1097/JAC.0000000000000354; Schumacher Catherine, 2008, Metabolic Syndrome and Related Disorders, V6, P267, DOI 10.1089/met.2008.0021; Strommer G. D., 2014, AM INDIAN L REV, V39, P1; Trevisi L, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1097-9; U.S. Census Bureau, 2011, DEM AN NAV NAT US 20; US Commission on Civil Rights, 2018, BROK PROM CONT FED F; van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548	30	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272089	10.1371/journal.pone.0272089	http://dx.doi.org/10.1371/journal.pone.0272089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925907	Green Published, gold			2022-12-26	WOS:000848077100069
J	Sadeghi, K; Poorolajal, J; Doosti-Irani, A				Sadeghi, Kamal; Poorolajal, Jalal; Doosti-Irani, Amin			Prevalence of modifiable risk factors of tuberculosis and their population attributable fraction in Iran: A cross-sectional study	PLOS ONE			English	Article							SMOKING	Background The mycobacterium tuberculosis (Mtb) is necessary for the morbidity of tuberculosis (TB), but it is insufficient. Many risk factors increase the risk of disease among infected people. We aimed to estimate the prevalence of modifiable risk factors of TB and their related population attributable fraction (PAF) in the marginal population of Markazi province in Iran. Design In this cross-sectional study, the prevalence of the modifiable risk factors of TB was estimated. We designed and validated a questionnaire to determine the risk factors. The measures of association for the modifiable risk factors of TB were obtained via the review of published literature. We calculated the PAF for each modifiable risk factor. Results Out of the 1275 calculated sample size, 1146 people participated in this study, and the participation rate was 89.9%. The mean age was 39.26. Out of 1146 participants, 76% did not know anything regarding TB. The highest prevalence was related to the lack of physical activity (58.73%), lack of fish consumption (50.79%), lack of red meat consumption (21.20%), and secondhand smoke (19.02%). The highest PAF was related to secondhand smoke; this value based on the crude relative risk (RR) and crude odds ratio (OR) was 24.54% and 23.44%, respectively. Based on crude hazard ratio (HR) and crude OR, the PAF for smoking was 14.81% and 11.19%, respectively. PAF for lack of BCG vaccination based on the crude OR was 14.79%. Conclusion Based on this study's results, poor nutrition, secondhand smoke, smoking, lack of BCG vaccination, and diabetes are the main prevalent modifiable risk factors for TB. The highest PAF for TB was related to secondhand smoke, smoking, lack of BCG vaccination, and diabetes.	[Sadeghi, Kamal; Poorolajal, Jalal; Doosti-Irani, Amin] Hamadan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Hamadan, Hamadan, Iran; [Poorolajal, Jalal] Hamadan Univ Med Sci, Modeling Noncommunicable Dis Res Ctr, Hamadan, Hamadan, Iran; [Doosti-Irani, Amin] Hamadan Univ Med Sci, Res Ctr Hlth Sci, Hamadan, Hamadan, Iran		Doosti-Irani, A (corresponding author), Hamadan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Hamadan, Hamadan, Iran.; Doosti-Irani, A (corresponding author), Hamadan Univ Med Sci, Res Ctr Hlth Sci, Hamadan, Hamadan, Iran.	a.doosti@umsha.ac.ir	Doosti-Irani, Amin/Q-1260-2016	Doosti-Irani, Amin/0000-0003-0623-7503	Hamadan University of Medical Sciences [9810107547]	Hamadan University of Medical Sciences	The study was funded by the Hamadan University of Medical Sciences (No. 9810107547). Funder has no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Ayelign B, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/6196532; Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157; Bloom BR, 2017, MAJOR INFECT DIS; Brunet L, 2011, EUR RESPIR J, V38, P139, DOI 10.1183/09031936.00137710; Chegeni M, 2020, DRUG ALCOHOL REV, V39, P525, DOI 10.1111/dar.13093; Darrow LA, 2011, EPIDEMIOLOGY, V22, P53, DOI 10.1097/EDE.0b013e3181fce49b; Godoy P, 2013, INT J TUBERC LUNG D, V17, P771, DOI 10.5588/ijtld.12.0696; Gupta KB, 2009, LUNG INDIA, V26, P9, DOI 10.4103/0970-2113.45198; Irani AD, 2015, AM J INFECT CONTROL, V43, pE7, DOI 10.1016/j.ajic.2015.01.020; Kant S, 2015, CRIT REV FOOD SCI, V55, P955, DOI 10.1080/10408398.2012.679500; Khosravi A., 2021, GLOB EPIDEMIOL, V3, DOI [DOI 10.1016/J.GLOEPI.2021.100062, 10.1016/J.GLOEPI.2021.100062]; Khosravi A, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0587-8; de Rezende LFM, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006269, 10.1590/s1518-8787.2016050006269]; Mansournia MA, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k757; Mars-Jones A, 2020, TLS-TIMES LIT SUPPL, P18; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; Nasehi M, 2017, EPIDEMIOL HEALTH, V39, DOI 10.4178/epih.e2017002; National Immunization Committee, 2015, SCHEDULE GUIDELINE I; Organization WH, 2014, GLOB STRAT TARG TUB; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Sayidah D., 2018, Journal of Epidemiology and Public Health, V3, P353, DOI 10.26911/jepublichealth.2018.03.03.06; Shimeles E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214235; SZKLO M., 2014, EPIDEMIOLOGY BASICS, V3; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wells G.A., 2000, NEWCASTLE OTTAWA SCA; World Health Organization, GLOBAL TUBERCULOSIS; World health organization, 2021, TUB PROF IR ISL REP; World health organization, IR ISL REP WHO UNICE; Zhang CY, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0515-y	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271511	10.1371/journal.pone.0271511	http://dx.doi.org/10.1371/journal.pone.0271511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35926063	Green Published, gold			2022-12-26	WOS:000848077100040
J	Meng, XQ; Peng, JX; Xie, XS; Yu, FH; Wang, WC; Pan, QH; Jin, HL; Huang, XL; Yu, HY; Li, SR; Feng, DY; Liu, QX; Fang, LK; Lee, MH				Meng, Xiangqi; Peng, Jingxuan; Xie, Xiaoshan; Yu, Fenghai; Wang, Wencong; Pan, Qihao; Jin, Huilin; Huang, Xiaoling; Yu, Hongyan; Li, Shengrong; Feng, Dianying; Liu, Qingxin; Fang, Lekun; Lee, Mong-Hong			Roles of lncRNA LVBU in regulating urea cycle/polyamine synthesis axis to promote colorectal carcinoma progression	ONCOGENE			English	Article							THERAPEUTIC TARGET; BCL6; HIF-1-ALPHA; IMMUNITY; HYPOXIA	Altered expression of Urea Cycle (UC) enzymes occurs in many tumors, resulting a metabolic hallmark termed as UC dysregulation. Polyamines are synthesized from ornithine, and polyamine synthetic genes are elevated in various tumors. However, the underlying deregulations of UC/ polyamine synthesis in cancer remain elusive. Here, we characterized a hypoxia-induced lncRNA LVBU (lncRNA regulation via BCL6/urea cycle) that is highly expressed in colorectal cancer (CRC) and correlates with poor cancer prognosis. Increased LVBU expression promoted CRC cells proliferation, foci formation and tumorigenesis. Further, LVBU regulates urea cycle and polyamine synthesis through BCL6, a negative regulator of p53. Mechanistically, overexpression of LVBU competitively bound miR-10a/miR-34c to protect BCL6 from miR-10a/34c-mediated degradation, which in turn allows BCL6 to block p53-mediated suppression of genes (arginase1 ARG1, ornithine transcarbamylase OTC, ornithine decarboxylase 1 ODC1) involved in UC/polyamine synthesis. Significantly, ODC1 inhibitor attenuated the growth of patient derived xenografts (PDX) that sustain high LVBU levels. Taken together, elevated LVBU can regulate BCL6-p53 signaling axis for systemic UC/polyamine synthesis reprogramming and confers a predilection toward CRC development. Our data demonstrates that further drug development and clinical evaluation of inhibiting UC/polyamine synthesis are warranted for CRC patients with high expression of LVBU.	[Meng, Xiangqi; Peng, Jingxuan; Xie, Xiaoshan; Yu, Fenghai; Wang, Wencong; Pan, Qihao; Jin, Huilin; Huang, Xiaoling; Feng, Dianying; Liu, Qingxin; Fang, Lekun; Lee, Mong-Hong] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Guangzhou 510655, Peoples R China; [Meng, Xiangqi; Peng, Jingxuan; Xie, Xiaoshan; Yu, Fenghai; Wang, Wencong; Pan, Qihao; Jin, Huilin; Huang, Xiaoling; Feng, Dianying; Liu, Qingxin; Fang, Lekun; Lee, Mong-Hong] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Res Inst Gastroenterol, Guangzhou 510655, Peoples R China; [Yu, Hongyan] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangzhou Inst Pediat, Dept Clin Biol Resource Bank, Guangzhou 510623, Peoples R China; [Li, Shengrong] Chengdu Univ Tradit Chinese Med, Pharm Coll, Chengdu 611137, Peoples R China; [Fang, Lekun] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Colorectal Surg, Guangzhou 510655, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; Chengdu University of Traditional Chinese Medicine; Sun Yat Sen University	Meng, XQ; Fang, LK; Lee, MH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Guangzhou 510655, Peoples R China.; Meng, XQ; Fang, LK; Lee, MH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Res Inst Gastroenterol, Guangzhou 510655, Peoples R China.; Fang, LK (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Colorectal Surg, Guangzhou 510655, Peoples R China.	mengxq3@mail.sysu.edu.cn; fanglk3@mail.sysu.edu.cn; limh33@mail.sysu.edu.cn		Meng, Xiangqi/0000-0002-6407-6122	National Key R&D Program of China [2020YFA0803300]; National Natural Science Foundation of China [81630072, 81702533]; Natural Science Foundation of Guangdong Province [2019A1515010099, 2021A1515012081]; Shenzhen Municipal Government of China [KQTD20170810160226082]; Fundamental Research Funds for the Central Universities [19ykpy07]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Shenzhen Municipal Government of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors would like to thank Xinhai Zhu for performing LC-MS/MS analysis, Xiangli Li, Junyan Feng and Manqi Meng for their technical help and Lishuo Shi for statistical analysis. This work was supported by the National Key R&D Program of China (2020YFA0803300), the National Natural Science Foundation of China (81630072 and 81702533), the Natural Science Foundation of Guangdong Province (2019A1515010099 and 2021A1515012081), Shenzhen Municipal Government of China (KQTD20170810160226082), and the Fundamental Research Funds for the Central Universities (19ykpy07).	Agostini M, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-0247-6; Bachmann AS, 2018, J BIOL CHEM, V293, P18757, DOI 10.1074/jbc.TM118.003336; Bassiri H, 2015, TRANSL PEDIATR, V4, P226, DOI 10.3978/j.issn.2224-4336.2015.04.06; Bhandari V, 2019, NAT GENET, V51, P308, DOI 10.1038/s41588-018-0318-2; Byrne AT, 2017, NAT REV CANCER, V17, P254, DOI 10.1038/nrc.2016.140; Cardenas MG, 2017, CLIN CANCER RES, V23, P885, DOI 10.1158/1078-0432.CCR-16-2071; Cardenas MG, 2016, J CLIN INVEST, V126, P3351, DOI 10.1172/JCI85795; Casero RA, 2018, NAT REV CANCER, V18, P681, DOI 10.1038/s41568-018-0050-3; Choi HH, 2020, ADV SCI, V7, DOI 10.1002/advs.202000681; Colgan SP, 2020, ANNU REV IMMUNOL, V38, P341, DOI 10.1146/annurev-immunol-100819-121537; Deng SJ, 2018, ONCOGENE, V37, P5811, DOI 10.1038/s41388-018-0382-1; Dragomir MP, 2020, GUT, V69, P748, DOI 10.1136/gutjnl-2019-318279; Fan Q, 2016, PROTEIN CELL, V7, P899, DOI 10.1007/s13238-016-0316-z; Gonzalez FJ, 2018, NAT REV ENDOCRINOL, V15, P21, DOI 10.1038/s41574-018-0096-z; He W, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0014-1; Hilton LK, 2019, BLOOD, V134, P1528, DOI 10.1182/blood.2019002600; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Kerres N, 2017, CELL REP, V20, P2860, DOI 10.1016/j.celrep.2017.08.081; Keshet R, 2018, NAT REV CANCER, V18, P634, DOI 10.1038/s41568-018-0054-z; Kocarnik JM, 2015, GASTROENTEROL REP, V3, P269, DOI 10.1093/gastro/gov046; Lee JS, 2018, CELL, V174, P1559, DOI 10.1016/j.cell.2018.07.019; Lee P, 2020, NAT REV MOL CELL BIO, V21, P268, DOI 10.1038/s41580-020-0227-y; Leeman-Neill RJ, 2018, EXPERT OPIN THER TAR, V22, P143, DOI 10.1080/14728222.2018.1420782; Li L, 2019, NATURE, V567, P253, DOI 10.1038/s41586-019-0996-7; Phan L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8530; Lucien F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15884; Matsumoto S, 2019, J HUM GENET, V64, P833, DOI 10.1038/s10038-019-0614-4; Miska J, 2019, CELL REP, V27, P226, DOI 10.1016/j.celrep.2019.03.029; Rabinovich S, 2015, NATURE, V527, P379, DOI 10.1038/nature15529; Seiffert M, 2020, HAEMATOLOGICA, V105, P856, DOI 10.3324/haematol.2019.246330; Siegel RL, 2019, CA-CANCER J CLIN, V69, P7, DOI 10.3322/caac.21551; Slabicki M, 2020, NATURE, V588, P164, DOI 10.1038/s41586-020-2925-1; Sun NH, 2020, CELL MOL BIOL LETT, V25, DOI 10.1186/s11658-020-00210-3; Sveen A, 2020, NAT REV CLIN ONCOL, V17, P11, DOI 10.1038/s41571-019-0241-1; Taylor CT, 2017, NAT REV IMMUNOL, V17, P774, DOI 10.1038/nri.2017.103; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Wang H, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0680-1; Welponer H, 2020, J CANCER, V11, P1446, DOI 10.7150/jca.33831; Willson JA, 2022, BLOOD, V139, P281, DOI 10.1182/blood.2021011010; Xiong SW, 2019, ONCOL REP, V42, P1635, DOI 10.3892/or.2019.7280; Xu L, 2017, P NATL ACAD SCI USA, V114, P3981, DOI 10.1073/pnas.1609758114; Zheng YL, 2019, THERANOSTICS, V9, P796, DOI 10.7150/thno.28992; Zou SM, 2018, GASTROENTEROL REP, V6, P1, DOI 10.1093/gastro/gox031	43	0	0	3	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 2	2022	41	36					4231	4243		10.1038/s41388-022-02413-8	http://dx.doi.org/10.1038/s41388-022-02413-8		JUL 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4G5OH	35906392	hybrid, Green Published			2022-12-26	WOS:000832824600001
J	Schirm, S; Haghikia, A; Brack, M; Ahnert, P; Nouailles, G; Suttorp, N; Loeffler, M; Witzenrath, M; Scholz, M				Schirm, Sibylle; Haghikia, Arash; Brack, Markus; Ahnert, Peter; Nouailles, Geraldine; Suttorp, Norbert; Loeffler, Markus; Witzenrath, Martin; Scholz, Markus			A biomathematical model of atherosclerosis in mice	PLOS ONE			English	Article							MATHEMATICAL-MODEL; MACROPHAGES; PROGRESSION; CHOLESTEROL; INFECTION; MONOCYTES; LDL	Atherosclerosis is one of the leading causes of death worldwide. Biomathematical modelling of the underlying disease and therapy processes might be a useful aid to develop and improve preventive and treatment concepts of atherosclerosis. We here propose a biomathematical model of murine atherosclerosis under different diet and treatment conditions including lipid modulating compound and antibiotics. The model is derived by translating known biological mechanisms into ordinary differential equations and by assuming appropriate response kinetics to the applied interventions. We explicitly describe the dynamics of relevant immune cells and lipid species in atherosclerotic lesions including the degree of blood vessel occlusion due to growing plaques. Unknown model parameters were determined by fitting the predictions of model simulations to time series data derived from mice experiments. Parameter fittings resulted in a good agreement of model and data for all 13 experimental scenarios considered. The model can be used to predict the outcome of alternative treatment schedules of combined antibiotic, immune modulating, and lipid lowering agents under high fat or normal diet. We conclude that we established a comprehensive biomathematical model of atherosclerosis in mice. We aim to validate the model on the basis of further experimental data.	[Schirm, Sibylle; Ahnert, Peter; Loeffler, Markus; Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Haghikia, Arash] Charite Univ Med Berlin, Dept Cardiol, Campus Benjamin Franklin, Berlin, Germany; [Haghikia, Arash] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany; [Brack, Markus; Nouailles, Geraldine; Suttorp, Norbert; Witzenrath, Martin] Charite Univ Medizin Berlin, Berlin, Germany; [Brack, Markus; Nouailles, Geraldine; Suttorp, Norbert; Witzenrath, Martin] Free Univ Berlin, Berlin, Germany; [Brack, Markus; Nouailles, Geraldine; Witzenrath, Martin] Humboldt Univ, Div Pulm Inflammat, Berlin, Germany; [Brack, Markus; Suttorp, Norbert; Witzenrath, Martin] Humboldt Univ, Dept Infect Dis & Resp Med, Berlin, Germany; [Scholz, Markus] Univ Leipzig, LIFE Res Ctr Civilizat Dis, Leipzig, Germany; [Haghikia, Arash] Berlin Inst Hlth BIH, Berlin, Germany	Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Free University of Berlin; Humboldt University of Berlin; Humboldt University of Berlin; Leipzig University; Berlin Institute of Health	Schirm, S (corresponding author), Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany.	sibylle.schirm@uni-leipzig.de	Haghikia, Arash/F-1348-2016; Ahnert, Peter/I-8150-2015	Ahnert, Peter/0000-0002-1771-0856; , Sibylle/0000-0002-5497-2791	German Federal Ministry of Education and Research (BMBF) [01ZX1906B, 01ZX1906A]; Berlin Institute of Health; Leipzig University for Open Access Publishing	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Berlin Institute of Health; Leipzig University for Open Access Publishing	This work was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (SYMPATH, grant numbers 01ZX1906B, 01ZX1906A). AH is participant in the BIH-Charite Advanced Clinician Scientist Pilotprogram funded by the Charite - Universitaetsmedizin Berlin and the Berlin Institute of Health. We acknowledge support from Leipzig University for Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Belli HM, 2010, MATH MODEL EFFECTS A; Bulelzai MAK, 2012, J THEOR BIOL, V297, P1, DOI 10.1016/j.jtbi.2011.11.023; Cilla M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0866; Duttaroy AK, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010144; Fok PW, 2017, MATH MED BIOL, V34, P77, DOI 10.1093/imammb/dqv040; Fok PW, 2012, J THEOR BIOL, V314, P23, DOI 10.1016/j.jtbi.2012.07.029; Fong IW, 2002, ANTIMICROB AGENTS CH, V46, P2321, DOI 10.1128/AAC.46.8.2321-2326.2002; Formanowicz D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239953; Francis AA, 2011, EXP CLIN CARDIOL, V16, P77; Friedman A, 2015, B MATH BIOL, V77, P758, DOI 10.1007/s11538-014-0010-3; GERRITY RG, 1981, AM J PATHOL, V103, P191; Gross A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-219; Haghikia A, 2022, EUR HEART J, V43, P518, DOI 10.1093/eurheartj/ehab644; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hao WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090497; Hernandez-Vargas EA, 2014, J VIROL, V88, P4123, DOI 10.1128/JVI.03644-13; Islam H., 2015, ANZIAM J, V57, P320, DOI [10.21914/anziamj.v57i0.10386, DOI 10.21914/ANZIAMJ.V57I0.10386]; Itabe H, 2011, J LIPIDS, V2011, DOI 10.1155/2011/418313; Kato R, 2009, ARTERIOSCL THROM VAS, V29, P33, DOI 10.1161/ATVBAHA.108.164723; Li Y, 2016, EUR REV MED PHARMACO, V20, P3863; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Masana L, 2020, CURR CARDIOL REP, V22, DOI 10.1007/s11886-020-01326-w; Mirzaei NM, 2021, MATH MED BIOL, V38, P59, DOI 10.1093/imammb/dqaa011; Mirzaei NM, 2020, AM J PHYSIOL-HEART C, V319, pH835, DOI 10.1152/ajpheart.00174.2020; Murgia A, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-2020-cass-13; Rahman K, 2017, J CLIN INVEST, V127, P2904, DOI 10.1172/JCI75005; Rechenberg I., 1994, EVOLUTIONSSTRATEGIE; Schirm S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243147; Schwefel H. P., 1984, Annals of Operations Research, V1, P165, DOI 10.1007/BF01876146; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; World Health Organization, 2021, TOP 10 CAUS DEATH; Xue HQ, 2010, ANN STAT, V38, P2351, DOI 10.1214/09-AOS784	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272079	http://dx.doi.org/10.1371/journal.pone.0272079			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921269	gold, Green Published			2022-12-26	WOS:000839311900050
J	Park, SY; Kang, MJ; Jin, NR; Lee, SY; Lee, YY; Jo, S; Eom, JY; Han, H; Chung, SI; Jang, K; Kim, TH; Park, J; Han, JS				Park, Shin-Young; Kang, Min-Jeong; Jin, Nuri; Lee, So Young; Lee, Yun Young; Jo, Sungsin; Eom, Jeong Yun; Han, Heejae; Chung, Sook In; Jang, Kiseok; Kim, Tae-Hwan; Park, Jungwon; Han, Joong-Soo			House dust mite-induced Akt-ERK1/2-C/EBP beta pathway triggers CCL20-mediated inflammation and epithelial-mesenchymal transition for airway remodeling	FASEB JOURNAL			English	Article						airway remodeling; asthma; CCL20 (C-C chemokine ligand 20); house dust mites; NLRP3 (Nod-like receptor family pyrin domain containing 3	INNATE IMMUNE ACTIVATION; GROWTH-FACTOR-BETA; NLRP3 INFLAMMASOME; PULMONARY INFLAMMATION; NALP3 INFLAMMASOME; ASTHMA; CELLS; CCL20; FIBROSIS; RECRUITMENT	House dust mite (HDM) allergens cause inflammatory responses and chronic allergic diseases such as bronchial asthma and atopic dermatitis. Here, we investigate the mechanism by which HDM induces C-C chemokine ligand 20 (CCL20) expression to promote chronic inflammation and airway remodeling in an HDM-induced bronchial asthma mouse model. We showed that HDM increased CCL20 levels via the Akt-ERK1/2-C/EBP beta pathway. To investigate the role of CCL20 in chronic airway inflammation and remodeling, we made a mouse model of CCL20-induced bronchial asthma. Treatment of anti-CCL20Ab in this mouse model showed the reduced airway hyper-responsiveness and inflammatory cell infiltration into peribronchial region by neutralizing CCL20. In addition, CCL20 induced the Nod-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome activation through NLRP3 deubiquitination and transcriptional upregulation in BEAS-2B cells. As expected, anti-CCL20Ab markedly suppressed NLRP3 activation induced by CCL20. Moreover, HDM-induced CCL20 leads to epithelial-mesenchymal transition in the lung epithelium which appears to be an important regulator of airway remodeling in allergic asthma. We also found that anti-CCL20Ab attenuates airway inflammation and remodeling in an HDM-induced mouse model of bronchial asthma. Taken together, our results suggest that HDM-induced CCL20 is required for chronic inflammation that contributes airway remodeling in a mouse model of asthma.	[Park, Shin-Young; Kang, Min-Jeong; Jin, Nuri; Han, Joong-Soo] Hanyang Univ, Coll Med, Biomed Res Inst, 222 Wangsimni Ro, Seoul 04763, South Korea; [Park, Shin-Young; Kang, Min-Jeong; Jin, Nuri; Han, Joong-Soo] Hanyang Univ, Coll Med, Dept Biochem, 222 Wangsimni Ro, Seoul 04763, South Korea; [Lee, So Young] EONE DIAGN Genome Ctr Co Ltd, Incheon, South Korea; [Lee, Yun Young] Gencurix Inc, Seoul, South Korea; [Jo, Sungsin; Kim, Tae-Hwan] Hanyang Univ, Inst Rheumatol Res, Seoul, South Korea; [Eom, Jeong Yun; Jang, Kiseok] Hanyang Univ Hosp, Dept Pathol, Seoul, South Korea; [Han, Heejae; Chung, Sook In; Park, Jungwon] Yonsei Univ, Inst Allergy, Coll Med, Seoul, South Korea	Hanyang University; Hanyang University; Hanyang University; Hanyang University; Hanyang University Hospital; Yonsei University; Yonsei University Health System	Park, SY; Han, JS (corresponding author), Hanyang Univ, Coll Med, Biomed Res Inst, 222 Wangsimni Ro, Seoul 04763, South Korea.; Park, SY; Han, JS (corresponding author), Hanyang Univ, Coll Med, Dept Biochem, 222 Wangsimni Ro, Seoul 04763, South Korea.	ttokttoki@hanyang.ac.kr; jshan@hanyang.ac.kr	park, shiny/ABY-8695-2022; Jo, Sungsin/AAL-3659-2021	park, shiny/0000-0002-6073-4634; Jo, Sungsin/0000-0003-3034-5029	National Research Foundation of Korea (NRF) [2021R1A2C1008317, 2018R1A1A1A05022185]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2021R1A2C1008317 and 2018R1A1A1A05022185	Al-Alawi M, 2014, RESP MED, V108, P1409, DOI 10.1016/j.rmed.2014.08.008; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Artlett CM, 2015, ANTIOXID REDOX SIGN, V22, P1162, DOI 10.1089/ars.2014.6148; Artlett Carol M, 2012, Open Rheumatol J, V6, P80, DOI 10.2174/1874312901206010080; Besnard AG, 2011, ALLERGY, V66, P1047, DOI 10.1111/j.1398-9995.2011.02586.x; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Faiz A, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00310-2018; Fehrenbach H, 2017, CELL TISSUE RES, V367, P551, DOI 10.1007/s00441-016-2566-8; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Garcia G, 2005, CURR ALLERGY ASTHM R, V5, P155, DOI 10.1007/s11882-005-0090-0; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Goto Y, 2000, AM J RESP CELL MOL, V23, P712, DOI 10.1165/ajrcmb.23.6.4031; Groslambert M, 2018, J INFLAMM RES, V11, P359, DOI 10.2147/JIR.S141220; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Heijink IH, 2010, AM J RESP CELL MOL, V42, P69, DOI 10.1165/rcmb.2008-0449OC; Hill Charlotte, 2019, J Lung Health Dis, V3, P31; Hirata T, 2010, ENDOCRINOLOGY, V151, P5468, DOI 10.1210/en.2010-0398; Hirota JA, 2012, J ALLERGY CLIN IMMUN, V129, P1116, DOI 10.1016/j.jaci.2011.11.033; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Hong GH, 2016, J IMMUNOL, V196, P2021, DOI 10.4049/jimmunol.1500747; Hosokawa Y, 2016, CELL PHYSIOL BIOCHEM, V38, P153, DOI 10.1159/000438617; Hu JB, 2001, J BIOL CHEM, V276, P287, DOI 10.1074/jbc.M004885200; Huang FL, 2018, IMMUNOBIOLOGY, V223, P300, DOI 10.1016/j.imbio.2017.10.035; Huang QQ, 2020, AGING-US, V12, P5812, DOI 10.18632/aging.102978; Jacquet Alain, 2013, ISRN Allergy, V2013, P735031, DOI 10.1155/2013/735031; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kallal LE, 2010, EUR J IMMUNOL, V40, P1042, DOI 10.1002/eji.200939778; Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328; Lee AYS, 2014, IMMUNOL CELL BIOL, V92, P354, DOI 10.1038/icb.2013.97; Lee HM, 2009, J CLIN IMMUNOL, V29, P795, DOI 10.1007/s10875-009-9319-3; Liu D, 2019, CLIN SCI, V133, P565, DOI 10.1042/CS20180600; Liu Y, 2016, ONCOTARGET, V7, P25328, DOI 10.18632/oncotarget.8291; Lu AL, 2017, J IMMUNOL, V198, P1119, DOI 10.4049/jimmunol.1600659; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Marsigliante S, 2016, MOL CARCINOGEN, V55, P1175, DOI 10.1002/mc.22360; Nathan AT, 2009, J ALLERGY CLIN IMMUN, V123, P612, DOI 10.1016/j.jaci.2008.12.006; Persson IM, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0725-z; Pichavant M, 2005, J ALLERGY CLIN IMMUN, V115, P771, DOI 10.1016/j.jaci.2004.11.043; Porsbjerg C, 2016, CLIN EXP ALLERGY, V46, P564, DOI 10.1111/cea.12702; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; Ryu JH, 2013, J ALLERGY CLIN IMMUN, V131, P549, DOI 10.1016/j.jaci.2012.07.050; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Shimizu H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46116-9; Song C, 2016, J CELL MOL MED, V20, P2064, DOI 10.1111/jcmm.12898; Sperling T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002833; Wang Huaying, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P758, DOI 10.3785/j.issn.1008-9292.2020.12.11; Weckmann M, 2007, NAT MED, V13, P1308, DOI 10.1038/nm1660; Xiao Fenglin WS., 2021, MOL CELL TOXICOL, V17, P315; Zahid A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02538	52	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22452	10.1096/fj.202200150RR	http://dx.doi.org/10.1096/fj.202200150RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3L4XD	35916017				2022-12-26	WOS:000834764400001
J	Wang, XH; Brea, L; Lu, XD; Gritsina, G; Park, SH; Xie, WQ; Zhao, JC; Yu, JD				Wang, Xiaohai; Brea, Lourdes; Lu, Xiaodong; Gritsina, Galina; Park, Su H.; Xie, Wanqing; Zhao, Jonathan C.; Yu, Jindan			FOXA1 inhibits hypoxia programs through transcriptional repression of HIF1A	ONCOGENE			English	Article							RESISTANT PROSTATE-CANCER; BIOCHEMICAL FAILURE; TUMOR HYPOXIA; RADIOTHERAPY; PROGRESSION; CCL2	Intratumoral hypoxia is associated with castration-resistant prostate cancer (CRPC), a lethal disease. FOXA1 is an epithelial transcription factor that is down-regulated in CRPC. We have previously reported that FOXA1 loss induces epithelial-mesenchymal transition (EMT) and cell motility through elevated TGF beta signaling. However, whether FOXA1 directly regulates hypoxia pathways of CRPC tumors has not been previously studied. Here we report that FOXA1 down-regulation induces hypoxia transcriptional programs, and FOXA1 level is negatively correlated with hypoxia markers in clinical prostate cancer (PCa) samples. Mechanistically, FOXA1 directly binds to an intragenic enhancer of HIF1A to inhibit its expression, and HIF1A, in turn, is critical in mediating FOXA1 loss-induced hypoxia gene expression. Further, we identify CCL2, a chemokine ligand that modulates tumor microenvironment and promotes cancer progression, as a crucial target of the FOXA1-HIF1A axis. We found that FOXA1 loss leads to immunosuppressive macrophage infiltration and increased cell invasion, dependent on HIF1A expression. Critically, therapeutic targeting of HIF1A-CCL2 using pharmacological inhibitors abolishes FOXA1 loss-induced macrophage infiltration and PCa cell invasion. In summary, our study reveals an essential role of FOXA1 in controlling the hypoxic tumor microenvironment and establishes the HIF1A-CCL2 axis as one mechanism of FOXA1 loss-induced CRPC progression.	[Wang, Xiaohai; Brea, Lourdes; Lu, Xiaodong; Gritsina, Galina; Park, Su H.; Xie, Wanqing; Zhao, Jonathan C.; Yu, Jindan] Northwestern Univ, Dept Med, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Wang, Xiaohai] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Shanghai, Peoples R China; [Yu, Jindan] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Yu, Jindan] Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Shanghai Jiao Tong University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine	Yu, JD (corresponding author), Northwestern Univ, Dept Med, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA.; Yu, JD (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.; Yu, JD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611 USA.	jindan-yu@northwestern.edu		Brea, Lourdes/0000-0001-9727-7185; Lu, xiaodong/0000-0003-4731-0762; Gritsina, Galina/0000-0002-3404-7961	NIH [P50CA180995, R50CA211271]; Prostate Cancer Foundation [2017CHAL2008]; NIH/NCI [T32 CA009560]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the NIH prostate SPORE P50CA180995 (to JY), NIH R50CA211271 (to JCZ), and Prostate Cancer Foundation 2017CHAL2008 (to JY, JCZ). LB, SHP, and GG were supported in part by NIH/NCI training grant T32 CA009560.	Brahimi-Horn MC, 2005, INT REV CYTOL, V242, P157; Fraga A, 2015, CLIN GENITOURIN CANC, V13, P295, DOI 10.1016/j.clgc.2015.03.006; Fumagalli D, 2016, ANN ONCOL, V27, P1860, DOI 10.1093/annonc/mdw286; Geng H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07411-7; Guo HY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08133-6; Gupta K, 2017, TRANSL CANCER RES, V6, pS104, DOI 10.21037/tcr.2017.01.20; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He YD, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI147025; Henze AT, 2016, J CLIN INVEST, V126, P3672, DOI 10.1172/JCI84427; Jin HJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4972; Jin HJ, 2013, CANCER RES, V73, P3725, DOI 10.1158/0008-5472.CAN-12-3468; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Kim J, 2017, ONCOGENE, V36, P4072, DOI 10.1038/onc.2017.50; Korbecki J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165647; Kupelian PA, 2006, UROLOGY, V68, P593, DOI 10.1016/j.urology.2006.03.075; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lee GT, 2018, BRIT J CANCER, V118, P670, DOI 10.1038/bjc.2017.451; Li N, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060799; Lim SY, 2016, ONCOTARGET, V7, P28697, DOI 10.18632/oncotarget.7376; Lin YX, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0760-3; Litwin MS, 2017, JAMA-J AM MED ASSOC, V317, P2532, DOI 10.1001/jama.2017.7248; Liu YW, 2014, NAT MED, V20, P272, DOI 10.1038/nm.3485; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; Liu YQ, 2001, PROSTATE CANCER P D, V4, P81, DOI 10.1038/sj.pcan.4500506; Lo CH, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00247; Loberg RD, 2007, NEOPLASIA, V9, P556, DOI 10.1593/neo.07307; Milosevic M, 2012, CLIN CANCER RES, V18, P2108, DOI 10.1158/1078-0432.CCR-11-2711; Mimeault M, 2013, J CELL MOL MED, V17, P30, DOI 10.1111/jcmm.12004; Narita T, 2009, NEURO-ONCOLOGY, V11, P946; Nguyen HM, 2017, PROSTATE, V77, P654, DOI 10.1002/pros.23313; Noman MZ, 2015, AM J PHYSIOL-CELL PH, V309, pC569, DOI 10.1152/ajpcell.00207.2015; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Ranasinghe WKB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054251; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Siegel RL, 2019, CA-CANCER J CLIN, V69, P7, DOI 10.3322/caac.21551; Song B, 2019, J CLIN INVEST, V129, P569, DOI 10.1172/JCI122367; Su WJ, 2019, CANCER CELL, V36, P139, DOI 10.1016/j.ccell.2019.06.009; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tran MGB, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-06890-6; Tsai YC, 2018, BBA-MOL BASIS DIS, V1864, P1717, DOI 10.1016/j.bbadis.2018.02.016; Tucci M, 2018, ONCOTARGETS THER, V11, P7353, DOI 10.2147/OTT.S153764; Vaupel P, 2001, SEMIN ONCOL, V28, P29, DOI 10.1016/S0093-7754(01)90210-6; Vergis R, 2008, LANCET ONCOL, V9, P342, DOI 10.1016/S1470-2045(08)70076-7; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang KL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15396-5; Wigerup C, 2016, PHARMACOL THERAPEUT, V164, P152, DOI 10.1016/j.pharmthera.2016.04.009; Zhong H, 2004, CANCER DETECT PREV, V28, P88, DOI 10.1016/j.cdp.2003.12.009	50	1	1	4	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 9	2022	41	37					4259	4270		10.1038/s41388-022-02423-6	http://dx.doi.org/10.1038/s41388-022-02423-6		AUG 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4L2AN	35931888				2022-12-26	WOS:000836492100001
J	Akter, Y; Barua, R; Uddin, MN; Sanaullah, AM; Marzan, LW				Akter, Yasmin; Barua, Rocktim; Uddin, Md Nasir; Sanaullah, Abul Fazal Muhammad; Marzan, Lolo Wal			Bioactive potentiality of secondary metabolites from endophytic bacteria against SARS-COV-2: An in-silico approach	PLOS ONE			English	Article							MEDICINAL-PLANTS; ANTIMICROBIAL ACTIVITY; GENE CLUSTERS; IDENTIFICATION; DIVERSITY; ANTIFUNGAL; STAPHYLOFERRIN; EVOLUTION	Five endophytic bacterial isolates were studied to identify morphologically and biochemically, according to established protocols and further confirmed by 16S rDNA Sanger sequencing, as Priestia megaterium, Staphylococcus caprae, Neobacillus drentensis, Micrococcus yunnanensis, and Sphingomonas paucimobiliz, which were then tested for phytohormone, ammonia, and hydrolytic enzyme production. Antioxidant compounds total phenolic content (TPC), and total flavonoid content (TFC) were assessed by using bacterial crude extracts obtained from 24-hour shake-flask culture. Phylogenetic tree analysis of those identified isolates shared sequence similarities with the members of Bacillus, Micrococcus, Staphylococcus, and Pseudomonas species, and after GenBank submission, accession numbers for the nucleotide sequences were found to be MW494406, MW494408, MW494401, MW494402, and MZ021340, respectively. In silico analysis was performed to identify their bioactive genes and compounds in the context of bioactive secondary metabolite production with medicinal value, where nine significant bioactive compounds according to six different types of bioactive secondary metabolites were identified, and their structures, gene associations, and protein-protein networks were analyzed by different computational tools and servers, which were reported earlier with their antimicrobial, anti-infective, antioxidant, and anti-cancer capabilities. These compounds were then docked to the 3-chymotrypsin-like protease (3CL(pro)) of the novel SARS-COV-2. Docking scores were then compared with 3CL(pro) reference inhibitor (lopinavir), and docked compounds were further subjected to ADMET and drug-likeness analyses. Ligand-protein interactions showed that two compounds (microansamycin and aureusimine) interacted favorably with coronavirus 3CL(pro). Besides, in silico analysis, we also performed NMR for metabolite detection whereas three metabolites (microansamycin, aureusimine, and stenothricin) were confirmed from the 1H NMR profiles. As a consequence, the metabolites found from NMR data aligned with our in-silico analysis that carries a significant outcome of this research. Finally, Endophytic bacteria collected from medicinal plants can provide new leading bioactive compounds against target proteins of SARS-COV-2, which could be an effective approach to accelerate drug innovation and development.	[Akter, Yasmin; Barua, Rocktim; Uddin, Md Nasir; Marzan, Lolo Wal] Univ Chittagong, Fac Biol Sci, Dept Genet Engn & Biotechnol, Chittagong, Bangladesh; [Sanaullah, Abul Fazal Muhammad] Univ Chittagong, Fac Sci, Dept Chem, Chittagong, Bangladesh	University of Chittagong; University of Chittagong	Marzan, LW (corresponding author), Univ Chittagong, Fac Biol Sci, Dept Genet Engn & Biotechnol, Chittagong, Bangladesh.	marzan.geb@cu.ac.bd		Barua, Rocktim/0000-0003-4085-4257; Uddin, Md. Nasir/0000-0002-2172-8872	Research & Publication Cell of the University of Chittagong, Bangladesh; Ministry of Science and Technology, Government of the peoples' republic of Bangladesh	Research & Publication Cell of the University of Chittagong, Bangladesh; Ministry of Science and Technology, Government of the peoples' republic of Bangladesh	This study was partially supported by the Research & Publication Cell of the University of Chittagong, Bangladesh, and the Ministry of Science and Technology, Government of the peoples' republic of Bangladesh (Special Allocation). This research was done in the `Molecular Biology Laboratory' of the Department of Genetic Engineering and Biotechnology, University of Chittagong. The authors are pleased to mention the valuable suggestions during this research from Professor Kazuyuki Shimizu, Department of Bioscience & Bioinformatics, Kyushu Institute of Technology, Iizuka, Fukuoka 820-8502, Japan, and Institute of Advanced Bioscience, Keio University, Tsuruoka, Yamagata 997-0017, Japan. The research team is pleased to acknowledge the Bangladesh Council of Scientific and Industrial Research (BCSIR), DHAKA, Bangladesh for NMR detection.	Aanouz I, 2021, J BIOMOL STRUCT DYN, V39, P2971, DOI 10.1080/07391102.2020.1758790; Addisu Desalegn, 2016, International Journal of Integrative Sciences, Innovation and Technology (IJIIT), V5, P5; Afzal I, 2019, MICROBIOL RES, V221, P36, DOI 10.1016/j.micres.2019.02.001; Ahmad SJ, 2021, PEERJ, V9, DOI 10.7717/peerj.10816; Akhter Mursheda, 2020, Microbiol Insights, V13, p1178636120913280, DOI 10.1177/1178636120913280; Ali S, 2014, J THEOR BIOL, V343, P193, DOI 10.1016/j.jtbi.2013.10.007; Alvin A, 2014, MICROBIOL RES, V169, P483, DOI 10.1016/j.micres.2013.12.009; Anand S, 2010, NUCLEIC ACIDS RES, V38, pW487, DOI 10.1093/nar/gkq340; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Asker D, 2018, METHODS MOL BIOL, V1852, P193, DOI 10.1007/978-1-4939-8742-9_11; Aswani R, 2020, MICROBIAL ENDOPHYTES: FUNCTIONAL BIOLOGY AND APPLICATIONS, P35, DOI [10.1016/B978-0-12-819654-0.00002-8, 10.1016/B978-0-12-818734-0.00002-4]; Ayuso-Sacido A, 2005, MICROB ECOL, V49, P10, DOI 10.1007/s00248-004-0249-6; Badshah SL, 2021, BIOMED PHARMACOTHER, V140, DOI 10.1016/j.biopha.2021.111596; Bardhan S., 2018, J IMMUNOL MICROBIOL, V2, P1; Barredo J-L., 2012, METHODS PROTOC, V5; Barrow G.I., 1993, COWAN STEELS MANUAL, V3rd; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Beasley FC, 2009, MOL MICROBIOL, V72, P947, DOI 10.1111/j.1365-2958.2009.06698.x; Beiranvand M, 2017, IRAN J MICROBIOL, V9, P11; Bergey DH., 1994, BERGEYS MANUAL DETER, pp. 395; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blin K, 2019, NUCLEIC ACIDS RES, V47, pW81, DOI 10.1093/nar/gkz310; Boopathi S, 2021, J BIOMOL STRUCT DYN, V39, P3409, DOI 10.1080/07391102.2020.1758788; Brader G, 2014, CURR OPIN BIOTECH, V27, P30, DOI 10.1016/j.copbio.2013.09.012; Cairns T, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3969-y; Castillo U, 2003, FEMS MICROBIOL LETT, V224, P183, DOI 10.1016/S0378-1097(03)00426-9; Castronovo LM, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10020106; Chang CC, 2002, J FOOD DRUG ANAL, V10, P178; Chen CC, 2021, FEBS J, V288, P5089, DOI 10.1111/febs.15696; Cheng FX, 2012, J CHEM INF MODEL, V52, P3099, DOI 10.1021/ci300367a; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Claus D., 1986, BERGEYS MANUAL SYSTE, P1105, DOI DOI 10.1016/0922-338X(92)90270-5; Clinical and Laboratory Standards Institute, 2011, PROC ER SED RAT TEST, V5, pH02; Contreras-Perez M, 2019, 3 BIOTECH, V9, DOI 10.1007/s13205-019-1911-5; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; Cruz FDN, 2021, INT J MICROBIOL, V2021, DOI 10.1155/2021/6618559; Deljou A, 2016, IRAN J BIOTECHNOL, V14, P25, DOI 10.15171/ijb.1259; Demain AL, 2009, J ANTIBIOT, V62, P5, DOI 10.1038/ja.2008.16; Demmig-Adams B, 2020, MOLECULES, V25, DOI 10.3390/molecules25163607; Dona AC, 2016, COMPUT STRUCT BIOTEC, V14, P135, DOI 10.1016/j.csbj.2016.02.005; Doroghazi JR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-611; Ek-Ramos MJ, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00463; Erjaee Z, 2019, J FOOD SCI TECH MYS, V56, P5262, DOI 10.1007/s13197-019-03995-0; Ferreira A, 2008, FEMS MICROBIOL LETT, V287, P8, DOI 10.1111/j.1574-6968.2008.01258.x; Fouad AF, 2002, J CLIN MICROBIOL, V40, P3223, DOI 10.1128/JCM.40.9.3223-3231.2002; Golinska P, 2015, ANTON LEEUW INT J G, V108, P267, DOI 10.1007/s10482-015-0502-7; Goris T, 2021, MICROB BIOTECHNOL, V14, P94, DOI 10.1111/1751-7915.13675; Gouda S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01538; Gram C., 1884, FORTSCHITTE MED, V2, P185; Hadden WL, 1999, J AGR FOOD CHEM, V47, P4189, DOI 10.1021/jf990096k; Halouska Steven, 2013, J Integr OMICS, V3, P120; Hanif A, 2019, TOXINS, V11, DOI 10.3390/toxins11050295; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; HASENBOHLER A, 1974, ARCH MICROBIOL, V99, P307, DOI 10.1007/BF00696245; Horng YB, 2019, AMB EXPRESS, V9, DOI 10.1186/s13568-019-0914-2; Jeso V, 2013, ANGEW CHEM INT EDIT, V52, P4800, DOI 10.1002/anie.201301323; Jo S, 2020, J ENZYM INHIB MED CH, V35, P145, DOI 10.1080/14756366.2019.1690480; Johnson E A, 1996, Adv Biochem Eng Biotechnol, V53, P119; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Kandel SL, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5040077; Kaspar F, 2019, J NAT PROD, V82, P2038, DOI 10.1021/acs.jnatprod.9b00110; Kaul S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00955; Kautsar SA, 2020, NUCLEIC ACIDS RES, V48, pD454, DOI 10.1093/nar/gkz882; Khamna S, 2009, WORLD J MICROB BIOT, V25, P649, DOI 10.1007/s11274-008-9933-x; Khan SA, 2021, J BIOMOL STRUCT DYN, V39, P2607, DOI 10.1080/07391102.2020.1751298; Kim S, 2021, NUCLEIC ACIDS RES, V49, pD1388, DOI 10.1093/nar/gkaa971; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Lazaro-Silva DN., 2015, CREAT ED, V6, P762; Lee N, 2020, COMPUT STRUCT BIOTEC, V18, P1548, DOI 10.1016/j.csbj.2020.06.024; Li J, 2014, NEW BIOTECHNOL, V31, P579, DOI 10.1016/j.nbt.2014.03.006; Liotti RG, 2018, MICROBIOL RES, V207, P8, DOI 10.1016/j.micres.2017.10.011; Liu TH, 2020, 3 BIOTECH, V10, DOI 10.1007/s13205-020-2084-y; Liu X., 2020, RCSB PROTEIN DATA BA, P10; Liu Y, 2019, NAT PROD RES, V33, P2466, DOI 10.1080/14786419.2018.1452012; Liu YH, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0522-7; Maggini V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17110-w; Maheshwari R, 2020, IRAN J BIOTECHNOL, V18, P11, DOI 10.30498/IJB.2020.137279.2308; Majdi H., 2022, NAT RESOUR HUM HLTH, V2, P62, DOI [10.53365/nrfhh/143085, DOI 10.53365/NRFHH/143085]; Martinez-Klimova E, 2017, BIOCHEM PHARMACOL, V134, P1, DOI 10.1016/j.bcp.2016.10.010; Marzan L. W., 2018, Bangladesh Journal of Agricultural Research, V43, P175, DOI 10.3329/bjar.v43i2.37312; Milner SJ, 2013, ORG BIOMOL CHEM, V11, P3461, DOI 10.1039/c3ob40162f; Mina SA, 2018, APPL WATER SCI, V8, DOI 10.1007/s13201-018-0673-2; Minaxi, 2012, APPL SOIL ECOL, V59, P124, DOI 10.1016/j.apsoil.2011.08.001; Monowar T, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/6951927; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Othoum G, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4796-5; Palama TL, 2016, ANALYST, V141, P4558, DOI [10.1039/C6AN00393A, 10.1039/c6an00393a]; Palanichamy P., 2018, EGYPT J BASIC APPL S, V5, P303, DOI [DOI 10.1016/J.EJBAS.2018.07.002, 10.1016/j.ejbas.2018.07.002]; Paniagua-Michel J, 2012, Methods Mol Biol, V892, P1, DOI 10.1007/978-1-61779-879-5_1; Parthasarathy Anutthaman, 2018, J Genomics, V6, P117, DOI 10.7150/jgen.28335; Passari AK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12235-4; Pinski A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081947; Prakash O, 2014, INT J SYST EVOL MICR, V64, P3427, DOI 10.1099/ijs.0.063339-0; Raihan T, 2021, FUTURE MICROBIOL, V16, P557, DOI 10.2217/fmb-2020-0259; Ranjan R, 2017, J PHARM ANAL, V7, P343, DOI 10.1016/j.jpha.2017.05.001; Rat A, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.633488; Ribeiro CM, 2012, MICROBIOL RES, V167, P69, DOI 10.1016/j.micres.2011.03.003; Roy Sudipta, 2016, Microbiol Insights, V9, P1, DOI [10.4137/mbi.s33394, 10.4137/MBI.S33394]; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Santoyo G, 2016, MICROBIOL RES, V183, P92, DOI 10.1016/j.micres.2015.11.008; Schulz B.J.E., 2006, MUTUALISTIC INTERACT, P261; Secor PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040973; Selim KA, 2018, FERMENTATION-BASEL, V4, DOI 10.3390/fermentation4030049; Shan WN, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1470305; Singh M, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0942-z; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2021, MOL BIOL EVOL, V38, P3022, DOI 10.1093/molbev/msab120; Tan XM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24313-2; Uche-Okereafor N, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16040602; Umeno D, 2002, J BACTERIOL, V184, P6690, DOI 10.1128/JB.184.23.6690-6699.2002; Vandana UK, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10020101; VANITTANAKOM N, 1986, J ANTIBIOT, V39, P888, DOI 10.7164/antibiotics.39.888; Verma VC., 2014, ADV ENDOPHYTIC RES, P203; Santos VSV, 2020, J TOXICOL ENV HEAL B, V23, P13, DOI [10.1080/10937404.2019.1689878, 10.1080/10937404.2018.1564712]; Wang JX, 2018, ORG LETT, V20, P1058, DOI 10.1021/acs.orglett.7b04018; Wang SS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46863-9; Williamson Deborah A, 2017, Clin Microbiol Rev, V30, P827, DOI 10.1128/CMR.00112-16; WILSON D, 1995, OIKOS, V73, P274, DOI 10.2307/3545919; Wu W, 2021, FRONT PLANT SCI, V12, DOI 10.3389/fpls.2021.646146; Xia S, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0184-0; Xu LL, 2009, PHYTOMEDICINE, V16, P609, DOI 10.1016/j.phymed.2009.03.014; Zakaryan H, 2017, ARCH VIROL, V162, P2539, DOI 10.1007/s00705-017-3417-y; Zhang HW, 2006, NAT PROD REP, V23, P753, DOI 10.1039/b609472b; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	127	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0269962	10.1371/journal.pone.0269962	http://dx.doi.org/10.1371/journal.pone.0269962			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925905	gold, Green Published			2022-12-26	WOS:000848077100015
J	Park, JW; Yea, JW; Park, J; Oh, SA				Park, Jae Won; Yea, Ji Woon; Park, Jaehyeon; Oh, Se An			Setup uncertainties and appropriate setup margins in the head-tilted supine position of whole-brain radiotherapy (WBRT)	PLOS ONE			English	Article							THERMOPLASTIC MASKS; IMMOBILIZATION	Various applications of head-tilting techniques in whole-brain radiotherapy (WBRT) have been introduced. However, a study on the setup uncertainties and margins in head-tilting techniques has not been reported. This study evaluated the setup uncertainties and determined the appropriate planning target volume (PTV) margins for patients treated in the head-tilted supine (ht-SP) and conventional supine position (c-SP) in WBRT. Thirty patients who received WBRT at our institution between October 2020 and May 2021 in the c-SP and ht-SP were investigated. The DUON head mask (60124, Orfit Industries, Wijnegem, Belgium) was used in the c-SP, and a thermoplastic U-Frame Mask (R420U, Klarity Medical & Equipment Co. Ltd., Lan Yu, China) was used in the ht-SP. Daily setup verification using planning computed tomography (CT) and cone-beam CT was corrected for translational (lateral, longitudinal, and vertical) and rotational (yaw) errors. In the c-SP, the means of systematic errors were -0.80, 0.79, and 0.37 mm and random errors were 0.27, 0.54, and 0.39 mm in the lateral, longitudinal, and vertical translational dimensions, respectively. Whereas, for the ht-SP, the means of systematic errors were -0.07, 0.73, and -0.63 mm, and random errors were 0.75, 1.39, 1.02 mm in the lateral, longitudinal, and vertical translational dimensions, respectively. The PTV margins were calculated using Stroom et al.'s [2 Sigma+0.7 sigma] and van Herk et al.'s recipe [2.5 Sigma+0.7 sigma]. Appropriate PTV margins with van Herk et al.'s recipe in WBRT were <2 mm and 1.5 degrees in the c-SP and <3 mm and 2 degrees in the ht-SP in the translational and rotational directions, respectively. Although the head tilt in the supine position requires more margin, it can be applied as a sufficiently stable and effective position in radiotherapy.	[Park, Jae Won; Yea, Ji Woon; Park, Jaehyeon; Oh, Se An] Yeungnam Univ, Dept Radiat Oncol, Med Ctr, Daegu, South Korea; [Park, Jae Won; Yea, Ji Woon; Park, Jaehyeon; Oh, Se An] Yeungnam Univ, Dept Radiat Oncol, Coll Med, Daegu, South Korea	Yeungnam University; Yeungnam University	Oh, SA (corresponding author), Yeungnam Univ, Dept Radiat Oncol, Med Ctr, Daegu, South Korea.; Oh, SA (corresponding author), Yeungnam Univ, Dept Radiat Oncol, Coll Med, Daegu, South Korea.	sean.oh5235@gmail.com		Oh, SeAn/0000-0002-8835-2814	Yeungnam University	Yeungnam University	This work was supported by the 2021 Yeungnam University Research Grant.	Brown PD, 2018, J CLIN ONCOL, V36, P483, DOI 10.1200/JCO.2017.75.9589; Deng X, 2017, BMC CANCER, V17, DOI 10.1186/s12885-016-3017-3; Gilbeau L, 2001, RADIOTHER ONCOL, V58, P155, DOI 10.1016/S0167-8140(00)00280-2; He YL, 2021, J APPL CLIN MED PHYS, V22, P156, DOI 10.1002/acm2.13341; Kim SH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216655; Lin YF, 2020, RADIAT PHYS CHEM, V173, DOI 10.1016/j.radphyschem.2020.108884; McTyre Emory, 2013, Surg Neurol Int, V4, pS236, DOI 10.4103/2152-7806.111301; Miao JJ, 2019, J APPL CLIN MED PHYS, V20, P78, DOI 10.1002/acm2.12763; Miura K, 2021, TECHNOL CANCER RES T, V20, DOI 10.1177/1533033820986824; Oh SA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232430; Oh SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156357; Oh SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151709; Oh SJ, 2017, RADIAT ONCOL J, V35, P101, DOI 10.3857/roj.2017.00325; Oh YK, 2014, J APPL CLIN MED PHYS, V15, P85, DOI 10.1120/jacmp.v15i2.4418; Ong CL, 2020, RADIAT ONCOL, V15, DOI 10.1186/s13014-020-01639-8; Paganelli C, 2018, MED PHYS, V45, pE908, DOI 10.1002/mp.13162; Park J, 2019, RADIAT ONCOL J, V37, P22, DOI 10.3857/roj.2019.00059; Park Jaehyeon, 2019, Yeungnam Univ J Med, V36, P36, DOI 10.12701/yujm.2019.00087; Remeijer P, 2000, INT J RADIAT ONCOL, V46, P1281, DOI 10.1016/S0360-3016(99)00468-X; Rigaud B, 2019, ACTA ONCOL, DOI 10.1080/0284186X.2019.1620331; Sharp L, 2005, INT J RADIAT ONCOL, V61, P250, DOI 10.1016/j.ijrobp.2004.04.047; Shimizu H, 2021, J APPL CLIN MED PHYS, V22, P49, DOI 10.1002/acm2.13151; Stroom JC, 1999, INT J RADIAT ONCOL, V43, P905, DOI 10.1016/S0360-3016(98)00468-4; Suteu Patricia, 2019, Med Pharm Rep, V92, P43, DOI 10.15386/cjmed-1040; Tomihara J, 2021, J APPL CLIN MED PHYS, V22, P360, DOI 10.1002/acm2.13382; Udayashankar AH, 2018, REP PRACT ONCOL RADI, V23, P233, DOI 10.1016/j.rpor.2018.04.007; van Herk M, 2000, INT J RADIAT ONCOL, V47, P1121, DOI 10.1016/S0360-3016(00)00518-6; van Herk M, 2004, SEMIN RADIAT ONCOL, V14, P52, DOI 10.1053/j.semradonc.2003.10.003; Zhang MT, 2016, PHYS MEDICA, V32, P379, DOI 10.1016/j.ejmp.2016.02.002; Zhou JN, 2010, MED DOSIM, V35, P31, DOI 10.1016/j.meddos.2009.01.005	30	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271077	10.1371/journal.pone.0271077	http://dx.doi.org/10.1371/journal.pone.0271077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925916	Green Published, gold			2022-12-26	WOS:000848077100031
J	Ali, FT; Soliman, RM; Hassan, NS; Ibrahim, AM; El-Gizawy, MM; Mandoh, AY; Ibrahim, EA				Ali, Fahmy T.; Soliman, Reham M.; Hassan, Nahla S.; Ibrahim, Ahmed M.; El-Gizawy, Mayada M.; Mandoh, Abd Allah Y.; Ibrahim, Ehab A.			Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer	PLOS ONE			English	Article							GENE SIGNATURE; MANAGEMENT; SURVIVAL	BackgroundOvarian cancer is usually detected at later stages and no effective screening approach, has been identified. Therefore, sensitive and specific biomarkers for detecting ovarian cancer are urgently needed. ObjectiveThis study aimed to investigate the efficacy of six biomarkers for the early clinical diagnosis of ovarian cancer. Subjects & methodsThe study included 120 patients (benign ovarian tumors and early and late ovarian carcinoma) and 30 control healthy volunteers. MiRNA-204, CA125, CA19.9, hepcidin, microfibril-associated glycoprotein 2, and ferroportin levels were determined in all patients and control volunteers. ResultsThe combined area under the receiver operating characteristic curves for miRNA-204, CA125, and CA19.9 were 0.938, 1.000, and 0.998 for benign tumors and early and late ovarian carcinomas, respectively. The sensitivities of miRNA-204, CA125, and CA19.9 were 98.04%, 100.00%, and 96.19% and the specificities were 58.33%, 62.50%, and 57.78%, respectively. ConclusionThe positive predictivity of miRNA-204, CA125, and CA19.9 for ovarian cancer is high (59.57%, 58.24%, and 61.67%, respectively). Thus, the combination of these three biomarkers is a good diagnostic tool for ovarian cancer.	[Ali, Fahmy T.; Soliman, Reham M.; Hassan, Nahla S.; Ibrahim, Ehab A.] Ain Shams Univ, Fac Sci, Dept Biochem, Cairo, Egypt; [Ibrahim, Ahmed M.] Ain Shams Univ, Fac Med, Dept Med, Cairo, Egypt; [El-Gizawy, Mayada M.] Natl Res Ctr, Med Physiol Dept, Med Div, Giza, Egypt; [Mandoh, Abd Allah Y.] Dept Mol Biol & Cytogen, Armed Forces Cent Lab & Blood Bank, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Hassan, NS (corresponding author), Ain Shams Univ, Fac Sci, Dept Biochem, Cairo, Egypt.	nahla_samir@hotmail.com		Ibrahim, Ehab/0000-0003-0520-7169; Hassan, Nahla/0000-0002-9530-0828				Al-dujaili AH., 2009, J FM BAGHDAD, V51, P223, DOI [10.32007/jfacmedbagdad.5121218, DOI 10.32007/JFACMEDBAGDAD.5121218]; Alshamrani AA, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01084; Aziz NB, 2020, ANALYST, V145, P2038, DOI 10.1039/c9an02263e; Bagde ND., 2020, ASIAN PAC J CANC BIO, V5, P167, DOI [10.31557/APJCB.2020.5.4.167, DOI 10.31557/APJCB.2020.5.4.167]; Basuli D., 2016, THESIS, V1248; Burges A, 2011, DTSCH ARZTEBL INT, V108, P635, DOI 10.3238/arztebl.2011.0635; Charkhchi P, 2020, CANCERS, V12, DOI 10.3390/cancers12123730; Craft CS, 2018, MATRIX BIOL, V71-72, P100, DOI 10.1016/j.matbio.2018.03.006; Doubeni CA, 2016, AM FAM PHYSICIAN, V93, P937; Funston G, 2020, PLOS MED, V17, DOI [10.1371/journal.pmed.1003295, 10.1371/journal.pmed.1003295.r001, 10.1371/journal.pmed.1003295.r002, 10.1371/journal.pmed.1003295.r003, 10.1371/journal.pmed.1003295.r004, 10.1371/journal.pmed.1003295.r005]; Gao YC, 2015, TUMOR BIOL, V36, P4843, DOI 10.1007/s13277-015-3138-3; Hu LL, 2019, CELL TRANSPLANT, V28, p51S, DOI 10.1177/0963689719877372; Kong YY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1854-0; Lee T, 2020, WORLD J GASTRO SURG, V12, DOI 10.4240/wjgs.v12.i12.468; Liang CY, 2020, RESP RES, V21, DOI 10.1186/s12931-020-1274-9; Liang Y, 2021, ONCOL LETT, V21, DOI 10.3892/ol.2021.12743; Liu SN, 2021, J CANCER, V12, P3976, DOI 10.7150/jca.47695; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JJ, 2019, ONCOL LETT, V17, P4417, DOI 10.3892/ol.2019.10117; Matulonis UA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.61; Michalczyk K, 2021, CANCER MANAG RES, V13, P2329, DOI 10.2147/CMAR.S290592; Mok SC, 2009, CANCER CELL, V16, P521, DOI 10.1016/j.ccr.2009.10.018; Montagnana M, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.05.13; Ors-Kumoglu G, 2019, CYTOTECHNOLOGY, V71, P411, DOI 10.1007/s10616-018-0291-8; Pendlebury A, 2017, BIOMED REP, V6, P319, DOI 10.3892/br.2017.847; Pusatcioglu CK, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-21; Radu MR, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9060693; Ren F, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/7184760; Savolainen K, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05155-6; Scara S, 2015, ADV EXP MED BIOL, V867, P247, DOI 10.1007/978-94-017-7215-0_15; Shah JS, 2018, GYNECOL ONCOL, V148, P181, DOI 10.1016/j.ygyno.2017.11.005; Spivey KA, 2010, CELL ADHES MIGR, V4, P169, DOI 10.4161/cam.4.2.11716; Tesfay L, 2015, CANCER RES, V75, P2254, DOI 10.1158/0008-5472.CAN-14-2465; Torre LA, 2018, CA-CANCER J CLIN, V68, P284, DOI 10.3322/caac.21456; Wang JY, 2020, J BUON, V25, P2287; Wang SM, 2021, MOL MED REP, V23, DOI 10.3892/mmr.2020.11724; Wu YM, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0284-0; Zhang S, 2015, MOL CANCER RES, V13, P393, DOI 10.1158/1541-7786.MCR-14-0424; Zhao LH, 2022, REPROD SCI, V29, P2760, DOI 10.1007/s43032-021-00717-w; Zhou LF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051545; Zhu SP, 2021, J CELL PHYSIOL, V236, P41, DOI 10.1002/jcp.29893; Zhu XL, 2017, ONCOTARGET, V8, P39154, DOI 10.18632/oncotarget.16610	42	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272308	http://dx.doi.org/10.1371/journal.pone.0272308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921382	Green Published, gold			2022-12-26	WOS:000839311900003
J	Li, ML; Jiang, MF; Zhang, GM; Liu, YJ; Zhou, XB				Li, Mingliang; Jiang, Mingfeng; Zhang, Guangming; Liu, Yujun; Zhou, Xiaobo			Prediction of fluid intelligence from T1-w MRI images: A precise two-step deep learning framework	PLOS ONE			English	Article								The Adolescent Brain Cognitive Development (ABCD) Neurocognitive Prediction Challenge (ABCD-NP-Challenge) is a community-driven competition that challenges competitors to develop algorithms to predict fluid intelligence scores from T1-w MRI images. In this work, a two-step deep learning pipeline is proposed to improve the prediction accuracy of fluid intelligence scores. In terms of the first step, the main contributions of this study include the following: (1) the concepts of the residual network (ResNet) and the squeeze-and-excitation network (SENet) are utilized to improve the original 3D U-Net; (2) in the segmentation process, the pixels in symmetrical brain regions are assigned the same label; (3) to remove redundant background information from the segmented regions of interest (ROIs), a minimum bounding cube (MBC) is used to enclose the ROIs. This new segmentation structure can greatly improve the segmentation performance of the ROIs in the brain as compared with the classical convolutional neural network (CNN), which yields a Dice coefficient of 0.8920. In the second stage, MBCs are used to train neural network regression models for enhanced nonlinearity. The fluid intelligence score prediction results of the proposed method are found to be superior to those of current state-of-the-art approaches, and the proposed method achieves a mean square error (MSE) of 82.56 on a test data set, which reflects a very competitive performance.	[Li, Mingliang; Jiang, Mingfeng; Zhang, Guangming; Liu, Yujun] Sichuan Univ, West China Hosp, West China Biomed Big Data Ctr, West China Sch Med, Chengdu, Peoples R China; [Li, Mingliang] Sichuan Univ, Med X Ctr Informat, Chengdu, Peoples R China; [Zhou, Xiaobo] Univ Texas Hlth Sci Ctr Houston, Ctr Computat Syst Med, Sch Biomed Informat, Houston, TX 77030 USA	Sichuan University; Sichuan University; University of Texas System; University of Texas Health Science Center Houston	Jiang, MF (corresponding author), Sichuan Univ, West China Hosp, West China Biomed Big Data Ctr, West China Sch Med, Chengdu, Peoples R China.; Zhou, XB (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Computat Syst Med, Sch Biomed Informat, Houston, TX 77030 USA.	17010230513@gznu.edu.cn; zhouxb2015@163.com			Center of Excellence-International Collaboration Initiative Grant [139170052]; 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University [ZYJC18010]	Center of Excellence-International Collaboration Initiative Grant; 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University	This research was supported by Center of Excellence-International Collaboration Initiative Grant (Grant Number: 139170052), 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University (Grant Number: ZYJC18010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	A.Emin Orhan, 2018, Arxiv, DOI arXiv:1701.09175; Anderson B, 1996, BRAIN, V119, P1983, DOI 10.1093/brain/119.6.1983; [Anonymous], 2016, DISSOCIABLE BRAIN BI, V137, P201, DOI [10.1016/j.neuroimage.2016.05.03727184204, DOI 10.1016/J.NEUROIMAGE.2016.05.03727184204]; Anuar N., 2010, VALIDATE C PAPER USI, V3; Avants BB, 2011, NEUROINFORMATICS, V9, P381, DOI 10.1007/s12021-011-9109-y; Awad M, 2015, MACHINE LEARNING ACT, DOI [10.1007/978-1-4302-5990-9, DOI 10.1007/978-1-4302-5990-9_11]; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; Eickhoff SB, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000497; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gignac GE, 2017, INTELLIGENCE, V64, P18, DOI 10.1016/j.intell.2017.06.004; Guerdan L., 2019, CHALLENGE ADOLESCENT; Hagler DJ, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116091; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; He K., 2016, CVPR, P770; Hu J, 2018, PROC CVPR IEEE, P7132, DOI [10.1109/CVPR.2018.00745, 10.1109/TPAMI.2019.2913372]; Hutsler J, 2003, TRENDS NEUROSCI, V26, P429, DOI 10.1016/S0166-2236(03)00198-X; Koenig KA, 2019, MULT SCLER J, V25, P574, DOI 10.1177/1352458518760716; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Li ML, 2014, BRAIN CONNECT, V4, P145, DOI 10.1089/brain.2013.0211; Liu L., 2019, PREDICTING FLUID INT; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; Ohlsson S., 2011, DEEP LEARNING MIND O; OROURKE J, 1985, INT J COMPUT INF SCI, V14, P183, DOI 10.1007/BF00991005; Oxtoby N. P., 2019, ABCD NEUROCOGNITIVE; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pominova M, 2019, ENSEMBLE 3D CNN REGR; Rohlfing T, 2010, HUM BRAIN MAPP, V31, P798, DOI 10.1002/hbm.20906; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Shelhamer E, 2017, IEEE T PATTERN ANAL, V39, P640, DOI 10.1109/TPAMI.2016.2572683; Smann P. G, FREESURFER BASED SEG; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Supekar K, 2013, P NATL ACAD SCI USA, V110, P8230, DOI 10.1073/pnas.1222154110; Vang Y. S., 2019, COMBINED DEEP LEARNI; Volkow ND, 2018, DEV COGN NEUROS-NETH, V32, P4, DOI 10.1016/j.dcn.2017.10.002; Wang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117295; Yushkevich P. A, 2018, USER GUIDED SEGMENTA, P1; Zhang RZ, 2018, IEEE T MED IMAGING, V37, P2149, DOI 10.1109/TMI.2018.2821244; Zou Y., 2019, ADOLESCENT BRAIN COG	42	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0268707	http://dx.doi.org/10.1371/journal.pone.0268707			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917308	Green Published, gold			2022-12-26	WOS:000837840000021
J	N'Gadjaga, MD; Perrinet, S; Connor, MG; Bertolin, G; Millot, GA; Subtil, A				N'Gadjaga, Maimouna D.; Perrinet, Stephanie; Connor, Michael G.; Bertolin, Giulia; Millot, Gael A.; Subtil, Agathe			Chlamydia trachomatis development requires both host glycolysis and oxidative phosphorylation but has only minor effects on these pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-SYNTHESIS; VIRULENCE FACTOR; METABOLISM; INHIBITION; PATHOGEN; CYTOKINESIS; PROTEIN; INNATE; PGP3	The obligate intracellular bacteria Chlamydia trachomatis obtain all nutrients from the cytoplasm of their epithelial host cells and stimulate glucose uptake by these cells. They even hijack host ATP, exerting a strong metabolic pressure on their host at the peak of the proliferative stage of their develop-mental cycle. However, it is largely unknown whether infection modulates the metabolism of the host cell. Also, the reliance of the bacteria on host metabolism might change during their progression through their biphasic developmental cycle. Herein, using primary epithelial cells and 2 cell lines of non -tumoral origin, we showed that between the 2 main ATP -producing pathways of the host, oxidative phosphorylation (OxPhos) remained stable and glycolysis was slightly increased. Inhibition of either pathway strongly reduced bacterial prolif-eration, implicating that optimal bacterial growth required both pathways to function at full capacity. While we found C. trachomatis displayed some degree of energetic autonomy in the synthesis of proteins expressed at the onset of infection, functional host glycolysis was necessary for the establishment of early inclusions, whereas OxPhos contributed less. These observations correlated with the relative contributions of the pathways in maintaining ATP levels in epithelial cells, with glycolysis contributing the most. Altogether, this work high-lights the dependence of C. trachomatis on both host glycolysis and OxPhos for efficient bacterial replication. However, ATP consumption appears at equilibrium with the normal produc-tion capacity of the host and the bacteria, so that no major shift between these pathways is required to meet bacterial needs.	[N'Gadjaga, Maimouna D.; Perrinet, Stephanie; Subtil, Agathe] Univ Paris Cite, Inst Pasteur, CNRS UMR3691, Cellular Biol Microbial Infect, Paris, France; [N'Gadjaga, Maimouna D.] Sorbonne Univ, Coll Doctoral, Paris, France; [Subtil, Agathe] Univ Paris Cite, Inst Pasteur Chromatin & Infect, Paris, France; [Bertolin, Giulia] Univ Rennes, IGDR Inst Genet & Dev Rennes, CNRS, UMR 6920, Rennes, France; [Millot, Gael A.] Univ Paris Cite, Inst Pasteur, Hub Bioinformat & Biostat DBC, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Subtil, A (corresponding author), Univ Paris Cite, Inst Pasteur, CNRS UMR3691, Cellular Biol Microbial Infect, Paris, France.	asubtil@pasteur.fr	Connor, Michael/AAB-4671-2021; Subtil, Agathe/C-7464-2017	Connor, Michael/0000-0002-5413-2338; Subtil, Agathe/0000-0002-7481-4846	Ministere de l'Enseignement superieur; de la Recherche et de l'Innovation; Fondation pour la Recherche Medicale [FDT202012010504]; Springboard to independence grant AirwayStasis; Pasteur Foundation Fellowship; G5 Chromatin and Infection group	Ministere de l'Enseignement superieur; de la Recherche et de l'Innovation; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Springboard to independence grant AirwayStasis; Pasteur Foundation Fellowship; G5 Chromatin and Infection group	M. D. N.'G. was funded by the Ministere de l'Enseignement superieur, de la Recherche et de l'Innovation, and by the Fondation pour la Recherche Medicale (FDT202012010504). M. G. C. is supported by the Springboard to independence grant AirwayStasis, the Pasteur Foundation Fellowship, and the G5 Chromatin and Infection group.	Agaisse H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057090; Bertolin G, 2019, ACS SENSORS, V4, P2018, DOI 10.1021/acssensors.9b00486; Boncompain G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086196; Boudreau A, 2016, NAT CHEM BIOL, V12, P779, DOI 10.1038/nchembio.2143; Brown HM, 2012, CELL MICROBIOL, V14, P1554, DOI 10.1111/j.1462-5822.2012.01820.x; Buckner LR, 2011, J REPROD IMMUNOL, V92, P8, DOI 10.1016/j.jri.2011.08.002; Chowdhury SR, 2017, J CELL BIOL, V216, P1071, DOI 10.1083/jcb.201608063; Colpaert M, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01794-y; de Padua MC, 2017, ONCOTARGET, V8, P87623, DOI 10.18632/oncotarget.21007; Ende RJ, 2020, INFECT IMMUN, V88, DOI 10.1128/IAI.00545-20; Fisher DJ, 2013, J BACTERIOL, V195, P3381, DOI 10.1128/JB.00433-13; Fling SP, 2001, P NATL ACAD SCI USA, V98, P1160, DOI 10.1073/pnas.98.3.1160; Rubino MEG, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133316; Gehre L, 2016, ELIFE, V5, DOI 10.7554/eLife.12552; Greene W, 2003, J INFECTION, V47, P45, DOI 10.1016/S0163-4453(03)00039-2; Grieshaber SS, 2003, J CELL SCI, V116, P3793, DOI 10.1242/jcs.00695; HA J, 1994, J BIOL CHEM, V269, P22162; Henrissat B, 2002, TRENDS GENET, V18, P437, DOI 10.1016/S0168-9525(02)02734-8; Hou SP, 2015, INFECT IMMUN, V83, P4701, DOI 10.1128/IAI.00746-15; Iliffe-Lee ER, 2000, MOL MICROBIOL, V38, P20, DOI 10.1046/j.1365-2958.2000.02102.x; Kading N, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00499; Kentner D, 2014, P NATL ACAD SCI USA, V111, P9929, DOI 10.1073/pnas.1406694111; Kurihara Y, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.12962; Lee JK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02432-0; Liang PD, 2018, J BIOL CHEM, V293, P510, DOI 10.1074/jbc.M117.797209; Liu Y, 2014, INFECT IMMUN, V82, P5327, DOI 10.1128/IAI.02576-14; Maffei B, 2020, EMBO J, V39, DOI 10.15252/embj.2019102166; Mehlitz A, 2017, MOL MICROBIOL, V103, P1004, DOI 10.1111/mmi.13603; Mesquita I, 2016, CELL MOL LIFE SCI, V73, P1225, DOI 10.1007/s00018-015-2119-4; Nakano M, 2011, ACS CHEM BIOL, V6, P709, DOI 10.1021/cb100313n; Ohmer M, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.12993; Omsland A, 2012, P NATL ACAD SCI USA, V109, P19781, DOI 10.1073/pnas.1212831109; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Powers JL, 2007, BIOCHEM MOL BIOL EDU, V35, P287, DOI 10.1002/bmb.74; R Core Team, 2021, R LANGUAGE ENV STAT; Rajeeve K, 2020, NAT MICROBIOL, V5, P1390, DOI 10.1038/s41564-020-0762-5; Roth A, 2010, P NATL ACAD SCI USA, V107, P19502, DOI 10.1073/pnas.1008178107; Rother M, 2018, CELL HOST MICROBE, V23, P661, DOI 10.1016/j.chom.2018.04.002; Russell M, 2011, INFECT IMMUN, V79, P98, DOI 10.1128/IAI.01105-10; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Shaw EI, 2000, MOL MICROBIOL, V37, P913, DOI 10.1046/j.1365-2958.2000.02057.x; Shima K, 2021, MBIO, V12, DOI 10.1128/mBio.00023-21; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Szaszak M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002108; Tang CF, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85123-7; TIPPLES G, 1993, MOL MICROBIOL, V8, P1105, DOI 10.1111/j.1365-2958.1993.tb01655.x; Tjaden J, 1999, J BACTERIOL, V181, P1196, DOI 10.1128/JB.181.4.1196-1202.1999; Triboulet S, 2022, FRONT CELL INFECT MI, V12, DOI 10.3389/fcimb.2022.866729; van der Windt Gerritje J W, 2016, Curr Protoc Immunol, V113, DOI 10.1002/0471142735.im0316bs113; Vromman F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099197; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Yao JW, 2015, J BIOL CHEM, V290, P22163, DOI 10.1074/jbc.M115.671008; Yao JW, 2015, J BIOL CHEM, V290, P18874, DOI 10.1074/jbc.M115.657148; Zdralevic M, 2018, J BIOL CHEM, V293, P15947, DOI 10.1074/jbc.RA118.004180	56	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102338	10.1016/j.jbc.2022.102338	http://dx.doi.org/10.1016/j.jbc.2022.102338			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9IM	35931114	gold, Green Published			2022-12-26	WOS:000863192700010
J	Zhou, N; Li, H; Xu, J; Shen, ZS; Tang, MX; Wang, XH; Su, WX; Sokabe, M; Zhang, Z; Tang, QY				Zhou, Nan; Li, Hui; Xu, Jie; Shen, Zhong-Shan; Tang, Mingxi; Wang, Xiao-Hui; Su, Wan-Xin; Sokabe, Masahiro; Zhang, Zhe; Tang, Qiong-Yao			Two types of peptides derived from the neurotoxin GsMTx4 inhibit a mechanosensitive potassium channel by modifying the mechanogate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIDER VENOM; DEPENDENT REGULATION; ATRIAL-FIBRILLATION; TARANTULA PEPTIDE; ION CHANNELS; BK CHANNEL; STRETCH; PIEZO1; TOXIN; BLOCK	Atrial fibrillation is the most common sustained cardiac arrhythmia in humans. Current atrial fibrillation antiarrhythmic drugs have limited efficacy and carry the risk of ventricular proarrhythmia. GsMTx4, a mechanosensitive channel-selective inhibitor, has been shown to suppress arrhythmias through the inhibition of stretch-activated channels (SACs) in the heart. The cost of synthesizing this peptide is a major obstacle to clinical use. Here, we studied two types of short peptides derived from GsMTx4 for their effects on a stretch-activated big potassium channel (SAKcaC) from the heart. Type I, a 17-residue peptide (referred to as Pept 01), showed comparable efficacy, whereas type II (i.e., Pept 02), a 10-residue peptide, exerted even more potent inhibitory efficacy on SAKcaC compared with GsMTx4. We identified through mutagenesis important sequences required for peptide functions. In addition, molecular dynamics simulations revealed common structural features with a hydrophobic head followed by a positively charged protrusion that may be involved in peptide channel-lipid interactions. Furthermore, we suggest that these short peptides may inhibit SAKcaC through a specific modification to the mechanogate, as the inhibitory effects for both types of peptides were mostly abolished when tested with a mechano-insensitive channel variant (STREX-del) and a nonmechanosensitive big potassium (mouse Slo1) channel. These findings may offer an opportunity for the development of a new class of drugs in the treatment of cardiac arrhythmia generated by excitatory SACs in the heart.	[Zhou, Nan; Li, Hui; Xu, Jie; Shen, Zhong-Shan; Wang, Xiao-Hui; Su, Wan-Xin; Zhang, Zhe; Tang, Qiong-Yao] Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China; [Li, Hui] Ninth Peoples Hosp Suzhou, Dept Anesthesiol, Suzhou 215200, Jiangsu, Peoples R China; [Tang, Mingxi] Southwest Med Univ, Affiliated Hosp, Dept Pathol, Luzhou, Sichuan, Peoples R China; [Sokabe, Masahiro] Nagoya Univ, Grad Sch Med, Mechanobiol Lab, Nagoya, Japan; [Sokabe, Masahiro] Kanazawa Inst Technol, Human Syst Informat Labs, Nonoichi, Japan; [Zhang, Zhe; Tang, Qiong-Yao] Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesia & Analgesia Applic, Xuzhou, Jiangsu, Peoples R China; [Zhang, Zhe; Tang, Qiong-Yao] Xuzhou Med Univ, NMPA Key Lab Res & Evaluat Narcot & Psychotrop Dru, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Southwest Medical University; Nagoya University; Kanazawa Institute of Technology; Xuzhou Medical University; Xuzhou Medical University	Zhang, Z; Tang, QY (corresponding author), Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China.; Sokabe, M (corresponding author), Nagoya Univ, Grad Sch Med, Mechanobiol Lab, Nagoya, Japan.; Sokabe, M (corresponding author), Kanazawa Inst Technol, Human Syst Informat Labs, Nonoichi, Japan.; Zhang, Z; Tang, QY (corresponding author), Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesia & Analgesia Applic, Xuzhou, Jiangsu, Peoples R China.; Zhang, Z; Tang, QY (corresponding author), Xuzhou Med Univ, NMPA Key Lab Res & Evaluat Narcot & Psychotrop Dru, Xuzhou, Jiangsu, Peoples R China.	msokabe@med.nagoya-u.ac.jp; Zhangzhe70@xzhmu.edu.cn; qiongyaotang@xzhmu.edu.cn			National Natural Science Foundation of China; Luzhou Science and Technology Bureau [81450064, 81471314]; Southwest Medical University of China [2021-SYF-28]; Xuzhou Medical University [2021ZKMS033];  [XZSYSKF2020043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Luzhou Science and Technology Bureau; Southwest Medical University of China; Xuzhou Medical University; 	This work was supported bythe National Natural Science Foundation of China (grant no.:81450064; [to Q.-Y. T.] and 81471314; [to Z. Z.]). Jiangsu specially appointed a professorship (to Q.-Y. T. and Z. Z), Luzhou Science and Technology Bureau (2021-SYF-28 to M. T.), Southwest Medical University of China (2021ZKMS033 to M. T.), and Xuzhou Medical University (XZSYSKF2020043 to H. L.). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of National Institute of General Medical Sciences or National Institutes of Health.	Alessandri-Haber N, 2009, J NEUROSCI, V29, P6217, DOI 10.1523/JNEUROSCI.0893-09.2009; AUERBACH A, 1991, BIOPHYS J, V60, P660, DOI 10.1016/S0006-3495(91)82095-1; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Bode F, 2001, NATURE, V409, P35, DOI 10.1038/35051165; Bode F, 2000, CIRCULATION, V101, P2200, DOI 10.1161/01.CIR.101.18.2200; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; CUEVAS J, 1994, BRIT J PHARMACOL, V111, P663, DOI 10.1111/j.1476-5381.1994.tb14789.x; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Garcia ML, 2004, NATURE, V430, P153, DOI 10.1038/430153a; Gnanasambandam R, 2017, BIOPHYS J, V112, P31, DOI 10.1016/j.bpj.2016.11.013; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; HENRY WL, 1976, CIRCULATION, V53, P273, DOI 10.1161/01.CIR.53.2.273; Hite RK, 2017, NATURE, V541, P52, DOI 10.1038/nature20775; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ilkan Z, 2017, J BIOL CHEM, V292, P9204, DOI 10.1074/jbc.M116.766196; LACAMPAGNE A, 1994, BBA-BIOMEMBRANES, V1191, P205, DOI 10.1016/0005-2736(94)90250-X; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Lee W, 2014, P NATL ACAD SCI USA, V111, pE5114, DOI 10.1073/pnas.1414298111; LEVINE JH, 1988, CIRCULATION, V77, P70, DOI 10.1161/01.CIR.77.1.70; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Li H, 2019, J BIOL CHEM, V294, P11892, DOI 10.1074/jbc.RA118.005511; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; Miyamoto T, 2014, J BIOL CHEM, V289, P16565, DOI 10.1074/jbc.M113.528638; Naruse K, 2009, BIOCHEM BIOPH RES CO, V385, P634, DOI 10.1016/j.bbrc.2009.05.105; Nishizawa K, 2015, BBA-BIOMEMBRANES, V1848, P2767, DOI 10.1016/j.bbamem.2015.09.003; Nishizawa M, 2007, BIOPHYS J, V92, P4233, DOI 10.1529/biophysj.106.101071; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Novak K, 2001, NAT MED, V7, P155, DOI 10.1038/84588; Oswald RE, 2002, J BIOL CHEM, V277, P34443, DOI 10.1074/jbc.M202715200; Park SP, 2008, PAIN, V137, P208, DOI 10.1016/j.pain.2008.02.013; Peng AW, 2016, J NEUROSCI, V36, P2945, DOI 10.1523/JNEUROSCI.3011-15.2016; Redaelli E, 2010, J BIOL CHEM, V285, P4130, DOI 10.1074/jbc.M109.054718; Rodriguez-Menchaca AA, 2012, P NATL ACAD SCI USA, V109, pE2399, DOI 10.1073/pnas.1207901109; RUKNUDIN A, 1993, AM J PHYSIOL, V264, pH960, DOI 10.1152/ajpheart.1993.264.3.H960; Sato R, 1998, J MEMBRANE BIOL, V163, P67, DOI 10.1007/s002329900371; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Schmidtko A, 2010, LANCET, V375, P1569, DOI 10.1016/S0140-6736(10)60354-6; Su JY, 2011, ACS NANO, V5, P351, DOI 10.1021/nn1014616; Suchyna TM, 2017, PROG BIOPHYS MOL BIO, V130, P244, DOI 10.1016/j.pbiomolbio.2017.07.011; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Sukharev S, 2004, TRENDS NEUROSCI, V27, P345, DOI 10.1016/j.tins.2004.04.006; Tang QY, 2016, CELL REP, V14, P129, DOI 10.1016/j.celrep.2015.12.019; Tang QY, 2014, J BIOL CHEM, V289, P18860, DOI 10.1074/jbc.M113.538033; Tang QY, 2010, CHANNELS, V4, P22, DOI 10.4161/chan.4.1.10481; Tang QY, 2009, J GEN PHYSIOL, V134, P409, DOI 10.1085/jgp.200910251; Tang QY, 2003, J MEMBRANE BIOL, V196, P185, DOI 10.1007/s00232-003-0637-8; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Torp-Pedersen C, 1999, NEW ENGL J MED, V341, P857, DOI 10.1056/NEJM199909163411201; Waldo AL, 1996, LANCET, V348, P7, DOI 10.1016/S0140-6736(96)02149-6; Wang GM, 2020, BRIT J PHARMACOL, V177, P3552, DOI 10.1111/bph.15078; Wang JL, 2016, J MOL CELL CARDIOL, V98, P83, DOI 10.1016/j.yjmcc.2016.07.005; Zabel M, 1996, CARDIOVASC RES, V32, P120, DOI 10.1016/0008-6363(96)00089-2; Zhang Z, 2010, J NEUROSCI, V30, P7554, DOI 10.1523/JNEUROSCI.0525-10.2010; Zhao HC, 2008, CELL RES, V18, P871, DOI 10.1038/cr.2008.88	58	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102326	10.1016/j.jbc.2022.102326	http://dx.doi.org/10.1016/j.jbc.2022.102326			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9IM	35933015	Green Published, gold			2022-12-26	WOS:000863192700008
J	Morkos, M; Eppelheimer, M; Nwotchouang, BST; Ebrahimzadeh, SA; Bhadelia, RA; Loth, D; Allen, PA; Lothid, F				Morkos, Mark; Eppelheimer, Maggie; Nwotchouang, Blaise Simplice Talla; Ebrahimzadeh, Seyed Amir; Bhadelia, Rafeeque A.; Loth, Dorothy; Allen, Philip A.; Lothid, Francis			The importance of precise plane selection for female adult Chiari Type I malformation midsagittal morphometrics	PLOS ONE			English	Article							EXTRACTION	Introduction Morphometric assessment of Chiari malformation type I (CMI) is typically performed on a midsagittal MRI. However, errors arising from an imprecise selection of the midsagittal plane are unknown. We define absolute parasagittal error as the absolute difference between morphometric measurements at the midsagittal and parasagittal planes. Our objective was to determine the absolute parasagittal error at various lateral distances for morphometric parameters commonly used in CMI research. Methods Sagittal T1-weighted MRI scans of 30 CMI adult female subjects were included. Image sets were evaluated to assess 14 CMI morphometric parameters in the midsagittal plane and four parasagittal planes located 1 and 2 mm lateral (left and right). Comparisons between measurements at the midsagittal and parasagittal planes were conducted to determine the mean individual absolute and mean group parasagittal errors for all 14 parameters. Results The mean individual absolute parasagittal error was > 1 unit (1 mm for lengths and 1 degree for angles) for 9/14 parameters within a lateral distance of 2 mm. No significant group parasagittal errors were seen in 14/14 parameters, including tonsillar position within a lateral distance of 2 mm. Conclusion Our results show that the absolute errors for imprecise midsagittal plane selection may impact the clinical assessment of an individual patient. However, the impact on group measurements, such as in a research setting, will be minimal.	[Morkos, Mark; Eppelheimer, Maggie; Nwotchouang, Blaise Simplice Talla] Univ Akron, Dept Biomed Engn, Conquer Chiari Res Ctr, Akron, OH USA; [Ebrahimzadeh, Seyed Amir; Bhadelia, Rafeeque A.] Harvard Med Sch, Dept Radiol, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Loth, Dorothy; Allen, Philip A.] Univ Akron, Dept Psychol, Conquer Chiari Res Ctr, Akron, OH USA; [Lothid, Francis] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA USA; [Lothid, Francis] Northeastern Univ, Dept Bioengn, Boston, MA USA	University System of Ohio; University of Akron; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University System of Ohio; University of Akron; Northeastern University; Northeastern University	Morkos, M (corresponding author), Univ Akron, Dept Biomed Engn, Conquer Chiari Res Ctr, Akron, OH USA.	mam585@uakron.edu			Conquer Chiari; National Institutes of Health, NINDS R15 [1R15NS109957-01A1]	Conquer Chiari; National Institutes of Health, NINDS R15	The authors would like to thank Conquer Chiari and the National Institutes of Health, NINDS R15 (Grant No. 1R15NS109957-01A1), for funding this research work, granted to FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkoc OA, 2015, J KOREAN NEUROSURG S, V58, P454, DOI 10.3340/jkns.2015.58.5.454; Allen PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094844; Biswas D, 2019, ANN BIOMED ENG, V47, P731, DOI 10.1007/s10439-018-02175-z; Ebrahimzadeh SA, 2022, NEURORADIOL J, V35, P233, DOI 10.1177/19714009211041524; Eppelheimer MS, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00002; Garcia MA, 2019, DISABIL HEALTH J, V12, P649, DOI 10.1016/j.dhjo.2019.05.004; Houston JR, 2019, NEURORADIOL J, V32, P458, DOI 10.1177/1971400919857212; Houston JR, 2019, NEUROPSYCHOLOGY, V33, P725, DOI 10.1037/neu0000547; Houston JR, 2018, J NEURORADIOLOGY, V45, P23, DOI 10.1016/j.neurad.2017.06.006; Kuijf HJ, 2014, NEUROINFORMATICS, V12, P395, DOI 10.1007/s12021-013-9215-0; Milhorat TH, 1999, NEUROSURGERY, V44, P1005, DOI 10.1097/00006123-199905000-00042; Richfield J., 2022, DIFFERENT SECTIONAL; Wu HS, 2014, PHYS MED BIOL, V59, P1367, DOI 10.1088/0031-9155/59/6/1367; Yucel F, 2014, ADV CLIN EXP MED, V23, P91	14	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2022	17	8								10.1371/journal.pone.0272725	http://dx.doi.org/10.1371/journal.pone.0272725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6G3CG	35947605	gold, Green Published			2022-12-26	WOS:000884632900001
J	Sun, F; Qian, P; Cao, SH; Chen, YP; Feng, ZY				Sun, Fei; Qian, Peng; Cao, Shouhui; Chen, Yuping; Feng, Ziyue			The impact of crop specialization on nutritional intake: Evidence from farm households in China	PLOS ONE			English	Article							DIETARY DIVERSITY; FOOD-CONSUMPTION; RURAL POVERTY; DIVERSIFICATION	BackgroundIn the wake of the severe impact of COVID-19 on the food security of the vulnerable groups in rural areas, the issue of how to achieve the Sustainable Development Goals 2 aims to "Zero Hunger" (SDG 2) and ensure the food safety of farmers has drawn unprecedented attention. Nutritional intake is generally used as an important indicator to reflect family food security. Under the background that Chinese farmers have gradually changed from the traditional diversified production mode to the specialized production of crops, the main purpose of this article is to explore what are the impact of crop specialization on farmers' nutritional intake? Could the specialization of crop production be taken as an important measure to ensure the food safety of farmers and achieve the SDG 2? MethodsBased on the micro-survey data from 866 farmer households in China, this paper using Seemingly Unrelated Regressions model, Group Regression model and Mediating Effect model to analyze the average and heterogeneous effects of crop specialization on the nutritional intake of farmers, as well as the mediating effect of income. In addition, robustness test and endogenous treatment were performed by using alternative explanatory variables and IV-2SLS method was used to estimate the results. ResultsAfter correcting for endogenous bias, crop specialization had a significant negative impact on energy intake and fat intake of farmers at the statistical level of 5% and 1% respectively, especially for farmers in mountainous areas. Household income played a mediating effect on the effect of crop specialization on farmers' energy and fat intake, and the proportion of the masking effect was 8.43% and 8.96% respectively. In addition, household financial capital and social capital have a significant positive impact on farmers' nutritional intake. ConclusionsCrop specialization cannot guarantee the food safety of farmers in terms of nutritional intake. However, when the development trend of crop specialization is irreversible, more attention should be paid to improving the level of various livelihood capital of farmers, especially those in mountainous areas, and to continuously increasing their income to ease and ultimately eliminate the negative impact of crop specialization on farmers' nutritional intake, which finally make everyone realize the SDG 2.	[Sun, Fei] Xuzhou Adm Inst, Ctr Social Survey Res, Xuzhou, Peoples R China; [Qian, Peng; Cao, Shouhui; Chen, Yuping] Zhongnan Univ Econ & Law, Sch Business Adm, Wuhan, Peoples R China; [Feng, Ziyue] Zhongnan Univ Econ & Law, Sch Econ, Wuhan, Peoples R China	Zhongnan University of Economics & Law; Zhongnan University of Economics & Law	Cao, SH (corresponding author), Zhongnan Univ Econ & Law, Sch Business Adm, Wuhan, Peoples R China.	caosh106@sina.com		Sun, Fei/0000-0002-5524-5668; Cao, Shouhui/0000-0002-1538-6976	Planning Fund Project of Humanities and Social Sciences of Ministry of Education of China [18YJA790013]; General Project of National Social Science Foundation of China [20BGL249]	Planning Fund Project of Humanities and Social Sciences of Ministry of Education of China; General Project of National Social Science Foundation of China	YC, the Planning Fund Project of Humanities and Social Sciences of Ministry of Education of China, grant/award number: 18YJA790013, Yuping Chen, https://www.sinoss. net/c/2018-07-31/549976.shtml. YES-Formal analysis, funding acquisition, resources, writing -review & editing. YC, the General Project of National Social Science Foundation of China, grant/ award number: 20BGL249, Yuping Chen, http:// www.nopss.gov.cn/n1/2020/0927/c219469-31876995.html. YES-Formal analysis, funding acquisition, resources, writing -review & editing.	Argyropoulou SE, 2016, THESIS WAGENINGEN U; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bentolila S, 2010, ECONOMICA, V77, P20, DOI 10.1111/j.1468-0335.2008.00717.x; Card D, 1996, J ECON PERSPECT, V10, P31, DOI 10.1257/jep.10.4.31; Chinnadurai M., 2016, Agricultural Economics Research Review, V29, P149; DFID, SUST LIV GUID SHEETS; Ellis F, 1998, J DEV STUD, V35, P1, DOI 10.1080/00220389808422553; Ellis Frank, 2000, RURAL LIVELIHOODS DI; FAO, STAT FOOD SEC NUTR W; Fongar A, 2019, PUBLIC HEALTH NUTR, V22, P391, DOI 10.1017/S1368980018002756; FSIN GNAFC, 2021, GLOB REP FOOD CRIS J; Gu R., 2016, FOOD NUTR CHINA, V1, P10; Hawkes C., AGR NUTR PATHWAYS SY; Huang ZY., 2019, SCI AGRIC SINICA, V18, P31; *IFPRI, 2017, 2017 GLOB FOOD POL R; Jones AD, 2017, J NUTR, V147, P86, DOI 10.3945/jn.116.235879; Kasem S, 2011, LAND USE POLICY, V28, P618, DOI 10.1016/j.landusepol.2010.12.001; Kennedy G, 2010, PUBLIC HEALTH NUTR, V13, P2010, DOI 10.1017/S136898001000145X; Lourme-Ruiz A, 2016, CAH AGRIC, V25, DOI 10.1051/cagri/2016038; Luo BL., 2017, AGR FAMILY MANAGEMEN; Meng X, 2009, ECON DEV CULT CHANGE, V57, P261, DOI 10.1086/592838; Min S, 2019, J INTEGR AGR, V18, P1780, DOI 10.1016/S2095-3119(19)62588-8; Mofya-Mukuka R, 2018, FOOD SECUR, V10, P1449, DOI 10.1007/s12571-018-0872-6; Mukherjee A, 2015, ECON STUD INEQUAL SO, P125, DOI 10.1007/978-981-287-420-7_7; Nie FY., 2011, FOOD SECURITY VULNER; Oster E, 2019, J BUS ECON STAT, V37, P187, DOI 10.1080/07350015.2016.1227711; Pellegrini L, 2014, CAN J DEV STUD, V35, P211, DOI 10.1080/02255189.2014.898580; Qin Y, 2016, WORLD DEV, V77, P1, DOI 10.1016/j.worlddev.2015.08.007; Rahman S, 2009, FOOD POLICY, V34, P340, DOI 10.1016/j.foodpol.2009.02.004; Roberts AA, 2019, J PUBLIC HEALTH AFR, V10, P35, DOI 10.4081/jphia.2019.885; Schmitz A., 2015, FOOD SECURITY STARVA; Schultz TW., 1993, ORIGINS INCREASING R; Sekabira H, 2020, SUSTAINABILITY-BASEL, V2, P1; Sibhatu KT, 2018, FOOD POLICY, V77, P1, DOI 10.1016/j.foodpol.2018.04.013; Sibhatu KT, 2018, FOOD SECUR, V10, P47, DOI 10.1007/s12571-017-0762-3; Sibhatu KT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186406; Thorne-Lyman AL, 2010, J NUTR, V140, p182S, DOI 10.3945/jn.109.110809; United Nations, 2015, SUSTAINABLE DEV GOAL, DOI DOI 10.1163/157180910X12665776638740; WBG, PROD DIV AFR AGR ITS; Wu HT, 2015, CHINA AGR ECON REV, V7, P65, DOI 10.1108/CAER-01-2014-0005; Yang XK., 1993, SPECIALIZATION EC OR; Yang XK, 2000, EC NEW CLASSICAL VER; [余颖雅 Yu Yingya], 2017, [中国农业大学学报, Journal of China Agricultural University], V22, P192	43	0	0	10	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2022	17	8							e0272347	10.1371/journal.pone.0272347	http://dx.doi.org/10.1371/journal.pone.0272347			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5A3IT	35930562	gold, Green Published			2022-12-26	WOS:000862784200012
J	Avian, M; Mancini, L; Voltolini, M; Bonnet, D; Dreossi, D; Macaluso, V; Pillepich, N; Prieto, L; Ramsak, A; Terlizzi, A; Motta, G				Avian, Massimo; Mancini, Lucia; Voltolini, Marco; Bonnet, Delphine; Dreossi, Diego; Macaluso, Vanessa; Pillepich, Nicole; Prieto, Laura; Ramsak, Andreja; Terlizzi, Antonio; Motta, Gregorio			A novel endocast technique providing a 3D quantitative analysis of the gastrovascular system in Rhizostoma pulmo: An unexpected through-gut in cnidaria	PLOS ONE			English	Article							INDEPENDENT EVOLUTION; JELLYFISH; MEDUSOZOAN; CTENOPHORA; GENOME	The investigation of jellyfish gastrovascular systems mainly focused on stain injections and dissections, negatively affected by thickness and opacity of the mesoglea. Therefore, descriptions are incomplete and data about tridimensional structures are scarce. In this work, morphological and functional anatomy of the gastrovascular system of Rhizostoma pulmo (Macri 1778) was investigated in detail with innovative techniques: resin endocasts and 3D X-ray computed microtomography. The gastrovascular system consists of a series of branching canals ending with numerous openings within the frilled margins of the oral arms. Canals presented a peculiar double hemi-canal structure with a medial adhesion area which separates centrifugal and centripetal flows. The inward flow involves only the "mouth" openings on the internal wing of the oral arm and relative hemi-canals, while the outward flow involves only the two outermost wings' hemi-canals and relative "anal" openings on the external oral arm. The openings differentiation recalls the functional characteristics of a through-gut apparatus. We cannot define the gastrovascular system in Rhizostoma pulmo as a traditional through-gut, rather an example of adaptive convergence, that partially invalidates the paradigm of a single oral opening with both the uptake and excrete function.	[Avian, Massimo; Macaluso, Vanessa; Pillepich, Nicole; Terlizzi, Antonio; Motta, Gregorio] Univ Trieste, Dept Life Sci, Trieste, Italy; [Mancini, Lucia; Voltolini, Marco; Dreossi, Diego] Elettra Sincrotrone Trieste SCpA, Trieste, Italy; [Bonnet, Delphine] Univ Montpellier, IFREMER, CNRS, MARBEC,IRD, Montpellier, France; [Prieto, Laura] Inst Ciencias Marinas Andalucia CSIC, Dept Ecol & Coastal Management, Grp Ecosyst Oceanog, Cadiz, Spain; [Ramsak, Andreja] Natl Inst Biol, Marine Biol Stn, Piran, Slovenia; [Terlizzi, Antonio; Motta, Gregorio] Dept Integrat Marine Ecol EMI, Stn Zool Anton Dohrn, Naples, Italy; [Mancini, Lucia] Slovenian Natl Bldg & Civil Engn Inst, Ljubljana, Slovenia; [Voltolini, Marco] Univ Milan, Dept Earth Sci Ardito Desio, Milan, Italy	University of Trieste; Elettra Sincrotrone Trieste; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); National Institute of Biology - Slovenia; Stazione Zoologica Anton Dohrn di Napoli; University of Milan	Avian, M (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	avian@units.its	; Prieto, Laura/B-3986-2009	Avian, Massimo/0000-0001-5562-6471; Prieto, Laura/0000-0003-4704-7757; Ramsak, Andreja/0000-0003-1961-5120				[Anonymous], CNID; ARAI MN, 1989, J PLANKTON RES, V11, P609; Arai MN, 1997, FUNCTIONAL BIOL SCYP; Brotz L, 2012, HYDROBIOLOGIA, V690, P3, DOI 10.1007/s10750-012-1039-7; Canepa Antonio, 2014, P237; Dougherty R., 2007, MICROSC MICROANAL, V13, P1678, DOI DOI 10.1017/S1431927607074430; Dular M, 2009, ENG APPL COMP FLUID, V3, P258, DOI 10.1080/19942060.2009.11015269; Dunn CW, 2015, TRENDS ECOL EVOL, V30, P282, DOI 10.1016/j.tree.2015.03.003; Duquet M, 1992, INVERTEBRES MARINS P; Fankboner P.V., 2003, ENCY LIFE SCI, P1; Feitl KE, 2009, BIOL BULL-US, V217, P283, DOI 10.1086/BBLv217n3p283; Han J, 2016, GONDWANA RES, V31, P150, DOI 10.1016/j.gr.2015.01.003; Hejnol A, 2008, NATURE, V456, P382, DOI 10.1038/nature07309; Hejnol A, 2015, ZOOL ANZ, V256, P61, DOI 10.1016/j.jcz.2015.02.006; Jarms G., 2019, WORLD ATLAS JELLYFIS; Jennings J.B, 1972, FEEDING DIGESTION AS; Kak A.C., 2001, PRINCIPLES COMPUTERI, V8, P180; Kapli P, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5162; Kayal E, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1142-0; Kogovsek T, 2010, HYDROBIOLOGIA, V645, P81, DOI 10.1007/s10750-010-0217-8; LARSON RJ, 1979, MAR BEHAV PHYSIOL, V6, P123, DOI 10.1080/10236247909378559; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Leoni V, 2021, GLOBAL ECOL BIOGEOGR, V30, P622, DOI 10.1111/geb.13241; Licandro P, 2010, BIOL LETTERS, V6, P688, DOI 10.1098/rsbl.2010.0150; MACKIE GO, 1989, ACTA ZOOL-STOCKHOLM, V70, P133, DOI 10.1111/j.1463-6395.1989.tb01063.x; Macri S, 1778, NUOVE OSSERVAZIONI I; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Musgrave EM, 1909, Q J MICROSC SCI, V54, P443; Nagata RM, 2016, MAR ECOL PROG SER, V557, P145, DOI 10.3354/meps11855; Nielsen C, 2013, OXFORD U PRESS DEMAN, V53, P1689; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Presnell JS, 2016, CURR BIOL, V26, P2814, DOI 10.1016/j.cub.2016.08.019; Rudolf D, 2010, COMM COM INF SC, V68, P59, DOI 10.1007/978-3-642-11840-1_5; Ruppert EE, 2004, INVERTEBRATE ZOOLOGY; Russell F. S., 1970, MEDUSAE BRIT ISLES; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Schierwater B., 2021, INVERTEBR ZOOL; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt-Rhaesa A, 2007, EVOLUTION ORGAN SYST; Smith H. G., 1937, Papers from the Tortugas Laboratory of the Carnegie Institution of Washington, V31, P17; SOUTHWARD AJ, 1955, J MAR BIOL ASSOC UK, V34, P201, DOI 10.1017/S0025315400027570; Steinmetz PRH, 2012, NATURE, V487, P231, DOI 10.1038/nature11180; Stiasny G., 1923, Zoologischer Anzeiger, V57, P241; STIASNY G., 1928, ZOOL MEDEDEEL, V11, P177; Stiasny G., 1921, Zoologische Mededeelingen Leiden, V6, P109; Tamm SL, 2016, SCIENCE, V352, P1182, DOI 10.1126/science.aaf8170; Voltoini M, 2017, GEODERMA, V305, P382, DOI 10.1016/j.geoderma.2017.06.005; Voltolini M, 2017, INT J GREENH GAS CON, V66, P230, DOI 10.1016/j.ijggc.2017.10.002; Wang X, 2017, PALAEONTOLOGY, V60, P853, DOI 10.1111/pala.12320; Whelan NV, 2015, P NATL ACAD SCI USA, V112, P5773, DOI 10.1073/pnas.1503453112	51	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272023	10.1371/journal.pone.0272023	http://dx.doi.org/10.1371/journal.pone.0272023			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925896	gold, Green Published			2022-12-26	WOS:000848077100064
J	Duan, JB; Wang, Q; Zhang, B; Liu, C; Li, CR; Wang, L				Duan, Junbo; Wang, Qing; Zhang, Bo; Liu, Chen; Li, Chenrui; Wang, Lei			Accurate detection of atrial fibrillation events with R-R intervals from ECG signals	PLOS ONE			English	Article							RATE-INDEPENDENT DETECTION; PEAKS	Atrial fibrillation (AF) is a typical category of arrhythmia. Clinical diagnosis of AF is based on the detection of abnormal R-R intervals (RRIs) with an electrocardiogram (ECG). Previous studies considered this detection problem as a classification problem and focused on extracting a number of features. In this study we demonstrate that instead of using any specific numerical characteristic as the input feature, the probability density of RRIs from ECG conserves comprehensive statistical information; hence, is a natural and efficient input feature for AF detection. Incorporated with a support vector machine as the classifier, results on the MIT-BIH database indicates that the proposed method is a simple and accurate approach for AF detection in terms of accuracy, sensitivity, and specificity.	[Duan, Junbo; Zhang, Bo; Liu, Chen; Li, Chenrui] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Minist Educ, Xian, Peoples R China; [Duan, Junbo; Zhang, Bo; Liu, Chen; Li, Chenrui] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Dept Biomed Engn, Xian, Peoples R China; [Wang, Qing] Xidian Univ, Sch Elect Engn, Xian, Peoples R China; [Wang, Lei] Weinan Cent Hosp, Cardiovasc Med, Weinan, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xidian University	Duan, JB (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Minist Educ, Xian, Peoples R China.; Duan, JB (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Dept Biomed Engn, Xian, Peoples R China.	junbo.duan@mail.xjtu.edu.cn			National Science Foundation of China [61771381]; Provincial Science Foundation of Shaanxi [2021JM-128]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Science Foundation of Shaanxi	This study was partially supported by National Science Foundation of China under grant number 61771381, and Provincial Science Foundation of Shaanxi under grant number 2021JM-128. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdala A, 2017, J PHYS CONF SER, V795, DOI 10.1088/1742-6596/795/1/012038; Andersen RS, 2019, EXPERT SYST APPL, V115, P465, DOI 10.1016/j.eswa.2018.08.011; Andersen RS, 2017, IEEE ENG MED BIO, P2039, DOI 10.1109/EMBC.2017.8037253; Babaeizadeh S, 2009, J ELECTROCARDIOL, V42, P522, DOI 10.1016/j.jelectrocard.2009.06.006; Benitez D, 2001, COMPUT BIOL MED, V31, P399, DOI 10.1016/S0010-4825(01)00009-9; Buscema PM, 2020, COMPUT METH PROG BIO, V191, DOI 10.1016/j.cmpb.2020.105401; Centers for Disease Control and Prevention, CTR DIS CONTROL PREV; Chen Z., 2018, J BIOMED ENG, V35, P56; Colloca R, 2013, COMPUT CARDIOL CONF, V40, P1047; Cui XR, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19120677; Czabanski R, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20030765; Dash S, 2009, ANN BIOMED ENG, V37, P1701, DOI 10.1007/s10439-009-9740-z; Du XC, 2014, ANN NONINVAS ELECTRO, V19, P217, DOI 10.1111/anec.12111; Dunn J, 2018, PERS MED, V15, P429, DOI 10.2217/pme-2018-0044; Faust O, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093093; Faust O, 2018, COMPUT BIOL MED, V102, P327, DOI 10.1016/j.compbiomed.2018.07.001; Garcia M, 2016, COMPUT METH PROG BIO, V131, P157, DOI 10.1016/j.cmpb.2016.04.009; Ghosh SK, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-01565-y; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Hu YS, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01337-1; Huang C, 2011, IEEE T BIO-MED ENG, V58, P1113, DOI 10.1109/TBME.2010.2096506; Islam MS, 2016, COMPUT BIOL MED, V72, P160, DOI 10.1016/j.compbiomed.2016.03.015; Ivanovic MD, 2019, IEEE ENG MED BIO, P1780, DOI 10.1109/EMBC.2019.8856806; Kennedy A, 2016, J ELECTROCARDIOL, V49, P871, DOI 10.1016/j.jelectrocard.2016.07.033; Kumar M, 2018, BIOCYBERN BIOMED ENG, V38, P564, DOI 10.1016/j.bbe.2018.04.004; Ladavich S, 2015, BIOMED SIGNAL PROCES, V18, P274, DOI 10.1016/j.bspc.2015.01.007; Lake DE, 2011, AM J PHYSIOL-HEART C, V300, pH319, DOI 10.1152/ajpheart.00561.2010; Lan Tianjie, 2019, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V36, P521, DOI 10.7507/1001-5515.201808019; Li YJ, 2017, AUSTRALAS PHYS ENG S, V40, P707, DOI 10.1007/s13246-017-0554-2; Lian J, 2011, AM J CARDIOL, V107, P1494, DOI 10.1016/j.amjcard.2011.01.028; Logan B, 2005, COMPUT CARDIOL, V32, P619; Manikandan MS, 2012, BIOMED SIGNAL PROCES, V7, P118, DOI 10.1016/j.bspc.2011.03.004; Marsili IA, 2020, COMPUT BIOL MED, V116, DOI 10.1016/j.compbiomed.2019.103540; Merah M, 2015, COMPUT METH PROG BIO, V121, P149, DOI 10.1016/j.cmpb.2015.06.003; Moody G. B., 1983, Computers in Cardiology 10th Annual Meeting (IEEE Cat. No. 83CH1927-3), P227; Mousavi S, 2020, COMPUT BIOL MED, V127, DOI 10.1016/j.compbiomed.2020.104057; Munger TM, 2014, J BIOMED RES, V28, P1, DOI 10.7555/JBR.28.20130191; Nuryani N, 2015, PROCEEDING JOINT INTERNATIONAL CONFERENCE ON ELECTRIC VEHICULAR TECHNOLOGY AND INDUSTRIAL, MECHANICAL, ELECTRICAL, AND CHEMICAL ENGINEERING (ICEVT & IMECE), P215, DOI 10.1109/ICEVTIMECE.2015.7496672; Petrenas A, 2015, COMPUT BIOL MED, V65, P184, DOI 10.1016/j.compbiomed.2015.01.019; Petrucci E, 2005, COMPUT CARDIOL, V32, P623; Petrutiu S, 2007, EUROPACE, V9, P466, DOI 10.1093/europace/eum096; PhysioNet, PHYSIONET; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Ravanshad N, 2014, IEEE J BIOMED HEALTH, V18, P183, DOI 10.1109/JBHI.2013.2274809; Shao MG, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20030606; Silva Ikaro, 2014, J Open Res Softw, V2; Tateno K, 2001, MED BIOL ENG COMPUT, V39, P664, DOI 10.1007/BF02345439; Tison GH, 2018, JAMA CARDIOL, V3, P409, DOI 10.1001/jamacardio.2018.0136; Vapnik V., 1998, STAT LEARNING THEORY; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wrobel J, 2018, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE MIXED DESIGN OF INTEGRATED CIRCUITS AND SYSTEM (MIXDES 2018), P460; Zhou XL, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-18	52	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271596	10.1371/journal.pone.0271596	http://dx.doi.org/10.1371/journal.pone.0271596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925979	gold, Green Published			2022-12-26	WOS:000848077100044
J	Liu, SS; Chan, KKL; Wei, TN; Tse, KY; Ngu, SF; Chu, MMY; Lau, LSK; Cheung, ANY; Ngan, HYS				Liu, Stephanie S.; Chan, Karen K. L.; Wei, Tina N.; Tse, Ka Yu; Ngu, Siew F.; Chu, Mandy M. Y.; Lau, Lesley S. K.; Cheung, Annie N. Y.; Ngan, Hextan Y. S.			Clinical performance of the Roche Cobas 4800 HPV test for primary cervical cancer screening in a Chinese population	PLOS ONE			English	Article							HYBRID CAPTURE 2; HUMAN-PAPILLOMAVIRUS; INTRAEPITHELIAL NEOPLASIA; RISK; PREVENTION; WOMEN; ASSAY; GENOTYPES; TRIAGE	High-risk human papillomavirus (HR-HPV) testing has become an increasing important strategy in primary cervical cancer screening in recent years. It warrants the evaluation of molecular-based HPV tests for accuracy and efficacy of screening. The performance of Roche Cobas 4800 HPV test was validated and compared with Digene Hybrid Capture 2 (HC2) high-risk HPV DNA test for primary screening in a large Chinese screening cohort. Of 6345 women screened, overall agreement between Cobas and HC2 was 92.23% (95% CI: 91.57-92.89). The inter-assay agreement was correlated with the severity of underlying biology, with an increasing concordance found in samples with more severe abnormalities. Most of the discordant samples had the test signal strength closer to the test limits of the detection than concordant samples, reflecting a low viral load and infection of a cluster of low-risk HPV in these samples. The Cobas test demonstrated significantly higher specificity in identifying CIN2+/CIN3+ cases than HC2 test (66.46% vs 43.67% and 65.42% vs 42.86%, p<0.001), with comparable sensitivity in clinical evaluation. Increased specificity of Cobas test would accent women having the highest risk of developing CIN2+, with the potential to reduce unnecessary colposcopy referral in a screening population.	[Liu, Stephanie S.; Chan, Karen K. L.; Wei, Tina N.; Tse, Ka Yu; Ngu, Siew F.; Chu, Mandy M. Y.; Lau, Lesley S. K.; Ngan, Hextan Y. S.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Obstet & Gynaecol, Hong Kong, Peoples R China; [Cheung, Annie N. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Ngan, HYS (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Obstet & Gynaecol, Hong Kong, Peoples R China.	hysngan@hku.hk						Arbyn M, 2015, CLIN MICROBIOL INFEC, V21, P817, DOI 10.1016/j.cmi.2015.04.015; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Bosgraaf RP, 2013, OBSTET GYNECOL, V121, P1209, DOI 10.1097/AOG.0b013e318293ab22; Castle PE, 2002, CANCER EPIDEM BIOMAR, V11, P1394; Castle PE, 2008, J CLIN MICROBIOL, V46, P2595, DOI 10.1128/JCM.00824-08; Castle PE, 2008, J CLIN MICROBIOL, V46, P109, DOI 10.1128/JCM.01667-07; Castle PE, 2012, VACCINE, V30, pF117, DOI 10.1016/j.vaccine.2012.05.071; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Chan KKL, 2020, INT J CANCER, V147, P1152, DOI 10.1002/ijc.32861; Cook DA, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1959-5; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; Ebisch RMF, 2016, BJOG-INT J OBSTET GY, V123, P59, DOI 10.1111/1471-0528.13530; Franco EL, 2001, CAN MED ASSOC J, V164, P1017; Gage JC, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju153; Gage JC, 2011, J CLIN MICROBIOL, V49, P4185, DOI 10.1128/JCM.01254-11; Heideman DAM, 2011, J CLIN MICROBIOL, V49, P3983, DOI 10.1128/JCM.05552-11; Huijsmans CJJ, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2961-2; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Levi AW, 2016, ARCH PATHOL LAB MED, V140, P153, DOI 10.5858/arpa.2015-0027-OA; Lindemann MLM, 2012, J MOL DIAGN, V14, P65, DOI 10.1016/j.jmoldx.2011.09.005; Meijer CJLM, 2009, INT J CANCER, V124, P516, DOI 10.1002/ijc.24010; Monsonego J, 2015, GYNECOL ONCOL, V137, P47, DOI 10.1016/j.ygyno.2015.01.551; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Nieves L, 2013, INT J GYNECOL CANCER, V23, P513, DOI 10.1097/IGC.0b013e318280f3bc; Poljak M, 2020, CLIN MICROBIOL INFEC, V26, P1144, DOI 10.1016/j.cmi.2020.03.033; Poljak M, 2002, J CLIN VIROL, V25, pS89; Rao A, 2013, J CLIN VIROL, V58, P161, DOI 10.1016/j.jcv.2013.06.041; Rebolj M, 2016, J CLIN MICROBIOL, V54, P2669, DOI 10.1128/JCM.01321-16; Rebolj M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086835; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Schiffman M, 2015, CANCER EPIDEM BIOMAR, V24, P1304, DOI 10.1158/1055-9965.EPI-14-1353; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT; Vink MA, 2015, INT J CANCER, V137, P420, DOI 10.1002/ijc.29381; Wright TC, 2011, AM J CLIN PATHOL, V136, P578, DOI 10.1309/AJCPTUS5EXAS6DKZ; Wu RF, 2010, INT J GYNECOL CANCER, V20, P1411, DOI 10.1111/IGC.0b013e3181f29547; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	38	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8							e0272721	10.1371/journal.pone.0272721	http://dx.doi.org/10.1371/journal.pone.0272721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P8ZE	35930575	gold, Green Published			2022-12-26	WOS:000837822100009
J	Moshkovits, Y; Rott, D; Chetrit, A; Dankner, R				Moshkovits, Yonatan; Rott, David; Chetrit, Angela; Dankner, Rachel			The insulin sensitivity Mcauley index (MCAi) is associated with 40-year cancer mortality in a cohort of men and women free of diabetes at baseline	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; SERUM TRIGLYCERIDES; METABOLIC SYNDROME; PLASMA-GLUCOSE; RISK; RESISTANCE; METAANALYSIS; DIAGNOSIS; MELLITUS; HEALTH	BackgroundThe association between insulin resistance and cancer-mortality is not fully explored. We investigated the association between several insulin sensitivity indices (ISIs) and cancer-mortality over 3.5 decades in a cohort of adult men and women. We hypothesized that higher insulin resistance will be associated with greater cancer-mortality risk. MethodsA cohort of 1,612 men and women free of diabetes during baseline were followed since 1979 through 2016 according to level of insulin resistance (IR) for cause specific mortality, as part of the Israel study on Glucose Intolerance, Obesity and Hypertension (GOH). IR was defined according to the Mcauley index (MCAi), calculated by fasting insulin and triglycerides, the Homeostatic Model Assessment (HOMA), the Matsuda Insulin Sensitivity Index (MISI), and the Quantitative Insulin Sensitivity Check Index (QUICKI), calculated by plasma glucose and insulin. ResultsMean age at baseline was 51.5 +/- 8.0 years, 804 (49.9%) were males and 871 (54.0%) had prediabetes. Mean follow-up was 36.7 +/- 0.2 years and 47,191 person years were accrued. Cox proportional hazard model and competing risks analysis adjusted for age, sex, country of origin, BMI, blood pressure, total cholesterol, smoking and glycemic status, revealed an increased risk for cancer-mortality, HR = 1.5 (95% CI: 1.1-2.0, p = 0.005) for the MCAi Q(1) compared with Q(2-4). No statistically significant associations were observed between the other ISIs and cancer-mortality. ConclusionThe MCAi was independently associated with an increased risk for cancer-mortality in adult men and women free of diabetes and should be further studied as an early biomarker for cancer risk.	[Moshkovits, Yonatan; Dankner, Rachel] Tel Aviv Univ, Sch Publ Hlth, Sackler Sch Med, Dept Epidemiol & Prevent Med, Tel Aviv, Israel; [Moshkovits, Yonatan; Rott, David] Leviev Heart Ctr, Sheba Med Ctr, Ramat Gan, Israel; [Chetrit, Angela; Dankner, Rachel] Gertner Inst Epidemiol & Hlth Policy Res, Sheba Med Ctr, Unit Cardiovasc Epidemiol, Ramat Gan, Israel	Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Dankner, R (corresponding author), Tel Aviv Univ, Sch Publ Hlth, Sackler Sch Med, Dept Epidemiol & Prevent Med, Tel Aviv, Israel.; Dankner, R (corresponding author), Gertner Inst Epidemiol & Hlth Policy Res, Sheba Med Ctr, Unit Cardiovasc Epidemiol, Ramat Gan, Israel.	racheld@gertner.health.gov.il	Dankner, Rachel/Q-5245-2019	Dankner, Rachel/0000-0001-6454-6000; Moshkovits, Yonatan/0000-0001-6282-7167				Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Arthur R, 2019, CANCER CAUSE CONTROL, V30, P195, DOI 10.1007/s10552-018-1093-1; Assi HR, 2019, DIABETES-METAB RES, V35, DOI 10.1002/dmrr.3121; Ausk KJ, 2010, DIABETES CARE, V33, P1179, DOI 10.2337/dc09-2110; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; Bowker SL, 2006, DIABETES CARE, V29, P1990, DOI 10.2337/dc06-0997; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Burzawa JK, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.033; CERASI E, 1973, LANCET, V1, P794; Cokkinides V., 2005, AM CANC SOC CANC FAC; Dankner R, 2016, QUAL LIFE RES, V25, P2889, DOI 10.1007/s11136-016-1291-9; Dankner R, 2007, ISRAEL MED ASSOC J, V9, P592; Dankner R, 2018, DIABETES-METAB RES, V34, DOI 10.1002/dmrr.3018; Dankner R, 2016, AM J EPIDEMIOL, V183, P1098, DOI 10.1093/aje/kwv290; Dankner R, 2012, DIABETES CARE, V35, P1538, DOI 10.2337/dc11-1513; De Vegt F, 1998, DIABETES CARE, V21, P1686, DOI 10.2337/diacare.21.10.1686; Emaus A, 2010, BREAST CANCER RES TR, V121, P651, DOI 10.1007/s10549-009-0603-y; Esposito K, 2014, ENDOCRINE, V46, P39, DOI 10.1007/s12020-013-0151-4; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gandini S, 2008, INT J CANCER, V122, P155, DOI 10.1002/ijc.23033; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Goldman A, 2019, INT J CARDIOL, V295, P36, DOI 10.1016/j.ijcard.2019.08.015; Hsing AW, 2003, J NATL CANCER I, V95, P67, DOI 10.1093/jnci/95.1.67; Jaggers JR, 2009, EUR J CANCER, V45, P1831, DOI 10.1016/j.ejca.2009.01.031; Johnson JA, 2011, DIABETOLOGIA, V54, P25, DOI 10.1007/s00125-010-1933-3; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kaye JA, 2002, BRIT J CANCER, V86, P1436, DOI 10.1038/sj.bjc.6600267; Kerr J, 2017, LANCET ONCOL, V18, pE457, DOI 10.1016/S1470-2045(17)30411-4; Kim TJ, 2016, KOREAN J FAM MED, V37, P188, DOI 10.4082/kjfm.2016.37.3.188; Li X, 2017, BREAST, V32, P1, DOI 10.1016/j.breast.2016.11.024; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460; MCKEOWNEYSSEN G, 1994, CANCER EPIDEM BIOMAR, V3, P687; Moshkovits Y, 2021, CARDIOVASC DIABETOL, V20, DOI 10.1186/s12933-021-01284-9; Pan K, 2020, CANCER-AM CANCER SOC, V126, P3638, DOI 10.1002/cncr.33002; Parekh N, 2010, CANCER CAUSE CONTROL, V21, P631, DOI 10.1007/s10552-009-9492-y; Perseghin G, 2012, ACTA DIABETOL, V49, P421, DOI 10.1007/s00592-011-0361-2; Placzkowska S, 2019, BIOMED PAP, V163, P187, DOI 10.5507/bp.2019.021; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Scappaticcio L, 2017, ENDOCRINE, V56, P231, DOI 10.1007/s12020-016-1216-y; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Stocks T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000201; Tsuchida K, 2016, ONCOL LETT, V11, P3337, DOI 10.3892/ol.2016.4415; Ulmer H, 2009, BRIT J CANCER, V101, P1202, DOI 10.1038/sj.bjc.6605264; Vigneri R, 2016, J ENDOCRINOL INVEST, V39, P1365, DOI 10.1007/s40618-016-0508-7; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wulaningsih W, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1928-z; Zhou XH, 2010, DIABETOLOGIA, V53, P1867, DOI 10.1007/s00125-010-1796-7	49	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272437	http://dx.doi.org/10.1371/journal.pone.0272437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921366	Green Submitted, Green Published, gold			2022-12-26	WOS:000839311900010
J	Parisi, L; Toffoli, A; Ghezzi, B; Lagonegro, P; Trevisi, G; Macaluso, GM				Parisi, Ludovica; Toffoli, Andrea; Ghezzi, Benedetta; Lagonegro, Paola; Trevisi, Giovanna; Macaluso, Guido M.			Preparation of hybrid samples for scanning electron microscopy (SEM) coupled to focused ion beam (FIB) analysis: A new way to study cell adhesion to titanium implant surfaces	PLOS ONE			English	Article							INTERFERENCE-CONTRAST MICROSCOPY; BONE APPOSITION; SOFT; HYDROPHILICITY; FLUORESCENCE; DEFECTS	The study of the intimate connection occurring at the interface between cells and titanium implant surfaces is a major challenge for dental materials scientists. Indeed, several imaging techniques have been developed and optimized in the last decades, but an optimal method has not been described yet. The combination of the scanning electron microscopy (SEM) with a focused ion beam (FIB), represents a pioneering and interesting tool to allow the investigation of the relationship occurring at the interface between cells and biomaterials, including titanium. However, major caveats concerning the nature of the biological structures, which are not conductive materials, and the physico-chemical properties of titanium (i.e. color, surface topography), require a fine and accurate preparation of the sample before its imaging. Hence, the aim of the present work is to provide a suitable protocol for cell-titanium sample preparation before imaging by SEM-FIB. The concepts presented in this paper are also transferrable to other fields of biomaterials research.	[Parisi, Ludovica] Univ Bern, Dept Orthodont & Dentofacial Orthoped, Lab Oral Mol Biol, Bern, Switzerland; [Toffoli, Andrea; Ghezzi, Benedetta; Macaluso, Guido M.] Univ Parma, Ctr Univ Odontoiatria, Parma, Italy; [Toffoli, Andrea; Macaluso, Guido M.] Univ Parma, Dipartimento Med & Chirurg, Parma, Italy; [Lagonegro, Paola] CNR SCITEC, Milan, Italy; [Trevisi, Giovanna; Macaluso, Guido M.] IMEM CNR, Parma, Italy	University of Bern; University of Parma; University of Parma; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Tecnologie Chimiche "Giulio Natta" (SCITEC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto dei Materiali per l'Elettronica ed il Magnetismo (IMEM-CNR)	Parisi, L (corresponding author), Univ Bern, Dept Orthodont & Dentofacial Orthoped, Lab Oral Mol Biol, Bern, Switzerland.	ludovica.parisi@zmk.unibe.ch		GHEZZI, BENEDETTA/0000-0002-8922-2915				Bornstein MM, 2008, CLIN ORAL IMPLAN RES, V19, P233, DOI 10.1111/j.1600-0501.2007.01473.x; Branemark Per-ingvar, 2003, Int J Oral Maxillofac Implants, V18, P770; Briggs JAG, 2013, CURR OPIN STRUC BIOL, V23, P261, DOI 10.1016/j.sbi.2013.02.003; Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704; Cizmar P, 2017, METHODS MOL BIOL, V1660, P221, DOI 10.1007/978-1-4939-7253-1_18; Curi MM, 2012, J ORAL MAXIL SURG, V70, P1551, DOI 10.1016/j.joms.2012.03.011; Fischer K, 2013, CLIN IMPLANT DENT R, V15, P498, DOI 10.1111/j.1708-8208.2011.00383.x; Fish Kenneth N, 2009, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1218s50; GINGELL D, 1987, J CELL SCI, V87, P677; Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006; Kiessling V, 2003, BIOPHYS J, V84, P408, DOI 10.1016/S0006-3495(03)74861-9; Kokovic V, 2014, CLIN ORAL IMPLAN RES, V25, pE114, DOI 10.1111/clr.12072; Lagonegro P, 2018, DENT MATER J, V37, P278, DOI 10.4012/dmj.2017-008; LANDIS WJ, 1978, J ULTRA MOL STRUCT R, V63, P188, DOI 10.1016/S0022-5320(78)80074-4; Lemmens V, 2020, DATA BRIEF, V29, DOI 10.1016/j.dib.2020.105348; Levine RA, 2021, INT J PERIODONT REST, V41, P49, DOI 10.11607/prd.4703; Limozin L, 2009, CHEMPHYSCHEM, V10, P2752, DOI 10.1002/cphc.200900601; McNally EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029258; Parisi L, 2020, MAT SCI ENG C-MATER, V117, DOI 10.1016/j.msec.2020.111307; Parisi L, 2019, NANOMATERIALS-BASEL, V9, DOI 10.3390/nano9101407; Roccuzzo A, 2022, CLIN ORAL IMPLAN RES, V33, P844, DOI 10.1111/clr.13966; Schmid E, 2021, CLIN IMPLANT DENT R, V23, P189, DOI 10.1111/cid.12973; Schmid E, 2020, CLIN ORAL IMPLAN RES, V31, P1243, DOI 10.1111/clr.13672; Schwarz F, 2008, J CLIN PERIODONTOL, V35, P64, DOI 10.1111/j.1600-051X.2007.01159.x; Schwarz F, 2007, J PERIODONTOL, V78, P2171, DOI 10.1902/jop.2007.070157; Toffoli A, 2020, J ORAL SCI, V62, P217, DOI 10.2334/josnusd.19-0235; Toffoli A, 2020, MAT SCI ENG C-MATER, V107, DOI 10.1016/j.msec.2019.110250; Wolff A, 2018, J MICROSC-OXFORD, V272, P47, DOI 10.1111/jmi.12731	28	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272486	http://dx.doi.org/10.1371/journal.pone.0272486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917303	gold, Green Published			2022-12-26	WOS:000837840000023
J	Vernaz, ZJ; Lottero-Leconte, RM; Alonso, CAI; Rio, S; Morales, MF; Arroyo-Salvo, C; Valiente, CCC; Diez, ML; Bogetti, ME; Arenas, G; Rey-Valzacchi, G; Perez-Martinez, S				Vernaz, Zoilo Jose; Lottero-Leconte, Raquel Maria; Alonso, Carlos Agustin Isidro; Rio, Sofia; Morales, Maia Florencia; Arroyo-Salvo, Camila; Valiente, Carla C. C.; Diez, Maria Lovaglio; Bogetti, Maria Eugenia; Arenas, Gabriela; Rey-Valzacchi, Gaston; Perez-Martinez, Silvina			Evaluation of sperm integrin alpha 5 beta 1 as a potential marker of fertility in humans	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; ACROSOME REACTION; BULL SPERM; FIBRONECTIN; SPERMATOZOA; EXPRESSION; CAPACITATION; ADHESION; FERTILIZATION; RECOGNITION	Sperm selection for assisted reproduction techniques is generally based on basic parameters, while key aspects of sperm competence and its journey from the deposition site to the fertilization site are overlooked. Consequently, identifying molecular markers in spermatozoa that can efficiently predict the fertility of a semen sample could be of great interest, particularly in cases of idiopathic male infertility. When spermatozoa reach the female reproductive tract, it provides to them the cellular and molecular microenvironment needed to acquire fertilizing ability. In this sense, considering the role that integrin alpha 5 beta 1 of spermatozoa plays in reproduction-related events, we investigated the correlation between the subcellular localization of sperm integrin alpha 5 beta 1 and early embryo development outcome after in vitro fertilization (IVF) procedures in human. Twenty-four semen samples from normozoospermic men and metaphase II (MII) oocytes from healthy women aged under 38 years, from couples who underwent IVF cycles, were used in this work. Sperm alpha 5 beta 1 localization was evaluated by immunofluorescence assay using an antibody against integrin alpha 5 subunit. Integrin alpha 5 beta 1 was mainly localized in the sperm acrosomal region (45.33 +/- 7.89%) or the equatorial segment (30.12 +/- 7.43%). The early embryo development rate (data obtained from the Fertility Center) correlated positively with the localization of alpha 5 beta 1 in the acrosomal region (number of usable embryos / inseminated oocytes: rho = 0.75; p<0.01 and number of usable embryos/total number of two pronuclear zygotes: rho = 0.80; p<0.01). However, this correlation was not significant when the equatorial segment mark was evaluated. In addition, human sperm released from co-culture with bovine oviductal epithelial cells (BOEC) showed a significant enrichment in the acrosomal localization pattern of alpha 5 beta 1 compared to those sperm that were not co-cultured with BOEC (85.20 +/- 5.35% vs 35.00 +/- 17.09%, respectively, p<0.05). In conclusion, the evaluation of sperm integrin alpha 5 beta 1 immunolocalization could be a useful tool to select sperm with fertilizing ability from human semen samples before IVF procedures.	[Vernaz, Zoilo Jose; Lottero-Leconte, Raquel Maria; Alonso, Carlos Agustin Isidro; Rio, Sofia; Arroyo-Salvo, Camila; Bogetti, Maria Eugenia; Perez-Martinez, Silvina] Univ Buenos Aires, Ctr Estudios Farmacol & Bot CEFYBO, Lab Biol Reprod Mamiferos, CONICET, Buenos Aires, Argentina; [Morales, Maia Florencia; Valiente, Carla C. C.; Diez, Maria Lovaglio; Arenas, Gabriela; Rey-Valzacchi, Gaston] PROCREARTE Red Med Reprod & Mol, Buenos Aires, Argentina; [Alonso, Carlos Agustin Isidro] McGill Univ, Dept Human Genet, Montreal, PQ, Canada	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; McGill University	Perez-Martinez, S (corresponding author), Univ Buenos Aires, Ctr Estudios Farmacol & Bot CEFYBO, Lab Biol Reprod Mamiferos, CONICET, Buenos Aires, Argentina.	perezms@fmed.uba.ar			Ministry of Science, Technology and Productive Innovation, Argentina (FONCyT) [PICT 2016-0870, PICT 2018 1681]	Ministry of Science, Technology and Productive Innovation, Argentina (FONCyT)	Authors thank to Maximiliano Cella for his technical supports.	Agarwal A., 2016, PROTEOMICS HUMAN REP; Agarwal A, 2021, LANCET, V397, P319, DOI 10.1016/S0140-6736(20)32667-2; Al-Dossary AA, 2015, J BIOL CHEM, V290, P17710, DOI 10.1074/jbc.M114.633156; Sedo CA, 2012, HUM REPROD, V27, P1912, DOI 10.1093/humrep/des126; Barraud-Lange V, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228494; Boerke A, 2008, THERIOGENOLOGY, V70, P1188, DOI 10.1016/j.theriogenology.2008.06.021; Cabodi S, 2010, ADV EXP MED BIOL, V674, P43; Candenas L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197022; Cao XD, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0334-1; Castellano L, 2021, THERIOGENOLOGY, V168, P66, DOI 10.1016/j.theriogenology.2021.04.001; Giojalas LC, 2020, MOL CELL ENDOCRINOL, V518, DOI 10.1016/j.mce.2020.110954; D'Occhio MJ, 2020, MOL REPROD DEV, V87, P206, DOI 10.1002/mrd.23312; De Silva T, 2020, AM ECON J-MACROECON, V12, P77, DOI 10.1257/mac.20180296; Diaz ES, 2007, HUM REPROD, V22, P1420, DOI 10.1093/humrep/dem023; Frolikova M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33714; Fusi FM, 1996, MOL HUM REPROD, V2, P169, DOI 10.1093/molehr/2.3.169; FUSI FM, 1992, J ANDROL, V13, P28; Gervasi MG, 2016, J CELL BIOCHEM, V117, P320, DOI 10.1002/jcb.25273; GLANDER HJ, 1993, INT J ANDROL, V16, P105, DOI 10.1111/j.1365-2605.1993.tb01162.x; Gervasi MG, 2009, REPRODUCTION, V137, P403, DOI 10.1530/REP-08-0204; Greither T, 2020, CYTOGENET GENOME RES, V160, P506, DOI 10.1159/000511117; Gunes S, 2020, ANDROLOGIA, DOI 10.1111/and.13586; Hirohashi N, 2008, DEV GROWTH DIFFER, V50, pS221, DOI 10.1111/j.1440-169X.2008.01017.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; Kuo YW, 2016, J REPROD DEVELOP, V62, P337, DOI 10.1262/jrd.2016-028; Lewis SEM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047704; Mahe C, 2021, BIOL REPROD, V105, P317, DOI 10.1093/biolre/ioab105; Martinez-Leon E, 2015, HUM REPROD, V30, P2138, DOI 10.1093/humrep/dev154; Martins AD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64434-1; Merc V, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222111809; MORTIMER D, 1990, HUM REPROD, V5, P99, DOI 10.1093/oxfordjournals.humrep.a137050; Osycka-Salut CE, 2020, THERIOGENOLOGY, V153, P91, DOI 10.1016/j.theriogenology.2020.04.031; Osycka-Salut CE, 2017, J CELL BIOCHEM, V118, P4095, DOI 10.1002/jcb.26067; Palermo GD, 2017, REPRODUCTION, V154, pF93, DOI 10.1530/REP-17-0374; Panner Selvam MK., 2020, MALE INFERTILITY, P123, DOI [10.1007/978-3-030-32300-4_9, DOI 10.1007/978-3-030-32300-4_9]; Reddy VRK, 2003, FERTIL STERIL, V79, P1590, DOI 10.1016/S0015-0282(03)00368-6; Rickard JP, 2019, THERIOGENOLOGY, V137, P104, DOI 10.1016/j.theriogenology.2019.05.044; Saez-Espinosa P, 2020, CYTOSKELETON, V77, P333, DOI 10.1002/cm.21631; Saraswat M, 2017, MOL CELL PROTEOMICS, V16, P57, DOI 10.1074/mcp.M116.061028; Satouh Y, 2012, J CELL SCI, V125, P4985, DOI 10.1242/jcs.100867; Siva AB, 2010, MOL HUM REPROD, V16, P452, DOI 10.1093/molehr/gaq009; Suarez SS, 2016, CELL TISSUE RES, V363, P185, DOI 10.1007/s00441-015-2244-2; Takagi J, 2004, BIOCHEM SOC T, V32, P403, DOI 10.1042/BST0320403; Talevi R, 2010, THERIOGENOLOGY, V73, P796, DOI 10.1016/j.theriogenology.2009.07.005; Thys M, 2009, REPRODUCTION, V138, P471, DOI 10.1530/REP-09-0094; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; WHO. World Health Organization, 2021, WHO LAB MAN EX PROC, V6th; Zhao C, 2007, FERTIL STERIL, V87, P436, DOI 10.1016/j.fertnstert.2006.06.057	50	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271729	http://dx.doi.org/10.1371/journal.pone.0271729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917320	Green Published, gold			2022-12-26	WOS:000837840000045
J	Howard, JD; Beghyn, M; Dewulf, N; De Vos, Y; Philips, A; Portwood, D; Kilby, PM; Oliver, D; Maddelein, W; Brown, S; Dickman, MJ				Howard, John D.; Beghyn, Myriam; Dewulf, Nathalie; De Vos, Yves; Philips, Annelies; Portwood, David; Kilby, Peter M.; Oliver, Duncan; Maddelein, Wendy; Brown, Stephen; Dickman, Mark J.			Chemically modified dsRNA induces RNAi effects in insects in vitro and in vivo: A potential new tool for improving RNA-based plant protection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; RIBONUCLEASE-III; MAMMALIAN-CELLS; INTERFERENCE; SIRNA; STABILITY; PESTS; GENE; OLIGONUCLEOTIDES; DICER-2	Global agriculture loses over $100 billion of produce annually to crop pests such as insects. Many of these crop pests either are not currently controlled by artificial means or have developed resistance against chemical pesticides. Long dsRNAs are capable of inducing RNAi in insects and are emerging as novel, highly selective alternatives for sustainable insect management strategies. However, there are significant challenges associated with RNAi efficacy in insects. In this study, we synthesized a range of chemically modified long dsRNAs in an approach to improve nuclease resistance and RNAi efficacy in insects. Our results showed that dsRNAs containing phosphorothioate modifications demonstrated increased resistance to southern green stink bug saliva nucleases. Phosphorothioate-modified and 20-fluoromodified dsRNA also demonstrated increased resistance to degradation by soil nucleases and increased RNAi efficacy in Drosophila melanogaster cell cultures. In live insects, we found chemically modified long dsRNAs successfully resulted in mortality in both stink bug and corn rootworm. These results provide further mechanistic insight into the dependence of RNAi efficacy on nucleotide modifications in the sense or antisense strand of the dsRNA in insects and demonstrate for the first time that RNAi can successfully be triggered by chemically modified long dsRNAs in insect cells or live insects.	[Howard, John D.; Dickman, Mark J.] Univ Sheffield, Dept Chem & Biol Engn, Sheffield, S Yorkshire, England; [Beghyn, Myriam; Dewulf, Nathalie; De Vos, Yves; Philips, Annelies; Oliver, Duncan; Maddelein, Wendy] Syngenta, Ghent Innovat Ctr, Ghent, Belgium; [Portwood, David; Kilby, Peter M.] Syngenta, Jealotts Hill Int Res Ctr, Bracknell, Berks, England; [Brown, Stephen] Univ Sheffield, Sch Biosci, Sheffield RNAi Screening Facil, Sheffield, S Yorkshire, England	University of Sheffield; Syngenta; University of Sheffield	Dickman, MJ (corresponding author), Univ Sheffield, Dept Chem & Biol Engn, Sheffield, S Yorkshire, England.	mdickman@sheffield.ac.uk		Howard, John/0000-0002-8633-2350; Brown, Stephen/0000-0002-7581-7491	Biotechnology and Biological Science Research Council iCASE studentship; Syngenta [BB/N504099/1]; Biotechnology and Biological Science Research Council [BB/M012166/1]	Biotechnology and Biological Science Research Council iCASE studentship; Syngenta(Syngenta); Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. D. H. was funded on a Biotechnology and Biological Science Research Council iCASE studentship in collaboration with Syngenta (BB/N504099/1). M. J. D. acknowledges further support from the Biotechnology and Biological Science Research Council (BB/M012166/1).	Aliyari R, 2009, IMMUNOL REV, V227, P176, DOI 10.1111/j.1600-065X.2008.00722.x; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bebber DP, 2015, ANNU REV PHYTOPATHOL, V53, P335, DOI 10.1146/annurev-phyto-080614-120207; Braasch DA, 2003, BIOCHEMISTRY-US, V42, P7967, DOI 10.1021/bi0343774; Bramsen JB, 2009, NUCLEIC ACIDS RES, V37, P2867, DOI 10.1093/nar/gkp106; CaraDonna PJ, 2018, FUNCT ECOL, V32, P2345, DOI 10.1111/1365-2435.13151; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Christiaens O, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00316; Cox-Foster D, 2009, SCI AM, V300, P40, DOI 10.1038/scientificamerican0409-40; Dande P, 2006, J MED CHEM, V49, P1624, DOI 10.1021/jm050822c; Deutsch CA, 2018, SCIENCE, V361, P916, DOI 10.1126/science.aat3466; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Doyle M, 2012, ENZYMES, V32, P1, DOI 10.1016/B978-0-12-404741-9.00001-5; Dubelman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093155; Evers MM, 2015, ADV DRUG DELIVER REV, V87, P90, DOI 10.1016/j.addr.2015.03.008; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Godfray HCJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1821; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Gould F, 2018, SCIENCE, V360, P728, DOI 10.1126/science.aar3780; Guan RB, 2018, J BIOL CHEM, V293, P6011, DOI 10.1074/jbc.RA117.001553; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Jahns H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7317; Jin L, 2019, NUCLEIC ACIDS RES, V47, P4707, DOI 10.1093/nar/gkz208; Kandasamy SK, 2016, P NATL ACAD SCI USA, V113, P14031, DOI 10.1073/pnas.1612393113; Kraynack BA, 2006, RNA, V12, P163, DOI 10.1261/rna.2150806; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Levanova AA, 2020, ANTIVIR RES, V182, DOI 10.1016/j.antiviral.2020.104916; Li J, 2013, INSECT SCI, V20, P31, DOI [10.1111/j.1744-7917.2012.01558.x, 10.1111/j.1744-7917.2012.01550.x]; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Lima WF, 2009, J BIOL CHEM, V284, P2535, DOI 10.1074/jbc.M803748200; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mogilicherla K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22035-z; Monia BP, 1996, J BIOL CHEM, V271, P14533, DOI 10.1074/jbc.271.24.14533; Nicholson AW, 2014, WIRES RNA, V5, P31, DOI 10.1002/wrna.1195; NICHOLSON AW, 1988, NUCLEIC ACIDS RES, V16, P1577, DOI 10.1093/nar/16.4.1577; Noel A, 2020, EMERG TOP LIFE SCI, V4, P45, DOI 10.1042/ETLS20190125; Nwokeoji AO, 2017, ANAL CHEM, V89, P13567, DOI 10.1021/acs.analchem.7b04000; Nwokeoji AO, 2016, ANAL BIOCHEM, V512, P36, DOI 10.1016/j.ab.2016.08.001; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Peacock H, 2011, J ORG CHEM, V76, P7295, DOI 10.1021/jo2012225; Peng YC, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00624; Petrick JS, 2016, REGUL TOXICOL PHARM, V81, P57, DOI 10.1016/j.yrtph.2016.07.009; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Salomon W, 2010, NUCLEIC ACIDS RES, V38, P3771, DOI 10.1093/nar/gkq055; San Miguel K, 2016, PEST MANAG SCI, V72, P801, DOI 10.1002/ps.4056; Shen XL, 2018, NUCLEIC ACIDS RES, V46, P1584, DOI 10.1093/nar/gkx1239; Shukla JN, 2016, RNA BIOL, V13, P656, DOI 10.1080/15476286.2016.1191728; Snead NM, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.36; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Spit J, 2017, INSECT BIOCHEM MOLEC, V81, P103, DOI 10.1016/j.ibmb.2017.01.004; Stein CA, 1996, TRENDS BIOTECHNOL, V14, P147, DOI 10.1016/0167-7799(96)20006-X; Sun W, 2005, NUCLEIC ACIDS RES, V33, P807, DOI 10.1093/nar/gki197; Vogel E, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01912; Vyas M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168921; Wang K, 2019, INSECT MOL BIOL, V28, P235, DOI 10.1111/imb.12546; Whalon ME, 2008, GLOBAL PESTICIDE RESISTANCE IN ARTHROPODS, P1, DOI 10.1079/9781845933531.0000	57	0	0	10	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102311	10.1016/j.jbc.2022.102311	http://dx.doi.org/10.1016/j.jbc.2022.102311			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5B1GH	35921898	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000863323200011
J	Kodakandla, G; West, SJ; Wang, QC; Tewari, R; Zhu, MX; Akimzhanov, AM; Boehning, D				Kodakandla, Goutham; West, Savannah J.; Wang, Qiaochu; Tewari, Ritika; Zhu, Michael X.; Akimzhanov, Askar M.; Boehning, Darren			Dynamic S-acylation of the ER-resident protein stromal interaction molecule 1 (STIM1) is required for store-operated Ca2+ entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOLOGICAL SYNAPSE; CRAC CHANNELS; ORAI1; PALMITOYLATION; DOMAIN	Many cell surface stimuli cause calcium release from endoplasmic reticulum (ER) stores to regulate cellular physiology. Upon ER calcium store depletion, the ER-resident protein stromal interaction molecule 1 (STIM1) physically interacts with plasma membrane protein Orai1 to induce calcium release-activated calcium (CRAC) currents that conduct calcium influx from the extracellular milieu. Although the physiological relevance of this process is well established, the mechanism supporting the assembly of these proteins is incompletely understood. Earlier we demonstrated a previously unknown post-translational modification of Orai1 with long-chain fatty acids, known as S-acylation. We found that S-acylation of Orai1 is dynamically regulated in a stimulus-dependent manner and essential for its function as a calcium channel. Here using the acyl resin-assisted capture assay, we show that STIM1 is also rapidly S-acylated at cysteine 437 upon ER calcium store depletion. Using a combination of live cell imaging and electrophysiology approaches with a mutant STIM1 protein, which could not be S-acylated, we determined that the S-acylation of STIM1 is required for the assembly of STIM1 into puncta with Orai1 and full CRAC channel function. Together with the S-acylation of Orai1, our data suggest that stimulus-dependent S-acylation of CRAC channel components Orai1 and STIM1 is a critical mechanism facilitating the CRAC channel assembly and function.	[Kodakandla, Goutham; Boehning, Darren] Rowan Univ, Cooper Med Sch, Dept Biomed Sci, Camden, NJ USA; [West, Savannah J.; Tewari, Ritika; Akimzhanov, Askar M.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Wang, Qiaochu; Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX USA	Rowan University; Cooper Medical School of Rowan University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Boehning, D (corresponding author), Rowan Univ, Cooper Med Sch, Dept Biomed Sci, Camden, NJ USA.; Akimzhanov, AM (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	Askar.M.Akimzhanov@uth.tmc.edu; boehning@rowan.edu	; Boehning, Darren/I-8539-2015	Akimzhanov, Askar/0000-0002-5592-8215; Zhu, Michael/0000-0002-5676-841X; West, Savannah/0000-0002-2106-7680; Boehning, Darren/0000-0001-7920-6922; Kodakandla, Goutham/0000-0003-2313-2965	National Institute of General Medical Sciences of the National Institutes of Health [F31GM140644, R01GM130840, R01GM115446, R01GM081685]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award numbers F31GM140644 (to S. J. W.), R01GM130840 (to D. B. and A. M. A.), R01GM115446 (to A. M. A.), and R01GM081685 (to D. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Akimzhanov AM, 2015, P NATL ACAD SCI USA, V112, P11876, DOI 10.1073/pnas.1509929112; Barr VA, 2008, MOL BIOL CELL, V19, P2802, DOI 10.1091/mbc.E08-02-0146; Bieerkehazhi S, 2022, J CELL SCI, V135, DOI 10.1242/jcs.258186; Calloway N, 2011, J CELL SCI, V124, P2602, DOI 10.1242/jcs.084178; Carreras-Sureda A, 2021, ELIFE, V10, DOI [10.7554/eLife.72051, 10.7554/eLife.72051.sa0, 10.7554/eLife.72051.sa1, 10.7554/eLife.72051.sa2]; Chen JJ, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.656440; Dynes JL, 2016, P NATL ACAD SCI USA, V113, P440, DOI 10.1073/pnas.1523410113; Emrich SM, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108760; Fan Y, 2020, MOL BIOL REP, V47, P6471, DOI 10.1007/s11033-020-05691-1; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Garcia MI, 2017, CELL CALCIUM, V61, P44, DOI 10.1016/j.ceca.2016.12.010; Gibhardt CS, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108292; Gudlur A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06816-8; Hirve N, 2018, CELL REP, V22, P72, DOI 10.1016/j.celrep.2017.12.030; Hoover PJ, 2011, P NATL ACAD SCI USA, V108, P13299, DOI 10.1073/pnas.1101664108; Katz ZB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46862-w; Kim JY, 2011, EMBO J, V30, P1673, DOI 10.1038/emboj.2011.107; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Pacheco J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29634; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Qin XN, 2020, BIOPHYS J, V118, P70, DOI 10.1016/j.bpj.2019.11.019; Shaw PJ, 2012, J PHYSIOL-LONDON, V590, P4157, DOI 10.1113/jphysiol.2012.233221; Tewari R, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100311; Tewari R, 2020, JOVE-J VIS EXP, DOI 10.3791/61016; van Dorp S, 2021, ELIFE, V10, DOI [10.7554/eLife.66194, 10.7554/eLife.66194.sa0, 10.7554/eLife.66194.sa1, 10.7554/eLife.66194.sa2]; West SJ, 2022, J CELL SCI, V135, DOI 10.1242/jcs.258579; Wu MM, 2014, MOL BIOL CELL, V25, P3672, DOI 10.1091/mbc.E14-06-1107; Yokosuka T, 2010, CURR TOP MICROBIOL, V340, P81, DOI 10.1007/978-3-642-03858-7_5; Zheng SS, 2018, PFLUG ARCH EUR J PHY, V470, P1555, DOI 10.1007/s00424-018-2165-5	33	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102303	10.1016/j.jbc.2022.102303	http://dx.doi.org/10.1016/j.jbc.2022.102303			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6F7ME	35934052	gold, Green Published			2022-12-26	WOS:000884241800001
J	Sano, M; Akagi, D; Naito, M; Hoshina, K; Miyata, K; Kataoka, K; Ishihara, S				Sano, Masaya; Akagi, Daisuke; Naito, Mitsuru; Hoshina, Katsuyuki; Miyata, Kanjiro; Kataoka, Kazunori; Ishihara, Soichiro			Systemic single administration of anti-inflammatory microRNA 146a-5p loaded in polymeric nanomedicines with active targetability attenuates neointimal hyperplasia by controlling inflammation in injured arteries in a rat model	FASEB JOURNAL			English	Article						anti-inflammatory effect; microRNA; miR146a-5p; nanomedicine; neointimal hyperplasia; polyion complex micelle	CYCLIC RGD PEPTIDE; POLYPLEX MICELLES; BALLOON INJURY; CAROTID-ARTERY; GENE DELIVERY; EXPRESSION; DISEASE; SIRNA; LESIONS; CANCER	Neointimal hyperplasia (NIH) after revascularization is a key unsolved clinical problem. Various studies have shown that attenuation of the acute inflammatory response on the vascular wall can prevent NIH. MicroRNA146a-5p (miR146a-5p) has been reported to show anti-inflammatory effects by inhibiting the NF-kappa B pathway, a well-known key player of inflammation of the vascular wall. Here, a nanomedicine, which can reach the vascular injury site, based on polymeric micelles was applied to deliver miR146a-5p in a rat carotid artery balloon injury model. In vitro studies using inflammation-induced vascular smooth muscle cell (VSMC) was performed. Results showed anti-inflammatory response as an inhibitor of the NF-kappa B pathway and VSMC migration, suppression of reactive oxygen species production, and proinflammatory cytokine gene expression in VSMCs. A single systemic administration of miR146a-5p attenuated NIH and vessel remodeling in a carotid artery balloon injury model in both male and female rats in vivo. MiR146a-5p reduced proinflammatory cytokine gene expression in injured arteries and monocyte/macrophage infiltration into the vascular wall. Therefore, miR146a-5p delivery to the injury site demonstrated therapeutic potential against NIH after revascularization.	[Sano, Masaya; Akagi, Daisuke; Hoshina, Katsuyuki; Ishihara, Soichiro] Univ Tokyo, Grad Sch Med, Dept Surg, Div Vasc Surg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Naito, Mitsuru] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo, Japan; [Miyata, Kanjiro] Univ Tokyo, Grad Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo, Japan; [Kataoka, Kazunori] Kawasaki Inst Ind Promot, Innovat Ctr NanoMed, Kawasaki, Kanagawa, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Akagi, D (corresponding author), Univ Tokyo, Grad Sch Med, Dept Surg, Div Vasc Surg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	dakagi-tky@umin.ac.jp	Kataoka, Kazunori/K-7108-2012; Ishihara, Soichiro/AFK-1375-2022	Kataoka, Kazunori/0000-0002-8591-413X; Miyata, Kanjiro/0000-0001-7044-190X; Sano, Masaya/0000-0002-0704-7042; Akagi, Daisuke/0000-0002-5995-6379; NAITO, Mitsuru/0000-0002-4237-871X	The 46th Japan Heart Foundation Grant; Japan Society for the Promotion of Science (JSPS) [17K10748]	The 46th Japan Heart Foundation Grant; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The 46th Japan Heart Foundation Grant; Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 17K10748	Akagi D, 2007, GENE THER, V14, P1029, DOI 10.1038/sj.gt.3302945; Ashino T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26291; Bhatt K, 2016, J AM SOC NEPHROL, V27, P2277, DOI 10.1681/ASN.2015010111; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Cao BJ, 2019, IUBMB LIFE, V71, P125, DOI 10.1002/iub.1946; Chen SJ, 1996, CIRCULATION, V93, P577, DOI 10.1161/01.CIR.93.3.577; Choi ET, 2004, CIRCULATION, V109, P1564, DOI 10.1161/01.CIR.0000121733.68724.FF; Christie RJ, 2012, ACS NANO, V6, P5174, DOI 10.1021/nn300942b; Das S, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009343; Golzar J, 2020, J ENDOVASC THER, V27, P296, DOI 10.1177/1526602820901723; Ho KJ, 2008, AM J PHYSIOL-HEART C, V295, pH1132, DOI 10.1152/ajpheart.00079.2008; Huang C, 2016, INT IMMUNOPHARMACOL, V32, P46, DOI 10.1016/j.intimp.2016.01.009; Kagaya H, 2012, GENE THER, V19, P61, DOI 10.1038/gt.2011.74; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Lacona JR, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1533; Louis SF, 2010, EXP CLIN CARDIOL, V15, pE75; Mann M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00972-z; Marques-Rocha JL, 2015, FASEB J, V29, P3595, DOI 10.1096/fj.14-260323; Matsumoto S, 2009, BIOMACROMOLECULES, V10, P119, DOI 10.1021/bm800985e; Miller AP, 2003, HYPERTENSION, V42, P657, DOI 10.1161/01.HYP.0000085560.02979.0C; Miyahara T, 2006, J VASC SURG, V43, P592, DOI 10.1016/j.jvs.2005.11.010; Monteiro R, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/615917; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Nishida H, 2016, J CONTROL RELEASE, V231, P29, DOI 10.1016/j.jconrel.2016.03.016; Oba M, 2007, BIOCONJUGATE CHEM, V18, P1415, DOI 10.1021/bc0700133; Paterson MR, 2017, PHYSIOL GENOMICS, V49, P243, DOI 10.1152/physiolgenomics.00133.2016; Rosenfield K, 2015, NEW ENGL J MED, V373, P145, DOI 10.1056/NEJMoa1406235; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Song PG, 2019, LANCET GLOB HEALTH, V7, pE1020, DOI 10.1016/S2214-109X(19)30255-4; Srivatsa SS, 1997, CARDIOVASC RES, V36, P408, DOI 10.1016/S0008-6363(97)00184-3; Suhara M, 2018, J CONTROL RELEASE, V286, P394, DOI 10.1016/j.jconrel.2018.07.049; Szilagyi Bernadett, 2019, EJIFCC, V30, P128; Taniguchi R, 2016, MOL PHARMACEUT, V13, P2108, DOI 10.1021/acs.molpharmaceut.6b00219; Tasaki Y, 2021, CANCER RES, V81, P1654, DOI 10.1158/0008-5472.CAN-20-3021; Tulis David A., 2007, V139, P3; Wu B, 2018, J VASC SURG, V68, p188S, DOI 10.1016/j.jvs.2018.05.206; Yoshimura S, 2001, GENE THER, V8, P1635, DOI 10.1038/sj.gt.3301566; Zhang H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48759-0; Zhang YQ, 2022, STEM CELL RES THER, V13, DOI 10.1186/s13287-022-02855-7	40	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22486	10.1096/fj.202101481R	http://dx.doi.org/10.1096/fj.202101481R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3N5JM	35929425				2022-12-26	WOS:000836183500001
J	Siebert, V; Silber, M; Heuten, E; Muhle-Goll, C; Lemberg, MK				Siebert, Verena; Silber, Mara; Heuten, Elena; Muhle-Goll, Claudia; Lemberg, Marius K.			Cleavage of mitochondrial homeostasis regulator PGAM5 by the intramembrane protease PARL is governed by transmembrane helix dynamics and oligomeric state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE; RHOMBOID PROTEASE; SUBSTRATE INTERACTIONS; QUALITY-CONTROL; AMINO-ACIDS; MEMBRANE; PROTEOLYSIS; PINK1; SEQUENCE	The intramembrane protease PARL acts as a crucial mitochondrial safeguard by cleaving the mitophagy regulators PINK1 and PGAM5. Depending on the stress level, PGAM5 can either stimulate cell survival or cell death. In contrast to PINK1, which is constantly cleaved in healthy mitochondria and only active when the inner mitochondrial membrane is depolarized, PGAM5 processing is inversely regulated. However, determinants of PGAM5 that indicate it as a conditional substrate for PARL have not been rigorously investigated, and it is unclear how uncoupling the mitochondrial membrane potential affects its processing compared to that of PINK1. Here, we show that several polar transmembrane residues in PGAM5 distant from the cleavage site serve as determinants for its PARL-catalyzed cleavage. Our NMR analysis indicates that a short N-terminal amphipathic helix, followed by a kink and a C-terminal transmembrane helix harboring the scissile peptide bond are key for a productive interaction with PARL. Furthermore, we also show that PGAM5 is stably inserted into the inner mitochondrial membrane until uncoupling the membrane potential triggers its disassembly into monomers, which are then cleaved by PARL. In conclusion, we propose a model in which PGAM5 is slowly processed by PARL-catalyzed cleavage that is influenced by multiple hierarchical substrate features, including a membrane potential-dependent oligomeric switch.	[Siebert, Verena; Heuten, Elena; Lemberg, Marius K.] Heidelberg Univ ZMBH, Ctr Mol Biol, Heidelberg, Germany; [Siebert, Verena; Heuten, Elena; Lemberg, Marius K.] Univ Cologne, Fac Med, Ctr Biochem & Cologne Excellence Cluster Cellular, Cologne, Germany; [Silber, Mara; Muhle-Goll, Claudia] Karlsruhe Inst Technol, Inst Biol Interfaces 4, Karlsruhe, Germany	Ruprecht Karls University Heidelberg; University of Cologne; Helmholtz Association; Karlsruhe Institute of Technology	Lemberg, MK (corresponding author), Heidelberg Univ ZMBH, Ctr Mol Biol, Heidelberg, Germany.; Lemberg, MK (corresponding author), Univ Cologne, Fac Med, Ctr Biochem & Cologne Excellence Cluster Cellular, Cologne, Germany.	m.lemberg@uni-koeln.de	; Lemberg, Marius K/B-8881-2016	Heuten, Elena/0000-0002-0579-9718; Lemberg, Marius K/0000-0002-0996-1268; Muhle-Goll, Claudia/0000-0002-9474-9041; Siebert, Verena/0000-0002-6951-6887	Helmholtz-Society; CarlZeiss fellowship	Helmholtz-Society(Helmholtz Association); CarlZeiss fellowship	C. M. G. acknowledges funding by the Helmholtz-Society. M. S. was supported by a CarlZeiss fellowship.	Akiyama Y, 2007, MOL MICROBIOL, V64, P1028, DOI 10.1111/j.1365-2958.2007.05715.x; Arutyunova E, 2014, EMBO J, V33, P1869, DOI 10.15252/embj.201488149; Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Baeza-Delgado C, 2013, EUR BIOPHYS J BIOPHY, V42, P199, DOI 10.1007/s00249-012-0813-9; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Bernkopf DB, 2018, J CELL BIOL, V217, P1383, DOI 10.1083/jcb.201708191; Bolduc DM, 2016, P NATL ACAD SCI USA, V113, pE509, DOI 10.1073/pnas.1512952113; Botelho SC, 2013, J BIOL CHEM, V288, P4792, DOI 10.1074/jbc.M112.430892; Chaikuad A, 2017, STRUCTURE, V25, P1089, DOI 10.1016/j.str.2017.05.020; Cheng MY, 2021, EUR J CELL BIOL, V100, DOI 10.1016/j.ejcb.2020.151144; Cho S, 2019, NAT STRUCT MOL BIOL, V26, P910, DOI 10.1038/s41594-019-0296-9; Cymer F, 2015, J MOL BIOL, V427, P999, DOI 10.1016/j.jmb.2014.09.014; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; DEBER CM, 1995, BIOPOLYMERS, V37, P295, DOI 10.1002/bip.360370503; Dickey SW, 2013, CELL, V155, P1270, DOI 10.1016/j.cell.2013.10.053; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Esser K, 2002, J MOL BIOL, V323, P835, DOI 10.1016/S0022-2836(02)01000-8; Fernandez MA, 2016, BIOCHEMISTRY-US, V55, P5675, DOI 10.1021/acs.biochem.6b00718; Gotz A, 2019, BIOPHYS J, V116, P2103, DOI 10.1016/j.bpj.2019.04.030; Ha Y, 2013, J BIOL CHEM, V288, P15430, DOI 10.1074/jbc.R112.422378; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Johnson N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07556-3; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Jung JI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111553; Juszkiewicz S, 2018, MOL CELL, V71, P443, DOI 10.1016/j.molcel.2018.07.001; Kamp F, 2015, BIOPHYS J, V108, P1229, DOI 10.1016/j.bpj.2014.12.045; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Langosch D, 2015, TRENDS BIOCHEM SCI, V40, P318, DOI 10.1016/j.tibs.2015.04.001; Langosch D, 2017, BIOL CHEM, V398, P441, DOI 10.1515/hsz-2016-0269; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lemberg MK, 2021, MOL CELL, V81, P2507, DOI 10.1016/j.molcel.2021.05.004; Lemmin T, 2014, J BIOL CHEM, V289, P6763, DOI 10.1074/jbc.M113.470781; LI SC, 1994, NAT STRUCT BIOL, V1, P368, DOI 10.1038/nsb0694-368; Liu LP, 1998, J BIOL CHEM, V273, P23645, DOI 10.1074/jbc.273.37.23645; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Lu W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5930; Lysyk L, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100383; Ma KL, 2020, CELL DEATH DIFFER, V27, P1036, DOI 10.1038/s41418-019-0396-4; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Meissner C, 2015, AUTOPHAGY, V11, P1484, DOI 10.1080/15548627.2015.1063763; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Moin SM, 2012, ELIFE, V1, DOI 10.7554/eLife.00173; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park YS, 2018, TOXICOL LETT, V284, P120, DOI 10.1016/j.toxlet.2017.12.004; Perrin F, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101887; Pester O, 2013, CHEMBIOCHEM, V14, P1943, DOI 10.1002/cbic.201300322; Pester O, 2013, J AM CHEM SOC, V135, P1317, DOI 10.1021/ja3112093; Petit D, 2019, EMBO J, V38, DOI 10.15252/embj.2019101494; Picca A, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11101508; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Rauschenberger V, 2017, DEVELOPMENT, V144, P2234, DOI 10.1242/dev.144477; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Ruiz K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08393-w; Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051; Saita S, 2018, EMBO J, V37, DOI 10.15252/embj.201797909; Saita S, 2017, NAT CELL BIOL, V19, P318, DOI 10.1038/ncb3488; Schafer A, 2010, J MOL BIOL, V401, P182, DOI 10.1016/j.jmb.2010.06.014; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Sekine S, 2019, MOL CELL, V73, P1028, DOI 10.1016/j.molcel.2019.01.002; Sekine S, 2012, J BIOL CHEM, V287, P34635, DOI 10.1074/jbc.M112.357509; Shen L, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.687246; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi G, 2011, HUM MOL GENET, V20, P1966, DOI 10.1093/hmg/ddr077; Silber M, 2020, ACS CHEM NEUROSCI, V11, P4426, DOI 10.1021/acschemneuro.0c00640; Spinazzi M, 2016, SEMIN CELL DEV BIOL, V60, P19, DOI 10.1016/j.semcdb.2016.07.034; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Strisovsky K, 2016, FEBS J, V283, P1837, DOI 10.1111/febs.13638; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Sugawara S, 2020, J BIOL CHEM, V295, P5588, DOI 10.1074/jbc.RA119.011508; Svagusa T, 2020, CROAT MED J, V61, P126, DOI 10.3325/cmj.2020.61.126; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; Urban S, 2016, P NATL ACAD SCI USA, V113, P1112, DOI 10.1073/pnas.1524151113; Urban S, 2014, CELL REP, V8, P1241, DOI 10.1016/j.celrep.2014.07.039; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wai T, 2016, EMBO REP, V17, P1844, DOI 10.15252/embr.201642698; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wilkins JM, 2014, J BIOL CHEM, V289, P25137, DOI 10.1074/jbc.M114.565549; Winkler E, 2015, BIOCHEMISTRY-US, V54, P6149, DOI 10.1021/acs.biochem.5b00986; Wishart DS, 2011, PROG NUCL MAG RES SP, V58, P62, DOI 10.1016/j.pnmrs.2010.07.004; Wolfe MS, 2019, BIOCHEMISTRY-US, V58, P2953, DOI 10.1021/acs.biochem.9b00401; Wrobel L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27484; Xu WJ, 2015, ONCOTARGET, V6, P30017, DOI 10.18632/oncotarget.5013; Yamaguchi A, 2019, J BIOCHEM, V165, P19, DOI 10.1093/jb/mvy077; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yan CJ, 2020, AUTOPHAGY, V16, P419, DOI 10.1080/15548627.2019.1628520; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yucel SS, 2019, CELL REP, V26, P3087, DOI 10.1016/j.celrep.2019.02.057; Zhang SL, 2019, BIOMED PHARMACOTHER, V111, P638, DOI 10.1016/j.biopha.2018.12.128; Zhuang M, 2013, MOL CELL, V49, P273, DOI 10.1016/j.molcel.2012.10.022	96	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102321	10.1016/j.jbc.2022.102321	http://dx.doi.org/10.1016/j.jbc.2022.102321			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6F7ME	35921890	Green Published, gold			2022-12-26	WOS:000884241800005
J	Takada, I; Hidano, S; Takahashi, S; Yanaka, K; Ogawa, H; Tsuchiya, M; Yokoyama, A; Sato, S; Ochi, H; Nakagawa, T; Kobayashi, T; Nakagawa, S; Makishima, M				Takada, Ichiro; Hidano, Shinya; Takahashi, Sayuri; Yanaka, Kaori; Ogawa, Hidesato; Tsuchiya, Megumi; Yokoyama, Atsushi; Sato, Shingo; Ochi, Hiroki; Nakagawa, Tohru; Kobayashi, Takashi; Nakagawa, Shinichi; Makishima, Makoto			Transcriptional coregulator Ess2 controls survival of post-thymic CD4(+) T cells through the Myc and IL-7 signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							22Q11.2 DELETION SYNDROME; GENE-EXPRESSION; DIGEORGE; REGION; MICE	Ess2, also known as Dgcr14, is a transcriptional co-regulator of CD4(+) T cells. Ess2 is located in a chromosomal region, the loss of which has been associated with 22q11.2 deletion syndrome (22q11DS), which causes heart defects, skeletal abnormalities, and immunodeficiency. However, the specific association of Ess2 with 22q11DS remains unclear. To elucidate the role of Ess2 in T-cell development, we generated Ess2 floxed (Ess2(fl/fl)) and CD4(+) T cell-specific Ess2 KO (Ess2(Delta CD4/Delta CD4)) mice using the Cre/loxP system. Interestingly, Ess2(Delta CD4/Delta CD4) mice exhibited reduced naive T-cell numbers in the spleen, while the number of thymocytes (CD4(-)CD8(-), CD4(+)CD8(+), CD4(+)CD8(-), and CD4(-)CD8(+)) in the thymus remained unchanged. Furthermore, Ess2(Delta CD4/Delta CD4) mice had decreased NKT cells and increased gamma delta T cells in the thymus and spleen. A genome-wide expression analysis using RNA-seq revealed that Ess2 deletion alters the expression of many genes in CD4 single-positive thymocytes, including genes related to the immune system and Myc target genes. In addition, Ess2 enhanced the transcriptional activity of c-Myc. Some genes identified as Ess2 targets in mice show expressional correlation with ESS2 in human immune cells. Moreover, Ess2(Delta CD4/Delta CD4) naive CD4(+) T cells did not maintain survival in response to IL-7. Our results suggest that Ess2 plays a critical role in post-thymic T-cell survival through the Myc and IL-7 signaling pathways.	[Takada, Ichiro; Makishima, Makoto] Nihon Univ, Sch Med, Dept Biomed Sci, Div Biochem,Itabashi Ku, Tokyo, Japan; [Hidano, Shinya; Kobayashi, Takashi] Oita Univ, Fac Med, Dept Infect Dis Control, Oita, Japan; [Takahashi, Sayuri] Univ Tokyo, Dept Urol, Bunkyo Ku, Tokyo, Japan; [Yanaka, Kaori] RIKEN, RNA Biol Lab, Adv Res Inst, Wako, Saitama, Japan; [Ogawa, Hidesato; Tsuchiya, Megumi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Yokoyama, Atsushi] Tohoku Univ, Dept Mol Endocrinol, Grad Sch Med, Sendai, Miyagi, Japan; [Sato, Shingo] Tokyo Med & Dent Univ Med Hosp, Ctr Innovat Canc Treatment, Tokyo, Japan; [Ochi, Hiroki] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama, Japan; [Nakagawa, Tohru] Teikyo Univ, Dept Urol, Itabashi Ku, Tokyo, Japan; [Nakagawa, Shinichi] Hokkaido Univ, Fac Pharmaceut Sci, RNA Biol Lab, Sapporo, Hokkaido, Japan	Nihon University; Oita University; University of Tokyo; RIKEN; Osaka University; Tohoku University; Tokyo Medical & Dental University (TMDU); Teikyo University; Hokkaido University	Takada, I; Makishima, M (corresponding author), Nihon Univ, Sch Med, Dept Biomed Sci, Div Biochem,Itabashi Ku, Tokyo, Japan.	takada.ichiro@nihon-u.ac.jp; makishima.makoto@nihon-u.ac.jp		Takada, Ichiro/0000-0002-6624-8506	Mitsui Life Social Welfare Foundation; Bristol-Myers Squibb [25462382, 18K09162]	Mitsui Life Social Welfare Foundation; Bristol-Myers Squibb(Bristol-Myers Squibb)	This study was supported by the Mitsui Life Social Welfare Foundation, Bristol-Myers Squibb, and a Grant-in-Aid for Scientific Research (C; 25462382 and 18K09162).	Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Carey R, 2008, INFLAMM BOWEL DIS, V14, P446, DOI 10.1002/ibd.20342; Daley SR, 2013, J EXP MED, V210, P269, DOI 10.1084/jem.20121458; Das R, 2010, IMMUNOL REV, V238, P195, DOI 10.1111/j.1600-065X.2010.00962.x; Eckerle S, 2009, LEUKEMIA, V23, P2129, DOI 10.1038/leu.2009.161; Fiala GJ, 2020, IMMUNOL REV, V298, P47, DOI 10.1111/imr.12918; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Guna A, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9113-x; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kalkat M, 2018, MOL CELL, V72, P836, DOI 10.1016/j.molcel.2018.09.031; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lindsay EA, 1996, GENOMICS, V32, P104, DOI 10.1006/geno.1996.0082; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McDonald-McGinn DM, 2011, MEDICINE, V90, P1, DOI 10.1097/MD.0b013e3182060469; Meechan DW, 2015, PROG NEUROBIOL, V130, P1, DOI 10.1016/j.pneurobio.2015.03.004; Motahari Z, 2019, J NEURODEV DISORD, V11, DOI 10.1186/s11689-019-9267-z; Parvin R, 2018, PPAR RES, V2018, DOI 10.1155/2018/5346272; Rizzu P, 1996, MAMM GENOME, V7, P639, DOI 10.1007/s003359900197; Robin NH, 2005, J PEDIATR-US, V147, P90, DOI 10.1016/j.jpeds.2005.03.007; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Saito R, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0723-z; Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Sullivan KE, 2019, IMMUNOL REV, V287, P186, DOI 10.1111/imr.12701; Sumitomo A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar6637; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Takada I, 2018, BIOCHEM BIOPH RES CO, V497, P597, DOI 10.1016/j.bbrc.2018.02.110; Takada I, 2015, MOL CELL BIOL, V35, P344, DOI 10.1128/MCB.00926-14; Tani-ichi S, 2013, P NATL ACAD SCI USA, V110, P612, DOI 10.1073/pnas.1219242110; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Zhao BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077008	42	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102342	10.1016/j.jbc.2022.102342	http://dx.doi.org/10.1016/j.jbc.2022.102342			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9EO	35933014	Green Published, gold			2022-12-26	WOS:000863182500009
J	Beyene, MB; Teshome, S; Yehenew, A; Terefework, Z; Stuitje, AR; Abebe, T; Beyene, HB				Beyene, Melkamu Bedimo; Teshome, Seifegebriel; Yehenew, A.; Terefework, Zewdu; Stuitje, Antoine R.; Abebe, Tamrat; Beyene, Habtamu B.			Assessing the diagnostic performance of a novel RT-PCR fluorescence method for the detection of human plasmodium species	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MALARIA; PREVALENCE; IDENTIFICATION; FALCIPARUM; BLOOD; ASSAY; RISK	Background Malaria elimination effort is hampered not only by the lack of effective medication but also due to the lack of sensitive diagnostic tools to detect infections with low levels of parasitemia. Therefore, more sensitive and specific high-throughput molecular diagnostic approaches are needed for accurate malaria diagnosis. Methods In the present study, the performance of a novel single-tube MC004 real-time polymerase chain reaction (PCR) assay (MRC-Holland, Amsterdam, the Netherlands) was assessed for the detection of infection and discrimination of Plasmodium species. Blood samples (n = 150) were collected from malaria suspected patients at Adama malaria diagnosis and treatment centre, Adama, central Ethiopia. The positive predictive value (PPV), negative predictive value (NPV), analytical sensitivity and specificity of the assay were assessed against the conventional microscopic method. Results Plasmodium species were detected in 59 (39.3%) of the samples by microscopy and in 62 (41.3%) by the novel MC004 RT-PCR. Plasmodium vivax, Plasmodium falciparum and mixed infections with Plasmodium falciparum & Plasmodium vivax accounted for 47.5%, 40.6% and 11.9% respectively as detected by microscopy. The MC004 RT-PCR assay identified 59.7% and 40.3% of the samples positive for Plasmodium vivaxand Plasmodium falciparum respectively. The sensitivity, specificity, PPV, and NPV of the MC004 RT-PCR assay were 95.8%, 97.8%, 92%, and 98.9%, respectively. No mixed infections were detected using the MC004 assay. Conclusion The MC004 RT-PCR assay is a useful tool for the early detection of malaria and identification of Plasmodium species with a high degree of sensitivity and specificity. Due to its high sensitivity, and simplicity (being a single-tube assay), the MC004 is suitable for use in clinical settings and epidemiological studies.	[Beyene, Melkamu Bedimo] Bahir Dar Univ, Coll Hlth Sci, Dept Publ Hlth, Bahir Dar, Ethiopia; [Teshome, Seifegebriel; Yehenew, A.; Abebe, Tamrat; Beyene, Habtamu B.] Addis Ababa Univ, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia; [Terefework, Zewdu] MRC ET Mol Diagnost PLC, Addis Ababa, Ethiopia; [Stuitje, Antoine R.] MRC Holland, Amsterdam, Netherlands	Bahir Dar University; Addis Ababa University	Beyene, HB (corresponding author), Addis Ababa Univ, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia.	habtish1976@gmail.com		Teshome, Seifegebriel/0000-0002-3334-522X; Beyene, Melkamu Bedimo/0000-0003-4349-9887	Addis Ababa University, Research and Technology Transfer Directorate [RD/LT/828/2016]	Addis Ababa University, Research and Technology Transfer Directorate	This work was supported by Addis Ababa University, Research and Technology Transfer Directorate (Ref: RD/LT/828/2016).	Adhanom TDW, 2006, EPIDEMIOLOGY ECOLOGY, P556; Alelign A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5913-8; Aschale Y, 2018, RES REP TROP MED, V9, P95, DOI 10.2147/RRTM.S165260; Britton S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1158-0; Coleman RE, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-121; Ferede Getachew, 2013, Malar Res Treat, V2013, P704730, DOI 10.1155/2013/704730; File T, 2020, PARASITE EPIDEM CONT, V11, DOI 10.1016/j.parepi.2020.e00175; File T, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2827-6; FMOH, 2003, URBAN FOOD SECURITY; FMoH F, 2012, MALARIA DIAGNOSIS TR, Vthird; Gatti S, 2007, ANN TROP MED PARASIT, V101, P195, DOI 10.1179/136485907X156997; Gebre S, 2015, J INFECT DIS IMMUN, V7, P1, DOI 10.5897/JIDI2014.0147; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Golassa L, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1944-3; Grabias B, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2743-9; Hanscheid T, 2002, TRENDS PARASITOL, V18, P395, DOI 10.1016/S1471-4922(02)02348-6; KAIN KC, 1991, J CLIN MICROBIOL, V29, P1171, DOI 10.1128/JCM.29.6.1171-1174.1991; Kamau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071539; Kang JM, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1765-4; Kattenberg JH, 2012, AM J TROP MED HYG, V87, P251, DOI 10.4269/ajtmh.2012.12-0125; Khairnar K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-284; Lee MA, 2002, J CLIN MICROBIOL, V40, P4343, DOI 10.1128/JCM.40.11.4343-4345.2002; Legesse Deresse, 2015, Malar Res Treat, V2015, P123682, DOI 10.1155/2015/123682; Leski TA, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03163-2; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; Mayxay M, 2004, TRENDS PARASITOL, V20, P233, DOI 10.1016/j.pt.2004.03.006; Mekonnen SK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-48; Mita T, 2012, JPN J INFECT DIS, V65, P465, DOI 10.7883/yoken.65.465; Nair CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146961; Organization W-WH, 2021, WORLD MALARIA REPORT; Patsoula E, 2003, ANN TROP MED PARASIT, V97, P15, DOI 10.1179/000349803125002535; Potkar C N, 1995, J Assoc Physicians India, V43, P336; Pradhan S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208943; Yan SLR, 2020, DIAGN MICR INFEC DIS, V98, DOI 10.1016/j.diagmicrobio.2020.115122; Roughton SA, 2012, J ROY ARMY MED CORPS, V158, P318, DOI 10.1136/jramc-158-04-08; Schneider R, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252887; Sema M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0559-9; Shiferaw M, 2018, ETHIOP J HEALTH SCI, V28, P539, DOI 10.4314/ejhs.v28i5.4; Shokoples SE, 2009, J CLIN MICROBIOL, V47, P975, DOI 10.1128/JCM.01858-08; Singh B, 1996, T ROY SOC TROP MED H, V90, P519, DOI 10.1016/S0035-9203(96)90302-8; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Tambo M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206848; van Bergen K, 2021, MALARIA J, V20, DOI 10.1186/s12936-021-03842-8	43	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272094	10.1371/journal.pone.0272094	http://dx.doi.org/10.1371/journal.pone.0272094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925877	gold, Green Published			2022-12-26	WOS:000848077100070
J	Jona, A; Kenyeres, A; Barna, S; Illes, A; Simon, Z				Jona, Adam; Kenyeres, Anna; Barna, Sandor; Illes, Arpad; Simon, Zsofia			Clinical and biological prognostic factors in follicular lymphoma patients	PLOS ONE			English	Article							BLOOD LYMPHOCYTE/MONOCYTE RATIO; RITUXIMAB PLUS CYCLOPHOSPHAMIDE; ABSOLUTE MONOCYTE COUNT; PERIPHERAL-BLOOD; POOLED ANALYSIS; ADVANCED-STAGE; BASE-LINE; FDG-PET; THERAPY; SURVIVAL	Introduction Follicular lymphoma (FL) is an indolent, yet heterogeneous, B-cell lymphoproliferative disorder. Although most FL patients respond well to treatment, few with specific traits have a poor prognosis; the latter are difficult to define. Patients and methods We retrospectively analyzed data from 143 FL patients treated at the University of Debrecen since 2009 and investigated prognostic factors that may influence the survival of FL patients. Results A maximum standardized uptake value (SUVmax) cut-off of 9.85 at the staging positron emission tomography/computed tomography (PET/CT) (p = 0.0001, hazard ratio [HR]: 0.2535, 95% confidence interval [CI]: 0.1118-0.4878) and a lymphocyte/monocyte (Ly/Mo) ratio of 3.41 (p = 0.0027, HR: 2.997, 95% CI: 1.463-6.142), drawn at diagnosis, significantly predicted FL patients' progression-free survival (PFS). A staging SUVmax >9.85 with Ly/Mo <3.41 could delineate a high-risk group of FL patients (p<0.0001, HR: 0.0957, 95% CI: 0.03416-0.2685). Similarly, a significant difference was shown with an SUVmax cut-off of 3.15 at the interim PET/CT (p<0.0001, HR: 0.1614, 95% CI: 0.06684-0.3897). A staging SUVmax >9.85 in conjunction with interim SUVmax >3.15 predicted poor prognosis (p<0.0001, HR: 0.1037, 95% CI: 0.03811-0.2824). The PFS difference was translated into overall survival (OS) advantage (p = 0.0506, HR: 0.1187, 95% CI: 0.01401-1.005). Conclusion Biological prognostic factors, such as the Ly/Mo ratio, may improve the prognostic assessment of staging PET/CT. The survival advantage observed in PFS is translated into OS when determined using a combination of staging and interim SUVmax. We recommend investigating additional biological prognostic factors while highlighting the role of PET/CT in FL.	[Jona, Adam; Kenyeres, Anna; Illes, Arpad; Simon, Zsofia] Univ Debrecen, Fac Med, Med Sch Clin Med, Dept Hematol, Debrecen, Hungary; [Jona, Adam; Kenyeres, Anna; Illes, Arpad; Simon, Zsofia] Univ Debrecen, Doctoral Sch Clin Med, Debrecen, Hungary; [Barna, Sandor] Scanomed Ltd, Debrecen, Hungary	University of Debrecen; University of Debrecen; Scanomed	Jona, A (corresponding author), Univ Debrecen, Fac Med, Med Sch Clin Med, Dept Hematol, Debrecen, Hungary.; Jona, A (corresponding author), Univ Debrecen, Doctoral Sch Clin Med, Debrecen, Hungary.	jadam1@unideb.hu			New National Excellence Program of the Ministry for Innovation and Technology of the National Research, Development and Innovation Fund [UNKP-20-4]	New National Excellence Program of the Ministry for Innovation and Technology of the National Research, Development and Innovation Fund	AJ was supported by the UNKP-20-4 New National Excellence Program of the Ministry for Innovation and Technology of the National Research, Development and Innovation Fund. The financial support had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Adams HJA, 2016, ANN HEMATOL, V95, P11, DOI 10.1007/s00277-015-2553-2; Ambinder Alexander J, 2012, Adv Hematol, V2012, P626035, DOI 10.1155/2012/626035; Ardeshna KM, 2014, LANCET ONCOL, V15, P424, DOI 10.1016/S1470-2045(14)70027-0; Ardeshna KM, 2003, LANCET, V362, P516, DOI 10.1016/S0140-6736(03)14110-4; Belotti A, 2015, CL LYMPH MYELOM LEUK, V15, P208, DOI 10.1016/j.clml.2014.10.001; Boo SH, 2019, NUCL MED MOLEC IMAG, V53, P263, DOI 10.1007/s13139-019-00602-0; Brice P, 1997, J CLIN ONCOL, V15, P1110, DOI 10.1200/JCO.1997.15.3.1110; Casulo C, 2015, J CLIN ONCOL, V33, P2516, DOI 10.1200/JCO.2014.59.7534; Federico M, 2009, J CLIN ONCOL, V27, P4555, DOI 10.1200/JCO.2008.21.3991; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Koh YW, 2012, ONCOLOGIST, V17, P871, DOI 10.1634/theoncologist.2012-0034; Lee SF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017904; Linet Martha S., 2014, Journal of the National Cancer Institute Monographs, P26, DOI 10.1093/jncimonographs/lgu006; Luminari S, 2014, ANN ONCOL, V25, P442, DOI 10.1093/annonc/mdt562; Maurer MJ, 2016, AM J HEMATOL, V91, P1096, DOI 10.1002/ajh.24492; Meignan M, 2016, J CLIN ONCOL, V34, P3618, DOI 10.1200/JCO.2016.66.9440; Porrata LF, 2012, HAEMATOL-HEMATOL J, V97, P262, DOI 10.3324/haematol.2011.050138; Shi Q, 2017, J CLIN ONCOL, V35, P552, DOI 10.1200/JCO.2016.70.8651; Siddiqui M, 2006, BRIT J HAEMATOL, V134, P596, DOI 10.1111/j.1365-2141.2006.06232.x; Simon Z, 2016, INT J HEMATOL, V103, P63, DOI 10.1007/s12185-015-1884-z; Smith A, 2015, BRIT J CANCER, V112, P1575, DOI 10.1038/bjc.2015.94; Tan D, 2013, BLOOD, V122, P981, DOI 10.1182/blood-2013-03-491514; Trotman J, 2014, LANCET HAEMATOL, V1, pE17, DOI 10.1016/S2352-3026(14)70008-0; Trotman J, 2011, J CLIN ONCOL, V29, P3194, DOI 10.1200/JCO.2011.35.0736; Watanabe R, 2013, LEUKEMIA RES, V37, P1208, DOI 10.1016/j.leukres.2013.07.015; Welaya K, 2019, HEMATOL ONCOL CLIN N, V33, P627, DOI 10.1016/j.hoc.2019.03.003; Yasuda H, 2020, CL LYMPH MYELOM LEUK, V20, P774, DOI 10.1016/j.clml.2020.08.017; Zhou YY, 2019, CANCER MANAG RES, V11, P6871, DOI 10.2147/CMAR.S216445	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272787	10.1371/journal.pone.0272787	http://dx.doi.org/10.1371/journal.pone.0272787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925993	Green Published, gold			2022-12-26	WOS:000848077100104
J	Bowra, A; Saeed, G; Gorodensky, A; Kohler, JC				Bowra, Andrea; Saeed, Gul; Gorodensky, Ariel; Kohler, Jillian Clare			An exploration of anti-corruption and health in international organizations	PLOS ONE			English	Article								Corruption is a global wicked problem that threatens the achievement of health, social and economic development goals, including Sustainable Development Goal # 3: Ensuring healthy lives and promoting well-being for all. The COVID-19 pandemic and its resulting strain on health systems has heightened risks of corruption both generally and specifically within health systems. Over the past years, international organizations, including those instrumental to the global COVID-19 response, have increased efforts to address corruption within their operations and related programs. However, as attention to anti-corruption efforts is relatively recent within international organizations, there is a lack of literature examining how these organizations address corruption and the impact of their anti-corruption efforts. This study addresses this gap by examining how accountability, transparency, and anti-corruption are taken up by international organizations within their own operations and the reported outcomes of such efforts. The following international organizations were selected as the focus of this document analysis: the World Health Organization, the Global Fund, the United Nations Development Programme, and the World Bank Group. Documents were identified through a targeted search of each organization's website. Documents were then analyzed combining elements of content analysis and thematic analysis. The findings demonstrate that accountability and transparency mechanisms have been employed by each of the four international organizations to address corruption. Further, these organizations commonly employed oversight mechanisms, including risk assessments, investigations, and audits to monitor their internal and external operations for fraud and corruption. All organizations used sanction strategies meant to reprimand identified transgressors and deter future corruption. Findings also demonstrate a marked increase in anti-corruption efforts by these international organizations in recent years. Though this is promising, there remains a distinct absence of evidence demonstrating the impact of such efforts on the prevalence and severity of corruption in international organizations.	[Bowra, Andrea; Kohler, Jillian Clare] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Saeed, Gul; Kohler, Jillian Clare] Univ Toronto, WHO Collaborating Ctr Governance, Accountabil & Transparency Pharmaceut Sect, Toronto, ON, Canada; [Gorodensky, Ariel; Kohler, Jillian Clare] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Kohler, Jillian Clare] Univ Toronto, Munk Sch Global Affairs & Publ Policy, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto	Bowra, A (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	andrea.bowra@mail.utoronto.ca			University of Toronto; Leslie Dan Faculty of Pharmacy's New Initiatives and Innovation Award	University of Toronto(University of Toronto); Leslie Dan Faculty of Pharmacy's New Initiatives and Innovation Award	This study was supported by University of Toronto in the form of Connaught Global<EM><STRONG> </STRONG></EM>Challenges Award and the Leslie Dan Faculty of Pharmacy's New Initiatives and Innovation Award to JKC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades A, 1997, POLIT STUD-LONDON, V45, P496, DOI 10.1111/1467-9248.00093; [Anonymous], 2014, ETH INT FRAM GLOB FU; [Anonymous], 2022, FLEMING FUND; [Anonymous], 2020, PUBLISH WHAT YOU FUN; Bauhr M, 2012, INT STUD REV, V14, P541, DOI 10.1111/misr.12009; Berkman S., 2008, J FINANC CRIME, V15, P124, DOI 10.1108/13590790810866863; Boswell NZ., 1996, AM SOC INT LAW, V90, P98; Bowen GA, 2009, QUAL RES J, V9, P27, DOI 10.3316/QRJ0902027; Brusca I, 2018, J COMP POLICY ANAL, V20, P486, DOI 10.1080/13876988.2017.1393951; Bukovansky M, 2006, REV INT POLIT ECON, V13, P181, DOI 10.1080/09692290600625413; Bureau for Management Services Office of Audit and Investigations Ethics Office, 2018, UNDP POL FRAUD OTH C; Cabral L., 2020, SELLER REPUTATION PR; Chang ZH, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00753-w; Coicaud JM, 2016, GLOB POLICY, V7, P420, DOI 10.1111/1758-5899.12358; Democratic Governance Group Bureau for Development Policy, 2008, MAINSTR ANT DEV UPD; Executive Board of the United Nations Development Programme and of the United Nations Population Fund, 2008, UNDP ACC SYST ACC FR; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; Friends of the Global Fight Against AIDS Tuburculosis and Malaria, 2017, GLOB FUNDS COMM TRAN; Glynn Patrick, 1997, CORRUPTION GLOBAL EC, P7; Hafner-Burton EM, 2019, INT STUD QUART, V63, P1108, DOI 10.1093/isq/sqz064; Hanf M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026990; Holmberg S, 2011, HEALTH ECON POLICY L, V6, P529, DOI 10.1017/S174413311000023X; Hopkin J, 2002, REV INT POLIT ECON, V9, P574, DOI 10.1080/09692290210150725; Hussmann K., 2020, HLTH SECTOR CORRUPTI, P1; Independent Evaluation Office UNDP, 2016, EV UNDP CONTR ANT AD; Kaufmann D, 1997, FOREIGN POLICY, P114, DOI 10.2307/1149337; Kim JY, 2016, COMMUNICATION; Kohler JC, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00629-5; Kohler JC, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2019.1694745; Kohler JC, 2018, CLIN PHARMACOL THER, V104, P1054, DOI 10.1002/cpt.1172; Lee K, 2009, GLOB INST, P1; Lewis J., 2003, QUALITATIVE RES PRAC, P263, DOI DOI 10.4135/9781483348858.N7; Lohaus M, 2021, OXFORD HDB QUALITY G; Mauro P, 2004, IMF STAFF PAPERS, V51, P1; MAURO P, 1995, Q J ECON, V110, P681, DOI 10.2307/2946696; Mauro P., 1997, ECON ISS, V6; Mauro P., 2019, COST CORRUPTION; McCoy J L, 2001, INT POLITICS, V38, P65; Moretti F, 2015, NEW LEFT REV, P75; Naher N, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08975-0; Office of Audit and Investigations, 2017, CHART OFF AUD INV; Office of Compliance Risk Management and Ethics of WHO, 2017, CODE ETHICS PROFESSI; Office of the Inspector General, 2019, 42 BOARD M GEN SWITZ; Office of the Inspector General, 2019, 41 BOARD M OFF INSP; Office of the Inspector General, 2017, BOARD REP OFF INSP G; Office of the Inspector General, 2019, AUD REP MAN ETH INT; Office of the Inspector General, 2020, INVESTIGATION REPORT; Office of the Inspector General. Office of the Inspector General, 2020, 44 BOARD M VIRT; OLeary Z, 2014, ESSENTIAL GUIDE DOIN, V2nd; Programme UND, 2021, UNDPS MAND HLTH DEV; Reinsberg B, 2021, SOCIO-ECON REV, V19, P607, DOI 10.1093/ser/mwz039; Reinsberg B, 2020, REGUL GOV, V14, P698, DOI 10.1111/rego.12265; Rhodes N., 2020, TRANSPARENCY INT; Rose-Ackerman S., 1999, CORRUPTION GOVT CAUS; Rose-Ackerman Susan., 1997, CORRUPTION GLOBAL EC; SHLEIFER A, 1993, Q J ECON, V108, P599, DOI 10.2307/2118402; Stake R.E., 1995, ART CASE STUDY RES; Tanzi V, 1998, ROADS NOWHERE CORRUP; Taylor L, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1724; The Global Fund, 2010, SECR FOLL UP INSP GE; The Global Fund, 2015, SANCT PAN PROC REL C; The Global Fund, WAMB ORG; The Global Fund, 2017, GLOB FUND POL COMB F; The Global Fund: Office of the Inspector General, 2017, GLOB FUND GUID FIN R; The Global Fund: Office of the Inspector General, 2019, AUDIT REPORT GLOBAL; The Global Fund: Office of the Inspector General, 2017, AUD REP WAMB ORG PLA; The World Bank, 2020, HEALTH-LONDON; The World Bank, 2016, POL WBG POL SANCT FR; The World Bank, 2018, UPD WORLD BANK COMM; The World Bank, 2022, US; The World Bank, 2017, ILLICIT FINANCIAL FL; The World Bank, 2008, WORLD BANKS ANT GUID; The World Bank, 2011, WORLD BANK SHIN SPOT; Transparency International, 2021, WHAT IS CORR; Transparency International, 2014, IMP CORR GROWTH IN A; Transparency International, 2022, HEALTH-LONDON; U4 Anti-Corruption Resource Centre, 2021, GLOSS; UNDP, 2020, HUM DEV REPORT 2020; UNESCO-United Nations Educational Scientific and Cultural Organization, 2014, UNESCO ROADM IMPL GL; United Nations, 2018, STAFF REG RUL UN SEC; United Nations Department of Economic and Social Affairs (UN DESA), 2021, 17 GOALS AG 2030 SUS; United Nations Development Programme, 2015, GLOBAL ANTICORRUPTIO; United Nations Development Programme, 2008, MAINSTR ANT DEV ANT; United Nations Development Programme, 2021, PROC PROT VEND SANCT; United Nations Development Programme, 2020, 19 INT ANT CORR C CL; United Nations Development Programme, UNDP FIN REG RUL; United Nations Development Programme, 2020, HUM DEV REP 2020 NEX; United Nations Development Programme (UNDP), 2004, ANT PRACT NOT FIN VE; United Nations Human Rights Office of the High Commissioner, 2013, HUM RIGHTS CAS CORR; United Nations Security Council, 2018, GLOB COST CORR LEAST; Vian T., 2016, MED TRANSPARENCY ALL; Vian T, 2008, HEALTH POLICY PLANN, V23, P83, DOI 10.1093/heapol/czm048; Vian T, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2019.1694744; Weaver C, 2008, HYPOCRISY TRAP: THE WORLD BANK AND THE POVERTY OF REFORM, P1; Wolfensohn James D., 2005, VOICE WORLDS POOR SE, P154; World Bank, 2020, REM LEARN COVID 19 O; World Bank, 2020, WORLD DEV REP 2020 T, DOI 10.1596/978-1-4648-1457-0; World Bank, 2014, CORP GOV-OXFORD; World Health Organization, 2014, GOOD GOV MED MOD FRA; World Health Organization, 2019, REP EP; World Health Organization, 2019, WHO OFF INT OV SERV; World Health Organization, EXT AUD; World Health Organization, 2015, MANAGEMENT ACCOUNTAB; World Health Organization, 2013, REP EXT AUD; World Health Organization, 2021, RED HLTH SYST CORR; World Health Organization, 2020, MED PROD ALERT N3 20; YIN RK, 1994, EVAL PRACT, V15, P283, DOI 10.1016/0886-1633(94)90023-X	107	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0269203	http://dx.doi.org/10.1371/journal.pone.0269203			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917329	Green Published, gold			2022-12-26	WOS:000837840000013
J	Gan, SL; Liang, SJ; Zou, QM; Shang, CH				Gan, Shanling; Liang, Shengjia; Zou, Qiman; Shang, Changhua			Optimization of carotenoid extraction of a halophilic microalgae	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; BETA-CAROTENE; DUNALIELLA-TERTIOLECTA; ASSISTED EXTRACTION; LUTEIN; ACCUMULATION; RECOVERY; SALINA; ENZYME; OIL	Dunaliella parva can produce abundant carotenoids under certain conditions. This paper optimized the extraction efficiency of carotenoids from D. parva. Different organic solvents were examined to determine the most suitable solvent for the extraction. After the determination of the solvent (dimethylsulfoxide, DMSO), the extraction conditions including time, temperature, and volume were then optimized to maximize the extraction efficiency of carotenoids from D. parva using response surface methodology. DMSO was identified as the most suitable solvent. The optimal extraction conditions were as follows: temperature of 57.2 degrees C, time of 11.35 min, the volume of 410 mu l, and the optimal extraction efficiency reached 0.517 parts per thousand. The results showed that the optimal extraction efficiency (0.517 parts per thousand) improved 31.69% in comparison to the initial extraction efficiency (0.3926 parts per thousand). In addition, The optimal levels of three influence factors (temperature of 57.2 degrees C, time of 11.35 min, volume of 410 mu l) decreased compared with the initial levels (temperature of 60 degrees C, time of 20 min, volume of 1000 mu l). In this paper, Central Composite Design (CCD) was used to optimize the extraction efficiency of carotenoids from D. parva, which would lay the groundwork for the extraction and utilization of carotenoids from D. parva in the future.	[Gan, Shanling; Liang, Shengjia; Zou, Qiman; Shang, Changhua] Guangxi Normal Univ, Coll Life Sci, Key Lab Ecol Rare & Endangered Species & Environm, Minist Educ, Guilin, Peoples R China; [Shang, Changhua] Guangxi Normal Univ, Guangxi Key Lab Landscape Resources Conservat & Su, Guilin, Peoples R China; [Shang, Changhua] Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Peoples R China	Guangxi Normal University; Guangxi Normal University; Sun Yat Sen University	Shang, CH (corresponding author), Guangxi Normal Univ, Coll Life Sci, Key Lab Ecol Rare & Endangered Species & Environm, Minist Educ, Guilin, Peoples R China.; Shang, CH (corresponding author), Guangxi Normal Univ, Guangxi Key Lab Landscape Resources Conservat & Su, Guilin, Peoples R China.; Shang, CH (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Peoples R China.	shangchanghua@mailbox.gxnu.edu.cn			National Natural Science Foundation of China [2021AB27009]; Guangxi Key Research and Development Program [2021AB27009, AB21220057]; Research Funds of the Guangxi Key Laboratory of Landscape Resources Conservation and Sustainable Utilization in Lijiang River Basin, Guangxi Normal University [LRCSU21Z0207]; Research Funds of Key Laboratory of Ecology of Rare and Endangered Species and Environmental Protection (Guangxi Normal University), Ministry of Education, China [ERESEP2022Z11];  [31860010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Key Research and Development Program; Research Funds of the Guangxi Key Laboratory of Landscape Resources Conservation and Sustainable Utilization in Lijiang River Basin, Guangxi Normal University; Research Funds of Key Laboratory of Ecology of Rare and Endangered Species and Environmental Protection (Guangxi Normal University), Ministry of Education, China; 	This research was funded by National Natural Science Foundation of China, grant number 31860010; Guangxi Key Research and Development Program, grant number 2021AB27009, AB21220057; Research Funds of the Guangxi Key Laboratory of Landscape Resources Conservation and Sustainable Utilization in Lijiang River Basin, Guangxi Normal University, grant number LRCSU21Z0207, Research Funds of Key Laboratory of Ecology of Rare and Endangered Species and Environmental Protection (Guangxi Normal University), Ministry of Education, China, grant number ERESEP2022Z11 and the APC was funded by 31860010. All funding was awarded to CS.	Ambati RR, 2019, CRIT REV FOOD SCI, V59, P1880, DOI 10.1080/10408398.2018.1432561; BENAMOTZ A, 1983, PLANT PHYSIOL, V72, P593, DOI 10.1104/pp.72.3.593; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Bueno M, 2020, ACS SUSTAIN CHEM ENG, V8, P11413, DOI 10.1021/acssuschemeng.0c03991; Ceron MC, 2008, J AGR FOOD CHEM, V56, P11761, DOI 10.1021/jf8025875; Cha KH, 2010, J AGR FOOD CHEM, V58, P793, DOI 10.1021/jf902628j; Choubert G, 2001, SCI ALIMENT, V21, P467, DOI 10.3166/sda.21.467-480; Chuyen HV, 2017, INT J FOOD SCI TECH, V52, P972, DOI 10.1111/ijfs.13361; Cisneros M, 2004, J CHROMATOGR B, V807, P105, DOI 10.1016/j.jchromb.2004.01.009; Deenu A, 2013, BIOTECHNOL BIOPROC E, V18, P1151, DOI 10.1007/s12257-013-0213-8; Dong SZ, 2014, SCI WORLD J, DOI 10.1155/2014/694305; Fernandez-Sevilla JM, 2010, APPL MICROBIOL BIOT, V86, P27, DOI 10.1007/s00253-009-2420-y; Gong MY, 2016, BIOTECHNOL ADV, V34, P1396, DOI 10.1016/j.biotechadv.2016.10.005; Hejazi MA, 2004, BIOTECHNOL BIOENG, V85, P475, DOI 10.1002/bit.10914; Hosseini SRP, 2017, J SUPERCRIT FLUID, V121, P89, DOI 10.1016/j.supflu.2016.11.006; Mai HC, 2013, FOOD TECHNOL BIOTECH, V51, P488; Imbs TI, 2013, MAR BIOTECHNOL, V15, P606, DOI 10.1007/s10126-013-9507-2; Ismaiel MMS, 2018, BIOCATAL AGR BIOTECH, V16, P378, DOI 10.1016/j.bcab.2018.09.011; Jaime L, 2010, LWT-FOOD SCI TECHNOL, V43, P105, DOI 10.1016/j.lwt.2009.06.023; Jin ES, 2003, BIOTECHNOL BIOPROC E, V8, P331, DOI 10.1007/BF02949276; Kadkhodaei S, 2015, RSC ADV, V5, P38141, DOI 10.1039/c5ra04546k; Kang CD, 2008, BIOTECHNOL LETT, V30, P441, DOI 10.1007/s10529-007-9578-0; Kim SM, 2011, APPL BIOCHEM BIOTECH, V165, P1296, DOI 10.1007/s12010-011-9347-3; Kitada K, 2009, J CHEM TECHNOL BIOT, V84, P657, DOI 10.1002/jctb.2096; Kleinegris DMM, 2011, J APPL PHYCOL, V23, P949, DOI 10.1007/s10811-010-9615-6; Kleinegris DMM, 2011, ENZYME MICROB TECH, V48, P253, DOI 10.1016/j.enzmictec.2010.11.005; Liau BC, 2010, J SUPERCRIT FLUID, V55, P169, DOI 10.1016/j.supflu.2010.07.002; Liu ZJ, 2021, SEP PURIF TECHNOL, V257, DOI 10.1016/j.seppur.2020.117946; Maki-Arvela P, 2014, J CHEM TECHNOL BIOT, V89, P1607, DOI 10.1002/jctb.4461; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Pinheiro N, 2019, SEP PURIF TECHNOL, V223, P243, DOI 10.1016/j.seppur.2019.04.083; Puri M, 2017, MICROBIOL AUST, V38, P85, DOI [10.1071/ma17036, 10.1071/MA17036]; SIMPSON KL, 1983, P NUTR SOC, V42, P7, DOI 10.1079/PNS19830003; Singh N, 2020, BIOMASS BIOENERG, V137, DOI 10.1016/j.biombioe.2020.105555; Song DH, 2016, J OCEAN U CHINA, V15, P124, DOI 10.1007/s11802-016-2797-z; Sovova H, 2019, J SUPERCRIT FLUID, V148, P93, DOI 10.1016/j.supflu.2019.03.002; Strati IF, 2015, FOOD BIOPROD PROCESS, V94, P668, DOI 10.1016/j.fbp.2014.09.012; Sui YX, 2021, FOODS, V10, DOI 10.3390/foods10051018; Suo G, 2021, IOP C SER EARTH ENV, V831, P012033; Tang HY, 2011, APPL ENERG, V88, P3324, DOI 10.1016/j.apenergy.2010.09.013; Tsiaka T, 2015, ANAL CHIM ACTA, V877, P100, DOI 10.1016/j.aca.2015.03.051; Werman MJ, 1999, J NUTR BIOCHEM, V10, P449, DOI 10.1016/S0955-2863(99)00026-1; Xu YN, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8050123; Xu YA, 2018, BIOLOGY-BASEL, V7, DOI 10.3390/biology7010014	44	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0270650	http://dx.doi.org/10.1371/journal.pone.0270650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917330	Green Published, gold			2022-12-26	WOS:000837840000009
J	Reta, C; Atlabachew, M; Asmellash, T; Hilluf, W; Yayinie, M; Wubieneh, TA				Reta, Chaltu; Atlabachew, Minaleshewa; Asmellash, Tihitinna; Hilluf, Woldegiorgis; Yayinie, Marie; Wubieneh, Tessera Alemneh			Polyphenol and flavonoid content in major Teff [Eragrostis tef (Zuccagni) Trotter] varieties in Amhara Region, Ethiopia	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; PHENOLIC COMPOSITION; ZUCC. TROTTER; CEREAL TEF; FERMENTATION; BIOAVAILABILITY; GRAINS	Teff [Eragrostis tef (Zuccagni) Trotter] is a small-sized cereal grain and an indigenous crop in Ethiopia. The Amhara region is one of the major teff producers regions in the country. However, information on the phenolic content of the region's teff varieties is limited. Seventy-two teff samples were collected from three administrative zones (West Gojjam zone, Awi zone, and East Gojjam zone) of the Amhara region of Ethiopia. The samples' total polyphenol and flavonoid contents were determined using colorimetric methods. The total flavonoid contents expressed as catechin equivalent, CE (i.e., under alkaline conditions) and quercetin equivalent, Q.E (i.e., under the methanolic solution of AlCl3) were found to be in the range of 7.66 +/- 0.60-57.36 +/- 3.87 mg C.E and 15.45 +/- 0.15-113.12 +/- 3.09 mg Q.E per 100 g of teff samples, respectively. The corresponding total polyphenol content (TPC), described as gallic acid equivalent (G.A.E.), was in the range of 46.21 +/- 1.20-133.32 +/- 5.44 mg G.A.E. The results showed that the mean TPC value of the teff samples from the West Gojjam zone was enriched with polyphenol than samples from the Awi zone and East Gojjam. Furthermore, it was noted that the mean TPC and TFC values did not vary significantly between samples of the East Gojjam and Awi zone (p > 0.05). In contrast, a significant difference in mean TPC and TFC-Q.E were noted between the sampling zone of East Gojjam and West Gojjam and between West Gojjam and Awi zones (p < 0.05). These significant variations in TPC and TFC might be due to observable variations in the agroecological zones and the genetic-make-up of the samples. Person correlation indicated a significant positive correlation matrix between the three variables (p = 0.01). The teff samples were trying to be classified based on their geographical origin using hierarchical cluster analysis (HCA) and biplots. Accordingly, the variance explained by component 1 (PC1) is 67.2%, and the variance explained by component 2 (PC2) is 20.0%.	[Reta, Chaltu; Atlabachew, Minaleshewa; Asmellash, Tihitinna; Hilluf, Woldegiorgis; Yayinie, Marie] Bahir Dar Univ, Coll Sci, Dept Chem, Bahir Dar, Ethiopia; [Yayinie, Marie] Debre Tabor Univ, Coll Nat Sci, Dept Chem, Debre Tabor, Ethiopia; [Wubieneh, Tessera Alemneh] Bahir Dar Univ, Coll Sci, Mat Sci & Engn Dept, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University	Atlabachew, M (corresponding author), Bahir Dar Univ, Coll Sci, Dept Chem, Bahir Dar, Ethiopia.	atminale2004@yahoo.com	Wubieneh, Tessera Alemneh/GZA-6954-2022	Wubieneh, Tessera Alemneh/0000-0002-6403-626X; Atlabachew, Minaleshewa/0000-0003-3261-8326; Yayinie, Marie/0000-0002-9915-8902				Asaye Demelash, 2017, International Journal of Biodiversity and Conservation, V9, P239, DOI 10.5897/ijbc2016.1045; Assefa K, 1999, EUPHYTICA, V106, P87, DOI 10.1023/A:1003582431039; Atlabachew M, 2014, INT J FOOD PROP, V17, P45, DOI 10.1080/10942912.2011.614367; Baye K, 2014, INT J FOOD SCI TECH, V49, P174, DOI 10.1111/ijfs.12295; Baye K, 2013, FOOD CHEM, V138, P430, DOI 10.1016/j.foodchem.2012.10.075; Boka B., 2013, CANADIAN CHEM T, V1, P7; Bultosa G, 2002, STARCH-STARKE, V54, P461, DOI 10.1002/1521-379X(200210)54:10<461::AID-STAR461>3.0.CO;2-U; Bultosa G., 2007, J APPL SCI RES, V3, P2042; Bultosa G., 2004, ENCY GRAIN SCI, V3, P281; Chaijan M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237844; Chang CC, 2002, J FOOD DRUG ANAL, V10, P178; Deng GF, 2012, J FUNCT FOODS, V4, P906, DOI 10.1016/j.jff.2012.06.008; Esmaeili F, 2021, J FOOD QUALITY, V2021, DOI 10.1155/2021/5520996; Forsido SF, 2013, INT J FOOD SCI NUTR, V64, P915, DOI 10.3109/09637486.2013.806448; Fu HB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244445; Gebremariam MM, 2014, J FOOD SCI TECH MYS, V51, P2881, DOI 10.1007/s13197-012-0745-5; Habtamu Ayalew, 2011, African Crop Science Journal, V19, P201; Habtegebrial K, 2007, SOIL TILL RES, V94, P55, DOI 10.1016/j.still.2006.07.002; Hager AS, 2012, J CEREAL SCI, V56, P239, DOI 10.1016/j.jcs.2012.06.005; Kotaskova E, 2016, J FOOD COMPOS ANAL, V46, P15, DOI 10.1016/j.jfca.2015.11.001; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Pekal A, 2014, FOOD ANAL METHOD, V7, P1776, DOI 10.1007/s12161-014-9814-x; Pourmorad F, 2006, AFR J BIOTECHNOL, V5, P1142; Ravisankar S, 2018, FOOD CHEM, V263, P265, DOI 10.1016/j.foodchem.2018.05.002; Rocchetti G, 2019, FOOD CHEM, V271, P157, DOI 10.1016/j.foodchem.2018.07.176; Roseberg RJ., 2005, YIELD QUALITY TEFF F; Salawu SO, 2014, J FOOD BIOCHEM, V38, P62, DOI 10.1111/jfbc.12026; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Shumoy H, 2016, CEREAL CHEM, V93, P465, DOI 10.1094/CCHEM-10-15-0210-R; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Spaenij-Dekking L, 2005, NEW ENGL J MED, V353, P1748, DOI 10.1056/NEJMc051492; Tian SQ, 2021, J FOOD QUALITY, V2021, DOI 10.1155/2021/7390425; Urga K, 1997, B CHEM SOC ETHIOPIA, V11, P3; Wang T, 2014, J FUNCT FOODS, V7, P101, DOI 10.1016/j.jff.2014.01.033; Zhu F, 2018, FOOD CHEM, V239, P402, DOI 10.1016/j.foodchem.2017.06.101	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272010	http://dx.doi.org/10.1371/journal.pone.0272010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917310	gold, Green Published			2022-12-26	WOS:000837840000038
J	Shen, XM				Shen, Xiumei			Accessibility calculation and equality evaluation of medical facilities for COVID-19 pandemic treatment: A case study of the Wuhan metropolitan development zone	PLOS ONE			English	Article							MEASURING SPATIAL ACCESSIBILITY; HEALTH-CARE SERVICES; ACCESS; EQUITY; AREAS	Medical facility equality is a critical metric for determining equal access to medical care. Their spatial distribution is important for effective pandemic treatment and daily prevention in cities. This paper used the Kernel Density Two-Step Floating Catchment Area (KD2SFCA) and shortest distance methods to calculate the accessibility of designated COVID-19 Fangcang hospitals and fever clinics in the Wuhan Metropolitan Development Zone. Their equality was evaluated by the Gini coefficient and Lorentz curve. Several results were obtained: (1) The facilities' accessibility declines radial from the central to peripheral areas. (2) Most of the demand points in the study area can reach the medical facilities for COVID-19 pandemic treatment within 60 minutes. (3) For the spatial distribution of these facilities, the equality evaluated for different time thresholds differed significantly, with long time thresholds having better equality than for short time thresholds. (4) While the distances distribution of fever clinics is balanced, the equality gap in various areas remains enormous when considering population distribution. Suggestions for optimizing the spatial distribution of pandemic treatment medical facilities in Wuhan are proposed, and which will serve as references for the planning of Wuhan's pandemic medical facilities in the future.	[Shen, Xiumei] Southeast Univ, Sch Architecture, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Shen, XM (corresponding author), Southeast Univ, Sch Architecture, Nanjing, Jiangsu, Peoples R China.	230198008@seu.edu.cn		Shen, Xiumei/0000-0003-0711-6340				Allan DP, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-32; Apolone G, 2021, TUMORI J, V107, P446, DOI 10.1177/0300891620974755; Chen X., SURVEY COVID 19 PATI; Cheng G, 2016, HABITAT INT, V53, P485, DOI 10.1016/j.habitatint.2015.12.023; Dai DJ, 2011, ENVIRON PLANN B, V38, P659, DOI 10.1068/b36149; Dai DJ, 2010, HEALTH PLACE, V16, P1038, DOI 10.1016/j.healthplace.2010.06.012; Delamater PL, 2013, HEALTH PLACE, V24, P30, DOI 10.1016/j.healthplace.2013.07.012; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Fransen K, 2015, HEALTH PLACE, V32, P65, DOI 10.1016/j.healthplace.2015.01.002; Hu P, 2019, URBAN POLICY RES, V37, DOI 10.1080/08111146.2018.1523055; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jin MH, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071150; Kang JY, 2020, INT J HEALTH GEOGR, V19, DOI 10.1186/s12942-020-00229-x; Kanuganti S, 2016, J TRANSP GEOGR, V56, P45, DOI 10.1016/j.jtrangeo.2016.08.011; Kim K, 2021, TRANSPORT POLICY, V110, P478, DOI 10.1016/j.tranpol.2021.07.004; Langford M, 2006, PROF GEOGR, V58, P294, DOI 10.1111/j.1467-9272.2006.00569.x; Lattman K, 2018, RES TRANSP ECON, V69, P501, DOI 10.1016/j.retrec.2018.06.002; Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18; Liu SR, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16101833; Luo J, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071503; Luo J, 2014, T GIS, V18, P436, DOI 10.1111/tgis.12096; Luo W, 2003, ENVIRON PLANN B, V30, P865, DOI 10.1068/b29120; Luo W, 2012, HEALTH PLACE, V18, P789, DOI 10.1016/j.healthplace.2012.04.002; Luo W, 2009, HEALTH PLACE, V15, P1100, DOI 10.1016/j.healthplace.2009.06.002; Mao L, 2013, HEALTH PLACE, V24, P115, DOI 10.1016/j.healthplace.2013.08.008; McGrail MR, 2014, APPL GEOGR, V54, P182, DOI 10.1016/j.apgeog.2014.08.005; McGrail MR, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-50; McMahon DE, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008412; Neutens T, 2015, J TRANSP GEOGR, V43, P14, DOI 10.1016/j.jtrangeo.2014.12.006; Newgard CD, 2010, ANN EMERG MED, V55, P235, DOI 10.1016/j.annemergmed.2009.07.024; Pan XF, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15092051; Pereira RHM, 2021, SOC SCI MED, V273, DOI 10.1016/j.socscimed.2021.113773; Piovani D, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171668; Radke J., 2000, GEOGRAPHIC INFORM SC, V6, P105, DOI [10.1080/10824000009480538, DOI 10.1080/10824000009480538]; Roj J, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12052043; Rong PJ, 2020, APPL GEOGR, V119, DOI 10.1016/j.apgeog.2020.102192; Siegel M, 2016, HEALTH POLICY, V120, P205, DOI 10.1016/j.healthpol.2016.01.001; Sun J, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0614-y; Taleai M, 2014, CITIES, V40, P56, DOI 10.1016/j.cities.2014.04.006; Tao ZL, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-33; The Chinese State Council, 2016, OP CPC CENTR COMM ST; Wan N, 2012, INT J GEOGR INF SCI, V26, P1073, DOI 10.1080/13658816.2011.624987; Wang F., 2011, ANN GIS, V17, P199, DOI [10.1080/19475683.2011.625977, DOI 10.1080/19475683.2011.625977]; Wang F, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11041103; Wu JH, 2020, COMPLEXITY, V2020, DOI 10.1155/2020/8819836; [吴中元 Wu Zhongyuan], 2019, [地理与地理信息科学, Geography and Geo-information Science], V35, P61; Xu G, 2021, INT J APPL EARTH OBS, V102, DOI 10.1016/j.jag.2021.102421; Yin CH, 2018, APPL GEOGR, V92, P50, DOI 10.1016/j.apgeog.2018.01.011; Zhou XX, 2020, ISPRS INT J GEO-INF, V9, DOI 10.3390/ijgi9060394; Zhou ZQ, 2021, ISPRS INT J GEO-INF, V10, DOI 10.3390/ijgi10050318; Zhu L, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16020242	51	0	0	13	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272458	http://dx.doi.org/10.1371/journal.pone.0272458			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917292	Green Published, gold			2022-12-26	WOS:000837840000043
J	Zielinski, M; Blanchet, J; Hailemariam, S; Berghuis, AM				Zielinski, Michal; Blanchet, Jonathan; Hailemariam, Sophia; Berghuis, Albert M.			Structural elucidation of substrate-bound aminoglycoside acetyltransferase (3)-IIIa	PLOS ONE			English	Article								Canonical aminoglycosides are a large group of antibiotics, where the part of chemical diversity stems from the substitution of the neamine ring system on positions 5 and 6. Certain aminoglycoside modifying enzymes can modify a broad range of 4,5- and 4,6-disubstituted aminoglycosides, with some as many as 15. This study presents the structural and kinetic results describing a promiscuous aminoglycoside acetyltransferase AAC(3)-IIIa. This enzyme has been crystallized in ternary complex with coenzyme A and 4,5- and 4,6-disubstituted aminoglycosides. We have followed up this work with kinetic characterization utilizing a panel of diverse aminoglycosides, including a next-generation aminoglycoside, plazomicin. Lastly, we observed an alternative binding mode of gentamicin in the aminoglycoside binding site, which was proven to be a crystallographic artifact based on mutagenesis.	[Zielinski, Michal; Blanchet, Jonathan; Hailemariam, Sophia; Berghuis, Albert M.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Zielinski, Michal; Blanchet, Jonathan; Hailemariam, Sophia; Berghuis, Albert M.] McGill Univ, Ctr Rech Biol Struct, Montreal, PQ, Canada; [Berghuis, Albert M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Berghuis, Albert M.] McGill Univ, McGill Antimicrobial Resistance Ctr, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University	Berghuis, AM (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.; Berghuis, AM (corresponding author), McGill Univ, Ctr Rech Biol Struct, Montreal, PQ, Canada.; Berghuis, AM (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.; Berghuis, AM (corresponding author), McGill Univ, McGill Antimicrobial Resistance Ctr, Montreal, PQ, Canada.	albert.berghuis@mcgill.ca		Zielinski, Michal/0000-0002-6220-7328; Hailemariam, Sophia/0000-0002-5999-4244				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bassenden AV, 2016, ACS CHEM BIOL, V11, P1339, DOI 10.1021/acschembio.5b01070; Becker B, 2013, ACS CHEM BIOL, V8, P105, DOI 10.1021/cb3005116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fong DH, 2002, EMBO J, V21, P2323, DOI 10.1093/emboj/21.10.2323; Frank U., 2012, DASCHNER GUIDE IN HO; Gao F, 2006, J MED CHEM, V49, P5273, DOI 10.1021/jm060732n; Golkar T, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02261-4; Jackson J, 2013, CURR OPIN INFECT DIS, V26, P516, DOI 10.1097/QCO.0000000000000012; Kumar P, 2018, J MED CHEM, V61, P10218, DOI 10.1021/acs.jmedchem.8b01393; Kumar P, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas8667; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Norris AL, 2010, BIOCHEMISTRY-US, V49, P4027, DOI 10.1021/bi100155j; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Schatz A, 1944, P SOC EXP BIOL MED, V57, P244, DOI 10.3181/00379727-57-14769; Shi K, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00022; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; VLIEGENTHART JS, 1991, ANTIMICROB AGENTS CH, V35, P892, DOI 10.1128/AAC.35.5.892; WILLIAMS JW, 1979, J ANTIBIOT, V32, P1147, DOI 10.7164/antibiotics.32.1147	21	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0269684	http://dx.doi.org/10.1371/journal.pone.0269684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921328	gold, Green Published			2022-12-26	WOS:000839311900059
J	Bobrovskyy, M; Oh, SY; Missiakas, D				Bobrovskyy, Maksym; Oh, So Young; Missiakas, Dominique			Contribution of the EssC ATPase to the assembly of the type 7b secretion system in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VII SECRETION; PROTEIN SECRETION; CRYSTAL-STRUCTURE; TRANSLOCATION; PATHOGENESIS; SUPERFAMILY; MECHANISMS; VIRULENCE; REVEALS; TOXINS	Secretion systems utilize ATPase activity to facilitate the translocation of proteins into and across membranes. In bacteria, the universally conserved SecA ATPase binds a large repertoire of preproteins and interacts with the SecYEG translocon. In contrast, the type 7b secretion system (T7bSS) of Staphylococcus aureus supports the secretion of a restricted subset of proteins. T7bSSs are found in several Firmicutes as gene clusters encoding secreted WXG100 proteins and FtsK/ SpoIIIE-like ATPase. In S. aureus, this ATPase is called EssC and comprises two cytosolic forkhead-associated domains (FHA(1-2)), two membrane-spanning segments (TM1-2), and four cytosolic modules named DUF (domain of unknown function) and ATPases(1-3) (D1D2D3). However, a detailed understanding of the interactions of EssC in the T7bSS is not clear. Here, we tagged EssC and performed affinity chromatography of detergent-solubilized extracts of wild type and isogenic mutants of S. aureus. We found that EssC recruits EsaA, EssA, and EssB in a complex referred to as the ESS (ESAT-6 like secretion system) translocon, and secreted substrates were not required for translocon assembly. Furthermore, deletions of FHA1 and DUF rendered EssC unstable, whereas FHA2 was required for association with EssB. This interaction was independent of EsaA, but EsaA was required to recruit EssA to the EssC-EssB complex. Finally, we show that assembly of the ESS translocon was impaired upon mutation of D2 structural motifs. Together, our data indicate that the ESS translocon is maintained fully assembled at the plasma membrane and that D2 is fundamental in sustaining the integrity of this complex.	[Bobrovskyy, Maksym; Missiakas, Dominique] Univ Chicago, Dept Microbiol, Lemont, IL 60637 USA; [Oh, So Young; Missiakas, Dominique] Univ Chicago, Howard Taylor Ricketts Lab, Lemont, IL 60637 USA		Missiakas, D (corresponding author), Univ Chicago, Dept Microbiol, Lemont, IL 60637 USA.; Missiakas, D (corresponding author), Univ Chicago, Howard Taylor Ricketts Lab, Lemont, IL 60637 USA.	dmissiak@bsd.uchicago.edu		Bobrovskyy, Maksym/0000-0002-2541-5451	National Institute of Allergy and Infectious Diseases, United States; National Institutes of Health, United States, postdoctoral fellowship award [F32AI085709]	National Institute of Allergy and Infectious Diseases, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health, United States, postdoctoral fellowship award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	M. B. was supported by the National Institute of Allergy and Infectious Diseases, United States, National Institutes of Health, United States, postdoctoral fellowship award (F32AI085709) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abd El-Fatah RM, 2018, TOXICON, V146, P129, DOI 10.1016/j.toxicon.2018.02.047; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Aly KA, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00482-17; Anderson M, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00527-16; Anderson M, 2013, MOL MICROBIOL, V90, P734, DOI 10.1111/mmi.12395; Anderson M, 2011, J BACTERIOL, V193, P1583, DOI 10.1128/JB.01096-10; Ates LS, 2016, VIRULENCE MECHANISMS OF BACTERIAL PATHOGENS, 5 EDITION, P357, DOI 10.1128/microbiolspec.VMBF-0011-2015; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bottai D, 2017, CURR TOP MICROBIOL, V404, P235, DOI 10.1007/82_2015_5015; Bowman L, 2021, ANNU REV MICROBIOL, V75, P471, DOI 10.1146/annurev-micro-012721-123600; Bunduc CM, 2021, NATURE, V593, P445, DOI 10.1038/s41586-021-03517-z; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Burts ML, 2008, MOL MICROBIOL, V69, P736, DOI 10.1111/j.1365-2958.2008.06324.x; Cao ZP, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.183; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Famelis N, 2019, NATURE, V576, P321, DOI 10.1038/s41586-019-1633-1; Fan Y, 2015, PROTEIN SCI, V24, P1389, DOI 10.1002/pro.2715; Garufi G, 2008, J BACTERIOL, V190, P7004, DOI 10.1128/JB.00458-08; Gey van Pittius NC, 2001, GENOME BIOL, V2; Green ER, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0012-2015; Ilghari D, 2011, J BIOL CHEM, V286, P29993, DOI 10.1074/jbc.M111.248732; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Jager F, 2018, MICROBIOL-SGM, V164, P816, DOI 10.1099/mic.0.000650; Jean NL, 2020, P NATL ACAD SCI USA, V117, P14202, DOI 10.1073/pnas.2001324117; Jessop M, 2021, CURR OPIN STRUC BIOL, V66, P119, DOI 10.1016/j.sbi.2020.10.027; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lee VT, 2001, GENE DEV, V15, P1725, DOI 10.1101/gad.896801; Lin JS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003991; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Mietrach N, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00646-19; Ohr RJ, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00528-16; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Poulsen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089313; Poweleit N, 2019, ELIFE, V8, DOI 10.7554/eLife.52983; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Rosenberg OS, 2015, CELL, V161, P501, DOI 10.1016/j.cell.2015.03.040; Ruhe ZC, 2020, ANNU REV MICROBIOL, V74, P497, DOI 10.1146/annurev-micro-020518-115638; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sundaramoorthy R, 2008, J MOL BIOL, V383, P603, DOI 10.1016/j.jmb.2008.08.047; Tanaka Y, 2007, PROTEINS, V69, P659, DOI 10.1002/prot.21302; Tassinari M. D, 2020, BIORXIV, DOI [10.1101/2020.1105.1109.085852, DOI 10.1101/2020.1105.1109.085852]; Tran HKR, 2021, MOL MICROBIOL, V115, P478, DOI 10.1111/mmi.14680; Troman L., 2021, FRONT MICROBIOL, V12; Ulhuq FR, 2020, P NATL ACAD SCI USA, V117, P20836, DOI 10.1073/pnas.2006110117; Wardenburg JB, 2006, P NATL ACAD SCI USA, V103, P13831, DOI 10.1073/pnas.0603072103; Warne B, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2426-7; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zhang DP, 2011, NUCLEIC ACIDS RES, V39, P4532, DOI 10.1093/nar/gkr036; Zoltner M, 2016, BIOCHEM J, V473, P1941, DOI 10.1042/BCJ20160257; Zoltner M, 2013, BIOCHEM J, V449, P469, DOI 10.1042/BJ20121209	57	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102318	10.1016/j.jbc.2022.102318	http://dx.doi.org/10.1016/j.jbc.2022.102318			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9IM	35921891	Green Published, gold			2022-12-26	WOS:000863192700002
J	Pena, KA; White, AD; Savransky, S; Castillo, IP; Jean-Alphonse, FG; Gardella, TJ; Sutkeviciute, I; Vilardaga, JP				Pena, Karina A.; White, Alex D.; Savransky, Sofya; Castillo, Ignacio Portales; Jean-Alphonse, Frederic G.; Gardella, Thomas J.; Sutkeviciute, Ieva; Vilardaga, Jean-Pierre			Biased GPCR signaling by the native parathyroid hormone-related protein 1 to 141 relative to its N-terminal fragment 1 to 36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTORS; PTH; ACTIVATION; EFFICACY	The parathyroid hormone (PTH)-related protein (PTHrP) is indispensable for the development of mammary glands, placental calcium ion transport, tooth eruption, bone formation and bone remodeling, and causes hypercalcemia in patients with malignancy. Although mature forms of PTHrP in the body consist of splice variants of 139, 141, and 173 amino acids, our current understanding on how endogenous PTHrP transduces signals through its cognate G-protein coupled receptor (GPCR), the PTH type 1 receptor (PTHR), is largely derived from studies done with its N-terminal fragment, PTHrP(1-36). Here, we demonstrate using various fluorescence imaging approaches at the single cell level to measure kinetics of (i) receptor activation, (ii) receptor signaling via Gs and Gq, and (iii) receptor internalization and recycling that the native PTHrP(1-141) displays biased agonist signaling properties that are not mimicked by PTHrP1-36. Although PTHrP1-36 induces transient cAMP production, acute intracellular Ca2+ (iCa(2+)) release and beta-arrestin recruitment mediated by ligand-PTHR interactions at the plasma membrane, PTHrP(1-141) triggers sustained cAMP signaling from the plasma membrane and fails to stimulate iCa(2+) release and recruit beta-arrestin. Furthermore, we show that the molecular basis for biased signaling differences between PTHrP(1-36) and properties of native PTHrP(1-141) are caused by the stabilization of a singular PTHR conformation and PTHrP(1-141) sensitivity to heparin, a sulfated glycosaminoglycan. Taken together, our results contribute to a better understanding of the biased signaling process of a native protein hormone acting in conjunction with a GPCR.	[Pena, Karina A.; White, Alex D.; Savransky, Sofya; Jean-Alphonse, Frederic G.; Sutkeviciute, Ieva; Vilardaga, Jean-Pierre] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Savransky, Sofya] Univ Pittsburgh, Grad Program Mol Pharmacol, Sch Med, Pittsburgh, PA USA; [Castillo, Ignacio Portales; Gardella, Thomas J.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA USA; [Castillo, Ignacio Portales; Gardella, Thomas J.] Harvard Med Sch, Boston, MA USA; [Jean-Alphonse, Frederic G.] Univ Tours, Inst Natl Rech Agr Alimentat & Environm INRAE, Ctr Natl Rech Sci CNRS,Physiol Reprod & Comportem, Inst Francais Cheval & Equitat IFCE, F-37380 Nouzilly, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Tours	Vilardaga, JP (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	jpv@pitt.edu		Pena, Karina/0000-0001-6401-5269; Portales, Ignacio/0000-0002-3598-6207; Vilardaga, Jean-Pierre/0000-0002-1217-1435; JEAN-ALPHONSE, Frederic/0000-0002-7380-5825	National Institute of General Medical Sciences (NIGMS) [T32GM133332]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), United States of the US National Institutes of Health (NIH), United States [DK116780, DK122259]; NIH [R01HD100468]; National Science Foundation (NSF), United States [CHE-9808188]	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), United States of the US National Institutes of Health (NIH), United States; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF), United States(National Science Foundation (NSF))	This research was supported by grant Award Numbers T32GM133332 (to S. S.) from the National Institute of General Medical Sciences (NIGMS), DK116780 and DK122259 (to J. P. V.) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), United States of the US National Institutes of Health (NIH), United States, R01HD100468 from the NIH, and grant number CHE-9808188 (to the Center of Molecular Analysis, Department of Chemistry, Carnegie Mellon University) from the National Science Foundation (NSF), United States. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Castro M, 2002, ENDOCRINOLOGY, V143, P3854, DOI 10.1210/en.2002-220232; Dean T, 2008, MOL ENDOCRINOL, V22, P156, DOI 10.1210/me.2007-0274; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Gidon A, 2014, NAT CHEM BIOL, V10, P707, DOI [10.1038/NCHEMBIO.1589, 10.1038/nchembio.1589]; HAMMONDS RG, 1989, J BIOL CHEM, V264, P14806; Ho PWM, 2019, BIOCHEM PHARMACOL, V169, DOI 10.1016/j.bcp.2019.113627; Jean-Alphonse FG, 2017, NAT CHEM BIOL, V13, P259, DOI [10.1038/nchembio.2267, 10.1038/NCHEMBIO.2267]; Li JF, 2012, ANGEW CHEM INT EDIT, V51, P12263, DOI 10.1002/anie.201207603; Liu S, 2019, J AM CHEM SOC, V141, P14486, DOI 10.1021/jacs.9b04179; McGarvey JC, 2016, J BIOL CHEM, V291, P10986, DOI 10.1074/jbc.M115.697045; Vilardaga JP, 2011, METHODS MOL BIOL, V756, P133, DOI 10.1007/978-1-61779-160-4_6; Vilardaga JP, 2009, MOL ENDOCRINOL, V23, P590, DOI 10.1210/me.2008-0204; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vilardaga JP, 2002, J BIOL CHEM, V277, P8121, DOI 10.1074/jbc.M110433200; Wehbi VL, 2013, P NATL ACAD SCI USA, V110, P1530, DOI 10.1073/pnas.1205756110; White AD, 2021, SCI SIGNAL, V14, DOI 10.1126/scisignal.abc5944; White AD, 2020, P NATL ACAD SCI USA, V117, P7455, DOI 10.1073/pnas.1918158117	18	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102332	10.1016/j.jbc.2022.102332	http://dx.doi.org/10.1016/j.jbc.2022.102332			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6F7ME	35933010	gold, Green Published			2022-12-26	WOS:000884241800008
J	Wang, Y; Shu, HY; Liu, J; Jin, X; Wang, LH; Qu, YZ; Xia, MJ; Peng, PH; Feng, YP; Wei, M				Wang, Yang; Shu, Hengyao; Liu, Jia; Jin, Xin; Wang, Lihua; Qu, Yanzhao; Xia, Mingjie; Peng, Pinghui; Feng, Yunpeng; Wei, Min			EGF promotes PKM2 O-GlcNAcylation by stimulating O-GlcNAc transferase phosphorylation at Y976 and their subsequent association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-KINASE M2; N-ACETYLGLUCOSAMINE; CANCER METABOLISM; CELL-METABOLISM; TRANSCRIPTION; THERAPY; STRESS; GROWTH; ROLES; STAT3	Epidermal growth factor (EGF) is one of the most well-characterized growth factors and plays a crucial role in cell proliferation and differentiation. Its receptor EGFR has been extensively explored as a therapeutic target against multiple types of cancers, such as lung cancer and glioblastoma. Recent studies have established a connection between deregulated EGF signaling and metabolic reprogramming, especially rewiring in aerobic glycolysis, which is also known as the Warburg effect and recognized as a hallmark in cancer. Pyruvate kinase M2 (PKM2) is a rate-limiting enzyme controlling the final step of glycolysis and serves as a major regulator of the Warburg effect. We previously showed that PKM2 T405/S406 O-GlcNAcylation, a critical mark important for PKM2 detetramerization and activity, was markedly upregulated by EGF. However, the mechanism by which EGF regulates PKM2 O-GlcNAcylation still remains uncharacterized. Here, we demonstrated that EGF promoted O-GlcNAc transferase (OGT) binding to PKM2 by stimulating OGT Y976 phosphorylation. As a consequence, we found PKM2 O-GlcNAcylation and detetramerization were upregulated, leading to a significant decrease in PKM2 activity. Moreover, distinct from PKM2, we observed that the association of additional phosphotyrosine-binding proteins with OGT was also enhanced when Y976 was phosphorylated. These proteins included STAT1, STAT3, STAT5, PKCd, and p85, which are reported to be O-GlcNAcylated. Together, we show EGF-dependent Y976 phosphorylation is critical for OGT-PKM2 interaction and propose that this posttranslational modification might be important for substrate selection by OGT.	[Wang, Yang; Shu, Hengyao; Liu, Jia; Jin, Xin; Wang, Lihua; Qu, Yanzhao; Xia, Mingjie; Peng, Pinghui; Feng, Yunpeng; Wei, Min] Northeast Normal Univ, Key Lab Mol Epigenet, Minist Educ MOE, Changchun, Jilin, Peoples R China	Northeast Normal University - China	Feng, YP; Wei, M (corresponding author), Northeast Normal Univ, Key Lab Mol Epigenet, Minist Educ MOE, Changchun, Jilin, Peoples R China.	fengyp0108@nenu.edu.cn; weim750@nenu.edu.cn			National Natural Science Foundation of China [31870896, 32101048]; China Postdoctoral Science Foundation [2020T130090, 2019M661190]; Science and Technology Project of Education Department of Jilin Province [JJKH20201174KJ]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Project of Education Department of Jilin Province	We thank Dr Gerald W. Hart (Department of Biological Chemistry, Johns Hopkins University School of Medicine) for providing the OGT plasmid. We thank Dr Weiwei Yang (Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences) for providing the EGFRvIII plasmid. This work was supported by the National Natural Science Foundation of China (31870896, 32101048), the China Postdoctoral Science Foundation (2020T130090, 2019M661190), the Science and Technology Project of Education Department of Jilin Province (JJKH20201174KJ).	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Arbour KC, 2019, JAMA-J AM MED ASSOC, V322, P764, DOI 10.1001/jama.2019.11058; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bosch RR, 2003, ENDOCRINE, V20, P247, DOI 10.1385/ENDO:20:3:247; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dionne U, 2018, MOL CELL, V70, P995, DOI 10.1016/j.molcel.2018.05.013; Dong XF, 2018, CLIN CANCER RES, V24, P3204, DOI 10.1158/1078-0432.CCR-17-2725; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Gan HK, 2017, NAT REV CLIN ONCOL, V14, P695, DOI 10.1038/nrclinonc.2017.95; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jin X, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107690; Jitschin R, 2019, LEUKEMIA, V33, P1783, DOI 10.1038/s41375-018-0376-6; Kasahara K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03117-y; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Li XH, 2017, J EXP MED, V214, P1093, DOI 10.1084/jem.20161105; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Lv L, 2013, MOL CELL, V52, P340, DOI 10.1016/j.molcel.2013.09.004; Martin SES, 2018, J AM CHEM SOC, V140, P13542, DOI 10.1021/jacs.8b07328; MENGINLECREULX D, 1983, J BACTERIOL, V154, P1284, DOI 10.1128/JB.154.3.1284-1290.1983; Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038; Rao XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9468; Singh JP, 2020, ONCOGENE, V39, P560, DOI 10.1038/s41388-019-0975-3; Skoulidis F, 2019, NAT REV CANCER, V19, P495, DOI 10.1038/s41568-019-0179-8; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Thai AA, 2021, LANCET, V398, P535, DOI 10.1016/S0140-6736(21)00312-3; Villa GR, 2016, NAT NEUROSCI, V19, P765, DOI 10.1038/nn.4302; Wang Y, 2017, P NATL ACAD SCI USA, V114, P13732, DOI 10.1073/pnas.1704145115; Xu C, 2018, CELL PHYSIOL BIOCHEM, V49, P1389, DOI 10.1159/000493444; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhang GZ, 2019, CANCER RES, V79, P2220, DOI 10.1158/0008-5472.CAN-18-2603; Zhang LW, 2009, BIOL PROCED ONLINE, V11, P170, DOI 10.1007/s12575-009-9016-x; Zhou QX, 2020, J EXP MED, V217, DOI 10.1084/jem.20191779	47	0	0	6	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102340	10.1016/j.jbc.2022.102340	http://dx.doi.org/10.1016/j.jbc.2022.102340			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9EO	35931120	gold, Green Published			2022-12-26	WOS:000863182500012
J	Ipsen, MB; Sorensen, EMG; Thomsen, EA; Weiss, S; Haldrup, J; Dalby, A; Palmfeldt, J; Bross, P; Rasmussen, M; Fredsoe, J; Klingenberg, S; Jochumsen, MR; Bouchelouche, K; Ulhoi, BP; Borre, M; Mikkelsen, JG; Sorensen, KD				Ipsen, Malene Blond; Sorensen, Ea Marie Givskov; Thomsen, Emil Aagaard; Weiss, Simone; Haldrup, Jakob; Dalby, Anders; Palmfeldt, Johan; Bross, Peter; Rasmussen, Martin; Fredsoe, Jacob; Klingenberg, Soren; Jochumsen, Mads R.; Bouchelouche, Kirsten; Ulhoi, Benedicte Parm; Borre, Michael; Mikkelsen, Jacob Giehm; Sorensen, Karina Dalsgaard			A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer	ONCOGENE			English	Article							CELL-FREE DNA; POLY(ADP-RIBOSE); REPAIR; ACTIVATION; AUTOPHAGY; OLAPARIB	DNA repair gene mutations are frequent in castration-resistant prostate cancer (CRPC), suggesting eligibility for poly(ADP-ribose) polymerase inhibitor (PARPi) treatment. However, therapy resistance is a major clinical challenge and genes contributing to PARPi resistance are poorly understood. Using a genome-wide CRISPR-Cas9 knockout screen, this study aimed at identifying genes involved in PARPi resistance in CRPC. Based on the screen, we identified PARP1, and six novel candidates associated with olaparib resistance upon knockout. For validation, we generated multiple knockout populations/clones per gene in C4 and/or LNCaP CRPC cells, which confirmed that loss of PARP1, ARH3, YWHAE, or UBR5 caused olaparib resistance. PARP1 or ARH3 knockout caused cross-resistance to other PARPis (veliparib and niraparib). Furthermore, PARP1 or ARH3 knockout led to reduced autophagy, while pharmacological induction of autophagy partially reverted their PARPi resistant phenotype. Tumor RNA sequencing of 126 prostate cancer patients identified low ARH3 expression as an independent predictor of recurrence. Our results advance the understanding of PARPi response by identifying four novel genes that contribute to PARPi sensitivity in CRPC and suggest a new model of PARPi resistance through decreased autophagy.	[Ipsen, Malene Blond; Sorensen, Ea Marie Givskov; Weiss, Simone; Haldrup, Jakob; Rasmussen, Martin; Fredsoe, Jacob; Klingenberg, Soren; Sorensen, Karina Dalsgaard] Aarhus Univ Hosp, Dept Mol Med, Aarhus, Denmark; [Ipsen, Malene Blond; Sorensen, Ea Marie Givskov; Weiss, Simone; Haldrup, Jakob; Palmfeldt, Johan; Bross, Peter; Rasmussen, Martin; Fredsoe, Jacob; Klingenberg, Soren; Jochumsen, Mads R.; Bouchelouche, Kirsten; Borre, Michael; Sorensen, Karina Dalsgaard] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Thomsen, Emil Aagaard; Haldrup, Jakob; Mikkelsen, Jacob Giehm] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Dalby, Anders] Teitur Troph, Aarhus, Denmark; [Palmfeldt, Johan; Bross, Peter] Aarhus Univ Hosp, Res Unit Mol Med, Aarhus, Denmark; [Klingenberg, Soren; Jochumsen, Mads R.; Bouchelouche, Kirsten] Aarhus Univ Hosp, Dept Nucl Med, Aarhus, Denmark; [Klingenberg, Soren; Jochumsen, Mads R.; Bouchelouche, Kirsten] Aarhus Univ Hosp, PET Ctr, Aarhus, Denmark; [Ulhoi, Benedicte Parm] Aarhus Univ Hosp, Dept Pathol, Aarhus, Denmark; [Borre, Michael] Aarhus Univ Hosp, Dept Urol, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Sorensen, KD (corresponding author), Aarhus Univ Hosp, Dept Mol Med, Aarhus, Denmark.; Sorensen, KD (corresponding author), Aarhus Univ, Dept Clin Med, Aarhus, Denmark.	kdso@clin.au.dk	Rasmussen, Martin/GRY-5664-2022; Thomsen, Emil Aagaard/ABB-9850-2021; Bross, Peter/B-7219-2013	Rasmussen, Martin/0000-0001-9077-7857; Thomsen, Emil Aagaard/0000-0002-2685-7745; Jochumsen, Mads Ryo/0000-0002-7676-2322; Klingenberg, Soren/0000-0003-4308-2950; Sorensen, Karina Dalsgaard/0000-0002-4902-5490; Fredsoe, Jacob/0000-0002-7319-2467; Mikkelsen, Jacob Giehm/0000-0002-1322-3209; Palmfeldt, Johan/0000-0001-5585-639X; Bross, Peter/0000-0001-9526-8525	Novo Nordisk Foundation; Aase & Ejnar Danielsens Fond; Fabrikant Einar Willumsens Mindelegat; Tomrermester Jorgen Holm & Hustru Elisa F. Hansens Mindelegat; Direktor Emil C. Hertz og Hustru Inge Hertz Fond; Graduate School of Health (Aarhus University); Beckett Fonden (MBI); NEYE Fonden; Helge Peetz & Verner Peetz & Hustru Vilma Peetz Fond	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Aase & Ejnar Danielsens Fond; Fabrikant Einar Willumsens Mindelegat; Tomrermester Jorgen Holm & Hustru Elisa F. Hansens Mindelegat; Direktor Emil C. Hertz og Hustru Inge Hertz Fond; Graduate School of Health (Aarhus University); Beckett Fonden (MBI); NEYE Fonden; Helge Peetz & Verner Peetz & Hustru Vilma Peetz Fond	This work was supported by grants from The Novo Nordisk Foundation (KDS), Aase & Ejnar Danielsens Fond (MBI), Fabrikant Einar Willumsens Mindelegat (MBI), Tomrermester Jorgen Holm & Hustru Elisa F. Hansens Mindelegat (MBI), Direktor Emil C. Hertz og Hustru Inge Hertz Fond (MBI), Graduate School of Health (Aarhus University; MBI), Helge Peetz & Verner Peetz & Hustru Vilma Peetz Fond (MBI), Beckett Fonden (MBI), and NEYE Fonden (MBI). The Danish Cancer Biobank is acknowledged for providing patient samples and information on handling and storage.	Abida W, 2017, JCO PRECIS ONCOL, V2017, DOI [DOI 10.1200/PO.17.00029, 10.1200/PO.17.00029, 10.1200/po.17.00029]; Arun B, 2015, INT J ONCOL, V47, P262, DOI 10.3892/ijo.2015.3003; Cahuzac M, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-022-03210-5; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen X, 2019, BIOCHEM BIOPH RES CO, V508, P620, DOI 10.1016/j.bbrc.2018.11.062; Cornford P, 2021, EUR UROL, V79, P263, DOI 10.1016/j.eururo.2020.09.046; de Bono J, 2020, NEW ENGL J MED, V382, P2091, DOI 10.1056/NEJMoa1911440; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Eliopoulos AG, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00204; FDA, 2021, FDA APPR OL HRR GEN; Formentini L, 2009, J BIOL CHEM, V284, P17668, DOI 10.1074/jbc.M109.002931; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gogola E, 2018, CANCER CELL, V33, P1078, DOI 10.1016/j.ccell.2018.05.008; Goodall J, 2017, CANCER DISCOV, V7, P1006, DOI 10.1158/2159-8290.CD-17-0261; Hazan I, 2019, CELL REP, V29, P560, DOI 10.1016/j.celrep.2019.09.001; He YJ, 2018, NATURE, V563, P522, DOI 10.1038/s41586-018-0670-5; Hopkins TA, 2015, MOL CANCER RES, V13, P1465, DOI 10.1158/1541-7786.MCR-15-0191-T; Hussain M, 2020, NEW ENGL J MED, V383, P2345, DOI 10.1056/NEJMoa2022485; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Kirby M, 2011, INT J CLIN PRACT, V65, P1180, DOI 10.1111/j.1742-1241.2011.02799.x; Kolde R, 2012, BIOINFORMATICS, V28, P573, DOI 10.1093/bioinformatics/btr709; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lee JS, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9092013; Li CYG, 2019, CELL REP, V26, P1333, DOI 10.1016/j.celrep.2019.01.013; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lord CJ, 2017, SCIENCE, V355, P1152, DOI 10.1126/science.aam7344; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Niere M, 2008, MOL CELL BIOL, V28, P814, DOI 10.1128/MCB.01766-07; Pennington KL, 2018, ONCOGENE, V37, P5587, DOI 10.1038/s41388-018-0348-3; Pettitt SJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03917-2; Quigley D, 2017, CANCER DISCOV, V7, P999, DOI 10.1158/2159-8290.CD-17-0146; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ryo LB, 2019, METHODS MOL BIOL, V1961, P93, DOI 10.1007/978-1-4939-9170-9_7; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Steensel V, TIDE TRACKING INDELS; Tai S, 2012, MOL CANCER THER, V11, P1320, DOI 10.1158/1535-7163.MCT-11-0954; Tukachinsky H, 2021, CLIN CANCER RES, V27, P3094, DOI 10.1158/1078-0432.CCR-20-4805; Valabrega G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22084203; Velimezi G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04649-z; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Zhang MQ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60849-y	45	0	0	7	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 9	2022	41	37					4271	4281		10.1038/s41388-022-02427-2	http://dx.doi.org/10.1038/s41388-022-02427-2		AUG 2022	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4L2AN	35933519				2022-12-26	WOS:000836761200001
J	Shin, JE; Seo, KD; Cha, HJ; Lee, JW; Heo, YM; Kim, KK; Kim, TG; Kang, C; Lee, GS; Song, JH				Shin, Ji Eun; Seo, Kyung Deok; Cha, Hyun Jae; Lee, Jong Wook; Heo, Youn Moo; Kim, Kwang Kyoun; Kim, Tae Gyun; Kang, Chan; Lee, Gi Soo; Song, Jae Hwang			Usefulness of the delta neutrophil index in predicting surgery in patients with foot and ankle infection	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CLINICAL UTILITY; DIAGNOSIS; MARKER; COUNT; PROCALCITONIN; MANAGEMENT; SEPSIS	Background In foot and ankle infections, cases with apparent soft-tissue necrosis or purulent fluid collections definitely require surgical treatments. However, clinicians often have difficulty in determining whether to perform surgery in ambiguous cases without these findings. This study aimed to investigate the impact of the delta neutrophil index as a predictor of surgical treatment in patients with foot and ankle infections. Methods In total, 66 patients diagnosed with foot and ankle infections who underwent the delta neutrophil index test were retrospectively investigated. Medical records, including data on diabetes mellitus status, delta neutrophil index values, white blood cell count, polymorphonuclear leukocyte count, erythrocyte sedimentation rate, and C-reactive protein level, were retrospectively investigated. Logistic regression models were analyzed for the correlation between biomarkers, such as the delta neutrophil index and surgical treatment. The area under the curve was investigated to evaluate the cut-off value of the logistic model in predicting surgery. Results The relationship between the delta neutrophil index and surgical treatment was analyzed. The delta neutrophil index, adjusted for diabetes mellitus, was the best predictor of future surgical intervention. Based on the Youden index, the cutoff point (the equation's adjusted by diabetes mellitus) for the prediction of surgical treatment was defined as a probability of 0.3, with sensitivity and specificity of 82.4% and 77.6%, respectively. Conclusions Based on the present study, the delta neutrophil index can help clinicians decide the appropriate surgical treatment for foot and ankle infections at the right time.	[Shin, Ji Eun] Konyang Univ, Coll Med, Dept Biomed Informat, Daejeon, South Korea; [Seo, Kyung Deok; Cha, Hyun Jae; Heo, Youn Moo; Kim, Kwang Kyoun; Kim, Tae Gyun; Song, Jae Hwang] Konyang Univ Hosp, Dept Orthoped Surg, Daejeon, South Korea; [Lee, Jong Wook] Konyang Univ Hosp, Dept Lab Med, Daejeon, South Korea; [Kang, Chan; Lee, Gi Soo] Chungnam Natl Univ Hosp, Dept Orthoped Surg, Daejeon, South Korea	Konyang University; Konyang University Hospital; Konyang University; Konyang University Hospital; Konyang University; Konyang University Hospital; Chungnam National University; Chungnam National University Hospital	Song, JH (corresponding author), Konyang Univ Hosp, Dept Orthoped Surg, Daejeon, South Korea.	songjajj@hanmail.net						Ablij Hans, 2002, Eur J Intern Med, V13, P412, DOI 10.1016/S0953-6205(02)00132-2; Alves JC, 2010, SHOCK, V34, P15, DOI 10.1097/SHK.0b013e3181e7e61b; Anakwenze OA, 2012, J AM ACAD ORTHOP SUR, V20, P684, DOI 10.5435/JAAOS-20-11-684; Ansari-Lari MA, 2003, AM J CLIN PATHOL, V120, P795, DOI 10.1309/LT30BV9UJJV9CFHQ; ARDRON MJ, 1994, AM J CLIN PATHOL, V102, P646, DOI 10.1093/ajcp/102.5.646; Bermejo-Martin JF, 2014, CRIT CARE, V18, DOI 10.1186/cc13728; Brigden ML, 1999, AM FAM PHYSICIAN, V60, P1443; Cornbleet PJ, 2002, CLIN LAB MED, V22, P101, DOI 10.1016/S0272-2712(03)00069-6; Fang DZ, 2014, BMJ QUAL SAF, V23, P994, DOI 10.1136/bmjqs-2014-003053; HyunNahm C, 2008, ANN CLIN LAB SCI, V38, P241; Kang HS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187629; Kim OH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148799; Kong T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15878-5; Kratz Alexander, 2006, Lab Hematol, V12, P63, DOI 10.1532/LH96.06010; Lapic I, 2020, AM J CLIN PATHOL, V153, P14, DOI 10.1093/ajcp/aqz142; Lee H, 2017, ANN SURG TREAT RES, V93, P272, DOI 10.4174/astr.2017.93.5.272; Liu D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129450; Moyer MW, 2012, NAT MED, V18, P999, DOI 10.1038/nm0712-999; Nigro KG, 2005, AM J CLIN PATHOL, V123, P618, DOI 10.1309/73H7K7UBW816PBJJ; Osei-Bimpong A, 2007, HEMATOLOGY, V12, P353, DOI 10.1080/10245330701340734; Park BH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-299; Park JH, 2017, INFLAMM RES, V66, P863, DOI 10.1007/s00011-017-1066-y; Pitts SR., 2008, NATL HLTH STAT REPOR, V7; Povoa P, 2002, INTENS CARE MED, V28, P235, DOI 10.1007/s00134-002-1209-6; Rast AC, 2015, J DERMATOL, V42, P778, DOI 10.1111/1346-8138.12922; Roberts AD, 2012, SEMIN VASC SURG, V25, P75, DOI 10.1053/j.semvascsurg.2012.04.010; Seebach JD, 1997, AM J CLIN PATHOL, V107, P582; Son S, 2021, ENT-EAR NOSE THROAT, DOI 10.1177/01455613211058491; Stevens DL, 2014, CLIN INFECT DIS, V59, P147, DOI [10.1093/cid/ciu444, 10.1093/cid/ciu296]; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Yang QX, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/2082840; Yoon NB, 2013, ANN LAB MED, V33, P105, DOI 10.3343/alm.2013.33.2.105	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272574	10.1371/journal.pone.0272574	http://dx.doi.org/10.1371/journal.pone.0272574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35926065	Green Published, gold			2022-12-26	WOS:000848077100100
J	Toscano, E; Sepe, L; del Giudice, G; Tufano, R; Paolella, G				Toscano, Elvira; Sepe, Leandra; del Giudice, Giusy; Tufano, Rossella; Paolella, Giovanni			A three component model for superdiffusive motion effectively describes migration of eukaryotic cells moving freely or under a directional stimulus	PLOS ONE			English	Article							FOCAL ADHESION KINASE; MOVEMENT	Although the simple diffusion model can effectively describe the movement of eukaryotic cells on a culture surface observed at relatively low sampling frequency, at higher sampling rates more complex models are often necessary to better fit the experimental data. Currently available models can describe motion paths by involving additional parameters, such as linearity or directional persistence in time. However sometimes difficulties arise as it is not easy to effectively evaluate persistence in presence of a directional bias. Here we present a procedure which helps solve this problem, based on a model which describes displacement as the vectorial sum of three components: diffusion, persistence and directional bias. The described model has been tested by analysing the migratory behaviour of simulated cell populations and used to analyse a collection of experimental datasets, obtained by observing cell cultures in time lapse microscopy. Overall, the method produces a good description of migration behaviour as it appears to capture the expected increase in the directional bias in presence of wound without a large concomitant increase in the persistence module, allowing it to remain as a physically meaningful quantity in the presence of a directional stimulus.	[Toscano, Elvira; Sepe, Leandra; del Giudice, Giusy; Paolella, Giovanni] Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Toscano, Elvira; Sepe, Leandra; Tufano, Rossella; Paolella, Giovanni] Ceinge Biotecnol Avanzate, Naples, Italy; [del Giudice, Giusy] Arvo Ylpon katu 3, Tampere, Finland	University of Naples Federico II; CEINGE Biotecnologie Avanzate	Paolella, G (corresponding author), Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy.; Paolella, G (corresponding author), Ceinge Biotecnol Avanzate, Naples, Italy.	giovanni.paolella@unina.it		Toscano, Elvira/0000-0001-5013-5198	MIUR [PON01_00486]; University Federico II	MIUR(Ministry of Education, Universities and Research (MIUR)); University Federico II	E.T., L.S, R.T. were partially founded by PON01_00486 Programma Operativo Nazionale "Ricerca e Competitivita 2007-2013" by MIUR (https://www.miur.gov.it). R.T was the recipient of a PhD fellowship by University Federico II (www. unina.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt W, 1990, CORR ANAL 2 DIM LOC; [Anonymous], R PROJECT STAT COMPU; [Anonymous], WWW RSTUDIO; [Anonymous], CRAN PROJECT ORG; [Anonymous], **DROPPED REF**; [Anonymous], MOTOCELL; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Cantarella C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-S12; Chapnick DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082444; CHEN TR, 1988, CYTOGENET CELL GENET, V48, P19, DOI 10.1159/000132579; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Cordelieres FP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081266; Deforet M, 2012, NAT METHODS, V9, P1081, DOI [10.1038/NMETH.2209, 10.1038/nmeth.2209]; DICKINSON RB, 1993, AICHE J, V39, P1995, DOI 10.1002/aic.690391210; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; DUNN GA, 1987, J CELL SCI, P81; Ellis J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74643-3; Furth R, 1920, Z F R PHYSIK, V2; GAIL MH, 1970, BIOPHYS J, V10, P980, DOI 10.1016/S0006-3495(70)86347-0; Hartman ZR, 2013, MOL CANCER RES, V11, P651, DOI 10.1158/1541-7786.MCR-12-0578; Martens L, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-289; Masuzzo P, 2017, SCI REP-UK, V7, DOI 10.1038/srep42383; Rossen NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025196; Selmeczi D, 2005, BIOPHYS J, V89, P912, DOI 10.1529/biophysj.105.061150; Sepe L, 2013, CELL PHYSIOL BIOCHEM, V31, P123, DOI 10.1159/000343355; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272259	http://dx.doi.org/10.1371/journal.pone.0272259			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917375	gold, Green Published			2022-12-26	WOS:000837840000040
J	Trosan, P; Cabral, JV; Smeringaiova, I; Studeny, P; Jirsova, K				Trosan, Peter; Cabral, Joao Victor; Smeringaiova, Ingrida; Studeny, Pavel; Jirsova, Katerina			Interleukin-13 increases the stemness of limbal epithelial stem cells cultures	PLOS ONE			English	Article							GROWTH-FACTOR-I; CORNEAL; EXPRESSION; DIFFERENTIATION; MIGRATION; LOCATION; THERAPY; MARKER; CYCLE	This study aimed to determine the effect of interleukin-13 (IL13) on the stemness, differentiation, proliferation, clonogenicity, and morphology of cultured limbal epithelial cells (LECs). Human limbal explants were used to culture LECs up to the second passage (P0-P2) with or without IL13 (IL13+ and IL13-, respectively). Cells were analyzed by qPCR (for the expression of Delta Np63 alpha, BMI-1, keratin (K) 3, K7, K12, K14, K17, mucin 4, and MKI67) and immunofluorescence staining for p63 alpha. The clonogenic ability was determined by colony-forming assay (CFA), and their metabolic activity was measured by WST-1 assay. The results of the CFA showed a significantly increased clonogenic ability in P1 and P2 cultures when LECs were cultured with IL13. In addition, the expression of putative stem cell markers (Delta Np63 alpha, K14, and K17) was significantly higher in all IL13+ cultures compared to IL13-. Similarly, immunofluorescence analysis showed a significantly higher percentage of p63 alpha positive cells in P2 cultures with IL13 than without it. LECs cultures without IL13 lost their cuboidal morphology with a high nucleocytoplasmic ratio after P1. The use of IL13 also led to significantly higher proliferation in P2, which can be reflected by a higher ability to reach confluence in P2 cultures. On the other hand, IL13 had no effect on corneal epithelial cell differentiation (K3 and K12 expression), and the expression of the conjunctival marker K7 significantly increased in all IL13+ cultures compared to the respective cell culture without IL13. This study showed that IL13 enhanced the stemness of LECs by increasing the clonogenicity and the expression of putative stem cell markers of LECs while maintaining their stem cell morphology. We established IL13 as a culture supplement for LESCs, which increases their stemness potential in culture, even after the second passage, and may lead to the greater success of LESCs transplantation in patients with LSCD.	[Trosan, Peter; Cabral, Joao Victor; Smeringaiova, Ingrida; Jirsova, Katerina] Charles Univ Prague, Gen Univ Hosp Prague, Inst Biol & Med Genet, Fac Med 1, Prague, Czech Republic; [Trosan, Peter] Rostock Univ, Med Ctr, Dept Ophthalmol, Rostock, Germany; [Studeny, Pavel] 3rd Med Fac, Ophthalmol Dept, Prague, Czech Republic; [Studeny, Pavel] Univ Hosp Kralovske Vinohrady, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; University of Rostock; University Hospital Vinohrady	Trosan, P (corresponding author), Charles Univ Prague, Gen Univ Hosp Prague, Inst Biol & Med Genet, Fac Med 1, Prague, Czech Republic.; Trosan, P (corresponding author), Rostock Univ, Med Ctr, Dept Ophthalmol, Rostock, Germany.	peter.trosan@med.uni-rostock.de			Norway Grants and Technology Agency of the Czech Republic within the KAPPA Programme [TO01000099]; project Ministry of Education, Youth and Sports [BBMRI_CZ LM2018125]; Bundesministerium fur Bildung und Forschung (BMBF) [FKZ 01IO1803]	Norway Grants and Technology Agency of the Czech Republic within the KAPPA Programme; project Ministry of Education, Youth and Sports; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by Norway Grants and Technology Agency of the Czech Republic within the KAPPA Programme (project TO01000099), by project Ministry of Education, Youth and Sports BBMRI_CZ LM2018125, and by Bundesministerium fur Bildung und Forschung (BMBF) (FKZ 01IO1803). Institutional support (Charles University, Prague) was provided by program Cooperatio: Medical Diagnostics and Basic Medical Sciences (JVC, KJ, PT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LPK, 2010, INVEST OPHTH VIS SCI, V51, P758, DOI 10.1167/iovs.09-3379; Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; Brejchova K, 2018, EXP EYE RES, V176, P20, DOI 10.1016/j.exer.2018.06.019; Calonge M, 2021, PHARMACEUTICS, V13, DOI 10.3390/pharmaceutics13091483; Castro-Munozledo F, 2011, EXP EYE RES, V92, P4, DOI 10.1016/j.exer.2010.11.002; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Daniels JT, 2003, INVEST OPHTH VIS SCI, V44, P1048, DOI 10.1167/iovs.02-0442; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; EBATO B, 1988, INVEST OPHTH VIS SCI, V29, P1533; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; GOSPODAROWICZ D, 1977, EXP EYE RES, V25, P631, DOI 10.1016/0014-4835(77)90142-7; JACOBSEN SEW, 1994, J EXP MED, V180, P75, DOI 10.1084/jem.180.1.75; Jirsova K, 2011, INVEST OPHTH VIS SCI, V52, P5892, DOI 10.1167/iovs.10-6748; Joseph A, 2004, BRIT J OPHTHALMOL, V88, P393, DOI 10.1136/bjo.2003.018481; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P1566; Junttila IS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00888; Kakazu A, 2004, INVEST OPHTH VIS SCI, V45, P3485, DOI 10.1167/iovs.04-0372; Kakizaki I, 2008, ARCH BIOCHEM BIOPHYS, V471, P85, DOI 10.1016/j.abb.2007.12.004; Kolli S, 2019, STEM CELLS, V37, P139, DOI 10.1002/stem.2921; Kramerov AA, 2015, MOL VIS, V21, P1357; Lee HK, 2006, INVEST OPHTH VIS SCI, V47, P873, DOI 10.1167/iovs.05-0826; Lehrer MS, 1998, J CELL SCI, V111, P2867; Li YJ, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0707-y; Lopez-Paniagua M, 2016, EXP EYE RES, V146, P83, DOI 10.1016/j.exer.2015.12.002; Lopez-Paniagua M, 2013, CURR EYE RES, V38, P537, DOI 10.3109/02713683.2013.767350; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; MEYER PAR, 1989, EYE, V3, P121, DOI 10.1038/eye.1989.19; Nappo G, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.23; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Saghizadeh M, 2014, EXP EYE RES, V129, P66, DOI 10.1016/j.exer.2014.10.022; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; SOTOZONO C, 1995, INVEST OPHTH VIS SCI, V36, P1524; Stadnikova A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211861; Trosan P, 2016, STEM CELLS DEV, V25, P874, DOI 10.1089/scd.2016.0030; Trosan P, 2012, STEM CELLS DEV, V21, P3341, DOI 10.1089/scd.2012.0180; Ueta M, 2011, JPN J OPHTHALMOL, V55, P405, DOI 10.1007/s10384-011-0030-6; Utheim O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118517; VANBUSKIRK EM, 1989, EYE, V3, P101, DOI 10.1038/eye.1989.16; Zhang Y, 2016, INT J MED SCI, V13, P835, DOI 10.7150/ijms.16563; Zhao B, 2008, INVEST OPHTH VIS SCI, V49, P3395, DOI 10.1167/iovs.07-1263; Zhu PP, 2019, NAT IMMUNOL, V20, P183, DOI 10.1038/s41590-018-0297-6	43	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272081	http://dx.doi.org/10.1371/journal.pone.0272081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917378	Green Published, gold			2022-12-26	WOS:000837840000018
J	Yokomizo, S; Roessing, M; Morita, A; Kopp, T; Ogawa, E; Katagiri, W; Feil, S; Huang, PL; Atochin, DN; Kashiwagi, S				Yokomizo, Shinya; Roessing, Malte; Morita, Atsuyo; Kopp, Timo; Ogawa, Emiyu; Katagiri, Wataru; Feil, Susanne; Huang, Paul L.; Atochin, Dmitriy N.; Kashiwagi, Satoshi			Near-infrared II photobiomodulation augments nitric oxide bioavailability via phosphorylation of endothelial nitric oxide synthase	FASEB JOURNAL			English	Article						endothelial nitric oxide synthase; near-infrared II; nitric oxide; photobiomodulation	CYTOCHROME-C-OXIDASE; ELECTRON-PARAMAGNETIC-RES; BIPHASIC DOSE-RESPONSE; LASER IRRADIATION; NITROSYL HEMOGLOBIN; CELL-PROLIFERATION; MAMMALIAN-CELLS; MULTIPLE ROLES; IN-VITRO; LIGHT	There is solid evidence of the beneficial effect of photobiomodulation (PBM) with low-power near-infrared (NIR) light in the NIR-I window in increasing bioavailable nitric oxide (NO). However, it is not established whether this effect can be extended to NIR-II light, limiting broader applications of this therapeutic modality. Since we have demonstrated PBM with NIR laser in the NIR-II window, we determined the causal relationship between NIR-II irradiation and its specific biological effects on NO bioavailability. We analyzed the impact of NIR-II irradiation on NO release in cultured human endothelial cells using a NO-sensitive fluorescence probe and single-cell live imaging. Two distinct wavelengths of NIR-II laser (1064 and 1270 nm) and NIR-I (808 nm) at an irradiance of 10 mW/cm(2) induced NO release from endothelial cells. These lasers also enhanced Akt phosphorylation at Ser 473, endothelial nitric oxide synthase (eNOS) phosphorylation at Ser 1177, and endothelial cell migration. Moreover, the NO release and phosphorylation of eNOS were abolished by inhibiting mitochondrial respiration, suggesting that Akt activation caused by NIR-II laser exposure involves mitochondrial retrograde signaling. Other inhibitors that inhibit known Akt activation pathways, including a specific inhibitor of PI3K, Src family PKC, did not affect this response. These two wavelengths of NIR-II laser induced no appreciable NO generation in cultured neuronal cells expressing neuronal NOS (nNOS). In short, NIR-II laser enhances bioavailable NO in endothelial cells. Since a hallmark of endothelial dysfunction is suppressed eNOS with concomitant NO deficiency, NIR-II laser technology could be broadly used to restore endothelial NO and treat or prevent cardiovascular diseases.	[Yokomizo, Shinya; Kashiwagi, Satoshi] Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Dept Radiol, 149 13th St, Charlestown, MA 02129 USA; [Yokomizo, Shinya] Tokyo Metropolitan Univ, Dept Radiol Sci, Tokyo, Japan; [Roessing, Malte; Kopp, Timo; Feil, Susanne] Univ Tubingen, Interfac Inst Biochem IFIB, Tubingen, Germany; [Roessing, Malte; Morita, Atsuyo; Kopp, Timo; Huang, Paul L.; Atochin, Dmitriy N.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Dept Med, 149 13th St, Charlestown, MA 02129 USA; [Ogawa, Emiyu] Kitasato Univ, Sch Allied Hlth Sci, Sagamihara, Kanagawa, Japan; [Katagiri, Wataru] Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa, Japan	Harvard University; Massachusetts General Hospital; Tokyo Metropolitan University; Eberhard Karls University of Tubingen; Harvard University; Massachusetts General Hospital; Kitasato University; Keio University	Kashiwagi, S (corresponding author), Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Dept Radiol, 149 13th St, Charlestown, MA 02129 USA.; Atochin, DN (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Dept Med, 149 13th St, Charlestown, MA 02129 USA.	atochin@cvrc.mgh.harvard.edu; skashiwagi@mgh.harvard.edu	Kashiwagi, Satoshi/T-2420-2019		CMI Inc.; National Institute of Allergy and Infectious Diseases (NIAID) [R21AI144103]; German Research Foundation [335549539-GRK2381]; National Institute of Neurological Disorders and Stroke (NINDS) [R01NS096237]; Massachusetts General Hospital (MGH); Reinhard Frank-Stiftung	CMI Inc.; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); German Research Foundation(German Research Foundation (DFG)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Massachusetts General Hospital (MGH); Reinhard Frank-Stiftung	CMI Inc., Grant/Award Number: Study Abroad Scholarship; National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: R21AI144103; German Research Foundation, Grant/Award Number: 335549539-GRK2381; National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS096237; Massachusetts General Hospital (MGH), Grant/Award Number: Executive Committee On Research (ECOR) Interim Support Funding; Reinhard Frank-Stiftung	Ball KA, 2011, J PHOTOCH PHOTOBIO B, V102, P182, DOI 10.1016/j.jphotobiol.2010.12.002; BOELENS R, 1983, BIOCHIM BIOPHYS ACTA, V724, P176, DOI 10.1016/0005-2728(83)90136-6; BOELENS R, 1982, BIOCHIM BIOPHYS ACTA, V679, P84, DOI 10.1016/0005-2728(82)90258-4; Bohovych I, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00109; Borutaite V, 2000, BBA-BIOENERGETICS, V1459, P405, DOI 10.1016/S0005-2728(00)00178-X; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cao J, 2020, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00487; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013; Chen CH, 2008, LASER SURG MED, V40, P46, DOI 10.1002/lsm.20589; Chen GY, 2012, ACS NANO, V6, P8280, DOI 10.1021/nn302972r; Chinnathambi S, 2019, SCI TECHNOL ADV MAT, V20, P337, DOI 10.1080/14686996.2019.1590731; da Cunha FM, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/482582; Dang XN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39502-w; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Dolgova D, 2019, BIOMED OPT EXPRESS, V10, P4261, DOI 10.1364/BOE.10.004261; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Gelfand JA, 2019, FASEB J, V33, P3074, DOI 10.1096/fj.201801095R; GHIGO D, 1995, J EXP MED, V181, P9, DOI 10.1084/jem.181.1.9; Grant MKO, 2002, LIFE SCI, V71, P813, DOI 10.1016/S0024-3205(02)01732-0; Hon YY, 2010, DRUG METAB DISPOS, V38, P1707, DOI 10.1124/dmd.110.034355; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Karu TI, 2005, J PHOTOCH PHOTOBIO B, V81, P98, DOI 10.1016/j.jphotobiol.2005.07.002; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Karu TI, 2005, LASER SURG MED, V36, P307, DOI 10.1002/lsm.20148; Karu T, 2013, PHOTOMED LASER SURG, V31, P189, DOI 10.1089/pho.2013.3510; Karu T, 2010, PHOTOMED LASER SURG, V28, P159, DOI 10.1089/pho.2010.2789; Karu TI, 2008, PHOTOCHEM PHOTOBIOL, V84, P1091, DOI 10.1111/j.1751-1097.2008.00394.x; Karu TI, 2010, IUBMB LIFE, V62, P607, DOI 10.1002/iub.359; Kashiwagi S, 2020, FASEB J, V34, P3485, DOI 10.1096/fj.201902164R; Kashiwagi Satoshi, 2016, J Vaccines Vaccin, V7; Kashiwagi S, 2014, HUM VACC IMMUNOTHER, V10, P1892, DOI 10.4161/hv.28840; Kashiwagi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082899; Katagiri W, 2020, J BIOMED OPT, V25, DOI 10.1117/1.JBO.25.3.036003; Kawabata A, 1996, BRIT J PHARMACOL, V117, P236, DOI 10.1111/j.1476-5381.1996.tb15181.x; Keszler A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00305; Khan I, 2015, SCI REP-UK, V5, DOI 10.1038/srep10581; Khokhlova A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54905-5; Kimizuka Y, 2018, J IMMUNOL, V201, P3587, DOI 10.4049/jimmunol.1701687; Kimizuka Y, 2017, VACCINE, V35, P2404, DOI 10.1016/j.vaccine.2017.03.036; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Lohr NL, 2013, J MOL CELL CARDIOL, V62, P36, DOI 10.1016/j.yjmcc.2013.05.007; Lohr NL, 2009, J MOL CELL CARDIOL, V47, P256, DOI 10.1016/j.yjmcc.2009.03.009; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; Mason MG, 2006, P NATL ACAD SCI USA, V103, P708, DOI 10.1073/pnas.0506562103; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Morbidelli L, 1996, AM J PHYSIOL-HEART C, V270, pH411, DOI 10.1152/ajpheart.1996.270.1.H411; Morse K, 2017, J IMMUNOL, V199, P1319, DOI 10.4049/jimmunol.1601873; Murohara T, 1999, ARTERIOSCL THROM VAS, V19, P1156, DOI 10.1161/01.ATV.19.5.1156; Namkoong S, 2005, EXP MOL MED, V37, P588, DOI 10.1038/emm.2005.72; Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105; Poyton RO, 2011, DISCOV MED, V11, P154; Quirk BJ, 2020, PHOTOBIOMOD PHOTOMED, V38, P527, DOI 10.1089/photob.2020.4905; Reichenbach Gustavo, 2005, Curr Drug Targets Cardiovasc Haematol Disord, V5, P65; Sarti P, 2000, BIOCHEM BIOPH RES CO, V274, P183, DOI 10.1006/bbrc.2000.3117; Sarti P., 2012, INT J CELL BIOL, V2012; Sobrevia L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9782346; Srivastava K, 2012, CELL MOL NEUROBIOL, V32, P319, DOI 10.1007/s10571-011-9777-z; Stael Simon, 2022, Methods Mol Biol, V2447, P127, DOI 10.1007/978-1-0716-2079-3_11; STAMLER JS, 1989, CIRC RES, V65, P796, DOI 10.1161/01.RES.65.3.796; Stiles BL, 2009, ADV DRUG DELIVER REV, V61, P1276, DOI 10.1016/j.addr.2009.07.017; Stirling DR, 2021, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-021-04344-9; Suarez-Arnedo A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232565; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Umbrello M, 2013, ANTIOXID REDOX SIGN, V19, P1690, DOI 10.1089/ars.2012.4979; Uruno A, 2004, HYPERTENS RES, V27, P887, DOI 10.1291/hypres.27.887; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30540; Zhang LL, 2009, J CELL PHYSIOL, V219, P553, DOI 10.1002/jcp.21697; Zhang R, 2009, J MOL CELL CARDIOL, V46, P4, DOI 10.1016/j.yjmcc.2008.09.707; ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	74	1	1	9	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22490	10.1096/fj.202101890R	http://dx.doi.org/10.1096/fj.202101890R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3N6HZ	35929438				2022-12-26	WOS:000836248900001
J	Zhuang, HX; Ren, Y; Mao, CY; Zhong, YY; Zhang, ZB; Cao, BY; Zhang, YM; Huang, JQ; Xu, GQ; Huang, ZQ; Xu, YJ; Mao, XL				Zhuang, Haixia; Ren, Ying; Mao, Chenyu; Zhong, Yueya; Zhang, Zubin; Cao, Biyin; Zhang, Yuming; Huang, Jinqi; Xu, Guoqiang; Huang, Zhenqian; Xu, Yujia; Mao, Xinliang			Induction of zinc finger protein RNF6 auto-ubiquitination for the treatment of myeloma and chronic myeloid leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE; DEUBIQUITINATION; DEGRADATION; USP7/HAUSP; INHIBITOR; NILOTINIB; BINDING	The zinc finger ubiquitin ligase RNF6 has been proposed as a potential therapeutic target in several cancers, but under-standing its molecular mechanism of degradation has been elusive. In the present study, we find that RNF6 is degraded via auto-ubiquitination in a manner dependent on its Really Interesting New Gene (RING) domain. We determine that when the RING domain is deleted (& UDelta;RING) or the core cysteine residues in the zinc finger are mutated (C632S/C635S), the WT protein, but not the & UDelta;RING or mutant RNF6 protein, un-dergoes polyubiquitination. We also identify USP7 as a deu-biquitinase of RNF6 by tandem mass spectrometry. We show that USP7 interacts with RNF6 and abolishes its K48-linked polyubiquitination, thereby preventing its degradation. In contrast, we found a USP7-specific inhibitor promotes RNF6 polyubiquitination, degradation, and cell death. Furthermore, we demonstrate the anti-leukemic drug Nilotinib and anti-myeloma drug Panobinostat (LBH589) induce RNF6 K48 -linked polyubiquitination and degradation in both multiple myeloma (MM) and leukemia cells. In agreement with our hypothesis on the mode of RNF6 degradation, we show these drugs promote RNF6 auto-ubiquitination in an in vitro ubiq-uitination system without other E3 ligases. Consistently, reexpression of RNF6 ablates drug-induced MM and leukemia cell apoptosis. Therefore, our results reveal that RNF6 is a RING E3 ligase that undergoes auto-ubiquitination, which could be abolished by USP7 and induced by anti-cancer drugs. We propose that chemical induction of RNF6 auto-ubiquitination and degradation could be a novel strategy for the treatment of hematological malignancies including MM and leukemia.	[Zhuang, Haixia; Zhong, Yueya; Huang, Zhenqian; Xu, Yujia; Mao, Xinliang] Guangzhou Med Univ, Affiliated Hosp 1, Dept Hematol, Guangzhou, Peoples R China; [Zhuang, Haixia; Zhong, Yueya; Huang, Zhenqian; Xu, Yujia; Mao, Xinliang] Guangzhou Med Univ, Sch Basic Med Sci, Guangdong Key Lab Prot Modificat & Degradat, Guangzhou, Peoples R China; [Ren, Ying; Zhang, Zubin; Cao, Biyin; Xu, Guoqiang] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Suzhou, Jiangsu, Peoples R China; [Mao, Chenyu] Southern Univ Sci & Technol, Sch Med, Shenzhen, Guangdong, Peoples R China; [Zhang, Yuming; Huang, Jinqi] Guangdong Med Univ, Affiliated Hosp, Hematol Res Inst, Dept Hematol, Zhanjiang, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Soochow University - China; Southern University of Science & Technology; Guangdong Medical University	Huang, ZQ; Xu, YJ; Mao, XL (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Hematol, Guangzhou, Peoples R China.; Huang, ZQ; Xu, YJ; Mao, XL (corresponding author), Guangzhou Med Univ, Sch Basic Med Sci, Guangdong Key Lab Prot Modificat & Degradat, Guangzhou, Peoples R China.	huangzq2013@163.com; xuyujiamm1992@163.com; xinliangmao@gzhmu.edu.cn		Huang, Jinqi/0000-0002-5961-6841; Huang, Zhan/0000-0002-6875-8550	National Natural Science Foundation of China [82100214, 81770154, 81970194]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding and additional information-This study was supported in part by National Natural Science Foundation of China (#82100214 to Y. X., #81770154 and #81970194 to X. M.) .	Ahmad T, 2021, INT J ONCOL, V59, DOI 10.3892/ijo.2021.5269; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; Cassandri M, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.71; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; He YM, 2020, J BIOL CHEM, V295, P2084, DOI 10.1074/jbc.RA119.010724; Huang X, 2019, CANCER IMMUNOL RES, V7, P1580, DOI 10.1158/2326-6066.CIR-18-0910; Jain P, 2015, LANCET HAEMATOL, V2, pE118, DOI 10.1016/S2352-3026(15)00021-6; Jiang SY, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03732-6; Laubach JP, 2021, BLOOD CANCER J, V11, DOI 10.1038/s41408-021-00407-5; Liang Q, 2018, CLIN CANCER RES, V24, P1473, DOI 10.1158/1078-0432.CCR-17-2133; Liu L, 2018, CANCER RES, V78, P1958, DOI 10.1158/0008-5472.CAN-17-2683; Lu Q, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00673; Ma JH, 2010, ARCH BIOCHEM BIOPHYS, V503, P207, DOI 10.1016/j.abb.2010.08.020; Ma J, 2019, NUCLEIC ACIDS RES, V47, pD1211, DOI 10.1093/nar/gky869; Maiso P, 2006, CANCER RES, V66, P5781, DOI 10.1158/0008-5472.CAN-05-4186; Oh YM, 2007, BIOCHEM BIOPH RES CO, V357, P615, DOI 10.1016/j.bbrc.2007.03.193; Park Y, 2020, CANCER RES, V80, P2537, DOI 10.1158/0008-5472.CAN-19-3428; Ran Y, 2016, J MOL CELL BIOL, V8, P31, DOI 10.1093/jmcb/mjv068; Ren Y, 2020, ACTA PHARMACOL SIN, V41, P394, DOI 10.1038/s41401-019-0309-6; Sacha T, 2019, FUTURE ONCOL, V15, P953, DOI 10.2217/fon-2018-0468; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021; Xu X, 2016, J BIOL CHEM, V291, P9617, DOI 10.1074/jbc.M115.701979; Xu YJ, 2021, BLOOD, V137, P1478, DOI 10.1182/blood.2020005199; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yang YL, 2000, CELL RES, V10, P169, DOI 10.1038/sj.cr.7290046; Zhang Y, 2018, BIOCHEM J, V475, P1507, DOI 10.1042/BCJ20180005; Zhang ZB, 2016, BLOOD, V127, P1676, DOI 10.1182/blood-2015-07-658203	27	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102314	10.1016/j.jbc.2022.102314	http://dx.doi.org/10.1016/j.jbc.2022.102314			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9IM	35926709	Green Published, gold			2022-12-26	WOS:000863192700005
J	Potter, B; Cannizzo, ZJ; Griffen, BD				Potter, Ben; Cannizzo, Zachary J.; Griffen, Blaine D.			Morphometric correlations between dietary and reproductive traits of two brachyuran crabs, Hemigrapsus sanguineus and Aratus pisonii	PLOS ONE			English	Article							OMNIVOROUS DIET; CLAW MORPHOLOGY; FECUNDITY; SELECTION; SIZE; PERFORMANCE; PREDATION; IMPACTS; HABITAT	Many animals have flexible morphological traits that allow them to succeed in differing circumstances with differing diets available to them. For brachyuran crabs, claw height and gut size are diet-specific and largely reflect foraging strategies, while abdomen width reflects relative levels of fecundity. However, the link between claw size and diet has largely been documented only for primarily carnivorous crabs, while the link between diet and fecundity is strong in herbivorous crabs. We sought to determine the nature of the intraspecific relationship between claw size, dietary habits, and fecundity for two primarily herbivorous crab species, Hemigrapsus sanguineus and Aratus pisonii. Specifically, we examined whether claw size and/or abdomen width can be used as reliable measures of individual diet strategy. To test these hypotheses, we collected crabs and measured the dimensions of their claws, abdomens, and guts. By comparing these dimensions for each individual, we found that strongly predictive relationships do not exist between these traits for the primarily herbivorous species in our study. Thus, identifying external morphological features that can be used to assess diets of primarily herbivorous crabs remains elusive.	[Potter, Ben; Griffen, Blaine D.] Brigham Young Univ, Biol Dept, Provo, UT 84602 USA; [Cannizzo, Zachary J.] NOAA, Off Natl Marine Sanctuaries, Natl Marine Protected Areas Ctr, Silver Spring, MD USA	Brigham Young University; National Oceanic Atmospheric Admin (NOAA) - USA	Griffen, BD (corresponding author), Brigham Young Univ, Biol Dept, Provo, UT 84602 USA.	blaine_griffen@byu.edu						Ali Malik H., 2017, Journal of Fisheries and Environment, V41, P6; BEEVER JW, 1979, OECOLOGIA, V43, P317, DOI 10.1007/BF00344958; Belgrad BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145481; Brousseau DJ, 2007, MAR ECOL PROG SER, V339, P221, DOI 10.3354/meps339221; Brousseau DJ, 2005, J CRUSTACEAN BIOL, V25, P130, DOI 10.1651/C-2530; Cannizzo ZJ, 2018, ECOL EVOL, V8, P1521, DOI 10.1002/ece3.3739; Cannizzo ZJ., 2020, SCI REP-UK, V10, P1; Edgell TC, 2009, J EXP MAR BIOL ECOL, V382, P1, DOI 10.1016/j.jembe.2009.10.004; Erickson AA, 2008, J SEA RES, V59, P59, DOI 10.1016/j.seares.2007.06.007; Griffen BD., 2020, SCI REP-UK, V10, P1; Griffen BD, 2021, BIOL INVASIONS, V23, P491, DOI 10.1007/s10530-020-02377-4; Griffen BD, 2020, MAR ECOL PROG SER, V640, P127, DOI 10.3354/meps13280; Griffen BD, 2015, BIOL INVASIONS, V17, P2533, DOI 10.1007/s10530-015-0890-7; Griffen BD, 2015, ECOL EVOL, V5, P1474, DOI 10.1002/ece3.1427; Griffen BD, 2014, OECOLOGIA, V174, P121, DOI 10.1007/s00442-013-2751-3; Griffen BD, 2012, BIOL INVASIONS, V14, P2545, DOI 10.1007/s10530-012-0251-8; Griffen BD, 2011, J ANIM ECOL, V80, P854, DOI 10.1111/j.1365-2656.2011.01832.x; Gul MR, 2020, ECOL INDIC, V117, DOI 10.1016/j.ecolind.2020.106636; Gul MR, 2020, HYDROBIOLOGIA, V847, P3025, DOI 10.1007/s10750-020-04308-9; Litulo Carlos, 2004, Western Indian Ocean Journal of Marine Science, V3, P87; Lohrer AM, 2002, MAR ECOL PROG SER, V227, P135, DOI 10.3354/meps227135; Quezada-Villa K., PREDICTING DIET USIN; Riley ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176263; Riley ME, 2014, AQUAT BIOL, V20, P35, DOI 10.3354/ab00543; Rodrigues Marcos Alaniz, 2011, Atlantica, V33, P141; Schmitz Oswald, 2017, F1000Res, V6, P1767, DOI 10.12688/f1000research.11813.1; Schmitz OJ, 2015, ADV ECOL RES, V52, P319, DOI 10.1016/bs.aecr.2015.01.003; Silva AC, 2010, J EXP MAR BIOL ECOL, V391, P84, DOI 10.1016/j.jembe.2010.06.012; SMITH LD, 1994, SCIENCE, V264, P710, DOI 10.1126/science.264.5159.710; Smith LD, 2004, MAR ECOL PROG SER, V276, P209, DOI 10.3354/meps276209; Stillman RA, 2015, BIOSCIENCE, V65, P140, DOI 10.1093/biosci/biu192; Wilcox M, 2015, J EXP MAR BIOL ECOL, V465, P121, DOI 10.1016/j.jembe.2015.01.009; WOLCOTT TG, 1978, J EXP MAR BIOL ECOL, V31, P67, DOI 10.1016/0022-0981(78)90137-5; Yamada SB, 1998, J EXP MAR BIOL ECOL, V220, P191; Yong Adeline Y.P., 2021, Zoological Studies, V60, P1, DOI 10.6620/ZS.2021.60-37	35	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0267369	10.1371/journal.pone.0267369	http://dx.doi.org/10.1371/journal.pone.0267369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925929	Green Published, gold			2022-12-26	WOS:000848077100004
J	Correa, RM; Baena, A; Valls, J; Colucci, MC; Mendoza, L; Rol, M; Wiesner, C; Ferrera, A; Fellner, MD; Gonzalez, JV; Basiletti, JA; Mongelos, P; de la Pena, MR; Saino, A; Kasamatsu, E; Velarde, C; Macavilca, N; Martinez, S; Venegas, G; Calderon, A; Rodriguez, G; Barrios, H; Herrero, R; Almonte, M; Picconi, MA				Mariel Correa, Rita; Baena, Armando; Valls, Joan; Celeste Colucci, Maria; Mendoza, Laura; Rol, Maryluz; Wiesner, Carolina; Ferrera, Annabelle; Dolores Fellner, Maria; Victor Gonzalez, Joaquin; Alejandro Basiletti, Jorge; Mongelos, Pamela; Rodriguez de la Pena, Mercedes; Saino, Agustina; Kasamatsu, Elena; Velarde, Carlos; Macavilca, Ninoska; Martinez, Sandra; Venegas, Gino; Calderon, Alejandro; Rodriguez, Guillermo; Barrios, Hernan; Herrero, Rolando; Almonte, Maribel; Alejandra Picconi, Maria		ESTAMPA Study Grp	Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; CANCER; RISK; INFECTION; AGE; METAANALYSIS; ATTRIBUTION; VACCINATION; POPULATION; VALIDATION	The proportion of HPV16 and 18-associated cervical cancer (CC) appears rather constant worldwide (>= 70%), but the relative importance of the other HR-HPV differs slightly by geographical region. Here, we studied the HPV genotype distribution of HPV positive Latin American (LA) women by histological grade, in a sub-cohort from the ESTAMPA study; we also explored the association of age-specific HPV genotypes in severe lesions. Cervical samples from 1,252 participants (854 <= CIN1, 121 CIN2, 194 CIN3 and 83 CC) were genotyped by two PCRs-Reverse Blotting Hybridization strategies: i) Broad-Spectrum General Primers 5+/6+ and ii) PGMY9/11 PCRs. HPV16 was the most frequently found genotype in all histological grades, and increased with the severity of lesions from 14.5% in <= CIN1, 19.8% in CIN2, 51.5% in CIN3 to 65.1% in CC (p < 0.001). For the remaining HR-HPVs their frequency in CC did not increase when compared to less severe categories. The nonavalent vaccine HR-types ranked at the top in CC, the dominant ones being HPV16 and HPV45. HR-HPV single infection occurs, respectively, in 57.1% and 57.0% of <= CIN1 and CIN2, increasing to 72.2% and 91.6% in CIN3 and CC (p< 0.001). No association between age and HPV type was observed in CC, although the risk of HPV16 infection in CIN3 cases increased with age. Results confirm the relevance of HPV16 in the whole clinical spectrum, with a strong rise of its proportion in CIN3 and cancer. This information will be relevant in evaluating the impact of HPV vaccination, as a baseline against which to compare genotype changes in HPV type-specific distribution as vaccinated women participate in screening in LA region. Likewise, these data may help select the best HPV testing system for HPV-base defficient, affordable, and sustainable screening programmes.	[Mariel Correa, Rita; Celeste Colucci, Maria; Dolores Fellner, Maria; Victor Gonzalez, Joaquin; Alejandro Basiletti, Jorge; Alejandra Picconi, Maria] Inst Nacl Enfermedades Infecciosas ANLIS Dr Malbr, Serv Virus Oncogen, Lab Nacl & Reg Referencia HPV, Buenos Aires, DF, Argentina; [Baena, Armando; Valls, Joan; Rol, Maryluz; Almonte, Maribel] WHO, Int Agcy Res Canc, Early Detect Prevent & Infect Branch, Lyon, France; [Valls, Joan] Ctr Invest Biorned Red Canc CIBERONC, Madrid, Spain; [Mendoza, Laura; Mongelos, Pamela; Kasamatsu, Elena; Barrios, Hernan] Univ Nacl Asuncion, Inst Invest Ciencias Salud, San Lorenzo, Paraguay; [Wiesner, Carolina; Martinez, Sandra] Inst Nacl Cancerol, Bogota, Colombia; [Ferrera, Annabelle] Univ Nacl Autonoma Honduras, Inst Invest Microbiol, Tegucigalpa, Honduras; [Rodriguez de la Pena, Mercedes] Hosp Nacl Prof Posadas, Serv Ginecol, El Palomar, Argentina; [Saino, Agustina] Hosp Nacl Prof Posadas, Serv Anat Patol, Secc Histol, El Palomar, Argentina; [Velarde, Carlos; Macavilca, Ninoska] Inst Nacl Enfermedades Neoplas, Surquillo, Peru; [Venegas, Gino] Clin Anglo Amer, Lima, Peru; [Calderon, Alejandro] Reg Pacifico Cent, Caja Costarricense Seguro Social, San Jose, Costa Rica; [Rodriguez, Guillermo] Comis Honoraria Lucha Canc, Montevideo, Uruguay; [Herrero, Rolando] Agencia Costarricense Invest Biomed, San Jose, Costa Rica	World Health Organization; International Agency for Research on Cancer (IARC); CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Research Institute for Health Sciences (IICS); Universidad Nacional de Asuncion; Universidad Nacional Autonoma de Honduras; Instituto Nacional de Enfermedades Neoplasicas	Correa, RM (corresponding author), Inst Nacl Enfermedades Infecciosas ANLIS Dr Malbr, Serv Virus Oncogen, Lab Nacl & Reg Referencia HPV, Buenos Aires, DF, Argentina.	correamariel01@gmail.com		Basiletti, Jorge/0000-0002-7247-1413; ROL, Mary Luz/0000-0003-4250-092X; Baena, Armando/0000-0001-8717-6911	Instituto Nacional del Cancer (Argentina); Agencia Nacional de Promocion de la Investigacion, el Desarrollo Tecnologico y la Innovacion (Argentina) [0364-2016]; IARC [CRA-PRI]	Instituto Nacional del Cancer (Argentina); Agencia Nacional de Promocion de la Investigacion, el Desarrollo Tecnologico y la Innovacion (Argentina); IARC	This research has been partially supported by grants from IARC (grant number CRA-PRI), the Instituto Nacional del Cancer (Argentina) and Agencia Nacional de Promocion de la Investigacion, el Desarrollo Tecnologico y la Innovacion (Argentina) (grant number 0364-2016), all awarded to MAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock R, 2019, CANCER EPIDEM BIOMAR, V28, P1816, DOI 10.1158/1055-9965.EPI-19-0239; Almonte M, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035796; [Anonymous], GUID SCREE TREATM CE; [Anonymous], 2009, HUMAN PAPILLOMAVIRUS, VFirst; Arbyn M, 2009, CANCER EPIDEM BIOMAR, V18, P321, DOI 10.1158/1055-9965.EPI-08-0510; Arbyn M, 2021, CLIN MICROBIOL INFEC, V27, P1083, DOI 10.1016/j.cmi.2021.04.031; Arbyn M, 2014, J PATHOL, V234, P431, DOI 10.1002/path.4424; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Aro K, 2019, GYNECOL ONCOL, V154, P354, DOI 10.1016/j.ygyno.2019.05.024; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bosch FX, 2008, BRIT J CANCER, V98, P15, DOI 10.1038/sj.bjc.6604146; Brotherton JML, 2017, INT J CANCER, V141, P1576, DOI 10.1002/ijc.30871; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Burd EM, 2016, CLIN MICROBIOL REV, V29, P291, DOI 10.1128/CMR.00013-15; Carozzi F, 2014, J CLIN VIROL, V60, P257, DOI 10.1016/j.jcv.2014.04.009; Chaturvedi AK, 2011, J INFECT DIS, V203, P910, DOI 10.1093/infdis/jiq139; Ciapponi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025493; Clifford GM, 2005, CANCER EPIDEM BIOMAR, V14, P1157, DOI 10.1158/1055-9965.EPI-04-0812; Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68; Cuzick J, 2016, PAPILLOMAVIRUS RES, V2, P112, DOI 10.1016/j.pvr.2016.05.004; de Sanjose S, 2019, CURR OPIN VIROL, V39, P16, DOI 10.1016/j.coviro.2019.06.006; de Sanjose S, 2013, CANCER EPIDEM BIOMAR, V22, P1313, DOI 10.1158/1055-9965.EPI-13-0053; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Demarco M, 2020, ECLINICALMEDICINE, V22, DOI 10.1016/j.eclinm.2020.100293; Dickson EL, 2014, GYNECOL ONCOL, V133, P405, DOI 10.1016/j.ygyno.2014.03.552; Drolet M, 2019, LANCET, V394, P497, DOI 10.1016/S0140-6736(19)30298-3; Eklund C, 2021, J CLIN VIROL, V141, DOI 10.1016/j.jcv.2021.104902; Estrade C, 2014, J CLIN MICROBIOL, V52, P4033, DOI 10.1128/JCM.01950-14; Estrade C, 2011, J CLIN MICROBIOL, V49, P3474, DOI 10.1128/JCM.05039-11; Falcaro M, 2021, LANCET, V398, P2084, DOI 10.1016/S0140-6736(21)02178-4; Ferlay J, 2021, INT J CANCER, V149, P778, DOI 10.1002/ijc.33588; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Hesselink AT, 2006, J CLIN MICROBIOL, V44, P3680, DOI 10.1128/JCM.02078-05; Huh WK, 2015, APPL HEALTH ECON HEA, V13, P95, DOI 10.1007/s40258-014-0135-4; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1; International HPV Reference Center, AS; Jeronimo J, 2016, J CLIN VIROL, V76, pS69, DOI 10.1016/j.jcv.2015.11.035; Joura EA, 2014, CANCER EPIDEM BIOMAR, V23, P1997, DOI 10.1158/1055-9965.EPI-14-0410; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Lei JY, 2020, NEW ENGL J MED, V383, P1340, DOI 10.1056/NEJMoa1917338; Leinonen MK, 2013, BRIT J CANCER, V109, P2941, DOI 10.1038/bjc.2013.647; Lew JB, 2017, LANCET PUBLIC HEALTH, V2, pE96, DOI 10.1016/S2468-2667(17)30007-5; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Liao GD, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00449; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Porras C, 2009, CANCER EPIDEM BIOMAR, V18, P863, DOI 10.1158/1055-9965.EPI-08-0951; Quint W, 2012, J PATHOL, V227, P62, DOI 10.1002/path.3970; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sargent A, 2010, J CLIN MICROBIOL, V48, P554, DOI 10.1128/JCM.00896-09; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; Schmitt M, 2013, J CLIN MICROBIOL, V51, P1458, DOI 10.1128/JCM.00087-13; Shen-Gunther J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3612-y; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Spinillo A, 2014, CANCER CAUSE CONTROL, V25, P1669, DOI 10.1007/s10552-014-0471-6; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT; van der Marel J, 2012, INT J CANCER, V131, pE946, DOI 10.1002/ijc.27532; Gonzalez JV, 2020, PAPILLOMAVIRUS RES, V10, DOI 10.1016/j.pvr.2020.100208; Wentzensen N, 2009, INT J CANCER, V125, P2151, DOI 10.1002/ijc.24528; Wheeler CM, 2009, JNCI-J NATL CANCER I, V101, P475, DOI 10.1093/jnci/djn510; WHO, CERV CANC EL; World Health Organization, HUMAN PAPILLOMAVIRUS	64	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2022	17	7							e0272205	10.1371/journal.pone.0272205	http://dx.doi.org/10.1371/journal.pone.0272205			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Q0KX	35905130	Green Published, gold			2022-12-26	WOS:000855776900060
J	Nzenwa, IP; Iqbal, H; Hardie, C; Smith, G; Matteucci, P; Totty, J				Nzenwa, Ikemsinachi P.; Iqbal, Hassan; Hardie, Claire; Smith, George; Matteucci, Paolo; Totty, Joshua			Wound complications following surgery to the lymph nodes: A protocol for a systematic review and meta-analysis	PLOS ONE			English	Review							INFECTION; MELANOMA	BackgroundMalignancies that spread to the lymph nodes may be identified through surgical biopsy, and treatment of metastatic disease may be through lymph node dissection. These surgeries, however, may be associated with significant adverse outcomes, particularly wound complications, the true incidence of which remains unknown. Multiple studies have reported their individual rates of complications in isolation. The aim of this study will be to systematically evaluate data that presents the incidence of wound complications in patients undergoing these surgeries. MethodsWe have designed and registered a protocol for a systematic review and meta-analysis of studies presenting incidence data. We will search MEDLINE, EMBASE and CENTRAL for relevant articles. Meta-analysis will be undertaken to synthesise an overall incidence of surgical site infection, wound dehiscence, haematoma and seroma. Subgroup analyses will investigate the effects of anatomical location, primary malignancy and study design on pooled incidence. Risk of bias will be evaluated for each included study using bespoke tools matched to the study design. DiscussionThe results of this study will provide the incidence of wound complications and secondary complications following lymph node surgery. This will directly impact upon the consent process, and may influence the nature of future research studies aimed at reducing post-operative complications.	[Nzenwa, Ikemsinachi P.; Iqbal, Hassan] Hull York Med Sch, Ctr Anat & Human Sci, Heslington, England; [Hardie, Claire] Leeds Teaching Hosp NHS Trust, Dept Plast & Reconstruct Surg, Leeds, England; [Smith, George; Totty, Joshua] Hull York Med Sch, Heslington, England; [Matteucci, Paolo; Totty, Joshua] Hull Univ Teaching Hosp NHS Trust, Dept Plast & Reconstruct Surg, Kingston Upon Hull, England; [Totty, Joshua] Univ Hull, Kingston Upon Hull, England	University of Hull; University of York - UK; University of Leeds; University of Hull; University of York - UK; University of Hull	Totty, J (corresponding author), Hull York Med Sch, Heslington, England.; Totty, J (corresponding author), Hull Univ Teaching Hosp NHS Trust, Dept Plast & Reconstruct Surg, Kingston Upon Hull, England.; Totty, J (corresponding author), Univ Hull, Kingston Upon Hull, England.	Joshua.Totty@hyms.ac.uk		Smith, George/0000-0002-8085-0886; Iqbal, Hassan/0000-0003-4651-4368; Totty, Joshua P/0000-0002-0063-1414				Ahmed A, 2013, IRISH J MED SCI, V182, pS348, DOI 10.1155/2013/382138; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; Faut M, 2017, ANN SURG ONCOL, V24, P330, DOI 10.1245/s10434-016-5461-3; Glarner CE, 2013, ANN SURG ONCOL, V20, P2049, DOI 10.1245/s10434-012-2856-7; Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014; Jorgensen MG, 2018, J PLAST RECONSTR AES, V71, P590, DOI 10.1016/j.bjps.2017.11.026; Lin LF, 2020, EPIDEMIOLOGY, V31, P713, DOI 10.1097/EDE.0000000000001232; Lin LF, 2020, HEALTH SCI REP-US, V3, DOI 10.1002/hsr2.178; Moher D, 2015, SYST REV, V4, DOI [10.1186/s13643-015-0087-2, 10.1186/2046-4053-4-1]; Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906]; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Wilson APR, 2004, BRIT MED J, V329, P720, DOI 10.1136/bmj.38232.646227.DE	13	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272490	http://dx.doi.org/10.1371/journal.pone.0272490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921309	Green Submitted, Green Published, gold			2022-12-26	WOS:000839311900075
J	Rodboon, T; Souza, G; Mutirangura, A; Ferreira, J				Rodboon, Teerapat; Souza, Glauco; Mutirangura, Apiwat; Ferreira, Joao			Magnetic bioassembly platforms for establishing craniofacial exocrine gland organoids as aging in vitro models	PLOS ONE			English	Article							HUMAN LACRIMAL GLAND; DRY EYE SYNDROME; SALIVARY-GLANDS; CULTURE	A multitude of aging-related factors and systemic conditions can cause lacrimal gland (LG) or salivary gland (SG) hypofunction leading to degenerative dry eye disease (DED) or dry mouth syndrome, respectively. Currently, there are no effective regenerative therapies that can fully reverse such gland hypofunction due to the lack of reproducible in vitro aging models or organoids required to develop novel treatments for multi-omic profiling. Previously, our research group successful developed three-dimensional (3D) bioassembly nanotechnologies towards the generation of functional exocrine gland organoids via magnetic 3D bioprinting platforms (M3DB). To meet the needs of our aging Asian societies, a next step was taken to design consistent M3DB protocols to engineer LG and SG organoid models with aging molecular and pathological features. Herein, a feasible step-by-step protocol was provided for producing both LG and SG organoids using M3DB platforms. Such protocol provided reproducible outcomes with final organoid products resembling LG or SG native parenchymal epithelial tissues. Both acinar and ductal epithelial compartments were prominent (21 +/- 4.32% versus 42 +/- 6.72%, respectively), and could be clearly identified in these organoids. Meanwhile, these can be further developed into aging signature models by inducing cellular senescence via chemical mutagenesis. The generation of senescence-like organoids will be our ultimate milestone aiming towards high throughput applications for drug screening and discovery, and for gene therapy investigations to reverse aging.	[Rodboon, Teerapat; Ferreira, Joao] Chulalongkorn Univ, Fac Dent, Avatar Biotechnol Oral Hlth & Hlth Longev Res Unit, Bangkok, Thailand; [Souza, Glauco] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA; [Souza, Glauco] Nano3D Biosci Inc, Houston, TX USA; [Souza, Glauco] Greiner Bioone North Amer Inc, Monroe, NC USA; [Mutirangura, Apiwat] Chulalongkorn Univ, Fac Med, Ctr Excellence Mol Genet Canc & Human Dis, Dept Anat, Bangkok, Thailand	Chulalongkorn University; University of Texas System; University of Texas Health Science Center Houston; Chulalongkorn University	Ferreira, J (corresponding author), Chulalongkorn Univ, Fac Dent, Avatar Biotechnol Oral Hlth & Hlth Longev Res Unit, Bangkok, Thailand.	Joao.F@chula.ac.th	Rodboon, Teerapat/GVT-7521-2022; Ferreira, Joao/M-1517-2016	Rodboon, Teerapat/0000-0001-6680-3701; Ferreira, Joao/0000-0002-4230-4593	Thailand Science Research and Innovation Fund Chulalongkorn University [CU_FRB65_hea (7)_013_32_08]; National Research Council of Thailand (NRCT) [NRCT5-RSA63001-12]; Avatar Biotechnologies for Oral Health and Healthy Longevity Research Unit - Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University [33/2565 : RU]; Ratchadapisek Somphot Fund, Chulalongkorn University	Thailand Science Research and Innovation Fund Chulalongkorn University; National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Avatar Biotechnologies for Oral Health and Healthy Longevity Research Unit - Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University; Ratchadapisek Somphot Fund, Chulalongkorn University(Chulalongkorn University)	This research is funded by Thailand Science Research and Innovation Fund Chulalongkorn University (Grant number: CU_FRB65_hea (7)_013_32_08) to JNF and AM. This project is funded by the National Research Council of Thailand (NRCT), by a Mid-career Research Grant (Grant number: NRCT5-RSA63001-12) to JNF. Avatar Biotechnologies for Oral Health and Healthy Longevity Research Unit is funded by the Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University (Grant number: 33/2565: RU). TR is supported by a Postdoctoral Fellowship, Ratchadapisek Somphot Fund, Chulalongkorn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann P, 2015, INVEST OPHTH VIS SCI, V56, P4350, DOI 10.1167/iovs.15-16475; Adine C, 2018, BIOMATERIALS, V180, P52, DOI 10.1016/j.biomaterials.2018.06.011; Agha-Hosseini F, 2012, GERODONTOLOGY, V29, P43, DOI 10.1111/j.1741-2358.2010.00403.x; ALLEN M, 1972, ARCH OPHTHALMOL-CHIC, V88, P493, DOI 10.1001/archopht.1972.01000030495005; Arglebe C, 1981, Adv Otorhinolaryngol, V26, P97; Bannier-Helaouet M, 2021, CELL STEM CELL, V28, P1221, DOI 10.1016/j.stem.2021.02.024; Burghartz M, 2018, TISSUE ENG PT A, V24, P301, DOI 10.1089/ten.tea.2016.0466; Chang YA, 2021, J CHIN MED ASSOC, V84, P459, DOI 10.1097/JCMA.0000000000000529; Chen TY, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.37; Chia EM, 2003, CLIN EXP OPHTHALMOL, V31, P229, DOI 10.1046/j.1442-9071.2003.00634.x; CyCIF, 2020, MIN LONGW AV; DAMATO BE, 1984, BRIT J OPHTHALMOL, V68, P674, DOI 10.1136/bjo.68.9.674; de Paiva Cintia S, 2017, Int Ophthalmol Clin, V57, P47, DOI 10.1097/IIO.0000000000000170; Ferreira JN, 2019, J TISSUE ENG REGEN M, V13, P495, DOI 10.1002/term.2809; He S., 2021, BIORXIV; Henker R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074046; Honkanen R, 2019, CURR EYE RES, V44, P863, DOI 10.1080/02713683.2019.1594933; Ikeura K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147407; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; Lombaert IMA, 2020, MOL THER-METH CLIN D, V18, P839, DOI 10.1016/j.omtm.2020.07.016; Moss SE, 2004, ARCH OPHTHALMOL-CHIC, V122, P369, DOI 10.1001/archopht.122.3.369; Nanda T, 2017, MED DOSIM, V42, P357, DOI 10.1016/j.meddos.2017.07.007; NanoString, UNC MOL AN ORG; Pornthanakasem W, 2008, NUCLEIC ACIDS RES, V36, P3667, DOI 10.1093/nar/gkn261; Proctor GB, 2016, PERIODONTOL 2000, V70, P11, DOI 10.1111/prd.12116; Rodboon T, 2022, SLAS DISCOV, V27, P151, DOI 10.1016/j.slasd.2021.11.002; Satoh K, 2013, PFLUG ARCH EUR J PHY, V465, P271, DOI 10.1007/s00424-012-1183-y; Schechter JE, 2010, OCUL SURF, V8, P111, DOI 10.1016/S1542-0124(12)70222-7; Schrader Stefan, 2008, Dev Ophthalmol, V41, P298, DOI 10.1159/000131097; SCOTT J, 1980, J BIOL BUCCALE, V8, P187; Stembirek J, 2012, LAB ANIM-UK, V46, P269, DOI 10.1258/la.2012.012062; Stern ME, 2013, INT REV IMMUNOL, V32, P19, DOI 10.3109/08830185.2012.748052; Su X, 2016, ORAL DIS, V22, P639, DOI 10.1111/odi.12508; Teng YN, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10061466; Thongsroy J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072706; Tiwari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029458; Tutt R, 2000, INVEST OPHTH VIS SCI, V41, P4117; Uchino Miki, 2013, Curr Ophthalmol Rep, V1, P51; van der Laan JW, 2010, J PHARMACOL TOX MET, V62, P184, DOI 10.1016/j.vascn.2010.05.005; VANHAERINGEN NJ, 1981, SURV OPHTHALMOL, V26, P84, DOI 10.1016/0039-6257(81)90145-4; Wu D, 2022, J DENT RES, V101, P983, DOI 10.1177/00220345221076122; Wu D, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.711602; Xiao S, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-019-1541-1; Yasom S, 2022, FASEB BIOADV, V4, P408, DOI 10.1096/fba.2021-00131; Ying Joanna Ngo Di, 2015, Singapore Dent J, V36, P12, DOI 10.1016/j.sdj.2014.12.001	45	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8							e0272644	10.1371/journal.pone.0272644	http://dx.doi.org/10.1371/journal.pone.0272644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P8ZE	35930565	Green Published, gold			2022-12-26	WOS:000837822100008
J	Saunders, V; Beck, M; McKechnie, J; Lincoln, M; Phillips, C; Herbert, J; Davey, R				Saunders, Vicky; Beck, Maddison; McKechnie, Jacqueline; Lincoln, Michelle; Phillips, Christine; Herbert, Jane; Davey, Rachel			A Good start in life: Effectiveness of integrated multicomponent multisector support on early child development-Study protocol	PLOS ONE			English	Article							HEALTH; EXPERIENCE; FRAMEWORK	Introduction Early childhood experiences have a lifelong impact on a child's future. Social and environmental experiences and interactions have a profound relational effect on children's physical and mental health which transfers agency to parents, caregivers and duty-bearers to care for the child's welfare. In the Australian context early child development indices have been in decline in some communities. Hence, there is a sense of urgency to reverse these trends from an integrated perspective. A multisector, multi component program of interventions named A Good Start in Life is proposed and is being tested in the Australian Capital Territory across suburbs with high levels of early childhood development disadvantage. The aim of this study is to evaluate the outcomes and processes related to targeted interventions, designed to integrate child and family services within the local district and embed allied health programs into early childhood education, care services and playgroups. Methods and analysis The Good Start in Life study will use a quasi-experimental design (with a matched control geographical area) consisting of a combination of interventions that will build multisectoral collaboration across education, health and social services that connect and support families with children from birth to 5 years. The control area will be matched on demographic characteristics and early child development outcomes and trends over the pre-intervention period. Evaluation data will be collected at baseline, and then on an annual basis for a further three years. A mixed methods approach will be used to evaluate delivery processes: quantitative (checklists, questionnaires) and qualitative methods (observations, focus groups and key stakeholder interviews). Effectiveness of the programme will be evaluated by comparing early child development outcomes between the comparator areas from the Australian Early Development Census in 2024. The primary focus will be on reducing the number of children who are developmentally vulnerable on at least one early development index (EDI). Separate tests will be conducted for significant differences in the percentage of children at risk in each of the five individual EDI domains. These domains are physical health and wellbeing, social competence, emotional maturity, language and cognitive skills, and communication and general knowledge.	[Saunders, Vicky; Beck, Maddison; Davey, Rachel] Univ Canberra, Hlth Res Inst, Bruce, ACT, Australia; [McKechnie, Jacqueline; Lincoln, Michelle] Univ Canberra, Fac Hlth, Bruce, ACT, Australia; [Phillips, Christine] Australian Natl Univ, Canberra, ACT, Australia; [Herbert, Jane] Univ Wollongong, Northfields Ave, Wollongong, NSW, Australia	University of Canberra; University of Canberra; Australian National University; University of Wollongong	Saunders, V; Beck, M (corresponding author), Univ Canberra, Hlth Res Inst, Bruce, ACT, Australia.	Maddison.beck@canberra.edu.au; Vicky.saunders@canberra.edu.au	Phillips, Christine/H-3041-2019	Phillips, Christine/0000-0001-5602-3664; McKechnie, Jacqueline/0000-0001-5747-0888	Medical Research Future Fund	Medical Research Future Fund(Medical Research Future Fund (MRFF))	This study has been funded by the Medical Research Future Fund. The grant was provided to RD for the Good Start in Life project. The funders will not play any role in the study<EM><STRONG> </STRONG></EM>design, data collection, analysis, decision to publish, or preparation for this manuscript.	ACT Health, 2021, ACT PLAY AUD TOOL AU; AEDC, 2018, BELC COMM AUSTR AUST; Australian Government, 2021, DAT COLL TOOL AUSTR; Browne Gina, 2004, Int J Integr Care, V4, pe03; Chen JJ, 2014, EARLY YEARS, V34, P271, DOI 10.1080/09575146.2014.912203; Corporation Carnegie., 1995, YEARS PROM COMPR LEA; Cunningham DD, 2010, EARLY CHILD EDUC J, V37, P501, DOI 10.1007/s10643-009-0370-8; Department of Education and Training, 2018, AUSTR EARL DEV CENS; Glisczinski D, 2018, J TRANSFORM EDUC, V16, P175, DOI 10.1177/1541344618777367; Gluckman PD, 2010, J DEV ORIG HLTH DIS, V1, P6, DOI 10.1017/S2040174409990171; Gregory T., 2016, EXPLORING CHANGE AUS; Grimmer T., 2019, CALLING ALL SUPERHER, P103; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Irwin L, 2007, EARLY CHILD DEV POWE; McDonald M., 2010, ARE DISADVANTAGED FA; Moore TG., 2013, ACTING EARLY CHANGIN; Moore TG, 2015, HEALTH PROMOT INT, V30, P102, DOI 10.1093/heapro/dav031; National Scientific Council on the Developing Child, 2007, 5 NSCDC HARV U CTR D; Neitzel J, 2019, J EARLY CHILD RES, V17, P408, DOI 10.1177/1476718X19873015; Nelson CA, 2000, DEVELOPMENTAL SCI, V3, P115, DOI 10.1111/1467-7687.00104; Peisner-Feinberg E., 2021, EVALUATION N CAROLIN; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Wagner M, 2002, TOP EARLY CHILD SPEC, V22, P67, DOI 10.1177/02711214020220020101; White M., 2021, SUCCESSFUL COLLABORA; Wong S, 2012, AUST J EARLY CHILD, V37, P81, DOI 10.1177/183693911203700110; Wong Sandie., 2010, INTEGRATED EARLY YEA	26	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8							e267666	10.1371/journal.pone.0267666	http://dx.doi.org/10.1371/journal.pone.0267666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921322	gold, Green Published			2022-12-26	WOS:000839311900061
J	Kremer, PG; Barb, AW				Kremer, Paul G.; Barb, Adam W.			The weaker-binding Fc gamma receptor IIIa F158 allotype retains sensitivity to N-glycan composition and exhibits a destabilized antibody-binding interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR-SPECTROSCOPY; IMMUNOGLOBULIN-G; GLYCOSYLATION; POLYMORPHISMS; EXPRESSION; AFFINITY; CELLS; GLYCOPROTEINS; ASSOCIATION; GLYCOFORMS	Antibodies engage Fc gamma receptors (Fc gamma Rs) to elicit healing cellular immune responses following binding to a target antigen. Fc gamma receptor IIIa/CD16a triggers natural killer cells to destroy target tissues with cytotoxic proteins and enhances phagocytosis mediated by macrophages. Multiple variables affect CD16a antibody-binding strength and the resulting immune response, including a genetic polymorphism. The pre-dominant CD16a F158 allotype binds antibodies with less affinity than the less common V158 allotype. This polymorphism likewise affects cellular immune responses and clinical efficacy of antibodies relying on CD16a engagement, though it remains unclear how V/F158 affects CD16a structure. Another relevant variable shown to affect affinity is composition of the CD16a asparagine-linked (N)-glycans. It is currently not known how N-glycan composition affects CD16a F158 affinity. Here, we determined N-glycan composition affects the V158 and F158 allotypes similarly, and N-glycan composition does not explain differences in V158 and F158 binding affinity. Our analysis of binding kinetics indicated the N162 glycan slows the binding event, and shortening the N-glycans or removing the N162 glycan increased the speed of binding. F158 displayed a slower binding rate than V158. Surprisingly, we found N-glycan composition had a smaller effect on the dissociation rate. We also identified conformational heterogeneity of CD16a F158 backbone amide and N162 glycan resonances using NMR spectroscopy. Residues exhibiting chemical shift perturbations between V158 and F158 mapped to the antibody-binding interface. These data support a model for CD16a F158 with increased interface conformational heterogeneity, reducing the population of binding-competent forms available and decreasing affinity.	[Kremer, Paul G.; Barb, Adam W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Barb, Adam W.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Barb, Adam W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Barb, AW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.; Barb, AW (corresponding author), Univ Georgia, Dept Chem, Athens, GA 30602 USA.; Barb, AW (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA.	abarb@uga.edu		Barb, Adam/0000-0003-3290-8649	National Institutes of Health, United States [U01 AI148114]	National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health, United States under Awards No. U01 AI148114 (NIAID) to A. W. B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barb AW, 2019, METHOD ENZYMOL, V614, P239, DOI 10.1016/bs.mie.2018.08.021; Binyamin L, 2008, J IMMUNOL, V180, P6392, DOI 10.4049/jimmunol.180.9.6392; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Cambay F, 2020, MOL IMMUNOL, V121, P144, DOI 10.1016/j.molimm.2020.03.010; Chen WT, 2013, J AM CHEM SOC, V135, P9877, DOI 10.1021/ja4040472; Chiesa S, 2005, MOL IMMUNOL, V42, P477, DOI 10.1016/j.molimm.2004.07.030; Dekkers G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00877; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Falconer DJ, 2018, ACS CHEM BIOL, V13, P2179, DOI 10.1021/acschembio.8b00342; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Hatjiharissi E, 2007, BLOOD, V110, P2561, DOI 10.1182/blood-2007-01-070656; Hayat S, 2020, ANN CLIN TRANSL NEUR, V7, P1040, DOI 10.1002/acn3.51072; Hayes JM, 2017, MOL CELL PROTEOMICS, V16, P1770, DOI 10.1074/mcp.M117.066944; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Karassa FB, 2003, KIDNEY INT, V63, P1475, DOI 10.1046/j.1523-1755.2003.00873.x; Kastbom A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001524; Lampros Elizabeth A, 2022, Curr Res Immunol, V3, P128, DOI 10.1016/j.crimmu.2022.05.005; Lehrnbecher T, 1999, BLOOD, V94, P4220, DOI 10.1182/blood.V94.12.4220.424k08_4220_4232; Mahaweni NM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34258-1; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Morales-Lara MJ, 2010, SCAND J RHEUMATOL, V39, P518, DOI 10.3109/03009741003781969; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Patel KR, 2019, MOL CELL PROTEOMICS, V18, P2178, DOI 10.1074/mcp.RA119.001607; Patel KR, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.015516; Patel KR, 2018, J BIOL CHEM, V293, P3477, DOI 10.1074/jbc.RA117.001207; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Roberts JT, 2020, MOL CELL PROTEOMICS, V19, P362, DOI 10.1074/mcp.RA119.001733; Rogals MJ, 2021, GLYCOBIOLOGY, V31, P425, DOI 10.1093/glycob/cwaa071; Sakae Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13845-8; Saremi L, 2019, J CELL BIOCHEM, V120, P12010, DOI 10.1002/jcb.28486; Shimizu C, 2016, BREAST CANCER-TOKYO, V23, P624, DOI 10.1007/s12282-015-0614-y; Stewart R, 2011, PROTEIN ENG DES SEL, V24, P671, DOI 10.1093/protein/gzr015; Subedi G. P., 2015, J VIS EXP, pe5356; Subedi GP, 2018, J BIOL CHEM, V293, P16842, DOI 10.1074/jbc.RA118.004998; Subedi GP, 2017, BIOCHEMISTRY-US, V56, P3174, DOI 10.1021/acs.biochem.7b00392; Subedi GP, 2014, STRUCTURE, V22, P1478, DOI 10.1016/j.str.2014.08.002; Varadi M, 2022, NUCLEIC ACIDS RES, V50, pD439, DOI 10.1093/nar/gkab1061; Weiskopf K, 2015, MABS-AUSTIN, V7, P303, DOI 10.1080/19420862.2015.1011450; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Wu JM, 1997, J CLIN INVEST, V100, P1059, DOI 10.1172/JCI119616; Yamaguchi Y, 1998, J BIOMOL NMR, V12, P385, DOI 10.1023/A:1008392229694; Yogo R, 2018, BIOMOL NMR ASSIGN, V12, P201, DOI 10.1007/s12104-018-9809-4; Zhu XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep22594	43	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102329	10.1016/j.jbc.2022.102329	http://dx.doi.org/10.1016/j.jbc.2022.102329			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9EO	35921896	gold, Green Published			2022-12-26	WOS:000863182500008
J	Houstin, A; Zitterbart, DP; Winterl, A; Richter, S; Planas-Bielsa, V; Chevallier, D; Ancel, A; Fournier, J; Fabry, B; Le Bohec, C				Houstin, Aymeric; Zitterbart, Daniel P.; Winterl, Alexander; Richter, Sebastian; Planas-Bielsa, Victor; Chevallier, Damien; Ancel, Andre; Fournier, Jerome; Fabry, Ben; Le Bohec, Celine			Biologging of emperor penguins-Attachment techniques and associated deployment performance	PLOS ONE			English	Article							ADELIE PENGUINS; APTENODYTES FORSTERI; FORAGING BEHAVIOR; FLIPPER-BANDS; PRE-MOLT; HABITAT; SEA; DEVICES; WINTER; GEOLOCATION	An increasing number of marine animals are equipped with biologgers, to study their physiology, behaviour and ecology, often for conservation purposes. To minimise the impacts of biologgers on the animals' welfare, the Refinement principle from the Three Rs framework (Replacement, Reduction, Refinement) urges to continuously test and evaluate new and updated biologging protocols. Here, we propose alternative and promising techniques for emperor penguin (Aptenodytes forsten) capture and on-site logger deployment that aim to mitigate the potential negative impacts of logger deployment on these birds. We equipped adult emperor penguins for short-term (GPS, Time-Depth Recorder (TDR)) and long-term (i.e. planned for one year) deployments (ARGOS platforms, TDR), as well as juvenile emperor penguins for long-term deployments (ARGOS platforms) in the Weddell Sea area where they had not yet been studied. We describe and qualitatively evaluate our protocols for the attachment of biologgers on-site at the colony, the capture of the animals and the recovery of the devices after deployment. We report unprecedented recaptures of long-term equipped adult emperor penguins (50% of equipped individuals recaptured after 290 days). Our data demonstrate that the traditional technique of long-term attachment by gluing the biologgers directly to the back feathers causes excessive feather breakage and the loss of the devices after a few months. We therefore propose an alternative method of attachment for back-mounted devices. This technique led to successful year-round deployments on 37.5% of the equipped juveniles. Finally, we also disclose the first deployments of leg-bracelet mounted TDRs on emperor penguins. Our findings highlight the importance of monitoring potential impacts of biologger deployments on the animals and the need to continue to improve methods to minimize disturbance and enhance performance and results.	[Houstin, Aymeric; Planas-Bielsa, Victor; Le Bohec, Celine] Ctr Sci Monaco, Dept Biol Polaire, Monaco, Monaco; [Houstin, Aymeric; Chevallier, Damien; Ancel, Andre; Le Bohec, Celine] Univ Strasbourg, IPHC, CNRS UMR 7178, Strasbourg, France; [Houstin, Aymeric; Zitterbart, Daniel P.; Winterl, Alexander; Richter, Sebastian; Fabry, Ben] Friedrich Alexander Univ Erlangen Nurnberg, Dept Phys, Erlangen, Germany; [Zitterbart, Daniel P.; Winterl, Alexander; Richter, Sebastian] Woods Hole Oceanog Inst, Appl Ocean Phys & Engn Woods Hole, Woods Hole, MA USA; [Zitterbart, Daniel P.] Kumamoto Univ, Int Res Org Adv Sci & Technol IROAST, Kumamoto, Japan; [Fournier, Jerome] Museum Natl Hist Nat, Stn Biol Marine, CNRS UMR 7204 CESCO, Concarneau, France; [Fournier, Jerome] Museum Natl Hist Nat, Ctr Rech Biol Populat Oiseaux, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Erlangen Nuremberg; Woods Hole Oceanographic Institution; Kumamoto University; Museum National d'Histoire Naturelle (MNHN); Museum National d'Histoire Naturelle (MNHN)	Houstin, A; Le Bohec, C (corresponding author), Ctr Sci Monaco, Dept Biol Polaire, Monaco, Monaco.; Houstin, A; Le Bohec, C (corresponding author), Univ Strasbourg, IPHC, CNRS UMR 7178, Strasbourg, France.; Houstin, A (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Dept Phys, Erlangen, Germany.	houstina@gmail.com; celine.lebohec@iphc.cnrs.fr		Zitterbart, Daniel/0000-0001-9429-4350	Centre Scientifique de Monaco; RTPI-NUTRESS (CSM/CNRSnotsign-University of Strasbourg); Penzance Endowed Fund; Grayce B. Kerr Fund in Support of Assistant Scientists; Deutsche Forschungsgemeinschaft (DFG) [ZI1525/3-1]; Alfred Wegener Institute (AWI);  [LIA-647]	Centre Scientifique de Monaco; RTPI-NUTRESS (CSM/CNRSnotsign-University of Strasbourg); Penzance Endowed Fund; Grayce B. Kerr Fund in Support of Assistant Scientists; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Alfred Wegener Institute (AWI); 	This study was funded by the Centre Scientifique de Monaco with additional support from the LIA-647 and RTPI-NUTRESS (CSM/CNRSnotsign -University of Strasbourg), by The Penzance Endowed Fund and The Grayce B. Kerr Fund in Support of Assistant Scientists and by the Deutsche Forschungsgemeinschaft (DFG) grants ZI1525/3-1 in the framework of the priority program "Antarctic research with comparative investigations in Arctic ice areas". Logistics and field efforts were supported by the Alfred Wegener Institute (AWI) within the framework of the program MARE.	ANCEL A, 1992, NATURE, V360, P336, DOI 10.1038/360336a0; Ancel A, 2017, GLOB ECOL CONSERV, V9, P171, DOI 10.1016/j.gecco.2017.01.003; ATS, 2020, GEN GUID VIS ANT ATT; Ballard G, 2010, ECOLOGY, V91, P2056, DOI 10.1890/09-0688.1; BANNASCH R, 1994, J EXP BIOL, V194, P83; Blair JJA, 2022, ENVIRON PLAN E-NAT, V5, P60, DOI 10.1177/2514848619882938; Bost CA, 2009, BIOL LETTERS, V5, P473, DOI 10.1098/rsbl.2009.0265; Carter MID, 2016, MOV ECOL, V4, DOI 10.1186/s40462-016-0090-9; Casper RM, 2009, ANIM BEHAV, V78, P1477, DOI 10.1016/j.anbehav.2009.09.023; CCAMLR, 2014, CCAMLR EC MON PROGR; Chimienti M, 2017, ECOL EVOL, V7, P10252, DOI 10.1002/ece3.3551; Cockrem JF, 2008, ZOOL SCI, V25, P291, DOI 10.2108/zsj.25.291; Cooke Steven J., 2008, Endangered Species Research, V4, P165, DOI 10.3354/esr00063; Costa DP, 2012, ANNU REV ECOL EVOL S, V43, P73, DOI 10.1146/annurev-ecolsys-102710-145045; Costantini D, 2013, CURR ZOOL, V59, P697, DOI 10.1093/czoolo/59.6.697; Cristofari R, 2018, NAT CLIM CHANGE, V8, P245, DOI 10.1038/s41558-018-0084-2; CULIK B, 1991, J COMP PHYSIOL B, V161, P285, DOI 10.1007/BF00262310; Dunn MJ, 2011, POLAR BIOL, V34, P205, DOI 10.1007/s00300-010-0870-4; Enstipp MR, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.208900; Enstipp MR, 2017, J EXP BIOL, V220, P2666, DOI 10.1242/jeb.160143; Forin-Wiart MA, 2019, INTEGR ZOOL, V14, P48, DOI 10.1111/1749-4877.12364; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; Gauthier-Clerc M, 2004, P ROY SOC B-BIOL SCI, V271, pS423, DOI 10.1098/rsbl.2004.0201; Gendner J.-P., 1992, P29; Gendner JP, 2005, J FIELD ORNITHOL, V76, P138, DOI 10.1648/0273-8570-76.2.138; Goetz KT, 2018, MAR ECOL PROG SER, V593, P155, DOI 10.3354/meps12486; Griesser M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051891; Haraway D, 2007, SPECIES MEET; Hays GC, 2019, TRENDS ECOL EVOL, V34, P459, DOI 10.1016/j.tree.2019.01.009; Hindell MA, 2020, NATURE, V580, P87, DOI 10.1038/s41586-020-2126-y; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Jackson S, 2002, FUNCT ECOL, V16, P141, DOI 10.1046/j.0269-8463.2001.00606.x; JOUVENTIN P, 1995, ANIM BEHAV, V50, P1023, DOI 10.1016/0003-3472(95)80102-2; Kay WP, 2019, METHODS ECOL EVOL, V10, P1222, DOI 10.1111/2041-210X.13216; Kays R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2478; Kenward RE., 2000, MANUAL WILDLIFE RADI; Kirkwood R, 1997, ECOL MONOGR, V67, P155, DOI 10.1890/0012-9615(1997)067[0155:TFEOFE]2.0.CO;2; Kooyman GL, 2007, AQUAT CONSERV, V17, pS37, DOI 10.1002/aqc.930; Kooyman Gerald L., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P183; KOOYMAN GL, 1992, J EXP BIOL, V165, P161; Kooyman GL, 2000, MAR ECOL PROG SER, V204, P269, DOI 10.3354/meps204269; Kooyman GL, 2004, MAR ECOL PROG SER, V267, P281, DOI 10.3354/meps267281; Kooyman GL., 2015, ANIM BIOTELEM, V3, P54, DOI [10.1186/s40317-015-0091-2, DOI 10.1186/S40317-015-0091-2]; Labrousse S, 2019, GEOPHYS RES LETT, V46, P11206, DOI 10.1029/2019GL084347; Labrousse S, 2019, MAR ECOL PROG SER, V609, P1, DOI 10.3354/meps12831; Le Bohec C, 2007, J ANIM ECOL, V76, P1149, DOI 10.1111/j.1365-2656.2007.01268.x; Le Maho Y, 2011, CR BIOL, V334, P378, DOI 10.1016/j.crvi.2011.04.004; Le Vaillant M, 2013, MAR BIOL, V160, P1147, DOI 10.1007/s00227-013-2167-y; MAHO YL, 1976, AM J PHYSIOL, V231, P913, DOI 10.1152/ajplegacy.1976.231.3.913; McIntyre T, 2014, AFR J MAR SCI, V36, P409, DOI 10.2989/1814232X.2014.976655; Mougin J., 1979, STRUCTURE DYNAMIQUE; Orgeret F, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0490; Orians G.H., 1979, P155; Pichegru L, 2011, POLAR BIOL, V34, P945, DOI 10.1007/s00300-010-0950-5; Pierce Andrew J., 2007, Ringing & Migration, V23, P205; Poupart TA, 2017, NEW ZEAL J ZOOL, V44, P225, DOI 10.1080/03014223.2017.1302970; Prevost J, 1961, ECOLOGIE MANCHOT EMP; Pritchard H., 2013, APRJA, V2; Putz K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097164; Ratcliffe Norman, 2014, Marine Ornithology, V42, P23; Ray SJ., 2014, GREEN LETT, V18, P236, DOI [10.1080/14688417.2014.964282, DOI 10.1080/14688417.2014.964282]; Richter S, 2018, METHODS ECOL EVOL, V9, P1168, DOI 10.1111/2041-210X.12971; Robertson Graham G., 1991, Marine Ornithology, V19, P91; Rodary D, 2000, MAR ECOL PROG SER, V207, P171, DOI 10.3354/meps207171; Ropert-Coudert Yan, 2010, Endangered Species Research, V10, P21, DOI 10.3354/esr00188; Russel W. M. S., 1959, PRINC HUM EXP TECH; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Stonehouse B, 1953, EMPEROR PENGUIN BREE; Takahashi A, 2018, MAR ECOL PROG SER, V589, P227, DOI 10.3354/meps12438; Thiebot JB, 2019, MAR POLICY, V109, DOI 10.1016/j.marpol.2019.103692; Thiebot JB, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0429; Thiebot JB, 2013, ANTARCT SCI, V25, P536, DOI 10.1017/S0954102012001198; Thiebot JB, 2011, ANTARCT SCI, V23, P117, DOI 10.1017/S0954102010000957; Thiebot JB, 2011, MAR ECOL PROG SER, V421, P279, DOI 10.3354/meps08907; Thiebot Jean-Baptiste, 2010, Endangered Species Research, V10, P341; Vandenabeele SP, 2011, ANIM WELFARE, V20, P559; Walker KA, 2012, WILDLIFE RES, V39, P15, DOI 10.1071/WR10177; Wanless R. M., 2000, Marine Ornithology, V28, P47; Wanless S, 2007, PROG OCEANOGR, V72, P30, DOI 10.1016/j.pocean.2006.07.007; Watanabe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050357; Weimerskirch H, 2014, J EXP MAR BIOL ECOL, V450, P68, DOI 10.1016/j.jembe.2013.10.021; Wienecke B, 2004, POLAR BIOL, V27, P83, DOI 10.1007/s00300-003-0574-0; Wienecke B, 2010, MAR ECOL PROG SER, V410, P269, DOI 10.3354/meps08629; Wienecke BC, 1997, MAR ECOL PROG SER, V159, P249, DOI 10.3354/meps159249; Wikipedia contributors, 2021, NEUM STAT 3; Williams CL, 2011, J EXP BIOL, V214, P1802, DOI 10.1242/jeb.052233; Williams HJ, 2020, J ANIM ECOL, V89, P186, DOI 10.1111/1365-2656.13094; Williams T.D., 1995, PENGUINS; Wilmers CC, 2015, ECOLOGY, V96, P1741, DOI 10.1890/14-1401.1; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2; WILSON RP, 1989, WILDLIFE SOC B, V17, P77; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; Wilson RP, 2002, MAR ECOL PROG SER, V228, P241, DOI 10.3354/meps228241; Zimmer I., 2007, CONSTRAINTS FORAGING, DOI [10.1007/s00300-007-0352-5, DOI 10.1007/S00300-007-0352-5]; Zimmer I, 2008, POLAR BIOL, V31, P229, DOI 10.1007/s00300-007-0352-5; Zimmer I, 2010, AQUAT BIOL, V8, P269, DOI 10.3354/ab00213	97	2	2	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0265849	10.1371/journal.pone.0265849	http://dx.doi.org/10.1371/journal.pone.0265849			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925903	Green Submitted, Green Published, gold			2022-12-26	WOS:000848077100002
J	Li, XN; Adnan, A; Hadi, S; Al-Qahtani, WS; Alwaili, MA; Alshaya, DS; Jalal, AS; Amer, SAM; Jin, F				Li, Xiao-Na; Adnan, Atif; Hadi, Sibte; Al-Qahtani, Wedad Saeed; Alwaili, Maha Abdullah; Alshaya, Dalal S.; Jalal, Areej S.; Amer, Sayed A. M.; Jin, Feng			Genetic characterization of the highlander Tibetan population from Qinghai-Tibet Plateau revealed by X chromosomal STRs	PLOS ONE			English	Article							HIGH-ALTITUDE ADAPTATION; TANDEM REPEAT MARKERS; DNA COMMISSION; Y-STRS; LOCI; POLYMORPHISMS; RECOMMENDATIONS; SAMPLES	Tibetans are considered an East Asian ethnic group and primarily live in the high Tibetan plateau, the western Sichuan and Yunnan mountains of central and southern China, and areas throughout the Himalayas and around the Tibetan plateau. These people exhibit rare molecular machinery that allows them to adapt to hypoxic environments in the Qinghai-Tibet Plateau and make them a potential candidate for providing insights related to medical genetic, molecular medicine and human population studies. In the current study, we have genotyped 549 individuals with Investigator Argus X-12 Kit. For 12 X-STRs, a total of 174 unique alleles were found, among them DXS10134 and DXS10135 were the most polymorphic loci. All of the loci were in Hardy-Weinberg Equilibrium (HWE). The numbers of observed haplotypes in Highlander Tibetans males were 161,112, 96 and 108, respectively, whereas haplotype diversities (HD) were 0.9959, 0.9880, 0.9809 and 0.9873, respectively. The combined discrimination power for males (PDm) was 0.999 999 99701 and for females (PDf) was 0.999 999 999 999 9958. This study represents an extensive report on X chromosomal STR markers variation in the Highlander Tibetans population for forensic applications and population genetic studies.	[Li, Xiao-Na] China Med Univ, Sch Fundamental Sci, Shenyang, Liaoning, Peoples R China; [Adnan, Atif; Hadi, Sibte; Al-Qahtani, Wedad Saeed; Amer, Sayed A. M.] Naif Univ Secur Sci, Dept Forens Sci, Coll Criminal Justice, Riyadh, Saudi Arabia; [Alwaili, Maha Abdullah; Alshaya, Dalal S.; Jalal, Areej S.] Princess Nourah Bint Abdulrahman Univ, Dept Biol, Coll Sci, Riyadh, Saudi Arabia; [Jin, Feng] China Med Univ, Dept Breast Surg, Hosp 1, Shenyang, Liaoning, Peoples R China	China Medical University; Princess Nourah bint Abdulrahman University; China Medical University	Adnan, A (corresponding author), Naif Univ Secur Sci, Dept Forens Sci, Coll Criminal Justice, Riyadh, Saudi Arabia.; Jin, F (corresponding author), China Med Univ, Dept Breast Surg, Hosp 1, Shenyang, Liaoning, Peoples R China.	mirzaatifadnan@gmail.com; jinfeng@cmu.edu.cn	Adnan, Atif/Q-7037-2019	Adnan, Atif/0000-0003-4537-0059; Alshaya, Dalal Sulaiman/0000-0002-0682-8189	Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia [PNURSP2022R227]	Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia(Princess Nourah bint Abdulrahman University)	This research was funded by Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2022R227), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.	Adnan A, 2018, INT J LEGAL MED, V132, P1301, DOI 10.1007/s00414-018-1815-7; Adnan A, 2018, FORENSIC SCI INT-GEN, V36, pE17, DOI 10.1016/j.fsigen.2018.07.001; Adnan A, 2018, INT J LEGAL MED, V132, P137, DOI 10.1007/s00414-017-1611-9; Aldenderfer M, 2011, HIGH ALT MED BIOL, V12, P141, DOI 10.1089/ham.2010.1094; Bar W, 1997, INT J LEGAL MED, V110, P175, DOI 10.1007/s004140050061; Beckwith CI., 1993, TIBETAN EMPIRE CENTR; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Butler John M, 2007, Biotechniques, V43, pii; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Chen MY, 2014, ELECTROPHORESIS, V35, P1912, DOI 10.1002/elps.201300645; COTES JE, 1974, PHILOS T R SOC B, V268, P349, DOI 10.1098/rstb.1974.0034; Denwood P., 2008, J INN ASIAN ART ARCH, V3, P7, DOI [10.1484/J.JIAA.3.1, DOI 10.1484/J.JIAA.3.1]; Diegoli TM, 2015, FORENSIC SCI INT-GEN, V18, P140, DOI 10.1016/j.fsigen.2015.03.013; Diegoli TM, 2016, FORENSIC SCI INT-GEN, V25, P39, DOI 10.1016/j.fsigen.2016.07.004; Edelmann J, 2004, INT CONGR SER, V1261, P257, DOI 10.1016/S0531-5131(03)01722-9; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J, 2009, PHYLIP PHYLOGENY INF; Guo F, 2017, FORENSIC SCI INT-GEN, V26, pE1, DOI 10.1016/j.fsigen.2016.10.012; Gusmao L, 2006, FORENSIC SCI INT, V157, P187, DOI 10.1016/j.forsciint.2005.04.002; Gusmao L, 2009, INT J LEGAL MED, V123, P227, DOI 10.1007/s00414-008-0309-4; He GL, 2020, LEGAL MED-TOKYO, V43, DOI 10.1016/j.legalmed.2020.101677; He GL, 2017, LEGAL MED-TOKYO, V29, P6, DOI 10.1016/j.legalmed.2017.09.001; Jeong CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4281; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lancuo ZM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226970; Li XN, 2014, FORENSIC SCI INT-GEN, V13, P143, DOI 10.1016/j.fsigen.2014.07.012; Lin M., 2011, J FAM PLANN, V19, P628; Listman JB, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-48; Luo HB, 2011, INT J LEGAL MED, V125, P127, DOI 10.1007/s00414-009-0386-z; Nadeem A, 2009, MOL BIOL REP, V36, P1671, DOI 10.1007/s11033-008-9367-4; Pamjav H, 2012, FORENSIC SCI INT-GEN, V6, pE95, DOI 10.1016/j.fsigen.2011.08.009; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Pereira R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029684; Prieto-Fernandez E, 2015, FORENS SCI INT-GEN S, V5, pE283, DOI 10.1016/j.fsigss.2015.09.112; Prinz M, 1997, FORENSIC SCI INT, V85, P209, DOI 10.1016/S0379-0738(96)02096-8; Purps J, 2014, FORENSIC SCI INT-GEN, V12, P12, DOI 10.1016/j.fsigen.2014.04.008; Qi XB, 2013, MOL BIOL EVOL, V30, P1761, DOI 10.1093/molbev/mst093; Qin ZD, 2010, AM J PHYS ANTHROPOL, V143, P555, DOI 10.1002/ajpa.21350; Ren Z, 2013, FORENS SCI INT-GEN S, V4, pE49, DOI 10.1016/j.fsigss.2013.10.025; Schneider PM, 1997, FORENSIC SCI INT, V88, P17, DOI 10.1016/S0379-0738(97)00079-0; Senn N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009375; Shin SH, 2005, FORENSIC SCI INT, V147, P35, DOI 10.1016/j.forsciint.2004.04.012; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Szibor R, 2003, INT J LEGAL MED, V117, P67, DOI 10.1007/s00414-002-0352-5; Szibor R, 2006, INT J LEGAL MED, V120, P252, DOI 10.1007/s00414-005-0029-y; Uray G., 1979, KHROM ADM UNITS TIBE, V2nd ed; Veselinovic I, 2018, INT J LEGAL MED, V132, P405, DOI 10.1007/s00414-017-1677-4; WOOLCOCK AJ, 1972, AM REV RESPIR DIS, V106, P692, DOI 10.1164/arrd.1972.106.5.692; Wu XJ., 2014, FORENSIC SCI TECHNOL, P23; Xing JX, 2019, GENE, V683, P153, DOI 10.1016/j.gene.2018.10.020; Xu J, 2013, FORENSIC SCI INT-GEN, V7, pE43, DOI 10.1016/j.fsigen.2012.11.007; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yang XY, 2017, SCI REP-UK, V7, DOI 10.1038/srep42782; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zeng XP, 2011, FORENSIC SCI INT-GEN, V5, pE114, DOI 10.1016/j.fsigen.2011.03.005; Zhan XN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22975-6; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106; 吴小洁, 2014, [中国法医学杂志, Chinese Journal of Forensic Medicine], V29, P365; 刘亚举, 2013, [法医学杂志, Journal of Forensic Medicine], V29, P297	60	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271769	10.1371/journal.pone.0271769	http://dx.doi.org/10.1371/journal.pone.0271769			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35926061	gold, Green Published			2022-12-26	WOS:000848077100052
J	Wang, J; Huo, YJ; Wang, YT; Zhao, HY; Li, K; Liu, L; Shi, YG				Wang, Jin; Huo, Yujia; Wang, Yutong; Zhao, Haoyu; Li, Kai; Liu, Li; Shi, Yinggang			Grading detection of "Red Fuji" apple in Luochuan based on machine vision and near-infrared spectroscopy	PLOS ONE			English	Article							SOLUBLE SOLIDS CONTENT; PREDICTION; SELECTION	A quality detection system for the "Red Fuji" apple in Luochuan was designed for automatic grading. According to the Chinese national standard, the grading principles of apple appearance quality and Brix detection were determined. Based on machine vision and image processing, the classifier models of apple defect, contour, and size were constructed. And then, the grading thresholds were set to detect the defective pixel ratio lambda, aspect ratio A, and the cross-sectional diameter W-p in the image of the apple. Spectral information of apples in the wavelength range of 400 nm similar to 1000 nm was collected and the multiple scattering correction (MSC) and standard normal variable (SNV) transformation methods were used to preprocess spectral reflectance data. The competitive adaptive reweighted sampling (CARS) algorithm and the successive projections algorithm (SPA) were used to extract characteristic wavelength points containing Brix information, and the CARS-PLS (partial least squares) algorithm was used to establish a Brix prediction model. Apple defect, contour, size, and Brix were combined as grading indicators. The apple quality online grading detection platform was built, and apple's comprehensive grading detection algorithm and upper computer software were designed. The experiments showed that the average accuracy of apple defect, contour, and size grading detection was 96.67%, 95.00%, and 94.67% respectively, and the correlation coefficient R-p of the Brix prediction set was 0.9469. The total accuracy of apple defect, contour, size, and Brix grading was 96.67%, indicating that the detection system designed in this paper is feasible to classify "Red Fuji" apple in Luochuan.	[Wang, Jin; Huo, Yujia; Wang, Yutong; Zhao, Haoyu; Li, Kai; Liu, Li; Shi, Yinggang] Northwest A&F Univ, Coll Mech & Elect Engn, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Liu, L (corresponding author), Northwest A&F Univ, Coll Mech & Elect Engn, Yangling 712100, Shaanxi, Peoples R China.	liuli_ren_79@nwafu.edu.cn		Liu, Li/0000-0001-5784-6726; shi, yinggang/0000-0001-6835-4604	Shaanxi Province Key Research and Development Projects of China [2020NY-144, 2019NY-171, 2019ZDLNY02-04]; Innovative Training Program for College Students of Northwest AF University [202110712136]; National Natural Science Foundation of China [31971805]; National Key Research and Development Program of China [2019YFD1002401]	Shaanxi Province Key Research and Development Projects of China; Innovative Training Program for College Students of Northwest AF University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	Shaanxi Province Key Research and Development Projects of China (2020NY-144, 2019NY-171, 2019ZDLNY02-04), Innovative Training Program for College Students of Northwest A&F University (202110712136), National Natural Science Foundation of China (31971805), And National Key Research and Development Program of China (2019YFD1002401).	[Anonymous], 2008, 106512008 GBT; Baneh NM, 2018, J FOOD MEAS CHARACT, V12, P1135, DOI 10.1007/s11694-018-9728-1; Bhargava A, 2022, FOOD ANAL METHOD, V15, P228, DOI 10.1007/s12161-021-02086-1; Chen HZ, 2021, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.616943; Chopra H, 2021, IEEE SENS J, V21, P16162, DOI 10.1109/JSEN.2021.3075465; Demir B, 2020, ERWERBS-OBSTBAU, V62, P47, DOI 10.1007/s10341-019-00468-8; Fan SX, 2015, CHINESE J ANAL CHEM, V43, P239; Fan SX, 2014, SPECTROSC SPECT ANAL, V34, P2707, DOI 10.3964/j.issn.1000-0593(2014)10-2707-06; Goncalves MW, 2017, REV BRAS FRUTIC, V39, DOI 10.1590/0100-29452017825; Hassan MM, 2022, FOOD CHEM, V374, DOI 10.1016/j.foodchem.2021.131765; Hu GR, 2021, HORTICULTURAE, V7, DOI 10.3390/horticulturae7090276; Ji W, 2019, IEEE ACCESS, V7, P119742, DOI 10.1109/ACCESS.2019.2937326; Keresztes JC, 2016, FOOD CONTROL, V66, P215, DOI 10.1016/j.foodcont.2016.02.007; Kutsanedzie FYH, 2018, FOOD CHEM, V240, P231, DOI 10.1016/j.foodchem.2017.07.117; Li L, 2020, POSTHARVEST BIOL TEC, V162, DOI 10.1016/j.postharvbio.2019.111101; Li MR, 2020, THEOR APPL CLIMATOL, V139, P191, DOI 10.1007/s00704-019-02965-y; Li XP, 2021, AGRICULTURE-BASEL, V11, DOI 10.3390/agriculture11121274; Liu PH, 2021, J FOOD PROCESS ENG, V44, DOI 10.1111/jfpe.13802; Lv JD, 2019, SCI HORTIC-AMSTERDAM, V257, DOI 10.1016/j.scienta.2019.108758; Ma T, 2020, COMPUT ELECTRON AGR, V177, DOI 10.1016/j.compag.2020.105683; Ma T, 2018, J FOOD ENG, V224, P53, DOI 10.1016/j.jfoodeng.2017.12.028; Nleya KM, 2014, J SCI FOOD AGR, V94, P857, DOI 10.1002/jsfa.6315; Rady AM, 2021, FOOD ANAL METHOD, V14, P581, DOI 10.1007/s12161-020-01886-1; Shao YY, 2020, RSC ADV, V10, P33148, DOI 10.1039/c9ra10630h; Sofu MM, 2016, COMPUT ELECTRON AGR, V127, P395, DOI 10.1016/j.compag.2016.06.030; Tan WY, 2018, J CHEMOMETR, V32, DOI 10.1002/cem.3067; Tian X, 2019, BIOSYST ENG, V183, P110, DOI 10.1016/j.biosystemseng.2019.04.012; Wei X, 2020, INFRARED PHYS TECHN, V105, DOI 10.1016/j.infrared.2019.103099; Wu ZS, 2014, OPT SPECTROSC+, V117, P703, DOI 10.1134/S0030400X1411023X; Xia Y, 2020, INFRARED PHYS TECHN, V110, DOI 10.1016/j.infrared.2020.103443; Xu KR, 2015, INT J AGR BIOL ENG, V8, P35, DOI 10.3965/j.ijabe.20150801.005; Zhang CL, 2017, INT J AGR BIOL ENG, V10, P74, DOI 10.3965/j.ijabe.20171002.2166; Zhang HL, 2020, POSTHARVEST BIOL TEC, V163, DOI 10.1016/j.postharvbio.2020.111148; Zhao M, 2021, POSTHARVEST BIOL TEC, V180, DOI 10.1016/j.postharvbio.2021.111615; Zunic D, 2014, APPL MATH COMPUT, V226, P406, DOI 10.1016/j.amc.2013.10.062	35	0	0	18	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271352	10.1371/journal.pone.0271352	http://dx.doi.org/10.1371/journal.pone.0271352			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925926	Green Published, gold			2022-12-26	WOS:000848077100036
J	Edrington, T; Wang, R; McKinnon, L; Kessenich, C; Hodge-Bell, K; Li, WZ; Tan, JG; Brown, G; Wang, CX; Li, B; Giddings, K				Edrington, Thomas; Wang, Rong; McKinnon, Lucas; Kessenich, Colton; Hodge-Bell, Kimberly; Li, Wenze; Tan, Jianguo; Brown, Gregory; Wang, Cunxi; Li, Bin; Giddings, Kara			Food and feed safety of the Bacillus thuringiensis derived protein Vpb4Da2, a novel protein for control of western corn rootworm	PLOS ONE			English	Article							TOXINS; TRANSLOCATION; DIVERSITY	Western corn rootworm (WCR), Diabrotica virgifera virgifera, LeConte, is an insect pest that poses a significant threat to the productivity of modern agriculture, causing significant economic and crop losses. The development of genetically modified (GM) crops expressing one or more proteins that confer tolerance to specific insect pests, such as WCR, was a historic breakthrough in agricultural biotechnology and continues to serve as an invaluable tool in pest management. Despite this, evolving resistance to existing insect control proteins expressed in current generation GM crops requires continued identification of new proteins with distinct modes of action while retaining targeted insecticidal efficacy. GM crops expressing insecticidal proteins must undergo extensive safety assessments prior to commercialization to ensure that they pose no increased risk to the health of humans or other animals relative to their non-GM conventional counterparts. As part of these safety evaluations, a weight of evidence approach is utilized to assess the safety of the expressed insecticidal proteins to evaluate any potential risk in the context of dietary exposure. This study describes the food and feed safety assessment of Vpb4Da2, a new Bacillus thuringiensis insecticidal protein that confers in planta tolerance to WCR. Vpb4Da2 exhibits structural and functional similarities to other insect control proteins expressed in commercialized GM crops. In addition, the lack of homology to known toxins or allergens, a lack of acute toxicity in mice, inactivation by conditions commonly experienced in the human gut or during cooking/food processing, and the extremely low expected dietary exposure to Vpb4Da2 provide a substantial weight of evidence to demonstrate that the Vpb4Da2 protein poses no indication of a risk to the health of humans or other animals.	[Edrington, Thomas; Wang, Rong; McKinnon, Lucas; Kessenich, Colton; Hodge-Bell, Kimberly; Li, Wenze; Tan, Jianguo; Brown, Gregory; Wang, Cunxi; Li, Bin; Giddings, Kara] Bayer Crop Sci, Chesterfield, MO 63017 USA	Bayer AG; Bayer CropScience	Wang, R (corresponding author), Bayer Crop Sci, Chesterfield, MO 63017 USA.	rong.wang@bayer.com		McKinnon, Lucas/0000-0002-2996-1548; Kessenich, Colton/0000-0001-8407-6050				Adang MJ, 2014, ADV INSECT PHYSIOL, V47, P39, DOI 10.1016/B978-0-12-800197-4.00002-6; Akbar W, 2019, PEST MANAG SCI, V75, P867, DOI 10.1002/ps.5234; Bel Y, 2017, TOXINS, V9, DOI 10.3390/toxins9040131; Betz FS, 2000, REGUL TOXICOL PHARM, V32, P156, DOI 10.1006/rtph.2000.1426; Brookes G, 2020, GM CROPS FOOD, V11, P242, DOI 10.1080/21645698.2020.1779574; Campbell JD, 2007, HUM VACCINES, V3, P205, DOI 10.4161/hv.3.5.4459; Chakrabarty S, 2020, PEST MANAG SCI, V76, P1612, DOI 10.1002/ps.5804; Chakroun M, 2016, MICROBIOL MOL BIOL R, V80, P329, DOI 10.1128/MMBR.00060-15; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; Delaney B, 2008, FOOD CHEM TOXICOL, V46, pS71, DOI 10.1016/j.fct.2008.01.045; Delaney B, 2018, TOXICOL SCI, V162, P361, DOI 10.1093/toxsci/kfx249; EPA, 1999, 600R98079 EPA; EPA, 2010, BIOPESTICIDE REGISTR; EPA, BIOPESTICIDES REGIST; EPA, 2011, BIOPESTICIDES REGIST; EPA, 2018, REG DEC NEW ACT INGR; Farmer DR, 2017, REGUL TOXICOL PHARM, V89, P155, DOI 10.1016/j.yrtph.2017.07.020; Frederiksen K, 2006, APPL ENVIRON MICROB, V72, P3435, DOI 10.1128/AEM.72.5.3435-3440.2006; Fu TT, 2002, J AGR FOOD CHEM, V50, P7154, DOI 10.1021/jf020599h; Hammond BG, 2004, J AGR FOOD CHEM, V52, P1390, DOI 10.1021/jf030441c; Hammond BG., 2012, BACILLUS THURINGIENS, P305; Head G, 2014, CROP PROT, V57, P38, DOI 10.1016/j.cropro.2013.11.025; HUNT DF, 1986, P NATL ACAD SCI USA, V83, P6233, DOI 10.1073/pnas.83.17.6233; ISAAA, 2019, ISAAA BRIEF; Jerga A, 2016, ARCH BIOCHEM BIOPHYS, V600, P1, DOI 10.1016/j.abb.2016.03.016; Juberg DR, 2009, REGUL TOXICOL PHARM, V54, P154, DOI 10.1016/j.yrtph.2009.03.008; Koch MS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00283; Kouadio JL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0260532; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Mann M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11747-z; Moar WJ, 2017, J INVERTEBR PATHOL, V142, P50, DOI 10.1016/j.jip.2016.05.007; Odumosu O., 2009, CODEX ALIMENTARIUS F, Vsecond; Odumosu O, 2010, TOXINS, V2, P1612, DOI 10.3390/toxins2071612; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Palma L, 2017, TOXINS, V9, DOI 10.3390/toxins9050165; Palma L, 2014, TOXINS, V6, P3296, DOI 10.3390/toxins6123296; Pearson W R, 2000, Methods Mol Biol, V132, P185; Perlak FJ, 2001, PLANT J, V27, P489, DOI 10.1046/j.1365-313X.2001.01120.x; Raybould A, 2013, TRANSGENIC RES, V22, P445, DOI 10.1007/s11248-012-9658-3; Raybould A, 2011, TRANSGENIC RES, V20, P599, DOI 10.1007/s11248-010-9442-1; Raymond B, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix084; Revision USPCCo, US PHARM NAT FORM 19; Rigden DJ, 2004, TRENDS BIOCHEM SCI, V29, P335, DOI 10.1016/j.tibs.2004.05.002; Roh JY, 2007, J MICROBIOL BIOTECHN, V17, P547; Shao E., 2020, OLIGOMER FORMATION I, V12; Thomas K, 2004, REGUL TOXICOL PHARM, V39, P87, DOI 10.1016/j.yrtph.2003.11.003; US EPA, 1998, EPA738R98004; USEPA, 2002, 006487 EPA AMENDED; USEPA, 2008, BIOPESTICIDES REGIST; Wang CX, 2018, REGUL TOXICOL PHARM, V99, P50, DOI 10.1016/j.yrtph.2018.09.003; Wang CX, 2016, REGUL TOXICOL PHARM, V81, P171, DOI 10.1016/j.yrtph.2016.08.014; Wang CX, 2015, REGUL TOXICOL PHARM, V71, P164, DOI 10.1016/j.yrtph.2014.12.014; Waters S., 2021, J REGULATORY SCI, V9, P16; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Yin Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242791; Zhao ZX, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41067-7; Zheng MY, 2020, PROTEIN SCI, V29, P824, DOI 10.1002/pro.3803	57	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272311	http://dx.doi.org/10.1371/journal.pone.0272311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921368	Green Published, gold			2022-12-26	WOS:000839311900007
J	Montales, K; Ruis, K; Lindsay, H; Michael, WM				Montales, Katrina; Ruis, Kenna; Lindsay, Howard; Michael, W. Matthew			MRN-dependent and independent pathways for recruitment of TOPBP1 to DNA double-strand breaks	PLOS ONE			English	Article							GENOME STABILITY; ATR ACTIVATION; COMPLEX; REPLICATION; PROTEIN; PHOSPHORYLATION; INTERACTS; RESECTION; CHK1; NBS1	Ataxia Telangiectasia mutated and RAD3-related (ATR) kinase is activated by DNA replication stress and also by various forms of DNA damage, including DNA double-strand breaks (DSBs). Recruitment to sites of damage is insufficient for ATR activation as one of two known ATR activators, either topoisomerase II-binding protein (TOPBP1) or Ewing's tumor-associated antigen 1, must also be present for signaling to initiate. Here, we employ our recently established DSB-mediated ATR activation in Xenopus egg extract (DMAX) system to examine how TOPBP1 is recruited to DSBs, so that it may activate ATR. We report that TOPBP1 is only transiently present at DSBs, with a half-life of less than 10 minutes. We also examined the relationship between TOPBP1 and the MRE11-RAD50-NBS1 (MRN), CtBP interacting protein (CtIP), and Ataxia Telangiectasia mutated (ATM) network of proteins. Loss of MRN prevents CtIP recruitment to DSBs, and partially inhibits TOPBP1 recruitment. Loss of CtIP has no impact on either MRN or TOPBP1 recruitment. Loss of ATM kinase activity prevents CtIP recruitment and enhances MRN and TOPBP1 recruitment. These findings demonstrate that there are MRN-dependent and independent pathways that recruit TOPBP1 to DSBs for ATR activation. Lastly, we find that both the 9-1-1 complex and MDC1 are dispensable for TOPBP1 recruitment to DSBs.	[Montales, Katrina; Ruis, Kenna; Michael, W. Matthew] Univ Southern Calif Los Angeles, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90007 USA; [Lindsay, Howard] Univ Lancaster, Fac Hlth & Med, Lancaster Med Sch, Lancaster, Lancashire, England	Lancaster University	Michael, WM (corresponding author), Univ Southern Calif Los Angeles, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90007 USA.	mattm@usc.edu	McDermott, Michael Francis/GZM-5330-2022		National Institutes of Health [R01GM12287]; North West Cancer Research [CR782]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North West Cancer Research	We thank Karlene Cimprich and Zhongseng You for the kind gifts of antibodies.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bigot N, 2019, ELIFE, V8, DOI 10.7554/eLife.44353; Blackford AN, 2015, MOL CELL, V57, P1133, DOI 10.1016/j.molcel.2015.02.012; Blaikley EJ, 2014, NUCLEIC ACIDS RES, V42, P5644, DOI 10.1093/nar/gku190; Cescutti R, 2010, EMBO J, V29, P3723, DOI 10.1038/emboj.2010.238; Choi SH, 2016, BIOCHEM BIOPH RES CO, V479, P5, DOI 10.1016/j.bbrc.2016.08.158; Day M, 2018, ELIFE, V7, DOI 10.7554/eLife.39979; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Duursma AM, 2013, MOL CELL, V50, P116, DOI 10.1016/j.molcel.2013.03.006; Frattini C, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.12.049; Gobbini E, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108287; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kim A, 2020, DNA REPAIR, V96, DOI 10.1016/j.dnarep.2020.102973; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Lee JH, 2021, NAT REV MOL CELL BIO, V22, P796, DOI 10.1038/s41580-021-00394-2; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lee J, 2013, MOL BIOL CELL, V24, P1343, DOI 10.1091/mbc.E13-01-0025; Leimbacher PA, 2019, MOL CELL, V74, P571, DOI 10.1016/j.molcel.2019.02.014; Liao SR, 2012, NUCLEIC ACIDS RES, V40, P4496, DOI 10.1093/nar/gks044; Ma M, 2020, CURR GENET, V66, P327, DOI 10.1007/s00294-019-01039-w; Montales K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80626-1; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Paull TT, 2015, ANNU REV BIOCHEM, V84, P711, DOI 10.1146/annurev-biochem-060614-034335; Ramirez-Lugo JS, 2011, CELL CYCLE, V10, P469, DOI 10.4161/cc.10.3.14711; Ruis K, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101992; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Shiotani B, 2013, CELL REP, V3, P1651, DOI 10.1016/j.celrep.2013.04.018; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; Takeishi Y, 2010, GENES CELLS, V15, P761, DOI 10.1111/j.1365-2443.2010.01418.x; Taylor EM, 2010, NUCLEIC ACIDS RES, V38, P441, DOI 10.1093/nar/gkp905; Thada V, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100455; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; Wardlaw CP, 2014, DNA REPAIR, V22, P165, DOI 10.1016/j.dnarep.2014.06.004; Waterman DP, 2020, ANNU REV BIOCHEM, V89, P103, DOI 10.1146/annurev-biochem-011520-104722; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Williams RM, 2021, PROG BIOPHYS MOL BIO, V161, P27, DOI 10.1016/j.pbiomolbio.2020.11.005; Williams RM, 2020, CURR OPIN STRUC BIOL, V61, P98, DOI 10.1016/j.sbi.2019.12.010; Wuehr M, 2014, CURR BIOL, V24, P1467, DOI 10.1016/j.cub.2014.05.044; Yoo HY, 2007, J BIOL CHEM, V282, P17501, DOI 10.1074/jbc.M701770200; Yoo HY, 2009, MOL BIOL CELL, V20, P2351, DOI 10.1091/mbc.E08-12-1190; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Zhao J, 2022, MOL CELL, V82, P2571, DOI 10.1016/j.molcel.2022.04.031	44	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271905	http://dx.doi.org/10.1371/journal.pone.0271905			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917319	gold, Green Published			2022-12-26	WOS:000837840000017
J	Pescetelli, N; Reichert, P; Rutherford, A				Pescetelli, Niccolo; Reichert, Patrik; Rutherford, Alex			A variational-autoencoder approach to solve the hidden profile task in hybrid human-machine teams	PLOS ONE			English	Article								Algorithmic agents, popularly known as bots, have been accused of spreading misinformation online and supporting fringe views. Collectives are vulnerable to hidden-profile environments, where task-relevant information is unevenly distributed across individuals. To do well in this task, information aggregation must equally weigh minority and majority views against simple but inefficient majority-based decisions. In an experimental design, human volunteers working in teams of 10 were asked to solve a hidden-profile prediction task. We trained a variational auto-encoder (VAE) to learn people's hidden information distribution by observing how people's judgments correlated over time. A bot was designed to sample responses from the VAE latent embedding to selectively support opinions proportionally to their under-representation in the team. We show that the presence of a single bot (representing 10% of team members) can significantly increase the polarization between minority and majority opinions by making minority opinions less prone to social influence. Although the effects on hybrid team performance were small, the bot presence significantly influenced opinion dynamics and individual accuracy. These findings show that self-supervized machine learning techniques can be used to design algorithms that can sway opinion dynamics and group outcomes.	[Pescetelli, Niccolo] New Jersey Inst Technol, Collect Intelligence Lab, Newark, NJ 07102 USA; [Reichert, Patrik] Univ Gothenburg, Sch Business Econ & Law, Gothenburg, Sweden; [Rutherford, Alex] Max Planck Inst Human Dev, Berlin, Germany	New Jersey Institute of Technology; University of Gothenburg; Max Planck Society	Pescetelli, N (corresponding author), New Jersey Inst Technol, Collect Intelligence Lab, Newark, NJ 07102 USA.	niccolo.pescetelli@njit.edu						Allen J, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay3539; Almaatouq A, 2021, BEHAV RES METHODS, V53, P2158, DOI 10.3758/s13428-020-01535-9; ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Bail CA, 2020, P NATL ACAD SCI USA, V117, P243, DOI 10.1073/pnas.1906420116; Bail CA, 2018, P NATL ACAD SCI USA, V115, P9216, DOI 10.1073/pnas.1804840115; Bramson A, 2016, J MATH SOCIOL, V40, P80, DOI 10.1080/0022250X.2016.1147443; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Brinkmann Levin., 2021, PHILOS T R SOC A; Broniatowski DA, 2018, AM J PUBLIC HEALTH, V108, P1378, DOI 10.2105/AJPH.2018.304567; de Bruin WB, 2020, J RISK UNCERTAINTY, V61, P177, DOI 10.1007/s11166-020-09336-3; Cresci S, 2017, WWW'17 COMPANION: PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P963, DOI 10.1145/3041021.3055135; Dunham K., 2009, MALICIOUS BOTS INSID; Endres K, 2019, J POLIT, V81, P1090, DOI 10.1086/703210; Ferrara E., 2016, 1 MONDAY, V21, DOI [DOI 10.5210/FM.V21I11.7090, 10.5210/fm.v21i11.7090]; Ferrara E, 2016, COMMUN ACM, V59, P96, DOI 10.1145/2818717; Flache A, 2017, JASSS-J ARTIF SOC S, V20, DOI 10.18564/jasss.3521; Guess A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau4586; Guilbeault D, 2018, P NATL ACAD SCI USA, V115, P9714, DOI 10.1073/pnas.1722664115; Hahn U, 2019, TOP COGN SCI, V11, P194, DOI 10.1111/tops.12401; Higgins I, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26751-5; Howard PN, 2018, IEEE SPECTRUM; Jurkowitz M., 2020, US MEDIA POLARIZATIO; Kakutani Michiko, 2018, DEATH TRUTH NOTES FA; Kalla JL, 2018, AM POLIT SCI REV, V112, P148, DOI 10.1017/S0003055417000363; Kao AB, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0378; Kao AB, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003762; Kelman H.C., 1958, J CONFLICT RESOLUT, V2, P51, DOI [10.1177/002200275800200106, DOI 10.1177/002200275800200106]; LADHA KK, 1992, AM J POLIT SCI, V36, P617, DOI 10.2307/2111584; LATANE B, 1981, AM PSYCHOL, V36, P343, DOI 10.1037/0003-066X.36.4.343; Ledford H, 2020, NATURE, V578, P17, DOI 10.1038/d41586-020-00141-1; Lerman K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147617; Lightle JP, 2009, MANAGE SCI, V55, P568, DOI 10.1287/mnsc.1080.0975; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Malte F., 2015, P 10 ANN ACMIEEE INT; Moeckli D, 2018, SWISS POLIT SCI REV, V24, P335, DOI 10.1111/spsr.12317; Orabi M, 2020, INFORM PROCESS MANAG, V57, DOI 10.1016/j.ipm.2020.102250; Pescetelli N, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2020.0025; Posner E., 2018, RADICAL MARKETS UPRO; Ratkiewicz M., 2011, P INT AAAI C WEB SOC, V5, P297; Sherif M., 1965, ATTITUDE ATTITUDE CH; Shirado H, 2017, NATURE, V545, P370, DOI 10.1038/nature22332; Stasser G, 2003, PSYCHOL INQ, V14, P304, DOI 10.1207/S15327965PLI1403&4_21; Stella M, 2018, P NATL ACAD SCI USA, V115, P12435, DOI 10.1073/pnas.1803470115; Stewart L. G., 2018, P ACM WSDM WORKSH MI; Stieglitz Stefan, 2017, SOCIAL BOTS DREAM EL, V10; Subrahmanian VS, 2016, COMPUTER, V49, P38, DOI 10.1109/MC.2016.183; Varol O, 2017, P INT AAAI C WEB SOC; Yaniv I, 2007, ORGAN BEHAV HUM DEC, V103, P104, DOI 10.1016/j.obhdp.2006.05.006; Zaller JohnR., 1992, NATURE ORIGINS MASS	49	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272168	http://dx.doi.org/10.1371/journal.pone.0272168			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917306	gold, Green Submitted, Green Published			2022-12-26	WOS:000837840000027
J	Liu, JH; Carlson, HA; Scott, EE				Liu, Jinghan; Carlson, Heather A.; Scott, Emily E.			The structure and characterization of human cytochrome P450 8B1 supports future drug design for nonalcoholic fatty liver disease and diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOXIDE-BINDING PIGMENT; PROSTACYCLIN SYNTHASE; ACID; PURIFICATION; EXPRESSION; MICROSOMES; P450	Human cytochrome P450 8B1 (CYP8B1) is involved in conversion of cholesterol to bile acids. It hydroxylates the steroid ring at C12 to ultimately produce the bile acid cholic acid. Studies implicated this enzyme as a good drug target for nonalcoholic fatty liver disease and type 2 diabetes, but there are no selective inhibitors known for this enzyme and no structures to guide inhibitor development. Herein, the human CYP8B1 protein was generated and used to identify and characterize interactions with a series of azole inhibitors, which tend to be poorly selective P450 inhibitors. Structurally related miconazole, econazole, and tioconazole bound with submicromolar dissociation constants and were effective inhibitors of the native reaction. CYP8B was cocrystallized with S-tioconazole to yield the first X-ray structure. This inhibitor bound in the active site with its azole nitrogen coordinating the heme iron, consistent with inhibitor binding and inhibition assay data. Additionally, the CYP8B1 active site was compared with similar P450 enzymes to identify features that may facilitate the design of more selective inhibitors. Selective inhibitors should promote a better understanding of the role of CYP8B1 inhibition in normal physiology and disease states and provide a possible treatment for nonalcoholic fatty liver disease and type 2 diabetes.	[Liu, Jinghan; Carlson, Heather A.; Scott, Emily E.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48103 USA; [Scott, Emily E.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48103 USA; [Scott, Emily E.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48103 USA; [Scott, Emily E.] Univ Michigan, Programs Chem Biol, Ann Arbor, MI 48103 USA; [Scott, Emily E.] Univ Michigan, Programs Biophys, Ann Arbor, MI 48103 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Scott, EE (corresponding author), Univ Michigan, Dept Med Chem, Ann Arbor, MI 48103 USA.; Scott, EE (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48103 USA.; Scott, EE (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48103 USA.; Scott, EE (corresponding author), Univ Michigan, Programs Chem Biol, Ann Arbor, MI 48103 USA.; Scott, EE (corresponding author), Univ Michigan, Programs Biophys, Ann Arbor, MI 48103 USA.				NIH [R37 GM076343]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research was supported by NIH R37 GM076343 (to E. E. S.) . The content is solely the re-sponsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arab JP, 2017, HEPATOLOGY, V65, P350, DOI 10.1002/hep.28709; Bart AG, 2017, J BIOL CHEM, V292, P20818, DOI 10.1074/jbc.RA117.000220; Chevre R, 2018, FASEB J, V32, P3792, DOI 10.1096/fj.201701084RR; Chiang John Yl, 2017, F1000Res, V6, P2029, DOI 10.12688/f1000research.12449.1; Chung E, 2022, STEROIDS, V178, DOI 10.1016/j.steroids.2021.108952; Eggertsen G, 1996, J BIOL CHEM, V271, P32269, DOI 10.1074/jbc.271.50.32269; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan LB, 2019, BIOL CHEM, V400, P625, DOI 10.1515/hsz-2018-0379; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Godamudunage MP, 2018, DRUG METAB DISPOS, V46, P1329, DOI 10.1124/dmd.118.082032; Goizet C, 2009, BRAIN, V132, P1589, DOI 10.1093/brain/awp073; GOTOH O, 1992, J BIOL CHEM, V267, P83; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; Han CY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072069; Hindson Jordan, 2020, Nat Rev Gastroenterol Hepatol, V17, P66, DOI 10.1038/s41575-020-0264-1; ISHIDA H, 1992, J BIOL CHEM, V267, P21319; Jiao Y, 2015, ACTA PHARMACOL SIN, V36, P44, DOI 10.1038/aps.2014.116; Kaur A, 2015, DIABETES, V64, P1168, DOI [10.2337/db14-0716, 10.2337/db15-0518]; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Li YC, 2008, J BIOL CHEM, V283, P2917, DOI 10.1074/jbc.M707470200; Lu C, 2021, J CHEM THEORY COMPUT, V17, P4291, DOI 10.1021/acs.jctc.1c00302; Manna SK, 2008, J INORG BIOCHEM, V102, P1312, DOI 10.1016/j.jinorgbio.2008.01.013; Manne V, 2018, CLIN LIVER DIS, V22, P23, DOI 10.1016/j.cld.2017.08.007; Mast N, 2005, BIOCHEMISTRY-US, V44, P3259, DOI 10.1021/bi047566a; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Mura C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000918; Muralidhara BK, 2006, J BIOL CHEM, V281, P8051, DOI 10.1074/jbc.M509696200; OMURA T, 1964, J BIOL CHEM, V239, P2379; OMURA T, 1964, J BIOL CHEM, V239, P2370; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pathak Preeti, 2019, Gene Expr, V19, P161, DOI 10.3727/105221619X15529371970455; Pullingr CR, 2002, J CLIN INVEST, V110, P109, DOI 10.1172/JCI200215387; Puri P, 2018, HEPATOLOGY, V67, P534, DOI 10.1002/hep.29359; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Staels B, 2009, DIABETES CARE, V32, pS237, DOI 10.2337/dc09-S355; Sun YH, 2013, BIOCHEMISTRY-US, V52, P5941, DOI 10.1021/bi400541v; Tempel W, 2014, J LIPID RES, V55, P1925, DOI 10.1194/jlr.M050765; Tuder RM, 1999, AM J RESP CRIT CARE, V159, P1925, DOI 10.1164/ajrccm.159.6.9804054; ULLRICH V, 1994, ANGEW CHEM INT EDIT, V33, P1911, DOI 10.1002/anie.199419111	42	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102344	10.1016/j.jbc.2022.102344	http://dx.doi.org/10.1016/j.jbc.2022.102344			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A7IQ	35944583	gold, Green Published			2022-12-26	WOS:000863057500004
J	Huang, XL; Lee, SJ; Kim, CZ; Choi, SH				Huang, Xilang; Lee, Sang Joon; Kim, Chang Zoo; Choi, Seon Han			An improved strabismus screening method with combination of meta-learning and image processing under data scarcity	PLOS ONE			English	Article							RISK	PurposeConsidering the scarcity of normal and strabismic images, this study proposed a method that combines a meta-learning approach with image processing methods to improve the classification accuracy when meta-learning alone is used for screening strabismus. MethodsThe meta-learning approach was first pre-trained on a public dataset to obtain a well-generalized embedding network to extract distinctive features of images. On the other hand, the image processing methods were used to extract the position features of eye regions (e.g., iris position, corneal light reflex) as supplementary features to the distinctive features. Afterward, principal component analysis was applied to reduce the dimensionality of distinctive features for integration with low-dimensional supplementary features. The integrated features were then used to train a support vector machine classifier for performing strabismus screening. Sixty images (30 normal and 30 strabismus) were used to verify the effectiveness of the proposed method, and its classification performance was assessed by computing the accuracy, specificity, and sensitivity through 5,000 experiments. ResultsThe proposed method achieved a classification accuracy of 0.805 with a sensitivity (correct classification of strabismus) of 0.768 and a specificity (correct classification of normal) of 0.842, whereas the classification accuracy of using meta-learning alone was 0.709 with a sensitivity of 0.740 and a specificity of 0.678. ConclusionThe proposed strabismus screening method achieved promising classification accuracy and gained significant accuracy improvement over using meta-learning alone under data scarcity.	[Huang, Xilang] Pukyong Natl Univ, Dept Artificial Intelligent Convergence, Busan, South Korea; [Lee, Sang Joon; Kim, Chang Zoo] Kosin Univ, Coll Med, Dept Ophthalmol, Busan, South Korea; [Kim, Chang Zoo] Kosin Univ Gospel Hosp, Korea Innovat Smart Healthcare Res Ctr, Busan, South Korea; [Choi, Seon Han] Ewha Womans Univ, Dept Elect & Elect Engn, Seoul, South Korea	Pukyong National University; Ewha Womans University	Kim, CZ (corresponding author), Kosin Univ, Coll Med, Dept Ophthalmol, Busan, South Korea.; Kim, CZ (corresponding author), Kosin Univ Gospel Hosp, Korea Innovat Smart Healthcare Res Ctr, Busan, South Korea.; Choi, SH (corresponding author), Ewha Womans Univ, Dept Elect & Elect Engn, Seoul, South Korea.	changzoo@hanmail.net; seonhan.choi@ewha.ac.kr		Kim, Changzoo/0000-0002-0807-6582	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean Government (MSIT) [2019M3E5D1A02070862]; Beginning Independent Researcher Program of the NRF - MSIT [2019R1G1A1098951]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean Government (MSIT)(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); Beginning Independent Researcher Program of the NRF - MSIT	This research was supported in part by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean Government (MSIT) under Grant 2019M3E5D1A02070862 and supported in part by the Beginning Independent Researcher Program of the NRF funded by the MSIT under Grant 2019R1G1A1098951. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Valente TLA, 2017, COMPUT METH PROG BIO, V140, P295, DOI 10.1016/j.cmpb.2017.01.002; Ce Zheng, 2018, Arxiv, DOI arXiv:1809.02940; Chernov N, 2005, J MATH IMAGING VIS, V23, P239, DOI 10.1007/s10851-005-0482-8; Cotter SA, 2009, OPHTHALMOLOGY, V116, P145, DOI 10.1016/j.ophtha.2008.08.031; Duangsang Suampa, 2012, Journal of the Medical Association of Thailand, V95, P699; Faes L, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.2.7; Ghiasi G, 2018, ADV NEUR IN, V31; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Huang X, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255643; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; King DE, 2009, J MACH LEARN RES, V10, P1755; Lee C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70660-4; Lee K, 2019, PROC CVPR IEEE, P10649, DOI 10.1109/CVPR.2019.01091; Mahajan K., 2020, P IEEECVF C COMPUTER, P730; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Park KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129035; Pineles SL, 2015, JAMA OPHTHALMOL, V133, P60, DOI 10.1001/jamaophthalmol.2014.3941; Ravi S, 2016, OPTIMIZATION MODEL F; Repka MX, 2018, OPHTHALMOLOGY, V125, P1646, DOI 10.1016/j.ophtha.2018.04.024; Rosten E, 2006, LECT NOTES COMPUT SC, V3951, P430, DOI 10.1007/11744023_34; Rublee E, 2011, IEEE I CONF COMP VIS, P2564, DOI 10.1109/ICCV.2011.6126544; Schmidhuber J, 1987, THESIS; Schneider RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056556; Smith A.R., 1978, ACM SIGGRAPH COMPUT, V12, P12, DOI [10.1145/965139.807361, DOI 10.1145/965139.807361]; de Almeida JDS, 2015, J DIGIT IMAGING, V28, P462, DOI 10.1007/s10278-014-9758-0; de Almeida JDS, 2012, COMPUT BIOL MED, V42, P135, DOI 10.1016/j.compbiomed.2011.11.001; Thrun S, 1998, LEARNING TO LEARN, P181; Vinyals O., 2016, NEURAL INFORM PROCES, P3630; Zhao Y, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3285-4; Zheng C, 2021, TRANSL VIS SCI TECHN, V10, DOI 10.1167/tvst.10.1.33	30	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2022	17	8							e0269365	10.1371/journal.pone.0269365	http://dx.doi.org/10.1371/journal.pone.0269365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5A3IT	35930530	gold, Green Published			2022-12-26	WOS:000862784200002
J	Zhang, HL; Lang, X; Li, X; Chen, G; Wang, CL				Zhang, Hailong; Lang, Xia; Li, Xiao; Chen, Guoshun; Wang, Cailian			Effect of Zanthoxylum bungeanum essential oil on rumen enzyme activity, microbiome, and metabolites in lambs	PLOS ONE			English	Article							GUT MICROBIOTA; FATTY-ACIDS; DIET; IDENTIFICATION; POPULATION; COMMUNITY; ABUNDANCE; DYNAMICS; STRAINS; OBESITY	Antibiotics were once used in animal production to improve productivity and resistance to pathogenic microbiota. However, due to its negative effects, the search for a new class of substances that can replace its efficacy has become one of the urgent problems to be solved. Plant essential oils (EOs) as a natural feed additive can maintain microbiota homeostasis and improve animal performance. However, its specific mechanism of action needs to be further investigated. Therefore, we added different doses of essential oil of Zanthoxylum bungeanum (EOZB) to the diets of Small Tail Han Sheep hybrid male lambs (STH lambs) to evaluate the effect of EOZB on rumen enzyme activity, rumen microbiology, and its metabolites in STH lambs. Twenty STH lambs were randomly divided into four groups (n = 5/group) and provided with the same diet. The dietary treatments were as follows: basal diet (BD) group; BD+EOZB 5 ml/kg group; BD+EOZB 10 ml/kg group; BD+EOZB 15 ml/kg group. We found that EOZB 10 ml/kg helped to increase rumen pectinase (P< 0.05) and lipase (P< 0.05) activities. Microbial 16S rRNA gene analysis showed that EOZB significantly altered the abundance of rumen microbiota (P< 0.05). LC/GC-MS metabolomic analysis showed that the addition of EOZB produced a total of 1073 differential metabolites, with 58 differential metabolites remaining after raising the screening criteria. These differential metabolites were mainly enriched in glycerophospholipid metabolism, choline metabolism in cancer, retrograde endocannabinoid signaling, benzoxazinoid biosynthesis, and protein digestion and absorption. Correlation analysis showed that some rumen microbiota were significantly correlated with differential metabolite and enzyme activities.	[Zhang, Hailong; Li, Xiao; Chen, Guoshun; Wang, Cailian] Gansu Agr Univ, Coll Anim Sci & Technol, Lanzhou, Peoples R China; [Zhang, Hailong; Lang, Xia; Wang, Cailian] Key Iaboratory Sheep Goat & Cattle Germplasm & St, Lanzhou, Peoples R China; [Lang, Xia; Wang, Cailian] Gansu Acad Agr Sci, Inst Anim Sci & Grass Sci & Green Agr, Lanzhou, Peoples R China	Gansu Agricultural University	Chen, G (corresponding author), Gansu Agr Univ, Coll Anim Sci & Technol, Lanzhou, Peoples R China.; Wang, CL (corresponding author), Key Iaboratory Sheep Goat & Cattle Germplasm & St, Lanzhou, Peoples R China.; Wang, CL (corresponding author), Gansu Acad Agr Sci, Inst Anim Sci & Grass Sci & Green Agr, Lanzhou, Peoples R China.	chengs@gsau.edu.cn; wangcl1974@163.com			 [1760683];  [18YF1NA091];  [18JR2RA032]	; ; 	We thank for the financial support: No. 1760683; No.18YF1NA091; No. 18JR2RA032; The funder, Cailian Wang, played an important role in the study design design. The funder, Guoshun Chen, played an important role in the decision to publish.	Abdallah A, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/8530961; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Badawy AAB, 2017, INT J TRYPTOPHAN RES, V10, DOI 10.1177/1178646917691938; Benchaar C, 2008, ANIM FEED SCI TECH, V145, P209, DOI 10.1016/j.anifeedsci.2007.04.014; Beydoun MA, 2007, AM J CLIN NUTR, V85, P1103; Bowman GL, 2012, NEUROLOGY, V78, P241, DOI 10.1212/WNL.0b013e3182436598; Cervenka I, 2017, SCIENCE, V357, DOI 10.1126/science.aaf9794; Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10; Geng SJ, 2018, J CROHNS COLITIS, V12, P1359, DOI 10.1093/ecco-jcc/jjy103; Gentile CL, 2018, SCIENCE, V362, P776, DOI 10.1126/science.aau5812; Giacobbe S, 2014, BIORESOURCES, V9, P4873; Gika HG, 2012, BIOANALYSIS, V4, P2239, DOI [10.4155/BIO.12.212, 10.4155/bio.12.212]; Guleria S, 2013, SCI WORLD J, DOI 10.1155/2013/790580; He B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10604; Ivarsson E, 2014, ANIMAL, V8, P1777, DOI 10.1017/S1751731114001827; JAEGER KE, 1994, FEMS MICROBIOL REV, V15, P29, DOI 10.1016/0168-6445(94)90025-6; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kurilshikov A, 2019, CIRC RES, V124, P1808, DOI 10.1161/CIRCRESAHA.118.314642; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Larsen JM, 2017, IMMUNOLOGY, V151, P363, DOI 10.1111/imm.12760; Li B, 2013, WATER RES, V47, P4207, DOI 10.1016/j.watres.2013.04.021; Li Q, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051017; Li Y, 2001, Zhong Yao Cai, V24, P572; Lloyd-Price J, 2017, NATURE, V550, P61, DOI 10.1038/nature23889; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mizrahi I, 2021, NAT REV MICROBIOL, V19, P553, DOI 10.1038/s41579-021-00543-6; Moharrery A, 2001, REPROD NUTR DEV, V41, P513, DOI 10.1051/rnd:2001106; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Naber M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13188; Norris SE, 2015, NEUROBIOL AGING, V36, P1659, DOI 10.1016/j.neurobiolaging.2015.01.002; Nuriel-Ohayon M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01031; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Paik SY, 2005, BIOL PHARM BULL, V28, P802, DOI 10.1248/bpb.28.802; Patra AK, 2012, APPL ENVIRON MICROB, V78, P4271, DOI 10.1128/AEM.00309-12; Peng BY, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0253-1; Philippeau C, 2017, J DAIRY SCI, V100, P2637, DOI 10.3168/jds.2016-11663; Rahman NA, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01469; Rinninella E, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010014; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rojo D, 2015, SCI REP-UK, V5, DOI 10.1038/srep08310; Sanna S, 2019, NAT GENET, V51, P600, DOI 10.1038/s41588-019-0350-x; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schrader SM, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abh2037; Seshadri G, 2004, P NATL ACAD SCI USA, V101, P5646, DOI 10.1073/pnas.0307639101; Seshadri R, 2018, NAT BIOTECHNOL, V36, P359, DOI 10.1038/nbt.4110; Shen HS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00732; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Tezuka Y, 2001, J ETHNOPHARMACOL, V77, P209, DOI 10.1016/S0378-8741(01)00300-2; Vecsei L, 2013, NAT REV DRUG DISCOV, V12, P64, DOI 10.1038/nrd3793; Wakabayashi T, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0315-7; Wallace RJ, 2004, P NUTR SOC, V63, P621, DOI 10.1079/PNS2004393; Wang Xiaoxue, 2015, Zhonghua Wei Chang Wai Ke Za Zhi, V18, P1106; Waters JL, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0699-4; Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803; Whiley L, 2014, NEUROBIOL AGING, V35, P271, DOI 10.1016/j.neurobiolaging.2013.08.001; Witte AV, 2014, CEREB CORTEX, V24, P3059, DOI 10.1093/cercor/bht163; Wurtman R, 2015, METABOLISM, V64, pS47, DOI 10.1016/j.metabol.2014.10.034; Xuan QH, 2020, ADV SCI, V7, DOI 10.1002/advs.202001714; Yang YZ, 2019, THERANOSTICS, V9, P4101, DOI 10.7150/thno.35186; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Yu P, 2019, WORLD J MICROB BIOT, V35, DOI 10.1007/s11274-019-2749-z; Zhang YG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109159, 10.1371/journal.pone.0105725, 10.1371/journal.pone.0093458, 10.1371/journal.pone.0088491]; Zhang ZC, 2017, J AGR FOOD CHEM, V65, P3312, DOI 10.1021/acs.jafc.7b01323; Zhou B, 2012, MOL BIOSYST, V8, P470, DOI 10.1039/c1mb05350g; Zhou R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217054	73	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2022	17	8							e0272310	10.1371/journal.pone.0272310	http://dx.doi.org/10.1371/journal.pone.0272310			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5Z1SE	35930558	Green Published, gold			2022-12-26	WOS:000879757700001
J	Badescu, I; Watts, DP; Curteanu, C; Desruelle, KJ; Sellen, DW				Badescu, Iulia; Watts, David P.; Curteanu, Cassandra; Desruelle, Kelly J.; Sellen, Daniel W.			Effects of infant age and sex, and maternal parity on the interaction of lactation with infant feeding development in chimpanzees	PLOS ONE			English	Article							KIBALE-NATIONAL-PARK; LIFE-HISTORY EVOLUTION; PAN-TROGLODYTES-SCHWEINFURTHII; RHESUS MACAQUES; SUCKLING BEHAVIOR; MILK-COMPOSITION; ENERGY-REQUIREMENTS; NONHUMAN-PRIMATES; PATTERNS; INVESTMENT	The interaction between infant feeding and maternal lactational physiology influences female inter-birth intervals and mediates maternal reproductive trade-offs. We investigated variation in feeding development in 72 immature wild chimpanzees (Pan troglodytes schweinfurthii) at Ngogo, Kibale National Park, Uganda, and made inferences about maternal lactation over the course of infancy. We compared the percentage (%) of time that mothers nursed infants as a function of infant age and assessed how hourly rates and bout durations of nursing and foraging varied in association with differences in offspring age, sex, and maternal parity. Nursing % times, rates and durations were highest for infants <= 6 months old but did not change significantly from 6 months to 5 years old. Nursing continued at a decreasing rate for some 5- to 7-year-olds. Infants <= 6 months old foraged little. Foraging rates did not change after 1 year old, but foraging durations and the % time devoted to foraging increased with age. Independent foraging probably became a dietary requirement for infants at 1 year old, when their energy needs may have surpassed the available milk energy. Infants spent as much time foraging by the time they were 4 to 5 years old as adults did. No sex effect on infant nursing or foraging was apparent, but infants of primiparous females had higher foraging rates and spent more time foraging than the infants of multiparous females did. Although no data on milk composition were collected, these findings are consistent with a working hypothesis that like other hominoids, chimpanzee mothers maintained a fixed level of lactation effort over several years as infants increasingly supplemented their growing energy, micronutrient and hydration needs via independent foraging. Plateauing lactation may be a more widespread adaptation that allows hominoid infants time to attain the physiology and skills necessary for independent feeding, while also providing them with a steady dietary base on which they could rely consistently through infancy, and enabling mothers to maintain a fixed, predictable level of lactation effort.	[Badescu, Iulia; Curteanu, Cassandra; Desruelle, Kelly J.] Univ Montreal, Dept Anthropol, Montreal, PQ, Canada; [Watts, David P.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Sellen, Daniel W.] Univ Toronto, Dept Anthropol, Toronto, ON, Canada	Universite de Montreal; Yale University; University of Toronto	Badescu, I (corresponding author), Univ Montreal, Dept Anthropol, Montreal, PQ, Canada.	iulia.badescu@umontreal.ca			L.S.B Leakey Foundation; Explorers Club; Canadian Association for Physical Anthropology; International Primatological Society; Ontario Graduate Scholarship; Natural Sciences and Engineering Research Council; Fonds de Recherche du Quebec-Nature et technologies; University of Toronto; Universite de Montreal	L.S.B Leakey Foundation; Explorers Club; Canadian Association for Physical Anthropology; International Primatological Society; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche du Quebec-Nature et technologies; University of Toronto(University of Toronto); Universite de Montreal	This research was funded by the L.S.B Leakey Foundation (IB), The Explorers Club (IB), Canadian Association for Physical Anthropology (IB), International Primatological Society (IB), Ontario Graduate Scholarship (IB), Natural Sciences and Engineering Research Council (IB), Fonds de Recherche du Que ' bec -Nature et technologies (IB), University of Toronto IB) and Universite ' de Montre ' al (IB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann J, 2005, BEHAV ECOL SOCIOBIOL, V57, P490, DOI 10.1007/s00265-004-0870-x; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Altmann J., 1980, BABOON MOTHERS INFAN; Alvarez HP, 2000, AM J PHYS ANTHROPOL, V113, P435, DOI 10.1002/1096-8644(200011)113:3<435::AID-AJPA11>3.0.CO;2-O; Badescu, 2018, TALKING SPECIES PERS, P165; Badescu I, 2022, BEHAV ECOL SOCIOBIOL, V76, DOI 10.1007/s00265-022-03153-1; Badescu I, 2020, J HUM EVOL, V143, DOI 10.1016/j.jhevol.2020.102794; Badescu I, 2017, AM J PHYS ANTHROPOL, V162, P285, DOI 10.1002/ajpa.23116; Badescu I, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160577; Ball H., 2008, EVOLUTIONARY MED HLT, P226; BARRETT L, 1995, ANIM BEHAV, V49, P805; Barrett L., 2006, REPROD FITNESS BABOO, P199; Boesch C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008901; Bogin B, 2014, ANN HUM BIOL, V41, P368, DOI 10.3109/03014460.2014.923938; BOINSKI S, 1989, ANIM BEHAV, V37, P415, DOI 10.1016/0003-3472(89)90089-4; Borries C, 2014, AM J PHYS ANTHROPOL, V154, P291, DOI 10.1002/ajpa.22511; Bray J, 2018, AM J PHYS ANTHROPOL, V165, P34, DOI 10.1002/ajpa.23325; Butte NF, 2005, PUBLIC HEALTH NUTR, V8, P1010, DOI 10.1079/PHN2005793; Butte NF, 2005, PUBLIC HEALTH NUTR, V8, P953, DOI 10.1079/PHN2005790; Cameron EZ, 1998, ANIM BEHAV, V56, P521, DOI 10.1006/anbe.1998.0793; Cerroni AM, 2003, AM J PHYS ANTHROPOL, V121, P252, DOI 10.1002/ajpa.10238; Chapman CA, 2005, J TROP ECOL, V21, P31, DOI 10.1017/S0266467404001993; CHARNOV EL, 1991, P NATL ACAD SCI USA, V88, P1134, DOI 10.1073/pnas.88.4.1134; Charnov Eric L., 1993, Evolutionary Anthropology, V1, P191, DOI 10.1002/evan.1360010604; Clark C. B., 1977, P235; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Colson SD, 2008, EARLY HUM DEV, V84, P441, DOI 10.1016/j.earlhumdev.2007.12.003; de Passille AMB, 2006, APPL ANIM BEHAV SCI, V101, P264, DOI 10.1016/j.applanim.2006.02.007; DREWETT RF, 1979, EARLY HUM DEV, V3, P315, DOI 10.1016/0378-3782(79)90042-2; Eckardt W, 2016, BEHAV ECOL SOCIOBIOL, V70, P493, DOI 10.1007/s00265-016-2066-6; Eveleth PB, 1990, WORLDWIDE VARIATION; Fahy GE, 2014, AM J PHYS ANTHROPOL, V153, P635, DOI 10.1002/ajpa.22464; FAIRBANKS LA, 1990, ANIM BEHAV, V40, P553, DOI 10.1016/S0003-3472(05)80536-6; Fletcher Alison, 2001, Cambridge Studies in Biological and Evolutionary Anthropology, V27, P153; Foerster Steffen, 2002, P245; German RZ, 1997, J EXP ZOOL, V278, P1, DOI 10.1002/(SICI)1097-010X(19970501)278:1&lt;1::AID-JEZ1&gt;3.0.CO;2-T; Ghisletta P, 2004, J EDUC BEHAV STAT, V29, P421, DOI 10.3102/10769986029004421; GOMENDIO M, 1989, J ZOOL, V217, P449, DOI 10.1111/j.1469-7998.1989.tb02501.x; GOMENDIO M, 1991, ANIM BEHAV, V42, P993, DOI 10.1016/S0003-3472(05)80152-6; GOMENDIO M, 1990, BEHAV ECOL SOCIOBIOL, V27, P365, DOI 10.1007/BF00164008; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; Hawkes K, 2014, HUM NATURE-INT BIOS, V25, P28, DOI 10.1007/s12110-013-9184-x; Hawkes K, 2013, EVOL ANTHROPOL, V22, P294, DOI 10.1002/evan.21382; Hinde K, 2009, AM J PHYS ANTHROPOL, V138, P148, DOI 10.1002/ajpa.20911; Hinde K, 2007, CURR BIOL, V17, pR958, DOI 10.1016/j.cub.2007.09.029; Hinde K, 2007, AM J PRIMATOL, V69, P625, DOI 10.1002/ajp.20373; Hinde K, 2009, AM J HUM BIOL, V21, P512, DOI 10.1002/ajhb.20917; Hinde K, 2011, EVOL ANTHROPOL, V20, P9, DOI 10.1002/evan.20289; Hiraiwa-Hasegawa M., 1990, P277; HOWIE PW, 1982, J REPROD FERTIL, V65, P545, DOI 10.1530/jrf.0.0650545; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; Humphrey LT, 2010, SEMIN CELL DEV BIOL, V21, P453, DOI 10.1016/j.semcdb.2009.11.003; Jaeggi AV, 2008, AM J PRIMATOL, V70, P533, DOI 10.1002/ajp.20525; Johnson RL, 1998, AM J PHYS ANTHROPOL, V105, P33, DOI 10.1002/(SICI)1096-8644(199801)105:1<33::AID-AJPA4>3.0.CO;2-E; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Katzenberg M. Anne, 1995, BODIES EVIDENCE RECO, P221; Kennedy GE, 2005, J HUM EVOL, V48, P123, DOI 10.1016/j.jhevol.2004.09.005; Kramer KL, 2015, J HUM EVOL, V84, P16, DOI 10.1016/j.jhevol.2015.01.009; Kramer KL, 2010, ANNU REV ANTHROPOL, V39, P417, DOI 10.1146/annurev.anthro.012809.105054; Kramer KL, 2005, EVOL ANTHROPOL, V14, P224, DOI 10.1002/evan.20082; Kunkele J, 1997, PHYSIOL ZOOL, V70, P571; Kunkele J, 2000, CAN J ZOOL, V78, P300, DOI 10.1139/cjz-78-2-300; Kuzawa CW, 2012, CURR ANTHROPOL, V53, pS369, DOI 10.1086/667410; Langer P, 2008, ZOOLOGY, V111, P148, DOI 10.1016/j.zool.2007.06.007; Langergraber K, 2009, AM J PRIMATOL, V71, P840, DOI 10.1002/ajp.20711; Lee P. C., 1996, Evolutionary Anthropology, V5, P87, DOI 10.1002/(SICI)1520-6505(1996)5:3<87::AID-EVAN4>3.0.CO;2-T; LEE PC, 1987, J ZOOL, V213, P409, DOI 10.1111/j.1469-7998.1987.tb03717.x; Lee PC, 2012, INT J PRIMATOL, V33, P1309, DOI 10.1007/s10764-011-9536-5; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lipkin EW, 2001, BONE, V29, P249, DOI 10.1016/S8756-3282(01)00508-7; Lonsdorf EV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099099; Lonsdorf EV, 2004, NATURE, V428, P715, DOI 10.1038/428715a; Lwanga JS, 2003, AFR J ECOL, V41, P9, DOI 10.1046/j.1365-2028.2003.00400.x; MARTIN P, 1984, ANIM BEHAV, V32, P1257, DOI 10.1016/S0003-3472(84)80245-6; Matsumoto T, 2017, AM J PHYS ANTHROPOL, V163, P356, DOI 10.1002/ajpa.23212; Motil KJ, 1997, J ADOLESCENT HEALTH, V20, P442, DOI 10.1016/S1054-139X(97)00036-0; Nicolson NA., 1982, WEANING DEV INDEPEND; Paul K, 1996, DEV PSYCHOBIOL, V29, P563, DOI 10.1002/(SICI)1098-2302(199611)29:7<563::AID-DEV2>3.0.CO;2-S; Piperata BA, 2007, AM J HUM BIOL, V19, P722, DOI 10.1002/ajhb.20628; Piperata BA, 2009, AM J HUM BIOL, V21, P817, DOI 10.1002/ajhb.20898; Potts KB., 2013, BUILDING BABIES PRIM, P83; Potts KB, 2015, INT J PRIMATOL, V36, P1101, DOI 10.1007/s10764-015-9880-y; Potts KB, 2011, INT J PRIMATOL, V32, P669, DOI 10.1007/s10764-011-9494-y; PRENTICE AM, 1995, P NUTR SOC, V54, P391, DOI 10.1079/PNS19950008; Prowse TL, 2008, AM J PHYS ANTHROPOL, V137, P294, DOI 10.1002/ajpa.20870; Pusey Anne, 2012, P343; Quinlan RJ, 2005, CURR ANTHROPOL, V46, P471, DOI 10.1086/430017; Rapaport LG, 2008, EVOL ANTHROPOL, V17, P189, DOI 10.1002/evan.20180; Robbins AM, 2006, AM J PHYS ANTHROPOL, V131, P511, DOI 10.1002/ajpa.20474; ROBERTS SB, 1985, AM J CLIN NUTR, V41, P1270, DOI 10.1093/ajcn/41.6.1270; Ross C, 1998, EVOL ANTHROPOL, V6, P54, DOI 10.1002/(SICI)1520-6505(1998)6:2<54::AID-EVAN3>3.3.CO;2-D; Sandel AA, 2021, INT J PRIMATOL, V42, P26, DOI 10.1007/s10764-020-00185-0; Sellen DW, 2009, ADV EXP MED BIOL, V639, P253, DOI 10.1007/978-1-4020-8749-3_18; Sellen DW, 2007, ANNU REV NUTR, V27, P123, DOI 10.1146/annurev.nutr.25.050304.092557; Sellen DW, 2006, SCH AM RES, P155; Smith TM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601517; Smith TM, 2013, P NATL ACAD SCI USA, V110, P2787, DOI 10.1073/pnas.1218746110; Stanton MA, 2020, BEHAV ECOL SOCIOBIOL, V74, DOI 10.1007/s00265-020-2804-7; Stanton MA, 2014, CURR ANTHROPOL, V55, P483, DOI 10.1086/677053; Stearns S.C., 1992, pi; STEWART KJ, 1988, J REPROD FERTIL, V83, P627; Tanaka I, 1997, AM J PRIMATOL, V42, P331, DOI 10.1002/(SICI)1098-2345(1997)42:4<331::AID-AJP8>3.3.CO;2-8; TANAKA I, 1992, ANIM BEHAV, V44, P129, DOI 10.1016/S0003-3472(05)80762-6; Tardif SD, 2001, BEHAV ECOL SOCIOBIOL, V51, P17, DOI 10.1007/s002650100400; Tilden CD, 1997, AM J PRIMATOL, V41, P195; Van Noordwijk MA, 2013, EVOL ANTHROPOL, V22, P202, DOI 10.1002/evan.21368; van Noordwijk MA, 2013, BEHAV ECOL SOCIOBIOL, V67, P805, DOI 10.1007/s00265-013-1504-y; Wakefield ML, 2008, INT J PRIMATOL, V29, P907, DOI 10.1007/s10764-008-9280-7; Wakefield ML, 2013, ANIM BEHAV, V85, P1303, DOI 10.1016/j.anbehav.2013.03.019; Watts DP, 2015, INT J PRIMATOL, V36, P728, DOI 10.1007/s10764-015-9851-3; Watts DP, 2012, AM J PRIMATOL, V74, P130, DOI 10.1002/ajp.21015; Watts DP, 2012, AM J PRIMATOL, V74, P114, DOI 10.1002/ajp.21016; Watts DP, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P244, DOI 10.1017/CBO9780511606397.024; Watts DP, 2002, INT J PRIMATOL, V23, P1, DOI 10.1023/A:1013270606320; WATTS DP, 1985, AM J PRIMATOL, V8, P1, DOI 10.1002/ajp.1350080102; Whittier CA, 2011, ZOO BIOL, V30, P308, DOI 10.1002/zoo.20363; Wood BM, 2017, J HUM EVOL, V105, P41, DOI 10.1016/j.jhevol.2017.01.003; WORLEIN JM, 1988, ANIM BEHAV, V36, P1472, DOI 10.1016/S0003-3472(88)80218-5; Zuur AF, 2009, STAT BIOL HLTH, P269	120	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272139	10.1371/journal.pone.0272139	http://dx.doi.org/10.1371/journal.pone.0272139			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925912	gold, Green Published			2022-12-26	WOS:000848077100073
J	Mekie, M; Bezie, M; Melkie, A; Addisu, D; Chanie, ES; Bayih, WA; Biru, S; Hailie, M; Seid, T; Dagnew, E; Muche, T; Alemu, EM				Mekie, Maru; Bezie, Minale; Melkie, Abenezer; Addisu, Dagne; Chanie, Ermias Sisay; Bayih, Wubet Alebachew; Biru, Shimeles; Hailie, Mekonnen; Seid, Tigist; Dagnew, Enyew; Muche, Tewachew; Alemu, Eshetie Molla			Perception towards preeclampsia and perceived barriers to early health-seeking among pregnant women in selected Hospitals of South Gondar Zone, Northwest Ethiopia: A qualitative study	PLOS ONE			English	Article								Background Preeclampsia is one of the top maternal morbidity and mortality that disproportionately affects pregnant women in low and middle-income countries where access and quality of health services are limited. People in different areas perceive preeclampsia differently which directly or indirectly affects the timing and place of heath seeking. Positive perception about perceived causes, perceived complications, and prevention of preeclampsia is central for the prediction and early diagnosis of the disease. However, little is known about the perception of pregnant women towards preeclampsia in Ethiopia. This study aimed to assess the perception towards preeclampsia and perceived barriers to early health-seeking among pregnant women in selected Hospitals of South Gondar Zone, Northwest Ethiopia. Methods A qualitative study using phenomenological approach was implemented among 20 purposively selected pregnant women who visited health facilities for antenatal care service in four selected Hospitals of the South Gondar Zone of the Amhara Region. Data were collected through an in-depth interview (IDI) using a semi-structured interview guide from January to February 2020. Thematic analysis was executed using Open Code Software version 4.03. Results The majority of the participants believed preeclampsia as a pregnancy-specific hypertensive disease and mainly associated it with overweight and nutritional problems. With regards to the perceived severity, the study participants agreed that preeclampsia can lead women to death. Personal delay, lack of awareness about the disease, transport problem, and low socioeconomic condition were perceived as the major reasons for the delay to early health-seeking (the 1st and the 2nd delay). While poor service provision and long waiting times were the barriers to receive services at the health facility level (the 3rd delay). Conclusion The majority of the participants believed preeclampsia as a pregnancy-specific hypertensive disease and mainly associated it with overweight and nutritional problems. The finding of this study implied that awareness creation about the danger of hypertension during pregnancy and its risk reduction mechanisms shall be emphasized. The care provision at health facilities shall be improved by decreasing long waiting time which discourages service utilizations aside from improving early seeking behavior of pregnant women through different interventions.	[Mekie, Maru; Bezie, Minale; Melkie, Abenezer; Addisu, Dagne; Biru, Shimeles; Hailie, Mekonnen; Seid, Tigist; Dagnew, Enyew; Muche, Tewachew] Debre Tabor Univ, Coll Hlth Sci, Dept Midwifery, Debre Tabor, Ethiopia; [Chanie, Ermias Sisay; Bayih, Wubet Alebachew] Debre Tabor Univ, Coll Hlth Sci, Dept Pediat & Child Hlth Nursing, Debre Tabor, Ethiopia; [Alemu, Eshetie Molla] Debre Tabor Univ, Coll Hlth Sci, Dept Publ Hlth, Debre Tabor, Ethiopia		Mekie, M (corresponding author), Debre Tabor Univ, Coll Hlth Sci, Dept Midwifery, Debre Tabor, Ethiopia.	maru.mekie1@gmail.com	Bayih, Wubet Alebachew/AAF-5099-2019	Bayih, Wubet Alebachew/0000-0003-1439-4402; Mekie, Maru/0000-0001-6022-4717	Debre Tabor University	Debre Tabor University	This study was a part of a multicenter study funded by Debre Tabor University [27]. The funding body had no contribution in data collection, analysis, interpretation, or write-up except covering the finances of the study.	Akeju DO, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0134-z; Akeju DO, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0139-7; Bartsch E, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1753; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P15, DOI 10.4314/ejhs.v24i0.3S; Boene H, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0135-y; Crombag NMTH, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-016-1195-2; Dempsey A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245371; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Gaym A, 2011, INT J GYNECOL OBSTET, V115, P112, DOI 10.1016/j.ijgo.2011.07.012; Gupta S, 2020, J FAM MED PRIM CARE, V9, P2830, DOI 10.4103/jfmpc.jfmpc_200_20; Jabeen M., 2018, MED TODAY, V30; Ka Tunau., 2014, GYNECOLOGY OBSTET, V4; Mekie M, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-03647-2; Mekie M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228127; Mol BJ, 2016, LANCET, V387, P999, DOI 10.1016/S0140-6736(15)00070-7; Musinguzi G, 2018, INT J HYPERTENS, V2018, DOI 10.1155/2018/8307591; Nabulo Harriet, 2021, J Glob Health Rep, V5, DOI 10.29392/001c.19464; Nankali A, 2013, J OBSTET GYN INDIA, V63, P112, DOI 10.1007/s13224-012-0283-0; Noubiap JJ, 2019, J CLIN HYPERTENS, V21, P479, DOI 10.1111/jch.13514; Oberoi Simmi, 2016, J Family Med Prim Care, V5, P463; Pennington KA, 2012, DIS MODEL MECH, V5, P9, DOI 10.1242/dmm.008516; Qureshi RN, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0140-1; Sibai BM, 2012, AM J OBSTET GYNECOL, V206, P470, DOI 10.1016/j.ajog.2011.09.002; Sripad P, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2582-2; Sripad Pooja, 2018, EXPLORING BARRIERS O; Vidler M, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0137-9; Wagnew M, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.supp.2016.25.2.9716; Warren CE, 2020, REPROD HEALTH, V17, DOI 10.1186/s12978-020-0897-0; WHO/RHR, 2013, WHO REC PREV TREATM; Worke MD, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4628-y; [World Health Organization 2013], 2013, WHODCOWHD20132; World Health Organization, 2011, WHO REC PREV TREATM	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271502	10.1371/journal.pone.0271502	http://dx.doi.org/10.1371/journal.pone.0271502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35926064	gold, Green Published			2022-12-26	WOS:000848077100039
J	Sun, LF; Gao, ZY; Hu, ZC; Chen, HY; Cai, JW; Cai, XO				Sun, Lifeng; Gao, Zhongyu; Hu, Zhongchao; Chen, Huyan; Cai, Jianwen; Cai, Xiaoou			Study on the grain refinement mechanism of Mg-Al alloy based on carbon addition	PLOS ONE			English	Article							REFINING MECHANISM; MAGNESIUM ALLOY; HETEROGENEOUS NUCLEATION; PRECIPITATION BEHAVIOR; MICROSTRUCTURE	In this study, a comprehensive treatment process based on the rotary injection of Ar+CO2 Mg-Al alloy melt is proposed. The effect of carbon on the grain refinement of Mg-Al alloy is studied according to the proposed integrated treatment process. The regularity of carbon refinement in the Mg-Al alloy is examined by microstructural observation and theoretical calculation. The results show that carbon has no effect on the grain refinement of Mg-Al alloy when the Al content is less than 1wt.%. However, when the Al content reaches 2 wt.%, the refining effect is obvious, and the grain refinement efficiency is 62%. The refining effect increases with the increase in the Al content, and the refinement efficiency becomes 79% when the Al content reaches 9 wt.%. The size of Al-C-O in the matrix is approximately 5 mu m, which confirms the existence of Al4C3 phase exists as a heterogeneous nucleating agent. The theoretical calculations suggest that the Al4C3 heterogeneous nucleating agent cannot be formed when the Al content in the Mg alloy is less than 1.34%, so there is no thinning effect under such Al content. The crystallographic calculations reveal that the mismatch between the Al4C3 phase and Mg alloy matrix is only 4.05%, and Al4C3 can exist as a heterogeneous nucleating agent for alpha-Mg phase. Combining the measured solidification curves with the classical nucleation theory, the wetting angle of Mg-Al alloy on Al4C3 is calculated to be 24.3 degrees.	[Sun, Lifeng] China Coal Res Inst CCRI, Emergency Res Inst, Beijing, Peoples R China; [Sun, Lifeng] State Key Lab Efficient Min & Clean Utilizat Coal, Beijing, Peoples R China; [Gao, Zhongyu; Hu, Zhongchao; Chen, Huyan; Cai, Jianwen; Cai, Xiaoou] Foshan Polytech, Foshan, Guangdong, Peoples R China		Hu, ZC (corresponding author), Foshan Polytech, Foshan, Guangdong, Peoples R China.	huzhongchao1017@126.com						BELTON GR, 1969, T METALL SOC AIME, V245, P2189; Cao P, 2004, SCRIPTA MATER, V51, P125, DOI 10.1016/j.scriptamat.2004.03.039; Chen XY, 2019, J RARE EARTH, V37, P1351, DOI 10.1016/j.jre.2018.12.014; Chen ZW, 2004, ACTA METALL SIN, V40, P1027; Gao SY., 2011, J JILIN U ENG TECHNO, V46, P1625; Hirst AR, 2004, CHEM-EUR J, V10, P5901, DOI 10.1002/chem.200400502; Hsieh YL, 2012, PHARM RES-DORDR, V29, P2738, DOI 10.1007/s11095-012-0759-8; Hu HQ., 1991, PRINCIPLE METAL SOLI; Jiang ZT, 2016, T NONFERR METAL SOC, V26, P1284, DOI 10.1016/S1003-6326(16)64229-2; Jin QL, 2003, SCRIPTA MATER, V49, P1129, DOI 10.1016/j.scriptamat.2003.07.001; Jing LJ, 2020, JOM-US, V72, P3725, DOI 10.1007/s11837-019-03970-2; Karakulak E, 2019, J MAGNES ALLOY, V7, P355, DOI 10.1016/j.jma.2019.05.001; Kim SH, 2018, J MATER SCI TECHNOL, V34, P265, DOI 10.1016/j.jmst.2017.11.019; Kim YM, 2007, SCRIPTA MATER, V57, P691, DOI 10.1016/j.scriptamat.2007.06.044; [赖春明 Lai Chunming], 2021, [机械工程材料, Materials for Mechanical Engineering], V45, P19; LATOURRETTE T, 1995, EARTH PLANET SC LETT, V135, P13, DOI 10.1016/0012-821X(95)00146-4; Li CB, 2020, J MAGNES ALLOY, V8, P1090, DOI 10.1016/j.jma.2019.12.007; Li PJ, 2005, MATER LETT, V59, P671, DOI 10.1016/j.matlet.2004.11.006; Liu SF, 2006, RARE METAL MAT ENG, V35, P970; Liu Yan-hui, 2003, Chinese Journal of Nonferrous Metals, V13, P622; Liu YH, 2004, MATER LETT, V58, P1282, DOI 10.1016/j.matlet.2003.09.022; Lu L, 2006, SCRIPTA MATER, V54, P2197, DOI 10.1016/j.scriptamat.2006.02.048; Lu L, 2005, SCRIPTA MATER, V53, P517, DOI 10.1016/j.scriptamat.2005.05.008; Makino A, 2012, IEEE T MAGN, V48, P1331, DOI 10.1109/TMAG.2011.2175210; Nasiri Z, 2021, MATER LETT, V296, DOI 10.1016/j.matlet.2021.129880; Pan HC, 2016, J ALLOY COMPD, V663, P321, DOI 10.1016/j.jallcom.2015.12.057; Qian M, 2007, ACTA MATER, V55, P943, DOI 10.1016/j.actamat.2006.09.016; Que ZP, 2021, MATER CHARACT, V171, DOI 10.1016/j.matchar.2020.110758; Rakshith M, 2021, J MAGNES ALLOY, V9, P1692, DOI 10.1016/j.jma.2021.03.019; Saber A, 2018, J ENG MATER-T ASME, V140, DOI 10.1115/1.4039791; Saha S, 2015, INT J METALCAST, V9, P39, DOI 10.1007/BF03356039; Wang J, 2012, MATER DESIGN, V36, P432, DOI 10.1016/j.matdes.2011.11.048; Weiler JP, 2019, J MAGNES ALLOY, V7, P297, DOI 10.1016/j.jma.2019.02.005; [席亚娟 Xi Yajuan], 2014, [热加工工艺, Hot Working Technology], V43, P16; Xiaoshu G., 2021, FORGING STAMPING TEC, V46, P77; Xu TC, 2019, J MAGNES ALLOY, V7, P536, DOI 10.1016/j.jma.2019.08.001; Ye DL., 1981, PRACTICAL INORGANIC, V79, P527; Yin HM, 2018, RARE METAL MAT ENG, V47, P1848; Zhang C, 2020, ANTI-CORROS METHOD M, V67, P31, DOI 10.1108/ACMM-06-2019-2146; Zhang H, 2015, MAT SCI ENG A-STRUCT, V637, P243, DOI 10.1016/j.msea.2015.04.057; Zhang MX, 2005, ACTA MATER, V53, P3261, DOI 10.1016/j.actamat.2005.03.030; 黄诚, 2004, [中国科学. E辑, 技术科学, Science in China], V34, P737	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271583	10.1371/journal.pone.0271583	http://dx.doi.org/10.1371/journal.pone.0271583			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35926058	Green Published, gold			2022-12-26	WOS:000848077100043
J	Udesen, NLJ; Helgestad, OKL; Josiassen, J; Hassager, C; Hojgaard, HF; Linde, L; Kjaergaard, J; Holmvang, L; Jensen, LO; Schmidt, H; Ravn, HB; Moller, JE				Udesen, Nanna Louise Junker; Helgestad, Ole Kristian Lerche; Josiassen, Jakob; Hassager, Christian; Hojgaard, Henrik Frederiksen; Linde, Louise; Kjaergaard, Jesper; Holmvang, Lene; Jensen, Lisette Okkels; Schmidt, Henrik; Ravn, Hanne Berg; Moller, Jacob Eifer			Vasoactive pharmacological management according to SCAI class in patients with acute myocardial infarction and cardiogenic shock	PLOS ONE			English	Article							NOREPINEPHRINE; EPINEPHRINE; DOBUTAMINE; GUIDELINES; ESC	Background Vasoactive treatment is a cornerstone in treating hypoperfusion in cardiogenic shock following acute myocardial infarction (AMICS). The purpose was to compare the achievement of treatment targets and outcome in relation to vasoactive strategy in AMICS patients stratified according to the Society of Cardiovascular Angiography and Interventions (SCAI) shock classification. Methods Retrospective analysis of patients with AMICS admitted to cardiac intensive care unit at two tertiary cardiac centers during 2010-2017 with retrieval of real-time hemodynamic data and dosages of vasoactive drugs from intensive care unit databases. Results Out of 1,249 AMICS patients classified into SCAI class C, D, and E, mortality increased for each shock stage from 34% to 60%, and 82% (p<0.001). Treatment targets of mean arterial blood pressure > 65mmHg and venous oxygen saturation > 55% were reached in the majority of patients; however, more patients in SCAI class D and E had values below treatment targets within 24 hours (p<0.001) despite higher vasoactive load and increased use of epinephrine for each severity stage (p<0.001). In univariate analysis no significant difference in mortality within SCAI class D and E regarding vasoactive strategy was observed, however in SCAI class C, epinephrine was associated with higher mortality and a significantly higher vasoactive load to reach treatment targets. In multivariate analysis there was no statistically association between individually vasoactive choice within each SCAI class and 30-day mortality. Conclusion Hemodynamic treatment targets were achieved in most patients at the expense of increased vasoactive load and more frequent use of epinephrine for each shock severity stage. Mortality was high regardless of vasoactive strategy; only in SCAI class C, epinephrine was associated with a significantly higher mortality, but the signal was not significant in adjusted analysis.	[Udesen, Nanna Louise Junker; Helgestad, Ole Kristian Lerche; Linde, Louise; Jensen, Lisette Okkels; Moller, Jacob Eifer] Odense Univ Hosp, Dept Cardiol, Odense, Denmark; [Josiassen, Jakob; Hassager, Christian; Kjaergaard, Jesper; Holmvang, Lene; Moller, Jacob Eifer] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark; [Hojgaard, Henrik Frederiksen; Schmidt, Henrik; Ravn, Hanne Berg] Odense Univ Hosp, Dept Cardiothorac Anesthesia, Odense, Denmark	University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Udesen, NLJ (corresponding author), Odense Univ Hosp, Dept Cardiol, Odense, Denmark.	Nanna.louise.junker.udesen@rsyd.dk	Ravn, Hanne Berg/K-3118-2016	Ravn, Hanne Berg/0000-0003-4702-5195; Linde, Louise/0000-0002-7757-2571; Udesen, Nanna Louise Junker/0000-0003-1542-3260; Hassager, Christian/0000-0002-1199-0981; Jensen, Lisette Okkels/0000-0002-4838-2429	Abiomed; Danish Heart association; University of Southern Denmark; Region of Southern Denmark	Abiomed; Danish Heart association; University of Southern Denmark; Region of Southern Denmark	JEM received a research grant from Abiomed and the Danish Heart association. NLJU received funding from the University of Southern Denmark and Region of Southern Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baran DA, 2019, CATHETER CARDIO INTE, V94, P29, DOI 10.1002/ccd.28329; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Follath F, 2011, INTENS CARE MED, V37, P619, DOI 10.1007/s00134-010-2113-0; Hanson ID, 2020, CATHETER CARDIO INTE, V96, P1137, DOI 10.1002/ccd.29139; Helgestad OKL, 2019, EUR J HEART FAIL, V21, P1370, DOI 10.1002/ejhf.1566; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393; Jentzer JC, 2019, J AM COLL CARDIOL, V74, P2117, DOI 10.1016/j.jacc.2019.07.077; Jentzer JC, 2020, SHOCK, V53, P452, DOI 10.1097/SHK.0000000000001390; Koponen T, 2019, BRIT J ANAESTH, V122, P428, DOI 10.1016/j.bja.2018.12.019; Leopold V, 2018, INTENS CARE MED, V44, P847, DOI 10.1007/s00134-018-5222-9; Levy B, 2008, SHOCK, V30, P417, DOI 10.1097/SHK.0b013e318167378f; Levy B, 2018, J AM COLL CARDIOL, V72, P173, DOI 10.1016/j.jacc.2018.04.051; Levy B, 2011, CRIT CARE MED, V39, P450, DOI 10.1097/CCM.0b013e3181ffe0eb; Mathew R, 2021, NEW ENGL J MED, V385, P516, DOI 10.1056/NEJMoa2026845; McDonagh TA, 2021, EUR HEART J, V42, P3599, DOI 10.1093/eurheartj/ehab368; Mebazaa A, 2007, JAMA-J AM MED ASSOC, V297, P1883, DOI 10.1001/jama.297.17.1883; Myburgh JA, 2008, INTENS CARE MED, V34, P2226, DOI 10.1007/s00134-008-1219-0; Naidu SS, 2022, J AM COLL CARDIOL, V79, P933, DOI 10.1016/j.jacc.2022.01.018; Pirracchio R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071659; Rohm CL, 2019, AM J CARDIOL, V124, P499, DOI 10.1016/j.amjcard.2019.05.039; Rui Q, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008402; Schrage B, 2020, CATHETER CARDIO INTE, V96, pE213, DOI 10.1002/ccd.28707; Schreiber W, 2002, RESUSCITATION, V55, P269, DOI 10.1016/S0300-9572(02)00266-6; Shah M, 2018, CLIN RES CARDIOL, V107, P287, DOI 10.1007/s00392-017-1182-2; Spinar J, 2011, CRIT CARE, V15, DOI 10.1186/cc10584; Tarvasmaki T, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1387-1; Thiele H, 2019, EUR HEART J, V40, P2671, DOI 10.1093/eurheartj/ehz363; Thygesen K, 2018, KARDIOL POL, V76, P1383, DOI [10.5603/KP.2018.0203, 10.1016/j.gheart.2018.08.004, 10.1161/CIR.0000000000000617]; Udesen NLJ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2816-8; van Diepen S, 2017, CIRCULATION, V136, pE232, DOI 10.1161/CIR.0000000000000525; Zotzmann V, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2605-4	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272279	10.1371/journal.pone.0272279	http://dx.doi.org/10.1371/journal.pone.0272279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925990	Green Published, gold			2022-12-26	WOS:000848077100080
J	Hoogerbrugge, AA; Strauch, CS; Olah, Z; Dalmaijer, E; Nijboer, TCW; van der Stigchel, S; Kasneci, E				Hoogerbrugge, Alex A.; Strauch, Christoph S.; Olah, Zoril; Dalmaijer, Edwin; Nijboer, Tanja C. W.; van der Stigchel, Stefan; Kasneci, Enkelejda			Seeing the Forrest through the trees: Oculomotor metrics are linked to heart rate	PLOS ONE			English	Article							MICROSACCADES; DIFFICULTY; VELOCITY	Fluctuations in a person's arousal accompany mental states such as drowsiness, mental effort, or motivation, and have a profound effect on task performance. Here, we investigated the link between two central instances affected by arousal levels, heart rate and eye movements. In contrast to heart rate, eye movements can be inferred remotely and unobtrusively, and there is evidence that oculomotor metrics (i.e., fixations and saccades) are indicators for aspects of arousal going hand in hand with changes in mental effort, motivation, or task type. Gaze data and heart rate of 14 participants during film viewing were used in Random Forest models, the results of which show that blink rate and duration, and the movement aspect of oculomotor metrics (i.e., velocities and amplitudes) link to heart rate-more so than the amount or duration of fixations and saccades. We discuss that eye movements are not only linked to heart rate, but they may both be similarly influenced by the common underlying arousal system. These findings provide new pathways for the remote measurement of arousal, and its link to psychophysiological features.	[Hoogerbrugge, Alex A.; Strauch, Christoph S.; Olah, Zoril; Nijboer, Tanja C. W.; van der Stigchel, Stefan] Univ Utrecht, Expt Psychol Helmholtz Inst, Utrecht, Netherlands; [Dalmaijer, Edwin] Univ Bristol, Sch Psychol Sci, Bristol, Gloucestershire, England; [Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, UMC Utrecht Brain Ctr, Hoogstraat Rehabil, Utrecht, Netherlands; [Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Dept Rehabil, Phys Therapy Sci & Sports, Utrecht, Netherlands	Utrecht University; University of Bristol; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Hoogerbrugge, AA (corresponding author), Univ Utrecht, Expt Psychol Helmholtz Inst, Utrecht, Netherlands.	a.j.hoogerbrugge@uu.nl	; Dalmaijer, Edwin/I-4279-2019	Hoogerbrugge, Alex/0000-0002-2859-5128; Strauch, Christoph/0000-0002-6380-8635; Dalmaijer, Edwin/0000-0003-3241-0760	ERC [ERC-CoG-863732]	ERC(European Research Council (ERC)European Commission)	The authors would like to thank Roy Hessels for his input regarding fixation detection.	Altmann A, 2010, BIOINFORMATICS, V26, P1340, DOI 10.1093/bioinformatics/btq134; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Borji A, 2014, J VISION, V14, DOI 10.1167/14.3.29; Buswell Guy Thomas, 1935, PEOPLE LOOK PICTURES; Charles RL, 2019, APPL ERGON, V74, P221, DOI 10.1016/j.apergo.2018.08.028; Di Stasi LL, 2013, NEUROSCI BIOBEHAV R, V37, P968, DOI 10.1016/j.neubiorev.2013.03.011; Di Stasi LL, 2010, AVIAT SPACE ENVIR MD, V81, P413, DOI 10.3357/ASEM.2579.2010; Duchowski AT, 2020, IEEE T VIS COMPUT GR, V26, P2904, DOI 10.1109/TVCG.2019.2901881; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Hanke M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.92; Hanke M, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.3; HART S G, 1988, P139; Hayes TR, 2016, BEHAV RES METHODS, V48, P510, DOI 10.3758/s13428-015-0588-x; Henderson J. M., 1998, EYE GUIDANCE READING, P269, DOI [10.1016/B978-008043361-5/50013-4, DOI 10.1016/B978-008043361-5/50013-4, 10.1016/b978-008043361-5/50013-4]; Hessels RS, 2020, ATTEN PERCEPT PSYCHO, V82, P2482, DOI 10.3758/s13414-019-01952-9; Hessels RS, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180502; Hooge ITC, 2022, BEHAV RES METHODS, DOI 10.3758/s13428-021-01723-1; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Kazmi SZH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157557; Kootstra T, 2020, J VISION, V20, DOI 10.1167/jov.20.9.1; Kosch T, 2018, PROCEEDINGS OF THE 2018 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2018), DOI 10.1145/3173574.3174010; Maffei A, 2019, PHYSIOL BEHAV, V204, P256, DOI 10.1016/j.physbeh.2019.02.037; Mather M, 2017, NEUROIMAGE, V150, P329, DOI 10.1016/j.neuroimage.2017.02.025; Mills M, 2011, J VISION, V11, DOI 10.1167/11.8.17; Muhammed K, 2020, CORTEX, V122, P198, DOI 10.1016/j.cortex.2018.12.001; Nakano T, 2017, INT J PSYCHOPHYSIOL, V121, P56, DOI 10.1016/j.ijpsycho.2017.09.003; Ohl S, 2016, J NEUROSCI, V36, P1237, DOI 10.1523/JNEUROSCI.2211-15.2016; Paas F, 2003, EDUC PSYCHOL-US, V38, P63, DOI 10.1207/S15326985EP3801_8; Pastukhov A, 2010, VISION RES, V50, P1173, DOI 10.1016/j.visres.2010.04.007; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rolfs M, 2009, VISION RES, V49, P2415, DOI 10.1016/j.visres.2009.08.010; Siegenthaler E, 2014, EUR J NEUROSCI, V39, P287, DOI 10.1111/ejn.12395; Strauch C, 2022, TRENDS NEUROSCI, V45, P635, DOI 10.1016/j.tins.2022.05.003; Strauch C, 2021, J VISION, V21, DOI 10.1167/jov.21.7.6; TEIGEN KH, 1994, THEOR PSYCHOL, V4, P525, DOI 10.1177/0959354394044004; Van Gent P, 2018, PROC 6 HUMMANIST C, V13, P13; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Vo MLH, 2015, ANN NY ACAD SCI, V1339, P72, DOI 10.1111/nyas.12667; Williamson A, 2011, ACCIDENT ANAL PREV, V43, P498, DOI 10.1016/j.aap.2009.11.011; WOOD JG, 1983, PSYCHOPHYSIOLOGY, V20, P18, DOI 10.1111/j.1469-8986.1983.tb00893.x; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	42	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272349	http://dx.doi.org/10.1371/journal.pone.0272349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917377	gold, Green Published			2022-12-26	WOS:000837840000004
J	Kaizer, A; Zabor, E; Nie, L; Hobbs, B				Kaizer, Alexander; Zabor, Emily; Nie, Lei; Hobbs, Brian			Bayesian and frequentist approaches to sequential monitoring for futility in oncology basket trials: A comparison of Simon's two-stage design and Bayesian predictive probability monitoring with information sharing across baskets	PLOS ONE			English	Article							CLINICAL-TRIALS; MASTER PROTOCOLS; SOLID TUMORS; PRIORS	This article discusses and compares statistical designs of basket trial, from both frequentist and Bayesian perspectives. Baskets trials are used in oncology to study interventions that are developed to target a specific feature (often genetic alteration or immune phenotype) that is observed across multiple tissue types and/or tumor histologies. Patient heterogeneity has become pivotal to the development of non-cytotoxic treatment strategies. Treatment targets are often rare and exist among several histologies, making prospective clinical inquiry challenging for individual tumor types. More generally, basket trials are a type of master protocol often used for label expansion. Master protocol is used to refer to designs that accommodates multiple targets, multiple treatments, or both within one overarching protocol. For the purpose of making sequential decisions about treatment futility, Simon's two-stage design is often embedded within master protocols. In basket trials, this frequentist design is often applied to independent evaluations of tumor histologies and/or indications. In the tumor agnostic setting, rarer indications may fail to reach the sample size needed for even the first evaluation for futility. With recent innovations in Bayesian methods, it is possible to evaluate for futility with smaller sample sizes, even for rarer indications. Novel Bayesian methodology for a sequential basket trial design based on predictive probability is introduced. The Bayesian predictive probability designs allow interim analyses with any desired frequency, including continual assessments after each patient observed. The sequential design is compared with and without Bayesian methods for sharing information among a collection of discrete, and potentially non-exchangeable tumor types. Bayesian designs are compared with Simon's two-stage minimax design.	[Kaizer, Alexander] Univ Colorado Anschutz Med Campus, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO 80045 USA; [Zabor, Emily] Cleveland Clin, Dept Quantitat Hlth Sci & Taussig Canc Inst, Cleveland, OH USA; [Nie, Lei] USFood & Drug Adm, Ctr Drug Evaluat & Res, Div Biometr 2, Off Biostat, Silver Spring, MD USA; [Hobbs, Brian] Univ Texas Austin, Dept Populat Hlth, Austin, TX USA	Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Cleveland Clinic Foundation; US Food & Drug Administration (FDA); University of Texas System; University of Texas Austin	Kaizer, A (corresponding author), Univ Colorado Anschutz Med Campus, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO 80045 USA.	alex.kaizer@cuanschutz.edu		Kaizer, Alexander/0000-0003-2334-5514	National Institutes of Health [P30 CA016672, K01 HL151754]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This manuscript reflects the views of the authors and should not be construed to represent FDA's views or policies. We would like to thank Nan Chen for his assistance in developing some of the code for simulations.	Al Baghdadi T, 2020, TARGET ONCOL, V15, P743, DOI 10.1007/s11523-020-00752-8; Beckman RA, 2016, CLIN PHARMACOL THER, V100, P617, DOI 10.1002/cpt.446; Chen N., 2021, BASKET BASKET TRIAL, V11; Chen N, 2018, COMPUT STAT DATA AN, V127, P50, DOI 10.1016/j.csda.2018.05.002; Chu YY, 2018, CLIN TRIALS, V15, P149, DOI 10.1177/1740774518755122; Coyne GO, 2017, CURR PROB CANCER, V41, P182, DOI 10.1016/j.currproblcancer.2017.02.001; Cunanan KM, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00181; Cunanan KM, 2017, STAT MED, V36, P1568, DOI 10.1002/sim.7227; Cunanan KM, 2017, J CLIN ONCOL, V35, P271, DOI 10.1200/JCO.2016.69.9751; De Santis F, 2006, AM STAT, V60, P122, DOI 10.1198/000313006X109269; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Dmitrienko A, 2006, STAT MED, V25, P2178, DOI 10.1002/sim.2204; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fisher JG, 2020, TARGET ONCOL, V15, P733, DOI 10.1007/s11523-020-00753-7; Food and Drug Administration, 2020, INTERACTING FDA COMP; Hallek M, 2018, BLOOD, V131, P2745, DOI 10.1182/blood-2017-09-806398; Hobbs BP, 2018, ANN ONCOL, V29, P2296, DOI 10.1093/annonc/mdy457; Hobbs BP, 2019, JNCI-J NATL CANCER I, V111, P118, DOI 10.1093/jnci/djy196; Hobbs BP, 2018, STAT MED, V37, P3557, DOI 10.1002/sim.7893; Hobbs BP, 2018, STAT METHODS MED RES, V27, P65, DOI 10.1177/0962280215620696; Hobbs BP, 2016, J R STAT SOC C-APPL, V65, P273, DOI 10.1111/rssc.12117; Hobbs BP, 2013, CLIN TRIALS, V10, P430, DOI 10.1177/1740774513483934; Hobbs BP, 2012, BAYESIAN ANAL, V7, P639, DOI 10.1214/12-BA722; Hyman DM, 2018, NATURE, V554, P189, DOI 10.1038/nature25475; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Ibrahim JG, 2000, STAT SCI, V15, P46; Jin J, 2020, STAT MED, V39, P3459, DOI 10.1002/sim.8675; Kaizer AM, 2021, STAT METHODS MED RES, V30, P785, DOI 10.1177/0962280220975187; Kaizer Alexander M, 2019, JCO Precis Oncol, V3, P1, DOI 10.1200/PO.19.00194; Kaizer AM, 2018, BIOMETRICS, V74, P1082, DOI 10.1111/biom.12841; Kaizer AM, 2018, BIOSTATISTICS, V19, P169, DOI 10.1093/biostatistics/kxx031; Kane M.J., 2021, R J, V12, P342, DOI [DOI 10.32614/RJ, 10.32614/RJ-2021-020]; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Looney AM, 2020, NAT REV DRUG DISCOV, V19, P383, DOI 10.1038/d41573-020-00015-1; McNeil C, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv193; Mitchell P, 2018, BIOM BIOSTAT INT J, V7, P299; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Offin Michael, 2018, Am Soc Clin Oncol Educ Book, V38, P184, DOI 10.1200/EDBK_200831; Pestana RC, 2020, NAT REV CLIN ONCOL, V17, P555, DOI 10.1038/s41571-020-0384-0; Poh A, 2017, CANCER DISCOV, V7, P656, DOI 10.1158/2159-8290.CD-NB2017-078; Prowell TM, 2016, NEW ENGL J MED, V374, P2001, DOI 10.1056/NEJMp1603747; Renfro LA, 2017, ANN ONCOL, V28, P34, DOI 10.1093/annonc/mdw413; Rietbergen C, 2011, CONTEMP CLIN TRIALS, V32, P848, DOI 10.1016/j.cct.2011.06.002; Saville BR, 2014, CLIN TRIALS, V11, P485, DOI 10.1177/1740774514531352; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; Simon R, 2018, J BIOPHARM STAT, V28, P245, DOI 10.1080/10543406.2017.1372779; Simon R, 2016, SEMIN ONCOL, V43, P13, DOI 10.1053/j.seminoncol.2016.01.002; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Woodcock J, 2017, NEW ENGL J MED, V377, P62, DOI 10.1056/NEJMra1510062; Zabor EC., 2021, SEQUENTIAL POSTERIOR; Zheng HY, 2022, BIOSTATISTICS, V23, P120, DOI 10.1093/biostatistics/kxaa019; Zhou TJ, 2021, BIOSTATISTICS, V22, P897, DOI 10.1093/biostatistics/kxaa005	53	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272367	http://dx.doi.org/10.1371/journal.pone.0272367			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917296	Green Published, gold			2022-12-26	WOS:000837840000029
J	Artan, M; Hartl, M; Chen, WQ; De Bono, M				Artan, Murat; Hartl, Markus; Chen, Weiqiang; De Bono, Mario			Depletion of endogenously biotinylated carboxylases enhances the sensitivity of TurboID-mediated proximity labeling in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; PLATFORM	Proximity-dependent protein labeling provides a powerful in vivo strategy to characterize the interactomes of specific proteins. We previously optimized a proximity labeling protocol for Caenorhabditis elegans using the highly active biotin ligase TurboID. A significant constraint on the sensitivity of TurboID is the presence of abundant endogenously biotinylated proteins that take up bandwidth in the mass spectrometer, notably carboxylases that use biotin as a cofactor. In C. elegans, these comprise POD-2/acetyl-CoA carboxylase alpha, PCCA-1/propionyl-CoA carboxylase alpha, PYC-1/pyruvate carboxylase, and MCCC-1/methylcrotonyl-CoA carboxylase alpha. Here, we developed ways to remove these carboxylases prior to streptavidin purification and mass spectrometry by engineering their corresponding genes to add a C-terminal His(10) tag. This allows us to deplete them from C. elegans lysates using immobilized metal affinity chromatography. To demonstrate the method's efficacy, we use it to expand the interactome map of the presynaptic active zone protein ELKS-1. We identify many known active zone proteins, including UNC-10/RIM, SYD-2/liprin-alpha, SAD-1/BRSK1, CLA-1/CLArinet, C16E9.2/Sentryn, as well as previously uncharacterized potentially synaptic proteins such as the ortholog of human angiomotin, F59C12.3 and the uncharacterized protein R148.3. Our approach provides a quick and inexpensive solution to a common contaminant problem in biotin-dependent proximity labeling. The approach may be applicable to other model organisms and will enable deeper and more complete analysis of interactors for proteins of interest.	[Artan, Murat; De Bono, Mario] Inst Sci & Technol Austria ISTA, Klosterneuburg, Austria; [Hartl, Markus; Chen, Weiqiang] Max Perutz Labs, Mass Spectrometry Facil, Vienna Biocenter VBC, Vienna, Austria	Institute of Science & Technology - Austria; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Artan, M; De Bono, M (corresponding author), Inst Sci & Technol Austria ISTA, Klosterneuburg, Austria.	martan@ista.ac.at; mdebono@ista.ac.at	Hartl, Markus/F-2866-2010	Hartl, Markus/0000-0002-4970-7336	Wellcome Investigator Award [209504/Z/17/Z, 754411]	Wellcome Investigator Award	This work was supported by a Wellcome Investigator Award (grant no.: 209504/Z/17/Z) to M.d.B. and an ISTplus Fellowship to M.A. (Marie Sklodowska-Curie agreement no.: 754411).	Andjelkovic U, 2017, HBK SEPART SCI, P107, DOI 10.1016/B978-0-12-805392-8.00005-0; Artan M, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101094; Bastos P, 2017, TALANTA, V170, P81, DOI 10.1016/j.talanta.2017.03.087; Bosch JA, 2021, WIRES DEV BIOL, V10, DOI 10.1002/wdev.392; Branon TC, 2018, NAT BIOTECHNOL, V36, P880, DOI 10.1038/nbt.4201; BRENNER S, 1974, GENETICS, V77, P71; Chen BJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01704-z; Chen Weiqiang, 2022, Zenodo, DOI 10.5281/ZENODO.6417139; Cho KF, 2020, NAT PROTOC, V15, P3971, DOI 10.1038/s41596-020-0399-0; Dionne U, 2022, FRONT MOL BIOSCI, V9, DOI 10.3389/fmolb.2022.852911; Fountoulakis M, 2004, AMINO ACIDS, V27, P249, DOI 10.1007/s00726-004-0141-1; Ghanta KS, 2020, GENETICS, V216, P643, DOI 10.1534/genetics.120.303564; Hollenstein D., 2022, PROTOCOLSIO, DOI [10.17504/protocols.io.b3sqqndw, DOI 10.17504/PROTOCOLS.IO.B3SQQNDW]; Holzer Elisabeth, 2022, PLoS Genet, V18, pe1010150, DOI 10.1371/journal.pgen.1010150; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Kuljanin M, 2017, BIOMATERIALS, V144, P130, DOI 10.1016/j.biomaterials.2017.08.012; Lavie J, 2018, CELL REP, V23, P2852, DOI 10.1016/j.celrep.2018.05.013; Liumbruno G, 2010, J PROTEOMICS, V73, P483, DOI 10.1016/j.jprot.2009.06.010; Malhotra A, 2009, METHOD ENZYMOL, V463, P239, DOI 10.1016/S0076-6879(09)63016-0; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Mock DM, 2017, J NUTR, V147, P1487, DOI 10.3945/jn.116.238956; Mullen GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040095; Natarajan SS, 2009, ANAL BIOCHEM, V394, P259, DOI 10.1016/j.ab.2009.07.048; Niinae T, 2021, J BIOCHEM, V170, P569, DOI 10.1093/jb/mvab123; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Qin W, 2021, NAT METHODS, V18, P133, DOI 10.1038/s41592-020-01010-5; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Roy-Bellavance C, 2017, G3-GENES GENOM GENET, V7, P2739, DOI 10.1534/g3.117.041681; S. Didusch, 2021, bioRxiv, DOI 10.1101/2021.11.23.466958; Sanchez AD, 2021, CURR BIOL, V31, P3586, DOI 10.1016/j.cub.2021.06.021; Schlager B, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-95; Seath CP, 2021, CHEM SOC REV, V50, P2911, DOI 10.1039/d0cs01366h; Shi BX, 2014, INT J MOL SCI, V15, P22918, DOI 10.3390/ijms151222918; SUZUKI H, 1988, ANAL BIOCHEM, V172, P259, DOI 10.1016/0003-2697(88)90440-X; Tong L, 2013, CELL MOL LIFE SCI, V70, P863, DOI 10.1007/s00018-012-1096-0; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Watts JS, 2018, J BIOL CHEM, V293, P610, DOI [10.1074/jbc.m117.798553, 10.1074/jbc.M117.798553]; Wigerius M, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.abc0635; Wigerius M, 2018, J CELL BIOL, V217, P715, DOI 10.1083/jcb.201705184; Zhang LY, 2015, DEVELOPMENT, V142, P4374, DOI 10.1242/dev.129635	42	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102343	10.1016/j.jbc.2022.102343	http://dx.doi.org/10.1016/j.jbc.2022.102343			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6F7ME	35933017	Green Published, gold			2022-12-26	WOS:000884241800011
J	She, YM; Klupt, K; Hatfield, G; Jia, ZC; Tam, RY				She, Yi-Min; Klupt, Kody; Hatfield, Grayson; Jia, Zongchao; Tam, Roger Y.			Unusual beta 1-4-galactosidase activity of an alpha 1-6-mannosidase from Xanthomonas manihotis in the processing of branched hybrid and complex glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-MANNOSIDASE-II; BETA-GALACTOSIDASE; GLYCOSYLATION; SIALYLGLYCOPEPTIDE; SPECIFICITY; CELLS	Mannosidases are a diverse group of glycoside hydrolases that play crucial roles in mannose trimming of oligomannose glycans, glycoconjugates, and glycoproteins involved in numerous cellular processes, such as glycan biosynthesis and metabolism, structure regulation, cellular recognition, and cell-pathogen interactions. Exomannosidases and endomannosidases cleave specific glycosidic bonds of mannoside linkages in glycans and can be used in enzyme-based methods for sequencing of isomeric glycan structures. alpha 1-6-mannosidase from Xanthomonas manihotis is known as a highly specific exoglycosidase that removes unbranched alpha 1-6 linked mannose residues from oligosaccharides. However, we discovered that this alpha 1-6-mannosidase also possesses an unexpected beta 1-4-galactosidase activity in the processing of branched hybrid and complex glycans through our use of enzymatic reactions, high performance anion-exchange chromatography, and liquid chromatography mass spectrometric sequencing. Our docking simulation of the alpha 1-6-mannosidase with glycan substrates reveals potential interacting residues in a relatively shallow pocket slightly differing from its homologous enzymes in the glycoside hydrolase 125 family, which may be responsible for the observed higher promiscuity in substrate binding and subsequent terminal glycan hydrolysis. This observation of novel beta 1-4-galactosidase activity of the alpha 1-6-mannosidase provides unique insights into its bifunctional activity on the substrate structure-dependent processing of terminal alpha 1-6-mannose of unbranched glycans and terminal beta 1-4-galactose of hybrid and complex glycans. The finding thus suggests the dual glycosidase specificity of this alpha 1-6-mannosidase and the need for careful consideration when used for the structural elucidation of glycan isomers.	[She, Yi-Min; Hatfield, Grayson; Tam, Roger Y.] Hlth Canada, Ctr Biol Evaluat, Biol & Radiopharmaceut Drugs Directorate, Ottawa, ON, Canada; [Klupt, Kody; Jia, Zongchao] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Health Canada; Queens University - Canada	Tam, RY (corresponding author), Hlth Canada, Ctr Biol Evaluat, Biol & Radiopharmaceut Drugs Directorate, Ottawa, ON, Canada.	roger.tam@hc-sc.gc.ca		She, Yi-Min/0000-0002-0571-4630	Government of Canada	Government of Canada(CGIAR)	We are grateful to Drs Sean Li, Yves Aubin, Simon Sauve, and Michael Rosu-Myles for critical reading and comments of the article. This work was funded by the Government of Canada.	Alonso-Gil S, 2017, J AM CHEM SOC, V139, P1085, DOI 10.1021/jacs.6b11247; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Athanasopoulos VI, 2004, J MOL CATAL B-ENZYM, V27, P215, DOI 10.1016/j.molcatb.2003.12.001; Bardor M, 2003, GLYCOBIOLOGY, V13, P427, DOI 10.1093/glycob/cwg024; BAZZOLI F, 1995, GASTROENTEROLOGY, V109, P783, DOI 10.1016/0016-5085(95)90385-2; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Calderon AD, 2017, ORG BIOMOL CHEM, V15, P7258, DOI 10.1039/c7ob01765k; Chao Q, 2020, FRONT CHEM, V8, DOI 10.3389/fchem.2020.00513; Coelho V, 2010, P NATL ACAD SCI USA, V107, P18587, DOI 10.1073/pnas.1009388107; Corbeil CR, 2012, J COMPUT AID MOL DES, V26, P775, DOI 10.1007/s10822-012-9570-1; Dupoiron S, 2015, J BIOL CHEM, V290, P6022, DOI 10.1074/jbc.M114.624593; Frappaolo A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122652; Goetze AM, 2011, GLYCOBIOLOGY, V21, P949, DOI 10.1093/glycob/cwr027; Gregg KJ, 2011, J BIOL CHEM, V286, P15586, DOI 10.1074/jbc.M111.223172; Hamilton BS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15891-8; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hollister J, 2002, BIOCHEMISTRY-US, V41, P15093, DOI 10.1021/bi026455d; Juers DH, 2000, PROTEIN SCI, V9, P1685, DOI 10.1110/ps.9.9.1685; Juers DH, 2012, PROTEIN SCI, V21, P1792, DOI 10.1002/pro.2165; Kato A, 2005, J MED CHEM, V48, P2036, DOI 10.1021/jm0495881; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Klamer Z, 2019, MOL CELL PROTEOMICS, V18, P28, DOI 10.1074/mcp.RA118.000906; Koizumi A, 2013, ANGEW CHEM INT EDIT, V52, P7426, DOI 10.1002/anie.201301613; Ladeveze S, 2017, BIOL REV, V92, P1969, DOI 10.1111/brv.12316; Lalonde ME, 2017, J BIOTECHNOL, V251, P128, DOI 10.1016/j.jbiotec.2017.04.028; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Liu L, 2017, CARBOHYD RES, V452, P122, DOI 10.1016/j.carres.2017.10.001; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mathew C, 2021, RSC CHEM BIOL, V2, P917, DOI 10.1039/d1cb00019e; Palacpac NQ, 1999, P NATL ACAD SCI USA, V96, P4692, DOI 10.1073/pnas.96.8.4692; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Schiller B, 2012, BIOL CHEM, V393, P661, DOI 10.1515/hsz-2012-0150; Shah N, 2008, P NATL ACAD SCI USA, V105, P9570, DOI 10.1073/pnas.0802206105; She YM, 2020, ANAL CHEM, V92, P14038, DOI 10.1021/acs.analchem.0c02951; Song T, 2014, ANAL CHEM, V86, P5661, DOI 10.1021/ac501102t; Sun BY, 2014, CARBOHYD RES, V396, P62, DOI 10.1016/j.carres.2014.07.013; Toonstra C, 2018, BIOCONJUGATE CHEM, V29, P1911, DOI 10.1021/acs.bioconjchem.8b00145; van Heteren J., 2020, CARBOHYDRATES DRUG D, P383; VANDENEIJNDEN DH, 1986, CARBOHYD RES, V151, P329, DOI 10.1016/S0008-6215(00)90352-5; Wang LT, 2021, AUTOPHAGY, V17, P4202, DOI 10.1080/15548627.2021.1907516; Wang T, 2014, PROTEIN PEPTIDE LETT, V21, P976, DOI 10.2174/0929866521666140626111237; Ward BJ, 2014, VACCINE, V32, P6098, DOI [10.1016/j.vaccine.2014.08.079, 10.10]; WONGMADDEN ST, 1995, GLYCOBIOLOGY, V5, P19, DOI 10.1093/glycob/5.1.19; Zhong W, 2008, J AM CHEM SOC, V130, P8975, DOI 10.1021/ja711248y	46	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102313	10.1016/j.jbc.2022.102313	http://dx.doi.org/10.1016/j.jbc.2022.102313			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9EO	35921895	gold, Green Published			2022-12-26	WOS:000863182500006
J	Yu, YQ; Ma, ZJ; Pacalon, J; Xu, L; Li, WH; Belloir, C; Topin, J; Briand, L; Golebiowski, J; Cong, XJ				Yu, Yiqun; Ma, Zhenjie; Pacalon, Jody; Xu, Lun; Li, Weihao; Belloir, Christine; Topin, Jeremie; Briand, Loic; Golebiowski, Jerome; Cong, Xiaojing			Extracellular loop 2 of G protein-coupled olfactory receptors is critical for odorant recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; BINDING; PREDICTION; MECHANISM; DOCKING; SITE	G protein-coupled olfactory receptors (ORs) enable us to detect innumerous odorants. They are also ectopically expressed in nonolfactory tissues and emerging as attractive drug targets. ORs can be promiscuous or highly specific, which is part of a larger mechanism for odor discrimination. Here, we demonstrate that the OR extracellular loop 2 (ECL2) plays critical roles in OR promiscuity and specificity. Using site-directed mutagenesis and molecular modeling, we constructed 3D OR models in which ECL2 forms a lid over the orthosteric pocket. We demonstrate using molecular dynamics simulations that ECL2 controls the shape and volume of the odorant-binding pocket, maintains the pocket hydrophobicity, and acts as a gatekeeper of odorant binding. Therefore, we propose the interplay between the specific orthosteric pocket and the variable, less specific ECL2 controls OR specificity and promiscuity. Furthermore, the 3D models created here enabled virtual screening of new OR agonists and antagonists, which exhibited a 70% hit rate in cell assays. Our approach can potentially be generalized to structure-based ligand screening for other G protein-coupled receptors that lack high-resolution 3D structures.	[Yu, Yiqun; Xu, Lun; Li, Weihao] Fudan Univ, Eye Ear Nose & Throat Hosp, Ear Nose & Throat Inst, Dept Otolaryngol, Shanghai, Peoples R China; [Yu, Yiqun] Fudan Univ, Eye Ear Nose & Throat Hosp, Clin & Res Ctr Olfactory Disorders, Shanghai, Peoples R China; [Ma, Zhenjie] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China; [Pacalon, Jody; Topin, Jeremie] Univ Cote Azur, Inst Chim Nice UMR7272, CNRS, Nice, France; [Belloir, Christine; Briand, Loic] Univ Bourgogne Franche Comte, Ctr Sci Gout & Alimentat CSGA, CNRS, INRA, Dijon, France; [Golebiowski, Jerome] Daegu Gyeongbuk Inst Sci & Technol, Dept Brain & Cognit Sci, Daegu, South Korea; [Cong, Xiaojing] Univ Montpellier, Inst Genom Fonct, CNRS, INSERM, Montpellier, France	Fudan University; Fudan University; Shanghai University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Daegu Gyeongbuk Institute of Science & Technology (DGIST); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Yu, YQ (corresponding author), Fudan Univ, Eye Ear Nose & Throat Hosp, Ear Nose & Throat Inst, Dept Otolaryngol, Shanghai, Peoples R China.; Yu, YQ (corresponding author), Fudan Univ, Eye Ear Nose & Throat Hosp, Clin & Res Ctr Olfactory Disorders, Shanghai, Peoples R China.; Topin, J (corresponding author), Univ Cote Azur, Inst Chim Nice UMR7272, CNRS, Nice, France.; Cong, XJ (corresponding author), Univ Montpellier, Inst Genom Fonct, CNRS, INSERM, Montpellier, France.	yu_yiqun@fudan.edu.cn; jerome.golebiowski@gmail.com; xiaojing.cong@igf.cnrs.fr		BELLOIR, Christine/0000-0002-2991-141X; Topin, Jeremie/0000-0003-1470-1206	National Natural Science Foundation of China [32070996, 31771155]; NeuroMod Institute of the University of Cote d'Azur; Roudnitska Foundation in France; GIRACT in Switzerland; Science and Technology Commission of Shanghai Municipality [21140900600]; Eye, Ear, Nose, and Throat Hospital, Fudan University, Excellent Doctors -Excellent Clinical Researchers Program [SYB202002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NeuroMod Institute of the University of Cote d'Azur; Roudnitska Foundation in France; GIRACT in Switzerland; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Eye, Ear, Nose, and Throat Hospital, Fudan University, Excellent Doctors -Excellent Clinical Researchers Program	This work was supported by the National Natural Science Foundation of China (grants 32070996 and 31771155; to Y. Y.), the NeuroMod Institute of the University of Cote d'Azur (2019-2020 project grant), the Roudnitska Foundation in France (2018-2021 research fellowship; to J. P.), GIRACT in Switzerland (2019 research fellowship; to J. P.), the Science and Technology Commission of Shanghai Municipality (grant 21140900600; to Y. Y.), and the Eye, Ear, Nose, and Throat Hospital, Fudan University, Excellent Doctors -Excellent Clinical Researchers Program (grant no.: SYB202002; to Y. Y.).	Abaffy T, 2007, J BIOL CHEM, V282, P1216, DOI 10.1074/jbc.M609355200; Baud O, 2011, BIOCHEMISTRY-US, V50, P843, DOI 10.1021/bi1017396; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; Bushdid C, 2014, SCIENCE, V343, P1370, DOI 10.1126/science.1249168; Bushdid C, 2019, CELL MOL LIFE SCI, V76, P995, DOI 10.1007/s00018-018-2996-4; Charlier L, 2012, CELL MOL LIFE SCI, V69, P4205, DOI 10.1007/s00018-012-1116-0; Cong XJ, 2022, ACS CENTRAL SCI, V8, P379, DOI 10.1021/acscentsci.1c01495; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; de March CA, 2015, PROTEIN SCI, V24, P1543, DOI 10.1002/pro.2717; de March CA, 2015, J AM CHEM SOC, V137, P8611, DOI 10.1021/jacs.5b04659; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Ferrer I, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00163; Forli S, 2016, NAT PROTOC, V11, P905, DOI 10.1038/nprot.2016.051; Geithe C, 2017, CELL MOL LIFE SCI, V74, P4209, DOI 10.1007/s00018-017-2576-z; Gelis L, 2012, ANGEW CHEM INT EDIT, V51, P1274, DOI 10.1002/anie.201103980; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116097; Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232; Karnik SS, 2003, TRENDS ENDOCRIN MET, V14, P431, DOI 10.1016/j.tem.2003.09.007; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Kida H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06806-w; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lee SJ, 2019, NAT REV DRUG DISCOV, V18, P116, DOI 10.1038/s41573-018-0002-3; Li EW, 2019, CELL METAB, V30, P319, DOI 10.1016/j.cmet.2019.05.022; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mirdita M, 2019, BIOINFORMATICS, V35, P2856, DOI 10.1093/bioinformatics/bty1057; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; Reddy G, 2018, ELIFE, V7, DOI [10.7554/elife.34958, 10.7554/eLife.34958]; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandal M, 2015, J CHEM THEORY COMPUT, V11, P4439, DOI 10.1021/acs.jctc.5b00472; Scalmani G., 2016, GAUSSIAN 09; Schott-Verdugo S, 2019, J CHEM INF MODEL, V59, P2522, DOI 10.1021/acs.jcim.9b00269; Sharma K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27790-7; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shepard BD, 2019, AM J PHYSIOL-RENAL, V316, pF372, DOI 10.1152/ajprenal.00069.2018; Thal DM, 2018, NATURE, V559, P45, DOI 10.1038/s41586-018-0259-z; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vainio MJ, 2007, J CHEM INF MODEL, V47, P2462, DOI 10.1021/ci6005646; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang LL, 2011, J PHYS CHEM B, V115, P9431, DOI 10.1021/jp204407d; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Wolf S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123533; Woolley MJ, 2017, MOL CELL ENDOCRINOL, V449, P3, DOI 10.1016/j.mce.2016.11.023; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221; Xu J, 2019, MOL CELL, V75, P53, DOI 10.1016/j.molcel.2019.04.028; Yu YQ, 2015, P NATL ACAD SCI USA, V112, P14966, DOI 10.1073/pnas.1517510112; Yuan SG, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0384-8; Yuan SG, 2016, ANGEW CHEM INT EDIT, V55, P10331, DOI 10.1002/anie.201605147; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120	64	0	0	8	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102331	10.1016/j.jbc.2022.102331	http://dx.doi.org/10.1016/j.jbc.2022.102331			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A7IQ	35926708	Green Submitted, gold, Green Published			2022-12-26	WOS:000863057500009
J	Friebel-Klingner, TM; Iyer, HS; Ramogola-Masire, D; Bazzett-Matabele, L; Monare, B; Seiphetlheng, A; Ralefala, TB; Mitra, N; Wiebe, DJ; Rebbeck, TR; Grover, S; McCarthy, AM				Friebel-Klingner, Tara M.; Iyer, Hari S.; Ramogola-Masire, Doreen; Bazzett-Matabele, Lisa; Monare, Barati; Seiphetlheng, Alexander; Ralefala, Tlotlo B.; Mitra, Nandita; Wiebe, Douglas J.; Rebbeck, Timothy R.; Grover, Surbhi; McCarthy, Anne Marie			Evaluating the geographic distribution of cervical cancer patients presenting to a multidisciplinary gynecologic oncology clinic in Gaborone, Botswana	PLOS ONE			English	Article							TIMELY ACCESS; PUBLIC-HEALTH; GLOBAL BURDEN; LOW-INCOME; MORTALITY; WORLDWIDE; RISK; CARE; GIS	Objective In Botswana, cervical cancer is the leading cause of cancer death for females. With limited resources, Botswana is challenged to ensure equitable access to advanced cancer care. Botswana's capital city, Gaborone, houses the only gynecologic oncology multi-disciplinary team (MDT) and the one chemoradiation facility in the country. We aimed to identify areas where fewer women were presenting to the MDT clinic for care. Methods This cross-sectional study examined cervical cancer patients presenting to the MDT clinic between January 2015 and March 2020. Patients were geocoded to residential sub-districts to estimate age-standardized presentation rates. Global Moran's I and Anselin Local Moran's I tested the null hypothesis that presentation rates occurred randomly in Botswana. Community- and individual-level factors of patients living in sub-districts identified with higher (HH) and lower (LL) clusters of presentation rates were examined using ordinary least squares with a spatial weights matrix and multivariable logistic regression, respectively, with a level 0.05. Results We studied 990 patients aged 22-95 (mean: 50.6). Presentation rates were found to be geographically clustered across the country (p = 0.01). Five sub-districts were identified as clusters, two high (HH) sub-district clusters and three low (LL) sub-district clusters (mean presentation rate: 35.5 and 11.3, respectively). Presentation rates decreased with increased travel distance (p = 0.033). Patients residing in LL sub-districts more often reported abnormal vaginal bleeding (aOR: 5.62, 95% CI: 1.31-24.15) compared to patients not residing in LL sub-districts. Patients in HH sub-districts were less likely to be living with HIV (aOR: 0.59; 95% CI: 0.38-0.90) and more likely to present with late-stage cancer (aOR: 1.78; 95%CI: 1.20-2.63) compared to patients not in HH sub-districts. Conclusions This study identified geographic clustering of cervical cancer patients presenting for care in Botswana and highlighted sub-districts with disproportionately lower presentation rates. Identified community- and individual level-factors associated with low presentation rates can inform strategies aimed at improving equitable access to cervical cancer care.	[Friebel-Klingner, Tara M.; Mitra, Nandita; Wiebe, Douglas J.; McCarthy, Anne Marie] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Friebel-Klingner, Tara M.; Monare, Barati; Seiphetlheng, Alexander; Wiebe, Douglas J.; Grover, Surbhi] Botswana Univ Pennsylvania Partnership, Gaborone, Botswana; [Iyer, Hari S.; Rebbeck, Timothy R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Iyer, Hari S.; Rebbeck, Timothy R.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Ramogola-Masire, Doreen; Bazzett-Matabele, Lisa] Univ Botswana, Fac Med, Dept Obstet & Gynecol, Gaborone, Botswana; [Ramogola-Masire, Doreen; Bazzett-Matabele, Lisa] Yale Univ, Dept Obstet & Gynecol, New Haven, CT USA; [Ralefala, Tlotlo B.] Princess Marina Hosp, Dept Oncol, Gaborone, Botswana; [Grover, Surbhi] Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of Botswana; Yale University; University of Pennsylvania	Grover, S (corresponding author), Botswana Univ Pennsylvania Partnership, Gaborone, Botswana.; Grover, S (corresponding author), Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA.	Surbi.Grover@pennmedicine.upenn.edu		Friebel, Tara/0000-0002-3726-9527	National Cancer Institute of the National Institutes of Health [F31CA254075]; Mentored Patient Oriented Career Research Development Award [1-K08CA230170-01A1]	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mentored Patient Oriented Career Research Development Award	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number F31CA254075 to TFK. Mentored Patient Oriented Career Research Development Award (1-K08CA230170-01A1 to SG) to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PV, 2014, PAP REG SCI, V93, DOI 10.1111/pirs.12034; Anakwenze C, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.18.00129; [Anonymous], BOTSWANA NATL CANC R; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Arbyn M, 2020, LANCET GLOB HEALTH, V8, pE191, DOI 10.1016/S2214-109X(19)30482-6; Banke-Thomas A, 2021, HEALTH POLICY PLANN, V36, P1384, DOI 10.1093/heapol/czab099; Barchi F, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6638-z; Bhatia RK, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.18.00088; Bhatla N, 2019, INT J GYNECOL OBSTET, V145, P129, DOI 10.1002/ijgo.12749; Boyda DC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216388; Brown CA, 2018, ONCOLOGIST, V23, P1453, DOI 10.1634/theoncologist.2017-0643; Brown CA, 2016, ONCOLOGIST, V21, P731, DOI 10.1634/theoncologist.2015-0387; Burt LM, 2021, JCO GLOB ONCOL, V7, P173, DOI 10.1200/GO.20.00079; Chirenda J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231637; Cohen PA, 2019, LANCET, V393, P169, DOI 10.1016/S0140-6736(18)32470-X; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; Eniu Alexandru E, 2017, Am Soc Clin Oncol Educ Book, V37, P409, DOI 10.14694/EDBK_175251; ESRI, MOD SPAT REL; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Friebel-Klingner TM, 2021, BMC WOMENS HEALTH, V21, DOI 10.1186/s12905-021-01402-5; Ginsburg O, 2017, LANCET, V389, P847, DOI [10.1016/S0140-6736(16)31392-7, 10.1]; Google, 2021, BOTSW GOOGL MAPS; Grover S, 2017, J GLOB ONCOL, V3, P666, DOI 10.1200/JGO.2016.006353; Grover S, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00239; International Agency for Research on Cancer (IARC), 2021, US; Iyer HS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218094; Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410; Kapwata T, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3006-0; Kirby RS, 2017, ANN EPIDEMIOL, V27, P1, DOI 10.1016/j.annepidem.2016.12.001; Liu G, 2018, AIDS, V32, P795, DOI [10.1097/QAD.0000000000001765, 10.1097/qad.0000000000001765]; Munyaneza F, 2018, AIDS BEHAV, V22, P77, DOI 10.1007/s10461-016-1658-5; Musa GJ, 2013, HEALTH SERV INSIGHTS, V6, P111, DOI 10.4137/HSI.S10471; NACA) NACA, 2013, BOTSW AIDS IMP SURV; Nykiforuk CIJ, 2011, HEALTH PROMOT PRACT, V12, P63, DOI 10.1177/1524839909334624; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Raykar NP, 2015, LANCET, V385, P16, DOI 10.1016/S0140-6736(15)60811-X; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954; Schootman M, 2017, CANCER EPIDEM BIOMAR, V26, P472, DOI 10.1158/1055-9965.EPI-17-0104; Seitio-Kgokgwe O, 2014, INT J HEALTH POLICY, V3, P179, DOI 10.15171/ijhpm.2014.85; Stelzle D, 2021, LANCET GLOB HEALTH, V9, pE161, DOI 10.1016/S2214-109X(20)30459-9; Stewart TS, 2018, CANCER EPIDEMIOL, V53, P81, DOI 10.1016/j.canep.2018.01.014; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Tapela NM, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00187; US Census Bureau, 2019, FOOD CONTROL	45	0	0	9	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271679	10.1371/journal.pone.0271679	http://dx.doi.org/10.1371/journal.pone.0271679			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925976	gold, Green Published			2022-12-26	WOS:000848077100046
J	Njoku, K; Barr, CE; Ramchander, NC; Crosbie, EJ				Njoku, Kelechi; Barr, Chloe E.; Ramchander, Neal C.; Crosbie, Emma J.			Impact of pre-treatment prognostic nutritional index and the haemoglobin, albumin, lymphocyte and platelet (HALP) score on endometrial cancer survival: A prospective database analysis	PLOS ONE			English	Article							SERUM-ALBUMIN; GUIDELINES RECOMMENDATIONS; PREDICTOR; ANGIOGENESIS; INFLAMMATION; MARKER	Purpose The Onodera's prognostic nutritional index (PNI) and the haemoglobin, albumin, lymphocyte and platelet (HALP) score are immune-nutritional indices that correlate with survival outcomes in several adult solid malignancies. The aim of this study was to investigate whether PNI and HALP are associated with survival outcomes in endometrial cancer. Patients and methods Women undergoing management for endometrial cancer were recruited to a single centre prospective cohort study. Pre-treatment PNI and HALP scores were computed for study participants and analysed as continuous variables and by selecting cut-off values based on previous publications. Both parameters were analysed in relation to overall, endometrial cancer-specific and recurrence-free survival using Kaplan-Meier estimation and multivariable Cox proportional regression. Results A total of 439 women, with a median age of 67 years (interquartile range (IQR), 58, 74) and BMI of 31kg/m(2) (IQR 26, 37) were included in the analysis. Most had low-grade (63.3%), early-stage (84.4% stage I/II) endometrial cancer of endometrioid histological subtype (72.7%). Primary treatment was surgery in 98.2% of cases. Adjusted overall mortality hazard ratios for PNI and HALP as continuous variables were 0.97(95%CI 0.94-1.00, p = 0.136) and 0.99(95%CI 10.98-1.01, p = 0.368), respectively. Women with pre-treatment PNI >45 had a 45% decrease in both overall (adjusted HR = 0.55, 95% CI 0.33-0.92, p = 0.022) and cancer-specific mortality risk (adjusted HR = 0.55, 95% CI 0.30-0.99, p = 0.048) compared to those with PNI <45. There was no evidence for an effect of PNI on recurrence free survival. HALP scores were associated with adverse clinico-pathologic factors, but not overall, cancer-specific or recurrence-free survival in the multivariable analysis. Conclusion PNI is an independent prognostic factor in endometrial cancer and has the potential to refine pre-operative risk assessment.	[Njoku, Kelechi; Barr, Chloe E.; Ramchander, Neal C.; Crosbie, Emma J.] Univ Manchester, Fac Biol Med & Hlth, Sch Med Sci, Div Canc Sci,St Marys Hosp, Manchester, Lancs, England; [Njoku, Kelechi] Univ Manchester, Fac Biol Med & Hlth, Stoller Biomarker Discovery Ctr, Inst Canc Sci, Manchester, Lancs, England; [Barr, Chloe E.; Crosbie, Emma J.] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Dept Obstet & Gynaecol, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Crosbie, EJ (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Med Sci, Div Canc Sci,St Marys Hosp, Manchester, Lancs, England.; Crosbie, EJ (corresponding author), Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Dept Obstet & Gynaecol, Manchester, Lancs, England.	emma.crosbie@manchester.ac.uk	Njoku, Kelechi/AAW-6462-2021	Njoku, Kelechi/0000-0001-6528-3476	Cancer Research UK (CRUK) Manchester Cancer Research Centre Clinical Research Fellowship [C147/A25254]; Wellcome Trust Manchester Translational Informatics Training Scheme; NIHR Manchester Biomedical Research Centre [IS-BRC-1215-20007]; NIHR Advanced Fellowship [NIHR300650]; Manchester University NHS Foundation Trust Clinical Research Fellowship; NIHR Academic Foundation Programme	Cancer Research UK (CRUK) Manchester Cancer Research Centre Clinical Research Fellowship; Wellcome Trust Manchester Translational Informatics Training Scheme; NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Advanced Fellowship; Manchester University NHS Foundation Trust Clinical Research Fellowship; NIHR Academic Foundation Programme	KN is supported by a Cancer Research UK (CRUK) Manchester Cancer Research Centre Clinical Research Fellowship (C147/A25254) and the Wellcome Trust Manchester Translational Informatics Training Scheme. EJC is supported by the NIHR Manchester Biomedical Research Centre (IS-BRC-1215-20007) and an NIHR Advanced Fellowship (NIHR300650). CEB is supported by a Manchester University NHS Foundation Trust Clinical Research Fellowship. NCR was supported by the NIHR Academic Foundation Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiles J M, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS39, DOI 10.1016/j.ejon.2005.09.006; Ataseven B, 2015, GYNECOL ONCOL, V138, P560, DOI 10.1016/j.ygyno.2015.07.005; Bolitho P, 2007, CURR OPIN IMMUNOL, V19, P339, DOI 10.1016/j.coi.2007.04.007; Busti F, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11040094; Cabrerizo S, 2015, MATURITAS, V81, P17, DOI 10.1016/j.maturitas.2015.02.009; Colombo I, 2020, MANAGEMENT OF ENDOMETRIAL CANCER, P133, DOI 10.1007/978-3-319-64513-1_9; Colombo N, 2016, INT J GYNECOL CANCER, V26, P2, DOI 10.1097/IGC.0000000000000609; Crosbie EJ, 2022, LANCET, V399, P1412, DOI 10.1016/S0140-6736(22)00323-3; CRUK, 2020, UT CANC INC STAT; Cummings M, 2015, BRIT J CANCER, V113, P311, DOI 10.1038/bjc.2015.200; Dai Y, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021840; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Flood A, 2014, CLIN NUTR, V33, P106, DOI 10.1016/j.clnu.2013.03.003; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guo YD, 2019, J CANCER, V10, P81, DOI 10.7150/jca.27210; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Haraga J, 2016, MOL CLIN ONCOL, V5, P567, DOI 10.3892/mco.2016.1028; Ida N, 2018, MOL CLIN ONCOL, V8, P257, DOI 10.3892/mco.2017.1508; Kaya C, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13766; Keller U, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060775; Komura Naoko, 2019, Oncotarget, V10, P3605, DOI 10.18632/oncotarget.26914; Lei J, 2020, FUTURE ONCOL, V16, P307, DOI 10.2217/fon-2019-0732; Levitt DG, 2016, INT J GEN MED, V9, P229, DOI 10.2147/IJGM.S102819; Li D, 2018, J THORAC DIS, V10, P5298, DOI 10.21037/jtd.2018.08.51; Li Q, 2021, GYNECOL ONCOL, V160, P91, DOI 10.1016/j.ygyno.2020.10.013; Li SH, 2019, NUTR CANCER, V71, P207, DOI 10.1080/01635581.2018.1559930; Lou CY, 2022, AM J TRANSL RES, V14, P3240; Luan CW, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-96598-9; Lv GY, 2018, CLIN CHIM ACTA, V476, P81, DOI 10.1016/j.cca.2017.11.019; Man ZR, 2018, HPB, V20, P888, DOI 10.1016/j.hpb.2018.03.019; Martinez-Lostao L, 2015, CLIN CANCER RES, V21, P5047, DOI 10.1158/1078-0432.CCR-15-0685; Morrison J, 2022, EUR J OBSTET GYN R B, V270, P50, DOI 10.1016/j.ejogrb.2021.11.423; Njoku K., 2020, BJOG-INT J OBSTET GY; Njoku K, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.890908; Njoku K, 2022, GYNECOL ONCOL, V164, P146, DOI 10.1016/j.ygyno.2021.11.009; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Peng D, 2018, BMC UROL, V18, DOI 10.1186/s12894-018-0333-8; Peng D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19146-y; Santoso JT, 2000, OBSTET GYNECOL, V95, P844, DOI 10.1016/S0029-7844(99)00658-4; Seebacher V, 2013, EUR J OBSTET GYN R B, V171, P101, DOI 10.1016/j.ejogrb.2013.07.044; Sierko E, 2004, SEMIN THROMB HEMOST, V30, P95; Sun GW, 2019, INT J COLORECTAL DIS, V34, P681, DOI 10.1007/s00384-019-03241-1; Sundar S, 2017, EUR J OBSTET GYN R B, V213, P71, DOI 10.1016/j.ejogrb.2017.04.015; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Tominaga T, 2020, SURG TODAY, V50, P1633, DOI 10.1007/s00595-020-02050-2; Van Cutsem Eric, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS51, DOI 10.1016/j.ejon.2005.09.007; Wan YL, 2016, GYNECOL ONCOL, V143, P287, DOI 10.1016/j.ygyno.2016.08.333; Wang D, 2021, J GASTROINTEST SURG, V25, P421, DOI 10.1007/s11605-019-04492-7; Wang XY, 2019, INT J SURG, V67, P79, DOI 10.1016/j.ijsu.2019.05.018; Wojtukiewicz MZ, 2017, CANCER METAST REV, V36, P249, DOI 10.1007/s10555-017-9673-1; Yalav O, 2020, CYPRUS J MED SCI, V5, P145, DOI 10.5152/cjms.2020.1747; Yang ZJ, 2014, TUMOR BIOL, V35, P12165, DOI 10.1007/s13277-014-2524-6; Zhang WW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10328-8	54	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272232	10.1371/journal.pone.0272232	http://dx.doi.org/10.1371/journal.pone.0272232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925991	Green Published, gold			2022-12-26	WOS:000848077100078
J	Mueller, LM; Kipnis, R; Ferreira, MP; Marzo, S; Fiedler, B; Lucas, M; Ilgner, J; Silva, HP; Roberts, P				Mueller, Leticia Morgana; Kipnis, Renato; Ferreira, Mariane Pereira; Marzo, Sara; Fiedler, Bianca; Lucas, Mary; Ilgner, Jana; Silva, Hilton P.; Roberts, Patrick			Late Holocene dietary and cultural variability on the Xingu River, Amazon Basin: A stable isotopic approach	PLOS ONE			English	Article							BONE-COLLAGEN; NITROGEN ISOTOPES; OXYGEN ISOTOPES; RAIN-FOREST; CARBON; ECOLOGY; ENAMEL; RATIOS; DOMESTICATION; CULTIVATION	Although once considered a 'counterfeit paradise', the Amazon Basin is now a region of increasing interest in discussions of pre-colonial tropical land-use and social complexity. Archaeobotany, archaeozoology, remote sensing and palaeoecology have revealed that, by the Late Holocene, populations in different parts of the Amazon Basin were using various domesticated plants, modifying soils, building earthworks, and even forming 'Garden Cities' along the Amazon River and its tributaries. However, there remains a relatively limited understanding as to how diets, environmental management, and social structures varied across this vast area. Here, we apply stable isotope analysis to human remains (n = 4 for collagen, n = 17 for tooth enamel), and associated fauna (n = 61 for collagen, n = 28 for tooth enamel), to directly determine the diets of populations living in the Volta Grande do Rio Xingu, an important region of pre-Columbian cultural interactions, between 390 cal. years BC and 1,675 cal. years AD. Our results highlight an ongoing dietary focus on C-3 plants and wild terrestrial fauna and aquatic resources across sites and time periods, with varying integration of C-4 plants (i.e. maize). We argue that, when compared to other datasets now available from elsewhere in the Amazon Basin, our study highlights the development of regional adaptations to local watercourses and forest types.	[Mueller, Leticia Morgana; Lucas, Mary; Ilgner, Jana; Roberts, Patrick] Max Planck Inst Geoanthropol Sci Human Hist, Dept Archaeol, Jena, Germany; [Mueller, Leticia Morgana; Silva, Hilton P.] Fed Univ, Grad Program Anthropol, Belem, PA, Brazil; [Mueller, Leticia Morgana; Kipnis, Renato; Ferreira, Mariane Pereira] Scientia Consultoria Cient, Sao Paulo, SP, Brazil; [Ferreira, Mariane Pereira] Univ Sao Paulo, Grad Program Archeol, Museum Archaeol & Etnol, Sao Paulo, Brazil; [Marzo, Sara] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Marzo, Sara] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Roberts, Patrick] Max Planck Inst Geoanthropol Sci Human Hist, isoTROP Independent Res Grp, Jena, Germany; [Roberts, Patrick] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia	Universidade de Sao Paulo; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Queensland	Mueller, LM; Roberts, P (corresponding author), Max Planck Inst Geoanthropol Sci Human Hist, Dept Archaeol, Jena, Germany.; Mueller, LM (corresponding author), Fed Univ, Grad Program Anthropol, Belem, PA, Brazil.; Mueller, LM (corresponding author), Scientia Consultoria Cient, Sao Paulo, SP, Brazil.; Roberts, P (corresponding author), Max Planck Inst Geoanthropol Sci Human Hist, isoTROP Independent Res Grp, Jena, Germany.; Roberts, P (corresponding author), Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia.	muller@shh.mpg.de; roberts@shh.mpg.de		Kipnis, Renato/0000-0003-2183-7566; Pereira Ferreira, Mariane/0000-0003-3345-2559	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001, 88881.190306/2018-01]; Max Planck Society	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior -Brasil (CAPES) -Finance Code 001", Programa de Doutorado Sandui ' che no Exterior -88881.190306/2018-01. https://www.gov.br/capes/pt-br.We would also like to thank the Max Planck Society for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida Fernando Ozorio de, 2015, Mana, V21, P499, DOI 10.1590/0104-93132015v21n3p499; Almeida FO., 2016, CER MICAS ARQUEOL GI, P171; Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Arroyo-Kalin M, 2012, QUATERN INT, V249, P4, DOI 10.1016/j.quaint.2011.08.004; BAILEY RC, 1989, AM ANTHROPOL, V91, P59, DOI 10.1525/aa.1989.91.1.02a00040; Barreto C., 2016, REV ARQUEOLOGIA, V29, P55; Benedito-Cecilio E, 2000, FISHERIES MANAG ECOL, V7, P305, DOI 10.1046/j.1365-2400.2000.007004305.x; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bleasdale M, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01324-2; Ribeiro ATB, 2016, LAT AM ANTIQ, V27, P318, DOI 10.7183/1045-6635.273318; Brugger SO, 2016, QUATERNARY SCI REV, V132, P114, DOI 10.1016/j.quascirev.2015.11.001; Cabral MP., 2011, REV AMAZANICA, P88; Capriles JM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav5449; Carvajal G., 1941, DESCOBRIMENTO RIO AM; Cascon LM., 2010, DISSERTACAO MESTRADO; Castro AM, 2020, REGIME OPULENCIA GRU; Castro AM., 2021, KORIABO CARIBBEAN SE, P203; Cerling TE, 2004, OECOLOGIA, V138, P5, DOI 10.1007/s00442-003-1375-4; Clement C. R., 2010, Diversity, V2, P72; Clement CR, 2015, P ROY SOC B-BIOL SCI, V282, P32, DOI 10.1098/rspb.2015.0813; Clement Charles Roland, 2016, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V11, P193, DOI 10.1590/1981.81222016000100010; Colonese AC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73540-z; Costa AGM., 2015, THESIS U FEDERAL SER; Costa BLS., 2012, AMAZ NICA, V4, P60; Costa FJA., 1988, RELAT RIO VIABILIDAD; de Paula Moraes C., 2012, AMAZONICA, V4, P122, DOI DOI 10.18542/AMAZONICA.V4I1.884; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Domingues-Lopes RC, 2003, ANAIS 8 REUNI O REGI, V1, P1; Dufour E, 1999, J ARCHAEOL SCI, V26, P617, DOI 10.1006/jasc.1998.0379; Erickson CL, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P157, DOI 10.1007/978-0-387-74907-5_11; Faria ESS., 2016, THESIS PPGA BELEM; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Fausto C, 2018, ANTIQUITY, V92, P1604, DOI 10.15184/aqy.2018.157; Fernandes GCB., 2018, HABITUS, P403; Garcia LLW., 2016, CER MICAS ARQUEOL GI, P183; de Souza JG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232367; Heckenberger MJ, 2008, SCIENCE, V321, P1214, DOI 10.1126/science.1159769; Heckenberger MJ, 2003, SCIENCE, V301, P1710, DOI 10.1126/science.1086112; Hedges REM., 2007, BUILDING MEMORIES NE, P239; Hedges REM, 2007, J ARCHAEOL SCI, V34, P1240, DOI 10.1016/j.jas.2006.10.015; Heriarte M., 1874, DESCRIPCAO ESTADO MA; Hermenegildo T, 2017, QUATERN INT, V448, P139, DOI 10.1016/j.quaint.2017.03.003; Herrera EA, 2011, J MAMMAL, V92, P12, DOI 10.1644/09-MAMM-S-420.1; Hilbert L, 2017, NAT ECOL EVOL, V1, P1693, DOI 10.1038/s41559-017-0322-4; Horton D., 1948, HDB S AM INDIANS, V3; Ieipari Teixeira-PintoM., 1997, SACRIFICIO VIDA SOCI; Instituto Brasileiro de Geografia e Estatistica, 1977, GEOGRAFIA BRASIL REG, V1; Instituto Brasileiro de Geografia e Estatistica, 2004, MAP VEG BRAS, V3rd; Jones KR, 2019, SCIENTIFICA, V2019, DOI 10.1155/2019/3759783; Corriale MJ, 2014, ECOL RES, V29, P191, DOI 10.1007/s11284-013-1113-2; Kipnis R., 2018, ESPECIARIACADERNO 10; Kistler L, 2018, SCIENCE, V362, P1309, DOI 10.1126/science.aav0207; Koch A, 2019, QUATERNARY SCI REV, V207, P13, DOI 10.1016/j.quascirev.2018.12.004; Lathrap DW., 1968, MAN HUNTER, P23; Lee-Thorp JA, 2008, ARCHAEOMETRY, V50, P925, DOI 10.1111/j.1475-4754.2008.00441.x; LEETHORP JA, 1989, J ARCHAEOL SCI, V16, P585, DOI 10.1016/0305-4403(89)90024-1; Leme, 2009, RIMARELATORIO IMP AM; Levis C, 2017, SCIENCE, V355, P925, DOI 10.1126/science.aal0157; Lima HP., 2015, MUSEU ARQUEOLOGIA ET, V21, P205; Lima HP., 2016, CER MICAS ARQUEOL GI, P224; Maezumi SY, 2018, NAT PLANTS, V4, P540, DOI 10.1038/s41477-018-0205-y; Marques AdJM., 2020, VARIABILIDADE ARTEFA; MEDINA E, 1980, OECOLOGIA, V45, P377, DOI 10.1007/BF00540209; Meggers BJ, 1954, AM ANTHROPOL, V56, P801, DOI 10.1525/aa.1954.56.5.02a00060; Meggers BJ, 1977, AMAZONIA ILUSAO PARA; Mortillaro JM, 2015, FRESHWATER BIOL, V60, P1659, DOI 10.1111/fwb.12598; Muller LM, 2018, RELATORIO ESCAVACAO; Muller LM., 2016, CER MICAS ARQUEOL GI, P196; Neme M., 1969, ANAIS MUSEU PAULISTA, VXXIII, P101; Neves EG, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P29, DOI 10.1007/1-4020-2597-1_3; Nimuendaju C., 1948, HDB S AM INDIANS, P213; Nimuendaju C, 1981, MAPA ETNO HIST; Palace MW, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.2035; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Pereira ES, 2002, CHE BELO MONTE ESTUD; Perota C., 1992, PREHISTORIA SUDAMERI, P219; Pestle WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102844; Piperno DR, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022213118; Posey D. A., 1984, Ethnobotany in the neotropics., P112; Prestes-Carneiro G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214638; Py Daniel A., 2009, THESIS USP SAO PAULO; Py-Daniel AR., 2015, THESIS U SAO PAULO S; Ramalho JP., 1971, PESQUISAS ANTROPOLOG; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reid DJ, 2006, J HUM EVOL, V50, P329, DOI 10.1016/j.jhevol.2005.09.003; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Ribeiro MBN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102187; Richards MP, 1999, J ARCHAEOL SCI, V26, P717, DOI 10.1006/jasc.1998.0387; Roberts P, 2018, RAPID COMMUN MASS SP, V32, P361, DOI 10.1002/rcm.8044; ROBINSON JG, 1986, AM NAT, V128, P665, DOI 10.1086/284596; Roosevelt A., 1989, ADV EC BOT, P30; ROOSEVELT AC, 1993, HOMME, V33, P255; Rostain S., 2010, DIVERSITY-BASEL, V2, P331, DOI DOI 10.3390/d2030331; Rostain S., 2004, LATE CERAMIC AGE SOC; Schaan D., 2010, Diversity, V2, P182; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Scientia Consultoria Cientifica, 2019, RELAT RIO PARCIAL 14; Scientia Consultoria Cientifica, 2014, RELAT RIO PARCIAL 7; Scientia Consultoria Cientifica, 2018, RELAT RIO PARCIAL 13; SEALY JC, 1987, GEOCHIM COSMOCHIM AC, V51, P2707, DOI 10.1016/0016-7037(87)90151-7; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Sneathlage E, 2002, SECRETARIA ESTADO CU; Sponheimer M, 1999, J ARCHAEOL SCI, V26, P723, DOI 10.1006/jasc.1998.0388; Szpak P, 2017, J ARCHAEOL SCI-REP, V13, P609, DOI 10.1016/j.jasrep.2017.05.007; TAPPEN M, 1994, J ARCHAEOL SCI, V21, P667, DOI 10.1006/jasc.1994.1066; Tejada JV, 2020, P NATL ACAD SCI USA, V117, P26263, DOI 10.1073/pnas.2007440117; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Troufflard Joanna, 2019, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V14, P553, DOI 10.1590/1981.81222019000200015; Turner T., 1992, HIST RIA NDIOS NO BR; Van Den Bel M., 2010, ARQUEOLOGIA AMAZ NIC, P61; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; VANDERMERWE NJ, 1981, NATURE, V292, P536, DOI 10.1038/292536a0; VOGEL JC, 1977, AM ANTIQUITY, V42, P238, DOI 10.2307/278984; Whitney BS, 2014, HOLOCENE, V24, P231, DOI 10.1177/0959683613517401; Wright LE, 1998, AM J PHYS ANTHROPOL, V106, P1	117	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271545	http://dx.doi.org/10.1371/journal.pone.0271545			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921285	Green Published, gold			2022-12-26	WOS:000839311900055
J	Salagnon, M; Cremona, S; Joliot, M; d'Errico, F; Mellet, E				Salagnon, Mathilde; Cremona, Sandrine; Joliot, Marc; d'Errico, Francesco; Mellet, Emmanuel			Neural correlates of perceiving and interpreting engraved prehistoric patterns as human production: Effect of archaeological expertise	PLOS ONE			English	Article							FUSIFORM FACE AREA; MIDDLE STONE-AGE; SALIENCE NETWORK; INTRINSIC CONNECTIVITY; COMPLEX COGNITION; SHELL BEADS; BONE TOOLS; TECHNOLOGY; NEANDERTHALS; NEUROSCIENCE	It has been suggested that engraved abstract patterns dating from the Middle and Lower Palaeolithic served as means of representation and communication. Identifying the brain regions involved in visual processing of these engravings can provide insights into their function. In this study, brain activity was measured during perception of the earliest known Palaeolithic engraved patterns and compared to natural patterns mimicking human-made engravings. Participants were asked to categorise marks as being intentionally made by humans or due to natural processes (e.g. erosion, root etching). To simulate the putative familiarity of our ancestors with the marks, the responses of expert archaeologists and control participants were compared, allowing characterisation of the effect of previous knowledge on both behaviour and brain activity in perception of the marks. Besides a set of regions common to both groups and involved in visual analysis and decision-making, the experts exhibited greater activity in the inferior part of the lateral occipital cortex, ventral occipitotemporal cortex, and medial thalamic regions. These results are consistent with those reported in visual expertise studies, and confirm the importance of the integrative visual areas in the perception of the earliest abstract engravings. The attribution of a natural rather than human origin to the marks elicited greater activity in the salience network in both groups, reflecting the uncertainty and ambiguity in the perception of, and decision-making for, natural patterns. The activation of the salience network might also be related to the process at work in the attribution of an intention to the marks. The primary visual area was not specifically involved in the visual processing of engravings, which argued against its central role in the emergence of engraving production.	[Salagnon, Mathilde; Cremona, Sandrine; Joliot, Marc; Mellet, Emmanuel] Univ Bordeaux, CNRS, CEA, IMN,GIN,UMR 5293, Bordeaux, France; [d'Errico, Francesco] Univ Bordeaux, PACEA UMR 5199, CNRS, Pessac, France; [d'Errico, Francesco] Univ Bergen, SFF Ctr Early Sapiens Behav SapienCE, Bergen, Norway	CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; University of Bergen	Mellet, E (corresponding author), Univ Bordeaux, CNRS, CEA, IMN,GIN,UMR 5293, Bordeaux, France.	emmanuel.mellet@u-bordeaux.fr	Mellet, Emmanuel/B-7125-2008	Mellet, Emmanuel/0000-0002-2676-9112	IdEx Bordeaux/CNRS (PEPS 2015); European Research Council [951388]; Research Council of Norway [262618]; Talents Programme the Bordeaux University [191022_001]; Grand Programme de Recherche 'Human Past' of the Initiative d'Excellence (IdEx) of the Bordeaux University	IdEx Bordeaux/CNRS (PEPS 2015); European Research Council(European Research Council (ERC)European Commission); Research Council of Norway(Research Council of Norway); Talents Programme the Bordeaux University; Grand Programme de Recherche 'Human Past' of the Initiative d'Excellence (IdEx) of the Bordeaux University	EM & FD: CNRS project 80 Prime Neurobeads, a grant from the IdEx Bordeaux/CNRS (PEPS 2015). FD: European Research Council through a Synergy Grant for the project Evolution of Cognitive Tools for Quantification (QUANTA), No. 951388; the Research Council of Norway through its Centres of Excellence funding scheme, SFF Centre for Early Sapiens Behaviour (SapienCE), project number 262618, the Talents Programme the Bordeaux University [grant number: 191022_001] and the Grand Programme de Recherche `Human Past' of the Initiative d'Excellence (IdEx) of the Bordeaux University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 2011, LEARN MEMORY, V18, P384, DOI 10.1101/lm.1884611; Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; Bilalic M., 2018, STUDIES ACTIVATION S, V2nd, P233; Bilalic M, 2016, J COGNITIVE NEUROSCI, V28, P1345, DOI 10.1162/jocn_a_00974; Bilalic M, 2016, CEREB CORTEX, V26, P1004, DOI 10.1093/cercor/bhu272; Bilalic M, 2011, J NEUROSCI, V31, P10206, DOI 10.1523/JNEUROSCI.5727-10.2011; Bird CM, 2017, CORTEX, V93, P155, DOI 10.1016/j.cortex.2017.05.016; Blessing MA, 2021, J ARCHAEOL SCI-REP, V38, DOI 10.1016/j.jasrep.2021.103096; Botha R, 2009, CRADLE LANGUAGE; Brooks AS, 2018, SCIENCE, V360, P90, DOI 10.1126/science.aao2646; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; Burke A, 2012, QUATERN INT, V247, P230, DOI 10.1016/j.quaint.2010.10.029; Chand GB, 2016, NEUROIMAGE, V134, P85, DOI 10.1016/j.neuroimage.2016.04.018; Coolidge FL, 2016, CURR DIR PSYCHOL SCI, V25, P386, DOI 10.1177/0963721416657085; Currie A, 2019, MIND LANG, V34, P263, DOI 10.1111/mila.12230; d'Errico F, 2009, P NATL ACAD SCI USA, V106, P16051, DOI 10.1073/pnas.0903532106; Davidson I, 2010, WIRES COGN SCI, V1, P214, DOI 10.1002/wcs.40; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; FernandezJalvo Y, 2016, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-94-017-7432-1; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gorgolewski K., 2011, FRONT NEUROINFORM, V5, DOI [10.3389/fninf.2011.00013 21897815, DOI 10.3389/FNINF.2011.0001321897815]; Harel A, 2016, NEUROPSYCHOLOGIA, V83, P88, DOI 10.1016/j.neuropsychologia.2015.06.004; Harley EM, 2009, CEREB CORTEX, V19, P2746, DOI 10.1093/cercor/bhp051; Hecht EE, 2015, BRAIN STRUCT FUNCT, V220, P2315, DOI 10.1007/s00429-014-0789-6; Henshilwood C., 2011, HOMOSYMBOLICUS DAWN, P249; Henshilwood C.S., 2011, HOMOSYMBOLICUS DAWN; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Hodgskiss T, 2014, CAMB ARCHAEOL J, V24, P405, DOI 10.1017/S0959774314000663; Hodgson D., 2016, FORMAL MODELS EVOLUT, P133; Hodgson D., 2006, PALEOANTHROPOLOGY, P54, DOI DOI 10.1017/S0959774306000023; Hodgson D, 2019, J ARCHAEOL SCI-REP, V28, DOI 10.1016/j.jasrep.2019.102041; Hodgson D, 2019, J ARCHAEOL SCI-REP, V24, P588, DOI 10.1016/j.jasrep.2019.02.025; Hodgson D, 2014, CAMB ARCHAEOL J, V24, P57, DOI 10.1017/S0959774313000450; Joliot M, 2015, J NEUROSCI METH, V254, P46, DOI 10.1016/j.jneumeth.2015.07.013; Joordens JCA, 2015, NATURE, V518, P228, DOI 10.1038/nature13962; Kafkas A, 2014, HIPPOCAMPUS, V24, P516, DOI 10.1002/hipo.22241; Kahn I, 2004, J NEUROSCI, V24, P4172, DOI 10.1523/JNEUROSCI.0624-04.2004; Lamichhane B, 2016, BRAIN CONNECT, V6, P558, DOI 10.1089/brain.2015.0392; Langley MC, 2016, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-94-024-0899-7; Langley MC, 2020, EVOL ANTHROPOL, V29, P299, DOI 10.1002/evan.21857; Leder D, 2021, NAT ECOL EVOL, V5, P1273, DOI 10.1038/s41559-021-01487-z; Lewis JE, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0233; Li ZY, 2019, ANTIQUITY, V93, P886, DOI 10.15184/aqy.2019.81; Majkic A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195049; Majkic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173435; Malafouris L, 2021, J ARCHAEOL METHOD TH, V28, P95, DOI 10.1007/s10816-020-09504-4; Malafouris L, 2010, J ANTHROPOL SCI, V88, P49; Marti AP, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021495118; Martinon-Torres M, 2021, NATURE, V593, P95, DOI 10.1038/s41586-021-03457-8; Mellet E, 2019, J ARCHAEOL SCI-REP, V28, DOI 10.1016/j.jasrep.2019.102043; Mellet E, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.190086; Menon V., 2015, BRAIN MAPPING ENCY R, V2, P597, DOI DOI 10.1016/B978-0-12-397025-1.00052-X; Neta M, 2017, CEREB CORTEX, V27, P2154, DOI 10.1093/cercor/bhw053; Neta M, 2015, J NEUROSCI, V35, P253, DOI 10.1523/JNEUROSCI.1313-14.2015; Nowell A., 2011, STONE TOOLS EVOLUTIO, P234; Prevost M., 2021, QUAT INT; Putt SS, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0102; Putt SSJ, 2019, NEUROIMAGE, V199, P57, DOI 10.1016/j.neuroimage.2019.05.056; Renfrew C., 1994, ANCIENT MIND ELEMENT, P3; Rijpma MG, 2021, COGN NEUROPSYCHOL, V38, P88, DOI 10.1080/02643294.2020.1868984; Rodriguez-Vidal J, 2014, P NATL ACAD SCI USA, V111, P13301, DOI 10.1073/pnas.1411529111; Salagnon M., 2020, INTELLECTICA, P67; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shaham D, 2019, CURR ANTHROPOL, V60, P708, DOI 10.1086/705677; Shipton C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04057-3; Soressi M, 2013, P NATL ACAD SCI USA, V110, P14186, DOI 10.1073/pnas.1302730110; Stout D., 2015, NEUROARCHAEOLOGY, P145, DOI [10.1007/978-3-319-08500-5_7, DOI 10.1007/978-3-319-08500-5_7]; Stout D, 2008, PHILOS T R SOC B, V363, P1939, DOI 10.1098/rstb.2008.0001; Stout D, 2007, NEUROPSYCHOLOGIA, V45, P1091, DOI 10.1016/j.neuropsychologia.2006.09.014; Stout D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121804; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; Touroutoglou A, 2016, NEUROIMAGE, V132, P190, DOI 10.1016/j.neuroimage.2016.02.029; Touroutoglou A, 2012, NEUROIMAGE, V60, P1947, DOI 10.1016/j.neuroimage.2012.02.012; Tylen K, 2020, P NATL ACAD SCI USA, V117, P4578, DOI 10.1073/pnas.1910880117; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; Uomini NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072693; Van Kolfschoten T, 2015, J HUM EVOL, V89, P226, DOI 10.1016/j.jhevol.2015.09.012; Vandermeersch B., 2019, PALEO, V30, P256, DOI DOI 10.4000/PALEO.4848; Vanhaeren M, 2006, SCIENCE, V312, P1785, DOI 10.1126/science.1128139; Villa P, 2001, J HUM EVOL, V41, P69, DOI 10.1006/jhev.2001.0479; Villa P, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256090; Wadley L, 2020, SCIENCE, V367, P87, DOI 10.1126/science.aaz5926; Wadley L, 2013, CAMB ARCHAEOL J, V23, P163, DOI 10.1017/S0959774313000309; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; White TP, 2014, BRAIN COGNITION, V85, P191, DOI 10.1016/j.bandc.2013.12.002; Xu YD, 2005, CEREB CORTEX, V15, P1234, DOI 10.1093/cercor/bhi006; Zhou KK, 2021, FRONT BEHAV NEUROSCI, V15, DOI 10.3389/fnbeh.2021.634618; Zilhao J, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00435	91	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271732	http://dx.doi.org/10.1371/journal.pone.0271732			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921273	gold, Green Submitted, Green Published			2022-12-26	WOS:000839311900002
J	Sriramkumar, S; Metcalfe, TX; Lai, T; Zong, XY; Fang, F; O'Hagan, HM; Nephew, KP				Sriramkumar, Shruthi; Metcalfe, Tara X.; Lai, Tim; Zong, Xingyue; Fang, Fang; O'Hagan, Heather M.; Nephew, Kenneth P.			Single-cell analysis of a high-grade serous ovarian cancer cell line reveals transcriptomic changes and cell subpopulations sensitive to epigenetic combination treatment	PLOS ONE			English	Article							STEM-CELLS; IDENTIFICATION	Ovarian cancer (OC) is a lethal gynecological malignancy with a five-year survival rate of only 46%. Development of resistance to platinum-based chemotherapy is a common cause of high mortality rates among OC patients. Tumor and transcriptomic heterogeneity are drivers of platinum resistance in OC. Platinum-based chemotherapy enriches for ovarian cancer stem cells (OCSCs) that are chemoresistant and contribute to disease recurrence and relapse. Studies examining the effect of different treatments on subpopulations of HGSOC cell lines are limited. Having previously demonstrated that combined treatment with an enhancer of zeste homolog 2 inhibitor (EZH2i) and a RAC1 GTPase inhibitor (RAC1i) inhibited survival of OCSCs, we investigated EZH2i and RAC1i combination effects on HGSOC heterogeneity using single cell RNA sequencing. We demonstrated that RAC1i reduced expression of stemness and early secretory marker genes, increased expression of an intermediate secretory marker gene and induced inflammatory gene expression. Importantly, RAC1i alone and in combination with EZH2i significantly reduced oxidative phosphorylation and upregulated Sirtuin signaling pathways. Altogether, we demonstrated that combining a RAC1i with an EZH2i promoted differentiation of subpopulations of HGSOC cells, supporting the future development of epigenetic drug combinations as therapeutic approaches in OC.	[Sriramkumar, Shruthi; Metcalfe, Tara X.; Zong, Xingyue; O'Hagan, Heather M.; Nephew, Kenneth P.] Indiana Univ Sch Med, Cell Mol & Canc Biol Grad Program, Bloomington, IN 47405 USA; [Sriramkumar, Shruthi; Metcalfe, Tara X.; Zong, Xingyue; O'Hagan, Heather M.; Nephew, Kenneth P.] Indiana Univ Sch Med, Med Sci Program, Bloomington, IN 47405 USA; [Lai, Tim] Indiana Univ, Luddy Sch Informat Comp & Engn, Bloomington, IN USA; [Lai, Tim] Indiana Univ, Dept Math, Bloomington, IN 47405 USA; [Fang, Fang; O'Hagan, Heather M.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [O'Hagan, Heather M.; Nephew, Kenneth P.] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN 46204 USA; [Nephew, Kenneth P.] Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Indianapolis, IN 46202 USA; [Nephew, Kenneth P.] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	O'Hagan, HM; Nephew, KP (corresponding author), Indiana Univ Sch Med, Cell Mol & Canc Biol Grad Program, Bloomington, IN 47405 USA.; O'Hagan, HM; Nephew, KP (corresponding author), Indiana Univ Sch Med, Med Sci Program, Bloomington, IN 47405 USA.; O'Hagan, HM (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.; O'Hagan, HM; Nephew, KP (corresponding author), Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN 46204 USA.; Nephew, KP (corresponding author), Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Indianapolis, IN 46202 USA.; Nephew, KP (corresponding author), Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA.	hmohagan@indiana.edu; knephew@indiana.edu			Ovarian Cancer Research Alliance [458788]; Ovarian Cancer Alliance of Greater Cincinnati; IU Simon Comprehensive Cancer Center P30 Support Grant [P30CA082709-20]; Doane and Eunice Dahl Wright Fellowship	Ovarian Cancer Research Alliance; Ovarian Cancer Alliance of Greater Cincinnati; IU Simon Comprehensive Cancer Center P30 Support Grant; Doane and Eunice Dahl Wright Fellowship	This research was funded in part by the Ovarian Cancer Research Alliance (grant number 458788 to HMOH and KPN), the Ovarian Cancer Alliance of Greater Cincinnati (to KPN) and through the IU Simon Comprehensive Cancer Center P30 Support Grant (P30CA082709-20). SS was supported by the Doane and Eunice Dahl Wright Fellowship generously provided by Ms. Imogen Dahl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Bowen NJ, 2007, GYNECOL ONCOL, V104, P331, DOI 10.1016/j.ygyno.2006.08.052; Chien J, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00251; Dagogo-Jack I, 2018, NAT REV CLIN ONCOL, V15, P81, DOI 10.1038/nrclinonc.2017.166; Dinh HQ, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.108978; Elefantova K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071985; Fan J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.65; Fang F, 2014, CLIN CANCER RES, V20, P6504, DOI 10.1158/1078-0432.CCR-14-1553; Gabbasov R, 2018, ONCOGENE, V37, P4854, DOI 10.1038/s41388-018-0296-y; Geistlinger L, 2020, CANCER RES, V80, P4335, DOI 10.1158/0008-5472.CAN-20-0521; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hao Q, 2021, CLIN TRANSL MED, V11, DOI 10.1002/ctm2.500; Hibbs K, 2004, AM J PATHOL, V165, P397, DOI 10.1016/S0002-9440(10)63306-8; Ippolito L, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00256; Kan TT, 2022, ONCOGENE, V41, P895, DOI 10.1038/s41388-021-02139-z; Kim Y, 2018, CELL REP, V23, P2550, DOI 10.1016/j.celrep.2018.04.105; Kryczek I, 2012, INT J CANCER, V130, P29, DOI 10.1002/ijc.25967; Li Y, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/1005793; Luvero D, 2019, CRIT REV ONCOL HEMAT, V140, P28, DOI 10.1016/j.critrevonc.2019.05.014; Miller SA, 2021, CANCER RES, V81, P3791, DOI 10.1158/0008-5472.CAN-20-3562; Nwani NG, 2019, CANCERS, V11, DOI 10.3390/cancers11040502; Parte SC, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0439-3; Pasto A, 2014, ONCOTARGET, V5, P4305, DOI 10.18632/oncotarget.2010; Regner MJ, 2021, MOL CELL, V81, P4924, DOI 10.1016/j.molcel.2021.10.013; Shaffer SM, 2017, NATURE, V546, P431, DOI 10.1038/nature22794; Sood R., 2021, BIORXIV; Sriramkumar S., 2022, BIORXIV, DOI [10.1186/s12967-022-03447-y, DOI 10.1186/S12967-022-03447-Y]; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Sun LN, 2013, J CELL SCI, V126, P3939, DOI 10.1242/jcs.127381; Sun LN, 2013, JNCI-J NATL CANCER I, V105, P887, DOI 10.1093/jnci/djt118; Suster NK, 2019, WORLD J STEM CELLS, V11, P383, DOI 10.4252/wjsc.v11.i7.383; Torre LA, 2018, CA-CANCER J CLIN, V68, P284, DOI 10.3322/caac.21456; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; Valle S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18954-z; Vegliante R, 2022, EMBO J, V41, DOI 10.15252/embj.2021109221; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Wang YN, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122360; Wang YN, 2014, CANCER RES, V74, P4922, DOI 10.1158/0008-5472.CAN-14-1022; Woo MMM, 2004, GYNECOL ONCOL, V93, P315, DOI 10.1016/j.ygyno.2004.01.047; Ye XQ, 2011, INT J CANCER, V129, P820, DOI 10.1002/ijc.25944; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6; Zong XY, 2020, CANCER RES, V80, P4371, DOI 10.1158/0008-5472.CAN-20-0458	44	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271584	http://dx.doi.org/10.1371/journal.pone.0271584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921335	Green Published, gold			2022-12-26	WOS:000839311900004
J	Williams, CD; Rocque, G; Caston, N; Gallagher, KS; Angove, RSMT; Anderson, EC; de Moor, J; Halpern, M; Ii, AO; Gidwani, R				Williams, Courtney D.; Rocque, Gabrielle; Caston, Nicole; Gallagher, Kathleen S.; Angove, Rebekah S. M. T.; Anderson, Eric C.; de Moor, Janet; Halpern, Michael; Offodile II, Anaeze; Gidwani, Risha			Health insurance and financial hardship in cancer survivors during the COVID-19 pandemic	PLOS ONE			English	Article								Uninsured or underinsured individuals with cancer are likely to experience financial hardship, including forgoing healthcare or non-healthcare needs such as food, housing, or utilities. This study evaluates the association between health insurance coverage and financial hardship among cancer survivors during the COVID-19 pandemic. This cross-sectional analysis used Patient Advocate Foundation (PAF) survey data from May to July 2020. Cancer survivors who previously received case management or financial aid from PAF self-reported challenges paying for healthcare and non-healthcare needs during the COVID-19 pandemic. Associations between insurance coverage and payment challenges were estimated using Poisson regression with robust standard errors, which allowed for estimation of adjusted relative risks (aRR). Of 1,437 respondents, 74% had annual household incomes <$48,000. Most respondents were enrolled in Medicare (48%), 22% in employer-sponsored insurance, 13% in Medicaid, 6% in an Affordable Care Act (ACA) plan, and 3% were uninsured. Approximately 31% of respondents reported trouble paying for healthcare during the COVID-19 pandemic. Respondents who were uninsured (aRR 2.58, 95% confidence interval [CI] 1.83-3.64), enrolled in an ACA plan (aRR 1.86, 95% CI 1.28-2.72), employer-sponsored insurance (aRR 1.70, 95% CI 1.23-2.34), or Medicare (aRR 1.49, 95% CI 1.09-2.03) had higher risk of trouble paying for healthcare compared to Medicaid enrollees. Challenges paying for non-healthcare needs were reported by 57% of respondents, with 40% reporting trouble paying for food, 31% housing, 28% transportation, and 20% internet. In adjusted models, Medicare and employer-sponsored insurance enrollees were less likely to have difficulties paying for non-healthcare needs compared to Medicaid beneficiaries. Despite 97% of our cancer survivor sample being insured, 31% and 57% reported trouble paying for healthcare and non-healthcare needs during the COVID-19 pandemic, respectively. Greater attention to both medical and non-medical financial burden is needed given the economic pressures of the COVID-19 pandemic.	[Williams, Courtney D.; Rocque, Gabrielle; Caston, Nicole] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Gallagher, Kathleen S.; Angove, Rebekah S. M. T.; Anderson, Eric C.] Patient Advocate Fdn, Hampton, VA USA; [de Moor, Janet; Halpern, Michael] NCI, Div Canc Control & Populat Sci, Rockville, MD USA; [Offodile II, Anaeze] Univ Texas MD Anderson Canc Ctr, Dept Plast Surg, Div Surg, Houston, TX USA; [Gidwani, Risha] UCLA Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA	University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Los Angeles	Williams, CD (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	courtneywilliams@uabmc.edu		Williams, Courtney/0000-0001-5328-7517; Halpern, Michael/0000-0001-8514-6313; Caston, Nicole E/0000-0001-7474-6110				Brooks T., 2019, MEDICAID CHIP ELIGIB; Chino F, 2017, JAMA ONCOL, V3, P1582, DOI 10.1001/jamaoncol.2017.2148; Claxton G, 2020, HEALTH AFFAIR, V39, P2018, DOI 10.1377/hlthaff.2020.01569; Cohen R.A., 2018, HLTH INSURANCE COVER; Collins Sara R, 2015, Issue Brief (Commonw Fund), V13, P1; Cox C., 2021, AFFORDABILITY ACA MA; Dusetzina SB, 2019, JAMA-J AM MED ASSOC, V321, P2025, DOI 10.1001/jama.2019.4492; Fletcher SA, 2020, CANCER-AM CANCER SOC, V126, P496, DOI 10.1002/cncr.32562; Garfield R CG, ELIGIBILITY ACA HLTH; Han XS, 2020, CANCER EPIDEM BIOMAR, V29, P308, DOI 10.1158/1055-9965.EPI-19-0460; Koonin LM, 2020, MMWR-MORBID MORTAL W, V69, P1595, DOI 10.15585/mmwr.mm6943a3; McDougall JA, 2020, JCO ONCOL PRACT, V16, pE922, DOI 10.1200/JOP.19.00736; Nipp RD, 2018, JAMA ONCOL, V4, P791, DOI 10.1001/jamaoncol.2018.0097; Resio BJ, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.4595; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	15	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8							e0272740	10.1371/journal.pone.0272740	http://dx.doi.org/10.1371/journal.pone.0272740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P8ZE	35930603	Green Published, gold			2022-12-26	WOS:000837822100011
J	Francis, V; Alshafie, W; Kumar, R; Girard, M; Brais, B; McPherson, PS				Francis, Vincent; Alshafie, Walaa; Kumar, Rahul; Girard, Martine; Brais, Bernard; McPherson, Peter S.			The ARSACS disease protein sacsin controls lysosomal positioning and reformation by regulating microtubule dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE SPASTIC ATAXIA; TRANSPORT; MUTATIONS; DEFECTS; COMPLEX; RHO	Autosomal recessive spastic ataxia of Charlevoix-Saguenay is a fatal brain disorder featuring cerebellar neurodegeneration leading to spasticity and ataxia. This disease is caused by mutations in the SACS gene that encodes sacsin, a massive 4579-amino acid protein with multiple modular domains. However, molecular details of the function of sacsin are not clear. Here, using live cell imaging and biochemistry, we demonstrate that sacsin binds to microtubules and regulates microtubule dynamics. Loss of sacsin function in various cell types, including knockdown and KO primary neurons and patient fibroblasts, leads to alterations in lysosomal transport, positioning, function, and reformation following autophagy. Each of these phenotypic changes is consistent with altered microtubule dynamics. We further show the effects of sacsin are mediated at least in part through interactions with JIP3, an adapter for microtubule motors. These data reveal a new function for sacsin that explains its previously reported roles and phenotypes.	[Francis, Vincent; Alshafie, Walaa; Kumar, Rahul; Girard, Martine; Brais, Bernard; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada	McGill University	McPherson, PS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	peter.mcpherson@mcgill.ca		Kumar, Rahul/0000-0002-7762-807X	Fonds de Recherche du Quebec-Sante; ALS Canada	Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); ALS Canada	V. F. was supported by a fellowship from the Fonds de Recherche du Quebec-Sante. R. K. was supported by a fellowship from ALS Canada.	Anderrson JF, 2011, J MOL BIOL, V411, P870, DOI 10.1016/j.jmb.2011.06.016; Anderson JF, 2010, J MOL BIOL, V400, P665, DOI 10.1016/j.jmb.2010.05.023; Bagci H, 2020, NAT CELL BIOL, V22, P120, DOI 10.1038/s41556-019-0438-7; Bagshaw RD, 2006, BIOCHEM BIOPH RES CO, V344, P1186, DOI 10.1016/j.bbrc.2006.03.221; Ballabio A, 2020, NAT REV MOL CELL BIO, V21, P101, DOI 10.1038/s41580-019-0185-4; Barisic M, 2015, SCIENCE, V348, P799, DOI 10.1126/science.aaa5175; BOUCHARD JP, 1978, CAN J NEUROL SCI, V5, P61, DOI 10.1017/S0317167100024793; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Chen Y, 2018, MOL CELLS, V41, P45, DOI 10.14348/molcells.2018.2265; Dai AB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11694-9; Drerup CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003303; Du WQ, 2016, DEV CELL, V37, P326, DOI 10.1016/j.devcel.2016.04.014; Duncan EJ, 2017, HUM MOL GENET, V26, P3130, DOI 10.1093/hmg/ddx197; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Farias GG, 2016, METHODS MOL BIOL, V1496, P13, DOI 10.1007/978-1-4939-6463-5_2; Girard M, 2012, P NATL ACAD SCI USA, V109, P1661, DOI 10.1073/pnas.1113166109; Gowrishankar S, 2017, J CELL BIOL, V216, P3291, DOI 10.1083/jcb.201612148; Huang SH, 2011, J NEUROSCI, V31, P10602, DOI 10.1523/JNEUROSCI.0436-11.2011; Khatter Divya, 2015, Cell Logist, V5, pe1086501; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kozlov G, 2011, J BIOL CHEM, V286, P20407, DOI 10.1074/jbc.M111.232884; Lariviere R, 2015, HUM MOL GENET, V24, P727, DOI 10.1093/hmg/ddu491; Matveeva EA, 2015, BIOL OPEN, V4, P1290, DOI 10.1242/bio.011874; Mohan N, 2019, J CELL BIOL, V218, P632, DOI 10.1083/jcb.201807124; Morani F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48047-x; NEELY MD, 1988, J CELL BIOL, V107, P1767, DOI 10.1083/jcb.107.5.1767; Parfitt DA, 2009, HUM MOL GENET, V18, P1556, DOI 10.1093/hmg/ddp067; Pu J, 2016, J CELL SCI, V129, P4329, DOI 10.1242/jcs.196287; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Romano A, 2013, HUM MUTAT, V34, P525, DOI 10.1002/humu.22269; Rong YG, 2012, NAT CELL BIOL, V14, P924, DOI 10.1038/ncb2557; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Synofzik M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-41; Vermeer S, 2008, NEUROGENETICS, V9, P207, DOI 10.1007/s10048-008-0131-7; Walczak CE, 2000, CURR OPIN CELL BIOL, V12, P52, DOI 10.1016/S0955-0674(99)00056-3; Yang C, 2017, J CELL BIOL, V216, P3179, DOI 10.1083/jcb.201701024; Yasuda J, 1999, MOL CELL BIOL, V19, P7245	38	2	2	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102320	10.1016/j.jbc.2022.102320	http://dx.doi.org/10.1016/j.jbc.2022.102320			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6F7ME	35933016	Green Published, gold			2022-12-26	WOS:000884241800004
J	Faccin, M; Gargiulo, F; Atlani-Duault, L; Ward, JK				Faccin, Mauro; Gargiulo, Floriana; Atlani-Duault, Laetitia; Ward, Jeremy K.			Assessing the influence of French vaccine critics during the two first years of the COVID-19 pandemic	PLOS ONE			English	Article							HESITANCY; NETWORK	When the threat of COVID-19 became widely acknowledged, many hoped that this pandemic would squash "the anti-vaccine movement". However, when vaccines started arriving in rich countries at the end of 2020, it appeared that vaccine hesitancy might be an issue even in the context of this major pandemic. Does it mean that the mobilization of vaccine-critical activists on social media is one of the main causes of this reticence to vaccinate against COVID-19? In this paper, we wish to contribute to current work on vaccine hesitancy during the COVID-19 pandemic by looking at one of the many mechanisms which can cause reticence towards vaccines: the capacity of vaccine-critical activists to influence a wider public on social media. We analyze the evolution of debates over the COVID-19 vaccine on the French Twittosphere, during two first years of the pandemic, with a particular attention to the spreading capacity of vaccine-critical websites. We address two main questions: 1) Did vaccine-critical contents gain ground during this period? 2) Who were the main actors in the diffusion of these contents? While debates over vaccines experienced a tremendous surge during this period, the share of vaccine-critical contents in these debates remains stable except for a limited number of short periods associated with specific events. Secondly, analyzing the community structure of the re-tweets hyper-graph, we reconstruct the mesoscale structure of the information flows, identifying and characterizing the major communities of users. We analyze their role in the information ecosystem: the largest right-wing community has a typical echo-chamber behavior collecting all the vaccine-critical tweets from outside and recirculating it inside the community. The smaller left-wing community is less permeable to vaccine-critical contents but, has a large capacity to spread it once adopted.	[Faccin, Mauro; Atlani-Duault, Laetitia] Univ Paris, IRD & CEPED, Paris, France; [Gargiulo, Floriana] CNRS, GEMASS, Paris, France; [Atlani-Duault, Laetitia] Univ Paris, Inst COVID 19 Add Memoriam, Paris, France; [Atlani-Duault, Laetitia] Univ Paris, WHO Collaborat Ctr Res Hlth & Humanitarian Polici, Paris, France; [Atlani-Duault, Laetitia] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Ward, Jeremy K.] Univ Paris, EHESS, CNRS, CERMES3,INSERM, Villejuif, France	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Columbia University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Faccin, M (corresponding author), Univ Paris, IRD & CEPED, Paris, France.	mauro.fccn@gmail.com	Gargiulo, Floriana/GYJ-8061-2022	faccin, mauro/0000-0003-0706-3007	Agence Nationale de la Recherche (ANR) through project TRACTRUST [ANR-20-COVI-0102]; Agence nationale de recherches sur le sida-Maladies infectieuses emergentes (ANRS-MIE), project MEDIACAM [ANRSCOV24]; Agence Nationale de la Recherche (ANR), through project SLAVACO [ANR 20-COV8-0009-01]	Agence Nationale de la Recherche (ANR) through project TRACTRUST(French National Research Agency (ANR)); Agence nationale de recherches sur le sida-Maladies infectieuses emergentes (ANRS-MIE), project MEDIACAM; Agence Nationale de la Recherche (ANR), through project SLAVACO(French National Research Agency (ANR))	This study was funded by Agence Nationale de la Recherche (ANR) through project TRACTRUST, (ANR-20-COVI-0102) Agence nationale de recherches sur le sida-Maladies infectieuses emergentes (ANRS-MIE), project MEDIACAM -ANRSCOV24 to MF and by Agence Nationale de la Recherche (ANR), through project SLAVACO -ANR 20-COV8-0009-01 to JW.	Altay S, 2021, MISINFORMATION MISIN, DOI [10.31234/osf.io/edqc8, DOI 10.31234/OSF.IO/EDQC8]; Arguedas AR, 2022, ECHO CHAMBERS FILTER; Berlivet L, 2020, MED ANTHROPOL Q, V34, P525, DOI 10.1111/maq.12622; Betsch C, 2012, VACCINE, V30, P3727, DOI 10.1016/j.vaccine.2012.02.025; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brede M., 2010, NETWORKS AN INTRO, V18, P241, DOI 10.1093/acprof:oso/9780199206650.001.0001/acprof-9780199206650; Bridgman A., 2021, FRONTIERS POLITICAL, V3, P20, DOI [10.3389/fpos.2021.727073, DOI 10.3389/FPOS.2021.727073]; Briggs CL, 2016, MAKING HEALTH PUBLIC: HOW NEWS COVERAGE IS REMAKING MEDIA, MEDICINE, AND CONTEMPORARY LIFE, P1, DOI 10.4324/9781315658049; Cafiero F, 2021, SOC NETWORKS, V65, P63, DOI 10.1016/j.socnet.2020.11.004; Carletti T, 2021, J PHYS-COMPLEXITY, V2, DOI 10.1088/2632-072X/abe27e; Carletti T, 2020, PHYS REV E, V101, DOI 10.1103/PhysRevE.101.022308; Cossard A, 2020, ARXIV; de Figueiredo A, 2021, ECLINICALMEDICINE, V40, DOI 10.1016/j.eclinm.2021.101109; Delvenne JC, 2010, P NATL ACAD SCI USA, V107, P12755, DOI 10.1073/pnas.0903215107; Dube E, 2021, ANNU REV PUBL HEALTH, V42, P175, DOI 10.1146/annurev-publhealth-090419-102240; Dugue N, 2015, SOC NETW ANAL MIN, V5, DOI 10.1007/s13278-015-0266-0; Eyal G, 2019, CRISIS EXPERTISE; Faccin M, DATACOVVAC; Gargiulo F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62880-5; Gauchat G, 2012, AM SOCIOL REV, V77, P167, DOI 10.1177/0003122412438225; Germani F, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247642; Goldenberg MJ, 2021, VACCINE HESITANCY, DOI [10.2307/j.ctv1ghv4-4, DOI 10.2307/J.CTV1GHV4-4]; Gurwitz D, 2021, VACCINE, V39, P3785, DOI 10.1016/j.vaccine.2021.05.085; Hacquin AS, 2020, SHARP RISE VACCINE H, DOI [10.31234/osf.io/r8h6z, DOI 10.31234/OSF.IO/R8H6Z]; Johnson NF, 2020, NATURE, V582, P230, DOI 10.1038/s41586-020-2281-1; Larson HJ, 2021, SCIENCE, V371, P1289, DOI 10.1126/science.abi6488; Larson HJ, 2019, SCIENCE, V364, P105, DOI 10.1126/science.aax6172; Lewandowsky S, 2021, COVID 19 VACCINE COM; Lindholt MF, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-048172; Mann M, 2020, SOC FORCES, V99, P305, DOI 10.1093/sf/soz156; Marshall GS, 2019, J PEDIAT INF DIS SOC, V8, P1, DOI 10.1093/jpids/piy082; Faccin M, 2022, Arxiv, DOI arXiv:2202.12810; Menczer F, 2019, ANTIVAXXERS APPEAR B; Omer SB, 2021, LANCET, V398, P2186, DOI 10.1016/S0140-6736(21)02507-1; Ooghe-Tabanou B, GAZOUILLOIRE TWITTER; Ortiz-Sanchez E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155394; Rousseau C, 2015, PUBLIC UNDERST SCI, V24, P225, DOI 10.1177/0963662513495149; Scheufele DA, 2021, J APPL RES MEM COGN, V10, P522; Schmidt AL, 2018, VACCINE, V36, P3606, DOI 10.1016/j.vaccine.2018.05.040; Schultz E, 2022, J SOCIOL, V58, P76, DOI 10.1177/1440783321999453; Smyrnaios N, 2021, COMMUNIQUER, P63, DOI 10.4000/communiquer.8309; Sturgis P, 2021, NAT HUM BEHAV, V5, P1528, DOI 10.1038/s41562-021-01115-7; Suldovsky B, 2019, PUBLIC UNDERST SCI, V28, P797, DOI 10.1177/0963662519856768; Theocharis Y, 2021, NEW MEDIA SOC, DOI 10.1177/14614448211045666; Trujillo KL, 2021, INT J PUBLIC OPIN R, V33, P551, DOI 10.1093/ijpor/edab012; Uscinski JE, 2021, AM J POLIT SCI, V65, P877, DOI 10.1111/ajps.12616; Waldersee V., 2020, REUTERS; Quattrociocchi W, 2021, Arxiv, DOI arXiv:2107.07946; Ward J.K., 2019, SOCIOLOGIE, V4, P377, DOI [DOI 10.3917/SOCIO.104.0377, 10.3917/socio.104.0377]; Ward JK, 2022, NAT MED, V28, P232, DOI 10.1038/s41591-021-01661-7; Ward JK, 2019, NAT IMMUNOL, V20, P1257, DOI 10.1038/s41590-019-0488-9; Ward JK, 2016, HUM VACC IMMUNOTHER, V12, P1924, DOI 10.1080/21645515.2016.1146430; Whitford P, APPG REPORT IMPROVIN; Williams HTP, 2015, GLOBAL ENVIRON CHANG, V32, P126, DOI 10.1016/j.gloenvcha.2015.03.006; Zuckerman E, 2019, MEDIA POLARIZATION A	55	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271157	10.1371/journal.pone.0271157	http://dx.doi.org/10.1371/journal.pone.0271157			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925962	gold, Green Submitted, Green Published			2022-12-26	WOS:000848077100033
J	Lagasse, BJ; Lanctot, RB; Brown, S; Dondua, AG; Kendall, S; Latty, CJ; Liebezeit, JR; Loktionov, EY; Maslovsky, KS; Matsyna, AI; Matsyna, EL; McGuire, RL; Payer, DC; Saalfeld, ST; Slaght, JC; Solovyeva, DV; Tomkovich, PS; Valchuk, OP; Wunder, MB				Lagasse, Benjamin J.; Lanctot, Richard B.; Brown, Stephen; Dondua, Alexei G.; Kendall, Steve; Latty, Christopher J.; Liebezeit, Joseph R.; Loktionov, Egor Y.; Maslovsky, Konstantin S.; Matsyna, Alexander, I; Matsyna, Ekaterina L.; McGuire, Rebecca L.; Payer, David C.; Saalfeld, Sarah T.; Slaght, Jonathan C.; Solovyeva, Diana, V; Tomkovich, Pavel S.; Valchuk, Olga P.; Wunder, Michael B.			Migratory network reveals unique spatial-temporal migration dynamics of Dunlin subspecies along the East Asian-Australasian Flyway	PLOS ONE			English	Article							CALIDRIS-ALPINA; POPULATION DECLINES; STAGING AREA; YELLOW SEA; RED KNOTS; CONSERVATION; SHOREBIRDS; CONNECTIVITY; STRATEGIES; CONSEQUENCES	Determining the dynamics of where and when individuals occur is necessary to understand population declines and identify critical areas for populations of conservation concern. However, there are few examples where a spatially and temporally explicit model has been used to evaluate the migratory dynamics of a bird population across its entire annual cycle. We used geolocator-derived migration tracks of 84 Dunlin (Calidris alpina) on the East Asian Australasian Flyway (EAAF) to construct a migratory network describing annual subspecies-specific migration patterns in space and time. We found that Dunlin subspecies exhibited unique patterns of spatial and temporal flyway use. Spatially, C. a. arcticola predominated in regions along the eastern edge of the flyway (e.g., western Alaska and central Japan), whereas C. a. sakhalina predominated in regions along the western edge of the flyway (e.g., N China and inland China). No individual Dunlin that wintered in Japan also wintered in the Yellow Sea, China seas, or inland China, and vice-versa. However, similar proportions of the 4 subspecies used many of the same regions at the center of the flyway (e.g., N Sakhalin Island and the Yellow Sea). Temporally, Dunlin subspecies staggered their south migrations and exhibited little temporal overlap among subspecies within shared migration regions. In contrast, Dunlin subspecies migrated simultaneously during north migration. South migration was also characterized by individuals stopping more often and for more days than during north migration. Taken together, these spatial-temporal migration dynamics indicate Dunlin subspecies may be differentially affected by regional habitat change and population declines according to where and when they occur. We suggest that the migration dynamics presented here are useful for guiding on-the-ground survey efforts to quantify subspecies' use of specific sites, and to estimate subspecies' population sizes and long-term trends. Such studies would significantly advance our understanding of Dunlin space-time dynamics and the coordination of Dunlin conservation actions across the EAAF.	[Lagasse, Benjamin J.; Wunder, Michael B.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [Lanctot, Richard B.; Saalfeld, Sarah T.] US Fish & Wildlife Serv, Div Migratory Bird Management, Anchorage, AK USA; [Brown, Stephen] Manomet Inc, Saxtons River, VT USA; [Dondua, Alexei G.] Beringia Natl Pk, Providenia, Russia; [Kendall, Steve; Latty, Christopher J.; Payer, David C.] US Fish & Wildlife Serv, Arctic Natl Wildlife Refuge, Fairbanks, AK USA; [Liebezeit, Joseph R.] Wildlife Conservat Soc, Portland, OR USA; [Loktionov, Egor Y.] Bauman Moscow State Tech Univ, Moscow, Russia; [Maslovsky, Konstantin S.; Valchuk, Olga P.] Russian Acad Sci, Fed Sci Ctr East Asia Terr Biodivers, Far Eastern Branch, Vladivostok, Russia; [Matsyna, Alexander, I; Matsyna, Ekaterina L.] Working Grp Waders Northern Eurasia, Nizhnii Novgorod, Russia; [McGuire, Rebecca L.; Slaght, Jonathan C.] Wildlife Conservat Soc, Arctic Beringia Reg Program, Fairbanks, AK USA; [Solovyeva, Diana, V] Inst Biol Problems North, Magadan, Russia; [Tomkovich, Pavel S.] Lomonosov Moscow State Univ, Zool Museum, Moscow, Russia; [Lagasse, Benjamin J.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA; [Liebezeit, Joseph R.] Portland Audubon, Portland, OR USA; [Payer, David C.] Natl Pk Serv, Anchorage, AK USA	University of Colorado System; University of Colorado Denver; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; Wildlife Conservation Society; Bauman Moscow State Technical University; Russian Academy of Sciences; Federal Scientific Center of the East Asia Terrestrial Biodiversity, Far Eastern Branch of the Russian Academy of Sciences; Wildlife Conservation Society; Institute of Biological Problems of the North; Lomonosov Moscow State University; University of Alaska System; University of Alaska Fairbanks; United States Department of the Interior	Lagasse, BJ (corresponding author), Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA.; Lagasse, BJ (corresponding author), Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA.	benjamin.j.lagasse@gmail.com			American Ornithological Society-Alexander Wetmore Research Award; NGO Amur-Ussuri Center for Avian Biodiversity (Vladivostok, Russia); Arctic Landscape Conservation Cooperative; Arctic Shorebird Demographics Network; BirdsRussia; Bureau of Land Management; Calvin J. Lensink Fund; MacArthur Foundation; Manomet Inc.Shorebird Recovery Program; National Fish and Wildlife Foundation; Neotropical Migratory Bird Conservation Act Grant Program; Nuttall Ornithological Club-Blake-Nuttall Fund Grant; Trust for Mutual Understanding; U.S. Fish and Wildlife Service; Wildlife Conservation Society-Arctic Beringia Regional Program; Wilson Ornithological SocietyPaul A. Stewart Grant	American Ornithological Society-Alexander Wetmore Research Award; NGO Amur-Ussuri Center for Avian Biodiversity (Vladivostok, Russia); Arctic Landscape Conservation Cooperative; Arctic Shorebird Demographics Network; BirdsRussia; Bureau of Land Management; Calvin J. Lensink Fund; MacArthur Foundation; Manomet Inc.Shorebird Recovery Program; National Fish and Wildlife Foundation; Neotropical Migratory Bird Conservation Act Grant Program; Nuttall Ornithological Club-Blake-Nuttall Fund Grant; Trust for Mutual Understanding; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Wildlife Conservation Society-Arctic Beringia Regional Program; Wilson Ornithological SocietyPaul A. Stewart Grant	This work was funded by the American Ornithological Society-Alexander Wetmore Research Award, NGO Amur-Ussuri Center for Avian Biodiversity (Vladivostok, Russia), Arctic Landscape Conservation Cooperative, Arctic Shorebird Demographics Network, BirdsRussia, Bureau of Land Management, Calvin J. Lensink Fund, The MacArthur Foundation, Manomet Inc.Shorebird Recovery Program, National Fish and Wildlife Foundation, Neotropical Migratory Bird Conservation Act Grant Program, The Nuttall Ornithological Club-Blake-Nuttall Fund Grant, The Trust for Mutual Understanding, U.S. Fish and Wildlife Service (Avian Influenza Program, Migratory Bird Management Division, National Wildlife Refuge Challenge Cost Share Program, National Wildlife Refuge Division), Wildlife Conservation Society-Arctic Beringia Regional Program, and the Wilson Ornithological SocietyPaul A. Stewart Grant.	Aharon-Rotman Y, 2017, ECOL EVOL, V7, P10440, DOI 10.1002/ece3.3566; Alerstam T., 1990, P331; Amano T, 2010, BIOL CONSERV, V143, P2238, DOI 10.1016/j.biocon.2010.06.010; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; Bamford M., 2008, MIGRATORY SHOREBIRDS; Bart J, 2007, J AVIAN BIOL, V38, P73, DOI 10.1111/j.2007.0908-8857.03698.x; Barter MA, 2004, STATUS CONSERVATION, V17, P183; Bauer S, 2016, OIKOS, V125, P605, DOI 10.1111/oik.02706; Bentzen Rebecca, 2016, Wader Study, V123, P86, DOI 10.18194/ws.00034; Blokhin AY, 2004, WADERS E EUROPE NO R, P21; Bracey A, 2018, AUK, V135, P385, DOI 10.1642/AUK-17-210.1; Briedis M, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0679; Brown SC, 2014, **DATA OBJECT**, DOI 10.18739/A2K89M; Cao L, 2009, EMU, V109, P170, DOI 10.1071/MU08051; Chan YC, 2019, J APPL ECOL, V56, P2305, DOI 10.1111/1365-2664.13474; Chen J, LIVING YANGTZE REPOR; Choi C.Y., 2020, CHINA COASTAL WATERB; Choi CY, 2011, J FIELD ORNITHOL, V82, P202, DOI 10.1111/j.1557-9263.2011.00323.x; Conklin J.R., 2014, PRIORITIZING MIGRATO; Dhanjal-Adams KL, 2017, CONSERV BIOL, V31, P646, DOI 10.1111/cobi.12842; Doll AC, 2015, AUK, V132, P408, DOI 10.1642/AUK-14-227.1; Edelhoff H, 2016, MOV ECOL, V4, DOI 10.1186/s40462-016-0086-5; Ekstrom Philip A., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P210; Engelmoer M., 1998, GEOGRAPHICAL VARIATI, DOI DOI 10.1007/978-94-011-5016-3; Fair J.M., 2010, GUIDELINES USE WILD; Finch T, 2015, DIVERS DISTRIB, V21, P1051, DOI 10.1111/ddi.12345; Fraser KC, 2012, P ROY SOC B-BIOL SCI, V279, P4901, DOI 10.1098/rspb.2012.2207; Fudickar AM, 2012, METHODS ECOL EVOL, V3, P47, DOI 10.1111/j.2041-210X.2011.00136.x; Gates HR, 2013, J FIELD ORNITHOL, V84, P389, DOI 10.1111/jofo.12038; Hewson CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12296; Hijmans R.J., 2016, RASTER GEOGRAPHIC DA; Hill RD., 1994, ELEPHANT SEALS POPUL, P228; HOLMES RT, 1966, AUK, V83, P517, DOI 10.2307/4083147; HOLMES RT, 1971, CONDOR, V73, P93, DOI 10.2307/1366128; HOLMGREN N, 1993, ORNIS SCAND, V24, P21, DOI 10.2307/3676405; Hua N, 2015, BIRD CONSERV INT, V25, P38, DOI 10.1017/S0959270914000380; Iwamura T, 2014, CONSERV BIOL, V28, P1710, DOI 10.1111/cobi.12319; Iwamura T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0325; Jacoby DMP, 2016, TRENDS ECOL EVOL, V31, P301, DOI 10.1016/j.tree.2016.01.011; Karagicheva J, 2016, J BIOL RHYTHM, V31, P509, DOI 10.1177/0748730416655929; Kirby J, 2011, REV 2 REV CURRENT KN; Kirby JS, 2008, BIRD CONSERV INT, V18, pS49, DOI 10.1017/S0959270908000439; Knight SM, 2018, ECOL MONOGR, V88, P445, DOI 10.1002/ecm.1298/full; Kolzsch A, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180438; Kolzsch A, 2015, J ANIM ECOL, V84, P272, DOI 10.1111/1365-2656.12281; Kramer GR, 2018, P NATL ACAD SCI USA, V115, pE3192, DOI 10.1073/pnas.1718985115; Kramer GR, 2017, CONDOR, V119, P108, DOI 10.1650/CONDOR-16-143.1; Lagasse BJ, 2020, CONDOR, V122, DOI 10.1093/condor/duaa054; Lamb JS, 2019, ECOL APPL, V29, DOI 10.1002/eap.1919; Lanctot RB, 2009, P 2009 INT S COASTAL, P149; Lank DB, 2003, OIKOS, V103, P303, DOI 10.1034/j.1600-0706.2003.12314.x; Lindstrom Ake, 2020, Wader Study, V127, P2, DOI 10.18194/ws.00181; Lisovski S, 2020, J ANIM ECOL, V89, P221, DOI 10.1111/1365-2656.13036; Lisovski S, 2012, METHODS ECOL EVOL, V3, P603, DOI 10.1111/j.2041-210X.2012.00185.x; Lopes RJ, 2008, DIVERS DISTRIB, V14, P732, DOI 10.1111/j.1472-4642.2008.00480.x; Lopes RJ, 2006, J ORNITHOL, V147, P385, DOI 10.1007/s10336-005-0048-y; McKinnon EA, 2018, AUK, V135, P834, DOI 10.1642/AUK-17-202.1; McKinnon Emily A., 2013, Animal Migration, V1, P31, DOI 10.2478/ami-2013-0001; Miller MP, 2015, EVOL APPL, V8, P149, DOI 10.1111/eva.12239; Moores N, 2016, EMU, V116, P136, DOI 10.1071/MU16006; Morrick ZN, 2022, CONSERV SCI PRACT, V4, DOI 10.1111/csp2.594; Murray NJ, 2018, ECOGRAPHY, V41, P867, DOI 10.1111/ecog.02957; Myers J.P., 1987, American Scientist, V75, P18; Pakanen VM, 2018, J AVIAN BIOL, V49, DOI 10.1111/jav.01513; Pennycuick CJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0419; Piersma T, 2007, J ORNITHOL, V148, pS45, DOI 10.1007/s10336-007-0240-3; Piersma T, 2016, J APPL ECOL, V53, P479, DOI 10.1111/1365-2664.12582; Priklonsky SG., 1960, ZOOL ZH, V39, P623; R Core Team, 2021, R LANG ENV STAT; Rakhimberdiev E, 2019, FLIGHTR SSM SOLAR GE; Rakhimberdiev E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06673-5; Rakhimberdiev E, 2017, METHODS ECOL EVOL, V8, P1482, DOI 10.1111/2041-210X.12765; Rakhimberdiev E, 2016, J AVIAN BIOL, V47, P589, DOI 10.1111/jav.00891; Rakhimberdiev E, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0062-5; Reed ET, 2018, CONDOR, V120, P357, DOI 10.1650/CONDOR-17-127.1; Reneerkens J, 2020, J ANIM ECOL, V89, P691, DOI 10.1111/1365-2656.13118; Rogers DI, 2010, EMU, V110, P307, DOI 10.1071/MU10024; Rushing CS, 2021, ORNITHOL APPL, V123, DOI 10.1093/ornithapp/duab010; Saalfeld ST, 2015, AUK, V132, P212, DOI 10.1642/AUK-13-193.1; Smith PA, 2020, AMBIO, V49, P732, DOI 10.1007/s13280-019-01308-5; Studds CE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14895; Sun FD, 2021, REMOTE SENS-BASEL, V13, DOI 10.3390/rs13050985; Taylor CM, 2016, ECOL APPL, V26, P424, DOI 10.1890/14-1410; Tomkovich Pavel S., 1998, Wader Study Group Bulletin, V85, P29; Urban DL, 2009, ECOL LETT, V12, P260, DOI 10.1111/j.1461-0248.2008.01271.x; Valchuk OP, 2019, P 11 INT SCI PRACTIC, P151; Wang XD, 2022, BIOL CONSERV, V269, DOI 10.1016/j.biocon.2022.109547; WARNOCK N, 1995, WILSON BULL, V107, P131; Warnock N, 2013, ARCTIC, V66, P407; Warnock N, 2010, J AVIAN BIOL, V41, P621, DOI 10.1111/j.1600-048X.2010.05155.x; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Weiser EL, 2020, CONDOR, V122, DOI 10.1093/condor/duaa026; Weiser EL, 2018, AUK, V135, P29, DOI 10.1642/AUK-17-107.1; Weiser EL, 2016, MOV ECOL, V4, DOI 10.1186/s40462-016-0077-6; Wennerberg L, 2001, MOL ECOL, V10, P1111, DOI 10.1046/j.1365-294X.2001.01256.x; White C.M., 2020, BIRDS OF THE WORLD; Wotherspoon S, 2016, TWGEOS BASIC DATA PR; Xia SX, 2017, BIOL CONSERV, V210, P72, DOI 10.1016/j.biocon.2016.07.025; Yang ZY, 2020, BIRD CONSERV INT, V30, P649, DOI 10.1017/S0959270920000210; Zhang SD, 2018, BIRD CONSERV INT, V28, P534, DOI 10.1017/S0959270917000430; Zhang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17136	101	0	0	11	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0270957	10.1371/journal.pone.0270957	http://dx.doi.org/10.1371/journal.pone.0270957			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925977	Green Published, gold			2022-12-26	WOS:000848077100029
J	Rabani, AS; Mizrachi, S; Sawicki, GS; Riemer, R				Rabani, Anat Shkedy; Mizrachi, Sarai; Sawicki, Gregory S.; Riemer, Raziel			Parametric equations to study and predict lower-limb joint kinematics and kinetics during human walking and slow running on slopes	PLOS ONE			English	Article							TRANSTIBIAL PROSTHESIS; GENDER-DIFFERENCES; LEVEL; GAIT; EXOSKELETON; GENERATION; MECHANICS; DESIGN; ANKLE	Comprehensive data sets for lower-limb kinematics and kinetics during slope walking and running are important for understanding human locomotion neuromechanics and energetics and may aid the design of wearable robots (e.g., exoskeletons and prostheses). Yet, this information is difficult to obtain and requires expensive experiments with human participants in a gait laboratory. This study thus presents an empirical mathematical model that predicts lower-limb joint kinematics and kinetics during human walking and running as a function of surface gradient and stride cycle percentage. In total, 9 males and 7 females (age: 24.56 +/- 3.16 years) walked at a speed of 1.25 m/s at five surface gradients (-15%, -10%, 0%, +10%, +15%) and ran at a speed of 2.25 m/s at five different surface gradients (-10%, -5%, 0%, +5%, +10%). Joint kinematics and kinetics were calculated at each surface gradient. We then used a Fourier series to generate prediction equations for each speed's slope (3 joints x 5 surface gradients x [angle, moment, mechanical power]), where the input was the percentage in the stride cycle. Next, we modeled the change in value of each Fourier series' coefficients as a function of the surface gradient using polynomial regression. This enabled us to model lower-limb joint angle, moment, and power as functions of the slope and as stride cycle percentages. The average adjusted R-2 for kinematic and kinetic equations was 0.92 +/- 0.18. Lastly, we demonstrated how these equations could be used to generate secondary gait parameters (e.g., joint work) as a function of surface gradients. These equations could be used, for instance, in the design of exoskeletons for walking and running on slopes to produce trajectories for exoskeleton controllers or for educational purposes in gait studies.	[Rabani, Anat Shkedy; Mizrachi, Sarai; Riemer, Raziel] Ben Gurion Univ Negev, Dept Ind Engn & Management, Beer Sheva, Israel; [Sawicki, Gregory S.] Georgia Tech, Sch Mech Engn, Atlanta, GA USA; [Sawicki, Gregory S.] Georgia Tech, Sch Biol Sci, Atlanta, GA USA	Ben Gurion University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Rabani, AS (corresponding author), Ben Gurion Univ Negev, Dept Ind Engn & Management, Beer Sheva, Israel.	shkedy@post.bgu.ac.il			U.S. Israel Binational Science Foundation (BSF) [2011152]; Helmsley Charitable Trust through the BenGurion Agricultural, Biological and Cognitive Robotics Initiative; Israeli Ministry of Science and Technology	U.S. Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Helmsley Charitable Trust through the BenGurion Agricultural, Biological and Cognitive Robotics Initiative; Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel)	This work was supported in part by the U.S. Israel Binational Science Foundation (BSF https://www.bsf.org.il/) grant (number 2011152) to authors RR and GSS. It was also supported in part by the Helmsley Charitable Trust through the BenGurion Agricultural, Biological and Cognitive Robotics Initiative (https://in.bgu.ac.il/en/robotics/Pages/default.aspx) and the Israeli Ministry of Science and Technology (https://www.gov.il/en/departments/ministry_of_science_and_ technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GROWTH CHARTS; [Anonymous], CGA NORMATIVE GAIT D; [Anonymous], OPENSIMSTANFORDEDU; Bruening DA, 2012, GAIT POSTURE, V35, P535, DOI 10.1016/j.gaitpost.2011.11.012; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Chumanov ES, 2008, CLIN BIOMECH, V23, P1260, DOI 10.1016/j.clinbiomech.2008.07.011; Collins SH, 2015, NATURE, V522, P212, DOI 10.1038/nature14288; CSA, 2008, SUMM STAT REP 2007 P; Dempster WT., 1955, E LANSING; DEVITA P, 1994, J BIOMECH, V27, P501, DOI 10.1016/0021-9290(94)90025-6; Devita P, 2016, MED SCI SPORT EXER, V48, P98, DOI 10.1249/MSS.0000000000000744; DeVita P, 2008, J BIOMECH, V41, P3354, DOI 10.1016/j.jbiomech.2008.09.024; Dewolf AH, 2018, J APPL PHYSIOL, V125, P642, DOI 10.1152/japplphysiol.01020.2017; Dixon PC, 2012, J BIOMECH, V45, P1011, DOI 10.1016/j.jbiomech.2012.01.001; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Esquenazi A, 2012, AM J PHYS MED REHAB, V91, P911, DOI 10.1097/PHM.0b013e318269d9a3; Farris DJ, 2012, J R SOC INTERFACE, V9, P110, DOI 10.1098/rsif.2011.0182; Faustini MC, 2008, IEEE T BIO-MED ENG, V55, P784, DOI 10.1109/TBME.2007.912638; Ferber R, 2003, CLIN BIOMECH, V18, P350, DOI 10.1016/S0268-0033(03)00025-1; Ferrari A, 2008, GAIT POSTURE, V28, P207, DOI 10.1016/j.gaitpost.2007.11.009; Hitt J, 2009, IND ROBOT, V36, P441, DOI 10.1108/01439910910980169; Hurd WJ, 2004, CLIN BIOMECH, V19, P465, DOI 10.1016/j.clinbiomech.2004.01.013; Jin L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41750-9; Lay AN, 2006, J BIOMECH, V39, P1621, DOI 10.1016/j.jbiomech.2005.05.005; MacWilliams BA, 2003, GAIT POSTURE, V17, P214, DOI 10.1016/S0966-6362(02)00103-0; Markowitz J, 2011, PHILOS T R SOC B, V366, P1621, DOI 10.1098/rstb.2010.0347; Moisio KC, 2003, J BIOMECH, V36, P599, DOI 10.1016/S0021-9290(02)00433-5; Park SK, 2019, GAIT POSTURE, V68, P181, DOI 10.1016/j.gaitpost.2018.11.007; Riemer R, 2008, GAIT POSTURE, V27, P578, DOI 10.1016/j.gaitpost.2007.07.012; Roberts TJ, 2005, J EXP BIOL, V208, P1963, DOI 10.1242/jeb.01555; Sanz-Merodio D, 2014, ADV ROBOTICS, V28, P329, DOI 10.1080/01691864.2013.867284; Segal AD, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4037563; Strausser K. A., 2011, 2011 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2011), P4911, DOI 10.1109/IROS.2011.6048674; Sup F, 2008, INT J ROBOT RES, V27, P263, DOI 10.1177/0278364907084588; Telhan G, 2010, J ATHL TRAINING, V45, P16, DOI 10.4085/1062-6050-45.1.16; Umberger BR, 2010, J R SOC INTERFACE, V7, P1329, DOI 10.1098/rsif.2010.0084; Walsh CJ, 2006, IEEE INT CONF ROBOT, P3485, DOI 10.1109/ROBOT.2006.1642234; Winter D. A, 2009, BIOMECHANICS MOTOR C; WINTER DA, 1983, CLIN ORTHOP RELAT R, P147; Yang ZH, 2019, J BIOMECH, V92, P35, DOI 10.1016/j.jbiomech.2019.05.027; Yokozawa T., 2005, INT J SPORT HEAL SCI, V3, P35, DOI [10.5432/ijshs.3.35, DOI 10.5432/IJSHS.3.35]; Zelik KE, 2018, J BIOMECH, V75, P1, DOI 10.1016/j.jbiomech.2018.04.017; Zoss AB, 2006, IEEE-ASME T MECH, V11, P128, DOI 10.1109/TMECH.2006.871087	43	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0269061	10.1371/journal.pone.0269061	http://dx.doi.org/10.1371/journal.pone.0269061			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925954	gold, Green Published			2022-12-26	WOS:000848077100009
J	Seneadza, NAH; Kwara, A; Lauzardo, M; Prins, C; Zhou, Z; Seraphin, MN; Ennis, N; Morano, JP; Brumback, B; Cook, RL				Seneadza, Nana Ayegua Hagan; Kwara, Awewura; Lauzardo, Michael; Prins, Cindy; Zhou, Zhi; Seraphin, Marie Nancy; Ennis, Nicole; Morano, Jamie P.; Brumback, Babette; Cook, Robert L.			Assessing risk factors for latent and active tuberculosis among persons living with HIV in Florida: A comparison of self-reports and medical records	PLOS ONE			English	Article							UNITED-STATES; CONCORDANCE; HOMELESS	Purpose This study examined factors associated with TB among persons living with HIV (PLWH) in Florida and the agreement between self-reported and medically documented history of tuberculosis (TB) in assessing the risk factors. Methods Self-reported and medically documented data of 655 PLWH in Florida were analyzed. Data on sociodemographic factors such as age, race/ethnicity, place of birth, current marital status, education, employment, homelessness in the past year and 'ever been jailed' and behavioural factors such as excessive alcohol use, marijuana, injection drug use (IDU), substance and current cigarette use were obtained. Health status information such as health insurance status, adherence to HIV antiretroviral therapy (ART), most recent CD4 count, HIV viral load and comorbid conditions were also obtained. The associations between these selected factors with self-reported TB and medically documented TB diagnosis were compared using Chi-square and logistic regression analyses. Additionally, the agreement between self-reports and medical records was assessed. Results TB prevalence according to self-reports and medical records was 16.6% and 7.5% respectively. Being age >= 55 years, African American and homeless in the past 12 months were statistically significantly associated with self-reported TB, while being African American homeless in the past 12 months and not on antiretroviral therapy (ART) were statistically significantly associated with medically documented TB. African Americans compared to Whites had odds ratios of 3.04 and 4.89 for self-reported and medically documented TB, respectively. There was moderate agreement between self-reported and medically documented TB (Kappa = 0.41). Conclusions TB prevalence was higher based on self-reports than medical records. There was moderate agreement between the two data sources, showing the importance of self-reports. Establishing the true prevalence of TB and associated risk factors in PLWH for developing policies may therefore require the use of self-reports and confirmation by screening tests, clinical signs and/or microbiologic data.	[Seneadza, Nana Ayegua Hagan] Univ Ghana, Dept Community Hlth, Med Sch, Accra, Ghana; [Kwara, Awewura; Lauzardo, Michael; Seraphin, Marie Nancy] Univ Florida, Coll Med, Div Infect Dis & Global Med, Gainesville, FL USA; [Prins, Cindy; Zhou, Zhi; Cook, Robert L.] Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess & Coll Med, Gainesville, FL USA; [Ennis, Nicole] Florida State Univ, Dept Behav Sci & Social Med, Tallahassee, FL USA; [Morano, Jamie P.] Univ S Florida, Morsani Coll Med, Tampa, FL USA; [Brumback, Babette] Univ Florida, Coll Publ Hlth, Dept Biostat, Gainesville, FL USA; [Brumback, Babette] Univ Florida, Dept Biostat, Coll Hlth Profess & Med, Gainesville, FL USA	University of Ghana; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; Florida State University; State University System of Florida; University of South Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Seneadza, NAH (corresponding author), Univ Ghana, Dept Community Hlth, Med Sch, Accra, Ghana.	nseneadza@ug.edu.gh		Kwara, Awewura/0000-0002-1118-8331	National Institute on Alcohol Abuse and Alcoholism (NIAAA) [U24AA022002, U24AA022003]; University of Florida-University of Ghana Training Program in Tuberculosis and HIV Research in Ghana - Fogarty International Center at the National Institutes of Health [TW010055]	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); University of Florida-University of Ghana Training Program in Tuberculosis and HIV Research in Ghana - Fogarty International Center at the National Institutes of Health	The Florida Cohort study was supported by The National Institute on Alcohol Abuse and Alcoholism (NIAAA), Grants U24AA022002 and U24AA022003. NAHS was supported under the University of Florida-University of Ghana Training Program in Tuberculosis and HIV Research in Ghana, funded by the Fogarty International Center at the National Institutes of Health, Grant TW010055.	Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; Bamrah S, 2013, INT J TUBERC LUNG D, V17, P1414, DOI 10.5588/ijtld.13.0270; Barber J, 2010, FAM PRACT, V27, P25, DOI 10.1093/fampra/cmp098; CDC, 2020, CLIN GROWTH CHARTS; Chan Kitty S, 2010, Med Care Res Rev, V67, P503, DOI 10.1177/1077558709359007; Chemtob D., 2019, TUB MORB; Cook RL, 2017, ADDICT SCI CLIN PRAC, V12, DOI 10.1186/s13722-017-0090-0; Dias M, 2017, INT J TUBERC LUNG D, V21, P327, DOI 10.5588/ijtld.16.0597; Hess, 2018, DIAGNOSES HIV INFECT; Ibanez GE, 2021, AIDS CARE, V33, P516, DOI 10.1080/09540121.2020.1748867; Khan A, 2018, AM J PUBLIC HEALTH, V108, pS321, DOI [10.2105/AJPH.2018.304606, 10.2105/ajph.2018.304606]; Kiboi NG, 2016, J PULM RESP MED; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Noppert GA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4461-y; Norwood MS, 2016, ANN EPIDEMIOL, V26, P612, DOI 10.1016/j.annepidem.2016.07.011; Odone A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112017; Oeltmann JE, 2006, EMERG INFECT DIS, V12, P1156, DOI 10.3201/eid1207.051436; Oksanen T, 2010, ANN EPIDEMIOL, V20, P547, DOI 10.1016/j.annepidem.2010.03.017; Paterson DL., 2013, ANN INTERN MED; Shea KM, 2014, AM J EPIDEMIOL, V179, P216, DOI 10.1093/aje/kwt246; Silva DR, 2018, J BRAS PNEUMOL, V44, P145, DOI [10.1590/s1806-37562017000000443, 10.1590/S1806-37562017000000443]; Skinner KM, 2005, J AMBUL CARE MANAG, V28, P102, DOI 10.1097/00004479-200504000-00002; Smith B, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-37; Story A, 2007, THORAX, V62, P667, DOI 10.1136/thx.2006.065409; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Talwar A, 2019, MMWR-MORBID MORTAL W, V68, P257, DOI 10.15585/mmwr.mm6811a2; Tiberi S, 2017, PRESSE MED, V46, pE23, DOI 10.1016/j.lpm.2017.01.017; Tisnado DM, 2006, MED CARE, V44, P132, DOI 10.1097/01.mlr.0000196952.15921.bf; Tsang CA, 2017, MMWR-MORBID MORTAL W, V66, P295, DOI 10.15585/mmwr.mm6611a3	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271917	10.1371/journal.pone.0271917	http://dx.doi.org/10.1371/journal.pone.0271917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925972	gold, Green Published			2022-12-26	WOS:000848077100058
J	Yamamoto, K; Yamada, N; Endo, S; Kurogi, K; Sakakibara, Y; Suiko, M				Yamamoto, Kohji; Yamada, Naotaka; Endo, Satoshi; Kurogi, Katsuhisa; Sakakibara, Yoichi; Suiko, Masahito			Novel silkworm (Bombyx mori) sulfotransferase swSULT ST3 is involved in metabolism of polyphenols from mulberry leaves	PLOS ONE			English	Article							CYTOSOLIC SULFOTRANSFERASE; IDENTIFICATION; ACID; SULFATION; GLANDS	Polyphenols in plants are important for defense responses against microorganisms, insect herbivory, and control of feeding. Owing to their antioxidant, anti-cancer, and anti-inflammatory activities, their importance in human nutrition has been acknowledged. However, metabolism of polyphenols derived from mulberry leaves in silkworms (Bombyx mori) remains unclear. Sulfotransferases (SULT) are involved in the metabolism of xenobiotics and endogenous compounds. The purpose of this study is to investigate the metabolic mechanism of polyphenols mediated by B. mori SULT. Here, we identified a novel SULT in silkworms (herein, swSULT ST3). Recombinant swSULT ST3 overexpressed in Escherichia co/i effectively sulfated polyphenols present in mulberry leaves. swSULT ST3 showed high specific activity toward genistein among the polyphenols. Genistein-7-sulfate was produced by the activity of swSULT ST3. Higher expression of swSULT ST3 mRNA was observed in the midgut and fat body than in the hemocytes, testis, ovary, and silk gland. Polyphenols inhibited the aldo-keto reductase detoxification of reactive aldehydes from mulberry leaves, and the most noticeable inhibition was observed with genistein. Our results suggest that swSULT ST3 plays a role in the detoxification of polyphenols, including genistein, and contributes to the effects of aldo-keto reductase in the midgut of silkworms. This study provides new insight into the functions of SULTs and the molecular mechanism responsible for host plant selection in lepidopteran insects.	[Yamamoto, Kohji; Yamada, Naotaka] Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch, Fukuoka, Japan; [Endo, Satoshi] Gifu Pharmaceut Univ, Lab Biochem, Gifu, Japan; [Kurogi, Katsuhisa; Sakakibara, Yoichi; Suiko, Masahito] Univ Miyazaki, Fac Agr, Dept Biochem & Appl Biosci, Miyazaki, Japan	Kyushu University; Gifu Pharmaceutical University; University of Miyazaki	Yamamoto, K (corresponding author), Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch, Fukuoka, Japan.	yamamok@agr.kyushu-u.ac.jp			Research Grant for Young Investigators of Faculty of Agriculture, Kyushu University	Research Grant for Young Investigators of Faculty of Agriculture, Kyushu University	The study was supported in part by the Research Grant for Young Investigators of Faculty of Agriculture, Kyushu University. No additional external funding was received for this study.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Bairam AF, 2020, ARCH INSECT BIOCHEM, V104, DOI 10.1002/arch.21671; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Blanchard RL, 2004, PHARMACOGENETICS, V14, P199, DOI 10.1097/00008571-200403000-00009; BOHREN KM, 1989, J BIOL CHEM, V264, P9547; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609; Fliszar-Nyul E, 2020, BIOMED PHARMACOTHER, V131, DOI 10.1016/j.biopha.2020.110732; Gilardini Montani MS, 2016, BBA-MOL BASIS DIS, V1862, P805, DOI 10.1016/j.bbadis.2016.01.001; Glatt H, 2000, CHEM-BIOL INTERACT, V129, P141, DOI 10.1016/S0009-2797(00)00202-7; Gunal S, 2019, J BIOL CHEM, V294, P12293, DOI 10.1074/jbc.REV119.007422; Inagami K., 1955, J SERIC SCI JPN, V24, P295; Kim Y, 2017, CLIN PHARM DRUG DEV, V6, P499, DOI 10.1002/cpdd.343; Lee JH, 2018, CHEM-BIOL INTERACT, V289, P68, DOI 10.1016/j.cbi.2018.04.023; Li H, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9020215; Lin JL, 2011, ARCH INSECT BIOCHEM, V76, P144, DOI 10.1002/arch.20373; Lin YC, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13379; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Neog K, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.13301; OHNISHI M, 1994, EXPERIENTIA, V50, P654, DOI 10.1007/BF01952866; Ranger CM, 2009, ENVIRON ENTOMOL, V38, P129, DOI 10.1603/022.038.0116; Shankar Eswar, 2017, Curr Pharmacol Rep, V3, P423, DOI 10.1007/s40495-017-0113-2; Shimohira T, 2018, BIOSCI BIOTECH BIOCH, V82, P1359, DOI 10.1080/09168451.2018.1464897; Shimohira T, 2017, J BIOSCI BIOENG, V124, P84, DOI 10.1016/j.jbiosc.2017.02.006; Shukla R, 2016, INT J BIOL MACROMOL, V91, P1110, DOI 10.1016/j.ijbiomac.2016.06.075; Sierens JE, 2004, J MOL ENDOCRINOL, V32, P703, DOI 10.1677/jme.0.0320703; Song DG, 2010, BMB REP, V43, P268, DOI 10.5483/BMBRep.2010.43.4.268; Tao Xiao-Yu, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3738; Weinshilboum R., 1994, CONJUGATION DECONJUG, P45; Xin YC, 2020, PLANT SCI, V296, DOI 10.1016/j.plantsci.2020.110473; Yamamoto K, 2020, INSECT MOL BIOL, V29, P490, DOI 10.1111/imb.12658; Yamamoto K, 2022, CHEM-BIOL INTERACT, V351, DOI 10.1016/j.cbi.2021.109717; Yamamoto K, 2016, BIOCHEM BIOPH RES CO, V474, P104, DOI 10.1016/j.bbrc.2016.04.079; Yamamoto Kohji, 2015, Journal of Insect Biotechnology and Sericology, V84, P63; Yamamoto K, 2013, ARCH BIOCHEM BIOPHYS, V538, P156, DOI 10.1016/j.abb.2013.08.018; Yan XH, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0179-x	37	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0270804	10.1371/journal.pone.0270804	http://dx.doi.org/10.1371/journal.pone.0270804			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925958	Green Published, gold			2022-12-26	WOS:000848077100022
J	Amewu, RK; Akolgo, GA; Asare, ME; Abdulai, Z; Ablordey, AS; Asiedu, K				Amewu, Richard K.; Akolgo, Gideon Atinga; Asare, Millicent Esi; Abdulai, Zigli; Ablordey, Anthony S.; Asiedu, Kingsley			Evaluation of the fluorescent-thin layer chromatography (f-TLC) for the diagnosis of Buruli ulcer disease in Ghana	PLOS ONE			English	Article							MYCOBACTERIUM-ULCERANS; LABORATORY DIAGNOSIS; PCR; IDENTIFICATION; SPECIMENS; IS2404	BackgroundBuruli ulcer is a tissue necrosis infection caused by an environmental mycobacterium called Mycobacterium ulcerans (MU). The disease is most prevalent in rural areas with the highest rates in West and Central African countries. The bacterium produces a toxin called mycolactone which can lead to the destruction of the skin, resulting in incapacitating deformities with an enormous economic and social burden on patients and their caregivers. Even though there is an effective antibiotic treatment for BU, the control and management rely on early case detection and rapid diagnosis to avert morbidities. The diagnosis of Mycobacterium ulcerans relies on smear microscopy, culture histopathology, and PCR. Unfortunately, all the current laboratory diagnostics have various limitations and are not available in endemic communities. Consequently, there is a need for a rapid diagnostic tool for use at the community health centre level to enable diagnosis and confirmation of suspected cases for early treatment. The present study corroborated the diagnostic performance and utility of fluorescent-thin layer chromatography (f-TLC) for the diagnosis of Buruli ulcer. Methodology/Principal findingsThe f-TLC method was evaluated for the diagnosis of Buruli ulcer in larger clinical samples than previously reported in an earlier preliminary study Wadagni et al. (2015). A total of 449 patients suspected of BU were included in the final data analysis out of which 122 (27.2%) were positive by f-TLC and 128 (28.5%) by PCR. Using a composite reference method generated from the two diagnostic methods, 85 (18.9%) patients were found to be truly infected with M. ulcerans, 284 (63.3%) were uninfected, while 80 (17.8%) were misidentified as infected or noninfected by the two methods. The data obtained was used to determine the discriminatory accuracy of the f-TLC against the gold standard IS2404 PCR through the analysis of its sensitivity, specificity, positive (+LR), and negative (-LR) likelihood ratio. The positive (PPV) and negative (NPV) predictive values, area under the receiver operating characteristic curve Azevedo et al. (2014), and diagnostic odds ratio were used to assess the predictive accuracy of the f-TLC method. The sensitivity of f-TLC was 66.4% (85/128), specificity was 88.5% (284/321), while the diagnostic accuracy was 82.2% (369/449). The AUC stood at 0.774 while the PPV, NPV, +LR, and-LR were 69.7% (85/122), 86.9% (284/327), 5.76, and 0.38, respectively. The use of the rule-of-thumb interpretation of diagnostic tests suggests that the method is good for use as a diagnostic tool. Conclusions/SignificanceLarger clinical samples than previously reported had been used to evaluate the f-TLC method for the diagnosis of Buruli ulcer. A sensitivity of 66.4%, a specificity of 88.5%, and diagnostic accuracy of 82.2% were obtained. The method is good for diagnosis and will help in making early clinical decisions about the patients as well as patient management and facilitating treatment decisions. However, it requires a slight modification to address the challenge of background interference and lack of automatic readout to become an excellent diagnostic tool.	[Amewu, Richard K.; Akolgo, Gideon Atinga; Asare, Millicent Esi; Abdulai, Zigli] Univ Ghana, Dept Chem, Accra, Ghana; [Ablordey, Anthony S.] Univ Ghana, Noguchi Mem Inst Med Res, Dept Bacteriol, Accra, Ghana; [Asiedu, Kingsley] WHO, Dept Control Neglected Trop Dis, Geneva, Switzerland	University of Ghana; University of Ghana; World Health Organization	Amewu, RK (corresponding author), Univ Ghana, Dept Chem, Accra, Ghana.	ramewu@ug.edu.gh	AMEWU, RICHARD KWAMLA/GQA-8505-2022	AMEWU, RICHARD KWAMLA/0000-0002-4676-436X; Akolgo, Gideon/0000-0002-9330-4526; Ablordey, Anthony/0000-0002-4486-0286	World Health Organization; ANESVAD	World Health Organization(World Health Organization); ANESVAD	The authors would like to thank the World Health Organization and ANESVAD for generous funding of this work. The authors are also thankful to Professor Kishi Yoshito of Harvard University for the donation of the synthetic mycolactone for the study as well as the training of the research team. The authors are also grateful to all the patients and workers at the various health facilities where the samples came from.	Ablordey A, 2005, J CLIN MICROBIOL, V43, P1546, DOI 10.1128/JCM.43.4.1546-1551.2005; Addison NO, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005331; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P145; Azevedo MF, 2014, ENDOCR REV, V35, P195, DOI 10.1210/er.2013-1053; Barogui Y, 2009, AM J TROP MED HYG, V81, P82, DOI 10.4269/ajtmh.2009.81.82; BAYLEY AC, 1971, BRIT MED J, V2, P401, DOI 10.1136/bmj.2.5758.401-c; Beissner M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004219; Beissner M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002011; Berzosa P, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2481-4; Bretzel G, 2007, TROP MED INT HEALTH, V12, P89, DOI 10.1111/j.1365-3156.2006.01761.x; Bretzel G, 2006, TROP MED INT HEALTH, V11, P1688, DOI 10.1111/j.1365-3156.2006.01722.x; Bretzel G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001228; CDC, 2015, BUR ULC; Chavarria-Bolanos D, 2017, PAIN RES MANAG, V2017, DOI 10.1155/2017/3108940; Connor D. H., 1965, INT J LEPROSY, V33, P698; Converse PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002618; de Souza DK, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-8; de Zeeuw J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003303; Demangel C, 2009, NAT REV MICROBIOL, V7, P50, DOI 10.1038/nrmicro2077; Fagbamigbe AF, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2678-1; Grietens KP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000321; Guarner J, 2003, EMERG INFECT DIS, V9, P651; HAYMAN J, 1991, LANCET, V337, P124, DOI 10.1016/0140-6736(91)90791-M; Iddrisah FN, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.supp.2016.25.1.6203; Junghanss T., 2014, MYCOBACTERIUM ULCERA; Marion E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033600; Mazzu-Nascimento T, 2017, ANAL CHIM ACTA, V950, P156, DOI 10.1016/j.aca.2016.11.011; Mulder AA, 2008, T ROY SOC TROP MED H, V102, P912, DOI 10.1016/j.trstmh.2008.05.026; Nienhuis WA, 2010, LANCET, V375, P664, DOI 10.1016/S0140-6736(09)61962-0; Ojurongbe Olusola, 2013, Malar Res Treat, V2013, P308069, DOI 10.1155/2013/308069; Omansen TF, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01478-18; Phillips R, 2005, J CLIN MICROBIOL, V43, P3650, DOI 10.1128/JCM.43.8.3650-3656.2005; Phillips RO, 2014, ANTIMICROB AGENTS CH, V58, P1161, DOI 10.1128/AAC.02165-13; Pormohammad A, 2017, J INFECTION, V74, P545, DOI 10.1016/j.jinf.2017.02.012; Portaels F, 1997, J CLIN MICROBIOL, V35, P1097, DOI 10.1128/JCM.35.5.1097-1100.1997; Portaels F., 2001, BURULI ULCER DIAGNOS; Ray P, 2010, ANESTHESIOLOGY, V112, P1023, DOI 10.1097/ALN.0b013e3181d47604; Sakyi SA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004950; Sarfo FS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001237; Siegmund V, 2007, CLIN INFECT DIS, V45, P68, DOI 10.1086/518604; Spangenberg T, 2010, CHEM COMMUN, V46, P1410, DOI 10.1039/b924896j; Stinear T, 1999, J CLIN MICROBIOL, V37, P1018, DOI 10.1128/JCM.37.4.1018-1023.1999; Tabah EN, 2019, BURULI ULCER, P43; Trellu LT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004385; Wadagni A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004247; WHO, 2015, DISTR BUR ULC WORLDW; World Health Organization (WHO), 2020, END NEGL ATT SUST DE; Yeboah-Manu D, 2004, J CLIN MICROBIOL, V42, P5875, DOI 10.1128/JCM.42.12.5875-5876.2004; Yeboah-Manu D, 2011, AM J TROP MED HYG, V85, P900, DOI 10.4269/ajtmh.2011.11-0362; Yotsu RR, 2018, CURR TROP MED REP, V5, P247, DOI 10.1007/s40475-018-0166-2; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	51	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0270235	http://dx.doi.org/10.1371/journal.pone.0270235			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917367	gold, Green Published			2022-12-26	WOS:000837840000041
J	Hu, BF; Gong, Q; Chen, SQ; Yue, L; Ma, WX; Wang, F; Feng, XW; Wang, JN; Li, C; Liu, MM; Wang, XF; Meng, XM; Li, J; Wen, JG				Hu, Bing-feng; Gong, Qian; Chen, Shi-qing; Yue, Lin; Ma, Wen-xian; Wang, Fang; Feng, Xiao-wen; Wang, Jia-nan; Li, Chao; Liu, Ming-ming; Wang, Xue-fu; Meng, Xiao-ming; Li, Jun; Wen, Jia-gen			Protective effect of inhibiting necroptosis on gentamicin-induced nephrotoxicity	FASEB JOURNAL			English	Article						acute kidney injury; gentamicin; necroptosis; necrostatin-1; nephrotoxicity; RIPK1	NONAPOPTOTIC CELL-DEATH; INFLAMMATION; PHARMACOKINETICS; CYTOTOXICITY; ACCUMULATION; CONTRIBUTES; KINASES; RATS	Necroptosis is defined as a novel programmed cell necrosis that is mediated by receptor interacting serine-threonine protein kinase 1 (RIPK1) and other related signals. Necrosis, apoptosis and inflammation are commonly considered as the leading mechanism in acute kidney injury (AKI) induced by gentamicin (GEN), which is a useful antibiotic for treating the infection of Gram-negative bacterial. However, the necroptosis in the pathogenesis of GEN-induced AKI is unknown. In this study, to investigate the process and function of necroptosis in GEN-induced AKI, NRK-52E and HK-2 cells and SD rats were used as the models. The necroptosis-related proteins, including RIPK1, RIPK3, mixed lineage kinase domain-like (MLKL) and phosphorylated MLKL (p-MLKL), were all increasing time-dependently when GEN was continuously given. By using the RIPK1 inhibitor necrostatin-1 (NEC-1) and RIPK3 inhibitor (CPD42), the GEN-induced toxicity of tubular cells was alleviated. Moreover, it was validated that GEN-induced cell apoptosis and inflammation were attenuated after treating with NEC-1 or CPD42, both in vivo and in vitro. When MLKL was knocked down by siRNA, NEC-1 and CPD42 can not further protect the damage of tubular cells by GEN. Although the using of pan-caspase inhibitor Z-VAD significantly decreased GEN-induced apoptosis, it enhanced necroptosis and slightly promoted the decreased cell viability in GEN-treated cells, with the protective effects weaker than NEC-1 or CPD42. Finally, in vitro minimum inhibitory concentration (MIC) tests and bacteriostatic ring studies showed that NEC-1 did not interfere with the antibiotic effects of GEN. Thus, suppressing necroptosis can serve as a promising strategy for the prevention of GEN-induced nephrotoxicity.	[Hu, Bing-feng; Chen, Shi-qing; Yue, Lin; Ma, Wen-xian; Wang, Fang; Feng, Xiao-wen; Wang, Jia-nan; Li, Chao; Liu, Ming-ming; Wang, Xue-fu; Meng, Xiao-ming; Li, Jun; Wen, Jia-gen] Anhui Med Univ, Anhui Inst Innovat Drugs, Sch Pharm, Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei 230032, Peoples R China; [Gong, Qian] Anhui Med Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Hefei, Peoples R China; [Wang, Fang] Anhui Med Univ, Luan Hosp, Luan Peoples Hosp Anhui Prov, Dept Pharm, Luan, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Wen, JG (corresponding author), Anhui Med Univ, Anhui Inst Innovat Drugs, Sch Pharm, Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei 230032, Peoples R China.	jiagen168@163.com			National Natural Science Foundation of China [81800606]; Doctoral Research Funding Program of Anhui Medical University [XJ201626]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Research Funding Program of Anhui Medical University	This work was supported by the National Natural Science Foundation of China (No. 81800606) and Doctoral Research Funding Program of Anhui Medical University (No. XJ201626).	Ahn JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048952; Bledsoe G, 2006, NEPHROL DIAL TRANSPL, V21, P624, DOI 10.1093/ndt/gfi225; Chen CH, 2015, MOL MED, V21, P886, DOI 10.2119/molmed.2015.00196; Chen SF, 2017, APOPTOSIS, V22, P626, DOI 10.1007/s10495-017-1358-2; Chen YC, 2011, EUR J PHARMACOL, V658, P213, DOI 10.1016/j.ejphar.2011.02.025; CHIU PJS, 1979, KIDNEY INT, V15, P618, DOI 10.1038/ki.1979.81; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Edwards Joshua R., 2007, BMC Physiology, V7, P1, DOI 10.1186/1472-6793-7-1; Gai ZB, 2016, ANTIMICROB AGENTS CH, V60, P5573, DOI 10.1128/AAC.00907-16; Gong XZ, 2012, RENAL FAILURE, V34, P487, DOI 10.3109/0886022X.2012.655684; Goodlet KJ, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02165-18; GYSELYNCK AM, 1971, J INFECT DIS, V124, pS70, DOI 10.1093/infdis/124.Supplement_1.S70; Hassanein EHM, 2021, ENVIRON SCI POLLUT R, V28, P11558, DOI 10.1007/s11356-020-11416-5; Hayward RS, 2018, BRIT J CLIN PHARMACO, V84, P223, DOI 10.1111/bcp.13439; He SD, 2018, NAT IMMUNOL, V19, P912, DOI 10.1038/s41590-018-0188-x; Karimi Z, 2020, CLIN EXP PHARMACOL P, V47, P1584, DOI 10.1111/1440-1681.13334; Li J, 2009, EUR J PHARMACOL, V620, P97, DOI 10.1016/j.ejphar.2009.08.021; LUFT FC, 1981, RES COMMUN CHEM PATH, V34, P89; MATHEW TH, 1992, MED J AUSTRALIA, V156, P724, DOI 10.5694/j.1326-5377.1992.tb121517.x; McWilliam SJ, 2017, PEDIATR NEPHROL, V32, P2015, DOI 10.1007/s00467-016-3533-z; Nagai J, 2002, J PHARM PHARMACOL, V54, P1491, DOI 10.1211/00223570272; Najjar M, 2016, IMMUNITY, V45, P46, DOI 10.1016/j.immuni.2016.06.007; Ouyang ZZ, 2012, PHARMAZIE, V67, P725, DOI 10.1691/ph.2012.1837; PRINS JM, 1993, LANCET, V341, P335, DOI 10.1016/0140-6736(93)90137-6; Quiros Y, 2011, TOXICOL SCI, V119, P245, DOI 10.1093/toxsci/kfq267; Seo J, 2021, EXP MOL MED, V53, P1007, DOI 10.1038/s12276-021-00634-7; SIMON VK, 1973, ANTIMICROB AGENTS CH, V3, P445, DOI 10.1128/AAC.3.4.445; Speir M, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11050646; Sureshbabu A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98411; SUZUKI S, 1995, COMP BIOCHEM PHYS C, V112, P15, DOI 10.1016/0742-8413(95)00075-5; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Tristao VR, 2012, RENAL FAILURE, V34, P373, DOI 10.3109/0886022X.2011.647343; Varzi HN, 2007, J VET PHARMACOL THER, V30, P477, DOI 10.1111/j.1365-2885.2007.00901.x; VERPOOTEN GA, 1989, CLIN PHARMACOL THER, V45, P22, DOI 10.1038/clpt.1989.4; Wang F, 2022, ACTA PHARMACOL SIN, V43, P330, DOI 10.1038/s41401-021-00649-w; Wang J, 2021, INT IMMUNOPHARMACOL, V98; Wang JN, 2019, CLIN SCI, V133, P1609, DOI 10.1042/CS20190599; Yao L, 2020, ACTA PHARMACOL SIN, V41, P866, DOI 10.1038/s41401-019-0342-5; Yuan JY, 2019, NAT REV NEUROSCI, V20, P19, DOI 10.1038/s41583-018-0093-1; Zappitelli M, 2011, NEPHROL DIAL TRANSPL, V26, P144, DOI 10.1093/ndt/gfq375; Zelic M, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109112; Zeng G., 2021, IMMUNOL INVEST, V51, P1; Zhang C, 2021, J ORTHOP SURG RES, V16, DOI 10.1186/s13018-021-02545-9; Zhang H, 2019, J MED CHEM, V62, P6665, DOI 10.1021/acs.jmedchem.9b00611; Zhang T, 2020, CELL, V180, P1115, DOI 10.1016/j.cell.2020.02.050; Zhu KZ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0524-y	47	2	2	9	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22487	10.1096/fj.202200163R	http://dx.doi.org/10.1096/fj.202200163R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3Q4LJ	35947125				2022-12-26	WOS:000838204400001
J	Stephen, C; Mishanina, TV				Stephen, Christine; Mishanina, Tatiana V.			Alkaline pH has an unexpected effect on transcriptional pausing during synthesis of the Escherichia coli pH-responsive riboswitch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE; DYNAMICS; MECHANISM; HAIRPIN	Riboswitches are 50-untranslated regions of mRNA that change their conformation in response to ligand binding, allowing post-transcriptional gene regulation. This ligand-based model of riboswitch function has been expanded with the discovery of a "pH-responsive element " (PRE) riboswitch in Escherichia coli. At neutral pH, the PRE folds into a translationally inactive structure with an occluded ribosome-binding sequence, whereas at alkaline pH, the PRE adopts a transla-tionally active structure. This unique riboswitch does not rely on ligand binding in a traditional sense to modulate its alter-native folding outcomes. Rather, pH controls riboswitch folding by two possible modes that are yet to be distinguished; pH either regulates the transcription rate of RNA polymerase (RNAP) or acts on the RNA itself. Previous work suggested that RNAP pausing is prolonged by alkaline pH at two sites, stimulating PRE folding into the active structure. To date, there has been no rigorous exploration into how pH influences RNAP pausing kinetics during PRE synthesis. To provide that understanding and distinguish between pH acting on RNAP versus RNA, we investigated RNAP pausing kinetics at key sites for PRE folding under different pH conditions. We find that pH influences RNAP pausing but not in the manner proposed previously. Rather, alkaline pH either decreases or has no effect on RNAP pause longevity, suggesting that the modulation of RNAP pausing is not the sole mechanism by which pH affects PRE folding. These findings invite the possibility that the RNA itself actively participates in the sensing of pH.	[Stephen, Christine; Mishanina, Tatiana V.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Mishanina, TV (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	tmishanina@ucsd.edu			National Institutes of Health/National Institute of General Medical Sciences (ESI) [R35 GM142785-01]; Burroughs Wellcome Fund CASI [1016945.01]; Yinan Wang Memorial Chancellor's Endowed Junior Faculty Fellowship; National Institutes of Health Molecular Biophysics Training Grant [T32 GM008326]	National Institutes of Health/National Institute of General Medical Sciences (ESI); Burroughs Wellcome Fund CASI(Burroughs Wellcome Fund); Yinan Wang Memorial Chancellor's Endowed Junior Faculty Fellowship; National Institutes of Health Molecular Biophysics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported byNational Institutes of Health/National Institute of General MedicalSciences (ESI; grant no.: R35 GM142785-01), Burroughs WellcomeFund CASI (grant no.: 1016945.01), UCSD institutional support,and Yinan Wang Memorial Chancellor's Endowed Junior Faculty Fellowship to T. V. M., and National Institutes of Health MolecularBiophysics Training Grant (grant no.: T32 GM008326) to C. S. Thecontent is solely the responsibility of the authors and does notnecessarily represent the official views of the National Institutes ofHealth.	Abdelkareem M, 2019, MOL CELL, V75, P298, DOI 10.1016/j.molcel.2019.04.029; Adeolu M, 2016, INT J SYST EVOL MICR, V66, P5575, DOI 10.1099/ijsem.0.001485; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Baisden JT, 2021, NAT CHEM BIOL, V17, DOI 10.1038/s41589-020-00667-5; BINGHAM RJ, 1990, J BACTERIOL, V172, P2184, DOI 10.1128/jb.172.4.2184-2186.1990; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Chawla M, 2011, J PHYS CHEM B, V115, P1469, DOI 10.1021/jp106848h; Guo XY, 2018, MOL CELL, V69, P816, DOI 10.1016/j.molcel.2018.02.008; Halder A, 2014, PHYS CHEM CHEM PHYS, V16, P18383, DOI 10.1039/c4cp02541e; Heilman-Miller SL, 2003, RNA, V9, P722, DOI 10.1261/rna.5200903; Houck-Loomis B, 2011, NATURE, V480, P561, DOI 10.1038/nature10657; Huppler A, 2002, NAT STRUCT BIOL, V9, P431, DOI 10.1038/nsb800; Kang JY, 2019, J MOL BIOL, V431, P4007, DOI 10.1016/j.jmb.2019.07.017; Kang JY, 2018, MOL CELL, V69, P802, DOI 10.1016/j.molcel.2018.01.018; Kerpedjiev P, 2015, BIOINFORMATICS, V31, P3374, DOI 10.1093/bioinformatics/btv372; Kyzer S, 2007, J BIOL CHEM, V282, P19020, DOI 10.1074/jbc.M701483200; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Landick R, 1996, METHOD ENZYMOL, V274, P334; Larson MH, 2014, SCIENCE, V344, P1042, DOI 10.1126/science.1251871; Mishanina TV, 2017, P NATL ACAD SCI USA, V114, pE5103, DOI 10.1073/pnas.1702383114; Nechooshtan G, 2014, NUCLEIC ACIDS RES, V42, P622, DOI 10.1093/nar/gkt868; Nechooshtan G, 2009, GENE DEV, V23, P2650, DOI 10.1101/gad.552209; Nixon PL, 2000, J MOL BIOL, V296, P659, DOI 10.1006/jmbi.1999.3464; Nshogozabahizi JC, 2019, J APPL MICROBIOL, V127, P968, DOI 10.1111/jam.14270; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Pan T, 1999, P NATL ACAD SCI USA, V96, P9545, DOI 10.1073/pnas.96.17.9545; Pechlaner M, 2015, ANGEW CHEM INT EDIT, V54, P9687, DOI 10.1002/anie.201504014; Perdrizet GA, 2012, P NATL ACAD SCI USA, V109, P3323, DOI 10.1073/pnas.1113086109; Ray-Soni A, 2016, ANNU REV BIOCHEM, V85, P319, DOI 10.1146/annurev-biochem-060815-014844; Saba J, 2019, ELIFE, V8, DOI 10.7554/eLife.40981; Saenger W., 1984, PRINCIPLES NUCL ACID; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Steinhart H, 2017, ELIFE, V6, DOI 10.7554/eLife.21297; Strobel E. J, 2017, NUCL ACIDS RES, V45, P1; Strobel EJ, 2019, NAT CHEM BIOL, V15, P1067, DOI 10.1038/s41589-019-0382-7; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; THEISSEN G, 1990, ANAL BIOCHEM, V189, P254, DOI 10.1016/0003-2697(90)90117-R; Thomen P, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128102; Watters KE, 2016, NAT STRUCT MOL BIOL, V23, P1124, DOI 10.1038/nsmb.3316; Widom JR, 2018, MOL CELL, V72, P541, DOI 10.1016/j.molcel.2018.08.046; Wong TN, 2007, P NATL ACAD SCI USA, V104, P17995, DOI 10.1073/pnas.0705038104; Yakhnin AV, 2006, MOL CELL, V24, P547, DOI 10.1016/j.molcel.2006.09.018; Yakhnin AV, 2020, P NATL ACAD SCI USA, V117, P21628, DOI 10.1073/pnas.2006873117; Yakhnin H, 2019, MBIO, V10, DOI 10.1128/mBio.02665-19; Zamft B, 2012, P NATL ACAD SCI USA, V109, P8948, DOI 10.1073/pnas.1205063109; Zeinert R, 2018, J BIOL CHEM, V293, P5715, DOI 10.1074/jbc.M117.790717; ZILBERSTEIN D, 1984, J BACTERIOL, V158, P246, DOI 10.1128/JB.158.1.246-252.1984	49	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102302	10.1016/j.jbc.2022.102302	http://dx.doi.org/10.1016/j.jbc.2022.102302			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4V3XX	35934054	gold, Green Published			2022-12-26	WOS:000859414300008
J	Wang, S; Liu, XN; Meng, ZQ; Feng, Q; Lin, YL; Niu, HL; Yu, C; Zong, YH; Guo, LL; Yang, WW; Ma, YH; Zhang, WJ; Li, CY; Yang, YR; Wang, WJ; Gao, XR; Hu, YX; Liu, C; Nie, L				Wang, Shuai; Liu, Xiaoning; Meng, Zeqi; Feng, Qi; Lin, Yanling; Niu, Honglin; Yu, Chao; Zong, Yanhong; Guo, Lingling; Yang, Weiwei; Ma, Yuehua; Zhang, Wenjun; Li, Chenyang; Yang, Yunran; Wang, Wenjuan; Gao, Xurui; Hu, Yaxin; Liu, Chao; Nie, Lei			DCBLD2 regulates vascular hyperplasia by modulating the platelet derived growth factor receptor-beta endocytosis through Caveolin-1 in vascular smooth muscle cells	FASEB JOURNAL			English	Article						Caveolin-1; DCBLD2; PDGFR-beta; vascular hyperplasia; vascular smooth muscle cell	PDGFR-BETA; TYROSINE PHOSPHORYLATION; UP-REGULATION; PROLIFERATION; MIGRATION; INTERNALIZATION; ASSOCIATION; HOMEOSTASIS; SURVIVAL; FAMILY	DCBLD2 is a neuropilin-like transmembrane protein that is up-regulated during arterial remodeling in humans, rats, and mice. Activation of PDGFR-beta via PDGF triggers receptor phosphorylation and endocytosis. Subsequent activation of downstream signals leads to the stimulation of phenotypic conversion of VSMCs and arterial wall proliferation, which are common pathological changes in vascular remodeling diseases such as atherosclerosis, hypertension, and restenosis after angioplasty. In this study, we hypothesized that DCBLD2 regulates neointimal hyperplasia through the regulation of PDGFR-beta endocytosis of vascular smooth muscle cells (VSMCs) through Caveolin-1 (Cav-1). Compared with wild-type (WT) mice or control littermate mice, the germline or VSMC conditional deletion of the Dcbld2 gene resulted in a significant increase in the thickness of the tunica media in the carotid artery ligation. To elucidate the underlying molecular mechanisms, VSMCs were isolated from the aorta of WT or Dcbld2(-/-) mice and were stimulated with PDGF. Western blotting assays demonstrated that Dcbld2 deletion increased the PDGF signaling pathway. Biotin labeling test and membrane-cytosol separation test showed that after DCBLD2 was knocked down or knocked out, the level of PDGFR-beta on the cell membrane was significantly reduced, while the amount of PDGFR-beta in the cytoplasm increased. Co-immunoprecipitation experiments showed that after DCBLD2 gene knock-out, the binding of PDGFR-beta and Cav-1 in the cytoplasm significantly increased. Double immunofluorescence staining showed that PDGFR-beta accumulated Cav-1/lysosomes earlier than for control cells, which indicated that DCBLD2 gene knock-down or deletion accelerated the endocytosis of PDGF-induced PDGFR-beta in VSMCs. In order to confirm that DCBLD2 affects the relationship between Cav-1 and PDGFR-beta, proteins extracted from VSMCs cultured in vitro were derived from WT and Dcbld2(-/-) mice, whereas co-immunoprecipitation suggested that the combination of DCBLD2 and Cav-1 reduced the bond between Cav-1 and PDGFR-beta, and DCBLD2 knock-out was able to enhance the interaction between Cav-1 and PDGFR-beta. Therefore, the current results suggest that DCBLD2 may inhibit the caveolae-dependent endocytosis of PDGFR-beta by anchoring the receptor on the cell membrane. Based on its ability to regulate the activity of PDGFR-beta, DCBLD2 may be a novel therapeutic target for the treatment of cardiovascular diseases.	[Wang, Shuai; Liu, Xiaoning; Meng, Zeqi; Feng, Qi; Lin, Yanling; Yu, Chao; Zong, Yanhong; Guo, Lingling; Yang, Weiwei; Ma, Yuehua; Zhang, Wenjun; Li, Chenyang; Yang, Yunran; Wang, Wenjuan; Gao, Xurui; Hu, Yaxin] Hebei Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Shijiazhuang, Hebei, Peoples R China; [Wang, Shuai; Liu, Xiaoning; Meng, Zeqi; Feng, Qi; Lin, Yanling; Yu, Chao; Zong, Yanhong; Guo, Lingling; Yang, Weiwei; Ma, Yuehua; Zhang, Wenjun; Li, Chenyang; Yang, Yunran; Wang, Wenjuan; Gao, Xurui; Hu, Yaxin; Nie, Lei] Hebei Med Univ, Key Lab Med Biotechnol Hebei Prov, Shijiazhuang, Hebei, Peoples R China; [Wang, Shuai; Liu, Xiaoning; Meng, Zeqi; Feng, Qi; Lin, Yanling; Yu, Chao; Zong, Yanhong; Guo, Lingling; Yang, Weiwei; Ma, Yuehua; Zhang, Wenjun; Li, Chenyang; Yang, Yunran; Wang, Wenjuan; Gao, Xurui; Hu, Yaxin; Nie, Lei] Hebei Med Univ, Cardiovasc Med Sci Ctr, Shijiazhuang, Hebei, Peoples R China; [Niu, Honglin] Hebei Med Univ, Sch Nursing, Shijiazhuang 050017, Hebei, Peoples R China; [Liu, Chao] Hebei Med Univ, Dept Lab Anim Sci, Shijiazhuang, Hebei, Peoples R China; [Liu, Chao] Hebei Med Univ, Key Lab Anim Sci Hebei Prov, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University	Nie, L (corresponding author), Hebei Med Univ, Key Lab Med Biotechnol Hebei Prov, Shijiazhuang, Hebei, Peoples R China.; Niu, HL (corresponding author), Hebei Med Univ, Sch Nursing, Shijiazhuang 050017, Hebei, Peoples R China.	niuhonglin126@126.com; leinie@hebmu.edu.cn		Niu, Honglin/0000-0003-0710-5959	Innovation Capability Support Program Project in Hebei Province [20567610D]; Research Project of Hebei Province Colleges and Universities [BJ2019026]; Precision medicine joint fund of Hebei Province of China [2021206393, 2020206432]; Natural Science Foundation of Hebei Province [2016206226]; National Natural Science Foundation of China [81600576, 31771268, 31571176]	Innovation Capability Support Program Project in Hebei Province; Research Project of Hebei Province Colleges and Universities; Precision medicine joint fund of Hebei Province of China; Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Innovation Capability Support Program Project in Hebei Province, Grant/Award Number: 20567610D; Research Project of Hebei Province Colleges and Universities, Grant/Award Number: BJ2019026; Precision medicine joint fund of Hebei Province of China, Grant/Award Number: 2021206393 and 2020206432; Natural Science Foundation of Hebei Province, Grant/Award Number: 2016206226; National Natural Science Foundation of China, Grant/Award Number: 81600576, 31771268 and 31571176	Alhamoudi KM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92026-0; Aten TM, 2013, FEBS LETT, V587, P2313, DOI 10.1016/j.febslet.2013.05.064; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Caglayan E, 2011, J AM COLL CARDIOL, V57, P2527, DOI 10.1016/j.jacc.2011.02.037; Chanakira A, 2012, AM J PHYSIOL-HEART C, V302, pH1173, DOI 10.1152/ajpheart.00411.2011; Chen Y, 2007, PROTEOMICS, V7, P2384, DOI 10.1002/pmic.200600968; Cheng C, 2012, ARTERIOSCL THROM VAS, V32, P1289, DOI 10.1161/ATVBAHA.112.245530; Cheng S, 2021, NEUROREPORT, V32, P507, DOI 10.1097/WNR.0000000000001611; Critchley WR, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7030022; Dong LH, 2015, CIRC RES, V117, P684, DOI 10.1161/CIRCRESAHA.115.306233; Feng HZ, 2014, J CLIN INVEST, V124, P3741, DOI 10.1172/JCI73093; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Guo XJ, 2009, J BIOL CHEM, V284, P29376, DOI 10.1074/jbc.M109.049684; Gutierrez-Pajares Jorge L, 2015, Front Cardiovasc Med, V2, P27, DOI 10.3389/fcvm.2015.00027; He J, 2020, CELL ONCOL, V43, P409, DOI 10.1007/s13402-020-00495-8; Jastrzebski K, 2017, J CELL SCI, V130, P577, DOI 10.1242/jcs.191213; Kazlauskas A, 2017, GENE, V614, P1, DOI 10.1016/j.gene.2017.03.003; Kikuta K, 2017, BBA-PROTEINS PROTEOM, V1865, P1160, DOI 10.1016/j.bbapap.2017.06.023; Kim Y, 2014, EUR J PHARMACOL, V733, P81, DOI 10.1016/j.ejphar.2014.03.037; Kobuke K, 2001, J BIOL CHEM, V276, P34105, DOI 10.1074/jbc.M105293200; Kohno T, 2013, AM J PHYSIOL-CELL PH, V305, pC591, DOI 10.1152/ajpcell.00011.2013; Lu QB, 2018, REDOX BIOL, V14, P656, DOI 10.1016/j.redox.2017.11.012; Lv P, 2016, AM J PHYSIOL-CELL PH, V311, pC758, DOI 10.1152/ajpcell.00033.2016; Mulder AB, 1996, BLOOD, V88, P1306, DOI 10.1182/blood.V88.4.1306.bloodjournal8841306; Nakayama A, 2013, GENE DEV, V27, P2576, DOI 10.1101/gad.224089.113; Nehru V, 2013, TRAFFIC, V14, P1242, DOI 10.1111/tra.12121; Nie L, 2013, J CLIN INVEST, V123, P5082, DOI 10.1172/JCI67752; Omote S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27672-y; Park ES, 2011, J PHARMACOL SCI, V116, P204, DOI 10.1254/jphs.10276FP; Park ES, 2013, EXP CELL RES, V319, P982, DOI 10.1016/j.yexcr.2012.12.024; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schmoker AM, 2019, BIOCHEM J, V476, P931, DOI 10.1042/BCJ20190022; Schmoker AM, 2017, BIOCHEM J, V474, P3963, DOI 10.1042/BCJ20170615; Sorokin V, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.599415; Thyberg J, 2000, LAB INVEST, V80, P915, DOI 10.1038/labinvest.3780095; Westerdijk K, 2020, BRIT J CLIN PHARMACO, V86, P258, DOI 10.1111/bcp.14185; Xie P, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.669285; Zhang JH, 2009, FASEB J, V23, P153, DOI 10.1096/fj.08-113860; Zhu BY, 2017, CELL TISSUE RES, V368, P591, DOI 10.1007/s00441-017-2587-y	40	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22488	10.1096/fj.202200156RR	http://dx.doi.org/10.1096/fj.202200156RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3N5LI	35929441				2022-12-26	WOS:000836188600001
J	Wijeratne, TU; Guiley, KZ; Lee, HW; Muller, GA; Rubin, SM				Wijeratne, Tilini U.; Guiley, Keelan Z.; Lee, Hsiau-Wei; Muller, Gerd A.; Rubin, Seth M.			Cyclin-dependent kinase-mediated phosphorylation and the negative regulatory domain of transcription factor B-Myb modulate its DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYB; CELL-CYCLE; PROTEIN-PHOSPHORYLATION; A-MYB; GENE; ACTIVATION; TRANSACTIVATION; TRANSFORMATION; A/CDK2; FOXM1	B-Myb is a highly conserved member of the vertebrate Myb family of transcription factors that plays a critical role in cell -cycle progression and proliferation. Myb proteins activate Myb-dependent promoters by interacting specifically with Myb-binding site (MBS) sequences using their DNA-binding domain (DBD). Transactivation of MBS promoters by B-Myb is repressed by its negative regulatory domain (NRD), and phosphorylation of the NRD by Cdk2-CyclinA relieves the repression to activate B-Myb-dependent promoters. However, the structural mechanisms underlying autoinhibition and activation of B-Myb-mediated transcription have been poorly characterized. Here, we determined that a region in the B-Myb NRD (residues 510-600) directly associates with the DBD and inhibits binding of the DBD to the MBS DNA sequence. We demonstrate using biophysical assays that phosphorylation of the NRD at T515, T518, and T520 is sufficient to disrupt the interaction between the NRD and the DBD, which results in increased affinity for MBS DNA and increased B-Myb-dependent promoter activation in cell assays. Our biochemical characterization of B-Myb autoregulation and the activating effects of phosphorylation provide insight into how B-Myb functions as a site-specific transcription factor.	[Wijeratne, Tilini U.; Guiley, Keelan Z.; Lee, Hsiau-Wei; Muller, Gerd A.; Rubin, Seth M.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Muller, GA; Rubin, SM (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	gemuelle@ucsc.edu; srubin@ucsc.edu	Müller, Gerd Armin/GYU-9447-2022; Müller, Gerd Armin/AAO-6714-2021	Müller, Gerd Armin/0000-0002-4967-2487; Müller, Gerd Armin/0000-0002-4967-2487; , Tilini/0000-0003-4534-036X; Rubin, Seth/0000-0002-1670-4147	National Institute of General Medical Sciences [R01GM124148, R01GM127707]; Ruth L. Kirschstein Predoctoral Fellowship from the National Cancer Institute [F31CA254090]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ruth L. Kirschstein Predoctoral Fellowship from the National Cancer Institute	Funding and additional information-This research was supported by grants from the National Institute of General Medical Sciences (R01GM124148 and R01GM127707) to S. M. R. T. U. W. is sup-ported by a Ruth L. Kirschstein Predoctoral Fellowship from the National Cancer Institute (F31CA254090) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrejka L, 2011, P NATL ACAD SCI USA, V108, P17438, DOI 10.1073/pnas.1111855108; Ansieau S, 1997, J MOL MED-JMM, V75, P815, DOI 10.1007/s001090050170; AZIZ N, 1995, P NATL ACAD SCI USA, V92, P6429, DOI 10.1073/pnas.92.14.6429; Bartsch O, 1999, EUR J BIOCHEM, V260, P384, DOI 10.1046/j.1432-1327.1999.00191.x; Bastidas M, 2015, CONCEPT MAGN RESON A, V44, P54, DOI 10.1002/cmr.a.21327; Basu U, 2020, J BIOL CHEM, V295, P6823, DOI 10.1074/jbc.RA120.013338; Bayley R, 2020, BBA-REV CANCER, V1874, DOI 10.1016/j.bbcan.2020.188407; Bergholtz S, 2001, NUCLEIC ACIDS RES, V29, P3546, DOI 10.1093/nar/29.17.3546; Bessa M, 2001, ONCOGENE, V20, P3376, DOI 10.1038/sj.onc.1204439; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; Brayer KJ, 2016, CANCER DISCOV, V6, P176, DOI 10.1158/2159-8290.CD-15-0859; Carr MD, 1996, EUR J BIOCHEM, V235, P721, DOI 10.1111/j.1432-1033.1996.00721.x; Charrasse S, 2000, ONCOGENE, V19, P2986, DOI 10.1038/sj.onc.1203618; Dash AB, 1996, GENE DEV, V10, P1858, DOI 10.1101/gad.10.15.1858; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Down CF, 2012, BBA-GENE REGUL MECH, V1819, P855, DOI 10.1016/j.bbagrm.2012.03.008; DUBENDORFF JW, 1992, GENE DEV, V6, P2524, DOI 10.1101/gad.6.12b.2524; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; GONDA TJ, 1989, EMBO J, V8, P1777, DOI 10.1002/j.1460-2075.1989.tb03571.x; Graf T, 1992, CURR OPIN GENET DEV, V2, P249, DOI 10.1016/S0959-437X(05)80281-3; Guiley KZ, 2018, P NATL ACAD SCI USA, V115, P10016, DOI 10.1073/pnas.1808136115; HU YL, 1991, ONCOGENE, V6, P1549; Johnson TK, 1999, J BIOL CHEM, V274, P36741, DOI 10.1074/jbc.274.51.36741; Lane S, 1997, ONCOGENE, V14, P2445, DOI 10.1038/sj.onc.1201086; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lipsick JS, 1996, ONCOGENE, V13, P223; Lipsick JS, 1999, ONCOGENE, V18, P3047, DOI 10.1038/sj.onc.1202745; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; Marceau AH, 2019, ELIFE, V8, DOI 10.7554/eLife.46131; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Muller GA, 2014, NUCLEIC ACIDS RES, V42, P10331, DOI 10.1093/nar/gku696; Musa J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.244; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; Nitta KR, 2015, ELIFE, V4, DOI 10.7554/eLife.04837; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Petrovas C, 2003, ONCOGENE, V22, P2011, DOI 10.1038/sj.onc.1206231; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Qin H, 2019, ONCOTARGETS THER, V12, P1917, DOI 10.2147/OTT.S190145; RAMSAY RG, 1995, ONCOGENE, V11, P2113; Robinson C, 1996, ONCOGENE, V12, P1855; Rubin SM, 2013, TRENDS BIOCHEM SCI, V38, P12, DOI 10.1016/j.tibs.2012.10.007; Sadasivam S, 2012, GENE DEV, V26, P474, DOI 10.1101/gad.181933.111; Sala A, 2005, EUR J CANCER, V41, P2479, DOI 10.1016/j.ejca.2005.08.004; Sala A, 1997, P NATL ACAD SCI USA, V94, P532, DOI 10.1073/pnas.94.2.532; Saville MK, 1998, ONCOGENE, V17, P2679, DOI 10.1038/sj.onc.1202503; Seong HA, 2003, J BIOL CHEM, V278, P9655, DOI 10.1074/jbc.M207478200; Sun C, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz153; Sun X, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021456118; TAKAHASHI T, 1995, FEBS LETT, V358, P89, DOI 10.1016/0014-5793(94)01402-M; TASHIRO S, 1995, ONCOGENE, V10, P1699; Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0; Werwein E, 2020, FEBS LETT, V594, P4266, DOI 10.1002/1873-3468.13940; Werwein E, 2019, NUCLEIC ACIDS RES, V47, P103, DOI 10.1093/nar/gky935; Xhani S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay3178; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Ziebold U, 1997, CURR BIOL, V7, P253, DOI 10.1016/S0960-9822(06)00121-7	57	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102319	10.1016/j.jbc.2022.102319	http://dx.doi.org/10.1016/j.jbc.2022.102319			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4V3XX	35926712	Green Published, gold			2022-12-26	WOS:000859414300007
J	Chen, MM; Ibrayim, M; Hamdulla, A				Chen, Mengmeng; Ibrayim, Mayire; Hamdulla, Askar			AAF-Net: Scene text detection based on attention aggregation features	PLOS ONE			English	Article								With the advent of the era of artificial intelligence, text detection is widely used in the real world. In text detection, due to the limitation of the receptive field of the neural network, most existing scene text detection methods cannot accurately detect small target text instances in any direction, and the detection rate of mutually adhering text instances is low, which is prone to false detection. To tackle such difficulties, in this paper, we propose a new feature pyramid network for scene text detection, Cross-Scale Attention Aggregation Feature Pyramid Network (CSAA-FPN). Specifically, we use a Attention Aggregation Feature Module (AAFM) to enhance features, which not only solves the problem of weak features and small receptive fields extracted by lightweight networks but also better handles multi-scale information and accurately separate adjacent text instances. An attention module CBAM is introduced to focus on effective information so that the output feature layer has richer and more accurate information. Furthermore, we design an Adaptive Fusion Module (AFM), which weights the output features and pays attention to the pixel information to further refine the features. Experiments conducted on CTW1500, Total-Text, ICDAR2015, and MSRA-TD500 have demonstrated the superiority of this model.	[Chen, Mengmeng; Ibrayim, Mayire; Hamdulla, Askar] Xinjiang Univ, Coll Informat Sci & Engn, Urumqi, Peoples R China; [Chen, Mengmeng; Ibrayim, Mayire; Hamdulla, Askar] Xinjiang Key Lab Signal Detect & Proc, Urumqi, Xinjiang, Peoples R China	Xinjiang University	Ibrayim, M (corresponding author), Xinjiang Univ, Coll Informat Sci & Engn, Urumqi, Peoples R China.; Ibrayim, M (corresponding author), Xinjiang Key Lab Signal Detect & Proc, Urumqi, Xinjiang, Peoples R China.	mayire401@xju.edu.cn		chen, mengmeng/0000-0003-4604-0051	Natural Science Foundation of China [U2003207, 62166043]; Natural Science Foundation of Xinjiang [2020D01C045]; Youth Fund for scientific research program of Autonomous Region [XJEDU2019Y007]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Xinjiang; Youth Fund for scientific research program of Autonomous Region	Natural Science Foundation of China (62166043) Natural Science Foundation of China (U2003207) Natural Science Foundation of Xinjiang (No.2020D01C045) Youth Fund for scientific research program of Autonomous Region (XJEDU2019Y007) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ch'ng CK, 2017, PROC INT CONF DOC, P935, DOI 10.1109/ICDAR.2017.157; Chaoxu Guo, 2020, 2020 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR). Proceedings, P12592, DOI 10.1109/CVPR42600.2020.01261; Cheng-Jun Li, 2018, Arxiv, DOI arXiv:1803.00085; Cordova M, 2020, IEEE ACCESS, V8, P223172, DOI 10.1109/ACCESS.2020.3043813; Deng D, 2018, AAAI CONF ARTIF INTE, P6773; Ding Liang, 2019, Arxiv, DOI arXiv:1903.11800; Epshtein B, 2010, PROC CVPR IEEE, P2963, DOI 10.1109/CVPR.2010.5540041; Guo G, 2007, PROCEEDINGS OF THE FOURTH INTERNATIONAL CONFERENCE ON IMAGE AND GRAPHICS, P484, DOI 10.1109/ICIG.2007.151; Guosheng Lin, 2018, Arxiv, DOI arXiv:1805.08365; Gupta A, 2016, PROC CVPR IEEE, P2315, DOI 10.1109/CVPR.2016.254; He WH, 2017, IEEE I CONF COMP VIS, P745, DOI 10.1109/ICCV.2017.87; Hu H, 2017, IEEE I CONF COMP VIS, P4950, DOI 10.1109/ICCV.2017.529; Hu M, 2021, PROC CVPR IEEE, P15338, DOI 10.1109/CVPR46437.2021.01509; Jiang XF, 2020, IEEE ACCESS, V8, P102106, DOI 10.1109/ACCESS.2020.2999069; Jin Lianwen, 2017, Arxiv, DOI arXiv:1712.02170; Karatzas D, 2015, PROC INT CONF DOC, P1156, DOI 10.1109/ICDAR.2015.7333942; Kim KI, 2003, IEEE T PATTERN ANAL, V25, P1631, DOI 10.1109/TPAMI.2003.1251157; Liao MH, 2020, AAAI CONF ARTIF INTE, V34, P11474; Liao MH, 2018, PROC CVPR IEEE, P5909, DOI 10.1109/CVPR.2018.00619; Liao MH, 2017, AAAI CONF ARTIF INTE, P4161; Lin TY, 2017, PROC CVPR IEEE, P936, DOI 10.1109/CVPR.2017.106; Liu S, 2018, PROC CVPR IEEE, P8759, DOI 10.1109/CVPR.2018.00913; Liu YL, 2017, PROC CVPR IEEE, P3454, DOI 10.1109/CVPR.2017.368; Long SB, 2018, LECT NOTES COMPUT SC, V11206, P19, DOI 10.1007/978-3-030-01216-8_2; Lyu PY, 2018, LECT NOTES COMPUT SC, V11218, P71, DOI 10.1007/978-3-030-01264-9_5; Ma JQ, 2018, IEEE T MULTIMEDIA, V20, P3111, DOI 10.1109/TMM.2018.2818020; Matas J, 2004, IMAGE VISION COMPUT, V22, P761, DOI 10.1016/j.imavis.2004.02.006; Mengli Cheng, 2018, Arxiv, DOI arXiv:1805.01167; Qin X, 2020, IEEE ACCESS, V8, P122685, DOI 10.1109/ACCESS.2020.3007351; Shi BG, 2017, PROC CVPR IEEE, P3482, DOI 10.1109/CVPR.2017.371; Tian Z, 2016, LECT NOTES COMPUT SC, V9912, P56, DOI 10.1007/978-3-319-46484-8_4; Wang W., 2021, IEEE T PATTERN ANAL, V2; Wang WCV, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20133661; Wang WH, 2019, IEEE I CONF COMP VIS, P8439, DOI 10.1109/ICCV.2019.00853; Wang WH, 2019, PROC CVPR IEEE, P9328, DOI 10.1109/CVPR.2019.00956; Woo SH, 2018, LECT NOTES COMPUT SC, V11211, P3, DOI 10.1007/978-3-030-01234-2_1; Xu YC, 2019, IEEE T IMAGE PROCESS, V28, DOI 10.1109/TIP.2019.2900589; Yao C, 2012, PROC CVPR IEEE, P1083, DOI 10.1109/CVPR.2012.6247787; Yin XC, 2014, IEEE T PATTERN ANAL, V36, P970, DOI 10.1109/TPAMI.2013.182; Yuxin Wang, 2020, 2020 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR). Proceedings, P11750, DOI 10.1109/CVPR42600.2020.01177; Zhang CQ, 2019, PROC CVPR IEEE, P10544, DOI 10.1109/CVPR.2019.01080; Zhong ZY, 2017, INT CONF ACOUST SPEE, P1208, DOI 10.1109/ICASSP.2017.7952348; Zhou XY, 2017, PROC CVPR IEEE, P2642, DOI 10.1109/CVPR.2017.283; Zhu YX, 2021, PATTERN RECOGN, V110, DOI 10.1016/j.patcog.2020.107336; Zhu YX, 2018, INT C PATT RECOG, P3735, DOI 10.1109/ICPR.2018.8545067	47	0	0	10	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2022	17	8							e0272322	10.1371/journal.pone.0272322	http://dx.doi.org/10.1371/journal.pone.0272322			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5A3IT	35930564	Green Published, gold			2022-12-26	WOS:000862784200014
J	Bao, Y; Maeki, M; Ishida, A; Tani, H; Tokeshi, M				Bao, Yi; Maeki, Masatoshi; Ishida, Akihiko; Tani, Hirofumi; Tokeshi, Manabu			Preparation of size-tunable sub-200 nm PLGA-based nanoparticles with a wide size range using a microfluidic platform	PLOS ONE			English	Article							DEPENDENT CELLULAR UPTAKE; IN-VITRO; DRUG; DELIVERY; RELEASE; NANOPRECIPITATION; MICROTUBULES; DEVICES; CELLS; TAXOL	The realization of poly (lactic-co-glycolic acid) nanoparticles (PLGA NPs) from laboratory to clinical applications remains slow, partly because of the lack of precise control of each condition in the preparation process and the rich selectivity of nanoparticles with diverse characteristics. Employing PLGA NPs to establish a large range of size-controlled drug delivery systems and achieve size-selective drug delivery targeting remains a challenge for therapeutic development for different diseases. In this study, we employed a microfluidic device to control the size of PLGA NPs. PLGA, poly (ethylene glycol)-methyl ether block poly (lactic-co-glycolide) (PEG-PLGA), and blend (PLGA + PEG-PLGA) NPs were engineered with defined sizes. Blend NPs exhibit the widest size range (40-114 nm) by simply changing the flow rate conditions without changing the precursor (polymer molecular weight, concentration, and chain segment composition). A model hydrophobic drug, paclitaxel (PTX), was encapsulated in the NPs, and the PTX-loaded NPs maintained a large range of controllable NP sizes. Furthermore, size-controlled NPs were used to investigate the effect of particle size of sub-200 nm NPs on tumor cell growth. The 52 nm NPs showed higher cell growth inhibition than 109 nm NPs. Our method allows the preparation of biodegradable NPs with a large size range without changing polymer precursors as well as the nondemanding fluid conditions. In addition, our model can be applied to elucidate the role of particle sizes of sub-200 nm particles in various biomedical applications, which may help develop suitable drugs for different diseases.	[Bao, Yi] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido, Japan; [Maeki, Masatoshi; Ishida, Akihiko; Tani, Hirofumi; Tokeshi, Manabu] Hokkaido Univ, Fac Engn, Div Appl Chem, Sapporo, Hokkaido, Japan; [Maeki, Masatoshi] JST PRESTO, Kawaguchi, Saitama, Japan	Hokkaido University; Hokkaido University; Japan Science & Technology Agency (JST)	Maeki, M; Tokeshi, M (corresponding author), Hokkaido Univ, Fac Engn, Div Appl Chem, Sapporo, Hokkaido, Japan.; Maeki, M (corresponding author), JST PRESTO, Kawaguchi, Saitama, Japan.	m.maeki@eng.hokudai.ac.jp; tokeshi@eng.hokudai.ac.jp	Maeki, Masatoshi/T-4051-2019	Maeki, Masatoshi/0000-0001-7500-4231	JST, CREST [JPMJCR17H1]; JST, PRESTO [JPMJPR19K8]; Special Education and Research Expenses from the Ministry of Education, Culture, Sports, Science and Technology, AMED [JP21zf0127004]; JSPS KAKENHI [JP19KK0140]; Hokkaido University Support Program for Frontier Research, Hosokawa Powder Technology Foundation; Iketani Science and Technology Foundation	JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); JST, PRESTO(Japan Science & Technology Agency (JST)); Special Education and Research Expenses from the Ministry of Education, Culture, Sports, Science and Technology, AMED; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hokkaido University Support Program for Frontier Research, Hosokawa Powder Technology Foundation; Iketani Science and Technology Foundation	This work was supported by JST, CREST (Grant Number JPMJCR17H1), JST, PRESTO (Grant Number JPMJPR19K8), Special Education and Research Expenses from the Ministry of Education, Culture, Sports, Science and Technology, AMED (Grant Number JP21zf0127004), JSPS KAKENHI (Grant Number JP19KK0140), Hokkaido University Support Program for Frontier Research, Hosokawa Powder Technology Foundation, and Iketani Science and Technology Foundation.	Ananta JS, 2016, NEUROL RES, V38, P51, DOI 10.1080/01616412.2015.1133025; Barichello JM, 1999, DRUG DEV IND PHARM, V25, P471, DOI 10.1081/DDC-100102197; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Choi JS, 2014, COLLOID SURFACE B, V122, P545, DOI 10.1016/j.colsurfb.2014.07.030; Cruz LJ, 2010, J CONTROL RELEASE, V144, P118, DOI 10.1016/j.jconrel.2010.02.013; Cun DM, 2011, EUR J PHARM BIOPHARM, V77, P26, DOI 10.1016/j.ejpb.2010.11.008; Damiati S, 2018, GENES-BASEL, V9, DOI 10.3390/genes9020103; Danhier F, 2009, J CONTROL RELEASE, V133, P11, DOI 10.1016/j.jconrel.2008.09.086; Dunn SS, 2019, NANOSCALE, V11, P1847, DOI 10.1039/c8nr09944h; FESSI H, 1989, INT J PHARM, V55, pR1, DOI 10.1016/0378-5173(89)90281-0; Giteau A, 2008, INT J PHARMACEUT, V350, P14, DOI 10.1016/j.ijpharm.2007.11.012; Ibrahim WN, 2020, INT J NANOMED, V15, P8059, DOI 10.2147/IJN.S269340; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Karnik R, 2008, NANO LETT, V8, P2906, DOI 10.1021/nl801736q; Kimura N, 2018, ACS OMEGA, V3, P5044, DOI 10.1021/acsomega.8b00341; Kreuter J, 2003, PHARM RES-DORDR, V20, P409, DOI 10.1023/A:1022604120952; Lepeltier E, 2014, ADV DRUG DELIVER REV, V71, P86, DOI 10.1016/j.addr.2013.12.009; Lu F, 2009, SMALL, V5, P1408, DOI 10.1002/smll.200900005; Maeki Masatoshi, 2022, J Vis Exp, DOI 10.3791/62999; Maeki M, 2022, J CONTROL RELEASE, V344, P80, DOI 10.1016/j.jconrel.2022.02.017; Maeki M, 2015, RSC ADV, V5, P46181, DOI 10.1039/c5ra04690d; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Rivas CJM, 2017, INT J PHARMACEUT, V532, P66, DOI 10.1016/j.ijpharm.2017.08.064; NIWA T, 1993, J CONTROL RELEASE, V25, P89, DOI 10.1016/0168-3659(93)90097-O; Osaki F, 2004, J AM CHEM SOC, V126, P6520, DOI 10.1021/ja048792a; Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4; Rhee M, 2011, ADV MATER, V23, pH79, DOI 10.1002/adma.201004333; Riehemann K, 2009, ANGEW CHEM INT EDIT, V48, P872, DOI 10.1002/anie.200802585; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Sharma S, 2016, TRAC-TREND ANAL CHEM, V80, P30, DOI 10.1016/j.trac.2015.06.014; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Singh R, 2009, EXP MOL PATHOL, V86, P215, DOI 10.1016/j.yexmp.2008.12.004; Stroock AD, 2002, SCIENCE, V295, P647, DOI 10.1126/science.1066238; Su Y, 2022, DRUG DELIV, V29, P1437, DOI 10.1080/10717544.2022.2072413; Valencia PM, 2010, ACS NANO, V4, P1671, DOI 10.1021/nn901433u; Wilczewska AZ, 2012, PHARMACOL REP, V64, P1020, DOI 10.1016/S1734-1140(12)70901-5; Win KY, 2005, BIOMATERIALS, V26, P2713, DOI 10.1016/j.biomaterials.2004.07.050; Xu AR, 2012, INT J NANOMED, V7, P3547, DOI 10.2147/IJN.S32188	41	1	1	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271050	10.1371/journal.pone.0271050	http://dx.doi.org/10.1371/journal.pone.0271050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925917	gold, Green Published			2022-12-26	WOS:000848077100030
J	Topaz, M; Zolnoori, M; Norful, AA; Perrier, A; Kostic, Z; George, M				Topaz, Maxim; Zolnoori, Maryam; Norful, Allison A.; Perrier, Alexis; Kostic, Zoran; George, Maureen			Speech recognition can help evaluate shared decision making and predict medication adherence in primary care setting	PLOS ONE			English	Article							ASTHMA; QUESTIONNAIRE; NONADHERENCE; BELIEFS	Objective Asthma is a common chronic illness affecting 19 million US adults. Inhaled corticosteroids are a safe and effective treatment for asthma, yet, medication adherence among patients remains poor. Shared decision-making, a patient activation strategy, can improve patient adherence to inhaled corticosteroids. This study aimed to explore whether audio-recorded patient-primary care provider encounters can be used to: 1. Evaluate the level of patient-perceived shared decision-making during the encounter, and 2. Predict levels of patient's inhaled corticosteroid adherence. Materials and methods Shared decision-making and inhaled corticosteroid adherence were assessed using the SDM Questionnaire-9 and the Medication Adherence Report Scale for Asthma (MARS-A). Speech-to-text algorithms were used to automatically transcribe 80 audio-recorded encounters between primary care providers and asthmatic patients. Machine learning algorithms (Naive Bayes, Support Vector Machines, Decision Tree) were applied to achieve the study's predictive goals. Results The accuracy of automated speech-to-text transcription was relatively high (ROUGE F-score = .9). Machine learning algorithms achieved good predictive performance for shared decision-making (the highest F-score = .88 for the Naive Bayes) and inhaled corticosteroid adherence (the highest F-score = .87 for the Support Vector Machines). Discussion This was the first study that trained machine learning algorithms on a dataset of audiorecorded patient-primary care provider encounters to successfully evaluate the quality of SDM and predict patient inhaled corticosteroid adherence. Conclusion Machine learning approaches can help primary care providers identify patients at risk for poor medication adherence and evaluate the quality of care by measuring levels of shared decision-making. Further work should explore the replicability of our results in larger samples and additional health domains.	[Topaz, Maxim; Zolnoori, Maryam; Norful, Allison A.; Perrier, Alexis; George, Maureen] Columbia Univ, Sch Nursing, New York, NY 10027 USA; [Topaz, Maxim; Zolnoori, Maryam; Norful, Allison A.; Perrier, Alexis; George, Maureen] Columbia Univ, Data Sci Inst, New York, NY 10027 USA; [Topaz, Maxim] Visiting Nurse Serv New York, New York, NY 10018 USA; [Norful, Allison A.] Columbia Univ, Irving Inst Clin & Translat Res, New York, NY USA; [Kostic, Zoran] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Columbia University	Topaz, M (corresponding author), Columbia Univ, Sch Nursing, New York, NY 10027 USA.; Topaz, M (corresponding author), Columbia Univ, Data Sci Inst, New York, NY 10027 USA.; Topaz, M (corresponding author), Visiting Nurse Serv New York, New York, NY 10018 USA.	mt3315@cumc.columbia.edu			National Institute of Nursing Research, National Institutes of Health [R21 NR016507]; National Center for Advancing Translational Sciences, National Institutes of Health [TL1 TR001875]	National Institute of Nursing Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the National Institute of Nursing Research, National Institutes of Health (R21 NR016507). Dr. Norful's efforts were supported, in part, by the National Center for Advancing Translational Sciences, National Institutes of Health (TL1 TR001875). The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battersby M, 2010, JT COMM J QUAL PATIE, V36, P561, DOI 10.1016/S1553-7250(10)36084-3; Bedi G, 2015, NPJ SCHIZOPHR, V1, DOI 10.1038/npjschz.2015.30; Blackley SV, 2019, J AM MED INFORM ASSN, V26, P324, DOI 10.1093/jamia/ocy179; Center for Substance Abuse Treatment, 1999, ENH MOT CHANG SUBST; Centers for Disease Control and Prevention, 2022, BEHAV RISK FACTOR SU; Chakravarthula SN., 2019, AUTOMATIC PREDICTION; Gamble C, 2010, J ALLERGY CLIN IMMUN, V126, P1149, DOI 10.1016/j.jaci.2010.08.049; George M., 2020, C14 BARRIERS FACILIT, pA4479; George M, 2019, PATIENT PREFER ADHER, V13, P1325, DOI 10.2147/PPA.S209532; George M, 2019, J ADV NURS, V75, P876, DOI 10.1111/jan.13916; George M, 2014, J ALLERGY CLIN IMMUN, V134, P1252, DOI 10.1016/j.jaci.2014.07.044; Global Initiative for Asthma, 2016, GINA; Joseph-Williams N, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3178; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Kew KM, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012330.pub2; Kriston L, 2010, PATIENT EDUC COUNS, V80, P94, DOI 10.1016/j.pec.2009.09.034; Lee J., 2018, COMMUNITY MED, V14, P217, DOI [10.1558/cam.32815, DOI 10.1558/CAM.32815]; Legare F, 2013, HEALTH AFFAIR, V32, P276, DOI 10.1377/hlthaff.2012.1078; Lin Chin-Yew, 2004, P ACL TEXT SUMM BRAN, P74, DOI DOI 10.3115/V1/D14-1020; Low DM, 2020, LARYNGOSCOPE INVEST, V5, P96, DOI 10.1002/lio2.354; Makoul G, 2006, PATIENT EDUC COUNS, V60, P301, DOI 10.1016/j.pec.2005.06.010; Marmar CR, 2019, DEPRESS ANXIETY, V36, P607, DOI 10.1002/da.22890; Menckeberg TT, 2008, J PSYCHOSOM RES, V64, P47, DOI 10.1016/j.jpsychores.2007.07.016; Miller W, 2002, MOTIVATIONAL INTERVI, V2<feminine; Mora PA, 2011, PSYCHOL HEALTH, V26, P713, DOI 10.1080/08870446.2010.490585; Narayanan S, 2013, P IEEE, V101, P1203, DOI 10.1109/JPROC.2012.2236291; Norful AA, 2020, J CLIN EPIDEMIOL, V121, P15, DOI 10.1016/j.jclinepi.2020.01.001; Petti U, 2020, J AM MED INFORM ASSN, V27, P1784, DOI 10.1093/jamia/ocaa174; Pollard S, 2017, ALLERGY, V72, P705, DOI 10.1111/all.13090; Pollard S, 2015, PATIENT EDUC COUNS, V98, P1046, DOI 10.1016/j.pec.2015.05.004; Witten IH, 2011, MOR KAUF D, P1; Wu AC, 2015, ANN AM THORAC SOC, V12, P161, DOI 10.1513/AnnalsATS.201410-459OC; Xiang J, 2015, J ALLER CL IMM-PRACT, V3, P436, DOI 10.1016/j.jaip.2014.11.022; Zhou L, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0530	34	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271884	10.1371/journal.pone.0271884	http://dx.doi.org/10.1371/journal.pone.0271884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925922	gold, Green Published			2022-12-26	WOS:000848077100055
J	Salam, MA; Abd El-Fatah, M; Hassan, NF				Abdul Salam, Mustafa; Abd El-Fatah, Mohamed; Hassan, Naglaa Fathy			Automatic grading for Arabic short answer questions using optimized deep learning model	PLOS ONE			English	Article							SIMILARITY	Auto-grading of short answer questions is considered a challenging problem in the processing of natural language. It requires a system to comprehend the free text answers to automatically assign a grade for a student answer compared to one or more model answers. This paper suggests an optimized deep learning model for grading short-answer questions automatically by using various sizes of datasets collected in the Science subject for students in seventh grade in Egypt. The proposed system is a hybrid approach that optimizes a deep learning technique called LSTM (Long Short Term Memory) with a recent optimization algorithm called a Grey Wolf Optimizer (GWO). The GWO is employed to optimize the LSTM by selecting the best dropout and recurrent dropout rates of LSTM hyperparameters rather than manual choice. Using GWO makes the LSTM model more generalized and can also avoid the problem of overfitting in forecasting the students' scores to improve the learning process and save instructors' time and effort. The model's performance is measured in terms of the Root Mean Squared Error (RMSE), the Pearson correlation coefficient, and R-Square. According to the simulation results, the hybrid GWO with the LSTM model ensured the best performance and outperformed the classical LSTM model and other compared models such that it had the highest Pearson correlation coefficient value, the lowest RMSE value, and the best R square value in all experiments, but higher training time than the traditional deep learning model.	[Abdul Salam, Mustafa] Benha Univ, Fac Comp & Artificial Intelligence, Artificial intelligence Dept, Banha, Egypt; [Abdul Salam, Mustafa] Arab open Univ, Fac Comp Studies, Nasr City, Egypt; [Abd El-Fatah, Mohamed] Benha Univ, Comp & Informat Fac, Informat Syst Dept, Banha, Egypt; [Hassan, Naglaa Fathy] Natl Ctr Examinat & Educ Evaluat NCEEE, Informat & Operat Dept, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Benha University; Egyptian Knowledge Bank (EKB); Benha University	Salam, MA (corresponding author), Benha Univ, Fac Comp & Artificial Intelligence, Artificial intelligence Dept, Banha, Egypt.; Salam, MA (corresponding author), Arab open Univ, Fac Comp Studies, Nasr City, Egypt.	mustafa.abdo@fci.bu.edu.eg		abdul salam, mustafa/0000-0003-1673-6947				Abbas AyadR., 2015, ENG TECHNOLOGY J, V33, P410; Al-Anzi FS, 2017, J KING SAUD UNIV-COM, V29, P189, DOI 10.1016/j.jksuci.2016.04.001; al-awaida Odeh, 2019, AUTOMATED ARABIC ESS; Alajmi A., 2012, INT J COMPUTER APPL, V46, P8; Alazab M, 2020, IEEE ACCESS, V8, P85454, DOI 10.1109/ACCESS.2020.2991067; Albitar S, 2014, LECT NOTES COMPUT SC, V8786, P105; Alessandro Lenci, 2016, Arxiv, DOI arXiv:1608.07738; Ali Abdulla, 2011, TEXTUAL SIMILARITY; Boling Chelsea, 2014, 2014 NCUR; Bookstein A, 2002, INFORM RETRIEVAL, V5, P353, DOI 10.1023/A:1020499411651; Burrows S, 2015, INT J ARTIF INTELL E, V25, P60, DOI 10.1007/s40593-014-0026-8; Buscaldi D, 2013, P 2 JOINT C LCS, P63; Chakraborty Udit Kr, 2019, International Journal of Advanced Intelligence Paradigms, V14, P260; Chaudhary Himanshu., 2021, RECENT ADV MECH ENG, P253, DOI [10.1007/978-981-15-8704-7_31, DOI 10.1007/978-981-15-8704-7_31]; Chris Dyer, 2016, Arxiv, DOI arXiv:1605.02276; Costa Hernani, 2015, P 9 INT WORKSH SEM E, P96, DOI DOI 10.18653/V1/S15-2017; Cutrone L., 2011, Proceedings of the 2011 Third International Conference on Technology for Education (T4E 2011), P81, DOI 10.1109/T4E.2011.21; Elghannam Fatma., 2016, COMMUNICATIONS APPL, V6, P16, DOI [10.5120/cae2016652430, DOI 10.5120/CAE2016652430]; Emmanuele Chersoni, 2018, Arxiv, DOI arXiv:1805.01923; Estes Zachary, 2006, P ANN M COGN SCI SOC, V28; Galhardi LB, 2018, LECT NOTES ARTIF INT, V11238, P380, DOI 10.1007/978-3-030-03928-8_31; George N., 2019, INT J INNOV TECHNOL, V8; Gomaa WH, 2012, INT J ADV COMPUT SC, V3, P115; Gomaa WH, 2014, COMPUT SPEECH LANG, V28, P833, DOI 10.1016/j.csl.2013.10.005; Gong T. a., 2019, INT J COMPUTER SCI S; Greg Corrado, 2013, Arxiv, DOI arXiv:1301.3781; Hakak S, 2021, FUTURE GENER COMP SY, V117, P47, DOI 10.1016/j.future.2020.11.022; Hassan S, 2018, INT J ADV COMPUT SC, V9, P397; Hindocha E., 2019, SHORT TEXT SEMANTIC; Hussein M., 2016, INT J COMPUT APPL, V135, P38, DOI [DOI 10.5120/IJCA2016908328, 10.5120/ijca2016908328]; Islam A., 2008, ACM T KNOWL DISCOV D, V2, P1, DOI DOI 10.1145/1376815.1376819; Kenter T., 2015, P 24 ACM INT C INFOR, P1411, DOI [10.1145/2806416.2806475, DOI 10.1145/2806416.2806475]; Krishnamurthy S., 2019, INT J RECTECHNOL ENG, V7, P1712; Kumar PA, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12104124; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Lesk M., 1986, P 5 ANN INT C SYST D, P24, DOI DOI 10.1145/318723.318728; Liu Yang, 2015, P 9 INT WORKSH SEM E, P80; Lofi C., 2015, INFORM MEDIA TECHNOL, V10, P493, DOI 10.11185/imt.10.493; Magooda Ahmed Ezzat, 2016, 20 9 INT FLAIRS C; Majumder Goutam., 2017, INT J COMPUTATIONAL, V8, P171; Mihalcea R., 2006, AAAI, P775; Mirjalili S, 2014, ADV ENG SOFTW, V69, P46, DOI 10.1016/j.advengsoft.2013.12.007; Mohler M, 2011, P 49 ANN M ASS COMPU, P752; Mohler M., 2009, P 12 C EUR CHAPT ASS, P567, DOI DOI 10.3115/1609067.1609130; Mueller J, 2016, AAAI CONF ARTIF INTE, P2786; Negi G, 2021, INT J SYST ASSUR ENG, V12, P1, DOI 10.1007/s13198-020-00995-8; Panchenko Alexander, 2012, P WORKSH INN HYBR AP, P10; Patil P., 2018, AUTOGRADER SHORT ANS; Prakoso DW, 2021, SOFT COMPUT, V25, P4699, DOI 10.1007/s00500-020-05479-2; Pribadi FS, 2017, AIP CONF PROC, V1818, DOI 10.1063/1.4976906; Pulman S. G., 2005, P 2 WORKSH BUILD ED, P9; Ravi Teja, 2017, Arxiv, DOI arXiv:1708.00241; Riordan B., 2017, P 12 WORKSHOP INNOVA, P159, DOI [10.18653/v1/W17-5017, DOI 10.18653/V1/W17-5017]; Saha S, 2018, LECT NOTES ARTIF INT, V10947, P503, DOI 10.1007/978-3-319-93843-1_37; Sahlgren M, 2008, ITAL J LINGUIST, V20, P33; Sanchez Rodriguez Ivan, 2017, TEXT SIMILARITY USIN; Santus E, 2016, AAAI CONF ARTIF INTE, P4260; Schmidt C.W., 2019, CORR ABS190209875; Shankar GS, 2020, WIREL COMMUN MOB COM, V2020, DOI 10.1155/2020/8879054; Shehab A, 2018, INT J ADV COMPUT SC, V9, P263; Shrestha P., 2011, P 17 RENC ET CHERCH; Soliman A, 2017, PROCEDIA COMPUT SCI, V117, P256, DOI 10.1016/j.procs.2017.10.117; Sowmya Vangapelli., 2017, INT J INTELLIGENT EN, V10, DOI [10.22266/ijies2017.0831.21, DOI 10.22266/IJIES2017.0831.21]; Sultan M.A., 2016, P 2016 C N AM CHAPTE, P1070; Suzen N., 2020, PROCEDIA COMPUT SCI, V169, P726, DOI 10.1016/j.procs.2020.02.171; Sweidan AH, 2015, INT CONF SOFT COMPUT, P1, DOI 10.1109/SOCPAR.2015.7492777; Turney Peter D., 2001, MACHINE LEARNING ECM, P491, DOI DOI 10.1007/3-540-44795-4_; Yang X, 2017, LECT NOTES ARTIF INT, V10331, P594, DOI 10.1007/978-3-319-61425-0_72; Yao L, 2019, IEEE ACCESS, V7, P3430, DOI 10.1109/ACCESS.2018.2885698; Zhu XQ, 2012, IEEE IJCNN	70	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272269	http://dx.doi.org/10.1371/journal.pone.0272269			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917309	gold, Green Published			2022-12-26	WOS:000837840000049
J	Dorell, A; Konradsen, H; Kallstroem, AP; Kabir, ZN				Dorell, Asa; Konradsen, Hanne; Kallstroem, Ana Paula; Kabir, Zarina Nahar			"A friend during troubled times": Experiences of family caregivers to persons with dementia when receiving professional support via a mobile app	PLOS ONE			English	Article							HEALTH; PEOPLE; INTERVENTIONS; BURDEN; CARE		[Dorell, Asa; Konradsen, Hanne; Kallstroem, Ana Paula; Kabir, Zarina Nahar] Karolinska Inst, Dept Neurobiol Care Sci & Soc, NVS, Stockholm, Sweden; [Konradsen, Hanne] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Konradsen, Hanne] Herley & Gentofte Hosp, Dept Gastroenterol, Herlev, Denmark	Karolinska Institutet; University of Copenhagen	Dorell, A (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, NVS, Stockholm, Sweden.	asa.dorell@ki.se		Konradsen, Hanne/0000-0002-7477-125X				Adelman RD, 2014, JAMA-J AM MED ASSOC, V311, P1052, DOI 10.1001/jama.2014.304; Bin Sallim A, 2015, J AM MED DIR ASSOC, V16, P1034, DOI 10.1016/j.jamda.2015.09.007; Blom MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116622; Boots LMM, 2014, INT J GERIATR PSYCH, V29, P331, DOI 10.1002/gps.4016; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brodaty Henry, 2009, Dialogues Clin Neurosci, V11, P217; Chi NC, 2015, J TELEMED TELECARE, V21, P37, DOI 10.1177/1357633X14562734; Dahlrup B, 2015, ARCH GERONTOL GERIAT, V61, P261, DOI 10.1016/j.archger.2015.06.007; Deeken F, 2019, AM J GERIAT PSYCHIAT, V27, P426, DOI 10.1016/j.jagp.2018.12.003; Dorell A, 2016, GERIATR NURS, V37, P260, DOI 10.1016/j.gerinurse.2016.02.015; Esandi N, 2018, GERONTOLOGIST, V58, pE56, DOI 10.1093/geront/gnx084; Eska K, 2013, DEMENT GER COGN D EX, V3, P426, DOI 10.1159/000355079; Grossman MR, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.9345; Hicken BL, 2017, J RURAL HEALTH, V33, P305, DOI 10.1111/jrh.12195; Hopwood J, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9548; Jang SI, 2016, AM J ALZHEIMERS DIS, V31, P481, DOI 10.1177/1533317515628048; Kabir ZN, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01712-7; Kales HC, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0801-8; Kampmeijer R, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1522-3; Karlsson S, 2015, J ADV NURS, V71, P1405, DOI 10.1111/jan.12581; Kirwan M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2588; Kovaleva M, 2018, J PSYCHOSOC NURS MEN, V56, P36, DOI 10.3928/02793695-20180329-04; Kristiansen S, 2022, J CLIN NURS, V31, P1874, DOI 10.1111/jocn.15440; Krouwel M, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0867-9; Laks J, 2016, INT J GERIATR PSYCH, V31, P176, DOI 10.1002/gps.4309; Lewis ML, 2010, AM J ALZHEIMERS DIS, V25, P674, DOI 10.1177/1533317510385812; Lindeza Patricia, 2020, BMJ Support Palliat Care, DOI 10.1136/bmjspcare-2020-002242; Moberg C, 2022, DEMENTIA-LONDON, V21, P1120, DOI 10.1177/14713012211065313; Olson KE, 2011, AGEING INT, V36, P123, DOI 10.1007/s12126-010-9077-9; Osaki T, 2016, ARCH GERONTOL GERIAT, V66, P42, DOI 10.1016/j.archger.2016.04.015; Parra-Vidales E, 2017, ACTAS ESP PSIQUIATRI, V45, P116; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Ploeg J, 2018, J MED INTERNET RES, V20, DOI 10.2196/11247; Rathnayake S, 2019, J CLIN NURS, V28, P4460, DOI 10.1111/jocn.15030; Ringer TJ, 2020, AGEING SOC, V40, P205, DOI 10.1017/S0144686X18000971; Roth DL, 2015, GERONTOLOGIST, V55, P309, DOI 10.1093/geront/gnu177; Ryan D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1756; Sherifali D, 2018, J MED INTERNET RES, V20, DOI 10.2196/10668; Short C, 2015, EUR HLTH PSYCHOL, V17, DOI DOI 10.1007/S00520-017-3786-5; Sieverink F, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.8578; Smalley KB, 2010, J CLIN PSYCHOL, V66, P479, DOI 10.1002/jclp.20688; Stutzel MC, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0839-3; Takai M, 2011, PSYCHOGERIATRICS, V11, P98, DOI 10.1111/j.1479-8301.2011.00354.x; Thyrian JR, 2017, Z GERONTOL GERIATR, V50, P4, DOI 10.1007/s00391-016-1119-9; Walter E, 2020, GERONTOLOGIST, V60, pE609, DOI 10.1093/geront/gnz118; Ward K, 2015, J ADV NURS, V71, P2775, DOI 10.1111/jan.12748; WHO Global Observatory for eHealth, 2011, MHEALTH NEW HORIZONS; Williamson Steven S, 2014, AMIA Annu Symp Proc, V2014, P1960; Zhao YN, 2019, J MED INTERNET RES, V21, DOI 10.2196/13415	49	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271972	http://dx.doi.org/10.1371/journal.pone.0271972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917295	Green Published, gold			2022-12-26	WOS:000837840000051
J	Wang, H; Cheng, JW; Wei, DL; Wu, H; Zhao, JM				Wang, Hui; Cheng, Jianwen; Wei, Donglei; Wu, Hong; Zhao, Jinmin			Causal relationships between sex hormone traits, lifestyle factors, and osteoporosis in men: A Mendelian randomization study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; BINDING GLOBULIN; TESTOSTERONE; MORTALITY; RISK; ASSOCIATION; DETERMINANT; FRACTURE; SMOKING; ADULTS	Although observational studies have explored factors that may be associated with osteoporosis, it is not clear whether they are causal. Osteoporosis in men is often underestimated. This study aimed to identify the causal risk factors associated with bone mineral density (BMD) in men. Single nucleotide polymorphisms (SNPs) associated with the exposures at the genome-wide significance (p < 5x10(-8)) level were obtained from corresponding genome-wide association studies (GWASs) and were utilized as instrumental variables. Summary-level statistical data for BMD were obtained from two large-scale UK Biobank GWASs. A Mendelian randomization (MR) analysis was performed to identify causal risk factors for BMD. Regarding the BMD of the heel bone, the odds of BMD increased per 1-SD increase of free testosterone (FT) (OR = 1.13, P = 9.4 x 10(-17)), together with estradiol (E2) (OR = 2.51, P = 2.3 x 10(-4)). The odds of BMD also increased with the lowering of sex-hormone binding globulin (SHBG) (OR = 0.87, P = 7.4 x 10(-8)) and total testosterone (TT) (OR = 0.96, P = 3.2 x 10(-2)) levels. Regarding the BMD of the lumbar spine, the odds of BMD increased per 1-SD increase in FT (OR = 1.18, P = 4.0 x 10(-3)). Regarding the BMD of the forearm bone, the odds of BMD increased with lowering SHBG (OR = 0.75, P = 3.0 x 10(-3)) and TT (OR = 0.85, P = 3.0 x 10(-3)) levels. Our MR study corroborated certain causal relationships and provided genetic evidence among sex hormone traits, lifestyle factors and BMD. Furthermore, it is a novel insight that TT was defined as a disadvantage for osteoporosis in male European populations.	[Wang, Hui; Cheng, Jianwen; Wei, Donglei; Zhao, Jinmin] Guangxi Med Univ, Dept Orthopaed Trauma & Hand Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Wang, Hui; Zhao, Jinmin] Guangxi Med Univ, Res Ctr Regenerat Med, Guangxi Key Lab Regenerat Med, Nanning, Guangxi, Peoples R China; [Wu, Hong] Guangxi Med Univ, Dept Med Res, Affiliated Tumor Hosp, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Zhao, JM (corresponding author), Guangxi Med Univ, Dept Orthopaed Trauma & Hand Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.; Zhao, JM (corresponding author), Guangxi Med Univ, Res Ctr Regenerat Med, Guangxi Key Lab Regenerat Med, Nanning, Guangxi, Peoples R China.	csgkswk@126.com						Alswat Khaled A, 2017, J Clin Med Res, V9, P382, DOI 10.14740/jocmr2970w; Black DM, 2020, NEW ENGL J MED, V383, P743, DOI 10.1056/NEJMoa1916525; Bland VL, 2022, OSTEOPOROSIS INT, V33, P391, DOI 10.1007/s00198-021-06140-w; Bliuc D, 2015, J BONE MINER RES, V30, P637, DOI 10.1002/jbmr.2393; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Burgess S, 2017, EUR J EPIDEMIOL, V32, P377, DOI 10.1007/s10654-017-0255-x; Deng GJ, 2021, SPINE J, V21, P332, DOI 10.1016/j.spinee.2020.10.019; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; He B, 2021, CALCIFIED TISSUE INT, V109, P675, DOI 10.1007/s00223-021-00886-5; Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Hoppe E, 2010, JOINT BONE SPINE, V77, P306, DOI 10.1016/j.jbspin.2010.03.011; Jiang HX, 2005, J BONE MINER RES, V20, P494, DOI 10.1359/JBMR.041133; Jorgensen HS, 2018, KIDNEY INT REP, V3, P661, DOI 10.1016/j.ekir.2018.01.009; Lee JH, 2018, J BONE MINER METAB, V36, P95, DOI 10.1007/s00774-017-0811-1; Liu J, 2019, J ENDOCRINOL INVEST, V42, P1149, DOI 10.1007/s40618-019-01041-6; Liu MZ, 2019, NAT GENET, V51, P237, DOI 10.1038/s41588-018-0307-5; Ma BS, 2021, J BONE MINER RES, V36, P1281, DOI 10.1002/jbmr.4296; Ma M, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.763677; Marques EA, 2018, BONE, V108, P186, DOI 10.1016/j.bone.2018.01.014; Morris JA, 2019, NAT GENET, V51, P258, DOI 10.1038/s41588-018-0302-x; Qu ZH, 2021, CALCIFIED TISSUE INT, V108, P281, DOI 10.1007/s00223-020-00770-8; Rinonapoli G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22042105; Ruth KS, 2020, NAT MED, V26, P252, DOI 10.1038/s41591-020-0751-5; Saitz R, 2018, ALCOHOL CLIN EXP RES, V42, P1518, DOI 10.1111/acer.13801; Schmitz D, 2021, J CLIN ENDOCR METAB, V106, pE4471, DOI 10.1210/clinem/dgab507; Shim H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120758; Shin J, 2016, OSTEOPOROSIS INT, V27, P643, DOI 10.1007/s00198-015-3298-4; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Song JD, 2020, CALCIFIED TISSUE INT, V107, P440, DOI 10.1007/s00223-020-00736-w; Song TH, 2018, CLIN PSYCHOPHARM NEU, V16, P282, DOI 10.9758/cpn.2018.16.3.282; Strozyk D, 2018, ARCH OSTEOPOROS, V13, DOI 10.1007/s11657-018-0426-8; Sun C, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19010355; Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7; Vitaca T, 2022, LANCET DIABETES ENDO, V10, P273, DOI 10.1016/S2213-8587(22)00012-2; Walsh JS, 2013, NAT REV ENDOCRINOL, V9, P637, DOI 10.1038/nrendo.2013.171; Wang N, 2021, J ORTHOP SURG RES, V16, DOI 10.1186/s13018-021-02714-w; Xu Li, 2022, Front Endocrinol (Lausanne), V13, P817418, DOI 10.3389/fendo.2022.817418; Yang F, 2021, INT J GEN MED, V14, P7707, DOI 10.2147/IJGM.S329992; Yavorska OO, 2017, INT J EPIDEMIOL, V46, P1734, DOI 10.1093/ije/dyx034; Yuan S, 2019, CALCIFIED TISSUE INT, V105, P582, DOI 10.1007/s00223-019-00606-0; Zha XY, 2014, ENDOCRINE, V47, P590, DOI 10.1007/s12020-013-0155-0; Zhang Q, 2021, OSTEOPOROSIS INT, V32, P715, DOI 10.1007/s00198-020-05640-5; Zheng HF, 2015, NATURE, V526, P112, DOI 10.1038/nature14878	44	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271898	10.1371/journal.pone.0271898	http://dx.doi.org/10.1371/journal.pone.0271898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925966	gold, Green Published			2022-12-26	WOS:000848077100057
J	Huang, AY; Shu, L; Chen, ZQ; Zhang, C				Huang, Ann Yehong; Shu, Li; Chen, Zhongqiang; Zhang, Chi			IL-6 is involved in thoracic ossification of the ligamentum flavum	PLOS ONE			English	Article							TRANSCRIPTION FACTOR OSTERIX; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; OSTEOGENIC DIFFERENTIATION; CLINICAL-FEATURES; INTERLEUKIN-6; CELLS; KINASE; PATHOPHYSIOLOGY; EXPRESSION; APOPTOSIS	Thoracic ossification of the ligamentum flavum (TOLF) is a heterotopic ossification of spinal ligaments. TOLF is the major cause of thoracic spinal canal stenosis and myelopathy, and its underlying mechanisms are not clear. Bone formation is a complex developmental process involving the differentiation of mesenchymal stem cells to osteoblasts, and regulated by BMP2, RUNX2, Osterix (OSX), etc. In this study, we continue to further characterize properties of TOLF. Our immunohistochemistry experiments showed that expressions of osteoblastic factors such as BMP2 and RUNX2 increased in TOLF. According to flow cytometry analysis the proportion of S phase of cell cycle in primary TOLF cells was 9% higher than the control. Alizarin red staining and ALP staining observations were consistent with immunohistochemistry results. It was also observed that inflammatory cytokine IL-6 level dramatically increased in the culture supernatant of primary TOLF cells. We propose the hypothesis that IL-6 is involved in TOLF. To testify the hypothesis, we examined the effect of IL-6. Our results showed that IL-6 was able to activate expressions of osteoblastic factors such as BMP2, RUNX2, OSX, OCN and ALP, and that expressions of cell proliferation factors cyclin D1 and cyclin C increased in the presence of IL-6. Moreover, IL-6-induced BMP2 expression was inhibited by p38 inhibitor SB203580, indicating that IL-6 regulated the osteogenic BMP2 activation through p38 MAPK pathway. These data suggest that IL-6 is involved in TOLF.	[Huang, Ann Yehong] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX USA; [Shu, Li; Chen, Zhongqiang; Zhang, Chi] Peking Univ Int Hosp, Dept Orthoped, Beijing, Peoples R China; [Chen, Zhongqiang] Peking Univ Third Hosp, Dept Orthoped, Beijing, Peoples R China; [Zhang, Chi] Peking Univ, Biomed Engn Dept, Beijing, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; Peking University; Peking University	Zhang, C (corresponding author), Peking Univ Int Hosp, Dept Orthoped, Beijing, Peoples R China.; Zhang, C (corresponding author), Peking Univ, Biomed Engn Dept, Beijing, Peoples R China.	chi.zhang@case.edu			Beijing Municipal Science&Technology Commission [Z181100001818006]	Beijing Municipal Science&Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by Beijing Municipal Science&Technology Commission to CZ (Grant number: Z181100001818006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balboni TA, 2006, INT J RADIAT ONCOL, V65, P1289, DOI 10.1016/j.ijrobp.2006.03.053; Cai HX, 2012, SPINE, V37, pE639, DOI 10.1097/BRS.0b013e318242a132; Chen RH, 1999, J BIOL CHEM, V274, P23013, DOI 10.1074/jbc.274.33.23013; Chung TDK, 2000, PROSTATE, V42, P1; DASGUPTA B, 1992, J RHEUMATOL, V19, P22; Feng FB, 2015, ORTHOP SURG, V7, P87, DOI 10.1111/os.12165; Franchimont N, 2005, BONE, V37, P601, DOI 10.1016/j.bone.2005.06.002; Guo JJ, 2010, SPINE, V35, P51, DOI 10.1097/BRS.0b013e3181b3f779; Hideshima T, 2001, ONCOGENE, V20, P5991, DOI 10.1038/sj.onc.1204833; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; Hou XF, 2016, CLIN SPINE SURG, V29, P86, DOI 10.1097/BSD.0000000000000081; Iwasaki K, 2004, CALCIFIED TISSUE INT, V74, P448, DOI 10.1007/s00223-002-0021-1; Iwasawa T, 2006, CALCIFIED TISSUE INT, V79, P422, DOI 10.1007/s00223-006-0147-7; Kang JD, 1996, SPINE, V21, P271, DOI 10.1097/00007632-199602010-00003; Kang YM, 2014, J SPINAL DISORD TECH, V27, P382, DOI 10.1097/BSD.0b013e3182a26532; Lang N, 2013, EUR SPINE J, V22, P857, DOI 10.1007/s00586-012-2492-8; Le Goff B, 2010, JOINT BONE SPINE, V77, P201, DOI 10.1016/j.jbspin.2010.03.002; Liu Y, 2010, CLIN ORTHOP RELAT R, V468, P3333, DOI 10.1007/s11999-010-1511-5; Lories RJU, 2012, RHEUM DIS CLIN N AM, V38, P555, DOI 10.1016/j.rdc.2012.08.003; Mu C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/494378; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ning SL, 2017, INT J MOL MED, V39, P135, DOI 10.3892/ijmm.2016.2803; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; Plotkin LI, 2015, CURR OSTEOPOROS REP, V13, P67, DOI 10.1007/s11914-015-0255-2; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; Qu XC, 2017, EUR J HUM GENET, V25, P565, DOI 10.1038/ejhg.2017.2; Qu XC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081370; Tang WJ, 2012, J BIOL CHEM, V287, P1671, DOI 10.1074/jbc.M111.288472; Tu YP, 2000, CANCER RES, V60, P6763; Wang BX, 2017, BIOCHEM BIOPH RES CO, V487, P834, DOI 10.1016/j.bbrc.2017.04.136; Yan Q, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-5; Yang HS, 2011, SPINE, V36, P2267, DOI 10.1097/BRS.0b013e31820ccfc6; Yang XX, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209300; Yang XX, 2018, INT J BIOL SCI, V14, P1457, DOI 10.7150/ijbs.26686; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178986; Zhang Chi, 2012, Beijing Da Xue Xue Bao Yi Xue Ban, V44, P659; Zhang P, 2012, INT J MOL MED, V29, P1083, DOI 10.3892/ijmm.2012.934	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2022	17	7							e0272357	10.1371/journal.pone.0272357	http://dx.doi.org/10.1371/journal.pone.0272357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Q0KX	35905126	Green Published, gold			2022-12-26	WOS:000855776900068
J	Dainton, A; Miller, M; White, B; Lambrakis, L; Aldrich, CG				Dainton, Amanda; Miller, Markus; White, Brittany; Lambrakis, Leah; Aldrich, Charles Gregory			Composition and thermal processing evaluation of yeast ingredients as thiamin sources compared to a standard vitamin premix for canned cat food	PLOS ONE			English	Article							DEGRADATION KINETICS; BREWERS-YEAST; DEFICIENCY; RETENTION; COLOR; RIBOFLAVIN; PRINCIPLES; QUALITY	Significant improvement in thiamin retention of canned cat food has not been achieved by altering processing conditions. Some ingredients, such as yeasts, may supply thiamin able to withstand thermal processing. Therefore, the study objective was to evaluate yeast ingredients as thiamin sources for canned cat food. Six yeast ingredients were screened for thiamin content, and values ranged from 9.9-4,283.8 mg/kg dry matter basis (DMB). Treatments for thermal processing were arranged as a 2x4 factorial with 2 levels of vitamin premix (with or without) and 4 yeast ingredients (NY = none and LBV, BY, or EA from the ingredient screening). Replicates (n = 3) were processed in a horizontal still retort to an average lethality of 79.23 minutes. Thiamin degradation was analyzed as a mixed model with pre-retort thiamin content as a covariate and production day as a random effect. Main effects of vitamin premix and yeast and their interaction were significant at P-values less than 0.05. The Fisher's LSD post hoc comparison test was used to separate means. On average, experimental formulas retained 33.75% thiamin. The main effect of vitamin premix (average -42.9 mg/kg DMB) was not significant (P > 0.05). Thiamin degradation between NY (-31.3 mg/kg DMB) and BY (-33.8 mg/kg DMB) was similar (P > 0.05) whereas EA (-40.5 mg/kg DMB) and LBV (-55.6 mg/kg DMB) lost more (P < 0.05) thiamin than NY. The experimental formula of EA with vitamin premix (-70.3 mg/kg DMB) lost more (P < 0.05) thiamin than no yeast, BY, or EA without vitamin premix (average -17.4 mg/kg DMB) and all others (average -57.3 mg/kg DMB) were intermediate (P > 0.05). In summary, thiamin from yeast ingredients didn't exhibit better thermal stability than thiamin mononitrate. However, those ingredients with similar degradation levels or uniquely high thiamin levels may provide added value.	[Dainton, Amanda; Aldrich, Charles Gregory] Kansas State Univ, Dept Grain Sci & Ind, Manhattan, KS 66506 USA; [Miller, Markus; White, Brittany; Lambrakis, Leah] Simmons Pet Food Inc, Siloam Springs, AR USA	Kansas State University	Aldrich, CG (corresponding author), Kansas State Univ, Dept Grain Sci & Ind, Manhattan, KS 66506 USA.	aldrich4@ksu.edu		Dainton, Amanda/0000-0002-3887-5086				Ariahu CC, 2000, INT J FOOD SCI TECH, V35, P315, DOI 10.1046/j.1365-2621.2000.00366.x; Association of American Feed Control Officials, 2012, AAFCO OFF PUBL; Awuah GB, 2007, CHEM ENG PROCESS, V46, P584, DOI 10.1016/j.cep.2006.08.004; BAGGS RB, 1978, LAB ANIM SCI, V28, P323; BANGA JR, 1993, Z LEBENSM UNTERS FOR, V197, P127, DOI 10.1007/BF01260307; BENDIX GH, 1951, FOOD RES, V16, P494; Black D.G., 2015, CANNED FOODS PRINCIP, Veighth; Bowley S., 2015, HITCHHIKERS GUIDE ST; BRIOZZO J, 1987, J FOOD SCI, V52, P827, DOI 10.1111/j.1365-2621.1987.tb06738.x; Case LP., 2011, CANINE FELINE NUTR, V3rd, P163; Chang YP, 2017, J FELINE MED SURG, V19, P336, DOI 10.1177/1098612X15625353; DAVIDSON MG, 1992, VET REC, V130, P94, DOI 10.1136/vr.130.5.94; DeNoya S., 2014, J ANIM SCI, V92, P90; Deutsch HF, 1943, P SOC EXP BIOL MED, V53, P63, DOI 10.3181/00379727-53-14186; Dzanis DA., 2003, PETFOOD TECHNOLOGY, V1st, P68; Hallman GV, 1932, IND ENG CHEM, V24, P659, DOI 10.1021/ie50270a019; Hendriks WH, 1999, J ANIM SCI, V77, P669; HILKER DM, 1966, J NUTR, V89, P419, DOI 10.1093/jn/89.4.419; Holt DA, 2021, J ANIM SCI, V99, P286; Irle E., 1982, EXP BRAIN RES, P48, DOI [10.1007/BF00237215, DOI 10.1007/BF00237215]; IWASHIMA A, 1979, BIOCHIM BIOPHYS ACTA, V557, P460, DOI 10.1016/0005-2736(79)90343-2; Kim BG, 2014, J ANIM SCI, V92, P5476, DOI 10.2527/jas.2013-7416; Krokida MK, 2000, DRY TECHNOL, V18, P1239, DOI 10.1080/07373930008917774; Kwok KC, 1998, J SCI FOOD AGR, V77, P473, DOI 10.1002/(SICI)1097-0010(199808)77:4&lt;473::AID-JSFA65&gt;3.0.CO;2-S; Lagos LV, 2020, J ANIM SCI, V98, DOI 10.1093/jas/skz375; Lee K-Y., 1993, PREDICTION THERMAL D, V26, P26; Li BS., 2015, J S CHINA U TECHNOL, P43; Lin CY, 2019, J ANIM SCI, V97, P1586, DOI 10.1093/jas/skz064; LOEW FM, 1970, CANADIAN VET J, V11, P109; LUH BS, 1978, J FOOD SCI, V43, P431, DOI 10.1111/j.1365-2621.1978.tb02322.x; Majumdar RK, 2017, J FOOD PROCESS PRES, V41, DOI 10.1111/jfpp.12925; Markovich JE, 2014, JAVMA-J AM VET MED A, V244, P175, DOI 10.2460/javma.244.2.175; Martins MS, 2014, J ANIM PHYSIOL AN N, V98, P948, DOI 10.1111/jpn.12145; MAURI LM, 1989, INT J FOOD SCI TECH, V24, P1; Molnar LM, 2017, J ANIM SCI, V95, P111, DOI 10.2527/asasann.2017.226; National Research Council, 2006, NUTR REQ DOGS CATS, V10th; Overland M, 2013, AQUACULTURE, V402, P1, DOI 10.1016/j.aquaculture.2013.03.016; Palus V, 2010, J FELINE MED SURG, V12, P807, DOI 10.1016/j.jfms.2010.04.005; Parteshko VG., 1975, APPL BIOCHEM MICRO+, V9, P133; Pekel AY, 2020, J APPL ANIM RES, V48, P281, DOI 10.1080/09712119.2020.1786391; Province of Nova Scotia, 2020, ROYAL GAZETTE 2; Reilly LM, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.667642; Rekha PN, 2004, FOOD CHEM, V85, P591, DOI 10.1016/j.foodchem.2003.08.004; Singh R.P., 2014, INTRO FOOD ENG, DOI [10.1016/c2011-0-06101-x, DOI 10.1016/C2011-0-06101-X, 10.1016/C2011-0-06101-X]; Stambuk BU, 2009, GENOME RES, V19, P2271, DOI 10.1101/gr.094276.109; SUPARNO, 1990, J SCI FOOD AGR, V53, P101, DOI 10.1002/jsfa.2740530111; Trible SD., 2015, J ANIM SCI, V93, P653; Varga E, 2002, ACTA ALIMENT HUNG, V31, P393, DOI 10.1556/AAlim.31.2002.4.8; Vinas P, 2003, J AGR FOOD CHEM, V51, P3222, DOI 10.1021/jf021071f	49	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271600	http://dx.doi.org/10.1371/journal.pone.0271600			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917321	gold, Green Published			2022-12-26	WOS:000837840000042
J	Paul, D; Rodrigue, A; Contento, N; Haber, S; Hoang, R; Rahmani, R; Hirad, AC; Shafiq, IC; Williams, ZC; Vates, GEC				Paul, David; Rodrigue, Alejandra; Contento, Nicholas; Haber, Sam; Hoang, Ricky; Rahmani, Redi; Hirad, Adnan C.; Shafiq, Ismat C.; Williams, Zoe C.; Vates, G. Edward C.			Prolactin at moderately increased levels confers a neuroprotective effect in non-secreting pituitary macroadenomas	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; SENSITIVITY; RECOVERY; CELLS	ContextProlactin, a hormone synthesized by the anterior pituitary gland demonstrates promise as a neuroprotective agent, however, its role in humans and in vivo during injury is not fully understood. ObjectiveTo investigate whether elevated levels of prolactin attenuate injury to the retinal nerve fiber layer (RNFL) following compression of the optic chiasm in patients with a prolactin secreting pituitary macroadenoma (i.e., prolactinoma). Design setting and participantsA retrospective cross-sectional study of all pituitary macroadenoma patients treated at a single institution between 2009 and 2019. Main outcome measure(s)Primary outcome measures included RNFL thickness, mean deviation, and prolactin levels for both prolactin-secreting and non-secreting pituitary macroadenoma patients. ResultsSixty-six patients met inclusion criteria for this study (14 prolactin-secreting and 52 non-secreting macroadenoma patients). Of 52 non-secreting macroadenoma patients, 12 had moderate elevation of prolactin secondary to stalk effect. Patients with moderate elevation in prolactin demonstrated increased RNFL thickness compared to patients with normal prolactin levels (p < 0.01). Additionally, a significant positive relation between increasing levels of prolactin and RNFL thickness was identified in patients with moderate prolactin elevation (R = 0.51, p-value = 0.035). No significant difference was identified between prolactinoma patients and those with normal prolactin levels. ConclusionsModerately increased serum prolactin is associated with increased RNFL thickness when compared to controls. These associations are lost when serum prolactin is < 30 ng/ml or elevated in prolactinomas. This suggests a neuroprotective effect of prolactin at moderately increased levels in preserving retinal function during optic chiasm compression.	[Paul, David; Rahmani, Redi; Williams, Zoe C.; Vates, G. Edward C.] Univ Rochester, Dept Neurosurg, Med Ctr, Rochester, NY 14618 USA; [Rodrigue, Alejandra; Contento, Nicholas; Haber, Sam; Hoang, Ricky; Hirad, Adnan C.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Rodrigue, Alejandra; Williams, Zoe C.] Univ Rochester, Dept Ophthalmol, Med Ctr, Rochester, NY USA; [Haber, Sam] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA; [Shafiq, Ismat C.] Univ Rochester, Med Ctr, Div Endocrinol & Metab, Rochester, NY USA; [Williams, Zoe C.] Univ Rochester, Dept Neurol, Med Ctr, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Vates, GEC (corresponding author), Univ Rochester, Dept Neurosurg, Med Ctr, Rochester, NY 14618 USA.	Edward_vates@urmc.rochester.edu		Paul, David/0000-0002-3517-8787	NIH/National Center for Advancing Translational Sciences at the University of Rochester [UL1 TR002001]; National Center for Advancing Translational Sciences at the University of Rochester [CTSI TL1 TR000096]	NIH/National Center for Advancing Translational Sciences at the University of Rochester; National Center for Advancing Translational Sciences at the University of Rochester	DP was supported by a UL1 TR002001 grant via the NIH/National Center for Advancing Translational Sciences at the University of Rochester and resources provided by the Program for Translational Brain Mapping at the University of Rochester. The program for Translational Brain Mapping was established, in part, with support from Norman and Arlene Leenhouts (see: www.tbm.urmc.rochester.edu).AR was supported by a CTSI TL1 TR000096 grant via the National Center for Advancing Translational Sciences at the University of Rochester.	Anagnostou I, 2018, GEN COMP ENDOCR, V265, P106, DOI 10.1016/j.ygcen.2018.01.024; Arnold E, 2014, J NEUROSCI, V34, P1868, DOI 10.1523/JNEUROSCI.2452-13.2014; Castillo X, 2018, NEUROENDOCRINOLOGY, V106, P221, DOI 10.1159/000477768; Danesh-Meyer HV, 2008, INVEST OPHTH VIS SCI, V49, P1879, DOI 10.1167/iovs.07-1127; Danesh-Meyer HV, 2006, INVEST OPHTH VIS SCI, V47, P4827, DOI 10.1167/iovs.06-0327; Danesh-Meyer HV, 2019, PROG RETIN EYE RES, V73, DOI 10.1016/j.preteyeres.2019.06.001; De Giglio L, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/732539; Fahie-Wilson M, 2007, CLIN LAB, V53, P301; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; Herrero R, 2012, INVEST OPHTH VIS SCI, V53, P8344, DOI 10.1167/iovs.12-10362; Karimian-Jazi K, 2019, RADIOLOGE, V59, P982, DOI 10.1007/s00117-019-0570-1; Kinet S, 1999, J BIOL CHEM, V274, P26033, DOI 10.1074/jbc.274.37.26033; Lee CC, 2016, PITUITARY, V19, P515, DOI 10.1007/s11102-016-0738-x; Leung CKS, 2012, OPHTHALMOLOGY, V119, P731, DOI 10.1016/j.ophtha.2011.10.010; Mancini T, 2008, ENDOCRIN METAB CLIN, V37, P67, DOI 10.1016/j.ecl.2007.10.013; Garcia RM, 2016, EBIOMEDICINE, V7, P35, DOI 10.1016/j.ebiom.2016.03.048; Melmed S, 2020, NEW ENGL J MED, V382, P937, DOI 10.1056/NEJMra1810772; Moon CH, 2011, INVEST OPHTH VIS SCI, V52, P8527, DOI 10.1167/iovs.11-8034; Moon CH, 2011, INVEST OPHTH VIS SCI, V52, P7966, DOI 10.1167/iovs.11-7450; Parikh RS, 2007, OPHTHALMOLOGY, V114, P921, DOI 10.1016/j.ophtha.2007.01.023; Paul DA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010798; Paul DAA, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.680602; Phal PM, 2016, INVEST OPHTH VIS SCI, V57, P3884, DOI 10.1167/iovs.15-18734; Porciatti V, 1999, CLIN NEUROPHYSIOL, V110, P876, DOI 10.1016/S1388-2457(99)00024-3; Roelfsema F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031305; Saleem Mohamed, 2018, Clin Biochem Rev, V39, P3; Schneider CL, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2733; Serri O, 2003, CAN MED ASSOC J, V169, P575; Teixeira LBC, 2016, INVEST OPHTH VIS SCI, V57, P4859, DOI 10.1167/iovs.16-19871	29	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271690	http://dx.doi.org/10.1371/journal.pone.0271690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921360	Green Published, gold			2022-12-26	WOS:000839311900080
J	Ding, CJ; Hong, Y; Che, Y; He, TY; Wang, Y; Zhang, SL; Wu, JW; Xu, WF; Hou, JY; Hao, HP; Cao, LJ				Ding, Chujie; Hong, Yu; Che, Yuan; He, Tianyu; Wang, Yun; Zhang, Shule; Wu, Jiawei; Xu, Wanfeng; Hou, Jingyi; Hao, Haiping; Cao, Lijuan			Bile acid restrained T cell activation explains cholestasis aggravated hepatitis B virus infection	FASEB JOURNAL			English	Article						bile acid; hepatitis B virus; SOCE; T cell activation	CALCIUM; INFLAMMATION; METABOLITES; MANAGEMENT; MECHANISM; GENES	Cholestasis is a common complication of hepatitis B virus (HBV) infection, characterized by increased intrahepatic and plasma bile acid levels. Cholestasis was found negatively associated with hepatitis outcome, however, the exact mechanism by which cholestasis impacts anti-viral immunity and impedes HBV clearance remains elusive. Here, we found that cholestatic mice are featured with dysfunctional T cells response, as indicated by decreased sub-population of CD25(+)/CD69(+) CD4(+) and CD8(+) cells, while CTLA-4(+) CD4(+) and CD8(+) subsets were increased. Mechanistically, bile acids disrupt intracellular calcium homeostasis via inhibiting mitochondria calcium uptake and elevating cytoplasmic Ca2+ concentration, leading to STIM1 and ORAI1 decoupling and impaired store-operated Ca2+ entry which is essential for NFAT signaling and T cells activation. Moreover, in a transgenic mouse model of HBV infection, we confirmed that cholestasis compromised both CD4(+) and CD8(+) T cells activation resulting in poor viral clearance. Collectively, our results suggest that bile acids play pivotal roles in anti-HBV infection via controlling T cells activation and metabolism and that targeting the regulation of bile acids may be a therapeutic strategy for host-virus defense.	[Ding, Chujie; Hong, Yu; Che, Yuan; He, Tianyu; Wang, Yun; Zhang, Shule; Wu, Jiawei; Xu, Wanfeng; Hou, Jingyi; Hao, Haiping; Cao, Lijuan] China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing 210009, Peoples R China	China Pharmaceutical University	Hao, HP; Cao, LJ (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing 210009, Peoples R China.	haipinghao@cpu.edu.cn; caolijuan0702@cpu.edu.cn		HONG, YU/0000-0001-5220-2382; Hao, Haiping/0000-0003-2522-7546	China Postdoctoral Science Foundation [2021M693514]; Chinese Academy of Medical Sciences (CAMS) [2021-I2M-5-011]; National Key Research and Development Program of China [2021YFA1301300]; National Natural Science Foundation of China (NSFC) [81720108032, 81930109, 81973559, 82173886]; Overseas Expertise Introduction Project For Discipline Innovation [G20582017001]; Sanming Project of Medicine in Shenzhen [SZSM201801060]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese Academy of Medical Sciences (CAMS); National Key Research and Development Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Overseas Expertise Introduction Project For Discipline Innovation; Sanming Project of Medicine in Shenzhen	China Postdoctoral Science Foundation, Grant/Award Number: 2021M693514; Chinese Academy of Medical Sciences (CAMS), Grant/Award Number: 2021-I2M-5-011; National Key Research and Development Program of China, Grant/Award Number: 2021YFA1301300; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81720108032, 81930109, 81973559 and 82173886; Overseas Expertise Introduction Project For Discipline Innovation, Grant/Award Number: G20582017001; Sanming Project of Medicine in Shenzhen, Grant/Award Number: SZSM201801060	Allen K, 2011, AM J PATHOL, V178, P175, DOI 10.1016/j.ajpath.2010.11.026; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Biagioli M, 2019, CELL MOL GASTROENTER, V8, P447, DOI 10.1016/j.jcmgh.2019.06.003; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Campbell C, 2020, NATURE, V581, P475, DOI 10.1038/s41586-020-2193-0; Chen YY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02048; FERRARI C, 1990, J IMMUNOL, V145, P3442; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341; Guo CS, 2016, IMMUNITY, V45, P802, DOI 10.1016/j.immuni.2016.09.008; Guo XH, 2018, INT J ANTIMICROB AG, V52, P201, DOI 10.1016/j.ijantimicag.2018.04.002; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; Hang SY, 2019, NATURE, V576, P143, DOI 10.1038/s41586-019-1785-z; Hao HP, 2017, CELL METAB, V25, P856, DOI 10.1016/j.cmet.2017.03.007; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Hosseinkhani F, 2021, GUT MICROBES, V13, P1, DOI 10.1080/19490976.2021.1882927; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Jena PK, 2019, J DERMATOL SCI, V95, P13, DOI 10.1016/j.jdermsci.2019.05.007; Jiang RA, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021416; Lang E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30627-y; Ma C, 2018, SCIENCE, V360, DOI 10.1126/science.aan5931; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Marschall HU, 2013, HEPATOLOGY, V58, P1385, DOI 10.1002/hep.26444; NICCHITTA CV, 1984, J BIOL CHEM, V259, P2978; Oehler N, 2014, HEPATOLOGY, V60, P1483, DOI 10.1002/hep.27159; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Postnikova OA, 2012, B EXP BIOL MED+, V153, P899, DOI 10.1007/s10517-012-1854-x; Sandalova E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001051; Sang C, 2021, J PROTEOME RES, V20, P2340, DOI 10.1021/acs.jproteome.0c00852; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; Sigalov Alexander B, 2022, Biochimie, V195, P86, DOI 10.1016/j.biochi.2021.11.005; Song XY, 2020, NATURE, V577, P410, DOI 10.1038/s41586-019-1865-0; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Vaeth Martin, 2018, F1000Res, V7, P260, DOI 10.12688/f1000research.13426.1; Vaeth M, 2017, IMMUNITY, V47, P664, DOI 10.1016/j.immuni.2017.09.003; Wang JX, 2022, J CARDIOVASC TRANSL, V15, P350, DOI 10.1007/s12265-021-10164-2; Wang YJ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3148pe42; Wong GLH, 2020, LANCET GASTROENTEROL, V5, P776, DOI 10.1016/S2468-1253(20)30190-4; Wu MQ, 2017, J PROTEOME RES, V16, P2250, DOI 10.1021/acs.jproteome.7b00111; Wykes MN, 2018, NAT REV IMMUNOL, V18, P91, DOI 10.1038/nri.2017.112; Xu WF, 2021, CELL METAB, V33, P424, DOI 10.1016/j.cmet.2020.11.018; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Zhang YY, 2018, EUR J GASTROEN HEPAT, V30, P682, DOI [10.1097/MEG.0000000000001100, 10.1097/meg.0000000000001100]; Zhong Z, 2003, AM J PHYSIOL-GASTR L, V285, pG1004, DOI 10.1152/ajpgi.00008.2003	46	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22468	10.1096/fj.202200332R	http://dx.doi.org/10.1096/fj.202200332R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3L0WD	35913801	Green Submitted			2022-12-26	WOS:000834490100001
J	Yu, ZL; Chen, JL; Takagi, E; Wang, F; Saha, B; Liu, X; Joubert, LM; Gleason, CE; Jin, ML; Li, CM; Nowotny, C; Agard, D; Cheng, YF; Pearce, D				Yu, Zanlin; Chen, Junliang; Takagi, Enzo; Wang, Feng; Saha, Bidisha; Liu, Xi; Joubert, Lydia-Marie; Gleason, Catherine E.; Jin, Mingliang; Li, Chengmin; Nowotny, Carlos; Agard, David; Cheng, Yifan; Pearce, David			Interactions between mTORC2 core subunits Rictor and mSin1 dictate selective and context-dependent of substrate kinases SGK1 and Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; RAPAMYCIN; COMPLEX; GROWTH; ACTIVATION; PROTEIN; RAPTOR; PHOSPHORYLATION; MECHANISM; PATHWAY	Mechanistic target of rapamycin complex 2 (mTORC2) is a multi-subunit kinase complex, central to multiple essential signaling pathways. Two core subunits, Rictor and mSin1, distinguish it from the related mTORC1 and support context-dependent phosphorylation of its substrates. mTORC2 structures have been determined previously; however, important questions remain, particularly regarding the structural determinants mediating substrate specificity and context-dependent activity. Here, we used cryo-EM to obtain high-resolution structures of the human mTORC2 apo-complex in the presence of substrates Akt and SGK1. Using functional assays, we then tested predictions suggested by substrate-induced structural changes in mTORC2. For the first time, we visualized in the apo-state the side chain interactions between Rictor and mTOR that sterically occlude recruitment of mTORC1 substrates and confer resistance to the mTORC1 inhibitor rapamycin. Also in the apo-state, we observed that mSin1 formed extensive contacts with Rictor via a pair of short alpha-helices nestled between two Rictor helical repeat clusters, as well as by an extended strand that makes multiple weak contacts with Rictor helical cluster 1. In co-complex structures, we found that SGK1, but not Akt, markedly altered the conformation of the mSin1 N-terminal extended strand, disrupting multiple weak interactions while inducing a large rotation of mSin1 residue Arg-83, which then interacts with a patch of negatively charged residues within Rictor. Finally, we demonstrate mutation of Arg-83 to Ala selectively disrupts mTORC2-dependent phosphorylation of SGK1, but not of Akt, supporting context-dependent substrate selection. These findings provide new structural and functional insights into mTORC2 specificity and context-dependent activity.	[Yu, Zanlin; Wang, Feng; Jin, Mingliang; Li, Chengmin; Nowotny, Carlos; Agard, David; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA; [Chen, Junliang; Takagi, Enzo; Saha, Bidisha; Gleason, Catherine E.; Pearce, David] UCSF, Dept Med, Div Nephrol, San Francisco, CA 94143 USA; [Chen, Junliang; Takagi, Enzo; Saha, Bidisha; Gleason, Catherine E.; Pearce, David] Dept Cellular & Mol Pharmacol, UCSF, San Francisco, CA 94143 USA; [Liu, Xi] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Joubert, Lydia-Marie] Stanford Univ, Div CryoEM & Bioimaging, SLAC Natl Accelerator Lab, SSRL, Menlo Pk, CA USA; [Cheng, Yifan] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Chen, Junliang] Sino United Hlth, Dept Internal Med, Shanghai, Peoples R China; [Gleason, Catherine E.] Circle Pharm, Cisco, CA 94080 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Cisco Systems Inc	Pearce, D (corresponding author), UCSF, Dept Med, Div Nephrol, San Francisco, CA 94143 USA.; Pearce, D (corresponding author), Dept Cellular & Mol Pharmacol, UCSF, San Francisco, CA 94143 USA.	david.pearce@ucsf.edu		Takagi, Enzo/0000-0002-2625-686X; Yu, Zanlin/0000-0001-8381-8788; Wang, Feng/0000-0002-1233-2745; , Catherine/0000-0002-0063-0729; Joubert, Lydia-Marie/0000-0002-4709-007X; Chen, Junliang/0000-0002-8967-2377	NIH [R01-DK56695, R35GM118099, R35GM140847]; James Hilton Manning and Emma Austin Manning Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James Hilton Manning and Emma Austin Manning Foundation	This work is supported by the NIH grants R01-DK56695 (D. P.) , R35GM118099 (D. A. A.) , R35GM140847 (Y. C.) and Grant from the James Hilton Manning and Emma Austin Manning Foundation (D. P.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institues of Health.	Albert V, 2016, EMBO MOL MED, V8, P232, DOI 10.15252/emmm.201505610; Allu PKR, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100632; Aylett CHS, 2016, SCIENCE, V351, P48, DOI 10.1126/science.aaa3870; Cameron AJM, 2011, BIOCHEM J, V439, P287, DOI 10.1042/BJ20110678; Chellappa K, 2019, AGING CELL, V18, DOI 10.1111/acel.13014; Chen XZ, 2018, CELL RES, V28, P518, DOI 10.1038/s41422-018-0029-3; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Fu WX, 2020, GENES-BASEL, V11, DOI 10.3390/genes11091045; Gaubitz C, 2016, TRENDS BIOCHEM SCI, V41, P532, DOI 10.1016/j.tibs.2016.04.001; Gleason CE, 2019, J CELL SCI, V132, DOI 10.1242/jcs.224931; Gleason CE, 2015, J CLIN INVEST, V125, P117, DOI 10.1172/JCI73935; Grant T, 2018, ELIFE, V7, DOI 10.7554/eLife.35383; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Johnson JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15193; Kazyken D, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav3249; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Li X, 2014, EMBO REP, V15, P191, DOI 10.1002/embr.201338119; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lu M, 2011, J BIOL CHEM, V286, P30647, DOI 10.1074/jbc.M111.257592; Lu M, 2010, J AM SOC NEPHROL, V21, P811, DOI 10.1681/ASN.2009111168; Luo YT, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7838647; Malik N, 2018, BIOCHEM J, V475, P117, DOI 10.1042/BCJ20170650; McMahon LP, 2002, MOL CELL BIOL, V22, P7428, DOI 10.1128/MCB.22.21.7428-7438.2002; Pao AC, 2007, AM J PHYSIOL-RENAL, V292, pF1741, DOI 10.1152/ajprenal.00027.2007; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Punjani A, 2021, J STRUCT BIOL, V213, DOI 10.1016/j.jsb.2021.107702; Rotin D, 2021, COMPR PHYSIOL, V11, P2017, DOI 10.1002/cphy.c200012; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato T, 2016, GENES CELLS, V21, P579, DOI 10.1111/gtc.12366; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scaiola A, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc1251; Sorensen MV, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126910; Srivastava RK, 2019, P NATL ACAD SCI USA, V116, P24583, DOI 10.1073/pnas.1911393116; Tang YF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11365; Tatebe H, 2017, ELIFE, V6, DOI 10.7554/eLife.19594; Venugopal SV, 2020, PROSTATE, V80, P412, DOI 10.1002/pros.23956; Wang F, 2020, P NATL ACAD SCI USA, V117, P24269, DOI 10.1073/pnas.2009707117; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wu YT, 2011, J BIOL CHEM, V286, P14190, DOI 10.1074/jbc.M111.219923; Yang G, 2015, CELL REP, V12, P937, DOI 10.1016/j.celrep.2015.07.016; Yang HJ, 2017, NATURE, V552, P368, DOI 10.1038/nature25023; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yuan T, 2017, DIABETOLOGIA, V60, P668, DOI 10.1007/s00125-016-4188-9; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	48	3	3	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102288	10.1016/j.jbc.2022.102288	http://dx.doi.org/10.1016/j.jbc.2022.102288			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A7IQ	35926713	Green Published, gold			2022-12-26	WOS:000863057500006
J	Tajeu, GS; Colvin, CL; Hardy, ST; Bress, AP; Gaye, B; Jaeger, BC; Ogedegbe, G; Sakhuja, S; Sims, M; Shimbo, D; O'Brien, EC; Spruill, TM; Muntner, P				Tajeu, Gabriel S.; Colvin, Calvin L.; Hardy, Shakia T.; Bress, Adam P.; Gaye, Bamba; Jaeger, Byron C.; Ogedegbe, Gbenga; Sakhuja, Swati; Sims, Mario; Shimbo, Daichi; O'Brien, Emily C.; Spruill, Tanya M.; Muntner, Paul			Prevalence, risk factors, and cardiovascular disease outcomes associated with persistent blood pressure control: The Jackson Heart Study	PLOS ONE			English	Article							HYPERTENSION CONTROL; UNITED-STATES; POPULATION; HEALTH; AGE; DISPARITIES; ADULTS; CARE	BackgroundMaintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking antihypertensive medication. MethodsThe Jackson Heart Study (JHS) enrolled 5,306 African-American adults >= 21 years of age and was used to determine the proportion of African Americans that maintain persistent BP control, identify factors associated with persistent BP control, and determine the association of persistent BP control with CVD events. This analysis included 1,604 participants who were taking antihypertensive medication at Visit 1 and had BP data at Visits 1 (2000-2004), 2 (2005-2008), and 3 (2009-2013). Persistent BP control was defined as systolic BP <140 mm Hg and diastolic BP <90 mm Hg at all three visits. CVD events were assessed from Visit 3 through December 31, 2016. Hazard ratios (HR) for the association of persistent BP control with CVD outcomes were adjusted for age, sex, systolic BP, smoking, diabetes, and total and high-density lipoprotein cholesterol at Visit 3. ResultsAt Visit 1, 1,226 of 1,604 participants (76.4%) with hypertension had controlled BP. Overall, 48.9% of participants taking antihypertensive medication at Visit 1 had persistent BP control. After multivariable adjustment for demographic, socioeconomic, clinical, behavioral, and psychosocial factors, and access-to-care, participants were more likely to have persistent BP control if they were <65 years of age, women, had family income >=$25,000 at each visit, and visited a health professional in the year prior to each visit. The multivariable adjusted HR (95% confidence interval) comparing participants with versus without persistent BP control was 0.71 (0.46-1.10) for CVD, 0.68 (0.34-1.34) for coronary heart disease, 0.65 (0.27-1.52) for stroke, and 0.55 (0.33-0.90) for heart failure. ConclusionLess than half of JHS participants taking antihypertensive medication had persistent BP control, putting them at increased risk for heart failure.	[Tajeu, Gabriel S.] Temple Univ, Dept Hlth Serv Adm & Policy, Philadelphia, PA 19122 USA; [Colvin, Calvin L.; Hardy, Shakia T.; Sakhuja, Swati; Muntner, Paul] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Bress, Adam P.] Univ Utah, Dept Populat Hlth Sci, Sch Med, Salt Lake City, UT USA; [Gaye, Bamba] Paris Cardiovasc Res Ctr, Dept Epidemiol, INSERM, U970, Paris, France; [Gaye, Bamba] Univ Paris 05, Fac Medecine, Sorbonne Paris Cite, Paris, France; [Jaeger, Byron C.] Wake Forest Univ, Dept Biostat & Data Sci, Sch Med, Wake Forest, NC USA; [Ogedegbe, Gbenga; Spruill, Tanya M.] NYU, Dept Populat Hlth, Grossman Sch Med, New York, NY USA; [Sims, Mario] Univ Mississippi, Dept Med, Med Ctr, Jackson, MS USA; [Shimbo, Daichi] Columbia Univ, Dept Med, Irving Med Ctr, New York, NY USA; [O'Brien, Emily C.] Duke Univ, Dept Neurol, Sch Med, Durham, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Alabama System; University of Alabama Birmingham; Utah System of Higher Education; University of Utah; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Wake Forest University; New York University; University of Mississippi; University of Mississippi Medical Center; Columbia University; NewYork-Presbyterian Hospital; Duke University	Tajeu, GS (corresponding author), Temple Univ, Dept Hlth Serv Adm & Policy, Philadelphia, PA 19122 USA.	gabriel.tajeu@temple.edu		Hardy, Shakia/0000-0001-9211-0474	National Heart, Lung, and Blood Institute [K24 HL125704, 1K01HL151974-01]; National Institute of Diabetes and Digestive and Kidney Diseases [3R01DK108628-05S1]; Jackson State University [HHSN268201800013I]; Tougaloo College [HHSN268201800014I]; Mississippi State Department of Health [HHSN268201800015I]; University of Mississippi Medical Center [HHSN268201800010I, HHSN268201800011I, HHSN268201800012I]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Jackson State University; Tougaloo College; Mississippi State Department of Health; University of Mississippi Medical Center	This study was supported by grants from the National Heart, Lung, and Blood Institute (grant number K24 HL125704) awarded to DS, and (grant number 1K01HL151974-01) awarded to GT. This study was also supported by the National Institute of Diabetes and Digestive and Kidney Diseases (grant number 3R01DK108628-05S1) awarded to GT. The Jackson Heart Study (JHS) is supported and conducted in collaboration with Jackson State University (grant number HHSN268201800013I), as well as Tougaloo College (grant number HHSN268201800014I), the Mississippi State Department of Health (grant number HHSN268201800015I) and the University of Mississippi Medical Center (grant numbers HHSN268201800010I, HHSN268201800011I and HHSN268201800012I).	Allen NB, 2014, JAMA-J AM MED ASSOC, V311, P490, DOI 10.1001/jama.2013.285122; Anstey DE, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013636; Benetos A, 2019, CIRC RES, V124, P1045, DOI 10.1161/CIRCRESAHA.118.313236; Borzecki AM, 2006, AM J HYPERTENS, V19, P520, DOI 10.1016/j.amjhyper.2005.10.022; Bowling CB, 2019, J CLIN HYPERTENS, V21, P451, DOI 10.1111/jch.13515; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Chen J, 2016, MED CARE, V54, P140, DOI 10.1097/MLR.0000000000000467; Chetty R, 2016, AM ECON REV, V106, P855, DOI 10.1257/aer.20150572; Currie G, 2018, J HYPERTENS, V36, P234, DOI 10.1097/HJH.0000000000001576; Dinkler JM, 2016, AM J HYPERTENS, V29, P934, DOI 10.1093/ajh/hpw010; Fontil V, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.117.004386; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Gu QP, 2010, AM J HYPERTENS, V23, P38, DOI 10.1038/ajh.2009.191; Keku E, 2005, ETHNIC DIS, V15, pS62; Kershaw KN, 2017, JAMA INTERN MED, V177, P996, DOI 10.1001/jamainternmed.2017.1226; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2007, HYPERTENSION, V50, P299, DOI 10.1161/HYPERTENSIONAHA.107.090290; Mancia G, 2016, EUR HEART J, V37, P955, DOI 10.1093/eurheartj/ehv633; Meredith PA, 2016, BLOOD PRESSURE, V25, P74, DOI 10.3109/08037051.2015.1127528; Mozaffarian D, 2016, CIRCULATION, V133, P38, DOI [10.1161/CIR.0000000000000350, DOI 10.1161/CIR.0000000000000350, 10.1161/cir.0000000000000350]; Muntner P, 2020, JAMA-J AM MED ASSOC, V324, P1190, DOI 10.1001/jama.2020.14545; Rocco MV, 2018, AM J KIDNEY DIS, V71, P352, DOI 10.1053/j.ajkd.2017.08.021; Seals SR, 2019, BLOOD PRESS MONIT, V24, P130, DOI 10.1097/MBP.0000000000000379; Shahu A, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012277; Sim JJ, 2014, CAN J CARDIOL, V30, P544, DOI 10.1016/j.cjca.2014.01.003; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Sumarsono A, 2021, CIRC-CARDIOVASC QUAL, V14, P58, DOI 10.1161/CIRCOUTCOMES.120.007492; Taylor HA, 2005, ETHNIC DIS, V15, pS4; US Department of Health and Human Services, 2020, SURG GEN CALL ACT CO; Victor RG, 2018, NEW ENGL J MED, V378, P1291, DOI 10.1056/NEJMoa1717250; Whelton PK, 2018, CIRCULATION, V138, pE426, DOI 10.1161/CIR.0000000000000597; Williamson JD, 2020, J AM GERIATR SOC, V68, P2489, DOI 10.1111/jgs.16750; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050; Yoon SS, 2015, HYPERTENSION, V65, P54, DOI 10.1161/HYPERTENSIONAHA.114.04012	34	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2022	17	8							e0270675	10.1371/journal.pone.0270675	http://dx.doi.org/10.1371/journal.pone.0270675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5A3IT	35930588	gold, Green Published			2022-12-26	WOS:000862784200016
J	Tan, F; Xu, J				Tan, Fei; Xu, Jin			Validation of the solution structure of dimerization domain of PRC1	PLOS ONE			English	Article							N-TERMINUS; MICROTUBULE-BINDING; CROSS-LINKING; PROTEIN; SPINDLE; STABILITY; INSIGHTS; KIF4	Cell-cycle dependent proteins are indispensible for the accurate division of cells, a group of proteins called Microtubule-associated proteins (MAPs) are important to cell division as it bind microtubules and participate with other co-factors to form the spindle midbody, which works as the workhorse of cell-division. PRC1 is a distinguishing member of MAPs, as it is a human MAP and works as the key in mediating daughter cell segregation in ana-phase and telo-phase. The physiological significance of PRC1 calls for a high resolution three-dimensional structure. The crystal structure of PRC1 was published but has low resolution (>3 angstrom) and incomplete sidechains, placing hurdles to understanding the structure-function relationships of PRC1, therefore, we determined the high-resolution solution structure of PRC1's dimerization domain using NMR spectroscopy. Significant differences between the crystal structure and the solution structure can be observed, the main differences center around the N terminus and the end of the alpha-Helix H2. Furthermore, detailed structure analyses revealed that the hydrophobic core packing of the solution and crystal structures are also different. To validate the solution structure, we used Hydrogen-deuterium exchange experiments that address the structural discrepancies between the crystal and solution structure; we also generated mutants that are key to the differences in the crystal and solution structures, measuring its structural or thermal stability by NMR spectroscopy and Fluorescence Thermal Shift Assays. These results suggest that N terminal residues are key to the integrity of the whole protein, and the solution structure of the dimerization domain better reflects the conformation PRC1 adopted in solution conditions.	[Tan, Fei; Xu, Jin] Peking Univ, Beijing, Peoples R China	Peking University	Tan, F (corresponding author), Peking Univ, Beijing, Peoples R China.	Tanfei777@pku.edu.cn			State Commission of Science Technology of China;  [2012CB910703]	State Commission of Science Technology of China; 	The authors acknowledge Qian Huang for some of the data contribution. This research study was partly supported by State Commission of Science Technology of China.	Alfieri A, 2021, CURR BIOL, V31, P2495, DOI 10.1016/j.cub.2021.03.034; BAI YW, 1994, PROTEINS, V20, P4, DOI 10.1002/prot.340200103; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Bechstedt S, 2013, DEV CELL, V26, P118, DOI 10.1016/j.devcel.2013.07.010; Bharadwaj A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003063; BILLETER M, 1992, J BIOMOL NMR, V2, P1, DOI 10.1007/BF02192796; Branchini BR, 2019, BIOCHEMISTRY-US, V58, P4293, DOI 10.1021/acs.biochem.9b00719; Castaneda-Garcia A, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay4453; Choi KHA, 2019, BIOCHEMISTRY-US, V58, P3744, DOI 10.1021/acs.biochem.9b00528; Fleisher RC, 2021, METHOD ENZYMOL, V656, P375, DOI 10.1016/bs.mie.2021.05.001; Fu CH, 2009, DEV CELL, V17, P257, DOI 10.1016/j.devcel.2009.06.012; Gaska I, 2020, DEV CELL, V54, P367, DOI 10.1016/j.devcel.2020.06.017; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Groftehauge MK, 2015, ACTA CRYSTALLOGR D, V71, P36, DOI 10.1107/S1399004714016617; Huyghues-Despointes B M, 2001, Methods Mol Biol, V168, P69; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kaiser M, 2013, BRENNERS ENCY GENETI, P501, DOI DOI 10.1016/B978-0-12-374984-0.01229-8; Kellogg EH, 2016, P NATL ACAD SCI USA, V113, P9430, DOI 10.1073/pnas.1609903113; Kovalchuk SN, 2018, MAR DRUGS, V16, DOI 10.3390/md16120471; Krishna SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081504; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li XH, 2021, FEBS J, V288, P3055, DOI 10.1111/febs.15634; Liang ZG, 2019, TRANSL CANCER RES, V8, P2059, DOI 10.21037/tcr.2019.09.19; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Marshall D, 2001, VIROLOGY, V285, P165, DOI 10.1006/viro.2001.0951; Mo XB, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007562; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Nishiya Y., 2014, INT J ANALYTICAL BIO, V2, P58; Nishiyama S, 2020, GENES CELLS, V25, P685, DOI 10.1111/gtc.12803; Poongavanam V, 2018, MEDCHEMCOMM, V9, P562, DOI 10.1039/c7md00600d; Pulavarti SVSRK, 2008, J MOL BIOL, V378, P165, DOI 10.1016/j.jmb.2008.02.027; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; She ZY, 2019, BIOL REV, V94, P2033, DOI 10.1111/brv.12547; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Subramanian R, 2013, CELL, V154, P377, DOI 10.1016/j.cell.2013.06.021; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; Tan F, 2022, CURR ISSUES MOL BIOL, V44, P1626, DOI 10.3390/cimb44040111; Vukusic K, 2021, DEV CELL, V56, P1253, DOI 10.1016/j.devcel.2021.04.005; Xue HP, 2012, J IND MICROBIOL BIOT, V39, P1279, DOI 10.1007/s10295-012-1140-y; Xue XY, 2007, J MOL BIOL, V366, P965, DOI 10.1016/j.jmb.2006.11.073; Yoshida S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16488-y; Zhong N, 2008, J VIROL, V82, P4227, DOI 10.1128/JVI.02612-07; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102	44	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2022	17	8							e0270572	10.1371/journal.pone.0270572	http://dx.doi.org/10.1371/journal.pone.0270572			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5A3IT	35930764	Green Published, gold			2022-12-26	WOS:000862784200010
J	Neto, EC; Perumal, TM; Pratap, A; Tediarjo, A; Bot, BM; Mangravite, L; Omberg, L				Neto, Elias Chaibub; Perumal, Thanneer M.; Pratap, Abhishek; Tediarjo, Aryton; Bot, Brian M.; Mangravite, Lara; Omberg, Larsson			Disentangling personalized treatment effects from "time-of-the-day" confounding in mobile health studies	PLOS ONE			English	Article							PARTIAL GRANGER CAUSALITY; EXOGENOUS INPUTS; HETEROSKEDASTICITY; INFERENCE; MODEL	Ideally, a patient's response to medication can be monitored by measuring changes in performance of some activity. In observational studies, however, any detected association between treatment ("on-medication" vs "off-medication") and the outcome (performance in the activity) might be due to confounders. In particular, causal inferences at the personalized level are especially vulnerable to confounding effects that arise in a cyclic fashion. For quick acting medications, effects can be confounded by circadian rhythms and daily routines. Using the time-of-the-day as a surrogate for these confounders and the performance measurements as captured on a smartphone, we propose a personalized statistical approach to disentangle putative treatment and "time-of-the-day" effects, that leverages conditional independence relations spanned by causal graphical models involving the treatment, time-of-the-day, and outcome variables. Our approach is based on conditional independence tests implemented via standard and temporal linear regression models. Using synthetic data, we investigate when and how residual autocorrelation can affect the standard tests, and how time series modeling (namely, ARIMA and robust regression via HAC covariance matrix estimators) can remedy these issues. In particular, our simulations illustrate that when patients perform their activities in a paired fashion, positive autocorrelation can lead to conservative results for the standard regression approach (i.e., lead to deflated true positive detection), whereas negative autocorrelation can lead to anticonservative behavior (i.e., lead to inflated false positive detection). The adoption of time series methods, on the other hand, leads to well controlled type I error rates. We illustrate the application of our methodology with data from a Parkinson's disease mobile health study.	[Neto, Elias Chaibub; Perumal, Thanneer M.; Pratap, Abhishek; Tediarjo, Aryton; Bot, Brian M.; Mangravite, Lara; Omberg, Larsson] Sage Bionetworks, Seattle, WA 98121 USA; [Perumal, Thanneer M.] Roche Innovat Ctr Basel, Pharmaceut Res & Early Dev, Basel, Basel Stadt, Switzerland; [Pratap, Abhishek] Univ Toronto, Ctr Addict & Mental Hlth, Dept Psychiat, Toronto, ON, Canada	Roche Holding; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Neto, EC (corresponding author), Sage Bionetworks, Seattle, WA 98121 USA.	elias.chaibub.neto@sagebionetworks.org		Pratap, Abhishek/0000-0002-5289-6932; Chaibub Neto, Elias/0000-0002-9575-861X; Omberg, Larsson/0000-0002-4719-9120	Robert Wood Johnson Foundation; NINDS [5U01NS107009-04, 5P50NS108676-04]	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded through a grant from the Robert Wood Johnson Foundation, and by NINDS grants 5U01NS107009-04 and 5P50NS108676-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhishek Pratap, 2017, Arxiv, DOI arXiv:1706.09574; Ahlskog JE., 2015, NEW PARKINSONS DIS T, V2nd ed; Tank A, 2018, Arxiv, DOI arXiv:1802.05842; Andrew D Trister, 2017, Arxiv, DOI arXiv:1604.01055; Arora S, 2015, PARKINSONISM RELAT D, V21, P650, DOI 10.1016/j.parkreldis.2015.02.026; Arora S, 2014, INT CONF ACOUST SPEE, DOI 10.1109/ICASSP.2014.6854280; Bell D, 1996, ECON LETT, V51, P7, DOI 10.1016/0165-1765(95)00791-1; Bot BM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.11; Chan YFY, 2017, NAT BIOTECHNOL, V35, P354, DOI 10.1038/nbt.3826; Chickering D. M., 2003, Journal of Machine Learning Research, V3, P507, DOI 10.1162/153244303321897717; Dang XH, 2018, ARXIV; Datta DD, 2012, INT FINANCE DISCUSSI; Demiralp S, 2003, OXFORD B ECON STAT, V65, P745, DOI 10.1046/j.0305-9049.2003.00087.x; Doerr M, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.6521; Entner D., 2010, PROBABILISTIC GRAPHI, P121; Friend SH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1206; Gerhardus A., 2020, ADV NEURAL INFORM PR, P12615; GEURTS M, 1977, J MARKETING RES, V14, P269, DOI 10.2307/3150485; Glymour C, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00524; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRANGER CWJ, 1980, J ECON DYN CONTROL, V2, P329, DOI 10.1016/0165-1889(80)90069-X; Gregorova M, 2015, ARXIV; Guo SX, 2008, J NEUROSCI METH, V172, P79, DOI 10.1016/j.jneumeth.2008.04.011; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Hoover KD, 2005, ECONOMET THEOR, V21, P69, DOI 10.1017/S026646660505005X; Hoyer P.O., 2009, ADV NEURAL INFORM PR; Huang BW, 2019, PR MACH LEARN RES, V97; Huang BW, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P1551, DOI 10.1145/3219819.3220104; Huber R, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102159; Hung YC, 2014, ELECTRON J STAT, V8, P1940, DOI 10.1214/14-EJS940; Hyndman RJ, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i03; Hyvarinen A., 2008, PROC INT C MACH LEAR, P424; Hyvarinen A, 2010, J MACH LEARN RES, V11, P1709; Jan Kautz, 2020, Arxiv, DOI arXiv:2001.01885; Lauritzen S.L.., 1996, GRAPHICAL MODELS; Madras D., 2020, ARXIV; Malinsky D., 2018, P 2018 ACM SIGKDD WO, V92, P23; Mastakouri A. A., 2021, PROC INT C MACH LEAR, V139, P7502; McConnell MV, 2017, JAMA CARDIOL, V2, P67, DOI 10.1001/jamacardio.2016.4395; MCGREGOR JR, 1989, BIOMETRIKA, V76, P735; Meng Y., 2019, ARXIV; Moneta A, 2006, P JOINT C INF SCI KA; Moraffah R, 2021, KNOWL INF SYST, V63, P3041, DOI 10.1007/s10115-021-01621-0; Nauta M, 2019, MACH LEARN KNOW EXTR, V1, DOI 10.3390/make1010019; Neto EC, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0178-x; Neto EC, 2016, BIOCOMPUT-PAC SYM, P273; NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610; NEWEY WK, 1994, REV ECON STUD, V61, P631, DOI 10.2307/2297912; Omberg L, 2022, NAT BIOTECHNOL, V40, P480, DOI 10.1038/s41587-021-00974-9; Peters J., 2013, ADV NEURAL INFORM PR, P154; R Core Team, 2021, R LANG ENV STAT; Rho SH, 2019, ECONOMET THEOR, V35, P601, DOI 10.1017/S0266466618000117; Rodas CB, 2021, ARXIV; Roelstraete B, 2012, J NEUROSCI METH, V206, P73, DOI 10.1016/j.jneumeth.2012.01.010; Rothenhausler D, 2015, ADV NEUR IN, V28; Runge J, 2018, CHAOS, V28, DOI 10.1063/1.5025050; Runge J., 2020, ARXIV; Runge J, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau4996; Runge J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10105-3; Schaechtle U., 2013, 23 INT JOINT C ARTIF; Schork NJ, 2015, NATURE, V520, P609, DOI 10.1038/520609a; Shimizu S, 2006, J MACH LEARN RES, V7, P2003; Shumway RH, 2011, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4419-7865-3; Snyder PT., 2020, J OPEN SOURCE SOFTW, V5, P2106, DOI [10.21105/joss.02106, DOI 10.21105/JOSS.02106]; Spirtes P., 2000, CAUSATION PREDICTION, Vsecond; Topol EJ, 2012, CREATIVE DESTRUCTION; Verma T., 1990, READINGS UNCERTAIN R; Vesel C, 2020, J AM MED INFORM ASSN, V27, P1007, DOI 10.1093/jamia/ocaa057; Xu CX, 2019, PROCEEDINGS OF THE 28TH ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM '19), P1853, DOI 10.1145/3357384.3357864; Zeileis A, 2004, J STAT SOFTWARE, V10, P1; Zhang K., 2009, P 25 C UNC ART INT	72	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271766	10.1371/journal.pone.0271766	http://dx.doi.org/10.1371/journal.pone.0271766			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925980	Green Published, gold			2022-12-26	WOS:000848077100049
J	Perovic, O; Duse, A; Chibabhai, V; Black, M; Said, M; Prentice, E; Wadula, J; Mahabeer, Y; Han, KSS; Mogokotleng, R; Strasheim, W; Lowe, M; Jallow, S; Ismail, H				Perovic, Olga; Duse, Adrian; Chibabhai, Vindana; Black, Marianne; Said, Mohamed; Prentice, Elizabeth; Wadula, Jeannette; Mahabeer, Yesholata; Han, K. Swe Swe; Mogokotleng, Ruth; Strasheim, Wilhelmina; Lowe, Michelle; Jallow, Sabelle; Ismail, Husna		GERMS-SA	Acinetobacter baumannii complex, national laboratory-based surveillance in South Africa, 2017 to 2019	PLOS ONE			English	Article							RESISTANCE	Objective We aimed to provide an analysis of A. baumannii complex (ABC) isolated from blood cultures in South Africa. Materials and methods ABC surveillance was conducted from 1 April 2017 to 30 September 2019 at 19 hospital sites from blood cultures of any age and sex. Organism identification was performed using the MALDI-TOF MS and antimicrobial susceptibility testing (AST), MicroScan Walkaway System. We confirmed colistin resistance with Sensititre, FRCOL panel, and selected for whole-genome sequencing. Results During the study period, we identified 4822 cases of ABC, of which 2152 cases were from 19 enhanced surveillance sites were reported during the enhanced surveillance period (1 August 2018 to 30 September 2019). Males accounted for 54% (2611/4822). Of the cases with known age, 41% (1968/4822) were infants (< 1-year-old). Seventy-eight percent (1688/2152) of cases had a known hospital outcome, of which 36% (602/1688) died. HIV status was known for 69% (1168/1688) of cases, and 14% (238/1688) were positive. Eighty-two percent (1389/1688) received antimicrobial treatment in admission. Three percent (35/1389) of cases received single colistin. Four percent (75/2033) were resistant to colistin. At least 75% of the isolates (1530/2033) can be classified as extensively drug-resistant (XDR), with resistance to most antibiotics except for colistin. The majority, 83% (20/24), of the colistin-resistant isolates were of the sequence type (ST) 1. Resistance genes, both plasmidand chromosomal- mediated were not observed. Although all isolates had, nine efflux pump genes related to antimicrobial resistance. Conclusion Our surveillance data contributed to a better understanding of the natural course of A. baumannii disease, the patient characteristics among infants, and the level of resistance. At least two-thirds of the isolates were extensively drug-resistant, and four percent of isolates were resistant to colistin.	[Perovic, Olga; Mogokotleng, Ruth; Strasheim, Wilhelmina; Lowe, Michelle; Jallow, Sabelle; Ismail, Husna] Natl Inst Communicable Dis, Ctr Healthcare Associated Infect Antimicrobial Re, Johannesburg, South Africa; [Perovic, Olga; Duse, Adrian; Chibabhai, Vindana; Black, Marianne; Wadula, Jeannette; Jallow, Sabelle] Univ Witwatersrand, Fac Hlth Sci, Div Clin Microbiol & Infect Dis, Sch Pathol, Johannesburg, South Africa; [Perovic, Olga; Duse, Adrian; Chibabhai, Vindana; Black, Marianne; Wadula, Jeannette; Jallow, Sabelle] Natl Hlth Lab Serv NHLS, Johannesburg, South Africa; [Chibabhai, Vindana; Black, Marianne] Charlotte Maxeke Johannesburg Acad Hosp, Natl Hlth Lab Serv, Microbiol Lab, Johannesburg, South Africa; [Said, Mohamed] Univ Pretoria, Dept Med Microbiol, Pretoria, South Africa; [Said, Mohamed] Tshwane Acad Div, Natl Hlth Lab Serv, Pretoria, South Africa; [Prentice, Elizabeth] Univ Cape Town, Dept Med Microbiol, Cape Town, South Africa; [Prentice, Elizabeth] Groote Schuur Hosp, Natl Hlth Lab Serv, Cape Town, South Africa; [Wadula, Jeannette] Chris Hani Baragwanath Acad Hosp, Soweto, South Africa; [Mahabeer, Yesholata; Han, K. Swe Swe] Inkosi Albert Luthuli Cent Hosp, Dept Med Microbiol, Natl Hlth Lab Serv, Durban, South Africa; [Mahabeer, Yesholata; Han, K. Swe Swe] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Sch Lab Med & Med Sci, Durban, South Africa	National Institute for Communicable Diseases (NICD); University of Witwatersrand; National Health Laboratory Service; National Health Laboratory Service; University of Witwatersrand; University of Pretoria; Tshwane University of Technology; University of Cape Town; University of Cape Town; University of Kwazulu Natal	Perovic, O (corresponding author), Natl Inst Communicable Dis, Ctr Healthcare Associated Infect Antimicrobial Re, Johannesburg, South Africa.; Perovic, O (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Div Clin Microbiol & Infect Dis, Sch Pathol, Johannesburg, South Africa.; Perovic, O (corresponding author), Natl Hlth Lab Serv NHLS, Johannesburg, South Africa.	olgap@nicd.ac.za	Lowe, Michelle/AAS-3511-2020	Lowe, Michelle/0000-0001-6399-6229; Perovic, Olga/0000-0001-5580-4629				Alcock BP, 2020, NUCLEIC ACIDS RES, V48, pD517, DOI 10.1093/nar/gkz935; Balkhair A, 2019, INT J INFECT DIS, V85, P10, DOI 10.1016/j.ijid.2019.05.004; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Chopjitt Peechanika, 2021, Infectious Disorders - Drug Targets, V21, pe270421188042, DOI 10.2174/1871526520999201116201911; Clinical and Laboratory Standards Institute, 2017, PERFORMANCE STANDARD, V27th; Dashti AA, 2009, KUWAIT MED J, V41, P117; El-Badawy M, 2021, INFECT DRUG RESIST, V14, P4739, DOI 10.2147/IDR.S324707; Eveillard M, 2013, INT J INFECT DIS, V17, pE802, DOI 10.1016/j.ijid.2013.03.021; Goff DA, 2017, LANCET INFECT DIS, V17, pE56, DOI 10.1016/S1473-3099(16)30386-3; Gramatniece A, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0537-z; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Kassamali Z, 2015, INT J INFECT DIS, V30, P125, DOI 10.1016/j.ijid.2014.10.014; Katip W, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9100647; Lin MF, 2017, J MICROBIOL, V55, P130, DOI 10.1007/s12275-017-6408-5; Lyu C, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05026-2; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Matuschek E, 2018, CLIN MICROBIOL INFEC, V24, P865, DOI 10.1016/j.cmi.2017.11.020; Mendelson M, 2018, LANCET INFECT DIS, V18, pE288, DOI 10.1016/S1473-3099(18)30119-1; Mootsikapun P, 2007, INT J INFECT DIS, V11, P226, DOI 10.1016/j.ijid.2006.02.010; Poirel L, 2017, CLIN MICROBIOL REV, V30, P557, DOI 10.1128/CMR.00064-16; Rebelo AR, 2018, EUROSURVEILLANCE, V23, P29, DOI 10.2807/1560-7917.ES.2018.23.6.17-00672; Sambrook J., MOL CLONING LAB MANU; Shi H, 2019, INFECT DRUG RESIST, V12, P3925, DOI 10.2147/IDR.S234211; Smelikova E, 2022, CLIN MICROBIOL INFEC, V28, P43, DOI 10.1016/j.cmi.2021.09.009; Snyman Y, 2021, J GLOB ANTIMICROB RE, V25, P102, DOI [10.1016/j.jgar.2021.03.002, 10.1016/j.jgar.2021.03.002BY-]; Snyman Y, 2020, INT J INFECT DIS, V91, P94, DOI 10.1016/j.ijid.2019.11.021; Vrancianu CO, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8060935; WHO, 2017, WHO PUBLISHES LIST B; Yahav D, 2020, CLIN MICROBIOL REV, V34, DOI 10.1128/CMR.00115-20	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271355	10.1371/journal.pone.0271355	http://dx.doi.org/10.1371/journal.pone.0271355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35926057	Green Published, gold			2022-12-26	WOS:000848077100037
J	Khajah, M; Khushaish, S; Luqmani, Y				Khajah, Maitham; Khushaish, Sarah; Luqmani, Yunus			Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro	PLOS ONE			English	Article							KETOGENIC DIET; LUNG-CANCER; OXIDATIVE STRESS; LOW-CARBOHYDRATE; METABOLISM; 2-DEOXY-D-GLUCOSE; THERAPY; INSULIN; KETOSIS; RISK	BackgroundBreast cancer chemotherapy with high dose alkylating agents is severely limited by their collateral toxicity to crucial normal tissues such as immune and gut cells. Taking advantage of the selective dependence of cancer cells on high glucose and combining glucose deprivation with these agents could produce therapeutic synergy. MethodsIn this study we examined the effect of glucose as well as its deprivation, and antagonism using the non-metabolized analogue 2-deoxy glucose, on the proliferation of several breast cancer cell lines MCF7, MDA-MB-231, YS1.2 and pII and one normal breast cell line, using the MTT assay. Motility was quantitatively assessed using the wound healing assay. Lactate, as the end product of anaerobic glucose metabolism, secreted into culture medium was measured by a biochemical assay. The effect of paclitaxel and doxorubicin on cell proliferation was tested in the absence and presence of low concentrations of glucose using MTT assay. ResultsIn all cell lines, glucose supplementation enhanced while glucose deprivation reduced both their proliferation and motility. Lactate added to the medium could substitute for glucose. The inhibitory effects of paclitaxel and doxorubicin were significantly enhanced when glucose concentration was decreased in the culture medium, requiring 1000-fold lesser concentration to achieve a similar degree of inhibition to that seen in glucose-containing medium. ConclusionOur data show that a synergy was obtained by combining paclitaxel and doxorubicin with glucose reduction to inhibit cancer cell growth, which in vivo, might be achieved by applying a carbohydrate-restricted diet during the limited phase of application of chemotherapy; this could permit a dose reduction of the cytotoxic agents, resulting in greater tolerance and lesser side effects.	[Khajah, Maitham; Khushaish, Sarah; Luqmani, Yunus] Kuwait Univ, Fac Pharm, Kuwait, Kuwait	Kuwait University	Khajah, M (corresponding author), Kuwait Univ, Fac Pharm, Kuwait, Kuwait.	maitham.khajah@ku.edu.kw			Kuwait University Research Sector grant [PT02/18]; Kuwait University [SRUL02/13]	Kuwait University Research Sector grant; Kuwait University	This work was supported by Kuwait University Research Sector grant PT02/18. Parts of this work were supported by grant SRUL02/13 to the Research Unit for Genomics, Proteomics and Cellomics Studies (OMICS), Kuwait University. the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza M, 2013, EXPERT REV ANTICANC, V13, P1229, DOI 10.1586/14737140.2013.843455; Al Saleh S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020610; Al Saleh S, 2011, INT J ONCOL, V38, P1197, DOI 10.3892/ijo.2011.942; Allen BG, 2013, CLIN CANCER RES, V19, P3905, DOI 10.1158/1078-0432.CCR-12-0287; Aminzadeh-Gohari S, 2017, ONCOTARGET, V8, P64728, DOI 10.18632/oncotarget.20041; Barbosa AM, 2020, CANCERS, V12, DOI 10.3390/cancers12010154; Benito A, 2017, ONCOTARGET, V8, P106693, DOI 10.18632/oncotarget.21601; Boedtkjer E, 2020, ANNU REV PHYSIOL, V82, P103, DOI 10.1146/annurev-physiol-021119-034627; Bose S, 2018, ADV EXP MED BIOL, V1063, P3, DOI 10.1007/978-3-319-77736-8_1; Boyle P, 2012, BRIT J CANCER, V107, P1608, DOI 10.1038/bjc.2012.414; Bozzetti F, 1996, CLIN NUTR, V15, P207, DOI 10.1016/S0261-5614(96)80243-3; Branca JJV, 2015, ANTICANCER RES, V35, P5525; Bronsveld HK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170084; Bueno NB, 2013, BRIT J NUTR, V110, P1178, DOI 10.1017/S0007114513000548; Cao J, 2013, CANCER RES, V73, P1362, DOI 10.1158/0008-5472.CAN-12-2072; Chen MC, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071598; Choi J, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/9369358; Clifton P, 2015, CURR OPIN LIPIDOL, V26, P594, DOI 10.1097/MOL.0000000000000241; Cohen CW, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091187; Cohen CW, 2018, J NUTR, V148, P1253, DOI 10.1093/jn/nxy119; Demirel Pinar Buket, 2019, Ann Med Res, V26, P2966, DOI 10.5455/annalsmedres.2019.09.542; Dogan S, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1840; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Dong TY, 2016, TUMOR BIOL, V37, P8159, DOI 10.1007/s13277-015-4729-8; Duan WX, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/461917; Dwarakanath BS, 2009, J CANCER RES THER, V5, P27, DOI 10.4103/0973-1482.55137; Elsakka AMA, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00020; FEARON KCH, 1988, AM J CLIN NUTR, V47, P42, DOI 10.1093/ajcn/47.1.42; Ferreira LMR, 2010, EXP MOL PATHOL, V89, P372, DOI 10.1016/j.yexmp.2010.08.006; Fujita M, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07414-y; Gallagher EJ, 2010, TRENDS ENDOCRIN MET, V21, P610, DOI 10.1016/j.tem.2010.06.007; Gao S, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0648-4; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Goday A, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.36; Gumbiner B, 1996, AM J CLIN NUTR, V63, P110, DOI 10.1093/ajcn/63.1.110; Hamadneh L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78833-x; Hopkins BD, 2018, NATURE, V560, P499, DOI 10.1038/s41586-018-0343-4; Hulikova A, 2013, J CELL PHYSIOL, V228, P743, DOI 10.1002/jcp.24221; Hwangbo Y, 2017, ENDOCRINOL METAB, V32, P23, DOI 10.3803/EnM.2017.32.1.23; Iyikesici MS, 2017, CUREUS, V9, DOI 10.7759/cureus.1445; Johnson JA, 2012, DIABETOLOGIA, V55, P1607, DOI 10.1007/s00125-012-2525-1; Kim SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101004; Klement Rainer J, 2016, BMC Res Notes, V9, P143, DOI 10.1186/s13104-016-1959-9; Klement RJ, 2018, COMPLEMENT MED RES, V25, P102, DOI 10.1159/000484045; Koobotse MO, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228674; Kowluru RA, 2004, J DIABETES COMPLICAT, V18, P282, DOI 10.1016/j.jdiacomp.2004.03.002; Kreuzaler P, 2020, MOL METAB, V33, P83, DOI 10.1016/j.molmet.2019.08.021; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Li XB, 2015, THORAC CANCER, V6, P17, DOI 10.1111/1759-7714.12148; Liao SC, 2011, ASIAN PAC J CANCER P, V12, P1061; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Lipscombe LL, 2008, BREAST CANCER RES TR, V109, P389, DOI 10.1007/s10549-007-9654-0; Luqmani YA, 2009, INT J ONCOL, V34, P231, DOI 10.3892/ijo_00000145; Maldonado R, 2021, ONCOL LETT, V21, DOI 10.3892/ol.2020.12326; Marin-Hernandez A, 2011, BBA-BIOENERGETICS, V1807, P755, DOI 10.1016/j.bbabio.2010.11.006; Martin-McGill KJ, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001903.pub4; Martin-Salces M, 2008, NUTRITION, V24, P769, DOI 10.1016/j.nut.2008.02.021; Morscher RJ, 2016, ONCOTARGET, V7, P17060, DOI 10.18632/oncotarget.7929; Muti P, 2002, CANCER EPIDEM BIOMAR, V11, P1361; NEBELING LC, 1995, J AM COLL NUTR, V14, P202; Nilchian A, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10121621; O'Neill S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39789-9; Pajak B, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010234; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; PHINNEY SD, 1983, METABOLISM, V32, P757, DOI 10.1016/0026-0495(83)90105-1; Pop-Busui R, 2010, CURR DIABETES REP, V10, P276, DOI 10.1007/s11892-010-0120-8; Pu HH, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0733-0; Rieger J, 2014, INT J ONCOL, V44, P1843, DOI 10.3892/ijo.2014.2382; Ryu TY, 2014, DIABETES METAB J, V38, P330, DOI 10.4093/dmj.2014.38.5.330; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Schmidt M, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-54; Schwartz K, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0129-1; Shin E, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.728759; Strowd RE, 2015, NEURO-ONCOL PRACT, V2, P127, DOI 10.1093/nop/npv010; Tonna S, 2010, NAT REV NEPHROL, V6, P332, DOI 10.1038/nrneph.2010.55; Tseng CW, 2018, CANCER RES, V78, P2799, DOI 10.1158/0008-5472.CAN-17-2906; Vaupel P, 2019, INT J RADIAT BIOL, V95, P912, DOI 10.1080/09553002.2019.1589653; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Wei ML, 2017, MOL MED REP, V16, P6690, DOI 10.3892/mmr.2017.7420; Wokoun U, 2017, ONCOL REP, V37, P2418, DOI 10.3892/or.2017.5491; Yancy William S Jr, 2005, Nutr Metab (Lond), V2, P34, DOI 10.1186/1743-7075-2-34; Yang XY, 2018, CLIN TRANSL ONCOL, V20, P1145, DOI 10.1007/s12094-018-1833-4; Zahra A, 2017, RADIAT RES, V187, P743, DOI [10.1667/RR14668.1, 10.1667/rr14668.1]; Zhang DS, 2014, CANCER LETT, V355, P176, DOI 10.1016/j.canlet.2014.09.003; Zhang FJ, 2009, J CANCER RES THER, V5, P41, DOI 10.4103/0973-1482.55140; Zhou J, 2020, BIOMED PHARMACOTHER, V132, DOI 10.1016/j.biopha.2020.110821; Zou YY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233662; Zuccoli G, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-33	90	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272449	http://dx.doi.org/10.1371/journal.pone.0272449			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917304	gold, Green Published			2022-12-26	WOS:000837840000031
J	Pisano, MB; Campbell, C; Anugwom, C; Re, VE; Debes, JD				Pisano, Maria Belen; Campbell, Christopher; Anugwom, Chimaobi; Re, Viviana Elizabeth; Debes, Jose D.			Hepatitis E virus infection in the United States: Seroprevalence, risk factors and the influence of immunological assays	PLOS ONE			English	Article							DIAGNOSTIC PERFORMANCE; NATIONAL-HEALTH; EPIDEMIOLOGY; TESTS; IGG	In the United States (U.S.), a hepatitis E virus (HEV) seroprevalence between 6 and 21% has been described, with a decreasing trend. We aimed to investigate HEV infection in the U.S. population from 2009 to 2016, and examine the differences in seroprevalence using different assays. We used data from the National Health and Nutrition Examination Survey (NHANES-CDC) to estimate HEV seroprevalence and analyze demographic variables related to the infection. Additionally, we compared 4 serological tests used. The estimated HEV seroprevalence between 2009-2016 was 6.1% (95% CI: 5.6%-7.0%) for IgG and 1.02% (0.8%-1.2%) for IgM. Higher HEV IgG prevalences were found in older people, females, non-Hispanic Asians and those born outside of the U.S. The in-house immunoassay and the Wantai HEV-IgG ELISA presented the highest sensitivity values in the tested population. The highest specificity values corresponded to the DSI-EIA-ANTI-HEV-IgG assay. The kappa statistical values showed concordances no greater than 0.64 between the assays. HEV prevalence in our study was similar to previously reported, and a decline in the prevalence was observed through the NHANES assessments (from 1988 to 2016). The sensitivity and specificity of the assays varied widely, making comparisons difficult and highlighting the need to develop a gold standard assay.	[Pisano, Maria Belen; Re, Viviana Elizabeth] Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Dr J M Vanella, CONICET, Cordoba, Argentina; [Campbell, Christopher] Minnesota Dept Hlth, Canc Control Sect, St Paul, MN USA; [Campbell, Christopher; Debes, Jose D.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Anugwom, Chimaobi; Debes, Jose D.] Univ Minnesota, Dept Med, Div Infect Dis & Int Med, Minneapolis, MN 55455 USA; [Anugwom, Chimaobi; Debes, Jose D.] Univ Minnesota, Div Gastroenterol & Hepatol, Minneapolis, MN 55455 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Minnesota Department of Health (MHD); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Pisano, MB (corresponding author), Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Dr J M Vanella, CONICET, Cordoba, Argentina.; Debes, JD (corresponding author), Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA.; Debes, JD (corresponding author), Univ Minnesota, Dept Med, Div Infect Dis & Int Med, Minneapolis, MN 55455 USA.; Debes, JD (corresponding author), Univ Minnesota, Div Gastroenterol & Hepatol, Minneapolis, MN 55455 USA.	debes003@umn.edu; mbelenpisano@gmail.com		Pisano, Maria Belen/0000-0002-0336-3750	Robert Wood Johnson Foundation; Harold Amos Medical Faculty Development Program, University of Minnesota AIRP; NIH National Center for Advancing Translational Sciences [UL1TR002494]	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Harold Amos Medical Faculty Development Program, University of Minnesota AIRP; NIH National Center for Advancing Translational Sciences	This work was supported by Robert Wood Johnson Foundation, Harold Amos Medical Faculty Development Program, University of Minnesota AIRP grant, and NIH National Center for Advancing Translational Sciences [grant UL1TR002494] all to JDD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH National Center for Advancing Translational Sciences.	[Anonymous], 1988, YEARS COVER, P1988; Anugwom C, 2021, J VIRAL HEPATITIS, V28, P1091, DOI 10.1111/jvh.13519; Avellon A, 2015, J MED VIROL, V87, P1934, DOI 10.1002/jmv.24251; Pisano MB, 2017, ARCH VIROL, V162, P787, DOI 10.1007/s00705-016-3171-6; Capai L, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010084; CDC, NHANES 1988 1994 IGG; CDC NCHS, 2018, NATL HLTH NUTR EXAMI; Cui WH, 2016, INT J INFECT DIS, V49, P62, DOI 10.1016/j.ijid.2016.05.028; Dalton HR, 2007, J VIRAL HEPATITIS, V14, P304, DOI 10.1111/j.1365-2893.2006.00800.x; Ditah I, 2014, HEPATOLOGY, V60, P815, DOI 10.1002/hep.27219; Drobeniuc J, 2013, EMERG INFECT DIS, V19, P218, DOI 10.3201/eid1902.120961; Faramawi MF, 2011, EPIDEMIOL INFECT, V139, P1145, DOI 10.1017/S0950268810002177; FAVOROV MO, 1992, J MED VIROL, V36, P246, DOI 10.1002/jmv.1890360403; Fontana RJ, 2020, CLIN TRANSL GASTROEN, V11, DOI 10.14309/ctg.0000000000000273; Fontana RJ, 2022, AM J GASTROENTEROL, V117, P1462, DOI 10.14309/ajg.0000000000001869; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Horvatits T, 2018, LIVER INT, V38, P1951, DOI 10.1111/liv.13859; Kamar N, 2014, CLIN MICROBIOL REV, V27, P116, DOI 10.1128/CMR.00057-13; Kamili S., 2011, HEPATITIS IGG ANTIBO; Katki HA, 2012, STAT MED, V31, P436, DOI 10.1002/sim.4422; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; Kwo PY, 1997, MAYO CLIN PROC, V72, P1133, DOI 10.4065/72.12.1133; Mansuy JM, 2009, J CLIN VIROL, V44, P74, DOI 10.1016/j.jcv.2008.09.010; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Murray CK, 2015, MIL MED, V180, P626, DOI 10.7205/MILMED-D-14-00691; Norder H, 2016, J CLIN MICROBIOL, V54, P549, DOI 10.1128/JCM.02343-15; Pas SD, 2013, J CLIN VIROL, V58, P629, DOI 10.1016/j.jcv.2013.10.010; Pisano MB, 2018, LIVER INT, V38, P1536, DOI 10.1111/liv.13881; Rein DB, 2012, HEPATOLOGY, V55, P988, DOI 10.1002/hep.25505; Sotelo-Diaz Indira, 2019, Nutrition and Health (Bicester), V25, P153, DOI 10.1177/0260106018820980; Wang MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161089; WHO: World Health Organization, 2020, FACT SHEET HEP E; Zhang Q, 2020, POL J MICROBIOL, V69, P217, DOI 10.33073/pjm-2020-025	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8							e0272809	10.1371/journal.pone.0272809	http://dx.doi.org/10.1371/journal.pone.0272809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P8ZE	35930611	Green Published, gold			2022-12-26	WOS:000837822100004
J	Taira, S; Ikeda, A; Sugiura, Y; Shikano, H; Kobayashi, S; Terauchi, T; Yokoyama, J				Taira, Shu; Ikeda, Akari; Sugiura, Yuki; Shikano, Hitomi; Kobayashi, Shoko; Terauchi, Tsutomu; Yokoyama, Jun			Pyrylium based derivatization imaging mass spectrometer revealed the localization of L-DOPA	PLOS ONE			English	Article							BRAIN; NEUROTRANSMITTERS; CATECHOLAMINES; NEURONS; ACID	Simultaneous imaging of l-dihydroxyphenylalanine (l-DOPA), dopamine (DA) and norepinephrine (NE) in the catecholamine metabolic pathway is particularly useful because l-DOPA is a neurophysiologically important metabolic intermediate. In this study, we found that 2,4,6-trimethylpyrillium tetrafluoroborate (TMPy) can selectively and efficiently react with target catecholamine molecules. Specifically, simultaneous visualization of DA and NE as metabolites of l-DOPA with high steric hinderance was achieved by derivatized-imaging mass spectrometry (IMS). Interestingly, l-DOPA showed strong localization in the brainstem, in contrast to the pattern of DA and NE, which co-localized with tyrosine hydroxylase (TH). In addition, to identify whether the detected molecules were endogenous or exogenous l-DOPA, mice were injected with l-DOPA deuterated in three positions (D-3-l-DOPA), which was identifiable by a mass shift of 3Da. TMPy-labeled l-DOPA, DA and NE were detected at m/z 302.1, 258.1 and 274.1, while their D-3 versions were detected at 305.0, 261.1 and 277.1 in mouse brain, respectively. l-DOPA and D-3-l-DOPA were localized in the BS. DA and NE, and D-3-DA and D-3-NE, all of which are metabolites of L-DOPA and D-3-l-DOPA, were localized in the striatum (STR) and locus coeruleus (LC). These findings suggest a mechanism in the brainstem that allows l-DOPA to accumulate without being metabolized to monoamines downstream of the metabolic pathway.	[Taira, Shu; Shikano, Hitomi] Fukushima Univ, Fac Food & Agr Sci, Fukushima, Japan; [Ikeda, Akari; Terauchi, Tsutomu; Yokoyama, Jun] Taiyo Nippon Sanso Co, Tokyo, Japan; [Sugiura, Yuki] Kyoto Univ, Ctr Canc Immunotherapy & Immunobiol, Grad Sch Med, Kyoto, Japan; [Kobayashi, Shoko] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan	Fukushima University; Taiyo Nippon Sanso Corporation; Kyoto University; University of Tokyo	Taira, S (corresponding author), Fukushima Univ, Fac Food & Agr Sci, Fukushima, Japan.	staira@agri.fukushima-u.ac.jp			Japan Science and Technology (JST) [VP30118067678, 21H02133]; LOTTE Foundation	Japan Science and Technology (JST)(Japan Science & Technology Agency (JST)); LOTTE Foundation	This research was funded by Japan Science and Technology (JST) Grants-in-A-STEP (VP30118067678 to S.T.), Grant-in-Aid for Scientific Research B (21H02133 to S.T.) and the LOTTE Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AD, 2017, J NEUROCHEM, V141, P614, DOI 10.1111/jnc.13997; Betarbet R, 1997, J NEUROSCI, V17, P6761; Callicott JH, 1998, NEUROPSYCHOPHARMACOL, V18, P186, DOI 10.1016/S0893-133X(97)00096-1; Casado-Aranda LA, 2018, HUM BRAIN MAPP, V39, P4360, DOI 10.1002/hbm.24276; Esteve C, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0926-0; Friedman JI, 1999, BIOL PSYCHIAT, V46, P1243, DOI 10.1016/S0006-3223(99)00232-2; Gittis AH, 2012, TRENDS NEUROSCI, V35, P557, DOI 10.1016/j.tins.2012.06.008; Ha M, 2012, FOOD CHEM, V133, P1155, DOI 10.1016/j.foodchem.2011.11.114; Hase T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45168-1; Huang LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24164; Kim HJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211047; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; Lieberman HR, 2015, PSYCHOPHARMACOLOGY, V232, P943, DOI 10.1007/s00213-014-3727-7; Mather M, 2016, BEHAV BRAIN SCI, V39, DOI 10.1017/S0140525X15000667; NISSBRANDT H, 1988, N-S ARCH PHARMACOL, V338, P148; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OKAMURA H, 1988, NEUROSCI LETT, V95, P42, DOI 10.1016/0304-3940(88)90629-5; Shariatgorji M, 2016, NEUROIMAGE, V136, P129, DOI 10.1016/j.neuroimage.2016.05.004; Shariatgorji M, 2014, NEURON, V84, P697, DOI 10.1016/j.neuron.2014.10.011; Shiono K, 2017, J AGR FOOD CHEM, V65, P7624, DOI 10.1021/acs.jafc.7b02255; Shiota M, 2018, FOOD CHEM, V245, P1218, DOI 10.1016/j.foodchem.2017.11.009; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Subramanian N, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.70; Sugiura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017952; Sugiyama E, 2020, PHARMACOL THERAPEUT, V208, DOI 10.1016/j.pharmthera.2020.107478; Taira S, 2008, ANAL CHEM, V80, P4761, DOI 10.1021/ac800081z; Taira S, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11136217; Taira S, 2010, AM J CHINESE MED, V38, P485, DOI 10.1142/S0192415X10008007; Tatsuta Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13257-8; Tatsuta Yukina, 2017, Mass Spectrom (Tokyo), V6, pS0069, DOI 10.5702/massspectrometry.S0069; Wang R, 2019, MOL CANCER THER, V18, P947, DOI 10.1158/1535-7163.MCT-18-0695; Xenias HS, 2015, J NEUROSCI, V35, P6584, DOI 10.1523/JNEUROSCI.0195-15.2015; Yu YY, 2020, ANAL CHEM, V92, P6312, DOI 10.1021/acs.analchem.9b05159	34	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271697	http://dx.doi.org/10.1371/journal.pone.0271697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917331	Green Published, gold			2022-12-26	WOS:000837840000050
J	May, SC; Sahoo, D				May, Sarah C.; Sahoo, Daisy			A short amphipathic alpha helix in scavenger receptor BI facilitates bidirectional HDL-cholesterol transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; TERMINAL TRANSMEMBRANE DOMAIN; SR-BI; SELECTIVE UPTAKE	During reverse cholesterol transport, high-density lipoprotein (HDL) carries excess cholesterol from peripheral cells to the liver for excretion in bile. The first and last steps of this pathway involve the HDL receptor, scavenger receptor BI (SR -BI). While the mechanism of SR-BI-mediated cholesterol transport has not yet been established, it has long been suspected that cholesterol traverses through a hydrophobic tunnel in SR-BI's extracellular domain. Confirmation of a hydrophobic tunnel is hindered by the lack of a full-length SR-BI structure. Part of SR-BI's structure has been resolved, encompassing residues 405 to 475, which includes the C-terminal transmembrane domain and its adjacent extracellular region. Within the extracellular segment is an amphipathic helix (residues 427-436, referred to as AH(427-436)) that showed increased protection from solvent in NMR-based studies. Homology models predict that hydrophobic residues in AH(427-436) line a core cavity in SR-BI's extracellular region that may facilitate cholesterol transport. Therefore, we hypothesized that hydrophobic residues in AH(427-436) are required for HDL cholesterol transport. Here, we tested this hypothesis by mutating individual residues along AH(427-436) to a charged residue (aspartic acid), transiently transfecting COS-7 cells with plasmids encoding wild-type and mutant SR -BI, and performing functional analyses. We found that mutating hydrophobic, but not hydrophilic, residues in AH(427-436) impaired SR-BI bidirectional cholesterol trans-port. Mutating phenylalanine-430 was particularly detrimental to SR-BI's functions, suggesting that this residue may facilitate important interactions for cholesterol delivery within the hydrophobic tunnel. Our results support the hypothesis that a hydrophobic tunnel within SR-BI mediates cholesterol transport.	[May, Sarah C.; Sahoo, Daisy] Med Coll Wisconsin, Dept Med, Div Endocrinol & Mol Med, Milwaukee, WI 53226 USA; [May, Sarah C.; Sahoo, Daisy] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Sahoo, Daisy] Med Coll Wisconsin, Cardiovasc Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Sahoo, D (corresponding author), Med Coll Wisconsin, Dept Med, Div Endocrinol & Mol Med, Milwaukee, WI 53226 USA.; Sahoo, D (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.; Sahoo, D (corresponding author), Med Coll Wisconsin, Cardiovasc Ctr, Milwaukee, WI 53226 USA.	dsahoo@mcw.edu			National Institutes of Health [R01HL58012, R01HL138907, R21AI147500, F31HL138744]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was financially supported by National Institutes of Health grants R01HL58012 (D. S.) , R01HL138907 (D. S.) , R21AI147500 (D. S.) , and F31HL138744 (S. C. M.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; AZHAR S, 1989, J LIPID RES, V30, P1799; Chadwick AC, 2017, STRUCTURE, V25, P446, DOI 10.1016/j.str.2017.01.001; Connelly MA, 2003, J BIOL CHEM, V278, P25773, DOI 10.1074/jbc.M302820200; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; Conrad KS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02044-8; de la Llera-Moya M, 1999, J LIPID RES, V40, P575; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gaidukov L, 2011, J BIOL CHEM, V286, P18452, DOI 10.1074/jbc.M111.229872; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Hsieh FL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12837; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Kartz GA, 2014, BIOCHEMISTRY-US, V53, P6173, DOI 10.1021/bi500706x; Kellner-Weibel G, 2000, BIOCHEMISTRY-US, V39, P221, DOI 10.1021/bi991666c; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marques PE, 2019, DEV CELL, V50, P283, DOI 10.1016/j.devcel.2019.05.026; Neculai D, 2013, NATURE, V504, P172, DOI 10.1038/nature12684; Papale GA, 2011, BIOCHEMISTRY-US, V50, P6245, DOI 10.1021/bi2005625; Papale GA, 2010, ARCH BIOCHEM BIOPHYS, V496, P132, DOI 10.1016/j.abb.2010.02.011; Parathath S, 2004, J BIOL CHEM, V279, P24976, DOI 10.1074/jbc.M402435200; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Powers HR, 2022, CURR ATHEROSCLER REP, V24, P277, DOI 10.1007/s11883-022-01001-1; Proudfoot SC, 2019, BIOCHEM J, V476, P951, DOI 10.1042/BCJ20180831; Qian HW, 2017, CELL, V169, P1228, DOI 10.1016/j.cell.2017.05.020; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yu M, 2011, P NATL ACAD SCI USA, V108, P12243, DOI 10.1073/pnas.1109078108	31	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102333	10.1016/j.jbc.2022.102333	http://dx.doi.org/10.1016/j.jbc.2022.102333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9IM	35926711	gold, Green Published			2022-12-26	WOS:000863192700009
J	Garcia, A; Gonzalez-Maya, JF; Ceballos, G				Garcia, Andres; Gonzalez-Maya, Jose F.; Ceballos, Gerardo			Biogeography of terrestrial vertebrates and its conservation implications in a transitional region in western Mexico	PLOS ONE			English	Article							SPECIES RICHNESS; VIPERIDAE CROTALINAE; MEGADIVERSE MEXICO; PROTECTED AREAS; BETA DIVERSITY; CLIMATE-CHANGE; DRY FORESTS; BIODIVERSITY; PATTERNS; MAMMALS	Conservation biogeography, which applies principles, theories, and analyses of biodiversity distribution patterns to address conservation challenges, can provide valuable insight and guidance to policy making for protection of biodiversity at multiple scales. The temperate and tropical ecosystems of the Nearctic-Neotropical transition in the small western state of Colima, Mexico, support a mosaic of remarkably diverse fauna and flora and provide a rare opportunity to determine spatial distribution patterns of terrestrial vertebrate species, assess human-induced threats, and identify potential conservation strategies. We analyzed the spatial distribution patterns and correlated them with the current land cover and extent of the protected areas. Despite its limited geographic extension, 29% (866) of all vertebrates, and almost a quarter of both endemic and threatened species in Mexico, live in Colima. Our analysis identified clear high-richness concentration sites (i.e., "hotspots") coincident for all groups and that elevation and both temperate and tropical ecosystems composition exert significant influence on richness patterns. Furthermore, current species ' distribution also showed significant correlation with natural and disturbed landcover. Significant hotspots for all species groups coincided poorly with the limited protected areas in the state (only 3.8%). The current state of natural land cover (less than 16%) in the state, coupled with its remarkable biological importance, highlights the need for further complementary conservation efforts including expansion and creation of new protected areas, significant restoration efforts and other conservation measures to maintain this uniquely biogeographic and biological diverse region of the country.	[Garcia, Andres] Univ Nacl Autonoma Mexico, Inst Biol, Estn Biol Chamela, La Huerta, Jalisco, Mexico; [Gonzalez-Maya, Jose F.] ProCAT Colombia Int, Proyecto Conservac Aguas & Tierras, Bogota, Colombia; [Gonzalez-Maya, Jose F.] Univ Autonoma Metropolitana Unidad Lerma, Dept Ciencias Ambientales, CBS, Lerma De Villada, Estado De Mexic, Mexico; [Ceballos, Gerardo] Univ Nacl Autonoma Mexico, Inst Ecol, Ciudad De Mexico, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Garcia, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biol, Estn Biol Chamela, La Huerta, Jalisco, Mexico.	chanoc@ib.unam.mx						Allan JR, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.187; [Anonymous], 2008, PROGR EST ORD EC TER; Arias-Alzate A, 2020, J MAMM EVOL, V27, P759, DOI 10.1007/s10914-020-09496-8; Arias-Gonzalez C, 2021, MAMM BIOL, V101, P531, DOI 10.1007/s42991-021-00151-0; Baselga A, 2015, METHODS ECOL EVOL, V6, P1069, DOI 10.1111/2041-210X.12388; Beck J, 2012, ECOGRAPHY, V35, P673, DOI 10.1111/j.1600-0587.2012.07364.x; Belmaker J, 2011, GLOBAL ECOL BIOGEOGR, V20, P464, DOI 10.1111/j.1466-8238.2010.00615.x; Berlanga H., 2019, LISTA ACTUALIZADA ES, P18; BirdLife International, 2018, STAT WORLDS BIRDS TA; BirdLife International, 2018, BIRDLIFE INT HDB BIR; Blair C, 2016, MOL PHYLOGENET EVOL, V97, P145, DOI 10.1016/j.ympev.2015.12.020; Boitani L, 2011, PHILOS T R SOC B, V366, P2623, DOI 10.1098/rstb.2011.0117; Botello F, 2015, BIOL CONSERV, V184, P59, DOI 10.1016/j.biocon.2014.11.035; Bryson RW, 2014, ZOOTAXA, V3826, P475, DOI 10.11646/zootaxa.3826.3.3; Buchanan GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029080; Buse Joern, 2012, International Journal of Zoology, V2012, P1; Camathias L, 2013, APPL VEG SCI, V16, P539, DOI 10.1111/avsc.12028; Carraway Leslie N., 2007, Monographs of the Western North American Naturalist, V3, P1, DOI 10.3398/1545-0228-3.1.1; Ceballos G, 1995, CONSERV BIOL, V9, P1349, DOI 10.1046/j.1523-1739.1995.09061349.x; Ceballos G, 1998, ECOL APPL, V8, P8, DOI 10.1890/1051-0761(1998)008[0008:ACPIMM]2.0.CO;2; Ceballos G, 2010, DIVERSIDAD AMENAZAS; Ceballos G, 2007, ECOL APPL, V17, P569, DOI 10.1890/06-0134; Ceballos Gerardo, 2012, Revista Mexicana de Mastozoologia Nueva Epoca, V2, P27; Ceballos G, 2013, CONSERVATION BIOLOGY: VOICES FROM THE TROPICS, P105; Chao A, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2852; Coblentz DD, 2004, J BIOGEOGR, V31, P1125, DOI 10.1111/j.1365-2699.2004.00981.x; Comision Nacional para el Conocimiento y Uso de la Biodiversidad, 2007, ESTR CONS US SUST DI; Comision Nacional para el Conocimiento y Uso de la Biodiversidad, 2019, BIODIVERSIDAD MICHOA; Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO), 2016, BIODIVERSIDAD COLIMA; Comision Nacional para el Conocimiento y Uso de la Biodiversidad y Secretaria de Medio Ambiente y Desarrollo Territorial, 2017, BIOD JAL; Comision Nacional para el Conocimiento y Uso de la Biodiversidad y Secretaria de Medio Ambiente y Desarrollo Territorial del Estado de Jalisco, 2020, ESTR CONS US SUST BI; CONANP-SEMARNAT, 2017, AR NAT PROT FED REP, P79; Coxe S, 2009, J PERS ASSESS, V91, P121, DOI 10.1080/00223890802634175; De la Mora A, 2013, BIODIVERS CONSERV, V22, P871, DOI 10.1007/s10531-013-0454-z; de Oca E., 2013, ZOOKEYS, V716, P43; Didan K., 2015, MYD13A2 MODIS AQUA V, DOI [10.5067/MODIS/MYD13A2.006, DOI 10.5067/MODIS/MYD13A2.006]; Economo EP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04218-4; Eisenlohr PV, 2013, BIODIVERS CONSERV, V22, P2767, DOI 10.1007/s10531-013-0553-x; Escalante T., 2007, BIODIVERSIDAD FAJA V, P485; Diniz JAF, 2010, INSECT CONSERV DIVER, V3, P172, DOI 10.1111/j.1752-4598.2010.00091.x; Feria-Ortiz M, 2012, ZOOTAXA, P57; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Flores-Villela O., 2007, BIODIVERSIDAD FAJA V, P407; Frost DR, AMPHIBIAN SPECIES WO; Gagne TO, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228065; Garcia A, 2016, BIODIVERSIDAD COLIMA, pp431; Garcia A, 2006, BIOL CONSERV, V130, P25, DOI 10.1016/j.biocon.2005.11.030; Garcia A, 2014, ENVIRON CONSERV, V41, P1, DOI 10.1017/S0376892913000349; García-Trejo Erick A., 2004, Acta Zool. Mex, V20, P167; Gaspard Guetchine, 2019, Journal of Ecology and Environment, V43, P19, DOI 10.1186/s41610-019-0118-3; Getis A, 2010, ADV SPAT SCI, P127, DOI 10.1007/978-3-642-01976-0_10; Gonzalez-Maya JF, 2016, ANIM BIODIV CONSERV, V39, P77, DOI 10.32800/abc.2016.39.0077; Gonzalez-Maya JF, 2021, BIODIVERS CONSERV, V30, P3151, DOI 10.1007/s10531-021-02240-5; Gonzalez-Maya JF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175931; Gonzalez-Maya JF, 2016, DIVERS DISTRIB, V22, P43, DOI 10.1111/ddi.12373; Gonzalez-Maya JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124480; Heino J, 2019, J BIOGEOGR, V46, P304, DOI 10.1111/jbi.13485; Hiley JR, 2016, DIVERS DISTRIB, V22, P1245, DOI 10.1111/ddi.12483; Hutcheson G, 2014, ORDINARY LEAST SQUAR, P225, DOI 10.4135/ 9781446251119.n67; Hutto R.L., 1986, Western Wildlands, V11, P12; Instituto Nacional de Estadistica y Geografia (INEGI), 2016, CONJ DAT VECT US SUE; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Lemos-Espinal JA, 2020, ZOOKEYS, P99, DOI 10.3897/zookeys.927.50064; Lleras C., 2005, ENCY SOCIAL MEASUREM, V3, P25, DOI DOI 10.1016/B0-12-369398-5/00483-7; Casillas JL, 2011, ORNITOL NEOTROP, V22, P187; Magurran A E., 2013, MEASURING BIOL DIVER; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Martínez-Cruz Juan, 2012, Act. Bot. Mex, P31; May F, 2016, GLOBAL ECOL BIOGEOGR, V25, P575, DOI 10.1111/geb.12438; McCain CM, 2010, GLOBAL ECOL BIOGEOGR, V19, P541, DOI 10.1111/j.1466-8238.2010.00528.x; McDonald RI, 2011, BIOL CONSERV, V144, P383, DOI 10.1016/j.biocon.2010.09.016; McIntosh EJ, 2017, ANNU REV ENV RESOUR, V42, P677, DOI 10.1146/annurev-environ-102016-060902; Mellink E, 2009, REV BIOL TROP, V57, P1; Mills M, 2014, BIOL CONSERV, V169, P6, DOI 10.1016/j.biocon.2013.10.015; Molina-Venegas R, 2016, BIODIVERS CONSERV, V25, P1133, DOI 10.1007/s10531-016-1113-y; Morales Ricardo, 2016, Therya, V7, P215, DOI 10.12933/therya-16-329; Morrone JJ, 2019, REV MEX BIODIVERS, V90, DOI 10.22201/ib.20078706e.2019.90.2980; Morrone Juan J., 2005, Rev. Mex. Biodiv., V76, P207; Morrone JJ, 2017, ZOOTAXA, V4277, P277, DOI 10.11646/zootaxa.4277.2.8; NASA/METI/AIST/Japan Spacesystems and U.S./Japan ASTER Science Team, 2018, ASTER GLOBAL DIGITAL, DOI [10.5067/ASTER/ASTGTM.00367, DOI 10.5067/ASTER/ASTGTM.00367]; Navarro-Siguenza A.G., 2007, BIODIVERSIDAD FAJA V; Navarro-Sigüenza Adolfo G., 2014, Rev. Mex. Biodiv., V85, pS476, DOI 10.7550/rmb.41882; Ochoa-Ochoa LM, 2014, BIOL J LINN SOC, V111, P305, DOI 10.1111/bij.12201; Ochoa-Ochoa LM., 2006, AREAS DIVERSIDAD END; Olden JD, 2010, DIVERS DISTRIB, V16, P496, DOI 10.1111/j.1472-4642.2010.00655.x; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Padilla-Velarde Eloy, 2006, Rev. Mex. Biodiv., V77, P271; Parra-Olea G, 2005, HERPETOLOGICA, V61, P145, DOI 10.1655/03-02; Peterson A. Townsend, 2000, Cotinga, V14, P42; Prieto-Torres DA, 2016, GLOBAL CHANGE BIOL, V22, P364, DOI 10.1111/gcb.13090; Qian H, 2010, ECOLOGY, V91, P1172, DOI 10.1890/09-0620.1; R Team Development Core, 2020, R LANG ENV STAT COMP; Rice A, 2019, NAT ECOL EVOL, V3, P265, DOI 10.1038/s41559-018-0787-9; Richardson DM, 2010, DIVERS DISTRIB, V16, P313, DOI 10.1111/j.1472-4642.2010.00660.x; Rondinini C, 2011, PHILOS T R SOC B, V366, P2722, DOI 10.1098/rstb.2011.0112; Rondinini C, 2011, PHILOS T R SOC B, V366, P2591, DOI 10.1098/rstb.2011.0111; Rosindell J, 2011, TRENDS ECOL EVOL, V26, P340, DOI 10.1016/j.tree.2011.03.024; Ruiz A., 2009, LAGUNA CUYUTLAN VASO; Rzedowski J, VEGETACION MEXICO, V1ra, P540; Sarkar S, 2010, NAT CONSERVACAO, V8, P19, DOI 10.4322/natcon.00801003; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schnell GD, 2016, BIODIVERSIDAD COLIMA, pp467; SEMARNAT, 2010, NOM 059 SEMARNAT 201; SEMARNAT, 2001, CART VEG PRIM ESC 1; Shi H, 2005, CONSERV BIOL, V19, P1273, DOI 10.1111/j.1523-1739.2005.00225.x; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Silva-Batiz FA, 2009, SITIOS MANGLAR CON R; Soberon J, 2007, ECOGRAPHY, V30, P152, DOI 10.1111/j.2006.0906-7590.04627.x; Stoner KE, 2002, BIOTROPICA, V34, P462, DOI 10.1111/j.1744-7429.2002.tb00562.x; Sunny A, 2018, J GENET, V97, P1119, DOI 10.1007/s12041-018-1004-y; The IUCN Red List of Threatened Species, AB US; Tingley R, 2019, BIOL CONSERV, V238, DOI 10.1016/j.biocon.2019.108203; Trabucco A., 2009, GLOBAL ARIDITY INDEX; Uetz P., 2020, REPTILE DATABASE; USGS, HYDRO1K GLOB HYDR DA; Vega-Rivera JH, 2016, BIODIVERSIDAD COLIMA, P445; Villasenor JL, 2005, CONSERV BIOL, V19, P232, DOI 10.1111/j.1523-1739.2005.00264.x; Villers-Ruiz L, 1998, GLOBAL ENVIRON CHANG, V8, P141, DOI 10.1016/S0959-3780(98)00012-0; Whitton FJS, 2012, GLOBAL ECOL BIOGEOGR, V21, P179, DOI 10.1111/j.1466-8238.2011.00660.x; Yamaura Y, 2011, OIKOS, V120, P427, DOI 10.1111/j.1600-0706.2010.18764.x; Zarza E, 2019, PEERJ, V7, DOI 10.7717/peerj.6744	121	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2022	17	8							e0267589	10.1371/journal.pone.0267589	http://dx.doi.org/10.1371/journal.pone.0267589			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5A3IT	35930545	Green Published, gold			2022-12-26	WOS:000862784200006
J	Maar, K; Riisager-Simonsen, C; MacKenzie, BR; Skov, C; Aarestrup, K; Svendsen, JC				Maar, Kristian; Riisager-Simonsen, Christian; MacKenzie, Brian R.; Skov, Christian; Aarestrup, Kim; Svendsen, Jon C.			Economic expenditures by recreational anglers in a recovering atlantic bluefin tuna fishery	PLOS ONE			English	Article							THUNNUS-THYNNUS; MOVEMENTS; MORTALITY; COAST	The recent return of Atlantic bluefin tuna to northern Europe following the recovery of the east Atlantic stock has sparked substantial public and scientific interest. This is particularly true for recreational anglers in Denmark, who often consider Atlantic bluefin tuna to be the catch of a lifetime. This attitude has previously sustained a substantial recreational fishery for bluefin tuna with annual tournaments in Denmark, which peaked in the 1950s before the subsequent collapse of the stock during the 1960s. Several scientific tagging programs have recruited recreational anglers in recent years to help catch and release tagged bluefin tuna. The anglers' investment of time and money in the scientific tagging projects indicate that the recreational fishery could recover in the future. However, the economic aspects of a potential future recreational bluefin tuna fishery remain unknown. We surveyed anglers participating in a scientific catch and release bluefin tuna fishery in Denmark across three years (2018-2020) and calculated the total annual expenditures associated with the activities. Additionally, we estimated the magnitude of the negative impact (i.e., incidental mortalities) on the bluefin tuna stock. Our results show that total annual expenditures by the recreational anglers approached 1,439,540(sic), totaling 4,318,620(sic) between 2018 and 2020. We found that recreational bluefin tuna anglers had mean annual expenditures directly related to the bluefin tuna fishing between 7,047(sic) and 2,176(sic) with an associated mortality impact on the stock of less than 1 tonne annually. By comparing the mortality impact to the expenditures, we estimate that each dead Atlantic bluefin tuna during the three study years generated 398,163(sic) in mean annual expenditures, equivalent to approximately 1636(sic) kg(-1). Our study demonstrates significant economic expenditures among recreational anglers who target Atlantic bluefin tuna. This provides a clear example of how a recovery of marine natural capital and related ecosystem services can support development in the blue economy.	[Maar, Kristian] Tech Univ Denmark, Ctr Ocean Life, Natl Inst Aquat Resources, DTU Aqua, Lyngby, Denmark; [Riisager-Simonsen, Christian] Tech Univ Denmark, Natl Inst Aquat Resources, Sect Maritime Serv, DTU Aqua, Lyngby, Denmark; [MacKenzie, Brian R.] Tech Univ Denmark, Natl Inst Aquat Resources, Sect Oceans & Arctic, DTU Aqua, Lyngby, Denmark; [Skov, Christian; Aarestrup, Kim; Svendsen, Jon C.] Tech Univ Denmark, Natl Inst Aquat Resources, Sect Freshwater Fisheries Ecol, DTU Aqua, Silkeborg, Denmark; [Svendsen, Jon C.] Tech Univ Denmark, Natl Inst Aquat Resources DTU Aqua, Sect Coastal Ecol, Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark; Technical University of Denmark; Technical University of Denmark; Technical University of Denmark	Maar, K (corresponding author), Tech Univ Denmark, Ctr Ocean Life, Natl Inst Aquat Resources, DTU Aqua, Lyngby, Denmark.	krmaa@aqua.dtu.dk	MacKenzie, Brian R./T-9379-2019; Skov, Christian/X-6511-2019; Aarestrup, Kim/AAK-9155-2021; Svendsen, Jon Christian/J-2716-2013	MacKenzie, Brian R./0000-0002-4798-0363; Skov, Christian/0000-0002-8547-6520; Aarestrup, Kim/0000-0001-8521-6270; Maar, Kristian/0000-0001-6329-7962; Svendsen, Jon Christian/0000-0002-0273-0985	EU interreg project MarGen II; Nordic Council of Ministers [141-2016, 180-2018]; European Maritime and Fisheries Fund; Hempel Foundation	EU interreg project MarGen II; Nordic Council of Ministers; European Maritime and Fisheries Fund; Hempel Foundation	Funding was provided by the EU interreg project MarGen II, Danish rod and net license funds, the Nordic Council of Ministers (project nos. 141-2016-Tuna; 180-2018-Tuna tagging), European Maritime and Fisheries Fund, and the Hempel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup K., 2021, RETURN KING 1 UNPUB; Armstrong M., 2013, SEA ANGLING 2012 SUR; Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; Bohnsack BL, 2002, N AM J FISH MANAGE, V22, P165, DOI 10.1577/1548-8675(2002)022&lt;0165:TEIOTR&gt;2.0.CO;2; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Cort JL, 2015, REV FISH SCI AQUAC, V23, P346, DOI 10.1080/23308249.2015.1079166; COWI, 2010, FOD AN ADF MOT PRAEF; European Commission, 2021, COM2021240 EUR COMM; European Commission, 2019, COMMISSION STAFF WOR; European Commission,, COM2020380FINAL; Ezzy E, 2012, ECON PAP, V31, P150, DOI 10.1111/j.1759-3441.2012.00174.x; FAO,, 2016, FAO FISHERIES AQUACU; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Goldsmith WM, 2018, N AM J FISH MANAGE, V38, P680, DOI 10.1002/nafm.10064; Haines-Young R, 2018, COMMON INT CLASSIFIC; Havorred Fyn, 2012, OK VAERD HAV REKR FI, P1; Hilger J., 2020, NMFSFSPO201 NOAA US; ICCAT, 2018, BFT 18 02 REC ICCAT, P1; ICCAT, 2006, 0605 ICCAT; ICCAT (International Commission for the Conservation of Atlantic Tunas), 2017, REP 2017 ICCAT BLUEF; Lopes P., 2017, ONE ECOSYSTEM, V2, DOI [10.3897/ oneeco.2.e12290, DOI 10.3897/ONEECO.2.E12290]; Lund HS, 2020, FISKERITIDENDE; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; MacKenzie BR., 2017, IMPROVED MANAGEMENT, P1; MacKenzie BR, 2007, FISH RES, V87, P229, DOI 10.1016/j.fishres.2007.01.013; MacKenzie Brian R., 2009, Conservation Letters, V2, P26, DOI 10.1111/j.1755-263X.2008.00039.x; Marcek BJ, 2014, COLL VOL SCI PAP ICC, V70, P654; MATHER FJ, 1974, FISH B-NOAA, V72, P900; McKinney R., 2020, NETTING BILLIONS 202; Morales-Nin B, 2015, FISH RES, V164, P45, DOI 10.1016/j.fishres.2014.10.010; Pawson MG, 2008, MAR POLICY, V32, P339, DOI 10.1016/j.marpol.2007.07.001; Prince Edwards island fishermen's association, 2019, 2019 BLUEF TUN CONS, P1; Rees EMA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178805; Roberts A, 2017, MAR POLICY, V83, P146, DOI 10.1016/j.marpol.2017.05.028; Rodriguez-Marin E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141478; Schleit K., 2015, REELING REVENUE; Skomal GB, 2002, AM FISH S S, V30, P57; Stokesbury MJW, 2007, HYDROBIOLOGIA, V582, P91, DOI 10.1007/s10750-006-0552-y; Stokesbury MJW, 2011, BIOL CONSERV, V144, P2684, DOI 10.1016/j.biocon.2011.07.029; Stokesbury MJW, 2004, CAN J FISH AQUAT SCI, V61, P1976, DOI 10.1139/F04-130; Sun CH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221147; Sutton S.G., 2001, HUM DIMENS WILDL, V6, P49, DOI [10.1080/10871200152668698, DOI 10.1080/10871200152668698]; The International Union for Conservation of Nature Red List of Threatened Species (IUCN), 2021, US; Williams C, 2020, MAR POLICY, V119, DOI 10.1016/j.marpol.2020.104066; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0	46	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271823	10.1371/journal.pone.0271823	http://dx.doi.org/10.1371/journal.pone.0271823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925974	gold, Green Published			2022-12-26	WOS:000848077100054
J	Marahwa, P; Makota, P; Chikomo, DT; Chakanyuka, T; Ruvai, T; Osafo, KS; Huang, TW; Chen, LM				Marahwa, Pamela; Makota, Panashe; Chikomo, Donald Tafadzwa; Chakanyuka, Tawanda; Ruvai, Tsitsi; Osafo, Kelvin Stefan; Huang, Tianwen; Chen, Limin			The psychological impact of COVID-19 on university students in China and Africa	PLOS ONE			English	Article							MENTAL-HEALTH; TRANSMISSION; DIAGNOSIS; DISORDER	The COVID-19 pandemic is alarmingly a global health catastrophe that has created an unprecedented mental health decline especially in young adults, who have been noted to be a vulnerable population. In this study, we investigated the prevalence of depression and anxiety in university students in China and Africa during the COVID-19 pandemic, the significant factors contributing to the prevalence of anxiety and depression, the differences in factors affecting the different groups being investigated and to emphasize that psychological intervention are as important as the physical interventions during and after the pandemic. The study was conducted through online surveys, with 684 participants using Patient Health Questionnaire-9 and Generalized Anxiety Disorder-7 standardized scales. Comparing all groups combined, of the 636 participants, 361 (56.8%) had depression and 227 (35.7%) had anxiety. Chi squared tests at significance level (P<0.05) showed that country of citizenship, religion, parents' educational background, household monthly income and, having family members with COVID-19 variables were strongly associated with depression and anxiety. In contrast, age, gender, educational background, and major showed no significant association. Comparing the individual groups separately using chi square (P<0.05), the Chinese students in China group had 35.6% with depression and 13.1% with anxiety. The variable associated with both depression and anxiety was education major, with depression only was parent's educational background and with anxiety only was gender. The African students in China group had 70.3% with depression and 45.0% with anxiety. Gender was strongly associated with both depression and anxiety, and religion and having family members with COVID-19 with anxiety only. Africans in Africa had 66.0% with depression and 50.5% with anxiety. Educational background was strongly associated with depression. There was no statistically significant variable for anxiety. Chi square test showed a statistically significant difference in depression and anxiety levels with the Chinese group compared to both African groups, and no significant difference between both African groups. Our findings demonstrated that COVID-19 had a negative psychological impact on university students. Therefore, more attention should be put on youth's mental health during this pandemic.	[Marahwa, Pamela; Chen, Limin] Fujian Med Univ Union Hosp, Dept Resp Med, Fuzhou, Fujian, Peoples R China; [Makota, Panashe; Chakanyuka, Tawanda] Fujian Med Univ, Fujian Prov Hosp, Fuzhou, Fujian, Peoples R China; [Chikomo, Donald Tafadzwa; Osafo, Kelvin Stefan] Fujian Med Univ, Union Hosp, Fuzhou, Fujian, Peoples R China; [Ruvai, Tsitsi] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China; [Huang, Tianwen] Fujian Med Univ, Dept Neurol, Union Hosp, Fuzhou, Fujian, Peoples R China; [Huang, Tianwen] Fujian Med Univ, Fujian Key Lab Vasc Aging, Fuzhou, Fujian, Peoples R China	Fujian Medical University; Fujian Provincial Hospital; Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Medical University	Chen, LM (corresponding author), Fujian Med Univ Union Hosp, Dept Resp Med, Fuzhou, Fujian, Peoples R China.; Huang, TW (corresponding author), Fujian Med Univ, Dept Neurol, Union Hosp, Fuzhou, Fujian, Peoples R China.; Huang, TW (corresponding author), Fujian Med Univ, Fujian Key Lab Vasc Aging, Fuzhou, Fujian, Peoples R China.	huangtianwen2002@163.com; 13599438522@163.com						Acharya B, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0262958; Ahmed MZ, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102092; Aloui-Zarrouk Z., 2020, AAS OPEN RES, V3, P36, DOI [10.12688/aasopenres.13079.1, DOI 10.12688/AASOPENRES.13079.1]; [Anonymous], 2020, LANCET, V395, P1168, DOI 10.1016/S0140-6736(20)30823-0; [Anonymous], COVID 19 PANDEMIC DA; [Anonymous], NAM COR DIS COVID 19; [Anonymous], COVID 19 DISR MENT H; [Anonymous], AFRICA COVID 19 LOCK; Baldessarini RJ, 2017, J AFFECT DISORDERS, V210, P19, DOI 10.1016/j.jad.2016.12.003; Bilgi K, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.637946; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Browning MHEM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245327; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Conklin AI, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019982; Dein S, 2020, MENT HEALTH RELIG CU, V23, P1, DOI 10.1080/13674676.2020.1768725; DOOLEY D, 1984, AM J COMMUN PSYCHOL, V12, P387, DOI 10.1007/BF00896502; Eid RS, 2019, PROG NEUROBIOL, V176, P86, DOI 10.1016/j.pneurobio.2019.01.006; El-Sadr WM, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2008193; Elebesunu EE, 2021, INT J HEALTH PLAN M, V36, P2035, DOI 10.1002/hpm.3296; Fu WN, 2021, J AFFECT DISORDERS, V280, P7, DOI 10.1016/j.jad.2020.11.032; Gao WJ, 2020, J AFFECT DISORDERS, V263, P292, DOI 10.1016/j.jad.2019.11.121; Gelaye B, 2013, PSYCHIAT RES, V210, P653, DOI 10.1016/j.psychres.2013.07.015; Goel N, 2014, COMPR PHYSIOL, V4, P1121, DOI 10.1002/cphy.c130054; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0; Harkness KL, 2010, J ABNORM PSYCHOL, V119, P791, DOI 10.1037/a0020629; Haug N, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-01009-0; Heinisch O., 1963, PREIS S BIOM J, V1965, P203, DOI [10.1002/bimj.19650070312, DOI 10.1002/BIMJ.19650070312]; Kowalczyk O, 2020, J RELIG HEALTH, V59, P2671, DOI 10.1007/s10943-020-01088-3; Li HY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113933; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Li XG, 2020, J MED VIROL, V92, P448, DOI 10.1002/jmv.25693; Mak IWC, 2009, GEN HOSP PSYCHIAT, V31, P318, DOI 10.1016/j.genhosppsych.2009.03.001; Mohammadi F, 2021, BMC FAM PRACT, V22, DOI 10.1186/s12875-021-01442-8; Nguyen HT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114164; Nguyen HC, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040965; Nurunnabi Mohammad, 2020, F1000Res, V9, P1115, DOI 10.12688/f1000research.25557.1; Ogunleye OO, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01205; Oleribe OO, 2019, INT J GEN MED, V12, P395, DOI 10.2147/IJGM.S223882; Phelps AC, 2009, JAMA-J AM MED ASSOC, V301, P1140, DOI 10.1001/jama.2009.341; Rabadan R., 2020, UNDERSTANDING CORONA; Rathore FA, 2020, J PAK MED ASSOC, V70, pS162, DOI 10.5455/JPMA.38; Reagu S, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045794; Ren ZY, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.641806; Serafini G, 2020, QJM-INT J MED, V113, P529, DOI 10.1093/qjmed/hcaa201; Solano P, 2016, PSYCHIAT RES, V246, P581, DOI 10.1016/j.psychres.2016.10.030; Song BJ, 2021, J EPIDEMIOL GLOB HEA, V11, P117, DOI 10.2991/jegh.k.201016.001; Song MK, 2020, WORLD DEV, V136, DOI 10.1016/j.worlddev.2020.105107; Tiirikainen K, 2019, PSYCHIAT RES, V272, P30, DOI 10.1016/j.psychres.2018.12.004; Twenge JM, 2019, J ABNORM PSYCHOL, V128, P185, DOI 10.1037/abn0000410; Tzeng NS, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-01021-y; Unfpa.Org, US; Vigod SN, 2020, ECLINICALMEDICINE, V20, DOI 10.1016/j.eclinm.2020.100311; Wang XM, 2020, J MED INTERNET RES, V22, DOI 10.2196/22817; Wang YN, 2021, PSYCHOL HEALTH MED, V26, P13, DOI 10.1080/13548506.2020.1746817; who.int, US; Xie L, 2020, INT J PUBLIC HEALTH, V65, P1445, DOI 10.1007/s00038-020-01475-3; Xiong P, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.603331; Xu T, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18189758	59	1	1	22	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0270824	10.1371/journal.pone.0270824	http://dx.doi.org/10.1371/journal.pone.0270824			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925915	gold, Green Published			2022-12-26	WOS:000848077100024
J	Cicerale, A; Blanzieri, E; Sacco, K				Cicerale, Alessandro; Blanzieri, Enrico; Sacco, Katiuscia			How does decision-making change during challenging times?	PLOS ONE			English	Article							INDIVIDUAL RISK ATTITUDES; PROSPECT-THEORY; FIELD EXPERIMENT; PREFERENCES; BEHAVIOR; AVERSION	Prospect Theory, proposed and developed by Kahneman and Tversky, demonstrated that people do not make rational decisions based on expected utility, but are instead biased by specific cognitive tendencies leading to neglect, under- or over- consider information, depending on the context of presentation. In this vein, the present paper focuses on whether and how individual decision-making attitudes are prone to change in the presence of globally challenging events. We ran three partial replications of the Kahneman and Tversky (1979) paper, focusing on a set of eight prospects, after a terror attack (Paris, November 2015, 134 subjects) and during the Covid-19 pandemic, both during the first lockdown in Italy (Spring 2020, 176 subjects) and after the first reopening (140 subjects). The results confirm patterns of choice characterizing uncertain times, as shown by previous literature. In particular, we note significant increase of risk aversion, both in the gain and in the loss domains, that consistently emerged in the three replications. Given the nature of our sample, and the heterogeneity between the three periods investigated, we suggest that the phenomenon we present can be explained stress-related effects on decision making rather than by other economic effects, such as the income effect.	[Cicerale, Alessandro; Sacco, Katiuscia] Univ Turin, BraIn Plast & Behav Changes, Dept Psychol, Turin, Italy; [Cicerale, Alessandro; Sacco, Katiuscia] Univ Turin, Neurosci Inst, Turin, Italy; [Blanzieri, Enrico] Univ Trento, Dept Engn & Informat Sci, Trento, Italy	University of Turin; University of Turin; University of Trento	Sacco, K (corresponding author), Univ Turin, BraIn Plast & Behav Changes, Dept Psychol, Turin, Italy.; Sacco, K (corresponding author), Univ Turin, Neurosci Inst, Turin, Italy.	katiuscia.sacco@unito.it			Regione Piemonte, European Structural and Investment Funds	Regione Piemonte, European Structural and Investment Funds(Regione Piemonte)	KS has benefited from research funding provided by Regione Piemonte, European Structural and Investment Funds 2014-2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allais M, 1953, ECONOMETRICA, V21, P503, DOI 10.2307/1907921; Angrisani M, 2020, SSRN SCHOLARLY PAPER, DOI [10.2139/ssrn.3609586, DOI 10.2139/SSRN.3609586]; Barberis N, 2016, REV FINANC STUD, V29, P3068, DOI 10.1093/rfs/hhw049; Barberis NC, 2013, J ECON PERSPECT, V27, P173, DOI 10.1257/jep.27.1.173; Beine M., 2020, SHAKING THINGS STABI; Belle N, 2018, PUBLIC ADMIN REV, V78, P828, DOI 10.1111/puar.12960; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BROWN R, 1977, COGNITION, V5, P73, DOI 10.1016/0010-0277(77)90018-X; Bu D, 2020, 3559870 SSRN, DOI [10.2139/ssrn.3559870, DOI 10.2139/SSRN.3559870]; Cameron L, 2015, J HUM RESOUR, V50, P484, DOI 10.3368/jhr.50.2.484; Carleton RN, 2016, J ANXIETY DISORD, V39, P30, DOI 10.1016/j.janxdis.2016.02.007; Cassar A, 2017, WORLD DEV, V94, P90, DOI 10.1016/j.worlddev.2016.12.042; Charpentier CJ, 2017, BIOL PSYCHIAT, V81, P1014, DOI 10.1016/j.biopsych.2016.12.010; Chuang YT, 2015, J DEV ECON, V117, P151, DOI 10.1016/j.jdeveco.2015.07.008; Davis JB, 1998, HDB EC METHODOLOGY; De Bortoli D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214062; Donkers B, 2001, J RISK UNCERTAINTY, V22, P165, DOI 10.1023/A:1011109625844; Drichoutis AC, 2020, STABILITY RISK TIME; Eckel CC, 2009, J ECON BEHAV ORGAN, V69, P110, DOI 10.1016/j.jebo.2007.08.012; Farashahi S, 2019, NAT HUM BEHAV, V3, P1215, DOI 10.1038/s41562-019-0714-3; Ferrari-Toniolo S, 2019, J NEUROSCI, V39, P2915, DOI 10.1523/JNEUROSCI.1454-18.2018; Filbeck G., 2005, J BEHAV FINANC, V6, P170, DOI [10.1207/s15427579jpfm0604_1, DOI 10.1207/S15427579JPFM0604_1]; Gigerenzer G, 2004, PSYCHOL SCI, V15, P286, DOI 10.1111/j.0956-7976.2004.00668.x; Guido G, 2015, PERS INDIV DIFFER, V76, P135, DOI 10.1016/j.paid.2014.11.053; Guiso L, 2018, J FINANC ECON, V128, P403, DOI 10.1016/j.jfineco.2018.02.007; HOLM S, 1979, SCAND J STAT, V6, P65; Ikeda S, 2020, 1106 ISER OS U; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kandasamy N, 2014, P NATL ACAD SCI USA, V111, P3608, DOI 10.1073/pnas.1317908111; Kellen D, 2020, BEHAVIOURAL SOCIAL S; Li JZ, 2011, APPL COGNITIVE PSYCH, V25, P104, DOI 10.1002/acp.1648; Lohmann P, 2020, SOCIAL PREFERENCES E, DOI [10.2139/ssrn.3705264, DOI 10.2139/SSRN.3705264]; Lonnqvist JE, 2015, J ECON BEHAV ORGAN, V119, P254, DOI 10.1016/j.jebo.2015.08.003; Oehler A, 2018, J BEHAV FINANC, V19, P30, DOI 10.1080/15427560.2017.1366495; Page L, 2014, EUR ECON REV, V71, P121, DOI 10.1016/j.euroecorev.2014.04.009; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Reynaud A, 2020, GENEVA RISK INS REV, V45, P36, DOI 10.1057/s10713-019-00044-w; Rieger MO, 2017, THEOR DECIS, V82, P567, DOI 10.1007/s11238-016-9582-8; Ruggeri K, 2020, NAT HUM BEHAV, V4, P622, DOI 10.1038/s41562-020-0886-x; Sacco K, 2003, APPL COGNITIVE PSYCH, V17, P1113, DOI 10.1002/acp.989; Shachat J, 2020, IMPACT COVID 19 PAND; Sharot T, 2007, P NATL ACAD SCI USA, V104, P389, DOI 10.1073/pnas.0609230103; Soane E, 2005, PERS INDIV DIFFER, V38, P1781, DOI 10.1016/j.paid.2004.10.005; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Voors MJ, 2012, AM ECON REV, V102, P941, DOI 10.1257/aer.102.2.941; Wang Y, 2020, FRONT ECON CHINA, V15, P575, DOI 10.3868/s060-011-020-0024-4	46	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2022	17	7							e0270117	10.1371/journal.pone.0270117	http://dx.doi.org/10.1371/journal.pone.0270117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Q0KX	35905131	gold, Green Published			2022-12-26	WOS:000855776900017
J	Castilla-Casadiego, DA; Miranda-Munoz, KA; Roberts, JL; Crowell, AD; Gonzalez-Nino, D; Choudhury, D; Aparicio-Solis, FO; Servoss, SL; Rosales, AM; Prinz, G; Zou, M; Zhang, YT; Coetzee, JF; Greenlee, LF; Powell, J; Almodovar, J				Castilla-Casadiego, David A.; Miranda-Munoz, Katherine A.; Roberts, Jesse L.; Crowell, Anne D.; Gonzalez-Nino, David; Choudhury, Dipankar; Aparicio-Solis, Frank O.; Servoss, Shannon L.; Rosales, Adrianne M.; Prinz, Gary; Zou, Min; Zhang, Yuntao; Coetzee, Johann F.; Greenlee, Lauren F.; Powell, Jeremy; Almodovar, Jorge			Biodegradable microneedle patch for delivery of meloxicam for managing pain in cattle	PLOS ONE			English	Article							DRUG; MANAGEMENT; CHITOSAN; PHARMACOKINETICS; PRACTITIONERS; DEGRADATION; ATTITUDES; FLUNIXIN; CHITIN; CALVES	Microneedle patches are a promising source for transdermal diffusion of macromolecules and are designed to painlessly penetrate the skin. In this study, a biodegradable chitosan microneedle patch to deliver meloxicam for managing pain in cattle was tested. The potential of reuse of the polymeric solution to fabricate the patches, optimization of fabrication, morphological analysis of the microneedle patch and analysis of preservation of the chemical composition after sterilization were evaluated. In-vitro analysis consisted of studying in-vitro penetration mechanical properties, compression testing analysis of microneedle patch, and in-vitro drug release analysis. In-vivo studies were performed to analyze the dissolution capability of the microneedle patch. Results regarding the physical characteristics, chemical composition, and mechanical properties confirmed that rheological properties of the chitosan solution, present significant differences over time, demonstrating that reusing the solution on the fourth day results in failure patches. Morphological characteristics and chemical composition studies revealed that the process of sterilization (ethylene oxide gas) needed for implanting the patches into the skin did not affect the properties of microneedle patches. In-vitro studies showed that approximately 33.02 +/- 3.88% of the meloxicam was released over 7 days. A full penetration of the microneedles into the skin can be obtained by applying approximately 3.2 N. In-vivo studies demonstrated that microneedle patches were capable of swelling and dissolving, exhibiting a dissolution percentage of more than 50% of the original height of microneedle after 7 days. No abnormal tissue, swelling, or inflammation was observed in the implanted area. The results of this work show that chitosan biodegradable microneedle patches may be useful to deliver meloxicam to improve pain management of cattle with positive effects for commercial manufacturing.	[Castilla-Casadiego, David A.; Roberts, Jesse L.; Aparicio-Solis, Frank O.; Servoss, Shannon L.; Greenlee, Lauren F.; Almodovar, Jorge] Univ Arkansas, Bell Engn Ctr 3202, Ralph E Martin Dept Chem Engn, Fayetteville, AR 72701 USA; [Castilla-Casadiego, David A.; Crowell, Anne D.; Rosales, Adrianne M.] Univ Texas Austin, Mcketta Dept Chem Engn, Austin, TX USA; [Miranda-Munoz, Katherine A.] Univ Arkansas, Coll Engn, Dept Biomed Engn, Fayetteville, AR USA; [Gonzalez-Nino, David; Prinz, Gary] Univ Arkansas, Bell Engn Ctr 4190, Dept Civil Engn, Fayetteville, AR USA; [Choudhury, Dipankar; Zou, Min] Univ Arkansas, Dept Mech Engn, 204 Mech Engn Bldg, Fayetteville, AR USA; [Zhang, Yuntao; Coetzee, Johann F.] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, 228 Coles Hall, Manhattan, KS USA; [Powell, Jeremy] Univ Arkansas, Dept Anim Sci, B110 Agr Food & Life Sci Bldg, Fayetteville, AR USA	University of Arkansas System; University of Arkansas Fayetteville; University of Texas System; University of Texas Austin; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville; Kansas State University; University of Arkansas System; University of Arkansas Fayetteville	Almodovar, J (corresponding author), Univ Arkansas, Bell Engn Ctr 3202, Ralph E Martin Dept Chem Engn, Fayetteville, AR 72701 USA.	jlalmodo@uark.edu		Gonzalez-Nino, David/0000-0001-5787-6888; Zou, Min/0000-0003-0647-0890; Prinz, Gary/0000-0003-2579-3214	US Department of Agriculture [2021-67015-35675]; Chancellor's Fund for Innovation and Collaboration from the University of Arkansas	US Department of Agriculture(United States Department of Agriculture (USDA)); Chancellor's Fund for Innovation and Collaboration from the University of Arkansas	The authors thank Dr. Jamie A. Hestekin from the University of Arkansas for FTIR equipment access.	Adcock SJJ, 2020, J DAIRY SCI, V103, P8518, DOI 10.3168/jds.2020-18337; American Veterinary Medical Association, 2021, WELF IMPL CASTR CATT; Amodwala S, 2017, EUR J PHARM SCI, V104, P114, DOI 10.1016/j.ejps.2017.04.001; Anderson DE, 2013, VET CLIN N AM-FOOD A, V29, P157, DOI 10.1016/j.cvfa.2012.11.006; [Anonymous], 2020, FARM ANIMAL CARE MAN; Association A. A. P, 2020, PUBCHEM COMP SUMM CI; Averineni RK, 2012, B MATER SCI, V35, P319, DOI 10.1007/s12034-012-0313-7; Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8; Caldeira MO, 2019, J DAIRY SCI, V102, P10277, DOI 10.3168/jds.2019-16630; Castilla-Casadiego DA, 2021, MAT SCI ENG C-MATER, V118, DOI 10.1016/j.msec.2020.111544; Chen MC, 2012, BIOMACROMOLECULES, V13, P4022, DOI 10.1021/bm301293d; Coetzee JF, 2017, VET CLIN N AM-FOOD A, V33, P389, DOI 10.1016/j.cvfa.2017.02.009; Dawkins MS, 2008, ETHOLOGY, V114, P937, DOI 10.1111/j.1439-0310.2008.01557.x; Fajt VR, 2011, JAVMA-J AM VET MED A, V238, P755, DOI 10.2460/javma.238.6.755; Fedoseeva EN, 2006, POLYM SCI SER B+, V48, P295, DOI 10.1134/S156009040609017X; Fraccaro E, 2013, RES VET SCI, V95, P204, DOI 10.1016/j.rvsc.2013.01.018; Gleerup KB, 2015, APPL ANIM BEHAV SCI, V171, P25, DOI 10.1016/j.applanim.2015.08.023; Huxley JN, 2006, VET REC, V159, P662, DOI 10.1136/vr.159.20.662; Ita K, 2017, BIOMED PHARMACOTHER, V93, P1116, DOI 10.1016/j.biopha.2017.07.019; Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004; Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005; Kleinhenz MD, 2017, J ANIM SCI, V95, P1993, DOI 10.2527/jas.2016.1138; Kleinhenz MD, 2021, APPL ANIM SCI, V37, P77, DOI 10.15232/aas.2020-02106; Kurita K, 2000, CARBOHYD POLYM, V42, P19, DOI 10.1016/S0144-8617(99)00127-7; Lee IC, 2015, J MATER CHEM B, V3, P276, DOI 10.1039/c4tb01555j; Lundmark F, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8010004; Millman ST, 2013, VET CLIN N AM-FOOD A, V29, P47, DOI 10.1016/j.cvfa.2012.11.007; Reppert EJ, 2019, J VET PHARMACOL THER, V42, P309, DOI 10.1111/jvp.12756; Saleem MA, 2010, INDIAN J PHARM SCI, V72, P710, DOI 10.4103/0250-474X.84579; Shock D, 2019, VET SCI, V6, DOI 10.3390/vetsci6030073; Sikorski D, 2021, MAR DRUGS, V19, DOI 10.3390/md19050236; Szymanska E, 2015, MAR DRUGS, V13, P1819, DOI 10.3390/md13041819; van der Maaden K, 2012, J CONTROL RELEASE, V161, P645, DOI 10.1016/j.jconrel.2012.01.042; Varum KM, 2001, CARBOHYD POLYM, V46, P89, DOI 10.1016/S0144-8617(00)00288-5; Vivancos M, 2015, CAN VET J, V56, P730; Waghule T, 2019, BIOMED PHARMACOTHER, V109, P1249, DOI 10.1016/j.biopha.2018.10.078; Wang XQ, 2016, POLYMERS-BASEL, V8, DOI 10.3390/polym8090338; Wright TL, 2017, J AM ASSOC LAB ANIM, V56, P539; Ye YQ, 2018, ADV DRUG DELIVER REV, V127, P106, DOI 10.1016/j.addr.2018.01.015; Zheng ML, 2011, CARBOHYD POLYM, V86, P231, DOI 10.1016/j.carbpol.2011.04.038	40	0	0	8	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272169	http://dx.doi.org/10.1371/journal.pone.0272169			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917312	Green Published, gold			2022-12-26	WOS:000837840000030
J	Fekadu, G; Yao, JQ; You, JHS				Fekadu, Ginenus; Yao, Jiaqi; You, Joyce H. S.			Bedaquiline-based treatment for extensively drug-resistant tuberculosis in South Africa: A cost-effectiveness analysis	PLOS ONE			English	Article							TREATMENT OUTCOMES; BURDEN; DISEASE	BackgroundThe treatment success rate of conventional anti-tuberculosis (TB) regimens for extensively drug-resistant TB (XDR-TB) is low, resulting in high morbidity and healthcare cost especially in the high TB burden countries. Recent clinical findings reported improved treatment outcomes of XDR-TB with the bedaquiline (BDQ)-based regimens. We aimed to evaluate the cost-effectiveness of BDQ-based treatment for XDR-TB from the perspective of the South Africa national healthcare provider. MethodsA 2-year decision-analytic model was designed to evaluate the clinical and economic outcomes of a hypothetical cohort of adult XDR-TB patients with (1) BDQ-based regimen and (2) injectable-based conventional regimen. The model inputs were retrieved from literature and public data. Base-case analysis and sensitivity analysis were performed. The primary model outputs included TB-related direct medical cost and disability-adjusted life years (DALYs). ResultsIn the base-case analysis, the BDQ group reduced 4.4152 DALYs with an incremental cost of USD1,606 when compared to the conventional group. The incremental cost per DALY averted (ICER) by the BDQ group was 364 USD/DALY averted. No influential factor was identified in the sensitivity analysis. In probabilistic sensitivity analysis, the BDQ group was accepted as cost-effective in 97.82% of the 10,000 simulations at a willingness-to-pay threshold of 5,656 USD/DALY averted (1x gross domestic product per capita in South Africa). ConclusionThe BDQ-based therapy appeared to be cost-effective and showed a high probability to be accepted as the preferred cost-effective option for active XDR-TB treatment.	[Fekadu, Ginenus; Yao, Jiaqi; You, Joyce H. S.] Chinese Univ Hong Kong, Fac Med, Sch Pharm, Hong Kong, Peoples R China	Chinese University of Hong Kong	You, JHS (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Pharm, Hong Kong, Peoples R China.	joyceyou@cuhk.edu.hk	You, Joyce H. S./C-2984-2008	You, Joyce H. S./0000-0002-5763-7403; Fekadu, Ginenus/0000-0002-4926-0685				Agnarson AM, 2020, EXPERT REV ANTI-INFE, V18, P475, DOI 10.1080/14787210.2020.1742109; Conradie F, 2020, NEW ENGL J MED, V382, P893, DOI 10.1056/NEJMoa1901814; Department of Health, 2019, MULT RES TB POL FRAM; Department of Health, 2013, MAN DRUG RES TUB POL; Department of Health South Africa, 2021, UN PAT FEE SCHED DEP; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Dick AW, 2015, AM J INFECT CONTROL, V43, P4, DOI 10.1016/j.ajic.2014.07.014; Drenth C, 2018, J PAIN SYMPTOM MANAG, V55, pS170, DOI 10.1016/j.jpainsymman.2017.04.024; Fan QQ, 2019, INT J INFECT DIS, V78, P44, DOI 10.1016/j.ijid.2018.10.007; Fekadu G, 2021, EXPERT REV PHARM OUT, V21, P897, DOI 10.1080/14737167.2021.1925111; Food Drug Administration, 2012, ANT DRUGS ADV COMM M; Gao JT, 2021, INFECT DIS POVERTY, V10, DOI 10.1186/s40249-021-00819-2; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Jordan RI, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01829-x; Kim JH, 2020, RESPIR INVESTIG, V58, P45, DOI 10.1016/j.resinv.2019.08.004; Kittikraisak W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029775; Kvasnovsky CL, 2016, EMERG INFECT DIS, V22, P1529, DOI 10.32301/eid2209.160084; Lu XY, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-016-1931-3; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Mutangadura GB, 2004, AGR ECON-BLACKWELL, V30, P170, DOI 10.1016/j.agecon.2003.11.006; National Department of Health, 2018, INT CLIN GUID IMPL I; Ndjeka N, 2015, INT J TUBERC LUNG D, V19, P979, DOI 10.5588/ijtld.14.0944; Nkurunziza J, 2018, INT J TUBERC LUNG D, V22, P1469, DOI 10.5588/ijtld.18.0205; Olayanju O, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00544-2018; Pooran A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054587; Pym AS, 2016, EUR RESPIR J, V47, P564, DOI 10.1183/13993003.00724-2015; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; Schnippel K, 2018, INT J TUBERC LUNG D, V22, P918, DOI 10.5588/ijtld.17.0869; Schnippel K, 2018, INT J TUBERC LUNG D, V22, P393, DOI 10.5588/ijtld.17.0661; Schnippel K, 2018, APPL HEALTH ECON HEA, V16, P43, DOI 10.1007/s40258-017-0352-8; Shean K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063057; Statistics South Africa, 2022, STAT REL P0141 CONS; Stop TB Partnership (Global Drug Facility), 2022, MED CAT; United Nations, 2020, DEC EC REST; Vasilyeva I, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02208-2018; World Bank, GDP CAP CURR US; World Health Organization, 2019, GLOB HLTH OBS DAT RE; World Health Organization, 2021, GLOBAL TUBERCULOSIS; Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8							e0272770	10.1371/journal.pone.0272770	http://dx.doi.org/10.1371/journal.pone.0272770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P8ZE	35930574	gold, Green Published			2022-12-26	WOS:000837822100007
J	Karr, A; Hauzel, J; Porter, A; Schaefer, M				Karr, Alan; Hauzel, Jason; Porter, Adam; Schaefer, Marcel			Measuring quality of DNA sequence data via degradation	PLOS ONE			English	Article								We formulate and apply a novel paradigm for characterization of genome data quality, which quantifies the effects of intentional degradation of quality. The rationale is that the higher the initial quality, the more fragile the genome and the greater the effects of degradation. We demonstrate that this phenomenon is ubiquitous, and that quantified measures of degradation can be used for multiple purposes, illustrated by outlier detection. We focus on identifying outliers that may be problematic with respect to data quality, but might also be true anomalies or even attempts to subvert the database.	[Karr, Alan; Hauzel, Jason; Porter, Adam; Schaefer, Marcel] Fraunhofer USA Ctr Midatlantic, Riverdale, MD 20737 USA; [Porter, Adam] Univ Maryland, Dept Comp Sci, College Pk, MD USA; [Hauzel, Jason] Capital One, Washington, DC USA	University System of Maryland; University of Maryland College Park	Karr, A (corresponding author), Fraunhofer USA Ctr Midatlantic, Riverdale, MD 20737 USA.	akarr@fraunhofer.org			National Institutes of Health [5R01AI100947--06]; University of Maryland College Park	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland College Park	All authors were supported by National Institutes of Health grant 5R01AI100947--06, "Algorithms and Software for the Assembly of Metagenomic Data," to the University of Maryland College Park (Mihai Pop, PI), via a subaward to Fraunhofer USA. The sponsor URL is www.nih.gov. The sponsor played no role in the research, decision to publish, or preparation of the manuscript.	Biggio B, 2018, PATTERN RECOGN, V84, P317, DOI 10.1016/j.patcog.2018.07.023; Commichaux S, 2021, BIOINFORMATICS, V37, P2848, DOI 10.1093/bioinformatics/btab216; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; Farbiash D, 2020, CYBERBIOSECURITY DNA; Holtgrewe M., 2010, TRB1006 FREE U BERL; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Karr AF., BMC BIOINFORMATICS; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P115, DOI 10.1007/BF02289694; Langdon WB, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Navarro G, 2001, ACM COMPUT SURV, V33, P31, DOI 10.1145/375360.375365; Nikulin M. S., 2001, ENCY MATH, V78; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; R Core Team, 2020, R LANG ENV STAT COMP; Steinegger M, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02023-1; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Valdivia-Granda WA., 2019, DEFENSE BIOLOGICAL A, P317; Wang ZY, 2020, BRIEF BIOINFORM, V21, P777, DOI 10.1093/bib/bbz025	19	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271970	http://dx.doi.org/10.1371/journal.pone.0271970			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921272	Green Submitted, gold, Green Published			2022-12-26	WOS:000839311900082
J	Mehta, CC; Hagen, KS; Rubtsova, AA; Lahiri, CD; Michopoulos, V; Moran, CA; Haddad, LB; Titanji, K; Collins, LF; Quyyumi, AA; Neigh, G; Shaw, LJ; Weitzmann, MN; Waller, L; Ofotokun, I				Mehta, C. Christina; Hagen, Kimberly S.; Rubtsova, Anna A.; Lahiri, Cecile D.; Michopoulos, Vasiliki; Moran, Caitlin A.; Haddad, Lisa B.; Titanji, Kehmia; Collins, Lauren F.; Quyyumi, Arshed A.; Neigh, Gretchen; Shaw, Leslee J.; Weitzmann, M. Neale; Waller, Lance; Ofotokun, Ighovwerha			Bone, Brain, Heart study protocol: A resilient nested, tripartite prospective cohort study of the role of estrogen depletion on HIV pathology	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; WOMENS INTERAGENCY HIV; INFECTED PATIENTS; MINERAL DENSITY; ANTIRETROVIRAL THERAPY; MICROBIAL TRANSLOCATION; MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK; INFLAMMATION; POPULATION	PurposeWe describe the rationale for and design of an innovative, nested, tripartite prospective observational cohort study examining whether relative estrogen insufficiency-induced inflammation amplifies HIV-induced inflammation to cause end organ damage and worsen age-related co-morbidities affecting the neuro-hypothalamic-pituitary-adrenal axis (Brain), skeletal (Bone), and cardiovascular (Heart/vessels) organ systems (BBH Study). MethodsThe BBH parent study is the Multicenter AIDS Cohort/Women's Interagency HIV Study Combined Cohort Study (MWCCS) with participants drawn from the Atlanta MWCCS site. BBH will enroll a single cohort of n = 120 women living with HIV and n = 60 HIV-negative women, equally distributed by menopausal status. The innovative multipart nested study design of BBH, which draws on data collected by the parent study, efficiently leverages resources for maximum research impact and requires extensive oversight and management in addition to careful implementation. The presence of strong infrastructure minimized BBH study disruptions due to changes in the parent study and the COVID-19 pandemic. ConclusionBBH is poised to provide insight into sex and HIV associations with the neuro-hypothalamic-pituitary-adrenal axis, skeletal, and cardiovascular systems despite several major, unexpected challenges.	[Mehta, C. Christina; Lahiri, Cecile D.; Moran, Caitlin A.; Collins, Lauren F.; Ofotokun, Ighovwerha] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Hagen, Kimberly S.; Rubtsova, Anna A.] Emory Univ, Rollins Sch Publ Hlth, Dept Behav Social & Hlth Educ Sci, Atlanta, GA USA; [Lahiri, Cecile D.; Moran, Caitlin A.; Collins, Lauren F.; Ofotokun, Ighovwerha] Grady Infect Dis Program, Grady Hlth Syst, Atlanta, GA USA; [Michopoulos, Vasiliki] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Haddad, Lisa B.] Populat Council, Ctr Biomed Res, New York, NY USA; [Titanji, Kehmia; Weitzmann, M. Neale] Emory Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Atlanta, GA USA; [Quyyumi, Arshed A.] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA; [Neigh, Gretchen] Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Richmond, VA USA; [Shaw, Leslee J.] Blavatnik Womens Hlth Res Inst, Icahn Sch Med Mt Sinai, New York, NY USA; [Weitzmann, M. Neale] Atlanta Vet Affairs Med Ctr, Decatur, GA USA; [Waller, Lance] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA USA	Emory University; Emory University; Rollins School Public Health; Emory University; Population Council; Emory University; Emory University; Virginia Commonwealth University; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; Rollins School Public Health	Mehta, CC (corresponding author), Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.	christina.mehta@emory.edu		Mehta, Cyra Christina/0000-0001-6854-7983	National Institutes of Health (NIH) [U54AG062334, U01HL146241, P30AI050409]; NIH [U01HL146241, P30AI050409, R01 AR070091, R01 AR068157]; U.S. Department of Veterans Affairs [U54AG062334]; National Center for Advancing Translational Sciences (NCATS) [R01 AR070091, R01 AR068157];  [K23 HL152903];  [K23 AI12491];  [BX000105];  [UL1TR002378];  [KL2TL1TR002381]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ; ; ; ; 	Supported by the National Institutes of Health (NIH, nih.gov) under Award Numbers U54AG062334, U01HL146241, P30AI050409. M. N.W. and I.O. are also supported in part by NIH grants R01 AR070091 and R01 AR068157. M.N. W. is also supported in part by award BX000105 from the U.S. Department of Veterans Affairs. C.A.M. is also supported in part by NIH award K23 HL152903. C.D.L. is also supported in part by NIH award K23 AI124913. L. F. C. is also supported by the National Center for Advancing Translational Sciences (NCATS) (NIH award numbers UL1TR002378 and KL2TL1TR002381). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders have not had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adimora AA, 2018, INT J EPIDEMIOL, V47, P393, DOI 10.1093/ije/dyy021; Amiel C, 2004, J BONE MINER RES, V19, P402, DOI 10.1359/JBMR.0301246; Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Bruera D, 2003, AIDS, V17, P1917, DOI 10.1097/00002030-200309050-00010; Chow FC, 2018, AIDS, V32, P59, DOI [10.1097/QAD.0000000000001650, 10.1097/qad.0000000000001650]; Chow FC, 2012, JAIDS-J ACQ IMM DEF, V60, P351, DOI 10.1097/QAI.0b013e31825c7f24; Collins Lauren F, 2022, Clin Infect Dis, DOI 10.1093/cid/ciac465; Collins LF, 2021, CLIN INFECT DIS, V73, pE2059, DOI 10.1093/cid/ciaa1928; Collins LF, 2021, CLIN INFECT DIS, V72, P1301, DOI 10.1093/cid/ciaa204; Corbeau P, 2011, BLOOD, V117, P5582, DOI 10.1182/blood-2010-12-322453; D'Souza G, 2021, AM J EPIDEMIOL, V190, P1457, DOI 10.1093/aje/kwab050; Ding T., 2021, CLIN INFECT DIS, V72, pe240, DOI [10.1093/cid/ciaa1022, DOI 10.1093/CID/CIAA1022]; Erlandson KM, 2018, JAIDS-J ACQ IMM DEF, V77, P288, DOI [10.1097/QAI.0000000000001591, 10.1097/qai.0000000000001591]; Failde-Garrido JM, 2008, PSYCHIAT CLIN NEUROS, V62, P494, DOI 10.1111/j.1440-1819.2008.01841.x; Fauci AS, 1996, ANN INTERN MED, V124, P654, DOI 10.7326/0003-4819-124-7-199604010-00006; Fernandez-Rivera J, 2003, HIV CLIN TRIALS, V4, P337, DOI 10.1310/4X0H-UVMJ-BHYW-CPFB; Aparicio AMG, 2006, CLIN RHEUMATOL, V25, P537, DOI 10.1007/s10067-005-0028-x; Green MS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250523; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Knobel H, 2001, AIDS, V15, P807, DOI 10.1097/00002030-200104130-00022; Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f; Lee K, 2009, GLOB INST, P1; Madeddu G, 2004, Q J NUCL MED MOL IM, V48, P39; Marchetti G, 2013, CLIN MICROBIOL REV, V26, P2, DOI 10.1128/CMR.00050-12; McLaurin KA, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00212; Michopoulos V, 2017, NEUROPSYCHOPHARMACOL, V42, P254, DOI 10.1038/npp.2016.146; Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067; Prior J, 2007, OSTEOPOROSIS INT, V18, P1345, DOI 10.1007/s00198-007-0428-7; Raff Gilbert L, 2009, J Cardiovasc Comput Tomogr, V3, P122, DOI 10.1016/j.jcct.2009.01.001; Ravi M, 2021, BJPSYCH ADV, V27, P158, DOI 10.1192/bja.2020.82; Ribeiro PS, 2008, INT J GYNECOL OBSTET, V102, P82, DOI 10.1016/j.ijgo.2008.01.025; Rubin LH, 2015, J NEUROVIROL, V21, P422, DOI 10.1007/s13365-015-0331-5; Shivers KY, 2015, CYTOKINE, V72, P121, DOI 10.1016/j.cyto.2015.01.007; Stork S, 2004, TRENDS ENDOCRIN MET, V15, P66, DOI 10.1016/j.tem.2004.01.005; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Tebas P, 2000, AIDS, V14, pF63, DOI 10.1097/00002030-200003100-00005; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; UNAIDS, 2020, GLOBAL AIDS UPDATE S; UNAIDS, UNAIDS REP GLOB AIDS; Vance DE, 2017, CURR HIV-AIDS REP, V14, P38, DOI 10.1007/s11904-016-0343-7; Vance DE, 2016, CURR HIV-AIDS REP, V13, P399, DOI 10.1007/s11904-016-0340-x; Vescini F, 2003, JAIDS-J ACQ IMM DEF, V33, P405, DOI 10.1097/00126334-200307010-00016; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; Womack JA, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001035; Yin MT, 2010, AIDS, V24, P2679, DOI 10.1097/QAD.0b013e32833f6294; Young B, 2011, CLIN INFECT DIS, V52, P1061, DOI 10.1093/cid/ciq242; Zevin AS, 2016, CURR OPIN HIV AIDS, V11, P182, DOI 10.1097/COH.0000000000000234	49	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272608	http://dx.doi.org/10.1371/journal.pone.0272608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921353	Green Published, gold			2022-12-26	WOS:000839311900016
J	Nguyen, MT; Lee, MA; Kim, YK; Kook, H; Jeong, D; Jang, SP; Kwak, TH; Park, WJ				Nguyen, Mai Tuyet; Lee, Min-Ah; Kim, Young-Kook; Kook, Hyun; Jeong, Dongtak; Jang, Seung Pil; Kwak, Tae Hwan; Park, Woo Jin			The matricellular protein CCN5 induces apoptosis in myofibroblasts through SMAD7-mediated inhibition of NF kappa B	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; HEART; FIBROBLAST; ACTIVATION; DISEASE; INJURY; CELLS	We previously showed that the matricellular protein CCN5 reverses established cardiac fibrosis (CF) through inducing apoptosis in myofibroblasts (MyoFBs) but not in cardiomyocytes or fibroblasts (FBs). In this study, we set out to elucidate the molecular mechanisms underlying CCN5-mediated selective apoptosis of MyoFBs. We first observed that the apoptotic protein p53 and the anti-apoptotic protein NF kappa B are simultaneously induced in MyoFBs. When the expression level of p53 was suppressed using a siRNA, CCN5 did not induce apoptosis in MyoFBs. By contrast, when NF kappa B signaling was inhibited using IKK VII, an I kappa B inhibitor, MyoFBs underwent apoptosis even in the absence of CCN5. SMAD7 is one of the downstream targets of CCN5 and it was previously shown to potentiate apoptosis in epithelial cells through inhibition of NF kappa B. In accordance with these reports, when the expression of SMAD7 was suppressed using a siRNA, NF kappa B signaling was enhanced, and CCN5 did not induce apoptosis. Lastly, we used a luciferase reporter construct to show that CCN5 positively regulated SMAD7 expression at the transcriptional level. Collectively, our data suggest that a delicate balance between the two mutually antagonistic proteins p53 and NF kappa B is maintained for MyoFBs to survive, and CCN5 tips the balance in favor of the apoptotic protein p53. This study provides insight into the anti-fibrotic activity of CCN5 during the regression of CF.	[Nguyen, Mai Tuyet; Lee, Min-Ah; Park, Woo Jin] Gwangju Inst Sci & Technol, Coll Life Sci, Gwangju, South Korea; [Kim, Young-Kook] Chonnam Natl Univ, Med Sch, Dept Biochem, Hwasun, Jeollanam Do, South Korea; [Kook, Hyun] Chonnam Natl Univ, Med Sch, Dept Pharmacol, Hwasun, Jeollanam Do, South Korea; [Jeong, Dongtak] Hanyang Univ, Coll Sci & Convergence Technol, Dept Mol & Life Sci, ERICA, Ansan, Gyeonggi Do, South Korea; [Jang, Seung Pil; Kwak, Tae Hwan] Gwangju Inst Sci & Technol, BethphaGen, S3 203, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Chonnam National University; Chonnam National University; Hanyang University; Gwangju Institute of Science & Technology (GIST)	Park, WJ (corresponding author), Gwangju Inst Sci & Technol, Coll Life Sci, Gwangju, South Korea.	woojinpark@icloud.com			National Research Foundation of Korea [2021R1A2C1008058, 2021R1A4A5032463]; Korean Government (MSIP)	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government (MSIP)	W.J.P. was supported by grants from National Research Foundation of Korea (2022R1A2C1004256) funded by the Korean Government (MSIP). Y.-K.K. and H. K. were supported by grants from National Research Foundation of Korea (2018R1A2B3001503, 2022R1A4A200076711, 2021R1A2B5B0200150). D.J. was supported by grants from National Research Foundation of Korea (2021R1A2C1008058, 2021R1A4A5032463).	Albensi BC, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00154; Baichwal VR, 1997, CURR BIOL, V7, pR94, DOI 10.1016/S0960-9822(06)00046-7; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Feng Y, 2020, EBIOMEDICINE, V54, DOI 10.1016/j.ebiom.2020.102715; Frangogiannis NG, 2019, CIRC RES, V125, P117, DOI 10.1161/CIRCRESAHA.119.311148; Frangogiannis NG, 2017, J CLIN INVEST, V127, P1600, DOI 10.1172/JCI87491; Heusch G, 2014, LANCET, V383, P1933, DOI 10.1016/S0140-6736(14)60107-0; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Hong S, 2007, CANCER RES, V67, P9577, DOI 10.1158/0008-5472.CAN-07-1179; Hou JW, 2018, J CELL PHYSIOL, V233, P2409, DOI 10.1002/jcp.26112; Jeong D, 2016, J AM COLL CARDIOL, V67, P1556, DOI 10.1016/j.jacc.2016.01.030; Kaltschmidt B, 2000, EUR J BIOCHEM, V267, P3828, DOI 10.1046/j.1432-1327.2000.01421.x; Kemp CD, 2012, CARDIOVASC PATHOL, V21, P365, DOI 10.1016/j.carpath.2011.11.007; Lagares D, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3765; Lallemand F, 2001, ONCOGENE, V20, P879, DOI 10.1038/sj.onc.1204167; Leask A, 2010, J CELL COMMUN SIGNAL, V4, P155, DOI 10.1007/s12079-010-0092-0; Li L, 2018, MATRIX BIOL, V68-69, P490, DOI 10.1016/j.matbio.2018.01.013; Lin BH, 1999, CELL DEATH DIFFER, V6, P570, DOI 10.1038/sj.cdd.4400528; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Murphy-Ullrich JE, 2014, MATRIX BIOL, V37, P1, DOI 10.1016/j.matbio.2014.07.005; NAG AC, 1980, CYTOBIOS, V28, P41; Okado T, 2002, KIDNEY INT, V62, P1178, DOI 10.1046/j.1523-1755.2002.00583.x; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Sabbah M, 2011, MOL CELL BIOL, V31, P1459, DOI 10.1128/MCB.01316-10; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Sun B, 2008, ONCOGENE, V27, P6228, DOI 10.1038/onc.2008.300; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Xu HH, 2015, CLIN EXP PHARMACOL P, V42, P1207, DOI 10.1111/1440-1681.12470; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; Yang XL, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.615505; Yoon PO, 2010, J MOL CELL CARDIOL, V49, P294, DOI 10.1016/j.yjmcc.2010.04.010	36	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0269735	http://dx.doi.org/10.1371/journal.pone.0269735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917315	gold, Green Published			2022-12-26	WOS:000837840000005
J	Pierre, JS; Stoeckel, S; Wajnberg, E				Pierre, Jean-Sebastien; Stoeckel, Solenn; Wajnberg, Eric			The advantage of sex: Reinserting fluctuating selection in the pluralist approach	PLOS ONE			English	Article							FREQUENCY-DEPENDENT SELECTION; DELETERIOUS MUTATIONS; RED QUEEN; PHENOTYPIC SELECTION; GENETIC-VARIABILITY; CLONAL REPRODUCTION; TEMPORAL DYNAMICS; TANGLED BANK; EVOLUTION; RECOMBINATION	The advantage of sex, and its fixation in some clades and species all over the eukaryote tree of life, is considered an evolutionary enigma, especially regarding its assumed two-fold cost. Several likely hypotheses have been proposed such as (1) a better response to the negative frequency-dependent selection imposed by the "Red Queen" hypothesis; (2) the competition between siblings induced by the Tangled Bank hypothesis; (3) the existence of genetic and of (4) ecological factors that can diminish the cost of sex to less than the standard assumed two-fold; and (5) a better maintenance of genetic diversity and its resulting phenotypic variation, providing a selective advantage in randomly fluctuating environments. While these hypotheses have mostly been studied separately, they can also act simultaneously. This was advocated by several studies which presented a pluralist point of view. Only three among the five causes cited above were considered yet in such a framework: the Red Queen hypothesis, the Tangled Bank and the genetic factors lowering the cost of sex. We thus simulated the evolution of a finite mutating population undergoing negative frequency-dependent selection on phenotypes and a two-fold (or less) cost of sexuality, experiencing randomly fluctuating selection along generations. The individuals inherited their reproductive modes, either clonal or sexual. We found that exclusive sexuality begins to fix in populations exposed to environmental variation that exceeds the width of one ecological niche (twice the standard deviation of a Gaussian response to environment). This threshold was lowered by increasing negative frequency-dependent selection and when reducing the two-fold cost of sex. It contributes advocating that the different processes involved in a short-term advantage of sex and recombination can act in combination to favor the fixation of sexual reproduction in populations.	[Pierre, Jean-Sebastien] Univ Rennes 1, UMR Ecol Biodivers Evolut 6553, CNRS INEE, OSUR, Campus Beaulieu, Rennes, France; [Stoeckel, Solenn] Univ Rennes, Inst Agro, IGEPP, INRAE, Le Rheu, France; [Wajnberg, Eric] INRAE, Sophia Antipolis, France; [Wajnberg, Eric] INRIA, Projet Hephaistos, Sophia Antipolis, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Rennes 2; Universite de Rennes; INRAE; Institut Agro; INRAE; Inria	Pierre, JS (corresponding author), Univ Rennes 1, UMR Ecol Biodivers Evolut 6553, CNRS INEE, OSUR, Campus Beaulieu, Rennes, France.	jean-sebastien.pierre@univ-rennes1.fr	Stoeckel, Solenn/K-8086-2017	Stoeckel, Solenn/0000-0001-6064-5941				Ackerman S, 2010, J HERED, V101, pS135, DOI 10.1093/jhered/esq019; ANTONOVICS J, 1984, EVOLUTION, V38, P103, DOI 10.1111/j.1558-5646.1984.tb00263.x; Ashby B, 2020, J EVOLUTION BIOL, V33, P1795, DOI 10.1111/jeb.13718; Ashby B, 2017, ECOL LETT, V20, P357, DOI 10.1111/ele.12734; Avise J., 2008, CLONALITY GENETICS E; Avise JC, 2015, P NATL ACAD SCI USA, V112, P8867, DOI 10.1073/pnas.1501820112; Becheler R, 2020, EVOL APPL, V13, P2086, DOI 10.1111/eva.12967; Bell G, 1982, MASTERPIECE NATURE E; Bell G, 2010, PHILOS T R SOC B, V365, P87, DOI 10.1098/rstb.2009.0150; Birch GF, 2001, ENVIRON POLLUT, V113, P357, DOI 10.1016/S0269-7491(00)00182-2; Burger R, 2005, J MATH BIOL, V50, P355, DOI 10.1007/s00285-004-0294-2; Burger R, 2002, GENET RES, V80, P31, DOI 10.1017/S0016672302005682; Burger R, 1999, GENETICS, V153, P1055; Burger R, 2004, EVOLUTIONARY CONSERV, P171; CARACO T, 1981, BEHAV ECOL SOCIOBIOL, V8, P213, DOI 10.1007/BF00299833; CHARLESWORTH B, 1993, GENET RES, V61, P205, DOI 10.1017/S0016672300031372; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; Dominguez-Garcia S, 2019, HEREDITY, V123, P709, DOI 10.1038/s41437-019-0263-6; Falconer D. S., 1996, Introduction to quantitative genetics.; FELSENSTEIN J, 1974, GENETICS, V78, P737; Fisher RA, 1930, GENETICAL THEORY NAT; Gibson AK, 2017, EVOL LETT, V1, P6, DOI 10.1002/evl3.1; GILLESPIE JH, 1974, GENETICS, V76, P601; Gillespie JH, 1998, POPULATION GENETICS; Hadany L, 2008, ANN NY ACAD SCI, V1133, P26, DOI 10.1196/annals.1438.011; Haldane J. B. S., 1963, Journal of Genetics, V58, P237, DOI 10.1007/BF02986143; Halligan DL, 2009, ANNU REV ECOL EVOL S, V40, P151, DOI 10.1146/annurev.ecolsys.39.110707.173437; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hartfield M, 2012, EVOLUTION, V66, P3658, DOI 10.1111/j.1558-5646.2012.01733.x; Howard RS, 1998, EVOLUTION, V52, P604, DOI [10.2307/2411094, 10.1111/j.1558-5646.1998.tb01658.x]; Jalvingh K., 2016, ENCY EVOLUTIONARY BI, P89; Kacelnik A, 1997, TRENDS COGN SCI, V1, P304, DOI 10.1016/S1364-6613(97)01093-0; Keightley PD, 2006, NATURE, V443, P89, DOI 10.1038/nature05049; KIMURA M, 1954, GENETICS, V39, P280; Koci J, 2020, MOL ECOL, V29, P3038, DOI 10.1111/mec.15539; KOELLA JC, 1988, J EVOLUTION BIOL, V1, P95, DOI 10.1046/j.1420-9101.1988.1020095.x; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1982, GENET RES, V40, P325, DOI 10.1017/S0016672300019194; Kondrashov FA, 2001, P NATL ACAD SCI USA, V98, P12089, DOI 10.1073/pnas.211214298; Kouyos RD, 2007, TRENDS ECOL EVOL, V22, P308, DOI 10.1016/j.tree.2007.02.014; Li XY, 2017, ANN INT SOC DYN GAME, V15, P217, DOI 10.1007/978-3-319-70619-1_10; Lively CM, 2014, J EVOLUTION BIOL, V27, P1292, DOI 10.1111/jeb.12354; LIVELY CM, 1990, NATURE, V344, P864, DOI 10.1038/344864a0; Luijckx P, 2017, P NATL ACAD SCI USA, V114, P534, DOI 10.1073/pnas.1604072114; MAC ARTHUR ROBERT H., 1967; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Meirmans S, 2006, BIOL J LINN SOC, V89, P605, DOI 10.1111/j.1095-8312.2006.00695.x; Meirmans S, 2010, J HERED, V101, pS3, DOI 10.1093/jhered/esq021; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; NEE S, 1989, J THEOR BIOL, V140, P499, DOI 10.1016/S0022-5193(89)80111-0; Neiman M, 2017, TRENDS ECOL EVOL, V32, P589, DOI 10.1016/j.tree.2017.05.004; Olofsson H, 2007, EVOL ECOL RES, V9, P1119; Payseur BA, 2006, TRENDS GENET, V22, P424, DOI 10.1016/j.tig.2006.06.009; Peck JR, 2000, NATURE, V406, P399, DOI 10.1038/35019055; PECK JR, 1993, P ROY SOC B-BIOL SCI, V254, P87, DOI 10.1098/rspb.1993.0131; Peters AD, 1999, AM NAT, V154, P393, DOI 10.1086/303247; R Core Team, 2020, R LANG ENV STAT COMP; Rice WR, 2002, NAT REV GENET, V3, P241, DOI 10.1038/nrg760; Ripa JR., 2010, BIOL SCI, V277, P1153; Roze D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001321; Salathe M, 2009, AM NAT, V174, pS31, DOI 10.1086/599085; Schon I, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P1; Siepielski AM, 2011, P ROY SOC B-BIOL SCI, V278, P1572, DOI 10.1098/rspb.2010.1973; Siepielski AM, 2009, ECOL LETT, V12, P1261, DOI 10.1111/j.1461-0248.2009.01381.x; SMITH JM, 1976, J THEOR BIOL, V63, P245, DOI 10.1016/0022-5193(76)90033-3; SMITH JM, 1978, EVOLUTION SEX; Song Y, 2011, OIKOS, V120, P1601, DOI 10.1111/j.1600-0706.2011.19698.x; Speijer D, 2015, P NATL ACAD SCI USA, V112, P8827, DOI 10.1073/pnas.1501725112; Starrfelt J, 2012, BIOL REV, V87, P742, DOI 10.1111/j.1469-185X.2012.00225.x; Stelzer CP, 2015, P NATL ACAD SCI USA, V112, P8851, DOI 10.1073/pnas.1501726112; Stoeckel S, 2021, MOL ECOL RESOUR, V21, P1068, DOI 10.1111/1755-0998.13316; TAKAHATA N, 1979, P NATL ACAD SCI USA, V76, P5813, DOI 10.1073/pnas.76.11.5813; Tejero H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-2; Tibayrenc M, 2015, P NATL ACAD SCI USA, V112, P8824, DOI 10.1073/pnas.1508087112; Toman J, 2018, ECOL EVOL, V8, P973, DOI 10.1002/ece3.3716; Tufto J, 2015, EVOLUTION, V69, P2034, DOI 10.1111/evo.12716; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; West SA, 1999, J EVOLUTION BIOL, V12, P1003; Whitlock AOB, 2016, GENETICS, V203, P923, DOI 10.1534/genetics.116.186916; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; WILLIAMS GC, 1973, J THEOR BIOL, V39, P545, DOI 10.1016/0022-5193(73)90067-2	82	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272134	http://dx.doi.org/10.1371/journal.pone.0272134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917359	gold, Green Published			2022-12-26	WOS:000837840000037
J	Wu, JJ; Zhu, JH; Zhang, DQ; Cheng, HY; Hao, BQ; Cao, AC; Yan, DD; Wang, QX; Li, Y				Wu, Jiajia; Zhu, Jiahong; Zhang, Daqi; Cheng, Hongyan; Hao, Baoqiang; Cao, Aocheng; Yan, Dongdong; Wang, Qiuxia; Li, Yuan			Beneficial effect on the soil microenvironment of Trichoderma applied after fumigation for cucumber production	PLOS ONE			English	Article							BACTERIAL; COMMUNITIES; 1,3-DICHLOROPROPENE; BIOFERTILIZER; CHLOROPICRIN; RHIZOBIUM; HEALTH; GROWTH; GENES; YIELD	Biocontrol agents applied after fumigation play an important role to the soil microenvironment. We studied the effect of Trichoderma applied after dimethyl disulfide (DMDS) plus chloropicrin (PIC) fumigation on the cucumber growth, soil physicochemical properties, enzyme activity, taxonomic diversity, and yield through laboratory and field experiments. The results confirmed that Trichoderma applied after fumigation significantly improved soil physicochemical properties, cucumber growth, soil-borne pathogens, and soil enzyme activity. Genetic analysis indicated that Trichoderma applied after fumigation significantly increased the relative abundance of Pseudomonas, Humicola and Chaetomium, and significantly decreased the relative abundance of the pathogens Fusarium spp. and Gibberella spp., which may help to control pathogens and enhanced the ecological functions of the soil. Moreover, Trichoderma applied after fumigation obviously improved cucumber yield (up to 35.6%), and increased relative efficacy of soil-borne pathogens (up to 99%) and root-knot nematodes (up to 96%). Especially, we found that Trichoderma applied after fumigation increased the relative abundance of some beneficial microorganisms (such as Sodiomyces and Rhizophlyctis) that can optimize soil microbiome. It is worth noting that with the decline in the impact of the fumigant, these beneficial microorganisms still maintain a higher abundance when the cucumber plants were uprooted. Importantly, we found one tested biocontrol agent Trichoderma 267 identified and stored in our laboratory not only improved cucumber growth, reduced soil-borne diseases in late cucumber growth stages but also optimized micro-ecological environment which may have good application prospect and help to keep environmental healthy and sustainable development.	[Wu, Jiajia; Zhu, Jiahong; Zhang, Daqi; Cheng, Hongyan; Hao, Baoqiang; Cao, Aocheng; Yan, Dongdong; Wang, Qiuxia; Li, Yuan] Chinese Acad Agr Sci, Inst Plant Protect, Beijing, Peoples R China; [Cao, Aocheng; Yan, Dongdong; Wang, Qiuxia; Li, Yuan] Beijing Innovat Consortium Agr Res Syst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Li, Y (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Beijing, Peoples R China.; Li, Y (corresponding author), Beijing Innovat Consortium Agr Res Syst, Beijing, Peoples R China.	liyuancaas@126.com		Yan, Dongdong/0000-0002-8196-4615	Beijing Innovation Consortium of Agriculture Research System [BAIC01-2019]; National Key Research and Development Program of China [2018YFD0201300]; National Natural Science Foundation of China [31672066]	Beijing Innovation Consortium of Agriculture Research System; National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Dr. Tom Batchelor for providing editorial comments and for revising the manuscript.	Arnault I, 2013, IND CROP PROD, V49, P265, DOI 10.1016/j.indcrop.2013.05.007; Asad SA, 2022, ECOL COMPLEX, V49, DOI 10.1016/j.ecocom.2021.100978; Basotra N, 2016, BIORESOURCE TECHNOL, V222, P413, DOI 10.1016/j.biortech.2016.10.018; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; [曹坳程 Cao Aocheng], 2017, [植物保护, Plant Protection], V43, P6; Chamkhi I, 2022, SAUDI J BIOL SCI, V29, P1246, DOI 10.1016/j.sjbs.2021.09.032; Chaparro JM, 2012, BIOL FERT SOILS, V48, P489, DOI 10.1007/s00374-012-0691-4; Chen Y, 2019, THESIS SHANXI AGR U, P12; Cheng HY, 2021, ENVIRON POLLUT, V283, DOI 10.1016/j.envpol.2021.117160; Cheng HongYan, 2020, Chinese Journal of Pesticide Science, V22, P734; Cheng HY, 2020, SCI TOTAL ENVIRON, V738, DOI 10.1016/j.scitotenv.2020.140345; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Fabio AS., 2021, BIOL CONTROL, V163, DOI [10.1016/j.biocontrol.2021.104755, DOI 10.1016/J.BIOCONTROL.2021.104755]; Fang WS, 2016, CHINA VEGETABLES, V7, P44; Fu J, 2019, PLANT SOIL, V436, P211, DOI 10.1007/s11104-018-03916-8; Gao ML, 2013, ENVIRON TOXICOL PHAR, V36, P667, DOI 10.1016/j.etap.2013.07.003; Gilardi G, 2020, PLANT DIS, V104, P2026, DOI 10.1094/PDIS-12-19-2621-PDN; Gleason F. H., 2019, Current Trends in Microbiology, V13, P67; Hollister EB, 2013, FEMS MICROBIOL ECOL, V83, P632, DOI 10.1111/1574-6941.12020; Inglis PW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228485; Jia XX., 2020, MOL PLANT BREEDING, V13; Khan MY, 2017, J INTEGR AGR, V16, P691, DOI 10.1016/S2095-3119(16)61350-3; Khomari S., 2017, PLANT PHYSL BREED, V7, P27; KOMADA H, 1975, Review of Plant Protection Research, V8, P114; Kumar R, 2021, FUNGAL BIOL-UK, V125, P167, DOI 10.1016/j.funbio.2020.07.009; Kuvarina AE, 2021, APPL BIOCHEM MICRO+, V57, P86, DOI 10.1134/S0003683821010142; Li J, 2017, ENVIRON POLLUT, V227, P534, DOI 10.1016/j.envpol.2017.03.076; Li QJ, 2021, ECOTOX ENVIRON SAFE, V220, DOI 10.1016/j.ecoenv.2021.112362; Li XG, 2014, SOIL BIOL BIOCHEM, V72, P11, DOI 10.1016/j.soilbio.2014.01.019; Liu W., 2000, PLANT PATHOGENIC NEM; [刘晓宇 Liu Xiaoyu], 2020, [沈阳农业大学学报, Journal of Shenyang Agricultural University], V51, P755; MASAGO H, 1977, PHYTOPATHOLOGY, V67, P425, DOI 10.1094/Phyto-67-425; Niu Xiao-yun, 2015, Yingyong Shengtai Xuebao, V26, P2663; Olenska E, 2020, SCI TOTAL ENVIRON, V743, DOI 10.1016/j.scitotenv.2020.140682; Olsen S., 1954, ESTIMATION AVAILABLE; Pan FengBing, 2017, Acta Ecologica Sinica - International Journal, V37, P315, DOI 10.1016/j.chnaes.2017.09.003; Ren ZJ, 2018, PEST MANAG SCI, V74, P2146, DOI 10.1002/ps.4911; Rudresh DL, 2005, APPL SOIL ECOL, V28, P139, DOI 10.1016/j.apsoil.2004.07.005; Sahebani N, 2008, SOIL BIOL BIOCHEM, V40, P2016, DOI 10.1016/j.soilbio.2008.03.011; Schinner F., 1995, METHODS SOIL BIOL, P386; Shoresh M, 2010, ANNU REV PHYTOPATHOL, V48, P21, DOI 10.1146/annurev-phyto-073009-114450; Sridharan AP, 2021, MICROB PATHOGENESIS, V150, DOI 10.1016/j.micpath.2020.104714; Tang M., 2019, AGR TECHNOLOGY SERVI, V36, P16; Tian T., 2013, THESIS CHINESE ACAD; Velazquez E, 2005, MOL PLANT MICROBE IN, V18, P1325, DOI 10.1094/MPMI-18-1325; Wang Qing, 2021, Chinese Journal of Pesticide Science, V23, P1063, DOI 10.16801/j.issn.1008-7303.2021.0102; Wang QX, 2010, J AGR FOOD CHEM, V58, P361, DOI 10.1021/jf902977a; Xiong W, 2017, SOIL BIOL BIOCHEM, V114, P238, DOI 10.1016/j.soilbio.2017.07.016; Yan DongDong, 2010, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V18, P934, DOI 10.3724/SP.J.1011.2010.00934; Yan S., 2011, SHANDONG AGR SCI, V000, P86; Yan YR, 2021, BIOL CONTROL, V158, DOI 10.1016/j.biocontrol.2021.104609; Ye L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56954-2; Zhang, 2018, EFFECT DIFFERENT SAL; Zhang DQ, 2019, SCI TOTAL ENVIRON, V675, P615, DOI 10.1016/j.scitotenv.2019.04.222; Zhang DL, 2019, ECOTOX ENVIRON SAFE, V169, P730, DOI 10.1016/j.ecoenv.2018.11.071; Zhang FG, 2013, APPL SOIL ECOL, V72, P41, DOI 10.1016/j.apsoil.2013.05.016; Zhao LJ, 2013, J AGR FOOD CHEM, V61, P11945, DOI 10.1021/jf404328e; Zhao XL., 2020, TEA NEWS, V194, P49; Zhou XF., 2020, J JILIN NORMAL U NAT, V41, P93; Zhu JH, 2020, J AGR FOOD CHEM, V68, P1226, DOI 10.1021/acs.jafc.9b07292	60	2	2	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0266347	http://dx.doi.org/10.1371/journal.pone.0266347			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917326	gold, Green Published			2022-12-26	WOS:000837840000007
J	Zhao, LQ; Wang, LL; Jia, YF; Cui, Y				Zhao, Liquan; Wang, Leilei; Jia, Yanfei; Cui, Ying			A lightweight deep neural network with higher accuracy	PLOS ONE			English	Article								To improve accuracy of the MobileNet network, a new lightweight deep neural network is designed based on the MobileNetV2 network. Firstly, it modifies the network depth of MobileNetV2 to balance the image resolution, network width and depth to keep the gradient stable, which reduces the generation of gradient vanishing or gradient exploding. Secondly, it proposes an improved Bottleneck module by introducing channel attention mechanism. It assigns different weights for different channels according to the degree of relevance between the object features and channels. Therefore, the network can extract more effective features from a complex background. In the end, a new usage strategy of the improved Bottleneck is proposed. It uses the improved Bottleneck module in the second, fourth and fifth stages of MobileNetV2, and uses the original Bottleneck module in other states. Compared with MobileNetV2, MobileNetV3, ShuffleNetV2, GhostNet and HBONetmethods, the proposed method has the highest classification accuracy on the ImageNet-1K dataset, CIFAR-10 and CIFAR-100. Compared with YOLOV4-Lite methods based on these lightweight network networks, YOLOV4-Lite based on our proposed network also has the highest detection accuracy on the PASCAL VOC07+12 dataset.	[Zhao, Liquan; Wang, Leilei] Northeast Elect Power Univ, Key Lab Modern Power Syst Simulat & Control & Rene, Minist Educ, Jilin, Jilin, Peoples R China; [Jia, Yanfei] Beihua Univ, Coll Elect & Informat Engn, Jilin, Jilin, Peoples R China; [Cui, Ying] Guangdong Elect Power Corp, Zhuhai Power Supply Bur, Zhuhai, Guangdong, Peoples R China	Northeast Electric Power University; Beihua University	Zhao, LQ (corresponding author), Northeast Elect Power Univ, Key Lab Modern Power Syst Simulat & Control & Rene, Minist Educ, Jilin, Jilin, Peoples R China.	zhao_liquan@163.com						Andrew G. Howard, 2017, Arxiv, DOI arXiv:1704.04861; Bochkovskiy A., 2020, YOLOV4 OPTIMAL SPEED; Chen JD, 2021, APPL ENTOMOL ZOOL, V56, P427, DOI 10.1007/s13355-021-00732-y; Feng JW, 2021, IEEE SENS J, V21, P21050, DOI 10.1109/JSEN.2021.3100636; Forrest N. Iandola, 2016, Arxiv, DOI arXiv:1602.07360; Guo KH, 2021, IEEE INTERNET THINGS, V8, P12623, DOI 10.1109/JIOT.2020.3015987; Han H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239070; Han K, 2020, PROC CVPR IEEE, P1577, DOI 10.1109/CVPR42600.2020.00165; Howard A, 2019, IEEE I CONF COMP VIS, P1314, DOI 10.1109/ICCV.2019.00140; Hu XW, 2019, IEEE T INTELL TRANSP, V20, P1010, DOI 10.1109/TITS.2018.2838132; Khan S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249436; Kong LZ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0258804; Li D, 2019, IEEE I CONF COMP VIS, P3315, DOI 10.1109/ICCV.2019.00341; Li YT, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8091678; Loshchilov I., 2017, ARXIV, DOI DOI 10.48550/ARXIV.1608.03983; Luo JH, 2019, IEEE T PATTERN ANAL, V41, P2525, DOI 10.1109/TPAMI.2018.2858232; Ma NN, 2018, LECT NOTES COMPUT SC, V11218, P122, DOI 10.1007/978-3-030-01264-9_8; Murthy CB, 2021, INT J MULTIMED INF R, V10, P171, DOI 10.1007/s13735-021-00212-7; Nahshan Y, 2021, MACH LEARN, V110, P3245, DOI 10.1007/s10994-021-06053-z; Pan HH, 2020, IEEE ACCESS, V8, P119951, DOI 10.1109/ACCESS.2020.3005450; Sandler M, 2018, PROC CVPR IEEE, P4510, DOI 10.1109/CVPR.2018.00474; Tan MX, 2019, PR MACH LEARN RES, V97; Wang JP, 2019, IEEE T VIS COMPUT GR, V25, P2168, DOI 10.1109/TVCG.2019.2903943; Wang W, 2020, MOB INF SYST, V2020, DOI 10.1155/2020/7602384; Zhang S, 2020, MATH PROBL ENG, V2020, DOI 10.1155/2020/3278235; Zhang X, 2018, PROC CVPR IEEE, P6848, DOI 10.1109/CVPR.2018.00716; Zhao LQ, 2022, IEEE SENS J, V22, P10890, DOI 10.1109/JSEN.2022.3172132; Zhao Z., 2020, COMPUTER AIDED DESIG, V18, P34, DOI [10.14733/cadaps.2021.S3.34-45, DOI 10.14733/CADAPS.2021.S3.34-45]	29	0	0	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271225	http://dx.doi.org/10.1371/journal.pone.0271225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917311	Green Published, gold			2022-12-26	WOS:000837840000012
J	Boland, AW; Gas-Pascual, E; Nottingham, BL; van der Wel, H; Daniel, NG; Sheikh, MO; Schafer, CM; West, CM				Boland, Andrew W.; Gas-Pascual, Elisabet; Nottingham, Braxton L.; van der Wel, Hanke; Daniel, Nitin G.; Sheikh, M. Osman; Schafer, Christopher M.; West, Christopher M.			Oxygen-dependent regulation of E3(SCF)ubiquitin ligases and a Skp1-associated JmjD6 homolog in development of the social amoeba Dictyostelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME INHIBITORS; PROLYL 4-HYDROXYLASE; UBIQUITIN LIGASES; PROTEIN SKP1; SWISS-MODEL; GLYCOSYLATION; DISCOIDEUM; BINDING; SCF; TOXOPLASMA	E3-SCF (Skp1/cullin-1/F-box protein) polyubiquitin ligases activate the proteasomal degradation of over a thousand proteins, but the evolutionary diversification of the F-box protein (FBP) family of substrate receptor subunits has challenged their elucidation in protists. Here, we expand the FBP candidate list in the social amoeba Dictyostelium and show that the Skp1 interactome is highly remodeled as cells transition from growth to multicellular development. Importantly, a subset of candi-date FBPs was less represented when the posttranslational hydroxylation and glycosylation of Skp1 was abrogated by deletion of the O-2-sensing Skp1 prolyl hydroxylase PhyA. A role for this Skp1 modification for SCF activity was indicated by partial rescue of development, which normally depends on high O-2 and PhyA, of phyA-KO cells by proteasomal inhibitors. Further examination of two FBPs, FbxwD and the Jumonji C protein JcdI, suggested that Skp1 was substituted by other factors in phyA-KO cells. Although a double-KO of jcdI and its paralog jcdH did not affect development, overexpression of JcdI increased its sensitivity to O-2. JcdI, a nonheme dioxygenase shown to have physiological O-2 dependence, is conserved across protists with its F-box and other domains, and is related to the human oncogene JmjD6. Sensitization of JcdI-overexpression cells to O(2 )depended on its dioxygenase activity and other domains, but not its F-box, which may however be the mediator of its reduced levels in WT relative to Skp1 modification mutant cells. The findings suggest that activation of JcdI by O-2 is tempered by homeostatic downregulation via PhyA and association with Skp1.	[Boland, Andrew W.; Gas-Pascual, Elisabet; van der Wel, Hanke; Daniel, Nitin G.; West, Christopher M.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Boland, Andrew W.; Gas-Pascual, Elisabet; West, Christopher M.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Gas-Pascual, Elisabet; West, Christopher M.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Nottingham, Braxton L.; van der Wel, Hanke; Sheikh, M. Osman; Schafer, Christopher M.; West, Christopher M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73019 USA; [Nottingham, Braxton L.] Integris Hlth Med Grp Cross Timbers, Edmond, OK 73034 USA; [Sheikh, M. Osman] Amicus Therapeut, Philadelphia, PA USA; [Schafer, Christopher M.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Daniel, Nitin G.] Univ Calif Berkeley, Dept Biophys, Berkeley, CA 94720 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; University of California System; University of California Berkeley	West, CM (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.; West, CM (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA.; West, CM (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.; West, CM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73019 USA.	westcm@uga.edu		Sheikh, Mohammed/0000-0002-9481-8318	NIH [R01-GM037539, R01-GM084383, R21-AI149405, RGP0051/2021]; Human Frontiers in Science Program	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers in Science Program(Human Frontier Science Program)	Acknowledgments-Steve Hartson (Oklahoma State University) is acknowledged for performing the proteomics analysis of pAb UOK77 co-IPs from vegetative cells. Julia Clarke (University of Georgia) is thanked for her assistance in preparing the JcdI expression vectors. Yuechi Xu (formerly at the University of Oklahoma Health Sciences Center) is acknowledged for his original BLASTp-based searches for F-box like sequences, and Angela Park (University of Georgia) is thanked for her cloning efforts. This work was supported by NIH grants R01-GM037539, R01-GM084383, and R21-AI149405, and a grant (RGP0051/2021) from the Human Frontiers in Science Program.	Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Baptista CG, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007946; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Bottger A, 2015, BIOCHEM J, V468, P191, DOI 10.1042/BJ20150278; Cavadini S, 2016, NATURE, V531, P598, DOI 10.1038/nature17416; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Charette SJ, 2004, BIOTECHNIQUES, V36, P574, DOI 10.2144/04364BM01; Cochet-Escartin O, 2021, ELIFE, V10, DOI 10.7554/eLife.64731; DAS OP, 1983, BIOCHIM BIOPHYS ACTA, V736, P45; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Demo SD, 2007, CANCER RES, V67, P6383, DOI 10.1158/0008-5472.CAN-06-4086; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; EARLY AE, 1993, DEVELOPMENT, V118, P353; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Ercan A, 2006, J BIOL CHEM, V281, P12713, DOI 10.1074/jbc.M513664200; Faix Jan, 2013, Methods Mol Biol, V983, P249, DOI 10.1007/978-1-62703-302-2_13; Gruenheit N, 2021, BMC BIOL, V19, DOI 10.1186/s12915-021-01108-y; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Harper JW, 2021, ANNU REV BIOCHEM, V90, P403, DOI 10.1146/annurev-biochem-090120-013613; Heim A, 2014, NUCLEIC ACIDS RES, V42, P7833, DOI 10.1093/nar/gku488; Islam MS, 2018, ANNU REV BIOCHEM, V87, P585, DOI 10.1146/annurev-biochem-061516-044724; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Kim HW, 2020, BIOCHEMISTRY-US, V59, P1527, DOI 10.1021/acs.biochem.0c00094; Kwok J, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00032; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lauinger L, 2020, P NATL ACAD SCI USA, V117, P21319, DOI 10.1073/pnas.1922891117; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Letunic I, 2021, NUCLEIC ACIDS RES, V49, pW293, DOI 10.1093/nar/gkab301; Liu TR, 2020, J BIOL CHEM, V295, P16545, DOI 10.1074/jbc.RA120.013998; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; LOOMIS WF, 1971, EXP CELL RES, V64, P484, DOI 10.1016/0014-4827(71)90107-8; Lundgren DH, 2010, EXPERT REV PROTEOMIC, V7, P39, DOI 10.1586/EPR.09.69; Mandalasi M, 2020, J BIOL CHEM, V295, P9223, DOI 10.1074/jbc.RA120.013792; Mantri M, 2010, J MOL BIOL, V401, P211, DOI 10.1016/j.jmb.2010.05.054; Mohanty S, 2001, GENE DEV, V15, P1435, DOI 10.1101/gad.871101; Muller E, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-00618-7; Muller T, 2017, MOL CELL PROTEOMICS, V16, P1173, DOI 10.1074/mcp.M116.064048; Nelson DE, 2011, J BIOL CHEM, V286, P19804, DOI 10.1074/jbc.M111.220079; Nguyen KM, 2020, ADV EXP MED BIOL, V1217, P111, DOI 10.1007/978-981-15-1025-0_8; O'Day DH, 2006, BIOCHEM BIOPH RES CO, V346, P879, DOI 10.1016/j.bbrc.2006.05.204; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pugh CW, 2017, EXP CELL RES, V356, P116, DOI 10.1016/j.yexcr.2017.03.008; Rahman K, 2016, J BIOL CHEM, V291, P4268, DOI 10.1074/jbc.M115.703751; Raykov L., 2021, BIORXIV, DOI [10.1101/2021.06.29.450281, DOI 10.1101/2021.06.29.450281]; Rayon T, 2020, SCIENCE, V369, P1449, DOI 10.1126/science.aba7667; Reiterer V, 2018, EMBO J, V37, DOI 10.15252/embj.201899170; Reitsma JM, 2017, CELL, V171, P1326, DOI 10.1016/j.cell.2017.10.016; Rosengarten RD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1491-7; Russell ID, 1999, J CELL BIOL, V145, P933, DOI 10.1083/jcb.145.5.933; Sassi S, 2001, GLYCOBIOLOGY, V11, P283, DOI 10.1093/glycob/11.4.283; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Sheikh MO, 2017, J BIOL CHEM, V292, P18897, DOI 10.1074/jbc.M117.809160; Sheikh MO, 2015, MOL CELL PROTEOMICS, V14, P66, DOI 10.1074/mcp.M114.044560; Sheikh MO, 2014, BIOCHEMISTRY-US, V53, P1657, DOI 10.1021/bi401707y; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Stein ML, 2014, ANGEW CHEM INT EDIT, V53, P1679, DOI 10.1002/anie.201308984; STERNFELD J, 1981, J CELL SCI, V50, P9; Studer G, 2020, BIOINFORMATICS, V36, P2647, DOI 10.1093/bioinformatics/btaa058; Taujale R, 2020, ELIFE, V9, DOI 10.7554/eLife.54532; Teng-umnuay P, 1998, J BIOL CHEM, V273, P18242, DOI 10.1074/jbc.273.29.18242; van der Wel H, 2005, J BIOL CHEM, V280, P14645, DOI 10.1074/jbc.M500600200; van der Wel H, 2019, GLYCOBIOLOGY, V29, P705, DOI 10.1093/glycob/cwz049; Wang KK, 2020, ADV EXP MED BIOL, V1217, P33, DOI 10.1007/978-981-15-1025-0_3; Wang ZA, 2011, DEV BIOL, V349, P283, DOI 10.1016/j.ydbio.2010.10.013; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weber RJM, 2012, BIOINFORMATICS, V28, P2856, DOI 10.1093/bioinformatics/bts527; West CM, 2007, DEVELOPMENT, V134, P3349, DOI 10.1242/dev.000893; West CM, 2015, CURR OPIN MICROBIOL, V26, P41, DOI 10.1016/j.mib.2015.04.006; West CM, 2002, GLYCOBIOLOGY, V12, p17R, DOI 10.1093/glycob/12.2.17R; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Willhoft O, 2017, SCI REP-UK, V7, DOI 10.1038/srep41626; Wilson J, 2020, J BIOMOL TECH, V31, pS1; Wong M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11132-w; Xu YC, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-31; Xu YC, 2012, J BIOL CHEM, V287, P25098, DOI 10.1074/jbc.M112.355446; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Yan KG, 2018, NAT STRUCT MOL BIOL, V25, P1103, DOI 10.1038/s41594-018-0154-1; Yu H, 2015, NAT PLANTS, V1, P1, DOI 10.1038/NPLANTS.2014.30; Zhang DM, 2012, J BIOL CHEM, V287, P2006, DOI 10.1074/jbc.M111.314021; Zhang YY, 1999, J CELL SCI, V112, P4367	85	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102305	10.1016/j.jbc.2022.102305	http://dx.doi.org/10.1016/j.jbc.2022.102305			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4V3XX	35933019	gold, Green Published			2022-12-26	WOS:000859414300013
J	Liu, XF; Zang, CY; Wu, YF; Meng, R; Chen, Y; Jiang, T; Wang, C; Yang, XY; Guo, YS; Situ, CH; Hu, ZB; Zhang, J; Guo, XJ				Liu, Xiaofei; Zang, Chunyan; Wu, Yifei; Meng, Ru; Chen, Yu; Jiang, Tao; Wang, Cheng; Yang, Xiaoyu; Guo, Yueshuai; Situ, Chenghao; Hu, Zhibin; Zhang, Jun; Guo, Xuejiang			Homeodomain-interacting protein kinase HIPK4 regulates phosphorylation of manchette protein RIMBP3 during spermiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALE-INFERTILITY; GENE; MECHANISMS; IDENTIFICATION; MICROTUBULES; ENVIRONMENT; FAMILY; DYNEIN; HEAD	Nonobstructive azoospermia (NOA) is the most serious form of spermatogenesis abnormalities in male infertility. Genetic factors are important to consider as elements leading to NOA. Although many pathogenic genes have been reported, the causative genes of NOA for many patients are still unknown. In this study, we found ten point mutations in the gene encoding homeodomain-interacting protein kinase 4 (HIPK4) in patients with NOA, and using in vitro studies, we determined a premature termination point mutation (p. Lys490*, c.1468A>T) that can cause decreased expression of HIPK4. Our phospho-proteomic analysis of Hipk4(-/-) testes revealed phosphorylation of multiple proteins regulated by HIPK4 during spermiogenesis. We also confirmed that a substrate of HIPK4 with four downregulated phosphorylation sites matching the xSPx motif is the known manchette-related protein RIMS-binding protein 3, which is required for sperm head morphogenesis. Therefore, we conclude HIPK4 regulates the phosphorylation of manchette protein RIMS-binding protein 3 and plays essential roles in sperm head shaping and male fertility.	[Liu, Xiaofei; Zang, Chunyan; Wu, Yifei; Meng, Ru; Chen, Yu; Jiang, Tao; Wang, Cheng; Guo, Yueshuai; Situ, Chenghao; Hu, Zhibin; Zhang, Jun; Guo, Xuejiang] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Peoples R China; [Yang, Xiaoyu] Nanjing Med Univ, Ctr Reprod Med, Affiliated Hosp 1, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University	Hu, ZB; Zhang, J; Guo, XJ (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Peoples R China.	zhibin_hu@njmu.edu.cn; zhang_jun@njmu.edu.cn; guo_xuejiang@njmu.edu.cn	Guo, Xuejiang/J-9600-2014	Guo, Xuejiang/0000-0002-0475-5705; Liu, Xiaofei/0000-0003-4379-4923	National Key R&D Program of China [2021YFC2700200]; National Natural Science Foundation of China [31530047, 31871445, 31501211, 81971439, 32071133]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key R&D Program of China (2021YFC2700200) and National Natural Science Foundation of China (31530047, 31871445, 31501211, 81971439 and 32071133).	Alfano M, 2018, HUM REPROD, V33, P1212, DOI 10.1093/humrep/dey116; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Ann EJ, 2016, CANCER RES, V76, P4728, DOI 10.1158/0008-5472.CAN-15-3310; Ben Khelifa M, 2014, AM J HUM GENET, V94, P95, DOI 10.1016/j.ajhg.2013.11.017; Berookhim BM, 2014, UROL CLIN N AM, V41, P97, DOI 10.1016/j.ucl.2013.08.004; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Cannarella R, 2019, HUM GENET, V138, P125, DOI 10.1007/s00439-019-01974-1; Cervan-Martin M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020300; Cheng A, 2019, BIOINFORMATICS, V35, P2774, DOI 10.1093/bioinformatics/bty1058; Cheng CY, 2010, NAT REV ENDOCRINOL, V6, P380, DOI 10.1038/nrendo.2010.71; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crapster JA, 2020, ELIFE, V9, DOI 10.7554/eLife.50209; deKretser DM, 1997, LANCET, V349, P787, DOI 10.1016/S0140-6736(96)08341-9; Don J, 2002, MOL CELL ENDOCRINOL, V187, P115, DOI 10.1016/S0303-7207(01)00696-7; GROOTEGOED JA, 1995, HUM REPROD, V10, P10, DOI 10.1093/humrep/10.suppl_1.10; Guo JT, 2018, CELL RES, V28, P1141, DOI 10.1038/s41422-018-0099-2; Irvine DS, 1998, HUM REPROD, V13, P33, DOI 10.1093/humrep/13.suppl_1.33; Jan SZ, 2012, BBA-MOL BASIS DIS, V1822, P1838, DOI 10.1016/j.bbadis.2012.02.008; JAROW JP, 1989, J UROLOGY, V142, P62, DOI 10.1016/S0022-5347(17)38662-7; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Kueng P, 1997, J CELL BIOL, V139, P1851, DOI 10.1083/jcb.139.7.1851; Lee JY, 2011, UROLOGY, V77, P598, DOI 10.1016/j.urology.2010.10.001; Lehti MS, 2016, REPRODUCTION, V151, pR43, DOI 10.1530/REP-15-0310; Liu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077367; MATSUMIYA K, 1994, INT J ANDROL, V17, P140, DOI 10.1111/j.1365-2605.1994.tb01233.x; Mendoza-Lujambio I, 2002, HUM MOL GENET, V11, P1647, DOI 10.1093/hmg/11.14.1647; Mruk DD, 2004, TRENDS ENDOCRIN MET, V15, P439, DOI 10.1016/j.tem.2004.09.009; Neesen J, 2001, HUM MOL GENET, V10, P1117, DOI 10.1093/hmg/10.11.1117; O'Donnell L., 2014, SPERMATOGENESIS, V4, pe979623, DOI [10.4161/21565562.2014.979623, DOI 10.4161/21565562.2014.979623]; O'Donnell L, 2014, SEMIN CELL DEV BIOL, V30, P45, DOI 10.1016/j.semcdb.2014.01.003; Ogurtsov AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003599; Pasch E, 2015, BIOL OPEN, V4, P1792, DOI 10.1242/bio.015768; Qi L, 2014, MOL CELL PROTEOMICS, V13, P3626, DOI 10.1074/mcp.M114.039073; RUSSELL LD, 1991, AM J ANAT, V192, P97, DOI 10.1002/aja.1001920202; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sperry AO, 2012, BIOL CELL, V104, P297, DOI 10.1111/boc.201100102; Sudhakar Digumarthi V S, 2021, J Hum Reprod Sci, V14, P217, DOI 10.4103/jhrs.jhrs_115_21; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van der Laden J, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-014-0082-6; Vogl AW, 2013, INT REV CEL MOL BIO, V303, P319, DOI 10.1016/B978-0-12-407697-6.00008-8; Wang D, 2020, BIOL REPROD, V102, P1033, DOI 10.1093/biolre/ioaa018; Wang M, 2018, CELL STEM CELL, V23, P599, DOI 10.1016/j.stem.2018.08.007; Wang ZH, 2014, METHOD ENZYMOL, V548, P1, DOI 10.1016/B978-0-12-397918-6.00001-X; Westlander G, 2020, UPSALA J MED SCI, V125, P99, DOI 10.1080/03009734.2020.1737600; Wong CH, 2005, DEV BIOL, V286, P1, DOI 10.1016/j.ydbio.2005.08.001; Yamada D, 2009, ONCOGENE, V28, P2535, DOI 10.1038/onc.2009.109; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zafar A, 2015, ENVIRON GEOCHEM HLTH, V37, P515, DOI 10.1007/s10653-014-9666-8; Zhao HC, 2019, ANTIOXID REDOX SIGN, V30, P542, DOI 10.1089/ars.2017.7151; Zhou J, 2009, DEVELOPMENT, V136, P373, DOI 10.1242/dev.030858	55	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102327	10.1016/j.jbc.2022.102327	http://dx.doi.org/10.1016/j.jbc.2022.102327			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6F7ME	35931115	gold, Green Published			2022-12-26	WOS:000884241800006
J	Audemard-Verger, A; Le Gouge, A; Pestre, V; Courjon, J; Langlois, V; Vareil, MO; Devaux, M; Bienvenu, B; Leroy, V; Goulabchand, R; Colombain, L; Bigot, A; Guimard, T; Douadi, Y; Urbanski, G; Faucher, JF; Maulin, L; Lioger, B; Talarmin, JP; Groh, M; Emmerich, J; Deriaz, S; Ferreira-Maldent, N; Cook, AR; Lengelle, C; Bourgoin, H; Mekinian, A; Aouba, A; Maillot, F; Caille, A				Audemard-Verger, Alexandra; Le Gouge, Amelie; Pestre, Vincent; Courjon, Johan; Langlois, Vincent; Vareil, Marc-Olivier; Devaux, Mathilde; Bienvenu, Boris; Leroy, Vincent; Goulabchand, Radjiv; Colombain, Lea; Bigot, Adrien; Guimard, Thomas; Douadi, Youcef; Urbanski, Geoffrey; Faucher, Jean Francois; Maulin, Laurence; Lioger, Bertrand; Talarmin, Jean-Philippe; Groh, Matthieu; Emmerich, Joseph; Deriaz, Sophie; Ferreira-Maldent, Nicole; Cook, Ann-Rose; Lengelle, Celine; Bourgoin, Helene; Mekinian, Arsene; Aouba, Achille; Maillot, Francois; Caille, Agnes			Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trial	PLOS ONE			English	Article							RECEPTOR BLOCKADE; INTERLEUKIN-1	Objective We aimed to investigate whether anakinra, an interleukin-1 receptor inhibitor, could improve outcome in moderate COVID-19 patients. Methods In this controlled, open-label trial, we enrolled adults with COVID-19 requiring oxygen. We randomly assigned patients to receive intravenous anakinra plus optimized standard of care (oSOC) vs. oSOC alone. The primary outcome was treatment success at day 14 defined as patient alive and not requiring mechanical ventilation or extracorporeal membrane oxygenation. Results Between 27th April and 6th October 2020, we enrolled 71 patients (240 patients planned to been enrolled): 37 were assigned to the anakinra group and 34 to oSOC group. The study ended prematurely by recommendation of the data and safety monitoring board due to safety concerns. On day 14, the proportion of treatment success was significantly lower in the anakinra group 70% (n = 26) vs. 91% (n = 31) in the oSOC group: risk difference-21 percentage points (95% CI, -39 to -2), odds ratio 0.23 (95% CI, 0.06 to 0.91), p = 0.027. After a 28-day follow-up, 9 patients in the anakinra group and 3 in the oSOC group had died. Overall survival at day 28 was 75% (95% CI, 62% to 91%) in the anakinra group versus 91% (95% CI, 82% to 100%) (p = 0.06) in the oSOC group. Serious adverse events occurred in 19 (51%) patients in the anakinra group and 18 (53%) in the oSOC group (p = 0.89). Conclusion This trial did not show efficacy of anakinra in patients with COVID-19. Furthermore, contrary to our hypothesis, we found that anakinra was inferior to oSOC in patients with moderate COVID-19 pneumonia.	[Audemard-Verger, Alexandra; Bigot, Adrien; Deriaz, Sophie; Ferreira-Maldent, Nicole; Cook, Ann-Rose; Maillot, Francois] CHRU Tours, Dept Internal Med & Clin Immunol, Tours, France; [Audemard-Verger, Alexandra; Maillot, Francois; Caille, Agnes] Univ Tours, Tours, France; [Le Gouge, Amelie; Caille, Agnes] CHRU Tours, INSERM CIC1415, Tours, France; [Pestre, Vincent] CH Avignon, Dept Internal Med & Infect Dis, Avignon, France; [Courjon, Johan] Univ Cote dAzur, Dept Infect Dis, CHU Nice, Nice, France; [Langlois, Vincent] CH Havre, Dept Internal Med, Le Havre, France; [Vareil, Marc-Olivier] CH Bayonne, Dept Infect Dis, Bayonne, France; [Devaux, Mathilde] CH Poissy, Dept Internal Med, Poissy, France; [Bienvenu, Boris] Hop St Joseph, Dept Internal Med, Marseille, France; [Leroy, Vincent] Clin Tessier, Dept Infect Dis, Valenciennes, France; [Goulabchand, Radjiv] Univ Montpellier, Nimes Univ Hosp, Internal Med Dept, Nimes, France; [Goulabchand, Radjiv] Univ Montpellier, Nimes Univ Hosp, Dept Infect & Trop Dis, Nimes, France; [Colombain, Lea] CH Perpignan, Dept Infect Dis, Perpignan, France; [Guimard, Thomas] CH la Roche sur Yon, Dept Infect Dis, La Roche Sur Yon, France; [Douadi, Youcef] CH St Quentin, Dept Infect Dis, St Quentin en Yvelines, France; [Urbanski, Geoffrey] CHU Angers, Dept Internal Med & Clin Immunol, Angers, France; [Faucher, Jean Francois] CHU Limoges, Dept Infect Dis, Limoges, France; [Maulin, Laurence] CH Aix Provence, Dept Infect Dis, Aix En Provence, France; [Lioger, Bertrand] CH Blois, Dept Internal Med, Blois, Loir & Cher, France; [Talarmin, Jean-Philippe] CH Quimper, Dept Internal Med & Infect Dis, Quimper, France; [Groh, Matthieu] Hop Foch, Dept Internal Med, Suresnes, France; [Emmerich, Joseph] GH St Joseph, Dept Vasc Med, Paris, France; [Emmerich, Joseph] Univ Paris, INSERM CRESS 1153, Paris, France; [Lengelle, Celine] CHRU Tours, Clin Res Vigilance Unit, Tours, France; [Bourgoin, Helene] CHRU Tours, Dept Pharmacol, Tours, France; [Mekinian, Arsene] Sorbonne Univ, Dept Internal Med, Hop St Antoine, Paris, France; [Aouba, Achille] CHU Caen, Dept Internal Med, Caen, France	CHU Tours; Universite de Tours; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Nimes; CHD Vendee; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Limoges; Hospital Foch; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Caen NORMANDIE; Universite de Caen Normandie	Audemard-Verger, A (corresponding author), CHRU Tours, Dept Internal Med & Clin Immunol, Tours, France.; Audemard-Verger, A (corresponding author), Univ Tours, Tours, France.	a.audemard-verger@chu-tours.fr			foundation of the Tours university hospital through the endowment fund of the university hospital of Tours	foundation of the Tours university hospital through the endowment fund of the university hospital of Tours	ANACONDA was supported by the foundation of the Tours university hospital through the endowment fund of the university hospital of Tours. Sobi supplied anakinra free of charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouba A, 2020, ANN RHEUM DIS, V79, P1381, DOI 10.1136/annrheumdis-2020-217706; Cauchois R, 2020, P NATL ACAD SCI USA, V117, P18951, DOI 10.1073/pnas.2009017117; Dimopoulos G, 2020, CELL HOST MICROBE, V28, P117, DOI 10.1016/j.chom.2020.05.007; Dinarello CA, 2013, SEMIN IMMUNOL, V25, P469, DOI 10.1016/j.smim.2013.10.008; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Huet T, 2020, LANCET RHEUMATOL, V2, pE393, DOI 10.1016/S2665-9913(20)30164-8; Jouan Y, 2020, J EXP MED, V217, DOI 10.1084/jem.20200872; Kyriazopoulou E, 2021, NAT MED, V27, P1752, DOI 10.1038/s41591-021-01499-z; Mariette X, 2021, LANCET RESP MED, V9, P295, DOI 10.1016/S2213-2600(20)30556-7; Marshall JC, 2020, LANCET INFECT DIS, V20, pE192, DOI 10.1016/S1473-3099(20)30483-7; Mehta P, 2020, LANCET RHEUMATOL, V2, pE358, DOI 10.1016/S2665-9913(20)30096-5; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Shakoory B, 2016, CRIT CARE MED, V44, P275, DOI 10.1097/CCM.0000000000001402; Spangfors M, 2016, INTENS CRIT CARE NUR, V37, P62, DOI 10.1016/j.iccn.2016.05.007; Vastert SJ, 2019, RHEUMATOLOGY, V58, P9, DOI 10.1093/rheumatology/kez350; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	18	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0269065	10.1371/journal.pone.0269065	http://dx.doi.org/10.1371/journal.pone.0269065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925914	Green Published, gold			2022-12-26	WOS:000848077100010
J	Lhopitallier, C; Perrault, C; Chauveau, F; Saurini, F; Berrard, S; Granon, S; Faure, A				Lhopitallier, Cyril; Perrault, Charlotte; Chauveau, Frederic; Saurini, Francoise; Berrard, Sylvie; Granon, Sylvie; Faure, Alexis			Characterization of social behavior in young and middle-aged ChAT-IRES-Cre mouse	PLOS ONE			English	Article							VESICULAR ACETYLCHOLINE TRANSPORTER; STRIATAL CHOLINERGIC INTERNEURONS; DORSOMEDIAL STRIATUM; NICOTINIC RECEPTORS; NUCLEUS-ACCUMBENS; BRAIN; COGNITION; MICE; MODULATION; DOPAMINE	The cholinergic system is an important modulator of brain processes. It contributes to the regulation of several cognitive functions and emotional states, hence altering behaviors. Previous works showed that cholinergic (nicotinic) receptors of the prefrontal cortex are needed for adapted social behaviors. However, these data were obtained in mutant mice that also present alterations of several neurotransmitter systems, in addition to the cholinergic system. ChAT-IRES-Cre mice, that express the Cre recombinase specifically in cholinergic neurons, are useful tools to investigate the role of the cholinergic circuits in behavior. However, their own behavioral phenotype has not yet been fully characterized, in particular social behavior. In addition, the consequences of aging on the cholinergic system of ChAT-IRES-Cre mice has never been studied, despite the fact that aging is known to compromise the cholinergic system efficiency. The aim of the current study was thus to characterize the social phenotype of ChAT-IRES-Cre mice both at young (2-3 months) and middle (10-11 months) ages. Our results reveal an alteration of the cholinergic system, evidenced by a decrease of ChAT, CHT and VAChT gene expression in the striatum of the mice, that was accompanied by mild social disturbances and a tendency towards anxiety. Aging decreased social dominance, without being amplified by the cholinergic alterations. Altogether, this study shows that ChAT-IRES-Cre mice are useful models for studying the cholinergic system's role in social behavior using appropriate modulating technics (optogenetic or DREADD).	[Lhopitallier, Cyril; Granon, Sylvie; Faure, Alexis] Univ Paris Saclay, Paris Saclay Inst Neurosci NeuroPSI, Neurobiol Decis Making, CNRS, Gif Sur Yvett, France; [Perrault, Charlotte] Univ Turku, Turku, Finland; [Chauveau, Frederic] Inst Rech Biomed Armees IRBA, Bretigny Sur Orge, France; [Saurini, Francoise; Berrard, Sylvie] Univ Paris, INSERM, NeuroDiderot, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Turku; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Faure, A (corresponding author), Univ Paris Saclay, Paris Saclay Inst Neurosci NeuroPSI, Neurobiol Decis Making, CNRS, Gif Sur Yvett, France.	alexia.faure@universite-paris-saclay.fr		FAURE, alexis/0000-0002-2033-3879; Lhopitallier, Cyril/0000-0003-2469-9701; PERRAULT, Charlotte/0000-0002-3821-0156				Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Aoki S, 2015, J NEUROSCI, V35, P9424, DOI 10.1523/JNEUROSCI.0490-15.2015; Apparsundaram S, 2000, BIOCHEM BIOPH RES CO, V276, P862, DOI 10.1006/bbrc.2000.3561; Araujo JA, 2005, PROG NEURO-PSYCHOPH, V29, P411, DOI 10.1016/j.pnpbp.2004.12.008; Ashkenazi SL, 2021, EUR J NEUROSCI, V53, P2078, DOI 10.1111/ejn.14873; Avale ME, 2008, P NATL ACAD SCI USA, V105, P15991, DOI 10.1073/pnas.0807635105; Avale ME, 2011, FASEB J, V25, P2145, DOI 10.1096/fj.10-178558; Baez-Mendoza R, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00233; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara Antoine, 2003, J Gambl Stud, V19, P23, DOI 10.1023/A:1021223113233; BEJANIN S, 1994, J BIOL CHEM, V269, P21944; Bloem B, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00017; Bourin M., 2013, PSN, V11, P39; Boyer F, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00055; Brandon EP, 2004, J NEUROSCI, V24, P5459, DOI 10.1523/JNEUROSCI.1106-04.2004; Brudzynski SM, 2007, BEHAV BRAIN RES, V182, P261, DOI 10.1016/j.bbr.2007.03.004; CERVINI R, 1995, J BIOL CHEM, V270, P24654, DOI 10.1074/jbc.270.42.24654; Chabout J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00468; Chabout J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029401; Chen E, 2018, J NEUROSCI, V38, P2177, DOI 10.1523/JNEUROSCI.1433-17.2018; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Collins AL, 2019, BIOL PSYCHIAT, V86, P388, DOI 10.1016/j.biopsych.2019.02.014; Coura RD, 2012, PSYCHOPHARMACOLOGY, V221, P1, DOI 10.1007/s00213-011-2596-6; Coura RS, 2013, FASEB J, V27, P4343, DOI 10.1096/fj.13-231084; Dautan D, 2014, J NEUROSCI, V34, P4509, DOI 10.1523/JNEUROSCI.5071-13.2014; Daviu N, 2019, NEUROBIOL STRESS, V11, DOI 10.1016/j.ynstr.2019.100191; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; De Gois S, 2000, J BIOL CHEM, V275, P36683, DOI 10.1074/jbc.M006895200; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; Dumas JA, 2011, PHARMACOL BIOCHEM BE, V99, P254, DOI 10.1016/j.pbb.2011.02.022; Eggermann E, 2014, CELL REP, V9, P1654, DOI 10.1016/j.celrep.2014.11.005; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; File SE, 1998, BEHAV NEUROSCI, V112, P1423, DOI 10.1037/0735-7044.112.6.1423; Fortier J, 2016, GERIATR PSYCHOL NEUR, V14, P438, DOI 10.1684/pnv.2016.0640; Furey ML, 2008, NEUROPSYCHOPHARMACOL, V33, P913, DOI 10.1038/sj.npp.1301461; GAGE FH, 1988, NEUROBIOL AGING, V9, P645, DOI 10.1016/S0197-4580(88)80129-5; GALLAGHER M, 1995, CURR OPIN NEUROBIOL, V5, P161, DOI 10.1016/0959-4388(95)80022-0; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Granon S, 2003, P NATL ACAD SCI USA, V100, P9596, DOI 10.1073/pnas.1533498100; Granon S, 2018, HBK BEHAV NEUROSCI, V25, P423, DOI 10.1016/B978-0-12-809600-0.00040-8; Gritton HJ, 2016, P NATL ACAD SCI USA, V113, pE1089, DOI 10.1073/pnas.1516134113; HAGA T, 1973, BIOCHIM BIOPHYS ACTA, V291, P564, DOI 10.1016/0005-2736(73)90508-7; Harno E, 2013, CELL METAB, V18, P21, DOI 10.1016/j.cmet.2013.05.019; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Holler T, 1996, NEUROSCI LETT, V212, P107, DOI 10.1016/0304-3940(96)12808-1; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; Kalmbach A, 2012, J NEUROPHYSIOL, V107, P2008, DOI 10.1152/jn.00870.2011; Karvat G, 2014, NEUROPSYCHOPHARMACOL, V39, P831, DOI 10.1038/npp.2013.274; Keightley ML, 2006, PSYCHOL AGING, V21, P558, DOI 10.1037/0882-7974.21.3.558; Kolisnyk B, 2013, J NEUROSCI, V33, P10427, DOI 10.1523/JNEUROSCI.0395-13.2013; Kucinski A, 2019, BEHAV NEUROSCI, V133, P121, DOI 10.1037/bne0000290; Lecomte MJ, 2018, ENDOCRINOLOGY, V159, P1844, DOI 10.1210/en.2017-03175; Lefebvre E, 2020, ANIM COGN, V23, P351, DOI 10.1007/s10071-019-01338-2; Li HL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213088; Li Y, 2018, CURR OPIN NEUROBIOL, V53, P120, DOI 10.1016/j.conb.2018.07.005; Lima RD, 2010, J NEUROCHEM, V113, P943, DOI 10.1111/j.1471-4159.2010.06657.x; Liu YJ, 2014, INTEGR ZOOL, V9, P255, DOI 10.1111/1749-4877.12057; Mandairon N, 2006, EUR J NEUROSCI, V24, P3234, DOI 10.1111/j.1460-9568.2006.05212.x; Mantanona CP, 2019, BRAIN STRUCT FUNCT, V224, P3095, DOI 10.1007/s00429-019-01957-y; Marking S, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00010; Martos YV, 2017, J NEUROSCI, V37, P2849, DOI 10.1523/JNEUROSCI.3460-16.2017; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Maskos U, 2007, J NEUROCHEM, V100, P596, DOI 10.1111/j.1471-4159.2006.04224.x; Matamales M, 2016, NEURON, V90, P362, DOI 10.1016/j.neuron.2016.03.006; Mei L, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.598811; Mena-Segovia J, 2017, NEURON, V94, P7, DOI 10.1016/j.neuron.2017.02.027; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; Mohrhardt J, 2018, CHEM SENSES, V43, P667, DOI 10.1093/chemse/bjy061; Moran JM, 2012, J NEUROSCI, V32, P5553, DOI 10.1523/JNEUROSCI.5511-11.2012; Naciff JM, 1997, NEUROREPORT, V8, P3467, DOI 10.1097/00001756-199711100-00011; Nagy PM, 2012, NEUROSCIENCE, V218, P1, DOI 10.1016/j.neuroscience.2012.05.047; Nieves-Martinez E, 2012, BEHAV BRAIN RES, V227, P258, DOI 10.1016/j.bbr.2011.10.048; Nosjean A, 2015, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00447; Okuda T, 2000, NAT NEUROSCI, V3, P120, DOI 10.1038/72059; Pittaras E, 2016, BRAIN STRUCT FUNCT, V221, P4615, DOI 10.1007/s00429-016-1192-2; Prado VF, 2017, NEUROSCIENCE, V345, P130, DOI 10.1016/j.neuroscience.2016.09.013; Ragozzino ME, 2003, NEUROBIOL LEARN MEM, V80, P257, DOI 10.1016/S1074-7427(03)00077-7; Raybuck JD, 2010, NEUROBIOL LEARN MEM, V94, P353, DOI 10.1016/j.nlm.2010.08.001; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Salchner P, 2004, BEHAV BRAIN RES, V151, P1, DOI 10.1016/j.bbr.2003.07.002; SCHAMBRA UB, 1989, J COMP NEUROL, V288, P101, DOI 10.1002/cne.902880109; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; SELDEN N, 1994, NEUROSCIENCE, V60, P621, DOI 10.1016/0306-4522(94)90491-X; Sharma PK, 2020, NEUROTHERAPEUTICS, V17, P1120, DOI 10.1007/s13311-019-00830-4; SHERMAN KA, 1990, INT J DEV NEUROSCI, V8, P689, DOI 10.1016/0736-5748(90)90063-8; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; Simola N, 2019, NEUROPHARMACOLOGY, V159, DOI 10.1016/j.neuropharm.2018.11.008; Smith RS, 2015, J NEUROSCI, V35, P10773, DOI 10.1523/JNEUROSCI.0099-15.2015; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Ting JT, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00111; Wilson MA, 2017, J NEUROSCI RES, V95, P836, DOI 10.1002/jnr.23840; WU M, 1993, CAN J PHYSIOL PHARM, V71, P407, DOI 10.1139/y93-061; Xiao C, 2016, NEURON, V90, P333, DOI 10.1016/j.neuron.2016.03.028; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Yilmaz M, 2013, CURR BIOL, V23, P2011, DOI 10.1016/j.cub.2013.08.015; Zoli M, 1999, EMBO J, V18, P1235, DOI 10.1093/emboj/18.5.1235	101	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272141	10.1371/journal.pone.0272141	http://dx.doi.org/10.1371/journal.pone.0272141			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925937	Green Published, gold			2022-12-26	WOS:000848077100074
J	Wang, J; Du, GJ; Liu, M				Wang, Jing; Du, Guangjie; Liu, Mohan			Spatiotemporal characteristics and influencing factors of carbon emissions from civil buildings: Evidence from urban China	PLOS ONE			English	Article							CO2 EMISSIONS; CONSTRUCTION-INDUSTRY; URBANIZATION PROCESS; ENERGY-CONSUMPTION; IMPACT; INDUSTRIALIZATION; STIRPAT	Carbon emissions from civil buildings refer to the carbon emissions generated during the operation of civil buildings. With the continuous development of the urban economy and the improvement of people's living standards, this part of carbon emission puts tremendous pressure on China to achieve the goal of carbon peaking and carbon neutral. In the context of rapid urbanization, studying the spatiotemporal characteristics and influencing factors of the carbon emissions from civil buildings have strong practical significance for China to achieve the "dual carbon" goal. Based on the emission data from 104 prefecture-level cities in China, we examine the spatiotemporal characteristics of the civil building carbon emissions from the perspectives of temporal evolution trend, spatial distribution and its dynamic evolution, spatial difference and its decomposition, and spatial autocorrelation characteristics. Finally, we reveal the influencing factors of the carbon emissions from civil buildings using static panel data models and spatial dynamic panel data models. The results of the study show that: (1) During the sample period, the carbon emissions from civil buildings have increased year by year. The civil building carbon emissions have become an important source of China's overall carbon emissions. Realizing energy saving and emission reduction in the operational stage of civil buildings is crucial to realizing China's "dual carbon" goal. (2) According to the estimated results, there is a significant inverted U-shaped non-linear relationship between urbanization and civil building carbon emissions. Most Chinese cities are located in the upward part of the inverted U-shaped curve at present. Thus, the traditional economic growth model characterized by high energy consumption and high emission during rapid urbanization should be abandoned to reduce the carbon emissions from civil buildings. (3) Technological progress and fixed asset investment can effectively reduce the carbon emissions from civil buildings. At the same time, the level of marketization and social consumption expenditure positively affect the carbon emissions from civil buildings. It is necessary to improve the relevant market mechanisms, policy subsidies, and other means to encourage the application of green energy-saving technologies in civil buildings. Also, it is needed to guide the urban residents' consumption structure and lifestyle in a low-carbon direction, to reduce the energy consumption and carbon emissions during the operation of civil buildings.	[Wang, Jing; Du, Guangjie; Liu, Mohan] Shanghai Univ Finance & Econ, Inst Finance & Econ Res, Shanghai, Peoples R China	Shanghai University of Finance & Economics	Wang, J (corresponding author), Shanghai Univ Finance & Econ, Inst Finance & Econ Res, Shanghai, Peoples R China.	wang.jing@sufe.edu.cn			National Natural Science Foundation of China [4207129]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors would like to acknowledge the financial support of the National Natural Science Foundation of China [grant numbers 4207129]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi MA, 2019, ENVIRON SCI POLLUT R, V26, P29978, DOI 10.1007/s11356-019-06154-2; Ali R, 2019, SUSTAIN CITIES SOC, V48, DOI 10.1016/j.scs.2019.101553; Anselin L., 1996, SPATIAL ANAL PERSPEC, P111, DOI [10.1201/9780203739051-8, DOI 10.1201/9780203739051-8]; Chen Y.C., 2017, BIOSTATISTICS EPIDEM, V1, P161, DOI 10.1080/24709360.2017.1396742; Dagum C., 1997, STATISTICA, V57, P295, DOI 10.6092/issn.1973-2201/1060; Davis SJ, 2011, P NATL ACAD SCI USA, V108, P18554, DOI 10.1073/pnas.1107409108; Dong F, 2019, RESOUR CONSERV RECY, V141, P61, DOI 10.1016/j.resconrec.2018.10.010; EHRLICH PR, 1971, SCIENCE, V171, P1212, DOI 10.1126/science.171.3977.1212; Fan JL, 2017, RENEW SUST ENERG REV, V75, P220, DOI 10.1016/j.rser.2016.10.066; Fan Y, 2006, ENVIRON IMPACT ASSES, V26, P377, DOI 10.1016/j.eiar.2005.11.007; He ZX, 2017, J CLEAN PROD, V140, P1719, DOI 10.1016/j.jclepro.2016.08.155; Hong JK, 2016, RENEW SUST ENERG REV, V53, P1303, DOI 10.1016/j.rser.2015.09.068; Hou HM, 2021, ENVIRON IMPACT ASSES, V86, DOI 10.1016/j.eiar.2020.106510; Hou HM, 2020, J CLEAN PROD, V264, DOI 10.1016/j.jclepro.2020.121738; Huang XQ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173105; Huo TF, 2021, SCI TOTAL ENVIRON, V772, DOI 10.1016/j.scitotenv.2021.145058; Huo TF, 2020, SUSTAIN CITIES SOC, V56, DOI 10.1016/j.scs.2020.102068; Kang P, 2020, ENVIRON IMPACT ASSES, V80, DOI 10.1016/j.eiar.2019.106336; Li K, 2015, RENEW SUST ENERG REV, V52, P1107, DOI 10.1016/j.rser.2015.07.185; Liddle B, 2010, POPUL ENVIRON, V31, P317, DOI 10.1007/s11111-010-0101-5; Lin B.Q., 2010, ECON RES-EKON ISTRAZ, V45, P66; Liu XY, 2018, J CLEAN PROD, V172, P178, DOI 10.1016/j.jclepro.2017.10.156; Lu YJ, 2016, BUILD ENVIRON, V95, P94, DOI 10.1016/j.buildenv.2015.09.011; Lv Q, 2019, J CLEAN PROD, V211, P481, DOI 10.1016/j.jclepro.2018.11.182; Prastiyo SE, 2020, ENVIRON SCI POLLUT R, V27, P42092, DOI 10.1007/s11356-020-10148-w; Quah D.T., 1997, J ECON GROWTH, V2, P27, DOI [10.1023/a:1009781613339, DOI 10.1023/A:1009781613339]; Sadorsky P, 2014, ENERG ECON, V41, P147, DOI 10.1016/j.eneco.2013.11.007; Wang JM, 2020, POL J ENVIRON STUD, V29, P331, DOI 10.15244/pjoes/105239; Wang Q, 2019, SUSTAIN CITIES SOC, V51, DOI 10.1016/j.scs.2019.101758; Wang QW, 2016, ENERGY, V113, P728, DOI 10.1016/j.energy.2016.07.108; Wang WX, 2014, SCI WORLD J, DOI 10.1155/2014/782750; Wang Z, 2019, J CLEAN PROD, V211, P1201, DOI 10.1016/j.jclepro.2018.11.272; Wu YZ, 2016, J CLEAN PROD, V135, P589, DOI 10.1016/j.jclepro.2016.06.121; Xu B, 2015, ENERG ECON, V48, P188, DOI 10.1016/j.eneco.2015.01.005; Xu SC, 2016, REG ENVIRON CHANGE, V16, P777, DOI 10.1007/s10113-015-0795-0; Xu XB, 2017, J CLEAN PROD, V142, P3607, DOI 10.1016/j.jclepro.2016.10.107; Yan Z, 2014, LANDSCAPE URBAN PLAN, V130, P184, DOI 10.1016/j.landurbplan.2014.05.006; Yao XL, 2018, ENVIRON IMPACT ASSES, V71, P70, DOI 10.1016/j.eiar.2018.04.005; York R, 2003, ECOL ECON, V46, P351, DOI 10.1016/S0921-8009(03)00188-5; Zhang CG, 2012, ENERG POLICY, V49, P488, DOI 10.1016/j.enpol.2012.06.048	40	2	2	34	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272295	10.1371/journal.pone.0272295	http://dx.doi.org/10.1371/journal.pone.0272295			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925953	gold, Green Published			2022-12-26	WOS:000848077100082
J	Elfalah, M; Sulyman, NK; Alrwashdeh, AK; Al Hajaj, SK; Alrawashdeh, SK; Al-Rawashdeh, AK; AlRyalat, SAK				Elfalah, Mutasem; Sulyman, Nesrin K.; Alrwashdeh, Anas K.; Al Hajaj, Sari K.; Alrawashdeh, Sonia K.; Al-Rawashdeh, Asad K.; AlRyalat, Saif Aldeen K.			Assessing the impact of color blindness on the ability of identifying benign and malignant skin lesions by naked-eye examination	PLOS ONE			English	Article							PRIMARY-CARE; CUTANEOUS MELANOMA; DIAGNOSIS; PRACTITIONERS; CRITERIA	BackgroundColor vision deficiency describes the inability to distinguish certain shades of color. The aim of this study was to assess the impact of having color vision deficiency on the accuracy of distinguishing benign and malignant skin lesions by naked-eye examination. MethodsThis was a cross-sectional study conducted during the period August 2020 to February 2021. We randomly selected a total of 20 nevi and 20 melanoma images from an open access image database. The 40 images were divided into four sets of images, each set contained 5 benign and 5 malignant skin lesion images simulated as if they were seen by a protanope physician, deuteranope physician, tritanope physician, and a set of images presented without simulation. In an online survey, students who were in their final year of medical school or had newly graduated were asked to diagnose each image as benign or malignant. ResultsA total of 140 participants were included with a mean (SD) age of 24.88 (1.51). We found a significantly higher mean accuracy for non-simulated images compared to deuteranope simulated images (p< 0.001, mean difference = 11.07, 95% CI 8.40 to 13.74). We did not find a significant difference in accuracy classification for protanope simulated images (p = 0.066), nor for tritanope simulated images (p = 0.315). Classification accuracy for malignant lesions was higher than classification accuracy for benign lesions, with the highest difference belonging to deuteranope simulated images, with a difference in mean accuracy of classifying malignant lesions by 32.2 (95% CI 27.0 to 37.6). ConclusionDeuteranope participants (i.e., green color deficiency) had a significantly lower accuracy of distinguishing pigmented skin lesions as benign or malignant, an impact not found for other color vision deficiencies, which was mainly for misdiagnosing benign lesions as malignant.	[Elfalah, Mutasem; AlRyalat, Saif Aldeen K.] Univ Jordan, Dept Ophthalmol, Amman, Jordan; [Sulyman, Nesrin K.] Primary Healthcare Corp, Internal Med, Doha, Qatar; [Alrwashdeh, Anas K.] King Hussein Canc Ctr, Internal Med, Amman, Jordan; [Al Hajaj, Sari K.] Univ Jordan, Sch Med, Amman, Jordan; [Alrawashdeh, Sonia K.] Saratoga Vitreo Retinal Ophthalmol, Dept Ophthalmol, New York, NY USA; [Al-Rawashdeh, Asad K.] Private Clin, Internal Med, Lubbock, TX USA	University of Jordan; King Hussein Cancer Center; University of Jordan	AlRyalat, SAK (corresponding author), Univ Jordan, Dept Ophthalmol, Amman, Jordan.	s.alryalat@ju.edu.jo		elfalah, `mutasem/0000-0002-9677-6203; ALRAWASHDEH, SONIA MALEK/0000-0002-8436-2943				Abbasi NR, 2004, JAMA-J AM MED ASSOC, V292, P2771, DOI 10.1001/jama.292.22.2771; AlRyalat SA., 2022, **DATA OBJECT**, DOI 10.7910/DVN/OX324U; AlRyalat SA, 2021, EYE, V35, P2229, DOI 10.1038/s41433-020-01232-z; [Anonymous], DERMATOLOGY DATABASE; [Anonymous], COLOR VISION DEFICIE; [Anonymous], CAN YOU RECOGNIZE BE; Carli P, 2005, EUR J CANCER PREV, V14, P51, DOI 10.1097/00008469-200502000-00007; Castillo-Arenas E, 2014, ACTAS DERMO-SIFILOGR, V105, P271, DOI [10.1016/j.ad.2013.10.003, 10.1016/j.adengl.2013.10.005]; Chan XBV, 2014, ASIA PAC FAM MED, V13, P10, DOI [10.1186/s12930-014-0010-3, DOI 10.1186/S12930-014-0010-3]; Chen SC, 2006, J GEN INTERN MED, V21, P678, DOI 10.1111/j.1525-1497.2006.00462.x; Conic RZ, 2018, J AM ACAD DERMATOL, V78, P40, DOI 10.1016/j.jaad.2017.08.039; Corbo MD, 2012, J CUTAN MED SURG, V16, P306, DOI 10.1177/120347541201600506; Cummins DL, 2006, MAYO CLIN PROC, V81, P500, DOI 10.4065/81.4.500; De Bedout V, 2021, DERMATOL PRACT CONCE, V11, DOI 10.5826/dpc.1101a145; FRIEDMAN RJ, 1985, CA-CANCER J CLIN, V35, P130, DOI 10.3322/canjclin.35.3.130; FROME FS, 1981, J OPT SOC AM, V71, P145, DOI 10.1364/JOSA.71.000145; Gachon J, 2005, ARCH DERMATOL, V141, P434, DOI 10.1001/archderm.141.4.434; Giotis I, 2015, EXPERT SYST APPL, V42, P6578, DOI 10.1016/j.eswa.2015.04.034; Girardi S, 2006, INT J CANCER, V118, P2276, DOI 10.1002/ijc.21351; Grange F, 2005, ANN DERMATOL VENER, V132, P956, DOI 10.1016/S0151-9638(05)79556-9; Hajdarevic S, 2014, DERMAT RES PRACT, V2014, DOI 10.1155/2014/294287; KAISER PK, 1990, J PHYSIOL-LONDON, V422, P153, DOI 10.1113/jphysiol.1990.sp017978; Lillo J, 2014, J VISION, V14, DOI 10.1167/14.8.15; Longo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136031; Pereira da Veiga CR., 2018, 3279188 ID, DOI [10.2139/ssrn.3279188, DOI 10.2139/SSRN.3279188]; Rigel DS, 2010, CA-CANCER J CLIN, V60, P301, DOI 10.3322/caac.20074; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Spalding JAB, 2010, CLIN EXP OPTOM, V93, P39, DOI 10.1111/j.1444-0938.2009.00434.x; Thilander K., 2016, CLIN RES DERMATOL OP, P3; Thomas L, 1998, DERMATOLOGY, V197, P11, DOI 10.1159/000017969; Tsao H, 2015, J AM ACAD DERMATOL, V72, P717, DOI 10.1016/j.jaad.2015.01.025; Weinstock MA, 1996, J AM ACAD DERMATOL, V34, P1063, DOI 10.1016/S0190-9622(96)90287-X	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0270487	http://dx.doi.org/10.1371/journal.pone.0270487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921375	Green Published, gold			2022-12-26	WOS:000839311900083
J	Salman, M; Javed, MR; Ali, H; Mustafa, G; Tariq, A; Sahar, T; Naheed, S; Gill, I; Abid, M; Tawab, A				Salman, Mahwish; Javed, Muhammad Rizwan; Ali, Hazrat; Mustafa, Ghulam; Tariq, Anam; Sahar, Tanzila; Naheed, Shazia; Gill, Iqra; Abid, Muhammad; Tawab, Abdul			Bioprotection of Zea mays L. from aflatoxigenic Aspergillus flavus by Loigolactobacillus coryniformis BCH-4	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; LACTOBACILLUS-PLANTARUM; ANTIFUNGAL ACTIVITY; CYCLIC DIPEPTIDES; PHENOLIC CONTENT; IN-VITRO; PROLIFERATION; INHIBITION; MECHANISMS; OXIDATION	Fungal infection causes deterioration, discoloration, and loss of nutritional values of food products. The use of lactic acid bacteria has diverse applications in agriculture to combat pathogens and to improve the nutritional values of cereal grains. The current research evaluated the potential of Loigolactobacillus coryniformis BCH-4 against aflatoxins producing toxigenic Aspergillus flavus strain. The cell free supernatant (CFS) of Loig. coryniformis was used for the protection of Zea mays L. treated with A. flavus. No fungal growth was observed even after seven days. The FT-IR spectrum of untreated (T1: without any treatment) and treated maize grains (T2: MRS broth + A. flavus; T3: CFS + A. flavus) showed variations in peak intensities of functional group regions of lipids, proteins, and carbohydrates. Total phenolics, flavonoid contents, and antioxidant activity of T3 were significantly improved in comparison with T1 and T2. Aflatoxins were not found in T3 while observed in T2 (AFB1 and AFB2 = 487 and 16 ng/g each). HPLC analysis of CFS showed the presence of chlorogenic acid, p-coumaric acid, 4-hydroxybenzoic acid, caffeic acid, sinapic acid, salicylic acid, and benzoic acid. The presence of these acids in the CFS of Loig. coryniformis cumulatively increased the antioxidant contents and activity of T3 treated maize grains. Besides, CFS of Loig. coryniformis was passed through various treatments (heat, neutral pH, proteolytic enzymes and catalase), to observe its stability. It suggested that the inhibitory potential of CFS against A. flavus was due to the presence of organic acids, proteinaceous compounds and hydrogen peroxide. Conclusively, Loig. coryniformis BCH-4 could be used as a good bioprotecting agent for Zea mays L. by improving its nutritional and antioxidant contents.	[Salman, Mahwish; Mustafa, Ghulam; Tariq, Anam; Gill, Iqra] Govt Coll Univ Faisalabad GCUF, Dept Biochem, Faisalabad, Pakistan; [Javed, Muhammad Rizwan] Govt Coll Univ Faisalabad GCUF, Dept Bioinformat & Biotechnol, Faisalabad, Pakistan; [Ali, Hazrat; Tawab, Abdul] Natl Inst Biotechnol & Genet Engn NIBGE, Faisalabad, Pakistan; [Sahar, Tanzila] Govt Coll Women Univ Faisalabad, Dept Biochem, Faisalabad, Pakistan; [Naheed, Shazia] Govt Coll Univ Faisalabad GCUF, Dept Chem, Faisalabad, Pakistan; [Abid, Muhammad] Govt Coll Univ Faisalabad GCUF, Dept Stat, Faisalabad, Pakistan	Government College University Faisalabad; Government College University Faisalabad; Pakistan Institute of Engineering & Applied Science; Government College University Faisalabad; Government College University Faisalabad	Salman, M (corresponding author), Govt Coll Univ Faisalabad GCUF, Dept Biochem, Faisalabad, Pakistan.; Tawab, A (corresponding author), Natl Inst Biotechnol & Genet Engn NIBGE, Faisalabad, Pakistan.	mahwishsalman@gcuf.edu.pk; atawab1@yahoo.com	Mustafa, Dr. Ghulam/A-1657-2017	Mustafa, Dr. Ghulam/0000-0001-6510-6496	Higher Education Commission Pakistan [20-13535/NRPU/RGM/RD/HEC/2020]	Higher Education Commission Pakistan(Higher Education Commission of Pakistan)	The authors would like to acknowledge the facilities provided by Hi-Tech Lab, Government College University Faisalabad (GCUF).	Ainsworth EA, 2007, NAT PROTOC, V2, P875, DOI 10.1038/nprot.2007.102; Akwaji P, 2016, WORLD SCI NEWS, V53, P157; Anand SP, 2013, INT J PHARM SCI RES, V4, P2496, DOI 10.13040/IJPSR.0975-8232.4(7).24960-01; Arena MP, 2018, APPL MICROBIOL BIOT, V102, P9949, DOI 10.1007/s00253-018-9403-9; Ben Taheur F, 2019, TOXICON, V166, P15, DOI 10.1016/j.toxicon.2019.05.004; Bukhari SA, 2020, MOL BIOL REP, V47, P1871, DOI 10.1007/s11033-020-05281-1; Bulgasem BY, 2016, MYCOBIOLOGY, V44, P302, DOI 10.5941/MYCO.2016.44.4.302; Chang Injeong, 2007, Mycobiology, V35, P76, DOI 10.4489/MYCO.2007.35.2.076; Couto JA, 2006, AM J ENOL VITICULT, V57, P166; Crowley S, 2013, TRENDS FOOD SCI TECH, V33, P93, DOI 10.1016/j.tifs.2013.07.004; Nazareth TD, 2020, TOXINS, V12, DOI 10.3390/toxins12010021; Truong DH, 2019, J FOOD QUALITY, DOI 10.1155/2019/8178294; Ding WR, 2017, J FUNCT FOODS, V35, P481, DOI 10.1016/j.jff.2017.06.008; Dolatabadi JEN, 2010, FOOD RES INT, V43, P1223, DOI 10.1016/j.foodres.2010.03.026; El Oirdi S, 2021, J FOOD PROCESS PRES, V45, DOI 10.1111/jfpp.15517; Erenstein O, 2021, GLOB FOOD SECUR-AGR, V30, DOI 10.1016/j.gfs.2021.100558; Gebru YA, 2020, J FOOD QUALITY, V2020, DOI 10.1155/2020/8819555; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Hemmalakshmi S., 2017, J PHARM SCI RES, V9, P2062; Jamali M, 2012, FOLIA MICROBIOL, V57, P27, DOI 10.1007/s12223-011-0090-5; Junnarkar M, 2019, INDIAN J EXP BIOL, V57, P825; Kachouri F, 2014, J FOOD PROTECT, V77, P1760, DOI 10.4315/0362-028X.JFP-13-360; Kamran M, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10020187; Kedare SB, 2011, J FOOD SCI TECH MYS, V48, P412, DOI 10.1007/s13197-011-0251-1; Khanafari A., 2007, Iranian Journal of Environmental Health Science & Engineering, V4, P163; Kim SH, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052461; Klich MA, 2007, MOL PLANT PATHOL, V8, P713, DOI 10.1111/J.1364-3703.2007.00436.X; Kumar SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106041; Kwak MK, 2014, J MICROBIOL, V52, P64, DOI 10.1007/s12275-014-3520-7; Kwak MK, 2013, J MICROBIOL, V51, P836, DOI 10.1007/s12275-013-3521-y; Lavermicocca P, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.711013; Marie C., 2017, J CLIN NUTR DIET, V3, P27, DOI DOI 10.4172/2472-1921.100062; Massomo SMS, 2020, SCI AFR, V10, DOI 10.1016/j.sciaf.2020.e00606; Mecozzi M, 2008, MAR CHEM, V112, P38, DOI 10.1016/j.marchem.2008.05.007; Morales J, 2017, J APPL MICROBIOL, V123, P969, DOI 10.1111/jam.13540; Muhialdin BJ, 2020, FOOD CONTROL, V109, DOI 10.1016/j.foodcont.2019.106898; Nayyeri N, 2017, J FOOD MEAS CHARACT, V11, P1734, DOI 10.1007/s11694-017-9554-x; Ndagano D, 2011, J FOOD SCI, V76, pM305, DOI 10.1111/j.1750-3841.2011.02257.x; Oliveira PM, 2014, FOOD MICROBIOL, V37, P78, DOI 10.1016/j.fm.2013.06.003; Park J, 2020, MOLECULES, V25, DOI 10.3390/molecules25173895; Pawar SS, 2018, J KING SAUD UNIV SCI, V30, P293, DOI 10.1016/j.jksus.2016.09.002; Pessione E, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00876; Quiles JM, 2018, MOLECULES, V23, DOI 10.3390/molecules23071638; Rahman M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20235-1; Ranjith FH, 2022, FOOD CONTROL, V135, DOI 10.1016/j.foodcont.2021.108789; Razzaghi-Abyaneh M, 2006, MYCOPATHOLOGIA, V161, P183, DOI 10.1007/s11046-005-0242-8; Russo P, 2017, INT J FOOD MICROBIOL, V247, P48, DOI 10.1016/j.ijfoodmicro.2016.04.027; Sadiq FA, 2019, COMPR REV FOOD SCI F, V18, P1403, DOI 10.1111/1541-4337.12481; Salman M, 2022, ARCH MICROBIOL, V204, DOI 10.1007/s00203-022-02884-z; Salman M, 2020, MOLECULES, V25, DOI 10.3390/molecules25204685; Salman M, 2018, TURK J BIOCHEM, V43, P323, DOI 10.1515/tjb-2017-0075; Samaneh SK, 2016, INT J MED RES HEALTH, V5, P265; Sawant S. G., 2011, Current Botany, V2, P43; Seyi-Amole DO., 2021, MICROBIOLOGICAL CONT; Siedler S, 2019, CURR OPIN BIOTECH, V56, P138, DOI 10.1016/j.copbio.2018.11.015; Sjogren J, 2003, APPL ENVIRON MICROB, V69, P7554, DOI 10.1128/AEM.69.12.7554-7557.2003; Suleiman R., 2013, Journal of Natural Sciences Research, V3, P147; Sung WS, 2010, PURE APPL CHEM, V82, P219, DOI 10.1351/PAC-CON-09-01-08; Swain MR., 2016, LACTIC ACID FERMENTA, V1, P37; Taranto F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020377; Tian J, 2013, SCI WORLD J, DOI 10.1155/2013/230795; Umana EJ., 2014, J AGR CROP RES, V2, P236; Wang AN, 2009, J APPL MICROBIOL, V107, P1140, DOI 10.1111/j.1365-2672.2009.04294.x; Wang HK, 2011, INT J DAIRY TECHNOL, V64, P585, DOI 10.1111/j.1471-0307.2011.00716.x; Waterhouse AL, 2006, AM J ENOL VITICULT, V57, P306; Yang EJ, 2010, INT J FOOD MICROBIOL, V139, P56, DOI 10.1016/j.ijfoodmicro.2010.02.012; Zalan Z, 2010, EUR FOOD RES TECHNOL, V230, P395, DOI 10.1007/s00217-009-1179-9	67	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271269	http://dx.doi.org/10.1371/journal.pone.0271269			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917314	gold, Green Published			2022-12-26	WOS:000837840000011
J	Stahley, LH; Camhi, SM; Wright, JA; Troped, PJ				Stahley, Lawrence H.; Camhi, Sarah M.; Wright, Julie A.; Troped, Philip J.			Correlates of bike share use and its association with weight status at an urban university	PLOS ONE			English	Article							ACTIVE TRANSPORTATION; PHYSICAL-ACTIVITY; BICYCLE; HEALTH; MONTREAL; PROGRAM; WALKING; CAMPUS; RISK	BackgroundResearch on the influences on bike share use and potential favorable relationships between use and obesity is limited, particularly in the U.S. context. Therefore, the aims of this exploratory study were to examine correlates of awareness and use of Boston's Bluebikes bike share system and assess the association between use and weight status. MethodsStudents, faculty, and staff (n = 256) at a public urban university completed an online survey that assessed sociodemographic, behavioral, and physical activity characteristics, Bluebikes awareness, and use of Bluebikes and personal bikes. Multivariable logistic regression models were estimated to examine associations between sociodemographic and behavioral factors and bike share awareness and use; and between use and overweight/obesity status. ResultsRespondents were mostly students (72.2%), female (69.1%), White (62.1%), and the mean age was 32.4 +/- 13.8 years. The percentage of respondents classified as aware of Bluebikes was 33.6% with only 12.9% reporting any use of the system. Living in a community where bike share stations were located (odds ratio (OR) = 2.01, 95% confidence interval (CI): 1.10, 3.67), personal bike ownership (OR = 2.27, 95% CI:1.27, 4.45), and not exclusively commuting to campus via car (OR = 3.19, 95% CI:1.63, 6.22) had significant positive associations with awareness. Living in a bike share community (OR = 2.34; 95% CI:1.04, 5.27) and personal bike ownership (OR = 3.09; 95% CI:1.27, 7.52) were positively associated with bike share use. Any reported use of Bluebikes was associated with 60% lower odds of being overweight/obese (OR = 0.40; 95% CI:0.17, 0.93). ConclusionsSeveral environmental and behavioral variables, including access to stations and personal bicycle ownership, were significantly associated with Bluebikes awareness and use. Findings also suggest a potential benefit to bike share users in terms of maintaining a healthy weight, though further longitudinal studies are needed to rule out the possibility that more active and leaner individuals tend to use bike share more frequently.	[Stahley, Lawrence H.; Wright, Julie A.; Troped, Philip J.] Univ Massachusetts Boston, Dept Exercise & Hlth Sci, Boston, MA 02125 USA; [Camhi, Sarah M.] Univ San Francisco, Dept Kinesiol, San Francisco, CA USA	University of Massachusetts System; University of Massachusetts Boston; University of San Francisco	Troped, PJ (corresponding author), Univ Massachusetts Boston, Dept Exercise & Hlth Sci, Boston, MA 02125 USA.	phil.troped@umb.edu		Wright, Julie/0000-0002-5115-7011				Bachand-Marleau J, 2012, TRANSPORT RES REC, P66, DOI 10.3141/2314-09; Bassett DR, 2008, J PHYS ACT HEALTH, V5, P795, DOI 10.1123/jpah.5.6.795; Bluebikes, 2020, BLUEB MED KIT; Bluebikes, BLUEB SYST DAT; Bopp M, 2015, J PHYS ACT HEALTH, V12, P418, DOI 10.1123/jpah.2013-0332; Bopp M, 2014, J AGING PHYS ACTIV, V22, P199, DOI [10.1123/JAPA.2012-0236, 10.1123/japa.2012-0236]; Boston Bikes, 2013, BOST BIK SURV 2013; Buck D., 2012, 91 TRANSP RES BOARD, P703; CDC, 2017, NAT DIAB STAT REP 20; Celis-Morales CA, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1456; Chen LT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207640; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; DeMaio P.J., 2009, J PUBLIC TRANSPORT, V12, P41, DOI [5038/2375-0901.12.410.5038/2375-0901.12.4.3, DOI 10.5038/2375-0901.12.4.3]; Dill J, 2009, J PUBLIC HEALTH POL, V30, pS95, DOI 10.1057/jphp.2008.56; Fan MY, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012556; Fishman E, 2012, J AUSTRALAS COLL ROA, V23, P19; Fishman E, 2013, TRANSPORT REV, V33, P148, DOI 10.1080/01441647.2013.775612; Fishman E, 2012, TRANSPORT RES F-TRAF, V15, P686, DOI 10.1016/j.trf.2012.08.002; Flint E., 2014, BMJ-BRIT MED J, V349, P1; Fuller D, 2013, AM J PUBLIC HEALTH, V103, pE85, DOI 10.2105/AJPH.2012.300917; Fuller D, 2011, AM J PREV MED, V41, P80, DOI 10.1016/j.amepre.2011.03.002; Gordon-Larsen P, 2009, ARCH INTERN MED, V169, P1216, DOI 10.1001/archinternmed.2009.163; Grimes A, 2020, HEALTH EDUC BEHAV, V47, P412, DOI 10.1177/1090198120914244; Hamer M, 2008, PREV MED, V46, P9, DOI 10.1016/j.ypmed.2007.03.006; Heinen E, 2010, TRANSPORT REV, V30, P59, DOI 10.1080/01441640903187001; Kellstedt D, 2019, PREV MED REP, V16, DOI 10.1016/j.pmedr.2019.100981; Kelly P, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0132-x; Kretman Stewart S., 2013, PREV CHRONIC DIS, V10, P1; Kutela B, 2019, J TRANSP GEOGR, V78, P160, DOI 10.1016/j.jtrangeo.2019.06.002; Milton K, 2011, BRIT J SPORT MED, V45, P203, DOI 10.1136/bjsm.2009.068395; Mooney SJ, 2019, J TRANSP GEOGR, V74, P91, DOI 10.1016/j.jtrangeo.2018.11.009; Nashville Area Metropolitan Planning Commission, BIK PED CRASH SURV 2; National Association of City Transportation Officials (NACTO), 2020, SHAR MICR US 2019; National Institutes of Health. National Heart Lung and Blood Institute, 1998, NIH PUBL; Peterman JE, 2021, J PHYS ACT HEALTH, V18, P1525, DOI 10.1123/jpah.2021-0245; Pucher J, 2010, AM J PUBLIC HEALTH, V100, P1986, DOI 10.2105/AJPH.2009.189324; Rojas-Rueda D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4521; Schauder SA, 2015, J TRANSP HEALTH, V2, P343, DOI 10.1016/j.jth.2015.06.006; Scott DM, 2019, TRAVEL BEHAV SOC, V16, P50, DOI 10.1016/j.tbs.2019.04.003; Shaheen S., 2014, PUBLIC BIKESHARING N, P12; Shaheen S., 2012, MINETA TRANSP I PUBL, V138; Shaheen SA, 2011, TRANSPORT RES REC, P33, DOI 10.3141/2247-05; Titze S, 2010, J PHYS ACT HEALTH, V7, P423, DOI 10.1123/jpah.7.4.423; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion, HLTH PEOPL 2030; University of Massachusetts Boston, U HEADC ENR GEND RAC; Wang KL, 2019, J TRANSP GEOGR, V76, P1, DOI 10.1016/j.jtrangeo.2019.02.003; Xu DF, 2019, TRANSPORT RES D-TR E, V67, P89, DOI 10.1016/j.trd.2018.11.002	48	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0270870	http://dx.doi.org/10.1371/journal.pone.0270870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921325	Green Published, gold			2022-12-26	WOS:000839311900077
J	Shi, YX; Yan, S; Shao, GC; Wang, JL; Jian, YP; Liu, B; Yuan, YQ; Qin, K; Nai, SS; Huang, XH; Wang, YC; Chen, ZH; Chen, X; Dong, MQ; Geng, YQ; Xu, ZX; Li, J				Shi, Yingxin; Yan, Sheng; Shao, Guang-Can; Wang, Jinglong; Jian, Yong-Ping; Liu, Bo; Yuan, Yanqiu; Qin, Ke; Nai, Shanshan; Huang, Xiahe; Wang, Yingchun; Chen, Zhenghui; Chen, Xing; Dong, Meng-Qiu; Geng, Yiqun; Xu, Zhi-Xiang; Li, Jing			O-GlcNAcylation stabilizes the autophagy-initiating kinase ULK1 by inhibiting chaperone-mediated autophagy upon HPV infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN-PAPILLOMAVIRUS; GLCNAC-MODIFICATION; CROSS-TALK; PHOSPHORYLATION; IDENTIFICATION; MECHANISMS; CELLS; AMPK	Human papillomaviruses (HPVs) cause a subset of head and neck squamous cell carcinomas (HNSCCs). Previously, we demonstrated that HPV16 oncogene E6 or E6/E7 transduction increases the abundance of O-linked beta-N-acetylglucosamine (O-GlcNAc) transferase (OGT), but OGT substrates affected by this increase are unclear. Here, we focus on the effects of O-GlcNAcylation on HPV-positive HNSCCs. We found that upon HPV infection, Unc-51-like kinase 1 (ULK1), an autophagyinitiating kinase, is hyper-O-GlcNAcylated, stabilized, and linked with autophagy elevation. Through mass spectrometry, we identified that ULK1 is O-GlcNAcylated at Ser409, which is distinct from the previously reported Thr635/Thr754 sites. It has been demonstrated that PKCa mediates phosphorylation of ULK1 at Ser423, which attenuates its stability by shunting ULK1 to the chaperone-mediated autophagy (CMA) pathway. Using biochemical assays, we demonstrate that ULK1 Ser409Ser410 O-GlcNAcylation antagonizes its phosphorylation at Ser423. Moreover, mutations of Ser409A and its neighboring site Ser410A (2A) render ULK1 less stable by promoting interaction with the CMA chaperone HSC70 (heat shock cognate 70 kDa protein). Furthermore, ULK1-2A mutants attenuate the association of ULK1 with STX17, which is vital for the fusion between autophagosomes and lysosomes. Analysis of The Cancer Genome Atlas (TCGA) database reveals that ULK1 is upregulated in HPV-positive HNSCCs, and its level positively correlates with HNSCC patient survival. Overall, our work demonstrates that O-GlcNAcylation of ULK1 is altered in response to environmental changes. O-GlcNAcylation of ULK1 at Ser409 and perhaps Ser410 stabilizes ULK1, which might underlie the molecular mechanism of HPV-positive HNSCC patient survival.	[Shi, Yingxin; Yan, Sheng; Liu, Bo; Nai, Shanshan; Li, Jing] Capital Normal Univ, Beijing Key Lab DNA Damage Response, Beijing, Peoples R China; [Shi, Yingxin; Yan, Sheng; Liu, Bo; Nai, Shanshan; Li, Jing] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Shao, Guang-Can; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing, Peoples R China; [Wang, Jinglong] Qingdao Univ, Med Coll, Affiliated Hosp, Qingdao, Shandong, Peoples R China; [Jian, Yong-Ping; Xu, Zhi-Xiang] Henan Univ, Sch Life Sci, Kaifeng, Henan, Peoples R China; [Yuan, Yanqiu] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Qin, Ke; Chen, Xing] Peking Univ, Coll Chem & Mol Engn, Peking Tsinghua Ctr Life Sci, Synthet & Funct Biomol Ctr,Beijing Natl Lab Mol S, Beijing, Peoples R China; [Qin, Ke; Chen, Xing] Peking Univ, Minist Educ, Key Lab Bioorgan Chem & Mol Engn, Beijing, Peoples R China; [Huang, Xiahe; Wang, Yingchun] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China; [Chen, Zhenghui; Geng, Yiqun] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing, Peoples R China; [Li, Jing] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China	Capital Normal University; Capital Normal University; National Institute of Biological Sciences, Beijing; Qingdao University; Henan University; Sun Yat Sen University; Peking University; Peking University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University	Li, J (corresponding author), Capital Normal Univ, Beijing Key Lab DNA Damage Response, Beijing, Peoples R China.; Li, J (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.; Xu, ZX (corresponding author), Henan Univ, Sch Life Sci, Kaifeng, Henan, Peoples R China.; Geng, YQ (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing, Peoples R China.; Li, J (corresponding author), Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China.	gengyiqun@imm.ac.cn; zhixiangxu08@gmail.com; Jing_li@mail.cnu.edu.cn	Li, Jing/C-2031-2013	Li, Jing/0000-0002-3977-1641	State Key Laboratory of Natural and Biomimetic Drugs [K202012]; R&D Program of Beijing Municipal Education Commission [KZ202210028043]; Yunnan Applied Basic Research Projects [202101AV070002, 2019FY003030]; National Natural Science Foundation of China [31670234, 31872720]; Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences [2020-RC350-001]	State Key Laboratory of Natural and Biomimetic Drugs; R&D Program of Beijing Municipal Education Commission; Yunnan Applied Basic Research Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences	This work was supported by the National Natural Science Foundation of China fund (grant no.: 31872720), the State Key Laboratory of Natural and Biomimetic Drugs (grant no.: K202012), R&D Program of Beijing Municipal Education Commission (grant no.: KZ202210028043), and the Yunnan Applied Basic Research Projects (grant nos.: 202101AV070002 and 2019FY003030) to J. L. and National Natural Science Foundation of China (grant no.: 31670234; to Y. W.), Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences (grant no.: 2020-RC350-001; to Y. G.).	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Cosway B, 2016, ORAL ONCOL, V54, P1, DOI 10.1016/j.oraloncology.2015.12.007; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Griffin LM, 2013, VIROLOGY, V437, P12, DOI 10.1016/j.virol.2012.12.004; Guo B, 2014, NAT CELL BIOL, V16, P1215, DOI 10.1038/ncb3066; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Huo BB, 2018, CHEM COMMUN, V54, P13790, DOI 10.1039/c8cc08416e; Hurley JH, 2017, ANNU REV BIOCHEM, V86, P225, DOI 10.1146/annurev-biochem-061516-044820; Kang JG, 2009, J BIOL CHEM, V284, P34777, DOI 10.1074/jbc.M109.026351; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Lajer CB, 2010, APMIS, V118, P510, DOI 10.1111/j.1600-0463.2010.02624.x; Li J, 2011, CELL CYCLE, V10, P2946, DOI 10.4161/cc.10.17.15922; Li JC, 2019, ACS CHEM BIOL, V14, P4, DOI 10.1021/acschembio.8b01052; Liu JL, 2014, BRIT J CANCER, V111, P944, DOI 10.1038/bjc.2014.355; Ma JF, 2021, GLYCOBIOLOGY, V31, P719, DOI 10.1093/glycob/cwab003; Mack HID, 2012, AUTOPHAGY, V8, P1197, DOI 10.4161/auto.20586; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Park S, 2015, CELL MOL LIFE SCI, V72, P3173, DOI 10.1007/s00018-015-1889-z; Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038; Pyo KE, 2018, CELL REP, V25, P2878, DOI 10.1016/j.celrep.2018.11.042; Qin K, 2018, ACS CHEM BIOL, V13, P1983, DOI 10.1021/acschembio.8b00414; Qin W, 2017, P NATL ACAD SCI USA, V114, pE6749, DOI 10.1073/pnas.1702688114; Ramakrishnan P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004097; Ruan HB, 2017, GENE DEV, V31, P1655, DOI 10.1101/gad.305441.117; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Surviladze Z, 2013, J VIROL, V87, P2508, DOI 10.1128/JVI.02319-12; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Tian J, 2016, J BIOL CHEM, V291, P12136, DOI 10.1074/jbc.M116.717850; Wang CY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05449-1; Wang P, 2012, P NATL ACAD SCI USA, V109, P17669, DOI 10.1073/pnas.1205748109; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Woo CM, 2018, MOL CELL PROTEOMICS, V17, P764, DOI 10.1074/mcp.RA117.000261; Yan J, 1998, BIOCHEM BIOPH RES CO, V246, P222, DOI 10.1006/bbrc.1998.8546; Yan J, 1999, ONCOGENE, V18, P5850, DOI 10.1038/sj.onc.1202988; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Zeng QH, 2016, P NATL ACAD SCI USA, V113, P9333, DOI 10.1073/pnas.1606801113; Zhu YP, 2018, ACS CHEM NEUROSCI, V9, P1366, DOI 10.1021/acschemneuro.8b00015	44	2	2	7	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102341	10.1016/j.jbc.2022.102341	http://dx.doi.org/10.1016/j.jbc.2022.102341			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9EO	35931119	gold, Green Published			2022-12-26	WOS:000863182500004
J	Frescura, L; Godfrey-Faussett, P; Feizzadeh, AA; El-Sadr, W; Syarif, O; Ghys, PD				Frescura, Luisa; Godfrey-Faussett, Peter; Feizzadeh, Ali A.; El-Sadr, Wafaa; Syarif, Omar; Ghys, Peter D.		2025 Testing Treatment Target Work	Achieving the 95 95 95 targets for all: A pathway to ending AIDS	PLOS ONE			English	Review							HIV	In December 2020, UNAIDS released a new set of ambitious targets calling for 95% of all people living with HIV to know their HIV status, 95% of all people with diagnosed HIV infection to receive sustained antiretroviral therapy, and 95% of all people receiving antiretroviral therapy to have viral suppression by 2025. Adopted by United Nations Member states in June 2021 as part of the new Political Declaration on HIV and AIDS, these targets, combined with ambitious primary prevention targets and focused attention to supporting enablers, aim to bridge inequalities in treatment coverage and outcomes and accelerate HIV incidence reductions by focusing on progress in all sub-populations, age groups and geographic settings. Here we summarise the evidence and decisions underpinning the new global targets.	[Frescura, Luisa; Godfrey-Faussett, Peter; Feizzadeh, Ali A.; Ghys, Peter D.] UNAIDS, Strateg Informat Dept, Geneva, Switzerland; [Godfrey-Faussett, Peter] London Sch Hyg & Trop Med, London, England; [El-Sadr, Wafaa] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA; [Syarif, Omar] Global Network People Network Living HIV GNP, Gardens, South Africa	UNAIDS; University of London; London School of Hygiene & Tropical Medicine; Columbia University	Frescura, L (corresponding author), UNAIDS, Strateg Informat Dept, Geneva, Switzerland.	frescural@unaids.org		Frescura, Luisa/0000-0002-2089-7818				[Anonymous], 2015, POPULATION BASED HIV; Ayala G, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0260555; Bbosa N, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13060970; de Oliveira T, 2017, LANCET HIV, V4, pE41, DOI 10.1016/S2352-3018(16)30186-2; Dieffenbach C., 2021, TBD UNPUB; Eisinger RW, 2019, JAMA-J AM MED ASSOC, V321, P451, DOI 10.1001/jama.2018.21167; Ghys PD, 2019, LANCET HIV, V6, pE150, DOI 10.1016/S2352-3018(19)30050-5; Giguere K, 2021, LANCET HIV, V8, pe284, DOI 10.1016/S2352-3018(20)30315-5; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Havlir D, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25455; Havlir DV, 2019, NEW ENGL J MED, V381, P219, DOI 10.1056/NEJMoa1809866; Hayes RJ, 2019, NEW ENGL J MED, V381, P207, DOI 10.1056/NEJMoa1814556; Holtgrave DR, 2004, INT J STD AIDS, V15, P789, DOI 10.1258/0956462042563639; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Mahy M, 2019, AIDS, V33, pS203, DOI 10.1097/QAD.0000000000002321; Marinda E, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09457-z; Marsh K, 2019, AIDS, V33, pS213, DOI 10.1097/QAD.0000000000002355; Nations U, TRANSF OUR WORLD 203; Organization WH, 2003, TREAT 3 MILL 2005 IN; Probert W HM., 2019, 10 IAS C ONHIV SCI; Solomon SS, 2019, LANCET HIV, V6, pE283, DOI 10.1016/S2352-3018(19)30034-7; Stone J, 2021, J INT AIDS SOC, V24, DOI 10.1002/jia2.25650; Tanser F, 2020, CURR HIV-AIDS REP, V17, P97, DOI 10.1007/s11904-020-00487-1; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2021, UNAIDS EP EST; UNAIDS, 2018, GLOB AIDS UPD 2018 M; UNAIDS, 2014, FAST TRACK END AIDS; UNAIDS, 2010, GLOB REP UNAIDS REP; UNAIDS, 2021, PREV PAND PUTT PEOPL; Vandormael A, 2020, INT J EPIDEMIOL, V49, P666, DOI 10.1093/ije/dyz269; White PJ, 2006, AIDS, V20, P1898, DOI 10.1097/01.aids.0000244213.23574.fa; WHO, 2011, US ASS REC INF EST H; Wirth KE, 2020, LANCET HIV, V7, pE422, DOI 10.1016/S2352-3018(20)30103-X	33	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272405	10.1371/journal.pone.0272405	http://dx.doi.org/10.1371/journal.pone.0272405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925943	gold, Green Published			2022-12-26	WOS:000848077100088
J	Puppala, S; Spradling-Reeves, KD; Chan, J; Birnbaum, S; Newman, DE; Comuzzie, AG; Mahaney, MC; VandeBerg, JL; Olivier, M; Cox, LA				Puppala, Sobha; Spradling-Reeves, Kimberly D.; Chan, Jeannie; Birnbaum, Shifra; Newman, Deborah E.; Comuzzie, Anthony G.; Mahaney, Michael C.; VandeBerg, John L.; Olivier, Michael; Cox, Laura A.			Hepatic transcript signatures predict atherosclerotic lesion burden prior to a 2-year high cholesterol, high fat diet challenge	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ACCELERATES ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; GENE VARIATION; FOOD-INTAKE; RECEPTOR; ESTROGEN; BABOONS; LIPOPROTEINS; ASSOCIATION	The purpose of this study was to identify molecular mechanisms by which the liver influences total lesion burden in a nonhuman primate model (NHP) of cardiovascular disease with acute and chronic feeding of a high cholesterol, high fat (HCHF) diet. Baboons (47 females, 64 males) were fed a HCHF diet for 2 years (y); liver biopsies were collected at baseline, 7 weeks (w) and 2y, and lesions were quantified in aortic arch, descending aorta, and common iliac at 2y. Unbiased weighted gene co-expression network analysis (WGCNA) revealed several modules of hepatic genes correlated with lesions at different time points of dietary challenge. Pathway and network analyses were performed to study the roles of hepatic module genes. More significant pathways were observed in males than females. In males, we found modules enriched for genes in oxidative phosphorylation at baseline, opioid signaling at 7w, and EIF2 signaling and HNF1A and HNF4A networks at baseline and 2y. One module enriched for fatty acid 13 oxidation pathway genes was found in males and females at 2y. To our knowledge, this is the first study of a large NHP cohort to identify hepatic genes that correlate with lesion burden. Correlations of baseline and 7w module genes with lesions at 2y were observed in males but not in females. Pathway analyses of baseline and 7w module genes indicate EIF2 signaling, oxidative phosphorylation, and mu-opioid signaling are possible mechanisms that predict lesion formation induced by HCHF diet consumption in males. Our findings of coordinated hepatic transcriptional response in male baboons but not female baboons indicate underlying molecular mechanisms differ between female and male primate atherosclerosis.	[Puppala, Sobha; Spradling-Reeves, Kimberly D.; Chan, Jeannie; Olivier, Michael; Cox, Laura A.] Wake Forest Sch Med, Ctr Precis Med, Winston Salem, NC 27101 USA; [Birnbaum, Shifra; Newman, Deborah E.; Cox, Laura A.] Texas Biomed Res Inst, San Antonio, TX USA; [Comuzzie, Anthony G.] Obes Soc, Silver Spring, MD USA; [Mahaney, Michael C.; VandeBerg, John L.] Univ Texas Rio Grande Valley, Sch Med, South Texas Diabet & Obes Inst, Brownsville, TX USA; [Mahaney, Michael C.; VandeBerg, John L.] Univ Texas Rio Grande Valley, Sch Med, Dept Human Genet, Brownsville, TX USA	Wake Forest University; Texas Biomedical Research Institute; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley	Puppala, S (corresponding author), Wake Forest Sch Med, Ctr Precis Med, Winston Salem, NC 27101 USA.	spuppala@wakehealth.edu		Newman, Deborah/0000-0003-4025-6601; Puppala, Sobha/0000-0002-2766-155X	National Institutes of Health [P01 HL028972]; Southwest National Primate Research Center grant from the National Center for Research Resources, National Institutes of Health - Office of Research Infrastructure Programs (ORIP), NIH [P51 RR013986, P51 OD011133]; ORIP [C06 RR14578, C06 RR15456, C06 RR013556, C06 RR017515]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southwest National Primate Research Center grant from the National Center for Research Resources, National Institutes of Health - Office of Research Infrastructure Programs (ORIP), NIH; ORIP	This work was supported in by a grant from the National Institutes of Health (P01 HL028972). This study used resources that were supported by the Southwest National Primate Research Center grant P51 RR013986 from the National Center for Research Resources, National Institutes of Health currently supported by the Office of Research Infrastructure Programs (ORIP), NIH through grant P51 OD011133. This investigation was conducted in facilities constructed with support from ORIP through grant numbers C06 RR14578, C06 RR15456, C06 RR013556, and C06 RR017515. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja HS, 2003, J BIOL REG HOMEOS AG, V17, P29; Al-Shali KZ, 2004, ARTERIOSCL THROM VAS, V24, P1591, DOI 10.1161/01.ATV.0000136392.59656.8b; [Anonymous], 2017, OFFICIAL METHODS REC; Anthony R, AVMA GUIDELINES EUTH; ATKINSON RL, 1987, FASEB J, V46, P178; Baciu C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189223; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Bieghs V, 2012, ATHEROSCLEROSIS, V220, P287, DOI 10.1016/j.atherosclerosis.2011.08.041; Blin J, 2013, GENES GENET SYST, V88, P199, DOI 10.1266/ggs.88.199; Bodnar RJ, 2016, PEPTIDES, V75, P18, DOI 10.1016/j.peptides.2015.10.009; Boekholdt SM, 2004, CURR OPIN LIPIDOL, V15, P393, DOI 10.1097/01.mol.0000137226.54278.60; Boese AC, 2017, AM J PHYSIOL-HEART C, V313, pH524, DOI 10.1152/ajpheart.00217.2016; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Chakass D, 2007, GUT, V56, P974, DOI 10.1136/gut.2006.105122; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cox LA, 2013, ILAR J, V54, P106, DOI 10.1093/ilar/ilt038; Crea F, 2017, EUR HEART J, V38, P154, DOI 10.1093/eurheartj/ehw620; Doege H, 2006, GASTROENTEROLOGY, V130, P1245, DOI 10.1053/j.gastro.2006.02.006; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Fox CS, 2005, J CLIN ENDOCR METAB, V90, P6257, DOI 10.1210/jc.2005-0670; Funk SD, 2012, ARTERIOSCL THROM VAS, V32, P686, DOI 10.1161/ATVBAHA.111.242792; Gallagher CJ, 2006, MOL GENET METAB, V87, P54, DOI 10.1016/j.ymgme.2005.07.013; Garcia-Rodriguez L, 2016, LARYNGOSCOPE, V126, pE319, DOI 10.1002/lary.25958; Gawrieh S, 2010, OBES SURG, V20, P1698, DOI 10.1007/s11695-010-0171-6; Ghosh A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082661; Gosnell BA, 2009, INT J OBESITY, V33, pS54, DOI 10.1038/ijo.2009.73; Grbic E, 2018, BALK J MED GENET, V21, P39, DOI 10.2478/bjmg-2018-0011; Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585; Hagberg JM, 2011, J APPL PHYSIOL, V111, P916, DOI 10.1152/japplphysiol.00153.2011; Haghighi A, 2014, MOL PSYCHIATR, V19, P63, DOI 10.1038/mp.2012.179; Hubbard B, 2006, GASTROENTEROLOGY, V130, P1259, DOI 10.1053/j.gastro.2006.02.012; Ismaiel A, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00202; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Karere GM, 2020, J MED PRIMATOL, V49, P3, DOI 10.1111/jmp.12449; Khan-Merchant N, 2002, J NUTR, V132, P3256, DOI 10.1093/jn/132.11.3256; Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9; Kushwaha RS, 1998, HUM REPROD UPDATE, V4, P420, DOI 10.1093/humupd/4.4.420; Lagraauw HM, 2014, ATHEROSCLEROSIS, V235, P196, DOI 10.1016/j.atherosclerosis.2014.04.025; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li BX, 2019, J CELL BIOCHEM, V120, P11418, DOI 10.1002/jcb.28420; Libby P, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0116-x, 10.1038/s41572-019-0106-z]; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Linner C, 2013, AGING MALE, V16, P52, DOI 10.3109/13685538.2013.772134; Lusis AJ, 2015, ATHEROSCLEROSIS, V242, P630, DOI 10.1016/j.atherosclerosis.2015.06.024; Mahaney MC, 2018, J MED PRIMATOL, V47, P3, DOI 10.1111/jmp.12283; Mallat Z, 2001, CIRC RES, V89, P930, DOI 10.1161/hh2201.099415; MCGILL HC, 1981, ARTERIOSCLEROSIS, V1, P337, DOI 10.1161/01.ATV.1.5.337; Misra BB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214487; Nijland MJ, 2007, J PHYSIOL-LONDON, V579, P643, DOI 10.1113/jphysiol.2006.122101; Northcott CA, 2012, EXP BIOL MED, V237, P99, DOI 10.1258/ebm.2011.011188; Pecina S, 2010, PHARMACOL BIOCHEM BE, V97, P34, DOI 10.1016/j.pbb.2010.05.016; Peter I, 2007, HYPERTENSION, V49, P1000, DOI 10.1161/HYPERTENSIONAHA.106.083790; Plutzky J, 2000, Curr Atheroscler Rep, V2, P327, DOI 10.1007/s11883-000-0067-3; Puppala S, 2018, J PHYSIOL-LONDON, V596, P5823, DOI 10.1113/JP275422; Qi S, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007743; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rogers J, 1997, AM J HUM GENET, V61, P489, DOI 10.1086/515527; Shang YL, 2015, J CELL BIOCHEM, V116, P252, DOI 10.1002/jcb.24962; Shao ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4528; SHAW WN, 1993, PHARMACOL BIOCHEM BE, V46, P653, DOI 10.1016/0091-3057(93)90557-A; Shi Q, 2012, J CELL MOL MED, V16, P2060, DOI 10.1111/j.1582-4934.2011.01501.x; Sookoian S, 2016, J PATHOL, V240, P437, DOI 10.1002/path.4803; Sookoian S, 2011, ATHEROSCLEROSIS, V218, P378, DOI 10.1016/j.atherosclerosis.2011.05.014; Spradling Kimberly D, 2013, PLoS One, V8, pe57563, DOI 10.1371/journal.pone.0057563; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Su J, 2018, MOL MED REP, V18, P1311, DOI 10.3892/mmr.2018.9077; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Tegude H, 2007, DRUG METAB DISPOS, V35, P946, DOI 10.1124/dmd.106.013565; van den Berg EH, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030705; VandeBerg JL W-BS, 2008, BABOON BIOMEDICAL RE; Vinue A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070939; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Vortherms TA, 2005, IDRUGS, V8, P491	73	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271514	10.1371/journal.pone.0271514	http://dx.doi.org/10.1371/journal.pone.0271514			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925965	Green Published, gold			2022-12-26	WOS:000848077100041
J	Al-Obaydi, S; Hennrikus, E; Mohammad, N; Lehman, EB; Thakur, A; Al-Shaikhly, T				Al-Obaydi, Sarah; Hennrikus, Eileen; Mohammad, Nazar; Lehman, Erik B.; Thakur, Abhishek; Al-Shaikhly, Taha			Hesitancy and reactogenicity to mRNA-based COVID-19 vaccines-Early experience with vaccine rollout in a multi-site healthcare system	PLOS ONE			English	Article								BackgroundHesitancy and incomplete vaccination against coronavirus disease 2019 (COVID-19) remains an obstacle to achieving herd immunity. Because of fear of vaccine reactions, patients with medical and allergic co-morbidities express heightened hesitancy. Limited information is available to guide these patients. We sought to identify factors associated with mRNA-based COVID-19 vaccines hesitancy and reactogenicity. MethodsWe surveyed employees of a multi-site health system in central Pennsylvania who were offered the COVID-19 vaccine (N = 18,740) inquiring about their experience with the Moderna and Pfizer-BioNTech mRNA-based vaccines. The survey was administered online using the REDCap platform. We used multivariable regression analysis to determine whether a particular factor(s) (e.g., demographics, selected co-morbid allergic and medical conditions, vaccine brand, and prior COVID-19) were associated with vaccine reactogenicity including the occurrence and severity of local and systemic reactions. We also explored factors and reasons associated with vaccine hesitancy. ResultsOf the 5709 who completed the survey (response rate, 30.4%), 369 (6.5%) did not receive the vaccine. Black race and allergy to other vaccines were associated with vaccine hesitancy. Reaction intensity following the first vaccine dose and allergic co-morbidities were associated with incomplete vaccination. Older individuals (>60 years) experienced less reactogenicity. Females had higher odds of local and systemic reactions and reported more severe reactions. Asians reported more severe reactions. As compared to Pfizer-BioNTech, the Moderna vaccine was associated with higher odds of vaccine reactions of higher severity. Prior COVID-19 resulted in more severe reactions following the first dose, but less severe reactions following the second dose. ConclusionsTargeted campaigns to enhance vaccination acceptance should focus on Black individuals, females, and those with allergic co-morbidities. Prior COVID-19 caused more severe reactions after the first but not the second vaccine dose. Moderna vaccine caused more vaccine reactions. Lessons learned from the early rollout of COVID-19 vaccine may serve to inform future novel vaccine experiences.	[Al-Obaydi, Sarah; Hennrikus, Eileen; Mohammad, Nazar] Penn State Coll Med, Div Hosp Med, Dept Med, Hershey, PA 17033 USA; [Lehman, Erik B.] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Thakur, Abhishek] Harrisburg Univ Sci & Technol, Harrisburg, PA USA; [Al-Shaikhly, Taha] Penn State Coll Med, Dept Med, Div Pulm Allergy & Crit Care Med, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Al-Obaydi, S (corresponding author), Penn State Coll Med, Div Hosp Med, Dept Med, Hershey, PA 17033 USA.	salobaydi@pennstatehealth.psu.edu		Thakur, Abhishek/0000-0003-3978-1302				Abbasi J, 2020, JAMA-J AM MED ASSOC, V324, P1125, DOI 10.1001/jama.2020.16866; [Anonymous], 2021, COVID DAT TRACK; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Blumenthal KG, 2021, JAMA-J AM MED ASSOC, V325, P1562, DOI 10.1001/jama.2021.3976; Browne SK, 2022, INFECT CONT HOSP EP, V43, P1424, DOI 10.1017/ice.2021.410; Chapin-Bardales J, 2021, JAMA-J AM MED ASSOC, V325, P2201, DOI 10.1001/jama.2021.5374; Coustasse A, 2021, J AMBUL CARE MANAG, V44, P71, DOI 10.1097/JAC.0000000000000360; Fisher KA, 2020, ANN INTERN MED, V173, P964, DOI 10.7326/M20-3569; Fontanet A, 2020, NAT REV IMMUNOL, V20, P583, DOI 10.1038/s41577-020-00451-5; Galea S, 2020, JAMA-J AM MED ASSOC, V324, P227, DOI 10.1001/jama.2020.11132; Gee J, 2021, MMWR-MORBID MORTAL W, V70, P283, DOI 10.15585/mmwr.mm7008e3; Giuntella O, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016632118; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Krammer F, 2021, NEW ENGL J MED, V384, P1372, DOI 10.1056/NEJMc2101667; Maruggi G, 2019, MOL THER, V27, P757, DOI 10.1016/j.ymthe.2019.01.020; Meo SA, 2021, EUR REV MED PHARMACO, V25, P1663, DOI 10.26355/eurrev_202102_24877; Paran Y, 2022, OPEN FORUM INFECT DI, V9, DOI 10.1093/ofid/ofab656; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Razai MS, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1138; Rosiello D, 2021, NARRA J, V1, P55, DOI DOI 10.52225/NARRA.V1I3.55; Sallam M., 2022, NARRA J, V2, DOI [10.52225/narra.v2i1.74, DOI 10.52225/NARRA.V2I1.74]; Shimabukuro T., 2021, ACIP M ATL GA US; Shimabukuro TT, 2021, JAMA-J AM MED ASSOC, V325, P1101, DOI 10.1001/jama.2021.1967; Stoler J, 2021, J GEN INTERN MED, V36, P3629, DOI 10.1007/s11606-021-06743-3; Volpp KG, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMp2107719	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8							e0272691	10.1371/journal.pone.0272691	http://dx.doi.org/10.1371/journal.pone.0272691			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P8ZE	35930586	Green Published, gold			2022-12-26	WOS:000837822100005
J	Hoving, J; Koopman, M; Tolhuisen, MA; van Voorst, HM; Brehm, M; Berkhemer, OA; Coutinho, JJ; Beenen, LFM; Marquering, H; Emmer, B; Majoie, CBLM				Hoving, Jan; Koopman, Miou; Tolhuisen, Manon A.; van Voorst, Henk M.; Brehm, Marcus; Berkhemer, Olvert A.; Coutinho, Jonathan J.; Beenen, Ludo F. M.; Marquering, Henk; Emmer, Bart; Majoie, Charles B. L. M.			Accuracy of CT perfusion ischemic core volume and location estimation: A comparison between four ischemic core estimation approaches using syngo.via	PLOS ONE			English	Article							STROKE; SEGMENTATION; RELIABILITY; GUIDELINE; MRI	Background and objectiveComputed tomography perfusion (CTP) is widely used in the evaluation of acute ischemic stroke patients for endovascular thrombectomy (EVT). The stability of CTP core estimation is suboptimal and varies between software packages. We aimed to quantify the volumetric and spatial agreement between the CTP ischemic core and follow-up infarct for four ischemic core estimation approaches using syngo.via. MethodsWe included successfully reperfused, EVT-treated patients with baseline CTP and 24h follow-up diffusion weighted magnetic resonance imaging (DWI) (November 2017-September 2020). Data were processed with syngo.via VB40 using four core estimation approaches based on: cerebral blood volume (CBV)<1.2mL/100mL with and without smoothing filter, relative cerebral blood flow (rCBF)<30%, and rCBFResultsIn 59 patients, median estimated CTP core volumes for four core estimation approaches ranged from 12-39 mL. Median 24h follow-up DWI infarct volume was 11 mL. The intraclass correlation coefficient (ICC) showed moderate-good volumetric agreement for all approaches (range 0.61-0.76). Median Dice was low for all approaches (range 0.16-0.21). CTP core overestimation >10mL occurred least frequent (14/59 [24%] patients) using the CBV-based core estimation approach with smoothing filter. ConclusionsIn successfully reperfused patients who underwent EVT, syngo.via CTP ischemic core estimation showed moderate volumetric and spatial agreement with the follow-up infarct on DWI. In patients with complete reperfusion after EVT, the volumetric agreement was excellent. A CTP core estimation approach based on CBV<1.2 mL/100mL with smoothing filter least often overestimated the follow-up infarct volume and is therefore preferred for clinical decision making using syngo.via.	[Hoving, Jan; Koopman, Miou; Tolhuisen, Manon A.; van Voorst, Henk M.; Berkhemer, Olvert A.; Beenen, Ludo F. M.; Marquering, Henk; Emmer, Bart; Majoie, Charles B. L. M.] Locat Univ Amsterdam, Dept Radiol & Nucl Med, Amsterdam UMC, Amsterdam, Netherlands; [Tolhuisen, Manon A.; van Voorst, Henk M.; Marquering, Henk] Locat Univ Amsterdam, Dept Biomed Engn & Phys, Amsterdam UMC, Amsterdam, Netherlands; [Brehm, Marcus] Siemens Healthcare GmbH, Computed Tomog, Forchheim, Germany; [Coutinho, Jonathan J.] Locat Univ Amsterdam, Dept Neurol, Amsterdam UMC, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Siemens AG; Siemens Germany; University of Amsterdam; Vrije Universiteit Amsterdam	Hoving, J (corresponding author), Locat Univ Amsterdam, Dept Radiol & Nucl Med, Amsterdam UMC, Amsterdam, Netherlands.	j.w.hoving@amsterdamumc.nl	Beenen, Ludo F/AAA-3114-2021	Beenen, Ludo F/0000-0001-9204-1026; Marquering, Henk/0000-0002-1414-6313; Koopman, Miou/0000-0003-4709-0130				Albers GW, 2018, NEW ENGL J MED, V378, P708, DOI 10.1056/NEJMoa1713973; Albers GW, 2016, ANN NEUROL, V79, P76, DOI 10.1002/ana.24543; Austein F, 2016, STROKE, V47, P2311, DOI 10.1161/STROKEAHA.116.013147; Bathla G, 2019, J NEUROINTERV SURG, V11, P1257, DOI 10.1136/neurintsurg-2019-014810; Berge E, 2021, EUR STROKE J, V6, pI, DOI 10.1177/2396987321989865; Boers AMM, 2018, J NEUROINTERV SURG, V10, P1137, DOI 10.1136/neurintsurg-2017-013724; Campbell BCV, 2012, J CEREBR BLOOD F MET, V32, P50, DOI 10.1038/jcbfm.2011.102; Cereda CW, 2016, J CEREBR BLOOD F MET, V36, P1780, DOI 10.1177/0271678X15610586; Chalos V., 2020, RATIONALE STUDY DESI, DOI [10.1186/s13063-020-04514-9, DOI 10.1186/S13063-020-04514-9]; Demeestere J, 2020, STROKE, V51, P1017, DOI 10.1161/STROKEAHA.119.028337; Geuskens RREG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141571; Hoving JW, 2018, STROKE, V49, P2368, DOI 10.1161/STROKEAHA.118.020846; Jansen IGH, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k949; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Karhi S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249772; Kim HY, 2014, J KOREAN NEUROSURG S, V55, P136, DOI 10.3340/jkns.2014.55.3.136; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Koennecke HC, 2001, CEREBROVASC DIS, V11, P157, DOI 10.1159/000047632; Konstas AA, 2009, AM J NEURORADIOL, V30, P662, DOI 10.3174/ajnr.A1487; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Koopman MS, 2019, J NEUROINTERV SURG, V11, P1249, DOI 10.1136/neurintsurg-2019-014822; Lansberg MG, 2001, ARCH NEUROL-CHICAGO, V58, P613, DOI 10.1001/archneur.58.4.613; Ma H, 2019, NEW ENGL J MED, V380, P1795, DOI 10.1056/NEJMoa1813046; Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442; Perkins CJ, 2001, STROKE, V32, P2774, DOI 10.1161/hs1201.099634; Pirson FAV, 2021, TRIALS, V22, DOI 10.1186/s13063-021-05092-0; Powers WJ, 2019, STROKE, V50, pE344, DOI 10.1161/STR.0000000000000211; Psychogios MN, 2021, CLIN NEURORADIOL, V31, P499, DOI 10.1007/s00062-020-00974-3; Schaefer PW, 1997, STROKE, V28, P1082, DOI 10.1161/01.STR.28.5.1082; The CONTRAST consortium, COLL NEW TREATM ACT; Treurniet KM, 2021, TRIALS, V22, DOI 10.1186/s13063-021-05063-5; Turc Guillaume, 2019, J Neurointerv Surg, DOI 10.1136/neurintsurg-2018-014569; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272276	http://dx.doi.org/10.1371/journal.pone.0272276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917382	Green Published, gold			2022-12-26	WOS:000837840000008
J	Cao, LL; Zhou, SM; Qiu, XS; Qiu, S				Cao, Lili; Zhou, Siming; Qiu, Xueshan; Qiu, Shui			Trehalose improves palmitic acid-induced apoptosis of osteoblasts by regulating SIRT3-medicated autophagy via the AMPK/mTOR/ULK1 pathway	FASEB JOURNAL			English	Article						autophagy; lipotoxicity; palmitic acid; SIRT3; Trehalose	MESENCHYMAL STEM-CELLS; POSTMENOPAUSAL WOMEN; DIFFERENTIATION; MECHANISM; THERAPY	Accumulation of lipid substances decreased the activity of osteoblasts. Trehalose is a typical stress metabolite to form a protective membrane on cell surface which has been demonstrated to regulate lipid metabolism. This activity of Trehalose indicates the potential effect of osteoporosis treatment. Our study aimed to determine the therapeutic effect of Trehalose in high fat-induced osteoporosis. We used palmitic acid (PA) to mimic the state of high fat and observed the apoptosis ratio of osteoblasts increased. After adding Trehalose, the apoptosis ratio decreased obviously. Autophagy is a regulatory means involved in the process of apoptosis. We detected the autophagy protein and found that the expression of Beclin-1, Atg5, and LC3 II increased, and p62 decreased after Trehalose treatment. When adding an autophagy inhibitor (3-MA), the expression of Beclin-1, Atg5, and LC3 II decreased, and p62 increased. These results indicated autophagy was an important factor involved in the preventive effect of Trehalose in PA-induced apoptosis. SIRT3 is a mitochondrial gene that can inhibit apoptosis, which has been reported to promote autophagy. We used SIRT3-siRNA to silence the expression of SIRT3 and found the effect of Trehalose was counteracted. The apoptosis ratio increased and the expression of Beclin-1, Atg5, and LC3 II decreased, p62 increased. Additionally, we also fed the mice with a high-fat diet (HFD) and intragastrical Trehalose. The results showed that Trehalose could inhibit the bone mass loss with HFD. Our study revealed the effect and mechanism of Trehalose in the treatment of osteoporosis.	[Cao, Lili] China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Peoples R China; [Zhou, Siming; Qiu, Shui] China Med Univ, Hosp 1, Dept Orthoped, 155 Nanjing North St, Shenyang, Peoples R China; [Qiu, Xueshan] China Med Univ, Hosp 1, Dept Pathol, Shenyang, Peoples R China; [Qiu, Xueshan] Coll Basic Med Sci, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Qiu, S (corresponding author), China Med Univ, Hosp 1, Dept Orthoped, 155 Nanjing North St, Shenyang, Peoples R China.	qiushuii@hotmail.com			China Medical University (CMU)	China Medical University (CMU)(China Medical University)	China Medical University (CMU)	Arai C, 2020, NUTR METAB, V17, DOI 10.1186/s12986-020-00443-1; Benini C, 2020, MINERVA OBSTET GYNEC, V73, P704, DOI 10.23736/S2724-606X.20.04682-1; Casado-Diaz A, 2017, EXP GERONTOL, V90, P71, DOI 10.1016/j.exger.2017.01.024; Cefalu WT, 2001, J WOMEN HEALTH GEN-B, V10, P241, DOI 10.1089/152460901300139998; Dalla Valle A, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00726; Elbers LPB, 2021, DRUGS, V81, P1645, DOI 10.1007/s40265-021-01587-x; Fathollahi A, 2018, LUPUS, V27, P1053, DOI 10.1177/0961203318768889; GUDMANDHOYER E, 1994, AM J CLIN NUTR, V59, p735S, DOI 10.1093/ajcn/59.3.735S; Hase K, 2021, METABOLITES, V11, DOI 10.3390/metabo11060348; Hsu YC, 2016, SEMIN CELL DEV BIOL, V52, P119, DOI 10.1016/j.semcdb.2016.02.011; Huang SY, 2022, BIOPRESERV BIOBANK, V20, P384, DOI 10.1089/bio.2021.0071; Ji ZJ, 2022, J GENET GENOMICS, V49, P287, DOI 10.1016/j.jgg.2021.11.005; Kang DW, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2021.166084; Lee HJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0749-9; Lei SS, 2021, INT J BIOL MACROMOL, V193, P1996, DOI 10.1016/j.ijbiomac.2021.11.030; Leonhardt Y, 2021, QUANT IMAG MED SURG, V11, P3715, DOI 10.21037/qims-20-1373; Li ZZ, 2022, BIOCHEM PHARMACOL, V197, DOI 10.1016/j.bcp.2021.114904; Li ZY, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.680328; Lu WJ, 2021, FOOD FUNCT, V12, P2995, DOI [10.1039/D0FO02906H, 10.1039/d0fo02906h]; Ma BC, 2021, EVID-BASED COMPL ALT, V2021, DOI 10.1155/2021/5563660; Mehta Devan, 2021, J Orthop Sci, DOI 10.1016/j.jos.2021.11.005; Migliorini F, 2021, J ORTHOP SURG RES, V16, DOI 10.1186/s13018-021-02678-x; Moseley KF, 2018, ENDOCR RES, V43, P155, DOI 10.1080/07435800.2018.1441868; Pan B, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.774709; Pilato CA, 2018, JOVE-J VIS EXP, DOI 10.3791/57263; Pomeisl K, 2020, MOLECULES, V25, DOI 10.3390/molecules25030497; Saad RK, 2022, OSTEOPOROSIS INT, V33, P511, DOI 10.1007/s00198-021-06206-9; Wang Z, 2021, INT J BIOL SCI, V17, P4192, DOI 10.7150/ijbs.61950; Wu NX, 2020, MOL CELL BIOCHEM, V470, P175, DOI 10.1007/s11010-020-03760-4; Xu XQ, 2020, FASEB J, V34, P8402, DOI 10.1096/fj.201902528RRR; Yang KD, 2021, EXP THER MED, V22, DOI 10.3892/etm.2021.10751; Yang SH, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.649698; Yu LB, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-021-02636-8; Zhao JW, 2011, AM J MED SCI, V341, P460, DOI 10.1097/MAJ.0b013e31820865d5; Zhao WY, 2021, LIFE SCI, V286, DOI 10.1016/j.lfs.2021.120005; Zhao X, 2019, EXP CLIN ENDOCR DIAB, V127, P50, DOI 10.1055/a-0762-0341; Zhou XJ, 2021, INT J BIOL SCI, V17, P3456, DOI 10.7150/ijbs.60401	37	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22491	10.1096/fj.202200608RR	http://dx.doi.org/10.1096/fj.202200608RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3R2QH	35947089				2022-12-26	WOS:000838762600001
J	Urrutia, KM; Xu, WY; Zhao, LL				Urrutia, Kathleen M.; Xu, Wenyan; Zhao, Linlin			The 5 '-phosphate enhances the DNA-binding and exonuclease activities of human mitochondrial genome maintenance exonuclease 1 (MGME1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE GAMMA; MUTATIONS; REPLICATION	In higher eukaryotes, mitochondria play multiple roles in energy production, signaling, and biosynthesis. Mitochondria possess multiple copies of mitochondrial DNA (mtDNA), which encodes 37 genes that are essential for mitochondrial and cellular function. When mtDNA is challenged by endogenous and exogenous factors, mtDNA undergoes repair, degradation, and compensatory synthesis. mtDNA degradation is an emerging pathway in mtDNA damage response and maintenance. A key factor involved is the human mitochondrial genome maintenance exonuclease 1 (MGME1). Despite previous biochemical and functional studies, controversies exist regarding the polarity of MGME1-mediated DNA cleavage. Also, how DNA sequence may affect the activities of MGME1 remains elusive. Such information is not only fundamental to the understanding of MGME1 but critical for deciphering the mechanism of mtDNA degradation. Herein, we use quantitative assays to examine the effects of substrate structure and sequence on the DNA-binding and enzymatic activities of MGME1. We demonstrate that MGME1 binds to and cleaves from the 5 '-end of single-stranded DNA substrates, especially in the presence of 5 '-phosphate, which plays an important role in DNA binding and optimal cleavage by MGME1. In addition, MGME1 tolerates certain modifications at the terminal end, such as a 5 '-deoxyribosephosphate intermediate formed in base excision repair. We show that MGME1 processes different sequences with varying efficiencies, with dT and dC sequences being the most and least efficiently digested, respectively. Our results provide insights into the enzymatic properties of MGME1 and a rationale for the coordination of MGME1 with the 3 '-5 ' exonuclease activity of DNA polymerase. in mtDNA degradation.	[Urrutia, Kathleen M.; Xu, Wenyan; Zhao, Linlin] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Zhao, Linlin] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Zhao, LL (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.; Zhao, LL (corresponding author), Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA.	linlin.zhao@ucr.edu	Xu, Wenyan/R-9537-2018; Zhao, Linlin/H-1652-2013	Xu, Wenyan/0000-0003-2034-2828; Zhao, Linlin/0000-0002-8821-4198	National Institutes of Health, United States [R35 GM128854]	National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health, United States (grant no.: R35 GM128854; to L. Z.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexeyev M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012641; AlMalki FA, 2016, NAT STRUCT MOL BIOL, V23, P640, DOI 10.1038/nsmb.3241; [Anonymous], J CLIN INVEST, V130, P108; Berney M, 2022, CHEMMEDCHEM, V17, DOI 10.1002/cmdc.202100603; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426; Del Dotto V, 2020, SSBP1 MUTATIONS CAUS; Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021; Fleming AM, 2017, J AM CHEM SOC, V139, P4682, DOI 10.1021/jacs.6b10117; Gustafson MA, 2020, DNA REPAIR, V93, DOI 10.1016/j.dnarep.2020.102916; Gustafson MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221829; Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402; Jurkute N, 2019, ANN NEUROL, V86, P368, DOI 10.1002/ana.25550; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Lee Y, 2021, GENES-BASEL, V12, DOI 10.3390/genes12020284; Liyanage SU, 2017, MITOCHONDRION, V32, P31, DOI 10.1016/j.mito.2016.11.001; Matic S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03552-x; Milenkovic D, 2022, PLOS GENET, V18, DOI 10.1371/journal.pgen.1010190; Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336; Nissanka N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04895-1; Peeva V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04131-w; Piro-Megy C, 2020, J CLIN INVEST, V130, P143, DOI 10.1172/JCI128513; Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029; Szymanski MR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14959; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Uhler JP, 2016, NUCLEIC ACIDS RES, V44, P5861, DOI 10.1093/nar/gkw468; Wilson KA, 2014, NUCLEIC ACIDS RES, V42, P6726, DOI 10.1093/nar/gku269; Wu Z, 2021, TRENDS BIOCHEM SCI, V46, P812, DOI 10.1016/j.tibs.2021.05.004; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Xu WY, 2019, J MOL BIOL, V431, P673, DOI 10.1016/j.jmb.2019.01.002; Yang C, 2018, NUCLEIC ACIDS RES, V46, P11075, DOI 10.1093/nar/gky855; Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005; Zhao LL, 2020, CHEM RES TOXICOL, V33, P2491, DOI 10.1021/acs.chemrestox.0c00083; Zhao LL, 2019, ENZYMES, V45, P311, DOI 10.1016/bs.enz.2019.08.004	36	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102306	10.1016/j.jbc.2022.102306	http://dx.doi.org/10.1016/j.jbc.2022.102306			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9EO	35934053	gold, Green Published			2022-12-26	WOS:000863182500007
J	Luo, YJ; Feng, A; Li, HX; Li, DY; Wu, X; Liao, J; Zhang, CW; Zheng, XQ; Pu, HB				Luo, Yuanjiang; Feng, Ao; Li, Hongxiang; Li, Danyang; Wu, Xuan; Liao, Jie; Zhang, Chengwu; Zheng, Xingqiang; Pu, Haibo			New deep learning method for efficient extraction of small water from remote sensing images	PLOS ONE			English	Article							INDEX NDWI; CLASSIFICATION	Extracting water bodies from remote sensing images is important in many fields, such as in water resources information acquisition and analysis. Conventional methods of water body extraction enhance the differences between water bodies and other interfering water bodies to improve the accuracy of water body boundary extraction. Multiple methods must be used alternately to extract water body boundaries more accurately. Water body extraction methods combined with neural networks struggle to improve the extraction accuracy of fine water bodies while ensuring an overall extraction effect. In this study, false color processing and a generative adversarial network (GAN) were added to reconstruct remote sensing images and enhance the features of tiny water bodies. In addition, a multi-scale input strategy was designed to reduce the training cost. We input the processed data into a new water body extraction method based on strip pooling for remote sensing images, which is an improvement of DeepLabv3+. Strip pooling was introduced in the DeepLabv3+ network to better extract water bodies with a discrete distribution at long distances using different strip kernels. The experiments and tests show that the proposed method can improve the accuracy of water body extraction and is effective in fine water body extraction. Compared with seven other traditional remote sensing water body extraction methods and deep learning semantic segmentation methods, the prediction accuracy of the proposed method reaches 94.72%. In summary, the proposed method performs water body extraction better than existing methods.	[Luo, Yuanjiang; Feng, Ao; Li, Hongxiang; Li, Danyang; Wu, Xuan; Liao, Jie; Pu, Haibo] Sichuan Agr Univ, Coll Informat Engn, Yaan, Sichuan, Peoples R China; [Zhang, Chengwu] Nanjing Forestry Univ, Coll Informat Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Zheng, Xingqiang] Sichuan Agr Univ, Coll Management, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Nanjing Forestry University; Sichuan Agricultural University	Pu, HB (corresponding author), Sichuan Agr Univ, Coll Informat Engn, Yaan, Sichuan, Peoples R China.	puhb@sicau.edu.cn	li, danyang/HHS-3319-2022	Pu, Haibo/0000-0001-6344-4053				Alan L. Yuille, 2016, Arxiv, DOI arXiv:1412.7062; Carr JR, 1996, COMPUT GEOSCI, V22, P849, DOI 10.1016/S0098-3004(96)00025-8; Chang CI, 2009, PATTERN RECOGN, V42, P395, DOI 10.1016/j.patcog.2008.07.016; Chen LCE, 2018, LECT NOTES COMPUT SC, V11211, P833, DOI 10.1007/978-3-030-01234-2_49; Chen LC, 2018, IEEE T PATTERN ANAL, V40, P834, DOI 10.1109/TPAMI.2017.2699184; Chen Y, 2022, IEEE T GEOSCI REMOTE, V60, DOI 10.1109/TGRS.2020.3043980; Chen Y, 2021, GISCI REMOTE SENS, V58, P624, DOI 10.1080/15481603.2021.1933367; Chen Y, 2020, J HYDROL, V588, DOI 10.1016/j.jhydrol.2020.125092; Eigen D, 2015, IEEE I CONF COMP VIS, P2650, DOI 10.1109/ICCV.2015.304; Florian Schroff, 2017, Arxiv, DOI arXiv:1706.05587; Foster S, 2014, HYDROGEOL J, V22, P1489, DOI 10.1007/s10040-014-1157-6; Goodfellow IJ, 2014, ADV NEUR IN, V27, P2672, DOI 10.1145/3422622; Vishwakarma RG, 2021, EUR PHYS J C, V81, DOI 10.1140/epjc/s10052-021-08981-5; Gu LX, 2021, INT J REMOTE SENS, V42, P2963, DOI 10.1080/01431161.2020.1842545; Hou QB, 2020, PROC CVPR IEEE, P4002, DOI 10.1109/CVPR42600.2020.00406; Jiang H, 2014, REMOTE SENS-BASEL, V6, P5067, DOI 10.3390/rs6065067; Jin S, 2021, REMOTE SENS ENVIRON, V255, DOI 10.1016/j.rse.2021.112297; Li LR, 2021, ISPRS J PHOTOGRAMM, V172, P59, DOI 10.1016/j.isprsjprs.2020.12.003; Lu SL, 2011, INT J APPL EARTH OBS, V13, P428, DOI 10.1016/j.jag.2010.09.006; Ma L, 2019, ISPRS J PHOTOGRAMM, V152, P166, DOI 10.1016/j.isprsjprs.2019.04.015; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Qi BG, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11030245; Revel C, 2019, EUR J REMOTE SENS, V52, P122, DOI 10.1080/22797254.2018.1562311; Teng JK, 2021, ECOL INDIC, V122, DOI 10.1016/j.ecolind.2020.107260; Valencia-Rosado LO, 2021, IEEE ACCESS, V9, P2975, DOI 10.1109/ACCESS.2020.3048083; Wang ZB, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12244140; Wang ZF, 2021, REMOTE SENS ENVIRON, V255, DOI 10.1016/j.rse.2020.112281; Wen ZF, 2021, INT J APPL EARTH OBS, V96, DOI 10.1016/j.jag.2020.102278; Wu ZF, 2019, PATTERN RECOGN, V90, P119, DOI 10.1016/j.patcog.2019.01.006; Xi Y, 2021, IEEE J-STARS, V14, P1705, DOI 10.1109/JSTARS.2020.3043109; Xu HQ, 2006, INT J REMOTE SENS, V27, P3025, DOI 10.1080/01431160600589179; Yang FY, 2020, J APPL REMOTE SENS, V14, DOI 10.1117/1.JRS.14.014502; Yang XC, 2017, J APPL REMOTE SENS, V11, DOI 10.1117/1.JRS.11.026016; Zeng Z, 2021, REMOTE SENS-BASEL, V13, DOI 10.3390/rs13010092; Zhang RN, 2019, J APPL REMOTE SENS, V13, DOI 10.1117/1.JRS.13.038501; Zhao B, 2017, INT J AUTOM COMPUT, V14, P119, DOI 10.1007/s11633-017-1053-3; Zhao HS, 2017, PROC CVPR IEEE, P6230, DOI 10.1109/CVPR.2017.660; Zhu XX, 2017, IEEE GEOSC REM SEN M, V5, P8, DOI 10.1109/MGRS.2017.2762307	38	0	0	23	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2022	17	8							e0272317	10.1371/journal.pone.0272317	http://dx.doi.org/10.1371/journal.pone.0272317			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5A3IT	35930531	gold, Green Published			2022-12-26	WOS:000862784200001
J	Nasrallah, M; Tamim, H; Mailhac, A; AlBuhairan, F				Nasrallah, Mona; Tamim, Hani; Mailhac, Aurelie; AlBuhairan, Fadia			Lifestyle habits in Saudi adolescents with diagnosed diabetes: An opportunity for health promotion	PLOS ONE			English	Article							GLYCEMIC CONTROL; GENDER-DIFFERENCES; PHYSICAL-ACTIVITY; YOUNG-ADULTS; RISK-FACTORS; TYPE-1; CHILDREN; PREVALENCE; ASSOCIATIONS; SURVEILLANCE	Aims This study assessed lifestyle and health behavior habits among a representative sample of Saudi adolescents with self-reported diabetes and compared them to non-diabetic peers. Methods This was a nested case-control study, from the Jeeluna cohort, a nationwide, cross-sectional study of 12,575 Saudi boys and girls aged 10-19 years. Non-diabetic adolescents were matched to those with diabetes on a ratio of 4:1 based on age, gender and region. Retained information from the original study included: socio-demographics, lifestyle behaviors, tobacco/substance use, screen use, anthropometric measurements, and laboratory results. Results The prevalence of diabetes was 0.7% (n = 87). Overall, 65% of diabetic participants were males, and 22.4% aged <= 14 years. Overall, both groups had low rates of healthful habits in their diet and physical activity. Both groups had similar rates of tobacco use, and high digital screen time. Adolescents with diabetes had more consistent sleeping pattern, were more likely to be on a diet, thought they spent enough time with their physician and obtained medical information more often from their health clinic. They were also more likely to feel down and to chat more often. Conclusion Adolescents with diabetes remain far from guideline targets but seem predisposed to better lifestyle and have more access to health as compared to their non-diabetic peers.	[Nasrallah, Mona; Mailhac, Aurelie] Amer Univ Beirut, Dept Internal Med, Div Endocrinol & Metab, Med Ctr, Beirut, Lebanon; [Tamim, Hani; AlBuhairan, Fadia] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia; [Tamim, Hani] Amer Univ Beirut, Dept Internal Med, Med Ctr, Beirut, Lebanon; [AlBuhairan, Fadia] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [AlBuhairan, Fadia] Hlth Sect Transformat Program, Riyadh, Saudi Arabia	American University of Beirut; Alfaisal University; American University of Beirut; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC)	AlBuhairan, F (corresponding author), Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.; AlBuhairan, F (corresponding author), King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.; AlBuhairan, F (corresponding author), Hlth Sect Transformat Program, Riyadh, Saudi Arabia.	fadia.albuhairan@gmail.com		AlBuhairan, Fadia/0000-0002-7377-503X	King Abdullah International Medical Research Center, Saudi Arabia	King Abdullah International Medical Research Center, Saudi Arabia	The Jeeluna study was funded and supported by the King Abdullah International Medical Research Center, Saudi Arabia.	Abou Abbas O, 2017, CHILD ADOL PSYCH MEN, V11, DOI 10.1186/s13034-017-0188-x; Abuyassin B, 2016, WORLD J DIABETES, V7, P165, DOI 10.4239/wjd.v7.i8.165; Al Ani MF, 2016, BRIT J NUTR, V115, P1092, DOI [10.1017/S0007114515005371, 10.1017/S0007114516003810]; Al-Hazzaa HM, 2013, INT J ENV RES PUB HE, V10, P6701, DOI 10.3390/ijerph10126701; Al-Herbish AS, 2008, SAUDI MED J, V29, P1285; Al-Hussaini M, 2016, ALEX J MED, V52, P61, DOI 10.1016/j.ajme.2015.04.001; Al-Mutairi Reem L, 2015, Sultan Qaboos Univ Med J, V15, pe398, DOI 10.18295/squmj.2015.15.03.015; Al-Rubeaan K, 2015, J EPIDEMIOL COMMUN H, V69, P1045, DOI 10.1136/jech-2015-205710; AlBuhairan FS, 2015, J ADOLESCENT HEALTH, V57, P263, DOI 10.1016/j.jadohealth.2015.06.009; AlBuhairan FS, 2015, J ADOLESCENT HEALTH, V57, P249, DOI 10.1016/j.jadohealth.2015.06.010; AlSayyari A, 2018, DRUG ALCOHOL DEPEN, V191, P174, DOI 10.1016/j.drugalcdep.2018.01.025; American Academy of Pediatrics (AAP) POLICY STATEMENT, 2013, CHILDREN ADOLESCENTS; Borus JS, 2010, CURR OPIN PEDIATR, V22, P405, DOI 10.1097/MOP.0b013e32833a46a7; Cefalu WT, 2019, DIABETES CARE, V42, pS148, DOI 10.2337/dc19-S013; Centers for Disease Control and Prevention, 2015, DEF CHILDH OB; Daneman D, 2005, HORM RES, V63, P75, DOI 10.1159/000083692; Depner CM, 2019, CURR BIOL, V29, P957, DOI 10.1016/j.cub.2019.01.069; Galler A, 2011, DIABETES CARE, V34, P2356, DOI 10.2337/dc11-0838; Kummer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112083; Mauvais-Jarvis F, 2018, PHYSIOL BEHAV, V187, P20, DOI 10.1016/j.physbeh.2017.08.016; Mayer-Davis EJ, 2017, NEW ENGL J MED, V376, P1419, DOI 10.1056/NEJMoa1610187; Menke A, 2016, JAMA-J AM MED ASSOC, V316, P344, DOI 10.1001/jama.2016.8544; Nasim M, 2019, SLEEP MED, V53, P165, DOI 10.1016/j.sleep.2018.08.031; Obermeyer C., 2015, DIFI FAM RES PROC, V2015, P1; Owens J, 2014, PEDIATRICS, V134, pE921, DOI 10.1542/peds.2014-1696; Park E, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.7731; Paruthi S, 2016, J CLIN SLEEP MED, V12, P785, DOI 10.5664/jcsm.5866; Patel NJ, 2018, PEDIATR DIABETES, V19, P1100, DOI 10.1111/pedi.12689; Patterson C, 2014, DIABETES RES CLIN PR, V103, P161, DOI 10.1016/j.diabres.2013.11.005; Popkin BM, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0631-4; Quirk H, 2014, DIABETIC MED, V31, P1163, DOI 10.1111/dme.12531; Rausch JR, 2012, DIABETES CARE, V35, P1219, DOI 10.2337/dc11-2163; Robert AA, 2018, INT J PEDIAT, V2018, DOI 10.1155/2018/9408370; Sharara E, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5472-z; Sibai AM, 2011, ANN NUTR METAB, V57, P193, DOI 10.1159/000321527; Vaala SE, 2015, INTERACT J MED RES, V4, P34, DOI 10.2196/ijmr.4504; WHO, 2003, WHO TECH REP SER, V916, P1; Wisting L, 2017, APPETITE, V114, P226, DOI 10.1016/j.appet.2017.03.035; Wndell PE, 2013, CURR DIABETES REV, V9, P342, DOI 10.2174/15733998113099990064; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333	40	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0270807	10.1371/journal.pone.0270807	http://dx.doi.org/10.1371/journal.pone.0270807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925967	gold, Green Published			2022-12-26	WOS:000848077100023
J	Salvi, N; Itta, KC; Lachyan, A; Hasan, AZ; Prosperi, C; Kumar, MS; Thangaraj, JWV; Kaduskar, O; Bhatt, V; Sapkal, GN; Murhekar, M; Gupta, N; Mehendale, S; Hayford, K; Moss, WJ; Chauhan, S; Kulkarni, R				Salvi, Neha; Itta, Krishna Chaaithanya; Lachyan, Abhishek; Hasan, Alvira Z.; Prosperi, Christine; Kumar, Muthusamy Santhosh; Thangaraj, Jeromie Wesley Vivian; Kaduskar, Ojas; Bhatt, Vaishali; Sapkal, Gajanan N.; Murhekar, Manoj; Gupta, Nivedita; Mehendale, Sanjay; Hayford, Kyla; Moss, William J.; Chauhan, Sanjay; Kulkarni, Ragini			Experiences of sharing results of community based serosurvey with participants in a district of Maharashtra, India	PLOS ONE			English	Article							CLINICAL-TRIAL	A growing number of organisations, including medical associations, recommend that research subjects should be given the option of being informed about the general outcome and results of the study. We recently completed a study involving nine serosurveys from 2018 to 2020 in five districts of India among three age groups (children 9 months to < 5 years; 5 to < 15 years of age, and women 15 to < 50 years of age before and after the measles and rubella (MR) vaccination campaigns). In Palghar district of Maharashtra all individuals in 30 selected clusters were enumerated, and 13 individuals per age group were randomly sampled. We established the procedures to return the results to the respondents for each stage of the survey. Of the 1,166 individuals selected for the measles and rubella serosurvey, 971 (83%) agreed to participate and were enrolled. Participants were informed that they will only be contacted if they test seronegative for measles and/or rubella antibodies. Overall, 140 individuals enrolled in the survey tested seronegative for IgG antibodies to measles and/or rubella viruses; were provided the reports and informed to seek medical advice. Upon follow up by phone, 10% (14) of the 140 participants reported to have been vaccinated. In this paper we discuss the procedures, experiences and considerations in returning results to participants in a community-based measles and rubella serosurvey. Although the lessons learned are specific to post measles-rubella vaccine campaign serosurvey in India, they might be helpful to those contemplating sharing results to participants of large scale survey settings.	[Salvi, Neha; Itta, Krishna Chaaithanya; Lachyan, Abhishek] Dept Hlth Res, Model Rural Hlth Res Unit, Dahanu, Maharashtra, India; [Itta, Krishna Chaaithanya; Chauhan, Sanjay; Kulkarni, Ragini] ICMR Natl Inst Res Reprod & Child Hlth, Mumbai, Maharashtra, India; [Hasan, Alvira Z.; Prosperi, Christine; Hayford, Kyla; Moss, William J.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, Baltimore, MD USA; [Kumar, Muthusamy Santhosh; Thangaraj, Jeromie Wesley Vivian; Murhekar, Manoj] ICMR Natl Inst Epidemiol, Chennai, Tamil Nadu, India; [Kaduskar, Ojas; Bhatt, Vaishali; Sapkal, Gajanan N.] ICMR Natl Inst Virol, Pune, Maharashtra, India; [Gupta, Nivedita] Indian Council Med Res, Div Epidemiol & Communicable Dis, New Delhi, India; [Mehendale, Sanjay] PD Hinduja Hosp & Med Res Ctr, Mumbai, Maharashtra, India	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Indian Council of Medical Research (ICMR)	Kulkarni, R (corresponding author), ICMR Natl Inst Res Reprod & Child Hlth, Mumbai, Maharashtra, India.	kulkarnir120@gmail.com		Hasan, Alvira Z/0000-0001-5665-2372	Bill & Melinda Gates Foundation [1094816]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was funded by grants from The Bill & Melinda Gates Foundation (https://www.gatesfoundation.org) to the International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Grant 1094816 was awarded to WJM and KH. KH conducted the study and analyses while working at the Johns Hopkins School of Public Health but is an employee at Pfizer, Inc. as of 26 October 2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown DW, 2020, CURR OPIN VIROL, V41, P77, DOI 10.1016/j.coviro.2020.05.007; Cox K, 2011, EUR J ONCOL NURS, V15, P124, DOI 10.1016/j.ejon.2010.06.009; Cutts FT, 2016, TROP MED INT HEALTH, V21, P1086, DOI 10.1111/tmi.12737; Elzinga KE, 2016, CLIN TRIALS, V13, P574, DOI 10.1177/1740774516665597; George MS., 2020, REVIEW, DOI [10.21203/rs.3.rs-43527/v1, DOI 10.21203/RS.3.RS-43527/V1]; Ghaffari A, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11010115; Hasan AZ, 2021, AM J TROP MED HYG, V105, P1608, DOI 10.4269/ajtmh.21-0401; Long CR, 2019, HEALTH RES POLICY SY, V17, DOI 10.1186/s12961-019-0422-5; Long CR, 2016, CLIN TRIALS, V13, P582, DOI 10.1177/1740774516665598; Lorimer K, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-10; main.icmr.nic, ICMR ETH GUID 2017; Miller FA, 2008, J MED ETHICS, V34, P210, DOI 10.1136/jme.2006.020289; mrctcenter, 2017 12 07 RET OF IN; National Academies of Sciences Engineering and Medicine 2018., RET IND RES RES PART; Partridge AH, 2005, LANCET, V365, P963, DOI 10.1016/S0140-6736(05)71085-0; Purvis Rachel S, 2017, AJOB Empir Bioeth, V8, P69, DOI 10.1080/23294515.2017.1310146; rchiips, PALGH; Scognamiglio P, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5680-6; Vears DF, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0258646; WMA-The World Medical Association, WMA DECL HELS ETH PR; World Health Organization. Council for International Organizations of Medical Sciences, 2017, INT ETH GUID HLTH RE	21	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271920	10.1371/journal.pone.0271920	http://dx.doi.org/10.1371/journal.pone.0271920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925959	gold, Green Published, Green Accepted			2022-12-26	WOS:000848077100059
J	Sangveraphunsiri, T; Fukushige, T; Jongwiriyanurak, N; Tanaksaranond, G; Jarumaneeroj, P				Sangveraphunsiri, Tawit; Fukushige, Tatsuya; Jongwiriyanurak, Natchapon; Tanaksaranond, Garavig; Jarumaneeroj, Pisit			Impacts of the COVID-19 pandemic on the spatio-temporal characteristics of a bicycle-sharing system: A case study of Pun Pun, Bangkok, Thailand	PLOS ONE			English	Article							URBAN MOBILITY; TRANSPORT	The COVID-19 pandemic is found to be one of the external stimuli that greatly affects mobility of people, leading to a shift of transportation modes towards private individual ones. To properly explain the change in people's transport behavior, especially in pre- and post- pandemic periods, a tensor-based framework is herein proposed and applied to Pun Pun-the only public bicycle-sharing system in Bangkok, Thailand-where multidimensional trip data of Pun Pun are decomposed into four different modes related to their spatial and temporal dimensions by a non-negative Tucker decomposition approach. According to our computational results, the first pandemic wave has a sizable influence not only on Pun Pun but also on other modes of transportation. Nonetheless, Pun Pun is relatively more resilient, as it recovers more quickly than other public transportation modes. In terms of trip patterns, we find that, prior to the pandemic, trips made during weekdays are dominated by business trips with two peak periods (morning and evening peaks), while those made during weekends are more related to leisure activities as they involve stations nearby a public park. However, after the first pandemic wave ends, the patterns of weekday trips have been drastically changed, as the number of business trips sharply drops, while that of educational trips connecting metro/subway stations with a major educational institute in the region significantly rises. These findings may be regarded as a reflection of the ever-changing transport behavior of people seeking a sustainable mode of private transport, with a more positive outlook on the use of bicycle-sharing system in Bangkok, Thailand.	[Sangveraphunsiri, Tawit; Jarumaneeroj, Pisit] Chulalongkorn Univ, Fac Engn, Dept Ind Engn, Bangkok, Thailand; [Fukushige, Tatsuya] Univ Calif Davis, Inst Transportat Studies, Davis, CA 95616 USA; [Jongwiriyanurak, Natchapon] UCL, Dept Civil Environm & Geomat Engn, SpaceTimeLab, London, England; [Tanaksaranond, Garavig] Chulalongkorn Univ, Fac Engn, Dept Survey Engn, Bangkok, Thailand; [Jarumaneeroj, Pisit] Chulalongkorn Univ, Reg Ctr Mfg Syst Engn, Bangkok, Thailand	Chulalongkorn University; University of California System; University of California Davis; University of London; University College London; Chulalongkorn University; Chulalongkorn University	Jarumaneeroj, P (corresponding author), Chulalongkorn Univ, Fac Engn, Dept Ind Engn, Bangkok, Thailand.	pisit.ja@chula.ac.th		Jarumaneeroj, Pisit/0000-0002-5191-5898; Fukushige, Tatsuya/0000-0002-6485-4537; Jongwiriyanurak, Natchapon/0000-0002-6188-8432; Sangveraphunsiri, Tawit Boom/0000-0002-0263-8652	Second Century Fund (C2F), Chulalongkorn University, Bangkok, Thailand	Second Century Fund (C2F), Chulalongkorn University, Bangkok, Thailand	TS is supported by the Second Century Fund (C2F), Chulalongkorn University, Bangkok, Thailand (https://www.research.chula.ac.th/thesecond-century-fund-chulalongkorn-university-c2f).	Abdullah Muhammad, 2020, Transp Res Interdiscip Perspect, V8, P100255, DOI 10.1016/j.trip.2020.100255; Antunes E., 2010, BICYCLE SHARING DEVE; Bakker S, 2018, INT J SUSTAIN TRANSP, V12, P416, DOI 10.1080/15568318.2017.1384522; Bangkok Metropolitan Authority [BMA], 2020, SATH BOR CHARKR SATH; Barbieri DM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245886; Batty M, 2020, ENVIRON PLAN B-URBAN, V47, P547, DOI 10.1177/2399808320926912; Bergantino AS, 2021, RES TRANSP ECON, V86, DOI 10.1016/j.retrec.2020.101028; Boeing G, 2017, COMPUT ENVIRON URBAN, V65, P126, DOI 10.1016/j.compenvurbsys.2017.05.004; Boomfueng K., 2019, SOCIAL EC ASPECTS HL, V12, P195; Boontaveeyuwat S., 2015, ANAL FACTORS AFFECTI, V26, P165, DOI [10.14416/j.kmutnb.2015.09.003, DOI 10.14416/J.KMUTNB.2015.09.003]; Bucsky Peter, 2020, Transp Res Interdiscip Perspect, V8, P100141, DOI 10.1016/j.trip.2020.100141; Buehler R, 2021, TRANSPORT REV, V41, P393, DOI 10.1080/01441647.2021.1914900; Cambe J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231550; Cao M, 2020, INT J GEOGR INF SCI, V34, P2225, DOI 10.1080/13658816.2020.1768259; Chakaravarthy VT, 2017, INT PARALL DISTRIB P, P1038, DOI 10.1109/IPDPS.2017.86; Chang XY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193795; Dai HR, 2020, J VISUAL-JAPAN, V23, P1053, DOI 10.1007/s12650-020-00673-8; Das S, 2021, TRANSPORT POLICY, V109, P1, DOI 10.1016/j.tranpol.2021.05.005; DeMaio P.J., 2009, J PUBLIC TRANSPORT, V12, P41, DOI [5038/2375-0901.12.410.5038/2375-0901.12.4.3, DOI 10.5038/2375-0901.12.4.3]; Dong HM, 2021, TRANSPORT POLICY, V101, P81, DOI 10.1016/j.tranpol.2020.12.004; Eren E, 2020, SUSTAIN CITIES SOC, V54, DOI 10.1016/j.scs.2019.101882; Falchetta G., 2020, LANCET INFECT DIS, V20, P533; Fishman E, 2016, TRANSPORT REV, V36, P92, DOI 10.1080/01441647.2015.1033036; Fukushige T, 2021, TRANSPORT RES D-TR E, V99, DOI 10.1016/j.trd.2021.102990; Galatoulas NF, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114611; Gauthier A, 2013, BIKE SHARE PLANNING; Gnerre M, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0265245; Guo YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185100; Gutierrez A., 2020, CITIES HLTH, V5, pS177, DOI [10.1080/23748834.2020.1804291, DOI 10.1080/23748834.2020.1804291]; Heinrichs D, 2017, TRANSP RES PROC, V25, DOI 10.1016/j.trpro.2017.05.346; Heydari S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0260969; Hu SH, 2021, J TRANSP GEOGR, V91, DOI 10.1016/j.jtrangeo.2021.102997; Jarumaneeroj P, 2022, COMPUT IND ENG, V167, DOI 10.1016/j.cie.2022.108031; Jobe J., 2021, TRANSPORTATION RES I, V10, DOI [10.1016/j.trip.2021.100353, DOI 10.1016/J.TRIP.2021.100353]; Kanjanasut W., 2017, FACTORS AFFECTING US; Kim Y. J., 2007, IEEE C COMP VIS PATT, P1, DOI [DOI 10.1109/CVPR.2007.383405, DOI 10.1061/40927(243)477]; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Kossaifi J, 2019, J MACH LEARN RES, V20; Kubalak S, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13126544; Laverty AA, 2020, J ROY SOC MED, V113, P251, DOI 10.1177/0141076820938997; Lekgothoane D., 2015, FEASIBILITY BICYCLIN; Maison D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0258133; Mateo-babiano I., 2015, J E ASIA SOC TRANSP, V11, P60, DOI [10.11175/easts.11.60, DOI 10.11175/EASTS.11.60]; Mateo-Babiano I, 2017, TRANSP RES PROC, V25, P4970, DOI 10.1016/j.trpro.2017.05.375; Ministry of Transport, KARN DERNT KHONG PRA; Nikiforiadis A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12198215; Office of Transport and Traffic Policy and Planning, 2018, TRAV DEM FREIGHT MOV; Office of Transport and Traffic Policy and Planning, 2014, PROJ STUD PROM NONM; Otero I, 2018, ENVIRON INT, V115, P387, DOI 10.1016/j.envint.2018.04.014; Pase F, 2020, IEEE ACCESS, V8, P187291, DOI 10.1109/ACCESS.2020.3030841; Patel SJ., 2018, INFRASTRUCTURE REV P, P111, DOI [10.1007/978-981-13-2032-3, DOI 10.1007/978-981-13-2032-3]; Phuphisith S, 2020, J CLEAN PROD, V253, DOI 10.1016/j.jclepro.2019.119882; Prasertsubpakij D, 2012, IATSS RES, V36, P56, DOI 10.1016/j.iatssr.2012.02.003; Qiu LY, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10041145; Raha U, 2013, PROCEDIA ENVIRON SCI, V17, P444, DOI 10.1016/j.proenv.2013.02.058; Rahman MSU, 2020, TRANSPORT RES A-POL, V142, P207, DOI 10.1016/j.tra.2020.09.022; Reuters, 2019, BANGKOK POST; Ricci M, 2015, RES TRANSP BUS MANAG, V15, P28, DOI 10.1016/j.rtbm.2015.03.003; Saetung P., 2016, RMUP RES J HUMANIT S, V1; Schilte P., 2020, COMPARING PERFORMANC; Sevtsuk A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252794; Shaaban K, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12041693; Shaheen SA, 2010, TRANSPORT RES REC, P159, DOI 10.3141/2143-20; Shang WL, 2021, APPL ENERG, V285, DOI 10.1016/j.apenergy.2020.116429; Sharifi A, 2020, SCI TOTAL ENVIRON, V749, DOI 10.1016/j.scitotenv.2020.142391; Sharmeen F, 2021, J TRANSP GEOGR, V90, DOI 10.1016/j.jtrangeo.2020.102898; Shelat S, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0264805; Si HY, 2019, J CLEAN PROD, V213, P415, DOI 10.1016/j.jclepro.2018.12.157; State Ministry of Health, 2018, AN STAT STRAT HLTH D; Sun LJ, 2016, TRANSPORT RES B-METH, V91, P511, DOI 10.1016/j.trb.2016.06.011; Tang H, 2019, PROCEEDINGS OF THE 12TH INTERNATIONAL SYMPOSIUM ON VISUAL INFORMATION COMMUNICATION AND INTERACTION, VINCI 2019, DOI 10.1145/3356422.3356440; Teixeira Joao Filipe, 2020, Transp Res Interdiscip Perspect, V6, P100166, DOI 10.1016/j.trip.2020.100166; Thaiger, 2018, THAIG; Thailand Meteorological Department, 2020, PHUMM KRUNGTH MAH NA; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464; van Erven T, 2014, IEEE T INFORM THEORY, V60, P3797, DOI 10.1109/TIT.2014.2320500; van Wee B, 2021, J TRANSP GEOGR, V95, DOI 10.1016/j.jtrangeo.2021.103144; Wang DH, 2022, TRANSPORTMETRICA A, V18, P29, DOI 10.1080/23249935.2019.1692961; Wojan TR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130903; Worldometer, 2021, COR WORLDW GRAPHS; Yan J., 2020, BUILT ENV J, V17, P85, DOI [10.24191/bej.v17i2.10118, DOI 10.24191/BEJ.V17I2.10118]; Yan YY, 2018, J VISUAL-JAPAN, V21, P495, DOI 10.1007/s12650-017-0463-1; Zhang JY, 2021, TRANSPORT POLICY, V103, P68, DOI 10.1016/j.tranpol.2021.01.011	83	0	0	9	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272537	10.1371/journal.pone.0272537	http://dx.doi.org/10.1371/journal.pone.0272537			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925948	Green Published, gold			2022-12-26	WOS:000848077100096
J	Cellini, M; Pecoraro, F; Rigby, M; Luzi, D				Cellini, Marco; Pecoraro, Fabrizio; Rigby, Michael; Luzi, Daniela			Comparative analysis of pre-Covid19 child immunization rates across 30 European countries and identification of underlying positive societal and system influences	PLOS ONE			English	Article							VACCINATION; VACCINES	This study provides a macro-level societal and health system focused analysis of child vaccination rates in 30 European countries, exploring the effect of context on coverage. The importance of demography and health system attributes on health care delivery are recognized in other fields, but generally overlooked in vaccination. The analysis is based on correlating systematic data built up by the Models of Child Health Appraised (MOCHA) Project with data from international sources, so as to exploit a one-off opportunity to set the analysis within an overall integrated study of primary care services for children, and the learning opportunities of the 'natural European laboratory'. The descriptive analysis shows an overall persistent variation of coverage across vaccines with no specific vaccination having a low rate in all the EU and EEA countries. However, contrasting with this, variation between total uptake per vaccine across Europe suggests that the challenge of low rates is related to country contexts of either policy, delivery, or public perceptions. Econometric analysis aiming to explore whether some population, policy and/or health system characteristics may influence vaccination uptake provides important results-GDP per capita and the level of the population's higher education engagement are positively linked with higher vaccination coverage, whereas mandatory vaccination policy is related to lower uptake rates. The health system characteristics that have a significant positive effect are a cohesive management structure; a high nurse/doctor ratio; and use of practical care delivery reinforcements such as the home-based record and the presence of child components of e-health strategies.	[Cellini, Marco; Pecoraro, Fabrizio; Luzi, Daniela] CNR, Inst Res Populat & Social Pol CNR IRPPS, Rome, Italy; [Rigby, Michael] Keele Univ, Sch Social Polit & Global Studies, Keele, England; [Rigby, Michael] Keele Univ, Sch Primary Community & Social Care, Keele, England	Consiglio Nazionale delle Ricerche (CNR); Keele University; Keele University	Pecoraro, F (corresponding author), CNR, Inst Res Populat & Social Pol CNR IRPPS, Rome, Italy.	f.pecoraro@irpps.cnr.it		Rigby, Michael/0000-0003-1342-6177				[Anonymous], 2014, HEALTH PROMOT INT, V29, P19, DOI 10.1093/heapro/dau035; [Anonymous], 2018, COUNCIL RECOMMENDATI; Bedford H, 2018, VACCINE, V36, P6556, DOI 10.1016/j.vaccine.2017.08.004; Betsch C, 2016, EUR J PUBLIC HEALTH, V26, P378, DOI 10.1093/eurpub/ckv154; Blair M., 2019, ISSUES OPPORTUNITIES, DOI [10.1108/9781789733518, DOI 10.1108/9781789733518]; Blair M, 2017, FINAL REPORT CURRENT; Boyce T, 2019, EUROSURVEILLANCE, V24, P17, DOI 10.2807/1560-7917.ES.2019.24.2.1800204; Bozzola E, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-018-0504-y; Cellini M., 2022, CORRES SPREADSHEET P, DOI [10.5281/zenodo.6619113, DOI 10.5281/ZENODO.6619113]; Deshpande S, 2018, WORK PACKAGE 8 USE E; European Center for Disease Prevention and Control (ECDC), 2019, VACC SCHED ALL COUNT; European Commission, 2019, VACC GLOB VACC SUMM; European Union. Committee of the Regions, 2017, MAN HLTH SYST EU MEM; Eurostat, 2020, EN BAL 2020, DOI DOI 10.2785/68334; Global Vaccination Summit, 2019, 10 ACT VACC ALL DOC; Hardy M.A., 2009, HDB DATA ANAL; Karafillakis E, 2017, VACCINE, V35, P4840, DOI 10.1016/j.vaccine.2017.07.061; Kuhne G, 2016, WORK PACKAGE 8 USE E; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Lernout T, 2014, VACCINE, V32, P284, DOI 10.1016/j.vaccine.2013.10.084; Mahase E, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5995; Mantel C, 2020, BUNDESGESUNDHEITSBLA, V63, P25, DOI 10.1007/s00103-019-03066-x; McKee M, 2019, EUR J PUBLIC HEALTH, V29, P373, DOI [10.1093/eurpub/ckz185.373, DOI 10.1093/EURPUB/CKZ185.373]; Paul KT, 2019, J PUBLIC HEALTH POL, V40, P166, DOI 10.1057/s41271-019-00163-8; Rezza G, 2019, PATHOG GLOB HEALTH, V113, P291, DOI 10.1080/20477724.2019.1705021; Rigby M., 2020, USE HOME BASED RECOR; Rigby MJ, 2021, INT J HEALTH PLAN M, V36, P1998, DOI 10.1002/hpm.3282; Rigby MJ, 2020, EUR J PUBLIC HEALTH, V30, P693, DOI 10.1093/eurpub/ckaa052; Rigby MJ, 2020, EUR J PUBLIC HEALTH, V30, P449, DOI 10.1093/eurpub/ckz199; Riise OR, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0487-4; SAGE Working Group on Vaccine Hesitancy, 2014, REP SAG WORK GROUP V; Sheikh S, 2018, VACCINE, V36, P4979, DOI 10.1016/j.vaccine.2018.06.044; Solt F, 2016, SOC SCI QUART, V97, P1267, DOI 10.1111/ssqu.12295; The World Bank, 2020, DAT ENR TERT ED GROS; WHO, 2019, BREASTFEEDING; WHO, 2014, INV CHILDR EUR CHILD; World Bank, 2022, RUR POP TOT POP; World bank, 2021, GDP PER CAP CURR US; World Health Organization, 2018, WHO REC HOM BAS REC; World Health Organization, 2012, GLOB HLTH OBS DAT RE; World Health Organization, 2019, GLOB HLTH OBS DAT RE; World Health Organization, 2020, DAT MED DOCT; World Health Organization, 2018, ORG DEL VACC SERV EU; World Health Organization Regional Office for Europe, 2005, EUR STRAT CHILD AD H; World Health Organization. Regional Office for Europe, 2018, EUR VACC ACT PLAN 20; Yeh AB., 2005, TECHNOMETRICS, V47, P1, DOI [10.1198/tech.2005.s266, DOI 10.1198/TECH.2005.S266]; Zdunek K., 2019, ISSUES OPPORTUNITIES, DOI [10.1108/978-1-78973-351-820191009/full/html, DOI 10.1108/978-1-78973-351-820191009/FULL/HTML]	47	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271290	http://dx.doi.org/10.1371/journal.pone.0271290			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921275	Green Published, Green Accepted, gold			2022-12-26	WOS:000839311900079
J	Jeannerod, L; Carlier, A; Schatz, B; Daise, C; Richel, A; Agnan, Y; Baude, M; Jacquemart, AL				Jeannerod, Lena; Carlier, Archibald; Schatz, Bertrand; Daise, Clothilde; Richel, Aurore; Agnan, Yannick; Baude, Mathilde; Jacquemart, Anne-Laure			Some bee-pollinated plants provide nutritionally incomplete pollen amino acid resources to their pollinators	PLOS ONE			English	Article							FLORAL RESOURCES; PROTEIN-CONTENT; PREFERENCES; BUMBLEBEES; DECLINES; REVEALS; FOOD	For pollinators such as bees, nectar mainly provides carbohydrates and pollen provides proteins, amino acids, and lipids to cover their nutritional needs. Here, to examine differences in pollinator resources, we compared the amino acid profiles and total amino acid contents of pollen from 32 common entomophilous plants in seven families. Our results showed that the amino acid profiles and contents in pollen samples differed according to the plant family and the chromatography method used, i.e., high-performance liquid chromatography (HPLC) versus ion exchange chromatography (IEX). Pollen from Boraginaceae species had the highest total amino acid contents (361.2-504 mu g/mg) whereas pollen from the Malvaceae family had the lowest total amino acid contents (136-243.1 mu g/mg). Calculating an amino acid score (AAS) that reflects pollen nutritional quality showed that slightly less than half of the species (19 out of 32) had the maximum nutritional score (AAS = 1) and offered high nutritional quality pollen amino acids for bee pollinators. Though they had high total amino acid contents, the amino acid composition of the studied Boraginaceae species and several members of the Fabaceae was not optimal, as their pollen was deficient in some essential amino acids, resulting in suboptimal amino acid scores (AAS < 0.7). Except for cysteine, the measured amino acid contents were higher using IEX chromatography than using HPLC. IEX chromatography is more robust and is to be preferred over HPLC in future amino acid analyses. Moreover, our observations show that some bee-pollinated species fail to provide complete amino acid resources for their pollinators. Although the implications for pollinator behavior remain to be studied, these deficiencies may force pollinators to forage from different species to obtain all nutritionial requirements.	[Jeannerod, Lena; Carlier, Archibald; Daise, Clothilde; Agnan, Yannick; Jacquemart, Anne-Laure] UC Louvain, Earth & Life Inst Agron, Louvain La Neuve, Belgium; [Schatz, Bertrand] Univ Montpellier, CEFE, CNRS, EPHE,IRD, Montpellier, France; [Richel, Aurore] Univ Liege Gembloux Agrobio Tech, Biomass & Green Technol, Gembloux, Belgium; [Baude, Mathilde] Univ Orleans, USC INRAE 1328, LBLGC, Orleans, France; [Baude, Mathilde] Sorbonne Univ, Univ Paris Cite, Inst Ecol & Sci Environm iEES Paris, UPEC,CNRS,IRD,INRAE, Paris, France	Universite Catholique Louvain; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Liege; INRAE; Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Jeannerod, L (corresponding author), UC Louvain, Earth & Life Inst Agron, Louvain La Neuve, Belgium.	lena.jeannerod@uclouvain.be	Agnan, Yannick/E-9438-2012	Agnan, Yannick/0000-0002-9349-6310; Jeannerod, Lena/0000-0002-0750-9390; Richel, Aurore/0000-0002-4352-6542	UCLouvain under FSR Grant (2016-2020, Belgium); Fonds national de la recherche scientifique FNRS, Belgium under Grant (FRFC) [2.4613]; Fondation Universitaire de Belgique	UCLouvain under FSR Grant (2016-2020, Belgium); Fonds national de la recherche scientifique FNRS, Belgium under Grant (FRFC)(Fonds de la Recherche Scientifique - FNRS); Fondation Universitaire de Belgique	The work was supported by the UCLouvain under FSR Grant (2016-2020, Belgium), and Fonds national de la recherche scientifique FNRS, Belgium under Grant (FRFC no 2.4613). The work was published with the support of the Fondation Universitaire de Belgique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barraud A, 2020, ACTA OECOL, V105, DOI 10.1016/j.actao.2020.103552; Baude M, 2016, NATURE, V530, P85, DOI 10.1038/nature16532; Bertazzini M, 2010, AMINO ACIDS, V39, P315, DOI 10.1007/s00726-010-0474-x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Carlier A., 2020, THESIS U CATHOLIQUE; Chapman RF., 2012, INSECTS STRUCTURE FU; Cook SM, 2003, ECOL ENTOMOL, V28, P622, DOI 10.1046/j.1365-2311.2003.00548.x; DEGROOT AP, 1952, EXPERIENTIA, V8, P192, DOI 10.1007/BF02173740; GARDNER MLG, 1984, ANAL BIOCHEM, V141, P429, DOI 10.1016/0003-2697(84)90066-6; Goodwin RM, 2011, NEW ZEAL J CROP HORT, V39, P7, DOI 10.1080/01140671.2010.520164; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Hanley ME, 2008, FUNCT ECOL, V22, P592, DOI 10.1111/j.1365-2435.2008.01415.x; Hicks DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158117; Hrassnigg N, 2003, AMINO ACIDS, V24, P205, DOI 10.1007/s00726-002-0311-y; IPBES, 2016, SUMM POL MAK ASS REP; Jacquemart A-L., 2019, FLORE ECOLOGIQUE BEL; Jacquemart AL, 2018, APIDOLOGIE, V49, P538, DOI 10.1007/s13592-018-0581-3; Kaspar H, 2009, J CHROMATOGR B, V877, P1838, DOI 10.1016/j.jchromb.2009.05.019; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; LABARCA C, 1973, PLANT PHYSIOL, V52, P87, DOI 10.1104/pp.52.2.87; Langlois A, 2020, INSECTS, V11, DOI 10.3390/insects11110818; Mariotti F, 2017, VEGETARIAN AND PLANT-BASED DIETS IN HEALTH AND DISEASE PREVENTION, P621, DOI 10.1016/B978-0-12-803968-7.00035-6; Meussen BJ, 2014, FOOD ANAL METHOD, V7, P1047, DOI 10.1007/s12161-013-9712-7; Michener C.D., 2007, BEES WORLD, P992; Moerman R, 2017, INSECT CONSERV DIVER, V10, P171, DOI 10.1111/icad.12213; Moerman R, 2016, J ECON ENTOMOL, V109, P25, DOI 10.1093/jee/tov279; Moquet L, 2017, INSECT CONSERV DIVER, V10, P78, DOI 10.1111/icad.12201; Nichols RN, 2019, J INSECT CONSERV, V23, P819, DOI 10.1007/s10841-019-00180-8; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Ouvrard P, 2018, BIODIVERS CONSERV, V27, P2193, DOI 10.1007/s10531-018-1531-0; Policarova J, 2019, BIOL J LINN SOC, V128, P486, DOI 10.1093/biolinnean/blz099; Powney GD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08974-9; Quinet M, 2016, EUR J AGRON, V77, P59, DOI 10.1016/j.eja.2016.04.001; Rayner C., 1996, DEP NATURAL RESOURCE; Requier F, 2017, J APPL ECOL, V54, P1161, DOI 10.1111/1365-2664.12836; Roger N, 2017, GLOBAL CHANGE BIOL, V23, P68, DOI 10.1111/gcb.13373; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Roulston TH, 2000, ECOL MONOGR, V70, P617, DOI 10.1890/0012-9615(2000)070[0617:WGPCOP]2.0.CO;2; Ruedenauer FA, 2019, OECOLOGIA, V191, P349, DOI 10.1007/s00442-019-04494-x; Seibold S, 2019, NATURE, V574, P671, DOI 10.1038/s41586-019-1684-3; Simcock N, 2014, ENERG POLICY, V65, P455, DOI 10.1016/j.enpol.2013.10.038; Somme L, 2016, URBAN ECOSYST, V19, P1149, DOI 10.1007/s11252-016-0555-z; Stabler D, 2018, METHODS ECOL EVOL, V9, P430, DOI 10.1111/2041-210X.12867; Standifer LN., 1980, APIDOLOGIE; Taha EA, 2019, SAUDI J BIOL SCI, V26, P232, DOI 10.1016/j.sjbs.2017.06.003; Teulier L, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0333; Timberlake TP, 2019, J APPL ECOL, V56, P1585, DOI 10.1111/1365-2664.13403; van Klink R, 2020, SCIENCE, V368, P417, DOI 10.1126/science.aax9931; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Vanderplanck M, 2020, INSECTS, V11, DOI 10.3390/insects11050304; Vanderplanck M, 2020, APIDOLOGIE, V51, P826, DOI 10.1007/s13592-020-00764-3; Vanderplanck M, 2014, APIDOLOGIE, V45, P192, DOI 10.1007/s13592-013-0239-0; Vanderplanck M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086209; Vaudo AD, 2020, INSECTS, V11, DOI 10.3390/insects11020132; Vaudo AD, 2015, CURR OPIN INSECT SCI, V10, P133, DOI 10.1016/j.cois.2015.05.008; Weiner CN, 2010, APIDOLOGIE, V41, P476, DOI 10.1051/apido/2009083; Zu PJ, 2021, NEW PHYTOL, V230, P1169, DOI 10.1111/nph.17227	58	0	0	10	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0269992	http://dx.doi.org/10.1371/journal.pone.0269992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917360	Green Published, gold			2022-12-26	WOS:000837840000033
J	Lieberman, R; Cortes, LK; Gao, GC; Park, H; Wang, B; Jones, PL; Hunter, RB; Leonard, JP; Jr, RBH				Lieberman, Richard; Cortes, Leslie K.; Gao, Grace; Park, Hyejung; Wang, Bing; Jones, Patrick L.; Hunter, R. Bridge; Leonard, John P.; Barker Jr, Robert H.			Human iPSC-derived astrocytes generated from donors with globoid cell leukodystrophy display phenotypes associated with disease	PLOS ONE			English	Article							VANISHING WHITE-MATTER; PLURIPOTENT STEM-CELLS; KRABBE-DISEASE; ALZHEIMERS-DISEASE; L-CYCLOSERINE; PSYCHOSINE; CERAMIDE; EXPRESSION; TWITCHER; ACTIVATION	Globoid cell leukodystrophy (Krabbe disease) is a fatal neurodegenerative, demyelinating disease caused by dysfunctional activity of galactosylceramidase (GALC), leading to the accumulation of glycosphingolipids including psychosine. While oligodendrocytes have been extensively studied due to their high levels of GALC, the contribution of astrocytes to disease pathogenesis remains to be fully elucidated. In the current study, we generated induced pluripotent stem cells (iPSCs) from two donors with infantile onset Krabbe disease and differentiated them into cultures of astrocytes. Krabbe astrocytes recapitulated many key findings observed in humans and rodent models of the disease, including the accumulation of psychosine and elevated expression of the pro-inflammatory cytokine IL-6. Unexpectedly, Krabbe astrocytes had higher levels of glucosylceramide and ceramide, and displayed compensatory changes in genes encoding glycosphingolipid biosynthetic enzymes, suggesting a shunting away from the galactosylceramide and psychosine pathway. In co-culture, Krabbe astrocytes negatively impacted the survival of iPSC-derived human neurons while enhancing survival of iPSC-derived human microglia. Substrate reduction approaches targeting either glucosylceramide synthase or serine palmitoyltransferase to reduce the sphingolipids elevated in Krabbe astrocytes failed to rescue their detrimental impact on neuron survival. Our results suggest that astrocytes may contribute to the progression of Krabbe disease and warrant further exploration into their role as therapeutic targets.	[Lieberman, Richard; Cortes, Leslie K.; Gao, Grace; Jones, Patrick L.; Hunter, R. Bridge; Leonard, John P.; Barker Jr, Robert H.] Sanofi, Rare & Neurol Dis Therapeut Area, Lysosomal Storage & Metab Dis Cluster, Framingham, MA 01701 USA; [Park, Hyejung; Wang, Bing] US Early Dev, Sanofi, Waltham 02451, MA USA	Sanofi-Aventis; Sanofi-Aventis	Lieberman, R; Cortes, LK (corresponding author), Sanofi, Rare & Neurol Dis Therapeut Area, Lysosomal Storage & Metab Dis Cluster, Framingham, MA 01701 USA.	Lieberman.rich@gmail.com; Lesliekcortes@gmail.com						Babcock MC, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93601-1; Ballou LR, 1996, BBA-LIPID LIPID MET, V1301, P273, DOI 10.1016/0005-2760(96)00004-5; Bechet S, 2020, J NEUROSCI, V40, P3104, DOI 10.1523/JNEUROSCI.2346-19.2020; Biswas S, 2003, NEUROSCI LETT, V347, P33, DOI 10.1016/S0304-3940(03)00633-5; Borda JT, 2008, AM J PATHOL, V172, P98, DOI 10.2353/ajpath.2008.070404; Brownjohn PW, 2018, STEM CELL REP, V10, P1294, DOI 10.1016/j.stemcr.2018.03.003; Bugiani M, 2018, BRAIN PATHOL, V28, P408, DOI 10.1111/bpa.12606; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; Castelvetri LC, 2013, J NEUROSCI, V33, P10048, DOI 10.1523/JNEUROSCI.0217-13.2013; Castelvetri LC, 2011, ACTA NEUROPATHOL, V122, P35, DOI 10.1007/s00401-011-0814-2; Cesani M, 2014, ANN NEUROL, V75, P127, DOI 10.1002/ana.24053; Chandrasekaran A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00215; Claycomb KI, 2014, J NEUROPATH EXP NEUR, V73, P964, DOI 10.1097/NEN.0000000000000117; Corado CR, 2020, MOL CELL NEUROSCI, V102, DOI 10.1016/j.mcn.2019.103451; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Cutler RG, 2002, ANN NEUROL, V52, P448, DOI 10.1002/ana.10312; de Wit NM, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1436-1; Di Malta C, 2012, P NATL ACAD SCI USA, V109, pE2334, DOI 10.1073/pnas.1209577109; Dietrich J, 2005, NAT MED, V11, P277, DOI 10.1038/nm1195; Dodge JC, 2015, P NATL ACAD SCI USA, V112, P8100, DOI 10.1073/pnas.1508767112; El Alwani M, 2006, PHARMACOL THERAPEUT, V112, P171, DOI 10.1016/j.pharmthera.2006.04.004; Esch SW, 2003, CELL MOL BIOL, V49, P779; Escolar ML, 2017, MOL GENET METAB, V121, P271, DOI 10.1016/j.ymgme.2017.05.015; Folts CJ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002583; Formichi P, 2007, J CELL PHYSIOL, V212, P737, DOI 10.1002/jcp.21070; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Giri S, 2006, J LIPID RES, V47, P1478, DOI 10.1194/jlr.M600084-JLR200; Giri S, 2002, FASEB J, V16, DOI 10.1096/fj.01-0798com; Giri S, 2008, J NEUROCHEM, V105, P1820, DOI 10.1111/j.1471-4159.2008.05279.x; Gortz AL, 2018, NEUROPATH APPL NEURO, V44, P363, DOI 10.1111/nan.12399; Gowrishankar S, 2020, NEUROBIOL DIS, V146, DOI 10.1016/j.nbd.2020.105142; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Guenzel AJ, 2020, GENET MED, V22, P1108, DOI 10.1038/s41436-020-0764-y; Haenseler W, 2017, STEM CELL REP, V8, P1727, DOI 10.1016/j.stemcr.2017.05.017; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; HANNUN YA, 1987, SCIENCE, V235, P670, DOI 10.1126/science.3101176; Haq E, 2003, J NEUROCHEM, V86, P1428, DOI 10.1046/j.1471-4159.2003.01941.x; Hawkins-Salsbury JA, 2013, J LIPID RES, V54, P3303, DOI 10.1194/jlr.M039610; Hu PR, 2016, J NEUROSCI RES, V94, P1152, DOI 10.1002/jnr.23847; Ijichi K, 2013, GLIA, V61, P765, DOI 10.1002/glia.22471; JesionekKupnicka D, 1997, FOLIA NEUROPATHOL, V35, P155; Julia TCW, 2017, STEM CELL REP, V9, P600, DOI 10.1016/j.stemcr.2017.06.018; Katsel P, 2007, NEUROCHEM RES, V32, P845, DOI 10.1007/s11064-007-9297-x; KOBAYASHI T, 1980, BRAIN RES, V202, P479, DOI 10.1016/0006-8993(80)90159-6; Kohlschutter A, 2013, HAND CLINIC, V113, P1611, DOI 10.1016/B978-0-444-59565-2.00029-0; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Kondo Y, 2005, P NATL ACAD SCI USA, V102, P18670, DOI 10.1073/pnas.0506473102; Kondo Y, 2011, J NEUROSCI, V31, P3610, DOI 10.1523/JNEUROSCI.6344-10.2011; Lanciotti A, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23010274; Lanciotti A, 2013, TRANSL NEUROSCI, V4, P144, DOI 10.2478/s13380-013-0118-1; Lee JT, 2004, J CELL BIOL, V164, P123, DOI 10.1083/jcb.200307017; LeVine SM, 1997, J NEUROIMMUNOL, V73, P47, DOI 10.1016/S0165-5728(96)00166-X; LeVine SM, 2000, J NEUROSCI RES, V60, P231, DOI 10.1002/(SICI)1097-4547(20000415)60:2<231::AID-JNR12>3.0.CO;2-E; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Li Y, 2019, P NATL ACAD SCI USA, V116, P20097, DOI 10.1073/pnas.1912108116; Lim SM, 2016, ONCOTARGET, V7, P74496, DOI 10.18632/oncotarget.12812; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Mangiameli E, 2021, STEM CELL REP, V16, P1478, DOI 10.1016/j.stemcr.2021.04.011; Meng XL, 2010, P NATL ACAD SCI USA, V107, P7886, DOI 10.1073/pnas.1002758107; Messing Albee, 2018, Handb Clin Neurol, V148, P693, DOI 10.1016/B978-0-444-64076-5.00044-2; Mielke MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073094; Misslin C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187217; Mohri I, 2006, J NEUROSCI, V26, P4383, DOI 10.1523/JNEUROSCI.4531-05.2006; Nicaise AM, 2016, J NEUROSCI RES, V94, P1049, DOI 10.1002/jnr.23773; O'Sullivan C, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0494-x; O'Sullivan C, 2015, J CELL SCI, V128, P3878, DOI 10.1242/jcs.169342; Ouali Alami N, 2018, EMBO J, V37, DOI 10.15252/embj.201798697; Potter GB, 2016, J NEUROSCI RES, V94, P1341, DOI 10.1002/jnr.23804; RAFI MA, 1995, HUM MOL GENET, V4, P1285, DOI 10.1093/hmg/4.8.1285; Rao KVR, 2016, NEUROSCIENCE, V323, P195, DOI 10.1016/j.neuroscience.2015.05.061; Roybon L, 2013, CELL REP, V4, P1035, DOI 10.1016/j.celrep.2013.06.021; Sassa T, 2012, BBA-MOL CELL BIOL L, V1821, P1031, DOI 10.1016/j.bbalip.2012.04.008; Satoi H, 2005, NEUROSCIENCE, V130, P657, DOI 10.1016/j.neuroscience.2004.08.056; Schulze H, 2014, BBA-MOL CELL BIOL L, V1841, P799, DOI 10.1016/j.bbalip.2013.10.015; Scott-Hewitt NJ, 2018, NEURAL REGEN RES, V13, P393, DOI 10.4103/1673-5374.228712; Scott-Hewitt NJ, 2017, HUM MOL GENET, V26, P2825, DOI 10.1093/hmg/ddx153; Smith BR, 2014, J PATHOL, V232, P509, DOI 10.1002/path.4328; Snook ER, 2014, AM J PATHOL, V184, P382, DOI 10.1016/j.ajpath.2013.10.011; Spassieva S, 2016, J NEUROSCI RES, V94, P974, DOI 10.1002/jnr.23888; SUGAMA S, 1990, PEDIATR RES, V28, P473, DOI 10.1203/00006450-199011000-00011; SUZUKI K, 1970, P NATL ACAD SCI USA, V66, P302, DOI 10.1073/pnas.66.2.302; Suzuki K, 2003, J CHILD NEUROL, V18, P595, DOI 10.1177/08830738030180090201; Suzuki K, 1998, NEUROCHEM RES, V23, P251, DOI 10.1023/A:1022436928925; SVENNERHOLM L, 1980, J LIPID RES, V21, P53; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takata K, 2017, IMMUNITY, V47, P183, DOI 10.1016/j.immuni.2017.06.017; Ungari S, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.38; van Wilgenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071098; Verkhratsky A, 2012, ASN NEURO, V4, DOI 10.1042/AN20120010; Vitner EB, 2014, NAT MED, V20, P204, DOI 10.1038/nm.3449; Wang Guanghu, 2018, Advances in Biological Regulation, V70, P51, DOI 10.1016/j.jbior.2018.09.013; Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513; Wenger DA, 2000, MOL GENET METAB, V70, P1, DOI 10.1006/mgme.2000.2990; WENGER DA, 1993, APMIS, V101, P81; White AB, 2009, J NEUROSCI, V29, P6068, DOI 10.1523/JNEUROSCI.5597-08.2009; Xing Y, 2016, J NEUROL SCI, V370, P82, DOI 10.1016/j.jns.2016.09.028; Zaccariotto E, 2022, BIOMED PHARMACOTHER, V149, DOI 10.1016/j.biopha.2022.112808; ZLOTOGORA J, 1990, AM J HUM GENET, V47, P37	100	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271360	http://dx.doi.org/10.1371/journal.pone.0271360			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921286	Green Published, gold			2022-12-26	WOS:000839311900017
J	Hansen, J; Siddiq, MM; Yadaw, AS; Tolentino, RE; Rabinovich, V; Jayaraman, G; Jain, MR; Liu, T; Li, H; Xiong, YG; Goldfarb, J; Iyengar, R				Hansen, Jens; Siddiq, Mustafa M.; Yadaw, Arjun Singh; Tolentino, Rosa E.; Rabinovich, Vera; Jayaraman, Gomathi; Jain, Mohit Raja; Liu, Tong; Li, Hong; Xiong, Yuguang; Goldfarb, Joseph; Iyengar, Ravi			Whole cell response to receptor stimulation involves many deep and distributed subcellular biochemical processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC MESSENGER-RNA; INDUCED NEURITE OUTGROWTH; GANGLIOSIDE BIOSYNTHESIS; PYRIMIDINE METABOLISM; NEURONAL POLARITY; AXON REGENERATION; SIGNALING NETWORK; CCR4-NOT COMPLEX; GROWTH; PHOSPHATIDYLCHOLINE	Neurite outgrowth is an integrated whole cell response triggered by the cannabinoid-1 receptor. We sought to identify the many different biochemical pathways that contribute to this whole cell response. To understand underlying mecha-nisms, we identified subcellular processes (SCPs) composed of one or more biochemical pathways and their interactions required for this response. Differentially expressed genes and proteins were obtained from bulk transcriptomics and prote-omic analysis of extracts from cells stimulated with a cannabinoid-1 receptor agonist. We used these differentially expressed genes and proteins to build networks of interacting SCPs by combining the expression data with prior pathway knowledge. From these SCP networks, we identified additional genes that when ablated, experimentally validated the SCP involvement in neurite outgrowth. Our experiments and informatics modeling allowed us to identify diverse SCPs such as those involved in pyrimidine metabolism, lipid biosynthesis, and mRNA splicing and stability, along with more predictable SCPs such as membrane vesicle transport and microtubule dynamics. We find that SCPs required for neurite outgrowth are widely distributed among many biochemical pathways required for constitutive cellular functions, several of which are termed 'deep', since they are distal to signaling pathways and the key SCPs directly involved in extension of the neurite. In contrast, 'proximal' SCPs are involved in microtubule growth and membrane vesicle transport dynamics required for neurite outgrowth. From these bioinformatics and dynamical models based on experimental data, we conclude that receptor -mediated regulation of subcellular functions for neurite outgrowth is both distributed, that is, involves many different biochemical pathways, and deep.	[Hansen, Jens; Siddiq, Mustafa M.; Yadaw, Arjun Singh; Tolentino, Rosa E.; Rabinovich, Vera; Jayaraman, Gomathi; Xiong, Yuguang; Goldfarb, Joseph; Iyengar, Ravi] Icahn Sch Med Mt Sinai, Inst Syst Biomed, Dept Pharmacol Sci, New York, NY 10029 USA; [Jain, Mohit Raja; Liu, Tong; Li, Hong] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NY USA; [Jain, Mohit Raja] Thermo Fisher Sci, 1400 North Point Pkwy,Suite 10, W Palm Beach, FL 33407 USA	Icahn School of Medicine at Mount Sinai; Rutgers State University Newark; Thermo Fisher Scientific	Iyengar, R (corresponding author), Icahn Sch Med Mt Sinai, Inst Syst Biomed, Dept Pharmacol Sci, New York, NY 10029 USA.	ravi.iyengar@mssm.edu		, Mustafa/0000-0002-8597-7376; Li, Hong/0000-0001-5731-5335; Hansen, Jens/0000-0002-1362-6534; Xiong, Yuguang/0000-0001-5221-6266	NIH [R01GM137056]; NYS Spinal Cord Injury Research Program [C34460GG]; Systems Biology Center [P50GM071558]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYS Spinal Cord Injury Research Program; Systems Biology Center	This research was supported by NIH grants R01GM137056, Systems Biology Center grant P50GM071558. NYS Spinal Cord Injury Research Program Con-tract number #C34460GG awarded to R. I. and M. M. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alberts B, 2015, MOLECULAR BIOLOGY OF THE CELL, SIXTH EDITION, P1035; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Bartlam M, 2010, PROTEIN CELL, V1, P443, DOI 10.1007/s13238-010-0060-8; Berg J. M., 2002, BIOCHEMISTRY-US, V5; BLUSZTAJN JK, 1987, J NEURAL TRANSM, P247; BLUSZTAJN JK, 1987, P NATL ACAD SCI USA, V84, P5474, DOI 10.1073/pnas.84.15.5474; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; Burgo A, 2012, DEV CELL, V23, P166, DOI 10.1016/j.devcel.2012.04.019; Campsteijn C, 2016, CURR OPIN CELL BIOL, V41, P1, DOI 10.1016/j.ceb.2016.03.008; Carter JM, 2008, J BIOL CHEM, V283, P202, DOI 10.1074/jbc.M706531200; Cheng AW, 2010, ASN NEURO, V2, P243, DOI 10.1042/AN20100019; Chisholm AD, 2016, GENETICS, V204, P849, DOI 10.1534/genetics.115.186262; Collart MA, 2016, WIRES RNA, V7, P438, DOI 10.1002/wrna.1332; CRUTCHER KA, 1986, CRIT REV NEUROBIOL, V2, P297; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; De Almeida C, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1440; de Anda FC, 2010, J NEUROSCI, V30, P10391, DOI 10.1523/JNEUROSCI.0381-10.2010; de Chaves EP, 2010, FEBS LETT, V584, P1748, DOI 10.1016/j.febslet.2009.12.010; Doidge R, 2012, BIOCHEM SOC T, V40, P896, DOI 10.1042/BST20120074; Estrada-Bernal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031858; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; Farias GG, 2015, CELL REP, V13, P1221, DOI 10.1016/j.celrep.2015.09.074; Gallon M, 2015, BIOCHEM SOC T, V43, P33, DOI 10.1042/BST20140290; Garavito MF, 2015, J GENET GENOMICS, V42, P195, DOI 10.1016/j.jgg.2015.04.004; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hansen J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16627-4; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; He JCJ, 2006, CAN J PHYSIOL PHARM, V84, P687, DOI 10.1139/Y06-025; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Jayne S, 2006, BIOCHEM J, V398, P461, DOI 10.1042/BJ20060406; Jordan JD, 2005, J BIOL CHEM, V280, P11413, DOI 10.1074/jbc.M411521200; Kilchert C, 2016, NAT REV MOL CELL BIO, V17, P227, DOI 10.1038/nrm.2015.15; Kim E, 2015, BMB REP, V48, P139, DOI 10.5483/BMBRep.2015.48.3.010; KOZLOWSKI MR, 1989, PEPTIDES, V10, P1121, DOI 10.1016/0196-9781(89)90002-8; Lannert H, 1998, J BIOL CHEM, V273, P2939, DOI 10.1074/jbc.273.5.2939; Li JJ, 2018, CELL, V174, P1361, DOI 10.1016/j.cell.2018.07.021; Lindhout FW, 2020, ELIFE, V9, DOI 10.7554/eLife.58124; Daniotti JL, 2011, IUBMB LIFE, V63, P513, DOI 10.1002/iub.477; Ma'ayan A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254cm1; Mandon EC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013342; Mattson MP, 1999, J NEUROSCI RES, V56, P8, DOI 10.1002/(SICI)1097-4547(19990401)56:1<8::AID-JNR2>3.3.CO;2-7; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; Nakazawa H, 2012, J NEUROSCI, V32, P12712, DOI 10.1523/JNEUROSCI.0989-12.2012; Norbury CJ, 2013, NAT REV MOL CELL BIO, V14, P643, DOI 10.1038/nrm3645; Ozturk Z, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00048; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Pooler AM, 2005, NEUROSCIENCE, V134, P207, DOI 10.1016/j.neuroscience.2005.03.050; Quail Michael A, 2009, Curr Protoc Hum Genet, VChapter 18, DOI 10.1002/0471142905.hg1802s62; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Rosenthal M. D., 2009, MEDICAL BIOCH HUMAN; Sadeghlar F, 2000, FEBS LETT, V478, P9, DOI 10.1016/S0014-5793(00)01818-4; Sandhoff R, 2018, FEBS LETT, V592, P3835, DOI 10.1002/1873-3468.13114; Sekine Y, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao4180; Siwaszek A, 2014, RNA BIOL, V11, P1122, DOI 10.4161/rna.34406; Stepanova T, 2003, J NEUROSCI, V23, P2655; Takano T, 2015, DEVELOPMENT, V142, P2088, DOI 10.1242/dev.114454; Taliaferro JM, 2016, MOL CELL, V61, P821, DOI 10.1016/j.molcel.2016.01.020; Tang N, 2012, J CELL SCI, V125, P4951, DOI 10.1242/jcs.038083; Tedeschi A, 2016, NEURON, V92, P419, DOI 10.1016/j.neuron.2016.09.026; Tracey TJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00010; Tsaneva-Atanasova K, 2009, BIOPHYS J, V96, P840, DOI 10.1016/j.bpj.2008.10.036; Ukleja M, 2016, BIOESSAYS, V38, P1048, DOI 10.1002/bies.201600092; VANECHTEN G, 1990, EUR J CELL BIOL, V51, P135; Vietri M, 2020, NAT REV MOL CELL BIO, V21, P25, DOI 10.1038/s41580-019-0177-4; Villanyi Z, 2015, BIOCHEM SOC T, V43, P1253, DOI 10.1042/BST20150167; Vincenzetti S, 2016, CURR MED CHEM, V23, P1408, DOI 10.2174/0929867323666160411125803; Voccoli V, 2009, BRAIN RES, V1252, P15, DOI 10.1016/j.brainres.2008.11.026; Wickramasinghe VO, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0749-3; Xiong YG, 2022, SCI DATA, V9, DOI 10.1038/s41597-021-01114-3; Yadaw AS, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006877; Yamaji T, 2008, IUBMB LIFE, V60, P511, DOI 10.1002/iub.83; Yu RK, 2004, J LIPID RES, V45, P783, DOI 10.1194/jlr.R3000020-JLR200; Yu RK, 2011, J OLEO SCI, V60, P537, DOI 10.5650/jos.60.537; Zappulo A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00690-6; Zhang F, 2009, NEUROPHARMACOLOGY, V57, P88, DOI 10.1016/j.neuropharm.2009.04.017; Zhang HF, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00079; Zhang RS, 2020, NEUROPEPTIDES, V81, DOI 10.1016/j.npep.2020.102044; ZIEGLER W, 1981, DEV BRAIN RES, V1, P622, DOI 10.1016/0165-3806(81)90014-6; Zorina Y, 2010, J BIOL CHEM, V285, P1358, DOI 10.1074/jbc.M109.049841	86	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102325	10.1016/j.jbc.2022.102325	http://dx.doi.org/10.1016/j.jbc.2022.102325			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5L6PJ	35926710	gold, Green Published			2022-12-26	WOS:000870533300005
J	Gao, SH; Zhang, WJ; Barrow, SL; Iavarone, AT; Klinman, JP				Gao, Shuaihua; Zhang, Wenju; Barrow, Samuel L.; Iavarone, Anthony T.; Klinman, Judith P.			Temperature-dependent hydrogen deuterium exchange shows impact of analog binding on adenosine deaminase flexibility but not embedded thermal networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE ANALOG; X-RAY-STRUCTURE; MASS-SPECTROMETRY; PROTEIN DYNAMICS; ENZYME; CATALYSIS; IDENTIFICATION; SPECIFICITY; ACTIVATION; MOTIONS	The analysis of hydrogen deuterium exchange by mass spectrometry as a function of temperature and mutation has emerged as a generic and efficient tool for the spatial resolution of protein networks that are proposed to function in the thermal activation of catalysis. In this work, we extend temperature-dependent hydrogen deuterium exchange from apoenzyme structures to protein-ligand complexes. Using adenosine deaminase as a prototype, we compared the impacts of a substrate analog (1-deaza-adenosine) and a very tight -binding inhibitor/transition state analog (pentostatin) at single and multiple temperatures. At a single temperature, we observed different hydrogen deuterium exchange-mass spectrometry properties for the two ligands, as expected from their 106-fold differences in strength of binding. By contrast, analogous patterns for temperature-dependent hydrogen deuterium exchange mass spectrometry emerge in the presence of both 1-deaza-adenosine and pentostatin, indicating similar impacts of either ligand on the enthalpic barriers for local protein unfolding. We extended temperature-dependent hydrogen deuterium exchange to a function-altering mutant of adenosine deaminase in the presence of pentostatin and revealed a protein thermal network that is highly similar to that previously reported for the apoenzyme (Gao et al., 2020, JACS 142, 19936-19949). Finally, we discuss the differential impacts of pentostatin binding on overall protein flexibility versus site -specific thermal transfer pathways in the context of models for substrate-induced changes to a distributed protein conformational landscape that act in synergy with embedded protein thermal networks to achieve efficient catalysis.	[Gao, Shuaihua; Barrow, Samuel L.; Iavarone, Anthony T.; Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Gao, Shuaihua; Iavarone, Anthony T.; Klinman, Judith P.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Zhang, Wenju] Univ Waterloo, David R Cheriton Sch Comp Sci, Waterloo, ON, Canada; [Klinman, Judith P.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Waterloo; University of California System; University of California Berkeley	Klinman, JP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Klinman, JP (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.; Klinman, JP (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	klinman@berkeley.edu		Gao, Shuaihua/0000-0003-3303-3856	National Institutes of Health [GM118117-015, 1S10OD020062-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work is supported by National Institutes of Health grants to J. P. K. (GM118117-015) and A. T. I. (1S10OD020062-01) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal PK, 2005, J AM CHEM SOC, V127, P15248, DOI 10.1021/ja055251s; Amyes TL, 2013, BIOCHEMISTRY-US, V52, P2021, DOI 10.1021/bi301491r; Arcus VL, 2020, ANNU REV BIOPHYS, V49, P163, DOI 10.1146/annurev-biophys-121219-081520; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Breslow R, 2000, PURE APPL CHEM, V72, P333, DOI 10.1351/pac200072030333; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Englander SW, 2006, J AM SOC MASS SPECTR, V17, P1481, DOI 10.1016/j.jasms.2006.06.006; Fried SD, 2017, ANNU REV BIOCHEM, V86, P387, DOI 10.1146/annurev-biochem-061516-044432; Gao SH, 2020, J AM CHEM SOC, V142, P19936, DOI 10.1021/jacs.0c07866; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Harel M, 1996, J AM CHEM SOC, V118, P2340, DOI 10.1021/ja952232h; Harrison RA, 2016, CURR OPIN STRUC BIOL, V41, P187, DOI 10.1016/j.sbi.2016.08.003; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Zaragoza JPT, 2022, bioRxiv, DOI 10.1101/2022.03.31.486235; Jackson CJ, 2009, P NATL ACAD SCI USA, V106, P21631, DOI 10.1073/pnas.0907548106; James EI, 2022, CHEM REV, V122, P7562, DOI 10.1021/acs.chemrev.1c00279; Jones HBL, 2017, FEBS J, V284, P2829, DOI 10.1111/febs.14152; Kaczmarski JA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19695-9; Klinman JP, 2013, ANNU REV BIOCHEM, V82, P471, DOI 10.1146/annurev-biochem-051710-133623; Knapp MJ, 2002, EUR J BIOCHEM, V269, P3113, DOI 10.1046/j.1432-1033.2002.03022.x; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Kornev A. P., 2022, BIORXIV, DOI [10.1101/2022.01.03.474877, DOI 10.1101/2022.01.03.474877]; KRAUT J, 1988, SCIENCE, V242, P533, DOI 10.1126/science.3051385; Liang ZX, 2004, P NATL ACAD SCI USA, V101, P9556, DOI 10.1073/pnas.0403337101; LIPSCOMB WN, 1982, ACCOUNTS CHEM RES, V15, P232, DOI 10.1021/ar00080a001; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Marcsisin SR, 2010, ANAL BIOANAL CHEM, V397, P967, DOI 10.1007/s00216-010-3556-4; Maria-Solano MA, 2018, CHEM COMMUN, V54, P6622, DOI 10.1039/c8cc02426j; Markin CJ, 2021, SCIENCE, V373, P411, DOI 10.1126/science.abf8761; Masson GR, 2019, NAT METHODS, V16, P595, DOI 10.1038/s41592-019-0459-y; Meadows CW, 2014, J PHYS CHEM B, V118, P6049, DOI 10.1021/jp500825x; Miller BG, 2002, ANNU REV BIOCHEM, V71, P847, DOI 10.1146/annurev.biochem.71.110601.135446; Miller MD, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100749; Naganathan AN, 2021, CURR RES STRUCT BIOL, V3, P257, DOI 10.1016/j.crstbi.2021.09.003; Nagel ZD, 2013, J BIOL CHEM, V288, P14087, DOI 10.1074/jbc.M113.453951; Narayan A, 2018, J PHYS CHEM B, V122, P11039, DOI 10.1021/acs.jpcb.8b05108; Niu WL, 2010, J PHYS CHEM B, V114, P16156, DOI 10.1021/jp106041v; Offenbacher AR, 2017, ACS CENTRAL SCI, V3, P570, DOI 10.1021/acscentsci.7b00142; Otten R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03562-9; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Persson F, 2015, P NATL ACAD SCI USA, V112, P10383, DOI 10.1073/pnas.1506079112; Petrovic D, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0330; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Ramanathan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015827; Richard JP, 2019, J AM CHEM SOC, V141, P3320, DOI 10.1021/jacs.8b10836; Schmidt SH, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2100844118; Schramm VL, 2007, J BIOL CHEM, V282, P28297, DOI 10.1074/jbc.R700018200; Schramm VL, 2015, ACCOUNTS CHEM RES, V48, P1032, DOI 10.1021/acs.accounts.5b00002; Schramm VL, 2005, CURR OPIN STRUC BIOL, V15, P604, DOI 10.1016/j.sbi.2005.10.017; Schulte M, 2018, ACS CATAL, V8, P3971, DOI 10.1021/acscatal.7b04408; Schwartz SD, 2009, NAT CHEM BIOL, V5, P552, DOI 10.1038/nchembio.202; Thompson EJ, 2021, J AM CHEM SOC, V143, P785, DOI 10.1021/jacs.0c09423; Vaughn MB, 2018, J AM CHEM SOC, V140, P900, DOI 10.1021/jacs.7b12369; Wang ZM, 1998, BIOCHEMISTRY-US, V37, P8314, DOI 10.1021/bi980324o; WILSON DK, 1993, BIOCHEMISTRY-US, V32, P1689, DOI 10.1021/bi00058a001; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539; Zaragoza JPT, 2019, J PHYS CHEM B, V123, P8662, DOI 10.1021/acs.jpcb.9b07228; Zhang JY, 2020, P NATL ACAD SCI USA, V117, P10797, DOI 10.1073/pnas.1917219117	59	1	1	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102350	10.1016/j.jbc.2022.102350	http://dx.doi.org/10.1016/j.jbc.2022.102350			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4V3XX	35933011	Green Published, gold			2022-12-26	WOS:000859414300002
J	Perry, CH; Mullins, NA; Sweileh, RBA; Shendy, NAM; Roberto, PA; Broadhurst, AL; Nelson, HA; Miranda-Carboni, GA; Abell, AN				Perry, Charles H.; Mullins, Nathan A.; Sweileh, Razan B. A.; Shendy, Noha A. M.; Roberto, Patrick A.; Broadhurst, Amber L.; Nelson, Hannah A.; Miranda-Carboni, Gustavo A.; Abell, Amy N.			MAP3K4 promotes fetal and placental growth by controlling the receptor tyrosine kinases IGF1R/IR and Akt signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; EPITHELIAL-MESENCHYMAL TRANSITION; TROPHOBLAST STEM-CELLS; INTRAUTERINE GROWTH; INSULIN-RECEPTOR; MOUSE; RESTRICTION; PHOSPHORYLATION; DEFECTS; AUTOPHOSPHORYLATION	Disruption of fetal growth results in severe consequences to human health, including increased fetal and neonatal morbidity and mortality, as well as potential lifelong health problems. Molecular mechanisms promoting fetal growth represent potential therapeutic strategies to treat and/or prevent fetal growth restriction (FGR). Here, we identify a previously unknown role for the mitogen-activated protein kinase kinase kinase 4 (MAP3K4) in promoting fetal and placental growth. We demonstrate that inactivation of MAP3K4 kinase activity causes FGR due in part to placental insufficiency. Significantly, MAP3K4 kinase-inactive mice display highly penetrant lethality prior to weaning and persistent growth reduction of surviving adults. Additionally, we elucidate molecular mechanisms by which MAP3K4 promotes growth through control of the insulin-like growth factor 1 receptor (IGF1R), insulin receptor (IR), and Akt signaling pathway. Specifically, MAP3K4 kinase inactivation in trophoblast stem (TS) cells results in reduced IGF1R and IR expression and decreased Akt activation. We observe these changes in TS cells also occur in differentiated trophoblasts created through in vitro differentiation of cultured TS cells and in vivo in placental tissues formed by TS cells. Furthermore, we show that MAP3K4 controls this pathway by promoting Igf1r transcript expression in TS cells through activation of CREB-binding protein (CBP). In the MAP3K4 kinase-inactive TS cells, Igf1r transcripts are repressed because of reduced CBP activity and increased histone deacetylase 6 expression and activity. Together, these data demonstrate a critical role for MAP3K4 in promoting fetal and placental growth by controlling the activity of the IGF1R/IR and Akt signaling pathway.	[Perry, Charles H.; Mullins, Nathan A.; Sweileh, Razan B. A.; Shendy, Noha A. M.; Roberto, Patrick A.; Broadhurst, Amber L.; Nelson, Hannah A.; Abell, Amy N.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Shendy, Noha A. M.] St Jude Childrens Res Hosp, Dept Oncol, Div Mol Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Miranda-Carboni, Gustavo A.] Univ Tennessee, Dept Med, Hlth Sci Ctr, Div Hematol Oncol,Ctr Canc Res, Memphis, TN 38104 USA	University of Memphis; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Abell, AN (corresponding author), Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA.	anabell@memphis.edu		Nelson, Hannah/0000-0001-8282-4262; Shendy, Noha/0000-0002-4765-6774; Mullins, Nathan/0000-0001-9085-7996; Abell, Amy/0000-0003-0604-7566	National Institutes of Health [GM116903]; Memphis Research Consortium; University of Memphis College of Arts and Sciences Research Grant Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memphis Research Consortium; University of Memphis College of Arts and Sciences Research Grant Fund	A. N. A. is supported by the National Institutes of Health grant (grant no.: GM116903), by the Memphis Research Consortium, and by a grant from University of Memphis College of Arts and Sciences Research Grant Fund. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abell AN, 2011, CELL STEM CELL, V8, P525, DOI 10.1016/j.stem.2011.03.008; Abell AN, 2009, MOL CELL BIOL, V29, P2748, DOI 10.1128/MCB.01391-08; Abell AN, 2005, MOL CELL BIOL, V25, P8948, DOI 10.1128/MCB.25.20.8948-8959.2005; Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Agrogiannis GD, 2014, MOL MED REP, V10, P579, DOI 10.3892/mmr.2014.2258; Alberry M, 2007, ARCH DIS CHILD-FETAL, V92, pF62, DOI 10.1136/adc.2005.082297; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Anteby EY, 2005, EUR J OBSTET GYN R B, V119, P27, DOI 10.1016/j.ejogrb.2004.05.014; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bamfo JEAK, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/640715; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bedzhov I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002609; Bogani D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000196; Boucher J, 2010, J BIOL CHEM, V285, P17235, DOI 10.1074/jbc.M110.118620; Brett KE, 2014, INT J MOL SCI, V15, P16153, DOI 10.3390/ijms150916153; Burton GJ, 2018, AM J OBSTET GYNECOL, V218, pS745, DOI 10.1016/j.ajog.2017.11.577; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Colella M, 2018, CURR PEDIATR REV, V14, P212, DOI 10.2174/1573396314666180712114531; Dumolt JH, 2021, OBSTET GYN CLIN N AM, V48, P247, DOI 10.1016/j.ogc.2021.02.001; Eaton M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226735; Efstratiadis A, 1998, INT J DEV BIOL, V42, P955; Fleiss B, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00188; Forbes K, 2008, HORM RES, V69, P129, DOI 10.1159/000112585; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Fowden AL, 2003, PLACENTA, V24, P803, DOI 10.1016/S0143-4004(03)00080-8; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Gardner RL, 1999, BIOL REPROD, V60, P190, DOI 10.1095/biolreprod60.1.190; Gaviraghi M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73835-1; Hagel M, 2015, CANCER DISCOV, V5, P424, DOI 10.1158/2159-8290.CD-14-1029; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Hemberger M, 2004, DEV BIOL, V271, P362, DOI 10.1016/j.ydbio.2004.03.040; HERNANDEZSANCHEZ C, 1995, J BIOL CHEM, V270, P29176, DOI 10.1074/jbc.270.49.29176; Igarashi M, 2000, EUR J CLIN INVEST, V30, P668; Jarvis S, 2003, LANCET, V362, P1106, DOI 10.1016/S0140-6736(03)14466-2; Jordan NV, 2011, CELL CYCLE, V10, P2865, DOI 10.4161/cc.10.17.17188; Kayali AG, 2000, DIABETES, V49, P1783, DOI 10.2337/diabetes.49.11.1783; Kent LN, 2012, INT J DEV BIOL, V56, P255, DOI 10.1387/ijdb.113407lk; Klammt J, 2008, TRENDS ENDOCRIN MET, V19, P197, DOI 10.1016/j.tem.2008.03.003; Lang LW, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010031; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Lee SY, 2021, INVEST OPHTH VIS SCI, V62, DOI 10.1167/iovs.62.15.25; Lin RT, 2018, MOL CELL, V69, P923, DOI 10.1016/j.molcel.2018.02.010; Longo S, 2014, EARLY HUM DEV, V90, pS42, DOI 10.1016/S0378-3782(14)70014-3; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Marsh B, 2020, ELIFE, V9, DOI 10.7554/eLife.60266; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; Mobley RJ, 2017, CELL REP, V18, P2387, DOI 10.1016/j.celrep.2017.02.030; Morino K, 2001, ENDOCRINOLOGY, V142, P2669, DOI 10.1210/en.142.6.2669; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Mukri F, 2008, BJOG-INT J OBSTET GY, V115, P1273, DOI 10.1111/j.1471-0528.2008.01833.x; NEERHOF MG, 1995, CLIN PERINATOL, V22, P375; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; Novitskaya T, 2011, ENDOCRINOLOGY, V152, P2503, DOI 10.1210/en.2010-1385; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Pitetti JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003160; POWELLBRAXTON L, 1993, ANN NY ACAD SCI, V692, P300; Raghu D, 2019, CELL REP, V26, P3684, DOI 10.1016/j.celrep.2019.02.093; Randhawa R, 2005, MOL GENET METAB, V86, P84, DOI 10.1016/j.ymgme.2005.07.028; Roberge S, 2017, AM J OBSTET GYNECOL, V216, P110, DOI 10.1016/j.ajog.2016.09.076; Roberts AB, 1999, AM J OBSTET GYNECOL, V180, P634, DOI 10.1016/S0002-9378(99)70266-8; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Sehat B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000340; Sferruzzi-Perri AN, 2016, P NATL ACAD SCI USA, V113, P11255, DOI 10.1073/pnas.1602012113; Shendy NAM, 2021, BIOL REPROD, V105, P491, DOI 10.1093/biolre/ioab083; Shendy NAM, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01200-z; Singh P, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0805-3; SOOTHILL PW, 1987, BRIT MED J, V294, P1051, DOI 10.1136/bmj.294.6579.1051; Sparrow LG, 2007, PROTEINS, V66, P261, DOI 10.1002/prot.21261; Spiroski AM, 2016, CURR PEDIATR REV, V12, P168, DOI 10.2174/1573396312666160808151856; Sutherland A, 2003, DEV BIOL, V258, P241, DOI 10.1016/S0012-1606(03)00130-1; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Thorn SR, 2011, SEMIN REPROD MED, V29, P225, DOI 10.1055/s-0031-1275516; WHITE MF, 1988, J BIOL CHEM, V263, P2969; Woods L, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00570; Xu J, 2006, J BIOL CHEM, V281, P982, DOI 10.1074/jbc.M505484200; Yang Z, 2015, ONCOTARGET, V6, P31916, DOI 10.18632/oncotarget.5577; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193; Zeke A, 2016, MICROBIOL MOL BIOL R, V80, P793, DOI 10.1128/MMBR.00043-14; Zhu DM, 2017, STEM CELL REP, V9, P2034, DOI 10.1016/j.stemcr.2017.10.014	84	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102310	10.1016/j.jbc.2022.102310	http://dx.doi.org/10.1016/j.jbc.2022.102310			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9EO	35921893	Green Published, gold			2022-12-26	WOS:000863182500010
J	Vigore, M; Granata, N; Braga, SS; Piaggi, G; Audifreddi, S; Ferrari, M; La Rovere, MT; Pierobon, A				Vigore, Martina; Granata, Nicolo; Braga, Simona Sarzi; Piaggi, Giancarlo; Audifreddi, Silvia; Ferrari, Marina; La Rovere, Maria Teresa; Pierobon, Antonia			Cognitive impairment, frailty and rehabilitation outcome in older cardiorespiratory patients. DEC_FRAinRIAB: Study protocol	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HEART-FAILURE; ASSOCIATION; VALIDATION; ANXIETY; SCALE; PREVALENCE; DEPRESSION; GUIDELINES; VERSION	Background Chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) are two clinical conditions often associated with functional worsening, cognitive dysfunctions, treatment non-adherence, psychological distress and poor quality of life (QoL). In addition, since patients suffering from these conditions are often older adults, the presence of frailty syndrome could worsen the clinical situation. Methods and design This study protocol of a prospective multi-center clinical trial, will be conducted at two hospitals of the Istituti Clinici Scientifici Maugeri IRCCS group, from July 2020 until December 2022. CHF and COPD older patients (age >= 65) will undergo a multidisciplinary assessment at admission, discharge and at 6 months follow-up, from an inpatient rehabilitation program: disease-related clinical characteristics, functional variables, cognitive screening, treatment adherence, anxiety, depression, QoL and frailty. The estimated sample size will consist of 300 patients Discussion The expected results are related to the possibility of an improvement in the areas of intervention after the rehabilitative program and the maintenance of these improvements over time. The assessment of clinical and functional status, cognitive impairment, treatment adherence, psychosocial characteristics, and frailty could provide more specific and useful information about the main features to be considered in the evaluation and treatment of older patients suffering from CHF and COPD undergoing a rehabilitative pathway.	[Vigore, Martina; Pierobon, Antonia] Ist Clin Sci Maugeri, IRCCS, Montescano Inst, Psychol Unit, Pavia, Italy; [Granata, Nicolo; Braga, Simona Sarzi] Ist Clin Sci Maugeri, Tradate Inst, IRCCS, Cardiac Rehabil Div, Varese, Italy; [Piaggi, Giancarlo] Ist Clin Sci Maugeri, IRCCS, Resp Rehabil Div, Montescano Inst, Pavia, Italy; [Audifreddi, Silvia] Ist Clin Sci Maugeri, Hlth Direct Tradate Inst, IRCCS, Varese, Italy; [Ferrari, Marina; La Rovere, Maria Teresa] Ist Clin Sci Maugeri, IRCCS, Cardiac Rehabil Div, Montescano Inst, Pavia, Italy	Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia	Granata, N (corresponding author), Ist Clin Sci Maugeri, Tradate Inst, IRCCS, Cardiac Rehabil Div, Varese, Italy.	n.granata05@gmail.com	Piaggi, Giancarlo/AAQ-1321-2021; La Rovere, Maria Teresa/D-6796-2019	Piaggi, Giancarlo/0000-0003-0896-6136; La Rovere, Maria Teresa/0000-0002-1884-5058; Granata, Nicolo/0000-0001-9743-6684	Italian National funding (5x1000): project name "Decadimento cognitivo, fragilita e outcome riabilitativo in pazienti anziani affetti da patologia cardiorespiratoria. DEC_FRAinRIAB" [2424_20 04 20]	Italian National funding (5x1000): project name "Decadimento cognitivo, fragilita e outcome riabilitativo in pazienti anziani affetti da patologia cardiorespiratoria. DEC_FRAinRIAB"	This work was supported by the Italian National funding (5x1000): project name "Decadimento cognitivo, fragilita e outcome riabilitativo in pazienti anziani affetti da patologia cardiorespiratoria. DEC_FRAinRIAB" (Grant Agreement Number 2424_20 04 20). MV and NG received a research grant from the project's funder.	Abete P, 2017, AGING CLIN EXP RES, V29, P913, DOI 10.1007/s40520-017-0793-9; Alosco ML, 2014, INT J GERIATR PSYCH, V29, P428, DOI 10.1002/gps.4023; Ampadu J, 2015, INT J CARDIOL, V178, P12, DOI 10.1016/j.ijcard.2014.10.087; [Anonymous], EQ 5D; Appollonio I, 2005, NEUROL SCI, V26, P108, DOI 10.1007/s10072-005-0443-4; BERGSTROM N, 1987, NURS RES, V36, P205, DOI 10.1097/00006199-198707000-00002; Cameron Jan, 2017, Curr Heart Fail Rep, V14, P13, DOI 10.1007/s11897-017-0317-0; Cannon JA, 2017, J CARD FAIL, V23, P464, DOI 10.1016/j.cardfail.2017.04.007; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dodd JW, 2010, EUR RESPIR J, V35, P913, DOI 10.1183/09031936.00125109; Fan VS, 2014, CLIN CHEST MED, V35, P399, DOI 10.1016/j.ccm.2014.02.012; Fattirolli F, 2018, EUR J PREV CARDIOL, V25, P1799, DOI 10.1177/2047487318789497; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Global Initiative for Chronic Obstructive Lung Disease, 2020, GLOBAL STRATEGY DIAG; Guigoz Y, 1999, NES NUTR WS, V1, P3; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Holland AE, 2016, CHRON RESP DIS, V13, P372, DOI 10.1177/1479972316670104; Kakkera K, 2018, CURR OPIN PULM MED, V24, P173, DOI 10.1097/MCP.0000000000000458; Kharbanda S, 2021, INDIAN J MED RES, V153, P459, DOI 10.4103/ijmr.IJMR_1812_18; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Maddocks M, 2016, THORAX, V71, P988, DOI 10.1136/thoraxjnl-2016-208460; Magni E, 1996, EUR J NEUROL, V3, P198, DOI 10.1111/j.1468-1331.1996.tb00423.x; MAHONEY F I, 1965, Md State Med J, V14, P61; McDonagh TA, 2021, EUR HEART J, V42, P3599, DOI 10.1093/eurheartj/ehab368; Millan-Calenti JC, 2011, INT J GERIATR PSYCH, V26, P1071, DOI 10.1002/gps.2646; Moradi M, 2020, HEART FAIL REV, V25, P993, DOI 10.1007/s10741-019-09890-2; Ostojic J, 2017, ACTA CLIN CROAT, V56, P269, DOI 10.20471/acc.2017.56.02.10; Pandey A, 2019, JACC-HEART FAIL, V7, P1079, DOI 10.1016/j.jchf.2019.10.003; PARMELEE PA, 1995, J AM GERIATR SOC, V43, P130, DOI 10.1111/j.1532-5415.1995.tb06377.x; Perracini MR, 2020, PHYS THER, V100, P90, DOI 10.1093/ptj/pzz154; Pierobon A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235570; Pierobon A, 2017, INT J CHRONIC OBSTR, V12, P2059, DOI 10.2147/COPD.S133586; Pigliautile M, 2019, INT PSYCHOGERIATR, V31, P241, DOI 10.1017/S104161021800073X; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Singh D, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00164-2019; Sommaruga M, 2018, MONALDI ARCH CHEST D, V88, P47, DOI 10.4081/monaldi.2018.966; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stratton RJ, 2004, BRIT J NUTR, V92, P799, DOI 10.1079/BJN20041258; Strini V, 2019, ASSIST INFERM RIC, V38, P87, DOI 10.1702/3169.31501; Uchmanowicz I, 2018, AGING CLIN EXP RES, V30, P617, DOI 10.1007/s40520-017-0824-6; Vigorito C, 2017, EUR J PREV CARDIOL, V24, P577, DOI 10.1177/2047487316682579; Vitacca M, 2016, INT J CHRONIC OBSTR, V11, P1199, DOI 10.2147/COPD.S104376; World Health Organisation, 2003, ADHERENCE LONG TERM	47	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272132	10.1371/journal.pone.0272132	http://dx.doi.org/10.1371/journal.pone.0272132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925981	gold, Green Published			2022-12-26	WOS:000848077100072
J	Song, SF; Luo, ZH; Li, CX; Huang, XM; Shiroma, EJ; Simonsick, EM; Chen, HL				Song, Shengfang; Luo, Zhehui; Li, Chenxi; Huang, Xuemei; Shiroma, Eric J.; Simonsick, Eleanor M.; Chen, Honglei			Depressive symptoms before and after Parkinson's diagnosis-A longitudinal analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; SUBSEQUENT RISK; OLDER ADULTS; DISEASE; HEALTH; ANXIETY; IMPACT; ASSOCIATION; SEROTONIN; OLFACTION	Background Depression is common in Parkinson's disease (PD). It is however unclear when and how depressive symptoms develop and progress in the course of PD development. Objective To assess how depressive symptoms evolve in PD, using repeated measures. Methods In 2994 older adults, ages 70-79 years, depressive symptoms were assessed 8 times over 11 years using the 10-item Center for Epidemiologic Studies Depression Scale (CESD-10). For each PD patient at each time point, we calculated the difference between CESD-10 score and its expected value estimated based on data from individuals without PD, and then realigned the time scale in reference to the year of PD diagnosis. We examined longitudinal changes in CESD-10 scores before and after PD diagnosis using a joint modeling approach to account for competing risks of non-participation and death. Results A total of 79 PD patients were identified at enrollment or during the follow-up, with repeatedly assessed depressive symptom data up to 9 years before and after PD diagnosis. We found a monotonic trend of increasing CESD-10 score in PD patients throughout the observational period (p = 0.002). The observed scores became higher than expected approximately 7 years before PD diagnosis and significantly different 1 year before PD diagnosis. Conclusions Increasing depressive symptomatology appears to precede PD diagnosis by a few years.	[Song, Shengfang; Luo, Zhehui; Li, Chenxi; Chen, Honglei] Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Huang, Xuemei] Penn State Univ, Hersey Med Ctr, Dept Neurol, Hershey, PA USA; [Shiroma, Eric J.; Simonsick, Eleanor M.] NIA, Intramural Res Program, Baltimore, MD 21224 USA	Michigan State University; Michigan State University College of Human Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Chen, HL (corresponding author), Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.	chenho19@msu.edu		Chen, Honglei/0000-0003-3446-7779	MSU CHM Kirk Gibson Parkinsons Research Fund	MSU CHM Kirk Gibson Parkinsons Research Fund	This analysis was supported by the MSU CHM Kirk Gibson Parkinsons Research Fund (HC received the award, URL: https://www.kirkgibsonfoundation.org/research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2009, J NEUROL NEUROSUR PS, V80, P928, DOI 10.1136/jnnp.2008.166959; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Barone P, 2009, MOVEMENT DISORD, V24, P1641, DOI 10.1002/mds.22643; Barry LC, 2014, AM J GERIAT PSYCHIAT, V22, P682, DOI 10.1016/j.jagp.2013.09.001; Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Chang TY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72381-0; Chen HL, 2003, ANN NEUROL, V53, P676, DOI 10.1002/ana.10577; Chen HL, 2018, J PARKINSON DIS, V8, pS9, DOI 10.3233/JPD-181493; Chen HL, 2017, NEUROLOGY, V89, P1441, DOI 10.1212/WNL.0000000000004382; Dalle E, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0356-9; Darweesh SKL, 2017, BRAIN, V140, P429, DOI 10.1093/brain/aww291; Duncan GW, 2014, MOVEMENT DISORD, V29, P195, DOI 10.1002/mds.25664; Elashoff RM, 2007, STAT MED, V26, P2813, DOI 10.1002/sim.2749; Fang F, 2010, MOVEMENT DISORD, V25, P1157, DOI 10.1002/mds.23092; Fernandez Carmen, IEEE SOFTWARE, V127, P163, DOI [10.1016/j.appet.2018.04.028, DOI 10.1109/MS.2018.2141016]; Frisina PG, 2009, PARKINSONISM RELAT D, V15, P144, DOI 10.1016/j.parkreldis.2008.04.038; Galts CPC, 2019, NEUROSCI BIOBEHAV R, V102, P56, DOI 10.1016/j.neubiorev.2019.04.002; Gustafsson H, 2015, NEUROLOGY, V84, P2422, DOI 10.1212/WNL.0000000000001684; Heinzel S, 2019, MOVEMENT DISORD, V34, P1464, DOI 10.1002/mds.27802; Ishihara-Paul L, 2008, EUR J NEUROL, V15, P1148, DOI 10.1111/j.1468-1331.2008.02299.x; Jaunarajs KLE, 2011, NEUROSCI BIOBEHAV R, V35, P556, DOI 10.1016/j.neubiorev.2010.06.007; Kelly MJ, 2019, MOVEMENT DISORD, V34, P1174, DOI 10.1002/mds.27783; Kohli P, 2016, CHEM SENSES, V41, P479, DOI 10.1093/chemse/bjw061; Leentjens AFG, 2003, MOVEMENT DISORD, V18, P414, DOI 10.1002/mds.10387; Lou JS, 2001, MOVEMENT DISORD, V16, P190, DOI 10.1002/mds.1042; MAYEUX R, 1984, NEUROLOGY, V34, P642, DOI 10.1212/WNL.34.5.642; Mendonca IP, 2020, INT IMMUNOPHARMACOL, V83, DOI 10.1016/j.intimp.2020.106434; Mohamad WNAW, 2015, MALAYS J MED SCI, V22, P29; Pankratz N, 2008, MOVEMENT DISORD, V23, P2216, DOI 10.1002/mds.22285; Polotis M, 2015, BEHAV BRAIN RES, V277, P136, DOI 10.1016/j.bbr.2014.07.037; Postuma RB, 2016, NAT REV NEUROL, V12, P622, DOI 10.1038/nrneurol.2016.152; Ravina B, 2007, NEUROLOGY, V69, P342, DOI 10.1212/01.wnl.0000268695.63392.10; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445; Rizopoulos D, 2012, CH CRC BIOSTAT SER, P1, DOI 10.1201/b12208; Roos DS, 2019, J NEURAL TRANSM, V126, P1471, DOI 10.1007/s00702-019-02074-0; Saari L, 2021, ANN NEUROL, V89, P1046, DOI 10.1002/ana.26046; Schrag A, 2007, MOVEMENT DISORD, V22, P1077, DOI 10.1002/mds.21333; Schrag A, 2015, LANCET NEUROL, V14, P57, DOI 10.1016/S1474-4422(14)70287-X; Sherbaf FG, 2018, ACTA NEUROL BELG, V118, P415, DOI 10.1007/s13760-018-0896-x; Shiba M, 2000, MOVEMENT DISORD, V15, P669, DOI 10.1002/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5; Simonsick EM, 2001, J GERONTOL A-BIOL, V56, pM644, DOI 10.1093/gerona/56.10.M644; Song SF, 2021, MOVEMENT DISORD, V36, P1617, DOI 10.1002/mds.28536; STARKSTEIN SE, 1992, J NEUROL NEUROSUR PS, V55, P377, DOI 10.1136/jnnp.55.5.377; Taylor CA, 1999, AM J MED GENET, V88, P742, DOI 10.1002/(SICI)1096-8628(19991215)88:6<742::AID-AJMG29>3.0.CO;2-#; Tran Angela A, 2021, Complex Psychiatry, V6, P47, DOI 10.1159/000512657; Weintraub D, 2005, J NUCL MED, V46, P227	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2022	17	7							e0272315	10.1371/journal.pone.0272315	http://dx.doi.org/10.1371/journal.pone.0272315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Q0KX	35905124	gold, Green Published			2022-12-26	WOS:000855776900066
J	Zhu, NN; Luo, Y; Luo, F; Li, X; Zeng, G				Zhu, Nina; Luo, Ya; Luo, Feng; Li, Xue; Zeng, Gang			The spatial heterogeneity of the impact of PM2.5 on domestic tourism flows in China	PLOS ONE			English	Article							INBOUND TOURISM; POLLUTION; CLIMATE; GROWTH	As haze pollution intensifies, its impact on tourism is becoming increasingly obvious. However, limited studies have analyzed the impacts of haze pollution on tourism. To explore the contribution rate and impact of PM2.5 pollution on tourism flows, panel data on 341 prefecture-level cities in China from 2001 to 2015 were used. The results illustrated that the changes in PM2.5 pollution and domestic tourism flows showed a similar partial-most antiphase main spatial pattern in space, as well as other spatial patterns of PM2.5. From a regional perspective, the contribution rate of PM2.5 to domestic tourism flows was less than that of traditional factors, such as GDP, GDP_500, and 45A, but larger than that of the Airport factor. The contribution rate of the interaction between PM2.5 and 45A on domestic tourism flows was the largest. From a local perspective, PM2.5 pollution had a negative impact on domestic tourism flows in northern China, while it had a positive impact in other regions. The classic environmental Kuznets curve (EKC) hypothesis showed applicability to the Chinese tourism industry, and the is of great significance for comprehensively understanding the impact of PM2.5 pollution on tourism flows and for promoting the sustainable development of domestic tourism.	[Zhu, Nina; Zeng, Gang] East China Normal Univ, Ctr Modern Chinese City Studies, Shanghai, Peoples R China; [Luo, Ya] Chengdu Coll Arts & Sci, Sch Foreign Language, Chengdu, Sichuan, Peoples R China; [Luo, Feng] Fudan Univ, China Inst, Shanghai, Peoples R China; [Li, Xue] Shanghai Lixin Univ Accounting & Finance, Sch Int Econ & Trade, Shanghai, Peoples R China	East China Normal University; Fudan University; Shanghai Lixin University of Accounting & Finance	Zeng, G (corresponding author), East China Normal Univ, Ctr Modern Chinese City Studies, Shanghai, Peoples R China.; Li, X (corresponding author), Shanghai Lixin Univ Accounting & Finance, Sch Int Econ & Trade, Shanghai, Peoples R China.	lixue@lixin.edu.cn; gzeng@re.ecnu.edu.cn		Zhu, Nina/0000-0002-1939-341X; LI, XUE/0000-0001-6004-8151	Shanghai Sailing Program [22YF1411000]	Shanghai Sailing Program	This work was finally only supported by the Shanghai Sailing Program (Grant No. 22YF1411000), and the funder had role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	ANSELIN L, 1984, PAP REG SCI ASSOC, V54, P165, DOI 10.1007/BF01940131; ANSELIN L, 1988, PAP REG SCI ASSOC, V65, P11; Aunan K, 2018, CHINA QUART, V234, P279, DOI 10.1017/S0305741017001369; Becken S., 2017, Journal of Sustainable Tourism, V25, P130, DOI 10.1080/09669582.2016.1177067; Chen CM, 2017, TRANSPORT RES D-TR E, V53, P398, DOI 10.1016/j.trd.2017.04.028; Day J, 2013, TOUR MANAG PERSPECT, V5, P51, DOI 10.1016/j.tmp.2012.11.001; Dong DX, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11154148; Dong ZX, 2013, ADV MATER RES-SWITZ, V788, P387, DOI 10.4028/www.scientific.net/AMR.788.387; Ebenstein A, 2015, AM ECON REV, V105, P226, DOI 10.1257/aer.p20151094; Gao YJ, 2022, SUSTAIN CITIES SOC, V76, DOI 10.1016/j.scs.2021.103431; Guo YX, 2017, REMOTE SENS ENVIRON, V198, P140, DOI 10.1016/j.rse.2017.06.001; Hao Y, 2021, J ENVIRON MANAGE, V295, DOI 10.1016/j.jenvman.2021.113051; He BJ, 2021, ENVIRON RES, V193, DOI 10.1016/j.envres.2020.110584; He G, 2019, HKUST IEMS WORKING P, DOI [10.2139/ssrn.3439831, DOI 10.2139/SSRN.3439831]; Ito K, 2020, J POLIT ECON, V128, P1627, DOI 10.1086/705554; Jiang Y., 2015, CHINA INBOUND TOURIS, P9; Jin SH, 2020, TOURISM MANAGE, V78, DOI 10.1016/j.tourman.2019.104070; Li CX, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11051446; Mathieson A., 1982, Tourism, economic, physical and social impacts.; Melamed ML, 2016, CURR OPIN ENV SUST, V23, P85, DOI 10.1016/j.cosust.2016.12.003; Mitra SK, 2019, ANN TOURISM RES, V79, DOI 10.1016/j.annals.2019.102754; Oh CO, 2005, TOURISM MANAGE, V26, P39, DOI 10.1016/j.tourman.2003.09.014; Ouyang X, 2019, SCI TOTAL ENVIRON, V657, P234, DOI 10.1016/j.scitotenv.2018.12.056; Sajjad F, 2014, ENVIRON SCI POLLUT R, V21, P12403, DOI 10.1007/s11356-014-3146-7; Shi H, 2020, CURR ISSUES TOUR, V23, P1122, DOI 10.1080/13683500.2019.1588864; Sonmez S. F., 1998, Journal of Travel Research, V37, P171, DOI 10.1177/004728759803700209; Sun G, 2020, J SICHUAN NORMAL U S, V242, P67; Sun JK, 2019, SCI TOTAL ENVIRON, V690, P151, DOI 10.1016/j.scitotenv.2019.06.415; Wang MC, 2018, TOURISM ECON, V24, P821, DOI 10.1177/1354816618781458; Wang T, 2020, J SPAT SCI, V65, P327, DOI 10.1080/14498596.2018.1494058; Wang Y, 2020, RESOUR POLICY, V66, DOI 10.1016/j.resourpol.2020.101610; Wu B, 1997, ACTA GEOGRAPHICA SIN, P3; [徐冬 Xu Dong], 2019, [地理学报, Acta Geographica Sinica], V74, P814; Xu D, 2020, TOURISM GEOGR, V22, P83, DOI 10.1080/14616688.2019.1612464; Xu XW, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16245127; Xu X, 2019, CURR ISSUES TOUR, V22, P601, DOI 10.1080/13683500.2018.1504898; Yang DY, 2018, ENVIRON POLLUT, V241, P475, DOI 10.1016/j.envpol.2018.05.043; Yang Y, 2014, ANN TOURISM RES, V46, P144, DOI 10.1016/j.annals.2014.03.007; Yang Y, 2014, TOURISM MANAGE, V40, P193, DOI 10.1016/j.tourman.2013.05.005; Yang Y, 2012, J TRAVEL RES, V51, P768, DOI 10.1177/0047287512437855; Zhang DH, 2022, ENVIRON DEV SUSTAIN, V24, P9429, DOI 10.1007/s10668-021-01832-z; Zhang N, 2020, ANN TOURISM RES, V85, DOI 10.1016/j.annals.2020.103032; Zhang XW, 2020, ANN TOURISM RES, V84, DOI 10.1016/j.annals.2020.102999; Zhao DX, 2022, CATENA, V209, DOI 10.1016/j.catena.2021.105791; Zhao ZQ, 2021, REMOTE SENS-BASEL, V13, DOI 10.3390/rs13214338; Zheng JJ, 2016, J CLEAN PROD, V114, P314, DOI 10.1016/j.jclepro.2015.07.011; Zhou B, 2018, TOUR ANAL, V23, P159, DOI 10.3727/108354217X15143857878714; Zhou C, 2020, ATMOSPHERE-BASEL, V11, DOI 10.3390/atmos11010032; Zhou CS, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13169392; Zhou XG, 2019, INT J TOUR RES, V21, P747, DOI 10.1002/jtr.2301; Zhu NN, 2022, TOURISM ECON, DOI 10.1177/13548166211052810; Zhu NN, 2019, ATMOSPHERE-BASEL, V10, DOI 10.3390/atmos10050258	52	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2022	17	7							e0271302	10.1371/journal.pone.0271302	http://dx.doi.org/10.1371/journal.pone.0271302			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Q0KX	35905128	Green Published, gold			2022-12-26	WOS:000855776900029
J	van Dijk, JA; de Jong, MC; Piantoni, G; Fracasso, A; Vansteensel, MJ; Groen, IIA; Petridou, N; Dumoulin, SO				van Dijk, Jelle A.; de Jong, Maartje C.; Piantoni, Gio; Fracasso, Alessio; Vansteensel, Mariska J.; Groen, Iris. I. A.; Petridou, Natalia; Dumoulin, Serge O.			Intracranial recordings show evidence of numerosity tuning in human parietal cortex	PLOS ONE			English	Article							QUANTITY DISCRIMINATION; NUMERICAL INFORMATION; REPRESENTATION; NUMBER; NETWORK; MEMORY; FMRI	Numerosity is the set size of a group of items. Numerosity perception is a trait shared across numerous species. Numerosity-selective neural populations are thought to underlie numerosity perception. These neurons have been identified primarily using electrical recordings in animal models and blood oxygen level dependent (BOLD) functional magnetic resonance imaging (fMRI) in humans. Here we use electrical intracranial recordings to investigate numerosity tuning in humans, focusing on high-frequency transient activations. These recordings combine a high spatial and temporal resolution and can bridge the gap between animal models and human recordings. In line with previous studies, we find numerosity-tuned responses at parietal sites in two out of three participants. Neuronal populations at these locations did not respond to other visual stimuli, i.e. faces, houses, and letters, in contrast to several occipital sites. Our findings further corroborate the specificity of numerosity tuning of in parietal cortex, and further link fMRI results and electrophysiological recordings.	[van Dijk, Jelle A.; de Jong, Maartje C.; Fracasso, Alessio; Dumoulin, Serge O.] Spinoza Ctr Neuroimaging, Amsterdam, Netherlands; [van Dijk, Jelle A.; Dumoulin, Serge O.] Univ Utrecht, Expt Psychol, Utrecht, Netherlands; [de Jong, Maartje C.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [de Jong, Maartje C.] Univ Amsterdam, Amsterdam Brain & Cognit ABC, Amsterdam, Netherlands; [Piantoni, Gio; Fracasso, Alessio; Petridou, Natalia] Univ Med Ctr Utrecht, Ctr Image Sci, Radiol Dept, Imaging Div, Utrecht, Netherlands; [Fracasso, Alessio] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Scotland; [Vansteensel, Mariska J.] UMC Utrecht, UMC Utrecht Brain Ctr, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Groen, Iris. I. A.] Univ Amsterdam, Informat Inst, Amsterdam, Netherlands; [Groen, Iris. I. A.] NYU, Dept Psychol, New York, NY USA; [Dumoulin, Serge O.] Vrije Univ Amsterdam, Expt & Appl Psychol, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Spinoza Centre for Neuroimaging (KNAW); Utrecht University; University of Amsterdam; University of Amsterdam; Utrecht University; Utrecht University Medical Center; University of Glasgow; Utrecht University; Utrecht University Medical Center; University of Amsterdam; New York University; Vrije Universiteit Amsterdam	de Jong, MC (corresponding author), Spinoza Ctr Neuroimaging, Amsterdam, Netherlands.; de Jong, MC (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.; de Jong, MC (corresponding author), Univ Amsterdam, Amsterdam Brain & Cognit ABC, Amsterdam, Netherlands.	m.dejong@spinozacentre.nl	Dumoulin, Serge/A-3603-2012	Dumoulin, Serge/0000-0001-7474-7711; de Jong, Maartje Cathelijne/0000-0003-4136-1753; van Dijk, Jelle/0000-0003-0135-3054	European Union; Dutch Research Council (NWO) [641805]; Vidi grant [016.Vici.185.050]; Amsterdam Brain and Cognition platform [13339]; Biotechnology and Biology research council (BBSRC); Bial Foundation [BB/S006605/1]; Bial Foundation Grants Programme 2020/21; BRAIN Initiative [A-29315]; National Institute of Mental Health of the National Institutes of Health;  [R01MH111417]	European Union(European Commission); Dutch Research Council (NWO)(Netherlands Organization for Scientific Research (NWO)); Vidi grant; Amsterdam Brain and Cognition platform; Biotechnology and Biology research council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bial Foundation(Bial Foundation); Bial Foundation Grants Programme 2020/21(Bial FoundationBial Group); BRAIN Initiative; National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); 	This work was supported by the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 641805 awarded to SOD; Dutch Research Council (NWO) Vici grant 016.Vici.185.050 awarded to SOD and Vidi grant 13339 awarded to NP. MCdJ was supported by a Talent grant from the Amsterdam Brain and Cognition platform. AF is supported by a grant from the Biotechnology and Biology research council (BBSRC, grant number: BB/S006605/1) and the Bial Foundation, Bial Foundation Grants Programme 2020/21, A-29315. The visual category experiments were funded by BRAIN Initiative, the National Institute of Mental Health of the National Institutes of Health under Award Number R01MH111417. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Spinoza Centre is a joint initiative of the Amsterdam University Medical Centra, VU University, Netherlands Institute for Neuroscience, and the Royal Netherlands Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; Cai YX, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23785-7; Cai YX, 2021, NEUROIMAGE, V237, DOI 10.1016/j.neuroimage.2021.118184; Cantlon JF, 2009, J COGNITIVE NEUROSCI, V21, P2217, DOI 10.1162/jocn.2008.21159; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Dehaene S., 2011, NUMBER SENSE MIND CR; Ditz HM, 2016, J NEUROSCI, V36, P12044, DOI 10.1523/JNEUROSCI.1521-16.2016; Ditz HM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0083; Ditz HM, 2015, P NATL ACAD SCI USA, V112, P7827, DOI 10.1073/pnas.1504245112; Eger E, 2009, CURR BIOL, V19, P1608, DOI 10.1016/j.cub.2009.08.047; Fracasso A, 2022, BRAIN STRUCT FUNCT, V227, P1371, DOI 10.1007/s00429-021-02342-4; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Harvey BM, 2013, SCIENCE, V341, P1123, DOI 10.1126/science.1239052; Harvey B, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0036; Harvey BM, 2017, NEUROIMAGE, V149, P200, DOI 10.1016/j.neuroimage.2017.02.012; Harvey BM, 2016, CURR BIOL, V26, pR419, DOI 10.1016/j.cub.2016.03.059; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P1441, DOI 10.1098/rspb.2003.2414; Hermes D, 2012, HUM BRAIN MAPP, V33, P1689, DOI 10.1002/hbm.21314; Hermes D, 2010, J NEUROSCI METH, V185, P293, DOI 10.1016/j.jneumeth.2009.10.005; Hofstetter S, 2021, NEUROIMAGE, V238, DOI 10.1016/j.neuroimage.2021.118178; Hofstetter S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20567-5; Kay KN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003079; Knops A, 2014, J NEUROSCI, V34, P9857, DOI 10.1523/JNEUROSCI.2758-13.2014; Kutter EF, 2018, NEURON, V100, P753, DOI 10.1016/j.neuron.2018.08.036; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Miller KJ, 2009, J NEUROSCI, V29, P3132, DOI 10.1523/JNEUROSCI.5506-08.2009; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2011, ATTENTION PERFORM, P267, DOI 10.1016/B978-0-12-385948-8.00017-7; Pinel P, 1999, NEUROREPORT, V10, P1473, DOI 10.1097/00001756-199905140-00015; Pisa P, 2009, J ETHOL, V27, P289, DOI 10.1007/s10164-008-0121-0; Potrich D, 2015, J COMP PSYCHOL, V129, P388, DOI 10.1037/com0000012; Sawamura H, 2002, NATURE, V415, P918, DOI 10.1038/415918a; Tokita M, 2010, ATTEN PERCEPT PSYCHO, V72, P1839, DOI 10.3758/APP.72.7.1839	40	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272087	http://dx.doi.org/10.1371/journal.pone.0272087			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921261	Green Published, Green Accepted, gold			2022-12-26	WOS:000839311900065
J	Fekry, B; Ribas-Latre, A; Van Drunen, R; Santos, RB; Shivshankar, S; Dai, YL; Zhao, Z; Yoo, SH; Chen, Z; Sun, K; Sladek, FM; Younes, M; Eckel-Mahan, K				Fekry, Baharan; Ribas-Latre, Aleix; Van Drunen, Rachel; Santos, Rafael Bravo; Shivshankar, Samay; Dai, Yulin; Zhao, Zhongming; Yoo, Seung-Hee; Chen, Zheng; Sun, Kai; Sladek, Frances M.; Younes, Mamoun; Eckel-Mahan, Kristin			Hepatic circadian and differentiation factors control liver susceptibility for fatty liver disease and tumorigenesis	FASEB JOURNAL			English	Article						BMAL1; circadian; HCC; hcpatoccllular carcinoma; HNF4 alpha; SR9009	NUCLEAR FACTOR 4-ALPHA; GENE-EXPRESSION; CYCLIN B1; HEPATOCELLULAR-CARCINOMA; BREAST-CANCER; CELL-PROLIFERATION; ACID SYNTHASE; DOWN-REGULATION; REV-ERBS; HNF4-ALPHA	Hepatocellular carcinoma (HCC) is a leading cause of cancer deaths, and the most common primary liver malignancy to present in the clinic. With the exception of liver transplant, treatment options for advanced HCC are limited, but improved tumor stratification could open the door to new treatment options. Previously, we demonstrated that the circadian regulator Aryl Hydrocarbon-Like Receptor Like 1 (ARNTL, or Bmal1) and the liver-enriched nuclear factor 4 alpha (HNF4 alpha) are robustly co-expressed in healthy liver but incompatible in the context of HCC. Faulty circadian expression of HNF4 alpha- either by isoform switching, or loss of expression- results in an increased risk for IICC, while BMAL1 gain-of-function in HNF4 alpha-positive HCC results in apoptosis and tumor regression. We hypothesize that the transcriptional programs of HNF4 alpha and BMAL1 are antagonistic in liver disease and HCC. Here, we study this antagonism by generating a mouse model with inducible loss of hepatic HNF4 alpha and BMAL1 expression. The results reveal that simultaneous loss of HNF4 alpha and BMAL1 is protective against fatty liver and HCC in carcinogen-induced liver injury and in the "STAM" model of liver disease. Furthermore, our results suggest that targeting Bmall expression in the absence of HNF4 alpha inhibits HCC growth and progression. Specifically, pharmacological suppression of Bmal1 in HNF4 alpha-deficient, BMAL1-positive HCC with REV-ERB agonist SR9009 impairs tumor cell proliferation and migration in a REV-ERB-dependent manner, while having no effect on healthy hepatocytes. Collectively, our results suggest that stratification of HCC based on HNF4 alpha and BMAL1 expression may provide a new perspective on HCC properties and potential targeted therapeutics.	[Fekry, Baharan; Ribas-Latre, Aleix; Van Drunen, Rachel; Santos, Rafael Bravo; Shivshankar, Samay; Sun, Kai; Eckel-Mahan, Kristin] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, McGovern Med Sch, 1825 Pressler Ave, Houston, TX 77030 USA; [Dai, Yulin; Zhao, Zhongming] Univ Texas Hlth Sci Ctr Houston, Ctr Precis Hlth, Sch Biomed Informat, Houston, TX 77030 USA; [Zhao, Zhongming] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Sch Publ Hlth, Houston, TX 77030 USA; [Yoo, Seung-Hee; Chen, Zheng] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, McGovern Med Sch, Houston, TX 77030 USA; [Sun, Kai; Eckel-Mahan, Kristin] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, McGovern Med Sch, Houston, TX 77030 USA; [Sladek, Frances M.] Univ Calif Riverside, Dept Mol Cell & Syst Biol, Riverside, CA 92521 USA; [Younes, Mamoun] George Washington Univ, Sch Med & Hlth Sci, Dept Pathol, Washington, DC 20052 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Riverside; George Washington University	Eckel-Mahan, K (corresponding author), Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, McGovern Med Sch, 1825 Pressler Ave, Houston, TX 77030 USA.	kristin.l.mahan@uth.tmc.edu		Sun, Kai/0000-0002-4778-4549; Van Drunen, Rachel/0000-0001-7438-1801; dai, yulin/0000-0003-1874-7893	American Cancer Society (ACS) [RSG-17-215-01-C]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP180734]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK114037]	American Cancer Society (ACS)(American Cancer Society); Cancer Prevention and Research Institute of Texas (CPRIT); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	American Cancer Society (ACS), Grant/ Award Number: RSG-17-215-01-C; Cancer Prevention and Research Institute of Texas (CPRIT), Grant/ Award Number: RP180734; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/ Award Number: DK114037	Abitbol S, 2018, J HEPATOL, V68, P1203, DOI 10.1016/j.jhep.2017.12.018; Arboatti AS, 2019, CHEM-BIOL INTERACT, V303, P70, DOI 10.1016/j.cbi.2019.02.024; Argemie J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11004-3; Bahitham W, 2016, BBA-MOL CELL BIOL L, V1861, P482, DOI 10.1016/j.bbalip.2016.03.009; Banerjee SK, 2000, AM J PATHOL, V156, P217, DOI 10.1016/S0002-9440(10)64722-0; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bauerschlag DO, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0511-3; Bjornson E, 2015, CELL REP, V13, P2014, DOI 10.1016/j.celrep.2015.10.045; Bolotin E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-560; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chang HY, 2016, NUCLEIC ACIDS RES, V44, P2514, DOI 10.1093/nar/gkw126; Chellappa K, 2016, ELIFE, V5, DOI 10.7554/eLife.10903; Chellappa K, 2012, P NATL ACAD SCI USA, V109, P2302, DOI 10.1073/pnas.1106799109; Chiba H, 2005, EXP CELL RES, V302, P11, DOI 10.1016/j.yexcr.2004.08.014; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Cicchini C, 2015, LIVER INT, V35, P302, DOI 10.1111/liv.12577; Dean S, 2010, GENE EXPRESSION, V14, P337, DOI 10.3727/105221610X12717040569901; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Dorn C, 2010, INT J CLIN EXP PATHO, V3, P505; Dubois V, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102185; Dunser MW, 2008, CURR OPIN ANESTHESIO, V21, P122, DOI 10.1097/ACO.0b013e3282f4571a; Erdmann S, 2007, BIOL CHEM, V388, P91, DOI 10.1515/BC.2007.011; Everett LJ, 2014, TRENDS ENDOCRIN MET, V25, P586, DOI 10.1016/j.tem.2014.06.011; Fang B, 2012, NUCLEIC ACIDS RES, V40, P5343, DOI 10.1093/nar/gks190; Farshadi E, 2019, CELL CYCLE, V18, P16, DOI 10.1080/15384101.2018.1558638; Fekry B, 2019, CANCER RES, V79, P5860, DOI 10.1158/0008-5472.CAN-19-1277; Fekry B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06648-6; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Giannelli G, 2016, J HEPATOL, V65, P798, DOI 10.1016/j.jhep.2016.05.007; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Grohmann M, 2018, CELL, V175, P1289, DOI 10.1016/j.cell.2018.09.053; Half E, 2002, CANCER RES, V62, P1676; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; Henkel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34633-y; Henkel J, 2012, LAB INVEST, V92, P1597, DOI 10.1038/labinvest.2012.128; Hui ST, 2018, HEPATOLOGY, V68, P2182, DOI 10.1002/hep.30113; Inoue Y, 2004, J BIOL CHEM, V279, P2480, DOI 10.1074/jbc.M311015200; Jia HL, 2007, CLIN CANCER RES, V13, P1133, DOI 10.1158/1078-0432.CCR-06-1025; Jiang L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02927; Johnson Christopher, 2012, Transl Gastrointest Cancer, V1, P58; Johnson DE, 2018, NAT REV CLIN ONCOL, V15, P234, DOI 10.1038/nrclinonc.2018.8; Jones SF, 2015, CLIN CANCER RES, V21, P5434, DOI 10.1158/1078-0432.CCR-15-0126; Joo M, 2001, LIVER, V21, P89, DOI 10.1034/j.1600-0676.2001.021002089.x; Kaestner KH, 2010, HEPATOLOGY, V51, P376, DOI 10.1002/hep.23487; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kanwal F, 2018, GASTROENTEROLOGY, V155, P1828, DOI 10.1053/j.gastro.2018.08.024; Kawamoto H, 1997, AM J PATHOL, V150, P15; Kettner NM, 2016, CANCER CELL, V30, P909, DOI 10.1016/j.ccell.2016.10.007; Kim MJ, 2017, MOL CANCER RES, V15, P1230, DOI 10.1158/1541-7786.MCR-17-0061; Koga H, 1999, HEPATOLOGY, V29, P688, DOI 10.1002/hep.510290355; Kulik L, 2019, GASTROENTEROLOGY, V156, P477, DOI 10.1053/j.gastro.2018.08.065; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lede V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172000; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010995; Li D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14185-z; Liao R, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-3; Lipton JO, 2015, CELL, V161, P1138, DOI 10.1016/j.cell.2015.04.002; Lu SY, 2005, CARCINOGENESIS, V26, P153, DOI 10.1093/carcin/bgh278; Luo JH, 2006, HEPATOLOGY, V44, P1012, DOI 10.1002/hep.21328; Lupien LE, 2019, J PHARMACOL EXP THER, V371, P171, DOI 10.1124/jpet.119.258947; Ma SB, 2014, CANCER RES, V74, P1969, DOI 10.1158/0008-5472.CAN-13-2534; Martinez-Jimenez CP, 2010, MOL CELL BIOL, V30, P565, DOI 10.1128/MCB.00927-09; Mehrotra S, 2006, J PATHOL, V208, P356, DOI 10.1002/path.1907; Monga SP, 2015, GASTROENTEROLOGY, V148, P1294, DOI 10.1053/j.gastro.2015.02.056; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nagasawa T, 2006, EUR J PHARMACOL, V536, P182, DOI 10.1016/j.ejphar.2006.02.028; Ning BF, 2010, CANCER RES, V70, P7640, DOI 10.1158/0008-5472.CAN-10-0824; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Oshima T, 2007, PATHOL INT, V57, P82, DOI 10.1111/j.1440-1827.2006.02061.x; Pan XY, 2020, J CLIN INVEST, V130, P4282, DOI 10.1172/JCI132765; Pan XY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13011; Park TJ, 2008, HEPATOLOGY, V47, P1533, DOI 10.1002/hep.22212; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Perez S, 2006, BBA-MOL CELL BIOL L, V1761, P160, DOI 10.1016/j.bbalip.2006.02.003; Peyrou M, 2012, PPAR RES, V2012, DOI 10.1155/2012/757803; Qu M, 2018, P NATL ACAD SCI USA, V115, pE12305, DOI 10.1073/pnas.1816411115; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Roelofs HMJ, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-1; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Sanderson LM, 2010, PHYSIOL GENOMICS, V41, P42, DOI 10.1152/physiolgenomics.00127.2009; SANO H, 1995, CANCER RES, V55, P3785; Schernhammer ES, 2006, EPIDEMIOLOGY, V17, P108, DOI 10.1097/01.ede.0000190539.03500.c1; Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004; Shi DM, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00423; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Solt LA, 2011, FUTURE MED CHEM, V3, P623, DOI [10.4155/FMC.11.9, 10.4155/fmc.11.9]; Soria JC, 2000, CANCER RES, V60, P4000; Stevens RG, 2009, INT J EPIDEMIOL, V38, P963, DOI 10.1093/ije/dyp178; Sulli G, 2018, NATURE, V553, P351, DOI 10.1038/nature25170; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takano K, 2009, PATHOL INT, V59, P462, DOI 10.1111/j.1440-1827.2009.02394.x; Tanaka T, 2006, J PATHOL, V208, P662, DOI 10.1002/path.1928; Tang QM, 2017, CANCER RES, V77, P532, DOI 10.1158/0008-5472.CAN-16-1322; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; van Zijl F, 2009, FUTURE ONCOL, V5, P1169, DOI [10.2217/fon.09.91, 10.2217/FON.09.91]; Walesky C, 2015, GENE EXPRESSION, V16, P101, DOI 10.3727/105221615X14181438356292; Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251; Walesky C, 2013, AM J PHYSIOL-GASTR L, V304, pG26, DOI 10.1152/ajpgi.00064.2012; Walker S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212860; Wang AJ, 1997, J CANCER RES CLIN, V123, P124, DOI 10.1007/BF01269891; Wang XF, 2020, BRIT J PHARMACOL, V177, P1865, DOI 10.1111/bph.14958; Wang Y, 2009, INT J CANCER, V124, P540, DOI 10.1002/ijc.23995; Wang YJ, 2015, BIOCHEM PHARMACOL, V96, P315, DOI 10.1016/j.bcp.2015.06.010; Wang Z, 2020, ONCOGENE, V39, P1572, DOI 10.1038/s41388-019-1080-3; Xie XF, 2009, MOL ENDOCRINOL, V23, P434, DOI 10.1210/me.2007-0531; Yang LH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-25; Yoshiji H, 1999, CANCER RES, V59, P4413; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609; Zang SB, 2013, HUM PATHOL, V44, P1681, DOI 10.1016/j.humpath.2013.04.007; Zhang W, 2012, BIOMED RES-TOKYO, V33, P83, DOI 10.2220/biomedres.33.83; Zhangdi HJ, 2019, WORLD J GASTROENTERO, V25, P4835, DOI 10.3748/wjg.v25.i33.4835; Zhao M., 2006, Experimental Oncology, V28, P44	118	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22482	10.1096/fj.202101398R	http://dx.doi.org/10.1096/fj.202101398R			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3R2RK	35947136				2022-12-26	WOS:000838765500001
J	Husmann, L; Huellner, MW; Gruenig, H; Messerli, M; Rancic, Z; Hasse, B				Husmann, L.; Huellner, M. W.; Gruenig, H.; Messerli, M.; Rancic, Z.; Hasse, B.			Imaging Characteristics and Diagnostic Accuracy of FDG-PET/CT, Contrast Enhanced CT and Combined Imaging in Patients with Suspected Mycotic or Inflammatory Abdominal Aortic Aneurysms	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract									Univ Zurich Hosp, Dept Nucl Med, Zurich, Switzerland; [Husmann, L.; Huellner, M. W.; Gruenig, H.; Messerli, M.] Univ Zurich Hosp, Dept Vasc Surg, Zurich, Switzerland; [Rancic, Z.] Univ Hosp Zurich, Div Infect Dis, Zurich, Switzerland; [Hasse, B.] Hosp Epidemiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital			; Ledergerber, Bruno/B-5656-2009	Hasse, Barbara/0000-0001-7196-3734; Ledergerber, Bruno/0000-0002-6881-4401					0	1	1	2	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	SEP	2022	49	SUPPL 1		1	SI	OP-519	S171	S171						1	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	4R9AE	35944039	Green Published, gold			2022-12-26	WOS:000857046600357
J	Luo, HG; Liu, YA; Li, Y; Zhang, CK; Yu, BB; Shao, C				Luo, Haoge; Liu, Yanan; Li, Yang; Zhang, Chaoke; Yu, Bingbing; Shao, Chen			Androgen receptor splicing variant 7 (ARv7) promotes DNA damage response in prostate cancer cells	FASEB JOURNAL			English	Article						ARv7; DNA damage response; homologous recombination; olaparib; PARP1; prostate cancer; radiotherapy	STRAND BREAK REPAIR; PARP INHIBITORS; DEPRIVATION; RESISTANCE; THERAPY; COMPLEX; AR-V7	In the treatment of patients with locally advanced prostate cancer (PCa), androgen deprivation therapy (ADT) significantly enhances the efficacy of radiotherapy by weakening the DNA damage response (DDR) pathway. Recently, several studies have suggested that androgen receptor splicing variants (ARvs) may mediate a compensatory DDR pathway when canonical androgen receptor (AR) signaling is inhibited, thus contributing to the resistance of some patients to this combinational treatment. However, the specific roles of certain ARvs as well as the detailed mechanism of how ARvs regulate the DDR are not well understood. Here, we demonstrated that AR splicing variant 7 (ARv7), which is the most abundant form of ARvs, significantly promotes the DDR of PCa cells under severe DNA damage independent of its parental AR by using the ionizing radiation (IR) and doxorubicin (Dox)-treated cell models. Mechanistically, ARv7 is sufficient to upregulate both the homologous recombination (HR) and the nonhomologous end joining (NHEJ) pathways by forming a positive regulatory loop with poly ADP-ribose polymerase 1 (PARP1). Moreover, the presence of ARv7 impairs the synergistic effect between AR antagonists and poly ADP-ribose polymerase (PARP) inhibitor, which has been recently shown to be a promising future treatment strategy for metastatic castration resistant prostate cancer (mCRPC). Combined, our data indicate that constitutively active ARv7 not only contributes to radioresistance after ADT, but may also serve as a potential predictive biomarker for assessing the efficacy of novel PARP inhibitor-based therapy in PCa.	[Luo, Haoge; Liu, Yanan; Li, Yang; Zhang, Chaoke; Yu, Bingbing; Shao, Chen] Jilin Univ, Coll Basic Med Sci, Dept Pathophysiol, 126 Xinmin St, Changchun 130021, Peoples R China	Jilin University	Shao, C (corresponding author), Jilin Univ, Coll Basic Med Sci, Dept Pathophysiol, 126 Xinmin St, Changchun 130021, Peoples R China.	shaochen@jlu.edu.cn		, Chen/0000-0001-5008-6912	Jilin University (JLU) [2018B30]; National Natural Science Foundation of China (NSFC) [81802579]	Jilin University (JLU); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Jilin University (JLU), Grant/Award Number: 2018B30; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81802579	Antonarakis ES, 2020, EUR UROL ONCOL, V3, P594, DOI 10.1016/j.euo.2020.07.005; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Asim M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00393-y; Bastos DA, 2018, EXPERT REV MOL DIAGN, V18, P155, DOI 10.1080/14737159.2018.1427068; Bolla M, 2010, LANCET ONCOL, V11, P1066, DOI 10.1016/S1470-2045(10)70223-0; Brandsma Inger, 2012, Genome Integr, V3, P9, DOI 10.1186/2041-9414-3-9; Cao B, 2014, ONCOTARGET, V5, P1646, DOI 10.18632/oncotarget.1802; Clarke N, 2018, LANCET ONCOL, V19, P975, DOI 10.1016/S1470-2045(18)30365-6; Dal Pra A, 2010, CURR ONCOL, V17, P219; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; De Lorenzo SB, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00228; Deshmukh D, 2015, AM J CLIN EXP UROL, V3, P1; Ellisen LW, 2011, CANCER CELL, V19, P165, DOI 10.1016/j.ccr.2011.01.047; Feiersinger GE, 2018, MOL ONCOL, V12, P561, DOI 10.1002/1878-0261.12185; Fujita K, 2019, WORLD J MENS HEALTH, V37, P288, DOI 10.5534/wjmh.180040; Goodwin JF, 2013, CANCER DISCOV, V3, P1254, DOI 10.1158/2159-8290.CD-13-0108; Graham L, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0759-3; Her J, 2018, J BIOL CHEM, V293, P10502, DOI 10.1074/jbc.TM118.000371; Hopkins TA, 2019, MOL CANCER RES, V17, P409, DOI 10.1158/1541-7786.MCR-18-0138; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Jones CU, 2011, NEW ENGL J MED, V365, P107, DOI 10.1056/NEJMoa1012348; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Kounatidou E, 2019, NUCLEIC ACIDS RES, V47, P5634, DOI 10.1093/nar/gkz286; Lan L, 2010, MOL CELL, V40, P976, DOI 10.1016/j.molcel.2010.12.003; Li H, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01227-0; Li LK, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam7479; Lu J, 2015, J UROLOGY, V193, P690, DOI 10.1016/j.juro.2014.08.043; Mladenov E, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00113; Nizialek E, 2020, CANCER MANAG RES, V12, P8105, DOI 10.2147/CMAR.S227033; Pezaro C, 2020, THER ADV MED ONCOL, V12, DOI 10.1177/1758835919897537; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Schiewer MJ, 2012, CANCER DISCOV, V2, P1134, DOI 10.1158/2159-8290.CD-12-0120; Shao C, 2019, LIFE SCI, V234, DOI 10.1016/j.lfs.2019.116768; Sharp A, 2019, J CLIN INVEST, V129, P192, DOI 10.1172/JCI122819; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sprenger CCT, 2014, HORM CANCER-US, V5, P207, DOI 10.1007/s12672-014-0177-y; Wadosky KM, 2017, ONCOTARGET, V8, P18550, DOI 10.18632/oncotarget.14537; Yin LL, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0810-7; Yin Y, 2017, CANCER RES, V77, P4745, DOI 10.1158/0008-5472.CAN-17-0164; Yu BB, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100276; Zang YC, 2018, CANCER LETT, V415, P198, DOI 10.1016/j.canlet.2017.11.028; Zhang T, 2020, CLIN GENITOURIN CANC, V18, P1, DOI 10.1016/j.clgc.2019.09.015	42	1	1	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22495	10.1096/fj.202200190R	http://dx.doi.org/10.1096/fj.202200190R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3Q4LK	35947121				2022-12-26	WOS:000838204500001
J	Cheng, HY; Fung, E; Choi, KC; Zou, HJ; Chair, SY				Cheng, Ho Yu; Fung, Erik; Choi, Kai Chow; Zou, Hui Jing; Chair, Sek Ying			Early risk of acute myocardial infarction following hospitalization for severe influenza infection in the middle-aged population of Hong Kong	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASES; TIME-SERIES; VIRUS; ASSOCIATION; VACCINATION	Introduction Despite evidence suggesting an association between influenza infection and increased risk of acute myocardial infarction (AMI) in the older adult population (aged 65 years or above), little is known about its near-term risks in middle-aged adults (aged 45 to 64 years). This study aims to estimate the risks of and association between severe influenza infection requiring hospitalization and subsequent AMI within 12 months in middle-aged adults. Method This is a retrospective case-control analysis of territorywide registry data of people aged 45 to 64 years admitting from up to 43 public hospitals in Hong Kong during a 20-year period from January 1997 to December 2017. The exposure was defined as severe influenza infection documented as the principal diagnosis using International Classification of Diseases codes and non-exposure as hospitalization for orthopedic surgery. Logistic regression was used to analyze the risk of subsequent hospitalization for AMI within 12 months following the exposure. Results Among 30,657 middle-aged adults with an indexed hospitalization, 8,840 (28.8%) had an influenza-associated hospitalization. 81 (0.92%) were subsequently rehospitalized with AMI within 12 months after the indexed hospitalization. Compared with the control group, the risk of subsequent hospitalization for AMI was significantly increased (odds ratio [OR]: 2.54, 95% confidence interval [CI]: 1.64-3.92, p<0.001). The association remained significant even after adjusting for potential confounders (adjusted OR: 1.81, 95% CI: 1.11-2.95, p = 0.02). Patients with a history of hypertension, but not those with diabetes mellitus, dyslipidemia or atrial fibrillation/flutter, were at increased risk (adjusted OR: 5.01, 95% CI: 2.93-8.56, p<0.001). Conclusion Subsequent hospitalization for AMI within 12 months following an indexed respiratory hospitalization for severe influenza increased nearly two-fold compared with the non-cardiopulmonary, non-exposure control. Recommendation of influenza vaccination extending to middle-aged adult population may be justified for the small but significant increased near-term risk of AMI.	[Cheng, Ho Yu; Choi, Kai Chow; Zou, Hui Jing; Chair, Sek Ying] Chinese Univ Hong Kong, Fac Med, Nethersole Sch Nursing, Hong Kong, Peoples R China; [Fung, Erik] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Lab Heart Failure Circulat Res, Hong Kong, Peoples R China; [Fung, Erik] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Div Cardiol, Hong Kong, Peoples R China; [Fung, Erik] Chinese Univ Hong Kong, Gerald Choa Cardiac Res Ctr, Dept Med & Therapeut, Fac Med, Hong Kong, Peoples R China; [Fung, Erik] Chinese Univ Hong Kong, CUHK Med Ctr, Hong Kong, Peoples R China; [Fung, Erik] Hong Kong Childrens Hosp, CUHK Hong Kong Hub Paediat Excellence, Lui Che Woo Inst Innovat Med, CARE Programme, Hong Kong, Peoples R China; [Fung, Erik] Imperial Coll London, Sch Publ Hlth, Dept Biostat & Epidemiol, St Marys Campus,Norfolk Pl, London, England	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Imperial College London	Cheng, HY (corresponding author), Chinese Univ Hong Kong, Fac Med, Nethersole Sch Nursing, Hong Kong, Peoples R China.; Fung, E (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Lab Heart Failure Circulat Res, Hong Kong, Peoples R China.; Fung, E (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Div Cardiol, Hong Kong, Peoples R China.; Fung, E (corresponding author), Chinese Univ Hong Kong, Gerald Choa Cardiac Res Ctr, Dept Med & Therapeut, Fac Med, Hong Kong, Peoples R China.; Fung, E (corresponding author), Chinese Univ Hong Kong, CUHK Med Ctr, Hong Kong, Peoples R China.; Fung, E (corresponding author), Hong Kong Childrens Hosp, CUHK Hong Kong Hub Paediat Excellence, Lui Che Woo Inst Innovat Med, CARE Programme, Hong Kong, Peoples R China.; Fung, E (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Biostat & Epidemiol, St Marys Campus,Norfolk Pl, London, England.	hycheng@cuhk.edu.hk; e.fung@cuhk.edu.hk	Cheng, Ho Yu/L-9917-2016; Chair, Sek Ying/G-9965-2016	Cheng, Ho Yu/0000-0002-5842-9390; Chair, Sek Ying/0000-0003-2387-7035				Ang LW, 2017, AM J EPIDEMIOL, V186, P202, DOI 10.1093/aje/kwx001; Barnes M, 2015, HEART, V101, P1738, DOI 10.1136/heartjnl-2015-307691; Blackburn R, 2018, CLIN INFECT DIS, V67, P8, DOI 10.1093/cid/cix1144; Caldeira D, 2019, EXPERT REV VACCINES, V18, P1211, DOI 10.1080/14760584.2019.1690459; Cardoso R, 2020, AM J CARDIOL, V125, P840, DOI 10.1016/j.amjcard.2019.12.032; Centers for Disease Control and Prevention, PREV CONTR SEAS INFL; Centers for Disease Control and Prevention United State, KEY FACTS INFL FLU; Centre for Health Protection Department of Health Hong Kong Special Administrative Region, GOV VACC PROGR; Cheng YY, 2020, AGEING RES REV, V62, DOI 10.1016/j.arr.2020.101124; Chiang MH, 2017, AM HEART J, V193, P1, DOI 10.1016/j.ahj.2017.07.020; Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229; Department of Health Australian Government, 2022 SEAS INFL VACC; Estabragh ZR, 2013, INT J CARDIOL, V167, P2397, DOI 10.1016/j.ijcard.2013.01.274; Guan XR, 2012, INFLAMM RES, V61, P591, DOI 10.1007/s00011-012-0449-3; Haidari M, 2010, ATHEROSCLEROSIS, V208, P90, DOI 10.1016/j.atherosclerosis.2009.07.028; Hall CB, 2007, CLIN INFECT DIS, V45, P353, DOI 10.1086/519433; Health Promotion Board Ministry of Health Singapore, HLTH HUB INFL; Kwong JC, 2018, NEW ENGL J MED, V378, P345, DOI 10.1056/NEJMoa1702090; Lichenstein R, 2012, J INFECT DIS, V206, P821, DOI 10.1093/infdis/jis435; Ministry of Health New Zealand Government, GETT FLU JAB; Muscente F, 2020, EUR HEART J SUPPL, V22, pE68, DOI 10.1093/eurheartj/suaa064; Nguyen JL, 2016, JAMA CARDIOL, V1, P274, DOI 10.1001/jamacardio.2016.0433; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; PONKA A, 1981, ANN CLIN RES, V13, P429; Seo J, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0262594; Vejpongsa P, 2019, AM J MED, V132, P1173, DOI 10.1016/j.amjmed.2019.05.002; Wang Q, 2018, VACCINE, V36, P7262, DOI 10.1016/j.vaccine.2018.10.045; Warren-Gash C, 2011, J INFECT DIS, V203, P1710, DOI 10.1093/infdis/jir171; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; WOODHOUSE PR, 1994, LANCET, V343, P435, DOI 10.1016/S0140-6736(94)92689-1; World Health Organization, INFL SEAS; Zangiabadian M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77679-7	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2022	17	8							e0272661	10.1371/journal.pone.0272661	http://dx.doi.org/10.1371/journal.pone.0272661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6C1NT	35944002	Green Published, gold			2022-12-26	WOS:000881789200001
J	Ogunyemi, D; Lee, T; Ma, M; Osuma, A; Eghbali, M; Bouri, N				Ogunyemi, Dotun; Lee, Tommy; Ma, Melissa; Osuma, Ashley; Eghbali, Mason; Bouri, Natalie			Improving wellness: Defeating Impostor syndrome in medical education using an interactive reflective workshop	PLOS ONE			English	Article							BURNOUT; HEALTH	Background Impostor syndrome is characterized by fraudulent self-doubt and correlates with burnout, and adverse mental health. Objective The objective was to investigate correlates of Impostor syndrome in a medical education cohort and determine if an interactive workshop can improve knowledge and perception of Impostor syndrome. Methods From June 2019 to February 2021 interactive educational workshops were conducted for medical education cohorts. Participants completed baseline knowledge and Impostor syndrome self-identification surveys, participated in interactive presentations and discussions, followed by post-intervention surveys. Results There were 198 participants including 19% residents, 10% medical students, 30% faculty and 41% Graduate Medical Education (GME) administrators. Overall, 57% were positive for Impostor syndrome. Participants classified as the following Impostor syndrome competence subtypes: Expert = 42%; Soloist = 34%; Super-person = 31%; Perfectionist = 25%; and Natural Genius = 21%. Self-identified contributors of IS included: parent expectations = 72%, female gender = 58%, and academic rat race = 37%. GME administrators compared to physicians/medical students had significantly higher number of self-identified contributors to Impostor syndrome. Knowledge survey scores increased from 4.94 (SD = 2.8) to 5.78 (2.48) post intervention (p = 0.045). Participants with Impostor syndrome competence subtypes had increased perceptions of Impostor syndrome as a cause of stress, failure to reach full potential, and negative relationships/teamwork (p = 0.032 -<0.001). Conclusion Impostor syndrome was common in this medical education cohort, and those with Impostor syndrome significantly attributed negative personal and professional outcomes to Impostor syndrome. An interactive workshop on Impostor syndrome can be used to increase perceptions and knowledge regarding Impostor syndrome. The materials can be adapted for relevance to various audiences.	[Ogunyemi, Dotun; Lee, Tommy] Arrowhead Reg Med Ctr, Colton, CA 92324 USA; [Ma, Melissa; Eghbali, Mason; Bouri, Natalie] Calif Univ Sci & Med, Colton, CA USA; [Osuma, Ashley] Univ Illinois, Coll Med, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria	Ogunyemi, D (corresponding author), Arrowhead Reg Med Ctr, Colton, CA 92324 USA.	dogunye@outlook.com		Eghbali, Mason/0000-0003-3509-8661; ogunyemi, dotun/0000-0002-4560-0611				[Anonymous], 5 TYPES IMPOSTORS; [Anonymous], IMPOSTOR SYNDROME; [Anonymous], RETHINKING IMPOSTOR; Baumann N., 2020, MEDEDPORTAL; Bravata DM, 2020, J GEN INTERN MED, V35, P1252, DOI 10.1007/s11606-019-05364-1; Chen C, 2020, CAN FAM PHYSICIAN, V66, pE268; CLANCE PR, 1978, PSYCHOTHER-THEOR RES, V15, P241, DOI 10.1037/h0086006; Ewen AM, 2018, J CONTIN EDUC HEALTH, V38, P165, DOI 10.1097/CEH.0000000000000209; Freeman BK, 2016, ACAD MED, V91, P987, DOI 10.1097/ACM.0000000000001020; Haney TS, 2018, CLIN NURSE SPEC, V32, P189, DOI 10.1097/NUR.0000000000000386; Kirkpatrick Donald L., 1994, SAN FRANCISCO EMERYV; Metz CJ, 2020, J DENT EDUC, V84, P1016, DOI 10.1002/jdd.12181; Neureiter M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00048; Ofei-Dodoo S, 2018, FAM MED, V50, P679, DOI 10.22454/FamMed.2018.921094; Paladugu S, 2021, J COMMUNITY HOSP INT, V11, P212, DOI 10.1080/20009666.2021.1877891; Perez C., 2020, DIGITAL USD; Ramsey JL, 2019, MED EDUC, V53, P504, DOI 10.1111/medu.13852; Rivera Nancy, 2021, MedEdPORTAL, V17, P11166, DOI 10.15766/mep_2374-8265.11166; Sweet LR, 2015, EDUC HEALTH, V28, P138, DOI 10.4103/1357-6283.170124; Thomas M, 2020, INT J MED EDUC, V11, P201, DOI 10.5116/ijme.5f54.c8f8; Villwock J, 2016, INT J MED EDUC, V7, P364, DOI 10.5116/ijme.5801.eac4; Wilding M., 5 DIFFERENT TYPES IM; Young V., 2011, SECRET THOUGHTS SUCC; Zackoff MW, 2019, ACAD PEDIATR, V19, P135, DOI 10.1016/j.acap.2018.08.003	24	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272496	10.1371/journal.pone.0272496	http://dx.doi.org/10.1371/journal.pone.0272496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925925	gold, Green Published			2022-12-26	WOS:000848077100093
J	Taghvaei, M; Sadeghi, R; Smith, B				Taghvaei, Mostafa; Sadeghi, Rohollah; Smith, Brennan			Seed to seed variation of proteins of the yellow pea (Pisum sativum L.)	PLOS ONE			English	Article							FUNCTIONAL-PROPERTIES; TOFU YIELD; LEGUMIN; CULTIVARS; PEPTIDES	The existing variation among pea protein isolates' functionality limits their application in food formulations. The source and extent of variations among yellow pea protein profiles was assessed in 10 single seeds of two varieties with different size and weight. A new approach was developed to analyze proteins of yellow pea combining three analytical methods of size exclusion chromatography (SEC), reverse phase high performance liquid chromatography (RP-HPLC), and microfluidic SDS-PAGE, to achieve the highest separation resolution. A high variation of protein concentration was observed not only between varieties, but also among seeds of the same variety. Vicilin to legumin ratio was between 2.72-4.19, and 1.70-2.22 among the individual seeds of AC Agassiz and CDC Saffron varieties, respectively. V/L ratio was significantly different among the individual seeds for both varieties. The amount of some protein fractions/subunits were correlated with seeds' size and weight for AC Agassiz, while such correlations were not observed for CDC Saffron.	[Taghvaei, Mostafa; Sadeghi, Rohollah; Smith, Brennan] Univ Idaho, Dept Anim Vet & Food Sci, Moscow, ID 83843 USA; [Smith, Brennan] USDA ARS, SRRC Food Proc & Sensory Qual, New Orleans, LA 70124 USA	Idaho; University of Idaho; United States Department of Agriculture (USDA)	Smith, B (corresponding author), Univ Idaho, Dept Anim Vet & Food Sci, Moscow, ID 83843 USA.; Smith, B (corresponding author), USDA ARS, SRRC Food Proc & Sensory Qual, New Orleans, LA 70124 USA.	Brennan.smith@usda.gov			Department of Agriculture, Agricultural Research Service (USDA-ARS) as part of the Pulse Crop Health Initiative [3060-21650-00100-D]	Department of Agriculture, Agricultural Research Service (USDA-ARS) as part of the Pulse Crop Health Initiative	This work was supported by the Department of Agriculture, Agricultural Research Service (USDA-ARS) as part of the Pulse Crop Health Initiative (project number 3060-21650-00100-D).	Aguilar Marie-Isabel, 2004, Methods Mol Biol, V251, P3; [Anonymous], 2016, AGILENT PROTEIN 230; Arntfield SD, 2011, WOODHEAD PUBL FOOD S, P233; Barac M. B., 2015, Acta Periodica Technologica, V46, P1; Boye J, 2010, FOOD RES INT, V43, P414, DOI 10.1016/j.foodres.2009.09.003; Casey R, 2003, IND PROTEINS PERSPEC, V23, P49; Choi H., 2022, ACS FOOD SCI TECHNOL; DAGORNSCAVINER C, 1986, NAHRUNG, V30, P337, DOI 10.1002/food.19860300332; DePalma K, 2021, FOOD SCI NUTR, V9, P1132, DOI 10.1002/fsn3.2091; DePalma K, 2019, J FOOD SCI, V84, P3463, DOI 10.1111/1750-3841.14940; Iseki K, 2020, PLANT PROD SCI, V23, P103, DOI 10.1080/1343943X.2019.1677161; Ji MP, 1999, J FOOD SCI, V64, P763, DOI 10.1111/j.1365-2621.1999.tb15907.x; Lam ACY, 2018, FOOD REV INT, V34, P126, DOI 10.1080/87559129.2016.1242135; Lam ACY, 2017, CEREAL CHEM, V94, P89, DOI [10.1094/CCHEM-04-16-0097-FI, 10.1094/cchem-04-16-0097-fi]; Lopez-Barrios L, 2014, J FOOD SCI, V79, pR273, DOI 10.1111/1750-3841.12365; Lu ZX, 2020, CRIT REV FOOD SCI, V60, P2593, DOI 10.1080/10408398.2019.1651248; Martinez-Villaluenga C, 2008, EUR FOOD RES TECHNOL, V226, P1465, DOI 10.1007/s00217-007-0678-9; Maruyama N, 1999, J AGR FOOD CHEM, V47, P5278, DOI 10.1021/jf990360+; Mujoo R, 2003, FOOD CHEM, V82, P265, DOI 10.1016/S0308-8146(02)00547-2; O'Kane FE, 2004, J AGR FOOD CHEM, V52, P5071, DOI 10.1021/jf035215h; Phillips GO, 2011, WOODHEAD PUBL FOOD S, P1, DOI 10.1533/9780857093639; Rangel A, 2003, J AGR FOOD CHEM, V51, P5792, DOI 10.1021/jf0340052; Schwenke KD, 2001, INT J BIOL MACROMOL, V28, P175, DOI 10.1016/S0141-8130(00)00167-7; Smith BM, 2010, J AGR FOOD CHEM, V58, P7794, DOI 10.1021/jf101523p; Taghvaei M, 2020, FOOD ANAL METHOD, V13, P1482, DOI 10.1007/s12161-020-01771-x; Tzitzikas EN, 2006, J AGR FOOD CHEM, V54, P425, DOI 10.1021/jf0519008	26	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271887	10.1371/journal.pone.0271887	http://dx.doi.org/10.1371/journal.pone.0271887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925911	Green Published, gold			2022-12-26	WOS:000848077100056
J	Mesic, A; Decroo, T; Mar, HT; Jacobs, BKM; Thandar, MP; Thwe, TT; Kyaw, AA; Sangma, M; Beversluis, D; Bermudez-Aza, E; Spina, A; Aung, DPP; Piriou, E; Ritmeijer, K; Van Olmen, J; Oo, HN; Lynen, L				Mesic, Anita; Decroo, Tom; Mar, Htay Thet; Jacobs, Bart K. M.; Thandar, Moe Pyae; Thwe, Thin Thin; Kyaw, Aung Aung; Sangma, Mitchell; Beversluis, David; Bermudez-Aza, Elkin; Spina, Alexander; Aung, Darli Po Po; Piriou, Erwan; Ritmeijer, Koert; Van Olmen, Josefien; Oo, Htun Nyunt; Lynen, Lutgarde			Viraemic-time predicts mortality among people living with HIV on second-line antiretroviral treatment in Myanmar: A retrospective cohort study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; VIRAL LOAD; COPY-YEARS; TREATMENT OUTCOMES; DRUG-RESISTANCE; THERAPY; REGIMENS; TRANSMISSION; INFECTION; SETTINGS	Introduction Despite HIV viral load (VL) monitoring being serial, most studies use a cross-sectional design to evaluate the virological status of a cohort. The objective of our study was to use a simplified approach to calculate viraemic-time: the proportion of follow-up time with unsuppressed VL above the limit of detection. We estimated risk factors for higher viraemic-time and whether viraemic-time predicted mortality in a second-line antiretroviral treatment (ART) cohort in Myanmar. Methods We conducted a retrospective cohort analysis of people living with HIV (PLHIV) who received second-line ART for a period >6 months and who had at least two HIV VL test results between 01 January 2014 and 30 April 2018. Fractional logistic regression assessed risk factors for having higher viraemic-time and Cox proportional hazards regression assessed the association between viraemic-time and mortality. Kaplan-Meier curves were plotted to illustrate survival probability for different viraemic-time categories. Results Among 1,352 participants, 815 (60.3%) never experienced viraemia, and 172 (12.7%), 214 (15.8%), and 80 (5.9%) participants were viraemic <20%, 20-49%, and 50-79% of their total follow-up time, respectively. Few (71; 5.3%) participants were >= 80% of their total fol-low-up time viraemic. The odds for having higher viraemic-time were higher among people with a history of injecting drug use (aOR 2.01, 95% CI 1.30-3.10, p = 0.002), sex workers (aOR 2.10, 95% CI 1.11-4.00, p = 0.02) and patients treated with lopinavir/ritonavir (vs. atazanavir; aOR 1.53, 95% CI 1.12-2.10, p = 0.008). Viraemic-time was strongly associated with mortality hazard among those with 50-79% and >= 80% viraemic-time (aHR 2.92, 95% CI 1.21-7.10, p = 0.02 and aHR 2.71, 95% CI 1.22-6.01, p = 0.01). This association was not observed in those with viraemic-time <50%. Conclusions Key populations were at risk for having a higher viraemic-time on second-line ART. Viraemic-time predicts clinical outcomes. Differentiated services should target subgroups at risk fora higher viraemic-time to control both HIV transmission and mortality.	[Mesic, Anita; Beversluis, David; Bermudez-Aza, Elkin; Spina, Alexander; Piriou, Erwan; Ritmeijer, Koert] Medecins Sans Frontieres, Publ Hlth Dept, Amsterdam, Netherlands; [Mesic, Anita; Decroo, Tom; Jacobs, Bart K. M.; Van Olmen, Josefien; Lynen, Lutgarde] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Decroo, Tom] Res Fdn Flanders, Brussels, Belgium; [Mar, Htay Thet; Thandar, Moe Pyae; Thwe, Thin Thin; Kyaw, Aung Aung; Sangma, Mitchell] Medecins Sans Frontieres, Med Dept, Yangon, Myanmar; [Spina, Alexander] Univ Exeter, Med Sch, Exeter, Devon, England; [Aung, Darli Po Po] Fdn Merieux, Yangon, Myanmar; [Van Olmen, Josefien] Univ Antwerp, Dept Family Med & Populat Hlth, Antwerp, Belgium; [Oo, Htun Nyunt] Minist Hlth & Sport, Natl AIDS Programme, Naypyidaw, Myanmar	Doctors Without Borders; Institute of Tropical Medicine (ITM); University of Exeter; University of Antwerp	Mesic, A (corresponding author), Medecins Sans Frontieres, Publ Hlth Dept, Amsterdam, Netherlands.; Mesic, A (corresponding author), Inst Trop Med, Dept Clin Sci, Antwerp, Belgium.	anitamesic@gmail.com	Jacobs, Bart K.M./AAE-6922-2022; Decroo, Tom/AAV-7208-2020	Jacobs, Bart K.M./0000-0002-4677-0911; Decroo, Tom/0000-0002-1205-1484; Spina, Alexander/0000-0001-8425-1867				Ajose O, 2012, AIDS, V26, P929, DOI 10.1097/QAD.0b013e328351f5b2; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bavinton BR, 2018, LANCET HIV, V5, pE438, DOI 10.1016/S2352-3018(18)30132-2; Gorrod HB, 2020, JAIDS-J ACQ IMM DEF, V84, P107, DOI 10.1097/QAI.0000000000002313; Cain LE, 2015, CLIN INFECT DIS, V60, P1262, DOI 10.1093/cid/ciu1167; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cole SR, 2010, AM J EPIDEMIOL, V171, P198, DOI 10.1093/aje/kwp347; Cruciani M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222229; de Melo MG, 2019, INT J INFECT DIS, V87, P128, DOI 10.1016/j.ijid.2019.08.004; Drain PK, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00097-18; Dube MP, 2010, J INFECT DIS, V201, P1783, DOI 10.1086/652751; Dubrocq G, 2018, HIV AIDS-RES PALLIAT, V10, P91, DOI 10.2147/HIV.S141965; Edessa D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220159; Eholie SP, 2019, LANCET HIV, V6, pE750, DOI 10.1016/S2352-3018(19)30228-0; El-Sadr WM, 2008, ANN INTERN MED, V149, P289, DOI 10.7326/0003-4819-149-5-200809020-00003; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Elvstam O, 2020, CLIN INFECT DIS; Estill J, 2016, LANCET HIV, V3, pE132, DOI 10.1016/S2352-3018(16)00016-3; Ford N, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25415; Gregson J, 2016, LANCET INFECT DIS, V16, P565, DOI 10.1016/S1473-3099(15)00536-8; Hermans LE, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25501; Hermans LE, 2018, LANCET INFECT DIS, V18, P188, DOI 10.1016/S1473-3099(17)30681-3; Hosseinipour MC, 2013, J INFECT DIS, V207, pS49, DOI 10.1093/infdis/jit107; Kanters S, 2017, LANCET HIV, V4, pE433, DOI 10.1016/S2352-3018(17)30109-1; Langford Simone E, 2007, AIDS Res Ther, V4, P11, DOI 10.1186/1742-6405-4-11; Lee HND., 2020, CATALOGUE BIAS; Lee K, 2009, GLOB INST, P1; Lesosky M, 2019, ANN EPIDEMIOL, V38, P22, DOI 10.1016/j.annepidem.2019.08.008; Llibre JM, 2015, AIDS REV, V17, P56; Luber Andrew D, 2005, MedGenMed, V7, P69, DOI 10.1186/1758-2652-7-3-69; Madeddu G, 2021, AIDS, V35, P1103, DOI 10.1097/QAD.0000000000002825; Marconi VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017956; Marks G, 2015, AIDS, V29, P947, DOI 10.1097/QAD.0000000000000640; Medecins Sans Frontieres, 2013, MSF ETH REV BOARD ST; Mesic A, 2021, AIDS RES THER, V18, DOI 10.1186/s12981-021-00336-0; Mugavero MJ, 2011, CLIN INFECT DIS, V53, P927, DOI 10.1093/cid/cir526; National AIDS Programme. Department of Health Ministry of Health Myanmar, 2014, GUIDELINES CLIN MANA, VFourth; National AIDS Programme. Ministry of Health and Sports Myanmar, 2018, INT BIOL BEH SURV SU; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Rodger AJ, 2019, LANCET, V393, P2428, DOI 10.1016/S0140-6736(19)30418-0; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Rohr JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161469; Rossetti B, 2019, ANTIVIR RES, V169, DOI 10.1016/j.antiviral.2019.104552; Sempa JB, 2016, AM J EPIDEMIOL, V184, P67, DOI 10.1093/aje/kwv303; Shroufi A, 2019, AIDS, V33, P1635, DOI 10.1097/QAD.0000000000002234; Taramasso L, 2021, AIDS PATIENT CARE ST, V35, P342, DOI 10.1089/apc.2021.0089; Taramasso L, 2019, AIDS RES THER, V16, DOI 10.1186/s12981-019-0236-0; Thinn KK, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032678; UNAIDS, 2018, UND UNTR PUBL HLTH H; UNAIDS, 2019, 2019 GLOB AIDS UPD C; UNAIDS, 2016, GLOB AIDS UPD; Wensing AMJ, 2010, ANTIVIR RES, V85, P59, DOI 10.1016/j.antiviral.2009.10.003; WHO, 2016, CONGUID UANT DRU; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2016, DIFF SERV DEL KEY PO; Wright ST, 2014, JAIDS-J ACQ IMM DEF, V66, P55, DOI 10.1097/QAI.0000000000000125; Zachariah R, 2012, LANCET INFECT DIS, V12, P415, DOI 10.1016/S1473-3099(11)70309-7; Zoufaly A, 2009, J INFECT DIS, V200, P79, DOI 10.1086/599313	59	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2022	17	7							e0271910	10.1371/journal.pone.0271910	http://dx.doi.org/10.1371/journal.pone.0271910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Q0KX	35905123	Green Published, gold			2022-12-26	WOS:000855776900053
J	Ghaedi, H; Reilly, AC; Baroud, H; Perrucci, DV; Ferreira, CM				Ghaedi, Hamed; Reilly, Allison C.; Baroud, Hiba; Perrucci, Daniel V.; Ferreira, Celso M.			Predicting flood damage using the flood peak ratio and Giovanni Flooded Fraction	PLOS ONE			English	Article							INSURANCE; MITIGATION; IMPACT	A spatially-resolved understanding of the intensity of a flood hazard is required for accurate predictions of infrastructure reliability and losses in the aftermath. Currently, researchers who wish to predict flood losses or infrastructure reliability following a flood usually rely on computationally intensive hydrodynamic modeling or on flood hazard maps (e.g., the 100-year floodplain) to build a spatially-resolved understanding of the flood's intensity. However, both have specific limitations. The former requires both subject matter expertise to create the models and significant computation time, while the latter is a static metric that provides no variation among specific events. The objective of this work is to develop an integrated data-driven approach to rapidly predict flood damages using two emerging flood intensity heuristics, namely the Flood Peak Ratio (FPR) and NASA's Giovanni Flooded Fraction (GFF). This study uses data on flood claims from the National Flood Insurance Program (NFIP) to proxy flood damage, along with other well-established flood exposure variables, such as regional slope and population. The approach uses statistical learning methods to generate predictive models at two spatial levels: nationwide and statewide for the entire contiguous United States. A variable importance analysis demonstrates the significance of FPR and GFF data in predicting flood damage. In addition, the model performance at the state-level was higher than the nationwide level analysis, indicating the effectiveness of both FPR and GFF models at the regional level. A data-driven approach to predict flood damage using the FPR and GFF data offer promise considering their relative simplicity, their reliance on publicly accessible data, and their comparatively fast computational speed.	[Ghaedi, Hamed; Reilly, Allison C.] Univ Maryland Coll Pk, Dept Civil & Environm Engn, College Pk, MD 20742 USA; [Baroud, Hiba; Perrucci, Daniel V.] Vanderbilt Univ, Dept Civil & Environm Engn, Nashville, TN USA; [Ferreira, Celso M.] George Mason Univ, Dept Civil Infrastructure & Environm Engn, Fairfax, VA USA	University System of Maryland; University of Maryland College Park; Vanderbilt University; George Mason University	Reilly, AC (corresponding author), Univ Maryland Coll Pk, Dept Civil & Environm Engn, College Pk, MD 20742 USA.	areilly2@umd.edu	Reilly, Allison/HGA-8219-2022	Perrucci, Daniel/0000-0001-9654-2020; Reilly, Allison/0000-0001-7209-3566				[Anonymous], 2010, US CENSUS BUREAU TIG; [Anonymous], 2016, OFFICE WATER PREDICT; [Anonymous], 2017, AMAZON WEB SERVICES; Atreya A, 2015, ECOL ECON, V117, P153, DOI 10.1016/j.ecolecon.2015.06.024; Bhattarai R, 2016, NAT HAZARD EARTH SYS, V16, P1063, DOI 10.5194/nhess-16-1063-2016; Blessing R, 2017, NAT HAZARDS REV, V18, DOI [10.1061/(ASCE)NH.1527-6996.0000242, 10.1061/(asce)nh.1527-6996.0000242]; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Brody S, 2014, J ENVIRON PLANN MAN, V57, P1252, DOI 10.1080/09640568.2013.802228; Brody SD, 2008, DISASTERS, V32, P1, DOI 10.1111/j.1467-7717.2007.01024.x; Brody SD, 2013, NAT HAZARDS REV, V14, P89, DOI [10.1061/(ASCE)NH.1527-6996.0000091, 10.1061/(ASCE)NH.1527-6996.8888891]; Brody SD, 2013, LAND USE POLICY, V32, P89, DOI 10.1016/j.landusepol.2012.10.017; Brody SD, 2009, RISK ANAL, V29, P912, DOI 10.1111/j.1539-6924.2009.01210.x; Chen TYJ, 2019, J INFRASTRUCT SYST, V25, DOI 10.1061/(ASCE)IS.1943-555X.0000482; Czajkowski J, 2017, SCI REP-UK, V7, DOI 10.1038/srep41609; Czajkowski J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044056; Dixon L., 2006, NATL FLOOD INSURANCE, DOI [10.7249/TR300, DOI 10.7249/TR300]; Federal Emergency Management Agency, 2021, OPENFEMA DAT SETS; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Frimpong E, 2020, APPL ECON PERSPECT P, V42, P245, DOI 10.1093/aepp/ppz013; Guikema SD, 2014, IEEE ACCESS, V2, P1364, DOI 10.1109/ACCESS.2014.2365716; GUPTA VK, 1994, WATER RESOUR RES, V30, P3405, DOI 10.1029/94WR01791; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Highfield WE, 2017, INT J DISAST RISK RE, V21, P396, DOI 10.1016/j.ijdrr.2017.01.013; Highfield WE, 2013, NAT HAZARDS REV, V14, P229, DOI 10.1061/(ASCE)NH.1527-6996.0000114; Holland G, 2008, MON WEATHER REV, V136, P3432, DOI 10.1175/2008MWR2395.1; Hollister JW, 2020, **DATA OBJECT**, DOI 10.5281/ZENODO.4282962; Horn DP., 2021, R44593 CRS; Horritt MS, 2002, J HYDROL, V268, P87, DOI 10.1016/S0022-1694(02)00121-X; Jasinski M. F., 2018, NCA LDAS NOAH 3 3 LA, DOI [10.5067/7V3N5DO04MAS, DOI 10.5067/7V3N5DO04MAS]; Jasinski MF, 2019, J HYDROMETEOROL, V20, P1595, DOI [10.1175/jhm-d-17-0234.1, 10.1175/JHM-D-17-0234.1]; Knighton J, 2020, J ENVIRON MANAGE, V272, DOI 10.1016/j.jenvman.2020.111051; Kousy C., 2018, RISK MANAG INSUR REV, V21, P11, DOI 10.1111/rmir.12090; Liu HB, 2005, J INFRASTRUCT SYST, V11, P258, DOI 10.1061/(ASCE)1076-0342(2005)11:4(258); Luke A, 2018, NAT HAZARD EARTH SYS, V18, P1097, DOI 10.5194/nhess-18-1097-2018; Mangalathu S, 2020, EARTHQ SPECTRA, V36, P183, DOI 10.1177/8755293019878137; Merz B, 2010, NAT HAZARD EARTH SYS, V10, P1697, DOI 10.5194/nhess-10-1697-2010; Michel-Kerjan E, 2012, RISK ANAL, V32, P644, DOI 10.1111/j.1539-6924.2011.01671.x; Mobley W, 2021, NAT HAZARD EARTH SYS, V21, P807, DOI 10.5194/nhess-21-807-2021; Mucia A, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12122020; Multi-Resolution Land Characteristics Consortium, 2021, NLCD 2016 LAND COV C; Nateghi R, 2018, IEEE ACCESS, V6, P13478, DOI 10.1109/ACCESS.2018.2792680; Nateghi R, 2011, RISK ANAL, V31, P1897, DOI 10.1111/j.1539-6924.2011.01618.x; National Centers for Environmental Information, 2021, STORM EV DAT; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Rui H., 2014, ANTARCT RES SER; Stuckey M., 2006, US GEOLOGICAL SURVEY, P2006; Thomas S, 2017, GEOMAT NAT HAZ RISK, V8, P177, DOI 10.1080/19475705.2016.1176604; Tonn G, 2018, ANAL US TROPICAL CYC; U.S. Census Bureau, 2016, EXPL CENS DAT; Villarini G, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016175; Villarini G, 2011, J AM WATER RESOUR AS, V47, P447, DOI 10.1111/j.1752-1688.2011.00540.x; Wells A., 2017, INSURANCE J; Yang Q, 2019, ACM T INTEL SYST TEC, V10, DOI 10.1145/3298981; Zahran S, 2009, ECOL ECON, V68, P2627, DOI 10.1016/j.ecolecon.2009.04.021	55	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271230	http://dx.doi.org/10.1371/journal.pone.0271230			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921327	Green Published, gold			2022-12-26	WOS:000839311900012
J	McPherson, S; Wada-Katsumata, A; Hatano, E; Silverman, J; Schal, C				McPherson, Samantha; Wada-Katsumata, Ayako; Hatano, Eduardo; Silverman, Jules; Schal, Coby			Nutritional condition affects tergal gland secretion and courtship success of male cockroaches	PLOS ONE			English	Article							GERMANICA L. DICTYOPTERA; NEOPYROCHROA FLABELLATA CANTHARIDIN; BLATTELLA-GERMANICA; PATERNAL INVESTMENT; SEX-PHEROMONE; SENSORY EXPLOITATION; NUPTIAL SECRETION; CHEMICAL BASIS; BEHAVIOR; FEMALE	An integral part of the courtship sequence of the German cockroach (Blattella germanica) involves the male raising his wings to expose tergal glands on his dorsum. When a female cockroach feeds on the secretion of these glands, she is optimally positioned for mating. Core chemical components have been identified, but the effect of male diet on the quality of the tergal gland secretion remains unexplored. After validating the pivotal role of tergal feeding in mating, we starved or fed reproductively mature males for one week. We then paired each male with a sexually receptive female and observed their interactions through an infrared-sensitive camera. While starvation had no effect on male courtship behavior, it did influence the duration of female tergal feeding and mating outcomes. Females fed longer on the gland secretion of fed males, and fed males experienced greater mating success than starved males (73.9% vs. 48.3%, respectively). These results suggest that the quality of the tergal gland secretions, and by association mating success, are dependent on the nutritional condition of the male.	[McPherson, Samantha; Wada-Katsumata, Ayako; Hatano, Eduardo; Silverman, Jules; Schal, Coby] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Schal, C (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.	coby@ncsu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358; Wada-Katsumata, Ayako/0000-0002-2895-1102	U.S. National Science Foundation [IOS-1557864]	U.S. National Science Foundation(National Science Foundation (NSF))	We thank Dr. R. Michael Roe and members of the Schal lab at North Carolina State University for their valuable feedback on all aspects of the project.	[Anonymous], 1877, DIFFERENT FORMS FLOW; Arnqvist G, 2006, PHILOS T R SOC B, V361, P375, DOI 10.1098/rstb.2005.1790; BELL WJ, 1980, ANIM BEHAV, V28, P86, DOI 10.1016/S0003-3472(80)80011-X; BIRKHEAD TR, 1988, BEHAVIOUR, V106, P112, DOI 10.1163/156853988X00115; BROSSUT R, 1975, INSECT BIOCHEM, V5, P719, DOI 10.1016/0020-1790(75)90016-5; BROSSUT R, 1977, J MORPHOL, V151, P259, DOI 10.1002/jmor.1051510206; CHRISTY JH, 1995, AM NAT, V146, P171, DOI 10.1086/285793; COCHRAN DG, 1985, ANNU REV ENTOMOL, V30, P29, DOI 10.1146/annurev.en.30.010185.000333; COCHRAN DG, 1979, ENTOMOL EXP APPL, V26, P259, DOI 10.1111/j.1570-7458.1979.tb02927.x; COCHRAN DG, 1983, ENTOMOL EXP APPL, V34, P51, DOI 10.1007/BF00300899; Costa-Schmidt LE, 2008, NATURWISSENSCHAFTEN, V95, P731, DOI 10.1007/s00114-008-0379-7; Darwin Charles, 1871, DESCENT MAN; Eisner T, 1996, P NATL ACAD SCI USA, V93, P6499, DOI 10.1073/pnas.93.13.6499; Eisner T, 1996, P NATL ACAD SCI USA, V93, P6494, DOI 10.1073/pnas.93.13.6494; Eliyahu D, 2008, J CHEM ECOL, V34, P229, DOI 10.1007/s10886-007-9409-8; FORSTER LM, 1992, AUST J ZOOL, V40, P1, DOI 10.1071/ZO9920001; Garcia CM, 2005, NATURE, V434, P501, DOI 10.1038/nature03363; HAMILTON RL, 1988, ANN ENTOMOL SOC AM, V81, P969, DOI 10.1093/aesa/81.6.969; Jensen K, 2018, BEHAV ECOL, V29, P1453, DOI 10.1093/beheco/ary104; Jones SA, 2001, J INSECT PHYSIOL, V47, P1169, DOI 10.1016/S0022-1910(01)00098-1; Kells SA, 1999, J INSECT PHYSIOL, V45, P709, DOI 10.1016/S0022-1910(99)00037-2; Kugimiya S, 2003, CHEMOECOLOGY, V13, P169, DOI 10.1007/s00049-003-0245-1; Kugimiya S, 2002, ENTOMOL EXP APPL, V104, P337, DOI 10.1023/A:1021210920704; LIANG D, 1993, EXPERIENTIA, V49, P324, DOI 10.1007/BF01923412; Lin TM, 1998, J INSECT PHYSIOL, V44, P1039, DOI 10.1016/S0022-1910(98)00069-9; McPherson S, 2021, J ECON ENTOMOL, V114, P2189, DOI 10.1093/jee/toab139; MULLINS DE, 1992, J EXP BIOL, V162, P55; MULLINS DE, 1980, NATURE, V283, P567, DOI 10.1038/283567a0; Nishida R., 1983, Memoirs of the College of Agriculture, Kyoto University, P1; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; Nojima S, 1996, APPL ENTOMOL ZOOL, V31, P537, DOI 10.1303/aez.31.537; Nojima S, 1999, NATURWISSENSCHAFTEN, V86, P193, DOI 10.1007/s001140050596; Nojima S, 1999, J INSECT BEHAV, V12, P627, DOI 10.1023/A:1020975619618; Nojima S, 2005, SCIENCE, V307, P1104, DOI 10.1126/science.1107163; Nojima S, 2002, J CHEM ECOL, V28, P1483, DOI 10.1023/A:1016260905653; RAMASWAMY SB, 1980, J EXP ZOOL, V214, P287, DOI 10.1002/jez.1402140306; Rapkin J, 2018, AM NAT, V191, P452, DOI 10.1086/696147; ROTH LM, 1969, ANN ENTOMOL SOC AM, V62, P176, DOI 10.1093/aesa/62.1.176; ROTH LM, 1955, J ECON ENTOMOL, V48, P57, DOI 10.1093/jee/48.1.57; ROTH LM, 1964, SCIENCE, V146, P782, DOI 10.1126/science.146.3645.782; ROTH LOUIS M., 1965, J INSECT PHYSIOL, V11, P1023, DOI 10.1016/0022-1910(65)90205-2; Sakaluk SK, 2019, ADV STUD BEHAV, V51, P1, DOI 10.1016/bs.asb.2018.12.001; Sakaluk SK, 2000, P ROY SOC B-BIOL SCI, V267, P339, DOI 10.1098/rspb.2000.1006; SCHAL C, 1982, SCIENCE, V218, P170, DOI 10.1126/science.218.4568.170; SCHAL C, 1995, EXPERIENTIA, V51, P994, DOI 10.1007/BF01921755; Schal C, 1997, ARCH INSECT BIOCHEM, V35, P405, DOI 10.1002/(SICI)1520-6327(1997)35:4<405::AID-ARCH5>3.3.CO;2-3; Schal C, 1997, INSECT PHEROMONE RESEARCH, P3; SRENG L, 1979, INT J INSECT MORPHOL, V8, P213, DOI 10.1016/0020-7322(79)90031-X; SRENG L, 1993, J INSECT BEHAV, V6, P715, DOI 10.1007/BF01201672; THORNHILL R, 1976, AM NAT, V110, P153, DOI 10.1086/283055; THORNHILL R, 1976, AM NAT, V110, P529, DOI 10.1086/283089; Tsuji H., 1965, Japanese Journal of Sanitary Zoology, V16, P255; Vahed K, 1998, BIOL REV, V73, P43, DOI 10.1017/S0006323197005112; Wada-Katsumata A, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-022-03415-8; Wada-Katsumata A, 2013, SCIENCE, V340, P972, DOI 10.1126/science.1234854; Wada-Katsumata A, 2009, J INSECT PHYSIOL, V55, P742, DOI 10.1016/j.jinsphys.2009.04.014; WEDELL N, 1994, BEHAV ECOL, V5, P418, DOI 10.1093/beheco/5.4.418	57	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271344	http://dx.doi.org/10.1371/journal.pone.0271344			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921282	Green Published, gold			2022-12-26	WOS:000839311900006
J	Balsamo, JA; Penton, KE; Zhao, ZH; Hayes, MJ; Lima, SM; Irish, JM; Bachmann, BO				Balsamo, Joseph A.; Penton, Kathryn E.; Zhao, Zhihan; Hayes, Madeline J.; Lima, Sierra M.; Irish, Jonathan M.; Bachmann, Brian O.			An immunogenic cell injury module for the single-cell multiplexed activity metabolomics platform to identify anti-cancer natural products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THAPSIGARGIN; DETERMINES; INHIBITION; MECHANISMS; DISCOVERY; AGENTS; MLKL	Natural products constitute and significantly impact many current anti-cancer medical interventions. A subset of natural products induces injury processes in malignant cells that recruit and activate host immune cells to produce an adaptive anti-cancer immune response, a process known as immuno-genic cell death. However, a challenge in the field is to delineate forms of cell death and injury that best promote durable antitumor immunity. Addressing this with a single-cell chemical biology natural product discovery platform, like multiplex activity metabolomics, would be especially valuable in human leukemia, where cancer cells are heterogeneous and may react differently to the same compounds. Herein, a new ten-color, fluorescent cell barcoding-compatible module measuring six immunogenic cell injury signaling readouts are as follows: DNA damage response (gamma H2AX), apoptosis (cCAS3), necroptosis (p-MLKL), mitosis (p-Histone H3), autophagy (LC3), and the unfolded protein response (p-EIF2 alpha). A proof-of-concept screen was performed to validate functional changes in single cells induced by secondary metabolites with known mechanisms within bacterial extracts. This assay was then applied in multiplexed activity metabolomics to reveal an un-expected mammalian cell injury profile induced by the natural product narbomycin. Finally, the functional consequences of injury pathways on immunogenicity were compared with three canonical assays for immunogenic hallmarks, ATP, HMGB1, and calreticulin, to correlate secondary metabolite-induced cell injury profiles with canonical markers of immunogenic cell death. In total, this work demonstrated a new phenotypic screen for discovery of natural products that modulate injury response pathways that can contribute to cancer immunogenicity.	[Balsamo, Joseph A.; Bachmann, Brian O.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; [Penton, Kathryn E.; Zhao, Zhihan; Bachmann, Brian O.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Hayes, Madeline J.; Lima, Sierra M.; Irish, Jonathan M.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN USA; [Hayes, Madeline J.; Lima, Sierra M.; Irish, Jonathan M.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Med Ctr, Nashville, TN USA; [Irish, Jonathan M.; Bachmann, Brian O.] Vanderbilt Inst Chem Biol, Nashville, TN 37235 USA; [Irish, Jonathan M.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Med Ctr, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Bachmann, BO (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA.; Bachmann, BO (corresponding author), Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA.; Bachmann, BO (corresponding author), Vanderbilt Inst Chem Biol, Nashville, TN 37235 USA.	brian.bachmann@vanderbilt.edu			National Institutes of Health [R01 GM092218, R01 CA226833, T32 GM07628]; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center	The authors are grateful to Kelsey Pilewski and Manuel Castro for valuable input during manuscript preparation. Special thanks to David Flaherty and Brittany Matlock of the VUMC Flow Cytometry Shared Resource for instrument training and scheduling. Flow Cytometry experiments were performed in the VUMC Flow Cytometry Shared Resource. The authors thank the National Institutes of Health for research R01 GM092218, R01 CA226833, and training support T32 GM07628. The VUMC Flow Cytometry Shared Resource is supported by the Vanderbilt Ingram Cancer Center (P30 CA68485) and the Vanderbilt Digestive Disease Research Center (DK058404) .	Aaes TL, 2016, CELL REP, V15, P274, DOI 10.1016/j.celrep.2016.03.037; Adomavicius T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10167-3; Amodio G, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00673; [Anonymous], 2021, WHOMHPHPSEML202102; Aurelius J, 2019, LEUKEMIA LYMPHOMA, V60, P2771, DOI 10.1080/10428194.2019.1599110; Bachmann BO, 2014, J IND MICROBIOL BIOT, V41, P175, DOI 10.1007/s10295-013-1389-9; Bains SJ, 2020, CANCER IMMUNOL IMMUN, V69, P355, DOI 10.1007/s00262-019-02458-x; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Bezu L, 2018, CELL DEATH DIFFER, V25, P1375, DOI 10.1038/s41418-017-0044-9; Bezu L, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1431089; Boyce JH, 2021, ANGEW CHEM INT EDIT, V60, P1263, DOI 10.1002/anie.202010338; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Earl DC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02470-8; Efimova I, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001369; Frank T, 2019, CELL DEATH DIFFER, V26, P2046, DOI 10.1038/s41418-019-0298-5; Galluzzi L, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000337; Glassman FY, 2018, J PHARM SCI-US, V107, P2048, DOI 10.1016/j.xphs.2018.03.027; Gordiyenko Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10606-1; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028491; Hirasawa K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164529; HORI T, 1971, J CHEM SOC CHEM COMM, P304, DOI 10.1039/c29710000304; Horwitz S B, 1994, Ann Oncol, V5 Suppl 6, pS3; Kenshole Emma, 2021, Curr Opin Chem Biol, V60, P47, DOI 10.1016/j.cbpa.2020.07.010; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Krutzik Peter O, 2011, Curr Protoc Cytom, VChapter 6, DOI 10.1002/0471142956.cy0631s55; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Kuo LJ, 2008, IN VIVO, V22, P305; Lecciso M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01918; Liu P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14848-1; LOWN JW, 1993, CHEM SOC REV, V22, P165, DOI 10.1039/cs9932200165; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Malsy M, 2019, EUR J MED RES, V24, DOI 10.1186/s40001-019-0365-x; Martins I, 2014, CELL DEATH DIFFER, V21, P79, DOI 10.1038/cdd.2013.75; Martins I, 2012, AUTOPHAGY, V8, P413, DOI 10.4161/auto.19009; Martins I, 2009, CELL CYCLE, V8, P3723, DOI 10.4161/cc.8.22.10026; Mauvezin C, 2015, AUTOPHAGY, V11, P1437, DOI 10.1080/15548627.2015.1066957; Mauvezin C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8007; MEGGIO F, 1995, EUR J BIOCHEM, V234, P317, DOI 10.1111/j.1432-1033.1995.317_c.x; Menger L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003807; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Minute L, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000325; Miura M, 2015, BIOL PHARM BULL, V38, P645, DOI 10.1248/bpb.b15-00103; Moriwaki K, 2017, INT REV CEL MOL BIO, V328, P253, DOI 10.1016/bs.ircmb.2016.08.007; Mukai S, 2016, INT J ONCOL, V48, P45, DOI 10.3892/ijo.2015.3237; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Naeini MB, 2020, CELL MOL BIOL LETT, V25, DOI 10.1186/s11658-020-00214-z; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Park SJ, 2019, ORAL ONCOL, V95, P127, DOI 10.1016/j.oraloncology.2019.06.016; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Popat A, 2019, CYTOM PART A, V95A, P672, DOI 10.1002/cyto.a.23665; Reisman BJ, 2021, CYTOM PART A, V99, P946, DOI 10.1002/cyto.a.24363; Rodriguez DA, 2016, CELL DEATH DIFFER, V23, P76, DOI 10.1038/cdd.2015.70; Runwal G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46657-z; Samson AL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16887-1; Sansone C, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020231; Sarhan J, 2019, CELL DEATH DIFFER, V26, P332, DOI 10.1038/s41418-018-0122-7; Sauler M, 2019, ANNU REV PHYSIOL, V81, P375, DOI 10.1146/annurev-physiol-020518-114320; Schneider JL, 2016, J PHARM SCI-US, V105, P3097, DOI 10.1016/j.xphs.2016.06.018; Schoof M, 2021, ELIFE, V10, DOI 10.7554/eLife.65703; Sehgal P, 2017, J BIOL CHEM, V292, P19656, DOI 10.1074/jbc.M117.796920; Shlomovitz I, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0437-0; Smith IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026338; Sriram G, 2021, SCI SIGNAL, V14, DOI 10.1126/scisignal.abc4764; Sukkurwala AQ, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28473; Tang R, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00946-7; Toriyama K, 2021, CANCER SCI, V112, P3324, DOI 10.1111/cas.14992; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Viswesh V, 2010, CHEM RES TOXICOL, V23, P99, DOI 10.1021/tx900301r; Wallberg Fredrik, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot087387; Wang R, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22111-5; Wang Y, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000462; Weber K, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-017-0007-1; Xie BS, 2020, BIOCHEM BIOPH RES CO, V521, P232, DOI 10.1016/j.bbrc.2019.10.114; Xu C, 2004, J BIOL CHEM, V279, P17973, DOI 10.1074/jbc.M313263200; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yatim N, 2015, SCIENCE, V350, P328, DOI 10.1126/science.aad0395	77	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102300	10.1016/j.jbc.2022.102300	http://dx.doi.org/10.1016/j.jbc.2022.102300			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4F0GK	35931117	Green Published, gold			2022-12-26	WOS:000848194800011
J	Takahashi, M; Yamamuro, D; Wakabayashi, T; Takei, A; Takei, S; Nagashima, S; Okazaki, H; Ebihara, K; Yagyu, H; Takayanagi, Y; Onaka, T; Goldberg, IJ; Ishibashi, S				Takahashi, Manabu; Yamamuro, Daisuke; Wakabayashi, Tetsuji; Takei, Akihito; Takei, Shoko; Nagashima, Shuichi; Okazaki, Hiroaki; Ebihara, Ken; Yagyu, Hiroaki; Takayanagi, Yuki; Onaka, Tatsushi; Goldberg, Ira J.; Ishibashi, Shun			Loss of myeloid lipoprotein lipase exacerbates adipose tissue fibrosis with collagen VI deposition and hyperlipidemia in leptin-deficient obese mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; APOLIPOPROTEIN-E; MACROPHAGES; INFLAMMATION; CELLS; ATHEROSCLEROSIS; METABOLISM; ACCUMULATION; DYSFUNCTION; BINDING	During obesity, tissue macrophages increase in number and become proinflammatory, thereby contributing to metabolic dysfunction. Lipoprotein lipase (LPL), which hydrolyzes triglyceride in lipoproteins, is secreted by macrophages. However, the role of macrophage-derived LPL in adipose tissue remodeling and lipoprotein metabolism is largely unknown. To clarify these issues, we crossed leptin-deficient Lep(ob/ob) mice with mice lacking the Lpl gene in myeloid cells (Lpl(m-/m-)) to generate Lpl(m-/m-);Lep(ob/ob) mice. We found the weight of per-igonadal white adipose tissue (WAT) was increased in Lpl(m-/m-);Lep(ob/ob) mice compared with Lep(ob/ob) mice due to substantial accumulation of both adipose tissue macrophages and collagen that surrounded necrotic adipocytes. In the fibrotic epidydimal WAT of Lpl(m-/m-);Lep(ob/ob) mice, we observed an increase in collagen VI and high mobility group box 1, while alpha-smooth muscle cell actin, a marker of myofibroblasts, was almost undetectable, suggesting that the adipocytes were the major source of the collagens. Furthermore, the adipose tissue macrophages from Lpl (m-/m-);Lep(ob/ob) mice showed increased expression of genes related to fibrosis and inflammation. In addition, we determined Lpl (m-/m-);Lep(ob/ob) mice were more hypertriglyceridemic than Lep(ob/ob) mice. Lpl(m-/m-);Lep(ob/ob) mice also showed slower weight gain than Lep(ob/ob )mice, which was primarily due to reduced food intake. In conclusion, we discovered that the loss of myeloid Lpl led to extensive fibrosis of perigonadal WAT and hyper-triglyceridemia. In addition to illustrating an important role of macrophage LPL in regulation of circulating triglyceride levels, these data show that macrophage LPL protects against fibrosis in obese adipose tissues.	[Takahashi, Manabu; Yamamuro, Daisuke; Wakabayashi, Tetsuji; Takei, Akihito; Takei, Shoko; Nagashima, Shuichi; Okazaki, Hiroaki; Ebihara, Ken; Yagyu, Hiroaki; Ishibashi, Shun] Jichi Med Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Tochigi, Japan; [Takayanagi, Yuki; Onaka, Tatsushi] Jichi Med Univ, Sch Med, Dept Physiol, Div Brain & Neurophysiol, Tochigi, Japan; [Goldberg, Ira J.] NYU, Langone Med Ctr, New York, NY USA	Jichi Medical University; Jichi Medical University; New York University; NYU Langone Medical Center	Takahashi, M; Ishibashi, S (corresponding author), Jichi Med Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Tochigi, Japan.	m-taka@jichi.ac.jp; ishibash@jichi.ac.jp		Nagashima, Shuichi/0000-0003-2509-8588	JSPS KAKENHI [JP16K21318]; Ministry of Education, Culture, Sports, Science, and Technology of Japan, Jichi Medical University Young Investigator Award; Astellas Pharma; Daiichi Sankyo Co; Ono Pharma; Shionogi Co; Boehringer Ingelheim Japan; Kowa; Co; Ono Pharma; Mitsubishi Tanabe Pharma; Takeda Pharma Co; Toyama Chemical Co; Teijin; Sumitomo Dainippon Pharma; Sano fi K.K.; Novo Nordisk Pharma; MSD K.K.; Pfizer Japan; Novartis Pharma; Eli Lilly Co; NHLBI; National Institutes of Health (USA);  [HL45095];  [73029]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan, Jichi Medical University Young Investigator Award; Astellas Pharma(Astellas Pharmaceuticals); Daiichi Sankyo Co(Daiichi Sankyo Company Limited); Ono Pharma; Shionogi Co; Boehringer Ingelheim Japan(Boehringer Ingelheim); Kowa; Co; Ono Pharma; Mitsubishi Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation); Takeda Pharma Co; Toyama Chemical Co; Teijin; Sumitomo Dainippon Pharma; Sano fi K.K.; Novo Nordisk Pharma(Novo Nordisk); MSD K.K.(Merck & Company); Pfizer Japan(Pfizer); Novartis Pharma; Eli Lilly Co(Eli Lilly); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; 	This study was supported by Grants-in-Aid for Scientific Research (JSPS KAKENHI Grant Number JP16K21318), Non-communicable diseases from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Jichi Medical University Young Investigator Award (for M. T.) and unrestricted grants from Astellas Pharma, Daiichi Sankyo Co, Shionogi Co, Boehringer Ingelheim Japan, Kowa, Co, Ono Pharma, Mitsubishi Tanabe Pharma, Takeda Pharma Co, Toyama Chemical Co, Teijin, Sumitomo Dainippon Pharma, Sano fi K.K., Novo Nordisk Pharma, MSD K.K., Pfizer Japan, Novartis Pharma, and Eli Lilly Co. I. J. G. is supported by grants HL45095 and 73029 from the NHLBI, National Institutes of Health (USA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aryal B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12313; Augustus A, 2004, J BIOL CHEM, V279, P25050, DOI 10.1074/jbc.M401028200; Babaev VR, 1999, J CLIN INVEST, V103, P1697, DOI 10.1172/JCI6117; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Blank T, 2016, EUR J IMMUNOL, V46, P1340, DOI 10.1002/eji.201646437; Chang HR, 2019, ARTERIOSCL THROM VAS, V39, P1967, DOI 10.1161/ATVBAHA.119.312389; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Crewe C, 2017, J CLIN INVEST, V127, P74, DOI 10.1172/JCI88883; Datta R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122289; De Luca SN, 2020, J NEUROENDOCRINOL, V32, DOI 10.1111/jne.12838; Gao JH, 2007, DIABETES, V56, P24, DOI 10.2337/db06-0144; Garcia-Arcos I, 2013, J BIOL CHEM, V288, P14046, DOI 10.1074/jbc.M113.469270; Ge XD, 2018, HEPATOLOGY, V68, P2380, DOI 10.1002/hep.30093; Guzman-Ruiz R, 2021, MOL CELL ENDOCRINOL, V536, DOI 10.1016/j.mce.2021.111417; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; ISHIBASHI S, 1990, J BIOL CHEM, V265, P3040; Jager M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197777; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kimura H, 2016, AM J PHYSIOL-ENDOC M, V311, pE881, DOI 10.1152/ajpendo.00174.2016; Marcelin G, 2017, CELL METAB, V25, P673, DOI 10.1016/j.cmet.2017.01.010; Martinez-Santibanez G, 2014, ANNU REV NUTR, V34, P57, DOI 10.1146/annurev-nutr-071812-161113; McCulloch LJ, 2015, ENDOCRINOLOGY, V156, P134, DOI 10.1210/en.2014-1042; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Morinaga H, 2015, DIABETES, V64, P1120, DOI 10.2337/db14-1238; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nagashima S, 2015, J LIPID RES, V56, P998, DOI 10.1194/jlr.M057406; OBRIEN KD, 1992, J CLIN INVEST, V89, P1544, DOI 10.1172/JCI115747; OBUNIKE JC, 1994, J BIOL CHEM, V269, P13129; Olivecrona G, 2016, CURR OPIN LIPIDOL, V27, P233, DOI 10.1097/MOL.0000000000000297; Pakshir P, 2020, J CELL SCI, V133, DOI 10.1242/jcs.227900; Pasarica M, 2009, J CLIN ENDOCR METAB, V94, P5155, DOI 10.1210/jc.2009-0947; Saraswathi V, 2006, J LIPID RES, V47, P1406, DOI 10.1194/jlr.M600159-JLR200; Sekiya M, 2004, J BIOL CHEM, V279, P15084, DOI 10.1074/jbc.M310985200; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Spencer M, 2010, AM J PHYSIOL-ENDOC M, V299, pE1016, DOI 10.1152/ajpendo.00329.2010; Stienstra R, 2014, DIABETES, V63, P4143, DOI 10.2337/db14-0256; Suganami T, 2012, ENDOCR J, V59, P849, DOI 10.1507/endocrj.EJ12-0271; Takahashi M, 2013, J LIPID RES, V54, P1124, DOI 10.1194/jlr.M035568; Takei A, 2020, DIABETES, V69, P158, DOI 10.2337/db19-0076; Takei S, 2020, DIABETES, V69, P2352, DOI 10.2337/db19-0996; Van Eck M, 2000, ARTERIOSCL THROM VAS, V20, pE53, DOI 10.1161/01.ATV.20.9.e53; Wang H, 2011, CELL METAB, V13, P105, DOI 10.1016/j.cmet.2010.12.006; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Wilson K, 2001, ARTERIOSCL THROM VAS, V21, P1809, DOI 10.1161/hq1101.097805; Wu HZ, 2017, J CLIN INVEST, V127, P43, DOI [10.1172/JCI88880, 10.1172/jci88880]; Yin BY, 1997, J CLIN INVEST, V100, P649, DOI 10.1172/JCI119576; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P10143, DOI 10.1073/pnas.88.22.10143; Zhou Y, 2015, CELL METAB, V22, P1045, DOI 10.1016/j.cmet.2015.09.013; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473	51	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102322	10.1016/j.jbc.2022.102322	http://dx.doi.org/10.1016/j.jbc.2022.102322			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9IM	35926714	Green Published, gold			2022-12-26	WOS:000863192700012
J	Gibson, JC; Marro, L; Borghese, MM; Brandow, D; Remedios, L; Fisher, M; Malowany, M; Kieliszkiewicz, K; Lukina, AO; Irwin, K				Gibson, Jennifer C.; Marro, Leonora; Borghese, Michael M.; Brandow, Danielle; Remedios, Lauren; Fisher, Mandy; Malowany, Morie; Kieliszkiewicz, Katarzyna; Lukina, Anna O.; Irwin, Kim			Development of an observational exposure human biomonitoring study to assess Canadian children's DEET exposure during protective use	PLOS ONE			English	Article							INSECT REPELLENT DEET; N,N-DIETHYL-M-TOLUAMIDE DEET; SUNSCREEN OXYBENZONE; DERMAL APPLICATION; ABSORPTION; METABOLISM; EXCRETION; URINE; BODY; SKIN	Biomonitoring data of N,N-diethyl-meta-toluamide (DEET) in children is scarce and limited to controlled exposure and surveillance studies. We conducted a 24-hour observational exposure and human biomonitoring study designed to estimate use of and exposure to DEET-based insect repellents by Canadian children in an overnight summer camp setting. Here, we present our study design and methodology. In 2019, children between the ages of 7 and 13 took part in the study (n = 126). Children controlled their use of DEET-based insect repellents, and provided an account of their activities at camp that could impact insect repellent absorption. Children provided a total of 389 urine samples throughout the study day, and reported the time that they applied insect repellent, which allowed us to contextualize urinary DEET and metabolite concentrations with respect to the timing of insect repellent application. DEET (2.3%< Limits of detection (LOD)) and two metabolites, N,N-diethyl-m-(hydroxymethyl)benzamide (DHMB) (0% <LOD), were measured in urine samples. Three time difference scenarios were established for the data and analysed to account for these complex time-dependent data, which demonstrated the need for DEET biomonitoring to be done in context with the timing of a known DEET exposure or over the course of at least 14 to 24 hours to better capture the excretion curve. To our knowledge, this is the first field-based study of real-world exposure to DEET in children. Our experience and results suggest that this type of real-world observational exposure study with a human biomonitoring component can generate data reflective of actual exposure, but is not without significant logistic, practical, and analytical challenges.	[Gibson, Jennifer C.; Marro, Leonora; Borghese, Michael M.; Brandow, Danielle; Remedios, Lauren; Fisher, Mandy; Malowany, Morie; Lukina, Anna O.] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON, Canada; [Kieliszkiewicz, Katarzyna] Hlth Canada, Pesticide Lab, Regulatory Operat & Enforcement Branch, Ottawa, ON, Canada; [Irwin, Kim] Hlth Canada, Pest Management Regulatory Agcy, Ottawa, ON, Canada	Health Canada; Health Canada; Health Canada	Gibson, JC (corresponding author), Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON, Canada.	jennifer.gibson@hc-sc.gc.ca		Gibson, Jennifer/0000-0002-7351-522X	Health Library at Health Canada; Public Health Agency of Canada	Health Library at Health Canada; Public Health Agency of Canada	The authors would like to acknowledge the participants and their families for their interest and participation in the study. The authors would also like to acknowledge the directors and staff of the three overnight summer camps for their enthusiasm and support for the study. Thanks to JAM and VH for their constructive feedback. The authors would also like to acknowledge the Health Library at Health Canada and the Public Health Agency of Canada for their high quality work in supporting this project.	ATSDR, 2017, TOXICOLOGICAL PROFIL; BLOMQUIST L, 1977, ACTA PHARMACOL TOX, V41, P235; Briassoulis G, 2001, HUM EXP TOXICOL, V20, P8, DOI 10.1191/096032701676731093; Calafat AM, 2016, ENVIRON INT, V92-93, P398, DOI 10.1016/j.envint.2016.04.021; CDC, 2019, 4 NAT REP HUM EXP EN; Constantino L, 1999, XENOBIOTICA, V29, P409, DOI 10.1080/004982599238588; Department of National Defence, 2020, WELL BEINGFR; Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083; Fediuk DJ, 2011, BIOPHARM DRUG DISPOS, V32, P369, DOI 10.1002/bdd.765; FELDMANN RJ, 1970, J INVEST DERMATOL, V54, P399, DOI 10.1111/1523-1747.ep12259184; Gibson JC, BIOMONITORING UNPUB; Health Canada, 2002, RRD200201 HLTH CAN; Heffernan AL, 2016, ENVIRON SCI POLLUT R, V23, P23436, DOI 10.1007/s11356-016-7571-7; Horiba, 2020, ABX PENTR CREAT 120; Kasichayanula S, 2007, TOXICOL APPL PHARM, V223, P187, DOI 10.1016/j.taap.2007.05.016; LIPSCOMB JW, 1992, ANN EMERG MED, V21, P315, DOI 10.1016/S0196-0644(05)80896-0; Menon KS, 2005, AM J IND MED, V47, P91, DOI 10.1002/ajim.20114; MOODY RP, 1989, J TOXICOL ENV HEALTH, V26, P137, DOI 10.1080/15287398909531240; Moore P, 1998, LANCET, V352, P630, DOI 10.1016/S0140-6736(05)79591-X; Organisation for Economic Co-operation and Development, 2019, ENV DIRECTORATE JOIN; Pearson MA, 2009, J EXPO SCI ENV EPID, V19, P336, DOI 10.1038/jes.2008.48; Pronczuk-Garbino J., 2005, CHILDRENS HLTH ENV G; Qiu H, 1997, Pharm Dev Technol, V2, P33, DOI 10.3109/10837459709022607; Qiu HC, 1997, J PHARM SCI-US, V86, P514, DOI 10.1021/js960283m; SELIM S, 1995, FUND APPL TOXICOL, V25, P95, DOI 10.1006/faat.1995.1043; SMALLWOOD AW, 1992, J ANAL TOXICOL, V16, P10, DOI 10.1093/jat/16.1.10; Sudakin DL, 2003, J TOXICOL-CLIN TOXIC, V41, P831, DOI 10.1081/CLT-120025348; Tavares EM, 2019, AM J EMERG MED, V37, DOI 10.1016/j.ajem.2019.04.019; Tian JN, 2014, J ENVIRON HEALTH, V76, P162; United States Centers for Disease Control (US CDC), LAB PROC MAN DEET ME; United States Environmental Protection Agency (USEPA), 1998, EPA738F95010; USEPA, 2021, DEET; Wang B, 2015, EUR J PEDIATR, V174, P1481, DOI 10.1007/s00431-015-2558-9; Yiin LM, 2015, ENVIRON SCI POLLUT R, V22, P7062, DOI 10.1007/s11356-014-3915-3	34	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0268341	10.1371/journal.pone.0268341	http://dx.doi.org/10.1371/journal.pone.0268341			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925987	Green Published, gold			2022-12-26	WOS:000848077100008
J	Fernandez-Luis, S; Fuente-Soro, L; Nhampossa, T; Lopez-Varela, E; Augusto, O; Nhacolo, A; Vazquez, O; Saura-Lazaro, A; Guambe, H; Tibana, K; Ngeno, B; Juga, AJC; Cowan, JG; Urso, M; Naniche, D				Fernandez-Luis, Sheila; Fuente-Soro, Laura; Nhampossa, Tacilta; Lopez-Varela, Elisa; Augusto, Orvalho; Nhacolo, Ariel; Vazquez, Olalla; Saura-Lazaro, Anna; Guambe, Helga; Tibana, Kwalila; Ngeno, Bernadette; Juga, Adelino Jose Chingore; Cowan, Jessica Greenberg; Urso, Marilena; Naniche, Denise			Prompt HIV diagnosis and antiretroviral treatment in postpartum women is crucial for prevention of mother to child transmission during breastfeeding: Survey results in a high HIV prevalence community in southern Mozambique after the implementation of Option B	PLOS ONE			English	Article							UNINFECTED CHILDREN; THERAPY; AFRICA	ObjectiveWorld Health Organization recommends promoting breastfeeding without restricting its duration among HIV-positive women on lifelong antiretroviral treatment (ART). There is little data on breastfeeding duration and mother to child transmission (MTCT) beyond 24 months. We compared the duration of breastfeeding in HIV-exposed and HIV-unexposed children and we identified factors associated with postpartum-MTCT in a semi-rural population of Mozambique. MethodsThis cross-sectional assessment was conducted from October-2017 to April-2018. Mothers who had given birth within the previous 48-months in the Manhica district were randomly selected to be surveyed and to receive an HIV-test along with their children. Postpartum MTCT was defined as children with an initial HIV positive result beyond 6 weeks of life who initiated breastfeeding if they had a first negative PCR result during the first 6 weeks of life or whose mother had an estimated date of infection after the child's birth. Cumulative incidence accounting for right-censoring was used to compare breastfeeding duration in HIV-exposed and unexposed children. Fine-Gray regression was used to assess factors associated with postpartum-MTCT. ResultsAmong the 5000 mother-child pairs selected, 69.7% (3486/5000) were located and enrolled. Among those, 27.7% (967/3486) children were HIV-exposed, 62.2% (2169/3486) were HIV-unexposed and for 10.0% (350/3486) HIV-exposure was unknown. Median duration of breastfeeding was 13.0 (95%CI:12.0-14.0) and 20.0 (95%CI:19.0-20.0) months among HIV-exposed and HIV-unexposed children, respectively (p<0.001). Of the 967 HIV-exposed children, 5.3% (51/967) were HIV-positive at the time of the survey. We estimated that 27.5% (14/51) of the MTCT occurred during pregnancy and delivery, 49.0% (2551) postpartum-MTCT and the period of MTCT remained unknown for 23.5% (12/51) of children. In multivariable analysis, mothers' ART initiation after the date of childbirth was associated (aSHR:9.39 [95%CI:1.75-50.31], p = 0.001), however breastfeeding duration was not associated with postpartum-MTCT (aSHR:0.99 [95%CI:0.96-1.03], p = 0.707). ConclusionThe risk for postpartum MTCT was nearly tenfold higher in women newly diagnosed and/or initiating ART postpartum. This highlights the importance of sustained HIV screening and prompt ART initiation in postpartum women in Sub-Saharan African countries. Under conditions where HIV-exposed infants born to mothers on ART receive adequate PMTCT, extending breastfeeding duration may be recommended.	[Fernandez-Luis, Sheila; Fuente-Soro, Laura; Nhampossa, Tacilta; Lopez-Varela, Elisa; Augusto, Orvalho; Nhacolo, Ariel; Saura-Lazaro, Anna; Naniche, Denise] Ctr Invest Saude Manh CISM, Maputo, Mozambique; [Fernandez-Luis, Sheila; Fuente-Soro, Laura; Lopez-Varela, Elisa; Saura-Lazaro, Anna; Naniche, Denise] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Spain; [Nhampossa, Tacilta] Inst Nacl Saude INS, Maputo, Mozambique; [Vazquez, Olalla] Hosp Clin Univ Stantiago Compostela, Stantiago, Spain; [Guambe, Helga; Tibana, Kwalila] Minist Saude Mocambique MISAU, Maputo, Mozambique; [Ngeno, Bernadette] US Ctr Dis Control & Prevent CDC, Atlanta, GA USA; [Juga, Adelino Jose Chingore; Cowan, Jessica Greenberg; Urso, Marilena] US Ctr Dis Control & Prevent CDC, Maputo, Mozambique	Centro de Investigacao em Saude de Manhica; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; Centers for Disease Control & Prevention - USA	Fernandez-Luis, S (corresponding author), Ctr Invest Saude Manh CISM, Maputo, Mozambique.; Fernandez-Luis, S (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Spain.	sheila.fernandez@isglobal.org	; Naniche, Denise/S-1814-2018	Fernandez-Luis, Sheila/0000-0003-3684-6713; vazquez, olalla/0000-0001-5306-9587; Saura Lazaro, Anna/0000-0001-9742-2725; Naniche, Denise/0000-0002-4495-6325	President's Emergency Plan for AIDS Relief (PEPFAR) through the Center for Disease Control (CDC) under the terms of CoAg [GH000479]; Secretariat of Universities and Research, Ministry of Enterprise and Knowledge of the Government of Catalonia; Spanish Pediatrics Association (AEP) fellowship; Ramon Areces Foundation fellowship	President's Emergency Plan for AIDS Relief (PEPFAR) through the Center for Disease Control (CDC) under the terms of CoAg; Secretariat of Universities and Research, Ministry of Enterprise and Knowledge of the Government of Catalonia; Spanish Pediatrics Association (AEP) fellowship; Ramon Areces Foundation fellowship	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Center for Disease Control (CDC) under the terms of CoAg GH000479. The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the CDC. S.F.L. receives a pre -doctoral fellowship from the Secretariat of Universities and Research, Ministry of Enterprise and Knowledge of the Government of Catalonia and cofounded by European Social Fund. E.L.V. is supported by a Spanish Pediatrics Association (AEP) fellowship and a Ramon Areces Foundation fellowship. For the remaining authors none were declared.	Alvarez-Uria Gerardo, 2012, ISRN Pediatr, V2012, P763591, DOI 10.5402/2012/763591; [Anonymous], 2010, HIV INFANT FEEDING G; [Anonymous], 2016, GUID UPD HIV INF FEE, DOI [DOI 10.1103/PHYSREVA.63.023818, 10.1103/PhysRevA.63.023818]; [Anonymous], 2011, MOC INQ DEM SAUD; Bispo S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21251; Brasil, 2018, POLITICA NACL ATENCA; Chaponda A, 2017, AFR J PRIM HEALTH CA, V9, DOI 10.4102/phcfm.v9i1.1278; Chinkonde JR, 2010, INT BREASTFEED J, V5, DOI 10.1186/1746-4358-5-11; Coetzee B, 2017, MATERN CHILD HLTH J, V21, P953, DOI 10.1007/s10995-016-2253-0; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; De Schacht C, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18808; Drake AL, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25271; Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis, 2000, LANCET LONDON ENGLAN, V355, P451; Flynn PM, 2018, JAIDS-J ACQ IMM DEF, V77, P383, DOI 10.1097/QAI.0000000000001612; Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x; Horwood C, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12726; Joint United Nations Programme on HIV/AIDS, 2019, UNAIDS DATA 2019; Kassa GM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3126-5; Kuhn L, 2010, CLIN INFECT DIS, V50, P437, DOI 10.1086/649886; Lambdin BH, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-30; le Roux SM, 2020, LANCET CHILD ADOLESC, V4, P220, DOI 10.1016/S2352-4642(19)30375-X; Lima H, 2018, RELATORIO FINAL MOCA; Maredza M, 2013, AJAR-AFR J AIDS RES, V12, P151, DOI 10.2989/16085906.2013.863215; Microsoft Corporation U.  Seattle WA, MICR ACC; Ministerio da Saude, 2014, GUIA TRAT ANT INF OP; Ministerio da Saude de Mocambique, 2016, GUIAO IMPL AB TEST I; Ministerio da Saude (MISAU), 2021, GUIAO OF PROF PREEXP; Ministerio da Saude (MISAU). Comite TARV, 2019, CIRC NORM CLIN ACT; Nyoni S, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6949-0; Oakley L, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12535; Obadia JF, 2018, NEW ENGL J MED, V379, P2297, DOI 10.1056/NEJMoa1805374; Onyango-Makumbi C, 2010, JAIDS-J ACQ IMM DEF, V53, P20, DOI 10.1097/QAI.0b013e3181bdf68e; Peltier CA, 2009, AIDS, V23, P2415, DOI 10.1097/QAD.0b013e32832ec20d; Pfeiffer JT, 2017, JAIDS-J ACQ IMM DEF, V76, P273, DOI 10.1097/QAI.0000000000001515; Republica de Mocambique . Ministerio da Saude, 2016, TRAT ANT INF OP AD A; Rollins N, 2012, SEX TRANSM INFECT, V88, pI44, DOI 10.1136/sextrans-2012-050709; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Samburu BM, 2021, INT BREASTFEED J, V16, DOI 10.1186/s13006-021-00385-1; Shirima R, 2001, PUBLIC HEALTH NUTR, V4, P147, DOI 10.1079/PHN200057; StataCorp, 2017, STAT REL 15 STAT SOF, DOI DOI 10.2307/2234838; Taha TE, 2011, CLIN INFECT DIS, V53, P388, DOI 10.1093/cid/cir413; UNAIDS, 2019, START FREE STAY FREE; van Rensburg LJ, 2016, HEALTH SA GESONDHEID, V21, DOI 10.1016/j.hsag.2015.12.001; WHO, VERB AUT STD ASC ATT; WHO, 2016, CONGUID UANT DRU; WHO, MOTH CHILD TRANSM HI; WHO, HIV DIAGN ARV US HIV; World Health Organization (WHO), 2003, HIV INF FEED GUID DE; World Heath Organization (WHO), HIV TRANSM BREASTF; World Heath Organization (WHO) and Centers for Disease Control and Prevention (CDC), 2005, UN HIV RAP TEST	50	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0269835	http://dx.doi.org/10.1371/journal.pone.0269835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917332	gold, Green Published			2022-12-26	WOS:000837840000034
J	Haddadin, Z; Spieker, AJ; Rahman, H; Rankin, DA; Talj, R; Yanis, A; Amarin, JZ; Schmitz, J; Chappell, J; Halasa, NB				Haddadin, Zaid; Spieker, Andrew J.; Rahman, Herdi; Rankin, Danielle A.; Talj, Rana; Yanis, Ahmad; Amarin, Justin Z.; Schmitz, Jonathan; Chappell, James; Halasa, Natasha B.			Respiratory pathogens during the COVID-19 pandemic: Alterations in detection and seasonality in Nashville, Tennessee	PLOS ONE			English	Article								Shortly after the implementation of community mitigation measures in response to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), sharp declines in respiratory syncytial virus and influenza circulation were noted; post-mitigation circulation of other respiratory pathogens has gone unexplored. We retrospectively analyzed all records of a provider-ordered multiplex test between April 1, 2018, and July 31, 2021, in Nashville, Tennessee, and we noted disrupted historical seasonal patterns for common respiratory pathogens during the SARS-CoV-2 pandemic.	[Haddadin, Zaid; Rahman, Herdi; Rankin, Danielle A.; Talj, Rana; Yanis, Ahmad; Amarin, Justin Z.; Chappell, James; Halasa, Natasha B.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37235 USA; [Spieker, Andrew J.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Rankin, Danielle A.] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol PhD Program, Nashville, TN USA; [Schmitz, Jonathan] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Halasa, NB (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37235 USA.	natasha.halasa@vumc.org	Amarin, Justin Z./G-7481-2017	Amarin, Justin Z./0000-0002-4484-1077; Yanis, Ahmad/0000-0003-2333-9050; Rankin, Danielle/0000-0003-3018-3373	National Institutes of Health [TL1TR002244]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Danielle A. Rankin is supported by the National Institutes of Health under award number TL1TR002244. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 4.	County MPHDND, SAF HOM ORD 2020; Foley DA, 2021, CLIN INFECT DIS, V73, pE2829, DOI 10.1093/cid/ciaa1906; Haddadin Z, 2021, PEDIATRICS, V148, DOI 10.1542/peds.2021-051462; Huang QS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21157-9; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Marriott D, 2021, CLIN INFECT DIS, V72, pE649, DOI 10.1093/cid/ciaa1256; Metro Public Health Department Nashville and Davidson County, 2020, AM 1 ORD 6 CHIEF MED, P1; Metro Public Health Department Nashville and Davidson County, 2020, ORDER 5 CHIEF MEDICA; Metro Public Health Department Nashville and Davidson County, 2020, EXT AM REST ORD 7 CH, P1; Murray AF, 2021, FRONT PEDIATR, V9, DOI 10.3389/fped.2021.686386; Oh DY, 2021, LANCET REG HEALTH-EU, V6, DOI 10.1016/j.lanepe.2021.100112; Park S, 2021, J INFECT DIS, V224, P1900, DOI 10.1093/infdis/jiab231; Sakamoto H, 2020, JAMA-J AM MED ASSOC, V323, P1969, DOI 10.1001/jama.2020.6173; Tennessee Office of the Governor, 2021, COVID 19 TIM; Tennessee Secretary of State, 2020, EX ORD GOV NO 23, V1; Tennessee Secretary of State, 2020, EX ORD GOV NO 22, P1; Yeoh DK, 2021, CLIN INFECT DIS, V72, P2199, DOI 10.1093/cid/ciaa1475	17	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0270469	http://dx.doi.org/10.1371/journal.pone.0270469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921608	gold, Green Published			2022-12-26	WOS:000839311900073
J	Parlak, GC; Camur, BB; Gul, S; Ozcan, O; Baris, I; Kavakli, IH				Parlak, Gizem Cagla; Camur, Bilge Bahar; Gul, Seref; Ozcan, Onur; Baris, Ibrahim; Kavakli, Ibrahim Halil			The secondary pocket of cryptochrome 2 is important for the regulation of its stability and localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN CIRCADIAN CLOCK; NUCLEAR-LOCALIZATION; DEGRADATION; PROTEINS; BINDING; RHYTHM; PER2; CRY; IDENTIFICATION; PATHOGENICITY	Human clock-gene variations contribute to the phenotypic differences observed in various behavioral and physiological processes, such as diurnal preference, sleep, metabolism, mood regulation, addiction, and fertility. However, little is known about the possible effects of identified variations at the molecular level. In this study, we performed a functional characterization at the cellular level of rare cryptochrome 2 (CRY2) missense variations that were identified from the Ensembl database. Our structural studies revealed that three variations (p.Pro123Leu, p.Asp406His, and p.Ser410Ile) are located at the rim of the secondary pocket of CRY2. We show that these variants were unable to repress CLOCK (circadian locomotor output cycles kaput)/BMAL1 (brain and muscle ARNT-like-1)-driven transcription in a cell-based reporter assay and had reduced affinity to CLOCK-BMAL1. Furthermore, our biochemical studies indicated that the variants were less stable than the WT CRY2, which could be rescued in the presence of period 2 (PER2), another core clock protein. Finally, we found that these variants were unable to properly localize to the nucleus and thereby were unable to rescue the circadian rhythm in a Cry1(-/-)Cry2(-/-) double KO mouse embryonic fibroblast cell line. Collectively, our data suggest that the rim of the secondary pocket of CRY2 plays a significant role in its nuclear localization independently of PER2 and in the intact circadian rhythm at the cellular level.	[Parlak, Gizem Cagla; Camur, Bilge Bahar; Ozcan, Onur; Baris, Ibrahim; Kavakli, Ibrahim Halil] Koc Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Gul, Seref] Istanbul Univ, Dept Biol, Biotechnol Div, Istanbul, Turkey; [Kavakli, Ibrahim Halil] Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey	Koc University; Istanbul University; Koc University	Kavakli, IH (corresponding author), Koc Univ, Dept Mol Biol & Genet, Istanbul, Turkey.; Kavakli, IH (corresponding author), Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey.	hkavakli@ku.edu.tr		baris, ibrahim/0000-0003-2185-3259; Kavakli, Ibrahim/0000-0001-6624-3505; Parlak, Gizem Cagla/0000-0002-2817-1069; Camur, Bilge Bahar/0000-0002-2374-266X	TUBITAK-KBAG [121Z862]	TUBITAK-KBAG(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work is supported by TUBITAK-KBAG 121Z862.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allada R, 2021, NEW ENGL J MED, V384, P550, DOI 10.1056/NEJMra1802337; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cal-Kayitmazbatir S, 2021, FEBS J, V288, P614, DOI 10.1111/febs.15360; Cao XM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021174118; Chen Z, 2018, ANNU REV PHARMACOL, V58, P231, DOI 10.1146/annurev-pharmtox-010617-052645; Doruk YU, 2020, J BIOL CHEM, V295, P3518, DOI 10.1074/jbc.RA119.011332; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fribourgh JL, 2020, ELIFE, V9, DOI 10.7554/eLife.55275; Gao P, 2013, J BIOL CHEM, V288, P35277, DOI 10.1074/jbc.M113.509604; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Gul S., 2021, BIORXIV, DOI [10.1101/2021.07.21.453206, DOI 10.1101/2021.07.21.453206]; Gul S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97962-5; Gul S, 2020, J BIOL CHEM, V295, P17187, DOI 10.1074/jbc.RA120.014333; Hirano A, 2016, ELIFE, V5, DOI 10.7554/eLife.16695; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hirayama J, 2003, J BIOL CHEM, V278, P35620, DOI 10.1074/jbc.M305028200; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Ioannidis NM, 2016, AM J HUM GENET, V99, P877, DOI 10.1016/j.ajhg.2016.08.016; Kao Shih-Han, 2015, Bio Protoc, V5, DOI 10.21769/BioProtoc.1374; Kavakli IH, 2022, ADV PROTEIN CHEM STR, P207, DOI 10.1016/bs.apcsb.2022.04.001; Kavakli IH, 2022, CURR OPIN CHEM ENG, V35, DOI 10.1016/j.coche.2021.100730; Kavakli IH, 2017, PHOTOCHEM PHOTOBIOL, V93, P93, DOI 10.1111/php.12669; Kavakli Ibrahim Halil, 2002, Mol Interv, V2, P484, DOI 10.1124/mi.2.8.484; Khan SK, 2012, J BIOL CHEM, V287, P25917, DOI 10.1074/jbc.M112.368001; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Koch AA, 2022, ELIFE, V11, DOI 10.7554/eLife.73976; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lavebratt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009407; Liu C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021464; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Michael AK, 2017, P NATL ACAD SCI USA, V114, P1560, DOI 10.1073/pnas.1615310114; Miki T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3444; Miyazaki K, 2001, MOL CELL BIOL, V21, P6651, DOI 10.1128/MCB.21.19.6651-6659.2001; Nangle S, 2013, CELL RES, V23, P1417, DOI 10.1038/cr.2013.136; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Onat OE, 2020, J CLIN INVEST, V130, P3885, DOI 10.1172/JCI135500; Ozber N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-69; Ozcan O., 2021, COMPUTER AIDED CHEM, V50, P2025; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Partch CL, 2005, BIOCHEMISTRY-US, V44, P3795, DOI 10.1021/bi047545g; Patke A, 2017, CELL, V169, P203, DOI 10.1016/j.cell.2017.03.027; Reischl S, 2007, J BIOL RHYTHM, V22, P375, DOI 10.1177/0748730407303926; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rosensweig C, 2020, EUR J NEUROSCI, V51, P139, DOI 10.1111/ejn.14254; Rosensweig C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03503-6; Sakakida Y, 2005, J BIOL CHEM, V280, P13272, DOI 10.1074/jbc.M413236200; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Schmalen I, 2014, CELL, V157, P1203, DOI 10.1016/j.cell.2014.03.057; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; SHERMAN B, 1985, J CLIN ENDOCR METAB, V61, P439, DOI 10.1210/jcem-61-3-439; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Takahashi JS, 2016, RES PERSPECT END INT, P13, DOI 10.1007/978-3-319-27069-2_2; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; Vielhaber EL, 2001, J BIOL CHEM, V276, P45921, DOI 10.1074/jbc.M107726200; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Ye R, 2014, GENE DEV, V28, P1989, DOI 10.1101/gad.249417.114; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	65	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9								10.1016/j.jbc.2022.102334	http://dx.doi.org/10.1016/j.jbc.2022.102334			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A9EO	35933018	Green Published, gold			2022-12-26	WOS:000863182500001
J	Zhuo, Y; Crecelius, JM; Marchese, A				Zhuo, Ya; Crecelius, Joseph M.; Marchese, Adriano			G protein-coupled receptor kinase phosphorylation of distal C-tail sites specifies beta arrestin1-mediated signaling by chemokine receptor CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN; ADAPTER MOLECULE-1; IDENTIFICATION; ENDOCYTOSIS; ACTIVATION; INTERACTS; BINDING; ROLES; UBIQUITINATION; TRAFFICKING	G protein-coupled receptor (GPCR) kinases (GRKs) and arrestins mediate GPCR desensitization, internalization, and signaling. The spatial pattern of GPCR phosphorylation is predicted to trigger these discrete GRK and arrestin-mediated functions. Here, we provide evidence that distal carboxylterminal tail (C-tail), but not proximal, phosphorylation of the chemokine receptor CXCR4 specifies 'larrestin1 ('larr1)dependent signaling. We demonstrate by pharmacologic inhibition of GRK2/3-mediated phosphorylation of the chemokine receptor CXCR4 coupled with site-directed mutagenesis and bioluminescence resonance energy transfer approaches that distal, not proximal, C-tail phosphorylation sites are required for recruitment of the adaptor protein STAM1 (signal-transducing adaptor molecule) to 'larr1 and focal adhesion kinase phosphorylation but not extracellular signal-regulated kinase 1/2 phosphorylation. In addition, we show that GPCRs that have similarly positioned C-tail phosphoresidues are also able to recruit STAM1 to 'larr1. However, although necessary for some GPCRs, we found that distal C-tail sites might not be sufficient to specify recruitment of STAM1 to 'larr1 for other GPCRs. In conclusion, this study provides evidence that distal C-tail phosphorylation sites specify GRK-'larrestin-mediated signaling by CXCR4 and other GPCRs.	[Zhuo, Ya; Crecelius, Joseph M.; Marchese, Adriano] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Marchese, A (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	amarchese@mcw.edu						Alekhina O, 2016, J BIOL CHEM, V291, P26083, DOI 10.1074/jbc.M116.757138; Baidya M, 2020, EMBO REP, V21, DOI 10.15252/embr.201949886; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Butcher AJ, 2011, J BIOL CHEM, V286, P11506, DOI 10.1074/jbc.M110.154526; Caballero A, 2019, J BIOL CHEM, V294, P8023, DOI 10.1074/jbc.RA118.005991; Coffa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028723; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; English EJ, 2018, J BIOL CHEM, V293, P11470, DOI 10.1074/jbc.RA118.001872; Garcia-Cuesta Eva M, 2022, Proc Natl Acad Sci U S A, V119, pe2119483119, DOI 10.1073/pnas.2119483119; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich VV, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00125; Huang WJ, 2020, NATURE, V579, P303, DOI 10.1038/s41586-020-1953-1; Jimenez-Sainz MC, 2006, MOL BIOL CELL, V17, P25, DOI 10.1091/mbc.e05-05-0399; Kang DS, 2013, METHOD ENZYMOL, V521, P91, DOI 10.1016/B978-0-12-391862-8.00005-3; Kaya AI, 2020, P NATL ACAD SCI USA, V117, P14139, DOI 10.1073/pnas.1918736117; Komolov KE, 2017, CELL SIGNAL, V41, P17, DOI 10.1016/j.cellsig.2017.07.004; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Latorraca NR, 2020, CELL, V183, P1813, DOI 10.1016/j.cell.2020.11.014; Le Y, 2005, J IMMUNOL, V174, P2582, DOI 10.4049/jimmunol.174.5.2582; Leduc M, 2009, J PHARMACOL EXP THER, V331, P297, DOI 10.1124/jpet.109.156398; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Liggett SB, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002331; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luo JS, 2017, MOL PHARMACOL, V91, P554, DOI 10.1124/mol.116.106468; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Malik R, 2012, J BIOL CHEM, V287, P9013, DOI 10.1074/jbc.M111.336792; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Martinez-Munoz L, 2018, MOL CELL, V71, P873, DOI 10.1016/j.molcel.2018.08.012; Mayer D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09204-y; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Mueller W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064975; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; Nguyen HT, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00497-x; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; Perry NA, 2019, P NATL ACAD SCI USA, V116, P810, DOI 10.1073/pnas.1819230116; Peterson YK, 2017, PHARMACOL REV, V69, P256, DOI 10.1124/pr.116.013367; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Thal DM, 2011, MOL PHARMACOL, V80, P294, DOI 10.1124/mol.111.071522; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Verma R, 2015, J BIOL CHEM, V290, P6810, DOI 10.1074/jbc.M114.606699; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; Wyatt D, 2011, J BIOL CHEM, V286, P3884, DOI 10.1074/jbc.M110.152116; Zhan XZ, 2014, CELL SIGNAL, V26, P766, DOI 10.1016/j.cellsig.2014.01.001; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002; Zhuo Y, 2020, J BIOL CHEM, V295, P14111, DOI 10.1074/jbc.RA120.015074; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522	62	0	0	6	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102351	10.1016/j.jbc.2022.102351	http://dx.doi.org/10.1016/j.jbc.2022.102351			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5A7IQ	35940305	Green Published, gold			2022-12-26	WOS:000863057500007
J	Hassen, FS; Malik, T; Dejenie, TA				Hassen, Fethya Seid; Malik, Tabarak; Dejenie, Tadesse Asmamaw			Evaluation of serum uric acid and liver function tests among pregnant women with and without preeclampsia at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia	PLOS ONE			English	Article							BLOOD-PRESSURE; HYPERTENSION; MANAGEMENT; DIAGNOSIS; MORTALITY; DISEASE	Background Pre-eclampsia can be described as new-onset hypertension (blood pressure >= 140/90 mmHg) together with proteinuria (24-hr urinary protein >= 0.3 g) or any indication of endorgan damage after 20 weeks of gestation. Liver and kidney dysfunction, thrombocytopenia, pulmonary edema, and neurologic dysfunction are common manifestations of end-organ damage due to pre-eclampsia. Pre-eclampsia is the most common cause of liver and kidney dysfunction due to hypoxia and endothelial dysfunction. Hyperuricemia indicates kidney dysfunction and is considered a predictor of the severity of preeclampsia. Therefore, the objective of this study is to evaluate the utility of the levels of serum uric acid and liver function tests [alanine aminotransferase (ALT) and aspartate aminotransferase (AST)] as biomarkers of preeclampsia-related organ damage. Methods and materials An institutional-based comparative cross-sectional study design was conducted, and a total of 102 subjects (51 patients with preeclampsia and 51 normotensive pregnant women) were recruited. The parameters measured were levels of serum uric acid and liver function tests. Results and discussion There were statistically significant differences in the mean serum uric acid, ALT, and AST levels between preeclamptic pregnant women and normotensive pregnant women (p<0.05). There were no statistically significant differences in the mean total and direct bilirubin levels. There was also a significant difference in mean serum uric acid, alanine transaminase, and aspartate transaminase levels across different gestational age categories. Conclusion Our study revealed that serum uric acid, ALT, and AST levels were higher in pre-eclamptic pregnant women compared to those of normotensive pregnant women, and the differences were statistically significant. As such, serum uric acid and liver function tests may be considered biomarkers of pre-eclampsia-related end-organ damage.	[Hassen, Fethya Seid; Malik, Tabarak; Dejenie, Tadesse Asmamaw] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Biochem, Gondar, Ethiopia	University of Gondar	Dejenie, TA (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Biochem, Gondar, Ethiopia.	as24tadesse@gmail.com	MALIK, TABARAK/M-3672-2014	MALIK, TABARAK/0000-0002-8332-7927; Asmamaw Dejenie, Tadesse/0000-0002-2033-6113				Abdulkadir K., 2015, British Journal of Medicine and Medical Research, V7, P604; Airoldi J, 2007, OBSTET GYNECOL SURV, V62, P117, DOI 10.1097/01.ogx.0000253301.55009.ac; Angel Garcia Alonso L, 2006, Ann Hepatol, V5, P184; Bell MJ, 2010, JOGNN-J OBST GYN NEO, V39, P510, DOI 10.1111/j.1552-6909.2010.01172.x; Cunningham F.G., 2005, WILLIAMS OBSTET, V22nd, P663; Dani R, 1996, AM J GASTROENTEROL, V91, P292; Ekun Oloruntoba Ayodele, 2018, Int J Reprod Med, V2018, P1594182, DOI 10.1155/2018/1594182; Gaym A, 2011, INT J GYNECOL OBSTET, V115, P112, DOI 10.1016/j.ijgo.2011.07.012; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Haram K, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-8; Hassanpour SH, 2018, GYNECOL OBSTET SUNNY, V8, P2161, DOI 10.4172/2161-0932.1000487; Jacobsson B, 2004, OBSTET GYNECOL, V104, P727, DOI 10.1097/01.AOG.0000140682.63746.be; Jaleel A., 1999, JCPSP-J COLL PHYSICI, V9, P41; Jasovic-Siveska E, 2011, REV MED CHILE, V139, P748, DOI /S0034-98872011000600008; Johnson RJ, 2011, HYPERTENSION, V58, P548, DOI 10.1161/HYPERTENSIONAHA.111.178921; Kaaja R, 2008, Minerva Ginecol, V60, P421; Lam C, 2005, SEMIN NEPHROL, V25, P56, DOI 10.1016/j.semnephrol.2004.09.009; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Malvino E, 2005, MEDICINA-BUENOS AIRE, V65, P17; MINAKAMI H, 1988, AM J OBSTET GYNECOL, V159, P1043, DOI 10.1016/0002-9378(88)90407-3; Munazza Bibi, 2011, J Ayub Med Coll Abbottabad, V23, P3; Nakimuli A, 2014, AM J OBSTET GYNECOL, V210, P510, DOI 10.1016/j.ajog.2013.10.879; Ogawa K, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1540-0; Punthumapol Chanvitya, 2008, Journal of the Medical Association of Thailand, V91; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Sarmah J., 2015, IOSR J DENT MED SCI, V14, P2279; Seely EW, 2014, CIRCULATION, V129, P1254, DOI 10.1161/CIRCULATIONAHA.113.003904; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; Soomro S, 2019, CUREUS, V11, DOI 10.7759/cureus.6115; Stepan H, 2020, HYPERTENSION, V75, P918, DOI 10.1161/HYPERTENSIONAHA.119.13763; Tessema GA, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0502-7; Wagner LK, 2004, AM FAM PHYSICIAN, V70, P2317; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Zhou GL, 2018, EUR J OBSTET GYN R B, V222, P64, DOI 10.1016/j.ejogrb.2018.01.008	34	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272165	10.1371/journal.pone.0272165	http://dx.doi.org/10.1371/journal.pone.0272165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35926005	Green Published, gold			2022-12-26	WOS:000848077100075
J	Kasujja, FX; Mayega, RW; Daivadanam, M; Kiracho, EE; Kusolo, R; Nuwaha, F				Kasujja, Francis Xavier; Mayega, Roy William; Daivadanam, Meena; Kiracho, Elizabeth Ekirapa; Kusolo, Ronald; Nuwaha, Fred			Glycated haemoglobin and fasting plasma glucose tests in the screening of outpatients for diabetes and abnormal glucose regulation in Uganda: A diagnostic accuracy study	PLOS ONE			English	Article							IRON-DEFICIENCY; A1C ASSAY; DISEASE; CARE	Background and objectives To understand the utility of glycated haemoglobin (HBA(1c)) in screening for diabetes and Abnormal Glucose Regulation (AGR) in primary care, we compared its performance to that of the fasting plasma glucose (FPG) test. Methods This was a prospective diagnostic accuracy study conducted in eastern Uganda. Patients eligible for inclusion were consecutive adults, 30-75 years, receiving care at the outpatient department of a general hospital in eastern Uganda. We determined the sensitivity, specificity and optimum cut-off points for HBA(1c) and FPG tests using the oral glucose tolerance test (OGTT) as a clinical reference standard. Results A total of 1659 participants underwent FPG testing of whom 310 were also HBA(1c) and OGTT tested. A total of 113 tested positive for diabetes and 168 for AGR on the OGTT. At recommended cut-off points for diabetes, the HBA(1c) and FPG tests had comparable sensitivity [69.8% (95% CI 46.3-86.1) versus 62.6% (95% CI 41.5-79.8), respectively] and specificity [98.6% (95% CI 95.4-99.6) versus 99.4% (95% CI 98.9-99.7), respectively]. Similarly, the sensitivity of HBA(1c) and the FPG tests for Abnormal Glucose Regulation (AGR) at ADA cut-offs were comparable [58.9% (95% CI 46.7-70.2) vs 47.7% (95% CI 37.3-58.4), respectively]; however, the HBA(1c) test had lower specificity [70.7% (95% CI 65.1-75.8)] than the FPG test [93.5% (95% CI 88.6-96.4)]. At the optimum cut-offs points for diabetes [45.0 mmol/mol (6.3%) for HBA(1c) and 6.4 mmol/L (115.2 mg/dl) for FPG], HBA(1c) and FPG sensitivity [71.2% (95% CI 46.9-87.8) versus 72.7% (95% CI 49.5-87.8), respectively] and specificity [95.1% (95% CI91.8 97.2) versus 98.7% (95% CI 98.0 99.2), respectively] were comparable. Similarly, at the optimum cut-off points for AGR [42.0 mmol/mol (6.0%) for the HBA(1c) and 5.5 mmol/l (99.0 mg/dl) for the FPG test], HBA(1c) and FPG sensitivity [42.3% (95% CI 31.8-53.6) and 53.2 (95% CI 43.1-63.1), respectively] and specificity [89.1% (95% CI 84.1 92.7) and 92.7% (95% CI 91.0 94.1), respectively] were comparable. Discussion HBA(1c) is a viable alternative diabetes screening and confirmatory test to the FPG test; however, the utility of both tests in screening for prediabetes in this outpatient population is limited.	[Kasujja, Francis Xavier; Mayega, Roy William; Kusolo, Ronald] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Kasujja, Francis Xavier] MRC UVRI & LSHTM Uganda Res Unit, Chron Dis & Canc Theme, Entebbe, Uganda; [Daivadanam, Meena] Uppsala Univ, Dept Food Studies Nutr & Dietet, Uppsala, Sweden; [Daivadanam, Meena] Uppsala Univ, Dept Womens & Childrens Hlth, Int Maternal & Child Hlth, Uppsala, Sweden; [Daivadanam, Meena] Karolinska Inst, Dept Global Publ Hlth, Solna, Sweden; [Kiracho, Elizabeth Ekirapa] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda; [Nuwaha, Fred] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda	Makerere University; Uppsala University; Uppsala University; Karolinska Institutet; Makerere University; Makerere University	Kasujja, FX (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda.; Kasujja, FX (corresponding author), MRC UVRI & LSHTM Uganda Res Unit, Chron Dis & Canc Theme, Entebbe, Uganda.	fxkasujja@musph.ac.ug	Daivadanam, Meena/F-1747-2018	Daivadanam, Meena/0000-0002-9532-6059; Kusolo, Ronald/0000-0002-8713-3812; Kasujja, Francis Xavier/0000-0002-4081-2826; Nuwaha, Fred/0000-0001-6285-0834; Mayega, Roy William/0000-0001-6898-4972	Swedish International Development Cooperation Agency (Sida) [HS343]; MRC/UVRI; LSHTM Uganda Research Unit	Swedish International Development Cooperation Agency (Sida); MRC/UVRI(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); LSHTM Uganda Research Unit	This study is funded by the Swedish International Development Cooperation Agency (Sida) capacity-building grant to Makerere University 2015-2020 Project HS343 (https://maksweden.mak.ac.ug/).We also acknowledge the support, both financial and in kind, received from the MRC/UVRI and LSHTM Uganda Research Unit to facilitate the publication of this work.	Albert PS, 2007, BIOMETRICS, V63, P947, DOI 10.1111/j.1541-0420.2006.00734.x; Asmelash D, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/4134937; Bennett CM, 2007, DIABETIC MED, V24, P333, DOI 10.1111/j.1464-5491.2007.02106.x; Bergman M, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108215; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; BROOKS AP, 1980, LANCET, V2, P141; Cavagnolli G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171315; Coban E, 2004, ACTA HAEMATOL-BASEL, V112, P126, DOI 10.1159/000079722; EBERENTZLHOMME C, 1984, DIABETES METAB, V10, P304; Goldenberg R., 2013, CAN J DIABETES, V37; Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319; Hird TR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161966; Imrit C, 2017, POINT CARE, V16, P135, DOI 10.1097/POC.0000000000000142; ISO, 2013, 151972013EN ISO; JAMDAR SC, 1978, BIOCHEM J, V170, P153, DOI 10.1042/bj1700153; Kibirige Davis, 2019, Clin Diabetes Endocrinol, V5, P2, DOI 10.1186/s40842-019-0077-8; Kweka B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244782; Leeflang MMG, 2013, CAN MED ASSOC J, V185, pE537, DOI 10.1503/cmaj.121286; Mayega RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072554; MCCANCE DR, 1994, BRIT MED J, V308, P1323, DOI 10.1136/bmj.308.6940.1323; Monnier L, 2007, DIABETES CARE, V30, P263, DOI 10.2337/dc06-1612; Muchira J, 2019, INT J STD AIDS, V30, P479, DOI 10.1177/0956462418823406; Mwangi MN, 2021, LANCET HAEMATOL, V8, pE732, DOI 10.1016/S2352-3026(21)00193-9; Nakanga WP, 2016, MALAWI MED J, V28, P28, DOI 10.4314/mmj.v28i1.7; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Ndeezi G, 2016, LANCET GLOB HEALTH, V4, pE195, DOI 10.1016/S2214-109X(15)00288-0; Nguyen KA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211483; Park PH, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/6093595; Sacks DB, 2011, DIABETES CARE, V34, P518, DOI 10.2337/dc10-1546; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Selvin E, 2007, ARCH INTERN MED, V167, P1545, DOI 10.1001/archinte.167.14.1545; Weykamp Cas, 2018, J Diabetes Sci Technol, V12, P747, DOI 10.1177/1932296817741320; Who, 2006, DEF DIAGN DIAB MELL; Woerle HJ, 2004, ARCH INTERN MED, V164, P1627, DOI 10.1001/archinte.164.15.1627; World Health Organization, 2019, CLASS DIAB MELL; Yu Hui-Jin, 2017, Laboratory Medicine Online, V7, P182; Zemlin AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022558	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272515	10.1371/journal.pone.0272515	http://dx.doi.org/10.1371/journal.pone.0272515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925994	Green Published, gold			2022-12-26	WOS:000848077100094
J	Kitajima, R; Matsuda, O; Mastunaga, K; Hara, R; Watanabe, A; Kume, A				Kitajima, Ryotaro; Matsuda, Osamu; Mastunaga, Koji; Hara, Ryotaro; Watanabe, Atsushi; Kume, Atsushi			Evaluation of thermoregulation of different pine organs in early spring and estimation of heat reward for the western conifer seed bug (Leptoglossus occidentalis) on male cones	PLOS ONE			English	Article							HOST SELECTION; DOUGLAS-FIR; HETEROPTERA; TEMPERATURE; COREIDAE; BUMBLEBEE; LODGEPOLE; PICEA; ABIES; CUES	The western conifer seed bug (WCSB, Leptoglossus occidentalis) is a pest of many pine species and is invasive worldwide. WCSB directly and indirectly deteriorates pine nut production by sucking seeds from cones. Currently, researchers think that WCSBs search for food by a combination of cues from visible light, infrared radiation, and chemicals such as monoterpenes. Some research revealed that WCSBs prefer larger cones, and it was thought that WCSBs suck seeds from and obtain more heat on larger cones. However, in early spring, we observed that most WCSBs gathered on male cones rather than on female cones and young cones. We hypothesized that male pine cones were warmer than female cones and needles, and WCSBs sucking male cones may receive more heat. To test these hypotheses, we measured spectral reflectance with a hyperspectral sensor and temperature of pine organs with tiny thermocouples, and the data were analyzed by a heat budget model. Our results revealed that male cones were significantly warmer and more reflective than female cones and needles, which may attract WCSBs. These results supported our hypothesis that WCSBs on male cones were warmer than those on other organs. This study will help further understanding of WCSBs and the adaptive value of pine cone colors.	[Kitajima, Ryotaro; Hara, Ryotaro; Watanabe, Atsushi; Kume, Atsushi] Kyushu Univ, Fac Agr, Dept Agroenvironm Sci, Fukuoka, Japan; [Matsuda, Osamu] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka, Japan; [Mastunaga, Koji] Forest Res & Management Org, Forest Tree Breeding Ctr, Forestry & Forest Prod Res Inst, Kyushu Reg Breeding Off, Koshi, Kumamoto, Japan	Kyushu University; Kyushu University; Forestry & Forest Products Research Institute - Japan	Kume, A (corresponding author), Kyushu Univ, Fac Agr, Dept Agroenvironm Sci, Fukuoka, Japan.	akume@agr.kyushu-u.ac.jp	Kume, Atsushi/G-3523-2011	Kume, Atsushi/0000-0002-0048-5680; Matsunaga, Koji/0000-0003-1967-0189	JSPS KAKENHI [JP18H02511]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by JSPS KAKENHI Grant Number JP18H02511,	[Anonymous], 2018, NLEQSLV SOLVE SYSTEM; Barta M, 2016, J PEST SCI, V89, P31, DOI 10.1007/s10340-015-0673-z; Bates SL, 2002, ENVIRON ENTOMOL, V31, P1023, DOI 10.1603/0046-225X-31.6.1023; Benoit T, 2019, **DATA OBJECT**; Blatt SE, 1999, ENVIRON ENTOMOL, V28, P246, DOI 10.1093/ee/28.2.246; Byeon DH, 2021, J ASIA-PAC ENTOMOL, V24, P1077, DOI 10.1016/j.aspen.2021.10.003; Campbell Gaylon S., 1998; Coescielny S, 1962, ROCZ DENDROL POL TOW, V23, P3178; Cruden RW, 2000, PLANT SYST EVOL, V222, P143, DOI 10.1007/BF00984100; DOSKEY PV, 1992, COMMUN SOIL SCI PLAN, V23, P15, DOI 10.1080/00103629209368566; DURZAN DJ, 1968, CAN J BOTANY, V46, P417, DOI 10.1139/b68-064; El Khoury Y, 2021, FORESTS, V12, DOI 10.3390/f12091167; Farinha AO, 2021, FOREST ECOL MANAG, V496, DOI 10.1016/j.foreco.2021.119422; Farinha AO, 2018, NEOBIOTA, P1, DOI 10.3897/neobiota.41.30041; Flores-Renteria L, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00536; Geburek T, 2007, CAN J BOT, V85, P132, DOI 10.1139/B07-003; Griesbach RJ, 2003, BIOCHEM SYST ECOL, V31, P261, DOI 10.1016/S0305-1978(02)00147-3; Heidemann Otto, 1910, Proceedings of the Entomological Society of Washington DC, V12; HEINRICH B, 1973, J EXP BIOL, V58, P677; HEINRICH B, 1972, SCIENCE, V175, P185, DOI 10.1126/science.175.4018.185; Jones H. G., 1992, Plants and microclimate: a quantitative approach to environmental plant physiology.; KOERBER THOMAS W., 1963, ANN ENTOMOL SOC AMER, V56, P229, DOI 10.1093/aesa/56.2.229; KRUGMAN SL, 1969, FOREST SCI, V15, P104; Kume A, 2018, J PLANT RES, V131, P961, DOI 10.1007/s10265-018-1052-7; Lesieur V, 2021, AGR FOREST ENTOMOL, V23, P323, DOI 10.1111/afe.12434; LIU BYH, 1960, SOL ENERGY, V4, P1, DOI 10.1016/0038-092X(60)90062-1; Marden JH, 1996, J EXP BIOL, V199, P529; Matsuda O, 2012, PLANT CELL PHYSIOL, V53, P1154, DOI 10.1093/pcp/pcs043; Miyatake T, 1997, J INSECT BEHAV, V10, P727, DOI 10.1007/BF02765389; R Core Team, 2021, R LANG ENV STAT; Richardson TA, 2017, AGR FOREST ENTOMOL, V19, P245, DOI 10.1111/afe.12203; Rudall PJ, 2020, J EXP BOT, V71, P759, DOI 10.1093/jxb/erz479; Sanborn AF, 2000, J COMP PHYSIOL A, V186, P551, DOI 10.1007/s003590000110; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHOWALTER TD, 1990, J ECON ENTOMOL, V83, P1485, DOI 10.1093/jee/83.4.1485; Strong WB, 2001, CAN ENTOMOL, V133, P857, DOI 10.4039/Ent133857-6; STURGEON KB, 1980, AM J BOT, V67, P1040, DOI 10.2307/2442195; Takacs S, 2009, P ROY SOC B-BIOL SCI, V276, P649, DOI 10.1098/rspb.2008.0742; Wakabayashi H., 2021, BIOL SCI SP, V35, P32, DOI [10.2187/bss.35.32, DOI 10.2187/BSS.35.32]; Zahradnik T, 2012, CAN ENTOMOL, V144, P658, DOI 10.4039/tce.2012.71	40	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272565	10.1371/journal.pone.0272565	http://dx.doi.org/10.1371/journal.pone.0272565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925894	Green Published, gold			2022-12-26	WOS:000848077100099
J	Geremew, AB; Gelagay, AA; Bisetegn, TA; Habitu, YA; Abebe, SM; Birru, EM; Mengistu, TA; Ayele, YT; Yeshita, HY				Geremew, Alehegn Bishaw; Gelagay, Abebaw Addis; Bisetegn, Telake Azale; Habitu, Yohannes Ayanaw; Abebe, Solomon Mekonen; Birru, Eshetie Melese; Mengistu, Temiro Azanaw; Ayele, Yilikal Tiruneh; Yeshita, Hedija Yenus			Prevalence of violence and associated factors among youth in Northwest Ethiopia: Community-based cross-sectional study	PLOS ONE			English	Article							RISK-FACTORS; INJURIES; HEALTH	BackgroundViolence as a known serious public health problem affects people in all stages of life, from childhood to the elderly. In society, one of the most visible forms of violence is young people violence, whereas they, adolescents and young adults, are the main victims of such violence. There was limited information on the burden of violence and factors among this age group. Therefore, this study aimed to determine the prevalence of violence and its associated factors among youth in Northwest, Ethiopia. MethodsA community-based cross-sectional study design was conducted to estimate the magnitude of violence among youth in Northwest, Ethiopia. Data were taken from the mega project entitled assessment of common health problem and risky health behavior among youth. Youth violence was the dependent variable whereas the socio-demographic variables and substance use were the independent-variables. The bivariate logistic regression model was employed to identify associated factors. An adjusted odds ratio with a 95% confidence interval was used to determine factors associated with violence. ResultsFrom the total 1765 representatives of the youth population,1597 (90.5%) youth participated in the study. Overall, the prevalence of violence among youth aged 15-24 years for the last 12 months was 21.5%. In the multivariable logistic regression model, factors significantly associated with violence were being married and divorced (AOR = 1.77, 95%CI: 1.13, 2.79) and (AOR = 5.67, 95%CI: 2.93, 10.99), respectively, living with mother's only (AOR = 1.85,95%CI: 1.28, 2.66) and father's only (AOR = 2.45, 95% CI: 1.30, 4.63), and substance use (AOR = 2.38,95% CI: 1.56, 3.66). ConclusionsThe prevalence of violence among youth was high compared to other studies. Special emphasis Should be given for youth violence in order to manage the victims as well as for preventing and controlling the identified factors through strengthening policies and strategies.	[Geremew, Alehegn Bishaw; Gelagay, Abebaw Addis; Habitu, Yohannes Ayanaw; Yeshita, Hedija Yenus] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Dept Reprod Hlth, Gondar, Ethiopia; [Bisetegn, Telake Azale] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Dept Hlth Educ & Behav Sci, Gondar, Ethiopia; [Abebe, Solomon Mekonen] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Dept Human Nutr, Gondar, Ethiopia; [Birru, Eshetie Melese] Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Pharmacol, Gondar, Ethiopia; [Mengistu, Temiro Azanaw] Hlth Dept, Gondar, Amhara Regional, Ethiopia; [Ayele, Yilikal Tiruneh] Amhara Reg Hlth Bur, Bahir Dar, Amhara Regional, Ethiopia	University of Gondar; University of Gondar; University of Gondar; University of Gondar	Yeshita, HY (corresponding author), Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Dept Reprod Hlth, Gondar, Ethiopia.	kedijayenus@gmail.com		Geremew, Alehegn/0000-0003-4535-1798				Brener N.D., 2004, METHODOLOGY YOUTH RI, DOI 10.2307/24832543; Butchart A., 2015, GLOBAL STATUS REPORT; Chikritzhs T, 2003, AUSTR ALCOHOL INDICA, P200; Ethiopia CSA, 2016, ETHIOPIA DEMOGRAPHIC; Fakhari A, 2012, ASIAN J PSYCHIATR, V5, P24, DOI 10.1016/j.ajp.2012.01.008; Federal Bureau of Investigation, UNIF CRIM REP CRIM U; Federal Democratic Republic of Ethiopia Central Statistical Agency, 2013, POPULATION PROJECTIO; Felitti VJ, 2019, AM J PREV MED, V56, P774, DOI 10.1016/j.amepre.2019.04.001; Golshiri Parastoo, 2018, Adv Biomed Res, V7, P138, DOI 10.4103/abr.abr_137_18; Homel R., 1994, CRIME PREVENTION STU, V3, P1; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Leen E, 2013, AGGRESS VIOLENT BEH, V18, P159, DOI 10.1016/j.avb.2012.11.015; Logie CH, 2019, CONFL HEALTH, V13, DOI 10.1186/s13031-019-0242-9; Lynch J.P., 2011, CRIME PUBLIC POLICY, P5; Mattila VM, 2005, SCAND J PUBLIC HEALT, V33, P307, DOI 10.1080/14034940510005851; Mekuria A, 2015, BMC INT HEALTH HUM R, V15, DOI 10.1186/s12914-015-0059-6; Mercy JA, 2008, INT J INJ CONTROL SA, V15, P197, DOI 10.1080/17457300802406955; MGLSD (Ministry of Gender Labour and Social Development), 2018, VIOL CHILDR SURV FIN; Mokdad AH, 2016, LANCET, V387, P2383, DOI 10.1016/S0140-6736(16)00648-6; Nadkarni A, 2015, ASIA-PAC J PUBLIC HE, V27, pNP2512, DOI 10.1177/1010539511418818; Obradovic-Tomasevic B, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173203; Philpart M, 2009, VIOLENCE VICTIMS, V24, P122, DOI 10.1891/0886-6708.24.1.122; Reza A, 2001, Inj Prev, V7, P104, DOI 10.1136/ip.7.2.104; Saminathan TA., 2019, PREVALENCE FACTORS A, V31; UNICEF, 2014, STAT AN VIOL CHILDR; UNICEF, 2017, FAM FAC VIOL LIV CHI; United Nations, 2021, 17 GOALS SUST DEV; Wang H, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6302-z; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organisation, 2015, WHAT AR INT PEOPL CT	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0264687	http://dx.doi.org/10.1371/journal.pone.0264687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917307	gold, Green Submitted, Green Published			2022-12-26	WOS:000837840000006
J	Kastovska, E; Choma, M; Capek, P; Kana, J; Tahovska, K; Kopacek, J				Kastovska, Eva; Choma, Michal; Capek, Petr; Kana, Jiri; Tahovska, Karolina; Kopacek, Jiri			Soil warming during winter period enhanced soil N and P availability and leaching in alpine grasslands: A transplant study	PLOS ONE			English	Article							NET NITROGEN MINERALIZATION; CLIMATE-CHANGE; ARCTIC TUNDRA; EXTRACTION METHOD; ROOT EXUDATION; PLANT-GROWTH; TEMPERATURE; SNOW; FOREST; MANIPULATION	Alpine meadows are strongly affected by climate change. Increasing air temperature prolongs the growing season and together with changing precipitation patterns alters soil temperature during winter. To estimate the effect of climate change on soil nutrient cycling, we conducted a field experiment. We transferred undisturbed plant-soil mesocosms from two wind-exposed alpine meadows at similar to 2100 m a.s.l. to more sheltered plots, situated similar to 300-400 m lower in the same valleys. The annual mean air temperature was 2 degrees C higher at the lower plots and soils that were normally frozen at the original plots throughout winters were warmed to similar to 0 degrees C due to the insulation provided by continuous snow cover. After two years of exposure, we analyzed the nutrient content in plants, and changes in soil bacterial community, decomposition, mineralization, and nutrient availability. Leaching of N and P from the soils was continuously measured using ion-exchange resin traps. Warming of soils to similar to 0 degrees C during the winter allowed the microorganisms to remain active, their metabolic processes were not restricted by soil freezing. This change accelerated nutrient cycling, as evidenced by increased soil N and P availability, their higher levels in plants, and elevated leaching. In addition, root exudation and preferential enzymatic mining of P over C increased. However, any significant changes in microbial biomass, bacterial community composition, decomposition rates, and mineralization during the growing season were not observed, suggesting considerable structural and functional resilience of the microbial community. In summary, our data suggest that changes in soil temperature and snow cover duration during winter periods are critical for altering microbially-mediated processes (even at unchanged soil microbial community and biomass) and may enhance nutrient availability in alpine meadows. Consequently, ongoing climate change, which leads to soil warming and decreasing snow insulation, has a potential to significantly alter nutrient cycling in alpine and subalpine meadows compared to the current situation and increase the year-on-year variability in nutrient availability and leaching.	[Kastovska, Eva; Choma, Michal; Capek, Petr; Kana, Jiri; Tahovska, Karolina] Univ South Bohemia Ceske Budejovice, Fac Sci, Dept Ecosyst Biol, Ceske Budejovice, Czech Republic; [Kana, Jiri; Kopacek, Jiri] Czech Acad Sci, Biol Ctr, Inst Hydrobiol, Vvi, Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Kastovska, E (corresponding author), Univ South Bohemia Ceske Budejovice, Fac Sci, Dept Ecosyst Biol, Ceske Budejovice, Czech Republic.	ekastovska@prf.jcu.cz	Kopacek, Jiri/A-7373-2014	Kopacek, Jiri/0000-0002-4409-4032	Czech Science Foundation [20-19284S]	Czech Science Foundation(Grant Agency of the Czech Republic)	The study was financed by the Czech Science Foundation (project no. 20-19284S) awarded to JK, URL: https://gacr.cz/en/.The funder had no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aerts R, 2006, PLANT ECOL, V182, P65, DOI 10.1007/s11258-005-9031-1; Aerts R, 2012, OECOLOGIA, V170, P809, DOI 10.1007/s00442-012-2330-z; Aerts R, 2009, FUNCT ECOL, V23, P680, DOI 10.1111/j.1365-2435.2009.01566.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andresen LC, 2005, OECOLOGIA, V144, P585, DOI 10.1007/s00442-005-0044-1; Bai E, 2013, NEW PHYTOL, V199, P441, DOI 10.1111/nph.12252; Barta J, 2014, BIOGEOCHEMISTRY, V117, P525, DOI 10.1007/s10533-013-9898-1; Bender E, 2020, FRONT EARTH SC-SWITZ, V8, DOI 10.3389/feart.2020.00100; Beniston M, 2012, WIRES CLIM CHANGE, V3, P349, DOI 10.1002/wcc.179; Blume-Werry G, 2016, NEW PHYTOL, V209, P978, DOI 10.1111/nph.13655; Bokhorst SF, 2009, J ECOL, V97, P1408, DOI 10.1111/j.1365-2745.2009.01554.x; Bond-Lamberty B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150599; Broadbent AAD, 2021, ISME J, V15, P2264, DOI 10.1038/s41396-021-00922-0; BROOKES PC, 1982, SOIL BIOL BIOCHEM, V14, P319, DOI 10.1016/0038-0717(82)90001-3; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Campbell JL, 2010, HYDROL PROCESS, V24, P2465, DOI 10.1002/hyp.7666; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardenas J, 2021, LAND-BASEL, V10, DOI 10.3390/land10080840; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Debouk H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141899; Diolaiuti GA, 2011, PROG PHYS GEOG, V35, P161, DOI 10.1177/0309133311399494; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elmendorf SC, 2012, NAT CLIM CHANGE, V2, P453, DOI 10.1038/NCLIMATE1465; Gavazov K, 2017, SCI TOTAL ENVIRON, V590, P316, DOI 10.1016/j.scitotenv.2017.03.010; German DP, 2011, SOIL BIOL BIOCHEM, V43, P1387, DOI 10.1016/j.soilbio.2011.03.017; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; Grogan P, 2004, SOIL BIOL BIOCHEM, V36, P641, DOI 10.1016/j.soilbio.2003.12.007; Hart SC, 2006, GLOBAL CHANGE BIOL, V12, P1032, DOI 10.1111/j.1365-2486.2006.01159.x; Henneron L, 2020, NEW PHYTOL, V228, P1269, DOI 10.1111/nph.16760; Henneron L, 2020, J ECOL, V108, P528, DOI 10.1111/1365-2745.13276; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; IPCC, 2021, AR6 CLIM CHANG 2021, DOI DOI 10.1017/9781009157896; Jing X, 2014, BIOGEOCHEMISTRY, V117, P39, DOI 10.1007/s10533-013-9844-2; Kaste O, 2008, AMBIO, V37, P29, DOI 10.1579/0044-7447(2008)37[29:MOSISH]2.0.CO;2; Kopacek J, 2004, WATER AIR SOIL POLL, V153, P307, DOI 10.1023/B:WATE.0000019948.23456.14; KOPACEK J, 1995, COMMUN SOIL SCI PLAN, V26, P1935, DOI 10.1080/00103629509369419; Kopacek J, 2021, ENVIRON POLLUT, V284, DOI 10.1016/j.envpol.2021.117522; Kopacek J, 2017, ENVIRON SCI TECHNOL, V51, P159, DOI 10.1021/acs.est.6b03575; Kudernatsch T, 2008, BASIC APPL ECOL, V9, P263, DOI 10.1016/j.baae.2007.02.005; Lazzaro A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01330; Lenth RV., 2021, EMMEANS ESTIMATED MA; Liang YT, 2015, ISME J, V9, P2561, DOI 10.1038/ismej.2015.78; Lipson DA, 2004, APPL ENVIRON MICROB, V70, P2867, DOI 10.1128/AEM.70.5.2867-2879.2004; Magurran A.E, 2004, MEASURING BIOL DIVER; McLaren JR, 2021, ECOSPHERE, V12, DOI 10.1002/ecs2.3838; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Monson RK, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002684; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; NADELHOFFER KJ, 1991, ECOLOGY, V72, P242, DOI 10.2307/1938918; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Parker TC, 2018, ECOLOGY, V99, P2284, DOI 10.1002/ecy.2442; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pederson GT, 2011, SCIENCE, V333, P332, DOI 10.1126/science.1201570; Pelto MS, 2008, NORTHWEST SCI, V82, P65, DOI 10.3955/0029-344X-82.1.65; Peng F, 2016, ECOL EVOL, V6, P8546, DOI 10.1002/ece3.2583; Pepin N, 2015, NAT CLIM CHANGE, V5, P424, DOI [10.1038/nclimate2563, 10.1038/NCLIMATE2563]; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Puissant J, 2015, SOIL BIOL BIOCHEM, V80, P296, DOI 10.1016/j.soilbio.2014.10.013; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rammig A, 2010, BIOGEOSCIENCES, V7, P2013, DOI 10.5194/bg-7-2013-2010; Rankinen K, 2004, HYDROL EARTH SYST SC, V8, P706, DOI 10.5194/hess-8-706-2004; Riley WJ, 2021, ENVIRON RES LETT, V16, DOI 10.1088/1748-9326/ac0e63; Rinnan R, 2007, GLOBAL CHANGE BIOL, V13, P28, DOI 10.1111/j.1365-2486.2006.01263.x; Rinnan R, 2009, GLOBAL CHANGE BIOL, V15, P2615, DOI 10.1111/j.1365-2486.2009.01959.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Santruckova H, 2009, BIOL FERT SOILS, V45, P395, DOI 10.1007/s00374-008-0349-4; Saxe H, 2001, NEW PHYTOL, V149, P369, DOI 10.1046/j.1469-8137.2001.00057.x; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schimel JP, 2004, SOIL BIOL BIOCHEM, V36, P217, DOI 10.1016/j.soilbio.2003.09.008; Schmidt SK, 2007, ECOLOGY, V88, P1379, DOI 10.1890/06-0164; Schuerings J, 2014, BIOGEOSCIENCES, V11, P7051, DOI 10.5194/bg-11-7051-2014; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; Shibata H, 2013, BIOGEOCHEMISTRY, V116, P69, DOI 10.1007/s10533-013-9882-9; Sinsabaugh RL, 2009, NATURE, V462, P795, DOI 10.1038/nature08632; Svitok M, 2021, FRESHWATER BIOL, V66, P2223, DOI 10.1111/fwb.13827; Tahovska K, 2020, SOIL BIOL BIOCHEM, V143, DOI 10.1016/j.soilbio.2020.107732; Tahovska K, 2016, COMMUN SOIL SCI PLAN, V47, P487, DOI 10.1080/00103624.2015.1123721; Tahovska K, 2010, BOREAL ENVIRON RES, V15, P553; Thomas G. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P159; Turner MM, 2010, OECOLOGIA, V162, P227, DOI 10.1007/s00442-009-1435-5; Uselman SM, 2000, PLANT SOIL, V222, P191, DOI 10.1023/A:1004705416108; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wahren CHA, 2005, GLOBAL CHANGE BIOL, V11, P537, DOI 10.1111/j.1365-2486.2005.00927.x; Wang CH, 2016, GLOBAL CHANGE BIOL, V22, P2963, DOI 10.1111/gcb.13353; Wang QX, 2016, SCI REP-UK, V6, DOI 10.1038/srep19219; Wipf S, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00099.1; Wipf S, 2010, POLAR RES-SWEDEN, V29, P95, DOI 10.1111/j.1751-8369.2010.00153.x; Yin HJ, 2013, GLOBAL CHANGE BIOL, V19, P2158, DOI 10.1111/gcb.12161; Zhang Y, 2008, COLD REG SCI TECHNOL, V52, P355, DOI 10.1016/j.coldregions.2007.07.001	92	0	0	12	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8							e0272143	10.1371/journal.pone.0272143	http://dx.doi.org/10.1371/journal.pone.0272143			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917373	gold, Green Published			2022-12-26	WOS:000837840000048
J	Poeta, LS; Ordonez, MP; Fournier, E; Nelson, AJ				Poeta, Lauren September; Ordonez, Maria Patricia; Fournier, Eric; Nelson, Andrew John			Correlative tomography and authentication features of a shrunken head (tsantsa)	PLOS ONE			English	Article							MULTISCALE	Museum personnel and the general public have become quite familiar with the presence of shrunken heads in museum collections, but the procedures to authenticate the history and origin of these unique cultural items are not yet reliable. These shrunken heads, called tsantsas, are meant to be the cultural material remains of ceremonies conducted by the Shuar and Achuar Peoples of South America. This project seeks to integrate the use of micro-computed tomography (micro-CT) scanning with methods used in previous studies (clinical computed tomography (CT) and visual inspections) to examine authentication procedures of shrunken heads (tsantsas) held in contemporary museum collections. We use a correlative tomographic approach using several scans at successively higher resolutions to determine whether a tsantsa was created from human remains, and if so, what key features can best contribute to its authentication. Conclusively, our correlative tomographic approaches provide new insights into the determination process of whether a tsantsa was created from real human remains or not. Also, this study questions whether the previously conceptualized dichotomy of ceremonial or commercial might be better thought of as a continuum of practice. Investigating and redefining the examination and authentication procedures of tsantsas is crucial for future ethical curation, management, and repatriation efforts of this unique cultural material of the Shuar and Achuar Peoples.	[Poeta, Lauren September; Nelson, Andrew John] Western Univ, Dept Anthropol, London, ON, Canada; [Ordonez, Maria Patricia] Univ San Fransisco Quito, Colegio Ciencias Sociales & Humanidades, Quito, Ecuador; [Fournier, Eric] ORS, Montreal, PQ, Canada	Western University (University of Western Ontario)	Poeta, LS (corresponding author), Western Univ, Dept Anthropol, London, ON, Canada.	lpoeta@uwo.ca		Poeta, Lauren/0000-0002-4818-1790				Acacho J., 2018, THESIS INT I SOCIAL; Aiello A., 1985, P213; [Anonymous], 2021, NEEDLE THREAD CHART; Arriaza BT., 1998, MUMMIES, P190; Baquero-Mendez V, 2021, FORENSIC SCI INT, V325, DOI 10.1016/j.forsciint.2021.110879; Bianchi C., 1982, ARTESANIAS TECNICAS; Bollaert W., 1863, T ETHNOLOGICAL SOC L, V2, P112; Botasso J., 2011, SALESIANOS SHUAR; Bradley RS, 2016, MRS BULL, V41, P549, DOI 10.1557/mrs.2016.137; Burnett TL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04711; Byron CD, 2021, HERIT SCI, V9, DOI 10.1186/s40494-021-00518-z; Caplan J, 2011, CURR OPIN STRUC BIOL, V21, P686, DOI 10.1016/j.sbi.2011.06.010; Castner JL, 2002, SHRUNKEN HEADS TSANT; Charlier P, 2012, FORENSIC SCI INT, V222, DOI 10.1016/j.forsciint.2012.06.009; Chumapi J., 2018, TRADITIONAL INDIGENO; Conlogue GJ., 2020, ADV PALEOIMAGING APP; Cortellini V., 2019, J FORENSIC SCI MED, V5, P20; Cotlow L, 1954, AMAZON HEAD HUNTERS; Fonta CL, 2015, ARCH BIOCHEM BIOPHYS, V581, P98, DOI 10.1016/j.abb.2015.05.017; Foxley S, 2021, NEUROIMAGE, V238, DOI 10.1016/j.neuroimage.2021.118250; Gardner JC, 2004, CAN ASSOC RADIOL J, V55, P228; Houlton TMR, 2016, J CULT HERIT, V20, P660, DOI 10.1016/j.culher.2016.01.009; Houlton TMR, 2018, J CULT HERIT, V32, P238, DOI 10.1016/j.culher.2018.01.004; Karsten R., 1935, COMMENTATIONES HUMAN, V7; Kleiss VE., 1984, ANAT ANZEIGER, V156, P389; Kleiss VE, 1966, WIENER TIERIIRZTLICH, V53, P482; Knecht Lisa, 2012, P129; Marín Manuel, 2012, Rev. peru biol., V19, P3; Mead CW, 1921, NAT HIST, V21, P160; Mutter G L, 1975, Trans Stud Coll Physicians Phila, V43, P78; Nantip E., 2018, TRADITIONAL INDIGENO; Okumura M, 2021, BOLET N ARQUEOLOG A, V30, P145; Peers L., 2009, SOCIAL BODIES, P77; Piniewska D, 2017, INT J LEGAL MED, V131, P643, DOI 10.1007/s00414-016-1448-7; Rae A., 1996, HUMAN MUMMIES MAN IC, V3, P33, DOI [10.1007/978-3-7091-6565-2_4, DOI 10.1007/978-3-7091-6565-2_4]; Rubenstein SL, 2007, CULT ANTHROPOL, V22, P357, DOI 10.1525/can.2007.22.3.357; Salazar E., 1977, INDIAN FEDERATION LO; Sauvageau A, 2009, AM J FOREN MED PATH, V30, P72, DOI 10.1097/PAF.0b013e3181873ca6; Slater TJA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06976-5; Stirling MW, 1938, SMITHSONIAN I BUREAU; Stock SR, 2011, MICROCOMPUTED TOMOGRAPHY: METHODOLOGY AND APPLICATIONS, P1; Timmermans FJ, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4905434; Von Hagen VW, 1937, THEIR HEADS; Wardle HN., 1914, P ACAD NAT SCI PHILA, V66, P197	44	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0270305	http://dx.doi.org/10.1371/journal.pone.0270305			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921270	gold, Green Published			2022-12-26	WOS:000839311900014
J	Schote, AB; Dietrich, K; Linden, AE; Dzionsko, I; Moreno, LDM; Winnikes, U; Zimmer, P; Domes, G; Meyer, J				Schote, Andrea B.; Dietrich, Katharina; Linden, Adrian E.; Dzionsko, Inga; Molano Moreno, Laura De Los Angeles; Winnikes, Ulrike; Zimmer, Patrick; Domes, Gregor; Meyer, Jobst			Real sweating in a virtual stress environment: Investigation of the stress reactivity in people with primary focal hyperhidrosis	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; SALIVARY ALPHA-AMYLASE; PSYCHOSOCIAL STRESS; PREVALENCE; DISORDERS; ANXIETY; GLANDS; RESPONSES; AUDIENCE; TOOL	BackgroundHyperhidrosis (excessive sweating, OMIM %114110) is a complex disorder with multifactorial causes. Emotional strains and social stress increase symptoms and lead to a vicious circle. Previously, we showed significantly higher depression scores, and normal cortisol awakening responses in patients with primary focal hyperhidrosis (PFH). Stress reactivity in response to a (virtual) Trier Social Stress Test (TSST-VR) has not been studied so far. Therefore, we measured sweat secretion, salivary cortisol and alpha amylase (sAA) concentrations, and subjective stress ratings in affected and non-affected subjects in response to a TSST-VR. MethodIn this pilot study, we conducted TSST-VRs and performed general linear models with repeated measurements for salivary cortisol and sAA levels, heart rate, axillary sweat and subjective stress ratings for two groups (diagnosed PFH (n = 11), healthy controls (n = 16)). ResultsPFH patients showed significantly heightened sweat secretion over time compared to controls (p = 0.006), with highest quantities during the TSST-VR. In both groups, sweating (p < 0.001), maximum cortisol levels (p = 0.002), feelings of stress (p < 0.001), and heart rate (p < 0.001) but not sAA (p = 0.068) increased significantly in response to the TSST-VR. However, no differences were detected in subjective ratings, cortisol concentrations and heart rate between PFH patients and controls (p(all) > 0.131). ConclusionPatients with diagnosed PFH showed stress-induced higher sweat secretion compared to healthy controls but did not differ in the stress reactivity with regard to endocrine or subjective markers. This pilot study is in need of replication to elucidate the role of the sympathetic nervous system as a potential pathway involved in the stress-induced emotional sweating of PFH patients.	[Schote, Andrea B.; Dietrich, Katharina; Linden, Adrian E.; Dzionsko, Inga; Molano Moreno, Laura De Los Angeles; Winnikes, Ulrike; Meyer, Jobst] Univ Trier, Inst Psychobiol, Dept Neurobehav Genet, Trier, Germany; [Zimmer, Patrick; Domes, Gregor] Univ Trier, Dept Biol & Clin Psychol, Trier, Germany	Universitat Trier; Universitat Trier	Meyer, J (corresponding author), Univ Trier, Inst Psychobiol, Dept Neurobehav Genet, Trier, Germany.	meyerjo@uni-trier.de			Trier University Research Priority Program "Psychobiology of Stress" - State Rhineland-Palatinate, Germany; Universtity of Trier; German Research Foundation (DFG)	Trier University Research Priority Program "Psychobiology of Stress" - State Rhineland-Palatinate, Germany; Universtity of Trier; German Research Foundation (DFG)(German Research Foundation (DFG))	The study was in part supported by the Trier University Research Priority Program "Psychobiology of Stress", funded by the State Rhineland-Palatinate, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The publication was funded by the Open Access Fund of the Universtity of Trier and the German Research Foundation (DFG) within the Open Access Publishing funding programme.	Ali N, 2020, INT J BEHAV MED, V27, P337, DOI 10.1007/s12529-019-09843-x; Annerstedt M, 2013, PHYSIOL BEHAV, V118, P240, DOI 10.1016/j.physbeh.2013.05.023; Asahina M, 2003, INT J PSYCHOPHYSIOL, V47, P87, DOI 10.1016/S0167-8760(02)00123-X; Augustin M, 2013, DERMATOLOGY, V227, P10, DOI 10.1159/000351292; BARTH JH, 1991, BRIT J DERMATOL, V125, P304, DOI 10.1111/j.1365-2133.1991.tb14162.x; Birner P, 2000, EUR NEUROL, V44, P112, DOI 10.1159/000008207; Boni R, 2001, SWISS MED FORUM, V18, P464, DOI [10.4414/smf.2001.04133, DOI 10.4414/SMF.2001.04133]; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Davidson JRT, 2002, PROG NEURO-PSYCHOPH, V26, P1327, DOI 10.1016/S0278-5846(02)00297-X; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Domes G, 2019, STRESS, V22, P455, DOI 10.1080/10253890.2019.1593366; Doolittle J, 2016, ARCH DERMATOL RES, V308, P743, DOI 10.1007/s00403-016-1697-9; DRESSENDORFER RA, 1992, J STEROID BIOCHEM, V43, P683, DOI 10.1016/0960-0760(92)90294-S; Braganca GMG, 2014, AN BRAS DERMATOL, V89, P230, DOI 10.1590/abd1806-4841.20142189; Gross KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092412; Haider Aamir, 2004, Dermatol Nurs, V16, P515; Harker M, 2013, SKIN PHARMACOL PHYS, V26, P92, DOI 10.1159/000346930; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Holzle Erhard, 2010, J Dtsch Dermatol Ges, V8, P379, DOI 10.1111/j.1610-0387.2009.07250.x; Homma S, 2001, NEUROSCI LETT, V305, P1, DOI 10.1016/S0304-3940(01)01759-1; Homma S, 1998, NEUROSCI LETT, V247, P25, DOI 10.1016/S0304-3940(98)00274-2; Hu Y, 2018, BRIT J DERMATOL, V178, P1246, DOI 10.1111/bjd.15808; Iwase S, 1997, J AUTONOM NERV SYST, V64, P65, DOI 10.1016/S0165-1838(97)00014-3; Kaufmann T, 2011, BEHAV RES METHODS, V43, P1161, DOI 10.3758/s13428-011-0107-7; Kaya D, 2005, ANN NONINVAS ELECTRO, V10, P1, DOI 10.1111/j.1542-474X.2005.00578.x; Kelly O, 2007, CYBERPSYCHOL BEHAV, V10, P655, DOI 10.1089/cpb.2007.9973; Kim SS, 2000, ARCH DERMATOL, V136, P430, DOI 10.1001/archderm.136.3.430; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kothgassner OD, 2016, LECT NOTES COMPUT SC, V9926, P51, DOI 10.1007/978-3-319-46100-7_5; Kritikos J, 2021, FRONT HUM NEUROSCI, V15, DOI 10.3389/fnhum.2021.596980; Kritikos J, 2019, I IEEE EMBS C NEUR E, P571, DOI 10.1109/NER.2019.8717170; Kudielka BM, 2010, STRESS, V13, P1, DOI 10.3109/10253890902874913; Lear W, 2007, DERMATOL SURG, V33, pS69, DOI 10.1111/j.1524-4725.2006.32334.x; Lennartsson AK, 2012, INT J PSYCHOPHYSIOL, V84, P246, DOI 10.1016/j.ijpsycho.2012.03.001; LIPPMAN N, 1994, AM J PHYSIOL, V267, pH411, DOI 10.1152/ajpheart.1994.267.1.H411; Liu YD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153719; Lorentz K, 1999, CLIN CHEM LAB MED, V37, P1053, DOI 10.1515/CCLM.1999.154; Mir MM, 2018, CHRONICLES PHARM SCI, V2, P614, DOI [10.19080/CTBEB.2018.15.555902, DOI 10.19080/CTBEB.2018.15.555902]; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Niu SF, 2011, J NURS RES, V19, P68, DOI 10.1097/JNR.0b013e31820c1879; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; REINAUER S, 1993, BRIT J DERMATOL, V129, P166, DOI 10.1111/j.1365-2133.1993.tb03521.x; Riva G, 2005, CYBERPSYCHOL BEHAV, V8, P220, DOI 10.1089/cpb.2005.8.220; ROBERTSHAW D, 1974, J INVEST DERMATOL, V63, P160, DOI 10.1111/1523-1747.ep12679280; Romero FR, 2016, AN BRAS DERMATOL, V91, P716, DOI 10.1590/abd1806-4841.20165358; Ruchinskas R, 2007, DERMATOLOGY, V214, P195, DOI 10.1159/000099581; SATO K, 1989, J AM ACAD DERMATOL, V20, P537, DOI 10.1016/S0190-9622(89)70063-3; Schlereth T, 2009, DTSCH ARZTEBL INT, V106, P32, DOI 10.3238/arztebl.2009.0032; Schote AB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244565; Schumacher S, 2013, PSYCHONEUROENDOCRINO, V38, P729, DOI 10.1016/j.psyneuen.2013.02.003; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Senard JM, 2003, CLIN AUTON RES, V13, P281, DOI 10.1007/s10286-003-0104-8; Shayesteh A, 2016, DERMATOLOGY, V232, P586, DOI 10.1159/000448032; SHIH CJ, 1983, J AUTONOM NERV SYST, V8, P33, DOI 10.1016/0165-1838(83)90021-8; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Smeets T, 2012, PSYCHONEUROENDOCRINO, V37, P1998, DOI 10.1016/j.psyneuen.2012.04.012; Solish N, 2007, DERMATOL SURG, V33, P908, DOI 10.1111/j.1524-4725.2007.33192.x; Sonntag M, 2004, ZFA Z F R ALLGEMEINM, V80, P289, DOI [10.1055/s-2004-822835, DOI 10.1055/S-2004-822835]; Strutton DR, 2004, J AM ACAD DERMATOL, V51, P241, DOI 10.1016/j.jaad.2003.12.040; Teale C., 2002, QUAL LIFE RES, V11, P619; Thornton MJ, 2002, EXP DERMATOL, V11, P487, DOI 10.1034/j.1600-0625.2002.110601.x; Turner-Cobb JM, 2019, COMPUT HUM BEHAV, V99, P76, DOI 10.1016/j.chb.2019.05.019; UNO H, 1977, J INVEST DERMATOL, V69, P112, DOI 10.1111/1523-1747.ep12497915; Vatheuer CC, 2021, J NEURAL TRANSM, V128, P1269, DOI 10.1007/s00702-021-02344-w; Wang Rena, 2008, Dermatol Nurs, V20, P467; Zimmer P, 2019, PHYSIOL BEHAV, V212, DOI 10.1016/j.physbeh.2019.112690; Zimmer P, 2019, PSYCHONEUROENDOCRINO, V101, P186, DOI 10.1016/j.psyneuen.2018.11.010	68	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272247	http://dx.doi.org/10.1371/journal.pone.0272247			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917298	gold, Green Published			2022-12-26	WOS:000837840000025
J	Senevirathna, N; Amarasiri, L; Jayamanne, D; Manel, K; Liyanage, G				Senevirathna, Niroshani; Amarasiri, Lakmali; Jayamanne, Deepal; Manel, Kanthi; Liyanage, Guwani			Thinness negatively affects lung function among Sri Lankan children	PLOS ONE			English	Article							PULMONARY-FUNCTION; BODY-MASS; OBESITY	BackgroundThere have been conflicting findings on the effect of body mass index (BMI) on lung functions in children. Therefore, we studied the relationship between spirometry parameters and BMI among healthy Sri Lankan school children aged 5-7 years. MethodsA cross-sectional study was conducted among 296 school children (5-7-year-old) without apparent lung disease. Recruitment was done with stratified random sampling. Spirometry parameters, FEV1, FVC, PEFR, and FEV1/FVC ratio were determined. The acceptable and reproducible spirometry recordings were included in the analysis. Simple and multivariate linear regression analysis examined possible associations of lung function parameters with BMI, socio-demographic variables and indoor risk factors. Also, the mediator effect of gender on lung function through BMI was explored. ResultsThe participants' mean age (SD) was 6.4 (0.65) years. One-third were thin/severely thin (37%). A statistically significant difference in FVC (p = 0.001) and FEV1 (p = 0.001) was observed between BMI groups (obesity/overweight, normal, and thinness). Yet, PEFR or FEV1/FVC did not significantly differ among BMI groups (p = 0.23 and p = 0.84). Multivariate regression analysis showed that FEV1 and FVC were significantly associated with BMI, child's age, gender, family income, father's education, having a pet, and exposure to mosquito coil smoke. Interaction between gender and BMI for lung functions was not significant. The thin children had significantly lower FVC (OR: -0.04, 95%CI: -0.077, -0.012, p = 0.008) and FEV1 (OR: -0.04, 95%CI: -0.075, -0.014, p = 0.004) than normal/overweight/obese children. Family income demonstrated the greatest effect on lung functions; FVC and FEV1 were 0.25L and 0.23L smaller in low-income than the high-income families. ConclusionLower lung function parameters (FVC and FEV1) are associated with thinness than normal/overweight/obese dimensions among children without apparent lung disease. It informs that appropriate nutritional intervention may play a role in improving respiratory health.	[Senevirathna, Niroshani] Gen Sir John Kotelawala Def Univ, Fac Allied Hlth Sci, Dept Nursing & Midwifery, Dehiwala Mt Lavinia, Sri Lanka; [Amarasiri, Lakmali] Univ Colombo, Fac Med, Dept Physiol, Colombo, Sri Lanka; [Jayamanne, Deepal] Univ Kelaniya, Fac Med, Dept Publ Hlth, Colombo, Sri Lanka; [Manel, Kanthi] Univ Sri Jayewardenepura, Fac Humanities & Social Sci, Dept Social Stat, Nugegoda, Sri Lanka; [Liyanage, Guwani] Univ Sri Jayewardenepura, Fac Med Sci, Dept Paediat, Nugegoda, Sri Lanka	General Sir John Kotelawala Defence University; University of Colombo; University Kelaniya; University of Colombo; University Sri Jayewardenepura; University Sri Jayewardenepura	Liyanage, G (corresponding author), Univ Sri Jayewardenepura, Fac Med Sci, Dept Paediat, Nugegoda, Sri Lanka.	guwani@sjp.ac.lk						Becklake MR, 1999, THORAX, V54, P1119, DOI 10.1136/thx.54.12.1119; Bejon P, 2008, AM J CLIN NUTR, V88, P1626, DOI 10.3945/ajcn.2008.26510; Chung Sochung, 2015, Ann Pediatr Endocrinol Metab, V20, P125, DOI 10.6065/apem.2015.20.3.125; Davidson WJ, 2014, PEDIATR PULM, V49, P1003, DOI 10.1002/ppul.22915; Davila I, 2018, ALLERGY, V73, P1206, DOI 10.1111/all.13391; Do JG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50488-3; Dong YH, 2019, LANCET CHILD ADOLESC, V3, P871, DOI 10.1016/S2352-4642(19)30302-5; Fernandez-Plata R, 2016, REV INVEST CLIN, V68, P119; Ferreira MS, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-01306-4; Forno E, 2018, J ALLER CL IMM-PRACT, V6, P570, DOI 10.1016/j.jaip.2017.07.010; Furukawa T, 2012, ALLERGOL INT, V61, P489, DOI 10.2332/allergolint.12-OA-0425; Gaffney AW, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2752-3; Graham BL, 2019, AM J RESP CRIT CARE, V200, pE70, DOI 10.1164/rccm.201908-1590ST; Jensen ME, 2014, PEDIATR RES, V75, P93, DOI 10.1038/pr.2013.181; Lin TS, 2005, B ENVIRON CONTAM TOX, V74, P184, DOI 10.1007/s00128-004-0566-y; Liu WL, 2003, ENVIRON HEALTH PERSP, V111, P1454, DOI 10.1289/ehp.6286; Liyanage G, 2016, CEYLON MED J, V61, P163, DOI 10.4038/cmj.v61i4.8382; Mafort TT, 2016, MULTIDISCIP RESP MED, V11, DOI 10.1186/s40248-016-0066-z; Moser JAS, 2019, INFLUENZA OTHER RESP, V13, P3, DOI 10.1111/irv.12618; Naotunna NPGCR, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-4001-1; Nystad W, 2002, THORAX, V57, P1021, DOI 10.1136/thorax.57.12.1021; Oguonu T, 2018, PAEDIATR INT CHILD H, V38, P121, DOI 10.1080/20469047.2018.1445506; Park CH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012281; Safaei M, 2021, COMPUT BIOL MED, V136, DOI 10.1016/j.compbiomed.2021.104754; Salome CM, 2010, J APPL PHYSIOL, V108, P206, DOI 10.1152/japplphysiol.00694.2009; Spathopoulos D, 2009, PEDIATR PULM, V44, P273, DOI 10.1002/ppul.20995; Tantisira KG, 2003, THORAX, V58, P1036, DOI 10.1136/thorax.58.12.1036; Weber David R, 2012, Pediatr Endocrinol Rev, V10, P130; World Health Organisation, 2021, MALN; World Health Organisation, BMI AG 5 19 YEARS	30	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272096	http://dx.doi.org/10.1371/journal.pone.0272096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917365	Green Published, gold			2022-12-26	WOS:000837840000035
J	Tozawa, T; Matsunaga, K; Izumi, T; Shigehisa, N; Uekita, T; Taoka, M; Ichimura, T				Tozawa, Takafumi; Matsunaga, Kohichi; Izumi, Tetsuro; Shigehisa, Naotake; Uekita, Takamasa; Taoka, Masato; Ichimura, Tohru			Ubiquitination-coupled liquid phase separation regulates the accumulation of the TRIM family of ubiquitin ligases into cytoplasmic bodies	PLOS ONE			English	Article							DYSTROPHY TYPE 2H; PROTEIN; TRIM5-ALPHA; AUTOPHAGY	Many members of the tripartite motif (TRIM) family of ubiquitin ligases localize in spherical, membrane-free structures collectively referred to as cytoplasmic bodies (CBs) in a concentration-dependent manner. These CBs may function as aggresome precursors or storage compartments that segregate potentially harmful excess TRIM molecules from the cytosolic milieu. However, the manner in which TRIM proteins accumulate into CBs is unclear. In the present study, using TRIM32, TRIM5 alpha and TRIM63 as examples, we demonstrated that CBs are in a liquid droplet state, resulting from liquid-liquid phase separation (LLPS). This finding is based on criteria that defines phase-separated structures, such as recovery after photobleaching, sensitivity to hexanediol, and the ability to undergo fusion. CB droplets, which contain cyan fluorescent protein (CFP)-fused TRIM32, were purified from HEK293 cells using a fluorescence-activated cell sorter and analyzed by LC-MS/MS. We found that in addition to TRIM32, these droplets contain a variety of endogenous proteins and enzymes including ubiquitin. Localization of ubiquitin within CBs was further verified by fluorescence microscopy. We also found that the activation of the intracellular ubiquitination cascade promotes the assembly of TRIM32 molecules into CBs, whereas inhibition causes suppression. Regulation is dependent on the intrinsic E3 ligase activity of TRIM32. Similar regulation by ubiquitination on the TRIM assembly was also observed with TRIM5 alpha and TRIM63. Our findings provide a novel mechanical basis for the organization of CBs that couples compartmentalization through LLPS with ubiquitination.	[Tozawa, Takafumi; Shigehisa, Naotake; Uekita, Takamasa; Ichimura, Tohru] Natl Def Acad, Dept Appl Chem, Yokosuka, Kanagawa, Japan; [Matsunaga, Kohichi; Izumi, Tetsuro] Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gunma, Japan; [Taoka, Masato] Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo, Japan	National Defence Academy - Japan; Gunma University; Tokyo Metropolitan University	Ichimura, T (corresponding author), Natl Def Acad, Dept Appl Chem, Yokosuka, Kanagawa, Japan.	Ichimura@nda.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21K05322]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank D. Kaganovich and S. Inoue for providing plasmids. We also thank S. Yamada for preparing figures and H. Uchiyama and A. Kashima for assistance in performing some of the experiments.	Albor A, 2006, J BIOL CHEM, V281, P25850, DOI 10.1074/jbc.M601655200; Asaoka K, 2005, BIOCHEM BIOPH RES CO, V338, P1950, DOI 10.1016/j.bbrc.2005.10.173; Azuma K, 2010, ENDOCR J, V57, P455, DOI 10.1507/endocrj.K09E-290; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Bolognesi B, 2016, CELL REP, V16, P222, DOI 10.1016/j.celrep.2016.05.076; Campbell EM, 2007, MOL BIOL CELL, V18, P2102, DOI 10.1091/mbc.E06-12-1075; Carter SD, 2020, P NATL ACAD SCI USA, V117, P29702, DOI 10.1073/pnas.1920323117; Cohen S, 2012, J CELL BIOL, V198, P575, DOI 10.1083/jcb.201110067; Dao TP, 2018, MOL CELL, V69, P965, DOI 10.1016/j.molcel.2018.02.004; Di Rienzo M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau8857; Di Rienzo M, 2019, AUTOPHAGY, V15, P1674, DOI 10.1080/15548627.2019.1635385; Fletcher AJ, 2018, CELL HOST MICROBE, V24, P761, DOI 10.1016/j.chom.2018.10.007; Fu BS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004960; Garcia-Garcia J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251279; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Ichimura T, 2013, J CELL SCI, V126, P2014, DOI 10.1242/jcs.122069; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Kawaguchi Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169436; Kempton HR, 2020, MOL CELL, V78, P184, DOI 10.1016/j.molcel.2020.01.016; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Lukic Z, 2012, CURR HIV-AIDS REP, V9, P73, DOI 10.1007/s11904-011-0102-8; Mandell MA, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00308; Mandell MA, 2014, DEV CELL, V30, P394, DOI 10.1016/j.devcel.2014.06.013; Matzov D, 2020, NUCLEIC ACIDS RES, V48, P11750, DOI 10.1093/nar/gkaa893; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Oshidari R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14546-z; Overa KS, 2019, J CELL SCI, V132, DOI 10.1242/jcs.236596; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Saegusa K, 2014, MOL BIOL CELL, V25, P3095, DOI 10.1091/mbc.E13-09-0530; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Sun DX, 2018, CELL RES, V28, P405, DOI 10.1038/s41422-018-0017-7; Taoka M, 2019, ANAL CHEM, V91, P13494, DOI 10.1021/acs.analchem.9b02555; Taoka M, 2017, ACS APPL MATER INTER, V9, P42661, DOI 10.1021/acsami.7b16095; Watanabe M, 2017, J BIOCHEM, V161, P135, DOI 10.1093/jb/mvw087; Weisberg SJ, 2012, P NATL ACAD SCI USA, V109, P15811, DOI 10.1073/pnas.1205829109; Yang Q, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006600; Yasuda S, 2020, NATURE, V578, P296, DOI 10.1038/s41586-020-1982-9; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608	41	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8							e0272700	10.1371/journal.pone.0272700	http://dx.doi.org/10.1371/journal.pone.0272700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P8ZE	35930602	gold, Green Published			2022-12-26	WOS:000837822100002
J	Pedersen, SS; Prause, M; Williams, K; Barres, R; Billestrup, N				Pedersen, Signe Schultz; Prause, Michala; Williams, Kristine; Barres, Romain; Billestrup, Nils			Butyrate inhibits IL-1 beta-induced inflammatory gene expression by suppression of NF-kappa B activity in pancreatic beta cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE 3; INTERLEUKIN-1-BETA-INDUCED NITRIC-OXIDE; ISLET-ASSOCIATED MACROPHAGES; SIGNAL-REGULATED KINASE; CHAIN FATTY-ACIDS; SODIUM-BUTYRATE; PROINFLAMMATORY CYTOKINES; INSULIN-SECRETION; GUT MICROBIOTA; DYSFUNCTION	Cytokine-induced beta cell dysfunction is a hallmark of type 2 diabetes (T2D). Chronic exposure of beta cells to inflammatory cytokines affects gene expression and impairs insulin secretion. Thus, identification of anti-inflammatory factors that preserve beta cell function represents an opportunity to prevent or treat T2D. Butyrate is a gut microbial metabolite with anti-inflammatory properties for which we recently showed a role in preventing interleukin-1 beta (IL-1 beta)-induced beta cell dysfunction, but how prevention is accomplished is unclear. Here, we investigated the mechanisms by which butyrate exerts anti-inflammatory activity in beta cells. We exposed mouse islets and INS-1E cells to a low dose of IL-1 beta and/or butyrate and measured expression of inflammatory genes and nitric oxide (NO) production. Additionally, we explored the molecular mechanisms underlying butyrate activity by dissecting the activation of the nuclear factor-kappa B (NF-kappa B) pathway. We found that butyrate suppressed IL-1 beta induced expression of inflammatory genes, such as Nos2, Cxcl1, and Ptgs2, and reduced NO production. Butyrate did not inhibit I kappa B alpha degradation nor NF-kappa B p65 nuclear translocation. Furthermore, butyrate did not affect binding of NF-kappa B p65 to target sequences in synthetic DNA but inhibited NF-kappa B p65 binding and RNA polymerase II recruitment to inflammatory gene promoters in the context of native DNA. We found this was concurrent with increased acetylation of NF-kappa B p65 and histone H4, suggesting butyrate affects NF-kappa B activity via inhibition of histone deacetylases. Together, our results show butyrate inhibits IL-1 beta-induced inflammatory gene expression and NO production through suppression of NF-kappa B activation and thereby possibly preserves beta cell function.	[Pedersen, Signe Schultz; Prause, Michala; Billestrup, Nils] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [Williams, Kristine; Barres, Romain] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Barres, Romain] Univ Cote dAzur, Inst Pharmacol Mol & Cellulaire, Valbonne, France; [Barres, Romain] CNRS, Valbonne, France	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS)	Billestrup, N (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark.	billestrup@sund.ku.dk	; BARRES, Romain/N-2501-2016	Pedersen, Signe Schultz/0000-0003-2951-0488; BARRES, Romain/0000-0002-0158-519X; Billestrup, Nils/0000-0002-4968-8067; Prause, Michala/0000-0002-5922-0396	Novo Nordisk Foundation [2019-0057194, 2020-0063502]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by the Novo Nordisk Foundation grants; 2019-0057194 and 2020-0063502.	Adam E, 2004, MOL CELL BIOL, V24, P6890, DOI 10.1128/MCB.24.15.6890.2004; Akesson B, 1996, BRIT J PHARMACOL, V119, P758, DOI 10.1111/j.1476-5381.1996.tb15737.x; Allin KH, 2018, DIABETOLOGIA, V61, P810, DOI 10.1007/s00125-018-4550-1; Bhatt D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00071; Blais M, 2007, DNA CELL BIOL, V26, P133, DOI 10.1089/dna.2006.0532; Burke SJ, 2015, AM J PHYSIOL-ENDOC M, V309, pE715, DOI 10.1152/ajpendo.00153.2015; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Burke SJ, 2013, MOL ENDOCRINOL, V27, P1724, DOI 10.1210/me.2013-1159; Butcher MJ, 2014, DIABETOLOGIA, V57, P491, DOI 10.1007/s00125-013-3116-5; Calao M, 2008, TRENDS BIOCHEM SCI, V33, P339, DOI 10.1016/j.tibs.2008.04.015; Chabane N, 2008, OSTEOARTHR CARTILAGE, V16, P1267, DOI 10.1016/j.joca.2008.03.009; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Christensen AA, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1196-4; Christensen P. D., 2014, LYSINE DEACETYLASE I, V111, P3; Cohrs CM, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.033; Collier JJ, 2017, J MOL ENDOCRINOL, V59, pR33, DOI 10.1530/JME-17-0042; CORBETT JA, 1991, J BIOL CHEM, V266, P21351; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; CORBETT JA, 1994, BIOCHEM J, V299, P719, DOI 10.1042/bj2990719; Darville MI, 1998, DIABETOLOGIA, V41, P1101, DOI 10.1007/s001250051036; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Dirice E, 2017, J BIOL CHEM, V292, P17598, DOI 10.1074/jbc.M117.804328; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donath MY, 2010, TRENDS ENDOCRIN MET, V21, P261, DOI 10.1016/j.tem.2009.12.010; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; Fan Y, 2021, NAT REV MICROBIOL, V19, P55, DOI 10.1038/s41579-020-0433-9; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Hu SX, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041542; Hu YM, 2018, ENVIRON TOXICOL PHAR, V64, P112, DOI 10.1016/j.etap.2018.09.002; Hugenholtz F., 2013, Bioactive Carbohydrates and Dietary Fibre, V2, P133; Huuskonen J, 2004, BRIT J PHARMACOL, V141, P874, DOI 10.1038/sj.bjp.0705682; International Diabetes Federation, 2015, IDF DIABETES ATLAS, V7th ed., DOI DOI 10.1214/AOMS/1177699147; Kaimori J. Y., 2016, SCI REP-UK, V6, P1; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Khan S, 2014, CHEM-BIOL INTERACT, V213, P1, DOI 10.1016/j.cbi.2014.02.001; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; KWON G, 1995, ENDOCRINOLOGY, V136, P4790, DOI 10.1210/en.136.11.4790; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen CM, 1998, J BIOL CHEM, V273, P15294, DOI 10.1074/jbc.273.24.15294; Larsen L, 2007, DIABETOLOGIA, V50, P779, DOI 10.1007/s00125-006-0562-3; Larsen L, 2005, DIABETOLOGIA, V48, P2582, DOI 10.1007/s00125-005-0039-9; Leus NGJ, 2016, CURR OPIN CHEM BIOL, V33, P160, DOI 10.1016/j.cbpa.2016.06.019; Li F, 2008, MOL PHARM, V5, P407, DOI 10.1021/mp700145f; Li HP, 2013, INT J CLIN EXP PATHO, V6, P1574; Liu TF, 2012, INFLAMMATION, V35, P1676, DOI 10.1007/s10753-012-9484-z; Lorza-Gil E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73467-5; Luhrs H, 2001, DIGEST DIS SCI, V46, P1968, DOI 10.1023/A:1010699418024; Martin BJE, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20543-z; Mu MM, 2001, J ENDOTOXIN RES, V7, P431, DOI 10.1179/096805101101533034; Muhammed SJ, 2012, DIABETES OBES METAB, V14, P1010, DOI 10.1111/j.1463-1326.2012.01632.x; NIEMANN A, 1994, MOL CELL ENDOCRINOL, V106, P151, DOI 10.1016/0303-7207(94)90197-X; Nordmann TM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06731-w; Park JeongWoo, 2019, Immune Network, V19, P1; Park JS, 2007, INT IMMUNOPHARMACOL, V7, P70, DOI 10.1016/j.intimp.2006.08.015; Pirozzi C, 2018, CELL PHYSIOL BIOCHEM, V51, P228, DOI 10.1159/000495203; Place RF, 2005, BIOCHEM PHARMACOL, V70, P394, DOI 10.1016/j.bcp.2005.04.030; Prause M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms221910427; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quivy V, 2004, BIOCHEM PHARMACOL, V68, P1221, DOI 10.1016/j.bcp.2004.05.039; Richardson SJ, 2009, DIABETOLOGIA, V52, P1686, DOI 10.1007/s00125-009-1410-z; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Sanna S, 2019, NAT GENET, V51, P600, DOI 10.1038/s41588-019-0350-x; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; Spinas GA, 1999, NEWS PHYSIOL SCI, V14, P49, DOI 10.1152/physiologyonline.1999.14.2.49; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Stiehl DP, 2007, CANCER RES, V67, P2256, DOI 10.1158/0008-5472.CAN-06-3985; Susick L, 2008, J CELL MOL MED, V12, P1571, DOI 10.1111/j.1582-4934.2007.00171.x; Susick L, 2009, J CELL MOL MED, V13, P1877, DOI 10.1111/j.1582-4934.2009.00672.x; Urizar AI, 2019, MOL CELL ENDOCRINOL, V496, DOI 10.1016/j.mce.2019.110524; Wang SS, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-04517-1; Wang T, 2018, EPIGENETICS-US, V13, P519, DOI 10.1080/15592294.2018.1475979; Wu H, 2020, CELL METAB, V32, P379, DOI 10.1016/j.cmet.2020.06.011; Xu YH, 2018, J ENDOCRINOL, V238, P231, DOI 10.1530/JOE-18-0137; Yin L, 2001, J BIOL CHEM, V276, P44641, DOI 10.1074/jbc.M105170200; Yu ZT, 2002, J AM SOC NEPHROL, V13, P2009, DOI 10.1097/01.ASN.0000024253.59665.F1; Yu ZY, 2006, AM J PHYSIOL-RENAL, V290, pF496, DOI 10.1152/ajprenal.00316.2005; Zhang L, 2021, TRENDS ENDOCRIN MET, V32, P159, DOI 10.1016/j.tem.2020.12.003; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Ziesche E, 2013, NUCLEIC ACIDS RES, V41, P90, DOI 10.1093/nar/gks916	87	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102312	10.1016/j.jbc.2022.102312	http://dx.doi.org/10.1016/j.jbc.2022.102312			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6F7ME	35921894	gold, Green Published			2022-12-26	WOS:000884241800003
J	Mendes, M; Jonnalagadda, M; Ozarkar, S; Torres, FCL; Pua, VB; Kendall, C; Tarazona-Santos, E; Parra, EJ				Mendes, Marla; Jonnalagadda, Manjari; Ozarkar, Shantanu; Torres, Flavia Carolina Lima; Pua, Victor Borda; Kendall, Christopher; Tarazona-Santos, Eduardo; Parra, Esteban J.			Identifying signatures of natural selection in Indian populations	PLOS ONE			English	Article							POSITIVE SELECTION; GENOMIC INSIGHTS; PERSPECTIVES; ADAPTATION; COMPONENTS; DIVERSITY; MIGRATION; GENES; SCANS	In this study, we present the results of a genome-wide scan for signatures of positive selection using data from four tribal groups (Kokana, Warli, Bhil, and Pawara) and two caste groups (Deshastha Brahmin and Kunbi Maratha) from West of the Maharashtra State In India, as well as two samples of South Asian ancestry from the 1KG project (Gujarati Indian from Houston, Texas and Indian Telugu from UK). We used an outlier approach based on different statistics, including PBS, xpEHH, IHS, CLR, Tajima's D, as well as two recently developed methods: Graph-aware Retrieval of Selective Sweeps (GRoSS) and Ascertained Sequentially Markovian Coalescent (ASMC). In order to minimize the risk of false positives, we selected regions that are outliers in all the samples included in the study using more than one method. We identified putative selection signals in 107 regions encompassing 434 genes. Many of the regions overlap with only one gene. The signals observed using microarray-based data are very consistent with our analyses using high-coverage sequencing data, as well as those identified with a novel coalescence-based method (ASMC). Importantly, at least 24 of these genomic regions have been identified in previous selection scans in South Asian populations or in other population groups. Our study highlights genomic regions that may have played a role in the adaptation of anatomically modern humans to novel environmental conditions after the out of Africa migration.	[Mendes, Marla; Torres, Flavia Carolina Lima; Tarazona-Santos, Eduardo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Genet Ecol & Evolucao, Belo Horizonte, MG, Brazil; [Mendes, Marla; Kendall, Christopher; Parra, Esteban J.] Univ Toronto, Dept Anthropol, Mississauga Campus, Mississauga, ON, Canada; [Jonnalagadda, Manjari] Symbiosis Int Univ SIU, Symbiosis Sch Liberal Arts SSLA, Pune, Maharashtra, India; [Ozarkar, Shantanu] Savitribai Phule Pune Univ, Dept Anthropol, Pune, Maharashtra, India; [Pua, Victor Borda] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA	Universidade Federal de Minas Gerais; University of Toronto; Symbiosis International University; Symbiosis School for Liberal Arts (SSLA); Savitribai Phule Pune University; University System of Maryland; University of Maryland Baltimore	Parra, EJ (corresponding author), Univ Toronto, Dept Anthropol, Mississauga Campus, Mississauga, ON, Canada.	esteban.parra@utoronto.ca		Aquino, Marla/0000-0002-6114-7482; Carolina Lima Torres, Flavia/0000-0001-6486-6418; parra, esteban J/0000-0002-2057-8577	Mitacs Globalink Research Award [FR37903]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [88887.474324/2020-00]; Fundacao de Amparo da Pesquisa do Estado de Minas Gerais (FAPEMIG); SSHRC insight grant; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) from Brazil; Canadian Natural Sciences and Engineering Research Council (NSERC)	Mitacs Globalink Research Award; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo da Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); SSHRC insight grant; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) from Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Canadian Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	MM was supported by a Mitacs Globalink Research Award (FR37903) and by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (88887.474324/2020-00), FCLT was supported by Fundacao de Amparo da Pesquisa do Estado de Minas Gerais (FAPEMIG), CK was supported by a SSHRC insight grant to B Viola, ETS was supported by Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnologico (CNPq) from Brazil and EJP has received funding from the Canadian Natural Sciences and Engineering Research Council (NSERC Discovery Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Basu A, 2016, P NATL ACAD SCI USA, V113, P1594, DOI 10.1073/pnas.1513197113; Benazzo A, 2015, ECOL EVOL, V5, P172, DOI 10.1002/ece3.1261; Bergstrom A, 2020, SCIENCE, V367, P1339, DOI 10.1126/science.aay5012; Bigham Abigail W., 2009, Human Genomics, V4, P79; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Bittles AH, 2002, J GENET, V81, P91, DOI 10.1007/BF02715905; Byrska-Bishop M., HIGH COVERAGE WHOLE, DOI [10.1101/2021.02.06.430068, DOI 10.1101/2021.02.06.430068, 10.1101/ 2021.02.06.430068]; CAVALLISFORZA LL, 1969, SCI AM, V221, P30, DOI 10.1038/scientificamerican0869-30; Chaubey G, 2007, BIOESSAYS, V29, P91, DOI 10.1002/bies.20525; Crawford JE, 2017, AM J HUM GENET, V101, P752, DOI 10.1016/j.ajhg.2017.09.023; Debortoli G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66953-3; Delaneau O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13225-y; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Hancock AM, 2008, ANNU REV ANTHROPOL, V37, P197, DOI 10.1146/annurev.anthro.37.081407.085141; Jain A, 2021, NUCLEIC ACIDS RES, V49, pD1225, DOI 10.1093/nar/gkaa923; Jonnalagadda M, 2019, GENOME BIOL EVOL, V11, P1066, DOI 10.1093/gbe/evz057; Jonnalagadda M, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.23012; Jonnalagadda M, 2016, AM J HUM BIOL, V28, P36, DOI 10.1002/ajhb.22738; Juyal G, 2014, HUM GENET, V133, P1273, DOI 10.1007/s00439-014-1462-0; Karlsson EK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006338; Kim Y, 2002, GENETICS, V160, P765; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Liu XY, 2017, EUR J HUM GENET, V25, P499, DOI 10.1038/ejhg.2016.181; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; McColl H, 2018, SCIENCE, V361, P88, DOI 10.1126/science.aat3628; Mellars P, 2013, P NATL ACAD SCI USA, V110, P10699, DOI 10.1073/pnas.1306043110; Metspalu M, 2018, CURR OPIN GENET DEV, V53, P128, DOI 10.1016/j.gde.2018.09.003; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; Meyer D, 2018, IMMUNOGENETICS, V70, P5, DOI 10.1007/s00251-017-1017-3; Nakatsuka N, 2017, NAT GENET, V49, P1403, DOI 10.1038/ng.3917; Narasimhan VM, 2019, SCIENCE, V365, P999, DOI 10.1126/science.aat7487; Nowick K, 2010, MOL BIOL EVOL, V27, P2606, DOI 10.1093/molbev/msq157; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; Owen RP, 2010, PHARMACOGENET GENOM, V20, P642, DOI 10.1097/FPC.0b013e32833433b6; Pagani L, 2016, NATURE, V538, P238, DOI 10.1038/nature19792; Palamara PF, 2018, NAT GENET, V50, P1311, DOI 10.1038/s41588-018-0177-x; Patillon B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053049; Patin E, 2017, SCIENCE, V356, P543, DOI 10.1126/science.aal1988; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pavlidis P, 2013, MOL BIOL EVOL, V30, P2224, DOI 10.1093/molbev/mst112; Perdomo-Sabogal A, 2019, GENOME BIOL EVOL, V11, P2178, DOI 10.1093/gbe/evz131; Peter BM, 2020, MOL BIOL EVOL, V37, P943, DOI 10.1093/molbev/msz280; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Racimo F, 2018, GENETICS, V208, P1565, DOI 10.1534/genetics.117.300489; Reddy BM, 2010, AM J HUM BIOL, V22, P410, DOI 10.1002/ajhb.20983; Rees JS, 2020, TRENDS GENET, V36, P415, DOI 10.1016/j.tig.2020.03.006; Refoyo-Martinez A., 2018, IDENTIFYING LOCI POS; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Ross KA, 2010, J HUM GENET, V55, P582, DOI 10.1038/jhg.2010.73; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Shinde V, 2019, CELL, V179, P729, DOI 10.1016/j.cell.2019.08.048; Silva M, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0936-9; Suo C, 2012, EUR J HUM GENET, V20, P102, DOI 10.1038/ejhg.2011.139; Szpiech ZA, 2014, MOL BIOL EVOL, V31, P2824, DOI 10.1093/molbev/msu211; TAJIMA F, 1989, GENETICS, V123, P585; Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Widjaja-Adhi MAK, 2017, P NATL ACAD SCI USA, V114, P11530, DOI 10.1073/pnas.1714963114; Xing JC, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r113; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	67	0	0	9	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0271767	10.1371/journal.pone.0271767	http://dx.doi.org/10.1371/journal.pone.0271767			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925921	gold, Green Published			2022-12-26	WOS:000848077100050
J	Dawkins, B; Aruparayil, N; Ensor, T; Gnanaraj, J; Brown, J; Jayne, D; Shinkins, B				Dawkins, Bryony; Aruparayil, Noel; Ensor, Tim; Gnanaraj, Jesudian; Brown, Julia; Jayne, David; Shinkins, Bethany			Cost-effectiveness of gasless laparoscopy as a means to increase provision of minimally invasive surgery for abdominal conditions in rural North-East India	PLOS ONE			English	Article							CARBON-DIOXIDE-PNEUMOPERITONEUM; WALL LIFT; CHOLECYSTECTOMY; INSUFFLATION; HEMODYNAMICS; BENEFITS; TRIAL; CO2	Laparoscopic surgery, a minimally invasive technique to treat abdominal conditions, has been shown to produce equivalent safety and efficacy with quicker return to normal function compared to open surgery. As such, it is widely accepted as a cost-effective alternative to open surgery for many abdominal conditions. However, access to laparoscopic surgery in rural North-East India is limited, in part due to limited equipment, unreliable supplies of CO2 gas, lack of surgical expertise and a shortage of anaesthetists. We evaluate the cost-effectiveness of gasless laparoscopy as a means to increase provision of minimally invasive surgery (MIS) for abdominal conditions in rural North-East India. A decision tree model was developed to compare costs, evaluated from a patient perspective, and health outcomes, disability adjusted life years (DALYs), associated with gasless laparoscopy, conventional laparoscopy or open abdominal surgery in rural North-East India. Results indicate that MIS (performed by conventional or gasless laparoscopy) is less costly and produces better outcomes, fewer DALYs, than open surgery. These results were consistent even when gasless laparoscopy was analysed using least favourable data from the literature. Scaling up provision of MIS through increased access to gasless laparoscopy would reduce the cost burden to patients and increase DALYs averted. Based on a sample of 12 facilities in the North-East region, if scale up was achieved so that all essential surgeries amenable to laparoscopic surgery were performed as such (using conventional or gasless laparoscopy), 64% of DALYS related to these surgeries could be averted, equating to an additional 454.8 DALYs averted in these facilities alone. The results indicate that gasless laparoscopy is likely to be a cost-effective alternative to open surgery for abdominal conditions in rural North-East India and provides a possible bridge to the adoption of full laparoscopic services.	[Dawkins, Bryony; Aruparayil, Noel; Shinkins, Bethany] Univ Leeds, Acad Unit Hlth Econ, Leeds, England; [Aruparayil, Noel; Jayne, David] St James Univ Leeds, Leeds Inst Med Res, Leeds, England; [Ensor, Tim] Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds, England; [Gnanaraj, Jesudian] Karunya Inst Technol & Sci, Coimbatore, India; [Brown, Julia] Univ Leeds, Leeds Inst Clin Trials Res, Leeds, England	University of Leeds; University of Leeds; Karunya Institute of Technology & Sciences; University of Leeds	Dawkins, B (corresponding author), Univ Leeds, Acad Unit Hlth Econ, Leeds, England.	B.Dawkins1@leeds.ac.uk		Shinkins, Bethany/0000-0001-5350-1018; brown, julia/0000-0002-2719-7064; Dawkins, Bryony/0000-0002-7038-1975; Aruparayil, Noel/0000-0002-2898-772X; Ensor, Timothy/0000-0003-0279-9576	National Institute for Health Research (NIHR) [16/137/44]; UK Government	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); UK Government	This research was funded by National Institute for Health Research (NIHR) (16/137/44) using UK Aid from the UK Government to support global health research. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the UK Department of Health and Social Care. The funding agency had no role in: the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; nor decision to submit the manuscript for publication.	Alijani A, 2004, ANN SURG, V239, P388, DOI 10.1097/01.sla.0000114226.31773.e3; Aruparayil N, 2021, SURG ENDOSC, V35, P6427, DOI 10.1007/s00464-021-08677-7; Bertram MY, 2016, B WORLD HEALTH ORGAN, V94, P925, DOI 10.2471/BLT.15.164418; Caro JJ, 2012, MED DECIS MAKING, V32, P667, DOI 10.1177/0272989X12454577; Chao TE, 2016, SURG ENDOSC, V30, P1, DOI 10.1007/s00464-015-4201-2; Drummond MF, 2015, METHODS EC EVALUATIO; Egawa H, 2006, SURG LAPARO ENDO PER, V16, P78, DOI 10.1097/00129689-200604000-00004; Galizia G, 2001, SURG ENDOSC-ULTRAS, V15, P477, DOI 10.1007/s004640000343; Gehrman J, 2020, SURG ENDOSC, V34, P4403, DOI 10.1007/s00464-019-07214-x; Global Burden of Disease Study, 2017, GLOBAL BURDEN DIS ST; GlobalSurg Collaborative, 2018, Lancet Infect Dis, V18, P516, DOI [10.1016/S1473-3099(18)30101-4, 10.1016/s1473-3099(18)30101-4]; Gnanaraj J, 2021, TROP DOCT, V51, P123, DOI 10.1177/0049475520945444; Government of India International Institute for Population Sciences (IIPS) and ICF, 2022, NATL FAMILY HLTH SUR; KITANO S, 1993, SURG ENDOSC-ULTRAS, V7, P311, DOI 10.1007/BF00725947; Koivusalo AM, 1996, BRIT J ANAESTH, V77, P576, DOI 10.1093/bja/77.5.576; Koivusalo AM, 1996, BRIT J SURG, V83, P1532, DOI 10.1002/bjs.1800831112; Larsen JF, 2004, BRIT J SURG, V91, P848, DOI 10.1002/bjs.4573; Larsen JF, 2001, J GASTROINTEST SURG, V5, P330, DOI 10.1016/S1091-255X(01)80056-1; Luks FI, 1999, ARCH PEDIAT ADOL MED, V153, P965, DOI 10.1001/archpedi.153.9.965; Masoomi H, 2015, WORLD J SURG, V39, P1240, DOI 10.1007/s00268-015-2958-z; Meijer DW, 1997, SURG ENDOSC-ULTRAS, V11, P645, DOI 10.1007/s004649900412; Mishra A, 2020, J AM COLL SURGEONS, V231, P511, DOI 10.1016/j.jamcollsurg.2020.07.783; National Institute for Health and Care Excellence (NICE), 2009, BORDERLINE PERSONALI; NHS, 2018, OV LAP KEYH SURG; NICE) NIfHaCE, 2004, LAP PYEL IPG 46; Ochalek J, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000964; Pawar M., 2006, JK SCI, V8, P73; Robinson LA, 2017, HEALTH POLICY PLANN, V32, P141, DOI 10.1093/heapol/czw096; Rosenbaum AJ, 2019, ANN GLOB HEALTH, V85, DOI 10.5334/aogh.2573; Schulze S, 1999, ARCH SURG-CHICAGO, V134, P1112, DOI 10.1001/archsurg.134.10.1112; Sietses C, 2002, SURG ENDOSC, V16, P525, DOI 10.1007/s00464-001-0063-x; Spiegel DA, 2013, WORLD J SURG, V37, P1462, DOI 10.1007/s00268-012-1831-6; Uen YH, 2002, J LAPAROENDOSC ADV A, V12, P7, DOI 10.1089/109264202753486867; Vazquez-Rosales MA, 2010, SURG LAPARO ENDO PER, V20, P416, DOI 10.1097/SLE.0b013e3182002fd0; Weiser TG, 2015, LANCET, V385, P11, DOI 10.1016/S0140-6736(15)60806-6; Wilkinson E, 2020, IJS GLOBAL HLTH, V3, pE29, DOI 10.1097/gh9.0000000000000029; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0271559	http://dx.doi.org/10.1371/journal.pone.0271559			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921367	Green Published, gold			2022-12-26	WOS:000839311900072
J	Getu, A; Wolde, HF; Animut, Y; Kibret, AA				Getu, Amare; Wolde, Haileab Fekadu; Animut, Yaregal; Kibret, Anteneh Ayelign			Incidence and predictors of Tuberculosis among patients enrolled in Anti-Retroviral Therapy after universal test and treat program, Addis Ababa, Ethiopia. A retrospective follow -up study	PLOS ONE			English	Article							HIV-ASSOCIATED TUBERCULOSIS; INFECTED PATIENTS; RISK-FACTORS	IntroductionTuberculosis (TB) is the leading killer of people living with HIV (PLHIV) and almost one-third of deaths in the world are attributed to it and many of these deaths occur in developing countries. Despite these evidences, after the implementation of universal test and treat (UTT) strategy, information regarding the incidence and predictors of tuberculosis among PLHIV is limited in Ethiopia. Therefore, this study aimed to assess the incidence and predictors of tuberculosis among patients enrolled in Anti-Retroviral Therapy (ART) after universal test and treat program at St. Peter hospital and Zewditu Memorial Hospital, Addis Ababa, Ethiopia. MethodsInstitutional-based retrospective cohort study was conducted from November 1 to 30, 2020. Simple random sampling was used to select a total of 539 adults records which was enrolled on ART. Data was collected and entered into EPI DATA 3.1 and analyzed using STATA version 14.1. Time-to-event distributions were estimated using Kaplan-Meier estimates. Hazards across different categories were compared using log-rank tests. Predictors were identified using the Cox proportional hazards model. The hazard ratio (HR) and 95% confidence interval (CI) were computed. Variables having P-value < 0.05 from the multivariable analysis were considered as a statistically significant. ResultAmong 539 records reviewed, 529 (98%) were included in the final analysis. The total follow-up period was 1529 Person-Year (PY). The incidence rate in this cohort was found to be 4.84 per 100-person year (95%CI,3.83-6.11). CD4 count<200 (AHR: 3.14,95% CI:1.64-7.10), poor adherence (AHR:2.16, 95% CI:1.21-3.85), underweight (AHR:2.42, 95% CI: 1.30-4.51), not taking isoniazid prophylaxis therapy (AHR: 2.78,95% CI: 1.06-7.30), being bedridden 3.06; (AHR: 3.06, 95% CI: 1.50-6.24), and baseline WHO stage three or four (AHR:2.33, 95% CI:1.08-5.02) were independent predictors for the incidence of TB among HIV positive patients. ConclusionIn this study, the incidence of tuberculosis is relatively low as compared to studies done before the initiation of test and treat program in Ethiopia. low CD4count, poor level of adherence, low BMI, not taking IPT prophylaxis, bedridden functional status, and being on baseline WHO stage III or IV were found to increase the hazard of tuberculosis. Hence, close follow up, reminders, surveillance, and tracing mechanisms targeting this higher risk group would decrease Tuberculosis among PLHIV.	[Getu, Amare] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Wolde, Haileab Fekadu; Animut, Yaregal] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Kibret, Anteneh Ayelign] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Human Anat, Gondar, Ethiopia	University of Gondar; University of Gondar	Kibret, AA (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Human Anat, Gondar, Ethiopia.	antesha04@gmail.com		Kibret, Anteneh Ayelign/0000-0002-4487-5015				Abdu M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248490; Abebe A., 2014, J HLTH MED INFORM, V5, P156, DOI [10.4172/2157-7420.1000156, DOI 10.4172/2157-7420.1000156]; Ahmed A., 2015, AIDS, V1, P3; Ahmed A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-016961; Alene KA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-292; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Barnard J, 2014, AM J RESP CRIT CARE, V186; CDC, 2019, ETH CDC DIV GLOB HIV; Centers for Diseases control and prevention (CDC), GLOB HIV TUB ETH COU; Dalbo M., 2016, ADV INFECT DIS, V06, P70, DOI 10.4236/aid.2016.62010; Fenton Kevin, 2005, GUIDELINES INVESTIGA, V54, P37; Geleto Ayele, 2017, Int J Health Sci (Qassim), V11, P1; Geremew D, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4031-2; Girum T., 2020, UNIVERSAL TEST TREAT, DOI [10.1186/s40794-020-00113-3, DOI 10.1186/S40794-020-00113-3]; Girum T, 2020, TROP DIS TRAVEL MED, V6, DOI 10.1186/s40794-020-00113-3; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Habtamu Oljira MI., 2015, J MED PHYS BIOPHYS, V33, P2422; Inzaule S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093106; Jonathan E., 2009, AIDS, V23; Kassa A, 2012, T ROY SOC TROP MED H, V106, P363, DOI 10.1016/j.trstmh.2012.03.002; Kenneth L., 2013, SUPPLEMENTS FEATURED, V19; Kibret KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064488; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Liu EJ, 2015, AIDS, V29, P1391, DOI 10.1097/QAD.0000000000000705; Markowitz N, 1997, ANN INTERN MED, V126, P123, DOI 10.7326/0003-4819-126-2-199701150-00005; Maro I, 2010, INT J TUBERC LUNG D, V14, P1447; Melkamu H, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/279876; Musa BM, 2015, ANN THORAC MED, V10, P185, DOI 10.4103/1817-1737.160838; NARAIN JP, 1992, TUBERCLE LUNG DIS, V73, P311, DOI 10.1016/0962-8479(92)90033-G; Okoye AA, 2013, IMMUNOL REV, V254, P54, DOI 10.1111/imr.12066; Taha M, 2011, ETHIOP J HEALTH SCI, V21, P131; Tesfaye B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203986; World Health Organization, 2021, 10 THREATS GLOB HLTH	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272358	http://dx.doi.org/10.1371/journal.pone.0272358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921384	Green Published, gold			2022-12-26	WOS:000839311900052
J	da Costa, GM; Sanchez, MN; Shimizu, HE				Marques da Costa, Geraldo; Niskier Sanchez, Mauro; Eri Shimizu, Helena			Factors associated with mortality of the elderly due to ambulatory care sensitive conditions, between 2008 and 2018, in the Federal District, Brazil	PLOS ONE			English	Article							HEALTH-CARE; DETERMINANTS	IntroductionIn Brazil, the Unified Health System (Sistema unico de Saude, or SUS) provides health care, and an aging population overwhelms the system due to the greater vulnerability of the elderly. In the Federal District, two models of primary care coexist-the traditional primary care and the family health strategy. The present study aimed to analyze the factors associated with mortality of the elderly due to conditions sensitive to ambulatory care in the Federal District, Brazil. Materials and methodsThis cross-sectional study investigated all deaths that occurred in people over 60 years old between 2008 and 2018. The variables studied were age at death, sex, marital status, education, race/color, death by condition sensitive to ambulatory care, and population coverage of primary care services. The Urban Well-Being Index (UWBI) was used, which includes the dimensions: mobility, environmental and housing conditions, infrastructure, and collective services, to analyze issues related to the place where the senior citizen resides. ResultsThe deaths 70,503 senior citizens were recorded during the study period. The factors associated with mortality in the elderly due to ambulatory care sensitive conditions were male, lower income, and less education. Residing in a place with poor UWBI presented a response gradient with higher mortality. Increased ambulatory care coverage was also associated with lower mortality. ConclusionsThe study evidenced an association between male gender, age, income, and education, and UWBI with lower mortality due to ambulatory care sensitive conditions, and these associations presented a response gradient. The study also found that increased coverage of the elderly population was associated with lower mortality from sensitive conditions.	[Marques da Costa, Geraldo; Niskier Sanchez, Mauro; Eri Shimizu, Helena] Univ Brasilia, Fac Hlth Sci, Publ Hlth Dept, Brasilia, DF, Brazil	Universidade de Brasilia	da Costa, GM (corresponding author), Univ Brasilia, Fac Hlth Sci, Publ Hlth Dept, Brasilia, DF, Brazil.	geraldomarques06@gmail.com						Alfradique ME, 2009, CAD SAUDE PUBLICA, V25, P1337, DOI 10.1590/S0102-311X2009000600016; [Anonymous], PORTAL INFORMACOES E; [Anonymous], R LANG ENV STAT COMP; Borim FSA, 2017, REV SAUDE PUBL, V51, DOI 10.1590/S1518-8787.2017051006708; Bento Jorge Avelino, 2021, Rev. bras. epidemiol., V24, pe210021, DOI 10.1590/1980-549720210021; Bernstein SF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195734; Brasil. Ministerio da Saude, 2008, PORT N 221 17 AB; Compton J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250564; Geib LTC, 2012, CIENC SAUDE COLETIVA, V17, P123, DOI 10.1590/S1413-81232012000100015; Crouse DL, 2017, LANCET PLANET HEALTH, V1, pE289, DOI 10.1016/S2542-5196(17)30118-3; da Silveira IH, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000290, 10.11606/s1518-8787.2018052000290]; Mendes AMDC, 2021, REV LAT-AM ENFERM, V29, DOI 10.1590/1518-8345.0000.3471; Borba AKDT, 2019, CIENC SAUDE COLETIVA, V24, P125, DOI 10.1590/1413-81232018241.35052016; Edwards ST, 2017, J GEN INTERN MED, V32, P1377, DOI 10.1007/s11606-017-4174-z; Facchini Luiz Augusto, 2018, Saúde debate, V42, P208, DOI 10.1590/0103-11042018s114; Kleinbaum DG, 2010, LOGISTIC REGRESSION, DOI DOI 10.1007/978-1-4419-1742-3; Macinko James, 2018, Saúde debate, V42, P18, DOI 10.1590/0103-11042018s102; Netto JJM, 2018, REV PANAM SALUD PUBL, V42, DOI 10.26633/RPSP.2018.2; Partanen VM, 2020, SCAND J PUBLIC HEALT, V48, P839, DOI 10.1177/1403494820944722; Pasternak Suzana, 2016, Estud. av., V30, P51, DOI 10.1590/S0103-40142016.00100004; da Fonseca HLP, 2019, CIENC SAUDE COLETIVA, V24, P1981, DOI 10.1590/1413-81232018246.07902019; Pitombeira DF, 2020, CIENC SAUDE COLETIVA, V25, P1699, DOI 10.1590/1413-81232020255.33972019; Correa DSRC, 2019, CIENC SAUDE COLETIVA, V24, P2031, DOI 10.1590/1413-81232018246.08802019; Rodrigues Mayara Marta, 2019, Rev. bras. epidemiol., V22, pe190010, DOI 10.1590/1980-549720190010; Saito M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16020182; Sawin G, 2019, PRIMARY CARE, V46, P549, DOI 10.1016/j.pop.2019.07.006; Schenker M, 2019, CIENC SAUDE COLETIVA, V24, P1369, DOI 10.1590/1413-81232018244.01222019; Secretaria de Economia do Distrito Federal, 2020, IND BEM EST URB IBEU; Sleeman KE, 2019, LANCET GLOB HEALTH, V7, pE883, DOI 10.1016/S2214-109X(19)30172-X; Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7; Campos ACV, 2018, REV BRAS ENFERM, V71, P591, DOI 10.1590/0034-7167-2017-0070; Wallar LE, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01160-0; Zueras P, 2020, INT J PUBLIC HEALTH, V65, P627, DOI 10.1007/s00038-020-01371-w	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8							e0272650	10.1371/journal.pone.0272650	http://dx.doi.org/10.1371/journal.pone.0272650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P8ZE	35930570	Green Published, gold			2022-12-26	WOS:000837822100006
J	Ogura, Y; Ohbayashi, N; Kanaho, Y; Kawaguchi, A; Funakoshi, Y				Ogura, Yukino; Ohbayashi, Norihiko; Kanaho, Yasunori; Kawaguchi, Atsushi; Funakoshi, Yuji			Ubiquitin-specific protease TRE17/USP6 promotes tumor cell invasion through the regulation of glycoprotein CD147 intracellular trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-INDEPENDENT CARGO; USP6 ONCOGENE; ENTER CELLS; DEGRADATION; METASTASIS; ACTIVATION; PROTEINS	Disordered expression and distribution of plasma membrane proteins at the cell surface leads to diverse malignant phenotypes in tumors, including cell invasion. The ubiquitin-specific protease TRE17/USP6, an oncogene identified in Ewing sarcoma, is highly expressed in several cancers and locally aggressive tumor-like lesions. We have previously demonstrated that TRE17 regulates the trafficking of plasma membrane proteins that enter cells via clathrin-independent endocytosis (CIE); TRE17 prevents CIE cargo proteins from being targeted to lysosomes for degradation by deubiquitylating them. However, functional insights into the effects of TRE17-mediated CIE cargo trafficking on cell invasion remain unknown. Here, we show that increased expression of TRE17 enhances invasiveness of the human sarcoma cell line HT-1080 by elevating the cell surface levels of the membrane glycoprotein CD147, which plays a central role in tumor progression. We demonstrate overexpression of TRE17 decreases ubiquitylated CD147, which is accompanied by suppression of CD147 transport to lysosomes, resulting in the stabilization and increase of cell surface-localized CD147. On the other hand, we show knockdown of TRE17 decreases cell surface CD147, which is coupled with reduced production of matrix metalloproteinases, the enzymes responsible for extracellular matrix degradation. Furthermore, we demonstrate that inhibition of CD147 by a specific inhibitor alleviated the TRE17-promoted tumor cell invasion. We therefore propose a model for the pathogenesis of TRE17-driven tumors in which TRE17 increases CD147 at the cell surface by preventing its lysosomal degradation, which in turn enhances matrix metalloproteinase synthesis and matrix degradation, thereby promoting tumor cell invasion.	[Ogura, Yukino; Ohbayashi, Norihiko; Kanaho, Yasunori; Funakoshi, Yuji] Univ Tsukuba, Dept Physiol Chem, Tsukuba, Japan; [Ogura, Yukino; Kanaho, Yasunori; Kawaguchi, Atsushi; Funakoshi, Yuji] Univ Tsukuba, Dept Infect Biol, Fac Med, Tsukuba, Japan; [Ogura, Yukino; Kanaho, Yasunori; Kawaguchi, Atsushi; Funakoshi, Yuji] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba	Kanaho, Y; Funakoshi, Y (corresponding author), Univ Tsukuba, Dept Physiol Chem, Tsukuba, Japan.; Kanaho, Y; Kawaguchi, A; Funakoshi, Y (corresponding author), Univ Tsukuba, Dept Infect Biol, Fac Med, Tsukuba, Japan.; Kanaho, Y; Kawaguchi, A; Funakoshi, Y (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Japan.	ykanaho@md.tsukuba.ac.jp; ats-kawaguchi@md.tsukuba.ac.jp; funa@md.tsukuba.ac.jp		Funakoshi, Yuji/0000-0002-9925-8663	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [18H02601, 21K06146, 19K06653, 17K07327, 22K06199]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work is supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (KAKENHI, 18H02601 and 21K06146 to Y. K., 19K06653 to N. O., and 17K07327 and 22K06199 to Y. F.).	Bai Y, 2014, INT J MOL SCI, V15, P6356, DOI 10.3390/ijms15046356; BISWAS C, 1995, CANCER RES, V55, P434; Bowden ET, 2001, METHOD CELL BIOL, V63, P613; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Durr HR, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2855-y; Erickson-Johnson MR, 2011, LAB INVEST, V91, P1427, DOI 10.1038/labinvest.2011.118; Eyster CA, 2011, MOL BIOL CELL, V22, P3218, DOI 10.1091/mbc.E10-11-0874; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Fan XB, 2013, CELL BIOL INT, V37, P737, DOI 10.1002/cbin.10104; Fu ZG, 2016, ONCOTARGET, V7, P9430, DOI 10.18632/oncotarget.6990; Funakoshi Y, 2014, J CELL SCI, V127, P4750, DOI 10.1242/jcs.156786; Gao C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-570; Grass GD, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150256; Henrich IC, 2021, CANCER RES, V81, P2171, DOI 10.1158/0008-5472.CAN-20-1458; Henrich IC, 2018, MOL CANCER RES, V16, P1834, DOI 10.1158/1541-7786.MCR-18-0289; Hiemcke-Jiwa LS, 2020, INT J SURG PATHOL, V28, P816, DOI 10.1177/1066896920938878; Li LS, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00320-17; Luo ZL, 2016, ONCOTARGET, V7, P7179, DOI 10.18632/oncotarget.6886; Ma HY, 2020, CANCER BIOMARK, V27, P389, DOI 10.3233/CBM-190236; Madan B, 2016, P NATL ACAD SCI USA, V113, pE2945, DOI 10.1073/pnas.1605691113; Maldonado-Baez L, 2013, EXP CELL RES, V319, P2759, DOI 10.1016/j.yexcr.2013.08.008; Maldonado-Baez L, 2013, J CELL BIOL, V201, P233, DOI 10.1083/jcb.201208172; Mellman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016949; NAKAMURA T, 1992, ONCOGENE, V7, P733; Nakayama S, 2021, CANCER GENOM PROTEOM, V18, P93, DOI 10.21873/cgp.20244; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Oliveira AM, 2005, ONCOGENE, V24, P3419, DOI 10.1038/sj.onc.1208506; Oliveira AM, 2004, AM J PATHOL, V165, P1773, DOI 10.1016/S0002-9440(10)63432-3; Oliveira Andre M, 2012, Front Biosci (Schol Ed), V4, P321; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Pringle LM, 2012, ONCOGENE, V31, P3525, DOI 10.1038/onc.2011.520; Qi SS, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1464-9; Qi SS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1709-8; Quick L, 2016, CANCER RES, V76, P5337, DOI 10.1158/0008-5472.CAN-15-2391; Sun JX, 2001, CANCER RES, V61, P2276; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Winkler J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18794-x; Wu B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010212; Xiong LJ, 2014, INT J MOL SCI, V15, P17411, DOI 10.3390/ijms151017411; Xu J, 2007, MOL CANCER RES, V5, P605, DOI 10.1158/1541-7786.MCR-06-0286; Ye Y, 2010, ONCOGENE, V29, P3619, DOI 10.1038/onc.2010.116; Zeng H, 2018, BIOCHEM BIOPH RES CO, V505, P816, DOI 10.1016/j.bbrc.2018.08.168; Zhou Y, 2017, EXP CELL RES, V357, P9, DOI 10.1016/j.yexcr.2017.04.020	43	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2022	298	9							102335	10.1016/j.jbc.2022.102335	http://dx.doi.org/10.1016/j.jbc.2022.102335			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6F7ME	35926707	Green Published, gold			2022-12-26	WOS:000884241800009
J	Tian, LS; Xie, XF; Das, U; Chen, YL; Sun, YL; Liu, F; Lu, HZ; Nan, P; Zhu, Y; Gu, XL; Deng, HT; Xie, JY; Zhao, XH				Tian, Lusong; Xie, Xiufeng; Das, Urmi; Chen, Yuling; Sun, Yulin; Liu, Fang; Lu, Haizhen; Nan, Peng; Zhu, Ying; Gu, Xinglu; Deng, Haiteng; Xie, Jiuyong; Zhao, Xiaohang			Forming cytoplasmic stress granules PUR alpha suppresses mRNA translation initiation of IGFBP3 to promote esophageal squamous cell carcinoma progression	ONCOGENE			English	Article							POSTNATAL BRAIN-DEVELOPMENT; FACTOR-BINDING-PROTEINS; SINGLE-STRANDED-DNA; GROWTH; CANCER; TRANSCRIPTION; ASSOCIATION; ACTIVATION; GENE; IDENTIFICATION	Esophageal squamous cell carcinoma (ESCC) is one of the most fatal malignancies worldwide. Recently, our group identified purine-rich element binding protein alpha (PUR alpha), a single-stranded DNA/RNA-binding protein, to be significantly associated with the progression of ESCC. Additional immunofluorescence staining demonstrated that PUR alpha forms cytoplasmic stress granules to suppress mRNA translation initiation. The expression level of cytoplasmic PUR alpha in ESCC tumor tissues was significantly higher than that in adjacent epithelia and correlated with a worse patient survival rate by immunohistochemistry. Functionally, PUR alpha strongly preferred to bind to UG-/U-rich motifs and mRNA 3 ' UTR by CLIP-seq analysis. Moreover, PUR alpha knockout significantly increased the protein level of insulin-like growth factor binding protein 3 (IGFBP3). In addition, it was further demonstrated that PUR alpha-interacting proteins are remarkably associated with translation initiation factors and ribosome-related proteins and that PUR alpha regulates protein expression by interacting with translation initiation factors, such as PABPC1, eIF3B and eIF3F, in an RNA-independent manner, while the interaction with ribosome-related proteins is significantly dependent on RNA. Specifically, PUR alpha was shown to interact with the mRNA 3 ' UTR of IGFBP3 and inhibit its expression by suppressing mRNA translation initiation. Together, this study identifies cytoplasmic PUR alpha as a modulator of IGFBP3, which could be a promising therapeutic target for ESCC treatment.	[Tian, Lusong; Xie, Xiufeng; Sun, Yulin; Liu, Fang; Nan, Peng; Zhu, Ying; Gu, Xinglu; Zhao, Xiaohang] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Mol Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China; [Das, Urmi; Xie, Jiuyong] Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada; [Chen, Yuling; Deng, Haiteng] Tsinghua Univ, Ctr Synthet & Systemat Biol, Sch Life Sci, MOE Key Lab Bioinformat, Beijing, Peoples R China; [Lu, Haizhen] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Pathol, Canc Hosp, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; University of Manitoba; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College	Zhao, XH (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Mol Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China.; Xie, JY (corresponding author), Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada.; Deng, HT (corresponding author), Tsinghua Univ, Ctr Synthet & Systemat Biol, Sch Life Sci, MOE Key Lab Bioinformat, Beijing, Peoples R China.	dht@mail.tsinghua.edu.cn; xiej@umanitoba.ca; zhaoxh@cicams.ac.cn	; Xie, Jiuyong/D-2899-2013	Das, Urmi/0000-0001-7639-6521; Xie, Jiuyong/0000-0003-2909-1033	National Natural Science Foundation of China [81872033, 81572365, 82073327]; National Key R&D Program of China [2018YFC1313101, 2016YFC0901403]; CAMS Innovation Fund for Medical Sciences [2016-I2M-1-001, 2019-I2M-1-003, 2021-I2M-1-066]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; CAMS Innovation Fund for Medical Sciences	This work was partly supported by the National Natural Science Foundation of China (81872033 and 81572365 to XZ; 82073327 to YS), the National Key R&D Program of China (2018YFC1313101 and 2016YFC0901403 to XZ) and the CAMS Innovation Fund for Medical Sciences (2016-I2M-1-001, 2019-I2M-1-003 and 2021-I2M-1-066 to XZ and YS) of China.	Asadi MR, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.745394; Bassler J, 2019, ANNU REV BIOCHEM, V88, P281, DOI 10.1146/annurev-biochem-013118-110817; BERGEMANN AD, 1992, MOL CELL BIOL, V12, P1257, DOI 10.1128/MCB.12.3.1257; Bratkovic T, 2020, NUCLEIC ACIDS RES, V48, P1627, DOI 10.1093/nar/gkz1140; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cai Q, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051261; Chen BB, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r18; CHEN NN, 1995, J VIROL, V69, P5843, DOI 10.1128/JVI.69.9.5843-5848.1995; Clemmons DR, 1998, MOL CELL ENDOCRINOL, V140, P19, DOI 10.1016/S0303-7207(98)00024-0; Daigle JG, 2016, ACTA NEUROPATHOL, V131, P605, DOI 10.1007/s00401-015-1530-0; Daniel DC, 2018, GENE, V643, P133, DOI 10.1016/j.gene.2017.12.004; Darbinian N, 2004, ANTICANCER RES, V24, P2585; Darbinian N, 2001, J NEUROIMMUNOL, V121, P3, DOI 10.1016/S0165-5728(01)00372-1; Di Salvio M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.295; Gallia GL, 1999, P NATL ACAD SCI USA, V96, P11572, DOI 10.1073/pnas.96.20.11572; Gao JJ, 2021, CANCER LETT, V498, P98, DOI 10.1016/j.canlet.2020.10.030; HAAS S, 1995, J CELL BIOL, V130, P1171, DOI 10.1083/jcb.130.5.1171; Han JF, 2011, CANCER LETT, V307, P200, DOI 10.1016/j.canlet.2011.04.004; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hirano H, 2019, JPN J CLIN ONCOL, V49, P412, DOI 10.1093/jjco/hyz034; Hokkanen S, 2012, HUM MOL GENET, V21, P473, DOI 10.1093/hmg/ddr476; Hunt D, 2014, J MED GENET, V51, P806, DOI 10.1136/jmedgenet-2014-102798; Ivanov P, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032813; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Johnson EM, 2006, J NEUROSCI RES, V83, P929, DOI 10.1002/jnr.20806; JOHNSON EM, 1995, J BIOL CHEM, V270, P24352, DOI 10.1074/jbc.270.41.24352; Johnson MA, 2014, GROWTH HORM IGF RES, V24, P164, DOI 10.1016/j.ghir.2014.04.007; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kelley KM, 1996, INT J BIOCHEM CELL B, V28, P619, DOI 10.1016/1357-2725(96)00005-2; Khalili K, 2003, MOL CELL BIOL, V23, P6857, DOI 10.1128/MCB.23.19.6857-6875.2003; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim JH, 2011, BLOOD, V118, P2622, DOI 10.1182/blood-2010-08-299784; Lee HY, 2002, CANCER RES, V62, P3530; Lezon-Geyda K, 2001, LEUKEMIA, V15, P954, DOI 10.1038/sj.leu.2402108; Lin DC, 2018, GASTROENTEROLOGY, V154, P374, DOI 10.1053/j.gastro.2017.06.066; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Martincorena I, 2018, SCIENCE, V362, P911, DOI 10.1126/science.aau3879; Merrick WC, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a033092; Mitsumori K, 2017, MOL BIOL CELL, V28, P1412, DOI 10.1091/mbc.E16-07-0497; Natsuizaka M, 2014, AM J CANCER RES, V4, P29; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Ojha S, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10050783; Pandey PR, 2020, NUCLEIC ACIDS RES, V48, P3789, DOI 10.1093/nar/gkaa035; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Rossi S, 2015, J CELL SCI, V128, P1787, DOI 10.1242/jcs.165332; Rustgi AK, 2014, NEW ENGL J MED, V371, P2499, DOI 10.1056/NEJMra1314530; Sariyer IK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156819; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Tanaka AJ, 2015, CSH MOL CASE STUD, V1, DOI 10.1101/mcs.a000356; Trau SP, 2020, PEDIATR NEUROL, V104, P62, DOI 10.1016/j.pediatrneurol.2019.09.008; Turriziani Benedetta, 2014, Biology (Basel), V3, P320, DOI 10.3390/biology3020320; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Wang LG, 2008, CANCER RES, V68, P2678, DOI 10.1158/0008-5472.CAN-07-6017; White MK, 2009, CELL CYCLE, V8, P414, DOI 10.4161/cc.8.3.7585; Wolozin B, 2019, NAT REV NEUROSCI, V20, P649, DOI 10.1038/s41583-019-0222-5; Xia H, 2017, BBA-GENE REGUL MECH, V1860, P911, DOI 10.1016/j.bbagrm.2017.07.004; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Yang PG, 2020, CELL, V181, P325, DOI 10.1016/j.cell.2020.03.046; Yokoyama A, 2019, NATURE, V565, P312, DOI 10.1038/s41586-018-0811-x; Youn JY, 2019, MOL CELL, V76, P286, DOI 10.1016/j.molcel.2019.09.014	62	0	0	3	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 16	2022	41	38					4336	4348		10.1038/s41388-022-02426-3	http://dx.doi.org/10.1038/s41388-022-02426-3		AUG 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4O3TC	35945453	hybrid, Green Published			2022-12-26	WOS:000837926900001
J	Bultum, ET; Roro, EM; Wolde, T; Regasa, IF				Bultum, Ejigayehu Tolessa; Roro, Elias Merdassa; Wolde, Tsedeke; Regasa, Ilili Feyessa			Factors influencing exclusive breast feeding among children born to HIV positive mothers attending public health facilities in western Ethiopia: Cross-sectional study	PLOS ONE			English	Article							TRANSMISSION	Only about 39% of infants in low- and middle-income countries are exclusively breast-fed for the first six months. In particular, human immunodeficiency virus (HIV) positive women report confusion about the best feeding methods. Exclusive Breastfeeding (EBF) practices in HIV positive mothers are sub-optimal in Ethiopia. This study aimed to identify the main factors influencing EBF among HIV positive breast-feeding mothers. A facility based cross-sectional study was carried out from September 2017 to June 30 2018 among HIV positive mothers with infants aged 6-23 months. Thirteen public health facilities (7 health centers and 6 hospitals) that provided anti-retroviral treatment (ART) and Prevention of mother-to-child transmission (PMTCT) services, found in three districts of West, East and Kellem Wollega Zones, were randomly selected. Respondents were recruited by systematic random sampling techniques from these facilities using client registers as a sampling frame. Data were collected using face to face interviews with a pre-tested questionnaire. Data were entered into EPI info Version 3.5.1 and analyzed using SPSS Version 20 for windows. Candidate variables for the final multi-variable model were selected considering P <= 0.05 at bivariable analysis. Associations were declared at P <= 0.05 by assuming Confidence Intervals did not cross '1'with corresponding 95%. A total of 218 HIV positive mothers were included in this study. Of these, only 122 (56.0%) practiced EBF in the first six months. The proportion of study participants who initiated EBF within the first hour of delivery was 134 (61.8%). Mean age of study participants was 28.6years with SD +/- 4. Mothers' having received advice on EBF [AOR 3, 95% CI (1.2-6.7)], disclosure of HIV status to someone close to them including their husband [AOR 6, 95% CI (1.2-29.6)] and believing HIV can be transmitted during delivery [AOR 5.2, 95% CI (1.1-24.0)] were found to increase the likelihood of EBF practices among the study participants (P-value <= 0.05). In this study, only just over half of the mothers practiced EBF for the first six months. Care providers should continue to encourage mothers to practice EBF in the first six months and to disclosure of HIV status to someone close to them including their partner. Efforts should be in place to curb the risk of HIV/AIDS transmission during delivery. Continues advise for mothers to practice EBF in the first 6 months is still needed.	[Bultum, Ejigayehu Tolessa; Roro, Elias Merdassa; Wolde, Tsedeke; Regasa, Ilili Feyessa] Wollega Univ, Inst Hlth Sci, Dept Publ Hlth, Oromia, Ethiopia; [Bultum, Ejigayehu Tolessa] Minist Hlth, Fed Democrat Republ Ethiopia, Addis Ababa, Ethiopia; [Wolde, Tsedeke] St Paul Millennium Med Coll, Fed Democrat Republ Ethiopia, Minist Hlth, Addis Ababa, Ethiopia		Roro, EM (corresponding author), Wollega Univ, Inst Hlth Sci, Dept Publ Hlth, Oromia, Ethiopia.	emerdassa@gmail.com	Roro, Elias/HGU-5987-2022	Roro, Elias/0000-0001-8985-5336				Belay GM, 2019, AIDS RES TREAT, V2019, DOI 10.1155/2019/3862098; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Eshetu K, 2015, AM J HLTH RES, V3, P2; Federal Democratic Republic of Ethiopia Population Census Commission, 2008, SUMM STAT REP POP HO; Federal ministry of health (FMOH, 2006, REP, V6th, P3; FHAPCO FMOH, 2007, GUIDELINE PREVENTION; Gibney MJ., 2006, CLIN NUTR, VSecond; Girma Y., 2014, J HIV AIDS INFECT DI, V2, P1; Hauck YL, 2011, MATERN CHILD HLTH J, V15, P260, DOI 10.1007/s10995-009-0554-2; Kagaayi J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003877; Kavle JA, 2017, PUBLIC HEALTH NUTR, V20, P3120, DOI 10.1017/S1368980017002531; Lawrence R, 2005, BREASTFEEDING GUIDE; Maru Y, 2009, ETHIOP J HEALTH DEV, V23, P107; Muluye D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-240; Oladokun RE, 2010, AIDS CARE, V22, P1108, DOI 10.1080/09540120903511008; Onyango-Makumbi C, 2010, JAIDS-J ACQ IMM DEF, V53, P20, DOI 10.1097/QAI.0b013e3181bdf68e; Ssenyonga R, 2004, J TROP PEDIATRICS, V50, P348, DOI 10.1093/tropej/50.6.348; Taha TE, 2011, EFFECTS CESSATION BR; UNAIDS, 2003, UNAIDS 03 39E; United Nations International Children's Emergency Fund (UNICEF), 2005, BAB FRIEND IN; WHO, 2003, GLOB STRAT INF YOUNG; WHO/UNAIDS/UNFPA/UNICEF, 2010, GUID HIV INF FEED PR; WHO/UNAIDS/UNICEF, 2009, PROGR REP; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, 2007, J NUTR METABOLISM 20; World Health Organization, 2010, PMTCT STRAT VIS 2010; Young SL, 2011, ADV NUTR, V2, P225, DOI 10.3945/an.110.000224	27	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2022	17	8							e0271167	10.1371/journal.pone.0271167	http://dx.doi.org/10.1371/journal.pone.0271167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4W7AB	35939427	gold, Green Published			2022-12-26	WOS:000860309800001
J	Chaichulee, S; Promchai, C; Kaewkomon, T; Kongkamol, C; Ingviya, T; Sangsupawanich, P				Chaichulee, Sitthichok; Promchai, Chissanupong; Kaewkomon, Tanyamai; Kongkamol, Chanon; Ingviya, Thammasin; Sangsupawanich, Pasuree			Multi-label classification of symptom terms from free-text bilingual adverse drug reaction reports using natural language processing	PLOS ONE			English	Article								Allergic reactions to medication range from mild to severe or even life-threatening. Proper documentation of patient allergy information is critical for safe prescription, avoiding drug interactions, and reducing healthcare costs. Allergy information is regularly obtained during the medical interview, but is often poorly documented in electronic health records (EHRs). While many EHRs allow for structured adverse drug reaction (ADR) reporting, a free-text entry is still common. The resulting information is neither interoperable nor easily reusable for other applications, such as clinical decision support systems and prescription alerts. Current approaches require pharmacists to review and code ADRs documented by healthcare professionals. Recently, the effectiveness of machine algorithms in natural language processing (NLP) has been widely demonstrated. Our study aims to develop and evaluate different NLP algorithms that can encode unstructured ADRs stored in EHRs into institutional symptom terms. Our dataset consists of 79,712 pharmacist-reviewed drug allergy records. We evaluated three NLP techniques: Naive Bayes-Support Vector Machine (NB-SVM), Universal Language Model Fine-tuning (ULMFiT), and Bidirectional Encoder Representations from Transformers (BERT). We tested different general-domain pre-trained BERT models, including mBERT, XLM-RoBERTa, and WanchanBERTa, as well as our domain-specific AllergyR-oBERTa, which was pre-trained from scratch on our corpus. Overall, BERT models had the highest performance. NB-SVM outperformed ULMFiT and BERT for several symptom terms that are not frequently coded. The ensemble model achieved an exact match ratio of 95.33%, a F-1 score of 98.88%, and a mean average precision of 97.07% for the 36 most frequently coded symptom terms. The model was then further developed into a symptom term suggestion system and achieved a Krippendorff's alpha agreement coefficient of 0.7081 in prospective testing with pharmacists. Some degree of automation could both accelerate the availability of allergy information and reduce the efforts for human coding.	[Chaichulee, Sitthichok] Prince Songkla Univ, Fac Med, Dept Biomed Sci & Biomed Engn, Hat Yai, Songkhla, Thailand; [Promchai, Chissanupong; Kaewkomon, Tanyamai] Prince Songkla Univ, Songklanagarind Hosp, Fac Med, Dept Pharm, Hat Yai, Songkhla, Thailand; [Kongkamol, Chanon; Ingviya, Thammasin] Prince Songkla Univ, Fac Med, Dept Family & Prevent Med, Hat Yai, Songkhla, Thailand; [Sangsupawanich, Pasuree] Prince Songkla Univ, Fac Med, Dept Pediat, Hat Yai, Songkhla, Thailand; [Chaichulee, Sitthichok; Kongkamol, Chanon; Ingviya, Thammasin] Prince Songkla Univ, Fac Med, Div Digital Innovat & Data Analyt, Hat Yai, Songkhla, Thailand	Prince of Songkla University; Prince of Songkla University; Prince of Songkla University; Prince of Songkla University; Prince of Songkla University	Chaichulee, S (corresponding author), Prince Songkla Univ, Fac Med, Dept Biomed Sci & Biomed Engn, Hat Yai, Songkhla, Thailand.; Chaichulee, S (corresponding author), Prince Songkla Univ, Fac Med, Div Digital Innovat & Data Analyt, Hat Yai, Songkhla, Thailand.	sitthichok.c@psu.ac.th	Kongkamol, Chanon/HGC-6460-2022	Kongkamol, Chanon/0000-0003-3364-0664; Ingviya, Thammasin/0000-0002-8894-3817; Chaichulee, Sitthichok/0000-0002-3159-7925	Kasikornthai Foundation; SCG Foundation	Kasikornthai Foundation; SCG Foundation	This study was approved by the Human Research Ethics Committee (HREC), Faculty of Medicine, Prince of Songkla University (REC. 64-100-25-2) with a waiver for written informed consent due to its retrospective nature. We acknowledge the support of computational resources from the Division of Digital Innovation and Data Analytics (DIDA), which was in turn supported by the Kasikornthai Foundation and the SCG Foundation. The authors have no conflicts of interest to declare.	Artstein R, 2008, COMPUT LINGUIST, V34, P555, DOI 10.1162/coli.07-034-R2; Changhan Wang, 2019, Arxiv, DOI arXiv:1909.03341; Conneau A., 2019, ARXIV; Epstein RH, 2013, J AM MED INFORM ASSN, V20, P962, DOI 10.1136/amiajnl-2013-001756; Goss Foster R, 2014, AMIA Annu Symp Proc, V2014, P580; Greenberger PA, 2019, ALLERGY ASTHMA PROC, V40, P474, DOI 10.2500/aap.2019.40.4275; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; Jaan Altosaar, 2020, Arxiv, DOI arXiv:1904.05342; Jackson RG, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012012; Jacob Devlin, 2019, Arxiv, DOI arXiv:1810.04805; Jeremy Howard, 2020, Arxiv, DOI arXiv:2002.04688; Jeremy Howard, 2018, Arxiv, DOI arXiv:1801.06146; Juhn Y, 2020, J ALLERGY CLIN IMMUN, V145, P463, DOI 10.1016/j.jaci.2019.12.897; Khan DA, 2010, J ALLERGY CLIN IMMUN, V125, pS126, DOI 10.1016/j.jaci.2009.10.028; Kudo T, 2018, CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING (EMNLP 2018): PROCEEDINGS OF SYSTEM DEMONSTRATIONS, P66; Lowphansirikul L, 2021, Arxiv, DOI arXiv:2101.09635; Lee J, 2020, BIOINFORMATICS, V36, P1234, DOI 10.1093/bioinformatics/btz682; Leiter RE, 2020, J PAIN SYMPTOM MANAG, V60, P948, DOI 10.1016/j.jpainsymman.2020.06.010; Lenivtceva ID, 2021, METHOD INFORM MED, V60, P95, DOI 10.1055/s-0041-1733945; Lin Y.-T., 2017, ARXIV, DOI DOI 10.48550/ARXIV.1708.02002; Mark Dredze, 2020, Arxiv, DOI arXiv:2005.09093; Naseem U, 2022, BMC BIOINFORMATICS, V23, DOI 10.1186/s12859-022-04688-w; Peter Usherwood, 2019, Arxiv, DOI arXiv:1907.07543; Pitt T, 2011, ALLERGY ASTHMA CL IM, V7, DOI [10.1186/1710-1492-7-S1-S1, 10.1186/1710-1492-7-S1-S10]; Sorin V, 2020, J AM COLL RADIOL, V17, P639, DOI 10.1016/j.jacr.2019.12.026; Sorower MS, 2010, CORVALLIS, V18, P1; Thong BYH, 2011, BRIT J CLIN PHARMACO, V71, P684, DOI 10.1111/j.1365-2125.2010.03774.x; Thoongsup S, 2009, P 7 WORKSH AS LANG R, P139, DOI [10.3115/1690299.1690319, DOI 10.3115/1690299.1690319]; Wagholikar Amol S, 2011, AMIA Annu Symp Proc, V2011, P1446; Wang S. I., 2012, P 50 ANN M ASS COMP, V2, P90; Wu S, 2020, J AM MED INFORM ASSN, V27, P457, DOI 10.1093/jamia/ocz200	32	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0270595	10.1371/journal.pone.0270595	http://dx.doi.org/10.1371/journal.pone.0270595			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925971	Green Published, gold			2022-12-26	WOS:000848077100021
J	Stone, K; Vasishth, S; von der Malsburg, T				Stone, Kate; Vasishth, Shravan; von der Malsburg, Titus			Does entropy modulate the prediction of German long-distance verb particles?	PLOS ONE			English	Article							LANGUAGE COMPREHENSION; BRAIN POTENTIALS; SENTENCE CONTEXT; LEXICAL PREDICTABILITY; TERM-MEMORY; ERP; WORD; N400; TIME; P600	In this paper we examine the effect of uncertainty on readers' predictions about meaning. In particular, we were interested in how uncertainty might influence the likelihood of committing to a specific sentence meaning. We conducted two event-related potential (ERP) experiments using particle verbs such as turn down and manipulated uncertainty by constraining the context such that readers could be either highly certain about the identity of a distant verb particle, such as turn the bed [...] down, or less certain due to competing particles, such as turn the music [...] up/down. The study was conducted in German, where verb particles appear clause-finally and may be separated from the verb by a large amount of material. We hypothesised that this separation would encourage readers to predict the particle, and that high certainty would make prediction of a specific particle more likely than lower certainty. If a specific particle was predicted, this would reflect a strong commitment to sentence meaning that should incur a higher processing cost if the prediction is wrong. If a specific particle was less likely to be predicted, commitment should be weaker and the processing cost of a wrong prediction lower. If true, this could suggest that uncertainty discourages predictions via an unacceptable cost-benefit ratio. However, given the clear predictions made by the literature, it was surprisingly unclear whether the uncertainty manipulation affected the two ERP components studied, the N400 and the PNP. Bayes factor analyses showed that evidence for our a priori hypothesised effect sizes was inconclusive, although there was decisive evidence against a priori hypothesised effect sizes larger than 1 mu Vfor the N400 and larger than 3 mu V for the PNP. We attribute the inconclusive finding to the properties of verb-particle dependencies that differ from the verb-noun dependencies in which the N400 and PNP are often studied.	[Stone, Kate; Vasishth, Shravan] Univ Potsdam, Dept Linguist, Potsdam, Brandenburg, Germany; [von der Malsburg, Titus] Univ Stuttgart, Inst Linguist, Stuttgart, Baden Wurttembe, Germany	University of Potsdam; University of Stuttgart	Stone, K (corresponding author), Univ Potsdam, Dept Linguist, Potsdam, Brandenburg, Germany.	stone@uni-potsdam.de		von der Malsburg, Titus/0000-0001-5925-5145; Stone, Kate/0000-0002-2180-9736	Potsdam Graduate School	Potsdam Graduate School	Kate Stone was supported by a doctoral scholarship from the Potsdam Graduate School.	AITKIN M, 1991, J ROY STAT SOC B MET, V53, P111; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bornkessel-Schlesewsky I, 2008, BRAIN RES REV, V59, P55, DOI 10.1016/j.brainresrev.2008.05.003; Brothers Trevor, 2020, Neurobiol Lang (Camb), V1, P135, DOI 10.1162/nol_a_00006; Brouwer H, 2017, COGNITIVE SCI, V41, P1318, DOI 10.1111/cogs.12461; Brouwer H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00758; BROWN C, 1993, J COGNITIVE NEUROSCI, V5, P34, DOI 10.1162/jocn.1993.5.1.34; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Cardoso JF, 1998, P IEEE, V86, P2009, DOI 10.1109/5.720250; Chung Y, 2015, J EDUC BEHAV STAT, V40, P136, DOI 10.3102/1076998615570945; Czypionka A, 2019, LANG COGN NEUROSCI, V34, P326, DOI 10.1080/23273798.2018.1539756; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; DeLong KA, 2014, NEUROPSYCHOLOGIA, V61, P150, DOI 10.1016/j.neuropsychologia.2014.06.016; Drummond A., 2016, IBEX SOFTWARE PSYCHO; Elman JL, 2005, BEYOND NATURE-NURTURE, P111; Federmeier KD, 2007, BRAIN RES, V1146, P75, DOI 10.1016/j.brainres.2006.06.101; Federmeier KD, 1999, J MEM LANG, V41, P469, DOI 10.1006/jmla.1999.2660; Fiebach CJ, 2002, J MEM LANG, V47, P250, DOI 10.1016/S0749-596X(02)00004-9; Fitz H, 2019, COGNITIVE PSYCHOL, V111, P15, DOI 10.1016/j.cogpsych.2019.03.002; Fleur DS, 2020, COGNITION, V204, DOI 10.1016/j.cognition.2020.104335; Frank SL, 2015, BRAIN LANG, V140, P1, DOI 10.1016/j.bandl.2014.10.006; Frank SL, 2013, TOP COGN SCI, V5, P475, DOI 10.1111/tops.12025; Frazier L, 2000, J PSYCHOLINGUIST RES, V29, P125, DOI 10.1023/A:1005136826534; FRIEDERICI AD, 1995, BRAIN LANG, V50, P259, DOI 10.1006/brln.1995.1048; Gelman A., 2019, PRIOR CHOICE RECOMME; Gelman A, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19100555; Gelman A, 2014, PERSPECT PSYCHOL SCI, V9, P641, DOI 10.1177/1745691614551642; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Gunter TC, 2000, J COGNITIVE NEUROSCI, V12, P556, DOI 10.1162/089892900562336; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hagoort P., 2009, REFLECTIONS NEUROBIO; Hale J, 2006, COGNITIVE SCI, V30, P643, DOI 10.1207/s15516709cog0000_64; Hoeks JCJ, 2004, COGNITIVE BRAIN RES, V19, P59, DOI 10.1016/j.cogbrainres.2003.10.022; Husain S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100986; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kim A, 2005, J MEM LANG, V52, P205, DOI 10.1016/j.jml.2004.10.002; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kuperberg GR, 2020, J COGNITIVE NEUROSCI, V32, P12, DOI 10.1162/jocn_a_01465; Kuperberg GR, 2016, LANG COGN NEUROSCI, V31, P32, DOI 10.1080/23273798.2015.1102299; Kuperberg GR, 2003, COGNITIVE BRAIN RES, V17, P117, DOI 10.1016/S0926-6410(03)00086-7; KUTAS M, 1993, LANG COGNITIVE PROC, V8, P533, DOI 10.1080/01690969308407587; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Kutas M., 2006, HDB PSYCHOLINGUISTIC, P659, DOI [10.1016/B978-012369374-7/50018-3, DOI 10.1016/B978-012369374-7/50018-3]; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lai MK, 2021, BRAIN RES, V1757, DOI 10.1016/j.brainres.2021.147290; Lau E, 2006, BRAIN LANG, V98, P74, DOI 10.1016/j.bandl.2006.02.003; Lau E, 2018, PSYCHOL LEARN MOTIV, V68, P117, DOI 10.1016/bs.plm.2018.08.004; Lee MD, 2013, BAYESIAN COGNITIVE M, DOI DOI 10.1017/CBO9781139087759; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; Linzen T, 2016, COGNITIVE SCI, V40, P1382, DOI 10.1111/cogs.12274; Lowder MW, 2018, COGNITIVE SCI, V42, P1166, DOI 10.1111/cogs.12597; Maess B, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00591; Makeig S, 1996, ADV NEUR IN, V8, P145; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; McRae K, 1998, J MEM LANG, V38, P283, DOI 10.1006/jmla.1997.2543; Metzner P, 2017, COGNITIVE SCI, V41, P1232, DOI 10.1111/cogs.12384; Michaelov James, 2020, P 24 C COMP NAT LANG, P652; Ness T, 2019, LANG COGN NEUROSCI, V34, P936, DOI 10.1080/23273798.2019.1591471; Ness T, 2018, J COGNITIVE NEUROSCI, V30, P1916, DOI 10.1162/jocn_a_01322; Nicenboim B., 2018, EEGUANA PACKAGE MANI, DOI 10.5281/zenodo.2533138; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Osterhout L, 1995, J MEM LANG, V34, P739, DOI 10.1006/jmla.1995.1033; Paczynski M, 2012, J MEM LANG, V67, P426, DOI 10.1016/j.jml.2012.07.003; Payne BR, 2015, PSYCHOPHYSIOLOGY, V52, P1456, DOI 10.1111/psyp.12515; Phillips C, 2005, COGNITIVE BRAIN RES, V22, P407, DOI 10.1016/j.cogbrainres.2004.09.012; Phillips C, 2011, SYNTAX SEMANTICS, V37, P147, DOI 10.1108/S0092-4563(2011)0000037009; Piai V, 2013, BRAIN LANG, V127, P296, DOI 10.1016/j.bandl.2013.09.015; PICKERING M, 1994, PERSPECTIVES ON SENTENCE PROCESSING, P199; Pickering MJ, 2018, PSYCHOL BULL, V144, P1002, DOI 10.1037/bul0000158; Rabovsky M, 2018, NAT HUM BEHAV, V2, P693, DOI 10.1038/s41562-018-0406-4; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Safavi MS., 2016, FRONT PSYCHOL, P1; Schad DJ., 2020, PSYCHOL METHODS; Smith NJ, 2013, COGNITION, V128, P302, DOI 10.1016/j.cognition.2013.02.013; Staub A, 2006, J EXP PSYCHOL LEARN, V32, P425, DOI 10.1037/0278-7393.32.2.425; Staub A, 2015, LANG LINGUIST COMPAS, V9, P311, DOI 10.1111/lnc3.12151; Staub A, 2015, J MEM LANG, V82, P1, DOI 10.1016/j.jml.2015.02.004; Stone K, 2020, PEERJ, V8, DOI 10.7717/peerj.10438; Szewczyk J., 2021, PSYARXIV; Szewczyk JM, 2013, J MEM LANG, V68, P297, DOI 10.1016/j.jml.2012.12.002; Szewczyk JM, 2020, EVENT RELATED POTENT; Thornhill DE, 2012, INT J PSYCHOPHYSIOL, V83, P382, DOI 10.1016/j.ijpsycho.2011.12.007; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; de Meerendonk N, 2009, LANG LINGUIST COMPAS, V3, DOI 10.1111/j.1749-818x.2009.00163.x; van Herten M, 2005, COGNITIVE BRAIN RES, V22, P241, DOI 10.1016/j.cogbrainres.2004.09.002; Van Petten C, 2012, INT J PSYCHOPHYSIOL, V83, P176, DOI 10.1016/j.ijpsycho.2011.09.015; van Schijndel M, 2021, COGNITIVE SCI, V45, DOI 10.1111/cogs.12988; VANPETTEN C, 1990, MEM COGNITION, V18, P380, DOI 10.3758/BF03197127; Vasishth S., 2021, SAMPLE SIZE DETERMIN, DOI [10.31234/osf.io/u8yvc, DOI 10.31234/OSF.IO/U8YVC]; Vissers CTWM, 2006, BRAIN RES, V1106, P150, DOI 10.1016/j.brainres.2006.05.012; Wagenmakers E.J, 2014, BAYESIAN COGNITIVE M, DOI DOI 10.1017/CBO9781139087759; Wagers MW, 2009, J LINGUIST, V45, P395, DOI 10.1017/S0022226709005726; Wlotko EW, 2007, NEUROPSYCHOLOGIA, V45, P3001, DOI 10.1016/j.neuropsychologia.2007.05.013	94	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0267813	10.1371/journal.pone.0267813	http://dx.doi.org/10.1371/journal.pone.0267813			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925906	Green Submitted, Green Published, gold			2022-12-26	WOS:000848077100006
J	Sun, HY; Cheng, LL; Li, Z; Wang, QY; Teng, JH				Sun, Haiyuan; Cheng, Linlin; Li, Zhuo; Wang, Qiyuan; Teng, Jiahua			A land-use benefit evaluation system with case study verification	PLOS ONE			English	Article							ECOSYSTEM SERVICES; VALUES; CONSERVATION; VALUATION	In regional land-use planning, many different demands for often-limited land resources must be weighed against each other. Analysis of the benefits of different land-use types is of great significance in land-use design. However, a good evaluation methodology does not exist. To facilitate a comparative analysis of land-use benefits, this paper presents an evaluation system consisting of four steps: (1) Connotation dissection to determine the land-use benefits, (2) construction of a land-use benefit classification system to summarize a limited number of land-use benefit types by an inductive method, (3) land-use benefit valuation, which includes a biophysical model, direct and indirect market valuations, and The Economics of Ecosystems and Biodiversity value conversion method, and (4) case analysis of the evaluation results according to local conditions. Empirical results from a case study of Mentougou District, Beijing, China, show that (i) the evaluation results of land-use benefit groups provides information on each land-use type and the spatial distribution of land-use benefits in Mentougou District, (ii) the topography of Mentougou District has an important influence on economic and ecological land-use benefits, and (iii) there is a synergistic effect of economic and social land-use benefits.	[Sun, Haiyuan; Cheng, Linlin; Wang, Qiyuan] China Univ Min & Technol Beijing, Coll Geosci & Surveying Engn, Beijing, Peoples R China; [Li, Zhuo] China Agr Univ, Coll Land Sci & Technol, Beijing, Peoples R China; [Teng, Jiahua] Ctr Satellite Applicat Ecol & Environm, Minist Ecol & Environm, Beijing, Peoples R China	China University of Mining & Technology; China Agricultural University	Cheng, LL (corresponding author), China Univ Min & Technol Beijing, Coll Geosci & Surveying Engn, Beijing, Peoples R China.	chll@cumtb.edu.cn			National Natural Science Foundation of China [41877533]; Social Science Foundation of Beijing, China [18GLB014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Science Foundation of Beijing, China	This research was funded by the National Natural Science Foundation of China (NO.41877533) and Social Science Foundation of Beijing, China(NO.18GLB014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinci H, 2013, COMPUT ELECTRON AGR, V97, P71, DOI 10.1016/j.compag.2013.07.006; Awuah KGB, 2014, GEOFORUM, V51, P37, DOI 10.1016/j.geoforum.2013.09.019; Beardmore L, 2019, LAND USE POLICY, V87, DOI 10.1016/j.landusepol.2019.104070; Beijing Mentougou Bureau of Statistics, 2011, BEIJ MENT STAT YB; Beijing Municipal Bureau of Statistics, 2011, BEIJ STAT YB; Beijing Municipal Commission Mentougou substation of Planning and Natural Resources, DAT LAND SURV DAT; Cen X.T, 2016, CORRELATION ANAL OPT; Chen HB, 2017, LAND USE POLICY, V64, P429, DOI 10.1016/j.landusepol.2017.03.018; China Meteorological Administration, DAT BAS EV DAT; China Meteorological Administration. China Meteorological Data Service Center, DAT MONTHL DAT SURF; Cilliers Luan, 2015, ONCOTARGET, V6, P265, DOI [10.18632/oncotarget.3246, DOI 10.18632/ONCOTARGET.3246]; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; de Groot R, 2006, LANDSCAPE URBAN PLAN, V75, P175, DOI 10.1016/j.landurbplan.2005.02.016; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; Ezirim O.N., 2020, J HUMAN EARTH, V1, P48, DOI DOI 10.28991/HEF-2020-01-02-01; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Glp G, 2009, ENV POLICY COLLECTIO, V20, P1262, DOI [10.1088/1009-9271/5/6/012, DOI 10.1088/1009-9271/5/6/012]; Guo ZW, 2001, ECOL ECON, V38, P141, DOI 10.1016/S0921-8009(01)00154-9; Huang X.J, 2016, LAND ECON, V2st; Jahanifar K, 2019, LAND USE POLICY, V88, DOI 10.1016/j.landusepol.2019.05.022; Juarez-Lucas AM, 2016, NAT HAZARDS, V84, P2243, DOI 10.1007/s11069-016-2551-2; Kazemi H, 2018, ECOL ENG, V116, P1, DOI 10.1016/j.ecoleng.2018.02.021; Krisnayanti DS, 2021, CIV ENG J-TEHRAN, V7, P1070, DOI 10.28991/cej-2021-03091711; Leemans R., 2003, MILLENNIUM ECOSYSTEM; Leh MDK, 2013, AGR ECOSYST ENVIRON, V165, P6, DOI 10.1016/j.agee.2012.12.001; Li Guang, 2011, Acta Prataculturae Sinica, V20, P18; Li J, 2004, J ARID ENVIRON, V59, P463, DOI 10.1016/j.jaridenv.2004.03.019; Li J, 2006, ECOL RES, V21, P597, DOI 10.1007/s11284-006-0148-z; Li X.Y, 2014, MEASURING SPATIAL TE; Liu LY, 2009, ENVIRON MONIT ASSESS, V153, P339, DOI 10.1007/s10661-008-0360-0; Liu PengFei, 2011, Scientia Agricultura Sinica, V44, P5117; Lovell ST, 2010, AGR SYST, V103, P327, DOI 10.1016/j.agsy.2010.03.003; Marr EJ, 2016, J RURAL STUD, V48, P77, DOI 10.1016/j.jrurstud.2016.10.002; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Ministry of Agriculture and Rural Affairs of the People's Republic of China, AGR INF NETW CHIN DA; [莫菲 MO Fei], 2011, [生态学报, Acta Ecologica Sinica], V31, P5009; Namatama N, 2020, LAND USE POLICY, V97, DOI 10.1016/j.landusepol.2020.104735; National Aeronautics and Space Administration, ASTGTM003 NASA JAP M; Pan K., DATABASE SOIL FEATUR; Paracchini ML, 2011, ECOL INDIC, V11, P71, DOI 10.1016/j.ecolind.2009.04.006; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Qian Y.W, 2010, STUDY VALUE EVALUATI; Raboin ML, 2012, MT RES DEV, V32, P158, DOI 10.1659/MRD-JOURNAL-D-10-00099.1; Rahman MM, 2022, ISPRS INT J GEO-INF, V11, DOI 10.3390/ijgi11040220; Rahman MM, 2021, LAND-BASEL, V10, DOI 10.3390/land10121398; ROBINSON WS, 1989, AM BEE J, V129, P477; Sannigrahi S, 2019, J ENVIRON MANAGE, V244, P208, DOI 10.1016/j.jenvman.2019.04.095; Standardization Administration of China, 2012, GBT284072012; State Environmental Protection Administration of China, 1996, CHIN AIR EM TAR; State Forestry Administration of China, 2011, CHIN FOR STAT YB; Su CH, 2012, ACTA OECOL, V44, P46, DOI 10.1016/j.actao.2011.11.006; Syed NSB, 2021, CIV ENG J-TEHRAN, V7, P1731, DOI 10.28991/cej-2021-03091756; Tallis H, 2009, ANN NY ACAD SCI, V1162, P265, DOI 10.1111/j.1749-6632.2009.04152.x; The People's Bank of China, MON BANK STAT 2010 S; Turner DP, 2006, REMOTE SENS ENVIRON, V102, P282, DOI 10.1016/j.rse.2006.02.017; Van der Ploeg S., TEEB VALUATION DATAB; Wallace KJ, 2016, AUSTRALAS J ENV MAN, V23, P36, DOI 10.1080/14486563.2014.999727; Wang Y, 2011, PRICE YB CHINA; Wiggering H, 2006, ECOL INDIC, V6, P238, DOI 10.1016/j.ecolind.2005.08.014; Willemen L, 2008, LANDSCAPE URBAN PLAN, V88, P34, DOI 10.1016/j.landurbplan.2008.08.004; Witherspoon R. E., 1976, MIXED USE DEV NEW WA; Wittmer H, 2014, EC ECOSYSTEMS BIODIV, DOI [10.4324/9780203124307, DOI 10.4324/9780203124307]; Xia CQ, 2020, LAND USE POLICY, V90, DOI 10.1016/j.landusepol.2019.104276; [谢高地 Xie Gaodi], 2015, [自然资源学报, Journal of Natural Resources], V30, P1243; Yang YY, 2020, ECOL INDIC, V117, DOI 10.1016/j.ecolind.2020.106512; Yu XY, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12052015; Zhang M.L., 2012, IMPROVED CASA MODEL; Zhang SY, 2011, CHINA YB AGR PRICE S; [张晓琳 Zhang Xiaolin], 2019, [自然资源学报, Journal of Natural Resources], V34, P689; [张志明 Zhang Zhiming], 2015, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V24, P1110; Zhu EM, 2011, CHINA WATER CONSERVA	71	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2022	17	7							e0271557	10.1371/journal.pone.0271557	http://dx.doi.org/10.1371/journal.pone.0271557			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Q0KX	35905132	gold, Green Published			2022-12-26	WOS:000855776900038
J	Zheng, QW; Ni, QZ; Zhu, B; Liang, X; Ma, N; Wang, YK; Xu, S; Cao, HJ; Xia, J; Zhang, FK; Zhang, EB; Qiu, XS; Ding, XF; Qiu, L; Zhang, XL; Dong, ZH; Li, ZG; Zhang, XL; Xie, D; Li, JJ				Zheng, Qian-Wen; Ni, Qian-Zhi; Zhu, Bing; Liang, Xin; Ma, Ning; Wang, Yi-Kang; Xu, Sheng; Cao, Hui-Jun; Xia, Ji; Zhang, Feng-Kun; Zhang, Er-Bin; Qiu, Xiao-Song; Ding, Xu-Fen; Qiu, Lin; Zhang, Xi-Lin; Dong, Zhao-Hui; Li, Zhi-Gang; Zhang, Xue-Li; Xie, Dong; Li, Jing-Jing			PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3	ONCOGENE			English	Article							MUTATIONS; PHENOTYPE; RECEPTOR; BMPR2	Lung cancer is the most common malignancy and the leading cause of cancer death worldwide, and lung adenocarcinoma (LUAD) is the most prevalent subtype. Considering the emergence of resistance to therapies, it is urgent to develop more effective therapies to improve the prognosis. Here we reported that pancreatic progenitor cell differentiation and proliferation factor (PPDPF) deficiency inhibited LUAD development both in vitro and in vivo. Mechanistically, PPDPF induces hyperactive STAT3 by interfering STAT3-PTPN1 interaction. Activated STAT3 promoted BMPR2 transcription, which further inhibited apoptosis. Moreover, PPDPF reduced NK cell infiltration and activation to develop an immunosuppressive microenvironment, which was also mediated by STAT3. Furthermore, we identified that the expression of PPDPF was positively correlated with the malignant features of LUAD, as well as BMPR2 and p-STAT3 level in clinical samples. Therefore, our study suggests that PPDPF positively regulates BMPR2 expression and facilitates immune escape via regulating STAT3 activity, providing a potential therapy target for LUAD.	[Zheng, Qian-Wen; Ni, Qian-Zhi; Zhu, Bing; Liang, Xin; Wang, Yi-Kang; Xu, Sheng; Cao, Hui-Jun; Xia, Ji; Zhang, Feng-Kun; Zhang, Er-Bin; Qiu, Xiao-Song; Ding, Xu-Fen; Qiu, Lin; Xie, Dong; Li, Jing-Jing] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Nutr Metab & Food Safety, Shanghai 200031, Peoples R China; [Zheng, Qian-Wen; Qiu, Xiao-Song; Xie, Dong] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Ma, Ning; Li, Zhi-Gang] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, Sect Esophageal Surg, Shanghai 200030, Peoples R China; [Zhang, Xi-Lin] Huzhou Univ, Affiliated Hosp 1, Dept Cent Lab, Huzhou 313000, Zhejiang, Peoples R China; [Dong, Zhao-Hui] Huzhou Univ, Affiliated Hosp 1, Dept Crit Care Med, Huzhou 313000, Zhejiang, Peoples R China; [Zhang, Xue-Li] Shanghai Fengxian Cent Hosp, Dept Gen Surg, Shanghai 201499, Peoples R China; [Xie, Dong] China Natl Ctr Food Safety Risk Assessment, NHC Key Lab Food Safety Risk Assessment, Beijing 100022, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Shanghai Jiao Tong University; Huzhou University; Huzhou University	Xie, D; Li, JJ (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Nutr Metab & Food Safety, Shanghai 200031, Peoples R China.; Xie, D (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.; Zhang, XL (corresponding author), Shanghai Fengxian Cent Hosp, Dept Gen Surg, Shanghai 201499, Peoples R China.; Xie, D (corresponding author), China Natl Ctr Food Safety Risk Assessment, NHC Key Lab Food Safety Risk Assessment, Beijing 100022, Peoples R China.	tide7@163.com; dxie@sibs.ac.cn; lejing_1996@163.com	Cao, Huijun/HDM-1523-2022	, Ning/0000-0003-1825-8854	National Natural Science Foundation of China [82172950, 81972757, 81730083, 82030084]; Youth Innovation Promotion Association of Chinese Academy of Sciences [2017324]; Sanofi-SIBS 2018 Young Faculty Award	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association of Chinese Academy of Sciences; Sanofi-SIBS 2018 Young Faculty Award	This work was supported by the National Natural Science Foundation of China (82172950, 81972757), Youth Innovation Promotion Association of Chinese Academy of Sciences grant (2017324) and Sanofi-SIBS 2018 Young Faculty Award to J-JL; and the National Natural Science Foundation of China (81730083 and 82030084) to DX.	Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Augeri DJ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0511-9; Bedel R, 2011, CANCER RES, V71, P1615, DOI 10.1158/0008-5472.CAN-09-4540; Beppu H, 2008, ONCOGENE, V27, P1063, DOI 10.1038/sj.onc.1210720; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bruno A, 2013, NEOPLASIA, V15, P133, DOI 10.1593/neo.121758; Cacalano NA, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00128; Degos C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00877; Galon J, 2020, IMMUNITY, V52, P55, DOI 10.1016/j.immuni.2019.12.018; Ihara S, 2012, CANCER RES, V72, P2990, DOI 10.1158/0008-5472.CAN-11-4062; Jiang Z, 2008, PLOS BIOL, V6, P2450, DOI 10.1371/journal.pbio.0060293; Jiao G, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.540; Johnson DE, 2018, NAT REV CLIN ONCOL, V15, P234, DOI 10.1038/nrclinonc.2018.8; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Liu GH, 2019, BIOCHEM BIOPH RES CO, V513, P207, DOI 10.1016/j.bbrc.2019.03.213; Liu MY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05095; Liu ZP, 2009, BBA-MOL CELL RES, V1793, P1819, DOI 10.1016/j.bbamcr.2009.09.012; Lund IK, 2005, J MOL ENDOCRINOL, V34, P339, DOI 10.1677/jme.1.01694; Ma N, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23285-8; Mao ZF, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014552; Myers JA, 2021, NAT REV CLIN ONCOL, V18, P85, DOI 10.1038/s41571-020-0426-7; Nakamura T, 2010, MOL CELL, V39, P184, DOI 10.1016/j.molcel.2010.07.002; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Peng CW, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-1060-2; Peters S, 2019, ANN ONCOL, V30, P884, DOI 10.1093/annonc/mdz109; Pickup MW, 2015, MOL ONCOL, V9, P179, DOI 10.1016/j.molonc.2014.08.004; Platonova S, 2011, CANCER RES, V71, P5412, DOI 10.1158/0008-5472.CAN-10-4179; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Remark R, 2015, AM J RESP CRIT CARE, V191, P377, DOI 10.1164/rccm.201409-1671PP; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Schuijs MJ, 2020, NAT IMMUNOL, V21, P998, DOI 10.1038/s41590-020-0745-y; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Soon E, 2015, AM J RESP CRIT CARE, V192, P859, DOI 10.1164/rccm.201408-1509OC; Sui QJ, 2014, J IMMUNOL, V193, P2016, DOI 10.4049/jimmunol.1302389; Sun XX, 2013, MOL CANCER THER, V12, P2885, DOI 10.1158/1535-7163.MCT-12-1087; Tkach M, 2012, J IMMUNOL, V189, P1162, DOI 10.4049/jimmunol.1102538; Tulotta C, 2019, CLIN CANCER RES, V25, P2769, DOI 10.1158/1078-0432.CCR-18-2202; Wang ZD, 2021, LEUKEMIA LYMPHOMA, V62, P937, DOI 10.1080/10428194.2020.1849680; Wellenstein MD, 2018, IMMUNITY, V48, P399, DOI 10.1016/j.immuni.2018.03.004; Xiao YJ, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.669603; Zeng FW, 2012, HYBRIDOMA, V31, P209, DOI 10.1089/hyb.2011.0115	41	0	0	3	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 2	2022	41	36					4244	4256		10.1038/s41388-022-02418-3	http://dx.doi.org/10.1038/s41388-022-02418-3		JUL 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4G5OH	35906391				2022-12-26	WOS:000832824600002
J	Dorji, T; Wangmo, K; Tshering, D; Tashi, U; Wangdi, K				Dorji, Thinley; Wangmo, Karma; Tshering, Dendup; Tashi, Ugyen; Wangdi, Kinley			Knowledge and attitude on sexually transmitted infections and contraceptive use among university students in Bhutan	PLOS ONE			English	Article							CONDOMS	ObjectivesThe unmet needs of contraception can lead to unintended pregnancy and transmission of sexually transmitted infections (STI). Therefore, this study aimed to evaluate the contraception use, knowledge, and attitude on STI among students under Royan University of Bhutan (RUB). MethodsThis was a cross-sectional study using an online questionnaire. The questionnaire was developed in Google forms and the link was shared through the college WeChat groups. The questionnaire consisted of four parts on socio-demographic, sexual behaviour and contraceptive use, knowledge, and attitude on STIs. All the students under RUB were invited to participate voluntarily in this study. The socio-demography was presented in frequency and proportion. ResultA total of 1,283 students participated in this survey and 55.0% (701) were females. Of this, 29.4% (377) were sexually active and 94.4% reported using modern contraception. Commonly used contraceptives were: condoms (83.8%, 316) and emergency contraceptives (20.6%, 78), respectively. The mean knowledge and attitude scores on STI were 9.94 (range 2-20) and 12 (range 2-14), respectively. Good knowledge and attitude on STI were reported in 53.2% (683) and 70.1% (899) of participants. ConclusionStudents reported average knowledge and a good attitude towards STI. Contraceptive use among university students was low. There is a need to strengthen health education on STIs in schools and universities. All forms of contraceptives especially condoms should be made easily available to sexually active people.	[Dorji, Thinley] Kanglung Hosp, Kanglung, Trashigang, Bhutan; [Wangmo, Karma] Reg Livestock Dev Ctr, Kanglung, Trashigang, Bhutan; [Tshering, Dendup] Royal Univ Bhutan, Sherubtse Coll, Kanglung, Trashigang, Bhutan; [Tashi, Ugyen] Minist Hlth, Kawajangsa, Thimphu, Bhutan; [Wangdi, Kinley] Australian Natl Univ, Coll Hlth & Med, Natl Ctr Epidemiol & Populat Hlth, Dept Global Hlth, Acton, Australia	Australian National University	Dorji, T (corresponding author), Kanglung Hosp, Kanglung, Trashigang, Bhutan.	thinleydorji2005@gmail.com		Wangdi, Dr Kinley/0000-0002-8857-2665; Dorji, Thinley/0000-0001-8664-3178				Abel G, 2005, AUST NZ J PUBL HEAL, V29, P254, DOI 10.1111/j.1467-842X.2005.tb00764.x; Alary M., 2001, GUIDELINES MANAGEMEN; Balocchini E, 2013, J Prev Med Hyg, V54, P191; Calsyn DA, 2010, AM J ADDICTION, V19, P119, DOI 10.1111/j.1521-0391.2009.00022.x; Choden J., 2015, BHUTAN HLTH J, V1, P30; Deitch J, 2019, GLOB PUBLIC HEALTH, V14, P1316, DOI 10.1080/17441692.2019.1583264; Dema K., 2015, KUENSEL; Folasayo AT, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020159; Ghandour LA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-671; Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454; Huber LRB, 2009, J WOMENS HEALTH, V18, P1063, DOI 10.1089/jwh.2008.1131; Kallner HK, 2016, UPSALA J MED SCI, V121, P252, DOI 10.1080/03009734.2016.1208310; Kantorova V, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003026; Khadr SN, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011961; Lei L, 2020, J MARRIAGE FAM, DOI 10.1111/jomf.12723; Li ZH, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.21437; MELLANBY A, 1992, GENITOURIN MED, V68, P241; Mermelstein S., 2016, CURRENT TREATMENT OP, V2, P156, DOI [10.1007/s40746-016-0058-4, DOI 10.1007/S40746-016-0058-4]; Meston CM, 1996, ARCH SEX BEHAV, V25, P33, DOI 10.1007/BF02437906; Ministry of Health, 2021, ANN HLTH B, V2021; Ministry of Health, 2010, SEXUAL BEHAV NETWORK; Mousarrezaei Z, 2020, NURS MIDWIFERY STUD, V9, P9, DOI 10.4103/nms.nms_93_18; Peltzer K, 2015, AFR HEALTH SCI, V15, P1056, DOI 10.4314/ahs.v15i4.2; Powers KA, 2011, SEX TRANSM DIS, V38, P657, DOI 10.1097/OLQ.0b013e31820cb223; Randolph ME, 2007, ARCH SEX BEHAV, V36, P844, DOI 10.1007/s10508-007-9213-0; Renjhen P, 2010, J TURK-GER GYNECOL A, V11, P78, DOI 10.5152/jtgga.2010.03; Santos MJ., 2016, ATENCI N PRIMARIA, V48, P188; Shelton JD, 2009, LANCET, V374, P367, DOI 10.1016/S0140-6736(09)61399-4; Sychareun V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1126; Tamang L, 2017, CONTRACEP REPROD MED, V2, DOI 10.1186/s40834-017-0040-y; Tshomo D., 2016, J BHUTAN STUDIES, V35, P42; Upchurch DM, 2004, PERSPECT SEX REPRO H, V36, P276, DOI 10.1363/3627604; Wangdi K., 2016, INT ARCH NURS HLTH C, V2, P2469; Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844; World Health Organization, ACC GLOB SEX TRANSM	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272507	http://dx.doi.org/10.1371/journal.pone.0272507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921369	Green Published, gold			2022-12-26	WOS:000839311900042
J	Yang, SW; Dou, WJ; Li, MJ; Wang, ZL; Chen, GH; Zhang, XM				Yang, Shaowu; Dou, Wenjun; Li, Mingjiang; Wang, Ziliao; Chen, Guohua; Zhang, Xiaoming			Flowering agricultural landscapes enhance parasitoid biological control to Bemisia tabaci on tomato in south China	PLOS ONE			English	Article							NATURAL ENEMIES; HEMIPTERA ALEYRODIDAE; OLFACTORY ATTRACTIVENESS; VIRUS PANDEMICS; LONGEVITY; SYSTEM; IMPACT; PLANTS; FOOD; MANAGEMENT	Agricultural landscape pattern may enhance biocontrol services by supporting parasitoid populations, including parasitoids of Bemisia tabaci Gennadius (Hemiptera: Aleyrodidae). In this study, we selected four landscape types in Yunnan province, in south China, which were characterized by flower fields, mountain, river, and urban areas as their main elements. We then carried out systematic surveys in tomato fields found within each landscape type, to determine the diversity, occurrence, and parasitism rate of parasitoids. We found that parasitoids from the genus Encarsia and Eretmocerus were the main natural enemies present, and the most abundant species were recorded in the flower and the mountain landscapes. Also, Encarsia formosa (Hymenoptera: Chalcidoidea) formed the highest relative abundance regardless of the landscape type. We also found that the population density of B. tabaci in flower landscapes was the lowest than that in other landscape types. During the main activity period of B. tabaci, the parasitism rate in the flower landscape was higher than that in other landscape types. Our findings showed that the occurrence of B. tabaci was relatively mild in the flower landscapes. The landscape type was also beneficial to parasitoids as it enhanced their parasitism rate. Therefore, agriculture environmental schemes should consider increasing the size of flower fields in the surrounding landscape to enhance the sustainable control of B. tabaci by the natural agricultural ecosystem.	[Yang, Shaowu; Dou, Wenjun; Li, Mingjiang; Wang, Ziliao; Chen, Guohua; Zhang, Xiaoming] Yunnan Agr Univ, Coll Plant Protect, State Key Lab Conservat & Utilizat Bioresources Yu, Kunming, Peoples R China; [Yang, Shaowu] Kunming Univ, Coll Agron & Life Sci, Yunnan Urban Agr Engn & Technol Res Ctr, Kunming, Peoples R China; [Dou, Wenjun] Yunnan Expo Hort Co Ltd, Kunming, Peoples R China	Yunnan Agricultural University; Kunming University	Chen, GH; Zhang, XM (corresponding author), Yunnan Agr Univ, Coll Plant Protect, State Key Lab Conservat & Utilizat Bioresources Yu, Kunming, Peoples R China.	chenghkm@126.com; zxmalex@126.com			Yunnan Fundamental Research Projects [202201AT070269]; National Natural Science Foundation of China [31760541]; Reserve Talent Project of Yunnan's Young and Middle-aged Academic and Technical Leaders [202105AC160071]; Young Top Talents of "High-level Talents Training Support Program in Yunnan Province" [YNWRQNBJ2020291]; Reserve Talents Project for the 17th Batch of Kunming's Young and Middle-aged Academic and Technical Leaders [KMRCH2019023]	Yunnan Fundamental Research Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Reserve Talent Project of Yunnan's Young and Middle-aged Academic and Technical Leaders; Young Top Talents of "High-level Talents Training Support Program in Yunnan Province"; Reserve Talents Project for the 17th Batch of Kunming's Young and Middle-aged Academic and Technical Leaders	This work was supported by Yunnan Fundamental Research Projects [grant no. 202201AT070269]; the National Natural Science Foundation of China [grant no. 31760541]; the Reserve Talent Project of Yunnan's Young and Middle-aged Academic and Technical Leaders [grant no. 202105AC160071]; the Young Top Talents of "High-level Talents Training Support Program in Yunnan Province" [grant no. YNWRQNBJ2020291]; and the Reserve Talents Project for the 17th Batch of Kunming's Young and Middle-aged Academic and Technical Leaders [grant no. KMRCH2019023]. One of the corresponding authors, Dr. Xiaoming Zhang, is the funder. He had role in Resources, Data Curation, Writing -Review and Editing, Funding acquisition.	Belz E, 2013, BIOCONTROL, V58, P163, DOI 10.1007/s10526-012-9472-0; Berndt LA, 2005, BIOL CONTROL, V32, P65, DOI 10.1016/j.biocontrol.2004.07.014; Bianchi FJJA, 2015, AGR ECOSYST ENVIRON, V207, P10, DOI 10.1016/j.agee.2015.03.018; Cao YaZhong, 1995, Acta Phytophylacica Sinica, V22, P134; Clough Y, 2007, J APPL ECOL, V44, P22, DOI 10.1111/j.1365-2664.2006.01239.x; Corbett A, 1996, ECOL ENTOMOL, V21, P155, DOI 10.1111/j.1365-2311.1996.tb01182.x; Duan ChangQun, 2021, Journal of West China Forestry Science, V50, P1, DOI 10.16473/j.cnki.xblykx1972.2021.05.001; Ellis JA, 2005, BIOL CONTROL, V34, P99, DOI 10.1016/j.biocontrol.2005.03.020; Fazekas J, 1997, EUR J ENTOMOL, V94, P473; Gagic V, 2011, P ROY SOC B-BIOL SCI, V278, P2946, DOI 10.1098/rspb.2010.2645; Gao Yue-Bo, 2014, Chinese Journal of Applied Entomology, V51, P392, DOI 10.7679/j.issn.2095-1353.2014.046; Geneau CE, 2013, BIOL CONTROL, V66, P16, DOI 10.1016/j.biocontrol.2013.02.007; Hao SX, 2019, SCI HORTIC-AMSTERDAM, V249, P143, DOI 10.1016/j.scienta.2019.01.045; Irvin NA, 2007, BIOL CONTROL, V40, P69, DOI 10.1016/j.biocontrol.2006.09.005; Jiang Xing-Fu, 2003, Acta Ecologica Sinica, V23, P738; Kanakala S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213946; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Langoya LA., 2008, PROCEEDING NETHERLAN, V19, P37; Lee JC, 2008, J ANIM ECOL, V77, P565, DOI 10.1111/j.1365-2656.2008.01355.x; Legg JP, 2011, VIRUS RES, V159, P161, DOI 10.1016/j.virusres.2011.04.018; Legg JP, 2014, PEST MANAG SCI, V70, P1446, DOI 10.1002/ps.3793; Li SJ, 2011, INSECT SCI, V18, P101, DOI 10.1111/j.1744-7917.2010.01395.x; Liu B, 2016, BIOL CONTROL, V93, P15, DOI 10.1016/j.biocontrol.2015.11.004; Liu Chunhui, 2021, Biodiversity Science, V29, P200, DOI 10.17520/biods.2020082; [罗礼智 Luo Lizhi], 2016, [植物保护, Plant Protection], V42, P1; Milenovic M, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00001; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; NILSSON C, 1985, Z ANGEW ENTOMOL, V100, P302; Lopez SN, 2009, BIOL CONTROL, V50, P317, DOI 10.1016/j.biocontrol.2009.05.002; Pillai GK, 2014, BIOCONTROL SCI TECHN, V24, P325, DOI 10.1080/09583157.2013.860952; Plecas M, 2014, AGR ECOSYST ENVIRON, V183, P1, DOI 10.1016/j.agee.2013.10.016; Qian GJ, 2019, J ASIA-PAC ENTOMOL, V22, P1123, DOI 10.1016/j.aspen.2019.07.006; Qio Bao-Li, 2004, Entomological Knowledge, V41, P333; Roland J, 1997, NATURE, V386, P710, DOI 10.1038/386710a0; Stansly PA, 2004, CROP PROT, V23, P701, DOI 10.1016/j.cropro.2003.11.016; Steffan-Dewenter I, 2001, P ROY SOC B-BIOL SCI, V268, P1685, DOI 10.1098/rspb.2001.1737; Tang JH., 2016, RESPONSE ADAPTATION; [唐继洪 Tang Jihong], 2016, [植物保护, Plant Protection], V42, P79; Thompson SN, 1999, ANNU REV ENTOMOL, V44, P561, DOI 10.1146/annurev.ento.44.1.561; Vyskocilova S, 2019, J PEST SCI, V92, P1071, DOI 10.1007/s10340-019-01113-9; Wackers FL, 2008, BIOL CONTROL, V45, P176, DOI 10.1016/j.biocontrol.2008.01.007; Wang Jian-Hong, 2017, Chinese Journal of Applied Entomology, V54, P126, DOI 10.7679/j.issn.2095-1353.2017.015; Wang Jian-Hong, 2015, Chinese Journal of Applied Entomology, V52, P289, DOI 10.7679/j.issn.2095-1353.2015.031; Winkler K, 2006, BASIC APPL ECOL, V7, P133, DOI 10.1016/j.baae.2005.06.001; Winkler K, 2009, BIOL CONTROL, V50, P299, DOI 10.1016/j.biocontrol.2009.04.009; Wratten SD, 2012, AGR ECOSYST ENVIRON, V159, P112, DOI 10.1016/j.agee.2012.06.020; Xiao YF, 2011, BIOL CONTROL, V58, P239, DOI 10.1016/j.biocontrol.2011.06.004; Zhang XM, 2020, PEST MANAG SCI, V76, P366, DOI 10.1002/ps.5524; Zhang XM, 2014, J INTEGR AGR, V13, P2211, DOI 10.1016/S2095-3119(13)60613-9; Zhang Xiaoming, 2017, Journal of Plant Protection, V44, P737; Zhang Xiaoming, 2014, Acta Ecologica Sinica, V34, P4652; Zhang XM, 2013, STUDY BIOECOLOGICAL; Zhao ZH, 2012, ECOL RES, V27, P303, DOI 10.1007/s11284-011-0903-7; Zhao ZH, 2013, SCI CHINA LIFE SCI, V56, P758, DOI 10.1007/s11427-013-4511-3	54	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272314	http://dx.doi.org/10.1371/journal.pone.0272314			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917374	gold, Green Published			2022-12-26	WOS:000837840000010
J	Orlowska, K; Fling, RR; Nault, R; Sink, WJ; Schilmiller, AL; Zacharewski, T				Orlowska, Karina; Fling, Russ R.; Nault, Rance; Sink, Warren J.; Schilmiller, Anthony L.; Zacharewski, Tim			Dioxin-elicited decrease in cobalamin redirects propionyl-CoA metabolism to the beta-oxidation-like pathway resulting in acrylyl-CoA conjugate buildup	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; LIVER-DISEASE; ITACONIC ACID; INBORN ERROR; TCDD; RECEPTOR; IDENTIFICATION; CHEMICALS; PROTEIN; SERUM	2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a persistent environmental contaminant that induces diverse biological and toxic effects, including reprogramming intermediate metabolism, mediated by the aryl hydrocarbon receptor. However, the specific reprogramming effects of TCDD are unclear. Here, we performed targeted LC-MS analysis of hepatic extracts from mice gavaged with TCDD. We detected an increase in S-(2-carboxyethyl)-L-cysteine, a conjugate from the spontaneous reaction between the cysteine sulfhydryl group and highly reactive acrylyl-CoA, an intermediate in the cobalamin (Cbl)-independent beta-oxidation-like metabolism of propionyl-CoA. TCDD repressed genes in both the canonical Cbl-dependent carboxylase and the alternate Cbl-independent beta-oxidation-like pathways as well as inhibited methylmalonyl-CoA mutase (MUT) at lower doses. Moreover, TCDD decreased serum Cbl levels and hepatic cobalt levels while eliciting negligible effects on gene expression associated with Cbl absorption, transport, trafficking, or derivatization to 5'-deoxy-adenosylcobalamin (AdoCbl), the required MUT cofactor. Additionally, TCDD induced the gene encoding aconitate decarboxylase 1 (Acod1), the enzyme responsible for decarboxylation of cis-aconitate to itaconate, and dose -dependently increased itaconate levels in hepatic extracts. Our results indicate MUT inhibition is consistent with itaconate activation to itaconyl-CoA, a MUT suicide inactivator that forms an adduct with adenosylcobalamin. This adduct in turn inhibits MUT activity and reduces Cbl levels. Collectively, these results suggest the decrease in MUT activity is due to Cbl depletion following TCDD treatment, which redirects propionyl-CoA metabolism to the alternate Cbl-independent beta-oxidation-like pathway. The resulting hepatic accumulation of acrylyl-CoA likely contributes to TCDD-elicited hepatotoxicity and the multihit progression of steatosis to steatohepatitis with fibrosis.	[Orlowska, Karina; Nault, Rance; Sink, Warren J.; Zacharewski, Tim] Michigan State Univ, Biochem & Mol Biol, E Lansing, MI 48824 USA; [Orlowska, Karina; Fling, Russ R.; Nault, Rance; Sink, Warren J.; Zacharewski, Tim] Michigan State Univ, Inst Integrat Toxicol, E Lansing, MI 48824 USA; [Fling, Russ R.] Michigan Sptate Univ, Microbiol & Mol Genet, E Lansing, MI USA; [Schilmiller, Anthony L.] Michigan State Univ, Mass Spectrometry & Metabol Core, E Lansing, MI USA	Michigan State University; Michigan State University; Michigan State University	Zacharewski, T (corresponding author), Michigan State Univ, Biochem & Mol Biol, E Lansing, MI 48824 USA.; Zacharewski, T (corresponding author), Michigan State Univ, Inst Integrat Toxicol, E Lansing, MI 48824 USA.	tzachare@msu.edu			National Institute of Environmental Health Sciences Super [NIEHS SRP P42ES004911, R01ES029541]; AgBioResearch at Michigan State University; NIEHS Multidisciplinary Training in Environmental Toxicology [T32ES007255]	National Institute of Environmental Health Sciences Super; AgBioResearch at Michigan State University; NIEHS Multidisciplinary Training in Environmental Toxicology	This project was supported by the National Institute of Environmental Health Sciences Super-fund Research Program [NIEHS SRP P42ES004911] and R01ES029541 to T. Z. T. Z. is partially supported by AgBioResearch at Michigan State University. R. R. F. and W. J. S. were supported by NIEHS Multidisciplinary Training in Environmental Toxicology [T32ES007255] . The content is solely the responsibility of the authors and does not necessarily represent the of fi cial views of the National Institutes of Health.	Al-Eryani L, 2015, TOXICOL PATHOL, V43, P482, DOI 10.1177/0192623314549960; Alcock RE, 1998, CHEMOSPHERE, V37, P1457, DOI 10.1016/S0045-6535(98)00136-2; Angrish MM, 2013, TOXICOL SCI, V131, P108, DOI 10.1093/toxsci/kfs277; [Anonymous], 2016, IARC Monogr Eval Carcinog Risks Hum, V107, P9; Antonenkov VD, 1997, J BIOL CHEM, V272, P26023, DOI 10.1074/jbc.272.41.26023; Avilla MN, 2020, CHEM RES TOXICOL, V33, P860, DOI 10.1021/acs.chemrestox.9b00476; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Boverhof DR, 2005, TOXICOL SCI, V85, P1048, DOI 10.1093/toxsci/kfi162; Brennan K., 2019, WATERS, P1; Burgin HJ, 2020, FEBS LETT, V594, P590, DOI 10.1002/1873-3468.13735; Calvert GM, 1996, ARCH ENVIRON HEALTH, V51, P100, DOI 10.1080/00039896.1996.9936001; Carlson EA, 2009, ENVIRON TOXICOL CHEM, V28, P759, DOI 10.1897/08-195R.1; Cholico GN, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95214-0; Cui YX, 2010, PHARMACOGENOMICS, V11, P573, DOI 10.2217/PGS.10.37; Dere E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-365; Eaton S, 2000, BIOCHEM SOC T, V28, P177, DOI 10.1042/bst0280177; Eckel J E, 2004, J Biopharm Stat, V14, P647, DOI 10.1081/BIP-200025656; Fader KA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42760-3; Fader KA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05656-8; Fader KA, 2017, TOXICOL APPL PHARM, V321, P1, DOI 10.1016/j.taap.2017.02.006; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Forgacs AL, 2013, TOXICOL SCI, V133, P54, DOI 10.1093/toxsci/kft028; Foulds C, 2017, NAT REV ENDOCRINOL, V13, P445, DOI 10.1038/nrendo.2017.42; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; GASIEWICZ TA, 1983, DRUG METAB DISPOS, V11, P397; Green R, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.40; HSU JM, 1966, NATURE, V210, P1264, DOI 10.1038/2101264a0; Hygum K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020638; Jennen DGJ, 2010, TOXICOL SCI, V115, P66, DOI 10.1093/toxsci/kfq026; Klaassen CD, 2013, CASARETT DOULLS TOXI, V8th; Kopec AK, 2010, TOXICOL SCI, V118, P286, DOI 10.1093/toxsci/kfq236; Krishnaiah SY, 2017, CELL METAB, V25, P961, DOI 10.1016/j.cmet.2017.03.019; Kuwajima M, 2021, MOL GENET METAB REP, V29, DOI 10.1016/j.ymgmr.2021.100809; La Marca G, 2007, CLIN CHEM, V53, P1364, DOI 10.1373/clinchem.2007.087775; LAKSHMAN MR, 1991, J PHARMACOL EXP THER, V258, P317; Lam JR, 2013, JAMA-J AM MED ASSOC, V310, P2435, DOI 10.1001/jama.2013.280490; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JH, 2010, GASTROENTEROLOGY, V139, P653, DOI 10.1053/j.gastro.2010.03.033; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; MABLY TA, 1990, TOXICOL APPL PHARM, V106, P518, DOI 10.1016/0041-008X(90)90346-V; MARTIN JV, 1984, BRIT J IND MED, V41, P254; Matsumoto I, 1996, MASS SPECTROM REV, V15, P43, DOI 10.1002/(SICI)1098-2787(1996)15:1<43::AID-MAS3>3.0.CO;2-B; McGregor DB, 1998, ENVIRON HEALTH PERSP, V106, P755, DOI 10.2307/3433830; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Nault R, 2021, CELL MOL GASTROENTER, V11, P147, DOI 10.1016/j.jcmgh.2020.07.012; Nault R, 2018, MOL PHARMACOL, V94, P876, DOI 10.1124/mol.118.112144; Nault R, 2017, CHEM RES TOXICOL, V30, P1060, DOI 10.1021/acs.chemrestox.6b00430; Nault R, 2016, TOXICOL SCI, V154, P253, DOI 10.1093/toxsci/kfw163; Nault R, 2015, TOXICOL PATHOL, V43, P366, DOI 10.1177/0192623314544379; O'Neill LAJ, 2019, NAT REV IMMUNOL, V19, P273, DOI 10.1038/s41577-019-0128-5; OLIVER RM, 1975, BRIT J IND MED, V32, P49; Paules R, 2003, ENVIRON HEALTH PERSP, V111, pA338, DOI 10.1289/ehp.111-a338; Pelclova Daniela, 2006, Reviews on Environmental Health, V21, P119; Peters H, 2015, MOL GENET METAB, V115, P168, DOI 10.1016/j.ymgme.2015.06.008; Peters H, 2014, BRAIN, V137, P2903, DOI 10.1093/brain/awu216; Polyzos SA, 2020, METABOLISM, V111, DOI 10.1016/j.metabol.2020.154203; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rives C, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10121702; Ruetz M, 2019, SCIENCE, V366, P589, DOI 10.1126/science.aay0934; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Sabari BR, 2017, NAT REV MOL CELL BIO, V18, P90, DOI 10.1038/nrm.2016.140; SAFE S, 1990, CRIT REV TOXICOL, V21, P51, DOI 10.3109/10408449009089873; Sato K, 1999, J BIOCHEM-TOKYO, V126, P668, DOI 10.1093/oxfordjournals.jbchem.a022501; SCHJONSBY H, 1989, GUT, V30, P1686, DOI 10.1136/gut.30.12.1686; Schwab MA, 2006, BIOCHEM J, V398, P107, DOI 10.1042/BJ20060221; Shelton AN, 2019, ISME J, V13, P789, DOI 10.1038/s41396-018-0304-9; Shen HY, 2017, CELL, V171, P771, DOI 10.1016/j.cell.2017.09.051; SHIMOMURA Y, 1994, J BIOL CHEM, V269, P14248; Singh Virmeet V., 2004, Curr Treat Options Gastroenterol, V7, P19, DOI 10.1007/s11938-004-0022-4; Sokolovskaya OM, 2019, MBIO, V10, DOI 10.1128/mBio.01303-19; Sorg O, 2009, LANCET, V374, P1179, DOI 10.1016/S0140-6736(09)60912-0; Strelko CL, 2011, J AM CHEM SOC, V133, P16386, DOI 10.1021/ja2070889; Sweeney MH, 1997, TERATOGEN CARCIN MUT, V17, P241, DOI 10.1002/(SICI)1520-6866(1997)17:4/5<241::AID-TCM6>3.0.CO;2-I; TAOKA S, 1994, J BIOL CHEM, V269, P31630; Taylor KW, 2013, ENVIRON HEALTH PERSP, V121, P774, DOI 10.1289/ehp.1205502; Tilg H, 2021, HEPATOLOGY, V73, P833, DOI 10.1002/hep.31518; Vezina CM, 2004, ENVIRON HEALTH PERSP, V112, P1636, DOI 10.1289/txg.7253; Wahlang B, 2019, CURR ENV HLTH REP, V6, P80, DOI 10.1007/s40572-019-00232-w; Warner M, 2019, INT J OBESITY, V43, P2233, DOI 10.1038/s41366-018-0306-8; Warner M, 2013, ENVIRON HEALTH PERSP, V121, P906, DOI 10.1289/ehp.1206113; Watkins D, 2011, J MED GENET, V48, P590, DOI 10.1136/jmedgenet-2011-100286; Watkins D, 2011, AM J MED GENET C, V157C, P33, DOI 10.1002/ajmg.c.30288; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; WOLFE WH, 1994, J TOXICOL ENV HEALTH, V41, P481, DOI 10.1080/15287399409531858; Wong RJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.20294; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149; Zaslona Z, 2020, MOL CELL, V78, P814, DOI 10.1016/j.molcel.2020.04.002; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	92	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	298	9							102301	10.1016/j.jbc.2022.102301	http://dx.doi.org/10.1016/j.jbc.2022.102301			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5E0XQ	35931118	gold, Green Published			2022-12-26	WOS:000865354500008
J	Hollosi, A; Paszty, K; Bunta, BL; Bozo, T; Kellermayer, M; Debreczeni, ML; Cervenak, L; Baccarini, M; Varga, A				Hollosi, Anna; Paszty, Katalin; Bunta, Balint Levente; Bozo, Tamas; Kellermayer, Miklos; Debreczeni, Marta Lidia; Cervenak, Laszlo; Baccarini, Manuela; Varga, Andrea			BRAF increases endothelial cell stiffness through reorganization of the actin cytoskeleton	FASEB JOURNAL			English	Article						actin cytoskeleton; atomic force microscopy; BRAF RNAi; endothelial monolayer; intercellular gaps; permeability	ATOMIC-FORCE MICROSCOPY; STRESS FIBERS; B-RAF; PERMEABILITY; DYNAMICS; ACTIVATION; MECHANICS; MIGRATION; BINDING; ROLES	The dynamics of the actin cytoskeleton and its connection to endothelial cell-cell junctions determine the barrier function of endothelial cells. The proper regulation of barrier opening/closing is necessary for the normal function of vessels, and its dysregulation can result in chronic and acute inflammation leading to edema formation. By using atomic force microscopy, we show here that thrombin-induced permeability of human umbilical vein endothelial cells, associated with actin stress fiber formation, stiffens the cell center. The depletion of the MEK/ERK kinase BRAF reduces thrombin-induced permeability prevents stress fiber formation and cell stiffening. The peripheral actin ring becomes stabilized by phosphorylated myosin light chain, while cofilin is excluded from the cell periphery. All these changes can be reverted by the inhibition of ROCK, but not of the MEK/ERK module. We propose that the balance between the binding of cofilin and myosin to F-actin in the cell periphery, which is regulated by the activity of ROCK, determines the local dynamics of actin reorganization, ultimately driving or preventing stress fiber formation.	[Hollosi, Anna; Paszty, Katalin; Bunta, Balint Levente; Bozo, Tamas; Kellermayer, Miklos; Varga, Andrea] Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary; [Debreczeni, Marta Lidia; Cervenak, Laszlo] Semmelweis Univ, Dept Internal Med & Haematol, Budapest, Hungary; [Baccarini, Manuela] Univ Vienna, Dept Microbiol Immunobiol & Genet, Max Perutz Labs, Vienna, Austria	Semmelweis University; Semmelweis University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Varga, A (corresponding author), Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary.	matkovicsne.andrea@med.semmelweis-univ.hu	Varga, Andrea/B-2759-2019	Varga, Andrea/0000-0002-9076-7007	European Joint Programme on Rare Diseases [PredACTINg EJPRD 19-033]; Hungarian Science Foundation [FK132144, K135360]; Ministry for Innovation and Technology [UNKP19-4]; Hungarian Academy of Sciences; Semmelweis University	European Joint Programme on Rare Diseases; Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Ministry for Innovation and Technology; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Semmelweis University	European Joint Programme on Rare Diseases, Grant/Award Number: PredACTINg EJPRD 19-033; Hungarian Science Foundation, Grant/Award Number: FK132144 and K135360; Ministry for Innovation and Technology, Grant/Award Number: UNKP19-4 New National Excellence Program; Hungarian Academy of Sciences, Grant/Award Number: Bolyai Janos Fellow ship; Semmelweis University, Grant/Award Number: Start-upgrant	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Birukova AA, 2009, NANOMED-NANOTECHNOL, V5, P30, DOI 10.1016/j.nano.2008.07.002; Bleicher P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62942-8; Borbiev T, 2003, AM J PHYSIOL-LUNG C, V285, pL43, DOI 10.1152/ajplung.00460.2001; Claesson-Welsh L, 2021, TRENDS MOL MED, V27, P314, DOI 10.1016/j.molmed.2020.11.006; Codan B, 2013, MAT SCI ENG C-MATER, V33, P3303, DOI 10.1016/j.msec.2013.04.009; Debreczeni ML, 2021, CLIN REV ALLERG IMMU, V60, P318, DOI 10.1007/s12016-021-08851-8; Desideri E, 2015, CELL, V161, P967, DOI 10.1016/j.cell.2015.04.045; Dorard C, 2019, FEBS J, V286, P2277, DOI 10.1111/febs.14802; Dorland YL, 2017, CELL MOL LIFE SCI, V74, P279, DOI 10.1007/s00018-016-2325-8; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Fazal F, 2009, J BIOL CHEM, V284, P21047, DOI 10.1074/jbc.M109.016444; Gavara N, 2016, BIOMECH MODEL MECHAN, V15, P511, DOI 10.1007/s10237-015-0706-9; Grimm KB, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/21/215101; Gronloh MLB, 2021, J CELL SCI, V134, DOI 10.1242/jcs.255653; Gunduz D, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01387; Hartmann S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00276; Heemskerk N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10493; Hino N, 2020, DEV CELL, V53, P646, DOI 10.1016/j.devcel.2020.05.011; Hirano M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20989; Hollosi A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22168989; Kassianidou E, 2017, MOL BIOL CELL, V28, P3832, DOI 10.1091/mbc.E17-06-0401; Katoh K, 2011, J R SOC INTERFACE, V8, P305, DOI 10.1098/rsif.2010.0419; Kazakova OA, 2020, BIOCHIMIE, V168, P83, DOI 10.1016/j.biochi.2019.10.010; Kellermayer MSZ, 2006, BIOPHYS J, V91, P2665, DOI 10.1529/biophysj.106.085456; Kern F, 2013, ONCOGENE, V32, P2483, DOI 10.1038/onc.2012.254; Kim SO, 2017, NANO CONVERG, V4, DOI 10.1186/s40580-017-0099-9; Krishnan R, 2011, AM J PHYSIOL-CELL PH, V300, pC146, DOI 10.1152/ajpcell.00195.2010; Oldenburg J, 2014, CELL TISSUE RES, V355, P545, DOI 10.1007/s00441-013-1792-6; Pritchard CA, 2004, MOL CELL BIOL, V24, P5937, DOI 10.1128/MCB.24.13.5937-5952.2004; Radeva MY, 2018, ACTA PHYSIOL, V222, DOI 10.1111/apha.12860; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; Sato M, 2000, J BIOMECH, V33, P127, DOI 10.1016/S0021-9290(99)00178-5; Schaefer A, 2015, J CELL SCI, V128, P2221, DOI 10.1242/jcs.163055; Schaefer A, 2014, J CELL SCI, V127, P4470, DOI 10.1242/jcs.154708; Stroka KM, 2011, CELL MOL BIOENG, V4, P9, DOI 10.1007/s12195-010-0142-y; Szulcek R, 2013, CARDIOVASC RES, V99, P471, DOI 10.1093/cvr/cvt075; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Valent ET, 2016, EXP CELL RES, V347, P161, DOI 10.1016/j.yexcr.2016.07.029; van Buul Jaap D, 2016, Small GTPases, V7, P21, DOI 10.1080/21541248.2015.1131802; van Steen ACI, 2020, ATHEROSCLEROSIS, V315, P102, DOI 10.1016/j.atherosclerosis.2020.06.004; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Wettschureck N, 2019, PHYSIOL REV, V99, P1467, DOI 10.1152/physrev.00037.2018; Wiggan O, 2012, DEV CELL, V22, P530, DOI 10.1016/j.devcel.2011.12.026; Wimmer R, 2012, DEV CELL, V22, P158, DOI 10.1016/j.devcel.2011.11.012; Yao Z, 2019, NAT MED, V25, P284, DOI 10.1038/s41591-018-0274-5; Zhang P, 2016, J BIOL CHEM, V291, P2087, DOI 10.1074/jbc.M115.696419	48	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22478	10.1096/fj.202200344R	http://dx.doi.org/10.1096/fj.202200344R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3L4XK	35916021	Green Accepted			2022-12-26	WOS:000834765100001
J	Diskin, B; Adam, S; Soto, GS; Liria, M; Aykut, B; Sundberg, B; Li, E; Leinwand, J; Chen, R; Kim, M; Salas, RD; Cassini, MF; Buttar, C; Wang, W; Farooq, MS; Shadaloey, SAA; Werba, G; Fnu, A; Yang, F; Hirsch, C; Glinski, J; Panjwani, A; Weitzner, Y; Cohen, D; Miller, G				Diskin, Brian; Adam, Salma; Soto, Gustavo Sanchez; Liria, Miguel; Aykut, Berk; Sundberg, Belen; Li, Eric; Leinwand, Joshua; Chen, Ruonan; Kim, Mirhee; Salas, Ruben D.; Cassini, Marcelo F.; Buttar, Chandan; Wang, Wei; Farooq, Mohammad Saad; Shadaloey, Sorin A. A.; Werba, Gregor; Fnu, Amreek; Yang, Fan; Hirsch, Carolina; Glinski, John; Panjwani, Angilee; Weitzner, Yael; Cohen, Deirdre; Miller, George			BTLA(+)CD200(+) B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer	ONCOGENE			English	Article							LIVER; ONCOGENESIS; RESPONSES; NICHE	Response to cancer immunotherapy in primary versus metastatic disease has not been well-studied. We found primary pancreatic ductal adenocarcinoma (PDA) is responsive to diverse immunotherapies whereas liver metastases are resistant. We discovered divergent immune landscapes in each compartment. Compared to primary tumor, liver metastases in both mice and humans are infiltrated by highly anergic T cells and MHCII(lo)IL10(+) macrophages that are unable to present tumor-antigen. Moreover, a distinctive population of CD24(+)CD44(-)CD40(-) B cells dominate liver metastases. These B cells are recruited to the metastatic milieu by Muc1(hi)IL18(hi) tumor cells, which are enriched >10-fold in liver metastases. Recruited B cells drive macrophage-mediated adaptive immune-tolerance via CD200 and BTLA. Depleting B cells or targeting CD200/BTLA enhanced macrophage and T-cell immunogenicity and enabled immunotherapeutic efficacy of liver metastases. Our data detail the mechanistic underpinnings for compartment-specific immunotherapy-responsiveness and suggest that primary PDA models are poor surrogates for evaluating immunity in advanced disease.	[Diskin, Brian; Adam, Salma; Soto, Gustavo Sanchez; Liria, Miguel; Aykut, Berk; Sundberg, Belen; Li, Eric; Leinwand, Joshua; Chen, Ruonan; Kim, Mirhee; Salas, Ruben D.; Cassini, Marcelo F.; Buttar, Chandan; Wang, Wei; Farooq, Mohammad Saad; Shadaloey, Sorin A. A.; Werba, Gregor; Fnu, Amreek; Yang, Fan; Hirsch, Carolina; Glinski, John; Panjwani, Angilee; Weitzner, Yael; Miller, George] NYU, Dept Surg, SA Localio Lab, Sch Med, New York, NY 10016 USA; [Cohen, Deirdre] NYU, Sch Med, Dept Med, New York, NY USA; [Miller, George] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Miller, George] Trinity Hlth New England, Waterbury, CT 06706 USA	New York University; New York University; New York University	Miller, G (corresponding author), NYU, Dept Surg, SA Localio Lab, Sch Med, New York, NY 10016 USA.; Miller, G (corresponding author), NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA.; Miller, G (corresponding author), Trinity Hlth New England, Waterbury, CT 06706 USA.	gedalyamil@gmail.com		Aykut, Berk/0000-0001-8343-4258; Salas Parra, Ruben Dario/0000-0002-8960-266X	American College of Surgeons Resident Research Fellowship; Deutsche Forschungsgemeinschaft [AY 126/1-1]; NIH [CA168611, CA203105, CA215471, CA19311, DK106025]	American College of Surgeons Resident Research Fellowship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the American College of Surgeons Resident Research Fellowship (BD), Deutsche Forschungsgemeinschaft grant AY 126/1-1 (BA), and NIH grants CA168611 (DC, GM), CA203105 (GM), CA215471 (GM), CA19311 (GM), and DK106025 (GM).	Bodogai M, 2015, CANCER RES, V75, P3456, DOI 10.1158/0008-5472.CAN-14-3077; Canning C, 2006, IMMUNOL LETT, V107, P83, DOI 10.1016/j.imlet.2006.07.002; Chen J, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/8282391; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Daley D, 2017, J EXP MED, V214, P1711, DOI 10.1084/jem.20161707; Daley D, 2017, NAT MED, V23, P556, DOI 10.1038/nm.4314; Daley D, 2016, CELL, V166, P1485, DOI 10.1016/j.cell.2016.07.046; Disibio G, 2008, ARCH PATHOL LAB MED, V132, P931, DOI 10.1043/1543-2165(2008)132[931:MPOCRF]2.0.CO;2; Enoksson SL, 2011, P NATL ACAD SCI USA, V108, pE1399, DOI 10.1073/pnas.1107830108; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Grunwald B, 2016, GASTROENTEROLOGY, V151, P1011, DOI 10.1053/j.gastro.2016.07.043; Gunderson AJ, 2016, CANCER DISCOV, V6, P270, DOI 10.1158/2159-8290.CD-15-0827; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lee JW, 2019, NATURE, V567, P249, DOI 10.1038/s41586-019-1004-y; Liu Y, 2016, CANCER CELL, V30, P668, DOI 10.1016/j.ccell.2016.09.011; Liu Y, 2016, J MOL MED, V94, P509, DOI 10.1007/s00109-015-1376-x; Mieli-Vergani G, 2018, NAT REV DIS PRIMERS, V4, DOI [10.1038/nrdp.2018.17, 10.1038/nrdp.2018.18]; Moini M, 2015, WORLD J HEPATOL, V7, P1355, DOI 10.4254/wjh.v7.i10.1355; Nielsen SR, 2016, NAT CELL BIOL, V18, P549, DOI 10.1038/ncb3340; Pylayeva-Gupta Y, 2016, CANCER DISCOV, V6, P247, DOI 10.1158/2159-8290.CD-15-0843; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wang Wei, 2018, Cancer Cell, V34, P757, DOI 10.1016/j.ccell.2018.10.006; Wrenshall LE, 2001, TRANSPLANTATION, V71, P841, DOI 10.1097/00007890-200104150-00004; Yachida S, 2009, ARCH PATHOL LAB MED, V133, P413, DOI 10.1043/1543-2165-133.3.413; Zhao Y., 2018, ONCOTARGET, V9, P14803, DOI [10.18632/oncotarget.22976, DOI 10.18632/ONCOTARGET.22976]; Zhu Y, 2017, IMMUNITY, V47, P323, DOI 10.1016/j.immuni.2017.07.014	28	0	0	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 16	2022	41	38					4349	4360		10.1038/s41388-022-02425-4	http://dx.doi.org/10.1038/s41388-022-02425-4		AUG 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4O3TC	35948648				2022-12-26	WOS:000838482900002
J	Chutimanukul, P; Mosaleeyanon, K; Janta, S; Toojinda, T; Darwell, CT; Wanichananan, P				Chutimanukul, Panita; Mosaleeyanon, Kriengkrai; Janta, Supattana; Toojinda, Theerayut; Darwell, Clive Terence; Wanichananan, Praderm			Physiological responses, yield and medicinal substance (andrographolide, AP1) accumulation of Andrographis paniculata (Burm. f) in response to plant density under controlled environmental conditions	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; ACTIVE DITERPENOIDS; VEGETATION INDEXES; LEAF; REFLECTANCE; GROWTH; LEAVES; WATER; NEES; INTERCEPTION	Agricultural practice in adjusting planting density and harvest date are important factors for plant development and crop improvement, reaching maximum yields and enhancing the production of secondary metabolites. However, it is unclear as to the optimal planting densities during mass production that encourage consistent, high yield secondary metabolite content. For this, controlled environment, crop production facilities such as plant factories with artificial lighting (PFAL) offer opportunity to enhance quality and stabilize production of herbal plants. This study assessed the effect of plant density and harvest date on physiological responses, yield and andrographolide (AP1) content in Andrographis paniculata (Andrographis) using hydroponic conditions in a PFAL system. Andrographis, harvested at vegetative stage (30 days after transplanting; 30 DAT) and initial stage of flowering (60 DAT) exhibited no significant differences in growth parameters or andrographolide accumulation according to planting densities. Harvest time at flowering stage (90 DAT) showed the highest photosynthetic rates at a planting density of 15 plants m(-2). Highest yield, number of leaves, and Andrographolide (AP1) content (mg per gram of DW in m(2)) were achieved at a more moderate planting density (30 plants m(-2)). Finally, five out of seventeen indices of leaf reflectance reveal high correlation (r= 0.8 to 1.0 and r= -0.8 to -1.0, P<0.01) with AP1 content. These results suggest that a planting density of 30 plants m(-2) and harvest time of 90 DAT provide optimal growing condition under the hydroponic PFAL system.	[Chutimanukul, Panita; Mosaleeyanon, Kriengkrai; Janta, Supattana; Toojinda, Theerayut; Darwell, Clive Terence; Wanichananan, Praderm] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Wanichananan, P (corresponding author), Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand.	praderm@biotec.or.th			National Center for Genetic Engineering and Biotechnology Technology Development Agency, Thailand [P2050861]	National Center for Genetic Engineering and Biotechnology Technology Development Agency, Thailand	This research was supported by National Center for Genetic Engineering and Biotechnology Technology Development Agency, Thailand (P2050861).	Akbar S, 2011, ALTERN MED REV, V16, P66; Bannari A., 1995, REMOTE SENS REV, V13, P95, DOI [10.1080/02757259509532298, DOI 10.1080/02757259509532298]; BARNES JD, 1992, ENVIRON EXP BOT, V32, P85, DOI 10.1016/0098-8472(92)90034-Y; Bascunan-Godoy L, 2016, PLANTA, V243, P591, DOI 10.1007/s00425-015-2424-z; BOARD JE, 1992, AGRON J, V84, P575, DOI 10.2134/agronj1992.00021962008400040006x; Broekman MJE, 2019, ECOL LETT, V22, P1957, DOI 10.1111/ele.13349; Broge NH, 2001, REMOTE SENS ENVIRON, V76, P156, DOI 10.1016/S0034-4257(00)00197-8; Burgos RA, 1997, J ETHNOPHARMACOL, V58, P219, DOI 10.1016/S0378-8741(97)00099-8; Carter TR, 1994, IPCC TECHNICAL GUIDE; CHANG RS, 1991, P SOC EXP BIOL MED, V197, P59; Cheung HY, 2001, J CHROMATOGR A, V930, P171, DOI 10.1016/S0021-9673(01)01160-8; Chutimanukul P, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-021-04577-x; Ciampitti IA, 2011, FIELD CROP RES, V121, P2, DOI 10.1016/j.fcr.2010.10.009; Daughtry CST, 2000, REMOTE SENS ENVIRON, V74, P229, DOI 10.1016/S0034-4257(00)00113-9; El-Hendawy SE, 2019, AGR WATER MANAGE, V212, P358, DOI 10.1016/j.agwat.2018.09.009; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Feng XP, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00468; GAMON JA, 1992, REMOTE SENS ENVIRON, V41, P35, DOI 10.1016/0034-4257(92)90059-S; Gitelson AA, 1997, INT J REMOTE SENS, V18, P2691, DOI 10.1080/014311697217558; Gitelson AA, 2002, PHOTOCHEM PHOTOBIOL, V75, P272, DOI 10.1562/0031-8655(2002)075<0272:ACCIPL>2.0.CO;2; Gitelson AA, 2001, PHOTOCHEM PHOTOBIOL, V74, P38, DOI 10.1562/0031-8655(2001)074&lt;0038:OPANEO&gt;2.0.CO;2; Goto E, 2012, ACTA HORTIC, V956, P37, DOI 10.17660/ActaHortic.2012.956.2; Guo Lan-Ping, 2020, Zhongguo Zhong Yao Za Zhi, V45, P1969, DOI 10.19540/j.cnki.cjcmm.20200302.101; Haboudane D, 2004, REMOTE SENS ENVIRON, V90, P337, DOI 10.1016/j.rse.2003.12.013; Haboudane D, 2002, REMOTE SENS ENVIRON, V81, P416, DOI 10.1016/S0034-4257(02)00018-4; Hiltbrunner J, 2007, FIELD CROP RES, V102, P163, DOI 10.1016/j.fcr.2007.03.009; Hossain Md Sanower, 2014, ScientificWorldJournal, V2014, P274905, DOI 10.1155/2014/274905; Huang JL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225810; Huang ZJ, 2021, FORESTS, V12, DOI 10.3390/f12070853; James SA, 2000, TREE PHYSIOL, V20, P1007; Khan MNI, 2004, J FOREST RES-JPN, V9, P205, DOI 10.1007/s10310-003-0074-7; Khan S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18734-8; Kuai J, 2016, FIELD CROP RES, V199, P89, DOI 10.1016/j.fcr.2016.09.025; Kumar RA, 2004, J ETHNOPHARMACOL, V92, P291, DOI 10.1016/j.jep.2004.03.004; LICHTENTHALER HK, 1986, RADIAT ENVIRON BIOPH, V25, P297, DOI 10.1007/BF01214643; Liu HJ, 2021, FRONT PLANT SCI, V12, DOI 10.3389/fpls.2021.628294; Liu Y, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00222; Ning K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217066; Okhuarobo A., 2014, Asian Pacific Journal of Tropical Disease, V4, P213; Ors S, 2017, AGR WATER MANAGE, V190, P31, DOI 10.1016/j.agwat.2017.05.003; PENUELAS J, 1995, PHOTOSYNTHETICA, V31, P221; Pholphana N, 2004, PHYTOCHEM ANALYSIS, V15, P365, DOI 10.1002/pca.789; Pholphana N, 2016, J ETHNOPHARMACOL, V194, P513, DOI 10.1016/j.jep.2016.09.058; Rao YK, 2004, PHYTOCHEMISTRY, V65, P2317, DOI 10.1016/j.phytochem.2004.05.008; Reddy MVB, 2003, J NAT PROD, V66, P295, DOI 10.1021/np020331k; Ren BZ, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1445-9; Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7; Rouse J.W, 1974, MONITORING VERNAL AD, P1; Rouse J.W., 1973, EARTH RES TECHN SAT, P309; Saraswat B., 1995, Fitoterapia, V66, P415; Shahjahan M., 2013, INT J AGR CROP SCI, V6, P769; Shen YC, 2002, BRIT J PHARMACOL, V135, P399, DOI 10.1038/sj.bjp.0704493; SHINOHARA Y, 1988, Acta Horticulturae (Wageningen), P279; SIRIPONG P, 1992, J SCI SOC THAILAND, V18, P187; Song YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154084; Verma K, 2021, IND CROP PROD, V159, DOI 10.1016/j.indcrop.2020.113076; Vinod P., 2017, IJCA, V172, P569; WELLS R, 1991, CROP SCI, V31, P755, DOI 10.2135/cropsci1991.0011183X003100030044x; Xia JB, 2021, SCI TOTAL ENVIRON, V761, DOI 10.1016/j.scitotenv.2020.143221; Xu C, 2010, FITOTERAPIA, V81, P610, DOI 10.1016/j.fitote.2010.03.003; Xue JR, 2017, J SENSORS, V2017, DOI 10.1155/2017/1353691; Yabuki K., 2004, PHOTOSYNTHETIC RATE; Yan Y., 2018, NATURAL SMALL MOL DR, P357; Yang B, 2019, J PLANT GROWTH REGUL, V38, P1489, DOI 10.1007/s00344-019-09951-8; Yang L, 2018, MOLECULES, V23, DOI 10.3390/molecules23040762; Yanivie Z., 1982, CULTIVATION UTILIZAT, P1; Zarco-Tejada PJ, 2000, REMOTE SENS ENVIRON, V74, P582, DOI 10.1016/S0034-4257(00)00148-6; Zhang WangFeng, 2004, Acta Phytoecologica Sinica, V28, P164; ZHAO HY, 1991, CHINESE MED J-PEKING, V104, P770; Zhi XY, 2016, J INTEGR AGR, V15, P1469, DOI 10.1016/S2095-3119(15)61174-1	70	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272520	10.1371/journal.pone.0272520	http://dx.doi.org/10.1371/journal.pone.0272520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925998	gold, Green Published			2022-12-26	WOS:000848077100095
J	Kunno, J; Supawattanabodee, B; Sumanasrethakul, C; Wiriyasirivaj, B; Yubonpunt, P				Kunno, Jadsada; Supawattanabodee, Busaba; Sumanasrethakul, Chavanant; Wiriyasirivaj, Budsaba; Yubonpunt, Pataraporn			Burnout prevalence and contributing factors among healthcare workers during the COVID-19 pandemic: A cross-sectional survey study in an urban community in Thailand	PLOS ONE			English	Article							PSYCHOLOGICAL IMPACT; STRESS; CHINA	Background Burnout is associated with an increased risk for severe COVID-19. Few studies have examined burnout prevalence related to healthcare workers during the pandemic. This study investigated the burnout prevalence and contributing factors among HCWs, including medical staff and support staff, during the COVID-19 pandemic in an urban community in Thailand. Methods A cross-sectional online survey was distributed among HCWs in Bangkok, Thailand, from July-August 2021. The independent t-test and one-way analysis of variance (ANOVA) were used to compare the contributing factors and burnout items. Variable factors associated with burnout among HCWs were used in multiple linear regression models. Results A total of 517 HCWs' survey responses were received. Most participants were medical staff (55.3%), female (83.4%), and over the age of 35 (59.4%); most participants (65.6%) did not have any diseases but had family members that did (63.6%). The prevalence of overall burnout presented among medical staff (25.9%). The results of the multiple linear regression models found that female (vs. male, beta 0.088; 95% CI 0.033, 6.614) was higher associated with overall burnout score. In addition, hours of sleep as > 6 hr./day (vs. <= 6 hr./day, beta -0.120; 95% CI -6.012, -0.969) was lower associated with overall burnout score. Conclusion This study highlights the importance of addressing burnout among HCWs, in which female medical staff who slept less than six hours per day were associated with burnout. Our study further suggested that both intervention and identification are needed of frontline HCWs to prevent and reduce the risk of burnout, as the proportion of females compared to males is high. Thus, the government should provide support in these areas to prevent a humanitarian crisis.	[Kunno, Jadsada; Supawattanabodee, Busaba] Navamindradhiraj Univ, Fac Med, Dept Res & Med Innovat, Vajira Hosp, Bangkok, Thailand; [Sumanasrethakul, Chavanant] Navamindradhiraj Univ, Fac Med, Dept Urban Med, Vajira Hosp, Bangkok, Thailand; [Wiriyasirivaj, Budsaba] Navamindradhiraj Univ, Fac Med, Dept Obstet & Gynecol, Vajira Hosp, Bangkok, Thailand; [Yubonpunt, Pataraporn] Huachiew Chalermprakiet Univ, Fac Publ & Environm Hlth, Dept Publ Hlth, Samutprakan, Thailand		Yubonpunt, P (corresponding author), Huachiew Chalermprakiet Univ, Fac Publ & Environm Hlth, Dept Publ Hlth, Samutprakan, Thailand.	Pataraporn.yubon@gmail.com		Kunno, Jadsada/0000-0001-5664-7266				Al Youha S, 2021, J INFECT PUBLIC HEAL; Albert PR, 2015, J PSYCHIATR NEUROSCI, V40, P219, DOI 10.1503/jpn.150205; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; Bruyneel A, 2021, INTENS CRIT CARE NUR, V65, DOI 10.1016/j.iccn.2021.103059; Charoentanyarak A, 2020, J MED EDUC CURRIC DE, V7, DOI 10.1177/2382120520944920; Chor WPD, 2021, AM J EMERG MED, V46, P700, DOI 10.1016/j.ajem.2020.10.040; Grainger R, 2021, BEST PRACT RES CL RH, V35, DOI 10.1016/j.berh.2020.101657; Gupta M.D, 2021, INDIAN HEART J; Gupta MD, 2021, J AM COLL CARDIOL, V77, P3110; Iacovides A, 2003, J AFFECT DISORDERS, V75, P209, DOI 10.1016/S0165-0327(02)00101-5; Ibar C, 2021, PSYCHONEUROENDOCRINO, V128, DOI 10.1016/j.psyneuen.2021.105213; Iftimie S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248029; Kamacooko O, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18137004; Khasne RW, 2020, INDIAN J CRIT CARE M, V24, P664, DOI 10.5005/jp-journals-10071-23518; Koutsimani P, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00284; Kunno Jadsada, 2021, Adv Prev Med, V2021, P5807056, DOI 10.1155/2021/5807056; Li Q., 2020, NEW ENGL J MED, V382, P1199; Luceno-Moreno L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155514; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Matsuo T, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.17271; Millan DLM, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.633723; Phuekphan P, 2016, J HEALTH RES, V30, P135, DOI 10.14456/jhr.2016.19; Pradhan D, 2020, ARCH MED RES, V51, P363, DOI 10.1016/j.arcmed.2020.04.020; Prasad K, 2021, ECLINICALMEDICINE, V35, DOI 10.1016/j.eclinm.2021.100879; Roslan NS, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9010090; Sahebi A, 2021, PROG NEURO-PSYCHOPH, V107, DOI 10.1016/j.pnpbp.2021.110247; Saragih ID, 2021, INT J NURS STUD, V121, DOI 10.1016/j.ijnurstu.2021.104002; Thongsonnboon W, 2020, PSYCHOL RES BEHAV MA, V13, P1115, DOI 10.2147/PRBM.S290196; West CP, 2018, J INTERN MED, V283, P516, DOI 10.1111/joim.12752; Wong TW, 2005, EUR J EMERG MED, V12, P13, DOI 10.1097/00063110-200502000-00005; Wright JG, 2011, PAED CHILD HEALT-CAN, V16, P409, DOI 10.1093/pch/16.7.409; Wu Y, 2020, J PAIN SYMPTOM MANAG, V60, pE60, DOI 10.1016/j.jpainsymman.2020.04.008; Xiao X, 2020, J AFFECT DISORDERS, V274, P405, DOI 10.1016/j.jad.2020.05.081; Zhang X, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.680614; Zutautiene R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103739	35	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0269421	10.1371/journal.pone.0269421	http://dx.doi.org/10.1371/journal.pone.0269421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35926013	gold, Green Published			2022-12-26	WOS:000848077100012
J	Mebrahtom, S; Worku, A; Gage, DJ				Mebrahtom, Samuel; Worku, Alemayehu; Gage, Daniel J.			Causes of infant deaths and patterns of associated factors in Eastern Ethiopia: Results of verbal autopsy (InterVA-4) study	PLOS ONE			English	Article							MORTALITY; DISEASES; MALARIA	Background In a range of setting, detecting and generate empirical information on the cause of infant death and contributing risk factors at population level is basically utmost essential to take evidence-based measures in reducing infant morbidity and mortality. An electronic verbal autopsy is suitable tool and best alternative solution to determine individuals' cause of death in a setting where the majority of deaths occur at home and civil registration systems do not exist. The present study was undertaken to find out cause of infant death, applying computer-based probabilistic model (InterVA-4) and analyze the patterns of association factors of mother's and the deceased infant's characteristics to the leading cause-specific infant mortality in Eastern Ethiopia. Methods The study employed a community-based prospective longitudinal survey, which was conducted with routinely enumeration of reported infant deaths for a period of two years (from September 2016 to August 2018) in Eastern part of Ethiopia. Using the two-stage cluster sampling technique, the study was undertaken in four randomly selected districts of West Hararghe zone and two districts of zone 3 in Oromia and Afar regional state, respectively. The study included a total of 362 infants who were deceased during the study period. Data was collected by trained enumerators by interviewing the mothers or guardians of the deceased infant using a 2014 standardize World Health Organization (WHO) Verbal Autopsy questionnaire. InterVA-4 model were used for processing and interpreting verbal autopsy data in order to arrive at the most likely causes of infant death. SPSS version 23 was also used for statistical analysis of frequency distribution and logistic regression for the association between covariates and outcomes. Findings Of the overall (362) deceased infants' during the study period, 53.0% of deaths occurred during neonatal time while 47.0% died in the post-neonatal period. Acute respiratory infection including neonatal and post-neonatal pneumonia (38.4%), birth asphyxia (16.4%), diarrheal diseases (16.3%), prematurity (7.4%) and malaria (4.3%) were found to be the leading causes of infant mortality in the study area. The independent factors strongly associated with probable ARI, including pneumonia related mortality as compared to all-causes of death were infants with maternal age lower than 20 years old (p = 0.001, AOR: 4.82, 95% CI: 1.88, 12.3) and infant being died outside of heath facilities (P = 0.007, AOR: 2.85, 95% CI: 1.33, 6.12). The post-neonatal period (P = 0.000, AOR: 15.5, 95% CI: 6.35, 37.8) and infant died in the wet season (P = 0.006, AOR: 2.38, 95% CI: 1.28, 4.44) had strong relationship with dying from diarrhea-related death than those infants died from all non-diarrhea. The death due to malaria robustly associated with infants whose mothers age between 20-35 years old (P = 0.024, AOR: 4.44, 95% CI: 1.22, 16.2) and infant who was dwelled in the districts of Afar region (P = 0.013, AOR: 4.08, 95% CI: 1.35, 12.4). Conclusion The highest cause of infant mortality was associated with disease of respiratory system, particularly acute respiratory infection, including both neonates and post-neonatal pneumonia. Most of the infant deaths existed are as a result of diseases and conditions that are readily preventable or treatable cause, similar to those reported in worldwide, which have needs of further attention. The patterns of significant associated factors across cause-specific mortality against all-cause of death were dissimilar. Therefore, strengthen maternal and child health program with effective preventive interventions emphasizing on the most common cause of infant deaths and those factors contributing in raising mortality risk are required.	[Mebrahtom, Samuel] Addis Ababa Univ, Ethiopian Inst Water Resources, Addis Ababa, Ethiopia; [Worku, Alemayehu] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia; [Gage, Daniel J.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA	Addis Ababa University; Addis Ababa University; University of Connecticut	Mebrahtom, S (corresponding author), Addis Ababa Univ, Ethiopian Inst Water Resources, Addis Ababa, Ethiopia.	samrontom@gmail.com						Adair T, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-006766; Amare Deribew, 2007, Ethiopian Journal of Health Development, V21, P117; Amha M, 1996, CHILD HLTH PROBLEMS; [Anonymous], CIVIL REGISTRATION W; Anteneh A, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-14; Asefa A, 2020, PEDIATR HEALTH MED T, V11, P171, DOI 10.2147/PHMT.S257804; Assefa N, 2013, DHS FURTHER ANAL REP, V79; Association of Maternal and Child Health Program, 2013, INF YOUNG CHILD FEED; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; Bauni E, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-49; Becher H, 2008, AM J TROP MED HYG, V78, P106, DOI 10.4269/ajtmh.2008.78.106; Caballero MT, 2019, J INFECT DIS, V219, P358, DOI 10.1093/infdis/jiy517; CDC, 2020, CONS REST BAR OP; Centers for Disease Control and Prevention, 2019, TERMINOLOGY; Central Statistical Agency, 2011, ETH DEM HLTH SURV; Central Statistical Agency (CSA) [Ethiopia] and ICF, 2016, ETH DEM HLTH SURV KE; Child Survival Partnership, 2004, BACKGROUND DOCUMENT; Das Abhishek, 2017, J Family Med Prim Care, V6, P191, DOI 10.4103/jfmpc.jfmpc_194_16; Desalew A, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02051-7; Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2016, WHAT CAUS INF MORT; Ewbank DC, 1993, TRENDS MORTALITY CAU; Farrar DS, 2019, ELIFE, V8, DOI 10.7554/eLife.46202; Federal Democratic Republic of Ethiopia; Population Census Commission, 2008, SUMM STAT REP 2007 P; Ferdous F, 2018, TROP MED HEALTH, V46, DOI 10.1186/s41182-018-0099-4; Fikree FF, 2002, B WORLD HEALTH ORGAN, V80, P271; Garenne M, 2006, B WORLD HEALTH ORGAN, V84, P164, DOI 10.2471/BLT.05.029124; Godefay H, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25264; Green RJ, 2016, PNEUMONIA, V8, DOI 10.1186/s41479-016-0003-0; Institute for Health Metrics and Evaluation, 2014, VERB AUT; Jha P, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-19; Kaduuli S., 1988, REV LITERATURA; Kazembe LN, 2007, GEOSPATIAL HEALTH, V2, P41, DOI 10.4081/gh.2007.253; Liang L, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00277; Lozano R, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-50; Mehal J., 2011, THESES EMORY U; Mengesha HG, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3979-8; Meshram R., 2019, SRI LANKA J CHILD HL, V48, P26; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; National Plan Commission, 2017, 2017 VOL NAT REV SDG; Onyiriuka A. N., 2006, Tropical Journal of Obstetrics and Gynaecology, V23, P34; Rai SK, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012856; Ramroth H, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1909; Robert M., 2020, COMP CAUSE DEATH CLA; Roro EM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221513; Shah MS, 2011, AUSTRALAS MED J, V4, P22, DOI 10.4066/AMJ.2011.470; Shamebo D., 1990, Ethiopian Journal of Health Development, V4, P15; SHAMEBO D, 1993, B WORLD HEALTH ORGAN, V71, P389; Tessema F., 2013, VITAL EVENTS INDICAT; Tunga M, 2021, TROP MED INT HEALTH, V26, P1560, DOI 10.1111/tmi.13678; Umea Center for Global Health Research, 2016, INTERVA SOFTW VERB A; UNICEF, 2013, STAT SNAPSH CHILD MO; UNICEF, 2017, NEON MORT UNICEF DAT; UNICEF, 2016, MAT NEWB HLTH DISP E; Verfurden Maximiliane L, 2020, CMAJ Open, V8, pE273, DOI 10.9778/cmajo.20190074; Ester PV, 2011, J PUBLIC HEALTH AFR, V2, P112, DOI 10.4081/jphia.2011.e27; Villa S, 1999, B WORLD HEALTH ORGAN, V77, P375; Weldearegawi B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2090-x; Weldearegawi B, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25550; Weldearegawi B, 2013, HEALTH POLICY PLANN, V28, P891, DOI 10.1093/heapol/czs135; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2014, CIV REG WHY COUNT BI; Wimalasena NN, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18062815; World Health Organization, 2012, WORLD HLTH STAT; World Health Organization, 2014, VERB AUT STAND 2014; World Health Organization, 2016, GLOB HLTH OBS PORP D; World Health Organization, 2018, US; World Health Organization, 2017, GLOB HLTH OBS INF MO; World Health Organization, 2018, EST CHILD CAUS DEATH; You D, 2015, LEVELS TRENDS CHILD; Zijlma Anouk, 2020, WEATHER CLIMATE ETHI	70	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0270245	10.1371/journal.pone.0270245	http://dx.doi.org/10.1371/journal.pone.0270245			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925957	gold, Green Published			2022-12-26	WOS:000848077100018
J	Montaha, S; Azam, S; Rafid, AKMRH; Islam, S; Ghosh, P; Jonkman, M				Montaha, Sidratul; Azam, Sami; Rafid, A. K. M. Rakibul Haque; Islam, Sayma; Ghosh, Pronab; Jonkman, Mirjam			A shallow deep learning approach to classify skin cancer using down-scaling method to minimize time and space complexity	PLOS ONE			English	Article							SEGMENTATION; STATISTICS; DERMOSCOPY; LESIONS; IMAGES	The complex feature characteristics and low contrast of cancer lesions, a high degree of inter-class resemblance between malignant and benign lesions, and the presence of various artifacts including hairs make automated melanoma recognition in dermoscopy images quite challenging. To date, various computer-aided solutions have been proposed to identify and classify skin cancer. In this paper, a deep learning model with a shallow architecture is proposed to classify the lesions into benign and malignant. To achieve effective training while limiting overfitting problems due to limited training data, image preprocessing and data augmentation processes are introduced. After this, the 'box blur' down-scaling method is employed, which adds efficiency to our study by reducing the overall training time and space complexity significantly. Our proposed shallow convolutional neural network (SCNN_12) model is trained and evaluated on the Kaggle skin cancer data ISIC archive which was augmented to 16485 images by implementing different augmentation techniques. The model was able to achieve an accuracy of 98.87% with optimizer Adam and a learning rate of 0.001. In this regard, parameter and hyper-parameters of the model are determined by performing ablation studies. To assert no occurrence of overfitting, experiments are carried out exploring k-fold cross-validation and different dataset split ratios. Furthermore, to affirm the robustness the model is evaluated on noisy data to examine the performance when the image quality gets corrupted.This research corroborates that effective training for medical image analysis, addressing training time and space complexity, is possible even with a light-weighted network using a limited amount of training data.	[Montaha, Sidratul; Rafid, A. K. M. Rakibul Haque; Islam, Sayma] Daffodil Int Univ, Dept Comp Sci & Engn, Dhaka, Bangladesh; [Azam, Sami; Jonkman, Mirjam] Charles Darwin Univ, Coll Engn It & Environm, Casuarina, NT, Australia; [Ghosh, Pronab] Lakehead Univ, Dept Comp Sci, Thunder Bay, ON, Canada	Daffodil International University; Charles Darwin University; Lakehead University	Azam, S (corresponding author), Charles Darwin Univ, Coll Engn It & Environm, Casuarina, NT, Australia.	sami.azam@cdu.edu.au		Ghosh, Pronab/0000-0002-5524-2328; Montaha, Sidratul/0000-0002-5276-3793; Azam, Sami/0000-0001-7572-9750				A Ameri, 2020, J Biomed Phys Eng, V10, P801, DOI 10.31661/jbpe.v0i0.2004-1107; A. Sagar, 2021, bioRxiv, DOI 10.1101/2020.05.22.110973; Adegun AA, 2020, IEEE ACCESS, V8, P7160, DOI 10.1109/ACCESS.2019.2962812; Adjed F, 2015, 2015 7TH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY AND ELECTRICAL ENGINEERING (ICITEE), P442, DOI 10.1109/ICITEED.2015.7408987; Akram T., 2018, J AMB INTEL HUM COMP, DOI [10.1007/s12652-018-1051-5, DOI 10.1007/S12652-018-1051-5]; Albahar MA, 2019, IEEE ACCESS, V7, P38306, DOI 10.1109/ACCESS.2019.2906241; Albahli S, 2020, IEEE ACCESS, V8, P198403, DOI 10.1109/ACCESS.2020.3035345; Ali AR, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00297; Alzubaidi L, 2021, J BIG DATA-GER, V8, DOI 10.1186/s40537-021-00444-8; [Anonymous], 2018, AUTOMATIC SEGMENTATI, V07, P223; Argenziano G, 2003, J AM ACAD DERMATOL, V48, P679, DOI 10.1067/mjd.2003.281; Ashraf R, 2020, IEEE ACCESS, V8, P147858, DOI 10.1109/ACCESS.2020.3014701; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Beeravolu AR, 2021, IEEE ACCESS, V9, P33438, DOI 10.1109/ACCESS.2021.3058773; Bhonsle D., 2012, INT J IMAGE GRAPH, V4, P36, DOI 10.5815/ijigsp.2012.06.06; Bircanoglu C, 2017, COMP LOSS FUNCTIONS; Boman J., 2018, EVALUATING DEEP CONV; Brinker TJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218713; Chauhan S, 2019, FRONT NEUROINFORM, V13, DOI 10.3389/fninf.2019.00053; Crow F. C., 1984, Computers & Graphics, V18, P207; Daghrir J, 2020, 2020 5TH INTERNATIONAL CONFERENCE ON ADVANCED TECHNOLOGIES FOR SIGNAL AND IMAGE PROCESSING (ATSIP'2020); Rodriguez JD, 2010, IEEE T PATTERN ANAL, V32, P569, DOI 10.1109/TPAMI.2009.187; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fontanillas P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20246-5; Fujisawa Y, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00191; Geavlete B., 2014, EUR UROL SUPPL, V13, pe227, DOI [10.1016/s1569-9056(14)60224-4, DOI 10.1016/S1569-9056(14)60224-4]; Goyal M, 2020, IEEE ACCESS, V8, P4171, DOI 10.1109/ACCESS.2019.2960504; Hosny KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217293; Institute of Electrical and Electronics Engineers, 2017, 2017 IEEE APPL IM PA; Jain S, 2015, PROCEDIA COMPUT SCI, V48, P735, DOI 10.1016/j.procs.2015.04.209; Jamil U, 2019, J AMB INTEL HUM COMP, V10, P4099, DOI 10.1007/s12652-019-01218-0; Jinnai S, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10081123; Kaggle, SKIN CANC MAL VS BEN; Kalouche S., 2016, VISION BASED CLASSIF; Khamparia A, 2021, MULTIDIM SYST SIGN P, V32, P747, DOI 10.1007/s11045-020-00756-7; Kharazmi P, 2017, IEEE J BIOMED HEALTH, V21, P1675, DOI 10.1109/JBHI.2016.2637342; Kim T., 2021, ARXIV PREPRINT ARXIV, DOI 10.24963/ijcai.2021/362; Knyazev A, 2016, PROCEDIA COMPUT SCI, V80, P607, DOI 10.1016/j.procs.2016.05.348; Kong LZ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0258804; Lei FY, 2020, SN APPL SCI, V2, DOI 10.1007/s42452-019-1903-4; Liu JG, 2009, 2009 INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND COMPUTATIONAL INTELLIGENCE, VOL III, PROCEEDINGS, P594, DOI [10.1109/AICI.2009.405, 10.1109/CSIE.2009.53]; Mondal PK., 2016, IOSR J COMPUT ENG, V18, P73, DOI [10.9790/0661-1804057378, DOI 10.9790/0661-1804057378]; Montaha S, 2021, BREASTNET18 HIGH ACC; Moreno-Barea FJ, 2018, 2018 IEEE SYMPOSIUM SERIES ON COMPUTATIONAL INTELLIGENCE (IEEE SSCI), P728, DOI 10.1109/SSCI.2018.8628917; Paris S, 2008, FOUND TRENDS COMPUT, V4, P1, DOI 10.1561/0600000020; Parthipan V, 2017, IMAGE DOWN SCALER US, V93; Patil A., 2021, SMART INNOVATION SYS, V195, P21, DOI 10.1007/978-981-15-7078-0_3; Perez F, 2018, LECT NOTES COMPUT SC, V11041, P303, DOI 10.1007/978-3-030-01201-4_33; Pires BR, 2011, IEEE IMAGE PROC, P85, DOI 10.1109/ICIP.2011.6116693; PITAS I, 1986, IEEE T ACOUST SPEECH, V34, P573, DOI 10.1109/TASSP.1986.1164857; Saba T, 2019, J MED SYST, V43, DOI 10.1007/s10916-019-1413-3; Sara U., 2019, JOUR COMP COMMU, V07, P8, DOI [10.4236/jcc.2019.73002, DOI 10.4236/JCC.2019.73002]; Schindler A., 2016, FMT, V1734, P17; Shahsavari Ali, 2021, Informatics in Medicine Unlocked, V24, DOI 10.1016/j.imu.2021.100628; Shallu, 2018, ICT EXPRESS, V4, P247, DOI 10.1016/j.icte.2018.10.007; Shorten C, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0197-0; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Song RY, 2020, IEEE ACCESS, V8, P75011, DOI 10.1109/ACCESS.2020.2986546; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Pham TC, 2018, LECT NOTES ARTIF INT, V10752, P573, DOI 10.1007/978-3-319-75420-8_54; Van Droogenbroeck M, 2005, J MATH IMAGING VIS, V22, P121, DOI 10.1007/s10851-005-4886-2; Wang SH, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00818; Wei LS, 2020, IEEE ACCESS, V8, P99633, DOI 10.1109/ACCESS.2020.2997710; Wong TT, 2017, IEEE T KNOWL DATA EN, V29, P2417, DOI 10.1109/TKDE.2017.2740926; Sikkandar MY, 2021, J AMB INTEL HUM COMP, V12, P3245, DOI 10.1007/s12652-020-02537-3; Youssef A, 1999, INTERNATIONAL CONFERENCE ON IMAGING SCIENCE, SYSTEMS, AND TECHNOLOGY, PROCEEDINGS, P132; Yu LQ, 2017, IEEE T MED IMAGING, V36, P994, DOI 10.1109/TMI.2016.2642839; Yu SD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176632; Zghal NS, 2020, CURR MED IMAGING, V16, P50, DOI 10.2174/1573405614666180911120546	69	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0269826	10.1371/journal.pone.0269826	http://dx.doi.org/10.1371/journal.pone.0269826			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35925956	Green Published, gold			2022-12-26	WOS:000848077100014
J	Shafodino, FS; Lusilao, JM; Mwapagha, LM				Shafodino, Festus S.; Lusilao, Julien M.; Mwapagha, Lamech M.			Phytochemical characterization and antimicrobial activity of Nigella sativa seeds	PLOS ONE			English	Article							PHYSICOCHEMICAL PROPERTIES; OIL; ANTIOXIDANT; EXTRACTION; ALLOPURINOL	Nigella sativa is one of the medicinal plant species that gained popularity for a wide range of medicinal applications due to its seeds which are rich in phytoconstituents. Continuous scientific investigations on N. sativa seeds are needed to better understand its many medicinal potentials. This will also form a composition-based foundation that support several old and/or new case beneficial histories of its seeds. In this study, the antimicrobial activity of N. sativa seeds was phytochemically characterized and evaluated. Different extracts of N. sativa seeds were obtained by maceration and soxhlet extraction methods using different extraction solvents. The obtained extracts were tested using UV-Vis, FTIR, TLC, and GC-MS techniques. Antimicrobial analysis against pathogenic bacterial strains (E. coli, P. aeruginosa, S. aureus and B. subtilis) was carried out by disc diffusion method using different preparations of N. sativa seeds. The screening analysis revealed the presence of all the tested phytochemicals. FT-IR analysis of N. sativa seeds oil extracted with absolute ethanol revealed functional groups that are associated with active ingredients of medicinal value. The GC-MS chromatograms revealed different chemical constituents whose known bioactivities and/or applications are essential in the management of life-threatening infections. Different extracts of N. sativa seeds showed antimicrobial activity with different efficacy against the tested pathogenic bacterial strains. Therefore, this study shows that extracts of N. sativa seeds contain a variety of chemical components and functional groups linked to their antimicrobial properties, and they might be natural precursors of nutraceuticals.	[Shafodino, Festus S.; Lusilao, Julien M.; Mwapagha, Lamech M.] Namibia Univ Sci & Technol, Fac Hlth & Appl Sci, Dept Nat & Appl Sci, Windhoek, Namibia	Namibia University of Science & Technology	Mwapagha, LM (corresponding author), Namibia Univ Sci & Technol, Fac Hlth & Appl Sci, Dept Nat & Appl Sci, Windhoek, Namibia.	lmwapa@gmail.com		Mwapagha, Lamech/0000-0003-1048-1787				Advisory F., 2010, 3 FURAN 1 ACUTE EXPO, V9, P1; Ahmad MF, 2021, J HERB MED, V25, DOI 10.1016/j.hermed.2020.100404; ALLEN E, 1955, ANAL CHEM, V27, P540, DOI 10.1021/ac60100a014; Alrashidi M, 2020, J KING SAUD UNIV SCI, V32, P3337, DOI 10.1016/j.jksus.2020.09.019; [Anonymous], 2000, IARC Monogr Eval Carcinog Risks Hum, V77, P227; Arbade GK, 2022, INT J POLYM MATER PO, V71, P208, DOI 10.1080/00914037.2020.1817020; Aumeeruddy MZ, 2018, ISTANB J PHARM, V48, P89, DOI 10.26650/IstanbulJPharm.2018.180003; Bharadwaj A, 2020, SSRN ELECT J; Britto A. J. de, 2013, International Journal of Pharma and Bio Sciences, V4, pP; Chandra S, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/253875; Chudobova D, 2014, INT J ENV RES PUB HE, V11, P3233, DOI 10.3390/ijerph110303233; Costa EV, 2013, NAT PROD RES, V27, P1002, DOI 10.1080/14786419.2012.688044; Dhivya S., 2017, INT J TRADIT HERB ME, V5, P40; Dinagaran S, 2016, INT J PHARM SCI RES, V7, P4473, DOI 10.13040/IJPSR.0975-8232.7(11).4473-79; Durai M V., 2016, INT J HERB MED, V4, P88; Eloff JN, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2519-3; Farquharson CA, 2002, CIRCULATION, V106, P221, DOI 10.1161/01.CIR.0000022140.61460.1D; Feng YX, 2021, INT BIODETER BIODEGR, V157, DOI 10.1016/j.ibiod.2020.105138; For TP., 2002, ATSDRS TOXICOL PROFI, DOI DOI 10.1201/9781420061888_CH22; Franco-Ramos RS, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051317; Gali-Muhtasib H, 2006, ADV PHYTOMED, V2, P133; Giri D., 2018, NUTR PHYTOCHEMICAL C, P1371; Hasan Khan N., 2019, PHARM PHARM INT J, V7; Haseena S., 2015, J PHARM SCI RES, V7, P514; Khoddami A, 2011, J AM OIL CHEM SOC, V88, P533, DOI 10.1007/s11746-010-1687-6; Kooti W, 2016, CHIN J NAT MEDICINES, V14, P732, DOI 10.1016/S1875-5364(16)30088-7; Madike LN., 2017, INT J PHARMACOGN PHY, V9; March A, 2017, URBAN PLANNING FOR DISASTER RECOVERY, P1, DOI 10.1016/B978-0-12-804276-2.00001-3; Masturi M., 2020, J PHYS C SER, V1567; Meena Sahu, 2014, World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS), V3, P694; Mohammed SJ, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/6515671; Mohammed Y.H., 2016, J PHARMACOGN PHYTHER, V8, P8; Montgomery J. H., 2007, GROUNDWATER CHEM DES; Moreno S, 2006, FREE RADICAL RES, V40, P223, DOI 10.1080/10715760500473834; Namazi MR, 2005, J EUR ACAD DERMATOL, V19, P319, DOI 10.1111/j.1468-3083.2004.01184.x; Nimbeshaho F., 2020, Journal of Medicinal Plants Research, V14, P129, DOI 10.5897/JMPR2020.6905; Padalia H., 2015, APPL MICROBIOL OPEN, V1, P106, DOI [10.4172/2471-9315.1000106, DOI 10.4172/2471-9315.1000106]; Patle TK, 2020, SPECTROCHIM ACTA A, V242, DOI 10.1016/j.saa.2020.118717; RCN T, 2018, AGR RES TECHNOL OPEN, V17; Rohman A, 2015, INT J FOOD PROP, V18, P775, DOI 10.1080/10942912.2014.908207; Saad SA., 2020, EGYPT RHEUMATOL REH, V47; Saleh F. A., 2018, Pharmacognosy Journal, V10, P99; Sangeetha S, 2014, RES J BIOTECHNOL, V9, P65; Shikwambi NC, 2021, PAN AFR MED J, V40, DOI 10.11604/pamj.2021.40.58.28515; Sivanandham V., 2016, PHYTOCHEMICAL TECHNI; Sonam Mehta, 2017, INTERJ PHARM PHYTO C, V9, P523, DOI DOI 10.25258/PHYTO.V9I4.8125; Spectrometry HR., 2016, 1 2 DIPHENYLETHYLAMI; Srinivasan K, 2018, FOOD QUAL SAF-OXFORD, V2, P1, DOI 10.1093/fqsafe/fyx031; Structures FS., 2021, ALLOPURINOL C5H4N4O, V2, P1; Talukdar D., 2010, BIOL ENV SCI, V5, P70; Tavakkoli A, 2017, J PHARMACOPUNCT, V20, P179, DOI 10.3831/KPI.2017.20.021; Tiwari S., 2016, BIOL FORUM, V8, P548; Wink CSD, 2015, ANAL BIOANAL CHEM, V407, P1545, DOI 10.1007/s00216-014-8414-3; Wong Y. C., 2014, Oriental Journal of Chemistry, V30, P37; WorldHealthOrganization, 2000, AIR QUAL GUID EUR, Vsecond; Yahaya MF., 2018, ANTIOXIDANT ANTIMICR, V111, P13; Yessuf A. M., 2015, AM J LIFE SCI, V3, P358, DOI DOI 10.11648/j.ajls.20150305.14; Yimer EM, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/1528635; Younus H., 2018, ACTIONS THYMOQUINONE, DOI [10.1007/978-981-10-8800-1, DOI 10.1007/978-981-10-8800-1]	59	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2022	17	8							e0272457	10.1371/journal.pone.0272457	http://dx.doi.org/10.1371/journal.pone.0272457			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4E8NP	35926002	Green Published, gold			2022-12-26	WOS:000848077100090
J	Koster, HRA; van Ommeren, J; Tang, CK; Bras, N				Koster, Hans R. A.; van Ommeren, Jos; Tang, Cheng Keat; Bras, Nander			Covid-19 restriction policies and shopping streets	PLOS ONE			English	Article							EXTERNALITIES; PRODUCTIVITY	Policymakers around the world are enforcing mobility restriction policies such as lockdowns, facemask requirements and social distancing to curb the spread of Covid-19. While these policies are effective in preventing the spread of virus, the economic implications are not well understood. We contribute to the literature by examining the impact of these policies on the offline retail sector. Specifically, we measure the effects of these policies on the daily number of shoppers passing by, which we refer to as 'footfall', along major shopping streets in Netherlands. We rely on unique proprietary Wifi data to accurately measure footfall. Our findings imply that all these policies attribute to a non-trivial reduction in footfall levels along shopping streets. While lockdowns led to a 50% reduction in footfall along major shopping streets, shopping streets faced with facemask regulations also experience a 25% drop in human traffic. A reduction in footfall translates into a substantial reduction in retail income of between 12% and 25%.	[Koster, Hans R. A.; van Ommeren, Jos; Bras, Nander] Vrije Univ Amsterdam, Dept Spatial Econ, Amsterdam, Netherlands; [Koster, Hans R. A.] Higher Sch Econ Univ, Ctr Market Studies & Spatial Econ, St Petersburg, Russia; [Koster, Hans R. A.; van Ommeren, Jos] Tinbergen Inst, Amsterdam, Netherlands; [Tang, Cheng Keat] Nanyang Technol Univ, Dept Econ, Singapore, Singapore	Vrije Universiteit Amsterdam; Tinbergen Institute; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Koster, HRA (corresponding author), Vrije Univ Amsterdam, Dept Spatial Econ, Amsterdam, Netherlands.; Koster, HRA (corresponding author), Higher Sch Econ Univ, Ctr Market Studies & Spatial Econ, St Petersburg, Russia.; Koster, HRA (corresponding author), Tinbergen Inst, Amsterdam, Netherlands.	h.koster@vu.nl	; Koster, Hans/G-7487-2018	Van Ommeren, Jos/0000-0003-4838-478X; Koster, Hans/0000-0002-7535-9718				Andersen Asger Lau, 2020, 3609814 SSRN; Bastille-Rousseau Guillaume, 2013, ECOL FRESHW FISH, V34, P588, DOI [10.1111/j.1600-0587.2010.06517.x, DOI 10.1111/J.1540-5885.2010.00733.X, DOI 10.1111/J.1600-0633.2009.00384.X, 10.1111/j.1469-8986.2008.00667.x, DOI 10.1111/J.1469-8986.2008.00667.X]; Bertrand M, 2002, Q J ECON, V117, P1369, DOI 10.1162/003355302320935052; Cheshire PC, 2015, J ECON GEOGR, V15, P43, DOI 10.1093/jeg/lbu007; Coibion O., 2020, LABOR MARKETS COVID, DOI 10.3386/w27017; Emerce, 2020, COR VER EXTR GROEI O; Glaeser E.L., 2001, J ECON GEOGR, V1, P27, DOI [10.1093/jeg/1.1.27, DOI 10.1093/JEG/1.1.27, 10.2139/ssrn.237462]; Goolsbee A, 2021, J PUBLIC ECON, V193, DOI 10.1016/j.jpubeco.2020.104311; Gould ED, 2005, REV ECON STAT, V87, P411, DOI 10.1162/0034653054638355; Haskel J, 2012, ECONOMICA, V79, P425, DOI 10.1111/j.1468-0335.2011.00903.x; Jacobs J, 1961, DEATH LIFE GREAT AM, V71; Koster HRA, 2019, J URBAN ECON, V114, DOI 10.1016/j.jue.2019.103194; Koster HRA, 2019, J REGIONAL SCI, V59, P187, DOI 10.1111/jors.12415; Li KL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256407; Oner O, 2017, SPAT ECON ANAL, V12, P72, DOI 10.1080/17421772.2017.1265663; Pashigian BP, 1998, J LAW ECON, V41, P115, DOI 10.1086/467386; Sanchez -Vidal M., 2016, SMALL SHOPS SALE EFF; Schelfaut S, 2020, TIENDUIZENDEN WINKEL; Schivardi F, 2011, ECON J, V121, P145, DOI 10.1111/j.1468-0297.2009.02348.x; Sheridan A, 2020, P NATL ACAD SCI USA, V117, P20468, DOI 10.1073/pnas.2010068117; Van Welie R, 2020, NEDERLANDSE CONSUMEN	21	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2022	17	7							e0267160	10.1371/journal.pone.0267160	http://dx.doi.org/10.1371/journal.pone.0267160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Q0KX	35905134	Green Published, gold			2022-12-26	WOS:000855776900008
J	Raichle, C; Borgmann, S; Bausewein, C; Rieg, S; Jakob, CEM; Simon, ST; Tometten, L; Vehreschild, JJ; Leisse, C; Erber, J; Stecher, M; Pauli, B; Ruthrich, MM; Pilgram, L; Hanses, F; Isberner, N; Hower, M; Degenhardt, C; Hertenstein, B; Vehreschild, MJGT; Rommele, C; Jung, N				Raichle, Claudia; Borgmann, Stefan; Bausewein, Claudia; Rieg, Siegbert; Jakob, Carolin E. M.; Simon, Steffen T.; Tometten, Lukas; Vehreschild, Jorg Janne; Leisse, Charlotte; Erber, Johanna; Stecher, Melanie; Pauli, Berenike; Ruethrich, Maria Madeleine; Pilgram, Lisa; Hanses, Frank; Isberner, Nora; Hower, Martin; Degenhardt, Christian; Hertenstein, Bernd; Vehreschild, Maria J. G. T.; Roemmele, Christoph; Jung, Norma		LEOSS Study Grp	Hospitalized patients dying with SARS-CoV-2 infection-An analysis of patient characteristics and management in ICU and general ward of the LEOSS registry	PLOS ONE			English	Article								Background COVID-19 is a severe disease with a high need for intensive care treatment and a high mortality rate in hospitalized patients. The objective of this study was to describe and compare the clinical characteristics and the management of patients dying with SARS-CoV-2 infection in the acute medical and intensive care setting. Methods Descriptive analysis of dying patients enrolled in the Lean European Open Survey on SARS-CoV-2 Infected Patients (LEOSS), a non-interventional cohort study, between March 18 and November 18, 2020. Symptoms, comorbidities and management of patients, including palliative care involvement, were compared between general ward and intensive care unit (ICU) by univariate analysis. Results 580/4310 (13%) SARS-CoV-2 infected patients died. Among 580 patients 67% were treated on ICU and 33% on a general ward. The spectrum of comorbidities and symptoms was broad with more comorbidities (>= four comorbidities: 52% versus 25%) and a higher age distribution (>65 years: 98% versus 70%) in patients on the general ward. 69% of patients were in an at least complicated phase at diagnosis of the SARS-CoV-2 infection with a higher proportion of patients in a critical phase or dying the day of diagnosis treated on ICU (36% versus 11%). While most patients admitted to ICU came from home (71%), patients treated on the general ward came likewise from home and nursing home (44% respectively) and were more frequently on palliative care before admission (29% versus 7%). A palliative care team was involved in dying patients in 15%. Personal contacts were limited but more often documented in patients treated on ICU (68% versus 47%). Conclusion Patients dying with SARS-CoV-2 infection suffer from high symptom burden and often deteriorate early with a demand for ICU treatment. Therefor a demand for palliative care expertise with early involvement seems to exist.	[Raichle, Claudia] Tropenklin Paul Lechler Krankenhaus, Dept Geriatr & Palliat Med, Tubingen, Germany; [Borgmann, Stefan] Ingolstadt Hosp, Dept Infect Dis & Infect Control, Ingolstadt, Germany; [Bausewein, Claudia] LMU Hosp, Dept Palliat Med, Munich, Germany; [Rieg, Siegbert] Univ Freiburg, Med Ctr, Fac Med, Dept Med 2,Div Infect Dis, Freiburg, Germany; [Jakob, Carolin E. M.; Tometten, Lukas; Vehreschild, Jorg Janne; Leisse, Charlotte; Stecher, Melanie; Jung, Norma] Univ Cologne, Fac Med, Dept Internal Med 1, Cologne, Germany; [Jakob, Carolin E. M.; Tometten, Lukas; Vehreschild, Jorg Janne; Leisse, Charlotte; Stecher, Melanie; Jung, Norma] Univ Cologne, Univ Hosp Cologne, Cologne, Germany; [Simon, Steffen T.; Pauli, Berenike] Univ Cologne, Fac Med, Dept Palliat Med, Cologne, Germany; [Vehreschild, Jorg Janne; Pilgram, Lisa] Univ Hosp Frankfurt, Ctr Internal Med, Med Dept 2, Hematol Oncol & Infect Dis, Frankfurt, Germany; [Vehreschild, Jorg Janne; Stecher, Melanie] German Ctr Infect Res, Partner Site Bonn Cologne, Cologne, Germany; [Erber, Johanna] Tech Univ Munich, Univ Hosp Rechts Isar, Dept Internal Med 2, Munich, Germany; [Ruethrich, Maria Madeleine] Univ Hosp Jena, Dept Internal Med 2, Hematol & Med Oncol, Jena, Germany; [Hanses, Frank] Univ Hosp Regensburg, Emergency Dept, Regensburg, Germany; [Hanses, Frank] Univ Hosp Regensburg, Dept Infect Dis & Infect Control, Regensburg, Germany; [Isberner, Nora] Univ Hosp Wurzburg, Dept Internal Med 2, Div Infect Dis, Wurzburg, Germany; [Hower, Martin] Klinikum Dortmund, Dept Internal Med, Dortmund, Germany; [Degenhardt, Christian] Stadt Klinikum, Dept Pharm, Karlsruhe, Germany; [Hertenstein, Bernd] Klinikum Bremen Mitte, Bremen, Germany; [Vehreschild, Maria J. G. T.] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Internal Med 2, Infect Dis, Frankfurt, Germany; [Roemmele, Christoph] Univ Hosp Augsburg, Dept Internal Med Gastroenterol & Infect Dis 3, Augsburg, Germany	University of Munich; University of Freiburg; University of Cologne; University of Cologne; University of Cologne; Goethe University Frankfurt; Goethe University Frankfurt Hospital; German Center for Infection Research; University of Cologne; Technical University of Munich; Friedrich Schiller University of Jena; University of Regensburg; University of Regensburg; University of Wurzburg; Klinikum Dortmund; Municipal Hospital Karlsruhe; Klinikum Bremen-Mitte; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Raichle, C (corresponding author), Tropenklin Paul Lechler Krankenhaus, Dept Geriatr & Palliat Med, Tubingen, Germany.; Jung, N (corresponding author), Univ Cologne, Fac Med, Dept Internal Med 1, Cologne, Germany.; Jung, N (corresponding author), Univ Cologne, Univ Hosp Cologne, Cologne, Germany.	raichle@tropenklinilk.de; norma.jung@uk-koeln.de	Vehreschild, Maria/HGB-6948-2022; Vehreschild, Jorg Janne/G-6764-2013	Pilgram, Lisa/0000-0002-1020-0650; Koll, Carolin E. M./0000-0001-7940-3264; Rommele, Christoph/0000-0002-8745-8510; Vehreschild, Jorg Janne/0000-0002-5446-7170; Raichle, Claudia/0000-0003-4452-0369	German Centre for Infection Research (DZIF); Willy Robert Pitzer Foundation; DZIF (German Center for Infection Research)	German Centre for Infection Research (DZIF); Willy Robert Pitzer Foundation; DZIF (German Center for Infection Research)	The LEOSS registry was supported by the German Centre for Infection Research (DZIF) and the Willy Robert Pitzer Foundation Funding: Lisa Pilgram received a grant from DZIF (German Center for Infection Research) and Willy Robert Pitzer Foundation.	Anderson-Shaw LK, 2020, J BIOETHIC INQ, V17, P777, DOI 10.1007/s11673-020-10040-9; Bajwah S, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00815-2020; Bausewein C, 2021, ZENODO, DOI [10.5281/zenodo.5012504, DOI 10.5281/ZENODO.5012504]; Cardoso FS, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03173-1; CDC, 2021, COVID 19 PREV 10 GUI; Chen SL, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.567296; Dasch B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175124; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Fusi-Schmidhauser T, 2020, J PAIN SYMPTOM MANAG, V60, pE27, DOI 10.1016/j.jpainsymman.2020.03.030; Group C-S, 2020, CLIN CHAR HOSP IND D; Gupta A, 2021, AM J HOSP PALLIAT ME, V38, P191, DOI 10.1177/1049909120963698; Jakob CEM, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00773-y; Jakob CEM, 2021, INFECTION, V49, P63, DOI 10.1007/s15010-020-01499-0; Katz NT, 2021, INTERN MED J, V51, P433, DOI 10.1111/imj.15101; Keeley P, 2020, BMJ SUPPORT PALLIAT, V10, P381, DOI 10.1136/bmjspcare-2020-002368; Kittelson SM, 2015, CRIT CARE NURS CLIN, V27, P315, DOI 10.1016/j.cnc.2015.05.010; Palmieri L, 2020, J GERONTOL A-BIOL, V75, P1796, DOI 10.1093/gerona/glaa146; Pilgram L, 2021, INFECTION, V49, P725, DOI 10.1007/s15010-021-01597-7; Ruthrich MM, 2021, ANN HEMATOL, V100, P383, DOI 10.1007/s00277-020-04328-4; Schloesser K, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06987-z; Strang P, 2020, J PAIN SYMPTOM MANAG, V60, pE2, DOI 10.1016/j.jpainsymman.2020.07.020; Uddin M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050526; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Wallace CL, 2020, J PAIN SYMPTOM MANAG, V60, pE70, DOI 10.1016/j.jpainsymman.2020.04.012; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; World Health Organization, TRUE DEATH TOLL COVI; World Health Organization, 2021, COR DIS COVID 19 SIT; Wortham JM, 2020, MMWR-MORBID MORTAL W, V69, P923, DOI 10.15585/mmwr.mm6928e1; Yuan J, 2020, INT J INFECT DIS, V95, P311, DOI 10.1016/j.ijid.2020.03.050; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	31	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2022	17	7							e0271822	10.1371/journal.pone.0271822	http://dx.doi.org/10.1371/journal.pone.0271822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Q0KX	35905129	Green Published, gold			2022-12-26	WOS:000855776900052
J	Gerber, L; MacSween, CE; Staples, JF; Gamperl, AK				Gerber, Lucie; MacSween, Courtney E.; Staples, James F.; Gamperl, A. Kurt			Cold-induced metabolic depression in cunner (Tautogolabrus adspersus): A multifaceted cellular event	PLOS ONE			English	Article							MITOCHONDRIAL PROTON LEAK; LOW-TEMPERATURE DORMANCY; PROTEIN-SYNTHESIS; POLAR FISH; HIBERNATION; TORPOR; HEPATOCYTES; RESPIRATION; CONSUMPTION; ADAPTATION	Metabolic depression and dormancy (i.e., stopping/greatly reducing activity and feeding) are strategies used by many animals to survive winter conditions characterized by food shortages and cold temperatures. However, controversy exists on whether the reduced metabolism of some fishes at cold temperatures is due to dormancy alone, or also involves active metabolic depression. Thus, we acclimated winter-dormant cunner [Tautogolabrus adspersus, a north temperate wrasse which in Newfoundland is at the northern limit of its distribution] and winter-active Atlantic salmon (Salmo salary to winter (0 degrees C; 8h light: 16h dark) and summer (10 degrees C; 16h light: 8 h dark) conditions, and measured the thermal sensitivity of ATP-producing and O-2-consuming processes in isolated liver mitochondria and hepatocytes when exposed in vitro to temperatures from 20 to 0 degrees C and 10 to 0 degrees C, respectively. We found that: 1) liver mitochondrial State 3 respiration and hepatocyte O-2 consumption in cunner were only similar to one-third and two-thirds of that measured in salmon, respectively, at all measurement temperatures; 2) cunner mitochondria also have proton conductance and leak respiration (State 4) values that are only approximately one-third of those in salmon; 3) the mitochondria of cunner show a dramatic reduction in respiratory control ratio (from similar to 8 to 3), and a much greater drop in State 3 respiration, between 10 and 5 degrees C (Q(10) values in 10-and 0 degrees C-acclimated fish of 14.5 and 141.2, respectively), as compared with salmon (3.9 and 9.6, respectively); and 4) lowering temperature from 5 to 0 degrees C resulted in similar to 40 and 30% reductions in hepatocyte O-2 consumption due to non-mitochondrial respiration and Na+-K+-ATPase activity, respectively, in cunner, but not in salmon. Collectively, these results highlight the intrinsic capacity for metabolic depression in hepatocytes and mitochondria of cunner, and clearly suggest that several cellular processes play a role in the reduced metabolic rates exhibited by some fishes at cold temperatures.	[Gerber, Lucie; MacSween, Courtney E.; Gamperl, A. Kurt] Mem Univ Newfoundland & Labrador, Dept Ocean Sci, St John, NL, Canada; [Staples, James F.] Univ Western Ontario, Dept Biol, London, ON, Canada; [Gerber, Lucie] Univ Oslo, Dept Biosci, Oslo, Norway; [MacSween, Courtney E.] Innovasea Inc, Bedford, NS, Canada	Memorial University Newfoundland; Western University (University of Western Ontario); University of Oslo	Gamperl, AK (corresponding author), Mem Univ Newfoundland & Labrador, Dept Ocean Sci, St John, NL, Canada.	kgamperl@mun.ca		Gamperl, Anthony/0000-0002-9852-4819	Natural Sciences and Engineering Research Council of Canada (NSERC) [AKG: 249926-2011, 412325-2011 JFS: R3061A03]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors would like to thank Kathy Clow for teaching CEM how to obtain isolated hepatocytes from salmon and cunner, and Dr. Jason Brown for assistance with salmon mitochondrial preparations and measurements.	Alzaid A., 2011, THESIS MEMORIAL U NE; Barger JL, 2003, AM J PHYSIOL-REG I, V284, pR1306, DOI 10.1152/ajpregu.00579.2002; Bishop T, 2000, J EXP BIOL, V203, P3603; Boutilier RG, 2002, J EXP BIOL, V205, P2287; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; Brookes PS, 1998, COMP BIOCHEM PHYS B, V119, P325, DOI 10.1016/S0305-0491(97)00357-X; Brown JCL, 2007, AM J PHYSIOL-REG I, V293, pR1833, DOI 10.1152/ajpregu.00310.2007; Chung DJ, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.227801; Corkum CP, 2009, J EXP ZOOL PART A, V311A, P231, DOI 10.1002/jez.520; Costa IASF, 2013, PHYSIOL BIOCHEM ZOOL, V86, P233, DOI 10.1086/669538; CRAWSHAW LI, 1982, J COMP PHYSIOL, V148, P41, DOI 10.1007/BF00688886; CRAWSHAW LI, 1984, AM J PHYSIOL, V246, pR479, DOI 10.1152/ajpregu.1984.246.4.R479; Curran MC, 1992, THESIS WOODS HOLE OC; DEMURA M, 1987, BIOCHIM BIOPHYS ACTA, V894, P355, DOI 10.1016/0005-2728(87)90113-7; ELLIOTT JM, 1991, FRESHWATER BIOL, V25, P61, DOI 10.1111/j.1365-2427.1991.tb00473.x; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Frolicher TL, 2018, NATURE, V560, P360, DOI 10.1038/s41586-018-0383-9; GREEN JM, 1984, MAR BIOL, V84, P7, DOI 10.1007/BF00394521; GREEN JM, 1971, CAN J ZOOLOG, V49, P1497, DOI 10.1139/z71-218; Guderley H, 1997, FISH PHYSIOL BIOCHEM, V16, P531, DOI 10.1023/A:1007708826437; Guppy M, 2004, COMP BIOCHEM PHYS B, V139, P435, DOI 10.1016/j.cbpc.2004.02.019; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Hand SC, 1996, ANNU REV PHYSIOL, V58, P539, DOI 10.1146/annurev.ph.58.030196.002543; HARPER ME, 1993, J BIOL CHEM, V268, P14850; Hobbs RS, 2011, FEBS J, V278, P3699, DOI 10.1111/j.1742-4658.2011.08288.x; HOLETON GF, 1974, PHYSIOL ZOOL, V47, P137, DOI 10.1086/physzool.47.3.30157851; Johnson AC, 2014, J EXP BIOL, V217, P1868, DOI 10.1242/jeb.101196; Kelly NI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114765; Lewis JM, 2007, AM J PHYSIOL-REG I, V293, pR474, DOI 10.1152/ajpregu.00594.2006; Lewis JM, 2010, J COMP PHYSIOL B, V180, P179, DOI 10.1007/s00360-009-0396-7; LUCAS MC, 1993, T AM FISH SOC, V122, P822, DOI 10.1577/1548-8659(1993)122<0822:UOPTAA>2.3.CO;2; Mortensen B, 1999, J EXP ZOOL, V283, P501, DOI 10.1002/(SICI)1097-010X(19990501)283:6<501::AID-JEZ1>3.0.CO;2-E; Porter E S, 2022, Curr Res Physiol, V5, P158, DOI 10.1016/j.crphys.2022.03.002; Rolfe David F. S., 1996, American Journal of Physiology, V271, pC1380; Rolfe DFS, 1997, BIOSCIENCE REP, V17, P9, DOI 10.1023/A:1027327015957; Rossi GS, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.213355; Sayer MDJ, 1996, J FISH BIOL, V49, P64, DOI 10.1111/j.1095-8649.1996.tb00005.x; Speers-Roesch B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1593; St-Pierre J, 2000, J EXP BIOL, V203, P1469; Staples JF, 2016, COMPR PHYSIOL, V6, P737, DOI 10.1002/cphy.c140064; Staples JF, 2014, J EXP BIOL, V217, P2032, DOI 10.1242/jeb.092973; Staples JF, 2009, COMP BIOCHEM PHYS A, V153, P95, DOI 10.1016/j.cbpa.2009.02.010; Steffensen JF, 2002, COMP BIOCHEM PHYS A, V132, P789, DOI 10.1016/S1095-6433(02)00048-X; Steffensen John F., 2005, Fish Physiology, V22, P203; Storey KB, 2004, BIOL REV, V79, P207, DOI 10.1017/S1464793103006195; Storey KB, 2001, EXPTL BIOL REV, P1; Storey Kenneth B., 1994, American Journal of Physiology, V266, pR1477; SUAREZ RK, 1981, J COMP PHYSIOL, V143, P269; Szekeres P, 2016, CLIM RES, V69, P239, DOI 10.3354/cr01404; TRIGARI G, 1992, LIPIDS, V27, P371, DOI 10.1007/BF02536152; ULTSCH GR, 1989, BIOL REV, V64, P435, DOI 10.1111/j.1469-185X.1989.tb00683.x; van Ginneken V, 2009, THERMOCHIM ACTA, V483, P1, DOI 10.1016/j.tca.2008.09.027; WALSH PJ, 1983, PHYSIOL ZOOL, V56, P532, DOI 10.1086/physzool.56.4.30155876	53	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8							e0271086	10.1371/journal.pone.0271086	http://dx.doi.org/10.1371/journal.pone.0271086			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917356	gold, Green Published			2022-12-26	WOS:000837840000036
J	Turner, L; Ball, J; Culliford, D; Kitson-Reynolds, E; Griffiths, P				Turner, Lesley; Ball, Jane; Culliford, David; Kitson-Reynolds, Ellen; Griffiths, Peter			Exploring the relationship between women's experience of postnatal care and reported staffing measures: An observational study	PLOS ONE			English	Article							CONSEQUENCES; SUPPORT	BackgroundWomen have reported dissatisfaction with care received on postnatal wards and this area has been highlighted for improvement. Studies have shown an association between midwifery staffing levels and postnatal care experiences, but so far, the influence of registered and support staff deployed in postnatal wards has not been studied. This work is timely as the number of support workers has increased in the workforce and there has been little research on skill mix to date. MethodsCross sectional secondary analysis including 13,264 women from 123 postnatal wards within 93 hospital Trusts. Staffing was measured in each organisation as Full Time Equivalent staff employed per 100 births, and on postnatal wards, using Hours Per Patient Day. Women's experiences were assessed using four items from the 2019 national maternity survey. Multilevel logistic regression models were used to examine relationships and adjust for maternal age, parity, ethnicity, type of birth, and medical staff. ResultsTrusts with higher levels of midwifery staffing had higher rates of women reporting positive experiences of postnatal care. However, looking at staffing on postnatal wards, there was no evidence of an association between registered nurses and midwives hours per patient day and patient experience. Wards with higher levels of support worker staffing were associated with higher rates of women reporting they had help when they needed it and were treated with kindness and understanding. ConclusionThe relationship between reported registered staffing levels on postnatal wards and women's experience is uncertain. Further work should be carried out to examine why relationships observed using whole Trust staffing were not replicated closer to the patient, with reported postnatal ward staffing. It is possible that recorded staffing levels on postnatal wards do not actually reflect staff deployment if midwives are floated to cover delivery units. This study highlights the potential contribution of support workers in providing quality care on postnatal wards.	[Turner, Lesley; Ball, Jane; Kitson-Reynolds, Ellen] Univ Southampton, Sch Hlth Sci, Southampton, England; [Culliford, David] Univ Southampton, Sch Hlth Sci, NIHR Appl Res Collaborat Wessex, Southampton, England; [Griffiths, Peter] Univ Southampton, Natl Inst Hlth Res Appl Res Ctr Wessex, Sch Hlth Sci, Southampton, England	University of Southampton; University of Southampton; University of Southampton	Turner, L (corresponding author), Univ Southampton, Sch Hlth Sci, Southampton, England.	lyt1g19@soton.ac.uk	; Griffiths, Peter/D-4016-2009	Turner, Lesley/0000-0003-1489-3471; Griffiths, Peter/0000-0003-2439-2857	National Institute for Health Research; National Institute for Health Research Applied Research Centre (Wessex); National Institute for Health Research's Health Services & Delivery Research programme [NIHR128056]; National Institute for Health Research Applied Research Collaboration (Wessex)	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research Applied Research Centre (Wessex); National Institute for Health Research's Health Services & Delivery Research programme; National Institute for Health Research Applied Research Collaboration (Wessex)	Peter Griffiths receives support from a Senior Investigator award made by the National Institute for Health Research and the National Institute for Health Research Applied Research Centre (Wessex). This research was part funded by the National Institute for Health Research's Health Services & Delivery Research programme (Award ID: NIHR128056) and the National Institute for Health Research Applied Research Collaboration (Wessex).	Alderdice F., 2016, BIRTH NI SURVEY WOME; [Anonymous], 2011, JOGNN-J OBST GYN NEO, V40, P131, DOI 10.1111/j.1552-6909.2010.01214.x; [Anonymous], 2019, HOSP EP STAT HES; Baxter J., 2005, BRIT J MIDWIFERY, V13, P378; Beake S, 2005, EVID BASED MIDWIFERY, V3, P80; Bhavnani V, 2010, FUNDAMENTALS MIDWIFE; Bick D, 2020, MIDWIFERY, V80, DOI 10.1016/j.midw.2019.102574; Birthrights, 2022, SYST RAC NOT BROK BO; Bowers J, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-015-1214-4; Care Quality Commission, 2020, MAN WOM HAV POS EXP; Care Quality Commission Picker Institute Europe, 2021, MAT SURV 2019 DAT CO, P8790; Clark RRS, 2022, JOGNN-J OBST GYN NEO, V51, P290, DOI 10.1016/j.jogn.2022.02.001; CQC, 2019, MID S ESS NHS FDN TR; Driscoll A, 2018, EUR J CARDIOVASC NUR, V17, P6, DOI 10.1177/1474515117721561; Dykes F, 2005, MIDWIFERY, V21, P241, DOI 10.1016/j.midw.2004.12.006; Gelman A, 2009, AM STAT, V63, P1, DOI 10.1198/tast.2009.0001; Grassley JS, 2015, JOGNN-J OBST GYN NEO, V44, P567, DOI 10.1111/1552-6909.12728; Griffin R., 2012, BRIT J MIDWIFERY, V20, P884; Harrison S., 2018, NATL SURVEY HLTH CAR; Health Education England, 2019, MAT WORKF STRAT TRAN; Henderson J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-196; Independent, NURS DRAFT SHOR UP U; Indigenous Allied Health Australia, 2015, CULT RESP ACT IAHA F; Kalisch BJ, 2011, MED CARE, V49, P775, DOI 10.1097/MLR.0b013e318222a6df; Kokab F, 2022, MIDWIFERY, V104, DOI 10.1016/j.midw.2021.103183; MBRRACE-UK, 2021, SAVING LIVES IMPROVI; McLachlan HL, 2008, MIDWIFERY, V24, P358, DOI 10.1016/j.midw.2006.10.006; McLeish J, 2021, WOMEN BIRTH, V34, pE451, DOI 10.1016/j.wombi.2020.10.012; McLeish J, 2020, QUAL HEALTH RES, V30, P1876, DOI 10.1177/1049732320944141; Merkow RP, 2022, J NURS CARE QUAL, V37, P195, DOI 10.1097/NCQ.0000000000000619; Min A, 2016, J NURS MANAGE, V24, P439, DOI 10.1111/jonm.12347; Morrow J, 2013, MIDWIFERY, V29, P159, DOI 10.1016/j.midw.2011.11.006; National Federation of Women's Institutes National Childbirth Trust, 2017, SUPP OV WOM EXP MAT; National Institute for Health Research, 2019, MAKING DECISIONS HEA; National Quality Board, 2016, SUPP NHS PROV DEL RI; NHS Digital, 2019, NHS MAT STAT ENGL 20; NHS Digital, 2019, NHS WORKF STAT; NHS Improvement, 2021, CAR HOURS PAT DAY CH; NHS Improvement, 2018, CAR HOURS PAT DAY CH; NHS Improvement, 2019, CAR HOURS PAT DAY CH; Nilsen Morch M., 2019, NORWEGIAN J CLIN NUR, DOI [10.4220/Sykepleienf.2019.76793, DOI 10.4220/SYKEPLEIENF.2019.76793]; NMPA Project Team, 2021, ETHN SOC EC IN NHS M; Ockenden D, 2022, FINAL REPORT OCKENDE; Royal College of Nursing, 2019, NURS MAT CAR; Russell Samantha, 2021, Nurs Womens Health, V25, P167, DOI 10.1016/j.nwh.2021.03.005; Sandall J, 2014, EFFICIENT USE MATERN; Scottish Government, 2019, MAT CAR SURV 2018 NA; Sheen JJ, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.08.034; Simpson KR, 2017, J PERINAT NEONAT NUR, V31, P32, DOI 10.1097/JPN.0000000000000203; Simpson KR, 2016, JOGNN-J OBST GYN NEO, V45, P481, DOI 10.1016/j.jogn.2016.02.011; Turner L, 2022, Women Birth, V35, pe583, DOI 10.1016/j.wombi.2022.02.005; Turner L, 2021, MIDWIFERY, V103, DOI 10.1016/j.midw.2021.103118; Twigg D, 2009, INT J NURS STUD, V46, P132, DOI 10.1016/j.ijnurstu.2008.08.005; United Nations Population Fund, 2021, STATE WORLDS MIDWIFE; Vitner D, 2019, J MATERN-FETAL NEO M, V32, P2580, DOI [10.1080/14767058.2018.1440546, 10.1080/14767058.2018.1531121]; Winter V, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-051133; World Health Organization, 2018, WHO REC ANT CAR POS; Wray J., 2006, BRIT J MIDWIFERY, V14, P520	58	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0266638	http://dx.doi.org/10.1371/journal.pone.0266638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3P9FR	35917338	Green Published, gold			2022-12-26	WOS:000837840000046
J	Wang, Y; Li, F; Liu, HT; Zhang, ZQ; Wang, DM; Chen, SG; Wang, CH; Lan, JH				Wang, Yuan; Li, Fan; Liu, Haoting; Zhang, Zhiqiang; Wang, Duming; Chen, Shanguang; Wang, Chunhui; Lan, Jinhui			Robust muscle force prediction using NMFSEMD denoising and FOS identification	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; NOISE; SENSITIVITY; ALGORITHM; SIGNALS; WHITE; BONE	In this paper, an aliasing noise restraint technique and a system identification-based surface electromyography (sEMG)-force prediction model are proposed to realize a type of robust sEMG and muscle force prediction. For signal denoising, a novel non-negative matrix factorization screening empirical mode decomposition (NMFSEMD) and a fast orthogonal search (FOS)-based muscle force prediction model are developed. First, the NMFSEMD model is used to screen the empirical mode decomposition (EMD) results into the noisy intrinsic mode functions (IMF). Then, the noise matrix is computed using IMF translation and superposition, and the matrix is used as the input of NMF to obtain the denoised IMF. Furthermore, the reconstruction outcome of the NMFSEMD method can be used to estimate the denoised sEMG. Finally, a new sEMG muscle force prediction model, which considers a kind of candidate function in derivative form, is constructed, and a data-training-based linear weighted model is obtained. Extensive experimental results validate the suggested method's correction: after the NMFSEMD denoising of raw sEMG signal, the signal-noise ratio (SNR) can be improved by about 15.0 dB, and the energy percentage (EP) can be greater than 90.0%. Comparing with the muscle force prediction models using the traditional pretreatment and LSSVM, and the NMFSEMD plus LSSVM-based method, the mean square error (MSE) of our approach can be reduced by at least 1.2%.	[Wang, Yuan; Liu, Haoting; Lan, Jinhui] Univ Sci & Technol Beijing, Beijing Engn Res Ctr Ind Spectrum Imaging, Sch Automat & Elect Engn, Beijing, Peoples R China; [Li, Fan; Chen, Shanguang; Wang, Chunhui] China Astronaut Res & Training Ctr, Natl Key Lab Human Factors Engn, Beijing, Peoples R China; [Liu, Haoting; Zhang, Zhiqiang] Univ Leeds, Sch Elect & Elect Engn, Sch Mech Engn, Leeds, England; [Wang, Duming] Zhejiang Sci Tech Univ, Dept Psychol, Hangzhou, Peoples R China	University of Science & Technology Beijing; Chinese Academy of Sciences; University of Leeds; Zhejiang Sci-Tech University	Liu, HT (corresponding author), Univ Sci & Technol Beijing, Beijing Engn Res Ctr Ind Spectrum Imaging, Sch Automat & Elect Engn, Beijing, Peoples R China.; Liu, HT (corresponding author), Univ Leeds, Sch Elect & Elect Engn, Sch Mech Engn, Leeds, England.	liuhaoting@ustb.edu.cn		Zhang, Zhiqiang/0000-0003-0204-3867	National Natural Science Foundation of China [61975011]; Fourth Batch of Chinese Manned Spaceflight Pre-research Foundation [020202]; Fund of State Key Laboratory of Intense Pulsed Radiation Simulation and Effect [SKLIPR2024]; Fundamental Research Fund for the China Central Universities of USTB [FRF-BD-19-002A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fourth Batch of Chinese Manned Spaceflight Pre-research Foundation; Fund of State Key Laboratory of Intense Pulsed Radiation Simulation and Effect; Fundamental Research Fund for the China Central Universities of USTB	This work was supported by the National Natural Science Foundation of China under Grant 61975011, the Fourth Batch of Chinese Manned Spaceflight Pre-research Foundation under grant No. 020202, the Fund of State Key Laboratory of Intense Pulsed Radiation Simulation and Effect under Grant SKLIPR2024, and the Fundamental Research Fund for the China Central Universities of USTB under Grant FRF-BD-19-002A.	Ackland DC, 2012, J BIOMECH, V45, P1463, DOI 10.1016/j.jbiomech.2012.02.023; Al Harrach M, 2017, COMPUT BIOL MED, V83, P34, DOI 10.1016/j.compbiomed.2017.02.003; Choi C, 2010, MED ENG PHYS, V32, P429, DOI 10.1016/j.medengphy.2010.04.004; Chon KH, 2001, IEEE T BIO-MED ENG, V48, P622, DOI 10.1109/10.923780; Clancy EA, 1997, IEEE T BIO-MED ENG, V44, P1024, DOI 10.1109/10.634654; Clark DJ, 2010, J NEUROPHYSIOL, V103, P844, DOI 10.1152/jn.00825.2009; De Luca CJ, 2010, J BIOMECH, V43, P1573, DOI 10.1016/j.jbiomech.2010.01.027; Eklund JM, 2004, P ANN INT IEEE EMBS, V26, P695; Farrell TR, 2007, IEEE T NEUR SYS REH, V15, P111, DOI 10.1109/TNSRE.2007.891391; Fu AS, 2016, ACTA ASTRONAUT, V120, P260, DOI 10.1016/j.actaastro.2015.12.007; Hashemi J, 2010, IEEE ENG MED BIO, P1328, DOI 10.1109/IEMBS.2010.5626382; Holmes JW, 2006, ADV PHYSIOL EDUC, V30, P67, DOI 10.1152/advan.00072.2005; Hu XY, 2012, INT J WAVELETS MULTI, V10, DOI 10.1142/S0219691312500312; Huang NE, 1999, ANNU REV FLUID MECH, V31, P417, DOI 10.1146/annurev.fluid.31.1.417; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Huigen E, 2002, MED BIOL ENG COMPUT, V40, P332, DOI 10.1007/BF02344216; Jia RS, 2015, CHINESE J GEOPHYS-CH, V58, P1013, DOI 10.6038/cjg20150326; JUTTEN C, 1991, SIGNAL PROCESS, V24, P1, DOI 10.1016/0165-1684(91)90079-X; KORENBERG MJ, 1989, ANN BIOMED ENG, V17, P219, DOI 10.1007/BF02368043; KORENBERG MJ, 1989, BIOL CYBERN, V60, P267, DOI 10.1007/BF00204124; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Li YX, 2020, DEF TECHNOL, V16, P543, DOI 10.1016/j.dt.2019.07.020; Liu YZ, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0970-4; Mak JNF, 2010, MED ENG PHYS, V32, P840, DOI 10.1016/j.medengphy.2010.05.007; Mobasser F, 2007, IEEE T BIO-MED ENG, V54, P683, DOI 10.1109/TBME.2006.889190; Nagaraja MP, 2013, J CELL BIOCHEM, V114, P1001, DOI 10.1002/jcb.24454; Papagiannis Georgios I., 2019, Journal of Medical Engineering & Technology, V43, P59, DOI 10.1080/03091902.2019.1609610; Quinn Andrew J, 2021, J Open Source Softw, V6, DOI 10.21105/joss.02977; Rehman NU, 2011, IEEE T SIGNAL PROCES, V59, P2421, DOI 10.1109/TSP.2011.2106779; Rodrigues J, 2015, J NEUROSCI METH, V245, P73, DOI 10.1016/j.jneumeth.2015.02.013; Shafqat K, 2009, IEEE ENG MED BIO, P2244, DOI 10.1109/IEMBS.2009.5335000; Smith SM, 2014, ANNU REV NUTR, V34, P377, DOI 10.1146/annurev-nutr-071813-105440; Spector ER, 2009, AVIAT SPACE ENVIR MD, V80, pA23, DOI 10.3357/ASEM.BR02.2009; Staudenmann D, 2010, J ELECTROMYOGR KINES, V20, P375, DOI 10.1016/j.jelekin.2009.08.005; Wu ZH, 2004, P ROY SOC A-MATH PHY, V460, P1597, DOI 10.1098/rspa.2003.1221; Xiao M, 2010, J APPL BIOMECH, V26, P142, DOI 10.1123/jab.26.2.142; Xu L, 2013, IEEE T NEUR SYS REH, V21, P275, DOI 10.1109/TNSRE.2012.2219555; Yang J, 2007, IEEE T SYST MAN CY B, V37, P1015, DOI [10.1109/TSMCB.2006.891541, 10.1109/TSMCB.2007.891541]; Ye C, 2020, IEEE T BIO-MED ENG, V67, P482, DOI 10.1109/TBME.2019.2915762; Zhang X, 2013, MED ENG PHYS, V35, P537, DOI 10.1016/j.medengphy.2012.10.009	40	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272118	http://dx.doi.org/10.1371/journal.pone.0272118			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921380	gold, Green Published			2022-12-26	WOS:000839311900058
J	Xu, HL; Gao, JY; Portieles, R; Du, LH; Gao, XY; Borras-Hidalgo, O				Xu, Hongli; Gao, Jingyao; Portieles, Roxana; Du, Lihua; Gao, Xiangyou; Borras-Hidalgo, Orlando			Endophytic bacterium Bacillus aryabhattai induces novel transcriptomic changes to stimulate plant growth	PLOS ONE			English	Article							ARGININE DECARBOXYLASE; GENE-EXPRESSION; STRESS RESPONSES; AMINO-ACIDS; ROOT-GROWTH; PROMOTION; APYRASES; PROTEIN; TOMATO; L.	In nature, plants interact with a wide range of microorganisms, and most of these microorganisms could induce growth through the activation of important molecular pathways. The current study evaluated whether the endophytic bacterium Bacillus aryabhattai encourages plant growth and the transcriptional changes that might be implicated in this effect. The endophytic bacterium promotes the growth of Arabidopsis and tobacco plants. The transcriptional changes in Arabidopsis plants treated with the bacterium were also identified, and the results showed that various genes, such as cinnamyl alcohol dehydrogenase, apyrase, thioredoxin H8, benzaldehyde dehydrogenase, indoleacetaldoxime dehydratase, berberine bridge enzyme-like and gibberellin-regulated protein, were highly expressed. Also, endophytic bacterial genes, such as arginine decarboxylase, D-hydantoinase, ATP synthase gamma chain and 2-hydroxyhexa-2,4-dienoate hydratase, were activated during the interaction. These findings demonstrate that the expression of novel plant growth-related genes is induced by interaction with the endophytic bacterium B. aryabhattai and that these changes may promote plant growth in sustainable agriculture.	[Xu, Hongli; Gao, Jingyao; Portieles, Roxana; Du, Lihua; Gao, Xiangyou; Borras-Hidalgo, Orlando] Yotabio Engineering Co Ltd, Joint R&D Ctr Biotechnol, RETDA, Rizhao, Shandong, Peoples R China; [Borras-Hidalgo, Orlando] Qilu Univ Technol, Shandong Acad Sci, State Key Lab Biobased Mat & Green Papermaking, Shandong Prov Key Lab Microbial Engn, Jinan, Peoples R China	Qilu University of Technology	Borras-Hidalgo, O (corresponding author), Yotabio Engineering Co Ltd, Joint R&D Ctr Biotechnol, RETDA, Rizhao, Shandong, Peoples R China.; Borras-Hidalgo, O (corresponding author), Qilu Univ Technol, Shandong Acad Sci, State Key Lab Biobased Mat & Green Papermaking, Shandong Prov Key Lab Microbial Engn, Jinan, Peoples R China.	borrasorlando@yahoo.com		Borras-Hidalgo, Orlando/0000-0002-1424-2022	Special Funds for Guiding Local Science and Technology Development of Central Government of Shandong Province [YDZX20193700004362]	Special Funds for Guiding Local Science and Technology Development of Central Government of Shandong Province	This study was supported by the Special Funds for Guiding Local Science and Technology Development of Central Government of Shandong Province (No. YDZX20193700004362).	Afzal I, 2019, MICROBIOL RES, V221, P36, DOI 10.1016/j.micres.2019.02.001; ALKahtani MDF, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10091325; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; APELBAUM A, 1985, PLANT PHYSIOL, V79, P635, DOI 10.1104/pp.79.3.635; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashraf M, 2004, BIOL FERT SOILS, V40, P157, DOI 10.1007/s00374-004-0766-y; Azab E., 2016, J BIOL CHEM RES, V33, P130; Barnawal D, 2013, J PLANT GROWTH REGUL, V32, P809, DOI 10.1007/s00344-013-9347-3; BAZIRAMAKENGA R, 1994, J CHEM ECOL, V20, P2821, DOI 10.1007/BF02098391; Benavides-Mendoza A, 2012, ACTA HORTIC, V938, P251, DOI 10.17660/ActaHortic.2012.938.32; Boes N, 2006, J BACTERIOL, V188, P6529, DOI 10.1128/JB.00308-06; Bogamuwa S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151574; Chen WC, 2019, CURR GENET, V65, P591, DOI 10.1007/s00294-018-0909-6; Choudhary DK, 2011, BIOTECHNOL LETT, V33, P2287, DOI 10.1007/s10529-011-0699-0; Clark GB, 2014, PLANT SCI, V225, P107, DOI 10.1016/j.plantsci.2014.06.002; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dursun A, 2010, PAK J BOT, V42, P3349; Elkelish A, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9040431; Fouda A, 2021, PLANTS-BASEL, V10, DOI 10.3390/plants10010076; Gordes D, 2011, AMINO ACIDS, V40, P553, DOI 10.1007/s00726-010-0674-4; Gugger PF, 2017, TREE PHYSIOL, V37, P632, DOI 10.1093/treephys/tpw122; Habib N, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9020285; Hao YJ, 2005, J EXP BOT, V56, P1105, DOI 10.1093/jxb/eri102; Hardtke CS, 2003, CURR BIOL, V13, pR366, DOI 10.1016/S0960-9822(03)00279-3; Hassan SE, 2017, J ADV RES, V8, P687, DOI 10.1016/j.jare.2017.09.001; Hener C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041109; Hussain A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241130; Inomata N, 2018, CLIN EXP ALLERGY, V48, P1509, DOI 10.1111/cea.13247; Inthama P, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.604662; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P36, DOI 10.1007/s10142-005-0142-5; Jiang WQ, 2020, MOL BIOL REP, V47, P3885, DOI 10.1007/s11033-020-05477-5; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang SM, 2014, INDIAN J MICROBIOL, V54, P427, DOI 10.1007/s12088-014-0476-6; Ke J, 2021, TRENDS BIOTECHNOL, V39, P244, DOI 10.1016/j.tibtech.2020.07.008; Kilian M., 2000, Pflanzenschutz-Nachrichten Bayer, V53, P72; Kim YH, 2010, PLANT CELL REP, V29, P779, DOI 10.1007/s00299-010-0864-2; Kleinwechter U, 2016, AGR SYST, V145, P51, DOI 10.1016/j.agsy.2016.02.011; Kolukisaoglu U, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155421; Lappin SL, 2021, STATPEARLS INTERNET; Li CH, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3170-8; Liu X, 2012, PLANT PHYSIOL, V160, P1985, DOI 10.1104/pp.112.202887; Luo J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010259; Ma F, 2017, J EXP BOT, V68, P5829, DOI 10.1093/jxb/erx383; Mata-Perez C, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00122; Matsuura HN, 2014, BIOTECHNOL LETT, V36, P191, DOI 10.1007/s10529-013-1348-6; Maver M, 2021, PEERJ, V9, DOI 10.7717/peerj.12498; McNeil MB, 2014, FEBS LETT, V588, P414, DOI 10.1016/j.febslet.2013.12.019; Montanez A, 2009, BIOL FERT SOILS, V45, P253, DOI 10.1007/s00374-008-0322-2; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Okada K, 2015, PLANT CELL PHYSIOL, V56, P16, DOI 10.1093/pcp/pcu158; Piromyou P, 2011, EUR J SOIL BIOL, V47, P44, DOI 10.1016/j.ejsobi.2010.11.004; Portieles R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91837-5; Pourbabaee AA, 2016, J AGR SCI TECH-IRAN, V18, P855; Radhakrishnan R, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00667; Radhakrishnan R, 2016, PLANT PHYSIOL BIOCH, V109, P181, DOI 10.1016/j.plaphy.2016.09.018; Riewe D, 2008, PLANT PHYSIOL, V147, P1092, DOI 10.1104/pp.108.117564; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Serralta-Interian AA, 2020, THEOR EXP PLANT PHYS, V32, P31, DOI 10.1007/s40626-020-00165-y; Siebers M, 2016, BBA-MOL CELL BIOL L, V1861, P1379, DOI 10.1016/j.bbalip.2016.02.021; Soliman M, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8120562; Song SY, 2021, CURR OPIN PLANT BIOL, V62, DOI 10.1016/j.pbi.2021.102003; Sultana S, 2020, CAN J MICROBIOL, V66, P144, DOI 10.1139/cjm-2019-0323; Tominaga R, 2008, DEVELOPMENT, V135, P1335, DOI 10.1242/dev.017947; Vo KTX, 2015, J PLANT BIOL, V58, P271, DOI 10.1007/s12374-015-0228-0; Wada T, 2015, PLANT SCI, V241, P260, DOI 10.1016/j.plantsci.2015.10.015; Wang J, 2011, J EXP BOT, V62, P2899, DOI 10.1093/jxb/erq463; Wasternack C, 2014, BIOTECHNOL ADV, V32, P31, DOI 10.1016/j.biotechadv.2013.09.009; Wu J, 2007, PLANT PHYSIOL, V144, P961, DOI 10.1104/pp.107.097568; Wu SC, 2005, GEODERMA, V125, P155, DOI 10.1016/j.geoderma.2004.07.003; Xie SS, 2014, MOL PLANT MICROBE IN, V27, P655, DOI 10.1094/MPMI-01-14-0010-R; Xu GC, 2016, APPL BIOCHEM BIOTECH, V179, P1, DOI 10.1007/s12010-015-1975-6; Xu MS, 2014, WORLD J MICROB BIOT, V30, P835, DOI 10.1007/s11274-013-1486-y; Ye BZ, 2020, ACS OMEGA, V5, P3487, DOI 10.1021/acsomega.9b03789; Yuan XW, 2013, GENE, V523, P126, DOI 10.1016/j.gene.2013.03.122; Zhang DN, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.692313	78	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	8								10.1371/journal.pone.0272500	http://dx.doi.org/10.1371/journal.pone.0272500			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3S0RT	35921359	Green Published, gold, Green Submitted			2022-12-26	WOS:000839311900039
